PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhou, PZ; Polovitskaya, MM; Jentsch, TJ				Zhou, Pingzheng; Polovitskaya, Maya M.; Jentsch, Thomas J.			LRRC8 N termini influence pore properties and gating of volume-regulated anion channels (VRACs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; chloride channel; biophysics; electrophysiology; membrane transport; ICl; swell; ICl; vol; swelling-activated chloride channel; VSOAC; VSOR; amino-terminus; N-terminus	1ST EXTRACELLULAR LOOP; LEUCINE-RICH REPEAT; GAP-JUNCTION CHANNEL; CALHM ION CHANNELS; LINING RESIDUES; CHLORIDE CHANNELS; CELL-VOLUME; ESSENTIAL COMPONENT; CHARGE SELECTIVITY; MOLECULAR IDENTITY	Volume-regulated anion channels (VRACs) are crucial for cell volume regulation and have various roles in physiology and pathology. VRACs were recently discovered to be formed by heteromers of leucine-rich repeat-containing 8 (LRRC8) proteins. However, the structural determinants of VRAC permeation and gating remain largely unknown. We show here that the short stretch preceding the first LRRC8 transmembrane domain determines VRAC conductance, ion permeability, and inactivation gating. Substituted-cysteine accessibility studies revealed that several of the first 15 LRRC8 residues are functionally important and exposed to a hydrophilic environment. Substituting glutamate 6 with cysteine decreased the amplitudes of swelling-activated I-Cl,I-vol currents, strongly increased iodide-over-chloride permeability, and markedly shifted the voltage dependence of channel inactivation. Importantly, these effects were reversed by 2-sulfonatoethyl methanethiosulfonate, which restores the negative charge at this amino acid position. Cd2+-mediated blocking of I-Cl,I-vol in cysteine variants suggested that the LRRC8 N termini come close together in the multimeric channel complex and might form part of the pore. We propose a model in which the N termini of the LRRC8 subunits line the cytoplasmic portion of the VRAC pore, possibly by folding back into the ion permeation pathway.	[Zhou, Pingzheng; Polovitskaya, Maya M.; Jentsch, Thomas J.] Leibniz Forschungsinst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Zhou, Pingzheng; Polovitskaya, Maya M.; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Jentsch, Thomas J.] Charite, Neurocure Cluster Excellence, D-10117 Berlin, Germany; [Polovitskaya, Maya M.] Free Univ Berlin, Fac Biol Chem & Pharm, Grad Program, D-14195 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Jentsch, TJ (corresponding author), FMP MDC, Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de		Polovitskaya, Maya/0000-0002-8144-9824; Jentsch, Thomas/0000-0002-3509-2553	European Research Council [294435, 740537]; Deutsche Forschungsgemeinschaft [JE 164/12-1, SFB 740 TPC05]; NeuroCure Cluster of Excellence; Alexander von Humboldt Foundation	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NeuroCure Cluster of Excellence; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by European Research Council Advanced Grants 294435 "Cytovolion" and 740537 "Volsignal" and Deutsche Forschungsgemeinschaft Grants JE 164/12-1, SFB 740 TPC05, and NeuroCure Cluster of Excellence (to T.J.J.) and by a stipend from the Alexander von Humboldt Foundation (to P.Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Abascal F, 2012, BIOESSAYS, V34, P551, DOI 10.1002/bies.201100173; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Cahalan M D, 1988, Soc Gen Physiol Ser, V43, P281; Cheung M, 1996, BIOPHYS J, V70, P2688, DOI 10.1016/S0006-3495(96)79838-7; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; De Jesus-Perez JJ, 2016, J GEN PHYSIOL, V147, P25, DOI 10.1085/jgp.201511424; Deneka D, 2018, NATURE, V558, P254, DOI 10.1038/s41586-018-0134-y; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Fatehi M, 2009, J MEMBRANE BIOL, V228, P151, DOI 10.1007/s00232-009-9167-3; Gaitan-Penas H, 2016, BIOPHYS J, V111, P1429, DOI 10.1016/j.bpj.2016.08.030; Gradogna A, 2017, J PHYSIOL-LONDON, V595, P6719, DOI 10.1113/JP274795; HAZAMA A, 1988, J PHYSIOL-LONDON, V402, P687, DOI 10.1113/jphysiol.1988.sp017229; Hernandez-Carballo CY, 2010, PFLUG ARCH EUR J PHY, V460, P633, DOI 10.1007/s00424-010-0842-0; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; JACKSON PS, 1994, AM J PHYSIOL-CELL PH, V267, pC1203, DOI 10.1152/ajpcell.1994.267.5.C1203; Jentsch TJ, 2016, NAT REV MOL CELL BIO, V17, P293, DOI 10.1038/nrm.2016.29; Kang C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02664-0; Kronengold J, 2003, CELL COMMUN ADHES, V10, P193, DOI 10.1080/15419060390264325; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Krovetz HS, 1997, BIOPHYS J, V72, P117, DOI 10.1016/S0006-3495(97)78651-X; Kubota K, 2004, FEBS LETT, V564, P147, DOI 10.1016/S0014-5793(04)00332-1; Kumar L, 2014, J EXP MED, V211, P929, DOI 10.1084/jem.20131379; Lee CC, 2014, J BIOL CHEM, V289, P17124, DOI 10.1074/jbc.M114.571257; Linsdell Paul, 2015, BioMolecular Concepts, V6, P191, DOI 10.1515/bmc-2015-0013; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Lutter D, 2017, J CELL SCI, V130, P1122, DOI 10.1242/jcs.196253; Ma ZM, 2016, PFLUG ARCH EUR J PHY, V468, P395, DOI 10.1007/s00424-015-1757-6; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Nilius B, 2003, ACTA PHYSIOL SCAND, V177, P119, DOI 10.1046/j.1365-201X.2003.01060.x; Nilius B, 1997, PROG BIOPHYS MOL BIO, V68, P69, DOI 10.1016/S0079-6107(97)00021-7; Noskov SY, 2006, BIOPHYS CHEM, V124, P279, DOI 10.1016/j.bpc.2006.05.033; Oh S, 2008, J PHYSIOL-LONDON, V586, P2445, DOI 10.1113/jphysiol.2008.150805; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Okada Y, 2006, CONTRIB NEPHROL, V152, P9, DOI 10.1159/000096285; Oshima A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13681; Pedersen SF, 2015, ACTA PHYSIOL, V213, P868, DOI 10.1111/apha.12450; Pedersen SF, 2016, PFLUG ARCH EUR J PHY, V468, P371, DOI 10.1007/s00424-015-1781-6; Pfenniger A, 2011, EUR J CLIN INVEST, V41, P103, DOI 10.1111/j.1365-2362.2010.02378.x; Planells-Cases R, 2015, EMBO J, V34, P2993, DOI 10.15252/embj.201592409; Purnick PEM, 2000, BIOPHYS J, V79, P2403, DOI 10.1016/S0006-3495(00)76485-X; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Sabirov RZ, 2000, PFLUG ARCH EUR J PHY, V439, P315, DOI 10.1007/s004240050945; Schober AL, 2017, J PHYSIOL-LONDON, V595, P6939, DOI 10.1113/JP275053; Srinivas M, 2018, BBA-BIOMEMBRANES, V1860, P192, DOI 10.1016/j.bbamem.2017.04.024; Strange K, 1996, AM J PHYSIOL-CELL PH, V270, pC711, DOI 10.1152/ajpcell.1996.270.3.C711; Stuhlmann T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04353-y; Syeda R, 2016, CELL, V164, P499, DOI 10.1016/j.cell.2015.12.031; Tanis JE, 2017, AM J PHYSIOL-CELL PH, V313, pC173, DOI 10.1152/ajpcell.00318.2016; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Ullrich F, 2016, J BIOL CHEM, V291, P17040, DOI 10.1074/jbc.M116.739342; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Verselis VK, 2009, J BIOL CHEM, V284, P4484, DOI 10.1074/jbc.M807430200; Voets T, 1997, J GEN PHYSIOL, V110, P313, DOI 10.1085/jgp.110.3.313; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wang JJ, 2010, J GEN PHYSIOL, V136, P515, DOI 10.1085/jgp.201010440; Zhou XW, 1997, BIOPHYS J, V72, P1946, DOI 10.1016/S0006-3495(97)78840-4	59	19	19	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13440	13451		10.1074/jbc.RA118.002853	http://dx.doi.org/10.1074/jbc.RA118.002853			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29925591	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000443375500008
J	Yang, J; Park, KW; Cho, S				Yang, Jiwon; Park, Keun Woo; Cho, Sunghee			Inhibition of the CD36 receptor reduces visceral fat accumulation and improves insulin resistance in obese mice carrying the BDNF-Val66Met variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BDNF VAL66MET POLYMORPHISM; NEUROTROPHIC FACTOR VAL66MET; MICROVASCULAR COMPLICATIONS; GENETIC VARIANT; ASIAN-AMERICANS; INFLAMMATION; EXPRESSION; ASSOCIATION; MACROPHAGE; ATHEROSCLEROSIS	Obesity-induced metabolic dysfunctions increase the risk for vascular diseases, including type II diabetes and stroke. Managing obesity is of interest to address the worldwide health problem; however, the role of genetic variability in human obesity development and specific targets for obesity-related metabolic disease have not been thoroughly studied. A SNP in the brain-derived neurotropic factor (BDNF) gene that results in the substitution of a valine with a methionine at codon 66 (Val66Met) occurs with a high frequency in humans. This study addressed the effect of genetic variability in developing obesity and the efficacy of the inhibition of cluster of differentiation 36 (CD36), a multifunctional receptor implicated in obesity and insulin resistance, in WT mice and mice with the BDNF Val66Met variant. CD36 inhibition by salvionolic acid B (SAB) in diet-induced obese WT mice reduced visceral fat accumulation and improved insulin resistance. The benefit of SAB was abrogated in CD36 knockout mice, showing the specificity of SAB. In addition, mice with the Val66Met variant in both alleles (BDNFM/M) fed a high-fat diet exhibited extreme obesity with increased CD36 gene and protein levels in macrophages. Chronic SAB treatment in BDNFM/M mice significantly decreased visceral fat accumulation and improved insulin resistance. Notably, the effect of SAB was greater in the extremely obese BDNFM/M mice compared with the WT mice. The study demonstrated a link between BDNF Val66Met and elevated CD36 expression and suggested that CD36 inhibition may be a potential strategy to improve metabolic dysfunctions and to normalize risk factors for vascular diseases in the obese population.	[Yang, Jiwon; Park, Keun Woo; Cho, Sunghee] Burke Med Res Inst, White Plains, NY 10605 USA; [Cho, Sunghee] Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA	Cornell University	Cho, S (corresponding author), Burke Med Res Inst, Weill Cornell Med, Feil Family Brain & Mind Res Inst, 785 Mamaroneck Ave, White Plains, NY 10605 USA.	suc2002@med.cornell.edu			NHLBI NIH HHS [R01 HL082511] Funding Source: Medline; NINDS NIH HHS [R01 NS095359, R01 NS077897] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS095359, R01NS077897] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alkhatatbeh MJ, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.1; Bao Y, 2012, ATHEROSCLEROSIS, V223, P152, DOI 10.1016/j.atherosclerosis.2012.05.006; Beckers S, 2008, MOL GENET METAB, V95, P110, DOI 10.1016/j.ymgme.2008.06.008; Castro AVB, 2014, ARQ BRAS ENDOCRINOL, V58, P600, DOI 10.1590/0004-2730000003223; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Finfer S, 2015, INTENS CARE MED, V41, P1037, DOI 10.1007/s00134-015-3757-6; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; GREENWALT DE, 1995, J CLIN INVEST, V96, P1382, DOI 10.1172/JCI118173; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; Handberg A, 2010, J CLIN ENDOCR METAB, V95, P1939, DOI 10.1210/jc.2009-2002; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hsu WC, 2015, DIABETES CARE, V38, P150, DOI 10.2337/dc14-2391; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; King GL, 2012, DIABETES CARE, V35, P1181, DOI 10.2337/dc12-0210; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Martin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024014; Mou ZY, 2015, CELL REP, V13, P1073, DOI 10.1016/j.celrep.2015.09.065; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nakagami T, 2003, DIABETOLOGIA, V46, P1063, DOI 10.1007/s00125-003-1158-9; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Peng JH, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-016-0393-0; Pentti K, 2009, EUR J ENDOCRINOL, V160, P979, DOI 10.1530/EJE-09-0151; Pivac N, 2009, CROAT MED J, V50, P43, DOI 10.3325/cmj.2009.50.43; Poirier H, 1996, EUR J BIOCHEM, V238, P368, DOI 10.1111/j.1432-1033.1996.0368z.x; Qin LY, 2014, J NEUROSCI, V34, P2493, DOI 10.1523/JNEUROSCI.4140-13.2014; Qin LY, 2011, J NEUROSCI, V31, P775, DOI 10.1523/JNEUROSCI.4547-10.2011; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Sampson MJ, 2003, ATHEROSCLEROSIS, V167, P129, DOI 10.1016/S0021-9150(02)00421-5; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Skledar M, 2012, PROG NEURO-PSYCHOPH, V36, P136, DOI 10.1016/j.pnpbp.2011.08.003; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Szmuilowicz ED, 2009, NAT REV ENDOCRINOL, V5, P553, DOI 10.1038/nrendo.2009.166; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vanesvki F, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00037; Vroegrijk IOCM, 2013, OBESITY, V21, P2037, DOI 10.1002/oby.20354; Wang L, 2010, J BIOMOL SCREEN, V15, P239, DOI 10.1177/1087057109359686; Woo MS, 2016, J BIOL CHEM, V291, P23654, DOI 10.1074/jbc.M116.750018; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	49	23	24	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13338	13348		10.1074/jbc.RA118.002405	http://dx.doi.org/10.1074/jbc.RA118.002405			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29914985	Green Published, hybrid			2022-12-26	WOS:000442730200030
J	Li, JZ; Fu, XQ; Cao, SB; Li, J; Xing, S; Li, DY; Dong, Y; Cardin, D; Park, HW; Mauvais-Jarvis, F; Zhang, HT				Li, Jianzhuo; Fu, Xueqi; Cao, Subing; Li, Jing; Xing, Shu; Li, Dongying; Dong, Yan; Cardin, Derrick; Park, Hee-Won; Mauvais-Jarvis, Franck; Zhang, Haitao			Membrane-associated androgen receptor (AR) potentiates its transcriptional activities by activating heat shock protein 27 (HSP27)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						androgen receptor; microtubule; plasma membrane; kinesin; heat shock protein (HSP); HSP27; KIF5B; prostate cancer; steroid hormone receptor; type I nuclear receptor	PROSTATE-CANCER CELLS; NON-GENOMIC ACTIONS; STEROID-HORMONES; LIPID RAFTS; MICRODOMAINS; TRANSPORT; SURVIVAL; VARIANT; DYNEIN; MODEL	The androgen receptor (AR) is a ligand-activated nuclear receptor that plays a critical role in normal prostate physiology, as well as in the development and progression of prostate cancer. In addition to the classical paradigm in which AR exerts its biological effects in the nucleus by orchestrating the expression of the androgen-regulated transcriptome, there is considerable evidence supporting a rapid, nongenomic activity mediated by membrane-associated AR. Although the genomic action of AR has been studied in depth, the molecular events governing AR transport to the plasma membrane and the downstream AR signaling cascades remain poorly understood. In this study, we report that AR membrane transport is microtubule-dependent. Disruption of the function of kinesin 5B (KIF5B), but not of kinesin C3 (KIFC3), interfered with AR membrane association and signaling. Co-immunoprecipitation and pulldown assays revealed that AR physically interacts with KIF5B and that androgen enhances this interaction. Furthermore, we show that heat shock protein 27 (HSP27) is activated by membrane-associated AR and that HSP27 plays an important role in mediating AR-mediated membrane-to-nuclear signal transduction. Together, these results indicate that AR membrane translocation is mediated by the microtubule cytoskeleton and the motor protein KIF5B. By activating HSP27, membrane-associated AR potentiates the transcriptional activity of nuclear AR. We conclude that disruption of AR membrane translocation may represent a potential strategy for targeting AR signaling therapeutically in prostate cancer.	[Li, Jianzhuo; Fu, Xueqi; Xing, Shu] Jilin Univ, Sch Life Sci, Changchun 130012, Jilin, Peoples R China; [Li, Jing] Jilin Univ, Sch Med, Changchun 130012, Jilin, Peoples R China; [Li, Jianzhuo; Li, Dongying; Cardin, Derrick; Zhang, Haitao] Tulane Univ, Sch Med, Dept Pathol & Lab Med, New Orleans, LA 70112 USA; [Cao, Subing; Dong, Yan] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, New Orleans, LA 70112 USA; [Park, Hee-Won] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Mauvais-Jarvis, Franck] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Li, Jianzhuo; Cao, Subing; Li, Dongying; Dong, Yan; Cardin, Derrick; Zhang, Haitao] Tulane Univ, Sch Med, Tulane Canc Ctr, New Orleans, LA 70112 USA; [Mauvais-Jarvis, Franck] Southeast Louisiana Vet Hlth Care Syst, New Orleans, LA 70119 USA; [Li, Dongying] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA	Jilin University; Jilin University; Tulane University; Tulane University; Tulane University; Tulane University; Tulane University; US Food & Drug Administration (FDA)	Zhang, HT (corresponding author), 1430 Tulane Ave, New Orleans, LA 70112 USA.	hzhang@tulane.edu	Li, Dongying/AAB-9232-2019	Li, Dongying/0000-0003-0721-2500; Dong, Yan/0000-0003-1622-5354	American Cancer Society [RSG-14-016-01-CCE, DOD W81XWH-12-1-0275, W81XWH-14-1-0480]; Louisiana Cancer Research Consortium Fund; Tulane University Carol Lavin Bernick Faculty Grants; National Institutes of Health [R01 DK074970, DK107444]; Department of Veterans Affairs Merit Review Award [BX003725]; NATIONAL CANCER INSTITUTE [R01CA188609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074970, R01DK107444] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003725] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Louisiana Cancer Research Consortium Fund; Tulane University Carol Lavin Bernick Faculty Grants; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by American Cancer Society Grants RSG-14-016-01-CCE, DOD W81XWH-12-1-0275, and W81XWH-14-1-0480; Louisiana Cancer Research Consortium Fund; and the Tulane University Carol Lavin Bernick Faculty Grants (to H. Z.). This work was also supported by National Institutes of Health Grants R01 DK074970 and DK107444 (to F.M.-J.) and Department of Veterans Affairs Merit Review Award BX003725. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahrens-Fath I, 2005, FEBS J, V272, P74, DOI 10.1111/j.1432-1033.2004.04395.x; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Cinar B, 2007, J BIOL CHEM, V282, P29584, DOI 10.1074/jbc.M703310200; Deng Q, 2017, CELL PHYSIOL BIOCHEM, V43, P223, DOI 10.1159/000480343; Deng Q, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/3985916; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; Garza-Contreras J, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0109-17.2017; Gelfand VI, 2001, METH MOL B, V164, P191; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Harrell JM, 2004, J BIOL CHEM, V279, P54647, DOI 10.1074/jbc.M406863200; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Jovcevski B, 2015, CHEM BIOL, V22, P186, DOI 10.1016/j.chembiol.2015.01.001; Katsogiannou M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00346; Konda JD, 2017, MOL ONCOL, V11, P599, DOI 10.1002/1878-0261.12042; Lu ML, 2001, J BIOL CHEM, V276, P13442, DOI 10.1074/jbc.M006598200; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Moreno-Altamirano MMB, 2007, IMMUNOLOGY, V120, P536, DOI 10.1111/j.1365-2567.2006.02531.x; Navarro G, 2016, CELL METAB, V23, P837, DOI 10.1016/j.cmet.2016.03.015; Nishiyama T, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2013.03.007; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; Notini AJ, 2005, J MOL ENDOCRINOL, V35, P547, DOI 10.1677/jme.1.01884; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Robitaille H, 2010, J INVEST DERMATOL, V130, P74, DOI 10.1038/jid.2009.185; Schmidt MR, 2009, P NATL ACAD SCI USA, V106, P15344, DOI 10.1073/pnas.0904268106; Simoncini T, 2003, EUR J ENDOCRINOL, V148, P281, DOI 10.1530/eje.0.1480281; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Tan MHE, 2015, ACTA PHARMACOL SIN, V36, P3, DOI 10.1038/aps.2014.18; Thadani-Mulero M, 2012, CANCER RES, V72, P4611, DOI 10.1158/0008-5472.CAN-12-0783; Voll EA, 2014, ONCOTARGET, V5, P2648, DOI 10.18632/oncotarget.1917; Yang X, 2011, J BIOL CHEM, V286, P36152, DOI 10.1074/jbc.M111.265124; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Zarif JC, 2015, ONCOTARGET, V6, P6862, DOI 10.18632/oncotarget.3119; Zhang GY, 2015, ONCOTARGET, V6, P23358, DOI 10.18632/oncotarget.4396; Zhuang LY, 2002, CANCER RES, V62, P2227; Zoubeidi A, 2007, CANCER RES, V67, P10455, DOI 10.1158/0008-5472.CAN-07-2057	41	13	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12719	12729		10.1074/jbc.RA118.003075	http://dx.doi.org/10.1074/jbc.RA118.003075			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29934310	Green Published, hybrid			2022-12-26	WOS:000442203500006
J	da Silva, WR; Campos, JADB; Maroco, J				da Silva, Wanderson Roberto; Duarte Bonini Campos, Juliana Alvares; Maroco, Joao			Impact of inherent aspects of body image, eating behavior and perceived health competence on quality of life of university students	PLOS ONE			English	Article							SHAPE QUESTIONNAIRE; MASS INDEX; VALIDATION; VARIABLES	The aim of this study was to assess the impact of inherent aspects of body image, eating behavior and perceived health competence on quality of life of university students. Participants completed the instruments Body Shape Questionnaire (reduced version, BSQ-8B), Male Body Dissatisfaction Scale (reduced version, MBDS-R), Three-Factor Eating Questionnaire (reduced version, TFEQ-18), Perceived Health Competence Scale (bifactorial version, PHCS-B), World Health Organization Quality of Life Questionnaire-Short Form (WHOQoL-bref) and a questionnaire for characterization of sample. Psychometric properties of instruments were previously evaluated by confirmatory factor analysis. A hypothetical model for each sex was developed and tested. In both model surveys the aspects of the body image (BSQ-8B: body shape concern; MBDS-R: musculature and general body appearance), of eating behavior (TFEQ-18: cognitive restriction, emotional eating, and uncontrolled eating) and of the perceived health competence (PHCS-B: expectations of achieving the desired health results and competence in health behaviors) were used as direct predictors on quality of life (WHOQoL-bref). The variables age, medication use for body change, food supplement use for body change, and body mass index (BMI) were inserted in the aspects of the body image. The variables course shift, initial expectation regarding the course, self-reported performance in the course, concomitant work activities to studies, and economic class were inserted into the quality of life. The model surveys were evaluated using structural equation modeling. A level of significance of 5% was used. A total of 2,198 university students (female = 63.5%), including 1,151 Brazilians and 1,047 Portuguese, participated of study (locally representative samples). The average age of women was 20.8 +/- 2.4 years and of men was 21.3 +/- 3.3 years. The psychometric properties of the instruments were adequate, except for the PHCS, which was adjusted for each sex. The models presented variance explained of 54% and 49% for women and men, respectively. In both sexes, the students' perceived health competence and academic variables contributed significantly to their quality of life, and age, BMI, and medication and supplement use were significant factors relating to how a student views his or her body image. Women's quality of life was associated with body shape concern and emotional eating aspects. Men's quality of life was associated with general body appearance and cognitive restriction aspects. These results can be used to create and implement educational programs to improve quality of life of university students.	[da Silva, Wanderson Roberto; Duarte Bonini Campos, Juliana Alvares] Sao Paulo State Univ UNESP, Dept Food & Nutr Sch Pharmaceut Sci, Araraquara, SP, Brazil; [Maroco, Joao] Univ Inst Psychol Social & Life Sci ISPA, WJCR, Lisbon, Portugal	Universidade Estadual Paulista	Maroco, J (corresponding author), Univ Inst Psychol Social & Life Sci ISPA, WJCR, Lisbon, Portugal.	jpmaroco@ispa.pt	Campos, Juliana Alvares Duarte Bonini/AAD-6383-2020; Marôco, João/H-3622-2019; Marôco, João P./A-5729-2010; Silva, Wanderson R/J-9022-2017	Campos, Juliana Alvares Duarte Bonini/0000-0001-7123-5585; Marôco, João/0000-0001-9214-5378; Marôco, João P./0000-0001-9214-5378; Silva, Wanderson R/0000-0001-8897-8772	Sao Paulo Research Foundation (FAPESP) [2014/03093-2, 2015/00228-7]; National Council for Scientific and Technological Development (CNPq) [142315/2014-1]; Coordination for the Improvement of Higher Education Personnel (CAPES); William James Center for Research (WJCR)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); William James Center for Research (WJCR)	The authors thank to Sao Paulo Research Foundation (FAPESP; grants #2014/03093-2, #2015/00228-7; http://www.fapesp.br; to WRdS), National Council for Scientific and Technological Development (CNPq; grant #142315/2014-1; http://www.cnpq.br; to WRdS), Coordination for the Improvement of Higher Education Personnel (CAPES, to WRdS), and William James Center for Research (WJCR; http://wjcr.ispa.pt; to JM) by the financial resources provided to carry out this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angle S, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-41; [Anonymous], 2000, WHO TECHN REP SER; Arora NK, 2002, PATIENT EDUC COUNS, V47, P37, DOI 10.1016/S0738-3991(01)00170-7; Associacao Brasileira de Empresas de Pesquisa (ABEP), 2015, BRAZ EC CLASS CRIT; Bailly N, 2012, APPETITE, V59, P853, DOI 10.1016/j.appet.2012.08.029; de Carvalho PHB, 2013, CAD SAUDE PUBLICA, V29, P403, DOI [10.1590/S0102-311X2013000200027, 10.1590/S0102-311X2013000600027]; Cash T.F., 2011, BODY IMAGE HDB SCI P, P471; Cash T.F., 2011, BODY IMAGE HDB SCI P, P129; COOPER PJ, 1987, INT J EAT DISORDER, V6, P485, DOI 10.1002/1098-108X(198707)6:4<485::AID-EAT2260060405>3.0.CO;2-O; Cox TL, 2011, J WOMENS HEALTH, V20, P1573, DOI 10.1089/jwh.2010.2637; Cox TL, 2010, SOC INDIC RES, V99, P531, DOI 10.1007/s11205-010-9602-y; da Silva WR, 2017, EAT WEIGHT DISORD-ST, V22, P515, DOI 10.1007/s40519-017-0420-y; da Silva WR, 2014, BODY IMAGE, V11, P384, DOI 10.1016/j.bodyim.2014.06.001; Dakanalis A, 2015, J PSYCHOL, V149, P85, DOI 10.1080/00223980.2013.842141; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dempster Martin, 2008, Psychol Health Med, V13, P123, DOI 10.1080/13548500701351984; EVANS C, 1993, INT J EAT DISORDER, V13, P315, DOI 10.1002/1098-108X(199304)13:3&lt;315::AID-EAT2260130310&gt;3.0.CO;2-3; Fayers P., 2007, QUALITY LIFE ASSESSM; Fleck Marcelo Pio de Almeida, 1999, Revista Brasileira de Psiquiatria, V21, P19; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Fu TST, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-37; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hildebrandt T, 2012, PSYCHOL ADDICT BEHAV, V26, P955, DOI 10.1037/a0027877; Jauregui-Lobera I, 2014, NUTRIENTS, V6, P5619, DOI 10.3390/nu6125619; Karlsson J, 2000, INT J OBESITY, V24, P1415; Kim Mi Joung, 2008, Nutr Res Pract, V2, P107, DOI 10.4162/nrp.2008.2.2.107; Kolodziejczyk JK, 2015, QUAL LIFE RES, V24, P251, DOI 10.1007/s11136-014-0745-1; Maroco J, 2014, ANALISE EQUACAES EST; McCabe SE, 2014, ADDICT BEHAV, V39, P1176, DOI 10.1016/j.addbeh.2014.03.008; Ochner CN, 2009, EAT BEHAV, V10, P197, DOI 10.1016/j.eatbeh.2009.06.002; Poinhos R, 2013, APPETITE, V71, P314, DOI 10.1016/j.appet.2013.08.024; Polchert MJ, 2015, OPEN J NURS, V05, P632; Quick VM, 2013, AM J PUBLIC HEALTH, V103, P508, DOI 10.2105/AJPH.2012.300898; Ribeiro Patrícia Russo Leite, 2012, Psico-USF, V17, P379; Rueda B, 2006, J HEALTH PSYCHOL, V11, P129, DOI 10.1177/1359105306058868; Salyer J, 2003, J HEART LUNG TRANSPL, V22, P309, DOI 10.1016/S1053-2498(02)00552-1; Sanftner JL, 2011, EAT BEHAV, V12, P136, DOI 10.1016/j.eatbeh.2011.01.003; Santana MS, 2016, CONTRIBUICAO INSATIS, P104; Shareef MA, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0476-1; Silva WR, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00133715; Silva WR, 2016, INT J RECENT SCI RES, V7, P13383; Silva WR, 2018, TRENDS PSYCHIATRY PS; SMITH MS, 1995, HEALTH EDUC RES, V10, P51, DOI 10.1093/her/10.1.51; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Togari T., 2004, J HLTH HUMAN ECOLOGY, V70, P184; Valladares M, 2016, J AM COLL NUTR, V35, P699, DOI 10.1080/07315724.2016.1157526; Yager Z, 2014, SPORTS NUTR REV J, V11, P1; Yoshitake Naomi, 2015, Health Psychol Open, V2, p2055102915598089, DOI 10.1177/2055102915598089	49	14	16	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199480	10.1371/journal.pone.0199480	http://dx.doi.org/10.1371/journal.pone.0199480			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK3VI	29933390	Green Submitted, Green Published, gold			2022-12-26	WOS:000436076600027
J	Ejnisman, L; Domb, BG; Souza, F; Junqueira, C; Vicente, JRN; Croci, AT				Ejnisman, Leandro; Domb, Benjamin G.; Souza, Felipe; Junqueira, Consuelo; Negreiros Vicente, Jose Ricardo; Croci, Alberto Tesconi			Are femoroacetabular impingement tomographic angles associated with the histological assessment of labral tears? A cadaveric study	PLOS ONE			English	Article							CENTER-EDGE ANGLE; ACETABULAR CARTILAGE; ASYMPTOMATIC VOLUNTEERS; CAM IMPINGEMENT; HIP; PREVALENCE; MORPHOLOGY; ALPHA; OSTEOARTHRITIS; MANAGEMENT	Purpose This study sought to investigate the association between tomographic femoroacetabular impingement (FAI) angles and histologically evaluated labral tears. The authors hypothesized that cadavers presenting with cam and pincer morphologies would present a higher prevalence of acetabular labral tears. Methods Twenty fresh cadavers were submitted to computed tomography. Standard FAI angles were measured, including the alpha angle, femoral version, acetabular version, Tonnis angle and center-edge angle. A cam lesion was defined as an alpha angle greater than 50 degrees. A pincer lesion was defined as a center-edge angle greater than 40 degrees, a Tonnis angle less than 0 degrees or acetabular version less than 0 degrees. After dissection, three fragments of each acetabulum, corresponding to the antero-superior, superior and postero-superior acetabular rim, were obtained. These fragments were submitted to routine histological preparation. Each slide was evaluated for possible labral tears. Tears were classified according to their Seldes type. Results The mean age of the cadavers was 50.2 years (SD: 7.4; 13 males). Sixteen (80%) of the cadavers had a cam lesion, and eight cadavers (40%) had a pincer lesion. Histologically, 16 (80%) of the cadavers had a labral tear in at least one region. According to the Seldes classification, 60.7% and 28.6% of these labral tears were type 1 and type 2, respectively. A mixed type of labral tear (10.7%), which represented a new form of Seldes tear, was described. Cadavers with a labral tear had significantly higher alpha angles than other cadavers (53.29 degrees vs 49.33 degrees, p = 0.01). Pincer lesions were not associated with labral tears. We found no association between pincer or cam lesions and Seldes classification. Conclusion Cadavers presenting with higher alpha angles had a higher incidence of labral tears. No association was found between FAI and Seldes classification. Clinical relevance This study demonstrated a high prevalence of FAI abnormalities associated with histological alterations in a cadaveric sample. Joint damage may be present in the early stages of FAI.	[Ejnisman, Leandro; Souza, Felipe; Junqueira, Consuelo; Negreiros Vicente, Jose Ricardo; Croci, Alberto Tesconi] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Ortopedia & Traumatol, Sao Paulo, Brazil; [Domb, Benjamin G.] Amer Hip Inst, Westmont, IL USA; [Domb, Benjamin G.] Hinsdale Orthoped, Westmont, IL USA	Universidade de Sao Paulo	Ejnisman, L (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Ortopedia & Traumatol, Sao Paulo, Brazil.	leandro.ejnisman@gmail.com	Croci, Alberto T/D-2412-2015	Ejnisman, Leandro/0000-0002-9866-1960; croci, alberto tesconi/0000-0003-3047-2757				Audenaert EA, 2012, ARTHROSCOPY, V28, P1784, DOI 10.1016/j.arthro.2012.06.012; Beaule PE, 2012, CLIN ORTHOP RELAT R, V470, P3361, DOI 10.1007/s11999-012-2601-3; Beck M, 2005, J BONE JOINT SURG BR, V87B, P1012, DOI 10.1302/0301-620X.87B7.15203; Bedi A, 2011, ARTHROSCOPY, V27, P1720, DOI 10.1016/j.arthro.2011.08.288; Clohisy JC, 2008, J BONE JOINT SURG AM, V90A, P47, DOI 10.2106/JBJS.H.00756; Dandachli W, 2011, SKELETAL RADIOL, V40, P877, DOI 10.1007/s00256-010-1065-3; Dolan MM, 2011, CLIN ORTHOP RELAT R, V469, P831, DOI 10.1007/s11999-010-1539-6; Domb Benjamin G, 2011, HSS J, V7, P145, DOI 10.1007/s11420-011-9198-z; Elias-Jones CJ, 2015, AM J SPORT MED, V43, P1875, DOI 10.1177/0363546515588176; Frank JM, 2015, ARTHROSCOPY, V31, P1199, DOI 10.1016/j.arthro.2014.11.042; Ganz R, 2003, CLIN ORTHOP RELAT R, P112, DOI 10.1097/01.blo.0000096804.78689.c2; Griffin DR, 2016, BRIT J SPORT MED, V50, P1169, DOI 10.1136/bjsports-2016-096743; Hack K, 2010, J BONE JOINT SURG AM, V92A, P2436, DOI 10.2106/JBJS.J.01280; Hashimoto S, 2013, J BONE JOINT SURG AM, V95A, P1457, DOI 10.2106/JBJS.L.00497; Ito K, 2004, CLIN ORTHOP RELAT R, P262, DOI 10.1097/01.blo.0000144861.11193.17; Johnston TL, 2008, ARTHROSCOPY, V24, P669, DOI 10.1016/j.arthro.2008.01.010; Kohl S, 2011, HIP INT, V21, P154, DOI 10.5301/HIP.2011.6515; Kutty S, 2012, INT ORTHOP, V36, P505, DOI 10.1007/s00264-011-1302-y; Monazzam S, 2013, BONE JOINT J, V95B, P598, DOI 10.1302/0301-620X.95B5.30118; Monazzam S, 2013, CLIN ORTHOP RELAT R, V471, P2233, DOI 10.1007/s11999-012-2651-6; Nepple JJ, 2013, J AM ACAD ORTHOP SUR, V21, pS20, DOI 10.5435/JAAOS-21-07-S20; Notzli HP, 2002, J BONE JOINT SURG BR, V84B, P556, DOI 10.1302/0301-620X.84B4.12014; Pfirrmann CWA, 2006, RADIOLOGY, V240, P778, DOI 10.1148/radiol.2403050767; Philippon MJ, 2007, AM J SPORT MED, V35, P1571, DOI 10.1177/0363546507300258; Pollard TCB, 2010, ACTA ORTHOP, V81, P134, DOI 10.3109/17453671003619011; Rakhra KS, 2009, CLIN ORTHOP RELAT R, V467, P660, DOI 10.1007/s11999-008-0627-3; Register B, 2012, AM J SPORT MED, V40, P2720, DOI 10.1177/0363546512462124; Seldes RM, 2001, CLIN ORTHOP RELAT R, P232; Siebenrock KA, 2004, CLIN ORTHOP RELAT R, P54; Siebenrock KA, 2003, J BONE JOINT SURG AM, V85A, P278, DOI 10.2106/00004623-200302000-00015; Tannast M, 2007, AM J ROENTGENOL, V188, P1540, DOI 10.2214/AJR.06.0921; Tomczak RJ, 1997, AM J ROENTGENOL, V168, P791, DOI 10.2214/ajr.168.3.9057536; Vawklang Navaphan, 2012, J Med Assoc Thai, V95 Suppl 9, pS104	33	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199352	10.1371/journal.pone.0199352	http://dx.doi.org/10.1371/journal.pone.0199352			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928035	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500077
J	Mehta, R; Shaw, G; Masschelin, P; Felix, S; Otgonsuren, M; Baranova, A; Goodman, Z; Younossi, Z				Mehta, Rohini; Shaw, Gladys; Masschelin, Peter; Felix, Sean; Otgonsuren, Munkzhul; Baranova, Ancha; Goodman, Zachary; Younossi, Zobair			Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH)	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INFLAMMATORY RESPONSE; DIABETIC-RETINOPATHY; NATURAL-HISTORY; SOLUBLE FORM; CANCER-RISK; GLYCOSYLATION; ENDPRODUCTS; ASSOCIATION; COMPLICATIONS	Non-alcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome and major cause of chronic liver disease in developed countries. Its prevalence is increasing in parallel with the prevalence of obesity and other components of the metabolic syndrome. As the liver is central to the clearance and catabolism of circulating advanced glycosylation end-products (AGEs), AGEs and their cognate receptors RAGE (receptor for AGEs) system might be involved in NAFLD in obese patients. To examine this, we investigated four common polymorphisms of RAGE gene: 1704G/T (rs184003), G82S (rs2070600), -374T/A (rs1800624) and -429T/C (rs1800625) in 340 obese patients with metabolic syndrome. and protein levels of AGE and RAGE. This is the first study to describe association of 4 common polymorphisms with non-alcoholic steatohepatitis (NASH) as well as to examine protein levels of RAGE and AGE. Univariate analysis showed patients carrying the rs1800624 heterozygote genotype (AT) exhibited 2.36-fold increased risk of NASH (odds ratio (OR) = 2.36; 95% confidence interval (95% CI): 1.35-4.19) after adjusting for confounders. The minor allele -374 A has been shown to suppress the expression of RAGE protein. The protein levels of esRAGE, total sRAGE and AGE protein levels did not correlate with each other in obese patients with no liver disease, indicative of RAGE signaling playing an independent role in liver injury. In obese patients with non-NASH NAFLD and NASH respectively, esRAGE protein showed strong positive correlation with total sRAGE protein. Further, haplotype analysis of the 4 SNPs, indicated that haplotype G-A-T-G was significantly associated with 2-fold increased risk for NASH (OR = 2.08; 95% CI: 1.21-3.5; P = 0.006) after adjusting for confounders. In conclusion, the presented data indicate that the G-A-T-G haplotype containing minor allele at position -374 A and major allele at position -429T, 1704G, and G82S G could be regarded as a marker for NASH.	[Mehta, Rohini; Felix, Sean; Otgonsuren, Munkzhul; Younossi, Zobair] Betty & Guy Beatty Ctr Integrated Res, Inova Fairfax Med Campus, Falls Church, VA 22042 USA; [Shaw, Gladys; Masschelin, Peter; Baranova, Ancha] George Mason Univ, Ctr Study Chron Metab Dis, Fairfax, VA 22030 USA; [Goodman, Zachary; Younossi, Zobair] Inova Fairfax Hosp, Ctr Liver Dis, Dept Med, Falls Church, VA 22042 USA	Inova Fairfax Hospital; George Mason University; Inova Fairfax Hospital	Younossi, Z (corresponding author), Betty & Guy Beatty Ctr Integrated Res, Inova Fairfax Med Campus, Falls Church, VA 22042 USA.; Younossi, Z (corresponding author), Inova Fairfax Hosp, Ctr Liver Dis, Dept Med, Falls Church, VA 22042 USA.	Zobair.younossi@inova.org	Baranova, Anna/HGB-3721-2022; , Ancha/B-4608-2012	, Ancha/0000-0001-6810-5982; Shaw, Gladys/0000-0003-4270-8157; Masschelin, Peter/0000-0002-5236-9462	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM090084] Funding Source: NIH RePORTER; NIGMS NIH HHS [R25 GM090084] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bellentani S, 2017, LIVER INT, V37, P81, DOI 10.1111/liv.13299; Cai W, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/310237; Cataldegirmen G, 2005, J EXP MED, V201, P473, DOI 10.1084/jem.20040934; Chavakis T, 2004, MICROBES INFECT, V6, P1219, DOI 10.1016/j.micinf.2004.08.004; Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540; Goh GBB, 2016, DIGEST DIS SCI, V61, P1226, DOI 10.1007/s10620-016-4095-4; Goodwin M, 2013, J GASTROEN HEPATOL, V28, P369, DOI 10.1111/jgh.12042; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hudson BI, 2001, DIABETES, V50, P1505, DOI 10.2337/diabetes.50.6.1505; Hyogo H, 2008, CURR PHARM DESIGN, V14, P969, DOI 10.2174/138161208784139701; Kalea AZ, 2009, CLIN SCI, V116, P621, DOI 10.1042/CS20080494; Kang PP, 2012, GENE, V500, P1, DOI 10.1016/j.gene.2012.03.056; Kankova K, 2005, NEPHROL DIAL TRANSPL, V20, P1093, DOI 10.1093/ndt/gfh711; Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721; Krechler T, 2010, CLIN BIOCHEM, V43, P882, DOI 10.1016/j.clinbiochem.2010.04.004; Leung C, 2016, WORLD J GASTROENTERO, V22, P8026, DOI 10.3748/wjg.v22.i35.8026; Li TJ, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0391-0; Mulrennan S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08931; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Neuschwander-Tetri BA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0806-8; Osawa M, 2007, BBA-GEN SUBJECTS, V1770, P1468, DOI 10.1016/j.bbagen.2007.07.003; Pan HM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04355; Ramasamy R, 2012, VASC PHARMACOL, V57, P160, DOI 10.1016/j.vph.2012.06.004; Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014; Stern D, 2002, ADV DRUG DELIVER REV, V54, P1615, DOI 10.1016/S0169-409X(02)00160-6; Stern DM, 2002, AGEING RES REV, V1, P1, DOI 10.1016/S0047-6374(01)00366-9; Su SC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001396; SUGAYA K, 1994, GENOMICS, V23, P408, DOI 10.1006/geno.1994.1517; Takeuchi M, 2014, WORLD J HEPATOL, V6, P880, DOI 10.4254/wjh.v6.i12.880; Teli MR, 1995, HEPATOLOGY, V22, P1714, DOI 10.1002/hep.1840220616; VISSING H, 1994, GENOMICS, V24, P606, DOI 10.1006/geno.1994.1676; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Yamagishi SI, 2007, CURR DRUG TARGETS, V8, P1138, DOI 10.2174/138945007782151298; Yamagishi S, 2007, ARTERIOSCL THROM VAS, V27, pE32, DOI 10.1161/ATVBAHA.107.139923; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268; Zhao DC, 2015, J BUON, V20, P614	38	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199294	10.1371/journal.pone.0199294	http://dx.doi.org/10.1371/journal.pone.0199294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928018	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500068
J	Archidona-Yuste, A; Cantalapiedra-Navarrete, C; Liebanas, G; Rapoport, HF; Castillo, P; Palomares-Rius, JE				Archidona-Yuste, Antonio; Cantalapiedra-Navarrete, Carolina; Liebanas, Gracia; Rapoport, Hava F.; Castillo, Pablo; Palomares-Rius, Juan E.			Diversity of root-knot nematodes of the genus Meloidogyne Goeldi, 1892 (Nematoda: Meloidogynidae) associated with olive plants and environmental cues regarding their distribution in southern Spain	PLOS ONE			English	Article							N. SP NEMATODA; IDENTIFICATION; INCOGNITA; JAVANICA; COMMON; HETERODERIDAE; SELECTION; ARENARIA; DENSITY; GROWTH	Root-knot nematodes of the genus Meloidogyne are recognised worldwide as a major production constraint in crops of primary economic importance. Knowledge of their diversity and prevalence, as well as the major environmental and agronomical cues for understanding their distribution in specific areas is of vital importance for designing control measures to reduce significant damage. We provide the first detailed information on the diversity, distribution and levels of Meloidogyne species infecting wild and cultivated olive soils in a wide-region in southern Spain that included 499 sampling sites. Overall Meloidogyne spp. were found in 6.6% of sampled olive plants, with 6.6% and 6.5% for cultivated and wild olive, respectively. We identified five previously described Meloidogyne spp. (Meloidogyne arenaria, M. baetica, M. hapla, M. incognita, M. javanica) and one new species (Meloidogyne oleae sp. nov.) which, characterized using integrative taxonomy, increases the known biodiversity of Meloidogyne spp. affecting olive. Meloidogyne arenaria and M. incognita were only found infecting cultivated olive varieties, while, M. baetica was only found infecting wild olive. Three major parameters drive the distribution of Meloidogyne spp. in cultivated olives in southern Spain, cover vegetation on alley, irrigation and soil texture, but different species respond differently to them. In particular the presence of M. incognita is highly correlated with sandy loamy soils, the presence of M. javanica with irrigated soils and cover vegetation, while the presence of M. arenaria is correlated with the absence of cover vegetation on alley and absence of irrigation. These parameters likely influence the selection of each particular Meloidogyne species from a major dispersal source, such as the rooted plantlets used to establish the orchards.	[Archidona-Yuste, Antonio; Cantalapiedra-Navarrete, Carolina; Rapoport, Hava F.; Castillo, Pablo; Palomares-Rius, Juan E.] CSIC, IAS, Ave Menendez Pidal S-N, Cordoba, Spain; [Liebanas, Gracia] Univ Jaen, Dept Biol Anim Biol Vegetal & Ecol, Campus Las Lagunillas S-N, Jaen, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Universidad de Jaen	Palomares-Rius, JE (corresponding author), CSIC, IAS, Ave Menendez Pidal S-N, Cordoba, Spain.	palomaresje@ias.csic.es	Archidona-Yuste, Antonio/C-2406-2018; , Antonio/ABF-4935-2020; Archidona-Yuste, Antonio/GRS-2729-2022; Rapoport, Hava/A-8743-2017; Castillo, Pablo/A-1445-2011; Palomares-Rius, Juan Emilio/K-8004-2015	Archidona-Yuste, Antonio/0000-0003-4446-0642; , Antonio/0000-0003-4446-0642; Archidona-Yuste, Antonio/0000-0003-4446-0642; Rapoport, Hava/0000-0003-1431-0598; Castillo, Pablo/0000-0003-0256-876X; Palomares-Rius, Juan Emilio/0000-0003-1776-8131	'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia [P12-AGR-1486]; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) [219262]; 'Ministerio de Economia y Competitividad' of Spain [AGL-2012-37521]; European Union [AGL-2012-37521]; Spanish National Research Council (CSIC) [201740E042]; Ministerio de Economia y Competitividad, Spain [BES-2013063495]	'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); 'Ministerio de Economia y Competitividad' of Spain(Spanish Government); European Union(European Commission); Spanish National Research Council (CSIC); Ministerio de Economia y Competitividad, Spain(Spanish Government)	This work was supported by Project P12-AGR-1486 from the 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia to PC, the grant 219262 ArimNET_ERANET FP7 2012-2015 Project PESTOLIVE 'Contribution of olive history for the management of soilborne parasites in the Mediterranean basin' from the Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) to PC, Project AGL-2012-37521 from the 'Ministerio de Economia y Competitividad' of Spain, FEDER financial support from the European Union, and grant 201740E042 "Analisis de diversidad molecular, barcoding, y relaciones filogeneticas de nematodos fitoparasitos en cultivos mediterraneos" from the Spanish National Research Council (CSIC) to PC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A. Archidona-Yuste is a recipient of research contract BES-2013063495 from the Ministerio de Economia y Competitividad, Spain.	Abolafia J., 2002, J NEMATODE MORPHOL, V4, P137; ABRANTES IMD, 1991, J NEMATOL, V23, P210; Adam MAM, 2007, PLANT PATHOL, V56, P190, DOI 10.1111/j.1365-3059.2006.01455.x; Afshar FJ, 2014, HELMINTHOLOGIA, V51, P46, DOI 10.2478/s11687-014-0207-x; Gomez JA, 2018, ENVIRON SCI POLLUT R, V25, P977, DOI 10.1007/s11356-016-8339-9; Ali N, 2016, AGR ECOSYST ENVIRON, V225, P22, DOI 10.1016/j.agee.2016.03.042; Ali N, 2015, EUR J PLANT PATHOL, V143, P25, DOI 10.1007/s10658-015-0662-3; Ali N, 2014, CR BIOL, V337, P423, DOI 10.1016/j.crvi.2014.05.006; Archidona-Yuste A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165412; Archidona-Yuste A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147689; Baldeck Claire A, 2013, Proc Biol Sci, V280, P20122532, DOI 10.1098/rspb.2012.2532; Belaj A, 2007, ANN BOT-LONDON, V100, P449, DOI 10.1093/aob/mcm132; BIRD ALAN F., 1965, NEMATOLOGICA, V11, P581; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Blok Vivian C., 2009, P98, DOI 10.1079/9781845934927.0098; Bohner J., 2006, GOTTINGER GEOGRAPHIS, V115, P13; Castillo P, 2003, PHYTOPATHOLOGY, V93, P1093, DOI 10.1094/PHYTO.2003.93.9.1093; Castillo P, 2009, PLANT PATHOL, V58, P606, DOI 10.1111/j.1365-3059.2008.01991.x; Castillo P, 2010, PLANT DIS, V94, P148, DOI 10.1094/PDIS-94-2-0148; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Conrad O, 2015, GEOSCI MODEL DEV, V8, P1991, DOI 10.5194/gmd-8-1991-2015; Cooler W.A., 1979, P317; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Daykin M. E., 1985, An advanced treatise on Meloidogyne.Volume II: Methodology., P39; De Ley I. T., 1999, J NEMATOL, V31, P530; Derycke S, 2005, MAR ECOL PROG SER, V300, P91, DOI 10.3354/meps300091; Di Vito M, 1985, NEMATOLOGIA MEDITERR, V13, P107; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dray, 2011, PACKFOR FORWARD SELE, P46; ESBENSHADE PR, 1985, J NEMATOL, V17, P6; FRANKLIN M T, 1961, J Helminthol, VSuppl, P85; Gamel S, 2014, EUR J PLANT PATHOL, V138, P807, DOI 10.1007/s10658-013-0355-8; Goeldi E.A., 1892, ARCH MUS NAC RIO JAN, V8, P7; GOLDEN AM, 1981, J NEMATOL, V13, P393; Gomez JA, 2014, AGRICULTURE-BASEL, V4, P170, DOI 10.3390/agriculture4020170; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamza MA, 2017, BMC ECOL, V17, DOI 10.1186/s12898-017-0153-9; HARTMAN K., 1985, METHODOLOGY, VII, P69; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; HUGALL A, 1994, GENETICS, V136, P903; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; Janssen T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172190; Jepson S.B., 1987, IDENTIFICATION ROOT; Karssen G, 1998, NEMATOLOGICA, V44, P713, DOI 10.1163/005725998X00096; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kokalis-Burelle N, 2012, J NEMATOL, V44, P142; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; LOOS C. A., 1953, PROC HELMINTHOL SOC WASHINGTON, V20, P83; MAGRAMA, 2017, EST AGR AGR STAT SPA; McSorley R, 2008, APPL SOIL ECOL, V39, P291, DOI 10.1016/j.apsoil.2008.01.002; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Mutatkar V.K., 1980, SOIL PLANT TESTING A; Nico AI, 2002, PLANT DIS, V86, P1075, DOI 10.1094/PDIS.2002.86.10.1075; Norton D. C., 1978, Ecology of plant-parasitic nematodes.; O'Donnell MS, 2012, US GEOLOGICAL SURVEY, V690; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Perry RN, 2010, ROOT-KNOT NEMATODES, P1; POWERS TO, 1993, J NEMATOL, V25, P1; Punchi-Manage R, 2014, ECOLOGY, V95, P376, DOI 10.1890/12-2102.1; R_Core_Team, 2017, R LENG ENV STAT COMP; Rallo L, 2013, HORTICUL RE, V41, P303; REDIAM, 2017, CONS MED AMB ORD TER; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rouquette JR, 2013, DIVERS DISTRIB, V19, P1429, DOI 10.1111/ddi.12120; SAKAI WS, 1973, STAIN TECHNOL, V48, P247, DOI 10.3109/10520297309116632; Sasanelli N., 1997, Nematologia Mediterranea, V25, P183; Sasanelli N, 2002, NEMATROPICA, V32, P59; SEINHORST JW, 1966, NEMATOLOGICA, V12, P178, DOI 10.1163/187529266X00239; Siddiqi M. R., 2000, TYLENCHIDA PARASITES; SSDS (Soil Science Division Staff),, 1993, SOIL SURV MAN HDB; Stanton J, 1997, FUND APPL NEMATOL, V20, P261; Tao Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182627; Timper P, 2011, PROG BIOL CONTROL, V11, P259, DOI 10.1007/978-1-4020-9648-8_11; Vovlas N, 2005, PHYTOPATHOLOGY, V95, P368, DOI 10.1094/PHYTO-95-0368; VRAIN TC, 1992, FUND APPL NEMATOL, V15, P563; WHITEHEAD A G, 1968, Transactions of the Zoological Society of London, V31, P263; WHITEHEAD AG, 1969, NEMATOLOGICA, V15, P315, DOI 10.1163/187529269X00362; ZEVENBERGEN LW, 1987, EARTH SURF PROCESSES, V12, P47, DOI 10.1002/esp.3290120107; Zijlstra C, 2000, NEMATOLOGY, V2, P847, DOI 10.1163/156854100750112798; Zuur Alain F., 2009, P1	81	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							0198236	10.1371/journal.pone.0198236	http://dx.doi.org/10.1371/journal.pone.0198236			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924813	Green Published, Green Submitted, gold			2022-12-26	WOS:000435655600013
J	Saarman, ET; Owens, B; Murray, SN; Weisberg, SB; Ambrose, RF; Field, JC; Nielsen, KJ; Carr, MH				Saarman, Emily T.; Owens, Brian; Murray, Steven N.; Weisberg, Stephen B.; Ambrose, Richard F.; Field, John C.; Nielsen, Karina J.; Carr, Mark H.			An ecological framework for informing permitting decisions on scientific activities in protected areas	PLOS ONE			English	Article							MARINE RESERVES; NETWORK; CHALLENGES; MANAGEMENT; SCIENCE; IMPLEMENTATION; CONSEQUENCES; COMPLEXITY; DYNAMICS; ACT	There are numerous reasons to conduct scientific research within protected areas, but research activities may also negatively impact organisms and habitats, and thus conflict with a protected area's conservation goals. We developed a quantitative ecological decision-support framework that estimates these potential impacts so managers can weigh costs and benefits of proposed research projects and make informed permitting decisions. The framework generates quantitative estimates of the ecological impacts of the project and the cumulative impacts of the proposed project and all other projects in the protected area, and then compares the estimated cumulative impacts of all projects with policy-based acceptable impact thresholds. We use a series of simplified equations (models) to assess the impacts of proposed research to: a) the population of any targeted species, b) the major ecological assemblages that make up the community, and c) the physical habitat that supports protected area biota. These models consider both targeted and incidental impacts to the ecosystem and include consideration of the vulnerability of targeted species, assemblages, and habitats, based on their recovery time and ecological role. We parameterized the models for a wide variety of potential research activities that regularly occur in the study area using a combination of literature review and expert judgment with a precautionary approach to uncertainty. We also conducted sensitivity analyses to examine the relationships between model input parameters and estimated impacts to understand the dominant drivers of the ecological impact estimates. Although the decision-support framework was designed for and adopted by the California Department of Fish and Wildlife for permitting scientific studies in the state-wide network of marine protected areas (MPAs), the framework can readily be adapted for terrestrial and freshwater protected areas.	[Saarman, Emily T.; Carr, Mark H.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Owens, Brian] Calif Dept Fish & Wildlife, Belmont, CA USA; [Murray, Steven N.] Calif State Univ Fullerton, Fullerton, CA 92634 USA; [Weisberg, Stephen B.] Southern Calif Coastal Water Res Project, Costa Mesa, CA USA; [Ambrose, Richard F.] Univ Calif Los Angeles, Los Angeles, CA USA; [Field, John C.] NOAA, Natl Marine Fisheries Serv, Santa Cruz, CA USA; [Nielsen, Karina J.] San Francisco State Univ, Romberg Tiburon Ctr Environm Studies, Tiburon, CA USA	University of California System; University of California Santa Cruz; California State University System; California State University Fullerton; Southern California Coastal Water Research Project; University of California System; University of California Los Angeles; National Oceanic Atmospheric Admin (NOAA) - USA; California State University System; San Francisco State University	Carr, MH (corresponding author), Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA.	mhcarr@ucsc.edu	Nielsen, Karina Johanne/AAQ-6430-2020; Ambrose, Richard F./AAQ-1192-2020; Weisberg, Stephen B/B-2477-2008	Ambrose, Richard F./0000-0001-8653-6487; Weisberg, Stephen B/0000-0002-0655-9425; Carr, Mark/0000-0001-9644-7680	California Department of Fish and Wildlife; California Ocean Science Trust; Partnership for Interdisciplinary Studies of Coastal Oceans - David and Lucile Packard Foundation; National Science Foundation [OCE-1538582]; Californias Ocean Protection Council	California Department of Fish and Wildlife; California Ocean Science Trust; Partnership for Interdisciplinary Studies of Coastal Oceans - David and Lucile Packard Foundation; National Science Foundation(National Science Foundation (NSF)); Californias Ocean Protection Council	ETS was supported by funding from the California Department of Fish and Wildlife (https://www.wildlife.ca.gov/), California Ocean Science Trust (http://www.oceansciencetrust.org/), and the Partnership for Interdisciplinary Studies of Coastal Oceans (http://www.piscoweb.org/), funded by the David and Lucile Packard Foundation. MHC was supported by the National Science Foundation (OCE-1538582). Without financial and logistical support from Californias Ocean Protection Council, and California Department of Fish and Wildlife, this project would not have been possible. BO, CDFW staff scientist and co-author, contributed to the study design, data collection and analysis, decision to publish, and preparation of the manuscript.; Without financial and logistical support from California's Ocean Protection Council, and California Department of Fish and Wildlife, this project would not have been possible. E.T.S. was supported by funding from the California Department of Fish and Wildlife, California Ocean Science Trust, and the Partnership for Interdisciplinary Studies of Coastal Ocean (PISCO) funded by the David and Lucile Packard Foundation. M.H.C. received support from the National Science Foundation (OCE-1538582).	Allen LG, 2006, ECOLOGY CALIFORNIA M; California Department of Fish and Wildlife, 2016, CAL MAR LIF PROT ACT; Carr MH, 2011, FRONT ECOL ENVIRON, V9, P342, DOI 10.1890/090096; Dayton P.K., 1972, P C CONSERVATION PRO, P81; Dayton PK, 2000, B MAR SCI, V66, P617; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Dudley N., 2008, GUIDELINES APPL PROT, DOI [10.2305/IUCN.CH.2008.PAPS.2.en, DOI 10.2305/IUCN.CH.2008.PAPS.2.EN]; Eastwood A, 2016, ECOSYST SERV, V17, P152, DOI 10.1016/j.ecoser.2015.12.001; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Field JC, 2006, FISH FISH, V7, P284, DOI 10.1111/j.1467-2979.2006.00226.x; FINLEY RB, 1988, WILDLIFE SOC B, V16, P75; Fowler CW, 2011, ECOSYSTEM BASED MANA, DOI [10.1080/03632415.2013.851558, DOI 10.1080/03632415.2013.851558]; Fox E, 2013, OCEAN COAST MANAGE, V74, P34, DOI 10.1016/j.ocecoaman.2012.07.007; Fox E, 2013, OCEAN COAST MANAGE, V74, P24, DOI 10.1016/j.ocecoaman.2012.07.008; Garrison TM, 2011, CAN J FISH AQUAT SCI, V68, P1761, DOI 10.1139/F2011-073; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; Gleason M, 2013, OCEAN COAST MANAGE, V74, P90, DOI 10.1016/j.ocecoaman.2012.08.013; Gleason M, 2010, OCEAN COAST MANAGE, V53, P52, DOI 10.1016/j.ocecoaman.2009.12.001; Golden NE, 2013, CALIFORNIA STATE WAT; Goudie Andrew, 2013, HUMAN IMPACT NATURAL; Gray CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12306; Grime J.P., 1987, SYMP BRIT ECOL SOC, V26, P413; Grorud-Colvert K, 2010, P NATL ACAD SCI USA, V107, P18306, DOI 10.1073/pnas.0914292107; GRUMBINE RE, 1994, CONSERV BIOL, V8, P27, DOI 10.1046/j.1523-1739.1994.08010027.x; Guidetti P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091841; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Henen BT, 2016, HERPETOL CONSERV BIO, V11, P13; Hermoso V, 2016, AQUAT CONSERV, V26, P3, DOI 10.1002/aqc.2681; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; Hockings M, 2003, BIOSCIENCE, V53, P823, DOI 10.1641/0006-3568(2003)053[0823:SFATEO]2.0.CO;2; HOENIG JM, 1983, FISH B-NOAA, V81, P898; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Holmes RT, 2016, HUBBARD BROOK STORYN; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson MC, 2016, GLOBAL CHANGE BIOL, V22, P180, DOI 10.1111/gcb.13028; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Kirlin J, 2013, OCEAN COAST MANAGE, V74, P3, DOI 10.1016/j.ocecoaman.2012.08.015; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Leverington F, 2010, ENVIRON MANAGE, V46, P685, DOI 10.1007/s00267-010-9564-5; Lindholm J, 2004, MAR ECOL PROG SER, V269, P61, DOI 10.3354/meps269061; Lubchenco J, 2015, SCIENCE, V350, P382, DOI 10.1126/science.aad5443; McArdle DA, 1997, CALIFORNIA MARINE PR; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; McGilliard CR, 2015, CAN J FISH AQUAT SCI, V72, P262, DOI 10.1139/cjfas-2013-0364; McLeod K., 2009, ECOSYSTEM BASED MANA; Minteer BA, 2014, SCIENCE, V344, P260, DOI 10.1126/science.1250953; MLPA Science Advisory Team, 2009, DRAFT METH US EV MAR; MLPA Science Advisory Team, 2008, DRAFT METH US EV MAR; MLPA Science Advisory Team, 2010, DRAFT METH US EV MAR; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Ono K, 2015, CAN J FISH AQUAT SCI, V72, P1177, DOI 10.1139/cjfas-2014-0146; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Paul E, 2013, ILAR J, V54, P14, DOI 10.1093/ilar/ilt013; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Saarman E, 2015, N CENTRAL COAST MPA; Saarman E, 2013, OCEAN COAST MANAGE, V74, P45, DOI 10.1016/j.ocecoaman.2012.08.021; Saarman ET, 2013, MAR POLICY, V41, P41, DOI 10.1016/j.marpol.2013.01.004; Sainsbury K, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P343, DOI 10.1079/9780851996332.0343; Sayce K, 2013, OCEAN COAST MANAGE, V74, P57, DOI 10.1016/j.ocecoaman.2012.06.012; Shamoo A. E., 2015, RESPONSIBLE CONDUCT; Smith ADM, 2007, ICES J MAR SCI, V64, P633, DOI 10.1093/icesjms/fsm041; Stab S, 2009, BIODIVERS CONSERV, VI, P127; Starr RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118502; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Tissot B.N., 2008, MARINE HABITAT MAPPI, DOI [10.4027/mhmta.2008.15, DOI 10.4027/MHMTA.2008.15]; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wade PR, 1998, MAR MAMMAL SCI, V14, P1, DOI 10.1111/j.1748-7692.1998.tb00688.x; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Williams A, 2011, FISH RES, V112, P154, DOI 10.1016/j.fishres.2011.01.028; Wilson JB, 1999, OIKOS, V86, P507, DOI 10.2307/3546655; Young M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116200	76	4	4	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199126	10.1371/journal.pone.0199126	http://dx.doi.org/10.1371/journal.pone.0199126			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920527	Green Published, Green Submitted, gold			2022-12-26	WOS:000435541300018
J	Blain, AM; Greally, E; McClorey, G; Manzano, R; Bette, CA; Godfrey, C; O'Donovan, L; Coursindel, T; Gait, MJ; Wood, MJ; MacGowan, GA; Straub, VW				Blain, Alison M.; Greally, Elizabeth; McClorey, Graham; Manzano, Raquel; Bette, Corinne A.; Godfrey, Caroline; O'Donovan, Liz; Coursindel, Thibault; Gait, Mike J.; Wood, Matthew J.; MacGowan, Guy A.; Straub, Volker W.			Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy	PLOS ONE			English	Article							MORPHOLINO OLIGOMER; TOXICOLOGY EVALUATION; HEART-FAILURE; CARDIOMYOPATHY; MICE; RESTORATION; THERAPY; GENE	Cardiac failure is a major cause of mortality in patients with Duchenne muscular dystrophy (DMD). Antisense-mediated exon skipping has the ability to correct out-of-frame mutations in DMD to produce truncated but functional dystrophin. Traditional antisense approaches have however been limited by their poor uptake into cardiac muscle. The addition of cell-penetrating peptides to antisense molecules has increased their potency and improved their uptake into all muscles, including the heart. We have investigated the efficacy of the Peptide-conjugated phosphodiamidate morpholino oligomer (P-PMO) Pip6a-PMO, for restoration of cardiac dystrophin and functional rescue in DMD mice- the mdx mouse and the less well characterised Cmah-/-mdx mouse (which carry a human-like mutation in the mouse Cmah gene as well as a mutation in DMD). In our first study male mdx mice were administered Pip6a-PMO, i.v, fortnightly from 12 to 30 weeks of age alongside mock-injected age-matched mdx and C57BL10 controls. Mice received 4 doses of 18 mg/kg followed by 8 doses of 12.5 mg/kg. The cardiac function of the mice was analysed 2 weeks after their final injection by MRI followed by conductance catheter and their muscles were harvested for dystrophin quantification. In the second study, male Cmah-/-mdx mice, received 12.5 mg/kg Pip6a-PMO, i.v fortnightly from 8 to 26 weeks and assessed by MRI at 3 time points (12, 18 and 28 weeks) alongside mock-injected age-matched mdx, C57BL10 and Cmah-/-mdx controls. The mice also underwent MEMRI and conductance catheter at 28 weeks. This allowed us to characterise the cardiac phenotype of Cmah-/-mdx mice as well as assess the effects of P-PMO on cardiac function. Pip6a-PMO treatment resulted in significant restoration of dystrophin in mdx and Cmah-/-mdx mice (37.5% and 51.6%, respectively), which was sufficient to significantly improve cardiac function, ameliorating both right and left ventricular dysfunction. Cmah-/-mdx mice showed an abnormal response to dobutamine stress test and this was completely ameliorated by PIP6a-PMO treatment. These encouraging data suggest that total restoration of dystrophin may not be required to significantly improve cardiac outcome in DMD patients and that it may be realistic to expect functional improvements with modest levels of dystrophin restoration which may be very achievable in future clinical trials.	[Blain, Alison M.; Greally, Elizabeth; MacGowan, Guy A.; Straub, Volker W.] Newcastle Univ, Int Ctr Life, Inst Genet Med, Times Sq, Newcastle Upon Tyne, Tyne & Wear, England; [McClorey, Graham; Manzano, Raquel; Bette, Corinne A.; Godfrey, Caroline; Wood, Matthew J.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [O'Donovan, Liz; Coursindel, Thibault; Gait, Mike J.] MRC, Lab Mol Biol, Cambridge, England; [MacGowan, Guy A.] Freeman Rd Hosp, Dept Cardiol, Newcastle Upon Tyne, Tyne & Wear, England; [Coursindel, Thibault] Lab Natoli & Associes, St Clement De Riviere, France	Newcastle University - UK; University of Oxford; MRC Laboratory Molecular Biology; Newcastle Freeman Hospital; Newcastle University - UK	Blain, AM (corresponding author), Newcastle Univ, Int Ctr Life, Inst Genet Med, Times Sq, Newcastle Upon Tyne, Tyne & Wear, England.	alison.blain@ncl.ac.uk	martinez, manzano/ACS-3663-2022; MANZANO, RAQUEL/AAB-1709-2020; Wood, Matthew/HDN-1469-2022; Godfrey, Caroline/GYN-0799-2022	martinez, manzano/0000-0002-7477-8742; MANZANO, RAQUEL/0000-0002-7477-8742; Wood, Matthew/0000-0002-5436-6011; Straub, Volker/0000-0001-9046-3540; Oliver, Alison/0000-0002-4564-9984; Betts, Corinne/0000-0003-0579-8843	Association Francaise Contre les Myopathies (AFM-Telethon) [17100]; MRC [MR/N024850/1, MC_U105178803] Funding Source: UKRI	Association Francaise Contre les Myopathies (AFM-Telethon); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Association Francaise Contre les Myopathies (AFM-Telethon) (Projet Stratigique, Francesco Muntoni, DMD Exon Skipping Natural History WP3 extension, dossier no. 17100). http://www.afm-telethon.com/.	Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; Bauer R, 2008, CARDIOVASC RES, V79, P652, DOI 10.1093/cvr/cvn131; Bauer R, 2009, EUR J HEART FAIL, V11, P463, DOI 10.1093/eurjhf/hfp028; Betts CC, 2012, PIP6 PMO NEW GENERAT, V1, pe38, DOI [10.1038/mtna.2012.30, DOI 10.1038/MTNA.2012.30]; Borlaug BA, 2011, CARDIOL CLIN, V29, P447, DOI 10.1016/j.ccl.2011.06.004; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P8; Burki U, 2017, METHODS MOL BIOL, V1565, P265, DOI 10.1007/978-1-4939-6817-6_22; Chandrasekharan K, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000692; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; COMI GP, 1994, BRAIN, V117, P1, DOI 10.1093/brain/117.1.1-a; Doria HB, 2017, ENVIRON SCI POLLUT R, V24, P13080, DOI 10.1007/s11356-017-8953-1; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Fletcher S, 2007, MOL THER, V15, P1587, DOI 10.1038/sj.mt.6300245; Goyenvalle A, 2010, MOL THER, V18, P198, DOI 10.1038/mt.2009.248; Greally E, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-4; Hamdani N, 2012, CURR PHARM BIOTECHNO, V13, P2522; Hu TCC, 2001, MAGNET RESON MED, V46, P884, DOI 10.1002/mrm.1273; Jearawiriyapaisarn N, 2010, CARDIOVASC RES, V85, P444, DOI 10.1093/cvr/cvp335; KOENIG M, 1989, AM J HUM GENET, V45, P498; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; Muntoni FF, 2003, LANCET NEUROL, V2, P10; Sazani P, 2011, INT J TOXICOL, V30, P313, DOI 10.1177/1091581811403505; Sazani P, 2011, INT J TOXICOL, V30, P322, DOI 10.1177/1091581811403504; Sharp PS, 2011, MOL THER, V19, P165, DOI 10.1038/mt.2010.213; Steendijk P, 2001, AM J PHYSIOL-HEART C, V281, pH755, DOI 10.1152/ajpheart.2001.281.2.H755; TOMKINS JK, 1980, MUSCLE NERVE, V3, P529; Townsend D, 2009, TRENDS CARDIOVAS MED, V19, P49, DOI 10.1016/j.tcm.2009.04.006; Wu B, 2008, P NATL ACAD SCI USA, V105, P14814, DOI 10.1073/pnas.0805676105; Wu B, 2011, MOL THER, V19, P576, DOI 10.1038/mt.2010.288	29	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198897	10.1371/journal.pone.0198897	http://dx.doi.org/10.1371/journal.pone.0198897			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912990	Green Published, gold, Green Submitted			2022-12-26	WOS:000435528600058
J	Kim, HJ; Choi, SM; Lee, J; Park, YS; Lee, CH; Yim, JJ; Yoo, CG; Kim, YW; Han, SK; Lee, SM				Kim, Hyung-Jun; Choi, Sun Mi; Lee, Jinwoo; Park, Young Sik; Lee, Chang-Hoon; Yim, Jae-Joon; Yoo, Chul-Gyu; Kim, Young Whan; Han, Sung Koo; Lee, Sang-Min			Respiratory virus of severe pneumonia in South Korea: Prevalence and clinical implications	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; INFLUENZA-LIKE ILLNESS; INTENSIVE-CARE-UNIT; SYNCYTIAL VIRUS; PATIENT OUTCOMES; VIRAL-INFECTIONS; LUNG-DISEASE; ADULTS; IMPACT; PATHOGENS	Background Severe viral pneumonia is associated with a high mortality rate. However, due to the vulnerability of critically ill patients, invasive diagnostic methods should be performed with caution in the intensive care unit (ICU). It would be helpful if the prevalence, risk factors, and clinical impact of virus detection are elucidated. Methods We evaluated patients with severe pneumonia between January 1 st 2008 and December 31 st 2015. Reverse transcription-polymerase chain reaction (RT-PCR) analysis was performed for 8 respiratory viruses when viral pathogen could not be excluded as the origin of severe pneumonia. The baseline characteristics, laboratory results, microbiological findings, and clinical outcomes of the patients were analyzed. Results Of the 2,347 patients admitted to the medical ICU, 515 underwent RT-PCR for respiratory viruses, 69 of whom had positive results. The detection rate was higher during the winter, with a community onset, in patients with history of recent chemotherapy, and low platelet count. Additional bronchoscopic sampling along with upper respiratory specimen increased the yield of viral detection. Respiratory syncytial virus was the most common pathogen detected, while influenza A was the most common virus with bacterial coinfection. Respiratory virus detection led to changes in clinical management in one-third of the patients. Conclusions The detection of viral pathogens in patients with severe pneumonia is not rare, and can be more common in certain group of patients. Invasive sampling for RT-PCR can be helpful, and such detection can lead to positive changes in clinical management.	[Kim, Hyung-Jun; Choi, Sun Mi; Lee, Jinwoo; Park, Young Sik; Lee, Chang-Hoon; Yim, Jae-Joon; Yoo, Chul-Gyu; Kim, Young Whan; Han, Sung Koo; Lee, Sang-Min] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU)	Lee, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	sangmin2@snu.ac.kr	Kim, Hyung-Jun/AAP-9020-2021; Lee, Chang-Hoon/AAC-7650-2021	Kim, Hyung-Jun/0000-0003-1984-8864; Yim, Jae-Joon/0000-0002-9605-0074				Alimi Y, 2017, J CLIN VIROL, V95, P26, DOI 10.1016/j.jcv.2017.07.019; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Aramburo A, 2011, PEDIATR CRIT CARE ME, V12, pE160, DOI 10.1097/PCC.0b013e3181f36e86; Cao B, 2016, CRIT CARE MED, V44, pE318, DOI 10.1097/CCM.0000000000001616; Chertow DS, 2013, JAMA-J AM MED ASSOC, V309, P275, DOI 10.1001/jama.2012.194139; Cho CH, 2013, J CLIN VIROL, V57, P338, DOI 10.1016/j.jcv.2013.04.014; Choi SH, 2012, AM J RESP CRIT CARE, V186, P325, DOI 10.1164/rccm.201112-2240OC; Crestanello JA, 2014, ANN THORAC SURG, V98, P2068, DOI 10.1016/j.athoracsur.2014.06.087; Crotty MP, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1120-5; Cunha BA, 2011, HEART LUNG, V40, P76, DOI 10.1016/j.hrtlng.2010.05.060; Das D, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.02.014; Drews SJ, 2008, ANN CLIN LAB SCI, V38, P376; Falsey AR, 2014, J INFECT DIS, V209, P1873, DOI 10.1093/infdis/jit839; Falsey AR, 2013, J INFECT DIS, V208, P432, DOI 10.1093/infdis/jit190; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Hong HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095865; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Kalil AC, 2016, CLIN INFECT DIS; Karhu J, 2014, CLIN INFECT DIS, V59, P62, DOI 10.1093/cid/ciu237; Kim SR, 2009, J VIROL METHODS, V156, P111, DOI 10.1016/j.jviromet.2008.11.007; Mayer LM, 2017, PNEUMONIA, V9, DOI 10.1186/s41479-017-0028-z; McCracken JP, 2013, J INFECT DIS, V208, pS197, DOI 10.1093/infdis/jit517; Micek ST, 2016, CHEST, V150, P1008, DOI 10.1016/j.chest.2016.04.009; Nguyen C, 2016, J INTENSIVE CARE MED, V31, P427, DOI 10.1177/0885066615585944; Oliveira EC, 2001, CHEST, V119, P1717, DOI 10.1378/chest.119.6.1717; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8183; Rogers BB, 2015, ARCH PATHOL LAB MED, V139, P636, DOI 10.5858/arpa.2014-0257-OA; Shorr AF, 2016, CHEST, V150, P991, DOI 10.1016/j.chest.2016.05.028; Subramony A, 2016, J PEDIATR-US, V173, P196, DOI 10.1016/j.jpeds.2016.02.050; Tramuto F, 2016, MICROBES INFECT, V18, P270, DOI 10.1016/j.micinf.2015.11.008; Viglio S, 2000, EUR RESPIR J, V15, P1039, DOI 10.1034/j.1399-3003.2000.01511.x; Waghmare A, 2016, BLOOD, V127, P2682, DOI [10.1182/blood-2016-01634873, 10.1182/blood-2016-01-634873]; Wiemken T, 2013, EUR J CLIN MICROBIOL, V32, P705, DOI 10.1007/s10096-012-1802-8; Zhan YQ, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-144	34	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198902	10.1371/journal.pone.0198902	http://dx.doi.org/10.1371/journal.pone.0198902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912989	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600059
J	Peng, A; Kirkham, NZ; Mareschal, D				Peng, Anna; Kirkham, Natasha Z.; Mareschal, Denis			Information processes of task-switching and modality-shifting across development	PLOS ONE			English	Article							EXECUTIVE FUNCTION; COGNITIVE CONTROL; COSTS; CHILDHOOD; CHILDREN; STIMULUS; FLEXIBILITY; INHIBITION; DOMINANCE; SELECTION	Developmental research on flexible attentional control in young children has often focused on the role of attention in task-switching in a unimodal context. In real life, children must master the art of switching attention not only between task demands, but also between sensory modalities. Previous study has shown that young children can be efficient at switching between unimodal tasks when the situation allows, incurring no greater task-switching costs than adults. However, young children may still experience a greater demand to shift attention between modalities than older participants. To address this, we tested 4-year-olds, 6-year-olds and adults on a novel cross-modal task-switching paradigm involving multisensory detection tasks. While we found age differences in absolute reaction time and accuracy, young children and adults both exhibited strikingly similar effects in task-switching, modality-shifting, and the interaction between them. Young children did not exhibit a greater attentional bottleneck on either the task level, or on the modality level; thus, the evidence suggests that young children engaged in similar cognitive operations in the current cross-modal tasks to adult participants. It appears that cognitive operations in multisensory task configuration are relatively mature between 4 and 6 years old.	[Peng, Anna; Kirkham, Natasha Z.; Mareschal, Denis] Birkbeck Univ London, Dept Psychol Sci, London, England	University of London; Birkbeck University London	Peng, A (corresponding author), Birkbeck Univ London, Dept Psychol Sci, London, England.	cpeng01@mail.bbk.ac.uk	Kirkham, Natasha/AAE-5712-2021; Mareschal, Denis/C-4671-2008; Peng, Anna/AAD-7798-2021; Mareschal, Denis/ABE-4342-2020	Mareschal, Denis/0000-0002-9828-9548; Peng, Anna/0000-0002-6417-5438; Mareschal, Denis/0000-0002-9828-9548; Kirkham, Natasha/0000-0002-3588-3945	Economic and Social Research Council (UK) [ES/K005308/1]; ESRC [ES/K005308/1] Funding Source: UKRI	Economic and Social Research Council (UK)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by the Economic and Social Research Council (UK) [grant number ES/K005308/1] to NK and DM (URL: http://www.esrc.ac.uk). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLPORT A, 1994, ATTENTION PERFORM, V15, P421; Anderson PJ, 2012, NEUROPSYCHOL REV, V22, P345, DOI 10.1007/s11065-012-9220-3; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Blair C, 2015, ANNU REV PSYCHOL, V66, P711, DOI 10.1146/annurev-psych-010814-015221; Blaye A, 2011, J EXP CHILD PSYCHOL, V108, P469, DOI 10.1016/j.jecp.2010.09.006; Bollen K.A., 1990, SOCIOL METHODOL, V20, P115, DOI [DOI 10.2307/271084, 10.2307/271084]; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brandwein AB, 2011, CEREB CORTEX, V21, P1042, DOI 10.1093/cercor/bhq170; Bremner A. J., 2012, MULTISENSORY DEV; Broadbent HJ, 2017, DEVELOPMENTAL SCI, P59; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Cepeda NJ, 2001, DEV PSYCHOL, V37, P715, DOI 10.1037/0012-1649.37.5.715; COHEN R, 1992, ANN NY ACAD SCI, V658, P163, DOI 10.1111/j.1749-6632.1992.tb22844.x; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Cragg L, 2016, DEV PSYCHOL, V52, P242, DOI 10.1037/dev0000074; Cragg L, 2009, DEV PSYCHOL, V45, P1465, DOI 10.1037/a0015360; Crone EA, 2004, DEVELOPMENTAL SCI, V7, P443, DOI 10.1111/j.1467-7687.2004.00365.x; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Dibbets P, 2006, COGNITIVE DEV, V21, P60, DOI 10.1016/j.cogdev.2005.09.004; Dick AS, 2014, J EXP CHILD PSYCHOL, V125, P13, DOI 10.1016/j.jecp.2014.01.021; Downing HC, 2015, FRONT PSYCHOL, V6, P1; Duncan J, 1997, NATURE, V387, P808, DOI 10.1038/42947; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Gade M, 2007, MEM COGNITION, V35, P603, DOI 10.3758/BF03193298; Garon N, 2008, PSYCHOL BULL, V134, P31, DOI 10.1037/0033-2909.134.1.31; Hanania R, 2010, J EXP CHILD PSYCHOL, V107, P325, DOI 10.1016/j.jecp.2010.05.002; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Hunt AR, 2004, BRAIN COGNITION, V55, P325, DOI 10.1016/j.bandc.2004.02.072; Johannsen J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00552; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; Kirkham NZ, 2003, DEVELOPMENTAL SCI, V6, P449, DOI 10.1111/1467-7687.00300; Kleiner M, 2007, PERCEPTION, V36, P14; Lewkowicz DJ, 2009, TRENDS COGN SCI, V13, P470, DOI 10.1016/j.tics.2009.08.004; Lien MC, 2006, PSYCHON B REV, V13, P530, DOI 10.3758/BF03193881; Mayr U, 2001, PSYCHOL AGING, V16, P96, DOI 10.1037/0882-7974.16.1.96; Meiran N, 2000, PSYCHOL RES-PSYCH FO, V63, P234, DOI 10.1007/s004269900004; Meiran N, 2008, J EXP PSYCHOL HUMAN, V34, P137, DOI 10.1037/0096-1523.34.1.137; Murray MM, 2009, BRAIN COGNITION, V69, P47, DOI 10.1016/j.bandc.2008.05.004; Nardini M, 2016, DEVELOPMENTAL SCI, V19, P803, DOI 10.1111/desc.12327; Nava E, 2013, CHILD DEV, V84, P604, DOI 10.1111/j.1467-8624.2012.01856.x; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peng A, 2018, J EXP CHILD PSYCHOL, V172, P59, DOI 10.1016/j.jecp.2018.01.019; Robinson CW, 2010, WIRES COGN SCI, V1, P135, DOI 10.1002/wcs.12; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rubin O, 2005, J EXP PSYCHOL LEARN, V31, P1477, DOI 10.1037/0278-7393.31.6.1477; Sandhu R, 2013, BRAIN COGNITION, V82, P90, DOI 10.1016/j.bandc.2013.02.011; Sandhu R, 2012, ACTA PSYCHOL, V140, P111, DOI 10.1016/j.actpsy.2012.04.003; Sloutsky VM, 2003, CHILD DEV, V74, P822, DOI 10.1111/1467-8624.00570; Soto-Faraco S, 2002, Q J EXP PSYCHOL-A, V55, P23, DOI 10.1080/02724980143000136; SUTTON S, 1961, AM J PSYCHOL, V74, P224, DOI 10.2307/1419407; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Thomas RL, 2017, J EXP CHILD PSYCHOL, V162, P72, DOI 10.1016/j.jecp.2017.04.020; Waszak F, 2003, COGNITIVE PSYCHOL, V46, P361, DOI 10.1016/S0010-0285(02)00520-0; Weeda WD, 2014, J EXP CHILD PSYCHOL, V126, P178, DOI 10.1016/j.jecp.2014.05.001; Wolff N, 2016, SCI REP, V6, P1, DOI [10.1038/s41598-016-0001-8, DOI 10.1038/S41598-016-0001-8]; Wylie G, 2000, PSYCHOL RES-PSYCH FO, V63, P212, DOI 10.1007/s004269900003; Wylie GR, 2004, NEUROREPORT, V15, P1079, DOI 10.1097/00001756-200404290-00030; Zelazo PD, 1996, COGNITIVE DEV, V11, P37, DOI 10.1016/S0885-2014(96)90027-1	59	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198870	10.1371/journal.pone.0198870	http://dx.doi.org/10.1371/journal.pone.0198870			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ6XV	29912921	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000435528600056
J	Reissman, T; Halsne, E; Lipschutz, R; Miller, L; Kuiken, T				Reissman, Timothy; Halsne, Elizabeth; Lipschutz, Robert; Miller, Laura; Kuiken, Todd			A novel gel liner system with embedded electrodes for use with upper limb myoelectric prostheses	PLOS ONE			English	Article							SUSPENSION	We present the development and evaluation of a gel liner system for upper limb prosthesis users that enables acquisition of electromyographic (myoelectric) control signals through embedded electrodes and flexible, conductive fabric leads. This liner system is constructed using a manufacturing approach rather than by modifying a commercially available liner. To evaluate the efficacy, eight male individuals with transhumeral amputations used this system, with standard myoelectric prostheses, for home trials lasting an average of 7.3 weeks. Before and after the home trials, electrical resistance of the cumulative 218 embedded electrodes and leads within 10 gel liner systems was measured and found to increase slightly (from an average of 13.4 to 27.5 Omega) after usage. While this increase was statistically significant (p = 0.001), all but one of the final resistance values remained low enough to enable consistent myoelectric control. User impressions were evaluated through a questionnaire comparing the liner prototypes to their own myoelectric prosthesis socket interface. Subjects preferred the liner prototype (p = 0.008) over their own system in the clinical areas of comfort, suspension, function, and, especially, ease of use. These results suggest that this gel liner system is a clinically viable option and that it may offer advantages over current clinical technology for users of upper limb myoelectric prostheses.	[Reissman, Timothy; Halsne, Elizabeth; Lipschutz, Robert; Miller, Laura; Kuiken, Todd] Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA; [Reissman, Timothy; Kuiken, Todd] Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA; [Reissman, Timothy] Univ Dayton, Dept Mech Engn, Dayton, OH 45469 USA	Shirley Ryan AbilityLab; Northwestern University; University of Dayton	Reissman, T (corresponding author), Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA.; Reissman, T (corresponding author), Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA.; Reissman, T (corresponding author), Univ Dayton, Dept Mech Engn, Dayton, OH 45469 USA.	treissman1@udayton.edu	Halsne, Elizabeth/ABD-1819-2020; Miller, Laura A/E-1110-2011	Halsne, Elizabeth/0000-0003-0640-1051; Miller, Laura A/0000-0002-7271-6214; Reissman, Timothy/0000-0003-1628-6632	US Army TATRC [W81-XWH-11-1-0720]; National Institute of Health CDMRP [W81XWH 12-02-0072]; NIH [T32 HD07418]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007418] Funding Source: NIH RePORTER	US Army TATRC; National Institute of Health CDMRP; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Development funding was given through US Army TATRC W81-XWH-11-1-0720 and National Institute of Health CDMRP W81XWH 12-02-0072 (TK). Funding for the lead author to conduct the research presented was supported by NIH T32 HD07418 (TR).	Daly W, 2000, J PROSTHET ORTHOT, V12, P88; FILLAUER CE, 1989, J PROSTHET ORTHOT, V1, P92, DOI 10.1097/00008526-198901000-00007; Gaber TAZK, 2001, PROSTHET ORTHOT INT, V25, P113, DOI 10.1080/03093640108726584; Hanspal RS, 2003, DISABIL REHABIL, V25, P1278, DOI 10.1080/09638280310001603983; HEIBERGER RM, 2014, J STAT SOFTW, V57; KRISTINSSON O, 1993, PROSTHET ORTHOT INT, V17, P49, DOI 10.3109/03093649309164354; Kuiken T, 2014, US Patent, Patent No. [2016/0038314 A1, 20160038314]; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Lipschutz R, 2014, AM ACAD ORTH PROSTH; Lipschutz R, 2012, US Patent, Patent No. [US 2013/0046394 Al., 20130046394]; Lipschutz RD, 2011, MEC MYOEL CONTR S, P123; Muzumdar A., 2004, POWERED UPPER LIMB P; RADOCY RB, 1995, J PROSTHET ORTHOT, V7, P65; Reissman T, 2014, MEC MYOEL CONTR S, P194; Salam Y, 1994, J PROSTHET ORTHOT, V6, P119; Staats TB, 1987, CLIN PROSTHET ORTHOT, V11, P118; TURKER KS, 1993, PHYS THER, V73, P698; WK Daly, 2002, MEC MYOELECTRIC CONT, P45	18	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198934	10.1371/journal.pone.0198934	http://dx.doi.org/10.1371/journal.pone.0198934			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912908	Green Published, gold			2022-12-26	WOS:000435528600062
J	Solino, M; Lopez, EM; Rey-Funes, M; Loidl, CF; Larrayoz, IM; Martinez, A; Girardi, E; Lopez-Costa, JJ				Solino, Manuel; Maria Lopez, Ester; Rey-Funes, Manuel; Fabian Loidl, Cesar; Larrayoz, Ignacio M.; Martinez, Alfredo; Girardi, Elena; Jose Lopez-Costa, Juan			Adenosine A1 receptor: A neuroprotective target in light induced retinal degeneration	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; A1 ADENOSINE RECEPTOR; GANGLION-CELLS; MACULAR DEGENERATION; VEGF EXPRESSION; RAT HIPPOCAMPUS; IN-VITRO; ACTIVATION; INCREASES; ISCHEMIA	Light induced retinal degeneration (LIRD) is a useful model that resembles human retinal degenerative diseases. The modulation of adenosine Al receptor is neuroprotective in different models of retinal injury. The aim of this work was to evaluate the potential neuroprotective effect of the modulation of Al receptor in LIRD. The eyes of rats intravitreally injected with N6-cyclopentyladenosine (CPA), an A1 agonist, which were later subjected to continuous illumination (CI) for 24 h, showed retinas with a lower number of apoptotic nuclei and a decrease of Glial Fibrillary Acidic Protein (GFAP) immunoreactive area than controls. Lower levels of activated Caspase 3 and GFAP were demonstrated by Western Blot (WB) in treated animals. Also a decrease of iNOS, TNF alpha and GFAP mRNA was demonstrated by RT-PCR. A decrease of Iba 1(+)/MHC-II+ reactive microglial cells was shown by immunohistochemistry. Electroretinograms (ERG) showed higher amplitudes of a-wave, b-wave and oscillatory potentials after CI compared to controls. Conversely, the eyes of rats intravitreally injected with dipropylcyclopentylxanthine (DPCPX), an A1 antagonist, and subjected to CI for 24 h, showed retinas with a higher number of apoptotic nuclei and an increase of GFAP immunoreactive area compared to controls. Also, higher levels of activated Caspase 3 and GFAP were demonstrated by Western Blot. The mRNA levels of iNOS, nNOS and inflammatory cytokines (IL-beta and TNF alpha) were not modified by DPCPX treatment. An increase of Iba 1(+)/MHC-II+ reactive microglial cells was shown by immunohistochemistry. ERG showed that the amplitudes of a-wave, b-wave, and oscillatory potentials after CI were similar to control values. A single pharmacological intervention prior illumination stress was able to swing retinal fate in opposite directions: CPA was neuroprotective, while DPCPX worsened retinal damage. In summary, A1 receptor agonism is a plausible neuroprotective strategy in LIRD.	[Solino, Manuel; Maria Lopez, Ester; Rey-Funes, Manuel; Fabian Loidl, Cesar; Girardi, Elena; Jose Lopez-Costa, Juan] Univ Buenos Aires, Fac Med, Dept Biol Celular Histol Embriol & Genet, Buenos Aires, DF, Argentina; [Solino, Manuel; Maria Lopez, Ester; Rey-Funes, Manuel; Fabian Loidl, Cesar; Girardi, Elena; Jose Lopez-Costa, Juan] Univ Buenos Aires, CONICET, Inst Biol Celular & Neurociencia Prof E De Robert, Buenos Aires, DF, Argentina; [Larrayoz, Ignacio M.] Ctr Biomed Res La Rioja CIBIR, Biomarkers & Mol Signaling Grp, Logrono, Spain; [Martinez, Alfredo] Ctr Biomed Res La Rioja CIBIR, Angiogenesis Study Grp, Logrono, Spain	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Lopez-Costa, JJ (corresponding author), Univ Buenos Aires, Fac Med, Dept Biol Celular Histol Embriol & Genet, Buenos Aires, DF, Argentina.; Lopez-Costa, JJ (corresponding author), Univ Buenos Aires, CONICET, Inst Biol Celular & Neurociencia Prof E De Robert, Buenos Aires, DF, Argentina.	jjlopez@fmed.oba.ar	Martinez, Alfredo/GQH-5998-2022; Larrayoz, Ignacio M/I-5613-2012	Martinez, Alfredo/0000-0003-4882-4044; Larrayoz, Ignacio M/0000-0003-1629-152X; Rey-Funes, Manuel/0000-0002-0213-3056; Lopez-Costa, Juan Jose/0000-0001-5802-1726	Universidad de Buenos Aires [UBACYT 2014-17/20020130100675BA]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 1098/2012-2014]; Institute de Salud Carlos III Fondo Social Europeo (Periodo de programacion) [CP15/00198]; Fondo de Desarrollo Regional	Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Institute de Salud Carlos III Fondo Social Europeo (Periodo de programacion); Fondo de Desarrollo Regional	This work was supported by grants of Universidad de Buenos Aires (UBACYT 2014-17/20020130100675BA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), PIP 1098/2012-2014 (granted to JJLC); Institute de Salud Carlos III (CP15/00198) Fondo Social Europeo (Periodo de programacion 2014-2020) and Fondo de Desarrollo Regional granted to IML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler AS, 1996, RES COMMUN MOL PATH, V92, P177; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Angulo E, 2003, BRAIN PATHOL, V13, P440; Gori MB, 2013, CELL MOL NEUROBIOL, V33, P803, DOI 10.1007/s10571-013-9947-2; BLAZYNSKI C, 1990, J NEUROCHEM, V54, P648, DOI 10.1111/j.1471-4159.1990.tb01920.x; BLAZYNSKI C, 1991, CELL MOL NEUROBIOL, V11, P463, DOI 10.1007/BF00734810; Boeck CR, 2005, NEUROPHARMACOLOGY, V49, P17, DOI 10.1016/j.neuropharm.2005.01.024; Boia R, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.451; Boison D, 2016, NEUROPHARMACOLOGY, V104, P131, DOI 10.1016/j.neuropharm.2015.08.046; Borea PA, 2016, TRENDS PHARMACOL SCI, V37, P419, DOI 10.1016/j.tips.2016.02.006; BRAAS KM, 1987, P NATL ACAD SCI USA, V84, P3906, DOI 10.1073/pnas.84.11.3906; Burnstock G, 2011, PROG NEUROBIOL, V95, P229, DOI 10.1016/j.pneurobio.2011.08.006; Chader GJ, 2002, VISION RES, V42, P393, DOI 10.1016/S0042-6989(01)00212-7; D'Amico AG, 2017, PEPTIDES, V97, P64, DOI 10.1016/j.peptides.2017.09.014; D'Amico AG, 2017, J MOL NEUROSCI, V61, P256, DOI 10.1007/s12031-016-0869-6; D'Amico AG, 2015, J MOL NEUROSCI, V57, P501, DOI 10.1007/s12031-015-0621-7; Dick AD, 2004, PROG RETIN EYE RES, V23, P617, DOI 10.1016/j.preteyeres.2004.06.005; dos Santos-Rodrigues A, 2015, VITAM HORM, V98, P487, DOI 10.1016/bs.vh.2014.12.014; DUNWIDDIE TV, 1985, J PHYSIOL-LONDON, V369, P365, DOI 10.1113/jphysiol.1985.sp015907; Dureau P, 2001, CURR EYE RES, V22, P74, DOI 10.1076/ceyr.22.1.74.6974; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; Fredholm BB, 2014, J MOL MED, V92, P201, DOI 10.1007/s00109-013-1101-6; Galvao J, 2014, FASEB J, V28, P1317, DOI 10.1096/fj.13-235440; GIULIAN D, 1994, DEV NEUROSCI-BASEL, V16, P128, DOI 10.1159/000112099; GIULIAN D, 1988, J NEUROSCI, V8, P2485; GORN RA, 1967, ARCH OPHTHALMOL-CHIC, V77, P115, DOI 10.1001/archopht.1967.00980020117025; Grishagin IV, 2015, ANAL BIOCHEM, V473, P63, DOI 10.1016/j.ab.2014.12.007; Gu F, 2014, EPILEPSIA, V55, P245, DOI 10.1111/epi.12487; Hafezi F, 1997, EXP EYE RES, V64, P963, DOI 10.1006/exer.1997.0288; HANCOCK MB, 1984, J HISTOCHEM CYTOCHEM, V32, P311, DOI 10.1177/32.3.6198359; Housley GD, 2009, TRENDS NEUROSCI, V32, P128, DOI 10.1016/j.tins.2009.01.001; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Kifley A., 2017, BR J OPHTHALMOL; Kvanta A, 1997, EXP EYE RES, V65, P595, DOI 10.1006/exer.1996.0352; Li B, 1999, EXP EYE RES, V68, P9, DOI 10.1006/exer.1998.0573; Linden J, 1994, BASIC NEUROCHEMISTRY, P1080; Luongo L, 2014, GLIA, V62, P122, DOI 10.1002/glia.22592; Madeira MH, 2016, TRANSL RES, V169, P112, DOI 10.1016/j.trsl.2015.11.005; Margalit E, 2003, ARTIF ORGANS, V27, P963, DOI 10.1046/j.1525-1594.2003.07304.x; Lopez EM, 2008, INT J NEUROSCI, V118, P1725, DOI 10.1080/00207450802174449; Marti A, 1998, INVEST OPHTH VIS SCI, V39, P846; Mittag TW, 1999, EXP EYE RES, V69, P677, DOI 10.1006/exer.1999.0748; Noell W K, 1966, Invest Ophthalmol, V5, P450; Ohsawa K, 2000, J CELL SCI, V113, P3073; Ostwald P, 1997, VISION RES, V37, P3453, DOI 10.1016/S0042-6989(96)00222-2; Panaitescu B, 2013, NEUROSCIENCE, V255, P158, DOI 10.1016/j.neuroscience.2013.09.058; Pennington KL, 2016, EYE VISION, V3, DOI 10.1186/s40662-016-0063-5; Perigolo-Vicente R, 2014, BIOCHEM BIOPH RES CO, V449, P477, DOI 10.1016/j.bbrc.2014.05.036; Perigolo-Vicente R, 2013, BIOCHEM BIOPH RES CO, V430, P512, DOI 10.1016/j.bbrc.2012.12.004; Piehl L, 2007, BRAIN RES, V1156, P112, DOI 10.1016/j.brainres.2007.04.030; Reme A C. E., 1998, RETINAL PIGMENT EPIT; Reme CE, 2003, DOC OPHTHALMOL, V106, P25, DOI 10.1023/A:1022423724376; Rosim FE, 2011, EPILEPSY BEHAV, V22, P207, DOI 10.1016/j.yebeh.2011.07.004; Roth S, 1997, EXP EYE RES, V65, P771, DOI 10.1006/exer.1997.0391; SAAVEDRA JP, 1976, CELL TISSUE RES, V166, P201; Scuderi S, 2015, J MOL NEUROSCI, V56, P431, DOI 10.1007/s12031-015-0505-x; SEVERNS ML, 1994, DOC OPHTHALMOL, V86, P23, DOI 10.1007/BF01224625; Stella SL, 2002, J NEUROPHYSIOL, V87, P351, DOI 10.1152/jn.00010.2001; Stone Trevor W, 2009, Handb Exp Pharmacol, P535, DOI 10.1007/978-3-540-89615-9_17; Sufianova GZ, 2014, B EXP BIOL MED+, V157, P228, DOI 10.1007/s10517-014-2531-z; Tsutsui S, 2004, J NEUROSCI, V24, P1521, DOI 10.1523/JNEUROSCI.4271-03.2004; Winerdal M, 2016, PURINERG SIGNAL, V12, P89, DOI 10.1007/s11302-015-9482-3	63	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198838	10.1371/journal.pone.0198838	http://dx.doi.org/10.1371/journal.pone.0198838			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912966	Green Published, gold, Green Submitted			2022-12-26	WOS:000435528600053
J	Uddin, S; Low, M; Parvin, S; Fitzgerald, GJ; Tausz-Posch, S; Armstrong, R; O'Leary, G; Tausz, M				Uddin, Shihab; Low, Markus; Parvin, Shahnaj; Fitzgerald, Glenn J.; Tausz-Posch, Sabine; Armstrong, Rogero; O'Leary, Garry; Tausz, Michael			Elevated [CO2] mitigates the effect of surface drought by stimulating root growth to access sub-soil water	PLOS ONE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; USE EFFICIENCY; WINTER-WHEAT; STOMATAL CONDUCTANCE; PENETRATION ABILITY; ENRICHMENT FACE; SOIL-MOISTURE; GRAIN QUALITY; SPRING WHEAT; DRYING SOIL	Through stimulation of root growth, increasing atmospheric CO2 concentration ([CO2]) may facilitate access of crops to sub-soil water, which could potentially prolong physiological activity in dryland environments, particularly because crops are more water use efficient under elevated [CO2] (e[CO2]). This study investigated the effect of drought in shallow soil versus sub-soil on agronomic and physiological responses of wheat to e[CO2] in a glasshouse experiment. Wheat (Triticum aestivum L. cv. Yitpi) was grown in split-columns with the top (0-30 cm) and bottom (31-60 cm; 'sub-soil') soil layer hydraulically separated by a wax-coated, root-penetrable layer under ambient [CO2] (a[CO2], similar to 400 mu mol mol(-1)) or e [CO2] (similar to 700 mu mol mol(-1)) [CO2]. Drought was imposed from stem-elongation in either the top or bottom soil layer or both by withholding 33% of the irrigation, resulting in four water treatments (WW, WD, DW, DD; D = drought, W = well-watered, letters denote water treatment in top and bottom soil layer, respectively). Leaf gas exchange was measured weekly from stem-elongation until anthesis. Above-and belowground biomass, grain yield and yield components were evaluated at three developmental stages (stem-elongation, anthesis and maturity). Compared with a[CO2], net assimilation rate was higher and stomatal conductance was lower under e[CO2], resulting in greater intrinsic water use efficiency. Elevated [CO2] stimulated both above- and belowground biomass as well as grain yield, however, this stimulation was greater under well-watered (WW) than drought (DD) throughout the whole soil profile. Imposition of drought in either or both soil layers decreased aboveground biomass and grain yield under both [CO2] compared to the well-watered treatment. However, the greatest 'CO2 fertilisation effect' was observed when drought was imposed in the top soil layer only (DW), and this was associated with e[CO2]-stimulation of root growth especially in the well-watered bottom layer. We suggest that stimulation of belowground biomass under e[CO2] will allow better access to sub-soil water during grain filling period, when additional water is converted into additional yield with high efficiency in Mediterranean-type dryland agro-ecosystems. If sufficient water is available in the sub-soil, e[CO2] may help mitigating the effect of drying surface soil.	[Uddin, Shihab; Low, Markus; Fitzgerald, Glenn J.; Tausz-Posch, Sabine] Univ Melbourne, Fac Vet & Agr Sci, Creswick, Vic, Australia; [Uddin, Shihab; Parvin, Shahnaj] Bangladesh Agr Univ, Dept Agron, Mymensingh, Bangladesh; [Parvin, Shahnaj; Tausz, Michael] Univ Melbourne, Sch Ecosyst & Forest Sci, Creswick, Vic, Australia; [Fitzgerald, Glenn J.; Armstrong, Rogero; O'Leary, Garry] Dept Econ Dev Jobs Transport & Resources, Horsham, Vic, Australia; [Armstrong, Rogero] La Trobe Univ, Ctr AgriBiosci, Dept Anim Plant & Soil Sci, Bundoora, Vic, Australia; [Tausz-Posch, Sabine] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Tausz, Michael] Univ Birmingham, Birmingham Inst Forest Res, Birmingham, W Midlands, England	University of Melbourne; Bangladesh Agricultural University (BAU); University of Melbourne; La Trobe University; University of Birmingham; University of Birmingham	Uddin, S (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Creswick, Vic, Australia.; Uddin, S (corresponding author), Bangladesh Agr Univ, Dept Agron, Mymensingh, Bangladesh.	shihab.uddin@unimelb.edu.au	Tausz, Michael/C-1990-2013; Tausz, Michael/AHC-9128-2022; Uddin, Shihab/W-3598-2019	Tausz, Michael/0000-0001-8205-8561; Tausz, Michael/0000-0001-8205-8561; Uddin, Shihab/0000-0002-1257-4269; Tausz-Posch, Sabine/0000-0002-1213-7907	Grains Research and Development Corporation [DAV00137]; Australian Department of Agriculture and Water Resources [FtRG1193982]; Melbourne International Research Scholarship; Melbourne International Fee Remission Scholarship	Grains Research and Development Corporation(Grains R&D Corp); Australian Department of Agriculture and Water Resources(Australian Government); Melbourne International Research Scholarship; Melbourne International Fee Remission Scholarship	This study was a part of the Australian Grains Free Air CO2 Enrichment (AGFACE) program. AGFACE is jointly run by the University of Melbourne and Agriculture Victoria (Department of Economic Development, Jobs, Transport and Resources) with funding from the Grains Research and Development Corporation (grant number: DAV00137) and the Australian Department of Agriculture and Water Resources (grant number: FtRG1193982). SU was supported by Melbourne International Research and Melbourne International Fee Remission Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna TLB, 2012, FIELD CROP RES, V138, P1, DOI 10.1016/j.fcr.2012.09.018; Acuna TLB, 2005, AUST J AGR RES, V56, P1235, DOI 10.1071/AR05067; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Aljazairi S, 2014, J PLANT PHYSIOL, V171, P1654, DOI 10.1016/j.jplph.2014.07.019; AlKaraki GN, 1997, MYCORRHIZA, V7, P83, DOI 10.1007/s005720050166; Amthor JS, 2001, FIELD CROP RES, V73, P1, DOI 10.1016/S0378-4290(01)00179-4; Angus JF, 2001, AGRON J, V93, P290, DOI 10.2134/agronj2001.932290x; ARP WJ, 1991, PLANT CELL ENVIRON, V14, P869, DOI 10.1111/j.1365-3040.1991.tb01450.x; B A Kimball, 2002, [应用生态学报, The Journal of Applied Ecology], V13, P1323; Bahrami H, 2017, J PLANT PHYSIOL, V216, P44, DOI 10.1016/j.jplph.2017.05.011; Benlloch-Gonzalez M, 2014, FIELD CROP RES, V165, P71, DOI 10.1016/j.fcr.2014.04.008; Benlloch-Gonzalez M, 2014, PLANT SOIL, V374, P963, DOI 10.1007/s11104-013-1934-3; Bernacchi CJ, 2007, PLANT PHYSIOL, V143, P134, DOI 10.1104/pp.106.089557; BLUM A, 1992, PLANT SOIL, V145, P141, DOI 10.1007/BF00009550; Bourgault M, 2013, FUNCT PLANT BIOL, V40, P172, DOI 10.1071/FP12193; Burkart S, 2011, PLANT BIOLOGY, V13, P258, DOI 10.1111/j.1438-8677.2010.00360.x; Cardoso-Vilhena J, 2001, J EXP BOT, V52, P1901, DOI 10.1093/jexbot/52.362.1901; Cassab GI, 2013, AM J BOT, V100, P14, DOI 10.3732/ajb.1200306; CHAUDHURI UN, 1990, CROP SCI, V30, P853, DOI 10.2135/cropsci1990.0011183X003000040017x; Dunbabin VM, 2009, AUST J SOIL RES, V47, P74, DOI 10.1071/SR08107; Edenhofer O., 2014, CONTRIBUTION WORKING; Farooq M, 2014, CRIT REV PLANT SCI, V33, P331, DOI 10.1080/07352689.2014.875291; Fitzgerald GJ, 2016, GLOBAL CHANGE BIOL, V22, P2269, DOI 10.1111/gcb.13263; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; Gagliano M, 2017, OECOLOGIA, V184, P151, DOI 10.1007/s00442-017-3862-z; GALLARDO M, 1994, J EXP BOT, V45, P909, DOI 10.1093/jxb/45.7.909; GIFFORD RM, 1985, PHYSIOL PLANTARUM, V63, P351, DOI 10.1111/j.1399-3054.1985.tb02309.x; Gray SB, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.132, 10.1038/nplants.2016.132]; GREGORY PJ, 1978, J AGR SCI, V91, P103, DOI 10.1017/S0021859600056665; HOCKING PJ, 1991, AUST J PLANT PHYSIOL, V18, P339, DOI 10.1071/PP9910339; Hogy P, 2009, PLANT BIOLOGY, V11, P60, DOI 10.1111/j.1438-8677.2009.00230.x; Hogy P, 2008, J CEREAL SCI, V48, P580, DOI 10.1016/j.jcs.2008.01.006; Houshmandfar A, 2016, EUR J AGRON, V76, P66, DOI 10.1016/j.eja.2016.01.018; Hussain MZ, 2013, GLOBAL CHANGE BIOL, V19, P1572, DOI 10.1111/gcb.12155; Kimball BA, 2016, CURR OPIN PLANT BIOL, V31, P36, DOI 10.1016/j.pbi.2016.03.006; Kirkegaard JA, 2007, AUST J AGR RES, V58, P303, DOI 10.1071/AR06285; Kubo K, 2004, PLANT SOIL, V262, P169, DOI 10.1023/B:PLSO.0000037033.23964.54; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Li DX, 2013, AGR WATER MANAGE, V129, P105, DOI 10.1016/j.agwat.2013.07.014; Li FS, 2004, AGR WATER MANAGE, V67, P221, DOI 10.1016/j.agwat.2004.01.005; Li FS, 2003, J PLANT NUTR, V26, P769, DOI 10.1081/PLN-120018564; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Madhu M, 2013, AGRON J, V105, P657, DOI 10.2134/agronj2013.0018; Manschadi AM, 2006, FUNCT PLANT BIOL, V33, P823, DOI 10.1071/FP06055; Martin-Vertedor AI, 2011, PLANT CELL ENVIRON, V34, P1164, DOI 10.1111/j.1365-3040.2011.02315.x; McGrath JM, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014054; MCMICHAEL BL, 1993, ENVIRON EXP BOT, V33, P53, DOI 10.1016/0098-8472(93)90055-K; MEYER WS, 1990, AUST J AGR RES, V41, P253, DOI 10.1071/AR9900253; Osmond C. B., 1980, PHYSL PROCESSES PLAN, DOI 10.1007/978-3-642-67637-6; Palta J, 2009, CROP PHYSIOLOGY: APPLICATIONS FOR GENETIC IMPROVEMENT AND AGRONOMY, P309, DOI 10.1016/B978-0-12-374431-9.00013-X; Palta JA, 2011, FUNCT PLANT BIOL, V38, P347, DOI 10.1071/FP11031; PASSIOURA JB, 1983, AGR WATER MANAGE, V7, P265, DOI 10.1016/0378-3774(83)90089-6; Poorter H, 2012, FUNCT PLANT BIOL, V39, P839, DOI 10.1071/FP12049; Pritchard SG, 2006, AGR ECOSYST ENVIRON, V113, P175, DOI 10.1016/j.agee.2005.09.010; Qiao YZ, 2010, AGR WATER MANAGE, V97, P1742, DOI 10.1016/j.agwat.2010.06.007; R Core Team, 2021, R LANGUAGE ENV STAT; Rich SM, 2016, FUNCT PLANT BIOL, V43, P173, DOI 10.1071/FP15182; Richards RA, 2008, PLANT PROD SCI, V11, P12, DOI 10.1626/pps.11.12; ROGERS HH, 1992, PLANT CELL ENVIRON, V15, P749, DOI 10.1111/j.1365-3040.1992.tb01018.x; Rogers HH, 1996, PLANT SOIL, V187, P229, DOI 10.1007/BF00017090; SAAB IN, 1989, PLANTA, V179, P466, DOI 10.1007/BF00397586; Saradadevi R, 2016, FUNCT PLANT BIOL, V43, P62, DOI 10.1071/FP15216; Saradadevi R, 2014, FIELD CROP RES, V165, P5, DOI 10.1016/j.fcr.2014.06.025; Schmid I, 2016, J AGRON CROP SCI, V202, P81, DOI 10.1111/jac.12127; Seibt U, 2008, OECOLOGIA, V155, P441, DOI 10.1007/s00442-007-0932-7; SIDDIQUE KHM, 1990, PLANT SOIL, V121, P89, DOI 10.1007/BF00013101; Signorell A., DESCTOOLS TOOLS DESC; STONE LR, 1976, AGRON J, V68, P677, DOI 10.2134/agronj1976.00021962006800040037x; Tausz-Posch S, 2013, PHYSIOL PLANTARUM, V148, P232, DOI 10.1111/j.1399-3054.2012.01701.x; Tausz-Posch S, 2012, FIELD CROP RES, V133, P160, DOI 10.1016/j.fcr.2012.04.007; van der Kooi CJ, 2016, ENVIRON EXP BOT, V122, P150, DOI 10.1016/j.envexpbot.2015.10.004; VanVuuren MMI, 1997, NEW PHYTOL, V135, P455, DOI 10.1046/j.1469-8137.1997.00682.x; Wall GW, 2006, AGRON J, V98, P354, DOI 10.2134/agronj2004.0089; Wall GW, 2001, AGR ECOSYST ENVIRON, V87, P261, DOI 10.1016/S0167-8809(01)00170-0; Wang L, 2013, AGR ECOSYST ENVIRON, V178, P57, DOI 10.1016/j.agee.2013.06.013; Wasson AP, 2012, J EXP BOT, V63, P3485, DOI 10.1093/jxb/ers111; Wechsung G, 1995, J BIOGEOGR, V22, P623, DOI 10.2307/2845963; Wechsung G, 1999, GLOBAL CHANGE BIOL, V5, P519, DOI 10.1046/j.1365-2486.1999.00243.x; WONG SC, 1991, AUST J PLANT PHYSIOL, V18, P137, DOI 10.1071/PP9910137; Wu DX, 2004, AGR ECOSYST ENVIRON, V104, P493, DOI 10.1016/j.agee.2004.01.018; YU LX, 1995, CROP SCI, V35, P684, DOI 10.2135/cropsci1995.0011183X003500030005x; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Ziska LH, 2008, DNA CELL BIOL, V27, P165, DOI 10.1089/dna.2007.0726	83	21	22	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198928	10.1371/journal.pone.0198928	http://dx.doi.org/10.1371/journal.pone.0198928			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902235	Green Published, Green Submitted, gold			2022-12-26	WOS:000435424900063
J	Lin, MC; Chien, PH; Wu, HY; Chen, ST; Juan, HF; Lou, PJ; Huang, MC				Lin, Mei-Chun; Chien, Pin-Hui; Wu, Hsin-Yi; Chen, Syue-Ting; Juan, Hsueh-Fen; Lou, Pei-Jen; Huang, Min-Chuan			C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer	ONCOGENE			English	Article							MOLECULAR CHAPERONE COSMC; CELL LUNG-CANCER; O-GLYCOSYLATION; HEPATOCELLULAR-CARCINOMA; PROSTATE-CANCER; EGF RECEPTOR; ITRACONAZOLE; GROWTH; DIMERIZATION; ANGIOGENESIS	Core 1 beta 1,3-galactosyltransferase (C1GALT1) controls the crucial step of GalNAc-type O-glycosylation and is overexpressed in various human malignancies. However, its role in head and neck squamous cell carcinoma (HNSCC) remains unclear. Here we demonstrate that C1GALT1 expression is upregulated in HNSCC tumors and is associated with adverse clinicopathologic features. Moreover, high C1GALT1 expression predicts poor disease-free and overall survivals. C1GALT1 overexpression enhances HNSCC cell viability, migration, and invasion, which can be reversed by erlotinib. Silencing of C1GALT1 suppresses the malignant behavior both in vitro and in vivo. Mass spectrometry and lectin pull-down assays demonstrate that C1GALT1 modifies O-glycans on EGFR. Blocking O-glycan elongation on EGFR by C1GALT1 knockdown decreases EGF-EGFR binding affinity and inhibits EGFR signaling, thereby suppressing malignant phenotypes. Using molecular docking simulations, we identify itraconazole as a C1GALT1 inhibitor that directly binds C1GALT1 and promotes its proteasomal degradation, leading to significant blockade of C1GALT1-mediated effects in HNSCC cells in vitro and in vivo. Collectively, our findings demonstrate a critical role of O-glycosylation in HNSCC progression and highlight the therapeutic potential of targeting C1GALT1 in HNSCC treatment.	[Lin, Mei-Chun; Chien, Pin-Hui] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Otolaryngol, Hsinchu, Taiwan; [Lin, Mei-Chun] Natl Taiwan Univ, Canc Ctr, Taipei, Taiwan; [Wu, Hsin-Yi] Natl Taiwan Univ, Instrumentat Ctr, Taipei, Taiwan; [Chen, Syue-Ting; Huang, Min-Chuan] Natl Taiwan Univ, Grad Inst Anat & Cell Biol, Coll Med, Taipei, Taiwan; [Juan, Hsueh-Fen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Dept Life Sci, Taipei, Taiwan; [Lou, Pei-Jen] Natl Taiwan Univ Hosp & Coll Med, Dept Otolaryngol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Huang, MC (corresponding author), Natl Taiwan Univ, Grad Inst Anat & Cell Biol, Coll Med, Taipei, Taiwan.; Lou, PJ (corresponding author), Natl Taiwan Univ Hosp & Coll Med, Dept Otolaryngol, Taipei, Taiwan.	pjlou@ntu.edu.tw; mchuang@ntu.edu.tw		LOU, PEI-JEN/0000-0002-3383-8593; HUANG, MIN-CHUAN/0000-0002-0704-3447	National Taiwan University Hospital, Hsinchu Branch [HCH104-045, 106-HCH067]; Ministry of Science and Technology, R.O.C. [104-2320-B-002-068-MY3, 103-2314-B-002-082-MY2, 106-2923-B-002-003-MY3, 105-2314-B-002-203-MY2]; Academia Sinica, Taiwan Head and Neck Cancer Biosignature	National Taiwan University Hospital, Hsinchu Branch; Ministry of Science and Technology, R.O.C.; Academia Sinica, Taiwan Head and Neck Cancer Biosignature	We thank Chia-Hsien Lee for help in homology modeling and docking simulation. This study was supported by the National Taiwan University Hospital, Hsinchu Branch, HCH104-045, 106-HCH067 (M.-C.L.) and Ministry of Science and Technology, R.O.C. 104-2320-B-002-068-MY3 (M.-C.H.), 103-2314-B-002-082-MY2, 106-2923-B-002-003-MY3 (P.-J.L.), 105-2314-B-002-203-MY2 (M.-C.L.), and the Academia Sinica, Taiwan Head and Neck Cancer Biosignature (P.-J.L.).	Aftab BT, 2011, CANCER RES, V71, P6764, DOI 10.1158/0008-5472.CAN-11-0691; Antonarakis ES, 2013, ONCOLOGIST, V18, P163, DOI 10.1634/theoncologist.2012-314; Aryal RP, 2014, J BIOL CHEM, V289, P11630, DOI 10.1074/jbc.M114.555870; Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Chen BZ, 2016, MOL CANCER THER, V15, P866, DOI 10.1158/1535-7163.MCT-15-0729-T; Chou CH, 2015, ONCOTARGET, V6, P6123, DOI 10.18632/oncotarget.3045; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Harris KA, 2002, J UROLOGY, V168, P542, DOI 10.1016/S0022-5347(05)64675-7; HOLMES EH, 1987, J BIOL CHEM, V262, P11331; Hung JS, 2014, ONCOTARGET, V5, P2096, DOI 10.18632/oncotarget.1815; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kannagi R, 2008, BBA-GEN SUBJECTS, V1780, P525, DOI 10.1016/j.bbagen.2007.10.007; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; King SL, 2017, BLOOD ADV, V1, P429, DOI 10.1182/bloodadvances.2016002121; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; Leemans CR, 2018, NAT REV CANCER, V18, P269, DOI 10.1038/nrc.2018.11; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Liang GZ, 2017, ONCOTARGET, V8, P28510, DOI 10.18632/oncotarget.15324; Lin MC, 2014, ORAL ONCOL, V50, P478, DOI 10.1016/j.oraloncology.2014.02.003; Nguyen-Tan PF, 2014, J CLIN ONCOL, V32, P3858, DOI 10.1200/JCO.2014.55.3925; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Rudin CM, 2013, J THORAC ONCOL, V8, P619, DOI 10.1097/JTO.0b013e31828c3950; Schachter H, 2000, GLYCOCONJUGATE J, V17, P465; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsai CH, 2016, CANCER RES, V76, P5756, DOI 10.1158/0008-5472.CAN-16-0641; Tsubamoto H, 2014, ANTICANCER RES, V34, P2481; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Wu YM, 2013, CANCER RES, V73, P5580, DOI 10.1158/0008-5472.CAN-13-0869; Wu YM, 2011, CANCER RES, V71, P7270, DOI 10.1158/0008-5472.CAN-11-1161; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Yokota M, 1997, HISTOCHEM J, V29, P555, DOI 10.1023/A:1026475926033	39	31	32	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 25	2018	37	43					5780	5793		10.1038/s41388-018-0375-0	http://dx.doi.org/10.1038/s41388-018-0375-0			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GY1KL	29930379	Green Published, hybrid			2022-12-26	WOS:000448288200006
J	Thomas, A; Ramananda, Y; Mun, K; Naren, AP; Arora, K				Thomas, Andrew; Ramananda, Yashaswini; Mun, KyuShik; Naren, Anjaparavanda P.; Arora, Kavisha			AC6 is the major adenylate cyclase forming a diarrheagenic protein complex with cystic fibrosis transmembrane conductance regulator in cholera	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride channel; chloride transport; cyclic AMP (cAMP); cholera toxin; cystic fibrosis transmembrane conductance regulator (CFTR); adenylate cyclase (adenylyl cyclase)	INTESTINAL ION-TRANSPORT; CHLORIDE CHANNEL; CFTR; TOXIN; CAMP; COMPARTMENTALIZATION; PATHOPHYSIOLOGY; RESISTANCE; DOMAIN; CELLS	The World Health Organization(WHO) has reported a worldwide surge in cases of cholera caused by the intestinal pathogen Vibrio cholerae, and, combined, such surges have claimed several million lives, mostly in early childhood. Elevated cAMP production in intestinal epithelial cells challenged with cholera toxin (CTX) results in diarrhea due to chloride transport by a cAMP-activated channel, the cystic fibrosis transmembrane conductance regulator (CFTR). However, the identity of the main cAMP-producing proteins that regulate CFTR in the intestine and may be relevant for secretory diarrhea is unclear. Here, using RNA-Seq to identify the predominant AC isoform in mouse and human cells and extensive biochemical analyses for further characterization, we found that the cAMP-generating enzyme adenylate cyclase 6 (AC6) physically and functionally associates with CFTR at the apical surface of intestinal epithelial cells. We generated epithelium-specific AC6 knockout mice and demonstrated that CFTR-dependent fluid secretion is nearly abolished in AC6 knockout mice upon CTX challenge in ligated ileal loops. Furthermore, loss of AC6 function dramatically impaired CTX-induced CFTR activation in human and mouse intestinal spheroids. Our finding that the CFTR-AC6 protein complex is the key mediator of CTX-associated diarrhea may facilitate development of antidiarrheal agents to manage cholera symptoms and improve outcomes.	[Thomas, Andrew; Ramananda, Yashaswini; Mun, KyuShik; Naren, Anjaparavanda P.; Arora, Kavisha] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Pulm Med, 3333 Burnet Ave,MLC 2021, Cincinnati, OH 45229 USA; [Ramananda, Yashaswini] Univ Illinois, Dept Biomed Sci, Chicago, IL 60607 USA	Cincinnati Children's Hospital Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Naren, AP; Arora, K (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Pulm Med, 3333 Burnet Ave,MLC 2021, Cincinnati, OH 45229 USA.	anaren@cchmc.org; kavisha.arora@cchmc.org			National Institutes of Health [DK080834, DK093045]; Cystic Fibrosis Foundation [ARORA16F0]; NAREN [14XX0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL113229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093045, P30DK117467, R01DK080834, P30DK078392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NAREN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK080834 and DK093045 (to A. P. N.) and Cystic Fibrosis Foundation Grants ARORA16F0 (to K. A.) and NAREN 14XX0 (to A. P. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arora K, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93686; Arora K, 2014, BIOCHEMISTRY-US, V53, P4169, DOI 10.1021/bi401263h; Arora K, 2013, PFLUG ARCH EUR J PHY, V465, P1397, DOI 10.1007/s00424-013-1280-6; Bozoky Z, 2017, P NATL ACAD SCI USA, V114, pE2086, DOI 10.1073/pnas.1613546114; Cheepala S, 2013, ANNU REV PHARMACOL, V53, P231, DOI 10.1146/annurev-pharmtox-010611-134609; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Chey WD, 2012, AM J GASTROENTEROL, V107, P1702, DOI 10.1038/ajg.2012.254; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Dessauer CW, 2017, PHARMACOL REV, V69, P93, DOI 10.1124/pr.116.013078; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Finkelstein R. A., 1996, MED MICROBIOLOGY; Foulke-Abel J, 2016, GASTROENTEROLOGY, V150, P638, DOI 10.1053/j.gastro.2015.11.047; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; Ma JJ, 1997, J BIOL CHEM, V272, P28133, DOI 10.1074/jbc.272.44.28133; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Melis N, 2014, BRIT J PHARMACOL, V171, P3716, DOI 10.1111/bph.12726; Moon C, 2015, J BIOL CHEM, V290, P11246, DOI 10.1074/jbc.M114.605410; Pasyk S, 2015, PROTEOMICS, V15, P447, DOI 10.1002/pmic.201400218; Sabbatini ME, 2013, J PHYSIOL-LONDON, V591, P3693, DOI 10.1113/jphysiol.2012.249698; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Torres VE, 2014, J AM SOC NEPHROL, V25, P18, DOI 10.1681/ASN.2013040398; Vanden Broeck D, 2007, INT J BIOCHEM CELL B, V39, P1771, DOI 10.1016/j.biocel.2007.07.005; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002	30	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12949	12959		10.1074/jbc.RA118.003378	http://dx.doi.org/10.1074/jbc.RA118.003378			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29903911	Green Published, hybrid			2022-12-26	WOS:000442203500029
J	Yang, Y; Kong, SY; Zhang, YN; Melo-Cardenas, J; Gao, BX; Zhang, YS; Zhang, DD; Zhang, B; Song, JX; Thorp, E; Zhang, KZ; Zhang, JP; Fang, DY				Yang, Yi; Kong, Sinyi; Zhang, Yana; Melo-Cardenas, Johanna; Gao, Beixue; Zhang, Yusi; Zhang, Donna D.; Zhang, Bin; Song, Jianxun; Thorp, Edward; Zhang, Kezhong; Zhang, Jinping; Fang, Deyu			The endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 controls a critical checkpoint in B cell development in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lymphocyte; unfolded protein response (UPR); ubiquitin ligase; ubiquitin; protein turnover; pre-BCR	SHOCK-PROTEIN GP96; TOLL-LIKE RECEPTORS; LIGHT-CHAIN; PRE-BCR; TRANSCRIPTIONAL ACTIVATION; NEGATIVE REGULATION; AUTOIMMUNE-DISEASE; MASTER CHAPERONE; TRANSMEMBRANE 5; DEGRADATION	Humoral immunity involves multiple checkpoints that occur in B cell development, maturation, and activation. The pre-B-cell receptor (pre-BCR) is expressed following the productive recombination of the immunoglobulin heavy-chain gene, and sSignalsing through the pre-BCR are required for the differentiation of pre-B cells into immature B cells. However, the molecular mechanisms controlling the pre-BCR expression and signaling strength remain undefined. Herein, we probed the role of the endoplasmic reticulum-associated, stress-activated E3 ubiquitin ligase HMG-CoA reductase degradation 1 (Hrd1) in B cell differentiation. Using mice with a specific Hrd1 deletion in pro-B cells and subsequent B cell developmental stages, we showed that the E3 ubiquitin ligase Hrd1 governs a critical checkpoint during B cell development. We observed that Hrd1 is required for degradation of the pre-BCR complex during the early stage of B cell development. As a consequence, loss of Hrd1 in the B cell lineage resulted in increased pre-BCR expression levels and a developmental defect in the transition from large to small pre-B cells. This defect, in turn, resulted in reduced fewer mature B cells in bone marrow and peripheral lymphoid organs. Our results revealed a novel critical role of Hrd1 in controlling a critical checkpoint in B cell-mediated immunity and suggest that Hrd1 may functioning as an E3 ubiquitin ligase of the pre-BCR complex.	[Yang, Yi; Zhang, Jinping] Soochow Univ, Inst Biol, Suzhou 215123, Jiangsu, Peoples R China; [Yang, Yi; Zhang, Jinping] Soochow Univ, Inst Med Sci, Suzhou 215123, Jiangsu, Peoples R China; [Yang, Yi; Kong, Sinyi; Zhang, Yana; Melo-Cardenas, Johanna; Gao, Beixue; Zhang, Yusi; Thorp, Edward; Fang, Deyu] Northwestern Univ, Feinberg Sch Med, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA; [Zhang, Yana] Guangzhou Women & Childrens Med Ctr, Dept Otolaryngol Head & Neck Surg, Guangzhou 510623, Guangdong, Peoples R China; [Zhang, Donna D.] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Zhang, Bin] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol,Dept Med, Chicago, IL 60611 USA; [Song, Jianxun] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA 16801 USA; [Zhang, Kezhong] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Dept Immunol & Microbiol, Detroit, MI 48201 USA	Soochow University - China; Soochow University - China; Northwestern University; Feinberg School of Medicine; University of Arizona; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Wayne State University	Zhang, JP (corresponding author), Soochow Univ, Inst Biol, Suzhou 215123, Jiangsu, Peoples R China.; Zhang, JP (corresponding author), Soochow Univ, Inst Med Sci, Suzhou 215123, Jiangsu, Peoples R China.; Fang, DY (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA.	j_pzhang@suda.edu.cn; fangd@northwestern.edu	zhang, jin/GXV-9154-2022	Zhang, Kezhong/0000-0002-6062-235X; Melo-Cardenas, Johanna/0000-0002-5122-3349	National Institutes of Health [AI079056, AI108634, AR006634]; National Natural Science Foundation of China (NSFC) [81600784, 31270939, 81471526, 81771667]; Training Program of the Major Research Plan in regional immunology of the National Natural Science Foundation of China [91442110]; Natural Science Foundation of Jiangsu Province [BK20170349]; postdoctoral foundation of China; Social development project of Jiangsu Province Grant [BE2016676]; Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences of Soochow University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL139812, R01HL122309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI079056, R01AI108634, R01AI079056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES026845, P30ES006694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Training Program of the Major Research Plan in regional immunology of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); postdoctoral foundation of China(China Postdoctoral Science Foundation); Social development project of Jiangsu Province Grant; Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences of Soochow University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health R01 Grants AI079056, AI108634, and AR006634 (to D. F.) and National Natural Science Foundation of China (NSFC) Grants 81600784 (to Y. Z.) 31270939, 81471526, and 81771667, Training Program of the Major Research Plan in regional immunology of the National Natural Science Foundation of China Grant 91442110,; Natural Science Foundation of Jiangsu Province Grant BK20170349, a postdoctoral foundation of China grant (to Y. Y.), Social development project of Jiangsu Province Grant BE2016676 (to Y. Y.), and the Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences of Soochow University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brouns GS, 1996, J BIOL CHEM, V271, P19272, DOI 10.1074/jbc.271.32.19272; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Fujita H, 2015, EMBO J, V34, P1042, DOI 10.15252/embj.201489897; Gao BX, 2008, EMBO REP, V9, P480, DOI 10.1038/embor.2008.37; Geier JK, 2006, SEMIN IMMUNOL, V18, P31, DOI 10.1016/j.smim.2005.11.001; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Ji YW, 2016, CELL REP, V16, P2630, DOI 10.1016/j.celrep.2016.08.003; Kawano Y, 2012, MOL CELL BIOL, V32, P4462, DOI 10.1128/MCB.00531-12; Keren Z, 2004, J BIOL CHEM, V279, P13418, DOI 10.1074/jbc.M311970200; Khan WN, 2009, J IMMUNOL, V183, P3561, DOI 10.4049/jimmunol.0800933; Kong SY, 2016, P NATL ACAD SCI USA, V113, P10394, DOI 10.1073/pnas.1606742113; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; Levine MH, 2000, P NATL ACAD SCI USA, V97, P2743, DOI 10.1073/pnas.050552997; LI ZH, 1993, EMBO J, V12, P3143, DOI 10.1002/j.1460-2075.1993.tb05983.x; Lin ZH, 2013, CELL REP, V5, P1639, DOI 10.1016/j.celrep.2013.11.029; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Liu B, 2003, P NATL ACAD SCI USA, V100, P15824, DOI 10.1073/pnas.2635458100; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Mackay F, 2010, IMMUNOL REV, V237, P205, DOI 10.1111/j.1600-065X.2010.00944.x; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; NISHIMOTO N, 1991, P NATL ACAD SCI USA, V88, P6284, DOI 10.1073/pnas.88.14.6284; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Ouchida R, 2010, J IMMUNOL, V185, P294, DOI 10.4049/jimmunol.1000371; Rickert RC, 2013, NAT REV IMMUNOL, V13, P578, DOI 10.1038/nri3487; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Staron M, 2011, BLOOD, V117, P7136, DOI 10.1182/blood-2011-01-330464; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; Sun SY, 2015, NAT CELL BIOL, V17, P1546, DOI 10.1038/ncb3266; Thaxton JE, 2014, J IMMUNOL, V192, P5679, DOI 10.4049/jimmunol.1302755; Ubelhart R, 2010, NAT IMMUNOL, V11, P759, DOI 10.1038/ni.1903; van Loo PF, 2007, IMMUNITY, V27, P468, DOI 10.1016/j.immuni.2007.07.018; Wu S, 2012, J BIOL CHEM, V287, P19896, DOI 10.1074/jbc.M112.343848; Wu S, 2012, J BIOL CHEM, V287, P6735, DOI 10.1074/jbc.M111.309526; Wu TD, 2014, GENE DEV, V28, P708, DOI 10.1101/gad.238246.114; Yang H, 2014, J EXP MED, V211, P2467, DOI 10.1084/jem.20140283; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhang YL, 2015, J CLIN INVEST, V125, P859, DOI 10.1172/JCI79014; Zheng H, 2001, J IMMUNOL, V167, P6731, DOI 10.4049/jimmunol.167.12.6731; Zhou AX, 2015, CIRC RES, V116, P1736, DOI 10.1161/CIRCRESAHA.116.305602	45	13	13	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12934	12944		10.1074/jbc.RA117.001267	http://dx.doi.org/10.1074/jbc.RA117.001267			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29907570	Green Published, hybrid			2022-12-26	WOS:000442203500024
J	Skotnicova, P; Sobotka, R; Shepherd, M; Hajek, J; Hrouzek, P; Tichy, M				Skotnicova, Petra; Sobotka, Roman; Shepherd, Mark; Hajek, Jan; Hrouzek, Pavel; Tichy, Martin			The cyanobacterial protoporphyrinogen oxidase HemJ is a new b-type heme protein functionally coupled with coproporphyrinogen III oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photosynthesis; heme; cyanobacteria; enzyme purification; membrane protein; coproporphyrinogen III oxidase; HemJ; protoporphyrinogen IX oxidase; Synechocystis sp; PCC 6803	ESCHERICHIA-COLI; PHOTOSYSTEM-II; TETRAPYRROLE BIOSYNTHESIS; GENE-EXPRESSION; PCC 6803; COMPLEX; PORPHYRIN; DISCOVERY; OXIDATION; SEQUENCE	Protoporphyrinogen IX oxidase (PPO), the last enzyme that is common to both chlorophyll and heme biosynthesis pathways, catalyzes the oxidation of protoporphyrinogen IX to protoporphyrin IX. PPO has several isoforms, including the oxygen-dependent HemY and an oxygen-independent enzyme, HemG. However, most cyanobacteria encode HemJ, the least characterized PPO form. We have characterized HemJ from the cyanobacterium Synechocystis sp. PCC 6803 (Synechocystis 6803) as a bona fide PPO; HemJ down-regulation resulted in accumulation of tetrapyrrole precursors and in the depletion of chlorophyll precursors. The expression of FLAG-tagged Synechocystis 6803 HemJ protein (HemJ.f) and affinity isolation of HemJ.f under native conditions revealed that it binds heme b. The most stable HemJ.f form was a dimer, and higher oligomeric forms were also observed. Using both oxygen and artificial electron acceptors, we detected no enzymatic activity with the purified HemJ.f, consistent with the hypothesis that the enzymatic mechanism for HemJ is distinct from those of other PPO isoforms. The heme absorption spectra and distant HemJ homology to several membrane oxidases indicated that the heme in HemJ is redox-active and involved in electron transfer. HemJ was conditionally complemented by another PPO, HemG from Escherichia coli. If grown photoautotrophically, the complemented strain accumulated tripropionic tetrapyrrole harderoporphyrin, suggesting a defect in enzymatic conversion of coproporphyrinogen III to protoporphyrinogen IX, catalyzed by coproporphyrinogen III oxidase (CPO). This observation supports the hypothesis that HemJ is functionally coupled with CPO and that this coupling is disrupted after replacement of HemJ by HemG.	[Skotnicova, Petra; Sobotka, Roman; Hajek, Jan; Hrouzek, Pavel; Tichy, Martin] Czech Acad Sci, Inst Microbiol, Ctr Algatech, Trebon 37981, Czech Republic; [Skotnicova, Petra; Sobotka, Roman; Hajek, Jan; Hrouzek, Pavel; Tichy, Martin] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Shepherd, Mark] Univ Kent, RAPID Grp, Sch Biosci, Canterbury CT2 7NZ, Kent, England	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Kent	Tichy, M (corresponding author), CAS, Ctr Algatech, Inst Microbiol, Novohradska 237, Trebon 37981, Czech Republic.	tichym@alga.cz	Skotnicová, Petra/J-6875-2014; Skotnicová, Petra/Y-5866-2019; Tichy, Martin/B-6545-2008; Sobotka, Roman/J-3077-2014	Skotnicová, Petra/0000-0002-6077-0256; Skotnicová, Petra/0000-0002-6077-0256; Tichy, Martin/0000-0003-2814-1959; Hrouzek, Pavel/0000-0002-2061-0266; Shepherd, Mark/0000-0002-7472-2300; Sobotka, Roman/0000-0001-5909-3879	Czech Science Foundation [P501/12/G055]; Czech Ministry of Education Projects [LO1416, LM2015055]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Education Projects	This work was supported by Project P501/12/G055 of the Czech Science Foundation and by Czech Ministry of Education Projects LO1416 and LM2015055. The authors declare that they have no conflicts of interest with the contents of this article.	Boynton TO, 2011, APPL ENVIRON MICROB, V77, P4795, DOI 10.1128/AEM.00171-11; Boynton TO, 2009, BIOCHEMISTRY-US, V48, P6705, DOI 10.1021/bi900850y; Brzezowski P, 2015, BBA-BIOENERGETICS, V1847, P968, DOI 10.1016/j.bbabio.2015.05.007; Buinska L., 2018, PLANT PHYSIOL, V176, P2931; Chidgey JW, 2014, PLANT CELL, V26, P1267, DOI 10.1105/tpc.114.124495; Czarnecki O, 2012, J EXP BOT, V63, P1675, DOI 10.1093/jxb/err437; Dailey HA, 1996, J BIOL CHEM, V271, P8714, DOI 10.1074/jbc.271.15.8714; Dailey HA, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00048-16; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dobakova M, 2009, PLANT PHYSIOL, V149, P1076, DOI 10.1104/pp.108.130039; ELDER GH, 1978, BIOCHEM J, V169, P215, DOI 10.1042/bj1690215; FERREIRA GC, 1988, J BIOL CHEM, V263, P3835; Gomelsky M, 1996, J BACTERIOL, V178, P1946, DOI 10.1128/jb.178.7.1946-1954.1996; Goto T, 2010, PLANT CELL PHYSIOL, V51, P650, DOI 10.1093/pcp/pcq023; Hobbs C, 2016, BIOCHEM J, V473, P3997, DOI 10.1042/BCJ20160696; JACOBS NJ, 1981, ARCH BIOCHEM BIOPHYS, V211, P305, DOI 10.1016/0003-9861(81)90458-6; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kahlon S, 2006, MICROBIOL-SGM, V152, P647, DOI 10.1099/mic.0.28510-0; Kato K, 2010, P NATL ACAD SCI USA, V107, P16649, DOI 10.1073/pnas.1000771107; KENNEDY GY, 1970, COMP BIOCHEM PHYSIOL, V36, P21, DOI 10.1016/0010-406X(70)90647-X; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Knoppova J, 2014, PLANT CELL, V26, P1200, DOI 10.1105/tpc.114.123919; Kobayashi K, 2014, GENOME BIOL EVOL, V6, P2141, DOI 10.1093/gbe/evu170; Komenda J, 2010, BBA-BIOENERGETICS, V1797, P566, DOI 10.1016/j.bbabio.2010.02.006; Kopecna J, 2015, PLANT PHYSIOL, V169, P1307, DOI 10.1104/pp.15.01150; Krynicka V, 2014, MOL MICROBIOL, V94, P609, DOI 10.1111/mmi.12782; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; Lermontova I, 2006, PLANT J, V48, P499, DOI 10.1111/j.1365-313X.2006.02894.x; Li T, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-13; Lim, 2010, HIGH PERFORMANCE LIQ; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Lu PL, 2014, P NATL ACAD SCI USA, V111, P1813, DOI 10.1073/pnas.1323931111; Ma JZ, 2012, BIOINFORMATICS, V28, pI59, DOI 10.1093/bioinformatics/bts213; Mann NH, 2000, FEBS LETT, V479, P72, DOI 10.1016/S0014-5793(00)01871-8; Masoumi A, 2008, MICROBIOL-SGM, V154, P3707, DOI 10.1099/mic.0.2008/018705-0; Medlock AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135896; MILLER MJ, 1988, J BIOL CHEM, V263, P5235; Mobius K, 2010, P NATL ACAD SCI USA, V107, P10436, DOI 10.1073/pnas.1000956107; Narita S, 1996, GENE, V182, P169, DOI 10.1016/S0378-1119(96)00545-8; Nishimura K., 1995, DNA RES, V2, P1, DOI 10.1093/dnares/2.1.1; NORDMANN Y, 1983, J CLIN INVEST, V72, P1139, DOI 10.1172/JCI111039; Phillips JD, 2004, J BIOL CHEM, V279, P38960, DOI 10.1074/jbc.M406050200; Pilny J., 2015, BIO-PROTOCOL, V5, pe1390; Rand K, 2010, BIOL CHEM, V391, P55, DOI 10.1515/BC.2010.006; Sarian FD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148358; SASARMAN A, 1993, CAN J MICROBIOL, V39, P1155, DOI 10.1139/m93-174; SASARMAN A, 1979, J GEN MICROBIOL, V113, P297, DOI 10.1099/00221287-113-2-297; Schmitt C, 2005, HUM MOL GENET, V14, P3089, DOI 10.1093/hmg/ddi342; SHEN GZ, 1993, PLANT CELL, V5, P1853, DOI 10.1105/tpc.5.12.1853; Shepherd M, 2005, ANAL BIOCHEM, V344, P115, DOI 10.1016/j.ab.2005.06.012; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Stadnichuk I, 1998, PLANT SCI, V136, P11, DOI 10.1016/S0168-9452(98)00088-0; Summerfield TC, 2011, MICROBIOL-SGM, V157, P301, DOI 10.1099/mic.0.041053-0; Wang S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005324; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Zhang CX, 2017, NUCLEIC ACIDS RES, V45, pW291, DOI 10.1093/nar/gkx366	57	12	12	3	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12394	12404		10.1074/jbc.RA118.003441	http://dx.doi.org/10.1074/jbc.RA118.003441			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29925590	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000441408500007
J	Murillo-de-Ozores, AR; Rodriguez-Gama, A; Bazua-Valenti, S; Leyva-Rios, K; Vazquez, N; Pacheco-Alvarez, D; De La Rosa-Velazquez, IA; Wengi, A; Stone, KL; Zhang, JH; Loffing, J; Lifton, RP; Yang, CL; Ellison, DH; Gamba, G; Castaneda-Bueno, M				Rafael Murillo-De-Ozores, Adrian; Rodriguez-Gama, Alejandro; Bazua-Valenti, Silvana; Leyva-Rios, Karla; Vazquez, Norma; Pacheco-Alvarez, Diana; De La Rosa-Velazquez, Inti A.; Wengi, Agnieszka; Stone, Kathryn L.; Zhang, Junhui; Loffing, Johannes; Lifton, Richard P.; Yang, Chao-Ling; Ellison, David H.; Gamba, Gerardo; Castaneda-Bueno, Maria			C-terminally truncated, kidney-specific variants of the WNK4 kinase lack several sites that regulate its activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kidney; hypertension; membrane transport; protein phosphatase; phosphoprotein phosphatase 1 (PP1); proteolysis; serine; threonine protein kinase; pseudohypoaldosteronism; Ste20-related proline; alanine-rich kinase; WNK lysine-deficient protein kinase 4	PROTEIN PHOSPHATASE 1; BLOOD-PRESSURE; NA+ CHANNEL; COTRANSPORTER; SPAK; ACTIVATION; PHOSPHORYLATION; UBIQUITINATION; HYPERTENSION; HOMEOSTASIS	WNK lysine-deficient protein kinase 4 (WNK4) is an important regulator of renal salt handling. Mutations in its gene cause pseudohypoaldosteronism type II, mainly arising from overactivation of the renal Na+/Cl- cotransporter (NCC). In addition to full-length WNK4, we have observed faster migrating bands (between 95 and 130 kDa) in Western blots of kidney lysates. Therefore, we hypothesized that these could correspond to uncharacterized WNK4 variants. Here, using several WNK4 antibodies and WNK4(-/-) mice as controls, we showed that these bands indeed correspond to short WNK4 variants that are not observed in other tissue lysates. LC-MS/MS confirmed these bands as WNK4 variants that lack C-terminal segments. In HEK293 cells, truncation of WNK4's C terminus at several positions increased its kinase activity toward Ste20-related proline/alanine-rich kinase (SPAK), unless the truncated segment included the SPAK-binding site. Of note, this gain-of-function effect was due to the loss of a protein phosphatase 1 (PP1)-binding site in WNK4. Cotransfection with PP1 resulted in WNK4 dephosphorylation, an activity that was abrogated in the PP1-binding site WNK4 mutant. The electrophoretic mobility of the in vivo short variants of renal WNK4 suggested that they lack the SPAK-binding site and thus may not behave as constitutively active kinases toward SPAK. Finally, we show that at least one of the WNK4 short variants may be produced by proteolysis involving a Zn2+-dependent metalloprotease, as recombinant full-length WNK4 was cleaved when incubated with kidney lysate.	[Rafael Murillo-De-Ozores, Adrian] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 14080, DF, Mexico; [Rodriguez-Gama, Alejandro; Bazua-Valenti, Silvana; Vazquez, Norma; Gamba, Gerardo] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 14080, DF, Mexico; [Leyva-Rios, Karla; Pacheco-Alvarez, Diana] Univ Panamer, Escuela Med, Mexico City 03920, DF, Mexico; [De La Rosa-Velazquez, Inti A.] Univ Nacl Autonoma Mexico, Genom Lab, RAI, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14080, DF, Mexico; [Wengi, Agnieszka; Loffing, Johannes] Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland; [Wengi, Agnieszka; Loffing, Johannes] Univ Zurich, Swiss Natl Ctr Competence Res Kidney Control Home, CH-8057 Zurich, Switzerland; [Stone, Kathryn L.] Yale Univ, Sch Med, MS & Prote Resource, WM Keck Biotechnol Resource Lab, New Haven, CT 06510 USA; [Zhang, Junhui; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Lifton, Richard P.] Rockefeller Univ, Lab Human Genet & Genom, New York, NY 10065 USA; [Yang, Chao-Ling; Ellison, David H.] Oregon Hlth & Sci Univ, Dept Med, Div Nephrol & Hypertens, Portland, OR 97239 USA; [Yang, Chao-Ling; Ellison, David H.] Vet Affairs Portland Hlth Care Syst, Portland, OR 97239 USA; [Gamba, Gerardo; Castaneda-Bueno, Maria] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nephrol & Mineral Metab, Mexico City 14080, DF, Mexico; [Gamba, Gerardo] Escuela Med & Ciencias Salud, Tecnol Monterrey, Monterrey 64710, Nuevo Leon, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Panamericana - Ciudad de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; University of Zurich; University of Zurich; Yale University; Yale University; Rockefeller University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Tecnologico de Monterrey	Castaneda-Bueno, M (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nephrol & Mineral Metab, Mexico City 14080, DF, Mexico.	mcasta85@yahoo.com.mx	Loffing, Johannes/ABG-9973-2020; CASTANEDA-BUENO, MARIA/GYR-1202-2022; , David/X-5730-2019	Rodriguez Gama, Alejandro/0000-0003-3257-5549; Loffing, Johannes/0000-0002-9415-6588; Pacheco-Alvarez, Diana/0000-0001-5454-9267	National Institutes of Health [DK51496]; Conacyt [23, 257726]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK51496 (to G.G., C.-L.Y., and D.H.E.) and Conacyt Grants 23 (to G.G.) and 257726 (to M.C.-B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Argaiz ER, 2018, AM J PHYSIOL-RENAL, V315, pF734, DOI 10.1152/ajprenal.00145.2018; Arvaniti E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26235; Bazua-Valenti S, 2015, J AM SOC NEPHROL, V26, P1781, DOI 10.1681/ASN.2014050470; Beynon R., 2000, PROTEOLYTIC ENZYMES, P105; Castaneda-Bueno M, 2017, P NATL ACAD SCI USA, V114, pE879, DOI 10.1073/pnas.1620315114; Castaneda-Bueno M, 2012, P NATL ACAD SCI USA, V109, P7929, DOI 10.1073/pnas.1200947109; Chavez-Canales M, 2014, HYPERTENSION, V64, P1047, DOI 10.1161/HYPERTENSIONAHA.114.04036; Correa LM, 2000, DEV BIOL, V225, P124, DOI 10.1006/dbio.2000.9825; de los Heros P, 2006, P NATL ACAD SCI USA, V103, P1976, DOI 10.1073/pnas.0510947103; Frenette-Cotton R, 2018, J CELL PHYSIOL, V233, P396, DOI 10.1002/jcp.25899; Gagnon KB, 2012, PHYSIOL REV, V92, P1577, DOI 10.1152/physrev.00009.2012; Grimm PR, 2017, J AM SOC NEPHROL, V28, P2598, DOI 10.1681/ASN.2016090948; Ishizawa K, 2016, BIOCHEM BIOPH RES CO, V480, P745, DOI 10.1016/j.bbrc.2016.10.127; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Koumangoye R, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13479; Krishnan N, 2012, MOL CELL BIOL, V32, P4306, DOI 10.1128/MCB.00382-12; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Lin DH, 2012, AM J PHYSIOL-RENAL, V303, pF110, DOI 10.1152/ajprenal.00676.2011; Lobbestael E, 2013, BIOCHEM J, V456, P119, DOI 10.1042/BJ20121772; Markadieu N, 2014, J BIOL CHEM, V289, P29273, DOI 10.1074/jbc.M114.604009; Markadieu N, 2012, AM J PHYSIOL-RENAL, V303, pF886, DOI 10.1152/ajprenal.00114.2012; McCormick JA, 2011, CELL METAB, V14, P352, DOI 10.1016/j.cmet.2011.07.009; Naraine MK, 2017, FASEB J, V31; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Piala AT, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005050; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Ponce-Coria J, 2014, J BIOL CHEM, V289, P17680, DOI 10.1074/jbc.M113.540518; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4025, DOI 10.1073/pnas.0611728104; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4020, DOI 10.1073/pnas.0611727104; San-Cristobal P, 2008, AM J PHYSIOL-RENAL, V295, pF1199, DOI 10.1152/ajprenal.90396.2008; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/nprot.2006.481; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shibata S, 2013, P NATL ACAD SCI USA, V110, P7838, DOI 10.1073/pnas.1304592110; Terker AS, 2015, CELL METAB, V21, P39, DOI 10.1016/j.cmet.2014.12.006; Thastrup JO, 2012, BIOCHEM J, V441, P325, DOI 10.1042/BJ20111879; Villa F, 2007, EMBO REP, V8, P839, DOI 10.1038/sj.embor.7401048; Wakabayashi M, 2013, CELL REP, V3, P858, DOI 10.1016/j.celrep.2013.02.024; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Xiao YX, 2015, ANAL BIOCHEM, V477, P95, DOI 10.1016/j.ab.2014.11.006; Yang CL, 2007, BIOCHEM BIOPH RES CO, V353, P535, DOI 10.1016/j.bbrc.2006.11.151; Yang CL, 2005, J CLIN INVEST, V115, P1379, DOI 10.1172/JCI200522452; Zhang C., 2016, AM J PHYSIOL-RENAL, V312, pF622	47	6	6	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12209	12221		10.1074/jbc.RA118.003037	http://dx.doi.org/10.1074/jbc.RA118.003037			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29921588	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000440803200019
J	Langerud, AK; Rustoen, T; Smastuen, MC; Kongsgaard, U; Stubhaug, A				Langerud, Anne Kathrine; Rustoen, Tone; Smastuen, Milada Cvancarova; Kongsgaard, Ulf; Stubhaug, Audun			Health-related quality of life in intensive care survivors: Associations with social support, comorbidity, and pain interference	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; SCORE SAPS-II; CRITICAL ILLNESS; LONG-TERM; PREEXISTING DISEASE; FOLLOW-UP; CANCER; UNIT; ICU; VALIDATION	Background Experiences during a stay in the intensive care unit (ICU), including pain, delirium, physical deterioration, and the critical illness itself, may all influence survivors' health-related quality of life (HRQOL). However, few studies have examined the influence of social support, comorbidity, and pain interference on ICU survivors' HRQOL. Objectives To investigate possible associations between social support, number of comorbidities, and pain interference on HRQOL in ICU survivors. Methods ICU survivors responded to a survey 3 months (n = 118) and 1 year (n = 89) after ICU discharge. HRQOL was measured using the Short Form Health Survey-12 (v1), social support using the revised Social Provision Scale, pain interference using the Brief Pain Inventory-Short Form, and comorbidities using the Self-Administered Comorbidity Questionnaire. Results Physical and mental HRQOL were reduced at both 3 months and 1 year in ICU survivors compared with the general population. This reduction was more pronounced at 3 months for physical HRQOL, while a small reduction in mental HRQOL was not clinically relevant. Social support was statistical significantly positively associated with mental HRQOL at 3 months, while number of comorbidities was statistical significantly associated with a reduction in physical HRQOL at 3 months and 1 year and mental HRQOL at 1 year. Lastly pain interference was significantly associated with a reduction in physical HRQOL at 3 months and 1 year. Conclusions ICU survivors primarily report reduced physical HRQOL. Social support was positively associated with mental HRQOL, while number of comorbidities, and pain interference were all significantly associated with a reduction in HRQOL. Pain interference was associated with the largest reduction in HRQOL.	[Langerud, Anne Kathrine; Rustoen, Tone] Oslo Univ Hosp, Dept Res & Dev, Div Emergencies & Crit Care, Oslo, Norway; [Langerud, Anne Kathrine] Oslo Univ Hosp, Rikshosp, Dept Postoperat & Crit Care, Div Emergencies & Crit Care, Oslo, Norway; [Langerud, Anne Kathrine; Kongsgaard, Ulf; Stubhaug, Audun] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Rustoen, Tone] Univ Oslo, Fac Med, Inst Hlth & Soc, Dept Nursing Sci, Oslo, Norway; [Smastuen, Milada Cvancarova] Oslo Metropolitan Univ, Fac Hlth Sci, Oslo, Norway; [Kongsgaard, Ulf] Oslo Univ Hosp, Radiumhospit, Dept Anesthesiol, Div Emergencies & Crit Care, Oslo, Norway; [Stubhaug, Audun] Oslo Univ Hosp, Dept Pain Management & Res, Div Emergencies & Crit Care, Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Oslo Metropolitan University (OsloMet); University of Oslo; University of Oslo	Langerud, AK (corresponding author), Oslo Univ Hosp, Dept Res & Dev, Div Emergencies & Crit Care, Oslo, Norway.; Langerud, AK (corresponding author), Oslo Univ Hosp, Rikshosp, Dept Postoperat & Crit Care, Div Emergencies & Crit Care, Oslo, Norway.; Langerud, AK (corresponding author), Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway.	alangeru@ous-hf.no			Oslo University Hospital, Department of Research and Development, Division of Emergencies and Critical Care	Oslo University Hospital, Department of Research and Development, Division of Emergencies and Critical Care	The first author was funded by internal funding from Oslo University Hospital, Department of Research and Development, Division of Emergencies and Critical Care. The funder had no role in the study.	Angus DC, 2003, INTENS CARE MED, V29, P368, DOI 10.1007/s00134-002-1624-8; Astrup GL, 2015, PAIN, V156, P967, DOI 10.1097/j.pain.0000000000000142; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Battle CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116304; Berntzen H, 2018, J CLIN NURS, V27, pE223, DOI 10.1111/jocn.13920; Bondevik M, 1997, LIFE OLDEST OLD STUD; Boyko Y, 2012, ACTA ANAESTH SCAND, V56, P950, DOI 10.1111/j.1399-6576.2012.02672.x; Boyle Martin, 2004, Aust Crit Care, V17, P104, DOI 10.1016/S1036-7314(04)80012-2; Brinkman S, 2013, INTENS CARE MED, V39, P1925, DOI 10.1007/s00134-013-3042-5; Cella D, 2002, MAYO CLIN PROC, V77, P384, DOI 10.4065/77.4.384; Chaboyer W, 2000, Intensive Crit Care Nurs, V16, P88, DOI 10.1054/iccn.1999.1582; Christensen VL, 2016, PAIN MANAG NURS, V17, P107, DOI 10.1016/j.pmn.2016.01.002; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; CONSTABLE JF, 1986, J HUM STRESS, V12, P20, DOI 10.1080/0097840X.1986.9936762; Cuthbertson BH, 2005, ANAESTHESIA, V60, P332, DOI 10.1111/j.1365-2044.2004.04109.x; Cutrona C.E., 1987, ADV PERSONAL RELATIO, V1, P37; CUTRONA CE, 1984, J ABNORM PSYCHOL, V93, P378, DOI 10.1037/0021-843X.93.4.378; CUTRONA CE, 1986, J PERS SOC PSYCHOL, V50, P349, DOI 10.1037/0022-3514.50.2.349; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; Dowdy DW, 2005, INTENS CARE MED, V31, P611, DOI 10.1007/s00134-005-2592-6; Duggan MC, 2017, J CRIT CARE, V37, P72, DOI 10.1016/j.jcrc.2016.08.023; Elliott R, 2014, INTENS CRIT CARE NUR, V30, P246, DOI 10.1016/j.iccn.2014.04.003; Ferrans C E, 1992, Prog Cardiovasc Nurs, V7, P2; Ferrans C E, 1990, Semin Oncol Nurs, V6, P248, DOI 10.1016/0749-2081(90)90026-2; Flaatten H, 2001, INTENS CARE MED, V27, P1005, DOI 10.1007/s001340100960; Gandek B, 1998, J CLIN EPIDEMIOL; Granja C, 2005, CRIT CARE, V9, pR96, DOI 10.1186/cc3026; Griffiths RD, 1999, BRIT MED J, V319, P427, DOI 10.1136/bmj.319.7207.427; Griffiths RD, 2011, AM J RESP CRIT CARE, V183, P833, DOI 10.1164/rccm.201012-1988ED; Hermans G, 2014, INTERVENTIONS PREVEN, V2014, DOI [10.1002/14651858.CD006832.pub3, DOI 10.1002/14651858.CD006832.PUB3]; Hofhuis JGM, 2015, INTENS CARE MED, V41, P495, DOI 10.1007/s00134-015-3669-5; Hofhuis JGM, 2009, CURR OPIN CRIT CARE, V15, P425, DOI 10.1097/MCC.0b013e32833079e4; Hough CL, 2012, CURR OPIN CRIT CARE, V18, P8, DOI 10.1097/MCC.0b013e32834f186d; Hui DS, 2005, CHEST, V128, P2247, DOI 10.1378/chest.128.4.2247; Johansen C, 2007, ACTA ONCOL, V46, P441, DOI 10.1080/02841860701316057; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Klepstad P, 2002, J PAIN SYMPTOM MANAG, V24, P517, DOI 10.1016/S0885-3924(02)00526-2; Kress JP, 2014, NEW ENGL J MED, V370, P1626, DOI 10.1056/NEJMra1209390; Kroenke K, 2012, J PAIN, V13, P764, DOI 10.1016/j.jpain.2012.05.004; Langerud AK, 2018, PAIN MANAG NURS, V19, P366, DOI 10.1016/j.pmn.2017.11.005; Langerud AK, 2018, NURS CRIT CARE, V23, P48, DOI 10.1111/nicc.12330; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Myhren H, 2010, CRIT CARE MED, V38, P1554, DOI 10.1097/CCM.0b013e3181e2c8b1; Orwelius L, 2005, CRIT CARE MED, V33, P1557, DOI 10.1097/01.CCM.0000168208.32006.1C; Orwelius L, 2010, CRIT CARE, V14, DOI 10.1186/cc8967; Pisani MA, 2015, AM J RESP CRIT CARE, V191, P731, DOI 10.1164/rccm.201411-2099CI; Ratzer M, 2014, HEALTH PSYCHOL BEHAV, V2, P882, DOI 10.1080/21642850.2014.943760; RUSSELL D, 1984, J PERS SOC PSYCHOL, V46, P1313, DOI 10.1037/0022-3514.46.6.1313; RUSSELL DW, 1987, J APPL PSYCHOL, V72, P269, DOI 10.1037/0021-9010.72.2.269; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Schuster HP, 1997, INTENS CARE MED, V23, P1056, DOI 10.1007/s001340050456; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Shen B J, 2005, Eura Medicophys, V41, P75; Soliman IW, 2015, J CRIT CARE, V30, P181, DOI 10.1016/j.jcrc.2014.09.009; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Stricker KH, 2011, J CRIT CARE, V26, P379, DOI 10.1016/j.jcrc.2010.11.004; Svenningsen H, 2017, NURS CRIT CARE, V22, P212, DOI 10.1111/nicc.12165; Tan G, 2004, J PAIN, V5, P133, DOI 10.1016/j.jpain.2003.12.005; Tilburgs B, 2015, INTENS CRIT CARE NUR, V31, P336, DOI 10.1016/j.iccn.2015.07.002; Timmers TK, 2011, ANN SURG, V253, P151, DOI 10.1097/SLA.0b013e3181ff45df; Varricchio Claudette G, 2010, Semin Oncol Nurs, V26, P12, DOI 10.1016/j.soncn.2009.11.003; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; VONROENN JH, 1993, ANN INTERN MED, V119, P121, DOI 10.7326/0003-4819-119-2-199307150-00005; Ware J., 1993, SF 36 HLTH SURVEY MA; Ware J., 1998, SF 12 SCORE SF 12 PH; Wu JSY, 2010, J PAIN SYMPTOM MANAG, V39, P230, DOI 10.1016/j.jpainsymman.2009.07.006	67	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199656	10.1371/journal.pone.0199656	http://dx.doi.org/10.1371/journal.pone.0199656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK3YY	29940026	Green Published, Green Submitted, gold			2022-12-26	WOS:000436088700032
J	Rock, T; Bartz-Schmidt, KU; Rock, D				Roeck, Tobias; Bartz-Schmidt, Karl U.; Roeck, Daniel			Trends in corneal transplantation at the University Eye Hospital in Tubingen, Germany over the last 12 years: 2004-2015	PLOS ONE			English	Article							MEMBRANE ENDOTHELIAL KERATOPLASTY; COLLAGEN CROSS-LINKING; PENETRATING KERATOPLASTY; LAMELLAR KERATOPLASTY; DESCEMETS-MEMBRANE; GRAFT-SURVIVAL; DONATION RATE; DMEK; KERATOCONUS; DONORS	Purpose This study aimed to investigate the trends in the surgical methods and leading indications for corneal transplantations carried out over the last 12 years. Methods The data from the corneal graft waiting list and from all keratoplasties carried out between 2004 and 2015 at the University Eye Hospital in Tubingen were retrospectively analyzed. Results A total of 1,185 keratoplasties were performed between 2004 and 2015 at this hospital. The most common surgical indications for corneal transplantation were Fuchs' endothelial corneal dystrophy (35.2%) and keratoconus (18.9%) with keratoconus being the leading cause during early years (from 2004 to 2009) and Fuch's dystrophy being the leading cause from 2010 to 2015. Overall, the total count of performed keratoplasties increased, from 385 corneal transplantations during the first 6-year period to 800 corneal transplantations during the second 6-year period (P = 0.008, using Mann-Whitney test). The Descemet's membrane endothelial keratoplasty has become the favored surgical method for endothelial disorders with the number of Descemet's membrane endothelial keratoplasties increasing significantly from 2008 to 2015. This increasing trend was statistically significant (P < 0.001 using multi-variate adaptive regression splines (MARS). A decreasing trend was also noted for the rate of penetrating keratoplasty since 2008 (P < 0.001 using MARS). Conclusions This research showed major changes in the preferred corneal transplantation techniques and leading indications for keratoplasty over the last 12 years. More importantly, it seems that the rapid development and implementation of endothelial keratoplasty, especially the Descemet's membrane endothelial keratoplasty, has had a profound effect on and begun a new era in corneal transplantation.	[Roeck, Tobias; Bartz-Schmidt, Karl U.; Roeck, Daniel] Eberhard Karls Univ Tubingen, Ctr Ophthalmol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Rock, T (corresponding author), Eberhard Karls Univ Tubingen, Ctr Ophthalmol, Tubingen, Germany.	Tobias.Roeck@med.uni-tuebingen.de			Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of TObingen	Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of TObingen	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of TObingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 1997, NATURE, V388, P4, DOI 10.1038/40219; Afshari NA, 2006, ARCH OPHTHALMOL-CHIC, V124, P777, DOI 10.1001/archopht.124.6.777; Anwar M, 2002, J CATARACT REFR SURG, V28, P398, DOI 10.1016/S0886-3350(01)01181-6; Arnalich-Montiel F, 2016, EYE VISION, V3, DOI 10.1186/s40662-016-0033-y; Bank Q Development, 2013, ENV STAT ANN REP, DOI [10.1179/000705975798320639, DOI 10.1179/000705975798320639]; Boimer C, 2011, CAN J OPHTHALMOL, V46, P360, DOI 10.1016/j.jcjo.2011.06.015; Cunningham WJ, 2012, CLIN EXP OPHTHALMOL, V40, P141, DOI 10.1111/j.1442-9071.2011.02681.x; Cursiefen C, 1998, CORNEA, V17, P468, DOI 10.1097/00003226-199809000-00002; Darlington JK, 2006, OPHTHALMOLOGY, V113, P2171, DOI 10.1016/j.ophtha.2006.06.034; Fasolo A, 2006, CORNEA, V25, P507, DOI 10.1097/01.ico.0000214211.60317.1f; Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776; Godefrooij DA, 2016, ACTA OPHTHALMOL, V94, P675, DOI 10.1111/aos.13095; GORE SM, 1991, BRIT MED J, V302, P149, DOI 10.1136/bmj.302.6769.149; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Guerra FP, 2011, OPHTHALMOLOGY, V118, P2368, DOI 10.1016/j.ophtha.2011.06.002; Heindl LM, 2011, OPHTHALMOLOGY, V118, P294, DOI 10.1016/j.ophtha.2010.05.025; Hyde R, 2012, LANCET, V380, P1135, DOI 10.1016/S0140-6736(12)61650-X; Iovieno A, 2017, CORNEA, V36, P637, DOI 10.1097/ICO.0000000000001202; Lam FC, 2014, JAMA OPHTHALMOL, V132, P1469, DOI 10.1001/jamaophthalmol.2014.3328; Maier AKB, 2015, GRAEF ARCH CLIN EXP, V253, P895, DOI 10.1007/s00417-015-2939-9; McKeown DW, 2012, BRIT J ANAESTH, V108, pI96, DOI 10.1093/bja/aer351; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Melles GRJ, 2006, CORNEA, V25, P879, DOI 10.1097/01.ico.0000243962.60392.4f; Moffatt SL, 2005, CLIN EXP OPHTHALMOL, V33, P642, DOI 10.1111/j.1442-9071.2005.01134.x; Okumura N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191306; Price FW, 2005, J REFRACT SURG, V21, P339; Price MO, 2017, ANNU REV VIS SCI, V3, P69, DOI 10.1146/annurev-vision-102016-061400; Raiskup-Wolf F, 2008, J CATARACT REFR SURG, V34, P796, DOI 10.1016/j.jcrs.2007.12.039; Rock Daniel, 2016, Ann Transplant, V21, P433; Rock D, 2017, ANN TRANSPL, V22, P425, DOI 10.12659/AOT.901385; Rock D, 2016, ANN TRANSPL, V21, P701, DOI 10.12659/AOT.900456; Rock T, 2016, GRAEF ARCH CLIN EXP, V254, P135, DOI 10.1007/s00417-015-3119-7; Rock T, 2015, GRAEF ARCH CLIN EXP, V253, P2217, DOI 10.1007/s00417-015-3103-2; Rock T, 2017, INT J OPHTHALMOL-CHI, V10, P1001, DOI 10.18240/ijo.2017.06.25; Sandvik GF, 2015, CORNEA, V34, P991, DOI 10.1097/ICO.0000000000000460; Schwettmann L, 2015, HEALTH POLICY, V119, P980, DOI 10.1016/j.healthpol.2015.01.017; Terry MA, 2005, OPHTHALMOLOGY, V112, P1541, DOI 10.1016/j.ophtha.2005.03.026; Ting DSJ, 2012, BRIT J OPHTHALMOL, V96, P405, DOI 10.1136/bjophthalmol-2011-300244; Yoeruek E, 2015, CORNEA, V34, pE6, DOI 10.1097/ICO.0000000000000341	39	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0198793	10.1371/journal.pone.0198793	http://dx.doi.org/10.1371/journal.pone.0198793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29939996	Green Published, Green Submitted, gold			2022-12-26	WOS:000436088700005
J	Ursu, RG; Danciu, M; Spiridon, IA; Ridder, R; Rehm, S; Maffini, F; McKay-Chopin, S; Carreire, C; Lucas, E; Costan, VV; Popescu, E; Cobzeanu, B; Ghetu, N; Iancu, LS; Tommasino, M; Pawlita, M; Holzinger, D; Gheit, T				Ursu, Ramona Gabriela; Danciu, Mihai; Spiridon, Irene Alexandra; Ridder, Ruediger; Rehm, Susanne; Maffini, Fausto; McKay-Chopin, Sandrine; Carreire, Christine; Lucas, Eric; Costan, Victor-Vlad; Popescu, Eugenia; Cobzeanu, Bogdan; Ghetu, Nicolae; Iancu, Luminita Smaranda; Tommasino, Massimo; Pawlita, Michael; Holzinger, Dana; Gheit, Tarik			Role of mucosal high-risk human papillomavirus types in head and neck cancers in Romania	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PROMOTER HYPERMETHYLATION; HPV INFECTION; UNKNOWN PRIMARY; LUNG-CANCER; EPIDEMIOLOGY CONSORTIUM; OROPHARYNGEAL CANCER; INTERNATIONAL HEAD; CAUSAL ASSOCIATION; CERVICAL-CANCER	Background Limited information is available about the involvement of human papillomavirus (HPV) in head and neck squamous cell carcinomas (HNSCCs) in Romanian patients. Objective To evaluate the HPV-attributable fraction in HNSCCs collected in Northeastern Romania. Materials and methods In total, 189 formalin-fixed paraffin-embedded tissue samples (99 oral cavity tumors, 28 oropharynx, 48 pharynx, and 14 larynx/hypopharynx) were analyzed for HPV DNA and RNA using Luminex-based assays, and for overexpression of p16(INK4a) (p16) by immunohistochemistry. Results Of the 189 cases, 23 (12.2%) were HPV DNA-positive, comprising half of the oropharyngeal cases (14/28, 50.0%) and 9/161 (5.6%) of the non-oropharyngeal cases. HPV16 was the most prevalent HPV type (20/23, 86.9%), followed by HPV18 (5/23, 21.7%) and HPV39 (1/23, 4.3%). Only two (2/189, 1.1%) HNSCC cases were HPV-driven, i.e. positive for both HPV DNA and RNA. Conclusion A very small subset of HNSCC cases within this cohort from Northeastern Romania appeared to be HPV-driven.	[Ursu, Ramona Gabriela; Iancu, Luminita Smaranda] Univ Med & Pharm Grigore T Popa, Discipline Microbiol, Iasi, Romania; [Danciu, Mihai; Spiridon, Irene Alexandra] Univ Med & Pharm Grigore T Popa, Dept Pathol, Iasi, Romania; [Ridder, Ruediger; Rehm, Susanne] Roche MTM Labs, Mannheim, Germany; [Ridder, Ruediger; Rehm, Susanne] Ventana Med Syst Inc, Tucson, AZ USA; [Maffini, Fausto] European Inst Oncol, Dept Pathol, Milan, Italy; [McKay-Chopin, Sandrine; Carreire, Christine; Lucas, Eric; Tommasino, Massimo; Gheit, Tarik] Int Agcy Res Canc, Infect & Canc Biol Grp, Lyon, France; [Costan, Victor-Vlad; Popescu, Eugenia] Univ Med & Pharm Grigore T Popa, Dept Oral & Maxillofacial Surg, Iasi, Romania; [Cobzeanu, Bogdan] Univ Med & Pharm Grigore T Popa, Dept Otorhinolaryngol, Iasi, Romania; [Ghetu, Nicolae] Univ Med & Pharm Grigore T Popa, Dept Plast surg, Iasi, Romania; [Pawlita, Michael; Holzinger, Dana] German Canc Res Ctr, Div Mol Diagnost Oncogen Infect, Heidelberg, Germany	Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy; Roche Holding; Ventana Medical Systems, Inc.; IRCCS European Institute of Oncology (IEO); World Health Organization; International Agency for Research on Cancer (IARC); Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy; Helmholtz Association; German Cancer Research Center (DKFZ)	Danciu, M (corresponding author), Univ Med & Pharm Grigore T Popa, Dept Pathol, Iasi, Romania.; Gheit, T (corresponding author), Int Agcy Res Canc, Infect & Canc Biol Grp, Lyon, France.	mihai.danciu@umfiasi.ro; icb@iarc.fr	Costan, Victor Vlad/B-6961-2018; Iancu, Luminita Smaranda C./C-8864-2015; Maffini, Fausto/AAS-4272-2020; Holzinger, Dana/I-3437-2013; Cobzeanu, Bogdan Mihail/AAX-2773-2020; Ursu, Ramona Gabriela/U-6053-2017; Danciu, Mihai/N-5012-2016; Iancu, Luminita-Smaranda/U-4331-2017	Costan, Victor Vlad/0000-0002-3978-5103; Iancu, Luminita Smaranda C./0000-0002-2592-3982; Maffini, Fausto/0000-0002-4554-8956; Iancu, Luminita-Smaranda/0000-0002-2592-3982; Tommasino, Massimo/0000-0002-0890-8596	European Commission [FP7-HEALTH- 2011-282562]; University of Medicine and Pharmacy "Grigore T. Popa", Iasi, Romania [30336 / 28.12.2017]	European Commission(European CommissionEuropean Commission Joint Research Centre); University of Medicine and Pharmacy "Grigore T. Popa", Iasi, Romania	This study was supported by the European Commission, grant HPV-AHEAD (FP7-HEALTH- 2011-282562) to MT. RGU is supported by the University of Medicine and Pharmacy "Grigore T. Popa", Iasi, Romania (grant no. 30336 / 28.12.2017). RR and SR are employees of Roche Diagnostics, a company that commercializes in vitro diagnostic tests used in this study. The funder provided support in the form of salaries for authors RR and SR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adilbay D, 2018, INFECT AGENTS CANCER, V13, DOI 10.1186/s13027-018-0175-8; Albano PM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172240; Alemany L, 2016, EUR UROL, V69, P953, DOI 10.1016/j.eururo.2015.12.007; Anantharaman D, 2014, CANCER RES, V74, P3525, DOI 10.1158/0008-5472.CAN-13-3548; [Anonymous], 2017, WHO REPORT GLOBAL TO; Attner P, 2010, INT J CANCER, V126, P2879, DOI 10.1002/ijc.24994; Baboci L, 2016, PAPILLOMAVIRUS RES, V2, P133, DOI 10.1016/j.pvr.2016.07.002; Baboci L, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-334; Barul C, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0286-5; Bleotu Coralia, 2010, Roum Arch Microbiol Immunol, V69, P153; Blumberg J, 2015, CANCER EPIDEMIOL, V39, P1000, DOI 10.1016/j.canep.2015.10.015; Boscolo-Rizzo P, 2016, CANCER TREAT REV, V42, P24, DOI 10.1016/j.ctrv.2015.10.009; Boscolo-Rizzo P, 2015, CLIN EXP METASTAS, V32, P835, DOI 10.1007/s10585-015-9744-z; Bratman SV, 2016, JAMA ONCOL, V2, P823, DOI 10.1001/jamaoncol.2015.6587; Bussu F, 2013, BRIT J CANCER, V108, P1157, DOI 10.1038/bjc.2013.55; CAIRNS P, 1994, SCIENCE, V265, P415, DOI 10.1126/science.8023167; Carlander ALF, 2017, EUR J CANCER, V70, P75, DOI 10.1016/j.ejca.2016.10.015; Castellsague X, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv403; Chaturvedi AK, 2012, HEAD NECK PATHOL S1, V6, pS16, DOI [DOI 10.1007/s12105-012-0377-0, 10.1007/s12105-012-0377-0]; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Chen XJ, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0526-2; Chernock RD, 2013, MODERN PATHOL, V26, P223, DOI 10.1038/modpathol.2012.159; Choudhury JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129808; Dayyani F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Georgiou E, 2007, EUR J CANCER PREV, V16, P396, DOI 10.1097/01.cej.0000236260.26265.d6; Gheit T, 2006, J CLIN MICROBIOL, V44, P2025, DOI 10.1128/JCM.02305-05; Gheit T, 2009, VACCINE, V27, P636, DOI 10.1016/j.vaccine.2008.11.041; Gheit T, 2017, INT J CANCER, V141, P143, DOI 10.1002/ijc.30712; Gheit T, 2014, J MED VIROL, V86, P642, DOI 10.1002/jmv.23866; Gillison ML, 2015, J CLIN ONCOL, V33, P3235, DOI 10.1200/JCO.2015.61.6995; Gillison ML, 2014, INT J CANCER, V134, P497, DOI 10.1002/ijc.28201; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Goodman MT, 2015, EUR J CANCER, V51, P2759, DOI 10.1016/j.ejca.2015.09.005; Guimera N, 2017, BRIT J CANCER, V116, P1218, DOI 10.1038/bjc.2017.74; Halec G, 2013, BRIT J CANCER, V109, P172, DOI 10.1038/bjc.2013.296; Halec G, 2017, MODERN PATHOL, V30, P549, DOI 10.1038/modpathol.2016.197; Halec G, 2016, INT J CANCER, V139, P85, DOI 10.1002/ijc.29911; Halec G, 2014, J PATHOL, V234, P441, DOI 10.1002/path.4405; Halec G, 2013, INT J CANCER, V132, P63, DOI 10.1002/ijc.27605; Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Hauck F, 2015, VIRCHOWS ARCH, V466, P685, DOI 10.1007/s00428-015-1761-4; HERMAN JG, 1995, CANCER RES, V55, P4525; Holzinger D, 2017, INT J CANCER, V140, P2748, DOI 10.1002/ijc.30697; Hong AM, 2010, VACCINE, V28, P3269, DOI 10.1016/j.vaccine.2010.02.098; IARC, 2004, IARC MON EV CARC RIS, V83, P1; Jung AC, 2010, INT J CANCER, V126, P1882, DOI 10.1002/ijc.24911; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kim DH, 2001, CANCER RES, V61, P3419; Lea JS, 2004, AM J OBSTET GYNECOL, V190, P674, DOI 10.1016/j.ajog.2003.09.036; Lucas-Roxburgh R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186424; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Mena M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184520; Merlo A, 5 CPG ISLAND METHYLA; Michaud DS, 2014, INT J CANCER, V135, P1653, DOI 10.1002/ijc.28811; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Ndiaye C, 2014, LANCET ONCOL, V15, P1319, DOI 10.1016/S1470-2045(14)70471-1; Pierini S, 2014, HEAD NECK-J SCI SPEC, V36, P1103, DOI 10.1002/hed.23413; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Riaz N, 2014, GENES DIS, V1, P75, DOI 10.1016/j.gendis.2014.07.002; Ribeiro KB, 2011, INT J EPIDEMIOL, V40, P489, DOI 10.1093/ije/dyq249; Riese U, 1999, INT J MOL MED, V4, P61; Rietbergen MM, 2013, INT J CANCER, V132, P1565, DOI 10.1002/ijc.27821; Rosas SLB, 2001, CANCER RES, V61, P939; Saraiya M, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv086; Schmitt M, 2010, J CLIN MICROBIOL, V48, P143, DOI 10.1128/JCM.00991-09; Schroeder L, 2018, INT J CANCER, V142, P1361, DOI 10.1002/ijc.31167; Schroeder L, 2017, EUR J CANCER, V74, P73, DOI 10.1016/j.ejca.2016.12.020; Sinha P, 2009, HEAD NECK-J SCI SPEC, V31, P1423, DOI 10.1002/hed.21122; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; Stornetta A, 2018, CANCERS, V10, DOI 10.3390/cancers10010020; Sturgis EM, 2007, CANCER-AM CANCER SOC, V110, P1429, DOI 10.1002/cncr.22963; Tachezy R, 2005, ORAL DIS, V11, P181, DOI 10.1111/j.1601-0825.2005.01112.x; Takeshima M, 2008, J ORAL PATHOL MED, V37, P475, DOI 10.1111/j.1600-0714.2008.00644.x; Ruesga MT, 2007, CANCER LETT, V250, P140, DOI 10.1016/j.canlet.2006.10.001; Tran TN, 2005, J ORAL PATHOL MED, V34, P150, DOI 10.1111/j.1600-0714.2004.00292.x; TUYNS AJ, 1988, INT J CANCER, V41, P483, DOI 10.1002/ijc.2910410403; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; von Zeidler SV, 2004, INT J MOL MED, V14, P807; Zhang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028882	82	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199663	10.1371/journal.pone.0199663	http://dx.doi.org/10.1371/journal.pone.0199663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940024	Green Published, gold, Green Submitted			2022-12-26	WOS:000436088700033
J	Tsai, WC; Kung, PT; Wang, YH; Kuo, WY; Li, YH				Tsai, Wen-Chen; Kung, Pei-Tseng; Wang, Yueh-Hsin; Kuo, Wei-Yin; Li, Ya-Hsin			Influence of the time interval from diagnosis to treatment on survival for early-stage liver cancer	PLOS ONE			English	Article							NATIONAL-HEALTH INSURANCE; PRIMARY BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; CERVICAL-CANCER; SOCIOECONOMIC-STATUS; DELAYED DIAGNOSIS; UNITED-STATES; NECK-CANCER; TAIWAN; MORTALITY	Objectives Liver cancer is the fifth most common cancer in men and the ninth most common cancer in women, and the WHO expects that there will be 1,341,344 cases in 2034 worldwide. Liver cancer also has the second-highest cancer death rate, accounting for 7% of all cancers. The study is going to explore the relationship between time interval from diagnosis to treatment and survival status of early-stage liver cancer patients. Materials and methods This is a retrospective cohort study using the national database from Taiwan. The datasets include the Taiwan Cancer Registry Database (TCR), the National Health Insurance Research Database (NHIRD), and the National Registry of Deaths. The target population for the study was patients newly diagnosed with stage I and stage II liver cancer between the years 2004 and 2010. Total of 26,038 cases were included in the study. Except descriptive analysis, the relationship between patient characteristics and the time interval from diagnosis to treatment was examined by chi-square tests. In addition, modified Cox proportional hazard models were used to analyze the hazard ratio of patient death with various treatment delay durations. Results There were 20,430 patients (78.46%) who received treatment less than 30 days after diagnosis, while 2,674 patients (10.27%) received treatment between 31 and 60 days after diagnosis, and 2,068 patients (7.94%) received treatment between 61 and 180 days after diagnosis, and 866 patients (3.33%) who received treatment 181 days after diagnosis. Those treated more than 181 days and 61 +/- 180 days after diagnosis had a 1.68-fold increased risk of death (95% confidence interval: 1.50 +/- 1.88) and a 1.39-fold increased risk of death (95% confidence interval: 1.31 +/- 1.17), respectively. Being male, being elderly, having a higher CCI level, and being treated in a hospital with a low service volume were factors associated with a poorer prognosis. Conclusion Overall, this study utilized a national cohort to conclude that for early-stage liver cancer patients, a longer the time interval from diagnosis to treatment results in a lower survival rate.	[Tsai, Wen-Chen; Wang, Yueh-Hsin; Kuo, Wei-Yin] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Kung, Pei-Tseng] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Li, Ya-Hsin] Chung Shan Med Univ, Chung Shan Med Univ Hosp, Dept Hlth Policy & Management, Taichung, Taiwan	China Medical University Taiwan; Asia University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital	Li, YH (corresponding author), Chung Shan Med Univ, Chung Shan Med Univ Hosp, Dept Hlth Policy & Management, Taichung, Taiwan.	yli@csmu.edu.tw	; Tsai, Wen-Chen/O-3095-2015	Wang, Yueh-Hsin/0000-0002-1282-5945; Tsai, Wen-Chen/0000-0002-9684-0789	Ministry of Science and Technology, Taiwan [MOST 104-2410-H-039-002]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Ministry of Science and Technology, Taiwan (MOST 104-2410-H-039-002), https://www.most.gov.tw/.	AFZELIUS P, 1994, ACTA ONCOL, V33, P345, DOI 10.3109/02841869409098427; Akram M, 2014, INT J PREVENTIVE MED, V5, P915; Artinyan A, 2010, CANCER-AM CANCER SOC, V116, P1367, DOI 10.1002/cncr.24817; Bilimoria KY, 2011, ANN SURG, V253, P779, DOI 10.1097/SLA.0b013e318211cc0f; Cance WG, 2000, CANCER, V88, P912, DOI 10.1002/(SICI)1097-0142(20000215)88:4<912::AID-CNCR23>3.0.CO;2-T; Caplan LS, 2000, AM J PUBLIC HEALTH, V90, P130, DOI 10.2105/AJPH.90.1.130; Chen Tzeng-Ji, 2007, J Chin Med Assoc, V70, P110; Chiang CJ, 2015, JPN J CLIN ONCOL, V45, P291, DOI 10.1093/jjco/hyu211; Chiang CJ, 2010, JPN J CLIN ONCOL, V40, P897, DOI 10.1093/jjco/hyq057; Chiou SJ, 2008, AM J MANAG CARE, V18, P488; Chu TB, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-60; Chuang YC, 2008, SOC SCI MED, V67, P1321, DOI 10.1016/j.socscimed.2008.06.033; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; FISHER B, 1977, CANCER-AM CANCER SOC, V39, P2827, DOI 10.1002/1097-0142(197706)39:6<2827::AID-CNCR2820390671>3.0.CO;2-I; Gau CS, 2007, PHARMACOEPIDEM DR S, V16, P86, DOI 10.1002/pds.1324; Griffiths RI, 2014, INT J BREAST CANCER, V2014, DOI 10.1155/2014/970780; Gullatte Mary Magee, 2006, J Natl Black Nurses Assoc, V17, P45; Gyenwali D, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-29; Gyenwali D, 2013, ASIAN PAC J CANCER P, V14, P4373, DOI 10.7314/APJCP.2013.14.7.4373; Hsiao YY, 2013, INT J QUAL HEALTH C, V25, P232, DOI 10.1093/intqhc/mzt029; Hu R, 2003, SURGERY, V133, P251, DOI 10.1067/msy.2003.102; Huo TI, 2007, SCAND J GASTROENTERO, V42, P485, DOI 10.1080/00365520600931402; Joshi S, 2008, PUBLIC HEALTH, V122, P1144, DOI 10.1016/j.puhe.2008.04.003; Kiderlen M, 2013, ANN ONCOL, V24, P3011, DOI 10.1093/annonc/mdt367; KO YC, 1992, J ORAL PATHOL MED, V21, P261, DOI 10.1111/j.1600-0714.1992.tb01007.x; Liu CY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-446; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Memon ZA, 2013, ASIAN PAC J CANCER P, V14, P7409, DOI 10.7314/APJCP.2013.14.12.7409; Montella M, 2001, EUR J CANCER PREV, V10, P53, DOI 10.1097/00008469-200102000-00006; Murphy CT, 2016, J CLIN ONCOL, V34, P169, DOI 10.1200/JCO.2015.61.5906; Noonan B, 2014, EUR J ONCOL NURS, V18, P118, DOI 10.1016/j.ejon.2013.07.005; Norsa'adah B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-141; Pack G. T., 1938, AM J CANCER, V33, P443, DOI DOI 10.1158/AJC.1938.443; Patnaik JL, 2011, JNCI-J NATL CANCER I, V103, P1101, DOI 10.1093/jnci/djr188; Poum A, 2014, J EPIDEMIOL, V24, P102, DOI 10.2188/jea.JE20130090; PRESSMAN PI, 1983, ARCH SURG-CHICAGO, V118, P992; ROSSI S, 1990, TUMORI, V76, P559, DOI 10.1177/030089169007600609; Singal AG, 2013, J NATL COMPR CANC NE, V11, P1101, DOI 10.6004/jnccn.2013.0131; Smith D, 1996, AUST NZ J PUBL HEAL, V20, P129, DOI 10.1111/j.1753-6405.1996.tb01806.x; Sogaard Mette, 2013, Clin Epidemiol, V5, P3, DOI 10.2147/CLEP.S47150; Tsai WC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175148; van Harten MC, 2015, ORAL ONCOL, V51, P272, DOI 10.1016/j.oraloncology.2014.12.003; World Health Organization Mortality Database, 2017, WHO STAT INF SYST; Yu T, 2008, J CAN DENT ASSOC, V74, P61	44	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199532	10.1371/journal.pone.0199532	http://dx.doi.org/10.1371/journal.pone.0199532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK3VI	29933395	gold, Green Published, Green Submitted			2022-12-26	WOS:000436076600029
J	Zhang, HG; Song, GL; Song, GB; Li, RL; Gao, M; Ye, L; Zhang, CF				Zhang, Haiguo; Song, Guanli; Song, Guanbo; Li, Ruolei; Gao, Min; Ye, Ling; Zhang, Chengfang			Identification of DNA methylation prognostic signature of acute myelocytic leukemia	PLOS ONE			English	Article							BONE-MARROW; BINDING-PROTEIN; GROWTH-FACTOR; TNF-ALPHA; CANCER; GENE; CELLS; AML; PROLIFERATION; SURVIVAL	Background The aim of this study is to find the potential survival related DNA methylation signature capable of predicting survival time for acute myelocytic leukemia (AML) patients. Methods DNA methylation data were downloaded. DNA methylation signature was identified in the training group, and subsequently validated in an independent validation group. The overall survival of DNA methylation signature was performed. Functional analysis was used to explore the function of corresponding genes of DNA methylation signature. Differentially methylated sites and CpG islands were also identified in poor-risk group. Results A DNA methylation signature involving 8 DNA methylation sites and 6 genes were identified. Functional analysis showed that protein binding and cytoplasm were the only two enriched Gene Ontology terms. A total of 70 differentially methylated sites and 6 differentially methylated CpG islands were identified in poor-risk group. Conclusions The identified survival related DNA methylation signature adds to the prognostic value of AML.	[Zhang, Haiguo] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan, Shandong, Peoples R China; [Zhang, Haiguo; Ye, Ling] Jining 1 Peoples Hosp, Dept Hematol, Jining, Shandong, Peoples R China; [Song, Guanli] China Acad Chinese Med Sci, Guanganmen Hosp, Dept Prevent & Hlth Care, Beijing, Peoples R China; [Song, Guanbo] Jining Chinese Med Hosp, Dept Clin Lab, Jining, Shandong, Peoples R China; [Li, Ruolei; Gao, Min; Zhang, Chengfang] Jining 1 Peoples Hosp, Dept Clin Lab, Jining, Shandong, Peoples R China	Shandong University; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS	Zhang, CF (corresponding author), Jining 1 Peoples Hosp, Dept Clin Lab, Jining, Shandong, Peoples R China.	chengfangzhangjn@163.com			science and technology development plan of Jining grant [2015-57-102, 2015-57-134]	science and technology development plan of Jining grant	This work was supported by the science and technology development plan of Jining grant numbers 2015-57-102 and 2015-57-134 to CZ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ali HK, 2014, J GERIATR ONCOL, V5, P89, DOI 10.1016/j.jgo.2013.08.004; Amatruda JF, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-313; Andreasson A, 2013, EPIGENETICS-US, V8, P1347, DOI 10.4161/epi.26686; AUSTIN H, 1988, AM J EPIDEMIOL, V127, P419, DOI 10.1093/oxfordjournals.aje.a114820; Benton MC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0569-x; BRAUN T, 1990, NATURE, V346, P663, DOI 10.1038/346663a0; BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; Bullinger L, 2010, BLOOD, V115, P636, DOI 10.1182/blood-2009-03-211003; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Chen AH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-274; Chen XF, 2015, EPIGENETICS-US, V10, P545, DOI 10.1080/15592294.2015.1048953; COZZOLINO F, 1989, P NATL ACAD SCI USA, V86, P2369, DOI 10.1073/pnas.86.7.2369; Deneberg S, 2010, LEUKEMIA, V24, P932, DOI 10.1038/leu.2010.41; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Dufour C, 2003, BLOOD, V102, P2053, DOI 10.1182/blood-2003-01-0114; Dybedal I, 2001, BLOOD, V98, P1782, DOI 10.1182/blood.V98.6.1782; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; EVANS DIK, 1972, LANCET, V2, P1322; Fan CN, 2014, NUTR HOSP, V30, P42, DOI 10.3305/nh.2014.30.1.7521; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Fleischer T, 2014, GENOME BIOL, V15, DOI [10.1186/s13059-014-0435-x, 10.1186/PREACCEPT-2333349012841587]; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; HANSPAL M, 1994, BLOOD, V84, P3494; Hanspal M, 1998, BLOOD, V92, P2940, DOI 10.1182/blood.V92.8.2940.420k31_2940_2950; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; HOANG T, 1988, J EXP MED, V168, P463, DOI 10.1084/jem.168.2.463; Horwitz M, 1996, AM J HUM GENET, V59, P990; Huang LY, 2012, ONCOL REP, V27, P917, DOI 10.3892/or.2011.1598; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Jost E, 2008, BRIT J HAEMATOL, V142, P745, DOI [10.1111/1.1365-21412008.07242.x, DOI 10.1111/1.1365-21412008.07242.X]; Kaushansky A, 2014, ADV EXPT MED BIOL, V844, P59, DOI [10.1007/978-1493920952_4, DOI 10.1007/978-1493920952_4]; Kim SH, 2004, BIOCHEM BIOPH RES CO, V315, P964, DOI 10.1016/j.bbrc.2004.01.149; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kohgo Yutaka, 2014, Nihon Rinsho, V72, P1063; Kushwaha G, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0071-5; Labno-Kirszniok K, 2013, HERED CANCER CLIN PR, V11, DOI 10.1186/1897-4287-11-11; Langevin SM, 2014, ORAL ONCOL, V50, P1072, DOI 10.1016/j.oraloncology.2014.08.015; Larkin Karilyn, 2014, Am Soc Clin Oncol Educ Book, pe341, DOI 10.14694/EdBook_AM.2014.34.e341; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; Levine RL, 2013, BEST PRACT RES CL HA, V26, P245, DOI 10.1016/j.beha.2013.10.003; Lv L, 2007, LEUKEMIA RES, V31, P1479, DOI 10.1016/j.leukres.2007.01.014; Masaki T, 2001, BRIT J CANCER, V84, P1317, DOI 10.1054/bjoc.2001.1790; Meyer E, 2005, CANCER RES, V65, P4261, DOI 10.1158/0008-5472.CAN-04-2908; Molnar Lenke, 2000, Pathology Oncology and Research, V6, P18; Plass C, 2008, SEMIN ONCOL, V35, P378, DOI 10.1053/j.seminoncol.2008.04.008; Poage GM, 2012, CANCER RES, V72, P2728, DOI 10.1158/0008-5472.CAN-11-4121-T; Rabinovich EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033770; Rao AV, 2009, J CLIN ONCOL, V27, P5580, DOI 10.1200/JCO.2009.22.2547; Ryningen A, 2005, LEUKEMIA RES, V29, P185, DOI 10.1016/j.leukres.2004.06.008; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shuichi M, 2013, JAPANESE J CLIN HEMA, V54, P1633; Sinha AU, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-88; Tang MZ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003103; Tao YF, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1760-5; Ting WC, 2013, INT J MED SCI, V10, P1022, DOI 10.7150/ijms.6686; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; Volk A, 2014, J EXP MED, V211, P1093, DOI 10.1084/jem.20130990; Wang CG, 2014, CHINESE J CANCER RES, V26, P17, DOI 10.3978/j.issn.1000-9604.2014.01.01; Wang P, 2016, ONCOTARGET, V7, P55343, DOI 10.18632/oncotarget.10533; Wang YD, 2017, BMC GENOMICS, V18, DOI [10.1186/s12864-017-4201-9, 10.1186/s12863-017-0550-2]; Wolters J, 2018, DATA BRIEF, V16, P161, DOI 10.1016/j.dib.2017.11.031; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Yoshinaga S, 2004, RADIOLOGY, V233, P313, DOI 10.1148/radiol.2332031119; Zeijlemaker W, 2014, CYTOM PART B-CLIN CY, V86, P3, DOI 10.1002/cyto.b.21134; Zhao YX, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-30; Zhao YX, 2013, ONCOL LETT, V5, P1211, DOI 10.3892/ol.2013.1161; Zhong CXY, 2001, TOXICOL LETT, V122, P223, DOI 10.1016/S0378-4274(01)00365-4; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	71	5	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199689	10.1371/journal.pone.0199689	http://dx.doi.org/10.1371/journal.pone.0199689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933410	Green Published, Green Submitted, gold			2022-12-26	WOS:000436076600042
J	Beal, J; Haddock-Angelli, T; Baldwin, G; Gershater, M; Dwijayanti, A; Storch, M; de Mora, K; Lizarazo, M; Rettberg, R				Beal, Jacob; Haddock-Angelli, Traci; Baldwin, Geoff; Gershater, Markus; Dwijayanti, Ari; Storch, Marko; de Mora, Kim; Lizarazo, Meagan; Rettberg, Randy		iGEM Interlab Study Contributors	Quantification of bacterial fluorescence using independent calibrants	PLOS ONE			English	Article							SYNTHETIC BIOLOGY	Fluorescent reporters are commonly used to quantify activities or properties of both natural and engineered cells. Fluorescence is still typically reported only in arbitrary or normalized units, however, rather than in units defined using an independent calibrant, which is problematic for scientific reproducibility and even more so when it comes to effective engineering. In this paper, we report an interlaboratory study showing that simple, low-cost unit calibration protocols can remedy this situation, producing comparable units and dramatic improvements in precision over both arbitrary and normalized units. Participants at 92 institutions around the world measured fluorescence from E. coli transformed with three engineered test plasmids, plus positive and negative controls, using simple, low-cost unit calibration protocols designed for use with a plate reader and/or flow cytometer. In addition to providing comparable units, use of an independent calibrant allows quantitative use of positive and negative controls to identify likely instances of protocol failure. The use of independent calibrants thus allows order of magnitude improvements in precision, narrowing the 95% confidence interval of measurements in our study up to 600-fold compared to normalized units.	[Beal, Jacob] Raytheon BBN Technol, Cambridge, MA 02138 USA; [Haddock-Angelli, Traci; de Mora, Kim; Lizarazo, Meagan; Rettberg, Randy] iGEM Fdn, Cambridge, MA 02139 USA; [Baldwin, Geoff; Dwijayanti, Ari; Storch, Marko] Imperial Coll London, Dept Life Sci, London, England; [Gershater, Markus] Synthace, London, England	Raytheon Technologies; Raytheon BBN Technologies; Imperial College London	Beal, J (corresponding author), Raytheon BBN Technol, Cambridge, MA 02138 USA.; Haddock-Angelli, T (corresponding author), iGEM Fdn, Cambridge, MA 02139 USA.; Baldwin, G (corresponding author), Imperial Coll London, Dept Life Sci, London, England.	jakebeal@ieee.org; traci@igerm.org; g.baldwin@imperial.ac.uk	Westmann, Caua A/A-9142-2016; Tan, Meng How/M-8605-2015; Kushwaha, Manish/E-4901-2010	Westmann, Caua A/0000-0003-1572-2279; Tan, Meng How/0000-0003-3627-5586; Kushwaha, Manish/0000-0002-8850-3272; Baldwin, Geoffrey/0000-0003-4800-023X; Kolla, Likhitha/0000-0002-1169-906X; Loke, Chun Mun/0000-0002-9188-3309; Marken, John/0000-0001-9696-088X; Thach, Daniel/0000-0002-7609-8775; Beal, Jacob/0000-0002-1663-5102	NSF Expeditions in Computing Program Award as part of the Living Computing Project [1522074]; Raytheon BBN Technologies; Synthace; EPSRC [EP/R034915/1] Funding Source: UKRI	NSF Expeditions in Computing Program Award as part of the Living Computing Project; Raytheon BBN Technologies; Synthace; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Partial support for this work was provided by NSF Expeditions in Computing Program Award #1522074 as part of the Living Computing Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Raytheon BBN Technologies and Synthace provided support in the form of salaries for authors JB and MG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Anderson J.C, ANDERSON PROMOTER CO; Beal Jacob, 2017, Engineering Biology, V1, P55, DOI 10.1049/enb.2017.0004; Cheng AA, 2012, ANNU REV BIOMED ENG, V14, P155, DOI [10.1146/annurev-bioeng-071811-150118, 10.1146/annurev.bioeng-071811-150118]; Hoffman RA, 2012, CYTOM PART A, V81A, P785, DOI 10.1002/cyto.a.22086; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Quinn JY, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002310; Roehner N, 2016, ACS SYNTH BIOL, V5, P498, DOI 10.1021/acssynbio.5b00215; SpheroTech, 2001, SPHER TECHN NOT; Stanton BC, 2014, NAT CHEM BIOL, V10, P99, DOI 10.1038/nchembio.1411; Stevenson K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38828; Vogt RF, 2008, SPRINGER SER FLUORES, V05, P3, DOI 10.1007/4243_2008_055; Yordanov B, 2014, ACS SYNTH BIOL, V3, P578, DOI 10.1021/sb400152n	13	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199432	10.1371/journal.pone.0199432	http://dx.doi.org/10.1371/journal.pone.0199432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928012	Green Published, Green Submitted, gold			2022-12-26	WOS:000435802500091
J	Buschmann, EE; Li, LL; Brix, M; Zietzer, A; Hillmeister, P; Busjahn, A; Bramlage, P; Buschmann, I				Buschmann, Eva Elina; Li, Lulu; Brix, Michele; Zietzer, Andreas; Hillmeister, Philipp; Busjahn, Andreas; Bramlage, Peter; Buschmann, Ivo			A novel computer-aided diagnostic approach for detecting peripheral arterial disease in patients with diabetes	PLOS ONE			English	Article							ANKLE-BRACHIAL INDEX; DOPPLER; CARDIOLOGY	Peripheral arterial disease (PAD) is an important manifestation of systemic atherosclerosis, with diabetes being one of its most significant risk factors. Owing to medial arterial calcification (MAC), the ankle brachial index (ABI) is not always a reliable tool for detecting PAD. Arterial Doppler flow parameters, such as systolic maximal acceleration (ACCmax) and relative pulse slope index (RPSI), may serve as effective surrogates to detect stenosis-induced flow alteration. In the present study, ACCmax and RPSI were prospectively evaluated in 166 patients (304 arteries) with clinical suspicion of PAD, including 76 patients with and 90 patients without diabetes. In the overall sample, the sensitivity of ACCmax (69%) was superior to that of ABI (58%) and RPSI (56%). In patients with diabetes, the sensitivity of ACCmax (57%), ABI (56%) and RPSI (57%) were similar, though a parallel test taking both ACCmax and RPSI into account further increased sensitivity to 68%. The specificity (98%) and accuracy (78%) of ACCmax were superior to those of ABI (83% and 70%, respectively), as were the specificity (95%) and accuracy (77%) of RPSI in patients with diabetes. The diagnostic properties of ACCmax and RPSI were superior to those of ABI for detecting PAD in patients with diabetes. Our acceleration algorithm (Gefasstachometer (R)) provides a rapid, safe, noninvasive tool for identifying PAD in patients with diabetes.	[Buschmann, Eva Elina] Med Univ Graz, Ctr Internal Med, Dept Cardiol, Graz, Austria; [Buschmann, Eva Elina; Li, Lulu; Hillmeister, Philipp; Bramlage, Peter; Buschmann, Ivo] Med Univ Brandenburg MHB, Dept Angiol, Ctr Internal Med 1, Brandenburg Havel, Germany; [Li, Lulu; Zietzer, Andreas; Hillmeister, Philipp; Buschmann, Ivo] Charite Univ Med Berlin, CCR, Richard Thoma Labs Arteriogenesis, Berlin, Germany; [Brix, Michele; Buschmann, Ivo] Dept Physiol Charite Benjamin Franklin, Berlin, Germany; [Zietzer, Andreas] Univ Bonn, Med Klin 2, Bonn, Germany; [Busjahn, Andreas] HealthTwiSt GmbH, Berlin, Germany; [Bramlage, Peter] Inst Pharmacol & Prevent Med, Cloppenburg, Germany	Medical University of Graz; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf	Buschmann, EE (corresponding author), Med Univ Graz, Ctr Internal Med, Dept Cardiol, Graz, Austria.; Buschmann, EE (corresponding author), Med Univ Brandenburg MHB, Dept Angiol, Ctr Internal Med 1, Brandenburg Havel, Germany.	eva.buschmann@medunigraz.at	Busjahn, Andreas/P-5023-2019	Busjahn, Andreas/0000-0001-9650-6919	Charite University Hospital (Berlin, Germany)	Charite University Hospital (Berlin, Germany)	The Charite University Hospital (Berlin, Germany) funded the research as part of their academic duties. No further external funding was obtained. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyans V, 2008, J VASC SURG, V48, P1197, DOI 10.1016/j.jvs.2008.06.005; Aboyans V, 2018, EUR HEART J, V39, P763, DOI 10.1093/eurheartj/ehx095; Ade CJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12414; Bardelli M, 2006, KIDNEY INT, V69, P580, DOI 10.1038/sj.ki.5000112; Buschmann I, 2010, DEVELOPMENT, V137, P2187, DOI 10.1242/dev.045351; Donnelly R, 2000, BRIT MED J, V320, P698, DOI 10.1136/bmj.320.7236.698; Gerhard-Herman MD, 2017, VASC MED, V22, pNP1, DOI 10.1177/1358863X17701592; Jeevanantham V, 2014, AM J CARDIOL, V114, P1105, DOI 10.1016/j.amjcard.2014.07.023; Lambert AP, 2003, DIABETES CARE, V26, P333, DOI 10.2337/diacare.26.2.333; Lanzer P, 2014, EUR HEART J; Nead KT, 2013, J AM COLL CARDIOL, V62, P553, DOI 10.1016/j.jacc.2013.04.061; NELSON TR, 1988, AM J ROENTGENOL, V151, P439, DOI 10.2214/ajr.151.3.439; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Ouriel K, 2001, LANCET, V358, P1257, DOI 10.1016/S0140-6736(01)06351-6; R Core Team, 2021, R LANGUAGE ENV STAT; Rac-Albu Marius, 2014, Maedica (Bucur), V9, P295; Reiber JHC, 2011, CARDIOVASC DIAGN THE, V1, P57, DOI 10.3978/j.issn.2223-3652.2011.09.03; Reinecke H, 2015, EUR HEART J; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schmitter S., 2015, THESIS; Schreuder TH, 2015, ATHEROSCLEROSIS; Spronk S, 2005, J VASC SURG, V42, P236, DOI 10.1016/j.jvs.2005.04.048; Tehan PE, 2016, VASC MED; Tehan PE, 2016, J DIABETES COMPLICAT, V30, P155, DOI 10.1016/j.jdiacomp.2015.07.019; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; van de Vosse FN, 2011, ANNU REV FLUID MECH, V43, P467, DOI 10.1146/annurev-fluid-122109-160730; van Tongeren RB, 2010, J CARDIOVASC SURG, V51, P391; Xu DC, 2013, CAN J CARDIOL, V29, P492, DOI 10.1016/j.cjca.2012.06.014	28	13	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199374	10.1371/journal.pone.0199374	http://dx.doi.org/10.1371/journal.pone.0199374			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928037	Green Published, Green Submitted, gold			2022-12-26	WOS:000435802500080
J	Ndlovu, M				Ndlovu, Mduduzi			Birdcall lures improve passerine mist-net captures at a sub-tropical African savanna	PLOS ONE			English	Article							PLAYBACK; SEX; SAMPLES; BIAS; SONG	Field research techniques are constantly evolving to meet the needs of the scientific community. There is a growing need for field biology studies to shift towards increasing efficiency and quality of results while simultaneously decreasing cost in both the researcher's time and resources. I tested the efficacy of using multiple recorded birdcall lures (n = 172 species) to improve mist-net captures at a subtropical African savanna setting. Capture success was compared between passive and birdcall enhanced mist-nets during winter and summer seasons. Results suggest that the use of birdcalls does significantly increase the total number of birds caught in both seasons and also increases the diversity of passerine species. Conventional passive mist-nets without an audio lure were initially productive but their capture rate subsequently decreased as sampling days progressed. Birdcall lure enhanced mist-nets had a constant capture output during the summer season. The most responsive birds to audio lures were gregarious species (e.g. Pycnonotus barbatus, Dryoscopus cubla, Prionops plumatus, Phoeniculus purpureus, Turdoides jardineii and Lamprotornis chalybaeus) and the aggressive Dicrurus adsimilis and Acridotheres tristis. I conclude that birdcall lures can be used in summer and winter seasons to improve mist-net captures especially for studies focusing on gregarious and aggressive passerine species in a sub-tropical African savanna setting.	[Ndlovu, Mduduzi] Univ Mpumalanga, Sch Biol & Environm Sci, Mbombela, Mpumalanga, South Africa		Ndlovu, M (corresponding author), Univ Mpumalanga, Sch Biol & Environm Sci, Mbombela, Mpumalanga, South Africa.	mduduzindlovu@gmail.com	Ndlovu, Mduduzi/B-1300-2019; Dabernig, Celina/GXW-0872-2022	Ndlovu, Mduduzi/0000-0002-2997-9430; 				ALATALO RV, 1982, BIRD BEHAV, V4, P42, DOI 10.3727/015613882791560576; Chin S, 2014, WILSON J ORNITHOL, V126, P599, DOI 10.1676/13-187.1; Chittenden H, 2008, ROBERTS BIRD GUIDE K; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Erdman TC, 1996, 2 OWL S, P533; Rivera-Gutierrez HF, 2015, BEHAVIOUR, V152, P1277, DOI 10.1163/1568539X-00003278; Figuerola J, 1995, J FIELD ORNITHOL, V66, P497; Food and Agriculture Organization of the United Nations, 2007, FAO AN PROD HLTH MAN; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Frieden TR, 2014, NEW ENGL J MED, V371, P1177, DOI 10.1056/NEJMp1409903; Harris JBC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077902; Hockey P.A.R., 2005, ROBERTSBIRDS SO AFRI, V7th; Lecoq M, 2003, J FIELD ORNITHOL, V74, P230, DOI 10.1648/0273-8570-74.3.230; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; Newman D., 2013, STRUIK NATURE; Pinchuk Pavel, 2006, Wader Study Group Bulletin, V110, P64; R Development Core Team, 2010, MIXTURE HIDDEN MARKO; Sakai H.F., 1983, North American Bird Bander, V8, P54; Schaub M, 1999, AUK, V116, P1047, DOI 10.2307/4089684; Schekkerman H., 1999, Ringing and Migration, V19, P299; Sibley David, 2011, PROPER USE PLAYBACK; STEENHOF K, 1994, J RAPTOR RES, V28, P194; Stoner KJ, 2007, NOVATROPICA, V1, P1; Van Lanen NJ, 2011, BIOL CONSERV, V144, P2194, DOI 10.1016/j.biocon.2011.05.011; Venter FJ, 1984, KOEDOE, V29, P139; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Wojczulanis-Jakubas K, 2016, J ORNITHOL, V157, P137, DOI 10.1007/s10336-015-1260-z	27	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199595	10.1371/journal.pone.0199595	http://dx.doi.org/10.1371/journal.pone.0199595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928048	Green Submitted, gold, Green Published			2022-12-26	WOS:000435802500113
J	Novo-Rodriguez, C; Garcia-Fontana, B; Luna-Del Castillo, JD; Andujar-Vera, F; Avila-Rubio, V; Garcia-Fontana, C; Morales-Santana, S; Rozas-Moreno, P; Munoz-Torres, M				Novo-Rodriguez, Cristina; Garcia-Fontana, Beatriz; De Dios Luna-Del Castillo, Juan; Andujar-Vera, Francisco; Avila-Rubio, Veronica; Garcia-Fontana, Cristina; Morales-Santana, Sonia; Rozas-Moreno, Pedro; Munoz-Torres, Manuel			Circulating levels of sclerostin are associated with cardiovascular mortality	PLOS ONE			English	Article							KIDNEY-DISEASE PATIENTS; SERUM SCLEROSTIN; HEMODIALYSIS-PATIENTS; VASCULAR CALCIFICATIONS; COMPETING RISK; EXPRESSION; BONE; ATHEROSCLEROSIS; ROMOSOZUMAB; PREVENTION	Cardiovascular diseases are a health problem throughout the world, especially in people with diabetes. The identification of cardiovascular disease biomarkers can improve risk stratification. Sclerostin is a modulator of the Wnt/beta-catenin signalling pathway in different tissues, and it has recently been linked to vascular biology. The current study aimed to evaluate the relationship between circulating sclerostin levels and cardiovascular and non-cardiovascular mortality in individuals with and without type 2 diabetes. We followed up a cohort of 130 participants (mean age 56.8 years; 48.5% females; 75 with type 2 diabetes; 46 with prevalent cardiovascular disease) in which serum sclerostin levels were measured at the baseline. Time to death (both of cardiovascular and non-cardiovascular causes) was assessed to establish the relationship between sclerostin and mortality. We found that serum sclerostin concentrations were significantly higher in patients with prevalent cardiovascular disease (p<0.001), and independently associated with cardiovascular mortality (p = 0.008), showing sclerostin to be a stronger predictor of mortality than other classical risk factors (area under the curve = 0.849 vs 0.823). The survival analysis showed that an increase of 10 pmol/L in the serum sclerostin level resulted in a 31% increase in cardiovascular mortality. However, no significant association was observed between sclerostin levels and non-cardiovascular mortality (p = 0.346). From these results, we conclude that high sclerostin levels are related to mortality due to cardiovascular causes. The clinical implication of these findings is based on the possible use of serum sclerostin as a new biomarker of cardiovascular mortality risk in order to establish preventive strategies.	[Novo-Rodriguez, Cristina; Garcia-Fontana, Beatriz; Andujar-Vera, Francisco; Avila-Rubio, Veronica; Garcia-Fontana, Cristina; Munoz-Torres, Manuel] Hosp Univ San Cecilio, Inst Invest Biosanitaria Granada Ibs GRANADA, Endocrinol & Nutr Unit, Av Ilustrac S-N, Granada, Spain; [Garcia-Fontana, Beatriz; Morales-Santana, Sonia; Rozas-Moreno, Pedro; Munoz-Torres, Manuel] Inst Salud Carlos III, CIBERFES, Carretera Majadahonda Pozuelo Km 2-200, Madrid, Spain; [De Dios Luna-Del Castillo, Juan] Univ Granada, Dept Biostat, Av Invest, Granada, Spain; [Morales-Santana, Sonia] Inst Invest Biosanitaria Granada Ibs GRANADA, Fdn Invest Biosanitaria Andalucia Oriental Alejan, Proteom Res Serv, Av Doctor Oloriz 16, Granada, Spain; [Rozas-Moreno, Pedro] Hosp Gen Ciudad Real, Endocrinol Div, C Obispo Rafael Torija S-N, Ciudad Real, Spain; [Munoz-Torres, Manuel] Univ Granada, Dept Med, Av Invest, Granada, Spain	Hospital Universitario San Cecilio; Instituto de Investigacion Biosanitaria IBS Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERFES; Instituto de Salud Carlos III; University of Granada; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada	Garcia-Fontana, B (corresponding author), Hosp Univ San Cecilio, Inst Invest Biosanitaria Granada Ibs GRANADA, Endocrinol & Nutr Unit, Av Ilustrac S-N, Granada, Spain.; Garcia-Fontana, B (corresponding author), Inst Salud Carlos III, CIBERFES, Carretera Majadahonda Pozuelo Km 2-200, Madrid, Spain.	bgfontana@fibao.es	Fontana, Cristina Garcia/AAJ-4536-2021; Torres, Manuel Muñoz/O-2330-2016; Garcia-Fontana, Beatriz/AAB-4330-2021; Andujar-Vera, Francisco/AAE-4210-2021; Morales-Santana, Sonia/ABG-8889-2020	Fontana, Cristina Garcia/0000-0002-9328-6022; Torres, Manuel Muñoz/0000-0002-9645-3260; Morales-Santana, Sonia/0000-0001-8403-2496; Rozas Moreno, Pedro Jesus/0000-0003-2050-1526; Andujar Vera, Francisco Luis/0000-0002-2663-8809; Garcia Fontana, Beatriz/0000-0002-4134-5561	Consejeria de Salud y Bienestar Social (Junta de Andalucia) [PI0207-2016]; Fondo de Investigacion Sanitaria (Institute de Salud Carlos III) [PI12/02141, PI15/01207]; FEDER	Consejeria de Salud y Bienestar Social (Junta de Andalucia)(Junta de Andalucia); Fondo de Investigacion Sanitaria (Institute de Salud Carlos III)(Instituto de Salud Carlos III); FEDER(European Commission)	The authors declare that this work was support in part by Consejeria de Salud y Bienestar Social (Junta de Andalucia) Grants (PI0207-2016 to Dr. Beatriz Garcia-Fontana), and Fondo de Investigacion Sanitaria (Institute de Salud Carlos III) Grants (PI12/02141, PI15/01207 to Dr. Manuel Munoz-Torres), with co-financing from FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and there was no additional external funding received for this study.	Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Balci M, 2015, HERZ, V40, P289, DOI 10.1007/s00059-013-3992-y; Barandon L, 2003, CIRCULATION, V108, P2282, DOI 10.1161/01.CIR.0000093186.22847.4C; Bezooijen RL, 2005, CYTOKINE GROWTH F R, V16, P319, DOI 10.1016/j.cytogfr.2005.02.005; Brandenburg VM, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-219; Goncalves FLC, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-190; Claes KJ, 2013, J CLIN ENDOCR METAB, V98, P3221, DOI 10.1210/jc.2013-1521; Daniele G, 2015, DIABETES CARE, V38, P1509, DOI 10.2337/dc14-2989; Desjardins L, 2014, NEPHROL THER, V10, P463, DOI 10.1016/j.nephro.2014.04.002; Didangelos A, 2010, MOL CELL PROTEOMICS, V9, P2048, DOI 10.1074/mcp.M110.001693; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GARCIA MJ, 1974, DIABETES, V23, P105, DOI 10.2337/diab.23.2.105; Garcia-Martin A, 2012, J CLIN ENDOCR METAB, V97, P234, DOI 10.1210/jc.2011-2186; Gay A, 2017, CURR OPIN LIPIDOL, V28, P387, DOI 10.1097/MOL.0000000000000445; Goday A., 2002, ENDOCRINOLOG A NUTRI, V49, P113; Kanbay M, 2016, INT UROL NEPHROL, V48, P2029, DOI 10.1007/s11255-016-1387-8; Kanbay M, 2014, J CLIN ENDOCR METAB, V99, pE1854, DOI 10.1210/jc.2014-2042; Kirkpantur A, 2015, CLIN KIDNEY J, V8, P737, DOI 10.1093/ckj/sfv077; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lips L, 2017, NEPHROL DIAL TRANSPL, V32, P1217, DOI 10.1093/ndt/gfw246; Madonna R, 2011, VASC PHARMACOL, V54, P68, DOI 10.1016/j.vph.2011.03.005; Malekar P, 2010, HYPERTENSION, V55, P939, DOI 10.1161/HYPERTENSIONAHA.109.141127; Morales-Santana S, 2013, DIABETES CARE, V36, P1667, DOI 10.2337/dc12-1691; Morena M, 2015, NEPHROL DIAL TRANSPL, V30, P1345, DOI 10.1093/ndt/gfv081; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Popovic DS, 2017, CURR NEUROVASC RES, V14, P200, DOI 10.2174/1567202614666170619080526; Popovic DS, 2016, INT J CARDIOL, V214, P48, DOI 10.1016/j.ijcard.2016.03.072; Qureshi AR, 2015, KIDNEY INT, V88, P1356, DOI 10.1038/ki.2015.194; Roman-Garcia P, 2010, BONE, V46, P121, DOI 10.1016/j.bone.2009.09.006; Rosen CJ, 2017, NEW ENGL J MED, V377, P1479, DOI 10.1056/NEJMe1711298; Saag KG, 2017, NEW ENGL J MED, V377, P1417, DOI 10.1056/NEJMoa1708322; Spencer GJ, 2006, J CELL SCI, V119, P1283, DOI 10.1242/jcs.02883; Ueland T, 2009, ARTERIOSCL THROM VAS, V29, P1228, DOI 10.1161/ATVBAHA.109.189761; Viaene L, 2013, NEPHROL DIAL TRANSPL, V28, P3024, DOI 10.1093/ndt/gft039; Wang XR, 2017, NEPHROLOGY, V22, P286, DOI 10.1111/nep.12813; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yang CY, 2015, NEPHROL DIAL TRANSPL, V30, P1356, DOI 10.1093/ndt/gfv043; Zhu DX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019595	41	32	34	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199504	10.1371/journal.pone.0199504	http://dx.doi.org/10.1371/journal.pone.0199504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928063	Green Published, Green Submitted, gold			2022-12-26	WOS:000435802500102
J	Sanfelix-Gimeno, G; Julia-Sanchis, ML; Librero, J; Peiro, S; Garcia-Sempere, A				Sanfelix-Gimeno, Gabriel; Julia-Sanchis, Maria-Lirios; Librero, Julian; Peiro, Salvador; Garcia-Sempere, Anibal			Variations in osteoporosis medication utilization. A population-based ecological cross-sectional study in the region of Valencia, Spain	PLOS ONE			English	Article							GEOGRAPHIC-VARIATION; ESOSVAL COHORT; PRIMARY-CARE; TRENDS; VARIABILITY; PREVALENCE; FRACTURES; WORLDWIDE; OUTCOMES; QUALITY	Little is known about the contextual variability in osteoporosis medication utilization. Our aims were 1) to describe variations in utilization and spending on osteoporotic medication between the Primary Care Health Zones (PHZ) of the Valencia region, Spain, 2) to analyze observed variations using Small Area Variation Analysis methods, and 3) to quantify the influence of the specialized care level on variations in utilization. We conducted a population-based cross-sectional ecological study of expenditure and utilization of five therapeutic groups marketed as osteoporosis treatments in Spain in 2009. The unit of analysis was the PHZ (in total 240) nested in the 23 Hospital Healthcare Departments (HHD) of the region of Valencia, covering a population of about 4.9 million inhabitants. Drug utilization was measured by dispensed Defined Daily Dose per 1000 women aged 50 years old and over and day (DID) per PHZ and cost was measured by the annual osteoporosis drug cost per woman aged 50 and older as well as the average price of DDD (Defined Daily Dose) in each PHZ. We calculated Indirect Standardized Drug Utilization Ratios (ISR) and we used Spear man's correlation to analyze associations between the ISRs of the different therapies. The average osteoporosis drug consumption was 119.1 DID, ranging from 77.6 to 171.3 DID (2.2 times higher) between PHZs in the 5th and 95th percentiles. Annual expenditure also showed a two-fold variation among PHZs. Average prices of the DDD by therapeutic group showed very low or no variation, although they differed substantially among therapeutic groups. Regarding the standardized consumption of osteoporotic drugs, HHDs explained a substantial part (39%) of the variance among PHZs. In conclusion, there is considerable variability in the volume and choice of anti-osteoporotic treatments between PHZs. with HHDs explaining an important proportion of the variation in utilization. Interventions aimed at reducing variation to improve appropriate care should take into account both the PHZ and HHD levels of care.	[Sanfelix-Gimeno, Gabriel; Julia-Sanchis, Maria-Lirios; Peiro, Salvador; Garcia-Sempere, Anibal] Ctr Publ Hlth Res CSISP FISABIO, Valencia, Spain; [Sanfelix-Gimeno, Gabriel; Peiro, Salvador; Garcia-Sempere, Anibal] Red Invest Serv Salud Enfermedades Cron REDISSEC, Valencia, Spain; [Librero, Julian] Navarra Biomed Ctr, Navarrabiomed, Pamplona, Navarra, Spain	Navarrabiomed	Sanfelix-Gimeno, G (corresponding author), Ctr Publ Hlth Res CSISP FISABIO, Valencia, Spain.; Sanfelix-Gimeno, G (corresponding author), Red Invest Serv Salud Enfermedades Cron REDISSEC, Valencia, Spain.	sanfelix_gab@gva.es	Librero, Julian/F-4947-2017; García-Sempere, Aníbal/ABA-7989-2021; Peiro, Salvador/H-5778-2017; Sanfélix-Gimeno, Gabriel/E-9140-2012; GARCIA-SEMPERE, ANIBAL/AAA-9137-2019	Librero, Julian/0000-0002-4859-9054; García-Sempere, Aníbal/0000-0002-4313-3976; Peiro, Salvador/0000-0002-3902-569X; Sanfélix-Gimeno, Gabriel/0000-0001-7098-4576; 	Department of Health of the Autonomous Government of Valencia [047/2010]; Institute de Salud Carlos III from the Spanish Ministry of Health [P109/90882, P113/01721]	Department of Health of the Autonomous Government of Valencia; Institute de Salud Carlos III from the Spanish Ministry of Health	This project was partially funded by the Department of Health of the Autonomous Government of Valencia (Project 047/2010, www.san.gva.es) and the Institute de Salud Carlos III from the Spanish Ministry of Health (Project P109/90882 and P113/01721, www.isciii.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anis AH, 1996, CAN MED ASSOC J, V154, P635; Bolland MJ, 2010, J CLIN ENDOCR METAB, V95, P1856, DOI 10.1210/jc.2009-2157; de Felipe R, 2010, ATEN PRIM, V42, P559, DOI 10.1016/j.aprim.2009.10.022; Devold HM, 2010, EUR J CLIN PHARMACOL, V66, P299, DOI 10.1007/s00228-009-0746-0; Donohue JM, 2012, NEW ENGL J MED, V366, P530, DOI 10.1056/NEJMsa1104816; Dubois RW, 2002, HEALTH AFFAIR, V21, P240, DOI 10.1377/hlthaff.21.1.240; Eisenberg JM, 2002, MED CARE, V40, P1016, DOI 10.1097/00005650-200211000-00004; Salgueiro ME, 2013, MATURITAS, V74, P74, DOI 10.1016/j.maturitas.2012.10.002; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Lopez-Valcarcel BG, 2013, MED CLIN-BARCELONA, V140, P104, DOI 10.1016/j.medcli.2011.11.030; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Hurtado I, 2014, J CLIN ENDOCR METAB, V99, P142, DOI 10.1210/jc.2013-3448; Ibanez B, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-60; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kahn HA, 1989, STAT METHODS EPIDEMI, P97; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Martin-Merino E, 2017, BONE, V105, P292, DOI 10.1016/j.bone.2017.08.031; Martin-Moreno JM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1170; National Research Council, 2013, VARIATION HLTH CARE, DOI [10.17226/18393, DOI 10.17226/18393]; Richards M, 2010, EXTENT CAUSES INT VA; Rocha Olavo, 2006, Acta Med Port, V19, P373; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P41; Sanfelix-Genoves J, 2013, OSTEOPOROSIS INT, V24, P1045, DOI 10.1007/s00198-012-2018-6; Sanfelix-Genoves J, 2014, MED CLIN-BARCELONA, V142, P15, DOI 10.1016/j.medcli.2012.10.025; Sanfelix-Gimeno G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135475; Wang L, 2013, PRIM HEALTH CARE RES, V14, P1, DOI 10.1017/S1463423612000114; Wennberg John E, 2002, Health Aff (Millwood), VSuppl Web Exclusives, pW96; WHO Collaborating Centre for Drug Statistics Methodology, 2012, GUID ATC CLASS DDD A; Zhang YT, 2012, NEW ENGL J MED, V367, P1724, DOI 10.1056/NEJMsa1203980; Zhang YT, 2010, NEW ENGL J MED, V363, P1985, DOI 10.1056/NEJMp1010220; Zhang YT, 2010, NEW ENGL J MED, V363, P405, DOI 10.1056/NEJMp1004872	32	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199086	10.1371/journal.pone.0199086	http://dx.doi.org/10.1371/journal.pone.0199086			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927952	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500042
J	da Rosa, CVD; de Campos, JM; Nakanishi, ABD; Comar, JF; Martine, IP; Mathias, PCD; Pedrosa, MMD; de Godoi, VAF; Natali, MRM				Dalto da Rosa, Carlos Vinicius; de Campos, Jessica Men; de Sa Nakanishi, Anacharis Babeto; Comar, Jurandir Fernando; Martine, Isabela Peixoto; de Freitas Mathias, Paulo Cezar; Diaz Pedrosa, Maria Montserrat; Ferreira de Godoi, Vilma Aparecida; Marcal Natali, Maria Raquel			Food restriction promotes damage reduction in rat models of type 2 diabetes mellitus	PLOS ONE			English	Article							BETA-CELL FUNCTION; CARDIOVASCULAR RISK-FACTORS; DIET-INDUCED OBESITY; LOW-CALORIE DIET; OXIDATIVE STRESS; GASTRIC BYPASS; ENERGY RESTRICTION; INSULIN-RESISTANCE; PHYSICAL-EXERCISE; SEVERELY OBESE	There are several animal models of type 2 diabetes mellitus induction but the comparison between models is scarce. Food restriction generates benefits, such as reducing oxidative stress, but there are few studies on its effects on diabetes. The objective of this study is to evaluate the differences in physiological and biochemical parameters between diabetes models and their responses to food restriction. For this, 30 male Wistar rats were distributed in 3 groups (n = 10/group): control (C); diabetes with streptozotocin and cafeteria-style diet (DE); and diabetes with streptozotocin and nicotinamide (DN), all treated for two months (pre-food restriction period). Then, the 3 groups were subdivided into 6, generating the groups CC (control), CCR (control+food restriction), DEC (diabetic+standard diet), DER (diabetic+food restriction), DNC (diabetic+standard diet) and DNR (diabetic+food restriction), treated for an additional two months (food restriction period). The food restriction (FR) used was 50% of the average daily dietary intake of group C. Throughout the treatment, physiological and biochemical parameters were evaluated. At the end of the treatment, serum biochemical parameters, oxidative stress and insulin were evaluated. Both diabetic models produced hyperglycemia, polyphagia, polydipsia, insulin resistance, high fructosamine, hepatic damage and reduced insulin, although only DE presented human diabeteslike alterations, such as dyslipidemia and neuropathy symptoms. Both DEC and DNC diabetic groups presented higher levels of protein carbonyl groups associated to lower antioxidant capacity in the plasma. FR promoted improvement of glycemia in DNR, lipid profile in DER, and insulin resistance and hepatic damage in both diabetes models. FR also reduced the protein carbonyl groups of both DER and DNR diabetic groups, but the antioxidant capacity was improved only in the plasma of DER group. It is concluded that FR is beneficial for diabetes but should be used in conjunction with other therapies.	[Dalto da Rosa, Carlos Vinicius; de Campos, Jessica Men; Marcal Natali, Maria Raquel] Univ Estadual Maringa, Dept Morphol Sci, Maringa, Parana, Brazil; [de Sa Nakanishi, Anacharis Babeto; Comar, Jurandir Fernando] Univ Estadual Maringa, Dept Biochem, Maringa, Parana, Brazil; [Martine, Isabela Peixoto; de Freitas Mathias, Paulo Cezar] Univ Estadual Maringa, Dept Biotechnol Cell Biol & Genet, Maringa, Parana, Brazil; [Diaz Pedrosa, Maria Montserrat; Ferreira de Godoi, Vilma Aparecida] Univ Estadual Maringa, Dept Physiol Sci, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Natali, MRM (corresponding author), Univ Estadual Maringa, Dept Morphol Sci, Maringa, Parana, Brazil.	mrmnatali@uem.br	Comar, Jurandir Fernando/D-8160-2019; de Freitas Mathias, Paulo Cezar PCFM/O-6056-2015; DE FREITAS MATHIAS, PAULO CEZAR/AAQ-9682-2021; Comar, Jurandir F./I-7285-2013; Pedrosa, Maria Montserrat Diaz/AAW-6411-2020; Diaz Pedrosa, Maria Montserrat/R-9128-2017	Comar, Jurandir Fernando/0000-0002-9518-7589; de Freitas Mathias, Paulo Cezar PCFM/0000-0001-6994-4585; Rosa, Carlos Vinicius Dalto da/0000-0001-9428-630X; Diaz Pedrosa, Maria Montserrat/0000-0002-0596-3557; Natali, Maria Raquel Marcal/0000-0002-7486-2581	Coordenagao de Aperfeigoamento de Pessoa de Nivel Superior - CAPES [40004015001M9]; CVDR JMC ABSN JFC IPM PCFM MMDP VAFG MRMN	Coordenagao de Aperfeigoamento de Pessoa de Nivel Superior - CAPES; CVDR JMC ABSN JFC IPM PCFM MMDP VAFG MRMN	This work was supported by 40004015001M9, http://www.capes.gov.br/, Coordenagao de Aperfeigoamento de Pessoa de Nivel Superior - CAPES, CVDR JMC ABSN JFC IPM PCFM MMDP VAFG MRMN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badole SL, 2013, EUR J PHARMACOL, V698, P470, DOI 10.1016/j.ejphar.2012.10.002; Barbosa MMC, 2018, ENDOCR METAB IMMUNE, V18, P268, DOI 10.2174/1871530318666180215102029; Barnosky AR, 2014, TRANSL RES, V164, P302, DOI 10.1016/j.trsl.2014.05.013; Belem MD, 2015, EXP GERONTOL, V69, P85, DOI 10.1016/j.exger.2015.05.002; Biazon AC, 2016, J BIOSC MED, V4, P15, DOI DOI 10.4236/JBM.2016.42003; Blagosklonny MV, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.506; Bracht A, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1671-1; Branquinho NTD, 2017, J PHARM PHARMACOL, V5, DOI [10.17265/2328-2150/2017.07.003, DOI 10.17265/2328-2150/2017.07.003]; Brereton MF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5639; Ghizoni CVC, 2017, J CELL BIOCHEM, V118, P3409, DOI 10.1002/jcb.25998; Cirilo CP, 2013, NUTRITION, V29, P673, DOI 10.1016/j.nut.2012.09.004; Colombo M, 2006, METABOLISM, V55, P43, DOI 10.1016/j.metabol.2005.07.005; Correia-Santos AM., 2012, MEDICINA RIBEIRAO PR, V45, P436, DOI DOI 10.11606/ISSN.2176-7262.V45I4P436-444; Crisostomo J, 2010, BRIT J NUTR, V104, P76, DOI 10.1017/S0007114510000164; Deng XQ, 2010, ACTA DIABETOL, V47, pS177, DOI 10.1007/s00592-009-0159-7; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Fakhruddin S, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/8379327; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Schoffen JPF, 2014, EXP GERONTOL, V51, P54, DOI 10.1016/j.exger.2014.01.001; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Goularte JF, 2012, BRIT J NUTR, V108, P1511, DOI 10.1017/S0007114511006933; Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171; Isbell JM, 2010, DIABETES CARE, V33, P1438, DOI 10.2337/dc09-2107; Islam Md Shahidul, 2012, Methods Mol Biol, V933, P161, DOI 10.1007/978-1-62703-068-7_10; Jazet IM, 2007, DIABETES RES CLIN PR, V77, P70, DOI 10.1016/j.diabres.2006.10.019; Kahleova H, 2014, DIABETOLOGIA, V57, P1552, DOI 10.1007/s00125-014-3253-5; Kanda Y, 2015, J NUTR BIOCHEM, V26, P219, DOI 10.1016/j.jnutbio.2014.10.007; Kapur Kavita, 2008, J Assoc Physicians India, V56, P27; Kashyap S. R., 2010, International Journal of Obesity, V34, P462, DOI 10.1038/ijo.2009.254; Kitada M, 2017, NEPHROLOGY, V22, P1030, DOI 10.1111/nep.13152; Kostolanska J, 2009, J PEDIATR ENDOCR MET, V22, P433; Kretschmer BD, 2005, LIFE SCI, V76, P1553, DOI 10.1016/j.lfs.2004.08.028; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Lips MA, 2014, CLIN ENDOCRINOL, V80, P834, DOI 10.1111/cen.12254; Malandrucco I, 2012, AM J CLIN NUTR, V95, P609, DOI 10.3945/ajcn.111.023697; Mallipattu SK, 2014, AM J PHYSIOL-RENAL, V306, pF1008, DOI 10.1152/ajprenal.00597.2013; Masiello P, 1998, DIABETES, V47, P224, DOI 10.2337/diabetes.47.2.224; Meng Y, 2017, DIABETES RES CLIN PR, V131, P124, DOI 10.1016/j.diabres.2017.07.006; Minamiyama Y, 2007, J PHARMACOL EXP THER, V320, P535, DOI 10.1124/jpet.106.110460; Nankar RP, 2017, PHYTOMEDICINE, V37, P4, DOI 10.1016/j.phymed.2017.10.014; Okoduwa Stanley I R, 2017, Medicines (Basel), V4, DOI 10.3390/medicines4040073; Pandey KB, 2010, CLIN BIOCHEM, V43, P508, DOI 10.1016/j.clinbiochem.2009.11.011; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Rizvi AA, 2010, METAB SYNDR RELAT D, V8, P287, DOI 10.1089/met.2009.0116; Ross AP, 2015, J DIABETES COMPLICAT, V29, P329, DOI 10.1016/j.jdiacomp.2014.12.017; Sahin I, 2011, MOL CELL BIOCHEM, V355, P299, DOI 10.1007/s11010-011-0867-5; SCOTT AM, 1981, DIABETOLOGIA, V21, P470; Sharma AK, 2012, J BIOMED RES, V26, P200, DOI 10.7555/JBR.26.20110054; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Srinivasan K, 2007, INDIAN J MED RES, V125, P451; Steinbrook R, 2004, NEW ENGL J MED, V350, P1075, DOI 10.1056/NEJMp048029; Stenkamp-Strahm CM, 2015, CELL TISSUE RES, V361, P411, DOI 10.1007/s00441-015-2132-9; Su HC, 2006, AM J PHYSIOL-ENDOC M, V290, pE1339, DOI 10.1152/ajpendo.00487.2005; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Szkudelska K, 2014, INT J EXP PATHOL, V95, P86, DOI 10.1111/iep.12073; Tiwari Brahm Kumar, 2013, J Biomark, V2013, P378790, DOI 10.1155/2013/378790; Trammell SAJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26933; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; Ugochukwu NH, 2004, CLIN CHIM ACTA, V348, P121, DOI 10.1016/j.cccn.2004.05.005; Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; WHO, 2016, GLOB REP PSOR; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Winiarska K, 2009, BIOCHIMIE, V91, P261, DOI 10.1016/j.biochi.2008.09.006; Zhou X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115148	66	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199479	10.1371/journal.pone.0199479	http://dx.doi.org/10.1371/journal.pone.0199479			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924854	Green Submitted, Green Published, gold			2022-12-26	WOS:000435655600072
J	Yang, TH; Chuang, FC; Kuo, HC				Yang, Tsai-Hwa; Chuang, Fei-Chi; Kuo, Hann-Chorng			Urodynamic characteristics of detrusor underactivity in women with voiding dysfunction	PLOS ONE			English	Article							URINARY-TRACT DYSFUNCTION; BLADDER OUTLET OBSTRUCTION; CONTINENCE SOCIETY; SYMPTOMS; TERMINOLOGY; DIAGNOSIS	Introduction and hypothesis Voiding dysfunction has gained interest due to its high prevalence in the elderly. This study characterized bladder dysfunction in women with voiding dysfunction using video urodynamic studies (VUDS) focused on detrusor underactivity (DU). Methods We studied 1914 women in which first-line medical treatment failed. Age, comorbidities, and urodynamic parameters were analyzed to determine the association between bladder sensation and contractility. Results VUDS were normal in 2.9% (n = 56) of patients and showed DU in 23.1% (n = 443), detrusor hyperactivity and impaired contractility (DHIC) in 12.0% (n = 231), hypersensitive bladder in 17.0% (n = 325), detrusor overactivity (DO) in 2.6% (n = 49) and bladder outlet obstruction in 42.3% (n = 810). The mean age of patients in the DU and DHIC groups was significantly older than in women with normal VUDS and those with hypersensitive bladders (p<0.01). Decreased bladder sensation and larger cystometric bladder capacity were noted in the DU group compared to the DHIC, HSB, and DO groups. Bladder sensation was negatively associated with the bladder contractility. Bladder contractility index and voiding efficiency were lower in the DU and DHIC groups compared to the normal group. Conclusions The bladder conditions of women with voiding dysfunction included DU, DHIC, HSB and DO. Bladder contractility index and voiding efficiency were significantly lowest in DU and DHIC groups and lower in HSB and DO groups than normal tracing group. Reduced bladder sensation was noted in DU and negatively associated with detrusor contractility.	[Yang, Tsai-Hwa; Chuang, Fei-Chi] Chang Gang Mem Hosp, Dept Obstet & Gynecol, Kaohsiung, Taiwan; [Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Kuo, Hann-Chorng] Tzu Chi Univ, Hualien, Taiwan	Chang Gung Memorial Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.; Kuo, HC (corresponding author), Tzu Chi Univ, Hualien, Taiwan.	hck@tzuchi.com.tw						Abrams P, 2002, AM J OBSTET GYNECOL, V187, P116, DOI 10.1067/mob.2002.125704; Araki I, 2000, J UROLOGY, V164, P1640, DOI 10.1016/S0022-5347(05)67048-6; Barapatre Y, 2009, NEUROUROL URODYNAM, V28, P1003, DOI 10.1002/nau.20718; Burney TL, 1996, J UROLOGY, V156, P1748, DOI 10.1016/S0022-5347(01)65498-3; Choi YS, 2013, INT UROL NEPHROL, V45, P989, DOI 10.1007/s11255-013-0475-2; Daneshgari F, 2009, J UROLOGY, V182, pS18, DOI 10.1016/j.juro.2009.08.070; Everaert K, 2000, INT UROGYNECOL J, V11, P254, DOI 10.1007/s001920070035; Gammie A, 2016, EUR UROL, V69, P361, DOI 10.1016/j.eururo.2015.08.014; Gillespie JI, 2009, BJU INT, V103, P1324, DOI 10.1111/j.1464-410X.2009.08377.x; Groutz A, 1999, UROLOGY, V54, P268, DOI 10.1016/S0090-4295(99)00097-7; Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798; Health Promotion Administration MoHaW Taiwan, 2014, ANN PREV DIAB MELL T; Hsiao SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07163-2; Jiang YH, 2017, J UROLOGY, V197, P197, DOI 10.1016/j.juro.2016.07.071; Kayigil O, 2007, INT UROL NEPHROL, V39, P445, DOI 10.1007/s11255-006-9023-7; Kuo HC, 2012, J FORMOS MED ASSOC, V111, P386, DOI 10.1016/j.jfma.2011.05.014; Kuo HC, 2000, J FORMOS MED ASSOC, V99, P386; Kuo HC, 2005, UROLOGY, V66, P1005, DOI 10.1016/j.urology.2005.05.047; Lee WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045578; Michel MC, 2015, N-S ARCH PHARMACOL, V388, P687, DOI 10.1007/s00210-015-1137-y; Miyazato Minoru, 2013, Rev Urol, V15, P11; Ramos ACS, 2013, LIFE SCI, V93, P820, DOI 10.1016/j.lfs.2013.09.008; Smith PP, 2015, NEUROUROL URODYNAM, V34, P752, DOI 10.1002/nau.22653; Smith PP, 2010, NEUROUROL URODYNAM, V29, P408, DOI 10.1002/nau.20765; Wagg AS, 1996, J UROLOGY, V156, P1984, DOI 10.1016/S0022-5347(01)65410-7; Yamaguchi O, 2014, NEUROUROL URODYNAM, V33, P54, DOI 10.1002/nau.22517	26	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0198764	10.1371/journal.pone.0198764	http://dx.doi.org/10.1371/journal.pone.0198764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924821	Green Submitted, gold, Green Published			2022-12-26	WOS:000435655600034
J	Axmon, A; Sandberg, M; Ahlstrom, G; Midlov, P				Axmon, Anna; Sandberg, Magnus; Ahlstrom, Gerd; Midlov, Patrik			Fall-risk-increasing drugs and falls requiring health care among older people with intellectual disability in comparison with the general population: A register study	PLOS ONE			English	Article							MEDICATION USE; ADULTS; PREVALENCE; INJURIES; ANTIPSYCHOTICS; INCIDENTS; DEMENTIA	Background Falls are the most common cause of injury for older people in the general population as well as among those with intellectual disability. There are many risk factors for falls, including a range of drugs which are considered to be fall-risk-increasing (FRIDs). The aim of the present study was to describe prescription patterns of FRIDs in itself as well as in relation to falls requiring health care among older people with intellectual disability and their age-peers in the general population. Moreover, to investigate possible differences between the two groups. Methods A cohort of people with intellectual disability and a referent cohort, one-to-one-matched by sex and year of birth, were established. Each cohort comprised 7936 people aged 55+ years at the end of 2012. Register data were collected for 2006 +/- 2012 on prescription of antidepressants, anxiolytics, hypnotics and sedatives, opioids, and antipsychotics, as well as for fall-related health care contacts. Analyses were performed on yearly data, using repeated measures models. Results People with intellectual disability were more likely to be prescribed at least one FRID (Relative Risk [RR] 2.31). The increase was highest for antipsychotics (RR 25.0), followed by anxiolytics (RR 4.18), antidepressants (RR 2.72), and hypnotics and sedatives (RR 1.42). For opioids, however, a lower prevalence (RR 0.74) was found. In both cohorts, those with prescription of at least one FRID were more likely to have a fall-related injury that required health care. The increased risk was higher in the referent cohort (RR 3.98) than among people with intellectual disability (RR 2.27), although people with intellectual disability and prescription still had a higher risk of falls than those with prescription in the referent cohort (RR 1.27). A similar pattern was found for all drug groups, except for opioids, where prescription carried the same risk of having a fall-related injury that required health care in both cohorts. Conclusions With or without prescription of FRIDs, older people with ID have a higher risk of falls requiring health care than their age-peers in the general population. It is important to be aware of this when prescribing drugs that further increase the risk of falls.	[Axmon, Anna] Lund Univ, Dept Lab Med, Occupat & Environm Med, Lund, Sweden; [Axmon, Anna; Sandberg, Magnus; Ahlstrom, Gerd] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Midlov, Patrik] Lund Univ, Dept Clin Sci Malmo, Ctr Primary Hlth Care Res, Lund, Sweden	Lund University; Lund University; Lund University	Axmon, A (corresponding author), Lund Univ, Dept Lab Med, Occupat & Environm Med, Lund, Sweden.; Axmon, A (corresponding author), Lund Univ, Dept Hlth Sci, Lund, Sweden.	anna.axmon@med.lu.se	Axmon, Anna/AAB-2001-2019; Midlov, Patrik/L-8201-2015	Axmon, Anna/0000-0002-4539-8337; Ahlstrom, Gerd/0000-0001-6230-7583; Midlov, Patrik/0000-0002-5871-8731	Forte, the Swedish Research Council for Health, Working Life and Welfare [2014-4753]; GA as Pl	Forte, the Swedish Research Council for Health, Working Life and Welfare; GA as Pl	This work was funded by Forte, the Swedish Research Council for Health, Working Life and Welfare (http://forte.se/en) no. 2014-4753 with GA as Pl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Axmon A, 2016, J INTELL DISABIL RES, V60, P1165, DOI 10.1111/jir.12338; Axmon A, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0174-1; Axmon A, 2017, RES DEV DISABIL, V62, P50, DOI 10.1016/j.ridd.2017.01.001; Balogh RS, 2015, DIABETIC MED, V32, P235, DOI 10.1111/dme.12573; Bauer TK, 2012, PHARMACOEPIDEM DR S, V21, P1321, DOI 10.1002/pds.3357; Cox CR, 2010, J INTELL DISABIL RES, V54, P1045, DOI 10.1111/j.1365-2788.2010.01333.x; Deb S, 2015, J INTELL DISABIL RES, V59, P11, DOI 10.1111/jir.12119; Doan TN, 2013, J INTELLECT DEV DIS, V38, P177, DOI 10.3109/13668250.2013.778968; Finlayson J, 2010, J INTELL DISABIL RES, V54, P966, DOI 10.1111/j.1365-2788.2010.01319.x; Guse Clare E, 2003, WMJ, V102, P37; Hale LA, 2016, DISABIL REHABIL, V38, P36, DOI 10.3109/09638288.2015.1017613; Ham AC, 2014, DRUG AGING, V31, P917, DOI 10.1007/s40266-014-0225-x; Haveman M, 2010, J POLICY PRACT INTEL, V7, P59, DOI 10.1111/j.1741-1130.2010.00248.x; Hermans H, 2013, J AFFECT DISORDERS, V144, P94, DOI 10.1016/j.jad.2012.06.011; Hsieh K, 2001, J INTELL DISABIL RES, V45, P76, DOI 10.1046/j.1365-2788.2001.00277.x; Hsieh K, 2012, AJIDD-AM J INTELLECT, V117, P442, DOI 10.1352/1944-7558-117.6.442; Knight M, 2010, J NURS CARE QUAL, V25, P208, DOI 10.1097/NCQ.0b013e3181d3766f; Lin JD, 2009, RES DEV DISABIL, V30, P294, DOI 10.1016/j.ridd.2008.05.001; National Board of Health and Welfare, 2020, STAT LAK; Ng N, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0665-3; O'Leary L, 2018, J APPL RES INTELLECT, V31, P325, DOI 10.1111/jar.12417; Park H, 2015, EUR J CLIN PHARMACOL, V71, P1429, DOI 10.1007/s00228-015-1955-3; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Robertson J, 2015, SEIZURE-EUR J EPILEP, V29, P46, DOI 10.1016/j.seizure.2015.03.016; Scheifes A, 2016, J CLIN PSYCHOPHARM, V36, P308, DOI 10.1097/JCP.0000000000000528; Sibley KM, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-22; Smulders E, 2013, J INTELL DISABIL RES, V57, P1173, DOI 10.1111/j.1365-2788.2012.01643.x; Srikanth R, 2011, J INTELL DISABIL RES, V55, P53, DOI 10.1111/j.1365-2788.2010.01346.x; Sterke CS, 2008, INT PSYCHOGERIATR, V20, P890, DOI 10.1017/S104161020800714X; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Stubbs B, 2014, ARCH PHYS MED REHAB, V95, P175, DOI 10.1016/j.apmr.2013.08.241; Tsiouris JA, 2013, J AUTISM DEV DISORD, V43, P719, DOI 10.1007/s10803-012-1617-6; Westerinen H, 2007, J INTELL DISABIL RES, V51, P715, DOI 10.1111/j.1365-2788.2007.00970.x; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; WHO, 2013, GUID ATC CLASS DDD A; Willgoss TG, 2010, J CLIN NURS, V19, P2100, DOI 10.1111/j.1365-2702.2009.03174.x	37	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199218	10.1371/journal.pone.0199218	http://dx.doi.org/10.1371/journal.pone.0199218			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ7CA	29920564	Green Published, Green Submitted, gold			2022-12-26	WOS:000435541300025
J	Moreno, MJ; Gallardo, A; Novelli, S; Mozos, A; Arago, M; Pavon, MA; Cespedes, MV; Pallares, V; Falgas, A; Alcoceba, M; Blanco, O; Gonzalez-Diaz, M; Sierra, J; Mangues, R; Casanova, I				Jose Moreno, Maria; Gallardo, Alberto; Novelli, Silvana; Mozos, Ana; Arago, Marc; Angel Pavon, Miguel; Virtudes Cespedes, Maria; Pallares, Victor; Falgas, Aida; Alcoceba, Miguel; Blanco, Oscar; Gonzalez-Diaz, Marcos; Sierra, Jorge; Mangues, Ramon; Casanova, Isolda			CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+patients with good prognosis	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; BETA-ARRESTIN; SURVIVAL; CXCL12	The CXCR4/CXCL12 axis has been extensively associated with different types of cancer correlating with higher aggressiveness and metastasis. In diffuse large B-cell lymphoma (DLBCL), the expression of the chemokine receptor CXCR4 is involved in the dissemination of malignant B cells and is a marker of poor prognosis. CXCR7 is a chemokine receptor that binds to the same ligand as CXCR4 and regulates de CXCR4-CXCL12 axis. These findings together with the report of CXCR7 prognostic value in several tumor types, led us to evaluate the expression of CXCR7 in diffuse large B-cell lymphoma biopsies. Here, we describe that CXCR7 receptor is an independent prognostic factor that associates with good clinical outcome. Moreover, the expression of CXCR7 associates with increased survival in CXCR4+ but not in CXCR4- DLBCL patients. Thus, the combined immunohistochemical evaluation of both CXCR7 and CXCR4 expression in DLBCL biopsies may improve their prognostic value as single markers. Finally, we show that CXCR7 overexpression in vitro is able to diminish DLBCL cell survival and increase their sensitivity to antitumor drugs. Hence, further studies on the CXCR7 receptor may establish its role in DLBCL and the molecular mechanisms that modulate CXCR4 activity.	[Jose Moreno, Maria; Arago, Marc; Angel Pavon, Miguel; Virtudes Cespedes, Maria; Pallares, Victor; Falgas, Aida; Mangues, Ramon; Casanova, Isolda] Hosp Santa Creu & Sant Pau, Biomed Res Inst St Pau IIB St Pau, Barcelona, Spain; [Jose Moreno, Maria; Angel Pavon, Miguel; Virtudes Cespedes, Maria; Mangues, Ramon; Casanova, Isolda] CIBER BBN, Barcelona, Spain; [Gallardo, Alberto; Mozos, Ana] Hosp Santa Creu & Sant Pau, Dept Pathol, Barcelona, Spain; [Novelli, Silvana; Pallares, Victor; Sierra, Jorge] Hosp Santa Creu & Sant Pau, Dept Hematol, Barcelona, Spain; [Alcoceba, Miguel; Blanco, Oscar; Gonzalez-Diaz, Marcos] IBSAL Univ Hosp, Ctr Canc Res IBMCC USAL CSIC, Dept Hematol & Pathol, Salamanca, Spain; [Alcoceba, Miguel; Gonzalez-Diaz, Marcos] CIBER Oncol CIBER ONC, Madrid, Spain; [Sierra, Jorge; Mangues, Ramon; Casanova, Isolda] Josep Carreras Res Inst, Barcelona, Spain	Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Institut de Recerca Contra la Leucemia Josep Carreras (IJC)	Mangues, R (corresponding author), Hosp Santa Creu & Sant Pau, Biomed Res Inst St Pau IIB St Pau, Barcelona, Spain.; Mangues, R (corresponding author), CIBER BBN, Barcelona, Spain.; Mangues, R (corresponding author), Josep Carreras Res Inst, Barcelona, Spain.	rmangues@santpau.cat	Alcoceba, Miguel/AAH-2784-2020; Mangues, Ramon/J-6396-2014; Alcoceba, Miguel/GXH-4002-2022; Alcoceba, Miguel/B-7873-2017; Aragó, Marc/AAG-3513-2021; BLANCO, OSCAR/AAB-6306-2019; Pavon, Miguel Angel/N-3538-2014; CASANOVA RIGAT, ISOLDA/I-5393-2014	Mangues, Ramon/0000-0003-2661-9525; Alcoceba, Miguel/0000-0002-3819-4846; Alcoceba, Miguel/0000-0002-3819-4846; BLANCO, OSCAR/0000-0002-2667-0489; Arago, Marc/0000-0002-9645-0131; Pavon, Miguel Angel/0000-0003-3677-5329; Gallardo, Alberto/0000-0002-2514-2027; Novelli, Silvana/0000-0001-8750-0195; Falgas, Aida/0000-0002-5040-2265; CASANOVA RIGAT, ISOLDA/0000-0002-1196-4724	Institute de Salud Carlos III [FIS PI11/00872, RD12/0036/0071, FIS PI14/00450, FIS PI15/00378, PIE15/00028, RD12/0036/0069, PS09/01382, PI15/01393, CD13/00074]; FEDER; Centro de Investigacion Biomedica en Red (GIBER) [CB06/01/1031, CB16/12/00233]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2014-SGR-1041, 2014PROD0005, 2014-SGR-1281, 2017E1300680]; Fundacio La Marato TV3 [416/C/2013-2030, 100830/31/32]; Josep Carreras Leukaemia Research Institute [P/AG]; Health Council of Castilla y Leon [BIO/SA56/13, BIO/SA78/15]; Centro de Investigacion Biomedica en Red (GIBER) [Nanomets3]	Institute de Salud Carlos III(Instituto de Salud Carlos III); FEDER(European Commission); Centro de Investigacion Biomedica en Red (GIBER); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Fundacio La Marato TV3; Josep Carreras Leukaemia Research Institute [P/AG]; Health Council of Castilla y Leon; Centro de Investigacion Biomedica en Red (GIBER) [Nanomets3]	This work was supported by Institute de Salud Carlos III (co-founding from FEDER) [FIS PI11/00872, RD12/0036/0071, FIS PI14/00450 to J.S., FIS PI15/00378 to R.M., PIE15/00028 to R.M. and J.S., RD12/0036/0069, PS09/01382 to M.G.D, PI15/01393 to MA, CD13/00074 to V.P.]; Centro de Investigacion Biomedica en Red (GIBER) [CB06/01/1031 and Nanomets3 to R.M. and CB16/12/00233 to M.G.D.]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2014-SGR-1041, 2014PROD0005 to R.M and 2014-SGR-1281 to J.S]; Fundacio La Marato TV3 [416/C/2013-2030 to R.M, 100830/31/32 to J.S and M.G.D.]; Josep Carreras Leukaemia Research Institute [P/AG 2014 to R.M.]; the Health Council of Castilla y Leon (BIO/SA56/13 and BIO/SA78/15 to MA.); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2017E1300680 to A.F.].	Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Melo RDC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085926; Chen JY, 2015, ONCOTARGET, V6, P5597, DOI 10.18632/oncotarget.3343; D'Alterio C, 2014, INT J CANCER, V135, P379, DOI 10.1002/ijc.28689; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Ghielmini M, 2013, ANN ONCOL, V24, P561, DOI [10.1093/annonc/mds517, 10.1093/annonc/mdr388]; Hernandez L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3074; Humpert ML, 2014, EUR J IMMUNOL, V44, P694, DOI 10.1002/eji.201343907; Humpert ML, 2012, PROTEOMICS, V12, P1938, DOI 10.1002/pmic.201100581; Moreno MJ, 2015, J PATHOL, V235, P445, DOI 10.1002/path.4446; Lee E, 2013, PIGM CELL MELANOMA R, V26, P58, DOI 10.1111/pcmr.12024; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Liberman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043665; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Perry AM, 2012, CANCER CONTROL, V19, P214, DOI 10.1177/107327481201900306; Pozzobon T, 2016, IMMUNOL LETT, V177, P6, DOI 10.1016/j.imlet.2016.06.006; Puchert M, 2014, CELL TISSUE RES, V355, P239, DOI 10.1007/s00441-013-1747-y; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Sanchez-Martin L, 2013, TRENDS MOL MED, V19, P12, DOI 10.1016/j.molmed.2012.10.004; Schrevel M, 2012, BRIT J CANCER, V106, P1520, DOI 10.1038/bjc.2012.110; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Singh AK, 2013, CYTOKINE GROWTH F R, V24, P41, DOI 10.1016/j.cytogfr.2012.08.007; Stein JV, 2005, IMMUNOLOGY, V116, P1, DOI 10.1111/j.1365-2567.2005.02183.x; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tarnowski M, 2010, EUR J HAEMATOL, V85, P472, DOI 10.1111/j.1600-0609.2010.01531.x; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Yates TJ, 2013, CANCER-AM CANCER SOC, V119, P61, DOI 10.1002/cncr.27661	35	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0198789	10.1371/journal.pone.0198789	http://dx.doi.org/10.1371/journal.pone.0198789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920526	Green Published, gold, Green Submitted			2022-12-26	WOS:000435541300009
J	Matsumoto, K; Wu, YH; Kitazawa, T; Fujita, S; Seto, K; Hasegawa, T				Matsumoto, Kunichika; Wu, Yinghui; Kitazawa, Takefumi; Fujita, Shigeru; Seto, Kanako; Hasegawa, Tomonori			Cost of illness of hepatocellular carcinoma in Japan: A time trend and future projections	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; VIRUS-INFECTION; DISEASE BURDEN; LIVER-DISEASE; OF-ILLNESS; CANCER; IMPACT	Background Hepatocellular carcinoma (HCC) is the fifth leading cause of death in Japan. The aim of this study was to calculate the social burden of HCC using the cost of illness (COI) method, and to identify the key factors driving changes in the economic burden of HCC. Methods Utilizing government-based statistical nationwide data, the cost of illness (COI) method was used to estimate the COI for 1996, 1999, 2002, 2005, 2008, and 2014 to make predictions for 2017, 2020, 2023, 2026, and 2029. The COI comprised direct and indirect costs (morbidity and mortality costs) of HCC. Results From 1996 to 2014, COI trended downward. In 2014, COI (579.2 billion JPY) was 0.71 times greater than that in 1996 (816.2 billion JPY). Mortality costs accounted for more than 70% of total COI and were a major contributing factor to the decrease in COI. It was predicted that COI would continue a downward trend until 2029, and that the rate of decline would be similar. Conclusions COI of HCC has been decreasing since 1996. Treatment of patients infected with hepatitis C virus using newly introduced technologies has high therapeutic effectiveness, and will affect the future prevalence of HCC. These policies and technologies may accelerate the downward tendency of COI, and the relative economic burden of HCC is likely to continue to decrease.	[Matsumoto, Kunichika; Kitazawa, Takefumi; Fujita, Shigeru; Seto, Kanako; Hasegawa, Tomonori] Toho Univ, Dept Social Med, Sch Med, Tokyo, Japan; [Wu, Yinghui] Shanghai Jiao Tong Univ, Sch Nursing, Shanghai, Peoples R China	Toho University; Shanghai Jiao Tong University	Hasegawa, T (corresponding author), Toho Univ, Dept Social Med, Sch Med, Tokyo, Japan.	health@med.toho-u.ac.jp		Kitazawa, Takefumi/0000-0002-8705-0005	Japan Society for the Promotion of Science KAKENHI [15K08569]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Japan Society for the Promotion of Science KAKENHI Grant No. 15K08569. And there was no additional external funding received for this study; URL: https://www.jsps.go.jp/english/index.html. There is no role of funder in this study.	[Anonymous], EST MON VAL UNP WORK; [Anonymous], 2012, POP PROJ JAP 2016 20; Are C, 2017, J SURG ONCOL, V115, P591, DOI 10.1002/jso.24518; Cancer Information Service National Cancer Center Japan (Ministry of Health Labour and Welfare National Cancer Registry, CANC REG STAT; Chan ATC, 2001, PHARMACOECONOMICS, V19, P947, DOI 10.2165/00019053-200119090-00006; Chiang CJ, 2015, HEPATOLOGY, V61, P1154, DOI 10.1002/hep.27630; Chung W, 2015, CLIN MOL HEPATOL, V21, P14, DOI 10.3350/cmh.2015.21.1.14; CRUM G, 1982, AM J PUBLIC HEALTH, V72, P1299, DOI 10.2105/AJPH.72.11.1299-b; Duberg AS, 2015, SCAND J GASTROENTERO, V50, P233, DOI 10.3109/00365521.2014.990505; Gane E, 2014, NEW ZEAL MED J, V127, P61; Haga K, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-283; Harris RJ, 2014, J HEPATOL, V61, P530, DOI 10.1016/j.jhep.2014.05.008; Hayata E, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0776-5; Jinjuvadia R, 2017, AM J MED SCI, V354, P362, DOI 10.1016/j.amjms.2017.05.016; Kaijima T, 2017, HOKENSHI J, V73, P475; Kitazawa T, 2018, HEPATOL RES, V48, P176, DOI 10.1111/hepr.12913; Kitazawa T, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1103-x; Kudo M, 2015, LIVER CANCER, V4, P39, DOI 10.1159/000367727; Lang K, 2009, J HEPATOL, V50, P89, DOI 10.1016/j.jhep.2008.07.029; Lee SD, 2011, J NEUROGASTROENTEROL, V17, P274, DOI 10.5056/jnm.2011.17.3.274; Lu JJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-37; Matsumoto K, 2012, J JPN SOC HLTH CARE, V13, P2; Matsumoto K, 2017, J STROKE CEREBROVASC, V26, P1934, DOI 10.1016/j.jstrokecerebrovasdis.2017.06.022; Matsumoto Kunichika, 2015, BMC Res Notes, V8, P539, DOI 10.1186/s13104-015-1516-y; Ministry of Health Labor and Welfare, VIT STAT; Ministry of Health Labor and Welfare, PAT SURV; Ministry of Health Labour and Welfare, BAS SURV WAG STRUCT; Ministry of Internal Affairs and Communications, LAB FORC SURV; Myers RP, 2014, CAN J GASTROENTEROL, V28, P243, DOI 10.1155/2014/317623; Nevens F, 2012, EUR J GASTROEN HEPAT, V24, P1191, DOI 10.1097/MEG.0b013e3283566658; Oliva-Moreno J, 2015, EUR J GASTROEN HEPAT, V27, P631, DOI 10.1097/MEG.0000000000000336; Rice D P, 1985, Health Care Financ Rev, V7, P61; Rice D P, 2000, Inj Prev, V6, P177, DOI 10.1136/ip.6.3.177; RICE DP, 1967, AM J PUBLIC HEALTH N, V57, P424, DOI 10.2105/AJPH.57.3.424; RICE DP, 1994, LANCET, V344, P1519, DOI 10.1016/S0140-6736(94)90342-5; RICE DP, 1982, AM J PUBLIC HEALTH, V72, P536, DOI 10.2105/AJPH.72.6.536; Sievert W, 2014, J GASTROEN HEPATOL, V29, P1, DOI 10.1111/jgh.12677; Tanaka J, 2015, NIPPON RINSHO, V73, P51; Tanaka J, 2008, INTERVIROLOGY, V51, P33, DOI 10.1159/000118794; Tanaka Junko, 2016, Rinsho Byori, V64, P465; Tarricone R, 2006, HEALTH POLICY, V77, P51, DOI 10.1016/j.healthpol.2005.07.016; Tsunoda T, 2011, KANZO, V52, P491; Ukawa S, 2017, J EPIDEMIOL, V27, pS43, DOI 10.1016/j.je.2016.12.007; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Xiao JP, 2015, INT J ENV RES PUB HE, V12, P14055, DOI 10.3390/ijerph121114055; Zhu RX, 2016, GUT LIVER, V10, P332, DOI 10.5009/gnl15257	46	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199188	10.1371/journal.pone.0199188	http://dx.doi.org/10.1371/journal.pone.0199188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ7CA	29920556	Green Submitted, Green Published, gold			2022-12-26	WOS:000435541300023
J	Alves, DR; de Morais, SM; Tomiotto-Pellissier, F; Vasconcelos, FR; Freire, FDO; da Silva, ING; Cataneo, AHD; Miranda-Sapla, MM; Pinto, GAS; Conchon-Costa, I; Noronha, ADA; Pavanelli, WR				Alves, Daniela Ribeiro; de Morais, Selene Maia; Tomiotto-Pellissier, Fernanda; Vasconcelos, Fabio Roger; Oliveira Freire, Francisco das Chagas; Goes da Silva, Isaac Neto; Depieri Cataneo, Alan Henrique; Miranda-Sapla, Milena Menegazzo; Saavedra Pinto, Gustavo Adolfo; Conchon-Costa, Ivete; Araripe Noronha, Arlindo de Alencar; Pavanelli, Wander Rogerio			Leishmanicidal and fungicidal activity of lipases obtained from endophytic fungi extracts	PLOS ONE			English	Article							ANTIFUNGAL ACTIVITY; MICROSPORUM-CANIS; IN-VITRO; L.	This work describes the production of lipases from endophytic fungi: Vermisporium-like, Emericella nidulans, Dichotomophtora portulacae and D. boerhaaviae and the biological activity against the dermatophyte fungi Malassezia sp and Microsporum canis and the parasite Leishmania amazonensis. All fungal enzymes extract showed lipolysis action in the media that contains long carbon chain lipids. The proteomic analysis of lipases exhibits several molecules mostly ranging in size from 220 to 20 kDa, with clear differences in protein profile's yield. All fungal enzymes were competent to eliminate promastigote forms of Leishmania amazonensis at 5 mg.mL(-1). The antileishmanial activity of lipases from Vermisporium-like, E. nidulans, D. portulacae and D. boerhaaviae in amastigote forms, promoted the reduction in viability of 78.88, 39.65, 63.17 and 98.13%, with selectivity index of 19.56, 30.68, 18.09 and 20.99. In relation to antifungal activity, Dichothomophtora enzymes demonstrate best action with MFC of 14.65 mu g.mL(-1) against Malassezia sp and Microsporum canis, respectively. These results allow us to infer that lipases from entophytic fungi displays activity against dermatophyte fungi (Malassezia sp. and Microsporum canis) as well as Leishmania.	[Alves, Daniela Ribeiro; de Morais, Selene Maia; Goes da Silva, Isaac Neto] Univ Estadual Ceara, Veterinarian Sci Post Grad Program, Campus Itaperi, Fortaleza, Ceara, Brazil; [Alves, Daniela Ribeiro; Vasconcelos, Fabio Roger; Oliveira Freire, Francisco das Chagas; Saavedra Pinto, Gustavo Adolfo] Empresa Brasileira Pesquisa Agr EMBRAPA Agroind T, Fortaleza, Ceara, Brazil; [Tomiotto-Pellissier, Fernanda; Depieri Cataneo, Alan Henrique; Miranda-Sapla, Milena Menegazzo; Conchon-Costa, Ivete; Pavanelli, Wander Rogerio] Univ Estadual Londrina, Pathol Sci, Campus Univ, Londrina, Parana, Brazil; [Vasconcelos, Fabio Roger; Araripe Noronha, Arlindo de Alencar] Univ Fed Ceara, Dept Anim Sci, Physiol Anim Lab, Campus Pici, Fortaleza, Ceara, Brazil	Universidade Estadual do Ceara; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual de Londrina; Universidade Federal do Ceara	de Morais, SM (corresponding author), Univ Estadual Ceara, Veterinarian Sci Post Grad Program, Campus Itaperi, Fortaleza, Ceara, Brazil.	selenemaiademorais@gmail.com	Miranda-Sapla, Milena Menegazzo/AAU-6241-2021; Alves, Daniela Ribeiro/P-7102-2019; PELLISSIER, FERNANDA TOMIOTTO/Q-9679-2018; Cataneo, Allan/AAB-7997-2020; Tomiotto-Pellissier, Fernanda/AAU-5222-2021; Pinto, Gustavo A S/G-5329-2016; Miranda-Sapla, Milena M/D-1231-2017; Costa, Ivete/AAM-7309-2021	Miranda-Sapla, Milena Menegazzo/0000-0001-8324-9642; Alves, Daniela Ribeiro/0000-0002-0746-2211; PELLISSIER, FERNANDA TOMIOTTO/0000-0002-7273-8237; Cataneo, Allan/0000-0002-3567-7471; Tomiotto-Pellissier, Fernanda/0000-0002-7273-8237; Pinto, Gustavo A S/0000-0002-3672-8795; Miranda-Sapla, Milena M/0000-0001-8324-9642; Vasconcelos, Fabio R./0000-0001-6080-6370	CNPq (National Counseil for scientific and technological development) [421445/2016-5]	CNPq (National Counseil for scientific and technological development)	This work was supported by CNPq (National Counseil for scientific and technological development), Project number: 421445/2016-5.	Accioly MP, 2012, VET PARASITOL, V187, P79, DOI 10.1016/j.vetpar.2011.12.029; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNIE JP, 1989, J IMMUNOL METHODS, V118, P179, DOI 10.1016/0022-1759(89)90004-5; Bussamara R, 2010, BIORESOURCE TECHNOL, V101, P268, DOI 10.1016/j.biortech.2008.10.063; Chandrani D., 2012, INT J PHARM BIOL SCI, V3, P773; Clinical and Laboratory Standards Institute, 2008, CLINICAL AND LABORAT; Colen G, 2006, WORLD J MICROB BIOT, V22, P881, DOI 10.1007/s11274-005-9116-y; Freire CO, 2012, ESSENTIA, V14, P11; Freire F das CO, 2014, ESSENTIA, V16, P61; de Lima SCG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/848293; HANKIN L, 1975, MYCOLOGIA, V67, P597, DOI 10.2307/3758395; Holetz FB, 2002, MEM I OSWALDO CRUZ, V97, P1027, DOI 10.1590/S0074-02762002000700017; Kamimura ES, 1999, BRAZ J CHEM ENG, V16, P103, DOI 10.1590/S0104-66321999000200001; Lecoeur H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002276; Li C, 2012, ENZYME MICROB TECHNO, V29, P258; Lopes G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072203; Miranda MM, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/392918; MODOLELL M, 1994, J IMMUNOL METHODS, V174, P203, DOI 10.1016/0022-1759(94)90023-X; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pinto EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105127; Rizk YS, 2014, MEM I OSWALDO CRUZ, V109, P1050, DOI 10.1590/0074-0276140312; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Silva AAS, 2014, PHYTOMEDICINE, V21, P1419, DOI 10.1016/j.phymed.2014.05.005; Silva A. A. S., 2015, J APPL PHARM SCI, V36, P189; Soares BV, 2015, B LATINOAM CARIBE PL, V14, P263; Torabzadeh P., 2013, Middle East Journal of Scientific Research, V13, P926; Zahur M, 2014, CURR PROTEIN PEPT SC, V15, P437, DOI 10.2174/1389203715666140512121349	27	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0196796	10.1371/journal.pone.0196796	http://dx.doi.org/10.1371/journal.pone.0196796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912872	Green Submitted, Green Published, gold			2022-12-26	WOS:000435528600007
J	Andersson, S; Belkic, K; Mints, M; Ostensson, E				Andersson, Sonia; Belkic, Karen; Mints, Miriam; Ostensson, Ellinor			Is self-sampling to test for high-risk papillomavirus an acceptable option among women who have been treated for high-grade cervical intraepithelial neoplasia?	PLOS ONE			English	Article							E6/E7 MESSENGER-RNA; MINORITY WOMEN; LOW-INCOME; FOLLOW-UP; CANCER; HPV; LATINAS; BREAST; COLLECTION; PREVENTION	Objective Self-sampling to test for high risk human papilloma virus (HPV) is becoming an increasingly important component of cervical cancer screening. The aim of this observational study is to examine how women treated for high-grade cervical intraepithelial neoplasia (CIN) view HPV self-sampling. Methods Invited to participate in the present study were patients who had undergone treatment of high-grade CIN (grade 2 or higher) and were followed-up at 6-months at the Karolinska University Hospital, Stockholm. The participants were instructed as to how to perform HPV self-sampling. Thereafter, the participants completed a questionnaire about HPV self-sampling and other cervical cancer screening methods, as well as about self-perceived risk of cervical cancer without regular gynecologic follow-up and about specific knowledge regarding HPV, CIN and cervical cancer. Results Altogether 479 women enrolled in this study. The participation rate was 96.6%. Nearly 75% of the participants stated they would consider performing the HPV self-sampling prior to their next gynecologic follow-up. Confidence in HPV self-sampling was a significant independent predictor of willingness to perform HPV self-sampling. However, confidence in HPV self-sampling was significantly lower than confidence in Papanicolaou smears and in HPV testing with samples collected by health professionals. Higher specific knowledge about HPV, CIN and cervical cancer was also a significant independent predictor of willingness to perform HPV self-sampling, as was having travelled longer distance to attend gynecologic follow-up. Participants with lower income and without completed university education expressed significantly higher confidence in HPV self-sampling and lower confidence in Papanicolaou smears than the other women. Conclusions To the best of our knowledge, this is the first study to examine the views of women treated for high-grade CIN vis-a-vis HPV self-sampling. The latter is an acceptable option for the vast majority of this cohort of women.	[Andersson, Sonia; Belkic, Karen; Mints, Miriam; Ostensson, Ellinor] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Belkic, Karen] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Belkic, Karen] Claremont Grad Univ, Sch Community & Global Hlth, Claremont, CA USA; [Belkic, Karen] Univ Southern Calif, Inst Prevent Res, Keck Sch Med, Alhambra, CA USA; [Ostensson, Ellinor] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Claremont Colleges; Claremont Graduate School; University of Southern California; Karolinska Institutet	Ostensson, E (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.; Ostensson, E (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	ellinor.ostensson@ki.se		Ostensson, Ellinor/0000-0003-0668-088X	Swedish Cancer Foundation [11 0544, CAN 2011/471]; Karolinska Institutet Cancer Strategic Grants [5888/05-722]; Swedish Research Council [521-2008-2899]; Stockholm County Council [20130097, 20160155]; Gustaf V Jubilee Fund [154022]	Swedish Cancer Foundation; Karolinska Institutet Cancer Strategic Grants; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Gustaf V Jubilee Fund	This work was supported by The Swedish Cancer Foundation (11 0544, CAN 2011/471), www.cancerfonden.se, SA; Karolinska Institutet Cancer Strategic Grants (5888/05-722), www.ki.se, SA; The Swedish Research Council (521-2008-2899), www.vr.se, SA; Stockholm County Council (20130097, 20160155), www.skl.se, SA; The Gustaf V Jubilee Fund (154022), www.rahfo.se, SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoli G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093174; Altobelli E, 2015, INT J GYNECOL CANCER, V25, P474, DOI 10.1097/IGC.0000000000000374; Andersson S., 2017, ANN SCI M MAY CARD C; Andersson S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190156; Anhang R, 2005, J WOMENS HEALTH, V14, P721, DOI 10.1089/jwh.2005.14.721; Arbyn M, 2015, CLIN MICROBIOL INFEC, V21, P817, DOI 10.1016/j.cmi.2015.04.015; Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Arrossi S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3474-2; Asciutto KC, 2016, ACTA OBSTET GYN SCAN, V95, P1251, DOI 10.1111/aogs.12960; Azerkan F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107624; Azerkan F, 2012, INT J CANCER, V130, P937, DOI 10.1002/ijc.26084; Baezconde-Garbanati L, 1999, HISPANIC J BEHAV SCI, V21, P302, DOI 10.1177/0739986399213007; Belinson JL, 2012, INT J CANCER, V130, P1855, DOI 10.1002/ijc.26202; Bloom Joan R, 2008, J Cancer Surviv, V2, P190, DOI 10.1007/s11764-008-0058-x; Brismar S, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.01.005; Brown DR, 2000, ANN EPIDEMIOL, V10, pS13, DOI 10.1016/S1047-2797(00)00197-6; Catarino R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143644; Chen Q, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027896; Chernesky M, 2014, SEX TRANSM DIS, V41, P365, DOI 10.1097/OLQ.0000000000000125; Cimprich B, 2005, PSYCHO-ONCOLOGY, V14, P704, DOI 10.1002/pon.891; Consedine NS, 2007, J HEALTH CARE POOR U, V18, P550, DOI 10.1353/hpu.2007.0057; Crofts V, 2015, INT J WOMENS HEALTH, V7, P149, DOI 10.2147/IJWH.S56307; Davis M, 2015, CURR TREAT OPTION ON, V16, DOI 10.1007/s11864-015-0373-1; Ducancelle A, 2015, J INFECTION, V71, P377, DOI 10.1016/j.jinf.2015.05.001; Ebisch RMF, 2017, J CLIN ONCOL, V35, P2542, DOI 10.1200/JCO.2016.71.4543; Elfstrom KM, 2015, EUR J CANCER, V51, P950, DOI 10.1016/j.ejca.2015.03.008; Foster C, 2011, BRIT J CANCER, V105, pS21, DOI 10.1038/bjc.2011.419; Fouad MN, 2006, J CANCER EDUC, V21, pS91, DOI 10.1207/s15430154jce2101s_16; Galbraith KV, 2014, J COMMUN HEALTH, V39, P849, DOI 10.1007/s10900-014-9931-x; Garutti P, 2017, EUR J OBSTET GYN R B, V210, P236, DOI 10.1016/j.ejogrb.2016.12.018; Goel MS, 2003, J GEN INTERN MED, V18, P1028, DOI 10.1111/j.1525-1497.2003.20807.x; Harper DM, 2017, GYNECOL ONCOL, V146, P196, DOI 10.1016/j.ygyno.2017.04.004; Jentschke M, 2016, J CLIN VIROL, V82, P46, DOI 10.1016/j.jcv.2016.06.016; Kahn JA, 2005, J WOMENS HEALTH, V14, P650, DOI 10.1089/jwh.2005.14.650; Katki HA, 2013, J LOW GENIT TRACT DI, V17, pS78, DOI 10.1097/LGT.0b013e31828543c5; Kocken M, 2012, GYNECOL ONCOL, V125, P500, DOI 10.1016/j.ygyno.2012.01.015; Kocken M, 2011, LANCET ONCOL, V12, P441, DOI 10.1016/S1470-2045(11)70078-X; Kuil LD, 2017, ACTA CYTOL, V61, P425, DOI 10.1159/000477331; Lim AWW, 2017, J MED SCREEN, V24, P43, DOI 10.1177/0969141316639346; Lindell M, 2012, BJOG-INT J OBSTET GY, V119, P245, DOI 10.1111/j.1471-0528.2011.03147.x; Luszczynska A, 2012, WOMEN HEALTH, V52, P162, DOI 10.1080/03630242.2012.656187; Ma'som M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-011022; Mao C, 2017, J WOMENS HEALTH, V26, P609, DOI 10.1089/jwh.2016.5965; Marlow LAV, 2015, BRIT J CANCER, V113, P833, DOI 10.1038/bjc.2015.248; Mousavi SM, 2012, INT J CANCER, V131, P497, DOI 10.1002/ijc.26395; Navarro AM, 1998, AM J PREV MED, V15, P32, DOI 10.1016/S0749-3797(98)00023-3; O'Connor M, 2014, BJOG-INT J OBSTET GY, V121, P1421, DOI 10.1111/1471-0528.12741; O'Connor M, 2015, WOMEN HEALTH ISS, V25, P528, DOI 10.1016/j.whi.2015.05.009; Ostensson E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128270; Ostensson E, 2013, ACTA OBSTET GYN SCAN, V92, P830, DOI 10.1111/aogs.12143; Otero-Sabogal R, 2003, HEALTH EDUC BEHAV, V30, P337, DOI 10.1177/1090198103030003008; Persson M, 2012, ONCOL REP, V28, P346, DOI 10.3892/or.2012.1755; Pimple S, 2016, CURR OPIN OBSTET GYN, V28, P4, DOI 10.1097/GCO.0000000000000241; Pruitt SL, 2009, CANCER EPIDEM BIOMAR, V18, P2579, DOI 10.1158/1055-9965.EPI-09-0135; Racey CS, 2016, J RURAL HEALTH, V32, P136, DOI 10.1111/jrh.12136; Remennick Larissa, 2003, J Immigr Health, V5, P153, DOI 10.1023/A:1026163008336; Singh GK, 2004, CANCER, V101, P1051, DOI 10.1002/cncr.20467; Smith RA, 2017, CA-CANCER J CLIN, V67, P100, DOI 10.3322/caac.21392; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Teran L, 2007, ANTICANCER RES, V27, P4325; Torre LA, 2017, CANCER EPIDEM BIOMAR, V26, P444, DOI 10.1158/1055-9965.EPI-16-0858; Vahabi M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3564-1; Wentzensen N, 2017, PREV MED, V98, P33, DOI 10.1016/j.ypmed.2016.12.040	64	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199038	10.1371/journal.pone.0199038	http://dx.doi.org/10.1371/journal.pone.0199038			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ6XV	29912903	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600069
J	Lagree, K; Mon, HH; Mitchell, AP; Ducker, WA				Lagree, Katherine; Mon, Htwe H.; Mitchell, Aaron P.; Ducker, William A.			Impact of surface topography on biofilm formation by Candida albicans	PLOS ONE			English	Article							BACTERIAL ADHESION; COLLOIDAL CRYSTALS; PROTEIN ADSORPTION; C. ALBICANS; IN-VITRO; SILICONE; CATHETER; COATINGS; COLONIZATION; AERUGINOSA	Candida albicans is a fungal pathogen that causes serious biofilm-based infections. Here we have asked whether surface topography may affect C. albicans biofilm formation. We tested biofilm growth of the prototypical wild-type strain SC5314 on a series of polydimethylsiloxane (PDMS) solids. The surfaces were prepared with monolayer coatings of monodisperse spherical silica particles that were fused together into a film using silica menisci. The surface topography was varied by varying the diameter of the silica particles that were used to form the film. Biofilm formation was observed to be a strong function of particle size. In the particle size range 4.0-8.0 mu m, there was much more biofilm than in the size range 0.5-2.0 mu m. The behavior of a clinical isolate from a Glade separate from SC5314, strain p76067, showed results similar to that of SC5314. Our results suggest that topographic coatings may be a promising approach to reduce C. albicans biofilm infections.	[Lagree, Katherine; Mitchell, Aaron P.] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Mon, Htwe H.; Ducker, William A.] Virginia Tech, Dept Chem Engn, Blacksburg, VA 24061 USA; [Mon, Htwe H.; Ducker, William A.] Virginia Tech, Ctr Soft Matter & Biol Phys, Blacksburg, VA 24061 USA	Carnegie Mellon University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Ducker, WA (corresponding author), Virginia Tech, Dept Chem Engn, Blacksburg, VA 24061 USA.; Ducker, WA (corresponding author), Virginia Tech, Ctr Soft Matter & Biol Phys, Blacksburg, VA 24061 USA.	wducker@vt.edu	Mon, Htwe Htwe/AAS-9751-2020	Mon, Htwe Htwe/0000-0002-4961-8966; Mitchell, Aaron/0000-0002-0868-4000	Virginia Commonwealth Commercialization Fund (CRCF) [MF15-010-LS]; NIH/NIAID [1R21AI135178]	Virginia Commonwealth Commercialization Fund (CRCF); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Virginia Commonwealth Commercialization Fund (CRCF) under grant number MF15-010-LS (WAD) and NIH/NIAID 1R21AI135178 (APM), http://www.cit.org/initiatives/crcf/, https://www.niaid.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alalwan H, 2018, NANOMED-NANOTECHNOL, V14, P1045, DOI 10.1016/j.nano.2018.01.011; BHATTACHARJEE A, 2017, EFFECTS GROWTH SURFA, V9, P18531, DOI DOI 10.1021/ACSAMI.7B04223; Cabral V, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004542; Chang YR, 2018, ACS APPL MATER INTER, V10, P9225, DOI 10.1021/acsami.7b16715; Chang YR, 2017, COLLOID SURFACE A, V514, P185, DOI 10.1016/j.colsurfa.2016.11.050; Chauhan A, 2014, J INFECT DIS, V210, P1347, DOI 10.1093/infdis/jiu249; Chidambaranathan AS, 2016, J CLIN DIAGN RES, V10, pZC56, DOI 10.7860/JCDR/2016/15473.7114; Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405; Cloutier M, 2015, TRENDS BIOTECHNOL, V33, P637, DOI 10.1016/j.tibtech.2015.09.002; Crick CR, 2011, THIN SOLID FILMS, V519, P3722, DOI 10.1016/j.tsf.2011.01.282; Decker JT, 2013, LANGMUIR, V29, P13023, DOI 10.1021/la402952u; Desai JV, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019729; Diaz C, 2009, ACS APPL MATER INTER, V1, P136, DOI 10.1021/am8000677; Epstein AK, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/9/095018; Fanning S, 2012, MOL MICROBIOL, V86, P284, DOI 10.1111/j.1365-2958.2012.08193.x; Finkel JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002525; GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hirakawa MP, 2015, GENOME RES, V25, P413, DOI 10.1101/gr.174623.114; Humblot V, 2009, BIOMATERIALS, V30, P3503, DOI 10.1016/j.biomaterials.2009.03.025; Iarikov DD, 2014, BIOMACROMOLECULES, V15, P169, DOI 10.1021/bm401440h; Kargar M, 2016, ACS BIOMATER SCI ENG, V2, P1039, DOI 10.1021/acsbiomaterials.6b00163; Kargar M, 2014, J MATER CHEM B, V2, P5962, DOI 10.1039/c4tb00835a; Kargar M, 2012, SOFT MATTER, V8, P10254, DOI 10.1039/c2sm26368h; Kawabe A, 2014, DENT MATER J, V33, P638, DOI 10.4012/dmj.2014-025; Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2; Kohler JR, 2018, FUNGAL KINGDOM, P813, DOI 10.1128/microbiolspec.FUNK-0014-2016; KRISTINSSON KG, 1989, J MED MICROBIOL, V28, P249, DOI 10.1099/00222615-28-4-249; Ling JF, 2012, NANO LIFE, V2, DOI 10.1142/S1793984412420044; Mann EE, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-28; Marosok R, 1996, J BIOMED MATER RES, V30, P245; McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781; Mon H, 2018, ACS BIOMATER SCI ENG, V4, P257, DOI 10.1021/acsbiomaterials.7b00799; MOSS AH, 1988, AM J KIDNEY DIS, V12, P492, DOI 10.1016/S0272-6386(88)80100-8; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Perni S, 2013, SOFT MATTER, V9, P1844, DOI 10.1039/c2sm26828k; Pessoa RS, 2017, APPL SURF SCI, V422, P73, DOI 10.1016/j.apsusc.2017.05.254; Polderman KH, 2002, INTENS CARE MED, V28, P1, DOI 10.1007/s00134-001-1154-9; Reddy ST, 2011, J ENDOUROL, V25, P1547, DOI 10.1089/end.2010.0611; Roosjen A, 2005, J BIOMED MATER RES B, V73B, P347, DOI 10.1002/jbm.b.30227; Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SEIFERT U, 1990, PHYS REV A, V42, P4768, DOI 10.1103/PhysRevA.42.4768; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Verran J, 1997, J PROSTHET DENT, V77, P535, DOI 10.1016/S0022-3913(97)70148-3; Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.11.010; Woolford CA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006487	47	26	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0197925	10.1371/journal.pone.0197925	http://dx.doi.org/10.1371/journal.pone.0197925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912894	Green Published, gold, Green Submitted			2022-12-26	WOS:000435528600012
J	Velasco-Tirado, V; Alonso-Sardon, M; Cosano-Quero, A; Romero-Alegria, A; Sanchez-los Arcos, L; Lopez-Bernus, A; Pardo-Lledias, J; Belhassen-Garcia, M				Velasco-Tirado, Virginia; Alonso-Sardon, Montserrat; Cosano-Quero, Adriana; Romero-Alegria, Angela; Sanchez-los Arcos, Leire; Lopez-Bernus, Amparo; Pardo-Lledias, Javier; Belhassen-Garcia, Moncef			Life-threatening dermatoses: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Impact on the Spanish public health system (2010-2015)	PLOS ONE			English	Article							ERYTHEMA MULTIFORME; UNITED-STATES; DRUGS; EPIDEMIOLOGY; MORTALITY; COHORT; RISK	Background Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are serious mucocutaneous reactions. In Spain, the epidemiology and resulting expenses of these diseases are not well established. Methodology Retrospective descriptive study using the Minimum Basic Data Set (CMBD in Spanish) in patients admitted to hospitals of the National Health System between 2010 and 2015 with a diagnosis of SJS and TEN (combination of ICD-9 codes 695.13, 695.14, and 695.15, along with length of hospital stay). Principal findings A total of 1,468 patients were recorded, 773 were men (52.7%). The mean age (+/- SD) was 52.25 +/- 26.15 years. The mean incidence rate for all diagnoses was 5.19 cases per million person-years (2.96 in SJS, 0.31 in SJS/TEN and 1.90 in TEN). 148 patients died (10.1%), 47 due to SJS (5.6%) and 90 (16.7%) due to TEN. The estimated total medical cost of SJS, SJS/TEN, and TEN in Spain was (sic)11.576.456,18, and the average medical cost per patient was (sic)7.885,86 +/- (sic)11.686,26, higher medical cost in TEN ((sic)10352.46 +/- (sic)16319,93) than in SJS ((sic)6340,05 +/- (sic)7078,85) (p<0.001). Conclusions Older patients have a more severe clinical picture and higher mortality rates. The overall mortality of both diseases is approximately 10%, and clinical diagnosis and age were the variables with the greatest influence on mortality. This study describes a stable incidence and a similar prevalence to other European countries. Additionally, the data show a high cost due to hospitalizations. Finally, the CMBD could be a good system of epidemiological analysis for the study of infrequent diseases and hospital management of conditions such as SJS and TEN.	[Velasco-Tirado, Virginia; Cosano-Quero, Adriana; Sanchez-los Arcos, Leire] Complejo Asistencial Univ Salamanca, Serv Dermatol, Salamanca, Spain; [Velasco-Tirado, Virginia; Alonso-Sardon, Montserrat; Romero-Alegria, Angela; Lopez-Bernus, Amparo; Belhassen-Garcia, Moncef] Inst Invest Biomed Salamanca, Salamanca, Spain; [Velasco-Tirado, Virginia; Alonso-Sardon, Montserrat; Romero-Alegria, Angela; Lopez-Bernus, Amparo; Belhassen-Garcia, Moncef] Univ Salamanca, Ctr Invest Enfermedades Trop, Salamanca, Spain; [Alonso-Sardon, Montserrat] Univ Salamanca, Fac Med, Area Med Prevent & Salud Publ, Salamanca, Spain; [Romero-Alegria, Angela] Complejo Asistencial Univ Salamanca, Serv Med Interna, Salamanca, Spain; [Lopez-Bernus, Amparo; Belhassen-Garcia, Moncef] Complejo Asistencial Univ Salamanca, Unidad Enfermedades Infecciosas, Serv Med Interna, Salamanca, Spain; [Pardo-Lledias, Javier] Hosp Marques de Valdecilla, Serv Med Interna, Ave Valdecilla, Santander, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; Hospital Universitario Marques de Valdecilla (HUMV)	Belhassen-Garcia, M (corresponding author), Inst Invest Biomed Salamanca, Salamanca, Spain.; Belhassen-Garcia, M (corresponding author), Univ Salamanca, Ctr Invest Enfermedades Trop, Salamanca, Spain.; Belhassen-Garcia, M (corresponding author), Complejo Asistencial Univ Salamanca, Unidad Enfermedades Infecciosas, Serv Med Interna, Salamanca, Spain.	mbelhassen@hotmail.com	Alonso-Sardon, Montserrat/E-2185-2018	Velasco Tirado, Virginia/0000-0001-7175-1758; Alonso-Sardon, Montserrat/0000-0003-1829-5858; Belhassen-Garcia, Moncef/0000-0002-2230-1256	Biomedical Research on Tropical Diseases (RICET) [RD16/0027/0018, RD12/0018/0002, RD12/0018/0011, RD12/0018/0023]; AESI [MPY1279/15]; IBSAL [IBY15/00003]; Technological Development Project in Health [DTS16/00207]; Health Research Project [PI16/01784]; Fondo Europeo de Desarrollo Regional (FEDER)	Biomedical Research on Tropical Diseases (RICET); AESI; IBSAL; Technological Development Project in Health; Health Research Project; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	We would like to acknowledge the work of Biomedical Research on Tropical Diseases (RICET) for their findings related to TEN that were used to support part of this study (RD16/0027/0018, RD12/0018/0002, RD12/0018/0011, RD12/0018/0023), and the AESI (MPY1279/15), IBSAL (IBY15/00003), Technological Development Project in Health (DTS16/00207) and Health Research Project (PI16/01784) for funding ISCIII-EU. Co-financing was also provided by Fondo Europeo de Desarrollo Regional (FEDER).	Bastuji-Garin S, 2000, J INVEST DERMATOL, V115, P149, DOI 10.1046/j.1523-1747.2000.00061.x; BASTUJIGARIN S, 1993, ARCH DERMATOL, V129, P92, DOI 10.1001/archderm.129.1.92; CHAN HL, 1990, ARCH DERMATOL, V126, P43, DOI 10.1001/archderm.126.1.43; Davis RL, 2015, PHARMACOEPIDEM DR S, V24, P684, DOI 10.1002/pds.3778; Finkelstein Y, 2014, JAMA-J AM MED ASSOC, V311, P2231, DOI 10.1001/jama.2014.839; Frey N, 2017, J INVEST DERMATOL, V137, P1240, DOI 10.1016/j.jid.2017.01.031; Garcia-Doval I, 2000, ARCH DERMATOL, V136, P323, DOI 10.1001/archderm.136.3.323; Hsu DY, 2017, J AM ACAD DERMATOL, V76, P811, DOI 10.1016/j.jaad.2016.12.024; Hsu DY, 2016, J INVEST DERMATOL, V136, P1387, DOI 10.1016/j.jid.2016.03.023; Laguna C, 2006, ACTAS DERMO-SIFILOGR, V97, P177, DOI 10.1016/S0001-7310(06)73376-2; Mittmann N, 2012, AM J CLIN DERMATOL, V13, P49, DOI 10.2165/11593240-000000000-00000; Mockenhaupt M, 2008, J INVEST DERMATOL, V128, P35, DOI 10.1038/sj.jid.5701033; ROUJEAU JC, 1990, ARCH DERMATOL, V126, P37, DOI 10.1001/archderm.126.1.37; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; Rzany B, 1996, J CLIN EPIDEMIOL, V49, P769, DOI 10.1016/0895-4356(96)00035-2; Sekula P, 2013, J INVEST DERMATOL, V133, P1197, DOI 10.1038/jid.2012.510; STROM BL, 1991, STAT MED, V10, P565, DOI 10.1002/sim.4780100408; Wetter DA, 2010, MAYO CLIN PROC, V85, P131, DOI 10.4065/mcp.2009.0379; Yang MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165933; Yarbrough Dabney R. Iii, 1996, Journal of Burn Care and Rehabilitation, V17, P30, DOI 10.1097/00004630-199601000-00008	20	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198582	10.1371/journal.pone.0198582	http://dx.doi.org/10.1371/journal.pone.0198582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912947	gold, Green Published, Green Submitted			2022-12-26	WOS:000435528600036
J	Allijn, IE; Oldenkamp, R; Storm, G; Ragas, AMJ; Schiffelers, RM				Allijn, Iris E.; Oldenkamp, Rik; Storm, Gert; Ragas, Ad M. J.; Schiffelers, Raymond M.			Environmental impact of switching from the synthetic glucocorticoid prednisolone to the natural alkaloid berberine	PLOS ONE			English	Article							WASTE-WATER; HUMAN PHARMACEUTICALS; AQUATIC ENVIRONMENT; TOXICITY; BIOCONCENTRATION; METABOLITES; EXPOSURE; FATE	Low amounts of human pharmaceuticals in the aquatic environment can affect bacteria, animals and ultimately humans. Here, the environmental consequences of a shift in prescription behavior from prednisolone to berberine was modeled using an environmental decision support system based on four consecutive steps: emission, fate, exposure and effect. This model estimates the relative aquatic and human health impacts of alternative pharmaceutical prescriptions throughout Europe. Since a Defined Daily Dose (DDD) of berberine has yet to be formulated, the environmental impacts of berberine and prednisolone were compared under the assumption of equal DDDs. Subsequently, the relative impact ratio indicates the extent to which the actual DDD of berberine might be higher to still be environmentally preferable over prednisolone. In fact, berberine can be administered at a six times higher dose throughout Europe before its impact on the aquatic environment exceeds that of one prescription of prednisolone. On average, the results for impacts on human health are similar, with the median impact ratio ranging between 5.87 and 22.8 depending on the level of drinking water purification. However, for some regions in Spain, Austria, Baltic States and Finland, berberine can only be considered an environmentally better alternative if it is administered at a lower dose than prednisolone. We conclude that for most regions in Europe it is, up until a certain dose of berberine, beneficial for the aquatic environment and therefore human health to prefer prescription of berberine over prednisolone.	[Allijn, Iris E.; Storm, Gert] Univ Twente, TechMed Ctr, Dept Biomat Sci & Technol, Enschede, Netherlands; [Oldenkamp, Rik; Ragas, Ad M. J.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Environm Sci, Nijmegen, Netherlands; [Oldenkamp, Rik] Univ York, Environm Dept, York, N Yorkshire, England; [Storm, Gert] Univ Utrecht, Dept Pharmaceut, Utrecht, Netherlands; [Ragas, Ad M. J.] Open Univ, Dept Sci, Heerlen, Netherlands; [Schiffelers, Raymond M.] Univ Med Ctr, Clin Chem & Haematol, Utrecht, Netherlands	University of Twente; Radboud University Nijmegen; University of York - UK; Utrecht University; Open University Netherlands; Utrecht University; Utrecht University Medical Center	Allijn, IE (corresponding author), Univ Twente, TechMed Ctr, Dept Biomat Sci & Technol, Enschede, Netherlands.	i.e.allijn@utwente.cl	Schiffelers, Raymond/E-8786-2011; Ragas, Ad/C-3231-2011; Oldenkamp, Rik/GRJ-4419-2022; Allijn, Iris E/H-1479-2012	Schiffelers, Raymond/0000-0002-1012-9815; Oldenkamp, Rik/0000-0002-2245-6987; Allijn, Iris E/0000-0002-4026-3273	NanoNextNL [03D.11]; European Commission [265346]	NanoNextNL; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by NanoNextNL grant 03D.11, http://www.nanonextnl.nl/programme/3d-drug-delivery-2 to RMS and GS and the European Commission, FP7 project PHARMAS, contract no. 265346, http://www.pharmas-eu.net/home to RO and AMJR. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MM, 2008, MONATSH CHEM, V139, P697, DOI 10.1007/s00706-007-0804-1; Ali S, 2012, BEHAV BRAIN RES, V228, P272, DOI 10.1016/j.bbr.2011.11.020; Allijn IE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155325; Besse JP, 2008, HUM ECOL RISK ASSESS, V14, P665, DOI 10.1080/10807030802235078; Boxall ABA, 2004, EMBO REP, V5, P1110, DOI 10.1038/sj.embor.7400307; CHMP, 2006, EMACHMPSWP446092010; Crane M, 2006, SCI TOTAL ENVIRON, V367, P23, DOI 10.1016/j.scitotenv.2006.04.010; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; DellaGreca M, 2004, CHEMOSPHERE, V54, P629, DOI 10.1016/j.chemosphere.2003.09.008; Doerr-MacEwen NA, 2006, ENVIRON MANAGE, V38, P853, DOI 10.1007/s00267-005-0306-z; European Chemicals Agency, REG EV AUTH RESTR CH; Eurostat, 2016, ANN FRESHW ABSTR SOU; Fan ZL, 2011, ENVIRON SCI TECHNOL, V45, P2725, DOI 10.1021/es103429c; Fatta-Kassinos D, 2011, ANAL BIOANAL CHEM, V399, P251, DOI 10.1007/s00216-010-4300-9; Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009; Freiburghaus F, 1996, J ETHNOPHARMACOL, V55, P1, DOI 10.1016/S0378-8741(96)01463-8; Fu WJ, 2009, ENVIRON TOXICOL CHEM, V28, P1372, DOI 10.1897/08-233.1; Galvez-Llompart M, 2011, INT J MOL SCI, V12, P9481, DOI 10.3390/ijms12129481; Gautam R, 2009, MED RES REV, V29, P767, DOI 10.1002/med.20156; Gross M, 2015, INTEGR ENVIRON ASSES, DOI [10.1002/ieam.1699, DOI 10.1002/IEAM.1699]; Halling-Sorensen B, 1998, CHEMOSPHERE, V36, P357, DOI 10.1016/S0045-6535(97)00354-8; Hillier SG, 2007, J ENDOCRINOL, V195, P1, DOI 10.1677/JOE-07-0309; Hollander A, 2009, ENVIRON TOXICOL CHEM, V28, P44, DOI 10.1897/08-158.1; Ikehata K, 2006, OZONE-SCI ENG, V28, P353, DOI 10.1080/01919510600985937; Jahnke GD, 2006, BIRTH DEFECTS RES B, V77, P195, DOI 10.1002/bdrb.20075; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Khetan SK, 2007, CHEM REV, V107, P2319, DOI 10.1021/cr020441w; Kim SH, 2002, PLANTA MED, V68, P277, DOI 10.1055/s-2002-23128; Kim YC, 1998, PLANTA MED, V64, P490, DOI 10.1055/s-2006-957499; Kummerer K, 2009, J ENVIRON MANAGE, V90, P2354, DOI 10.1016/j.jenvman.2009.01.023; Li Z, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/289264; Lyman W. J., 1990, HDB CHEM PROPERTY ES; MASCITEL.E, 1970, ARZNEI-FORSCHUNG, V20, P111; Moffat A.C., 2011, PHARM BODY FLUIDS PO; Mongelli E, 1999, PLANTA MED, V65, P376, DOI 10.1055/s-2006-960793; Morrow D, 2001, PLANTA MED, V67, P843, DOI 10.1055/s-2001-18859; National Library of Medicine (US), 2016, CHEMIDPLUS A TOXNET; Nearing M, 1985, IDRC Rep, V14, P10; Nikolaou A, 2007, ANAL BIOANAL CHEM, V387, P1225, DOI 10.1007/s00216-006-1035-8; Oldenkamp R, 2014, CHEMOSPHERE, V115, P88, DOI 10.1016/j.chemosphere.2014.01.012; Oldenkamp R, 2013, ENVIRON INT, V51, P13, DOI 10.1016/j.envint.2012.09.010; Pan JF, 2002, ACTA PHARMACOL SIN, V23, P77; Pistocchi A, 2006, J HYDROL, V329, P553, DOI 10.1016/j.jhydrol.2006.03.009; Qin WW, 2015, ENVIRON EARTH SCI, V73, P4939, DOI 10.1007/s12665-015-4192-2; Qiu GL, 2013, J HAZARD MATER, V246, P34, DOI 10.1016/j.jhazmat.2012.12.010; Saeidnia S, 2009, PHARMACOGN RES, V1, P428; STUMM-ZOLLINGER ELIZABETH, 1965, J WATER POLLUT CONTR FED, V37, P1506; Tangney CC, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0324-x; Ternes TA, 1998, WATER RES, V32, P3245, DOI 10.1016/S0043-1354(98)00099-2; TONELLI G, 1966, TOXICOL APPL PHARM, V8, P250, DOI 10.1016/S0041-008X(66)80011-X; Tong AYC, 2011, ENVIRON INT, V37, P292, DOI 10.1016/j.envint.2010.10.002; Trapp S, 2000, PEST MANAG SCI, V56, P767, DOI 10.1002/1526-4998(200009)56:9<767::AID-PS198>3.0.CO;2-Q; TRAVIS CC, 1988, ENVIRON SCI TECHNOL, V22, P271, DOI 10.1021/es00168a005; US EPA, 2012, EST PROGR INT SUIT M; Wang XH, 2014, ENVIRON POLLUT, V186, P203, DOI 10.1016/j.envpol.2013.12.007; Xiao SH, 2012, ADV MATER RES-SWITZ, V599, P496, DOI 10.4028/www.scientific.net/AMR.599.496; Yang N, 2012, STEROIDS, V77, P1041, DOI 10.1016/j.steroids.2012.05.007; Ye XL, 2012, MED CHEM RES, V21, P1353, DOI 10.1007/s00044-011-9651-z	58	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199095	10.1371/journal.pone.0199095	http://dx.doi.org/10.1371/journal.pone.0199095			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902284	Green Published, gold			2022-12-26	WOS:000435424900086
J	Amano, I; Kitajima, S; Suzuki, H; Koeduka, T; Shitan, N				Amano, Ikuko; Kitajima, Sakihito; Suzuki, Hideyuki; Koeduka, Takao; Shitan, Nobukazu			Transcriptome analysis of Petunia axillaris flowers reveals genes involved in morphological differentiation and metabolite transport	PLOS ONE			English	Article							FLORAL SCENT PRODUCTION; ABC TRANSPORTER; SUCROSE TRANSPORTERS; SUGAR TRANSPORTERS; ARABIDOPSIS; NUTRITION; PROTEIN; BIOSYNTHESIS; ISOEUGENOL; EMISSION	The biosynthesis of plant secondary metabolites is associated with morphological and metabolic differentiation. As a consequence, gene expression profiles can change drastically, and primary and secondary metabolites, including intermediate and end-products, move dynamically within and between cells. However, little is known about the molecular mechanisms underlying differentiation and transport mechanisms. In this study, we performed a transcriptome analysis of Petunia axillaris subsp. parodii, which produces various volatiles in its corolla limbs and emits metabolites to attract pollinators. RNA-sequencing from leaves, buds, and limbs identified 53,243 unigenes. Analysis of differentially expressed genes, combined with gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses, showed that many biological processes were highly enriched in limbs. These included catabolic processes and signaling pathways of hormones, such as gibberellins, and metabolic pathways, including phenylpropanoids and fatty acids. Moreover, we identified five transporter genes that showed high expression in limbs, and we performed spatiotemporal expression analyses and homology searches to infer their putative functions. Our systematic analysis provides comprehensive transcriptomic information regarding morphological differentiation and metabolite transport in the Petunia flower and lays the foundation for establishing the specific mechanisms that control secondary metabolite biosynthesis in plants.	[Amano, Ikuko; Shitan, Nobukazu] Kobe Pharmaceut Univ, Lab Med Cell Biol, Higashinada Ku, Motoyamakita Machi, Kobe, Hyogo, Japan; [Kitajima, Sakihito] Kyoto Inst Technol, Dept Appl Biol, Matsugasaki Sakyo Ku, Kyoto, Japan; [Kitajima, Sakihito] Kyoto Inst Technol, Ctr Adv Insect Res Promot, Matsugasaki Sakyo Ku, Kyoto, Japan; [Suzuki, Hideyuki] Kazusa DNA Res Inst, Dept Res & Dev, Chiba, Japan; [Koeduka, Takao] Yamaguchi Univ, Dept Biol Chem, Grad Sch Sci & Technol Innovat Agr, Yamaguchi, Japan	Kobe Pharmaceutical University; Kyoto Institute of Technology; Kyoto Institute of Technology; Kazusa DNA Research Institute; Yamaguchi University	Shitan, N (corresponding author), Kobe Pharmaceut Univ, Lab Med Cell Biol, Higashinada Ku, Motoyamakita Machi, Kobe, Hyogo, Japan.	shitan@kobepharma-u.ac.jp	Suzuki, Hideyuki/J-7571-2016	Shitan, Nobukazu/0000-0001-7760-2745				Adebesin F, 2017, SCIENCE, V356, P1386, DOI 10.1126/science.aan0826; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2018, LANG ENV STAT COMP; Balzan S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00393; Bombarely A, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2016.74, 10.1038/NPLANTS.2016.74]; Broderick SR, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0307-2; Chen LQ, 2015, PLANT CELL, V27, P607, DOI 10.1105/tpc.114.134585; Chen LQ, 2014, NEW PHYTOL, V201, P1150, DOI 10.1111/nph.12445; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chiba Y, 2015, J PLANT RES, V128, P679, DOI 10.1007/s10265-015-0710-2; Colquhoun TA, 2010, PHYTOCHEMISTRY, V71, P158, DOI 10.1016/j.phytochem.2009.09.036; Dexter R, 2007, PLANT J, V49, P265, DOI 10.1111/j.1365-313X.2006.02954.x; Fenske MP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00462; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Ge YX, 2000, PLANT J, V24, P725, DOI 10.1046/j.1365-313x.2000.00926.x; Hwang JU, 2016, MOL PLANT, V9, P338, DOI 10.1016/j.molp.2016.02.003; Jorgensen ME, 2017, ELIFE, V6, DOI 10.7554/eLife.19466; JULICH A, 1995, COMPUT APPL BIOSCI, V11, P3; Klahre U, 2011, CURR BIOL, V21, P730, DOI 10.1016/j.cub.2011.03.059; Koeduka T, 2008, PLANT J, V54, P362, DOI 10.1111/j.1365-313X.2008.03412.x; Koeduka T, 2016, PLANTA, V244, P725, DOI 10.1007/s00425-016-2542-2; Koeduka T, 2009, PLANT J, V58, P961, DOI 10.1111/j.1365-313X.2009.03834.x; Kondo M, 2007, BIOSCI BIOTECH BIOCH, V71, P458, DOI 10.1271/bbb.60507; Landgraf R, 2014, PLANT CELL, V26, P3403, DOI 10.1105/tpc.114.124776; Lin IW, 2014, NATURE, V508, P1, DOI 10.1038/nature13082; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; O'Donoghue EM, 2009, PLANTA, V229, P709, DOI 10.1007/s00425-008-0862-6; Otsu CT, 2004, J EXP BOT, V55, P1643, DOI 10.1093/jxb/erh195; Oyama-Okubo N, 2013, PHYTOCHEMISTRY, V90, P37, DOI 10.1016/j.phytochem.2013.03.006; OZEKI Y, 1981, PHYSIOL PLANTARUM, V53, P570, DOI 10.1111/j.1399-3054.1981.tb02753.x; Panikashvili D, 2011, NEW PHYTOL, V190, P113, DOI 10.1111/j.1469-8137.2010.03608.x; Park J, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0443-x; Rautengarten C, 2014, P NATL ACAD SCI USA, V111, P11563, DOI 10.1073/pnas.1406073111; Ravid J, 2017, NEW PHYTOL, V215, P411, DOI 10.1111/nph.14504; Sauer N, 2007, FEBS LETT, V581, P2309, DOI 10.1016/j.febslet.2007.03.048; Shiono K, 2014, PLANT J, V80, P40, DOI 10.1111/tpj.12614; Shitan N, 2016, BIOSCI BIOTECH BIOCH, V80, P1283, DOI 10.1080/09168451.2016.1151344; Takanashi K, 2014, PLANT BIOTECHNOL-NAR, V31, P417, DOI 10.5511/plantbiotechnology.14.0904a; Tal I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11486; Van Moerkercke A, 2012, J EXP BOT, V63, P3157, DOI 10.1093/jxb/ers034; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065800; Wang PF, 2017, PLANT J, V92, P596, DOI 10.1111/tpj.13704; Yadav V, 2014, PLANT CELL, V26, P3569, DOI 10.1105/tpc.114.129049; Yamaguchi N, 2014, SCIENCE, V344, P638, DOI 10.1126/science.1250498	44	3	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198936	10.1371/journal.pone.0198936	http://dx.doi.org/10.1371/journal.pone.0198936			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902274	Green Published, gold, Green Submitted			2022-12-26	WOS:000435424900065
J	Yamada, K; Zuka, M; Ito, K; Mizuguchi, K; Kakuchi, Y; Onoe, T; Suzuki, Y; Yamagishi, M; Izui, S; Malissen, M; Malissen, B; Kawano, M				Yamada, Kazunori; Zuka, Masahiko; Ito, Kiyoaki; Mizuguchi, Keishi; Kakuchi, Yasushi; Onoe, Tamehito; Suzuki, Yasunori; Yamagishi, Masakazu; Izui, Shozo; Malissen, Marie; Malissen, Bernard; Kawano, Mitsuhiro			Lat(Y136F) knock-in mouse model for human IgG4-related disease	PLOS ONE			English	Article							REGULATORY IMMUNE-REACTIONS; AUTOIMMUNE PANCREATITIS; KIDNEY-DISEASE; SCLEROSING PANCREATITIS; CLINICAL-FEATURES; MIKULICZS-DISEASE; MULTICENTER; TH2; CELLS; MICE	Background The adaptor protein Linker for activation of T cell (LAT) is a key signaling hub used by the T cell antigen receptor. Mutant mice expressing loss-of-function mutations affecting LAT and including a mutation in which tyrosine 136 is replaced by a phenylalanine (Lat(Y136F)) develop lymphoproliferative disorder involving T helper type 2 effector cells capable of triggering a massive polyclonal B cell activation that leads to hypergammaglobulinemia G1 and E and to non-resolving inflammation and autoimmunity. The purpose of this study was to evaluate whether the phenotypes of Lat(Y136F) knock-in mice resemble the immunohistopathological features of immunoglobulin G4-related disease (IgG4-RD). Methods Lat(Y136F) knock-in mice were sacrificed at 4-20 weeks of age, and pancreas, kidney, salivary gland and lung were obtained. All organs were stained with hematoxylin-eosin and with Azan for estimation of collagen in fibrosis, and the severity scores of inflammation and fibrosis were evaluated. Immunostainings were performed to analyze the types of infiltrating cells. In addition, the effects of corticosteroid treatment on the development of tissue lesions and serum levels of IgG1 were assessed. Results Tissue lesions characterized by inflammatory mononuclear cell infiltration and fibrosis were detected in pancreas, kidney, and salivary gland starting from 6 weeks of age. Immunostainings showed pronounced infiltration of plasma cells, CD4-positive T cells, and macrophages. Infiltrating plasma cells predominantly expressed IgG1. The extent of inflammation in pancreas and salivary glands was markedly reduced by corticosteroid treatment. Conclusions Lat(Y136F) knock-in mice displayed increased production of Th2-type IgG1 (a homologue of human IgG4) and developed multiple organ tissue lesions reminiscent of those seen in patients with IgG4-RD. Moreover, the development of these tissue lesions was highly sensitive to corticosteroid treatment like in IgG4-RD. For these reasons we consider the Lat(Y136F) knock-in mouse strain to represent a promising model for human IgG4-RD.	[Yamada, Kazunori; Ito, Kiyoaki; Mizuguchi, Keishi; Kakuchi, Yasushi; Onoe, Tamehito; Suzuki, Yasunori; Kawano, Mitsuhiro] Kanazawa Univ, Dept Internal Med, Div Rheumatol, Grad Sch Med, Kanazawa, Ishikawa, Japan; [Yamada, Kazunori] Kanazawa Univ, Dept Adv Res Community Med, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Zuka, Masahiko] Kanazawa Univ, Dept Forens Med & Pathol, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Mizuguchi, Keishi] Kanazawa Univ, Grad Sch Med Sci, Dept Med Neurosci, Kanazawa, Ishikawa, Japan; [Yamagishi, Masakazu] Kanazawa Univ, Dept Internal Med, Div Cardiol, Grad Sch Med, Kanazawa, Ishikawa, Japan; [Izui, Shozo] Univ Geneva, Univ Med Ctr, Dept Pathol & Immunol, Geneva, Switzerland; [Malissen, Marie; Malissen, Bernard] Aix Marseille Univ, CNRS, INSERM, Ctr Immunol Marseille Luminy, F-13288 Marseille, France	Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; University of Geneva; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Kawano, M (corresponding author), Kanazawa Univ, Dept Internal Med, Div Rheumatol, Grad Sch Med, Kanazawa, Ishikawa, Japan.	sk33166@gmail.com	; Malissen, Bernard/AAK-4659-2020	Malissen, Marie/0000-0003-2331-1445; Malissen, Bernard/0000-0003-1340-9342	Research Program of Intractable Diseases of the Ministry of Health, Labor, and Welfare of Japan; JSPS KAKENHI [26461487, 17K09999]; THE KATO MEMORIAL NAM BYO RESEARCH	Research Program of Intractable Diseases of the Ministry of Health, Labor, and Welfare of Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); THE KATO MEMORIAL NAM BYO RESEARCH	This work was supported by the Research Program of Intractable Diseases of the Ministry of Health, Labor, and Welfare of Japan (http://www.mhlw.go.jp/english/) to MK; JSPS KAKENHI, 26461487 (https://www.jsps.go.jp/english/e-grants/) to MK; JSPS KAKENHI, 17K09999 (https://www.jsps.go.jp/english/e-grants/) to KY and A grant-in-aid from THE KATO MEMORIAL NAM BYO RESEARCH to KY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Boomershine CS, 2009, GUT, V58, P1267, DOI 10.1136/gut.2008.170779; Campochiaro C, 2016, SCAND J RHEUMATOL, V45, P135, DOI 10.3109/03009742.2015.1055796; Chang MC, 2007, CLIN CHEM, V53, P1700, DOI 10.1373/clinchem.2007.085951; Chang MC, 2015, J CYST FIBROS, V14, P661, DOI 10.1016/j.jcf.2015.03.009; Chang MC, 2014, J GASTROEN HEPATOL, V29, P2038, DOI 10.1111/jgh.12649; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Ebbo M, 2012, MEDICINE, V91, P49, DOI 10.1097/MD.0b013e3182433d77; Fernandez-Codina A, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001275; Freitag TL, 2010, GASTROENTEROLOGY, V139, P281, DOI 10.1053/j.gastro.2010.03.038; Gao F, 2013, WORLD J GASTROENTERO, V19, P3332, DOI 10.3748/wjg.v19.i21.3332; Genton C, 2006, J IMMUNOL, V177, P2285, DOI 10.4049/jimmunol.177.4.2285; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Hara S, 2016, HUM PATHOL, V55, P164, DOI 10.1016/j.humpath.2016.05.010; Haruta I, 2010, LAB INVEST, V90, P1757, DOI 10.1038/labinvest.2010.153; Inoue D, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000680; Kinugawa Y, 2017, PANCREAS, V46, P614, DOI 10.1097/MPA.0000000000000804; Koonpaew S, 2006, J EXP MED, V203, P119, DOI 10.1084/jem.20050903; Koyabu M, 2013, INT J RHEUMATOL, V2013, DOI 10.1155/2013/367325; Kurisaki H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073862; Liu QC, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.32; Meagher C, 2008, J IMMUNOL, V180, P7793, DOI 10.4049/jimmunol.180.12.7793; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miyake K, 2008, MOD RHEUMATOL, V18, P86, DOI 10.1007/s10165-007-0010-3; Mizushima I, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1175-y; Roncagalli R, 2010, TRENDS IMMUNOL, V31, P253, DOI 10.1016/j.it.2010.05.001; Saeki T, 2013, KIDNEY INT, V84, P826, DOI 10.1038/ki.2013.191; Seleznik GM, 2012, GASTROENTEROLOGY, V143, P1361, DOI 10.1053/j.gastro.2012.07.112; Shiokawa M, 2016, GUT, V65, P1322, DOI 10.1136/gutjnl-2015-310336; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Tanaka A, 2012, ARTHRITIS RHEUM-US, V64, P254, DOI 10.1002/art.33320; Umehara H, 2012, INTERNAL MED, V51, P821, DOI 10.2169/internalmedicine.51.7223; Wallace ZS, 2015, ARTHRITIS RHEUMATOL, V67, P2466, DOI 10.1002/art.39205; Yamada K, 2008, CLIN EXP IMMUNOL, V152, P432, DOI 10.1111/j.1365-2249.2008.03651.x; Yamada K, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1467-x; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697	36	11	11	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198417	10.1371/journal.pone.0198417	http://dx.doi.org/10.1371/journal.pone.0198417			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902238	Green Published, Green Submitted, gold			2022-12-26	WOS:000435424900021
J	Bruggeman, JW; Koster, J; Lodder, P; Repping, S; Hamer, G				Bruggeman, Jan Willem; Koster, Jan; Lodder, Paul; Repping, Sjoerd; Hamer, Geert			Massive expression of germ cell-specific genes is a hallmark of cancer and a potential target for novel treatment development	ONCOGENE			English	Article							CANCER/TESTIS-ANTIGEN; MESSENGER-RNA; IDENTIFICATION; DATABASE	Cancer cells have been found to frequently express genes that are normally restricted to the testis, often referred to as cancer/testis (CT) antigens or genes. Because germ cell-specific antigens are not recognized as "self" by the innate immune system, CT-genes have previously been suggested as ideal candidate targets for cancer therapy. The use of CT-genes in cancer therapy has thus far been unsuccessful, most likely because their identification has relied on gene expression in whole testis, including the testicular somatic cells, precluding the detection of true germ cell-specific genes. By comparing the transcriptomes of micro-dissected germ cell subtypes, representing the main developmental stages of human spermatogenesis, with the publicly accessible transcriptomes of 2617 samples from 49 different healthy somatic tissues and 9232 samples from 33 tumor types, we here discover hundreds of true germ cell-specific cancer expressed genes. Strikingly, we found these germ cell cancer genes (GC-genes) to be widely expressed in all analyzed tumors. Many GC-genes appeared to be involved in processes that are likely to actively promote tumor viability, proliferation and metastasis. Targeting these true GC-genes thus has the potential to inhibit tumor growth with infertility being the only possible side effect. Moreover, we identified a subset of GC-genes that are not expressed in spermatogonial stem cells. Targeting of this GC-gene subset is predicted to only lead to temporary infertility, as untargeted spermatogonial stem cells can recover spermatogenesis after treatment. Our GC-gene dataset enables improved understanding of tumor biology and provides multiple novel targets for cancer treatment.	[Bruggeman, Jan Willem; Lodder, Paul; Repping, Sjoerd; Hamer, Geert] Univ Amsterdam, Acad Med Ctr, Amsterdam Res Inst Reprod & Dev, Ctr Reprod Med, Amsterdam, Netherlands; [Koster, Jan] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Hamer, G (corresponding author), Univ Amsterdam, Acad Med Ctr, Amsterdam Res Inst Reprod & Dev, Ctr Reprod Med, Amsterdam, Netherlands.	g.hamer@amc.uva.nl	Koster, Jan/C-5934-2008	Koster, Jan/0000-0002-0890-7585; Hamer, Geert/0000-0002-9583-6796; Bruggeman, Jan Willem/0000-0003-1901-4720	ZonMw VIDI [91796362]; AMC Fellowship; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme [CIG 293765]	ZonMw VIDI(Netherlands Organization for Health Research and Development); AMC Fellowship; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme	This work was financed by ZonMw VIDI-grant 91796362 to SR and; an AMC Fellowship and The People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (CIG 293765) to GH.	Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chen YT, 2005, P NATL ACAD SCI USA, V102, P7940, DOI 10.1073/pnas.0502583102; Dawkins Richard, 1976, SELFISH GENE; Gjerstorff MF, 2015, ONCOTARGET, V6, P15772, DOI 10.18632/oncotarget.4694; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Jan SZ, 2017, DEVELOPMENT, V144, P3659, DOI 10.1242/dev.152413; Jan SZ, 2012, BBA-MOL BASIS DIS, V1822, P1838, DOI 10.1016/j.bbadis.2012.02.008; JANITZ M, 1994, MOL REPROD DEV, V38, P231, DOI 10.1002/mrd.1080380215; Jungbluth Achim A, 2007, Cancer Immun, V7, P15; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; Koster J, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.TRANSCAGEN-A2-45; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Maxfield KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9840; Nielsen AY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060890; Scanlan MJ, 2002, INT J CANCER, V98, P485, DOI 10.1002/ijc.10276; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vincent MD, 2011, ADV CANCER RES, V112, P283, DOI 10.1016/B978-0-12-387688-1.00010-7; Wang C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10499; Whitehurst AW, 2014, ANNU REV PHARMACOL, V54, P251, DOI 10.1146/annurev-pharmtox-011112-140326; Yokoe T, 2008, CANCER RES, V68, P1074, DOI 10.1158/0008-5472.CAN-07-0964	25	31	31	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 18	2018	37	42					5694	5700		10.1038/s41388-018-0357-2	http://dx.doi.org/10.1038/s41388-018-0357-2			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX3JJ	29907769	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000447619100008
J	Sloin, HE; Ruggiero, G; Rubinstein, A; Storz, SS; Foulkes, NS; Gothilf, Y				Sloin, Hadas E.; Ruggiero, Gennaro; Rubinstein, Amir; Storz, Sima Smadja; Foulkes, Nicholas S.; Gothilf, Yoav			Interactions between the circadian clock and TGF-beta signaling pathway in zebrafish	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; RECEPTOR KINASE DOMAIN; LOCOMOTOR-ACTIVITY; PINEAL-GLAND; EXPRESSION; LIGHT; CELL; CANCER; INHIBITORS; SMAD3	Background TGF-beta signaling is a cellular pathway that functions in most cells and has been shown to play a role in multiple processes, such as the immune response, cell differentiation and proliferation. Recent evidence suggests a possible interaction between TGF-beta signaling and the molecular circadian oscillator. The current study aims to characterize this interaction in the zebrafish at the molecular and behavioral levels, taking advantage of the early development of a functional circadian clock and the availability of light-entrainable clock-containing cell lines. Results Smad3a, a TGF-beta signaling-related gene, exhibited a circadian expression pattern throughout the brain of zebrafish larvae. Both pharmacological inhibition and indirect activation of TGF-beta signaling in zebrafish Pac-2 cells caused a concentration dependent disruption of rhythmic promoter activity of the core clock gene Per1b. Inhibition of TGF-beta signaling in intact zebrafish larvae caused a phase delay in the rhythmic expression of Per1b mRNA. TGF-beta inhibition also reversibly disrupted, phase delayed and increased the period of circadian rhythms of locomotor activity in zebrafish larvae. Conclusions The current research provides evidence for an interaction between the TGF-beta signaling pathway and the circadian clock system at the molecular and behavioral levels, and points to the importance of TGF-beta signaling for normal circadian clock function. Future examination of this interaction should contribute to a better understanding of its underlying mechanisms and its influence on a variety of cellular processes including the cell cycle, with possible implications for cancer development and progression.	[Sloin, Hadas E.; Storz, Sima Smadja; Gothilf, Yoav] Tel Aviv Univ, George S Wise Fac Life Sci, Sch Neurobiol Biochem & Biophys, Tel Aviv, Israel; [Sloin, Hadas E.; Gothilf, Yoav] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Ruggiero, Gennaro; Foulkes, Nicholas S.] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein, Germany; [Rubinstein, Amir] Tel Aviv Univ, Blavatnik Sch Comp Sci, Tel Aviv, Israel; [Sloin, Hadas E.] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Helmholtz Association; Karlsruhe Institute of Technology; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Gothilf, Y (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Sch Neurobiol Biochem & Biophys, Tel Aviv, Israel.; Gothilf, Y (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.	yoavgothilf@gmail.com	Rubinstein, Amir/HIR-3611-2022	Gothilf, Yoav/0000-0002-6054-4128; Ruggiero, Gennaro/0000-0003-4382-423X; Sloin, Hadas E./0000-0003-0419-4079	German-Israel Foundation for Scientific Research and Development (GIF) [I-1320-203.13/2015]; BIF-TM Helmholtz research programme; Dan David Fellowship	German-Israel Foundation for Scientific Research and Development (GIF)(German-Israeli Foundation for Scientific Research and Development); BIF-TM Helmholtz research programme; Dan David Fellowship	This study was supported by the German-Israel Foundation for Scientific Research and Development (GIF grant number I-1320-203.13/2015 to NSF and YG) and by the BIF-TM Helmholtz research programme (to NSF). AR was supported by the Dan David Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrial M, 2017, CELL REP, V20, P973, DOI 10.1016/j.celrep.2017.07.002; Ben-Moshe Z, 2014, NUCLEIC ACIDS RES, V42, P3750, DOI 10.1093/nar/gkt1359; Beynon AL, 2009, NEUROIMMUNOMODULAT, V16, P392, DOI 10.1159/000228914; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bragado P, 2013, NAT CELL BIOL, V15, P1351, DOI 10.1038/ncb2861; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Casari A, 2014, DEV BIOL, V396, P81, DOI 10.1016/j.ydbio.2014.09.025; Chen W-D, 2015, AM J PATHOL AM SOC I, V185, P1, DOI [10.1016/j.aipath.2015.08.003, DOI 10.1016/GAJPETH.2015.08.003]; Falcon J, 1999, PROG NEUROBIOL, V58, P121, DOI 10.1016/S0301-0082(98)00078-1; Gast H, 2012, ANN NY ACAD SCI, V1261, P79, DOI 10.1111/j.1749-6632.2012.06640.x; Gays D, 2017, DEVELOPMENT, V144, P464, DOI 10.1242/dev.133926; Hayashida T, 2010, P NATL ACAD SCI USA, V107, P1100, DOI 10.1073/pnas.0912710107; Hurd MW, 1998, PHYSIOL BEHAV, V65, P465, DOI 10.1016/S0031-9384(98)00183-8; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Li HY, 2006, J MED CHEM, V49, P2138, DOI 10.1021/jm058209g; Li Y, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004086; Li Y, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002940; LIN S, 1994, SCIENCE, V265, P666, DOI 10.1126/science.8036514; Livne ZB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006445; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Moore RY, 1997, ANNU REV MED, V48, P253, DOI 10.1146/annurev.med.48.1.253; Morelli LG, 2012, SCIENCE, V336, P187, DOI 10.1126/science.1215478; Musiek ES, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00029; Nagaraj NS, 2010, EXPERT OPIN INV DRUG, V19, P77, DOI 10.1517/13543780903382609; Peng SB, 2005, BIOCHEMISTRY-US, V44, P2293, DOI 10.1021/bi048851x; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rubinstein A, 2016, J PROTEOME RES, DOI [10.1021/acs.jproteorne.6b00278, DOI 10.1021/ACS.JPROTEORNE.6B00278]; Rubinstein A, 2007, P NATL ACAD SCI USA, V104, P6241, DOI 10.1073/pnas.0611168104; Rubinstein Amir, 2013, BMC Res Notes, V6, P311, DOI 10.1186/1756-0500-6-311; Santibanez JF, 2011, CLIN SCI, V121, P233, DOI 10.1042/CS20110086; Sato F, 2012, BIOCHEM BIOPH RES CO, V419, P441, DOI 10.1016/j.bbrc.2012.02.076; Savvidis C, 2012, MOL MED, V18, P1249, DOI 10.2119/molmed.2012.00077; Sawyer JS, 2004, BIOORG MED CHEM LETT, V14, P3581, DOI 10.1016/j.bmcl.2004.04.007; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Schmid B, 2011, J BIOL RHYTHM, V26, P464, DOI 10.1177/0748730411414264; Shi Y, 2011, J BIOMOL SCREEN, V16, P525, DOI 10.1177/1087057111398486; Singh J, 2003, BIOORG MED CHEM LETT, V13, P4355, DOI 10.1016/j.bmcl.2003.09.028; Storz SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054189; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Tovin A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003116; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Vallone D, 2004, P NATL ACAD SCI USA, V101, P4106, DOI 10.1073/pnas.0305436101; Vallone D, 2005, ZEBRAFISH, V2, P171, DOI 10.1089/zeb.2005.2.171; Vallone Daniela, 2007, Methods Mol Biol, V362, P429; Vanhauwaert S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109091; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Willaert A, 2012, HUM MOL GENET, V21, P1248, DOI 10.1093/hmg/ddr555; Wood PA, 2009, INTEGR CANCER THER, V8, P303, DOI 10.1177/1534735409355292; Wotton D, 1999, J BIOL CHEM, V274, P37105, DOI 10.1074/jbc.274.52.37105; Zhou Y, 2011, NATURE, V474, P645, DOI 10.1038/nature10094; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	58	16	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199777	10.1371/journal.pone.0199777	http://dx.doi.org/10.1371/journal.pone.0199777			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940038	Green Published, gold, Green Submitted			2022-12-26	WOS:000436088700042
J	Eschenfeldt, PC; Kartoun, U; Heberle, CR; Kong, CY; Nishioka, NS; Ng, K; Kamarthi, S; Hur, C				Eschenfeldt, Patrick C.; Kartoun, Uri; Heberle, Curtis R.; Kong, Chung Yin; Nishioka, Norman S.; Ng, Kenney; Kamarthi, Sagar; Hur, Chin			Analysis of factors associated with extended recovery time after colonoscopy	PLOS ONE			English	Article							PATIENT; MODELS; CLASSIFICATION; PREDICTION; REGRESSION; PROPOFOL; FENTANYL	Background & aims A common limiting factor in the throughput of gastrointestinal endoscopy units is the availability of space for patients to recover post-procedure. This study sought to identify predictors of abnormally long recovery time after colonoscopy performed with procedural sedation. In clinical research, this type of study would be performed using only one regression modeling approach. A goal of this study was to apply various "machine learning" techniques to see if better prediction could be achieved. Methods Procedural data for 31,442 colonoscopies performed on 29,905 adult patients at Massachusetts General Hospital from 2011 to 2015 were analyzed to identify potential predictors of long recovery times. These data included the identities of hospital personnel, and the initial statistical analysis focused on the impact of these personnel on recovery time via multivariate logistic regression. Secondary analyses included more information on patient vitals both to identify secondary predictors and to predict long recoveries using more complex techniques. Results In univariate analysis, the endoscopist, procedure room nurse, recovery room nurse, and surgical technician all showed a statistically significant relationship to long recovery times, with p-value below 0.0001 in all cases. In the multivariate logistic regression, the most significant predictor of a long recovery time was the identity of the recovery room nurse, with the endoscopist also showing a statistically significant relationship with a weaker effect. Complex techniques led to a negligible improvement over simple techniques in prediction of long recovery periods. Conclusion The hospital personnel involved in performing a colonoscopy show a strong association with the likelihood of a patient spending an abnormally long time recovering from the procedure, with the most pronounced effect for the nurse in the recovery room. The application of more advanced approaches to improve prediction in this clinical data set only yielded modest improvements.	[Eschenfeldt, Patrick C.; Heberle, Curtis R.; Kong, Chung Yin; Hur, Chin] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [Eschenfeldt, Patrick C.; Heberle, Curtis R.; Nishioka, Norman S.; Hur, Chin] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Eschenfeldt, Patrick C.; Kong, Chung Yin; Nishioka, Norman S.; Hur, Chin] Harvard Med Sch, Boston, MA 02115 USA; [Kartoun, Uri; Ng, Kenney] IBM Res, Ctr Computat Hlth, Cambridge, MA USA; [Kamarthi, Sagar] Northeastern Univ, Coll Engn, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; International Business Machines (IBM); Northeastern University	Hur, C (corresponding author), Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA.; Hur, C (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.; Hur, C (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	chur@mgh.harvard.edu	Jovani, Manol/AAF-5333-2020					[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Austin PC, 2013, J CLIN EPIDEMIOL, V66, P398, DOI 10.1016/j.jclinepi.2012.11.008; Beam AL, 2017, SCI REP-UK, V7, DOI 10.1038/srep42282; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BURNS LR, 1991, MED CARE, V29, P251, DOI 10.1097/00005650-199103000-00007; Churpek MM, 2016, CRIT CARE MED, V44, P368, DOI 10.1097/CCM.0000000000001571; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; Ehrenfeld JM, JOINT COMM J QUAL IM, V38, P73, DOI [10.1016/31553-7250(12)38010-0, DOI 10.1016/31553-7250(12)38010-0]; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Ho WM, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-164; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Jonas DE, 2007, AM J GASTROENTEROL, V102, P2401, DOI 10.1111/j.1572-0241.2007.01387.x; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lazaraki G, 2007, SURG ENDOSC, V21, P1631, DOI 10.1007/s00464-007-9215-y; Lin CC, 2010, INJURY, V41, P869, DOI 10.1016/j.injury.2010.04.023; Meyer D., 2017, E1071 MISC FUNCTIONS; Ripley B, 2016, TREE CLASSIFICATION; Sipe BW, 2002, GASTROINTEST ENDOSC, V55, P815, DOI 10.1067/mge.2002.124636; Tambuyzer T, 2017, J CLIN MONIT COMPUT, V31, P407, DOI 10.1007/s10877-016-9870-4; Therneau Terry., 2017, RPART RECURSIVE PART; Tsugawa Y, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1797; Veelo DP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172806; Venables WN., 2002, MODERN APPL STAT S 4; Wanderer JP, 2013, ANESTHESIOLOGY, V119, P516, DOI 10.1097/ALN.0b013e31829ce8fd; Wanderer JP, 2013, ANESTH ANALG, V117, P494, DOI 10.1213/ANE.0b013e318294fb64; Wu JL, 2010, MED CARE, V48, pS106, DOI 10.1097/MLR.0b013e3181de9e17; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	27	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199246	10.1371/journal.pone.0199246	http://dx.doi.org/10.1371/journal.pone.0199246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927978	Green Submitted, Green Published, gold			2022-12-26	WOS:000435802500062
J	Kesinger, E; Liu, JN; Jensen, A; Chia, CP; Demers, A; Moriyama, H				Kesinger, Evan; Liu, Jianing; Jensen, Aaron; Chia, Catherine P.; Demers, Andrew; Moriyama, Hideaki			Influenza D virus M2 protein exhibits ion channel activity in Xenopus laevis oocytes	PLOS ONE			English	Article							CATION-PI INTERACTIONS; C-VIRUS; A VIRUS; PROTON CHANNEL; CM2 PROTEIN; CURRENTS; IDENTIFICATION; STABILITY; MODEL; HYPERPOLARIZATION	Background A new type of influenza virus, known as type D, has recently been identified in cattle and pigs. Influenza D virus infection in cattle is typically asymptomatic; however, its infection in swine can result in clinical disease. Swine can also be infected with all other types of influenza viruses, namely A, B, and C. Consequently, swine can serve as a "mixing vessel" for highly pathogenic influenza viruses, including those with zoonotic potential. Currently, the only antiviral drug available targets influenza M2 protein ion channel is not completely effective. Thus, it is necessary to develop an M2 ion channel blocker capable of suppressing the induction of resistance to the genetic shift. To provide a basis for developing novel ion channel-blocking compounds, we investigated the properties of influenza D virus M2 protein (DM2) as a drug target. Results To test the ion channel activity of DM2, the DNA corresponding to DM2 with cMyc-tag conjugated to its carboxyl end was cloned into the shuttle vector pNCB1. The mRNA of the DM2-cMyc gene was synthesized and injected into Xenopus oocytes. The translation products of DM2-cMyc mRNA were confirmed by immunofluorescence and mass spectrometry analyses. The DM2-cMyc mRNA-injected oocytes were subjected to the two-electrode voltage clamp (TEVC) method, and the induced inward current was observed. The midpoint (V-mid) values in Boltzmann modeling for oocytes injected with DM2-cMyc RNA or a buffer were -152 and -200 mV, respectively. Assuming the same expression level in the Xenopus oocytes, DM2 without tag and influenza C virus M2 protein (CM2) were subjected to the TEVC method. DM2 exhibited ion channel activity under the condition that CM2 ion channel activity was reproduced. The gating voltages represented by V-mid for CM2 and DM2 were -141 and -146 mV, respectively. The reversal potentials observed in ND96 for CM2 and DM2 were -21 and -22 mV, respectively. Compared with intact DM2, DM2 variants with mutation in the YxxxK motif, namely Y72A and K76A DM2, showed lower Vmid values while showing no change in reversal potential. Conclusion The M2 protein from newly isolated influenza D virus showed ion channel activity similar to that of CM2. The gating voltage was shown to be affected by the YxxxK motif and by the hydrophobicity and bulkiness of the carboxyl end of the molecule.	[Kesinger, Evan; Liu, Jianing; Jensen, Aaron; Chia, Catherine P.; Demers, Andrew; Moriyama, Hideaki] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Moriyama, H (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	hideaki@unl.edu		Jensen, Aaron/0000-0002-3101-8321	Hatch Equipment Grants from the University of Nebraska-Lincoln; Nebraska Corn Board [1759080]; Central States Center for Agricultural Safety and Health (CS-CASH) Pilot Project, College of Public Health, Nebraska Medical Center; Undergraduate Creative Activities and Research Experience (UCARE) at University of Nebraska-Lincoln; Graduate Student Special Funds, School of Biological Sciences, University of Nebraska-Lincoln; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U54OH010162] Funding Source: NIH RePORTER	Hatch Equipment Grants from the University of Nebraska-Lincoln; Nebraska Corn Board; Central States Center for Agricultural Safety and Health (CS-CASH) Pilot Project, College of Public Health, Nebraska Medical Center; Undergraduate Creative Activities and Research Experience (UCARE) at University of Nebraska-Lincoln; Graduate Student Special Funds, School of Biological Sciences, University of Nebraska-Lincoln; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This work was supported by Hatch Equipment Grants from the University of Nebraska-Lincoln (2013-2014; Blair Siegfried, Etsuko Moriyama, Hideaki Moiryma; bought the Two-electrode voltage clamp tool; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript), https://ard.unl.edu/funding-programrfa-title/hatch-equipment-grants; Nebraska Corn Board (1759080; PI, Etsuko Moriyama; Hideaki Moriyama Co-PI; partly support supplies and partly support for Evan Kesinger; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript), http://www.nebraskacorn.org; Central States Center for Agricultural Safety and Health (CS-CASH) Pilot Project, College of Public Health, Nebraska Medical Center (Hideaki Moriyama; partly support supplies and publication fee; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript), https://www.unmc.edu/publichealth/cscash/; Undergraduate Creative Activities and Research Experience (UCARE) at University of Nebraska-Lincoln (2015-2016; Aaron Jensen; support for Aaron Jensen in part; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript), https://ucare.unl.edu; Graduate Student Special Funds, School of Biological Sciences, University of Nebraska-Lincoln (2017-2018; Evan Kesinger; support for supply in part; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript), https://biosci.unl.edu/financial-aid-current-graduate-students.	Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BRON R, 1993, VIROLOGY, V195, P808, DOI 10.1006/viro.1993.1435; Byington CL, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-2550; CIAMPOR F, 1992, VIRUS RES, V22, P247, DOI 10.1016/0168-1702(92)90056-F; CIAMPOR F, 1992, VIROLOGY, V188, P14, DOI 10.1016/0042-6822(92)90730-D; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Ferguson L, 2016, J VIROL, V90, P5636, DOI 10.1128/JVI.03122-15; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gaspari M, 2011, METHODS MOL BIOL, V790, P115, DOI 10.1007/978-1-61779-319-6_9; Goto T, 2017, J VIROL, V91, DOI 10.1128/JVI.00773-17; Hass J, 2011, INFECT GENET EVOL, V11, P437, DOI 10.1016/j.meegid.2010.12.001; Hause BM, 2014, MBIO, V5, DOI 10.1128/mBio.00031-14; Hause BM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003176; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; HONGO S, 1994, J GEN VIROL, V75, P3503, DOI 10.1099/0022-1317-75-12-3503; Hongo S, 1997, J VIROL, V71, P2786, DOI 10.1128/JVI.71.4.2786-2792.1997; Hongo S, 2004, ARCH VIROL, V149, P35, DOI 10.1007/s00705-003-0209-3; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Koster AK, 2018, P NATL ACAD SCI USA, V115, pE4900, DOI 10.1073/pnas.1720584115; KOWDLEY GC, 1994, J GEN PHYSIOL, V103, P217, DOI 10.1085/jgp.103.2.217; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kukol A, 2000, J BIOL CHEM, V275, P4225, DOI 10.1074/jbc.275.6.4225; Liang RB, 2016, P NATL ACAD SCI USA, V113, pE6955, DOI 10.1073/pnas.1615471113; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lin-Moshier Yaping, 2013, Cold Spring Harb Protoc, V2013, DOI 10.1101/pdb.prot072793; Lodish H, 2000, MOL CELL BIOL; Miller AJ, 2000, BBA-BIOMEMBRANES, V1465, P343, DOI 10.1016/S0005-2736(00)00148-6; Muraki Y, 2004, J GEN VIROL, V85, P1885, DOI 10.1099/vir.0.79937-0; Muraki Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060510; Muraki Y, 2011, VIRUS RES, V157, P99, DOI 10.1016/j.virusres.2011.02.013; Nakachi M, 2008, MAR BIOTECHNOL, V10, P564, DOI 10.1007/s10126-008-9096-7; PARKER I, 1988, PROC R SOC SER B-BIO, V233, P191, DOI 10.1098/rspb.1988.0018; Parrish CR, 2015, J VIROL, V89, P2990, DOI 10.1128/JVI.03146-14; Pekosz A, 1997, VIROLOGY, V237, P439, DOI 10.1006/viro.1997.8788; Pielak RM, 2011, BBA-BIOMEMBRANES, V1808, P522, DOI 10.1016/j.bbamem.2010.04.015; Prajapati RS, 2006, BIOCHEMISTRY-US, V45, P15000, DOI 10.1021/bi061275f; Ran ZG, 2015, J VIROL, V89, P4818, DOI 10.1128/JVI.00059-15; Rewar S, 2015, ANN GLOB HEALTH, V81, P645, DOI 10.1016/j.aogh.2015.08.014; RITCHEY MB, 1976, J VIROL, V18, P738, DOI 10.1128/JVI.18.2.738-744.1976; ROBINSON KR, 1979, P NATL ACAD SCI USA, V76, P837, DOI 10.1073/pnas.76.2.837; Samji Tasleem, 2009, Yale Journal of Biology and Medicine, V82, P153; Schroeder JI, 1995, METHOD CELL BIOL, V50, P519, DOI 10.1016/S0091-679X(08)61054-7; Sharma M, 2010, SCIENCE, V330, P509, DOI 10.1126/science.1191750; Takeuchi H, 2003, FEBS LETT, V552, P35, DOI 10.1016/S0014-5793(03)00781-6; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Taubenberger JK, 2013, MBIO, V4, DOI 10.1128/mBio.00365-13; Tayubi IA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P912, DOI 10.1134/S000629791007014X; Thomaston JL, 2015, P NATL ACAD SCI USA, V112, P14260, DOI 10.1073/pnas.1518493112; Wang J, 2013, P NATL ACAD SCI USA, V110, P1315, DOI 10.1073/pnas.1216526110; Wang JF, 2009, NAT STRUCT MOL BIOL, V16, P1267, DOI 10.1038/nsmb.1707; White SK, 2016, J CLIN VIROL, V81, P31, DOI 10.1016/j.jcv.2016.05.017; Wilkins MR, 1999, METH MOL B, V112, P531; Wintjens R, 2000, J MOL BIOL, V302, P395, DOI 10.1006/jmbi.2000.4040; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P647, DOI 10.1113/jphysiol.1995.sp020997	55	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199227	10.1371/journal.pone.0199227	http://dx.doi.org/10.1371/journal.pone.0199227			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927982	Green Published, Green Submitted, gold			2022-12-26	WOS:000435802500057
J	Sahoo, PK; Panda, SK; Satapathy, AK; Pati, S				Sahoo, Prakash Kumar; Panda, Santosh K.; Satapathy, Ashok Kumar; Pati, Sanghamitra			Anti-filarial immunity blocks parasite development and plays a protective role	PLOS ONE			English	Article							HUMAN BANCROFTIAN FILARIASIS; BRUGIA-MALAYI; MICROFILARIAE CARRIERS; LYMPHATIC FILARIASIS; ENDEMIC NORMALS; SHEATH; IGG; ANTIBODIES; RESPONSES; INDIA	Lymphatic filariasis is a complex parasitic disease having a spectrum of clinical parameters which are critical in deciding the severity of the pathogenesis. Individuals residing in the endemic areas are categorized into different clinical groups such as: EC (endemic controls-free of disease and infection), AS (asymptomatic carriers-free of disease but carries both antigens and microfilaria (Mf) in circulation), CR (cryptic-free of disease and Mf but having circulatory antigen) and CH (chronic-having manifestations of elephantiasis and hydrocele). The immune response to the parasitic infection is well studied, whereas the protective mechanism explaining the fate of antigenemia and filaremia between AS and CR group remains unexplained. Increased anti-Mf antibodies have been implicated for Mf clearance in experimental infection models whereas its role in clinical filariasis is not known. Here, we followed up two groups of 24 and 33 CR cases for 18 and 36 months respectively and analyzed both the clinical parameters and the anti-filarial antibody response. The humoral response to both whole filarial antigen and Mf antigens as well as recombinant active parasitic antigens was significantly higher in CR cases than AS individuals, whereas the clinical parameters remain unchanged. This study made insights into the protective immune mechanism responsible for the clearance of Mf from circulation in CR individuals.	[Sahoo, Prakash Kumar; Panda, Santosh K.; Satapathy, Ashok Kumar; Pati, Sanghamitra] ICMR Reg Med Res Ctr, Div Immunol, Bhubaneswar, Odisha, India; [Panda, Santosh K.] Medimmune, One Medimmune Way, Gaithersburg, MD USA	Indian Council of Medical Research (ICMR); ICMR - Regional Medical Research Centre (RMRC), Bhubaneswar; AstraZeneca; Medimmune	Sahoo, PK (corresponding author), ICMR Reg Med Res Ctr, Div Immunol, Bhubaneswar, Odisha, India.	shuvaprakash@gmail.com			Indian Council of Medical Research	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This study was supported by the Indian Council of Medical Research. SKP was an employee of Regional Medical Research Center, Bhubaneswar, at the time of the study conducted. Medimmune did not play a role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The funder provided support in the form of salaries for SKP but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adjobimey T, 2010, ANN TROP MED PARASIT, V104, P455, DOI 10.1179/136485910X12786389891407; Arndts K, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001611; Cuenco KT, 2009, J INFECT DIS, V200, P1271, DOI 10.1086/605844; DAFAALLA TH, 1992, CLIN EXP IMMUNOL, V88, P258, DOI 10.1111/j.1365-2249.1992.tb03070.x; Hewitson JP, 2011, J PROTEOMICS, V74, P1573, DOI 10.1016/j.jprot.2011.06.002; Jaoko WG, 2006, AM J TROP MED HYG, V75, P97, DOI 10.4269/ajtmh.2006.75.97; Jawaharlal JPP, 2014, ACTA PARASITOL, V59, P454, DOI 10.2478/s11686-014-0270-y; Joseph SK, 2012, INDIAN J MED RES, V135, P650; Meyrowitsch DW, 1995, ANN TROP MED PARASIT, V89, P665, DOI 10.1080/00034983.1995.11813000; Mishra R, 2017, PARASITE IMMUNOL, V39, DOI 10.1111/pim.12421; Mishra R, 2014, PARASITE IMMUNOL, V36, P207, DOI 10.1111/pim.12105; Mohanty MC, 2001, CLIN EXP IMMUNOL, V124, P54, DOI 10.1046/j.1365-2249.2001.01484.x; Myung K, 1998, AM J TROP MED HYG, V59, P222, DOI 10.4269/ajtmh.1998.59.222; Paciorkowski N, 2003, INFECT IMMUN, V71, P1370, DOI 10.1128/IAI.71.3.1370-1378.2003; Panda SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002717; Pfarr KM, 2009, PARASITE IMMUNOL, V31, P664, DOI 10.1111/j.1365-3024.2009.01133.x; RAVINDRAN B, 1994, PARASITE IMMUNOL, V16, P321, DOI 10.1111/j.1365-3024.1994.tb00355.x; Ravindran B, 2000, PARASITE IMMUNOL, V22, P633, DOI 10.1046/j.1365-3024.2000.00347.x; Sabesan S, 2010, J POSTGRAD MED, V56, P232, DOI 10.4103/0022-3859.68650; Sahoo PK, 2000, T ROY SOC TROP MED H, V94, P515, DOI 10.1016/S0035-9203(00)90070-1; Sahoo PK, 2002, PARASITOLOGY, V124, P191, DOI 10.1017/S0031182001001007; Sauerbrei A, 2004, J VIROL METHODS, V119, P25, DOI 10.1016/j.jviromet.2004.02.012; Shenoy RK, 1996, PARASITOL RES, V82, P382, DOI 10.1007/s004360050132; Simonsen PE, 1998, AM J TROP MED HYG, V59, P667, DOI 10.4269/ajtmh.1998.59.667; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Turner JD, 2009, J BIOL CHEM, V284, P22364, DOI 10.1074/jbc.M901528200; WHO, 2014, WEEKLY EPIDEMIOLOGIC, V89, P409; World Health Organization, 2011, WKLY EPIDEMIOL REC, V86, P377; Zipperer GR, 2013, EXP PARASITOL, V135, P446, DOI 10.1016/j.exppara.2013.08.007	29	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199090	10.1371/journal.pone.0199090	http://dx.doi.org/10.1371/journal.pone.0199090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927974	Green Published, Green Submitted, gold			2022-12-26	WOS:000435802500043
J	Torocsik, D; Kovacs, D; Poliska, S; Szentkereszty-Kovacs, Z; Lovaszi, M; Hegyi, K; Szegedi, A; Zouboulis, CC; Stahle, M				Torocsik, Daniel; Kovacs, Dora; Poliska, Szilard; Szentkereszty-Kovacs, Zita; Lovaszi, Marianna; Hegyi, Katalin; Szegedi, Andrea; Zouboulis, Christos C.; Stahle, Mona			Genome wide analysis of TLR1/2-and TLR4-activated SZ95 sebocytes reveals a complex immune-competence and identifies serum amyloid A as a marker for activated sebaceous glands	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; PROPIONIBACTERIUM-ACNES BIOFILMS; INFLAMMATORY CYTOKINE; PROSTAGLANDIN E-2; HUMAN SKIN; EXPRESSION; LIPOGENESIS; VULGARIS; PATHWAY; KERATINOCYTES	Toll-like receptors (TLR) 2 and 4 are active in sebaceous glands and play a central role in the development of acne. Still, there is only limited knowledge on their effect on sebocytes. In this work we performed global gene expression profile analysis with functional clustering of the differentially regulated genes of TLR1/2 (PAM3CSK4)- and TLR4 (lipopolysaccharide [LPS])-activated SZ95 sebocytes. Both TLR1/2- and 4-activation promoted inflammation in a similar manner already at an early time-point (6 hours), regulating genes involved in inflammation, wound healing and chemotaxis reflecting a more complex cytokine and chemokine regulation than previously known. Importantly, lipid metabolism, the primary feature of sebocytes, was affected at the level of gene expression only at a later time point (24 hours) indicating that sebocytes prioritize to exert a pro-inflammatory phenotype when confronted with a danger signal. Supporting the biological relevance of our results, a meta-analysis revealed that the genes showing the strongest up-regulation were also found up regulated in acne. Of these genes, serum amyloid A 1/2 (SAA1/2) was confirmed to be a suitable protein marker for in vivo activated sebocytes, underlining their immune-competence, which is structurally defined within sebaceous glands of acne and rosacea skin samples. Altogether our findings demonstrate that sebocytes are not only positioned at the end point of inflammation but are actively involved in shaping the inflammatory response with putative diagnostic and therapeutic relevance.	[Torocsik, Daniel; Kovacs, Dora; Szentkereszty-Kovacs, Zita; Lovaszi, Marianna; Hegyi, Katalin; Szegedi, Andrea] Univ Debrecen, Fac Med, Dept Dermatol, Debrecen, Hungary; [Torocsik, Daniel; Stahle, Mona] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Unit Dermatol & Venereol, Stockholm, Sweden; [Poliska, Szilard] Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Genom Med & Bioinformat Core Facil, Debrecen, Hungary; [Szegedi, Andrea] Univ Debrecen, Fac Med, Div Dermatol Allergol, Debrecen, Hungary; [Zouboulis, Christos C.] Brandenburg Med Sch Theodore Fontane, Dessau Med Ctr, Dept Dermatol, Dessau, Germany; [Zouboulis, Christos C.] Brandenburg Med Sch Theodore Fontane, Dessau Med Ctr, Dept Venereol, Dessau, Germany; [Zouboulis, Christos C.] Brandenburg Med Sch Theodore Fontane, Dessau Med Ctr, Dept Allergol, Dessau, Germany; [Zouboulis, Christos C.] Brandenburg Med Sch Theodore Fontane, Dessau Med Ctr, Dept Immunol, Dessau, Germany	University of Debrecen; Karolinska Institutet; Karolinska University Hospital; University of Debrecen; University of Debrecen; Dessau Medical Center; Dessau Medical Center; Dessau Medical Center; Dessau Medical Center	Torocsik, D (corresponding author), Univ Debrecen, Fac Med, Dept Dermatol, Debrecen, Hungary.; Torocsik, D (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Med, Unit Dermatol & Venereol, Stockholm, Sweden.	dtorocsik@gmail.com	Zouboulis, Christos C./I-4493-2013	Zouboulis, Christos C./0000-0003-1646-2608; Torocsik, Daniel/0000-0002-6094-6266; Kovacs, Dora/0000-0002-8300-3519; Dull, Katalin/0000-0001-5594-0364	Hungarian National Research, Development and Innovation Fund [NN117020]; Marie Sklodowska-Curie actions [627547]; New National Excellence Program of the Ministry of Human Capacities;  [GINOP-2.3.2-15-2016-00005];  [GINOP-2.3.2-15-2016-00050];  [EFOP-3.6.1-16-2016-00022]	Hungarian National Research, Development and Innovation Fund; Marie Sklodowska-Curie actions; New National Excellence Program of the Ministry of Human Capacities; ; ; 	This research was supported by the Hungarian National Research, Development and Innovation Fund (NN117020) to D.T., Marie Sklodowska-Curie actions (627547 RNAsebgland FP7-PEOPLE-2013-IEF) to D.T., the New National Excellence Program of the Ministry of Human Capacities to D.T., the GINOP-2.3.2-15-2016-00005 (D.T.), GINOP-2.3.2-15-2016-00050 and EFOP-3.6.1-16-2016-00022 (A.Sz.) projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisen E, 2010, J EUR ACAD DERMATOL, V24, P32, DOI 10.1111/j.1468-3083.2009.03347.x; Agak GW, 2014, J INVEST DERMATOL, V134, P366, DOI 10.1038/jid.2013.334; Alestas T, 2006, J MOL MED, V84, P75, DOI 10.1007/s00109-005-0715-8; Allhorn M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36412; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Beke G, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00424; Blankley S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097702; Choi JJ, 2012, J DERMATOL SCI, V65, P179, DOI 10.1016/j.jdermsci.2011.11.005; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Georgel P, 2005, INFECT IMMUN, V73, P4512, DOI 10.1128/IAI.73.8.4512-4521.2005; He L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3870; HOEFFLER U, 1977, J CLIN MICROBIOL, V6, P555; Huang YC, 2015, LIFE SCI, V139, P123, DOI 10.1016/j.lfs.2015.07.028; Iinuma K, 2010, EXP DERMATOL, V19, P1107, DOI 10.1111/j.1600-0625.2010.01141.x; Jahns AC, 2012, BRIT J DERMATOL, V167, P50, DOI 10.1111/j.1365-2133.2012.10897.x; Jahns AC, 2014, EXP DERMATOL, V23, P687, DOI 10.1111/exd.12482; Jeremy AHT, 2003, J INVEST DERMATOL, V121, P20, DOI 10.1046/j.1523-1747.2003.12321.x; Jugeau S, 2005, BRIT J DERMATOL, V153, P1105, DOI 10.1111/j.1365-2133.2005.06933.x; Kelhala HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105238; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; Kovacs D, 2016, EXP DERMATOL, V25, P194, DOI 10.1111/exd.12879; Kurokawa I, 2009, EXP DERMATOL, V18, P821, DOI 10.1111/j.1600-0625.2009.00890.x; Lee SE, 2013, BRIT J DERMATOL, V168, P47, DOI 10.1111/bjd.12009; Lheure C, 2016, TLR 2 RECOGNIZES PRO, V11, DOI [10.1371/journal.pone.0167237, DOI 10.1371/JOURNAL.PONE.0167237]; Lovaszi M, 2017, BRIT J DERMATOLOGY, DOI 10.1111thjd.15754; Lovaszi M, 2017, DERM-ENDOCRINOL, V9, DOI 10.1080/19381980.2017.1375636; Mattii M, 2018, BRIT J DERMATOL, V178, P722, DOI 10.1111/bjd.15879; Meissner F, 2013, SCIENCE, V340, P475, DOI 10.1126/science.1232578; Mirdamadi Y, 2015, MOL CELL ENDOCRINOL, V415, P32, DOI 10.1016/j.mce.2015.08.001; Nagy I, 2005, J INVEST DERMATOL, V124, P931, DOI 10.1111/j.0022-202X.2005.23705.x; Nagy I, 2006, MICROBES INFECT, V8, P2195, DOI 10.1016/j.micinf.2006.04.001; Nakatsuji T, 2010, J INVEST DERMATOL, V130, P985, DOI 10.1038/jid.2009.384; Oeff MK, 2006, DERMATOLOGY, V213, P266, DOI 10.1159/000095056; Ottaviani M, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/858176; Picardo M, 2009, DERM-ENDOCRINOL, V1, P68, DOI 10.4161/derm.1.2.8472; Qin M, 2014, J INVEST DERMATOL, V134, P381, DOI 10.1038/jid.2013.309; Rocha MAD, 2017, MODULATION TOLL LIKE, DOI [10.1080/19381980.2017.1361570, DOI 10.1080/19381980.2017.1361570]; Su Q, 2017, PHARM RES; Tax G, 2016, ACTA DERM-VENEREOL, V96, P43, DOI 10.2340/00015555-2154; Torocsik D, 2014, BRIT J DERMATOL, V171, P1326, DOI 10.1111/bjd.13229; Trivedi NR, 2006, J INVEST DERMATOL, V126, P1071, DOI 10.1038/sj.jid.5700213; WEBSTER GF, 1985, INFECT IMMUN, V49, P116, DOI 10.1128/IAI.49.1.116-121.1985; WHITESIDE JA, 1973, J INVEST DERMATOL, V60, P94, DOI 10.1111/1523-1747.ep12724177; Yu N, 2015, CLIN EXP IMMUNOL, V179, P344, DOI 10.1111/cei.12458; Zhang QW, 2006, EXP DERMATOL, V15, P769, DOI 10.1111/j.1600-0625.2006.00458.x; Zouboulis CC, 2014, J EUR ACAD DERMATOL, V28, P527, DOI 10.1111/jdv.12298; Zouboulis CC, 2011, BRIT J DERMATOL, V165, P269, DOI 10.1111/j.1365-2133.2011.10340.x; Zouboulis CC, 2001, DERMATOLOGY, V203, P277, DOI 10.1159/000051771; Zouboulis CC, 2002, P NATL ACAD SCI USA, V99, P7148, DOI 10.1073/pnas.102180999; Zouboulis CC, 1998, DERMATOLOGY, V196, P21, DOI 10.1159/000017861; Zouboulis CC, 1999, J INVEST DERMATOL, V113, P1011, DOI 10.1046/j.1523-1747.1999.00771.x; Zouboulis CC, 2016, REV ENDOCRINE METABO, DOI [10.1007011154-016-9389-5, DOI 10.1007011154-016-9389-5]; Zouboulis CC, 2008, ARCH DERMATOL RES, V300, P397, DOI 10.1007/s00403-008-0879-5; Zouboulis CC, 2010, EXP DERMATOL, V19, P148, DOI 10.1111/j.1600-0625.2009.00929.x	55	20	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198323	10.1371/journal.pone.0198323	http://dx.doi.org/10.1371/journal.pone.0198323			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927962	gold, Green Published, Green Submitted			2022-12-26	WOS:000435802500016
J	Barrera, N; Neto, PCD; Cuadro, F; Bosolasco, D; Mulet, AP; Crispo, M; Menchaca, A				Barrera, Natalibeth; Neto, Pedro C. dos Santos; Cuadro, Federico; Bosolasco, Diego; Mulet, Ana P.; Crispo, Martina; Menchaca, Alejo			Impact of delipidated estrous sheep serum supplementation on in vitro maturation, cryotolerance and endoplasmic reticulum stress gene expression of sheep oocytes	PLOS ONE			English	Article							DEVELOPMENTAL COMPETENCE; BOVINE OOCYTES; LIPID-CONTENT; VITRIFICATION; EMBRYOS; FERTILIZATION; METABOLISM; PCR	High lipid content of oocytes and embryos in domestic animals is one of the well-known factors associated with poor cryosurvival. Herein, we wanted to determine whether the use of delipidated estrous sheep serum during in vitro maturation (IVM) of ovine oocytes reduces the cytoplasmic lipid droplets content and improves embryo development and cryotolerance after vitrification. Cumulus oocytes complexes (COCs) were matured in vitro for 24 h in medium supplemented with whole or delipidated estrous sheep serum prior to vitrification. Neutral lipid present in lipid droplets of COCs, cleavage rate, embryo development rate on Day 6 and Day 8, and hatching rate on Day 8, were compared among experimental groups. Endoplasmic reticulum stress genes were evaluated in in vitro matured COCs under different lipid conditions prior to vitrification. The lipid droplets' content (mean fluorescence intensity) of oocytes cultured with IVM media supplemented with delipidated serum was lower than COCs matured with whole serum (7.6 +/- 1.7 vs. 22.8 +/- 5.0 arbitrary units, respectively; P< 0.05). Despite IVM treatment, oocytes subjected to vitrification showed impaired competence compared with the non-vitrified groups (P<0.05). No significant differences in embryo production were observed in non-vitrified COCs after maturation in delipidated or whole serum (33.4 +/- 4.9 vs 31.9 +/- 4.2). COCs matured in delipidated serum and subjected to vitrification showed increased expression of ATF4, ATF6, GRP78, and CHOP10 genes (ER stress markers). Collectively, our results demonstrate that although supplementation of IVM medium with delipidated estrous sheep serum reduces the presence of cytoplasmic lipid droplets in oocytes after maturation, oocyte cryotolerance is not improved. Notably, the expression of genes associated with the unfolded protein response (UPR) was increased in COCs, with fewer lipid droplets subjected to vitrification, suggesting that oocyte cryopreservation is associated with ER stress and activation of adaptive responses.	[Barrera, Natalibeth; Neto, Pedro C. dos Santos; Cuadro, Federico; Bosolasco, Diego; Menchaca, Alejo] Fdn IRAUy, Inst Reprod Anim Uruguay, Montevideo, Uruguay; [Mulet, Ana P.; Crispo, Martina] Inst Pasteur Montevideo, Unidad Anim Transgen & Expt, Montevideo, Uruguay	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Barrera, N; Menchaca, A (corresponding author), Fdn IRAUy, Inst Reprod Anim Uruguay, Montevideo, Uruguay.	natalibethbarrera@gmail.com; menchaca.alejo@gmail.com	Menchaca, Alejo/S-1835-2017; Crispo, Martina/R-2591-2019; Mulet, Ana/AAW-5713-2021	Menchaca, Alejo/0000-0002-2494-9574; Barrera, Natalibeth/0000-0002-8491-2394; Cuadro, Federico/0000-0002-5764-5155; Crispo, Martina/0000-0002-9852-5563	Agencia Nacional de Innovacion e Investigacion NB Union Agriculture Group (UAG) [POSNAC201311217]; Union Agriculture Group (UAG); Agencia Nacional de Investigacion e Innovacion (ANII) [POSNAC201311217]	Agencia Nacional de Innovacion e Investigacion NB Union Agriculture Group (UAG); Union Agriculture Group (UAG); Agencia Nacional de Investigacion e Innovacion (ANII)	This work was supported by Agencia Nacional de Innovacion e Investigacion POSNAC201311217 NB Union Agriculture Group (UAG) to AM. AM and MC are fellows of Sistema Nacional de Investigadores (SNI) and PEDECIBA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Victoria de Brun and Marcela Diaz for their technical support. The authors would also like to thank Dr. Stephan du Plessis and Dr. Sumantha Bhatt for their help in preparing this manuscript. This study received financial support of Union Agriculture Group (UAG) and Agencia Nacional de Investigacion e Innovacion (ANII; POSNAC201311217). AM and MC are fellows of Sistema Nacional de Investigadores (SNI) and PEDECIBA.	Aardema H, 2011, BIOL REPROD, V85, P62, DOI 10.1095/biolreprod.110.088815; Abe H, 2002, MOL REPROD DEV, V61, P57, DOI 10.1002/mrd.1131; Accorsi MF, 2016, ZYGOTE, V24, P485, DOI 10.1017/S0967199415000428; Babayev E, 2016, REPROD SCI, V23, P352, DOI 10.1177/1933719115602770; Bhat MH, 2015, REPROD FERT DEVELOP, V27, P1175, DOI 10.1071/RD14024; Bhat MH, 2013, SMALL RUMINANT RES, V112, P136, DOI 10.1016/j.smallrumres.2012.12.017; Castro AR, 2000, CLIN DIAGN LAB IMMUN, V7, P197, DOI 10.1128/CDLI.7.2.197-199.2000; Collado-Fernandez E, 2012, INT J DEV BIOL, V56, P799, DOI 10.1387/ijdb.120140ec; del Collado M, 2016, REPROD FERT DEVELOP, V28, P1721, DOI 10.1071/RD15067; dos Santos Neto PC, 2015, CRYOBIOLOGY; dos Santos-Neto PC, 2017, CRYOBIOLOGY, V78, P8, DOI 10.1016/j.cryobiol.2017.08.002; Du Y, 2008, REPRODUCTION, V135, P13, DOI 10.1530/REP-07-0362; Dunning KR, 2014, REPRODUCTION; Dunning KR, 2012, ANIM REPROD SCI, V134, P69, DOI 10.1016/j.anireprosci.2012.08.013; Ferguson EM, 1999, J REPROD FERTIL, V116, P373, DOI 10.1530/jrf.0.1160373; Gordon I., 2003, LAB PRODUCTION CATTL, V2nd; Hwang IS, 2014, BIOMED RES INT, V2014; Kikuchi K, 2002, ZYGOTE, V10, P355, DOI 10.1017/S0967199402004100; Kim JY, 2001, REPRODUCTION, V122, P131, DOI 10.1530/rep.0.1220131; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300, DOI 10.1016/S1472-6483(10)60837-1; Leroy J, 2005, SHORT COMMUNICATION, V78, P76; Leroy JLMR, 2005, REPROD DOMEST ANIM, V40, P76, DOI 10.1111/j.1439-0531.2004.00556.x; Listenberger LL, 2007, CURR PROTOC CELL BIO, DOI [DOI 10.1002/0471143030.CB2402S35, 10.1002/0471143030.cb2402s35]; Lonergan P, 2016, ANNU REV ANIM BIOSCI, V4, P255, DOI 10.1146/annurev-animal-022114-110822; Menchaca A, 2016, ANIM REPROD, V13, P273, DOI 10.21451/1984-3143-AR871; Menchaca A, 2004, REPROD FERT DEVELOP, V16, P403, DOI 10.1071/RD04037; Michalak Marek, 2015, Clin Exp Reprod Med, V42, P1, DOI 10.5653/cerm.2015.42.1.1; Mishra A, 2016, INDIAN J EXP BIOL, V54, P630; Mullen SF, 2012, THERIOGENOLOGY, V78, P1709, DOI 10.1016/j.theriogenology.2012.06.008; O'Connor T, 2013, REPROD DOMEST ANIM, V48, P477, DOI 10.1111/rda.12112; Oslowski C. M., 2013, METHOD ENZYMOL, V490, P71; PARRISH JJ, 1986, THERIOGENOLOGY, V25, P591, DOI 10.1016/0093-691X(86)90143-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prates EG, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/692067; Pribenszky C, 2012, REPROD DOMEST ANIM, V47, P197, DOI 10.1111/j.1439-0531.2012.02076.x; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Seidel GE, 2006, THERIOGENOLOGY, V65, P228, DOI 10.1016/j.theriogenology.2005.09.025; Shabankareh HK, 2010, FERTIL STERIL, V94, P335, DOI 10.1016/j.fertnstert.2009.01.160; Shirazi A, 2016, THERIOGENOLOGY, V86, P2136, DOI 10.1016/j.theriogenology.2016.07.005; Sturmey RG, 2003, REPRODUCTION, V126, P197, DOI 10.1530/rep.0.1260197; Sudano MJ, 2011, THERIOGENOLOGY, V75, P1211, DOI 10.1016/j.theriogenology.2010.11.033; Tamura AN, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108167; Vajta G, 2000, ANIM REPROD SCI, V60, P357, DOI 10.1016/S0378-4320(00)00097-X; Vladykovskaya E, 2012, J BIOL CHEM, V287, P11398, DOI 10.1074/jbc.M111.320416; Volmer R, 2015, CURR OPIN CELL BIOL, V33, P67, DOI 10.1016/j.ceb.2014.12.002; Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004; Wirtu G, 2013, TARGETING LIPID META, V1, P15; Woods EJ, 2004, CRYOBIOLOGY, V48, P146, DOI 10.1016/j.cryobiol.2004.03.002; Wrenzycki C, 2013, REPROD DOMEST ANIM, V48, P38, DOI 10.1111/rda.12204; Wu LDL, 2012, MOL ENDOCRINOL, V26, P562, DOI 10.1210/me.2011-1362; Yang X, 2012, FERTIL STERIL, V97, P1438, DOI 10.1016/j.fertnstert.2012.02.034; Zhang JY, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095059; Zhang X, 2012, BIOCH RES INT, V2012; Zhao N, 2015, CRYOBIOLOGY, V70, P48, DOI 10.1016/j.cryobiol.2014.12.001; Zhou GB, 2009, MOL HUM REPROD, V15, P279, DOI 10.1093/molehr/gap016	55	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198742	10.1371/journal.pone.0198742	http://dx.doi.org/10.1371/journal.pone.0198742			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912910	gold, Green Published, Green Submitted			2022-12-26	WOS:000435528600045
J	Ozeki, T; Ando, M; Yamaguchi, M; Katsuno, T; Kato, S; Yasuda, Y; Tsuboi, N; Maruyama, S				Ozeki, Takaya; Ando, Masahiko; Yamaguchi, Makoto; Katsuno, Takayuki; Kato, Sawako; Yasuda, Yoshinari; Tsuboi, Naotake; Maruyama, Shoichi			Treatment patterns and steroid dose for adult minimal change disease relapses: A retrospective cohort study	PLOS ONE			English	Article							CHANGE NEPHROTIC SYNDROME; ONSET; RITUXIMAB; RESPONSIVENESS; NEPHROPATHY; PROTEINURIA; PREVALENCE; REMISSION; FREQUENCY	Background In patients with adult minimal change disease (MCD), proteinuria relapse is a problem to solve. However, the optimal relapse treatment regimen remains unclear regarding steroid dose. We described the treatment pattern of adult MCD patients and evaluated the appropriate steroid dose for relapse treatment. Methods This retrospective multicenter cohort study included 192 patients with adult biopsy-proven MCD from 14 hospitals in Japan. The prescription pattern of immunosuppressive drugs in relapse was reviewed. To assess the association between steroid dose used for relapse and subsequent outcomes, data of patients with tapered prednisolone (PSL) dosage to <10 mg/day before the first relapse in whom the dose was subsequently increased to >= 10 mg/day were extracted and assigned to the High-PSL or Low-PSL groups, based on the median dose of 20 mg/day. Multivariate Cox proportional hazard model and propensity score analysis with multiple imputations were conducted to compare their clinical course. Results During a median observation period of 37.6 months, 186/192 (96.9%) patients achieved complete remission (CR) and 100 (52.1%) relapsed. The median urinary protein level at the first relapse was 3.12 g/gCr or g/day. The proportion of non-steroidal immunosuppressant use increased with relapses; cyclosporine was the most common. No significant differences were found in the second relapse, frequent relapses, or adverse events between High-PSL (n = 34) and Low-PSL (n = 36) groups. A multivariate Cox proportional hazard model revealed that the hazard ratios adjusted with propensity score for the second relapse were 0.94 (High-PSL vs. Low-PSL; 95% confidence interval, 0.42-2.10; P = 0.88) and 0.82 (PSL dose per 10 mg/day; 95% confidence interval, 0.58-1.16; P = 0.25). Conclusions Among patients in CR with PSL dose <10 mg/day, higher steroid dose (PSL >20 mg/day) was not associated with favorable outcomes after the first relapse as compared to lower dose (10-20 mg/day).	[Ozeki, Takaya; Katsuno, Takayuki; Kato, Sawako; Yasuda, Yoshinari; Tsuboi, Naotake; Maruyama, Shoichi] Nagoya Univ, Dept Nephrol, Grad Sch Med, Nagoya, Aichi, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Yamaguchi, Makoto] Yokkaichi Municipal Hosp, Dept Nephrol, Yokaichi, Japan; [Katsuno, Takayuki] Aichi Med Univ, Dept Nephrol & Rheumatol, Nagakute, Aichi, Japan	Nagoya University; Nagoya University; Aichi Medical University	Maruyama, S (corresponding author), Nagoya Univ, Dept Nephrol, Grad Sch Med, Nagoya, Aichi, Japan.	marus@med.nagoya-u.ac.jp	Kato, Sawako/T-2422-2019; Tsuboi, Naotake/L-5960-2019	Kato, Sawako/0000-0001-7210-1888; Tsuboi, Naotake/0000-0003-0760-845X; Ozeki, Takaya/0000-0002-1839-1180; Mauryama, Shoichi/0000-0002-8858-632X	Asahi Kasei Pharmaceutical Co; Alexion Pharmaceutical Co; Otsuka Pharmaceutical Co; Kissei Pharmaceutical Co; Novartis Pharma K.K; Kowa Pharmaceutical Co; Chugai Pharmaceutical Co; Nippon Boehringer Ingelheim Co., Ltd.; Pfizer Japan Inc.; Kyowa Hakko Kirin Co., Ltd.; Torii Pharmaceutical Co.,Ltd; Astellas Pharma Inc.; MSD K.K.; Daiichi Sankyo Company Limited; Takeda Pharmaceutical Company Limited; Bristol-Myers Squibb; Mitsubishi Tanabe Pharma Corporation; Sumitomo Dainippon Pharma Co., Ltd.; Teijin Pharma Limited; Mochida Pharmaceutical Co., Ltd; Baxter Limited	Asahi Kasei Pharmaceutical Co; Alexion Pharmaceutical Co; Otsuka Pharmaceutical Co(Otsuka Pharmaceutical); Kissei Pharmaceutical Co(Kissei Pharmaceutical Co Ltd); Novartis Pharma K.K(Novartis); Kowa Pharmaceutical Co; Chugai Pharmaceutical Co; Nippon Boehringer Ingelheim Co., Ltd.(Boehringer Ingelheim); Pfizer Japan Inc.(Pfizer); Kyowa Hakko Kirin Co., Ltd.(Kyowa Kirin Ltd); Torii Pharmaceutical Co.,Ltd; Astellas Pharma Inc.(Astellas Pharmaceuticals); MSD K.K.(Merck & Company); Daiichi Sankyo Company Limited(Daiichi Sankyo Company Limited); Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd); Bristol-Myers Squibb(Bristol-Myers Squibb); Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation); Sumitomo Dainippon Pharma Co., Ltd.; Teijin Pharma Limited(Teijin Pharma Limited); Mochida Pharmaceutical Co., Ltd; Baxter Limited	Department of Nephrology, Nagoya University Graduate School of Medicine is supported by the following funders: Asahi Kasei Pharmaceutical Co, Alexion Pharmaceutical Co, Otsuka Pharmaceutical Co, Kissei Pharmaceutical Co, Novartis Pharma K.K, Kowa Pharmaceutical Co, Chugai Pharmaceutical Co, Nippon Boehringer Ingelheim Co., Ltd., Pfizer Japan Inc., Kyowa Hakko Kirin Co., Ltd., Torii Pharmaceutical Co.,Ltd, Astellas Pharma Inc., MSD K.K., Daiichi Sankyo Company Limited, Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb, Mitsubishi Tanabe Pharma Corporation, Sumitomo Dainippon Pharma Co., Ltd., Teijin Pharma Limited, grants from Mochida Pharmaceutical Co., Ltd and Baxter Limited. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barisoni L, 2007, CLIN J AM SOC NEPHRO, V2, P529, DOI 10.2215/CJN.04121206; Bruchfeld A, 2014, NEPHROL DIAL TRANSPL, V29, P851, DOI 10.1093/ndt/gft312; Chang JH, 2009, NEPHROL DIAL TRANSPL, V24, P2406, DOI 10.1093/ndt/gfp091; Crump RK, 2009, BIOMETRIKA, V96, P187, DOI 10.1093/biomet/asn055; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Francois H, 2007, AM J KIDNEY DIS, V49, P158, DOI 10.1053/j.ajkd.2006.10.015; Garin EH, 2009, J AM SOC NEPHROL, V20, P260, DOI 10.1681/ASN.2007080836; Glassock RJ, 2003, NEPHROL DIAL TRANSPL, V18, P52, DOI 10.1093/ndt/gfg1060; Haas M, 1997, AM J KIDNEY DIS, V30, P621, DOI 10.1016/S0272-6386(97)90485-6; Huang JJ, 2001, AM J NEPHROL, V21, P28, DOI 10.1159/000046215; Kazi JI, 2009, CLIN EXP NEPHROL, V13, P38, DOI 10.1007/s10157-008-0075-0; Komukai D, 2016, NEPHROLOGY, V21, P887, DOI 10.1111/nep.12678; Korbet SM, 1996, AM J KIDNEY DIS, V27, P647, DOI 10.1016/S0272-6386(96)90098-0; Lennon R, 2008, J AM SOC NEPHROL, V19, P2140, DOI 10.1681/ASN.2007080940; Maas RJ, 2017, AM J KIDNEY DIS, V69, P637, DOI 10.1053/j.ajkd.2016.10.032; Maas RJ, 2014, NEPHROL DIAL TRANSPL, V29, P2207, DOI 10.1093/ndt/gfu355; Mak SK, 1996, NEPHROL DIAL TRANSPL, V11, P2192, DOI 10.1093/oxfordjournals.ndt.a027136; Mathieson PW, 2008, NEW ENGL J MED, V359, P2492, DOI 10.1056/NEJMcibr0806881; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Munyentwali H, 2013, KIDNEY INT, V83, P511, DOI 10.1038/ki.2012.444; Nakayama M, 2002, AM J KIDNEY DIS, V39, P503, DOI 10.1053/ajkd.2002.31400; Nishi S, 2016, CLIN EXP NEPHROL, V20, P342, DOI 10.1007/s10157-015-1216-x; Polito MG, 2010, NEPHROL DIAL TRANSPL, V25, P490, DOI 10.1093/ndt/gfp355; Raja K, 2017, PEDIATR NEPHROL, V32, P99, DOI 10.1007/s00467-016-3458-6; Rivera F, 2004, KIDNEY INT, V66, P898, DOI 10.1111/j.1523-1755.2004.00833.x; Shinzawa M, 2013, CLIN EXP NEPHROL, V17, P839, DOI 10.1007/s10157-013-0793-9; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Szeto CC, 2015, AM J KIDNEY DIS, V65, P710, DOI 10.1053/j.ajkd.2014.09.022; Takei T, 2013, NEPHROL DIAL TRANSPL, V28, P1225, DOI 10.1093/ndt/gfs515; Takei Takashi, 2007, Clin Exp Nephrol, V11, P214, DOI 10.1007/s10157-007-0484-5; Tse KC, 2003, NEPHROL DIAL TRANSPL, V18, P1316, DOI 10.1093/ndt/gfg134; Vivarelli M, 2017, CLIN J AM SOC NEPHRO, V12, P332, DOI 10.2215/CJN.05000516; Waldman M, 2007, CLIN J AM SOC NEPHRO, V2, P445, DOI 10.2215/CJN.03531006; Wang HE, 2013, NEPHROL DIAL TRANSPL, V28, P1447, DOI 10.1093/ndt/gfs533; Yokoyama H, 2012, CLIN EXP NEPHROL, V16, P557, DOI 10.1007/s10157-012-0593-7	35	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199228	10.1371/journal.pone.0199228	http://dx.doi.org/10.1371/journal.pone.0199228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912938	Green Submitted, Green Published, gold			2022-12-26	WOS:000435528600094
J	Rapala, L; Starzynski, RR; Trzeciak, PZ; Dabrowski, S; Gajewska, M; Jurka, P; Smolarczyk, R; Duszewska, AM				Rapala, Lukasz; Starzynski, Rafal R.; Trzeciak, Piotr Z.; Dabrowski, Sebastian; Gajewska, Malgorzata; Jurka, Piotr; Smolarczyk, Roman; Duszewska, Anna M.			Influence of elevated temperature on bovine oviduct epithelial cells (BOECs)	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; EARLY EMBRYONIC-DEVELOPMENT; IN-VITRO; PREIMPLANTATION EMBRYO; OXIDATIVE STRESS; ZONA-PELLUCIDA; ESTROUS-CYCLE; BOS-INDICUS; CROSS-TALK; FERTILIZATION	The aim of this study was to evaluate the influence of elevated temperature on bovine oviduct epithelial cells (BOECs), based on the expression and localization of both heat shock protein 70 (HSP70), responsible for the cellular defence mechanism, and oviduct specific glycoprotein 1 (OVGP1) which is the most important embryotrophic protein. BOECs were cultured alone and co-cultured with cattle embryos at control (38.5 degrees C) and elevated temperature (41 degrees C) for 168 h. The elevated temperature had no effect on the viability of BOECs but exerted a negative effect on embryo development. The elevated temperature increased the expression of HSP70 and decreased the expression of OVGP1 at both mRNA and protein levels in BOECs cultured alone and those co-cultured with embryos. However, the presence of embryos limited the decrease in OVGP1 expression in BOECs at elevated temperature but did not alter the expression of HSP70. These results demonstrate for the first time the influence of elevated temperature on BOECs, consequently providing insights into the interactions between the embryo and the oviduct at elevated temperature.	[Rapala, Lukasz; Trzeciak, Piotr Z.; Dabrowski, Sebastian; Duszewska, Anna M.] Warsaw Univ Life Sci, Fac Vet Med, Dept Morphol Sci, Div Histol & Embryol, Warsaw, Poland; [Starzynski, Rafal R.] Polish Acad Sci, Inst Genet & Anim Breeding, Jastrzebiec, Poland; [Gajewska, Malgorzata] Warsaw Univ Life Sci, Fac Vet Med, Dept Physiol Sci, Warsaw, Poland; [Jurka, Piotr] Warsaw Univ Life Sci, Fac Vet Med, Dept Small Anim Dis Clin, Warsaw, Poland; [Smolarczyk, Roman] Med Univ Warsaw, Fac Med, Dept Gynecol Endocrinol, Warsaw, Poland	Warsaw University of Life Sciences; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; Warsaw University of Life Sciences; Warsaw University of Life Sciences; Medical University of Warsaw	Duszewska, AM (corresponding author), Warsaw Univ Life Sci, Fac Vet Med, Dept Morphol Sci, Div Histol & Embryol, Warsaw, Poland.	duszewskaanna@hotmail.com		, Rafal/0000-0002-7470-0507; Gajewska, Malgorzata/0000-0001-7249-8627; Duszewska, Anna/0000-0003-3336-9667	Ministry of Science and Higher Education Republic of Poland MNiSZW COST [453/N-COST/2009/0]	Ministry of Science and Higher Education Republic of Poland MNiSZW COST	This work was financed by Ministry of Science and Higher Education Republic of Poland MNiSZW COST 453/N-COST/2009/0 to AMD. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Aviles M, 2010, MOL HUM REPROD, V16, P896, DOI 10.1093/molehr/gaq056; Bauersachs S, 2004, J MOL ENDOCRINOL, V32, P449, DOI 10.1677/jme.0.0320449; Besenfelder U, 2012, REPROD DOMEST ANIM, V47, P156, DOI 10.1111/j.1439-0531.2012.02070.x; Biamonti G, 2009, TRENDS BIOCHEM SCI, V34, P146, DOI 10.1016/j.tibs.2008.11.004; BOICE ML, 1990, BIOL REPROD, V43, P340, DOI 10.1095/biolreprod43.2.340; Buhi WC, 2002, REPRODUCTION, V123, P355, DOI 10.1530/rep.0.1230355; Cebrian-Serrano A, 2013, REPROD DOMEST ANIM, V48, P331, DOI 10.1111/j.1439-0531.2012.02157.x; Collier RJ, 2008, J DAIRY SCI, V91, P445, DOI 10.3168/jds.2007-0540; Coy P, 2008, P NATL ACAD SCI USA, V105, P15809, DOI 10.1073/pnas.0804422105; Duszewska AM, 2012, J ANIM FEED SCI, V21, P217, DOI 10.22358/jafs/66068/2012; Duszewska AM, 2016, ANIM SCI PAP REP, V34, P329; EALY AD, 1995, J ANIM SCI, V73, P1401; Edwards JL, 1997, MOL REPROD DEV, V46, P138, DOI 10.1002/(SICI)1098-2795(199702)46:2&lt;138::AID-MRD4&gt;3.0.CO;2-R; Feng HL, 1996, HUM REPROD, V11, P1525; Garcia-Ispierto I, 2007, THERIOGENOLOGY, V67, P1379, DOI 10.1016/j.theriogenology.2007.02.009; Georgiou AS, 2005, MOL CELL PROTEOMICS, V4, P1785, DOI 10.1074/mcp.M500119-MCP200; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Hansen PJ, 2007, THERIOGENOLOGY, V68, pS242, DOI 10.1016/j.theriogenology.2007.04.008; Hansen PJ, 2007, THERIOGENOLOGY, V68, pS40, DOI 10.1016/j.theriogenology.2007.03.013; Hansen PJ, 2009, PHILOS T R SOC B, V364, P3341, DOI 10.1098/rstb.2009.0131; Holt WV, 2010, MOL REPROD DEV, V77, P934, DOI 10.1002/mrd.21234; IRELAND JJ, 1980, J DAIRY SCI, V63, P155, DOI 10.3168/jds.S0022-0302(80)82901-8; Jousan FD, 2007, MOL REPROD DEV, V74, P189, DOI 10.1002/mrd.20527; KAN FWK, 1993, BIOL REPROD, V48, P77, DOI 10.1095/biolreprod48.1.77; Killian GJ, 2004, ANIM REPROD SCI, V82-3, P141, DOI 10.1016/j.anireprosci.2004.04.028; Kolle S, 2009, BIOL REPROD, V81, P267, DOI 10.1095/biolreprod.108.073874; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; Leese HJ, 2001, REPRODUCTION, V121, P339, DOI 10.1530/rep.0.1210339; Makarevich AV, 2002, BIOL REPROD, V66, P386, DOI 10.1095/biolreprod66.2.386; Mondejar I, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111385; Noble EG, 2008, APPL PHYSIOL NUTR ME, V33, P1050, DOI 10.1139/H08-069; Orsi NM, 2007, THERIOGENOLOGY, V67, P441, DOI 10.1016/j.theriogenology.2006.10.011; PARRISH JJ, 1987, J ANDROL, V8, P259; Paula-Lopes FF, 2013, J ANIM SCI, V91, P1143, DOI 10.2527/jas.2012-5802; Paula-Lopes FF, 2012, ANIM REPROD, V9, P395; Payton RR, 2011, J REPROD DEVELOP, V57, P481, DOI 10.1262/jrd.10-163M; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rivera RM, 2004, REPRODUCTION, V128, P33, DOI 10.1530/rep.1.00146; Rivera RM, 2003, BIOL REPROD, V69, P2068, DOI 10.1095/biolreprod.103.020347; Rivera RM, 2001, REPRODUCTION, V121, P107, DOI 10.1530/rep.0.1210107; Rottmayer R, 2006, REPRODUCTION, V132, P637, DOI 10.1530/rep.1.01136; Rynkowska Anna, 2011, Biotechnologia (Poznan), V92, P45; SALO DC, 1991, FREE RADICAL BIO MED, V11, P239, DOI 10.1016/0891-5849(91)90119-N; Sartori R, 2002, J DAIRY SCI, V85, P2803, DOI 10.3168/jds.S0022-0302(02)74367-1; Silva CF, 2013, THERIOGENOLOGY, V79, P351, DOI 10.1016/j.theriogenology.2012.10.003; Silver JT, 2012, CELL STRESS CHAPERON, V17, P1, DOI 10.1007/s12192-011-0290-6; Ulbrich SE, 2010, THERIOGENOLOGY, V73, P802, DOI 10.1016/j.theriogenology.2009.09.036; Vila-Carriles WH, 2007, J BIOL CHEM, V282, P34381, DOI 10.1074/jbc.M705354200; Wijayagunawardane MPB, 2005, MOL REPROD DEV, V72, P511, DOI 10.1002/mrd.20379; Wolf E, 2003, REPROD DOMEST ANIM, V38, P276, DOI 10.1046/j.1439-0531.2003.00435.x; Xu JS, 2003, FERTIL STERIL, V80, P178, DOI 10.1016/S0015-0282(03)00570-3; Yaniz JL, 2000, ANAT REC, V260, P268, DOI 10.1002/1097-0185(20001101)260:3<268::AID-AR60>3.0.CO;2-L	54	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2018	13	6							e0198843	10.1371/journal.pone.0198843	http://dx.doi.org/10.1371/journal.pone.0198843			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5RI	29906278	gold, Green Submitted, Green Published			2022-12-26	WOS:000435439400007
J	Subramanian, K; Gora, A; Spruijt, R; Mitusinska, K; Suarez-Diez, M; dos Santos, VM; Schaap, PJ				Subramanian, Kalyanasundaram; Gora, Artur; Spruijt, Ruud; Mitusinska, Karolina; Suarez-Diez, Maria; dos Santos, Vitor Martins; Schaap, Peter J.			Modulating D-amino acid oxidase (DAAO) substrate specificity through facilitated solvent access	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; ACTIVE-SITE; CATALYTIC-PROPERTIES; DIRECTED EVOLUTION; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; INHIBITORS; MECHANISM; KIDNEY; SCHIZOPHRENIA	D-amino acid oxidase (DAAO) degrades D-amino acids to produce alpha-ketoacids, hydrogen peroxide and ammonia. DAAO has often been investigated and engineered for industrial and clinical applications. We combined information from literature with a detailed analysis of the structure to engineer mammalian DAAOs. The structural analysis was complemented with molecular dynamics simulations to characterize solvent accessibility and product release mechanisms. We identified non-obvious residues located on the loops on the border between the active site and the secondary binding pocket essential for pig and human DAAO substrate specificity and activity. We engineered DAAOs by mutating such critical residues and characterised the biochemical activity of the resulting variants. The results highlight the importance of the selected residues in modulating substrate specificity, product egress and enzyme activity, suggesting further steps of DAAO re-engineering towards desired clinical and industrial applications.	[Subramanian, Kalyanasundaram; Spruijt, Ruud; Suarez-Diez, Maria; dos Santos, Vitor Martins; Schaap, Peter J.] Wageningen Univ & Res, Lab Syst & Synthet Biol, Wageningen, Netherlands; [Gora, Artur; Mitusinska, Karolina] Silesian Tech Univ, Biotechnol Ctr, Tunneling Grp, Ul Krzywoustego, Gliwice, Poland; [Mitusinska, Karolina] Silesian Tech Univ, Dept Chem, Gliwice, Poland	Wageningen University & Research; Silesian University of Technology; Silesian University of Technology	Schaap, PJ (corresponding author), Wageningen Univ & Res, Lab Syst & Synthet Biol, Wageningen, Netherlands.; Gora, A (corresponding author), Silesian Tech Univ, Biotechnol Ctr, Tunneling Grp, Ul Krzywoustego, Gliwice, Poland.	a.gora@tunnelinggroup.pl; Peter.Schaap@wur.nl	Diez, Maria Suarez/AAI-1354-2020; Góra, Artur/D-5041-2012; Mitusińska, Karolina/AAI-8848-2021	Góra, Artur/0000-0003-2530-6957; Suarez-Diez, Maria/0000-0001-5845-146X; Schaap, Peter/0000-0002-4346-6084; Subramanian, Kalyanasundaram/0000-0002-6110-1046	Netherlands Organisation for Scientific Research (NWO) [11319]; National Science Centre, Poland [DEC-2013/10/E/NZ1/00649]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Science Centre, Poland(National Science Centre, Poland)	This work is part of the research programme STW with project number 11319, which is financed by the Netherlands Organisation for Scientific Research (NWO). The work of AG and KM was supported by the National Science Centre, Poland (DEC-2013/10/E/NZ1/00649).	Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Antony J, 2000, J AM CHEM SOC, V122, P1057, DOI 10.1021/ja993784t; Atkinson F, STANDARDIZER TOOL; Bava A, 2013, NANOMEDICINE-UK, V8, P1797, DOI 10.2217/nnm.12.187; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biedermannova L, 2012, J BIOL CHEM, V287, P29062, DOI 10.1074/jbc.M112.377853; Boselli A, 2004, BBA-PROTEINS PROTEOM, V1702, P19, DOI 10.1016/j.bbapap.2004.07.005; Brezovsky J, 2016, ACS CATAL, V6, P7597, DOI 10.1021/acscatal.6b02081; Cappelletti P, 2015, BBA-PROTEINS PROTEOM, V1854, P1150, DOI 10.1016/j.bbapap.2015.02.005; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; DeLano WL, 2014, PYMOL MOL GRAPH SYST; Durrant A.R., 2014, ADV PSYCHIAT, V2014, P1, DOI [10.1155/2014/859735, DOI 10.1155/2014/859735]; Fernanda Duarte F, 2017, THEORY APPL EMPIRICA; Friedman M, 2010, CHEM BIODIVERS, V7, P1491, DOI 10.1002/cbdv.200900225; GASTEIGER J, 1978, TETRAHEDRON LETT, P3181; Gora A, 2013, CHEM REV, V113, P5871, DOI 10.1021/cr300384w; Gulaj E, 2010, ADV MED SCI-POLAND, V55, P204, DOI 10.2478/v10039-010-0023-6; Harris CM, 1999, J BIOL CHEM, V274, P36233, DOI 10.1074/jbc.274.51.36233; Hatano T, 2010, PSYCHIAT RES, V177, P27, DOI 10.1016/j.psychres.2010.02.014; Hondo T, 2013, J MED CHEM, V56, P3582, DOI 10.1021/jm400095b; Hopkins SC, 2013, J MED CHEM, V56, P3710, DOI 10.1021/jm4002583; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iizuka H, 2011, J CHROMATOGR B, V879, P3208, DOI 10.1016/j.jchromb.2011.02.014; Kaushik S, 2018, FEBS J, V285, P1456, DOI 10.1111/febs.14418; Kawazoe T, 2006, PROTEIN SCI, V15, P2708, DOI 10.1110/ps.062421606; Khoronenkova SV, 2008, ANAL BIOCHEM, V374, P405, DOI 10.1016/j.ab.2007.12.021; Kourist R, 2015, ANGEW CHEM INT EDIT, V54, P12547; Kozlikova B, 2014, BIOINFORMATICS, V30, P2684, DOI 10.1093/bioinformatics/btu364; Lin CH, 2014, BIOL PSYCHIAT, V75, P678, DOI 10.1016/j.biopsych.2013.08.010; Ma S, 2015, J PHARMACEUT BIOMED, V116, P131, DOI 10.1016/j.jpba.2015.03.021; Madeira C, 2008, SCHIZOPHR RES, V101, P76, DOI 10.1016/j.schres.2008.02.002; Magdziarz T, 2017, BIOINFORMATICS, V33, P2045, DOI 10.1093/bioinformatics/btx125; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Martinez-Rodriguez S, 2010, CHEM BIODIVERS, V7, P1531, DOI 10.1002/cbdv.200900245; Miura R, 1997, J BIOCHEM-TOKYO, V122, P825; Nueangaudom A, 2014, RSC ADV, V4, P54096, DOI 10.1039/c4ra05211k; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; Pollegioni L, 2002, J MOL BIOL, V324, P535, DOI 10.1016/S0022-2836(02)01062-8; Pollegioni L, 2004, BIOTECHNOL PROGR, V20, P467, DOI 10.1021/bp034206q; Pollegioni L, 2007, CURR PROTEIN PEPT SC, V8, P600, DOI 10.2174/138920307783018677; Pollegioni L, 2011, TRENDS BIOTECHNOL, V29, P276, DOI 10.1016/j.tibtech.2011.01.010; Raje M, 2013, BIOORG MED CHEM LETT, V23, P3910, DOI 10.1016/j.bmcl.2013.04.062; RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040; Rosini E, 2011, FEBS J, V278, P482, DOI 10.1111/j.1742-4658.2010.07969.x; Saam J, 2010, J BIOL CHEM, V285, P24439, DOI 10.1074/jbc.M110.131193; Sacchi S, 2002, J BIOL CHEM, V277, P27510, DOI 10.1074/jbc.M203946200; Sacchi S, 2004, PROTEIN ENG DES SEL, V17, P517, DOI 10.1093/protein/gzh064; Sacchi S, 2013, CURR PHARM DESIGN, V19, P2499, DOI 10.2174/1381612811319140002; Sacchi S, 2012, AMINO ACIDS, V43, P1833, DOI 10.1007/s00726-012-1345-4; Schymkowitz J, 2005, NUCL ACIDS RES S2, V33; Setoyama C, 2006, J BIOCHEM, V139, P873, DOI 10.1093/jb/mvj094; Terry-Lorenzo RT, 2014, BIOSCIENCE REP, V34, P487, DOI 10.1042/BSR20140071; Tishkov VI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P40, DOI 10.1007/s10541-005-0050-2; Todone F, 1997, BIOCHEMISTRY-US, V36, P5853, DOI 10.1021/bi9630570; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Umhau S, 2000, P NATL ACAD SCI USA, V97, P12463, DOI 10.1073/pnas.97.23.12463; Vanoni MA, 1997, BIOCHEMISTRY-US, V36, P5624, DOI 10.1021/bi963023s; Wang J, 2014, AMBER14 REFERENCE MA; WATANABE F, 1988, FEBS LETT, V238, P269, DOI 10.1016/0014-5793(88)80494-0; Wichapong K, 2014, MOL SIMULAT, V40, P1167, DOI 10.1080/08927022.2013.854892; Wong KS, 2010, NEW BIOTECHNOL, V27, P78, DOI 10.1016/j.nbt.2009.11.002; Wu M, 2006, CLIN EXP PHARMACOL P, V33, P1042, DOI 10.1111/j.1440-1681.2006.04484.x; Xu D, 2008, NAT CHEM BIOL, V4, P200, DOI 10.1038/nchembio.66; Yasukawa K, 2014, ANGEW CHEM INT EDIT, V53, P4428, DOI 10.1002/anie.201308812	65	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2018	13	6							e0198990	10.1371/journal.pone.0198990	http://dx.doi.org/10.1371/journal.pone.0198990			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5RI	29906280	Green Published, Green Submitted, gold			2022-12-26	WOS:000435439400009
J	Tabong, PTN; Bawontuo, V; Dumah, DN; Kyilleh, JM; Yempabe, T				Tabong, Philip Teg-Nefaah; Bawontuo, Vitalis; Dumah, Doris Ningwiebe; Kyilleh, Joseph Maaminu; Yempabe, Tolgou			Premorbid risk perception, lifestyle, adherence and coping strategies of people with diabetes mellitus: A phenomenological study in the Brong Ahafo Region of Ghana	PLOS ONE			English	Article							GLYCEMIC CONTROL; FAMILY-HISTORY; TYPE-2; PREVALENCE; PROJECTIONS; MORTALITY; SCORE; TOOL	Background One of the non-communicable diseases which is on the rise is type 2 diabetes (T2D). T2D is largely preventable with healthy lifestyle. We therefore conducted this study to explore premorbid perception of risk, behavioural practices and the coping strategies of patients with T2D. Methods Using descriptive phenomenology approach to qualitative enquiry, we conducted eight focus group discussions (N = 73) with diabetic patients; four among males (N = 36) and four among females (N = 37). In addition, we conducted in-depth interviews with 15 patients, seven caretakers and three physicians. We adopted Colaizzi's descriptive phenomenology approach to analyse the data with the aid of NVivo 11. Results We found that respondents believed diabetes was a condition for the aged and rich and this served as a premorbid risk attenuator. Majority of them engaged in diabetes-related high risk behaviours such as lack of exercise, sedentary lifestyle and unhealthy eating despite their foreknowledge about the role of lifestyle in diabetes pathogenesis. We also found that patients used moringa, noni, prekese, and garlic concurrently with orthodox medications. Adherence to dietary changes and exercises was a challenge with females reporting better adherence than males. The study also revealed that patients believed biomedical health facilities paid little attention to psychosocial aspects of care despite its essential role in coping with the condition. Conclusion Diabetic patients had low premorbid perception of risk and engaged in diabetes-related risky behaviours. Diabetic patients had challenges adhering to lifestyle changes and use both biomedical and local remedies in the management of the condition. Psychosocial support is necessary to enhance coping with the condition.	[Tabong, Philip Teg-Nefaah] Univ Ghana, Sch Publ Heal, Dept Social & Behav Sci, Legon, Ghana; [Bawontuo, Vitalis] Catholic Univ, Coll Ghana, Fac Publ Hlth & Allied Sci, Sunyani, Brong Ahafo Reg, Ghana; [Dumah, Doris Ningwiebe] Catholic Educ Unit, Sunyani, Brong Ahafo Reg, Ghana; [Kyilleh, Joseph Maaminu] Nurses Training Coll, Tamale, Northern Region, Ghana; [Yempabe, Tolgou] Tamale Teaching Hosp, Dept Surg, Tamale, Ghana	University of Ghana	Tabong, PTN (corresponding author), Univ Ghana, Sch Publ Heal, Dept Social & Behav Sci, Legon, Ghana.	hilgh2001@yahoo.com	Tabong, Philip Teg-Nefaah/AAG-5478-2020	Tabong, Philip/0000-0001-9445-1643; Bawontuo, Vitalis/0000-0001-8440-0172; Kyilleh, Joseph/0000-0003-1089-2690				Ahmad M, 2009, PAK J BOT, V41, P2777; Al-Qazaz HK, 2011, INT J CLIN PHARM-NET, V33, P1028, DOI 10.1007/s11096-011-9582-2; Ali Naseer, 2013, J Assoc Physicians India, V61, P619; Amoah AGB, 2002, DIABETES RES CLIN PR, V56, P197, DOI 10.1016/S0168-8227(01)00374-6; Anderson LM, 2009, AM J PREV MED, V37, P358, DOI 10.1016/j.amepre.2009.07.004; Assah FK, 2009, EUR ENDOCRINOL, V5, P13, DOI DOI 10.17925/EE.2009.05.00.13; Bailey CJ, 2011, INT J CLIN PRACT, V65, P314, DOI 10.1111/j.1742-1241.2010.02544.x; Balde NM, 2006, DIABETES METAB, V32, P171, DOI 10.1016/S1262-3636(07)70265-3; Barbour R. S., 2003, QUALITATIVE HLTH RES, V13, P1010; Beagley J, 2014, DIABETES RES CLIN PR, V103, P150, DOI 10.1016/j.diabres.2013.11.001; Bernard H. R., 2017, RES METHODS ANTHR; Chen L, 2010, MED J AUSTRALIA, V192, P197, DOI 10.5694/j.1326-5377.2010.tb03478.x; Damiao EBC, 2007, REV LAT-AM ENFERM, V15, P568, DOI 10.1590/S0104-11692007000400008; Clark JP, 2003, PEER REV HLTH SCI, P219; Colaizzi Paul, 1978, EXISTENTIAL PHENOMEN, P48; Colberg SR, 2010, MED SCI SPORT EXER, V42, P2282, DOI 10.1249/MSS.0b013e3181eeb61c; Creswell J.W., 2018, QUAL INQ, V4; Danquah I, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-210; de-Graft Aikins A, 2005, BR MED J, V331; El Mahalli AA, 2015, INT J HEALTH SCI-IJH, V9, P119; FAO, 2008, 91 FAO; Fezeu LK, 2008, OBESITY, V16, P1144, DOI 10.1038/oby.2008.44; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Frenk J, 2017, LANCET, V389, P667, DOI 10.1016/S0140-6736(16)30181-7; Gearing RE, 2004, QUAL HEALTH RES, V14, P1429, DOI 10.1177/1049732304270394; Ghana Statistical Service (GSS), 2014, 2010 POP HOUS CENS; Green J., 2018, QUALITATIVE METHODS, VFourth; GSS, 2011, 2010 POP HOUS REP; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Harding JL, 2014, DIABETES CARE, V37, P2579, DOI 10.2337/dc14-0096; Herman WH, 2015, DIABETES CARE, V38, P1449, DOI 10.2337/dc14-2459; International Diabetes Federation Africa, 2016, DIAB SIT REP; Iunes DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114151; Jarald E., 2008, DIABETES VS HERBAL M, V2, P97, DOI DOI 10.1016/J.JEP.2011.10.009; Kasperson RE, 1996, ANN AM ACAD POLIT SS, V545, P95, DOI 10.1177/0002716296545001010; Kratzer J, 2012, Ghana Med J, V46, P39; Laverty S.M., 2003, INT J QUAL METH, V21-35, P21, DOI [10.1177/160940690300200303, DOI 10.1177/160940690300200303]; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Lopez KA, 2004, QUAL HEALTH RES, V14, P726, DOI 10.1177/1049732304263638; Meiloud G, 2013, PRIM CARE DIABETES, V7, P19, DOI 10.1016/j.pcd.2012.12.002; Mihaescu Raluca, 2011, PLoS Curr, V3, pRRN1208, DOI 10.1371/currents.RRN1208; Modak M, 2007, J CLIN BIOCHEM NUTR, V40, P163, DOI 10.3164/jcbn.40.163; Mogre V, 2017, BMC ENDOCR DISORD, V17, DOI 10.1186/s12902-017-0169-3; MoH, 2007, REG HLTH SHIFT EMPH; Mohan V, 2007, DIABETES OBES METAB, V9, P337, DOI 10.1111/j.1463-1326.2006.00612.x; Nerurkar PV, 2015, MOLECULES, V20, P17684, DOI 10.3390/molecules201017684; Nielsen JV, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-22; Ozougwu JC, 2013, J PHYSL PATHOPHYSIOL, V4, P46, DOI [DOI 10.5897/JPAP2013.0001, 10.5897/jpap2013.0001]; Park Chan Young, 2015, Osong Public Health Res Perspect, V6, P224, DOI 10.1016/j.phrp.2015.05.004; Parker B, 2002, DIABETES CARE, V25, P425, DOI 10.2337/diacare.25.3.425; Polonsky WH, 2016, PATIENT PREFER ADHER, V10, P1299, DOI 10.2147/PPA.S106821; Raum E, 2012, DIABETES RES CLIN PR, V97, P377, DOI 10.1016/j.diabres.2012.05.026; Sanz C, 2010, DIABETES METAB, V36, P346, DOI 10.1016/j.diabet.2010.06.001; Scott RA, 2013, DIABETOLOGIA, V56, P60, DOI 10.1007/s00125-012-2715-x; Shah Kshamata M, 2012, Foot (Edinb), V22, P130, DOI 10.1016/j.foot.2012.05.001; Sleiman D, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00069; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tovilla-Zarate C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036887; WHO, 2008, PREV NONC DIS WORKPL; WHO, 2013, GLOB ACT PLAN PREV C, V102; WHO, 2016, GLOB REP PSOR; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2015, WHO MOD LIST ESS MED; World Health Organization, 2013, IMPL TOOLS PACK ESS	65	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198915	10.1371/journal.pone.0198915	http://dx.doi.org/10.1371/journal.pone.0198915			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ5MF	29902224	Green Submitted, Green Published, gold			2022-12-26	WOS:000435424900059
J	Brough, R; Gulati, A; Haider, S; Kumar, R; Campbell, J; Knudsen, E; Pettitt, SJ; Ryan, CJ; Lord, CJ				Brough, Rachel; Gulati, Aditi; Haider, Syed; Kumar, Rahul; Campbell, James; Knudsen, Erik; Pettitt, Stephen J.; Ryan, Coim J.; Lord, Christopher J.			Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancer	ONCOGENE			English	Article							COP9 SIGNALOSOME; CELL-CYCLE; NEOADJUVANT CHEMOTHERAPY; PATHWAY DISRUPTION; PROTEIN EXPRESSION; OVARIAN-CANCER; LARGE-SCALE; P53; ASSOCIATION; INHIBITORS	Although defects in the RB1 tumour suppressor are one of the more common driver alterations found in triple-negative breast cancer (TNBC), therapeutic approaches that exploit this have not been identified. By integrating molecular profiling data with data from multiple genetic perturbation screens, we identified candidate synthetic lethal (SL) interactions associated with RB1 defects in TNBC. We refined this analysis by identifying the highly penetrant effects, reasoning that these would be more robust in the face of molecular heterogeneity and would represent more promising therapeutic targets. A significant proportion of the highly penetrant RB1 SL effects involved proteins closely associated with RB1 function, suggesting that this might be a defining characteristic. These included nuclear pore complex components associated with the MAD2 spindle checkpoint protein, the kinase and bromodomain containing transcription factor TAF1, and multiple components of the SCFSKP Cullin F box containing complex. Small-molecule inhibition of SCFSKP elicited an increase in p27Kip levels, providing a mechanistic rationale for RB1 SL. Transcript expression of SKP2, a SCFSKP component, was elevated in RB1-defective TNBCs, suggesting that in these tumours, SKP2 activity might buffer the effects of RB1 dysfunction.	[Brough, Rachel; Gulati, Aditi; Haider, Syed; Kumar, Rahul; Campbell, James; Pettitt, Stephen J.; Lord, Christopher J.] Breast Canc Now Toby Robins Breast Canc Res Ctr, London SW3 6JB, England; [Brough, Rachel; Gulati, Aditi; Kumar, Rahul; Campbell, James; Pettitt, Stephen J.; Lord, Christopher J.] Inst Canc Res, CRUK Gene Funct Lab, London SW3 6JB, England; [Knudsen, Erik] Univ Arizona, Dept Med, Tucson, AZ 85721 USA; [Ryan, Coim J.] Univ Coll Dublin, Syst Biol Ireland, Dublin, Ireland; [Ryan, Coim J.] Univ Coll Dublin, Sch Comp Sci, Dublin, Ireland	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Arizona; University College Dublin; University College Dublin	Lord, CJ (corresponding author), Breast Canc Now Toby Robins Breast Canc Res Ctr, London SW3 6JB, England.; Lord, CJ (corresponding author), Inst Canc Res, CRUK Gene Funct Lab, London SW3 6JB, England.; Ryan, CJ (corresponding author), Univ Coll Dublin, Syst Biol Ireland, Dublin, Ireland.; Ryan, CJ (corresponding author), Univ Coll Dublin, Sch Comp Sci, Dublin, Ireland.	Colm.RyanRyan@ucd.ie; Chris.Lord@icr.ac.uk	Lord, Christopher/AAX-7130-2021; kumar, rahul/GZG-2171-2022; Kumar, Rahul/ABB-3530-2020; Lord, Christopher/B-3295-2012	Pettitt, Stephen/0000-0003-3313-3857; Lord, Christopher/0000-0002-3226-0515; Ryan, Colm/0000-0003-2750-9854; Kumar, Rahul/0000-0002-6927-5390	Breast Cancer Now and Cancer Research UK Programme; Science Foundation Ireland; Health Research Board; Wellcome Trust under the SFI-HRB-Wellcome Trust Biomedical Research Partnership [103049/Z/13/Z]; NHS; Cancer Research UK; British Columbia Cancer Agency Branch; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER	Breast Cancer Now and Cancer Research UK Programme; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board; Wellcome Trust under the SFI-HRB-Wellcome Trust Biomedical Research Partnership(Wellcome Trust); NHS; Cancer Research UK(Cancer Research UK); British Columbia Cancer Agency Branch; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by Breast Cancer Now and Cancer Research UK Programme Grants to CJL. CJR was a Sir Henry Wellcome Fellow jointly funded by Science Foundation Ireland, the Health Research Board and the Wellcome Trust (grant number 103049/Z/13/Z) under the SFI-HRB-Wellcome Trust Biomedical Research Partnership. We acknowledge NHS funding to the NIHR Biomedical Research Centre at the Royal Marsden Hospital. This study makes use of data generated by the Molecular Taxonomy of Breast Cancer International Consortium, which was funded by Cancer Research UK and the British Columbia Cancer Agency Branch. The results published here are based, in part, upon data generated by The Cancer Genome Atlas pilot project established by the NCI and NHGRI. Information about TCGA and the investigators and institutions who constitute the TCGA research network can be found at http://cancergenome.nih.gov/.	Asghar US, 2017, CLIN CANCER RES, V23, P5561, DOI 10.1158/1078-0432.CCR-17-0369; Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bernad R, 2006, J BIOL CHEM, V281, P19378, DOI 10.1074/jbc.M512585200; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Bouche L, 2017, J MED CHEM, V60, P4002, DOI 10.1021/acs.jmedchem.7b00306; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Campbell J, 2016, CELL REP, V14, P2490, DOI 10.1016/j.celrep.2016.02.023; Ceron J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-30; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen X, 2012, CANCER INFORM, V11, P147, DOI 10.4137/CIN.S9983; Choi W, 2017, EUR UROL, V72, P354, DOI 10.1016/j.eururo.2017.03.010; Chung D, 2015, BIOMOLECULES, V5, P2388, DOI 10.3390/biom5042388; Corney DC, 2008, ADV EXP MED BIOL, V622, P99, DOI 10.1007/978-0-387-68969-2_9; Crawford TD, 2016, J MED CHEM, V59, P5391, DOI 10.1021/acs.jmedchem.6b00264; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Ertel A, 2010, CELL CYCLE, V9, P4153, DOI 10.4161/cc.9.20.13454; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Goldhoff P, 2012, J NEUROPATH EXP NEUR, V71, P83, DOI 10.1097/NEN.0b013e31823fe8f1; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Haverty PM, 2016, NATURE, V533, P333, DOI 10.1038/nature17987; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; HIGASHIYAMA M, 1994, ONCOLOGY-BASEL, V51, P544; Ji P, 2004, MOL CELL, V16, P47, DOI 10.1016/j.molcel.2004.09.029; Jiang Z, 2011, CELL CYCLE, V10, P1563, DOI 10.4161/cc.10.10.15703; Johnson J, 2016, ONCOGENE, V35, P4829, DOI 10.1038/onc.2016.32; Jones RA, 2016, J CLIN INVEST, V126, P3739, DOI 10.1172/JCI81568; Knudsen ES, 2015, CELL CYCLE, V14, P109, DOI 10.4161/15384101.2014.967118; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lawrence RT, 2015, CELL REP, V11, P630, DOI 10.1016/j.celrep.2015.03.050; Lehmann BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157368; Li P, 2017, J CELL PHYSIOL, V232, P1246, DOI 10.1002/jcp.25696; Lin CY, 2002, CURR BIOL, V12, P2142, DOI 10.1016/S0960-9822(02)01389-1; Lingaraju GM, 2014, NATURE, V512, P161, DOI 10.1038/nature13566; Lord CJ, 2017, SCIENCE, V355, P1152, DOI 10.1126/science.aam7344; Lord CJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-38; Lu ZL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4463; Marcotte R, 2016, CELL, V164, P293, DOI 10.1016/j.cell.2015.11.062; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; McDonald ER, 2017, CELL, V170, P577, DOI 10.1016/j.cell.2017.07.005; Nittner D, 2012, NAT CELL BIOL, V14, P958, DOI 10.1038/ncb2556; Orjalo AV, 2006, MOL BIOL CELL, V17, P3806, DOI 10.1091/mbc.E05-11-1061; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson TJW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078641; Rodriguez-Bravo V, 2014, CELL, V156, P1017, DOI 10.1016/j.cell.2014.01.010; Russnes HG, 2017, AM J PATHOL, V187, P2152, DOI 10.1016/j.ajpath.2017.04.022; Schvartzman JM, 2011, CANCER CELL, V19, P701, DOI 10.1016/j.ccr.2011.04.017; Sdelci S, 2016, NAT CHEM BIOL, V12, P504, DOI 10.1038/nchembio.2080; Searle JS, 2010, ONCOTARGET, V1, P228; Semczuk A, 2000, PATHOL RES PRACT, V196, P41, DOI 10.1016/S0344-0338(00)80020-5; SHAO ZH, 1995, P NATL ACAD SCI USA, V92, P3115, DOI 10.1073/pnas.92.8.3115; Shao ZH, 1997, ONCOGENE, V15, P385, DOI 10.1038/sj.onc.1201204; Stefansson OA, 2011, EPIGENETICS-US, V6, P638, DOI 10.4161/epi.6.5.15667; Takada M, 2014, BREAST CANCER RES TR, V145, P143, DOI 10.1007/s10549-014-2907-9; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Trere D, 2009, ANN ONCOL, V20, P1818, DOI 10.1093/annonc/mdp209; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; Witkiewicz AK, 2012, CLIN CANCER RES, V18, P5110, DOI 10.1158/1078-0432.CCR-12-0903; Wu L, 2012, CHEM BIOL, V19, P1515, DOI 10.1016/j.chembiol.2012.09.015; Wu ZG, 2016, CELL BIOL INT, V40, P968, DOI 10.1002/cbin.10633; Xu XLL, 2014, NATURE, V514, P385, DOI 10.1038/nature13813; Zhao H, 2017, ONCOGENE, V36, P60, DOI 10.1038/onc.2016.175	68	20	21	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 25	2018	37	43					5701	5718		10.1038/s41388-018-0368-z	http://dx.doi.org/10.1038/s41388-018-0368-z			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GY1KL	29915391	Green Published, hybrid			2022-12-26	WOS:000448288200001
J	Leighton, PLA; Kanyo, R; Neil, GJ; Pollock, NM; Allison, WT				Leighton, Patricia L. A.; Kanyo, Richard; Neil, Gavin J.; Pollock, Niall M.; Allison, W. Ted			Prion gene paralogs are dispensable for early zebrafish development and have nonadditive roles in seizure susceptibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurodevelopment; zebrafish; prion disease; transcription activator-like effector nuclease; TALEN; PrPC; excitotoxicity; neurodegeneration; gene editing; neural hyperactivity; targeted mutagenesis	ALZHEIMERS-DISEASE; LATERAL-LINE; NEURITE OUTGROWTH; CELL-MIGRATION; PROTEIN; EXPRESSION; RECEPTOR; PRP; LACKING; MICE	Normally folded prion protein (PrPC) and its functions in healthy brains remain underappreciated compared with the intense study of its misfolded forms (prions, PrPSc) during the pathobiology of prion diseases. This impedes the development of therapeutic strategies in Alzheimer's and prion diseases. Disrupting the zebrafish homologs of PrPC has provided novel insights; however, mutagenesis of the zebrafish paralog prp2 did not recapitulate previous dramatic developmental phenotypes, suggesting redundancy with the prp1 paralog. Here, we generated zebrafish prp1 loss-of-function mutant alleles and dual prp1(-/-);prp2(-/-) mutants. Zebrafish prp1(-/-) and dual prp1(-/-);prp2(-/-) mutants resemble mammalian Prnp knockouts insofar as they lack overt phenotypes, which surprisingly contrasts with reports of severe developmental phenotypes when either prp1 or prp2 is knocked down acutely. Previous studies suggest that PrPC participates in neural cell development/adhesion, including in zebrafish where loss of prp2 affects adhesion and deposition patterns of lateral line neuromasts. In contrast with the expectation that prp1's functions would be redundant to prp2, they appear to have opposing functions in lateral line neurodevelopment. Similarly, loss of prp1 blunted the seizure susceptibility phenotypes observed in prp2 mutants, contrasting the expected exacerbation of phenotypes if these prion gene paralogs were serving redundant roles. In summary, prion mutant fish lack the overt phenotypes previously predicted, and instead they have subtle phenotypes similar to mammals. No evidence was found for functional redundancy in the zebrafish prion gene paralogs, and the phenotypes observed when each gene is disrupted individually are consistent with ancient functions of prion proteins in neurodevelopment and modulation of neural activity.	Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Univ Alberta, Ctr Prion & Prot Folding Dis, Edmonton, AB T6G 2E9, Canada	University of Alberta; University of Alberta	Allison, WT (corresponding author), Univ Alberta, Dept Biol Sci, CW Biol Sci Ctr 405, Edmonton, AB T6G 2E9, Canada.	ted.allison@ualberta.ca			Alberta Prion Research Institute-Alberta Innovates BioSolutions; Alzheimer Society of Alberta; Northwest Territories; Alzheimer Society of Canada; Alberta Innovates Health Solutions	Alberta Prion Research Institute-Alberta Innovates BioSolutions; Alzheimer Society of Alberta; Northwest Territories; Alzheimer Society of Canada; Alberta Innovates Health Solutions	This work was supported in part by operating grants from the Alberta Prion Research Institute-Alberta Innovates BioSolutions and the Alzheimer Society of Alberta and the Northwest Territories (to W. T. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by studentships from Alzheimer Society of Canada and Alberta Innovates Health Solutions.	Allison WT, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102223; Aman A, 2008, DEV CELL, V15, P749, DOI 10.1016/j.devcel.2008.10.002; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baraban SC, 2007, EPILEPSIA, V48, P1151, DOI 10.1111/j.1528-1167.2007.01075.x; Bayes A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14613; Bedell VM, 2011, BRIEF FUNCT GENOMICS, V10, P181, DOI 10.1093/bfgp/elr021; Benestad SL, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-87; Beraldo FH, 2011, FASEB J, V25, P265, DOI 10.1096/fj.10-161653; Bertani I, 2017, J NEUROSCI, V37, P10278, DOI 10.1523/JNEUROSCI.1301-17.2017; Bhinder G., 2012, NEUROMETHODS, P71; Brethour D, 2017, SCI REP-UK, V7, DOI 10.1038/srep40313; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carulla P, 2015, SCI REP-UK, V5, DOI 10.1038/srep11971; Cotto E, 2005, FEBS J, V272, P500, DOI 10.1111/j.1742-4658.2004.04492.x; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Daude N, 2012, PRION, V6, DOI 10.4161/pri.21867; Daude N, 2012, P NATL ACAD SCI USA, V109, P9035, DOI 10.1073/pnas.1202130109; deCarvalho TN, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00098; Ehsani S, 2012, PRION, V6, P317, DOI 10.4161/pri.20196; Ehsani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026800; Ehsani S, 2011, PROG NEUROBIOL, V93, P405, DOI 10.1016/j.pneurobio.2010.12.001; Fleisch VC, 2013, NEUROBIOL DIS, V55, P11, DOI 10.1016/j.nbd.2013.03.007; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Gompel N, 2001, MECH DEVELOP, V105, P69, DOI 10.1016/S0925-4773(01)00382-3; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Hernandez-Rapp J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04881; Huc-Brandt S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113331; Kaiser DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051305; Komiya Yuko, 2008, Organogenesis, V4, P68; Lauren J, 2014, J ALZHEIMERS DIS, V38, P227, DOI 10.3233/JAD-130950; Leighton PLA, 2018, BIOL OPEN, V7, DOI 10.1242/bio.025734; Leighton PLA, 2016, J ALZHEIMERS DIS, V54, P3, DOI 10.3233/JAD-160361; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Malaga-Trillo E, 2016, PRION, V10, P352, DOI 10.1080/19336896.2016.1221873; Malaga-Trillo E, 2011, BBA-MOL BASIS DIS, V1812, P402, DOI 10.1016/j.bbadis.2010.09.013; Malaga-Trillo E, 2009, PRION, V3, P129, DOI 10.4161/pri.3.3.9651; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Matsuda M, 2010, DEVELOPMENT, V137, P3477, DOI 10.1242/dev.052761; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Mehrabian M, 2016, ASN NEURO, V8, DOI 10.1177/1759091416679074; Mehrabian M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133741; Mehrabian M, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00053; Miesbauer M, 2006, BIOCHEM BIOPH RES CO, V341, P218, DOI 10.1016/j.bbrc.2005.12.168; Nourizadeh-Lillabadi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013573; Ochs K, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00063; Pantera B, 2009, J NEUROCHEM, V110, P194, DOI 10.1111/j.1471-4159.2009.06123.x; Parrie LE, 2018, DEV BIOL, V438, P23, DOI 10.1016/j.ydbio.2018.03.012; Reimann RR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005401; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; Rivera-Milla E, 2006, FASEB J, V20, P317, DOI 10.1096/fj.05-4279fje; Ryan NS, 2016, LANCET NEUROL, V15, P1326, DOI 10.1016/S1474-4422(16)30193-4; Salazar SV, 2017, BIOCHEM BIOPH RES CO, V483, P1143, DOI 10.1016/j.bbrc.2016.09.062; Salta E, 2014, VIRUSES-BASEL, V6, P4398, DOI 10.3390/v6114398; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Schmitt-Ulms G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007208; Schmitz M, 2014, MOL NEUROBIOL, V50, P923, DOI 10.1007/s12035-014-8655-3; Sempou E, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0076-5; Shum EY, 2016, CELL, V165, P382, DOI 10.1016/j.cell.2016.02.046; Singh S. K., 2010, J PROTEOM BIOINFORM, V3, P135, DOI DOI 10.4172/JPB.1000132; Solis GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070327; Solis GP, 2012, MOL BIOL CELL, V23, P1812, DOI 10.1091/mbc.E11-12-1006; Stainier DYR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007000; Striebel JF, 2013, PRION, V7, P280, DOI 10.4161/pri.25738; Suzuki T, 2002, BIOCHEM BIOPH RES CO, V294, P912, DOI 10.1016/S0006-291X(02)00546-6; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Villablanca EJ, 2006, DEV DYNAM, V235, P1578, DOI 10.1002/dvdy.20743; Vossel KA, 2017, LANCET NEUROL, V16, P311, DOI 10.1016/S1474-4422(17)30044-3; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wieser HG, 2006, CLIN NEUROPHYSIOL, V117, P935, DOI 10.1016/j.clinph.2005.12.007; Wulf MA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0375-5; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Young R, 2009, FEBS LETT, V583, P3296, DOI 10.1016/j.febslet.2009.09.027; Yu GH, 2009, MOL REPROD DEV, V76, P3, DOI 10.1002/mrd.20960; Zhang Y, 2013, DEV CELL, V24, P411, DOI 10.1016/j.devcel.2013.01.018	81	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12576	12592		10.1074/jbc.RA117.001171	http://dx.doi.org/10.1074/jbc.RA117.001171			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29903907	Green Published, hybrid			2022-12-26	WOS:000441408500022
J	Pourfarjam, Y; Ventura, J; Kurinov, I; Cho, A; Moss, J; Kim, IK				Pourfarjam, Yasin; Ventura, Jessica; Kurinov, Igor; Cho, Ahra; Moss, Joel; Kim, In-Kwon			Structure of human ADP-ribosyl-acceptor hydrolase 3 bound to ADP-ribose reveals a conformational switch that enables specific substrate recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation; conformational change; structural biology; substrate specificity; hydrolase; ARH3; PARP1	39-KDA POLY(ADP-RIBOSE) GLYCOHYDROLASE; PAR POLYMER; CELL-DEATH; PROTEIN; ADP-RIBOSYLHYDROLASE-3; PURIFICATION; COMPLEXES; MECHANISM; INSIGHTS; FEATURES	ADP-ribosyl-acceptor hydrolase 3 (ARH3) plays important roles in regulation of poly(ADP-ribosyl)ation, a reversible post-translational modification, and in maintenance of genomic integrity. ARH3 degrades poly(ADP-ribose) to protect cells from poly(ADP-ribose)-dependent cell death, reverses serine mono(ADP-ribosyl)ation, and hydrolyzes O-acetyl-ADP-ribose, a product of Sirtuin-catalyzed histone deacetylation. ARH3 preferentially hydrolyzes O-linkages attached to the anomeric C1 of ADP-ribose; however, how ARH3 specifically recognizes and cleaves structurally diverse substrates remains unknown. Here, structures of full-length human ARH3 bound to ADP-ribose and Mg2+, coupled with computational modeling, reveal a dramatic conformational switch from closed to open states that enables specific substrate recognition. The glutamate flap, which blocks substrate entrance to Mg2+ in the unliganded closed state, is ejected from the active site when substrate is bound. This closed-to-open transition significantly widens the substrate-binding channel and precisely positions the scissile 1-O-linkage for cleavage while securing tightly 2- and 3-hydroxyls of ADP-ribose. Our collective data uncover an unprecedented structural plasticity of ARH3 that supports its specificity for the 1-O-linkage in substrates and Mg2+-dependent catalysis.	[Pourfarjam, Yasin; Ventura, Jessica; Cho, Ahra; Kim, In-Kwon] Univ Cincinnati, Dept Chem, 301 Clifton Ct, Cincinnati, OH 45221 USA; [Kurinov, Igor] Cornell Univ, Dept Chem & Chem Biol, Northeastern Collaborat Access Team, Adv Photon Source NE CAT APS, Argonne, IL 60439 USA; [Moss, Joel] NHLBI, Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA	University System of Ohio; University of Cincinnati; Cornell University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kim, IK (corresponding author), Univ Cincinnati, Dept Chem, 301 Clifton Ct, Cincinnati, OH 45221 USA.	in-kwon.kim@uc.edu		Kim, In-Kwon/0000-0002-2779-9735	National Institutes of Health [P41 GM103403, S10OD021527]; United States Department of Energy [DE-AC02-06CH11357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work used NE-CAT beamlines (National Institutes of Health Grant P41 GM103403) and an Eiger 16M detector on 24-ID-E beam line (National Institutes of Health Grant S10OD021527) at the APS (United States Department of Energy Grant DE-AC02-06CH11357).	Abplanalp J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02253-1; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Beck C, 2014, EXP CELL RES, V329, P18, DOI 10.1016/j.yexcr.2014.07.003; Berthold CL, 2009, P NATL ACAD SCI USA, V106, P14247, DOI 10.1073/pnas.0905906106; Bieche I, 2013, INT J CANCER, V133, P2791, DOI 10.1002/ijc.28304; Bonfiglio JJ, 2017, MOL CELL, V65, P932, DOI 10.1016/j.molcel.2017.01.003; BRAUN SA, 1994, EUR J BIOCHEM, V220, P369, DOI 10.1111/j.1432-1033.1994.tb18633.x; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finch KE, 2012, ACS CHEM BIOL, V7, P563, DOI 10.1021/cb200506t; Fontana P, 2017, ELIFE, V6, DOI 10.7554/eLife.28533; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gottipati P, 2010, CANCER RES, V70, P5389, DOI 10.1158/0008-5472.CAN-09-4716; Hakme A, 2008, EMBO REP, V9, P1094, DOI 10.1038/embor.2008.191; HATAKEYAMA K, 1986, J BIOL CHEM, V261, P4902; Jankevicius G, 2013, NAT STRUCT MOL BIOL, V20, P508, DOI 10.1038/nsmb.2523; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kasamatsu A, 2011, J BIOL CHEM, V286, P21110, DOI 10.1074/jbc.M111.237636; Kim IK, 2015, J BIOL CHEM, V290, P3775, DOI 10.1074/jbc.M114.624718; Kim IK, 2012, NAT STRUCT MOL BIOL, V19, P653, DOI 10.1038/nsmb.2305; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Li XD, 2009, J MOL BIOL, V390, P737, DOI 10.1016/j.jmb.2009.05.031; Mashimo M, 2013, P NATL ACAD SCI USA, V110, P18964, DOI 10.1073/pnas.1312783110; Megnin-Chanet F, 2010, CELL MOL LIFE SCI, V67, P3649, DOI 10.1007/s00018-010-0490-8; MIWA M, 1974, J BIOL CHEM, V249, P3475; Mueller-Dieckmann C, 2006, P NATL ACAD SCI USA, V103, P15026, DOI 10.1073/pnas.0606762103; NORDLUND S, 1984, BIOCHIM BIOPHYS ACTA, V791, P21, DOI 10.1016/0167-4838(84)90276-0; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Ono T, 2006, P NATL ACAD SCI USA, V103, P16687, DOI 10.1073/pnas.0607911103; Ossovskaya V, 2010, GENES CANC, V1, P812, DOI 10.1177/1947601910383418; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palazzo L, 2018, ELIFE, V7, DOI 10.7554/eLife.34334; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Rojo F, 2012, ANN ONCOL, V23, P1156, DOI 10.1093/annonc/mdr361; Rosenthal F, 2013, NAT STRUCT MOL BIOL, V20, P502, DOI 10.1038/nsmb.2521; Sharifi R, 2013, EMBO J, V32, P1225, DOI 10.1038/emboj.2013.51; Slade D, 2011, NATURE, V477, P616, DOI 10.1038/nature10404; Tucker JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050889; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103	45	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12350	12359		10.1074/jbc.RA118.003586	http://dx.doi.org/10.1074/jbc.RA118.003586			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29907568	Green Published, hybrid			2022-12-26	WOS:000441408500004
J	Kowalski, E; Geng, S; Rathes, A; Lu, R; Li, LW				Kowalski, Elizabeth; Geng, Shuo; Rathes, Allison; Lu, Ran; Li, Liwu			Toll-interacting protein differentially modulates HIF1 and STAT5-mediated genes in fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast; inflammation; gene expression; innate immunity; signal transduction	AUTOPHAGIC CLEARANCE; INFLAMMATION; HYPOXIA; DISEASE; BINDING; MACROPHAGES; RESPONSES; ALPHA	Toll-interacting protein (Tollip) deficiency has been implicated in complex inflammatory and infectious diseases whose mechanisms are poorly understood. Comparing the gene expression profiles of WT and Tollip-deficient murine embryonic fibroblasts, we observed here that Tollip deficiency selectively reduces the expression of the inflammatory cytokines interleukin 6 (IL-6), IL-12, and tumor necrosis factor (TNF) but potentiates the expression of fatty acid-binding protein 4 (FABP4) in these cells. We also observed that expression of hypoxia-inducible factor 1- (HIF1) is reduced, whereas that of signal transducer and activator of transcription 5 (STAT5) is elevated, in Tollip-deficient cells, correlating with the decreased expression of inflammatory cytokines and increased expression of FABP4 in these cells. We further found that the coupling of ubiquitin to ER degradation (CUE) domain of Tollip is required for stimulating HIF1 activity, because Tollip CUE-domain mutant cells exhibited reduced levels of HIF1 and selected cytokines. Tollip is known to mediate autophagy and lysosome fusion, and herein we observed that Tollip's autophagy function is required for modulating STAT5 and FABP4 expression. Bafilomycin A, an inhibitor of lysosome fusion, enhanced STAT5 and FABP4 expression in WT fibroblasts, whereas torin 2, an activator of autophagy, reduced STAT5 and FABP4 expression in Tollip-deficient fibroblasts. Taken together, our study reveals that Tollip differentially modulates HIF1 and STAT5 expression in fibroblasts, potentially explaining the complex and context-dependent contribution of Tollip to disease development.	[Kowalski, Elizabeth; Geng, Shuo; Rathes, Allison; Lu, Ran; Li, Liwu] Virginia Tech, Dept Biol Sci & Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Li, LW (corresponding author), Virginia Tech, Dept Biol Sci, 162 Life Sci 1 Bldg,907 Washington St, Blacksburg, VA 24061 USA.	lwli@vt.edu	lu, ran/HHC-8613-2022		National Institutes of Health [R01 AI136386, HL115835]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI136386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants R01 AI136386 and HL115835 (to L.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agardh HE, 2013, J CELL MOL MED, V17, P303, DOI 10.1111/jcmm.12011; Andreasen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023999; Ankem G, 2011, BIOCHEM J, V435, P597, DOI 10.1042/BJ20102160; Baker B, 2015, J BIOL CHEM, V290, P6670, DOI 10.1074/jbc.M114.611442; Bertsch S, 2011, SHOCK, V35, P266, DOI 10.1097/SHK.0b013e3181fd068c; Chen KQ, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004078; Chen S, 2012, BRAIN PATHOL, V22, P110, DOI 10.1111/j.1750-3639.2011.00546.x; Chmiest D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13476; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Ferreira JV, 2013, AUTOPHAGY, V9, P1349, DOI 10.4161/auto.25190; Hu FL, 2014, ANN RHEUM DIS, V73, P928, DOI 10.1136/annrheumdis-2012-202444; Huang C, 2016, CLIN EXP ALLERGY, V46, P1549, DOI 10.1111/cea.12793; Hubbi ME, 2013, J BIOL CHEM, V288, P10703, DOI 10.1074/jbc.M112.414771; Jaber N, 2013, ANN NY ACAD SCI, V1280, P48, DOI 10.1111/nyas.12026; Kalliolias GD, 2010, J IMMUNOL, V185, P7047, DOI 10.4049/jimmunol.1001290; Kasivisvanathan V, 2011, CURR VASC PHARMACOL, V9, P333, DOI 10.2174/157016111795495602; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Li T, 2004, MOL IMMUNOL, V41, P85, DOI 10.1016/j.molimm.2004.03.009; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Maitra U, 2012, J IMMUNOL, V189, P1014, DOI 10.4049/jimmunol.1200857; Mitra S, 2013, J BIOL CHEM, V288, P25780, DOI 10.1074/jbc.M113.484170; Mizoguchi F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02892-y; Morris MC, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00680; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Richard AJ, 2014, BBA-MOL BASIS DIS, V1842, P431, DOI 10.1016/j.bbadis.2013.05.030; Ritter Mirko, 2005, J Inflamm (Lond), V2, P16, DOI 10.1186/1476-9255-2-16; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sohn C, 2015, ARTHRITIS RHEUMATOL, V67, P86, DOI 10.1002/art.38871; Spath GF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000381; Steen KA, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00282-16; Suojalehto H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127003; Watanabe Y, 2011, J CELL SCI, V124, P2692, DOI 10.1242/jcs.081232; Wolfe DM, 2013, EUR J NEUROSCI, V37, P1949, DOI 10.1111/ejn.12169; Xu HL, 2016, MOL ENDOCRINOL, V30, P325, DOI 10.1210/me.2015-1301; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	37	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12239	12247		10.1074/jbc.RA118.003382	http://dx.doi.org/10.1074/jbc.RA118.003382			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29921584	Green Published, hybrid			2022-12-26	WOS:000440803200021
J	Hughes-Austin, JM; Deane, KD; Giles, JT; Derber, LA; Zerbe, GO; Dabelea, DM; Sokolove, J; Robinson, WH; Holers, VM; Norris, JM				Hughes-Austin, Jan M.; Deane, Kevin D.; Giles, Jon T.; Derber, Lezlie A.; Zerbe, Gary O.; Dabelea, Dana M.; Sokolove, Jeremy; Robinson, William H.; Holers, V. Michael; Norris, Jill M.			Plasma adiponectin levels are associated with circulating inflammatory cytokines in autoantibody positive first-degree relatives of rheumatoid arthritis patients	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASES; CHEMOKINES	Background Extra-articular manifestations of rheumatoid arthritis (RA), potentially due to systemic inflammation, include cardiovascular disease and sarcopenic obesity. Adiponectin, an adipose- derived cytokine, has been implicated in inflammatory processes in RA, but little is known regarding its association with inflammation in a pre-clinical period. Therefore, we investigated whether adiponectin was associated with inflammatory markers in individuals at risk for RA, and whether RA-related autoimmunity modifies these associations. Methods We analyzed samples from 144 first-degree relatives (FDRs) of RA probands, of whom 23 were positive for anti-cyclic citrullinated peptide antibody and/or >= 2 rheumatoid factor isotypes (IgM, IgG or IgA). We called this phenotype the 'high risk autoantibody profile (HRP)' as it has been shown in prior work to be >96% specific for future RA. We measured adiponectin, cytokines, and high-sensitivity C-reactive protein (hsCRP). Using linear mixed effects models, we evaluated interaction between HRP positivity and adiponectin on inflammatory markers, adjusting for age, sex, ethnicity, body mass index, pack-years smoking, and use of cholesterol-lowering medications. Results In everyone, adiponectin concentration was inversely associated with hsCRP and IL-1 beta in adjusted models, where a 1% higher adiponectin was associated with a 26% lower hsCRP (p = 0.04) and a 26% lower IL-1 beta (p = 0.04). Significant interactions between HRP and adiponectin for associations with GM-CSF, IL-6, and IL-9 were detected in fully adjusted models (p = 0.0006, p = 0.006, p = 0.01, respectively). In HRP positive FDRs but not HRP negative FDRs, a 1% higher adiponectin was associated with 97% higher GM-CSF, 73% higher IL-6, and 54% higher IL-9 concentrations. Conclusions Adiponectin associates with inflammatory markers, and these associations differ in individuals with a high-risk autoantibody profile compared with those without. The interaction between adiponectin and autoimmunity warrants further investigation into the potential systemic effects of RA-related autoantibodies and adiponectin on inflammation in the absence of clinically apparent RA.	[Hughes-Austin, Jan M.] Univ Calif San Diego, Sch Med, Dept Orthopaed Surg, La Jolla, CA 92093 USA; [Deane, Kevin D.; Derber, Lezlie A.; Holers, V. Michael] Univ Colorado, Dept Rheumatol, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Giles, Jon T.] Columbia Univ, Coll Phys & Surg, Div Rheumatol, New York, NY USA; [Zerbe, Gary O.] Univ Colorado, Dept Biostat & Informat, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO USA; [Dabelea, Dana M.; Norris, Jill M.] Univ Colorado, Dept Epidemiol, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO USA; [Sokolove, Jeremy; Robinson, William H.] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Sokolove, Jeremy; Robinson, William H.] Stanford Univ, Sch Med, Div Immunol & Rheumatol, Stanford, CA 94305 USA	University of California System; University of California San Diego; University of Colorado System; University of Colorado Anschutz Medical Campus; Columbia University; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Hughes-Austin, JM (corresponding author), Univ Calif San Diego, Sch Med, Dept Orthopaed Surg, La Jolla, CA 92093 USA.	jhughesaustin@ucsd.edu		Hughes-Austin, Jan/0000-0002-7255-274X; Robinson, William/0000-0003-4385-704X	National Heart Lung and Blood Institute [K01 HL122394]; National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health [R01 AR051394]; ACR Research and Education Foundation Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign; Autoimmunity Prevention Center at the National Institutes of Health [U19 AI05086410]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL122394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI050864, U01AI101981] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); ACR Research and Education Foundation Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign; Autoimmunity Prevention Center at the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this research was made possible by grants from the National Heart Lung and Blood Institute (K01 HL122394) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR051394) at the National Institutes of Health, the ACR Research and Education Foundation Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign, and the Autoimmunity Prevention Center (U19 AI05086410) at the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella V, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/343746; Beltowski Jerzy, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P7, DOI 10.2174/187152908783884920; Chen XP, 2013, CYTOKINE GROWTH F R, V24, P83, DOI 10.1016/j.cytogfr.2012.07.004; Deane KD, 2010, ARTHRITIS RHEUM-US, V62, P3161, DOI 10.1002/art.27638; Deane KD, 2010, RHEUM DIS CLIN N AM, V36, P213, DOI 10.1016/j.rdc.2010.02.001; Hughes-Austin JM, 2013, ANN RHEUM DIS, V72, P901, DOI 10.1136/annrheumdis-2012-201505; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Kolfenbach JR, 2009, ARTHRIT RHEUM-ARTHR, V61, P1735, DOI 10.1002/art.24833; Neumann E, 2011, ARTHRITIS RHEUM-US, V63, P1159, DOI 10.1002/art.30291; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Senolt L, 2006, CYTOKINE, V35, P247, DOI 10.1016/j.cyto.2006.09.002; Sokolove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035296; Szodoray P, 2007, RHEUMATOLOGY, V46, P417, DOI 10.1093/rheumatology/kel306; Todd DJ, 2011, ARTHRITIS RHEUM-US, V63, P894, DOI 10.1002/art.30213; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233	16	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199578	10.1371/journal.pone.0199578	http://dx.doi.org/10.1371/journal.pone.0199578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940013	Green Published, Green Submitted, gold			2022-12-26	WOS:000436088700025
J	Shen, XQ; Bai, L; Cai, L; Cao, XS				Shen, Xiaoqin; Bai, Lin; Cai, Li; Cao, Xiaoshan			A geometric model for the human pulmonary valve in its fully open case	PLOS ONE			English	Article							HUMAN HEART; ANATOMY; CT	The human pulmonary valve, one of the key cardiac structures, plays an important role in circulatory system. However, there are few mathematical models to accurately simulate it. In this paper, we establish a geometric model of the normal human pulmonary valve from a mathematical perspective in the fully opening case. Based on the statistical data of the human pulmonary valves, we assume that the motions of the three cusps are symmetrical in the cardiac cycle. Thus, we first propose that each cusp is a part of the cylindrical shell according to its structure and physiological feature. The parameters for the pulmonary valve cusps in three-dimensional space are obtained by the fitting functions. We verify the accuracy of our results by comparing the areas of the pulmonary valve and pulmonary valve flap.	[Shen, Xiaoqin; Bai, Lin; Cao, Xiaoshan] Xian Univ Technol, Sch Sci, Xian 710054, Shaanxi, Peoples R China; [Shen, Xiaoqin; Cai, Li] Northwestern Polytech Univ, NPU UoG Int Cooperat Lab Computat & Applicat Card, Xian 710072, Shaanxi, Peoples R China; [Shen, Xiaoqin; Cai, Li] Chinese Acad Sci, State Key Lab Transducer Technol, Shanghai 200050, Peoples R China	Xi'an University of Technology; Northwestern Polytechnical University; Chinese Academy of Sciences	Shen, XQ (corresponding author), Xian Univ Technol, Sch Sci, Xian 710054, Shaanxi, Peoples R China.; Shen, XQ (corresponding author), Northwestern Polytech Univ, NPU UoG Int Cooperat Lab Computat & Applicat Card, Xian 710072, Shaanxi, Peoples R China.; Shen, XQ (corresponding author), Chinese Acad Sci, State Key Lab Transducer Technol, Shanghai 200050, Peoples R China.	xqshen@xaut.edu.cn	Li, Cai/Y-7599-2018	, Xiaoshan/0000-0003-2711-3921	National Natural Science Foundation of China [11571275, 11572244, 11471261]; Natural Science Foundation of Shaanxi Province [2018JM1014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province)	This paper is supported by National Natural Science Foundation of China (NO.11571275, 11572244, 11471261) and by the Natural Science Foundation of Shaanxi Province (NO. 2018JM1014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174834; Drake RL., 2014, GRAYS ANATOMY STUDEN, P569; Fan R, 2013, J BIOMECH, V46, P662, DOI 10.1016/j.jbiomech.2012.11.046; Grbic S, 2012, MED IMAGE ANAL, V16, P1003, DOI 10.1016/j.media.2012.02.003; Gross L, 1931, AM J PATHOL, V7, P0445; Joyce EM, 2009, ANN THORAC SURG, V87, P1240, DOI 10.1016/j.athoracsur.2008.12.049; Li Z, 1997, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V14, P115; MARON BJ, 1974, AM J PATHOL, V74, P331; Masoumi N., 2013, THESIS; Misfeld M, 2007, PHILOS T R SOC B, V362, P1421, DOI 10.1098/rstb.2007.2125; Naso F, 2011, ACTA BIOMATER, V7, P1728, DOI 10.1016/j.actbio.2010.11.030; Peng Liqing, 2012, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V29, P862; ROSS DN, 1967, LANCET, V2, P956; Saremi F, 2014, RADIOGRAPHICS, V34, P51, DOI 10.1148/rg.341135026; Shen XQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183362; Soares ALF, 2014, J MECH BEHAV BIOMED, V29, P557, DOI 10.1016/j.jmbbm.2013.07.009; Stamm C, 1998, J AM COLL CARDIOL, V31, P1420, DOI 10.1016/S0735-1097(98)00089-8; Stradins P, 2004, EUR J CARDIO-THORAC, V26, P634, DOI 10.1016/j.ejcts.2004.05.043; Sun W, 2014, ANNU REV BIOMED ENG, V16, P53, DOI 10.1146/annurev-bioeng-071813-104517; Yang C, 2003, J LUZHOU MED COLL, V26, P300	20	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199390	10.1371/journal.pone.0199390	http://dx.doi.org/10.1371/journal.pone.0199390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940008	Green Submitted, Green Published, gold			2022-12-26	WOS:000436088700014
J	de Freitas, MB; Moreira, EAM; Tomio, C; Moreno, YMF; Daltoe, FP; Barbosa, E; Neto, NL; Buccigrossi, V; Guarino, A				de Freitas, Maiara Brusco; Machado Moreira, Emilia Addison; Tomio, Camila; Franco Moreno, Yara Maria; Daltoe, Felipe Perozzo; Barbosa, Eliana; Neto, Norberto Ludwig; Buccigrossi, Vittoria; Guarino, Alfredo			Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis	PLOS ONE			English	Article							FECAL MICROBIOTA; GUT MICROBIOTA; INFECTION; BIFIDOBACTERIA; DYSBIOSIS; DISEASE; HEALTH; GROWTH	The aim of the present study was to evaluate the effect of cystic fibrosis and antibiotic therapy on intestinal microbiota composition and intestinal inflammation in children and adolescents. A cross-sectional controlled study was conducted with 36 children and adolescents: 19 in the cystic fibrosis group (CFG) and 17 in the control group (CG) matched for age and sex. The CFG was subdivided based on the use of antibiotic therapy (CFAB group) and non-use of antibiotic therapy (CFnAB group). The following data were evaluated: colonization, antibiotic therapy, mutation, breastfeeding, use of infant formula, type of delivery, introduction of solid foods, body mass index, fecal calprotectin and intestinal microbiota composition (fluorescence in situ hybridization). Intestinal inflammation evaluated by fecal calprotectin was significantly higher in the CFG (median: 40.80 mu g/g, IQR: 19.80 +/- 87.10, p = 0.040) and CFAB group (median: 62.95 mu g/g, IQR: 21.80 +/- 136.62, p = 0.045) compared to the CG (median: 20.15 mu g/g, IQR: 16.20 +/- 31.00), and the Bacteroides, Firmicutes, Eubacterium rectale and Faecalibacterium prausnitzii were significantly decreased (p < 0.05) in the CFG compared to the CG, whereas the bacteria Clostridium difficile, Escherichia coli and Pseudomonas aeruginosa were significantly increased in the CFG (p < 0.05). The main differences were found between the CG and CFAB group for Eubacterium rectale (p = 0.006), Bifidobacterium (p = 0.017), Escherichia coli (p = 0.030), Firmicutes (p = 0.002), Pseudomonas aeruginosa (p < 0.001) and Clostridium difficile (p = 0.006). The results of this study confirm intestinal inflammation in patients with CF, which may be related to changes in the composition of the intestinal microbiota.	[de Freitas, Maiara Brusco; Machado Moreira, Emilia Addison; Tomio, Camila] Univ Fed Santa Catarina, Grad Program Nutr, Florianopolis, SC, Brazil; [Franco Moreno, Yara Maria] Univ Fed Santa Catarina, Dept Nutr, Grad Program Nutr, Florianopolis, SC, Brazil; [Daltoe, Felipe Perozzo] Univ Fed Santa Catarina, Dept Pathol, Florianopolis, SC, Brazil; [Barbosa, Eliana; Neto, Norberto Ludwig] Joana de Gusmao Childrens Hosp, Florianopolis, SC, Brazil; [Buccigrossi, Vittoria; Guarino, Alfredo] Univ Naples Federico II, Dept Translat Med Sci, Sect Pediat, Naples, Italy	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); University of Naples Federico II	Moreira, EAM (corresponding author), Univ Fed Santa Catarina, Grad Program Nutr, Florianopolis, SC, Brazil.	emilia.moreira@ufsc.br	Guarino, Alfredo/AAC-4812-2022; Buccigrossi, Vittoria/AAA-1226-2020	Guarino, Alfredo/0000-0003-0199-0336; Daltoe, Felipe/0000-0002-3077-4600; Addison Machado Moreira, Emilia/0000-0002-9060-2288	National Council for Scientific and Technological Development (CNPq) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [471197/2013-0]; Programa de Bolsas de Estudo da Educacao Superior de Santa Catarina (UNIEDU);  [304281/2012-3]	National Council for Scientific and Technological Development (CNPq) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Programa de Bolsas de Estudo da Educacao Superior de Santa Catarina (UNIEDU); 	We thank the National Council for Scientific and Technological Development (CNPq) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for their financial support (#471197/2013-0) and scholarships for EAMM (#304281/2012-3); Programa de Bolsas de Estudo da Educacao Superior de Santa Catarina (UNIEDU) for scholarships to MBF.	[Anonymous], 1995, PHYS STAT UINT ANT; Azad MB, 2016, BJOG-INT J OBSTET GY, V123, P983, DOI 10.1111/1471-0528.13601; Berrington JE, 2013, ARCH DIS CHILD-FETAL, V98, pF286, DOI 10.1136/archdischild-2012-302134; Borowitz D, 2002, J PEDIATR GASTR NUTR, V35, P246, DOI 10.1097/00005176-200209000-00004; Bruzzese E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087796; Burke DG, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0968-8; Burke DG, 2017, J CYST FIBROS, V16, P291, DOI 10.1016/j.jcf.2016.09.008; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; De Lisle RC, 2013, COLD SPRING HARB PER, V3; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dhaliwal J, 2015, J PEDIATR GASTR NUTR, V60, P521, DOI 10.1097/MPG.0000000000000683; Duytschaever G, 2013, J CYST FIBROS, V12, P206, DOI 10.1016/j.jcf.2012.10.003; Duytschaever G, 2011, APPL ENVIRON MICROB, V77, P8015, DOI 10.1128/AEM.05933-11; Fagerberg UL, 2003, J PEDIATR GASTR NUTR, V37, P468, DOI 10.1097/00005176-200310000-00013; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Hawrelak Jason A, 2004, Altern Med Rev, V9, P180; Hoffman LR, 2014, CLIN INFECT DIS, V58, P396, DOI 10.1093/cid/cit715; Hussain SZ, 2004, DIGEST DIS SCI, V49, P116, DOI 10.1023/B:DDAS.0000011612.74033.78; Kerckhoffs APM, 2011, J MED MICROBIOL, V60, P236, DOI 10.1099/jmm.0.022848-0; Lahiri T, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1784; Lee JM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/948367; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Lynch SV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009738; Lynch SV, 2013, GUT MICROBES, V4, P41, DOI 10.4161/gmic.22430; Madan JC, 2012, MBIO, V3, DOI 10.1128/mBio.00251-12; Miragoli F, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fiw230; Norkina O, 2004, INFECT IMMUN, V72, P6040, DOI 10.1128/IAI.72.10.6040-6049.2004; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pannaraj PS, 2017, JAMA PEDIATR, V171, P647, DOI 10.1001/jamapediatrics.2017.0378; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Pereira LCR, 2014, LIFE SCI, V109, P30, DOI 10.1016/j.lfs.2014.06.002; Rautava S, 2012, NAT REV GASTRO HEPAT, V9, P565, DOI 10.1038/nrgastro.2012.144; Russell DA, 2011, INT J FOOD MICROBIOL, V149, P88, DOI 10.1016/j.ijfoodmicro.2011.06.003; Schippa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061176; Swidsinski A, 2008, GASTROENTEROLOGY, V135, P568, DOI 10.1053/j.gastro.2008.04.017; Weiss B, 2010, PEDIATR PULM, V45, P536, DOI 10.1002/ppul.21138; Yasmin F, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00200; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	38	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0198457	10.1371/journal.pone.0198457	http://dx.doi.org/10.1371/journal.pone.0198457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933382	gold, Green Submitted, Green Published			2022-12-26	WOS:000436076600010
J	Lee, H; Hwang, SI; Lee, HJ; Byun, SS; Lee, SE; Hong, SK				Lee, Hakmin; Hwang, Sung Il; Lee, Hak Jong; Byun, Seok-Soo; Lee, Sang Eun; Hong, Sung Kyu			Diagnostic performance of diffusion-weighted imaging for prostate cancer: Peripheral zone versus transition zone	PLOS ONE			English	Article							PI-RADS V2; ACTIVE SURVEILLANCE; DATA SYSTEM; HYPERPLASIA; BIOPSY; GRADE; AGGRESSIVENESS; FEATURES; MRI	Objectives Diffusion-weighted imaging (DWI) has been shown to be an important component of multiparametric magnetic resonance imaging (mpMRI). We compared performance of DWI for detection of prostate cancer (PCa) in peripheral zone (PZ) and transition zone (TZ) of prostate. Materials and methods We reviewed data of 460 subjects who underwent preoperative 3.0-Tesla mpMRI and subsequently radical prostatectomy. Level of suspicion for PCa was graded using 5-grade Likert-scale from DWI. Topographic analyses were performed for location of tumor foci at each surgical specimen. Among those with DWI grade >= III, we analyzed concordance rate on the location of radiologic and pathologic index lesions between DWI and surgical specimens. Results Among 460 patients, 351 (76.3%) patients showed suspicious DWI lesions (57.5% in PZ, 42.5% in TZ). Multivariates regression analyses revealed significant associations between high DWI grade and adverse pathologic outcomes including pathologic stage, Gleason score, tumor volume and extracapsular extension (all p < 0.05). Overall concordance rates between DWI and surgical specimen were 75.8%, significantly higher in PZ than TZ (82.2% vs. 67.1% p = 0.002). Such concordance rate showed a positive linear association with increase in DWI grading (p < 0.001). Among 109 patients with DWI grade I-II, 28 (25.7%) harbored high grade disease (pathologic Gleason score >= 4 + 3). Conclusions DWI detects tumors in PZ of prostate more accurately than those in TZ. Such accuracy of DWI was shown to be more evident with higher DWI grade. Meanwhile, a negative DWI did not guarantee absence of high grade PCa.	[Lee, Hakmin; Byun, Seok-Soo; Lee, Sang Eun; Hong, Sung Kyu] Seoul Natl Univ, Bundang Hosp, Dept Urol, Seongnam, South Korea; [Hwang, Sung Il; Lee, Hak Jong] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam, South Korea; [Hwang, Sung Il; Lee, Hak Jong] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Byun, Seok-Soo; Lee, Sang Eun; Hong, Sung Kyu] Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Hong, SK (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Urol, Seongnam, South Korea.; Hong, SK (corresponding author), Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea.	skhong@snubh.org		Hong, Sung Kyu/0000-0002-8344-6774; Hwang, Sung Il/0000-0001-7516-5369				Akin O, 2006, RADIOLOGY, V239, P784, DOI 10.1148/radiol.2392050949; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Baur ADJ, 2014, INVEST RADIOL, V49, P411, DOI 10.1097/RLI.0000000000000030; Benndorf M, 2017, EUR J RADIOL, V93, P9, DOI 10.1016/j.ejrad.2017.05.015; Branger N, 2017, BJU INT, V119, P449, DOI 10.1111/bju.13657; Choi YJ, 2007, RADIOGRAPHICS, V27, P63, DOI 10.1148/rg.271065078; Coakley FV, 2017, J AM COLL RADIOL, V14, pS245, DOI 10.1016/j.jacr.2017.02.026; DEERING RE, 1995, PROSTATE, V26, P111, DOI 10.1002/pros.2990260302; Hambrock T, 2011, RADIOLOGY, V259, P453, DOI 10.1148/radiol.11091409; ISHIDA J, 1994, RADIOLOGY, V190, P329, DOI 10.1148/radiology.190.2.7506836; Jeong CW, 2014, PROSTATE INT, V2, P169, DOI 10.12954/PI.14057; Kasel-Seibert M, 2016, EUR J RADIOL, V85, P726, DOI 10.1016/j.ejrad.2016.01.011; Kim K, 2016, SCI REP-UK, V6, DOI 10.1038/srep36781; Langer DL, 2010, RADIOLOGY, V255, P485, DOI 10.1148/radiol.10091343; Le JD, 2015, EUR UROL, V67, P569, DOI 10.1016/j.eururo.2014.08.079; Lee DH, 2013, KOREAN J UROL, V54, P229, DOI 10.4111/kju.2013.54.4.229; Moosavi B, 2016, CLIN RADIOL, V71, P405, DOI 10.1016/j.crad.2016.01.002; Oto A, 2010, RADIOLOGY, V257, P715, DOI 10.1148/radiol.10100021; Pokorny MR, 2014, EUR UROL, V66, P22, DOI 10.1016/j.eururo.2014.03.002; Polanec S, 2016, EUR J RADIOL, V85, P1125, DOI 10.1016/j.ejrad.2016.03.025; Qayyum A, 2009, RADIOGRAPHICS, V29, P1797, DOI 10.1148/rg.296095521; Scheenen TWJ, 2015, INVEST RADIOL, V50, P594, DOI 10.1097/RLI.0000000000000163; Schieda N, 2015, EUR J RADIOL, V84, P1843, DOI 10.1016/j.ejrad.2015.06.016; Vargas HA, 2011, RADIOLOGY, V259, P775, DOI 10.1148/radiol.11102066; Verma S, 2011, AM J ROENTGENOL, V196, P374, DOI 10.2214/AJR.10.4441; Weinreb JC, 2016, EUR UROL, V69, P16, DOI 10.1016/j.eururo.2015.08.052; Wysock JS, 2016, BJU INT, V118, P515, DOI 10.1111/bju.13427; Yoo S, 2015, KOREAN J UROL, V56, P487, DOI 10.4111/kju.2015.56.7.487	28	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199636	10.1371/journal.pone.0199636	http://dx.doi.org/10.1371/journal.pone.0199636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933396	gold, Green Submitted, Green Published			2022-12-26	WOS:000436076600038
J	de Sa, A; Hart, DA; Khan, K; Scott, A				de Sa, Agnetha; Hart, David A.; Khan, Karim; Scott, Alexander			Achilles tendon structure is negatively correlated with body mass index, but not influenced by statin use: A cross-sectional study using ultrasound tissue characterization	PLOS ONE			English	Article							SERUM-CHOLESTEROL; TENDINOPATHY; RISK	Introduction Statins are widely used to inhibit cholesterol production in the liver among people with hyper-cholesterolemia. A recent epidemiological study in the UK has shown that statin use (unlike elevated BMI) is not associated with an increased risk of Achilles tendon rupture. However, because of laboratory reports suggesting a negative influence of statins on tenocyte metabolism, we decided to directly compare the Achilles tendon structure (cross-sectional area and longitudinal collagen organization) in regular statin users compared to non-users. Methods We conducted ultrasound tissue characterization (UTC) of the Achilles tendon in statin users and a comparison group of similar age and gender. Statin users and control participants were recruited from May 10 2015 to February 17 2017 through a cardiovascular health centre and from the general community. Cross-sectional area of the Achilles tendon and longitudinal collagen organization (% type I echoes) were assessed using quantitative ultrasound tissue characterization by a blinded observer at a predetermined location (2 cm proximal to the calcaneus). Results Sixty-six individuals who were either taking statins for at least one year (ST, n = 33) or a comparison group who had never taken statins (CG, n = 33) were included in the study. The Achilles tendon cross-sectional area (ST 59.7 (13) mm(2), CG 59.9 (8.5) mm(2)) and proportion of echo-type I patterns [ST 70 (10)%, CG 74 (13)%] were equivalent in the two groups. In contrast, there was a negative correlation between BMI (r(s) = -0.25, p = 0.042) and type I echo values. Obese individuals demonstrated a significantly lower percentage of type I echoes (62 (11)%) than individuals of normal body mass index (73 (10)% p<0.05). Conclusion These findings demonstrate that there is no evidence of a negative statin influence on Achilles tendon structure. Given earlier reports that the risk of Achilles injury is equivalent in statin users and non-users, weightbearing exercise may be prescribed without placing the Achilles tendon at a higher risk of injury than among the general population. The results of this study are consistent with the known negative effects of elevated BMI on tendon structure, suggesting that an assessment of the Achilles tendons prior to prescribing weightbearing exercise may be prudent in obese individuals.	[de Sa, Agnetha; Khan, Karim; Scott, Alexander] Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [de Sa, Agnetha] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Hart, David A.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Khan, Karim] Univ British Columbia, Dept Family Practice, Vancouver, BC, Canada; [Scott, Alexander] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada	Vancouver Coastal Health Research Institute; University of British Columbia; University of Calgary; University of British Columbia; University of British Columbia	Scott, A (corresponding author), Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada.; Scott, A (corresponding author), Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada.	ascott@mail.ubc.ca		Scott, Alex/0000-0003-0366-8404	Michael Smith Foundation for Health Research	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	Alex Scott received salary support from the Michael Smith Foundation for Health Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, PHYS STATUS USE INTE; Chazerain P, 2001, JOINT BONE SPINE, V68, P430, DOI 10.1016/S1297-319X(01)00300-1; Claessen FMAP, 2014, SPORTS MED, V44, P1241, DOI 10.1007/s40279-014-0200-z; de Jonge S, 2015, BRIT J SPORT MED, V49, P995, DOI 10.1136/bjsports-2014-093696; de Oliveira LP, 2013, TOXICOLOGY, V311, P162, DOI 10.1016/j.tox.2013.06.010; Eliasson P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172797; Forsen L, 2010, SPORTS MED, V40, P601, DOI 10.2165/11531350-000000000-00000; Ganestam A, 2016, KNEE SURG SPORT TR A, V24, P3730, DOI 10.1007/s00167-015-3544-5; Grewal N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114214; Kolovou G, 2004, ANGIOLOGY, V55, P335, DOI 10.1177/000331970405500314; Kuzma-Kuzniarska M, 2015, J CELL PHYSIOL, V230, P2543, DOI 10.1002/jcp.25010; Marie I, 2008, ARTHRIT RHEUM-ARTHR, V59, P367, DOI 10.1002/art.23309; McAuliffe S, 2016, BRIT J SPORT MED, V50, P1516, DOI 10.1136/bjsports-2016-096288; Rosengarten SD, 2015, BRIT J SPORT MED, V49, P183, DOI 10.1136/bjsports-2013-092713; Scott A, 2015, BRIT J SPORT MED, V49, P984, DOI 10.1136/bjsports-2014-093989; Scott Ryan T, 2013, Foot Ankle Spec, V6, P283, DOI 10.1177/1938640013490019; Silsbury Z, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008430; Spoendlin J, 2016, DRUG SAFETY, V39, P1229, DOI 10.1007/s40264-016-0462-5; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Thompson PD, 2016, J AM COLL CARDIOL, V67, P2395, DOI 10.1016/j.jacc.2016.02.071; Tilley BJ, 2015, BRIT J SPORT MED, V49, P1504, DOI 10.1136/bjsports-2015-095100; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Wasfy MM, 2016, CIRCULATION, V133, P2297, DOI 10.1161/CIRCULATIONAHA.116.018093; Waugh CM, 2018, SCAND J MED SCI SPOR, V28, P436, DOI 10.1111/sms.12930; Wezenbeek E, 2017, SCAND J MED SCI SPOR, V27, P746, DOI 10.1111/sms.12706; Wynter Bee W, BR J SPORTS MED	27	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199645	10.1371/journal.pone.0199645	http://dx.doi.org/10.1371/journal.pone.0199645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928054	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500118
J	Lehnen, L; Schorcht, W; Karst, I; Biedermann, M; Kerth, G; Puechmaille, SJ				Lehnen, Lisa; Schorcht, Wigbert; Karst, Inken; Biedermann, Martin; Kerth, Gerald; Puechmaille, Sebastien J.			Using Approximate Bayesian Computation to infer sex ratios from acoustic data	PLOS ONE			English	Article							BATS RHINOLOPHUS-HIPPOSIDEROS; POPULATION-GENETICS; ECHOLOCATION CALLS; HABITAT USE; CONSERVATION; IDENTIFICATION; SIZE; AGE; DIVERGENCE; SPECIATION	Population sex ratios are of high ecological relevance, but are challenging to determine in species lacking conspicuous external cues indicating their sex. Acoustic sexing is an option if vocalizations differ between sexes, but is precluded by overlapping distributions of the values of male and female vocalizations in many species. A method allowing the inference of sex ratios despite such an overlap will therefore greatly increase the information extractable from acoustic data. To meet this demand, we developed a novel approach using Approximate Bayesian Computation (ABC) to infer the sex ratio of populations from acoustic data. Additionally, parameters characterizing the male and female distribution of acoustic values (mean and standard deviation) are inferred. This information is then used to probabilistically assign a sex to a single acoustic signal. We furthermore develop a simpler means of sex ratio estimation based on the exclusion of calls from the overlap zone. Applying our methods to simulated data demonstrates that sex ratio and acoustic parameter characteristics of males and females are reliably inferred by the ABC approach. Applying both the ABC and the exclusion method to empirical datasets (echolocation calls recorded in colonies of lesser horseshoe bats, Rhinolophus hipposideros) provides similar sex ratios as molecular sexing. Our methods aim to facilitate evidence-based conservation, and to benefit scientists investigating ecological or conservation questions related to sex- or group specific behaviour across a wide range of organisms emitting acoustic signals. The developed methodology is non-invasive, low-cost and time-efficient, thus allowing the study of many sites and individuals. We provide an R-script for the easy application of the method and discuss potential future extensions and fields of applications. The script can be easily adapted to account for numerous biological systems by adjusting the type and number of groups to be distinguished (e.g. age, social rank, cryptic species) and the acoustic parameters investigated.	[Lehnen, Lisa; Kerth, Gerald; Puechmaille, Sebastien J.] Ernst Moritz Arndt Univ Greifswald, Zool Inst & Museum, Appl Zool & Nat Conservat, Greifswald, Germany; [Schorcht, Wigbert; Karst, Inken; Biedermann, Martin] NACHTakt Biologists Bat Res GbR, Erfurt, Germany	Ernst Moritz Arndt Universitat Greifswald	Puechmaille, SJ (corresponding author), Ernst Moritz Arndt Univ Greifswald, Zool Inst & Museum, Appl Zool & Nat Conservat, Greifswald, Germany.	s.puechmaille@gmail.com	Lehnen, Lisa/AAC-9019-2019; Puechmaille, Sebastien/D-1612-2010	Lehnen, Lisa/0000-0002-2481-7344; Puechmaille, Sebastien/0000-0001-9517-5775	RTG 2010 Research Training Programme (Deutsche Forschungsgemeinschaft, German Science Foundation DFG); Deutsche Bundesstiftung Umwelt DBU (German Federal Environmental Foundation) [AZ3186-45]; Bundesinstitut fur Bau-, Stadtund Raumforschung BBSR (Federal Institute for Research on Building, Urban Affairs, and Spatial Development) [AZ WD-10.08.18.7-14.23]; NACHTaktiv; Eric Petit	RTG 2010 Research Training Programme (Deutsche Forschungsgemeinschaft, German Science Foundation DFG)(German Research Foundation (DFG)); Deutsche Bundesstiftung Umwelt DBU (German Federal Environmental Foundation); Bundesinstitut fur Bau-, Stadtund Raumforschung BBSR (Federal Institute for Research on Building, Urban Affairs, and Spatial Development); NACHTaktiv; Eric Petit	LL was funded by a PhD position in the framework of the RTG 2010 Research Training Programme (Deutsche Forschungsgemeinschaft, German Science Foundation DFG; http://www.dfg.del/; grant awarded to SJP, GK). Additional financial support was provided by the Deutsche Bundesstiftung Umwelt DBU (https://www.dbu.de/; German Federal Environmental Foundation,AZ3186-45) and the Bundesinstitut fur Bau-, Stadtund Raumforschung BBSR (http://www.bbsr.bund.de/; Federal Institute for Research on Building, Urban Affairs, and Spatial Development, AZ WD-10.08.18.7-14.23), both awarded to IK, WS, MB. Three of the authors are employees of NACHTaktiv, an environmental consultancy involved in bat monitoring and impact assessment studies for bats. NACHTaktiv provided support in the form of salaries for authors WS, IK, MB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Eric Petit for providing support and facilities, Anne-Laure Besnard and Pierre-Loup Jan for their help with the genetic analyses, Bernadette Wimmer for discussions concerning acoustic sex determination in Rhip, Johannes Rehhausen for help with the Anabat acoustic processing, volunteers of the Interessengemeinschaft fur Fledermausschutz und-forschung Thuringen e.V. who facilitated data collection and Serena Dool for proofreading the manuscript.	Ancillotto L, 2017, MAMMAL REV, V47, P6, DOI 10.1111/mam.12076; Andrews MM, 2017, ACTA CHIROPTEROL, V19, P161, DOI 10.3161/15081109ACC2017.19.1.013; Angulo A, 2008, ZOOL J LINN SOC-LOND, V152, P59, DOI 10.1111/j.1096-3642.2007.00338.x; Aubin T, 2007, POLAR BIOL, V30, P1027, DOI 10.1007/s00300-007-0262-6; Azam C, 2016, LANDSCAPE ECOL, V31, P2471, DOI 10.1007/s10980-016-0417-3; Barataud M, 2012, ECOLOGIE ACOUSTIQUE; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bontadina F, 2002, J ZOOL, V258, P281, DOI 10.1017/S0952836902001401; Boston ESM, 2012, ACTA CHIROPTEROL, V14, P45, DOI 10.3161/150811012X654259; Brigham R., 2004, BAT ECHOLOCATION RES; Charlton BD, 2009, ANIM BEHAV, V78, P893, DOI 10.1016/j.anbehav.2009.06.029; Chesmore ED, 2004, B ENTOMOL RES, V94, P319, DOI 10.1079/BER2004306; Colafrancesco KC, 2016, SPRINGER HANDB AUDIT, V53, P51, DOI 10.1007/978-3-319-27721-9_3; Colleye O, 2009, J FISH BIOL, V75, P908, DOI 10.1111/j.1095-8649.2009.02316.x; Covarrubias-Pazaran G, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0365-6; Cvikel N, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2274; Dool SE, 2016, ACTA CHIROPTEROL, V18, P377, DOI 10.3161/15081109ACC2016.18.2.006; Fischer J, 2004, BEHAV ECOL SOCIOBIOL, V56, P140, DOI 10.1007/s00265-003-0739-4; Francis Charles M., 1998, P169; Gaisler J., 1963, Vestnik Ceskoslovenske Zoologicke Spolecnosti, V27, P211; Gannon DP, 2008, T AM FISH SOC, V137, P638, DOI 10.1577/T04-142.1; Gillam E, 2016, SPRINGER HANDB AUDIT, V54, P117, DOI 10.1007/978-1-4939-3527-7_5; Gotze S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30978; Griffiths ET, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156578; Harris SA, 2016, METHODS ECOL EVOL, V7, P713, DOI 10.1111/2041-210X.12527; Heinicke S, 2015, METHODS ECOL EVOL, V6, P753, DOI 10.1111/2041-210X.12384; Henry CS, 2014, SYST ENTOMOL, V39, P380, DOI 10.1111/syen.12061; Hughes AC, 2010, ACTA CHIROPTEROL, V12, P311, DOI 10.3161/150811010X537891; Issel W., 1950, Zoologische Jahrbuecher Jena Systematik, V79, P71; Jabot F., 2015, EASYABC EFFICIENT AP; Jiang TL, 2015, INTEGR ZOOL, V10, P241, DOI 10.1111/1749-4877.12129; JONES G, 1992, MAMMALIA, V56, P189; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Jones G, 1997, ADV STUD BEHAV, V26, P317, DOI 10.1016/S0065-3454(08)60383-6; Kalcounis-Rueppell Matina C, 2006, Front Zool, V3, P3, DOI 10.1186/1742-9994-3-3; Kingston T, 2001, P ROY SOC B-BIOL SCI, V268, P1381, DOI 10.1098/rspb.2001.1630; Kloepper LN, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160022; Kruschke J. K., 2015, DOING BAYESIAN DATA, V2nd, DOI 10.1016/B978-0-12-405888-0.00010-6; Ladich F, 2015, SOUND COMMUNICATION; Laiolo P, 2001, CONDOR, V103, P287, DOI 10.1650/0010-5422(2001)103[0287:GVITCO]2.0.CO;2; Laiolo P, 2010, BIOL CONSERV, V143, P1635, DOI 10.1016/j.biocon.2010.03.025; Lenormand M, 2013, COMPUTATION STAT, V28, P2777, DOI 10.1007/s00180-013-0428-3; LEONARD ML, 1995, ANIM BEHAV, V49, P1283, DOI 10.1006/anbe.1995.0160; Lopez-Baucells A, 2018, BIOACOUSTICS, V27, P341, DOI 10.1080/09524622.2017.1357145; Maluleke T, 2017, ECOL EVOL, V7, P7347, DOI 10.1002/ece3.3251; Marcoux M, 2017, POLAR BIOL, V40, P1127, DOI 10.1007/s00300-016-2040-9; Marques TA, 2013, BIOL REV, V88, P287, DOI 10.1111/brv.12001; Morinha F, 2012, THERIOGENOLOGY, V78, P703, DOI 10.1016/j.theriogenology.2012.04.015; Peake TM, 1998, IBIS, V140, P120, DOI 10.1111/j.1474-919X.1998.tb04548.x; Pellet J, 2005, BIOL CONSERV, V123, P27, DOI 10.1016/j.biocon.2004.10.005; Puechmaille SJ, 2007, ACTA CHIROPTEROL, V9, P269, DOI 10.3161/1733-5329(2007)9[269:GDFBD]2.0.CO;2; Puechmaille SJ, 2007, J APPL ECOL, V44, P843, DOI 10.1111/j.1365-2664.2007.01321.x; Puechmaille SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103452; Puechmaille SJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1582; R Development Core Team, 2017, R LANG ENV STAT COMP; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Safi K, 2007, BIOL CONSERV, V137, P28, DOI 10.1016/j.biocon.2007.01.011; Schuchmann M, 2012, ACTA CHIROPTEROL, V14, P161, DOI 10.3161/150811012X654376; Scrucca L, 2016, R J, V8, P289; Simon M, 2010, J MAR BIOL ASSOC UK, V90, P1539, DOI 10.1017/S0025315409991226; Thomas JA, 2004, ECHOLOCATION BATS DO; Volodin IA, 2015, AVIAN RES, V6, DOI 10.1186/s40657-015-0033-y; Walters CL, 2012, J APPL ECOL, V49, P1064, DOI 10.1111/j.1365-2664.2012.02182.x; Wedekind C., 2012, TOPICS CONSERVATION, P81, DOI [10.5772/37601, DOI 10.5772/37601]; Whitby MD, 2014, ACTA CHIROPTEROL, V16, P223, DOI 10.3161/150811014X683417; Wimmer B, 2017, AKUSTISCHE ERFASSUNG; Wimmer J, 2013, ECOL APPL, V23, P1419, DOI 10.1890/12-2088.1; Wrege PH, 2017, METHODS ECOL EVOL, V8, P1292, DOI 10.1111/2041-210X.12730; Zamora-Gutierrez V, 2016, METHODS ECOL EVOL, V7, P1082, DOI 10.1111/2041-210X.12556; Zarzoso-Lacoste D, 2018, MOL ECOL RESOUR, V18, P217, DOI 10.1111/1755-0998.12727; Zsebek S, 2015, ECOL INFORM, V27, P1, DOI 10.1016/j.ecoinf.2015.02.002	71	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199428	10.1371/journal.pone.0199428	http://dx.doi.org/10.1371/journal.pone.0199428			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928036	gold, Green Published			2022-12-26	WOS:000435802500088
J	McNeely, RN; Moutari, S; Arba-Mosquera, S; Verma, S; Moore, JE				McNeely, Richard N.; Moutari, Salissou; Arba-Mosquera, Samuel; Verma, Shwetabh; Moore, Jonathan E.			An alternative application of Rasch analysis to assess data from ophthalmic patient-reported outcome instruments	PLOS ONE			English	Article							NEI-RQL-42 QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; VISION; QUALITY; VALIDITY; IMPAIRMENT; VALIDATION	Purpose To highlight the potential shortcomings associated with the current use Rasch analysis for validation of ophthalmic questionnaires, and to present an alternative application of Rasch analysis to derive insights specific to the cohort of patients under investigation. Methods An alternative application of Rasch analysis was used to investigate the quality of vision (QoV) for a cohort of 481 patients. Patients received multifocal intraocular lenses and completed a QoV questionnaire one and twelve months post-operatively. The rating scale variant of the polytomous Rasch model was utilized. The parameters of the model were estimated using the joint maximum likelihood estimation. Analysis was performed on data at both post-operative assessments, and the outcomes were compared. Results The distribution of the location of symptoms altered between assessments with the most annoyed patients completely differing. One month post-operatively, the most prevalent symptom was starbursts compared to glare at twelve months. The visual discomfort from the most annoyed patients is substantially higher at twelve months. The current most advocated approach for validating questionnaires using Rasch analysis found that the questionnaire was "Rasch-valid" one month post-operatively and "Rasch-invalid" twelve months post-operatively. Conclusion The proposed alternative application of Rasch analysis to questionnaires can be used as an effective decision support tool at population and individual level. At population level, this new approach enables one to investigate the prevalence of symptoms across different cohorts of patients. At individual level, the new approach enables one to identify patients with poor QoV over time. This study highlights some of the potential shortcomings associated with the current use of Rasch analysis to validate questionnaires.	[McNeely, Richard N.; Moore, Jonathan E.] Cathedral Eye Clin, 89-91 Acad St, Belfast BT1 2LS, Antrim, North Ireland; [McNeely, Richard N.; Moore, Jonathan E.] Univ Ulster, Biomed Sci Res Inst, Coleraine, Londonderry, North Ireland; [Moutari, Salissou] Queens Univ Belfast, Sch Math & Phys, Univ Rd, Belfast BT7 1NN, Antrim, North Ireland; [Arba-Mosquera, Samuel; Verma, Shwetabh] SCHWIND Eye Tech Solut, Res & Dev, Biomed Engn Off, Mainparkstr 6-10, D-63801 Kleinostheim, Germany; [Verma, Shwetabh] Heidelberg Univ, Univ Med Ctr Mannheim, Expt Radiat Oncol, Heidelberg, Germany; [Verma, Shwetabh] Heidelberg Univ, Interdisciplinary Ctr Sci Comp IWR, Heidelberg, Germany; [Verma, Shwetabh] Heidelberg Univ, Cent Inst Comp Engn ZITI, Heidelberg, Germany; [Arba-Mosquera, Samuel] Univ Valladolid, Recognized Res Grp Opt Diagnost Tech, Valladolid, Spain; [Arba-Mosquera, Samuel] Univ Oviedo, Dept Ophthalmol & Sci Vis, Oviedo, Spain	Ulster University; Queens University Belfast; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Universidad de Valladolid; University of Oviedo	Moore, JE (corresponding author), Cathedral Eye Clin, 89-91 Acad St, Belfast BT1 2LS, Antrim, North Ireland.; Moore, JE (corresponding author), Univ Ulster, Biomed Sci Res Inst, Coleraine, Londonderry, North Ireland.	jmoorecathedral@gmail.com	Mosquera, Samuel Arba/AAA-5777-2021	Mosquera, Samuel Arba/0000-0002-3152-0557	SCHWIND Eye-Tech Solutions	SCHWIND Eye-Tech Solutions	The funder, SCHWIND Eye-Tech Solutions, provided support in the form of salaries for authors [SA, SV], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; [Anonymous], 2014, MATLAB VERSION 8 4 0; Bohlig M., 1998, BASCH MEASUREMENT T, V12, P607; Finger RP, 2012, OPHTHALMOLOGY, V119, P2351, DOI 10.1016/j.ophtha.2012.05.031; Garamendi E, 2006, VISION RES, V46, P1375, DOI 10.1016/j.visres.2005.07.007; Gothwal VK, 2010, INVEST OPHTH VIS SCI, V51, P1401, DOI 10.1167/iovs.09-4180; Gothwal VK, 2009, OPHTHAL EPIDEMIOL, V16, P296, DOI 10.3109/09286580902999454; Gothwal VK, 2009, J CATARACT REFR SURG, V35, P1509, DOI 10.1016/j.jcrs.2009.03.056; Gothwal VK, 2009, OPTOMETRY VISION SCI, V86, P836, DOI 10.1097/OPX.0b013e3181ae1ec7; Huang JH, 2017, BRIT J OPHTHALMOL, V101, P475, DOI 10.1136/bjophthalmol-2016-308866; Khadka J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164182; Khadka J, 2013, OPTOMETRY VISION SCI, V90, P720, DOI 10.1097/OPX.0000000000000001; Khadka J, 2012, INVEST OPHTH VIS SCI, V53, P1276, DOI 10.1167/iovs.12-9541; Khadka J, 2011, INVEST OPHTH VIS SCI, V52, P6971, DOI 10.1167/iovs.11-7423; Lamoureux EL, 2008, OPHTHAL EPIDEMIOL, V15, P224, DOI 10.1080/09286580802256559; Lamoureux EL, 2007, INVEST OPHTH VIS SCI, V48, P1001, DOI 10.1167/iovs.06-0361; Lamoureux EL, 2009, INVEST OPHTH VIS SCI, V50, P2607, DOI 10.1167/iovs.08-2359; Linacre JM., 1999, J OUTCOME MEASUREMEN, V3, P381; Linacre John M, 2004, J Appl Meas, V5, P95; Marella M, 2010, INVEST OPHTH VIS SCI, V51, P2878, DOI 10.1167/iovs.09-4494; Massof RW, 2005, ARCH PHYS MED REHAB, V86, P954, DOI 10.1016/j.apmr.2004.09.017; McAlinden C, 2012, INVEST OPHTH VIS SCI, V53, P7370, DOI 10.1167/iovs.12-9969; McAlinden C, 2011, INVEST OPHTH VIS SCI, V52, P5685, DOI 10.1167/iovs.10-67951; McAlinden C, 2010, INVEST OPHTH VIS SCI, V51, P5537, DOI 10.1167/iovs.10-5341; MESSICK S, 1995, AM PSYCHOL, V50, P741, DOI 10.1037/0003-066X.50.9.741; Pesudovs K, 2005, INVEST OPHTH VIS SCI, V46, P38; Pesudovs K, 2007, OPTOMETRY VISION SCI, V84, P663, DOI 10.1097/OPX.0b013e318141fe75; Pesudovs K, 2010, BRIT J OPHTHALMOL, V94, P777, DOI 10.1136/bjo.2009.169490; Pesudovs K, 2010, J CATARACT REFR SURG, V36, P718, DOI 10.1016/j.jcrs.2009.11.019; RASCH G, 1966, BRIT J MATH STAT PSY, V19, P49, DOI 10.1111/j.2044-8317.1966.tb00354.x; Rasch G., 1980, PROBABILISTIC MODELS; Rasch G., 1977, DANISH YB PHILOS, V14, P58; Rasch G, 1961, P 4 BERK S MATH STAT, V4, P321; Wilson EB, 1931, P NATL ACAD SCI USA, V17, P684, DOI 10.1073/pnas.17.12.684; Wright B., 1999, MEASUREMENT ESSENTIA, V2nd; Wright B.D., 1999, MEASUREMENT ESSENTIA; Wright BD, 1982, RATING SCALE ANAL	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0197503	10.1371/journal.pone.0197503	http://dx.doi.org/10.1371/journal.pone.0197503			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK0LV	29928004	Green Published, Green Submitted, gold			2022-12-26	WOS:000435802500006
J	Zhang, ZF; Feng, JN; Mao, A; Le, K; La Placa, D; Wu, XW; Longmate, J; Marek, C; St Amand, RP; Neuhausen, SL; Shively, JE				Zhang, Zhifang; Feng, Jinong; Mao, Allen; Le, Keith; La Placa, Deirdre; Wu, Xiwei; Longmate, Jeffrey; Marek, Claudia; St Amand, R. Paul; Neuhausen, Susan L.; Shively, John E.			SNPs in inflammatory genes CCL11, CCL4 and MEFV in a fibromyalgia family study	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; INSULIN-DEGRADING ENZYME; SIGNAL PEPTIDASE; NEUROPATHIC PAIN; PLASMA-LEVELS; EOTAXIN; ASSOCIATION; PREVALENCE; BIOMARKERS; VARIANTS	Background Fibromyalgia (FM) is a chronic pain syndrome with a high incidence in females that may involve activation of the immune system. We performed exome sequencing on chemokine genes in a region of chromosome 17 identified in a genome-wide family association study. Methods and findings Exome sequence analysis of 100 FM probands was performed at 17p13.3-q25 followed by functional analysis of SNPs found in the chemokine gene locus. Missense SNPs (413) in 17p13.3-q25 were observed in at least 10 probands. SNPs rs1129844 in CCL11 and rs1719152 in CCL4 were associated with elevated plasma chemokine levels in FM. In a transmission disequilibrium test (TDT), rs1129844 was unequally transmitted from parents to their affected children (p< 0.0074), while the CCL4 SNP was not. The amino acid change (Ala23Thr), resulting from rs1129844 in CCL11, predicted to alter processing of the signal peptide, led to reduced expression of CCL11. The variant protein from CCL4 rs1719152 exhibited protein aggregation and a potent down-regulation of its cognate receptor CCR5, a receptor associated with hypotensive effects. Treatment of skeletal muscle cells with CCL11 produced high levels of CCL4 suggesting CCL11 regulates CCL4 in muscle. The immune association of FM with SNPs in MEFV, a chromosome 16 gene associated with recurrent fevers, had a p< 0.008 TDT for a combined 220 trios. Conclusions SNPs with significant TDTs were found in 36% of the cohort for CCL11 and 12% for MEFV, along with a protein variant in CCL4 (41%) that affects CCR5 down-regulation, supporting an immune involvement for FM.	[Zhang, Zhifang; Feng, Jinong; Mao, Allen; Le, Keith; La Placa, Deirdre; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Imaging & Therapy, Duarte, CA 91010 USA; [Wu, Xiwei] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA USA; [Longmate, Jeffrey] City Hope Natl Med Ctr, Beckman Res Inst, Dept Biostat, Duarte, CA USA; [Marek, Claudia; St Amand, R. Paul] RP St Amand MD Inc, Marina Del Rey, CA USA; [Neuhausen, Susan L.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Shively, JE (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Imaging & Therapy, Duarte, CA 91010 USA.	jshively@coh.org		Mao, Allen/0000-0002-7411-7100	Los Angeles Fibromyalgia Foundation; R.P. St. Amand MD Inc.	Los Angeles Fibromyalgia Foundation; R.P. St. Amand MD Inc.	Los Angeles Fibromyalgia Foundation. This work was supported in part from donations from patients with fibromyalgia. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. R.P. St. Amand MD Inc. provided support in the form of salaries for authors CM and RPSA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ang DC, 2011, PAIN MED, V12, P1154, DOI 10.1111/j.1526-4637.2011.01179.x; Arnold LM, 2013, ARTHRITIS RHEUM-US, V65, P1122, DOI 10.1002/art.37842; Behm FG, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-25; Bondy B, 1999, NEUROBIOL DIS, V6, P433, DOI 10.1006/nbdi.1999.0262; Bote ME, 2012, NEUROIMMUNOMODULAT, V19, P343, DOI 10.1159/000341664; BouHolaigah I, 1997, CLIN EXP RHEUMATOL, V15, P239; Buskila D, 2004, MOL PSYCHIATR, V9, P973, DOI 10.1038/sj.mp.4001568; Buskila D, 2007, PHARMACOGENOMICS, V8, P67, DOI 10.2217/14622416.8.1.67; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Clauw DJ, 2015, MAYO CLIN PROC, V90, P680, DOI 10.1016/j.mayocp.2015.03.014; Cui JQ, 2015, J BIOL CHEM, V290, P28131, DOI 10.1074/jbc.M115.692350; Dadabhoy D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2443; de Torre-Minguela C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00043; Docampo E, 2014, PAIN, V155, P1102, DOI 10.1016/j.pain.2014.02.016; Feng JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008480; Gonzalez B, 2013, PSYCHOL HEALTH MED, V18, P461, DOI 10.1080/13548506.2012.752098; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; ITO M, 1993, J CLIN INVEST, V91, P2565, DOI 10.1172/JCI116494; Jones KD, 2016, CLIN EXP RHEUMATOL, V34, pS89; Karakus N, 2012, CLIN CHIM ACTA, V414, P36, DOI 10.1016/j.cca.2012.07.019; Kato K, 2006, ARTHRITIS RHEUM-US, V54, P1682, DOI 10.1002/art.21798; Kosek E, 2015, J NEUROIMMUNOL, V280, P49, DOI 10.1016/j.jneuroim.2015.02.002; Lee B, 1999, P NATL ACAD SCI USA, V96, P5215, DOI 10.1073/pnas.96.9.5215; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liang WG, 2015, J MOL BIOL, V427, P1345, DOI 10.1016/j.jmb.2015.01.012; Lieberman-Blum SS, 2008, CLIN THER, V30, P1228, DOI 10.1016/S0149-2918(08)80048-3; Manukyan G, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00456; Noso N, 1998, EUR J BIOCHEM, V253, P114, DOI 10.1046/j.1432-1327.1998.2530114.x; Ren M, 2010, EMBO J, V29, P3952, DOI 10.1038/emboj.2010.256; Rigoli L, 2008, CLIN EXP DERMATOL, V33, P316, DOI 10.1111/j.1365-2230.2007.02672.x; Saika F, 2012, EUR J PAIN, V16, P1271, DOI 10.1002/j.1532-2149.2012.00146.x; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Singh P, 2015, AM J GASTROENTEROL, V110, P1539, DOI 10.1038/ajg.2015.296; Sperber AD, 1999, AM J GASTROENTEROL, V94, P3541, DOI 10.1111/j.1572-0241.1999.01643.x; Staud Roland, 2008, Curr Rheumatol Rep, V10, P463; WOLFE F, 1990, ARCH INTERN MED, V150, P460, DOI 10.1001/archinte.150.2.460; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; Wolfe F, 2010, ARTHRIT CARE RES, V62, P583, DOI 10.1002/acr.20156; Zhang ZF, 2008, EXP BIOL MED, V233, P1171, DOI 10.3181/0712-RM-328; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	40	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198625	10.1371/journal.pone.0198625	http://dx.doi.org/10.1371/journal.pone.0198625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927949	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500026
J	Jensen, KS; Adams, R; Bennett, RS; Bernbaum, J; Jahrling, PB; Holbrook, MR				Jensen, Kenneth S.; Adams, Ricky; Bennett, Richard S.; Bernbaum, John; Jahrling, Peter B.; Holbrook, Michael R.			Development of a novel real-time polymerase chain reaction assay for the quantitative detection of Nipah virus replicative viral RNA	PLOS ONE			English	Article							BANGLADESH; TRANSMISSION; PARAMYXOVIRUS; ENCEPHALITIS; INFECTION; OUTBREAK; HUMANS	Nipah virus (NiV) is a highly pathogenic zoonotic paramyxovirus that can result in severe pulmonary disease and fatal encephalitis in humans and is responsible for outbreaks in Bangladesh, Malaysia, Singapore, India and possibly the Philippines. NiV has a negative-sense RNA genome that contains six genes and serves as a template for production of viral mRNA transcripts. NiV mRNA transcripts are subsequently translated into viral proteins. Traditionally, NiV quantitative real-time reverse transcriptase polymerase chain reaction (qRT-PCR) assays have relied on using primer sets that amplify a target (N that encodes the nucleocapsid) within the coding region of the viral gene that also amplifies viral mRNA. Here we describe a novel one-step qRT-PCR assay targeting the intergenic region separating the viral F and G proteins, thereby eliminating amplification of the viral mRNA. This assay is more accurate than the traditional qRT-PCR in quantifying concentrations of viral genomic RNA.	[Jensen, Kenneth S.; Adams, Ricky; Bennett, Richard S.; Bernbaum, John; Jahrling, Peter B.; Holbrook, Michael R.] NIAID, Integrated Res Facil, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Holbrook, MR (corresponding author), NIAID, Integrated Res Facil, Frederick, MD 21702 USA.	Michael.holbrook@nih.gov	Holbrook, Michael/AAT-6865-2020	Holbrook, Michael/0000-0002-0824-2667; Bennett, Richard/0000-0002-7227-4831	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID); Integrated Research Facility (NIAID, Division of Clinical Research); Battelle Memorial Institute's [HHS N272200700016I]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI009006, ZIDAI009006] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Integrated Research Facility (NIAID, Division of Clinical Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Battelle Memorial Institute's; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID); Integrated Research Facility (NIAID, Division of Clinical Research); and Battelle Memorial Institute's prime contract with NIAID (Contract # HHS N272200700016I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bukreyev A, 2001, J VIROL, V75, P12128, DOI 10.1128/JVI.75.24.12128-12140.2001; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chang LY, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-47; Ching PKG, 2015, EMERG INFECT DIS, V21, P328, DOI 10.3201/eid2102.141433; Chong HT, 2003, NEUROL J SE ASIA, V8, P109; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Cong Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005532; DeBuysscher BL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002024; Guillaume V, 2004, J VIROL METHODS, V120, P229, DOI 10.1016/j.jviromet.2004.05.018; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Harcourt BH, 2000, VIROLOGY, V271, P334, DOI 10.1006/viro.2000.0340; Islam MS, 2016, EMERG INFECT DIS, V22, P664, DOI 10.3201/eid2204.151747; Kulkarni DD, 2013, INDIAN J VIROL, V24, P398, DOI 10.1007/s13337-013-0171-y; Lo MK, 2014, ANTIVIR RES, V101, P26, DOI 10.1016/j.antiviral.2013.10.012; Lo MK, 2012, EMERG INFECT DIS, V18, P248, DOI 10.3201/eid1802.111492; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Luby SP, 2009, EMERG INFECT DIS, V15, P1229, DOI 10.3201/eid1508.081237; Mathieu C, 2015, EXPERT REV ANTI-INFE, V13, P343, DOI 10.1586/14787210.2015.1001838; Sherrini B A, 2014, Med J Malaysia, V69 Suppl A, P103; Tan CT, 2002, ANN NEUROL, V51, P703, DOI 10.1002/ana.10212	20	8	11	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199534	10.1371/journal.pone.0199534	http://dx.doi.org/10.1371/journal.pone.0199534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920552	Green Submitted, Green Published, gold			2022-12-26	WOS:000435541300050
J	Park, SH; Kyndt, J; Chougule, K; Park, JJ; Brown, JK				Park, Sang-Hyuck; Kyndt, John; Chougule, Kapeel; Park, Jeong-Jin; Brown, Judith K.			Low-phosphate-selected Auxenochlorella protothecoides redirects phosphate to essential pathways while producing more biomass	PLOS ONE			English	Article							CHLORELLA-PROTOTHECOIDES; LIPID-ACCUMULATION; GROWTH; TOOL; CULTIVATION; ADAPTATION; MICROALGAE; BIOFUELS	Despite the capacity to accumulate similar to 70% w/w of lipids, commercially produced unicellular green alga A. protothecoides may become compromised due to the high cost of phosphate fertilizers. To address this limitation A. protothecoides was selected for adaptation to conditions of 100x and 5x lower phosphate and peptone, respectively, compared to wild-type media'. The A. protothecoides showed initial signs of adaptation by 45-50days, and steady state growth at similar to 100 days. The low phosphate (P)-adapted strain produced up to similar to 30% greater biomass, while total lipids (similar to 10% w/w) remained about the same, compared to the wild-type strain. Metabolomic analyses indicated that the low P -adapted produced 3.3-fold more saturated palmitic acid (16:0) and 2.2-fold less linolenic acid (18:3), compared to the wild-type strain, resulting in an similar to 11% increase in caloric value, from 19.5kJ/g for the wild type strain to 21.6kJ/g for the low P -adapted strain, due to the amounts and composition of certain saturated fatty acids, compared to the wild type strain. Biochemical changes in A. protothecoides adapted to lower phosphate conditions were assessed by comparative RNA-Seq analysis, which yielded 27,279 transcripts. Among them, 2,667 and 15 genes were significantly down- and up-regulated, at >999-fold and >3-fold (adjusted p-value <0.1), respectively. The expression of genes encoding proteins involved in cellular processes such as division, growth, and membrane biosynthesis, showed a trend toward down-regulation. At the genomic level, synonymous SNPs and Indels were observed primarily in coding regions, with the 40S ribosomal subunit gene harboring substantial SNPs. Overall, the adapted strain out-performed the wild-type strain by prioritizing the use of its limited phosphate supply for essential biological processes. The low P-adapted A. protothecoides is expected to be more economical to grow over the wild-type strain, based on overall greater productivity and caloric content, while importantly, also requiring 100-fold less phosphate.	[Park, Sang-Hyuck] Colorado State Univ, Dept Biol, Pueblo, CO USA; [Kyndt, John] Bellevue Univ, Coll Sci & Technol, Bellevue, NE USA; [Chougule, Kapeel] Univ Arizona, Arizona Genom Inst, Tucson, AZ USA; [Park, Jeong-Jin] Univ Virginia, Biomol Anal Facil, Charlottesville, VA USA; [Brown, Judith K.] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA	Colorado State University; University of Arizona; University of Virginia; University of Arizona	Brown, JK (corresponding author), Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA.	jbrown@ag.arizona.edu		Kyndt, John/0000-0001-7168-8015; Brown, Judith/0000-0003-4669-8443	National Alliance for Advanced Biofuels and Bioproducts (NAABB)	National Alliance for Advanced Biofuels and Bioproducts (NAABB)	National Alliance for Advanced Biofuels and Bioproducts (NAABB); This research was funded by National Alliance for Advanced Biofuels and Bioproducts (NAABB) sub-grant awarded to the last author. The authors acknowledge the Dr. David Gang laboratory for carrying out the lipid and colorometric analysis, a rate-based service provided by the Institute of Biological Chemistry, Washington State University, Pullman, WA 99164.	Aslam A, 2017, BIORESOURCE TECHNOL, V233, P271, DOI 10.1016/j.biortech.2017.02.111; Bumbak F, 2011, APPL MICROBIOL BIOT, V91, P31, DOI 10.1007/s00253-011-3311-6; Campbell MS, 2014, PLANT PHYSIOL, V164, P513, DOI 10.1104/pp.113.230144; FRANCIS JC, 1973, GENETICS, V74, P259; Greenwell HC, 2010, J R SOC INTERFACE, V7, P703, DOI 10.1098/rsif.2009.0322; Hortensteiner S, 2000, PLANT MOL BIOL, V42, P439, DOI 10.1023/A:1006380125438; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Kaneko H, 2004, WATER RES, V38, P2173, DOI 10.1016/j.watres.2004.02.006; Khozin-Goldberg I, 2006, PHYTOCHEMISTRY, V67, P696, DOI 10.1016/j.phytochem.2006.01.010; Kraemer SA, 2016, J EVOLUTION BIOL, V29, P583, DOI 10.1111/jeb.12807; Li XF, 2007, BIOTECHNOL BIOENG, V98, P764, DOI 10.1002/bit.21489; Luque L, 2016, BIORESOURCE TECHNOL, V214, P660, DOI 10.1016/j.biortech.2016.05.030; MALEK I, 1966, FOLIA MICROBIOL, V11, P479, DOI 10.1007/BF02875863; Mammadov Jafar, 2012, Int J Plant Genomics, V2012, P728398, DOI 10.1155/2012/728398; Maresova H, 2001, BIOTECHNOL BIOENG, V75, P46, DOI 10.1002/bit.1163; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; NYHOLM N, 1978, J THEOR BIOL, V70, P415, DOI 10.1016/0022-5193(78)90250-3; NYHOLM N, 1977, BIOTECHNOL BIOENG, V19, P467, DOI 10.1002/bit.260190404; Roth MS, 2017, P NATL ACAD SCI USA, V114, pE4296, DOI 10.1073/pnas.1619928114; Schneemann I, 2011, MAR DRUGS, V9, P772, DOI 10.3390/md9050772; Ullah K, 2014, PROG NAT SCI-MATER, V24, P329, DOI 10.1016/j.pnsc.2014.06.008; Unkefer CJ, 2017, ALGAL RES, V22, P187, DOI 10.1016/j.algal.2016.06.002; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Yang WN, 2016, BIORESOURCE TECHNOL, V202, P15, DOI 10.1016/j.biortech.2015.11.070	25	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0198953	10.1371/journal.pone.0198953	http://dx.doi.org/10.1371/journal.pone.0198953			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920531	Green Published, Green Submitted, gold			2022-12-26	WOS:000435541300013
J	Bugge, A; Moller, S; Westfall, DR; Tarp, J; Gejl, AK; Wedderkopp, N; Hillman, CH				Bugge, Anna; Moller, Soren; Westfall, Daniel R.; Tarp, Jakob; Gejl, Anne K.; Wedderkopp, Niels; Hillman, Charles H.			Associations between waist circumference, metabolic risk and executive function in adolescents: A cross-sectional mediation analysis	PLOS ONE			English	Article							SCHOOL-AGE-CHILDREN; COGNITIVE IMPAIRMENT; INSULIN SENSITIVITY; BLOOD-PRESSURE; OVERWEIGHT; OBESITY; PERFORMANCE; DEMENTIA; DECLINE; CHOLESTEROL	The main objective of this study was to investigate the associations between waist circumference, metabolic risk factors, and executive function in adolescents. Methods: The study was cross-sectional and included 558 adolescents (mean age 14.2 years). Anthropometrics and systolic blood pressure (sysBP) were measured and fasting blood samples were analyzed for metabolic risk factors. A metabolic risk factor cluster score (MetS-cluster score) was computed from the sum of standardized sysBP, triglycerides (TG), inverse high-density lipid cholesterol (HDLc) and insulin resistance (homeostasis model assessment). Cognitive control was measured with a modified flanker task. Results: Regression analyses indicated that after controlling for demographic variables, HDLc exhibited a negative and TG a positive association with flanker reaction time (RT). Waist circumference did not demonstrate a statistically significant total association with the cognitive outcomes. In structural equation modeling, waist circumference displayed an indirect positive association with incongruent RT through a higher MetS-cluster score and through lower HDLc. The only statistically significant direct association between waist circumference and the cognitive outcomes was for incongruent RT in the model including HDLc as mediator. Conclusions: These findings are consonant with the previous literature reporting an adverse association between certain metabolic risk factors and cognitive control. Accordingly, these results suggest specificity between metabolic risk factors and cognitive control outcomes. Further, results of the present study, although cross-sectional, provide new evidence that specific metabolic risk factors may mediate an indirect association between adiposity and cognitive control in adolescents, even though a direct association between these variables was not observed. However, taking the cross-sectional study design into consideration, these results should be interpreted with caution and future longitudinal or experimental studies should verify the findings of this study.	[Bugge, Anna; Tarp, Jakob; Gejl, Anne K.; Wedderkopp, Niels] Univ Southern Denmark, Inst Sport Sci & Clin Biomech, Ctr Res Childhood Hlth, Odense, Denmark; [Bugge, Anna] Univ Coll Copenhagen, Dept Physiotherapy & Occupat Therapy, Copenhagen, Denmark; [Moller, Soren] Univ Southern Denmark, Odense Univ Hosp, OPEN Odense Patient Data Explorat Network, Odense, Denmark; [Moller, Soren] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Westfall, Daniel R.; Hillman, Charles H.] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Wedderkopp, Niels] Univ Southern Denmark, Inst Reg Hlth Res, Middelfart Hosp, Sports Med Clin,Orthoped Dept, Middelfart, Denmark; [Hillman, Charles H.] Northeastern Univ, Dept Phys Therapy Movement & Rehabil Sci, Boston, MA 02115 USA	University of Southern Denmark; University College Copenhagen; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Northeastern University; University of Southern Denmark; Northeastern University	Bugge, A (corresponding author), Univ Southern Denmark, Inst Sport Sci & Clin Biomech, Ctr Res Childhood Hlth, Odense, Denmark.; Bugge, A (corresponding author), Univ Coll Copenhagen, Dept Physiotherapy & Occupat Therapy, Copenhagen, Denmark.	abug@phmetropol.dk	Wedderkopp, Niels/L-9810-2019; Möller, Sören/X-8738-2019; Hillman, Charles/AAD-4828-2019; Bugge, Anna/P-5100-2016	Möller, Sören/0000-0003-0858-4269; Tarp, Jakob/0000-0002-9186-7077; Wedderkopp, Niels/0000-0002-9660-6618; Bugge, Anna/0000-0002-8345-1434; Kaer Gejl, Anne/0000-0001-6781-2263; Hillman, Charles/0000-0002-3722-5612	TrygFonden [104982]; Fulbright scholarship	TrygFonden; Fulbright scholarship	The CHAMPS III-study was supported by the TrygFonden (104982). https://trygfonden.dk/. AB was funded by a Fulbright scholarship while working on this study. https://educationusa.state.gov/centers/danish-american-fulbright-commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro FJ, 2018, METABOLISM, V78, P52, DOI 10.1016/j.metabol.2017.08.009; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Andersen LB, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/539835; Anstey KJ, 2008, AM J GERIAT PSYCHIAT, V16, P343, DOI 10.1097/JGP.0b013e31816b72d4; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dik MG, 2007, DIABETES CARE, V30, P2655, DOI 10.2337/dc06-1190; Duron E, 2008, VASC HEALTH RISK MAN, V4, P363; Eisenmann JC, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-17; Fitzpatrick S, 2013, NEUROPSYCHOL REV, V23, P138, DOI 10.1007/s11065-013-9224-7; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Gaesser GA, 2011, PHYSICIAN SPORTSMED, V39, P87, DOI 10.3810/psm.2011.05.1898; Gonzales MM, 2010, OBESITY, V18, P2131, DOI 10.1038/oby.2010.183; Gunstad J, 2008, APPETITE, V50, P246, DOI 10.1016/j.appet.2007.07.008; Hillman CH, 2014, PEDIATRICS, V134, pE1063, DOI 10.1542/peds.2013-3219; Hjorth MF, 2015, OBESITY, V23, P733, DOI 10.1002/oby.21034; Huang T, 2015, J PEDIATR-US, V167, P810, DOI 10.1016/j.jpeds.2015.07.009; Huang TTK, 2007, APPL PHYSIOL NUTR ME, V32, P13, DOI [10.1139/H06-094, 10.1139/h06-094]; Kim B, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.3; Lande MB, 2003, J PEDIATR-US, V143, P720, DOI 10.1067/S0022-3476(03)00412-8; Li YF, 2008, OBESITY, V16, P1809, DOI 10.1038/oby.2008.296; Little T. D., 2013, LONGITUDINAL STRUCTU; Mameli C, 2017, PHARMACOL RES, V119, P99, DOI 10.1016/j.phrs.2017.01.017; Marks GN, 2008, SOC INDIC RES, V85, P293, DOI 10.1007/s11205-007-9132-4; Miyake Akira, 2000, Seminars in Speech and Language, V21, P169, DOI 10.1055/s-2000-7563; Moon JH, 2016, ENDOCRINOL METAB, V31, P185, DOI 10.3803/EnM.2016.31.2.185; Nassis GP, 2005, METABOLISM, V54, P1472, DOI 10.1016/j.metabol.2005.05.013; Novak V, 2010, NAT REV CARDIOL, V7, P686, DOI 10.1038/nrcardio.2010.161; Perry LA, 2009, NUTR NEUROSCI, V12, P160, DOI 10.1179/147683009X423328; Reaven G, 2002, CIRCULATION, V106, P286, DOI 10.1161/01.CIR.0000019884.36724.D9; Rubens M, 2016, METAB SYNDR RELAT D, V14, P397, DOI 10.1089/met.2016.0015; Scudder MR, 2015, HEALTH PSYCHOL, V34, P243, DOI 10.1037/hea0000114; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stoeckel Luke E, 2016, F1000Res, V5, P353, DOI 10.12688/f1000research.8300.1; TANNER JM, 1981, NUTR REV, V39, P43, DOI 10.1111/j.1753-4887.1981.tb06734.x; Tsai CK, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004791; Verdejo-Garcia A, 2010, OBESITY, V18, P1572, DOI 10.1038/oby.2009.475; Wallace TM, 2002, DIABETIC MED, V19, P527, DOI 10.1046/j.1464-5491.2002.00745.x; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wedderkopp N, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-128; WHO, 2016, REP COMM END CHILDH; Yaffe K, 2007, ALZ DIS ASSOC DIS, V21, P167, DOI 10.1097/WAD.0b013e318065bfd6; Yau PL, 2012, PEDIATRICS, V130, pE856, DOI 10.1542/peds.2012-0324; Yeh TK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/520619	46	6	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199281	10.1371/journal.pone.0199281	http://dx.doi.org/10.1371/journal.pone.0199281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ6XV	29912925	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600101
J	Reynolds, A; Ceccon, E; Baldauf, C; Medeiros, TK; Miramontes, O				Reynolds, Andy; Ceccon, Eliane; Baldauf, Cristina; Medeiros, Tassia Karina; Miramontes, Octavio			Levy foraging patterns of rural humans	PLOS ONE			English	Article							SEARCH BEHAVIOR; RANDOM-WALKS; FLIGHTS; DISTRIBUTIONS; MOVEMENT; CONTEXT; CELLS	Movement patterns resembling Levy walks, often attributed to the execution of an advantageous probabilistic searching strategy, are found in a wide variety of organisms, from cells to human hunter-gatherers. It has been suggested that such movement patterns may be fundamental to how humans interact and experience the world and that they may have arisen early in our genus with the evolution of a hunting and gathering lifestyle. Here we show that Levy walks are evident in the Me'Phaa of Mexico, in Brazilian Cariri farmers and in Amazonian farmers when gathering firewood, wild fruit and nuts. Around 50% of the search patterns resemble Levy walks and these are characterized by Levy exponents close to 1.7. The other search patterns more closely resemble bi-phasic walks. We suggest potential generative mechanisms for the occurrence of these ubiquitous Levy walks which can be used to guide future studies on human mobility. We show that frequent excursions and meanderings from pre-existing trails can account for our observations.	[Reynolds, Andy] Rothamsted Res, Harpenden, Herts, England; [Ceccon, Eliane] UNAM, Ctr Reg Invest Multidisciplinarias, Cuernavaca, Morelos, Mexico; [Baldauf, Cristina; Medeiros, Tassia Karina] Fed Rural Univ Semiarid Reg UFERSA, Biol & Hlth Sci Ctr, Mossoro, Brazil; [Miramontes, Octavio] Univ Nacl Autonoma Mexico, Inst Fis, Mexico City, DF, Mexico; [Miramontes, Octavio] Univ Nacl Autonoma Mexico, C3, Mexico City, DF, Mexico; [Miramontes, Octavio] Univ Politecn Madrid, Appl Math & Stat, EIAE, Madrid, Spain	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Universidad Nacional Autonoma de Mexico; Universidade Federal Rural do Semi-Arido (UFERSA); Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Politecnica de Madrid	Reynolds, A (corresponding author), Rothamsted Res, Harpenden, Herts, England.	andy.reynolds@rothamsted.ac.uk	miramontes, octavio/ABG-8963-2020	miramontes, octavio/0000-0001-8306-0014	UK Biotechnology and Biological Sciences Research Council (BBSRC); National Council for Scientific and Technological Development (CNPq) [308628/2016-0]; PAPIIT-UNAM grant [IN105015]; BBSRC [BBS/E/C/00005195] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PAPIIT-UNAM grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research is a national institute of bioscience strategically funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC) to AR and the National Council for Scientific and Technological Development (CNPq) productivity grant (308628/2016-0) to CB. OM and EC were supported by PAPIIT-UNAM grant IN105015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen E S, 1953, MATH SCAND, V1, P263, DOI DOI 10.7146/MATH.SCAND.A-10385; Andersen E. Sparre, 1954, MATH SCAND, V2, P195, DOI DOI 10.7146/MATH.SCAND.A-10407; Ariel G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9396; Baldauf C, 2013, ECON BOT, V67, P110, DOI 10.1007/s12231-013-9228-5; Barthelemy M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.138702; Boyer D, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434015; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Boyer D, 2012, J R SOC INTERFACE, V9, P842, DOI 10.1098/rsif.2011.0582; Brown CT, 2007, HUM ECOL, V35, P129, DOI 10.1007/s10745-006-9083-4; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chen KJ, 2015, NAT MATER, V14, P589, DOI [10.1038/NMAT4239, 10.1038/nmat4239]; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; da Luz MGE, 2016, P NATL ACAD SCI USA, V113, P8571, DOI 10.1073/pnas.1609369113; Feder J, 1988, FRACTALS; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Hays GC, 2012, P ROY SOC B-BIOL SCI, V279, P465, DOI 10.1098/rspb.2011.0978; HUGHES BD, 1981, P NATL ACAD SCI USA, V78, P3287, DOI 10.1073/pnas.78.6.3287; Humphries NE, 2013, METHODS ECOL EVOL, V4, P930, DOI 10.1111/2041-210X.12096; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Isliker H., 2013, PHYS REV E, V67; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; Maus HM, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0594; Miramontes O, 2012, HUM ECOL, V40, P167, DOI 10.1007/s10745-012-9465-8; Namboodiri VMK, 2016, P NATL ACAD SCI USA, V113, P8747, DOI 10.1073/pnas.1601664113; Raichlen DA, 2014, P NATL ACAD SCI USA, V111, P728, DOI 10.1073/pnas.1318616111; Ramos-Fernandez G., BEHAV ECOLOGY SOCIOB, V55, P223; Reynolds A. M., 2013, SPRINGER LECT NOTES, V2071; Reynolds AM, 2007, ECOLOGY, V88, P1955, DOI 10.1890/06-1916.1; Reynolds AM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0468; SHLESINGER MF, 1983, J CHEM PHYS, V78, P416, DOI 10.1063/1.444518; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2014, P NATL ACAD SCI USA, V111, P11073, DOI 10.1073/pnas.1405966111; Souman JL, 2009, CURR BIOL, V19, P1538, DOI 10.1016/j.cub.2009.07.053; Tromer RM, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.022147; Turcotte D. L, 1992, FRACTALS CHAOS GEOLO; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002; Viswanathan G. M., 2011, PHYS FORAGING; Wiens JA, 1989, LANDSCAPE ECOL, V3, P87, DOI 10.1007/BF00131172; ZIFF RM, 1984, J PHYS A-MATH GEN, V17, P3009, DOI 10.1088/0305-4470/17/15/018	43	23	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199099	10.1371/journal.pone.0199099	http://dx.doi.org/10.1371/journal.pone.0199099			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ6XV	29912927	Green Submitted, Green Published, gold			2022-12-26	WOS:000435528600073
J	Samraj, AN; Bertrand, KA; Luben, R; Khedri, Z; Yu, H; Nguyen, D; Gregg, CJ; Diaz, SL; Sawyer, S; Chen, X; Eliassen, H; Padler-Karavani, V; Wu, KN; Khaw, KT; Willett, W; Varki, A				Samraj, Annie N.; Bertrand, Kimberly A.; Luben, Robert; Khedri, Zahra; Yu, Hai; Nguyen, Dzung; Gregg, Christopher J.; Diaz, Sandra L.; Sawyer, Sherilyn; Chen, Xi; Eliassen, Heather; Padler-Karavani, Vered; Wu, Kana; Khaw, Kay-Tee; Willett, Walter; Varki, Ajit			Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk	PLOS ONE			English	Article							PROCESSED MEAT; ACETYLNEURAMINIC ACID; EPIC-NORFOLK; ANTI-NEU5GC ANTIBODIES; BREAST-CANCER; CONSUMPTION; INFLAMMATION; MORTALITY; QUESTIONNAIRE; HYDROXYLASE	Background N-glycolylneuraminic acid (Neu5Gc) is a non-human red-meat-derived sialic acid immuno-genic to humans. Neu5Gc can be metabolically incorporated into glycan chains on human endothelial and epithelial surfaces. This represents the first example of a "xeno-autoantigen", against which circulating human "xeno-autoantibodies" can react. The resulting inflammation ("xenosialitis") has been demonstrated in human-like Neu5Gc-deficient mice and contributed to carcinoma progression via antibody-mediated inflammation. Anti-Neu5Gc antibodies have potential as biomarkers for diseases associated with red meat consumption such as carcinomas, atherosclerosis, and type 2 diabetes. Methods ELISA assays measured antibodies against Neu5Gc or Neu5Gc-glycans in plasma or serum samples from the Nurses' Health Studies, the Health Professionals Follow-up Study, and the European Prospective Investigation into Cancer and Nutrition, including inter-assay reproducibility, stability with delayed sample processing, and within-person reproducibility over 1-3 years in archived samples. We also assessed associations between antibody levels and coronary artery disease risk (CAD) or red meat intake. A glycan microarray was used to detected antibodies against multiple Neu5Gc-glycan epitopes. A nested case-control study design assessed the association between total anti-Neu5Gc antibodies detected in the glycan array assay and the risk of colorectal cancer (CRC). Results ELISA assays showed a wide range of anti-Neu5Gc responses and good inter-assay reproducibility, stability with delayed sample processing, and within-person reproducibility over time, but these antibody levels did not correlate with CAD risk or red meat intake. Antibodies against Neu5Gc alone or against individual Neu5Gc-bearing epitopes were also not associated with colorectal cancer (CRC) risk. However, a sialoglycan microarray study demonstrated positive association with CRC risk when the total antibody responses against all Neu5Gc-glycans were combined. Individuals in the top quartile of total anti-Neu5Gc IgG antibody concentrations had nearly three times the risk compared to those in the bottom quartile (Multivariate Odds Ratio comparing top to bottom quartile: 2.98, 95% CI: 0.80, 11.1; P for trend = 0.02). Conclusions Further work harnessing the utility of these anti-Neu5Gc antibodies as biomarkers in red meat-associated diseases must consider diversity in individual antibody profiles against different Neu5Gc-bearing glycans. Traditional ELISA assays for antibodies directed against Neu5Gc alone, or against specific Neu5Gc-glycans may not be adequate to define risk associations. Our finding of a positive association of total anti-Neu5Gc antibodies with CRC risk also warrants confirmation in larger prospective studies.	[Samraj, Annie N.; Khedri, Zahra; Nguyen, Dzung; Gregg, Christopher J.; Diaz, Sandra L.; Padler-Karavani, Vered; Varki, Ajit] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Samraj, Annie N.; Khedri, Zahra; Nguyen, Dzung; Gregg, Christopher J.; Diaz, Sandra L.; Padler-Karavani, Vered; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, San Diego, CA 92103 USA; [Bertrand, Kimberly A.] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA; [Luben, Robert; Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Yu, Hai; Chen, Xi] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Sawyer, Sherilyn; Eliassen, Heather] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Sawyer, Sherilyn; Eliassen, Heather] Harvard Med Sch, Boston, MA USA; [Sawyer, Sherilyn; Eliassen, Heather] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Wu, Kana; Willett, Walter] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Khedri, Zahra] Ajinomoto Althea, San Diego, CA USA; [Nguyen, Dzung] BioLegend Inc, San Diego, CA USA; [Gregg, Christopher J.] GRO Biosci, Boston, MA USA; [Sawyer, Sherilyn] VA Boston Healthcare Syst, Ctr Populat Genom, Boston, MA USA; [Padler-Karavani, Vered] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, Tel Aviv, Israel	University of California System; University of California San Diego; University of California System; University of California San Diego; Boston University; University of Cambridge; University of California System; University of California Davis; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Tel Aviv University	Varki, A (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.; Varki, A (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, San Diego, CA 92103 USA.; Khaw, KT (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.; Willett, W (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA.	kk101@medschl.cam.ac.uk; wwillett@hsph.harvard.edu; a1varki@ucsd.edu	PADLER-KARAVANI, VERED/AAC-6055-2022; Chen, Xi/H-1811-2018; Luben, Robert N/H-5519-2015; chen, xi/GXH-3653-2022; Khaw, Kay-Tee/AAZ-3209-2021	PADLER-KARAVANI, VERED/0000-0002-4761-3571; Chen, Xi/0000-0002-3160-614X; Luben, Robert N/0000-0002-5088-6343; Diaz, Sandra/0000-0002-6243-8847; Bertrand, Kimberly/0000-0002-4565-7618	National Institutes of Health [R01GM32373, UM1CA186107, UM1CA176726]; Medical Research Council UK; Cancer Research UK; NATIONAL CANCER INSTITUTE [UM1CA186107, UM1CA176726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER; MRC [MR/N003284/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by: National Institutes of Health, Award number R01GM32373 to Ajit Varki; National Institutes of Health, Award number UM1CA186107 to Walter Willet; National Institutes of Health, Award number UM1CA176726 to Walter Willet. EPIC-Norfolk is supported by grants from the Medical Research Council UK and Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar-Kharghan V, 2017, J CLIN INVEST, V127, P780, DOI 10.1172/JCI90962; Alisson-Silva F, 2016, MOL ASPECTS MED, V51, P16, DOI 10.1016/j.mam.2016.07.002; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; [Anonymous], 2018, NUTRIENTS; Bandera EV, 2007, CANCER CAUSE CONTROL, V18, P967, DOI 10.1007/s10552-007-9038-0; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Bingham SA, 1997, INT J EPIDEMIOL, V26, pS137, DOI 10.1093/ije/26.suppl_1.S137; Blixt O, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2841; Cascella M, 2018, INFECT AGENTS CANCER, V13, DOI 10.1186/s13027-018-0174-9; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Chu NF, 2001, INT J OBESITY, V25, P346, DOI 10.1038/sj.ijo.0801549; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Cross AJ, 2004, ENVIRON MOL MUTAGEN, V44, P44, DOI 10.1002/em.20030; Day N, 1999, BRIT J CANCER, V80, P95; Eleftheriou P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/963230; Eleftheriou Phaedra, 2014, Hell J Nucl Med, V17 Suppl 1, P35; Eliassen AH, 2006, JNCI-J NATL CANCER I, V98, P1406, DOI 10.1093/jnci/djj376; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Etemadi A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1957; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Figueiredo JC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004228; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayakawa T, 2001, P NATL ACAD SCI USA, V98, P11399, DOI 10.1073/pnas.191268198; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Hedlund M, 2008, P NATL ACAD SCI USA, V105, P18936, DOI 10.1073/pnas.0803943105; Heimburg-Molinaro J, 2011, VACCINE, V29, P8802, DOI 10.1016/j.vaccine.2011.09.009; HIGASHI H, 1984, GANN, V75, P1025; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Kaluza J, 2012, STROKE, V43, P2556, DOI 10.1161/STROKEAHA.112.663286; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Larsson SC, 2014, AM J EPIDEMIOL, V179, P282, DOI 10.1093/aje/kwt261; Le Berre L, 2017, CLIN IMMUNOL, V180, P128, DOI 10.1016/j.clim.2017.05.006; Lentjes MAH, 2014, BRIT J NUTR, V111, P516, DOI 10.1017/S0007114513002754; Ley SH, 2014, AM J CLIN NUTR, V99, P352, DOI 10.3945/ajcn.113.075663; Long C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180768; Ma F, 2016, J BIOL CHEM, V291, P18222, DOI 10.1074/jbc.M116.739169; Malykh YN, 2001, BIOCHIMIE, V83, P623, DOI 10.1016/S0300-9084(01)01303-7; McCullough ML, 2013, J CLIN ONCOL, V31, P2773, DOI 10.1200/JCO.2013.49.1126; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; MUCHMORE EA, 1989, J BIOL CHEM, V264, P20216; Muthana SM, 2014, CANCER BIOMARK, V14, P29, DOI 10.3233/CBM-130383; Nagy E, 2010, ARTERIOSCL THROM VAS, V30, P1347, DOI 10.1161/ATVBAHA.110.206433; Nguyen DH, 2005, J IMMUNOL, V175, P228, DOI 10.4049/jimmunol.175.1.228; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Padler-Karavani V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058443; Padler-Karavani V, 2012, J BIOL CHEM, V287, P22593, DOI 10.1074/jbc.M112.359323; Padler-Karavani V, 2011, CANCER RES, V71, P3352, DOI 10.1158/0008-5472.CAN-10-4102; Padler-Karavani V, 2011, XENOTRANSPLANTATION, V18, P1, DOI 10.1111/j.1399-3089.2011.00622.x; Pan A, 2011, AM J CLIN NUTR, V94, P1088, DOI 10.3945/ajcn.111.018978; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; PATIENTS, 2017, CLIN IMMUNOL, V5, P6, DOI DOI 10.1016/J.CLIM.2017.05.006; Pearce OMT, 2014, P NATL ACAD SCI USA, V111, P5998, DOI 10.1073/pnas.1209067111; Pham T, 2009, BLOOD, V114, P5225, DOI 10.1182/blood-2009-05-220400; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Rada-Fernandez de Jauregui D, 2018, INT J CANC; Reuven EM, 2016, XENOTRANSPLANTATION, V23, P381, DOI 10.1111/xen.12260; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; RIBOLI E, 1992, ANN ONCOL, V3, P783, DOI 10.1093/oxfordjournals.annonc.a058097; Rohrmann S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-63; Salama A, 2015, XENOTRANSPLANTATION, V22, P85, DOI 10.1111/xen.12142; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Samraj AN, 2015, P NATL ACAD SCI USA, V112, P542, DOI 10.1073/pnas.1417508112; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Schwingshackl L, 2018, INT J CANCER, V142, P1748, DOI 10.1002/ijc.31198; SHAW L, 1988, BIOL CHEM H-S, V369, P477, DOI 10.1515/bchm3.1988.369.1.477; Shilova N, 2015, TOP CURR CHEM, V366, P169, DOI 10.1007/128_2013_469; Singh PN, 2003, AM J CLIN NUTR, V78, p526S, DOI 10.1093/ajcn/78.3.526S; Sroga JM, 2015, CLIN OBSTET GYNECOLR, V1, P72; Tan TT, 2007, CURR OPIN IMMUNOL, V19, P209, DOI 10.1016/j.coi.2007.01.001; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Taylor RE, 2010, J EXP MED, V207, P1637, DOI 10.1084/jem.20100575; Varki A., 2017, ESSENTIALS GLYCOBIOL; Varki A, 2017, ESSENTIALS GLYCOBIOL, DOI [10.1186/s12885-017-3891-3, DOI 10.1186/S12885-017-3891-3]; Vieira AR, 2017, ANN ONCOL, V28, P1788, DOI 10.1093/annonc/mdx171; Wallace K, 2009, CANCER EPIDEM BIOMAR, V18, P2310, DOI 10.1158/1055-9965.EPI-09-0211; Wandall HH, 2010, CANCER RES, V70, P1306, DOI 10.1158/0008-5472.CAN-09-2893; WANG D, 1993, J BIOL CHEM, V268, P20584; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168; Weinberg RA, 2014, BIOLOGY OF CANCER, SECOND EDITION, P1; Welch AA, 2001, PUBLIC HEALTH NUTR, V4, P1253, DOI 10.1079/PHN2001196; WILLETT WC, 1988, AM J EPIDEMIOL, V127, P188, DOI 10.1093/oxfordjournals.aje.a114780; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wilson KM, 2009, CANCER CAUSE CONTROL, V20, P269, DOI 10.1007/s10552-008-9241-7; WOOD C, 1981, J EXP MED, V154, P432, DOI 10.1084/jem.154.2.432; Yan ZQ, 2007, IMMUNOL REV, V219, P187, DOI 10.1111/j.1600-065X.2007.00554.x; Yu H, 2007, ORG BIOMOL CHEM, V5, P2458, DOI 10.1039/b706507h; Zelber-Sagi S., 2018, J HEPATOL; Zhao ZW, 2017, ONCOTARGET, V8, P83306, DOI 10.18632/oncotarget.20667; Zur Hausen H, 2017, CURR TOP MICROBIOL I	91	33	34	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0197464	10.1371/journal.pone.0197464	http://dx.doi.org/10.1371/journal.pone.0197464			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912879	gold, Green Submitted, Green Published			2022-12-26	WOS:000435528600009
J	Ayanful-Torgby, R; Quashie, NB; Boampong, JN; Williamson, KC; Amoah, LE				Ayanful-Torgby, Ruth; Quashie, Neils B.; Boampong, Johnson N.; Williamson, Kim C.; Amoah, Linda E.			Seasonal variations in Plasmodium falciparum parasite prevalence assessed by varying diagnostic tests in asymptomatic children in southern Ghana	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MALARIA TRANSMISSION; GAMETOCYTES; QUANTIFICATION; IDENTIFICATION; INFECTIONS; EXPRESSION; MICROSCOPY; VIVAX; STAGE	Plasmodium falciparum infections presenting either as symptomatic or asymptomatic may contain sexual stage parasites (gametocytes) that are crucial to malaria transmission. In this study, the prevalence of microscopic and submicroscopic asexual and gametocyte parasite stages were assessed in asymptomatic children from two communities in southern Ghana. Eighty children aged twelve years and below, none of whom exhibited signs of clinical malaria living in Obom and Cape Coast were sampled twice, one during the rainy (July 2015) and subsequently during the dry (January 2016) season. Venous blood was used to prepare thick and thin blood smears, spot a rapid malaria diagnostic test (PfHRP2 RDT) as well as prepare filter paper blood spots. Blood cell pellets were preserved in Trizol for RNA extraction. Polymerase chain reaction (PCR) and semi-quantitative real time reverse transcriptase PCR (qRT-PCR) were used to determine submicroscopic parasite prevalence. In both sites 87% (95% CI: 78-96) of the asymptomatic individuals surveyed were parasites positive during the 6 month study period. The prevalence of asexual and gametocyte stage parasites in the rainy season were both significantly higher in Obom than in Cape Coast (P < 0.001). Submicroscopic gametocyte prevalence was highest in the rainy season in Obom but in the dry season in Cape Coast. Parasite prevalence determined by PCR was similar to that determined by qRT-PCR in Obom but significantly lower than that determined by qRT-PCR in Cape Coast. Communities with varying parasite prevalence exhibit seasonal variations in the prevalence of gametocyte carriers. Submicroscopic asymptomatic parasite and gametocyte carriage is very high in southern Ghana, even during the dry season in communities with low microscopic parasite prevalence and likely to be missed during national surveillance exercises.	[Ayanful-Torgby, Ruth; Amoah, Linda E.] Univ Ghana, Noguchi Mem Inst Med Res, Dept Immunol, Accra, Ghana; [Ayanful-Torgby, Ruth; Boampong, Johnson N.] Univ Cape Coast, Sch Biomed Sci, Cape Coast, Ghana; [Quashie, Neils B.] Univ Ghana, Ctr Trop Clin Pharmacol & Therapeut, Accra, Ghana; [Williamson, Kim C.] Uniform Serv Univ Hlth Sci, Dept Microbiol, Bethesda, MD USA	University of Ghana; University of Cape Coast; University of Ghana	Amoah, LE (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Dept Immunol, Accra, Ghana.	lamoah@noguchi.ug.edu.gh	Amoah, Linda/AAY-6198-2021	Amoah, Linda/0000-0002-1652-8489; Ayanful-Torgby, Ruth/0000-0003-1066-3345; Boampong, Johnson/0000-0003-2464-2289; QUASHIE, NEILS/0000-0002-2538-0324	Ghana government Book and Research allowance; US-NIH Grant [AI069314]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069314] Funding Source: NIH RePORTER	Ghana government Book and Research allowance; US-NIH Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Ghana government Book and Research allowance to LEA as well as a US-NIH Grant # AI069314 awarded to KW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1038-z; Amoah LE, 2016, MALARIA J, P15; Arnott A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-14; Atelu Geoffrey R, 2016, Ghana Med J, V50, P220, DOI 10.4314/gmj.v50i4.4; Ayanful-Torgby R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1640-8; Babiker HA, 1999, MOL BIOCHEM PARASIT, V99, P143, DOI 10.1016/S0166-6851(98)00175-3; Badu K, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0861-y; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; BRUCE MC, 1990, PARASITOLOGY, V100, P191, DOI 10.1017/S0031182000061199; Clinical Group, 2015, MOL TEST MAL STAND O; Dery DB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-314; Dinko B, 2013, INT J PARASITOL-DRUG, V3, P45, DOI 10.1016/j.ijpddr.2013.01.001; Dolo A, 2005, AM J TROP MED HYG, V72, P243, DOI 10.4269/ajtmh.2005.72.243; Drakeley C, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002452; Eksi S, 2002, MOL BIOCHEM PARASIT, V122, P127, DOI 10.1016/S0166-6851(02)00091-9; Eksi S, 2008, MOL BIOCHEM PARASIT, V160, P148, DOI 10.1016/j.molbiopara.2008.04.005; Galactionova K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127818; Ghana Health Service, 2014, NAT MAL CONTR PROGR; Ghana Statistical Service, 2017, GHAN MAL IND SURV GM; Ghana Statistical Service, 2011, MULT IND CLUST SURV; Ghana Urban Malaria Study, 2013, REP GHAN URB MAL STU; Greenhouse B, 2015, P NATL ACAD SCI USA, V112, P6782, DOI 10.1073/pnas.1507727112; Hawkes M, 2007, EXPERT REV ANTI-INFE, V5, P485, DOI 10.1586/14787210.5.3.485; Houze S, 2011, J CLIN MICROBIOL, V49, P2694, DOI 10.1128/JCM.00281-11; Karl S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-98; Koepfli C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126747; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Kyabayinze DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156954; LOBO CA, 1994, MOL BIOCHEM PARASIT, V68, P151, DOI 10.1016/0166-6851(94)00155-3; Mahende C, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1450-z; McKenzie FE, 2003, AM J TROP MED HYG, V69, P372, DOI 10.4269/ajtmh.2003.69.372; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Murphy SC, 2012, AM J TROP MED HYG, V86, P383, DOI 10.4269/ajtmh.2012.10-0658; Nankabirwa J. I., 2015, Malaria Journal, V14; Niang M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182189; Nkumama IN, 2017, TRENDS PARASITOL, V33, P128, DOI 10.1016/j.pt.2016.11.006; Nonvignon J, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1418-z; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Pava Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165340; Perandin F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004; Reiner Robert C Jr, 2015, Malar J, V14, P343, DOI 10.1186/s12936-015-0849-2; Schneider P, 2004, MOL BIOCHEM PARASIT, V137, P35, DOI 10.1016/j.molbiopara.2004.03.018; Schneider P, 2015, MOL BIOCHEM PARASIT, V199, P29, DOI 10.1016/j.molbiopara.2015.03.006; Severini C, 1999, MOL BIOCHEM PARASIT, V100, P247, DOI 10.1016/S0166-6851(99)00050-X; Shiff C, 2002, CLIN MICROBIOL REV, V15, P278, DOI 10.1128/CMR.15.2.278-293.2002; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Speybroeck N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016705; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Tangpukdee N, 2009, KOREAN J PARASITOL, V47, P93, DOI 10.3347/kjp.2009.47.2.93; Wampfler R, 2014, J INFECT DIS, V210, P1188, DOI 10.1093/infdis/jiu236; Wampfler R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076316; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2016, MAL MICR STAND OP PR; WHO, 2014, POL BRIEF MAL DIAG L; Wilson ML, 2012, CLIN INFECT DIS, V54, P1637, DOI 10.1093/cid/cis228; World Health Organization, 1990, T ROYAL SOC TROPI S2, V84, P23; World Health Organization, 2012, WHO WHO POL REC SEAS	60	26	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2018	13	6							e0199172	10.1371/journal.pone.0199172	http://dx.doi.org/10.1371/journal.pone.0199172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5RI	29906275	Green Published, Green Submitted, gold			2022-12-26	WOS:000435439400012
J	Dumais, KM; Chernyak, S; Nickerson, LD; Janes, AC				Dumais, Kelly M.; Chernyak, Sergey; Nickerson, Lisa D.; Janes, Amy C.			Sex differences in default mode and dorsal attention network engagement	PLOS ONE			English	Article							VERBAL WORKING-MEMORY; GENERALIZED ANXIETY DISORDER; HUMAN CONNECTOME PROJECT; PREFRONTAL CORTEX; INDIVIDUAL-DIFFERENCES; GENDER-DIFFERENCES; REWARD SENSITIVITY; EMOTION REGULATION; BRAIN ACTIVATION; SMOKING CUES	Focusing on sex differences is necessary to fully understand basic neurobiological processes such as the engagement of large-scale brain networks involved in attention. Prior work suggests that women show enhanced attention during tasks of reward/punishment relative to men. Yet, sex differences in the engagement of neural networks sub serving internal and external focus has been unexplored in regard to reward and punishment. Using data from a large sample (n = 190) of healthy participants from the Human Connectome Project, we investigated sex differences in default mode network (DMN), dorsal attention network (DAN), and frontal parietal network (FPN) activation during exposure to reward and punishment. To determine if sex differences are specific to valenced stimuli, we analyzed network activation during working memory. Results indicate that, relative to men, women have increased suppression of the DMN and greater activation of the DAN during exposure to reward and punishment. Given the relative roles of these networks in internal (DMN) and external (DAN) attention, this pattern of activation suggests that women have enhanced external attention to reward and punishment. In contrast, there were no sex differences in network activation during working memory, indicating that this sex difference is specific to the processing of reward and punishment. These findings suggest a neurobiological explanation for prior work showing women have greater sensitivity to reward/punishment and are more prone to psychiatric disorders characterized by enhanced attention to such stimuli. Furthermore, given the large sample from the Human Connectome Project, the current findings provide general implications for the study of sex as a biological variable in investigation of reward processes.	[Dumais, Kelly M.; Chernyak, Sergey; Nickerson, Lisa D.; Janes, Amy C.] McLean Hosp, McLean Imaging Ctr, 115 Mill St, Belmont, MA 02178 USA; [Dumais, Kelly M.; Chernyak, Sergey; Nickerson, Lisa D.; Janes, Amy C.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA	Harvard University; McLean Hospital; Harvard University; Harvard Medical School	Janes, AC (corresponding author), McLean Hosp, McLean Imaging Ctr, 115 Mill St, Belmont, MA 02178 USA.; Janes, AC (corresponding author), Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA.	ajanes@mclean.harvard.edu	Janes, Amy/A-5322-2013	Janes, Amy/0000-0002-3749-5006; Dumais, Kelly/0000-0002-8955-8400	National Institute on Drug Abuse [K01 029645, K02 DA042987, T32 DA015036-15, R21 M024565]; McDonnell Center for Systems Neuroscience at Washington University;  [1U54MH091657]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA024565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA042987, T32DA015036] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); McDonnell Center for Systems Neuroscience at Washington University; ; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute on Drug Abuse grants K01 029645 and K02 DA042987 to ACJ, T32 DA015036-15 to S. Lukas, and R21 M024565 to LDN. Data were in part provided by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research and by the McDonnell Center for Systems Neuroscience at Washington University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admon R, 2015, CURR OPIN PSYCHOL, V4, P114, DOI 10.1016/j.copsyc.2014.12.011; Andrews-Hanna JR, 2014, ANN NY ACAD SCI, V1316, P29, DOI 10.1111/nyas.12360; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; Barman A, 2015, SOC COGN AFFECT NEUR, V10, P1537, DOI 10.1093/scan/nsv044; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Costumero V, 2015, BRAIN STRUCT FUNCT, V220, P1807, DOI 10.1007/s00429-014-0760-6; Cross CP, 2011, PSYCHOL BULL, V137, P97, DOI 10.1037/a0021591; Dainer-Best J, 2017, BIOL PSYCHOL, V129, P231, DOI 10.1016/j.biopsycho.2017.09.005; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; DeVido J, 2009, PSYCHOL MED, V39, P1153, DOI 10.1017/S003329170800487X; Ding Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174100; Domes G, 2010, HUM BRAIN MAPP, V31, P758, DOI 10.1002/hbm.20903; Dumais KM, 2017, DRUG ALCOHOL DEPEN, V178, P469, DOI 10.1016/j.drugalcdep.2017.05.044; Evans KL, 2015, BRAIN COGNITION, V93, P42, DOI 10.1016/j.bandc.2014.11.006; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Goldstein JM, 2005, NEUROPSYCHOLOGY, V19, P509, DOI 10.1037/0894-4105.19.4.509; Gruber O, 2001, CEREB CORTEX, V11, P1047, DOI 10.1093/cercor/11.11.1047; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Harrison BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022964; Hill AC, 2014, BIOL PSYCHOL, V102, P18, DOI 10.1016/j.biopsycho.2014.06.008; Keller K, 2009, NEUROIMAGE, V47, P342, DOI 10.1016/j.neuroimage.2009.04.042; Kessler RC, 2007, ANNU REV CLIN PSYCHO, V3, P137, DOI 10.1146/annurev.clinpsy.3.022806.091444; Kinney KL, 2017, BEHAV THER, V48, P277, DOI 10.1016/j.beth.2016.06.002; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Konova AB, 2016, PSYCHIAT RES-NEUROIM, V248, P110, DOI 10.1016/j.pscychresns.2016.01.001; Krebs RM, 2012, CEREB CORTEX, V22, P607, DOI 10.1093/cercor/bhr134; Kroger JK, 2002, CEREB CORTEX, V12, P477, DOI 10.1093/cercor/12.5.477; Kujawa A., 2017, INT J PSYCHOPHYSIOL; Leach LS, 2008, SOC PSYCH PSYCH EPID, V43, P983, DOI 10.1007/s00127-008-0388-z; Li T, 2010, BEHAV BRAIN RES, V209, P148, DOI 10.1016/j.bbr.2010.01.033; Lithari C, 2010, BRAIN TOPOGR, V23, P27, DOI 10.1007/s10548-009-0130-5; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Lu SF, 2017, J INT MED RES, V45, P1518, DOI 10.1177/0300060517708920; Lusk BR, 2017, COGN AFFECT BEHAV NE, V17, P886, DOI 10.3758/s13415-017-0520-1; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; McLean CP, 2009, CLIN PSYCHOL REV, V29, P496, DOI 10.1016/j.cpr.2009.05.003; Miettunen J, 2007, COMPR PSYCHIAT, V48, P161, DOI 10.1016/j.comppsych.2006.10.007; Must A, 2006, J AFFECT DISORDERS, V90, P209, DOI 10.1016/j.jad.2005.12.005; Nickerson LD, 2018, BIORXIV, DOI [10.1101/111021, DOI 10.1101/111021]; Nolen-Hoeksema S, 2012, ANNU REV CLIN PSYCHO, V8, P161, DOI 10.1146/annurev-clinpsy-032511-143109; Pfabigan DM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01477; Santesso DL, 2011, PSYCHOPHYSIOLOGY, V48, P1481, DOI 10.1111/j.1469-8986.2011.01229.x; Schmidt H, 2009, HUM BRAIN MAPP, V30, P3609, DOI 10.1002/hbm.20783; Schoofs D, 2013, BEHAV BRAIN RES, V241, P144, DOI 10.1016/j.bbr.2012.12.004; Sharma A, 2017, AM J PSYCHIAT, V174, P657, DOI 10.1176/appi.ajp.2016.16070774; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spreckelmeyer KN, 2009, SOC COGN AFFECT NEUR, V4, P158, DOI 10.1093/scan/nsn051; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Ugurbil K, 2013, NEUROIMAGE, V80, P80, DOI 10.1016/j.neuroimage.2013.05.012; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Volkow ND, 2010, BIOESSAYS, V32, P748, DOI 10.1002/bies.201000042; Wang ZS, 2016, PSYCHIAT RES-NEUROIM, V249, P76, DOI 10.1016/j.pscychresns.2015.07.008; Wetherill RR, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-9; Winkler AM, 2015, NEUROIMAGE, V123, P253, DOI 10.1016/j.neuroimage.2015.05.092	62	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199049	10.1371/journal.pone.0199049	http://dx.doi.org/10.1371/journal.pone.0199049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ5MF	29902249	Green Published, Green Submitted, gold			2022-12-26	WOS:000435424900081
J	Oros, CL; Alves, F				Oros, Carl L.; Alves, Fabio			Leaf wound induced ultraweak photon emission is suppressed under anoxic stress: Observations of Spathiphyllum under aerobic and anaerobic conditions using novel in vivo methodology	PLOS ONE			English	Article							FLUORESCENCE; LIPOXYGENASE; LIGHT; BIOLUMINESCENCE; LUMINESCENCE; INDUCTION; VOLATILES; ORIGIN; LEAVES; PLANTS	Plants have evolved a variety of means to energetically sense and respond to abiotic and biotic environmental stress. Two typical photochemical signaling responses involve the emission of volatile organic compounds and light. The emission of certain leaf wound volatiles and light are mutually dependent upon oxygen which is subsequently required for the wound-induced lipoxygenase reactions that trigger the formation of fatty acids and hydroperoxides; ultimately leading to photon emission by chlorophyll molecules. A low noise photomultiplier with sensitivity in the visible spectrum (300-720 nm) is used to continuously measure long duration ultraweak photon emission of dark-adapting whole Spathiphyllum leaves (in vivo). Leaves were mechanically wounded after two hours of dark adaptation in aerobic and anaerobic conditions. It was found that (1) nitrogen incubation did not affect the pre-wound basal photocounts; (2) wound induced leaf biophoton emission was significantly suppressed when under anoxic stress; and (3) the aerobic wound induced emission spectra observed was > 650 nm, implicating chlorophyll as the likely emitter. Limitations of the PMT photocathode's radiant sensitivity, however, prevented accurate analysis from 700-720 nm. Further examination of leaf wounding profile photon counts revealed that the pre-wounding basal state (aerobic and anoxic), the anoxic wounding state, and the post-wounding aerobic state statistics all approximate a Poisson distribution. It is additionally observed that aerobic wounding induces two distinct exponential decay events. These observations contribute to the body of plant wound-induced luminescence research and provide a novel methodology to measure this phenomenon in vivo.	[Oros, Carl L.] Naval Postgrad Sch, Informat Sci Dept, Grad Sch Operat & Informat Sci, Monterey, CA 93943 USA; [Alves, Fabio] Naval Postgrad Sch, Phys Dept, Grad Sch Engn & Appl Sci, Monterey, CA USA	United States Department of Defense; United States Navy; Naval Postgraduate School; United States Department of Defense; United States Navy; Naval Postgraduate School	Oros, CL (corresponding author), Naval Postgrad Sch, Informat Sci Dept, Grad Sch Operat & Informat Sci, Monterey, CA 93943 USA.	cloros@nps.edu		Oros, Carl/0000-0002-5427-7684	Naval Postgraduate School Foundation	Naval Postgraduate School Foundation	Nominal funding for basic research equipment and supplies was received from the Naval Postgraduate School Foundation (http://www.npsfoundaton.org) (CLO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES FB, 1978, PLANT PHYSIOL, V62, P696, DOI 10.1104/pp.62.5.696; ABELES FB, 1986, ANNU REV PLANT PHYS, V37, P49, DOI 10.1146/annurev.pp.37.060186.000405; Akoumianaki-Ioannidou A, 2004, J PHOTOCH PHOTOBIO B, V73, P149, DOI 10.1016/j.jphotobiol.2003.11.007; Bajpai RP, 1999, J THEOR BIOL, V198, P287, DOI 10.1006/jtbi.1999.0899; Birtic S, 2011, PLANT J, V67, P1103, DOI 10.1111/j.1365-313X.2011.04646.x; BOVERIS A, 1980, PHOTOBIOCH PHOTOBIOP, V1, P175; Brilli F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020419; BUTLER WL, 1962, BIOCHIM BIOPHYS ACTA, V64, P309, DOI 10.1016/0006-3002(62)90739-4; Chen J, 2003, ENH958; Cifra M, 2014, J PHOTOCH PHOTOBIO B, V139, P2, DOI 10.1016/j.jphotobiol.2014.02.009; COLLI L, 1955, EXPERIENTIA, V11, P479, DOI 10.1007/BF02166829; Cordon GB, 2006, PHOTOCH PHOTOBIO SCI, V5, P735, DOI 10.1039/b517610g; Creath K, 2005, PROC SPIE, V5866, P338, DOI 10.1117/12.620846; Creath K, 2008, PROC SPIE, V7057, DOI 10.1117/12.800667; Evans J. R., 2018, LIGHT USE LEAF GAS E; Fall R, 1999, J GEOPHYS RES-ATMOS, V104, P15963, DOI 10.1029/1999JD900144; Flor-Henry Michel, 2004, BMC Plant Biology, V4, P19, DOI 10.1186/1471-2229-4-19; Flors C, 2006, J EXP BOT, V57, P1725, DOI 10.1093/jxb/erj181; Lagorio MG, 2015, PHOTOCH PHOTOBIO SCI, V14, P1538, DOI 10.1039/c5pp00122f; Gasanov R. A., 1963, SOV PHYSICSDOKLADY, V8, P619; HIDEG E, 1989, FEBS LETT, V250, P275, DOI 10.1016/0014-5793(89)80737-9; Hideg E, 2002, PHOTOCH PHOTOBIO SCI, V1, P934, DOI 10.1039/b201916g; Lichtenthaler HK, 2005, PHOTOSYNTHETICA, V43, P379, DOI 10.1007/s11099-005-0062-6; Lichtenthaler HK, 1997, TRENDS PLANT SCI, V2, P316, DOI 10.1016/S1360-1385(97)89954-2; Loreto F, 2006, PLANT CELL ENVIRON, V29, P1820, DOI 10.1111/j.1365-3040.2006.01561.x; Matsui K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036433; Misra AN, 2012, CHLOROPHYLL FLUORESC, DOI [10.5772/35111, DOI 10.5772/35111]; Mochizuki S, 2016, FEBS LETT, V590, P1017, DOI 10.1002/1873-3468.12133; Morker KH, 2011, PLANT SIGNAL BEHAV, V6, P1087, DOI 10.4161/psb.6.8.15823; MUKERJI I, 1993, BIOCHIM BIOPHYS ACTA, V1142, P311, DOI 10.1016/0005-2728(93)90159-D; Pedros R, 2008, PHOTOCH PHOTOBIO SCI, V7, P498, DOI 10.1039/b719506k; Ping Wu, 2009, Journal of Biomedical Science & Engineering, V2, P155, DOI 10.4236/jbise.2009.23026; Popp F.-A., 1994, Modern Physics Letters B, V8, P1269, DOI 10.1142/S0217984994001266; POPP F A, 1981, Collective Phenomena (London), V3, P187; POPP FA, 1988, EXPERIENTIA, V44, P576, DOI 10.1007/BF01953305; POPP FA, 1988, EXPERIENTIA, V44, P543, DOI 10.1007/BF01953300; Popp FA, 2003, INTEGRATIVE BIOPHYSICS: BIOPHOTONICS, P387; Popp Fritz-Albert, 2003, Indian Journal of Experimental Biology, V41, P391; Pospisil P, 2014, J PHOTOCH PHOTOBIO B, V139, P11, DOI 10.1016/j.jphotobiol.2014.02.008; Prasad A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09758-1; Prasad A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022345; Radotic K, 1998, GEN PHYSIOL BIOPHYS, V17, P289; ROSCHGER P, 1992, PHOTOCHEM PHOTOBIOL, V56, P281, DOI 10.1111/j.1751-1097.1992.tb02159.x; Shen X, 2003, INTEGRATIVE BIOPHYSICS: BIOPHOTONICS, P287; SHEN X, 1993, EXPERIENTIA, V49, P291, DOI 10.1007/BF01923404; SLAWINSKA D, 1983, PHOTOCHEM PHOTOBIOL, V37, P709, DOI 10.1111/j.1751-1097.1983.tb04544.x; ul Hassan MN, 2015, PLANT BIOTECHNOL J, V13, P727, DOI 10.1111/pbi.12368; Vartapetian BB, 2005, RUSS J PLANT PHYSL+, V52, P826, DOI 10.1007/s11183-005-0122-6; Vartapetian BB, 1997, ANN BOT-LONDON, V79, P3, DOI 10.1006/anbo.1996.0295; Vartapetian BB, 2015, PLANT ANEROBIC STRES, P1; Vartapetian BB, 1974, NATURE, V269; VESELOVSKII V. A., 1963, BIOFIZIKA, V8, P125; Wei JN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000852; Winkler R, 2009, PHOTOCHEM PHOTOBIOL, V85, P962, DOI 10.1111/j.1751-1097.2009.00537.x; Yang DS, 2009, HORTSCIENCE, V44, P396, DOI 10.21273/HORTSCI.44.2.396	55	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198962	10.1371/journal.pone.0198962	http://dx.doi.org/10.1371/journal.pone.0198962			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902232	Green Submitted, gold, Green Published			2022-12-26	WOS:000435424900068
J	Katsuno, Y; Qin, J; Oses-Prieto, J; Wang, HJ; Jackson-Weaver, O; Zhang, TW; Lamouille, S; Wu, J; Burlingame, A; Xu, J; Derynck, R				Katsuno, Yoko; Qin, Jian; Oses-Prieto, Juan; Wang, Hongjun; Jackson-Weaver, Olan; Zhang, Tingwei; Lamouille, Samy; Wu, Jian; Burlingame, Alma; Xu, Jian; Derynck, Rik			Arginine methylation of SMAD7 by PRMT1 in TGF-beta-induced epithelial-mesenchymal transition and epithelial stem-cell generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; DRUG-RESISTANCE; MIGRATION; RECEPTOR; GROWTH; ZEB1; EMT; DIFFERENTIATION; TUMORIGENICITY; PROLIFERATION	The epithelial-to-mesenchymal transdifferentiation (EMT) is crucial for tissue differentiation in development and drives essential steps in cancer and fibrosis. EMT is accompanied by reprogramming of gene expression and has been associated with the epithelial stem-cell state in normal and carcinoma cells. The cytokine transforming growth factor beta (TGF-beta) drives this program in cooperation with other signaling pathways and through TGF-beta-activated SMAD3 as the major effector. TGF-beta-induced SMAD3 activation is inhibited by SMAD7 and to a lesser extent by SMAD6, and SMAD6 and SMAD7 both inhibit SMAD1 and SMAD5 activation in response to the TGF-beta-related bone morphogenetic proteins (BMPs). We previously reported that, in response to BMP, protein arginine methyltransferase 1 (PRMT1) methylates SMAD6 at the BMP receptor complex, thereby promoting its dissociation from the receptors and enabling BMP-induced SMAD1 and SMAD5 activation. We now provide evidence that PRMT1 also facilitates TGF-beta-signaling by methylating SMAD7, which complements SMAD6 methylation. We found that PRMT1 is required for TGF-beta-induced SMAD3 activation, through a mechanism similar to that of BMP-induced SMAD6 methylation, and thus promotes the TGF-beta-induced EMT and epithelial stem-cell generation. This critical mechanism positions PRMT1 as an essential mediator of TGF-beta-signaling that controls the EMT and epithelial cell stemness through SMAD7 methylation.	[Katsuno, Yoko; Wang, Hongjun; Lamouille, Samy; Xu, Jian; Derynck, Rik] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Katsuno, Yoko; Wang, Hongjun; Lamouille, Samy; Xu, Jian; Derynck, Rik] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Oses-Prieto, Juan; Burlingame, Alma] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Derynck, Rik] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Derynck, Rik] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Qin, Jian; Jackson-Weaver, Olan; Zhang, Tingwei; Wu, Jian; Xu, Jian] Univ Southern Calif, Herman Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90033 USA; [Xu, Jian] Univ Southern Calif, Dept Biochem & Mol Med, Keck Sch Med, Los Angeles, CA 90033 USA; [Katsuno, Yoko] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan; [Qin, Jian] Wuhan Univ, Renmin Hosp, Cent Lab, Wuhan 430060, Hubei, Peoples R China; [Wang, Hongjun] NIAMS, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20852 USA; [Zhang, Tingwei] Virginia Tech, Caril Res Inst, Roanoke, VA 24016 USA; [Zhang, Tingwei] Virginia Tech, Sch Med, Roanoke, VA 24016 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Southern California; University of Southern California; University of Tokyo; Wuhan University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Xu, J (corresponding author), Univ Southern Calif, Ctr Craniofacial Mol Biol, 2250 Alcazar St,CSA 106, Los Angeles, CA 90033 USA.; Derynck, R (corresponding author), Univ Calif San Francisco, Broad Ctr Regenerat Med & Stem Cell Res, 35 Med Ctr Way,RMB 1027, San Francisco, CA 94143 USA.	xujian@usc.edu; rik.derynck@ucsf.edu	Wu, Jian/H-9404-2019; Xu, Jian/AAE-1415-2019	Wu, Jian/0000-0002-9272-5732; Zhang, Tingwei/0000-0003-2173-4663; Jackson-Weaver, Olan/0000-0002-0545-0647	Biomedical Research Technology Program of the National Institutes of Health National Center for Research Resources [5P41RR001614-29]; NIGMS, National Institutes of Health [8 P41 GM103481-29]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA136690, R01CA063101] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE026468, T90DE021982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER	Biomedical Research Technology Program of the National Institutes of Health National Center for Research Resources; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The MS analysis was provided by the Bio-Organic Biomedical Mass Spectrometry Resource at University of California San Francisco (A.L. Burlingame, Director) supported by the Biomedical Research Technology Program of the National Institutes of Health National Center for Research Resources under Grant 5P41RR001614-29; NIGMS, National Institutes of Health Grant 8 P41 GM103481-29; and the Howard Hughes Medical Institute.	Avasarala S, 2015, J BIOL CHEM, V290, P13479, DOI 10.1074/jbc.M114.636050; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Chuang CY, 2017, ONCOL REP, V38, P1115, DOI 10.3892/or.2017.5737; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gao YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19874; Gou YC, 2018, MECH DEVELOP, V152, P13, DOI 10.1016/j.mod.2018.05.001; Guan SH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010728; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hashimoto M, 2016, J BIOL CHEM, V291, P2237, DOI 10.1074/jbc.M115.684514; Hwang WL, 2014, NAT CELL BIOL, V16, P268, DOI 10.1038/ncb2910; Itoh F, 2014, SEMIN CELL DEV BIOL, V32, P98, DOI 10.1016/j.semcdb.2014.05.017; Krampert M, 2010, MOL CELL BIOL, V30, P3685, DOI 10.1128/MCB.00434-09; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Liao HW, 2015, J CLIN INVEST, V125, P4529, DOI 10.1172/JCI82826; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Miyazawa K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022095; Muthusamy BP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002325; Nakai K, 2018, BREAST CANCER-TOKYO, V25, P74, DOI 10.1007/s12282-017-0790-z; Oshimori N, 2015, CELL, V160, P963, DOI 10.1016/j.cell.2015.01.043; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Shia WJ, 2012, BLOOD, V119, P4953, DOI 10.1182/blood-2011-04-347476; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Tang SY, 2010, DEV BIOL, V344, P233, DOI 10.1016/j.ydbio.2010.05.004; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; Visvader JE, 2014, GENE DEV, V28, P1143, DOI 10.1101/gad.242511.114; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Xu J, 2013, MOL CELL, V51, P5, DOI 10.1016/j.molcel.2013.05.004; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu PL, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022087; Xu PL, 2014, MOL CELL, V56, P723, DOI 10.1016/j.molcel.2014.11.027; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09; Zhang T, 2018, J DENT RES, V97, P810, DOI 10.1177/0022034518755688; Zheng SS, 2013, MOL CELL, V52, P37, DOI 10.1016/j.molcel.2013.08.039; Zhou WZ, 2016, TUMOR BIOL, V37, P2613, DOI 10.1007/s13277-015-4098-3	43	42	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13059	13072		10.1074/jbc.RA118.002027	http://dx.doi.org/10.1074/jbc.RA118.002027			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29907569	hybrid, Green Published			2022-12-26	WOS:000442730200008
J	Taguchi, Y; Lu, L; Marrero-Winkens, C; Otaki, H; Nishida, N; Schatzl, HM				Taguchi, Yuzuru; Lu, Li; Marrero-Winkens, Cristobal; Otaki, Hiroki; Nishida, Noriyuki; Schatzl, Hermann M.			Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrPSc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prion; prion disease; protein crosslinking; protein misfolding; protein structure; protein conformation; prion conversion; prion protein	CREUTZFELDT-JAKOB-DISEASE; CODON 219; BETA-2-ALPHA-2 LOOP; TRANSGENIC MICE; NMR STRUCTURE; TRANSMISSION; MUTATION; POLYMORPHISM; AGGREGATION; BRIDGES	Prions are composed solely of the pathological isoform (PrPSc) of the normal cellular prion protein (PrPC). Identification of different PrPSc structures is crucially important for understanding prion biology because the pathogenic properties of prions are hypothesized to be encoded in the structures of PrPSc. However, these structures remain yet to be identified, because of the incompatibility of PrPSc with conventional high-resolution structural analysis methods. Previously, we reported that the region between the first and the second alpha-helix (H1 similar to H2) of PrPC might cooperate with the more C-terminal side region for efficient interactions with PrPSc. From this starting point, we created a series of PrP variants with two cysteine substitutions (C;C-PrP) forming a disulfide-crosslink between H1 similar to H2 and the distal region of the third helix (Ctrm). We then assessed the conversion capabilities of the C;C-PrP variants in N2a cells infected with mouse-adapted scrapie prions (22L-ScN2a). Specifically, Cys substitutions at residues 165, 166, or 168 in H1 similar to H2 were combined with cysteine scanning along Ctrm residues 220-229. We found that C;C-PrPs are expressed normally with glycosylation patterns and subcellular localization similar to WT PrP, albeit differing in expression levels. Interestingly, some C;C-PrPs converted to protease-resistant isoforms in the 22L-ScN2a cells, but not in Fukuoka1 prion-infected cells. Crosslink patterns of convertible C;C-PrPs indicated a positional change of H1 similar to H2 toward Ctrm in PrPSc-induced conformational conversion. Given the properties of the C;C-PrPs reported here, we propose that these PrP variants may be useful tools for investigating prion strain-specific structures and structure-phenotype relationships of PrPSc.	[Taguchi, Yuzuru; Lu, Li; Marrero-Winkens, Cristobal; Schatzl, Hermann M.] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB T2N 4Z6, Canada; [Taguchi, Yuzuru; Nishida, Noriyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Cellular & Mol Biol, Nagasaki 8528523, Japan; [Lu, Li; Marrero-Winkens, Cristobal; Schatzl, Hermann M.] Univ Calgary, Calgary Prion Res Unit, Calgary, AB, Canada; [Otaki, Hiroki] Nagasaki Univ, Grad Sch Biomed Sci, Ctr Bioinformat & Mol Med, Nagasaki 8528523, Japan	University of Calgary; Nagasaki University; University of Calgary; Nagasaki University	Taguchi, Y (corresponding author), Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB T2N 4Z6, Canada.; Taguchi, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Cellular & Mol Biol, Nagasaki 8528523, Japan.; Schatzl, HM (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	ytaguchi@nagasaki-u.ac.jp; hschaetz@ucalgary.ca	Otaki, Hiroki/N-1540-2019	Otaki, Hiroki/0000-0002-0556-8434; Schatzl, Hermann/0000-0003-4972-8740	National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health [R01 NS076853-01A1]; Alberta Innovates Health Solutions (AIHS) [201200002, 201600010]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076853] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alberta Innovates Health Solutions (AIHS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health Grant R01 NS076853-01A1 and Alberta Innovates Health Solutions (AIHS) Grants 201200002 and 201600010. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrimi U, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000113; Angers R, 2014, P NATL ACAD SCI USA, V111, P11169, DOI 10.1073/pnas.1404739111; Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Baron GS, 2011, BIOCHEMISTRY-US, V50, P4479, DOI 10.1021/bi2003907; Bett C, 2012, FASEB J, V26, P2868, DOI 10.1096/fj.11-200923; Biljan I, 2012, BIOCHEM J, V446, P243, DOI 10.1042/BJ20111940; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Damberger FF, 2011, P NATL ACAD SCI USA, V108, P17308, DOI 10.1073/pnas.1106325108; DeMarco ML, 2006, BIOCHEMISTRY-US, V45, P15573, DOI 10.1021/bi0612723; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Giachin G, 2013, MOLECULES, V18, P9451, DOI 10.3390/molecules18089451; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Hill AF, 2006, BRAIN, V129, P676, DOI 10.1093/brain/awl013; Hizume M, 2009, J BIOL CHEM, V284, P3603, DOI 10.1074/jbc.M809254200; Ishibashi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137958; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Knowles TPJ, 2006, BIOPHYS J, V91, P1494, DOI 10.1529/biophysj.106.081653; Kurt TD, 2014, J BIOL CHEM, V289, P10660, DOI 10.1074/jbc.M114.549030; Lukic A, 2010, ARCH NEUROL-CHICAGO, V67, P1021, DOI 10.1001/archneurol.2010.184; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Ohhashi Y, 2018, P NATL ACAD SCI USA, V115, P2389, DOI 10.1073/pnas.1715483115; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Saijo E, 2016, J VIROL, V90, P4905, DOI 10.1128/JVI.00088-16; Saverioni D, 2013, J BIOL CHEM, V288, P27972, DOI 10.1074/jbc.M113.477547; Seno H, 2000, ACTA NEUROPATHOL, V99, P125, DOI 10.1007/PL00007415; Shibuya S, 1998, ANN NEUROL, V43, P826, DOI 10.1002/ana.410430618; Shindoh R, 2009, J VIROL, V83, P3852, DOI 10.1128/JVI.01740-08; Shirai T, 2014, STRUCTURE, V22, P560, DOI 10.1016/j.str.2013.12.019; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; Striebel JF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002275; Taguchi Y, 2013, PRION, V7, P452, DOI 10.4161/pri.27500; Taguchi Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003466; Tamguney G, 2013, J GEN VIROL, V94, P443, DOI 10.1099/vir.0.045989-0; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Vazquez-Fernandez E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005835; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; Winklhofer KF, 2003, J BIOL CHEM, V278, P14961, DOI 10.1074/jbc.M209942200; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Zahn R, 2003, J MOL BIOL, V326, P225, DOI 10.1016/S0022-2836(02)01332-3	46	2	2	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12730	12740		10.1074/jbc.RA117.001633	http://dx.doi.org/10.1074/jbc.RA117.001633			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29934306	hybrid, Green Published			2022-12-26	WOS:000442203500007
J	Borzooeian, Z; Taslim, ME; Ghasemi, O; Rezvani, S; Borzooeian, G; Nourbakhsh, A				Borzooeian, Zahra; Taslim, Mohammad E.; Ghasemi, Omid; Rezvani, Saina; Borzooeian, Giti; Nourbakhsh, Amirhasan			A high precision method for length-based separation of carbon nanotubes using bio-conjugation, SDS-PAGE and silver staining	PLOS ONE			English	Article							CAPILLARY-ELECTROPHORESIS; SIZE SEPARATION; PURIFICATION; DNA; FRACTIONATION; CHROMATOGRAPHY; PROTEINS; HYDROGEN; POLYMER; STORAGE	Parametric separation of carbon nanotubes, especially based on their length is a challenge for a number of nano-tech researchers. We demonstrate a method to combine bio-conjugation, SDS-PAGE, and silver staining in order to separate carbon nanotubes on the basis of length. Egg-white lysozyme, conjugated covalently onto the single-walled carbon nanotubes surfaces using carbodiimide method. The proposed conjugation of a biomolecule onto the carbon nanotubes surfaces is a novel idea and a significant step forward for creating an indicator for length-based carbon nanotubes separation. The conjugation step was followed by SDS-PAGE and the nanotube fragments were precisely visualized using silver staining. This high precision, inexpensive, rapid and simple separation method obviates the need for centrifugation, additional chemical analyses, and expensive spectroscopic techniques such as Raman spectroscopy to visualize carbon nanotube bands. In this method, we measured the length of nanotubes using different image analysis techniques which is based on a simplified hydrodynamic model. The method has high precision and resolution and is effective in separating the nanotubes by length which would be a valuable quality control tool for the manufacture of carbon nanotubes of specific lengths in bulk quantities. To this end, we were also able to measure the carbon nanotubes of different length, produced from different sonication time intervals.	[Borzooeian, Zahra; Taslim, Mohammad E.] Northeastern Univ, Coll Engn, Dept Mech & Ind Engn, Boston, MA 02115 USA; [Ghasemi, Omid] Merrimack Pharmaceut Inc, Cambridge, MA USA; [Rezvani, Saina] Worcester Polytech Inst, Dept Comp Sci, Worcester, MA 01609 USA; [Borzooeian, Giti] Payamnoor Univ Esfahan, Dept Biol, Esfahan, Iran; [Nourbakhsh, Amirhasan] MIT, Dept Elect Engn Comp Sci, Boston, MA USA; [Ghasemi, Omid] Takeda Pharmaceut Co Ltd, Cambridge, MA USA	Northeastern University; Worcester Polytechnic Institute; Massachusetts Institute of Technology (MIT)	Borzooeian, Z (corresponding author), Northeastern Univ, Coll Engn, Dept Mech & Ind Engn, Boston, MA 02115 USA.	z.borzooeian@northeastern.edu						Asuri P, 2007, LANGMUIR, V23, P12318, DOI 10.1021/la702091c; Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Bandow S, 1997, J PHYS CHEM B, V101, P8839, DOI 10.1021/jp972026r; Bauer BJ, 2008, J PHYS CHEM C, V112, P1842, DOI 10.1021/jp077364z; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Becker ML, 2007, ADV MATER, V19, P939, DOI 10.1002/adma.200602667; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bonard JM, 1997, ADV MATER, V9, P827, DOI 10.1002/adma.19970091014; Borzooeian MET Z., 2017, RSC ADV; Borzooeian Z, 2010, J EXP NANOSCI, V5, P536, DOI 10.1080/17458081003699122; Chen P, 1999, SCIENCE, V285, P91, DOI 10.1126/science.285.5424.91; Cheng JP, 2012, INT J NANOMED, V7, P3731, DOI 10.2147/IJN.S30459; Chun J, 2008, ANAL CHEM, V80, P2514, DOI 10.1021/ac7023624; Coleman JN, 2000, ADV MATER, V12, P213, DOI 10.1002/(SICI)1521-4095(200002)12:3<213::AID-ADMA213>3.0.CO;2-D; Dillon AC, 1997, NATURE, V386, P377, DOI 10.1038/386377a0; Dillon AC, 1999, ADV MATER, V11, P1354, DOI 10.1002/(SICI)1521-4095(199911)11:16<1354::AID-ADMA1354>3.0.CO;2-N; Ding Z, 2004, BIOMATERIALS, V25, P1059, DOI 10.1016/S0142-9612(03)00615-X; DONG A, 1992, BIOCHEMISTRY-US, V31, P182, DOI 10.1021/bi00116a027; DONG A, 1992, BIOCHEMISTRY-US, V31, P9364, DOI 10.1021/bi00154a006; Doorn SK, 2003, J PHYS CHEM B, V107, P6063, DOI 10.1021/jp022631g; Doorn SK, 2002, J AM CHEM SOC, V124, P3169, DOI 10.1021/ja012364c; Duesberg GS, 1999, CHEM PHYS LETT, V310, P8, DOI 10.1016/S0009-2614(99)00594-1; Duesberg GS, 1998, APPL PHYS A-MATER, V67, P117, DOI 10.1007/s003390050747; Duesberg GS, 1998, CHEM COMMUN, P435, DOI 10.1039/a707465d; Duesberg GS, 1999, SYNTHETIC MET, V103, P2484, DOI 10.1016/S0379-6779(98)01068-6; Fagan JA, 2008, ADV MATER, V20, P1609, DOI 10.1002/adma.200702353; Fagan JA, 2007, J AM CHEM SOC, V129, P10607, DOI 10.1021/ja073115c; Farkas E, 2002, CHEM PHYS LETT, V363, P111, DOI 10.1016/S0009-2614(02)01203-4; Franklin AD, 2010, NAT NANOTECHNOL, V5, P858, DOI [10.1038/nnano.2010.220, 10.1038/NNANO.2010.220]; Goux-Capes L, 2006, PHYS STATUS SOLIDI A, V203, P1132, DOI 10.1002/pssa.200566164; Heller DA, 2004, J AM CHEM SOC, V126, P14567, DOI 10.1021/ja046450z; Hersam MC, 2008, NAT NANOTECHNOL, V3, P387, DOI 10.1038/nnano.2008.135; Holzinger M, 2000, APPL PHYS A-MATER, V70, P599, DOI 10.1007/s003390051087; Huang WJ, 2002, NANO LETT, V2, P311, DOI [10.1021/nl010095i, 10.1021/n1010095i]; Huang XY, 2005, ANAL CHEM, V77, P6225, DOI 10.1021/ac0508954; IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154, DOI 10.1080/00021369.1971.10860050; Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622; Li F, 2000, CARBON, V38, P2041, DOI 10.1016/S0008-6223(00)00061-0; Liu C, 1999, SCIENCE, V286, P1127, DOI 10.1126/science.286.5442.1127; Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253; Lustig SR, 2005, J PHYS CHEM B, V109, P2559, DOI 10.1021/jp0452913; Nair N, 2006, ANAL CHEM, V78, P7689, DOI 10.1021/ac0610917; Niyogi S, 2001, J AM CHEM SOC, V123, P733, DOI 10.1021/ja0024439; O'Connell MJ, 2001, CHEM PHYS LETT, V342, P265, DOI 10.1016/S0009-2614(01)00490-0; Raffaini G, 2010, J APPL BIOMATER BIOM, V8, P135, DOI 10.5301/JABB.2010.6093; Sayes CM, 2006, TOXICOL LETT, V161, P135, DOI 10.1016/j.toxlet.2005.08.011; Silverstein R.M., 2014, SPECTROMETRIC IDENTI, V8th; Singh BP, 2013, J NANOPART RES, V16, DOI [10.1007/s11051-013-2161-9, 10.1007/s11051-014-2354-x]; Strano MS, 2004, NANO LETT, V4, P543, DOI 10.1021/nl034937k; Sun XM, 2008, J AM CHEM SOC, V130, P6551, DOI 10.1021/ja8006929; Tagmatarchis N, 2005, CARBON, V43, P1984, DOI 10.1016/j.carbon.2005.03.011; Tasis D, 2003, CHEM-EUR J, V9, P4001, DOI 10.1002/chem.200304800; Tohji K, 1997, J PHYS CHEM B, V101, P1974, DOI 10.1021/jp962888c; Usrey ML, 2007, LANGMUIR, V23, P7768, DOI 10.1021/la063667t; Vetcher AA, 2006, NANOTECHNOLOGY, V17, P4263, DOI 10.1088/0957-4484/17/16/043; Wang X, 2013, CARBON, V53, P145, DOI 10.1016/j.carbon.2012.10.041; Yamamoto K, 1998, J PHYS D APPL PHYS, V31, pL34, DOI 10.1088/0022-3727/31/8/002; Yao Z, 1999, NATURE, V402, P273, DOI 10.1038/46241; Yudasaka M, 2000, APPL PHYS A-MATER, V71, P449, DOI 10.1007/s003390000688; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877; Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911; Ziegler KJ, 2007, J NANOSCI NANOTECHNO, V7, P2917, DOI 10.1166/jnn.2007.608; Ziegler KJ, 2005, NANO LETT, V5, P2355, DOI 10.1021/nl0510208; [No title captured], DOI DOI 10.1155/2013/578290	64	9	9	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0197972	10.1371/journal.pone.0197972	http://dx.doi.org/10.1371/journal.pone.0197972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29939999	Green Published, gold, Green Submitted			2022-12-26	WOS:000436088700001
J	Found, R; Kloppers, EL; Hurd, TE; St Clair, CC				Found, Rob; Kloppers, Elsabe L.; Hurd, Thomas E.; St Clair, Colleen Cassady			Intermediate frequency of aversive conditioning best restores wariness in habituated elk (Cervus canadensis)	PLOS ONE			English	Article							LONG-TERM-MEMORY; BEHAVIORAL SYNDROMES; WILDLIFE RESPONSES; PREDATION RISK; NORTH-AMERICA; MANAGEMENT; WOLVES; UNGULATE; MIGRATION; DISTANCE	In protected areas around the world, wildlife habituate to humans and human infrastructure, potentially resulting in human-wildlife conflict, and leading to trophic disruptions through excess herbivory and disconnection of predators from prey. For large species that threaten human safety, wildlife managers sometimes attempt to reverse habituation with aversive conditioning. This technique associates people as a conditioned stimulus with a negative, unconditioned stimulus, such as pain or fright, to increase wariness and prevent the need for lethal wildlife management. Resistance to aversive conditioning by some habituated individuals often results in more frequent conditioning events by managers, but there are few studies of conditioning frequency with which to evaluate the usefulness of this management response. We evaluated the effect of conditioning frequency on the wariness of elk (Cervus canadensis) by subjecting marked individuals to predator- resembling chases by people over a period of three months. In that time, animals were subjected to conditioning a total of 3, 4, 5, 6, 7, or 9 times which we analyzed as both an ordinal variable and a binary one divided into low (3-5) and high (6-9) conditioning frequencies. We measured wariness before, during, and after the conditioning period using flight response distances from an approaching researcher. During the conditioning period, overall wariness increased significantly for elk in both treatment groups, although the increase was significantly greater in individuals subjected to high conditioning frequencies. However in the post-conditioning period, wariness gains also declined most in the high-frequency group, equating to more rapid extinction of learned behaviour. Across all treatment frequencies, rapid changes in flight responses also characterized the individuals with the lowest wariness at the beginning of the study period, suggesting that individuals with greater behavioural flexibility are more likely to habituate to both people and their attempts to change wariness via aversive conditioning. Together, our results imply that aversive conditioning may be most effective at intermediate frequencies and that its utility might be further increased with proactive assessment of individual personalities in habituated wildlife.	[Found, Rob; Kloppers, Elsabe L.; St Clair, Colleen Cassady] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Hurd, Thomas E.] Pk Canada, Banff Natl Pk, Banff, AB, Canada; [Found, Rob] Pk Canada, Elk Isl Natl Pk, Ft Saskatchewan, AB, Canada	University of Alberta	Found, R (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.; Found, R (corresponding author), Pk Canada, Elk Isl Natl Pk, Ft Saskatchewan, AB, Canada.	found@ualberta.ca	Kloppers, Elsabe L/B-3570-2008; St. Clair, Colleen Cassady/A-2953-2016	St. Clair, Colleen Cassady/0000-0002-3378-795X	Alberta Conservation Association [0000334393]; Wildlife Foundation [0008780]; Canadian Circumpolar Institute [0010338]; Alberta Ingenuity/Innovates; Natural Science and Engineering Research Council [217166]	Alberta Conservation Association; Wildlife Foundation; Canadian Circumpolar Institute; Alberta Ingenuity/Innovates; Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funded by Alberta Conservation Association (grant #0000334393 to RF). Alberta Sports, Parks, Recreation and Wildlife Foundation (grant #0008780 to RF). Canadian Circumpolar Institute (grant #0010338 to RF). Alberta Ingenuity/Innovates (graduate scholarships to RF). Natural Science and Engineering Research Council (via a Vanier Scholarship to RF and a DiscoveryGrant grant, #217166, to CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGERMEIER WF, 1977, NATURWISSENSCHAFTEN, V64, P345, DOI 10.1007/BF00368732; Atickem A, 2014, ETHOLOGY, V120, P715, DOI 10.1111/eth.12242; Bejder L, 2009, MAR ECOL PROG SER, V395, P177, DOI 10.3354/meps07979; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Burns GL, 2003, TOURISM MANAGE, V24, P699, DOI 10.1016/S0261-5177(03)00146-8; Caniglia R, 2013, FORENSIC SCI INT-GEN, V7, P397, DOI 10.1016/j.fsigen.2012.11.001; Conover M., 2002, RESOLVING HUMAN WILD; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Dalla C, 2009, PHYSIOL BEHAV, V97, P229, DOI 10.1016/j.physbeh.2009.02.035; Demant H, 2011, APPL ANIM BEHAV SCI, V133, P228, DOI 10.1016/j.applanim.2011.05.010; Domjan M., 2010, PRINCIPLES LEARNING; Doran-Sheehy DM, 2007, AM J PRIMATOL, V69, P1354, DOI 10.1002/ajp.20442; Fernando P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050917; Found R, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160958; Found R, 2016, ANIM BEHAV, V115, P35, DOI 10.1016/j.anbehav.2016.02.007; Found R, 2018, J WILDLIFE MANAGE, V82, P747, DOI 10.1002/jwmg.21449; Geist V., 1982, ELK N AM ECOLOGY MAN; GOLDSTEIN ML, 1962, PSYCHOL REP, V11, P841; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; Herrero S, 2005, WILDLIFE SOC B, V33, P362, DOI 10.2193/0091-7648(2005)33[362:FTFBBH]2.0.CO;2; Holland W.D., 1983, ECOLOGICAL BIOPHYSIC, V1; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Johnson TL, CROSS BOUND PARK MAN; Kemenes I, 2011, EUR J NEUROSCI, V33, P143, DOI 10.1111/j.1460-9568.2010.07479.x; Kloppers EL, 2005, ECOL SOC, V10; Knight J, 2009, SOC ANIM, V17, P167, DOI 10.1163/156853009X418091; Malo JE, 2011, BIODIVERS CONSERV, V20, P3477, DOI 10.1007/s10531-011-0136-7; Marvin Zuckerman, 1991, PSYCHOBIOLOGY PERSON; Mazur R, 2008, J WILDLIFE MANAGE, V74, P48; McGuire TM, 2000, CAN J CIVIL ENG, V27, P523, DOI 10.1139/cjce-27-3-523; Mineka S, 2008, ACTA PSYCHOL, V127, P567, DOI 10.1016/j.actpsy.2007.11.007; Nietvelt CN, 2001, HERBIVORY INTERACTIO; Nolte D., 1999, GRAZING BEHAV LIVEST; Nolte DL, 2003, P 10 WILDL DAM MAN C; NORTH AJ, 1960, PSYCHOL REP, V6, P227; Ohta U, 2012, ECOL MODEL, V242, P20, DOI 10.1016/j.ecolmodel.2012.05.011; Proffitt KM, 2009, J WILDLIFE MANAGE, V73, P345, DOI 10.2193/2008-210; Rauer Georg, 2003, Ursus (Knoxville), V14, P215; Robbins P, 2006, GEOFORUM, V37, P185, DOI 10.1016/j.geoforum.2004.11.011; Rossler ST, 2012, WILDLIFE SOC B, V36, P176, DOI 10.1002/wsb.93; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Spaedtke HR, 2009, THESIS; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Stout RJ, 1997, WILDLIFE SOC B, V25, P348; Taylor AR, 2003, WILDLIFE SOC B, V31, P1263; Walter WD, 2010, WILDLIFE RES, V37, P630, DOI 10.1071/WR10021; Watters JV, 2007, APPL ANIM BEHAV SCI, V102, P364, DOI 10.1016/j.applanim.2006.05.036; White CA, 1998, WILDLIFE SOC B, V26, P449; White PCL, 2010, WILDLIFE RES, V37, P623, DOI 10.1071/WR10191; Whittaker D, 1998, WILDLIFE SOC B, V26, P312; Winnie J, 2006, BEHAV ECOL SOCIOBIOL, V61, P277, DOI 10.1007/s00265-006-0258-1; [No title captured]	54	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199216	10.1371/journal.pone.0199216	http://dx.doi.org/10.1371/journal.pone.0199216			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK3YY	29940021	Green Submitted, gold, Green Published			2022-12-26	WOS:000436088700010
J	Yang, JC; Roman-Urrestarazu, A; Brayne, C				Yang, Justin Christopher; Roman-Urrestarazu, Andres; Brayne, Carol			Binge alcohol and substance use across birth cohorts and the global financial crisis in the United States	PLOS ONE			English	Article							GREAT RECESSION; SOCIAL VULNERABILITY; AUSTERITY; HEALTH; PERSPECTIVE; DRINKING; IMPACT; POLICY	Background The social and economic consequences of the global financial crisis (GFC) of 2007-9 has had serious impacts on population health, economic prospects, and overall wellbeing in all generations, particularly Millennials, Generation X, and Baby Boomers. The ways in which intergenerational inequality and global economic crises have affected population health, particularly with respect to excessive drinking and substance use in disadvantaged population groups has been understudied. Consequently, in this article, we seek to characterise the effects of the GFC on national trends in binge alcohol and substance use among Millennials, Generation X, and Baby Boomers. By doing so, we aim to contribute to a fuller understanding of the ways in which socioeconomic disadvantage engendered by the GFC has disparately affected the wellbeing of these generational cohorts. Methods and findings We present results from National Survey on Drug Use and Health from 2007-16 to characterise binge alcohol and substance use among different generational cohorts in the United States during and after the GFC. Bivariate descriptive analysis and maximum-likelihood logit regressions focused on: (a) individual substances and binge drinking, (b) poly-use and (c) any use to simultaneously model how socioeconomic, demographic, and health characteristics were related to past-month substance use and to report the social, economic, and demographic correlates of substance use. Socioeconomic vulnerability was captured on a five-point scale comprised of: (1) health insurance status, (2) government assistance, (3) income, (4) self rated health, and (5) employment status. Millennials showed generally higher risk of binge alcohol and substance use during 2007-16 than Generation X, while Baby Boomers generally exhibited lower risk. Comparison of individual and poly-use patterns for the birth cohorts before and after reveals: Millennials were at significantly increased risk of use of binge alcohol (AOR = 1.51; 95% CI = 1.46-1.56), cocaine (AOR = 1.19; 95% CI = 1.03-1.37), heroin (AOR = 1.39; 95% CI = 1.01-1.91), and oxycontin (AOR = 2.33; 95% CI = 1.74-3.12) than Gen X while Baby Boomers were at significantly reduced risk of all substances. Nevertheless, Millennials were at significantly reduced risk of crack use (AOR = 0.33; 95% CI = 0.25-0.43) and poly-use (AOR = 0.56; 95% CI = 0.45-0.70) compared to Gen X. These differences may be related to measures of austerity and socioeconomic vulnerability. Millennials exhibited the highest vulnerability related to austerity with an average vulnerability score of 0.97 (95% CI = 0.96-0.98) while Baby Boomers exhibited the lowest average vulnerability score of 0.65 (95% CI = 0.64-0.66) with Generation X in between with 0.72 (95% CI = 0.71-0.73). Increased social and economic vulnerability after the 2007 crisis is strongly associated with higher rates of substance use in all generations. Conclusion Millennials have been especially affected by socioeconomic changes associated with the GFC as reflected by their heightened vulnerability and increased use of binge alcohol and other substances compared to preceding generations. These findings suggest that attention is needed to address disparities in socioeconomic vulnerability, relationships to substance use and overall mental health of Millennials to mitigate the potential long term negative impacts of the GFC. In the context of a continuing international opioid and heroin crisis, the ways in which Millennials have been differentially affected warrants much greater attention both from policymakers and from researchers.	[Yang, Justin Christopher; Roman-Urrestarazu, Andres; Brayne, Carol] Univ Cambridge, Inst Publ Hlth, Cambridge, England	University of Cambridge	Yang, JC (corresponding author), Univ Cambridge, Inst Publ Hlth, Cambridge, England.	jcy25@medschl.cam.ac.uk	Roman-Urrestarazu, Andres/U-9224-2018; Brayne, Carol/AAA-4285-2020; Yang, Justin Christopher/H-1780-2018	Roman-Urrestarazu, Andres/0000-0002-2405-9432; Brayne, Carol/0000-0001-5307-663X; Yang, Justin Christopher/0000-0003-2881-4906	Gillings Fellowship in Global Public Health	Gillings Fellowship in Global Public Health	Dr. Andres Roman-Urrestarazu was funded through the Gillings Fellowship in Global Public Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannon S., 2011, CPA J, V81, P61; Bor J, 2013, ALCOHOL ALCOHOLISM, V48, P343, DOI 10.1093/alcalc/agt002; Center for Behavioral Health Statistics and Quality, 2015, 2014 NAT SURV DRUG U; Chau PH, 2014, J URBAN HEALTH, V91, P1048, DOI 10.1007/s11524-014-9901-8; Chung JJ, 2016, WEALTH INEQUALITY EX; Danziger S., ANN AM ACAD POLITICA, V650, P6; Darvas Z, 2014, AUSTERITY POVERTY EU; Durdu C.B., 2017, MEASURING SEVERITY S; Elliott W, 2015, J ECON SURV, V29, P614, DOI 10.1111/joes.12124; Eyerman R, 1998, EUR J SOC THEORY, V1, P91, DOI [10.1177/136843198001001007, DOI 10.1177/136843198001001007]; Frasquilho D, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2720-y; Granados JAT, 2015, HEALTH POLICY, V119, P941, DOI 10.1016/j.healthpol.2015.04.009; Howe N, 2007, HARVARD BUS REV, V85, P41; International Monetary Fund, 2010, WORLD EC OUTL REB GR; Jenkins S.P., 2013, GREAT RECESSION DIST; Kolodny A, 2015, ANNU REV PUBL HEALTH, V36, P559, DOI 10.1146/annurev-publhealth-031914-122957; Kuerbis AN, 2015, J AM GERIATR SOC, V63, P321, DOI 10.1111/jgs.13237; Levenson AR, 2010, J BUS PSYCHOL, V25, P257, DOI 10.1007/s10869-010-9170-9; Manrique-Espinoza B, 2016, J AGING HEALTH, V28, P740, DOI 10.1177/0898264315609909; Matsaganis M, 2014, S EUR SOC POLIT, V19, P393, DOI 10.1080/13608746.2014.947700; Mechler H., 2013, J COLL CHARACTER, V14, P3570, DOI [10.1515/jcc-2013-0045, DOI 10.1515/JCC-2013-0045]; Merikangas KR, 2012, HUM GENET, V131, P779, DOI 10.1007/s00439-012-1168-0; Meyer BD, 2013, AM ECON REV, V103, P178, DOI 10.1257/aer.103.3.178; Mladovsky P, HLTH POLICY RESPONSE; Nadelmann E, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0157-y; National Center for Education Statistics, 2014, DEGR GRANT POSTS I C; Peek L, 2010, CHILD DEV, V81, P1260, DOI 10.1111/j.1467-8624.2010.01466.x; Rhodes W, 2002, 191856 US DEP JUST; Richman JA, 2012, J ADDICT DIS, V31, P158, DOI 10.1080/10550887.2012.665692; Stuckler D, 2015, HEALTH ECON POLICY L, V10, P83, DOI 10.1017/S1744133114000255; Suffoletto B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142877; Verick S, 2011, FROM THE GREAT RECESSION TO LABOUR MARKET RECOVERY: ISSUES, EVIDENCE AND POLICY OPTIONS, P119; Verick S, 2010, IZA DISCUSSION PAPER; Vijayasiri G, 2012, ADDICT BEHAV, V37, P1019, DOI 10.1016/j.addbeh.2012.04.007; Zahran S, 2011, RISK ANAL, V31, P1107, DOI 10.1111/j.1539-6924.2010.01580.x; Zezza G, 2012, REV KEYNES ECON, P37	36	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199741	10.1371/journal.pone.0199741	http://dx.doi.org/10.1371/journal.pone.0199741			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK3YY	29940033	Green Published, Green Submitted, gold			2022-12-26	WOS:000436088700040
J	Hofma, BR; Wardill, HR; Mavrangelos, C; Campaniello, MA; Dimasi, D; Bowen, JM; Smid, SD; Bonder, CS; Beckett, EA; Hughes, PA				Hofma, Ben R.; Wardill, Hannah R.; Mavrangelos, Chris; Campaniello, Melissa A.; Dimasi, David; Bowen, Joanne M.; Smid, Scott D.; Bonder, Claudine S.; Beckett, Elizabeth A.; Hughes, Patrick A.			Colonic migrating motor complexes are inhibited in acute tri-nitro benzene sulphonic acid colitis	PLOS ONE			English	Article							PIG DISTAL COLON; IRRITABLE-BOWEL-SYNDROME; ENTERIC NERVOUS-SYSTEM; TNBS-INDUCED COLITIS; MYENTERIC NEURONS; INFLAMMATION; ACTIVATION; MOTILITY; MOUSE; NEUROPLASTICITY	Background Inflammatory Bowel Disease (IBD) is characterized by overt inflammation of the intestine and is typically accompanied by symptoms of bloody diarrhea, abdominal pain and cramping. The Colonic Migrating Motor Complex (CMMC) directs the movement of colonic luminal contents over long distances. The tri-nitrobenzene sulphonic acid (TNBS) model of colitis causes inflammatory damage to enteric nerves, however it remains to be determined whether these changes translate to functional outcomes in CMMC activity. We aimed to visualize innate immune cell infiltration into the colon using two-photon laser scanning intravital microscopy, and to determine whether CMMC activity is altered in the tri-nitro benzene sulphonic (TNBS) model of colitis. Methods Epithelial barrier permeability was compared between TNBS treated and healthy control mice in-vitro and in-vivo. Innate immune activation was determined by ELISA, flow cytometry and by 2-photon intravital microscopy. The effects of TNBS treatment and IL-1 beta on CMMC function were determined using a specialized organ bath. Results TNBS colitis increased epithelial barrier permeability in-vitro and in-vivo. Colonic IL-1 beta concentrations, colonic and systemic CD11b+ cell infiltration, and the number of migrating CD11b+ cells on colonic blood vessels were all increased in TNBS treated mice relative to controls. CMMC frequency and amplitude were inhibited in the distal and mid colon of TNBS treated mice. CMMC activity was not altered by superfusion with IL-1 beta. Conclusions TNBS colitis damages the epithelial barrier and increases innate immune cell activation in the colon and systemically. Innate cell migration into the colon is readily identifiable by two-photon intra-vital microscopy. CMMC are inhibited by inflammation, but this is not due to direct effects of IL-1 beta.	[Hofma, Ben R.; Bowen, Joanne M.; Smid, Scott D.; Bonder, Claudine S.; Beckett, Elizabeth A.; Hughes, Patrick A.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia; [Hofma, Ben R.; Mavrangelos, Chris; Campaniello, Melissa A.; Hughes, Patrick A.] Univ Adelaide, Ctr Nutr & GI Dis, Adelaide Med Sch, Adelaide, SA, Australia; [Hofma, Ben R.; Mavrangelos, Chris; Campaniello, Melissa A.; Hughes, Patrick A.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Dimasi, David; Bonder, Claudine S.] Univ South Australia, Ctr Canc Biol, Adelaide, SA, Australia; [Dimasi, David; Bonder, Claudine S.] SA Pathol, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI); Centre for Cancer Biology; University of South Australia; SA Pathology	Hughes, PA (corresponding author), Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia.; Hughes, PA (corresponding author), Univ Adelaide, Ctr Nutr & GI Dis, Adelaide Med Sch, Adelaide, SA, Australia.; Hughes, PA (corresponding author), South Australian Hlth & Med Res Inst, Adelaide, SA, Australia.	patrick.hughes@adelaide.edu.au	Hughes, Patrick Anthony/R-1283-2019	Hughes, Patrick Anthony/0000-0001-7324-3626; Beckett, Elizabeth/0000-0001-8256-0375; Bonder, Claudine S./0000-0001-9875-967X	NHMRC Australia [1085080, 1042952]; NHMRC R.D. Wright Fellowship	NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC R.D. Wright Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by NHMRC Australia project grant #1085080 and #1042952, and a NHMRC R.D. Wright Fellowship to PAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes KJ, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00096; BELL CJ, 1995, AM J PHYSIOL-GASTR L, V268, pG622, DOI 10.1152/ajpgi.1995.268.4.G622; Boyer L, 2005, AUTON NEUROSCI-BASIC, V117, P41, DOI 10.1016/j.autneu.2004.10.006; Brierley SM, 2014, NAT REV GASTRO HEPAT, V11, P611, DOI 10.1038/nrgastro.2014.103; Campaniello MA, 2016, NEUROGASTROENT MOTIL, V28, P54, DOI 10.1111/nmo.12696; Campaniello MA, 2017, BRAIN BEHAV IMMUN, V60, P319, DOI 10.1016/j.bbi.2016.11.015; Coulie B, 2001, ALIMENT PHARM THERAP, V15, P653, DOI 10.1046/j.1365-2036.2001.00959.x; Fida R, 1997, NEUROGASTROENT MOTIL, V9, P99, DOI 10.1046/j.1365-2982.1997.d01-25.x; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Hoffman JM, 2011, NEUROGASTROENT MOTIL, V23, P673, DOI 10.1111/j.1365-2982.2011.01702.x; Hughes PA, 2009, CLIN EXP PHARMACOL P, V36, P1034, DOI 10.1111/j.1440-1681.2009.05248.x; Hughes PA, 2009, GUT, V58, P1333, DOI 10.1136/gut.2008.170811; Hughes PA, 2014, BRAIN BEHAV IMMUN, V42, P191, DOI 10.1016/j.bbi.2014.07.001; Hughes PA, 2013, AM J GASTROENTEROL, V108, P1066, DOI 10.1038/ajg.2013.120; Hughes PA, 2013, GUT, V62, P1456, DOI 10.1136/gutjnl-2011-301856; Kelles A, 2002, NEUROGASTROENT MOTIL, V14, P321, DOI 10.1046/j.1365-2982.2002.00336.x; Kinoshita K, 2006, NEUROGASTROENT MOTIL, V18, P578, DOI 10.1111/j.1365-2982.2006.00784.x; Linden DR, 2005, NEUROGASTROENT MOTIL, V17, P751, DOI 10.1111/j.1365-2982.2005.00703.x; Linden DR, 2003, J PHYSIOL-LONDON, V547, P589, DOI 10.1113/jphysiol.2002.035147; Manning J, 2016, NEUROGASTROENT MOTIL, V28, P1016, DOI 10.1111/nmo.12803; Mawe GM, 2015, J CLIN INVEST, V125, P949, DOI 10.1172/JCI76306; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Poli E, 2001, NEUROCHEM RES, V26, P1085, DOI 10.1023/A:1012313424144; Safdari BK, 2016, CYTOKINE, V83, P231, DOI 10.1016/j.cyto.2016.04.017; Sanovic S, 1999, AM J PATHOL, V155, P1051, DOI 10.1016/S0002-9440(10)65207-8; Sarnelli G, 2009, DIGEST LIVER DIS, V41, P185, DOI 10.1016/j.dld.2008.06.004; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Smith TK, 2014, J NEUROGASTROENTEROL, V20, P423, DOI 10.5056/jnm14092; Spencer NJ, 2016, J PHYSIOL-LONDON, V594, P4099, DOI 10.1113/JP271919; Spencer NJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00184; Spencer Nick J., 2001, Current Opinion in Pharmacology, V1, P604, DOI 10.1016/S1471-4892(01)00103-5; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Strong DS, 2010, J PHYSIOL-LONDON, V588, P847, DOI 10.1113/jphysiol.2009.185082; Sun WY, 2016, J IMMUNOL, V196, P3854, DOI 10.4049/jimmunol.1501510; Tjwa ETTL, 2003, AM J PHYSIOL-GASTR L, V285, pG1268, DOI 10.1152/ajpgi.00073.2003; Wardill HR, 2016, MOL CANCER THER, V15, P2767, DOI 10.1158/1535-7163.MCT-16-0330; Winston JH, 2013, AM J PHYSIOL-GASTR L, V305, pG295, DOI 10.1152/ajpgi.00052.2013; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Xia Y, 1999, J CLIN INVEST, V103, P1309, DOI 10.1172/JCI5823	39	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199394	10.1371/journal.pone.0199394	http://dx.doi.org/10.1371/journal.pone.0199394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933379	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000436076600023
J	Wattenberg, BW				Wattenberg, Binks W.			The long and the short of ceramides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							HELA-CELLS; SYNTHASES; APOPTOSIS; STRESS	The sphingolipid ceramide is not only a precursor of more complex sphingolipids, but also a potent signaling molecule. Specific ceramide species have distinct cellular functions, and each ceramide synthase therefore has particular roles in cells and organisms. Tidhar and colleagues, utilizing two ceramide synthases differing widely in fatty acid specificity, have identified a short amino acid sequence that is critical for this specificity. This work represents a crucial first step in the understanding of both the enzymology and the biology driving the diverse functions of ceramide.	[Wattenberg, Binks W.] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA	Virginia Commonwealth University	Wattenberg, BW (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA.	brian.wattenberg@vcuhealth.org			National Institutes of Health [1R01HL131340]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant 1R01HL131340. The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Ferreira NS, 2017, J BIOL CHEM, V292, P7588, DOI 10.1074/jbc.M117.785345; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Law BA, 2018, FASEB J, V32, P1403, DOI 10.1096/fj.201700300R; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Rana MS, 2018, SCIENCE, V359, P176, DOI 10.1126/science.aao6326; Sassa T, 2012, BBA-MOL CELL BIOL L, V1821, P1031, DOI 10.1016/j.bbalip.2012.04.008; Senkal CE, 2011, J BIOL CHEM, V286, P42446, DOI 10.1074/jbc.M111.287383; Tidhar R, 2018, J BIOL CHEM, V293, P9912, DOI 10.1074/jbc.RA118.001936; Tidhar R, 2012, J BIOL CHEM, V287, P3197, DOI 10.1074/jbc.M111.280271	10	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9922	9923		10.1074/jbc.H118.003522	http://dx.doi.org/10.1074/jbc.H118.003522			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29934368	Green Published, hybrid			2022-12-26	WOS:000436102300033
J	Wong, EHC; Dong, YY; Coray, M; Cortada, M; Levano, S; Schmidt, A; Brand, Y; Bodmer, D; Muller, L				Wong, Eugene H. C.; Dong, You Yi; Coray, Mali; Cortada, Maurizio; Levano, Soledad; Schmidt, Alexander; Brand, Yves; Bodmer, Daniel; Muller, Laurent			Inner ear exosomes and their potential use as biomarkers	PLOS ONE			English	Article							GENTAMICIN-INDUCED TOXICITY; AUDITORY HAIR-CELLS; IN-VITRO; CANCER	Exosomes are nanovesicles involved in intercellular communications. They are released by a variety of cell types; however, their presence in the inner ear has not been described in the literature. The aims of this study were to determine if exosomes are present in the inner ear and, if present, characterize the changes in their protein content in response to ototoxic stress. In this laboratory investigation, inner ear explants of 5-day-old Wistar rats were cultured and treated with either cisplatin or gentamicin. Hair cell damage was assessed by confocal microscopy. Exosomes were isolated using ExoQuick, serial centrifugation, and minicolumn methods. Confirmation and characterization of exosomes was carried out using transmission electron microscopy (TEM), ZetaView, BCA protein analysis, and proteomics. Vesicles with a typical size distribution for exosomes were observed using TEM and ZetaView. Proteomic analysis detected typical exosome markers and markers for the organ of Corti. There was a statistically significant reduction in the exosome protein level and number of particles per cubic centimeter when the samples were exposed to ototoxic stress. Proteomic analysis also detected clear differences in protein expression when ototoxic medications were introduced. Significant changes in the proteomes of the exosomes were previously described in the context of hearing loss and ototoxic treatment. This is the first report describing exosomes derived from the inner ear. These findings may present an opportunity to conduct further studies with the hope of using exosomes as a biomarker to monitor inner ear function in the future.	[Wong, Eugene H. C.; Brand, Yves; Bodmer, Daniel; Muller, Laurent] Univ Hosp Basel, Dept Otolaryngol Head & Neck Surg, Basel, Switzerland; [Wong, Eugene H. C.; Dong, You Yi; Coray, Mali; Cortada, Maurizio; Levano, Soledad; Brand, Yves; Bodmer, Daniel; Muller, Laurent] Univ Basel, Dept Biomed, Basel, Switzerland; [Schmidt, Alexander] Univ Basel, Biozentrum, Prote Core Facil, Basel, Switzerland	University of Basel; University of Basel; University of Basel	Muller, L (corresponding author), Univ Hosp Basel, Dept Otolaryngol Head & Neck Surg, Basel, Switzerland.; Muller, L (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.	laurent.muller@usb.ch	Wong, Eugene/AAI-5955-2020	Wong, Eugene/0000-0001-7780-2616; Muller, Laurent/0000-0002-5987-6694; Levano, Soledad/0000-0002-0963-7951	University of Basel [DMS2334]; Krebsliga Beider Basel grant [18_2016]	University of Basel; Krebsliga Beider Basel grant	The study was supported by the University of Basel grant #DMS2334 and the Krebsliga Beider Basel grant #18_2016 to LM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrne E, 2016, J PROTEOME RES, V15, P2537, DOI 10.1021/acs.jproteome.6b00066; Brand Y, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-114; Caelers A, 2009, LARYNGOSCOPE, V119, P933, DOI 10.1002/lary.20058; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; De Toro J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00203; Denzer K, 2000, J CELL SCI, V113, P3365; Duscha S., 2015, AMINOGLYCOSIDE INDUC; Glutz A, 2015, AUDIOL NEURO-OTOL, V20, P360, DOI 10.1159/000438918; Hedlund M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016899; Hong CS, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.29289; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Levano S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.362; May LA, 2013, J CLIN INVEST, V123, P3577, DOI 10.1172/JCI68480; Muller L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20254; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; Patel M, 2013, NEUROSCIENCE, V248, P1, DOI 10.1016/j.neuroscience.2013.05.038; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Soares VYR, 2016, NEURO-ONCOLOGY, V18, P1498, DOI 10.1093/neuonc/now099; Szczepanski MJ, 2011, HAEMATOL-HEMATOL J, V96, P1302, DOI 10.3324/haematol.2010.039743; Urade Takeshi, 2014, Kobe J Med Sci, V60, pE57; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Zhang HG, 2014, AM J PATHOL, V184, P28, DOI 10.1016/j.ajpath.2013.09.027; Zhang X, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0181-x; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	25	15	15	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0198029	10.1371/journal.pone.0198029	http://dx.doi.org/10.1371/journal.pone.0198029			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933376	Green Published, gold, Green Submitted			2022-12-26	WOS:000436076600006
J	Pinho, P; Dias, T; Cordovil, CMDS; Dragosits, U; Dise, NB; Sutton, MA; Branquinho, C				Pinho, Pedro; Dias, Teresa; Cordovil, Claudia M. D. S.; Dragosits, Ulrike; Dise, Nancy B.; Sutton, Mark A.; Branquinho, Cristina			Mapping Portuguese Natura 2000 sites in risk of biodiversity change caused by atmospheric nitrogen pollution	PLOS ONE			English	Article							CRITICAL LOADS; COMMUNITY CHANGE; CLIMATE-CHANGE; DEPOSITION; AMMONIA; VEGETATION; IMPACT; HETEROGENEITY; ECOSYSTEMS; INDICATORS	In this paper, we assess and map the risk that atmospheric nitrogen (atN) pollution poses to biodiversity in Natura 2000 sites in mainland Portugal. We first review the ecological impacts of atN pollution on terrestrial ecosystems, focusing on the biodiversity of Natura 2000 sites. These nature protection sites, especially those located within the Mediterranean Basin, are under-characterized regarding the risk posed by atN pollution. We focus on ammonia (NH3) because this N form is mostly associated with agriculture, which co-occurs at or in the immediate vicinity of most areas of conservation interest in Portugal. We produce a risk map integrating NH3 emissions and the susceptibility of Natura 2000 sites to atN pollution, ranking habitat sensitivity to atN pollution using expert knowledge from a panel of Portuguese ecological and habitat experts. Peats, mires, bogs, and similar acidic and oligotrophic habitats within Natura 2000 sites (most located in the northern mountains) were assessed to have the highest relative risk of biodiversity change due to atN pollution, whereas Natura 2000 sites in the Atlantic and Mediterranean climate zone (coastal, tidal, and scrubland habitats) were deemed the least sensitive. Overall, results allowed us to rank all Natura 2000 sites in mainland Portugal in order of evaluated risk posed by atN pollution. The approach is of great relevance for stakeholders in different countries to help prioritize site protection and to define research priorities. This is especially relevant in countries with a lack of expertise to assess the impacts of nitrogen on biodiversity and can represent an important step up from current knowledge in such countries.	[Pinho, Pedro; Dias, Teresa; Branquinho, Cristina] Univ Lisbon, Fac Ciencias, cE3c, Lisbon, Portugal; [Pinho, Pedro] Univ Lisbon, Ctr Recursos Nat & Ambiente, Inst Super Tecn, CERENA, Lisbon, Portugal; [Cordovil, Claudia M. D. S.] Univ Lisbon, Inst Super Agron, LEAF, Lisbon, Portugal; [Dragosits, Ulrike; Dise, Nancy B.; Sutton, Mark A.] Edinburgh Res Stn, NERC Ctr Ecol & Hydrol CEH, Bush Estate, Penicuik, Midlothian, Scotland	Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; UK Centre for Ecology & Hydrology (UKCEH)	Pinho, P (corresponding author), Univ Lisbon, Fac Ciencias, cE3c, Lisbon, Portugal.; Pinho, P (corresponding author), Univ Lisbon, Ctr Recursos Nat & Ambiente, Inst Super Tecn, CERENA, Lisbon, Portugal.	ppinho@fc.ul.pt	Branquinho, Cristina/B-3670-2008; Pinho, Pedro/D-1232-2010; Sutton, Mark/K-2700-2012; dos Santos Cordovil, Claudia Marques/F-9505-2010; Machado Dias, Maria Teresa/E-8816-2015	Branquinho, Cristina/0000-0001-8294-7924; Pinho, Pedro/0000-0001-5571-9619; Sutton, Mark/0000-0002-1342-2072; dos Santos Cordovil, Claudia Marques/0000-0001-8864-2611; Machado Dias, Maria Teresa/0000-0002-5421-4763	'NitroPortugal: Strengthening Portuguese research and innovation capacities in the field of excess reactive nitrogen'; EU [H2020-TWINN-2015 692331]; Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BPD/75425/2010, SFRH/BPD/85419/2012]; Investigador FCT; NERC [ceh020011, ceh020001] Funding Source: UKRI	'NitroPortugal: Strengthening Portuguese research and innovation capacities in the field of excess reactive nitrogen'; EU(European Commission); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Investigador FCT(Portuguese Foundation for Science and Technology); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We are grateful for the funding through the project 'NitroPortugal: Strengthening Portuguese research and innovation capacities in the field of excess reactive nitrogen', funded by EU H2020-TWINN-2015 692331 and Fundacao para a Ciencia e Tecnologia (FCT) through the Post Doctoral grants SFRH/BPD/75425/2010 to Pedro Pinho and SFRH/BPD/85419/2012 to Teresa Dias, and Investigador FCT contract to Cristina Branquinho.	Balakrishnan N, 2012, MAYDICA, V57, P129; Bleeker A, 2011, ENVIRON POLLUT, V159, P2280, DOI 10.1016/j.envpol.2010.10.036; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Bobbink R, 2011, EFFECTS CCF; Bohan DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029028; Britto DT, 2002, J PLANT PHYSIOL, V159, P567, DOI 10.1078/0176-1617-0774; Bugalho MN, 2011, FRONT ECOL ENVIRON, V9, P278, DOI 10.1890/100084; Dias T, 2012, BIOGEOSCIENCES, V9, P193, DOI 10.5194/bg-9-193-2012; Dias T, 2014, PLOS ONE, V9, DOI [10.1371/journal0092517, DOI 10.1371/JOURNAL0092517]; Dias T, 2015, PLANT SOIL, V395, P243, DOI 10.1007/s11104-015-2552-z; Dias T, 2013, SOIL BIOL BIOCHEM, V58, P163, DOI 10.1016/j.soilbio.2012.10.027; Dias T, 2011, PLANT SOIL, V341, P125, DOI 10.1007/s11104-010-0628-3; Dise N.B., 2011, EUROPEAN NITROGEN AS, P463; Dragosits U, 2006, ENVIRON SCI POLICY, V9, P626, DOI 10.1016/j.envsci.2006.07.002; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Erisman JW, 2008, NAT GEOSCI, V1, P636, DOI 10.1038/ngeo325; FANGMEIER A, 1994, ENVIRON POLLUT, V86, P43, DOI 10.1016/0269-7491(94)90008-6; FAO, FAOSTAT FOOD AGR DAT; Fenn ME, 2010, J ENVIRON MANAGE, V91, P2404, DOI 10.1016/j.jenvman.2010.07.034; Field CD, 2014, ECOSYSTEMS, V17, P864, DOI 10.1007/s10021-014-9765-5; Fowler D, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0164; Hertel O, 2012, BIOGEOSCIENCES, V9, P4921, DOI 10.5194/bg-9-4921-2012; Holmberg M, 2013, ECOL INDIC, V24, P256, DOI 10.1016/j.ecolind.2012.06.013; Klausmeyer KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006392; Munzi S, 2011, PLANTA, V233, P333, DOI 10.1007/s00425-010-1300-0; Nilsson J, 1988, REPORT SKOKLOSTER WO, DOI DOI 10.1007/978-94-009-4003-1_11; Ochoa-Hueso R, 2017, ENVIRON POLLUT, V227, P194, DOI 10.1016/j.envpol.2017.04.062; Ochoa-Hueso R, 2014, BIOL FERT SOILS, V50, P191, DOI 10.1007/s00374-013-0838-y; Ochoa-Hueso R, 2011, ENVIRON POLLUT, V159, P2265, DOI 10.1016/j.envpol.2010.12.019; Pardo LH, 2011, ECOL APPL, V21, P3049, DOI 10.1890/10-2341.1; Payne RJ, 2017, FRONT ECOL ENVIRON, V15, P431, DOI 10.1002/fee.1528; Payne RJ, 2013, P NATL ACAD SCI USA, V110, P984, DOI 10.1073/pnas.1214299109; Pereira PM, 2003, CONSERV ECOL, V7; Phoenix GK, 2006, GLOBAL CHANGE BIOL, V12, P470, DOI 10.1111/j.1365-2486.2006.01104.x; Pinho P, 2014, ENVIRON POLLUT, V188, P88, DOI 10.1016/j.envpol.2014.01.024; Pinho P, 2012, BIOGEOSCIENCES, V9, P1205, DOI 10.5194/bg-9-1205-2012; Pinho P, 2012, ECOL INDIC, V15, P36, DOI 10.1016/j.ecolind.2011.09.022; Pinho P, 2011, J APPL ECOL, V48, P1107, DOI 10.1111/j.1365-2664.2011.02033.x; Pinho P, 2009, ATMOSPHERIC AMMONIA, P109, DOI 10.1007/978-1-4020-9121-6_10; Pinto-Marijuan M, 2013, TREE PHYSIOL, V33, P1328, DOI 10.1093/treephys/tpt077; Reef R, 2010, TREE PHYSIOL, V30, P1148, DOI 10.1093/treephys/tpq048; Reis S, 2012, SCIENCE, V338, P1153, DOI 10.1126/science.1226514; Robroek BJM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01350-5; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Samways J. M, 2010, INSECT CONSERVATION; Sheppard LJ, 2008, ENVIRON POLLUT, V154, P404, DOI 10.1016/j.envpol.2007.10.040; Sutton M.A, 2011, EUROPEAN NITROGEN AS, DOI DOI 10.1017/CBO9780511976988; Sutton MA, 1998, ENVIRON POLLUT, V102, P349, DOI 10.1016/S0269-7491(98)80054-7; Sutton MA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0166; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; Tylianakis JM, 2008, PLOS BIOL, V6, P947, DOI 10.1371/journal.pbio.0060122; van den Berg LJL, 2016, ENVIRON POLLUT, V208, P890, DOI 10.1016/j.envpol.2015.09.017; Vandenkoornhuyse P, 2007, P NATL ACAD SCI USA, V104, P16970, DOI 10.1073/pnas.0705902104; Vogt E, 2013, ENVIRON POLLUT, V179, P120, DOI 10.1016/j.envpol.2013.04.014; Wilkins K, 2016, ATMOS ENVIRON, V146, P324, DOI 10.1016/j.atmosenv.2016.07.016; Winiwarter W, 2013, CLIMATIC CHANGE, V120, P889, DOI 10.1007/s10584-013-0834-0	57	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198955	10.1371/journal.pone.0198955	http://dx.doi.org/10.1371/journal.pone.0198955			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927996	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000435802500037
J	Synnot, A; Bragge, P; Lunny, C; Menon, D; Clavisi, O; Pattuwage, L; Volovici, V; Mondello, S; Cnossen, MC; Donoghue, E; Gruen, RL; Maas, A				Synnot, Anneliese; Bragge, Peter; Lunny, Carole; Menon, David; Clavisi, Ornella; Pattuwage, Loyal; Volovici, Victor; Mondello, Stefania; Cnossen, Maryse C.; Donoghue, Emma; Gruen, Russell L.; Maas, Andrew			The currency, completeness and quality of systematic reviews of acute management of moderate to severe traumatic brain injury: A comprehensive evidence map	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIALS; INTRACRANIAL-PRESSURE MONITORS; SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; THERAPEUTIC HYPOTHERMIA; HYPERTONIC SALINE; MASS-PRODUCTION; OXYGEN-TENSION; ADULT PATIENTS; DOUBLE-BLIND	Objective To appraise the currency, completeness and quality of evidence from systematic reviews (SRs) of acute management of moderate to severe traumatic brain injury (TBI). Methods We conducted comprehensive searches to March 2016 for published, English-language SRs and RCTs of acute management of moderate to severe TBI. Systematic reviews and RCTs were grouped under 12 broad intervention categories. For each review, we mapped the included and non-included RCTs, noting the reasons why RCTs were omitted. An SR was judged as 'current' when it included the most recently published RCT we found on their topic, and 'complete' when it included every RCT we found that met its inclusion criteria, taking account of when the review was conducted. Quality was assessed using the AMSTAR checklist (trichotomised into low, moderate and high quality). Findings We included 85 SRs and 213 RCTs examining the effectiveness of treatments for acute management of moderate to severe TBI. The most frequently reviewed interventions were hypothermia (n = 17, 14.2%), hypertonic saline and/or mannitol (n = 9, 7.5%) and surgery (n = 8, 6.7%). Of the 80 single-intervention SRs, approximately half (n = 44, 55%) were judged as current and two-thirds (n = 52, 65.0%) as complete. When considering only the most recently published review on each intervention (n = 25), currency increased to 72.0% (n = 18). Less than half of the 85 SRs were judged as high quality (n = 38, 44.7%), and nearly 20% were low quality (n = 16, 18.8%). Only 16 (20.0%) of the single-intervention reviews (and none of the five multi-intervention reviews) were judged as current, complete and highquality. These included reviews of red blood cell transfusion, hypothermia, management guided by intracranial pressure, pharmacological agents (various) and prehospital intubation. Over three-quarters (n = 167, 78.4%) of the 213 RCTs were included in one or more SR. Of the remainder, 17 (8.0%) RCTs post-dated or were out of scope of existing SRs, and 29 (13.6%) were on interventions that have not been assessed in SRs. Conclusion A substantial number of SRs in acute management of moderate to severe TBI lack currency, completeness and quality. We have identified both potential evidence gaps and also substantial research waste. Novel review methods, such as Living Systematic Reviews, may ameliorate these shortcomings and enhance utility and reliability of the evidence underpinning clinical care.	[Synnot, Anneliese; Donoghue, Emma] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr ANZI, Melbourne, Vic, Australia; [Synnot, Anneliese; Clavisi, Ornella; Pattuwage, Loyal] Monash Univ, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Synnot, Anneliese; Lunny, Carole] Monash Univ, Cochrane Australia, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Synnot, Anneliese] La Trobe Univ, Sch Psychol & Publ Hlth, Cochrane Consumers & Commun, Melbourne, Vic, Australia; [Bragge, Peter] Monash Univ, Monash Sustainable Dev Inst, BehaviourWorks Australia, Melbourne, Vic, Australia; [Menon, David] Univ Cambridge, Addenbrookes Hosp, Neurosci Crit Care Unit, Queens Coll,Div Anaesthesia, Cambridge, England; [Clavisi, Ornella] Bone & Joint Hlth Ltd, MOVE Muscle, Melbourne, Vic, Australia; [Pattuwage, Loyal] Monash Univ, Monash Ctr Occupat & Environm Hlth MonCOEH, Melbourne, Vic, Australia; [Volovici, Victor] Erasmus MC Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Volovici, Victor] Erasmus MC Univ, Dept Neurosurg, Med Ctr, Rotterdam, Netherlands; [Mondello, Stefania] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Cnossen, Maryse C.] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands; [Gruen, Russell L.] Nanyang Technol Univ, Singapore, Singapore; [Gruen, Russell L.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Maas, Andrew] Univ Antwerp Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew] Univ Antwerp, Edegem, Belgium	Monash University; Monash University; Monash University; La Trobe University; Monash University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Monash University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Messina; Erasmus University Rotterdam; Erasmus MC; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Monash University; University of Antwerp; University of Antwerp	Synnot, A (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr ANZI, Melbourne, Vic, Australia.; Synnot, A (corresponding author), Monash Univ, Natl Trauma Res Inst, Melbourne, Vic, Australia.; Synnot, A (corresponding author), Monash Univ, Cochrane Australia, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.; Synnot, A (corresponding author), La Trobe Univ, Sch Psychol & Publ Hlth, Cochrane Consumers & Commun, Melbourne, Vic, Australia.	anneliese.synnot@monash.edu	Volovici, Victor/AAZ-8901-2020; Maas, Andrew IR/C-5584-2013; Mondello, Stefania/A-1813-2012	Volovici, Victor/0000-0002-5798-5360; Maas, Andrew IR/0000-0003-1612-1264; Mondello, Stefania/0000-0002-8587-3614; Lunny, Carole/0000-0002-7825-6765; Synnot, Anneliese/0000-0002-4008-4208; Bragge, Peter/0000-0003-0745-5131; Donoghue, Emma/0000-0002-2745-9108; Menon, David/0000-0002-3228-9692	European Union FP 7th Framework program [602150]; National Institute for Health Research (UK)	European Union FP 7th Framework program; National Institute for Health Research (UK)(National Institute for Health Research (NIHR))	This work was supported by the European Union FP 7th Framework program (Grant 602150). The funder provided support in the form of salary for AS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. DKM is supported by the National Institute for Health Research (UK). The specific roles of AS and DKM are articulated in the 'author contributions' section.	Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Aloizos S, 2015, TURK NEUROSURG, V25, P552, DOI 10.5137/1019-5149.JTN.9685-14.4; [Anonymous], 2017, LANCET T; [Anonymous], 2016, LIV SYST REV METH S; Arango MF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005400.pub3; Asehnoune K, 2014, LANCET RESP MED, V2, P706, DOI 10.1016/S2213-2600(14)70144-4; Badgett RG, 2015, JAMA PEDIATR, V169, P788, DOI 10.1001/jamapediatrics.2015.0681; Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; Banks CJ, 2008, EMERG MED AUSTRALAS, V20, P294, DOI 10.1111/j.1742-6723.2008.01086.x; Beca J, 2015, CRIT CARE MED, V43, P1458, DOI 10.1097/CCM.0000000000000947; Bennett MH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004609.pub3; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Boutin A, 2016, TRANSFUS MED REV, V30, P15, DOI 10.1016/j.tmrv.2015.08.004; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Bragge P, 2012, J NEUROTRAUM, V29, P1539, DOI 10.1089/neu.2011.2193; Bragge P, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-92; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Carney N, 2016, GUIDELINES MANAGEMEN; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Charidimou A, LANCET NEUROL, V15, P900, DOI [10.1016/81474-4422(16)30124-7, DOI 10.1016/81474-4422(16)30124-7]; CHENG SX, 2011, J NEUROTRAUM, V28, pA86; Cnossen MC, 2016, J NEUROTRAUMA; Cohen L, 2015, ANN EMERG MED, V65, P43, DOI 10.1016/j.annemergmed.2014.06.018; Crequit P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011841; Crequit P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0555-0; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Ebrahim S, 2016, J CLIN EPIDEMIOL, V70, P155, DOI 10.1016/j.jclinepi.2015.08.021; Eden J, 2011, I MED US COMM STAND; Elliott JH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001603; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; Fan Jun-Yu, 2004, J Neurosci Nurs, V36, P278; FANCONI S, 1988, INTENS CARE MED, V14, P163; Finfer S, 2015, INTENS CARE MED, V41, P1037, DOI 10.1007/s00134-015-3757-6; Flynn LMC, 2015, THER HYPOTHERMIA TEM, V5, P143, DOI 10.1089/ther.2015.0002; Forsyth RJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003984.pub2; Forsyth RJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002043.pub3; Fox JL, 2010, CAN J EMERG MED, V12, P355; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Fuller G, 2014, BRIT J NEUROSURG, V28, P452, DOI 10.3109/02688697.2013.865708; Gal R, 2012, BRAIN INJURY, V26, P629; Garner AA, 2015, EMERG MED J, V32, P869, DOI 10.1136/emermed-2014-204390; Garner P, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3507; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Grecu I, 2008, NUTR THER METAB, V26, P199; Gu JW, 2014, J CRIT CARE, V29, P287, DOI 10.1016/j.jcrc.2013.10.021; Guresir E, 2012, NEUROSURGERY, V70, P881, DOI 10.1227/NEU.0b013e318237a6a6; Gultekin R, 2016, INJURY, V47, P516, DOI 10.1016/j.injury.2015.10.011; Harris B, 2012, BRAIN INJURY, V26, P372, DOI 10.3310/hta16450; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Higgins J.P.T., 2016, METHODOLOGICAL EXPEC; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Ioannidis JPA, 2016, MILBANK Q, V94, P485, DOI 10.1111/1468-0009.12210; Jacob AT, 2011, PEDIATR NEUROSURG, V47, P81, DOI 10.1159/000329624; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Ker K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004896.pub4; Khalaf MM, 2011, EGYPTIAN J NEUROLOGY, V48, P43; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kim YJ, 2014, INT EMERG NURS, V22, P214, DOI 10.1016/j.ienj.2014.02.005; Koskinen LOD, 2015, NEUROCRIT CARE, V22, P26, DOI 10.1007/s12028-014-0030-8; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Kredo T, 2016, INT J QUAL HEALTH C, V28, P122, DOI 10.1093/intqhc/mzv115; Langham J, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000565/abstract, DOI 10.1002/14651858.CD000565/ABSTRACT]; Lazaridis C, 2014, NEUROCRIT CARE, V21, P345, DOI 10.1007/s12028-014-0007-7; Lecky F, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20010; Lefebvre C., 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184.CH6; Lei J, 2012, CHIN J TRAUMATOL, V15, P17, DOI 10.3760/cma.j.issn.1008-1275.2012.01.004; Lei Q, 2012, J MED COLL PLA, V27, P20; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Li MX, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002133; Li PC, 2014, BRAIN INJURY, V28, P1036, DOI 10.3109/02699052.2014.910609; Li ZM, 2012, NEUROSURG QUART, V22, P26, DOI 10.1097/WNQ.0b013e3182277e0c; Lin CM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/529580; Lourens A, 2015, AFRICAN J EMERGENCY, V4, P188; Lu J, 2015, ARCH PHYS MED REHAB, V96, P702, DOI 10.1016/j.apmr.2014.10.026; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Lunny C, 2016, OVERVIEW REV EXPLORE; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Madden LK, 2015, J NEUROSCI NURS, V47, P190, DOI 10.1097/JNN.0000000000000142; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; McDonagh M, 2004, ARCH PHYS MED REHAB, V85, P1198, DOI 10.1016/j.apmr.2003.12.026; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Mendelow AD, 2015, J NEUROTRAUM, V32, P1312, DOI 10.1089/neu.2014.3644; Mendelson AA, 2012, CAN J NEUROL SCI, V39, P571, DOI 10.1017/S0317167100015286; Meyer MJ, 2010, BRAIN INJURY, V24, P706, DOI 10.3109/02699051003692126; Miake-Lye IM, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0204-x; Moein H, 2012, NEUROSURG QUART, V22, P149, DOI 10.1097/WNQ.0b013e318240f1e0; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morrison LJ, 2011, J CRIT CARE, V26, P363, DOI 10.1016/j.jcrc.2010.08.021; Muzevic D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010193.pub2; Naghibi T, 2016, TURK J MED SCI, V46, P1, DOI 10.3906/sag-1404-125; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Nursal TZ, 2007, J CLIN NEUROSCI, V14, P344, DOI 10.1016/j.jocn.2005.11.011; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; OXMAN AD, 1994, JAMA-J AM MED ASSOC, V272, P1367, DOI 10.1001/jama.272.17.1367; Page MJ, 2016, MILBANK Q, V94, P515, DOI 10.1111/1468-0009.12211; Page MJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002028; Panic N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083138; Parveen Y, 2015, INDIAN J NEUROTRAUM, V12, P128, DOI 10.1055/s-0035-1569470; PENRY JK, 1979, NEUROLOGY, V29, P600; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; Perel P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007877.pub2; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Pickering A, 2015, J TRAUMA ACUTE CARE, V78, P164, DOI 10.1097/TA.0000000000000483; Pieper D, 2015, J CLIN EPIDEMIOL, V68, P574, DOI 10.1016/j.jclinepi.2014.12.009; Rahal AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153417; Razmkon Ali, 2011, Clin Neurosurg, V58, P133; Rickard AC, 2014, EMERG MED J, V31, P679, DOI 10.1136/emermed-2013-202679; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Roberts I, 1997, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000566/abstract, DOI 10.1002/14651858.CD000566/ABSTRACT]; Roberts I., 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001527/abstract, DOI 10.1002/14651858.CD001527/ABSTRACT]; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Robin Graham MM, 2011, CLIN PRACTICE GUIDEL, P75; Robinson KA, 2011, J CLIN EPIDEMIOL, V64, P1325, DOI 10.1016/j.jclinepi.2011.06.009; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Ryan R, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007768.pub2; Sadaka F, 2013, NEUROCRIT CARE, V19, pS283; Sadaka F, 2013, BRAIN INJURY, V27, P600, DOI 10.3109/02699052.2013.772238; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sanfilippo F, 2015, NEUROCRIT CARE, V22, P325, DOI 10.1007/s12028-014-0061-1; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Saxena M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006811.pub3; Schibler A, 2012, CRIT CARE RESUSC, V14, P20; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; Semenov A, 2012, J NEUROTRAUM, V29, pA37; Shakur H, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-109; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shen X, 2014, J HEAD TRAUMA REHAB, P1, DOI [10.1097/HTR.0b013e318281966e, DOI 10.1097/HTR.0B013E318281966E]; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Siddall ORM, 2005, ANN PHARMACOTHER, V39, P1309, DOI 10.1345/aph.1E637; Su SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087432; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub4; Synnot A., 2015, J NEUROTRAUMA; Szaflarski J, 2015, EPILEPSY CURR, V15, P144, DOI [10.5698/1535-7597-15.3.144, DOI 10.5698/1535-7597-15.3.144]; Taher A, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.26772; Tan M, 2011, CRIT CARE, V15, DOI 10.1186/cc10579; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Teasell R, 2007, BRAIN INJURY, V21, P201, DOI 10.1080/02699050701201854; Tendal B, 2009, BMJ, V339; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; TWYMAN D, 1985, JPEN-PARENTER ENTER, V9, P679, DOI 10.1177/0148607185009006679; Vandvik PO, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0596-4; Wakai A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub5; Wang R, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001733; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838; Wang X, 2014, J ANESTH, V28, P821, DOI 10.1007/s00540-014-1845-3; Wang Z, 2015, MOL NEUROBIOLOGY; Wangila DS, 2015, J ECON ENTOMOL, V108, P742, DOI 10.1093/jee/tou063; Wenjianfeng, 2011, J NEUROTRAUM, V28, pA45; Whiting P, 2016, J CLIN EPIDEMIOL, V69, P225, DOI 10.1016/j.jclinepi.2015.06.005; Willis C, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003986.pub2/abstract, DOI 10.1002/14651858.CD003986.PUB2/ABSTRACT]; Wong V, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007700.pub3/abstract, DOI 10.1002/14651858.CD007700.PUB3/ABSTRACT]; Yaghoobi S, 2015, J CLIN DIAGN RES, V9, pUC5, DOI 10.7860/JCDR/2015/13955.6383; Yan Y, 2010, J CLIN NEUROSCI, V17, P196, DOI 10.1016/j.jocn.2009.05.022; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460; Zafar SN, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-30; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023; Zeiler FA, 2014, NEUROCRIT CARE, V21, P332, DOI 10.1007/s12028-014-9978-7; Zeiler FA, 2014, NEUROCRIT CARE, V21, P163, DOI 10.1007/s12028-013-9950-y; Zeiler FA, 2015, J INTENSIVE CARE MED, P1; Zeng YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140624; Zhang BF, 2015, WORLD NEUROSURG, V83, P567, DOI 10.1016/j.wneu.2014.12.010	174	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198676	10.1371/journal.pone.0198676	http://dx.doi.org/10.1371/journal.pone.0198676			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK0LV	29927963	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500027
J	Garrido, F; Pacheco, M; Vargas-Martinez, R; Velasco-Garcia, R; Jorge, I; Serrano, H; Portillo, F; Vazquez, J; Pajares, MA				Garrido, Francisco; Pacheco, Maria; Vargas-Martinez, Rocio; Velasco-Garcia, Roberto; Jorge, Inmaculada; Serrano, Horacio; Portillo, Francisco; Vazquez, Jesus; Angeles Pajares, Maria			Identification of hepatic protein-protein interaction targets for betaine homocysteine S-methyltransferase	PLOS ONE			English	Article							RAT-LIVER; PEPTIDE IDENTIFICATION; METHIONINE METABOLISM; PLASMA HOMOCYSTEINE; MASS-SPECTROMETRY; GENE-EXPRESSION; MESSENGER-RNA; HEARING-LOSS; REVEALS; PHOSPHORYLATION	Protein-protein interactions are an important mechanism for the regulation of enzyme function allowing metabolite channeling, crosstalk between pathways or the introduction of post-translational modifications. Therefore, a number of high-throughput studies have been carried out to shed light on the protein networks established under different pathophysiological settings. Surprisingly, this type of information is quite limited for enzymes of intermediary metabolism such as betaine homocysteine S-methyltransferase, despite its high hepatic abundancy and its role in homocysteine metabolism. Here, we have taken advantage of two approaches, affinity purification combined with mass spectrometry and yeast two-hybrid, to further uncover the array of interactions of betaine homocysteine S-methyltransferase in normal liver of Rattus norvegicus. A total of 131 non-redundant putative interaction targets were identified, out of which 20 were selected for further validation by coimmunoprecipitation. Interaction targets validated by two different methods include: S-methylmethionine homocysteine methyltransferase or betaine homocysteine methyltransferase 2, methionine adenosyltransferases alpha 1 and alpha 2, cAMP-dependent protein kinase catalytic subunit alpha, 4-hydroxyphenylpyruvic acid dioxygenase and aldolase b. Network analysis identified 122 nodes and 165 edges, as well as a limited number of KEGG pathways that comprise: the biosynthesis of amino acids, cysteine and methionine metabolism, the spliceosome and metabolic pathways. These results further expand the connections within the hepatic methionine cycle and suggest putative cross-talks with additional metabolic pathways that deserve additional research.	[Garrido, Francisco; Pacheco, Maria; Vargas-Martinez, Rocio; Velasco-Garcia, Roberto; Portillo, Francisco; Angeles Pajares, Maria] UAM, CSIC, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid, Spain; [Jorge, Inmaculada; Vazquez, Jesus] Spanish Natl Ctr Cardiovasc Res, CNIC, Cardiovasc Prote Grp, Melchor Fernandez de Almagro 3, Madrid, Spain; [Jorge, Inmaculada; Vazquez, Jesus] CIBERCV, Melchor Fernandez de Almagro 3, Madrid, Spain; [Serrano, Horacio] Univ Puerto Rico, Dept Internal Med, Med Sci Campus, San Juan, PR 00936 USA; [Portillo, Francisco; Angeles Pajares, Maria] Inst Invest Sanitaria La Paz IdiPAZ, Paseo Castellana 261, Madrid, Spain; [Portillo, Francisco] Univ Autonoma Madrid, Fac Med, Dept Bioquim, Arzobispo Morcillo 4, Madrid, Spain; [Portillo, Francisco] Inst Salud Carlos III, Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain; [Angeles Pajares, Maria] CSIC, Ctr Invest Biol, Dept Biol Estruct & Quim, Ramiro de Maeztu 9, Madrid, Spain; [Vargas-Martinez, Rocio; Velasco-Garcia, Roberto] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Tlalnepantla, Estado De Mexic, Mexico	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Centro Nacional de Investigaciones Cardiovasculares (CNIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidad Nacional Autonoma de Mexico	Pajares, MA (corresponding author), UAM, CSIC, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid, Spain.; Pajares, MA (corresponding author), Inst Invest Sanitaria La Paz IdiPAZ, Paseo Castellana 261, Madrid, Spain.; Pajares, MA (corresponding author), CSIC, Ctr Invest Biol, Dept Biol Estruct & Quim, Ramiro de Maeztu 9, Madrid, Spain.	mapajares@cib.csic.es	Vazquez, Jesus/B-7697-2015; Pajares, Maria Angeles/I-5952-2012	Vazquez, Jesus/0000-0003-1461-5092; Jorge, Inmaculada/0000-0001-8645-9477; Portillo Perez, Francisco/0000-0003-4922-346X; Pajares, Maria Angeles/0000-0002-4714-9051	Ministerio de Economia, Industria y Competitividad [BFU2005-00050, BFU2008-00666, BFU2009-08977, BFU2008-04285]; Ministerio de Economia, Industria y Competitividad (MEIC); Pro CNIC Foundation; Severo Ochoa Center of Excellence [SEV-2015-0505]	Ministerio de Economia, Industria y Competitividad(Spanish Government); Ministerio de Economia, Industria y Competitividad (MEIC); Pro CNIC Foundation; Severo Ochoa Center of Excellence(Spanish Government)	This work was supported by grants of the Ministerio de Economia, Industria y Competitividad (BFU2005-00050, BFU2008-00666, BFU2009-08977 to MAP; BFU2008-04285 to FP). The CNIC is supported by the Ministerio de Economia, Industria y Competitividad (MEIC) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Antonov AV, 2011, NUCLEIC ACIDS RES, V39, pW323, DOI 10.1093/nar/gkr372; Arrondo JLR, 2006, BIOPHYS J, V90, p73a; Avila MA, 2000, J HEPATOL, V33, P907, DOI 10.1016/S0168-8278(00)80122-1; Bai GQ, 2005, WORLD J GASTROENTERO, V11, P3899; BERGER R, 1983, CLIN CHIM ACTA, V134, P129, DOI 10.1016/0009-8981(83)90191-2; Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014; Bonzon-Kulichenko E, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003335; Bouteldja N, 2010, J INHERIT METAB DIS, V33, P105, DOI 10.1007/s10545-010-9053-2; Breksa AP, 1999, BIOCHEMISTRY-US, V38, P13991, DOI 10.1021/bi991003v; Cheng P, 2005, WORLD J GASTROENTERO, V11, P5117; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; Delgado M, 2014, ANTIOXID REDOX SIGN, V20, P2541, DOI 10.1089/ars.2013.5342; Delgado-Reyes CV, 2001, ARCH BIOCHEM BIOPHYS, V393, P184, DOI 10.1006/abbi.2001.2474; Drew K, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167490; Evans JC, 2002, STRUCTURE, V10, P1159, DOI 10.1016/S0969-2126(02)00796-7; Fan WH, 2013, MOL MED REP, V7, P618, DOI 10.3892/mmr.2012.1232; Garcia-Pacios M, 2013, BIOPHYS J, V104, p73A, DOI 10.1016/j.bpj.2012.11.439; Garrido F, 2005, BIOCHEM J, V391, P589, DOI 10.1042/BJ20050505; Garrow TA, 1996, J BIOL CHEM, V271, P22831, DOI 10.1074/jbc.271.37.22831; Gertsman I, 2015, MOL GENET METAB, V114, P431, DOI 10.1016/j.ymgme.2015.01.005; Gonzalez B, 2004, J MOL BIOL, V338, P771, DOI 10.1016/j.jmb.2004.03.005; Gonzalez B, 2003, BIOCHEM J, V370, P945, DOI 10.1042/BJ20021510; Gonzalez B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050329; Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004; Hedman E, 2006, PROTEOMICS, V6, P3114, DOI 10.1002/pmic.200500266; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Ichikawa A, 2004, INT J BIOCHEM CELL B, V36, P1981, DOI 10.1016/j.biocel.2004.02.014; Ichikawa A, 2008, BIOSCI BIOTECH BIOCH, V72, P1056, DOI 10.1271/bbb.70796; Jakubowski H, 2011, ADV CLIN CHEM, V55, P81, DOI 10.1016/B978-0-12-387042-1.00005-8; Jorge I, 2007, J MASS SPECTROM, V42, P1391, DOI 10.1002/jms.1314; Kim HS, 2007, J BIOCHEM MOL BIOL, V40, P604; Li F, 2008, MOL GENET METAB, V94, P326, DOI 10.1016/j.ymgme.2008.03.013; Lopez-Ferrer D, 2004, ANAL CHEM, V76, P6853, DOI 10.1021/ac049305c; Lopez-Sanchez LM, 2010, LAB INVEST, V90, P116, DOI 10.1038/labinvest.2009.104; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Lundby A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1871; Martinez-Bartolome S, 2008, MOL CELL PROTEOMICS, V7, P1135, DOI 10.1074/mcp.M700239-MCP200; Martinez-Vega R, 2015, FASEB J, V29, P418, DOI 10.1096/fj.14-259283; MCKEEVER MP, 1991, CLIN SCI, V81, P551, DOI 10.1042/cs0810551; MICHALS K, 1978, J AM DIET ASSOC, V73, P507; Mingorance J, 1997, INT J BIOCHEM CELL B, V29, P485, DOI 10.1016/S1357-2725(96)00151-3; Navarro P, 2009, J PROTEOME RES, V8, P1792, DOI 10.1021/pr800362h; Newton BW, 2009, J PROTEOME RES, V8, P1663, DOI 10.1021/pr800905w; Noga AA, 2003, J BIOL CHEM, V278, P5952, DOI 10.1074/jbc.M212194200; Oeffner F, 2008, CELL MOTIL CYTOSKEL, V65, P143, DOI 10.1002/cm.20250; Pajares MA, 2006, CELL MOL LIFE SCI, V63, P2792, DOI 10.1007/s00018-006-6249-6; Pajares MA, 2013, FEBS LETT, V587, P1711, DOI 10.1016/j.febslet.2013.04.034; Pajares Maria A, 2011, Adv Enzymol Relat Areas Mol Biol, V78, P449; Perez C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161672; Perez-Hernandez D, 2013, J BIOL CHEM, V288, P11649, DOI 10.1074/jbc.M112.445304; Perez-Miguelsanz J, 2017, BBA-MOL CELL RES, V1864, P1165, DOI 10.1016/j.bbamcr.2017.03.004; Qaradakhi T, 2017, CARDIOVASC THER, V35, DOI 10.1111/1755-5922.12306; Rao PV, 1998, J BIOL CHEM, V273, P30669, DOI 10.1074/jbc.273.46.30669; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; ROSEN S, 1965, B NEW YORK ACAD MED, V41, P1052; Sanchez-Perez GF, 2003, J BIOL CHEM, V278, P7285, DOI 10.1074/jbc.M210177200; Sandu C, 2000, BIOL CHEM, V381, P619, DOI 10.1515/BC.2000.080; Sharma GS, 2015, BBA-GEN SUBJECTS, V1850, P2239, DOI 10.1016/j.bbagen.2015.08.013; Sowden MP, 1999, BIOCHEM J, V341, P639, DOI 10.1042/0264-6021:3410639; Sparks JD, 2006, BIOCHEM J, V395, P363, DOI 10.1042/BJ20051966; Sunden SLF, 1997, ARCH BIOCHEM BIOPHYS, V345, P171, DOI 10.1006/abbi.1997.0246; Szegedi SS, 2008, J BIOL CHEM, V283, P8939, DOI 10.1074/jbc.M710449200; Szegedi SS, 2004, ARCH BIOCHEM BIOPHYS, V426, P32, DOI 10.1016/j.abb.2004.03.040; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; UELAND PM, 1989, J LAB CLIN MED, V114, P473; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Wang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.67; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Wijekoon EP, 2007, BIOCHEM SOC T, V35, P1175, DOI 10.1042/BST0351175; Willis WL, 2018, J BIOL CHEM, V293, P8394, DOI 10.1074/jbc.RA117.001078; Wilson-Grady JT, 2013, METHODS, V61, P277, DOI 10.1016/j.ymeth.2013.03.031; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V269, P110, DOI 10.1006/bbrc.2000.2272; ZEISEL SH, 1980, P NATL ACAD SCI-BIOL, V77, P4417, DOI 10.1073/pnas.77.8.4417; Zeisel SH, 1979, TRANSMETHYLATION, P59; Zhang TJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010167	80	2	2	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199472	10.1371/journal.pone.0199472	http://dx.doi.org/10.1371/journal.pone.0199472			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924862	Green Published, gold			2022-12-26	WOS:000435655600069
J	Kundu, R; Knight, R; Dunga, M; Peakman, M				Kundu, Rhiannon; Knight, Robin; Dunga, Meenakshi; Peakman, Mark			In silico and ex vivo approaches indicate immune pressure on capsid and non-capsid regions of coxsackie B viruses in the human system	PLOS ONE			English	Article							T-CELLS; ENTEROVIRUS RNA; BETA-CELLS; TYPE-1; INFECTION; PHENOTYPE; CHILDREN; BLOOD; IDENTIFICATION; HETEROGENEITY	Coxsackie B Virus (CBV) infection has been linked to the aetiology of type 1 diabetes (T1D) and vaccination has been proposed as prophylaxis for disease prevention. Serum neutralising antibodies and the presence of viral protein and RNA in tissues have been common tools to examine this potential disease relationship, whilst the role of anti-CBV cytotoxic T cell responses and their targets have not been studied. To address this knowledge gap, we augmented conventional HLA-binding predictive algorithm-based epitope discovery by cross-referencing epitopes with sites of positive natural selection within the CBV3 viral genome, identified using mixed effects models of evolution. Eight epitopes for the common MHC class I allele HLA-A*0201 occur at sites that appear to be positively selected. Furthermore, such epitopes span the viral genome, indicating that effective anti-viral responses may not be restricted to the capsid region. To assess the spectrum of IFNy responses in non-diabetic subjects and recently diagnosed type 1 diabetes (T1D) patients, we stimulated PBMC ex vivo with pools of synthetic peptides based on component-restricted sequences identified in silico. We found responders were more likely to recognize multiple rather than a single CBV peptide pool, indicating that the natural course of infection results in multiple targets for effector memory responses, rather than immunodominant epitopes or viral components. The finding that anti-CBV CD8 T cell immunity is broadly targeted has implications for vaccination strategies and studies on the pathogenesis of CBV-linked diseases.	[Kundu, Rhiannon; Knight, Robin; Dunga, Meenakshi; Peakman, Mark] Kings Coll London, Fac Life Sci & Med, Sch Immunol Infect & Inflammatory Dis, Dept Immunobiol, London, England; [Peakman, Mark] Kings Coll London, Fac Life Sci & Med, Div Diabet & Nutr, London, England; [Peakman, Mark] Guys & St Thomas NHS Fdn Trust, NIHR Biomed Res Ctr, London, England; [Peakman, Mark] Kings Coll London, London, England	University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Peakman, M (corresponding author), Kings Coll London, Fac Life Sci & Med, Sch Immunol Infect & Inflammatory Dis, Dept Immunobiol, London, England.; Peakman, M (corresponding author), Kings Coll London, Fac Life Sci & Med, Div Diabet & Nutr, London, England.; Peakman, M (corresponding author), Guys & St Thomas NHS Fdn Trust, NIHR Biomed Res Ctr, London, England.; Peakman, M (corresponding author), Kings Coll London, London, England.	mark.peakman@kcl.ac.uk	Knight, Robin/ABA-6399-2020	Knight, Robin/0000-0002-9480-6675; Peakman, Mark/0000-0003-3328-3513	European Union's Seventh Framework Programme PEVNET [FP7] [261441]	European Union's Seventh Framework Programme PEVNET [FP7]	The work was supported by funding from the European Union's Seventh Framework Programme PEVNET [FP7/2007-007-2013] under grant agreement number 261441. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MA, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf7779; Alirezaei M, 2012, CELL HOST MICROBE, V11, P298, DOI 10.1016/j.chom.2012.01.014; Andreoletti L, 1997, J MED VIROL, V52, P121, DOI 10.1002/(SICI)1096-9071(199706)52:2&lt;121::AID-JMV1&gt;3.0.CO;2-5; Arif S, 2017, DIABETIC MED, V34, P419, DOI 10.1111/dme.13153; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Arif S, 2014, DIABETES, V63, P3835, DOI 10.2337/db14-0365; Bulek AM, 2012, NAT IMMUNOL, V13, P283, DOI 10.1038/ni.2206; Chehadeh T, 2000, J INFECT DIS, V181, P1929, DOI 10.1086/315516; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Grant E, 2013, IMMUNOL CELL BIOL, V91, P184, DOI 10.1038/icb.2012.78; Herold KC, 2009, DIABETES, V58, P2588, DOI 10.2337/db09-0249; Horwitz MS, 2004, CLIN IMMUNOL, V110, P134, DOI 10.1016/j.clim.2003.09.014; Kanno T, 2006, J VIROL, V80, P5637, DOI 10.1128/JVI.02361-05; Kemball CC, 2012, VIROLOGY, V429, P74, DOI 10.1016/j.virol.2012.04.005; Kemball CC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000618; Krogvold L, 2015, DIABETES, V64, P1682, DOI 10.2337/db14-1370; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Laitinen OH, 2014, DIABETES, V63, P446, DOI 10.2337/db13-0619; Larsen ME, 2011, IMMUNOGENETICS, V63, P43, DOI 10.1007/s00251-010-0493-5; Larsson PG, 2015, DIABETOLOGIA, V58, P346, DOI 10.1007/s00125-014-3436-0; Lin HC, 2015, DIABETOLOGIA, V58, P79, DOI 10.1007/s00125-014-3400-z; Liu W, 2012, EXP MOL PATHOL, V92, P327, DOI 10.1016/j.yexmp.2012.03.009; MCKINNEY RE, 1987, REV INFECT DIS, V9, P334; Moya-Suri V, 2005, J MED MICROBIOL, V54, P879, DOI 10.1099/jmm.0.46015-0; Nurminen Noora, 2012, Rev Diabet Stud, V9, P260, DOI 10.1900/RDS.2012.9.260; Oikarinen S, 2014, DIABETES, V63, P655, DOI 10.2337/db13-0620; Opavsky MA, 1999, CIRC RES, V85, P551, DOI 10.1161/01.RES.85.6.551; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Redchenko IV, 1999, J VIROL, V73, P334, DOI 10.1128/JVI.73.1.334-342.1999; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Shi XD, 2016, ARCH VIROL, V161, P2197, DOI 10.1007/s00705-016-2896-6; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skarsvik S, 2006, DIABETES, V55, P996, DOI 10.2337/diabetes.55.04.06.db05-0630; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Solache A, 1999, J IMMUNOL, V163, P5512; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Lummel M, 2014, DIABETES, V63, P237, DOI 10.2337/db12-1214; Varela-Calvino R, 2004, J VIROL, V78, P13399, DOI 10.1128/JVI.78.24.13399-13408.2004; Wegner J, 2015, BLOOD, V126, P185, DOI 10.1182/blood-2015-01-622704; Weinzierl AO, 2008, J GEN VIROL, V89, P2090, DOI 10.1099/vir.0.2008/000711-0; WILFERT CM, 1977, NEW ENGL J MED, V296, P1485, DOI 10.1056/NEJM197706302962601; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Yeung WCG, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d35; Yin H, 2002, DIABETES, V51, P1964, DOI 10.2337/diabetes.51.6.1964	44	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199323	10.1371/journal.pone.0199323	http://dx.doi.org/10.1371/journal.pone.0199323			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924875	Green Submitted, gold, Green Published			2022-12-26	WOS:000435655600062
J	Cantanhede, LM; Fernandes, FG; Ferreira, GEM; Porrozzi, R; Ferreira, RDGM; Cupolillo, E				Cantanhede, Lilian Motta; Fernandes, Flavia Goncalves; Melim Ferreira, Gabriel Eduardo; Porrozzi, Renato; Mattos Ferreira, Ricardo de Godoi; Cupolillo, Elisa			New insights into the genetic diversity of Leishmania RNA Virus 1 and its species-specific relationship with Leishmania parasites	PLOS ONE			English	Article							CUTANEOUS LEISHMANIASIS; COMPLETE SEQUENCE; IDENTIFICATION; BRAZILIENSIS; EVOLUTIONARY; COEVOLUTION; GUYANENSIS	Cutaneous leishmaniasis is a neglected parasitic disease that manifests in infected individuals under different phenotypes, with a range of factors contributing to its broad clinical spectrum. One factor, Leishmania RNA Virus 1 (LRV1), has been described as an endosymbiont present in different species of Leishmania. LRV1 significantly worsens the lesion, exacerbating the immune response in both experimentally infected animals and infected individuals. Little is known about the composition and genetic diversity of these viruses. Here, we investigated the relationship between the genetic composition of LRV1 detected in strains of Leishmania (Viannia) braziliensis and L. (V.) guyanensis and the interaction between the endosymbiont and the parasitic species, analyzing an approximately 850 base pair region of the viral genome. We also included one LRV1 sequence detected in L. (V.) shawi, representing the first report of LRV1 in a species other than L. braziliensis and L. guyanensis. The results illustrate the genetic diversity of the LRV1 strains analyzed here, with smaller divergences detected among viral sequences from the same parasite species. Phylogenetic analyses showed that the LRV1 sequences are grouped according to the parasite species and possibly according to the population of the parasite in which the virus was detected, corroborating the hypothesis of joint evolution of the viruses with the speciation of Leishmania parasites.	[Cantanhede, Lilian Motta; Fernandes, Flavia Goncalves; Melim Ferreira, Gabriel Eduardo; Mattos Ferreira, Ricardo de Godoi] Fundacao Oswaldo Cruz, Lab Epidemiol Genet, Unidade Rondonia, Porto Velho, Rondonia, Brazil; [Porrozzi, Renato; Cupolillo, Elisa] Fundacao Oswaldo Cruz, Lab Pesquisa Leishmaniose, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Cupolillo, E (corresponding author), Fundacao Oswaldo Cruz, Lab Pesquisa Leishmaniose, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.	elisa.cupolillo@ioc.fiocruz.br	Porrozzi, Renato/U-2166-2019; Ferreira, Gabriel EM/M-6028-2018; Cupolillo, Elisa/U-1667-2019; Cantanhede, Lilian M/L-2451-2014; Porrozzi, Renato/U-2059-2019	Porrozzi, Renato/0000-0003-2167-316X; Ferreira, Gabriel EM/0000-0002-3514-3031; Cupolillo, Elisa/0000-0002-0620-3250; Cantanhede, Lilian M/0000-0002-2376-4236; 	Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Epidemiologia da Amazonia Ocidental and Fundacao de Amparo ao Desenvolvimento das Acoes Cientificas e Tecnologicas de Pesquisa (FAPERO)	Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Epidemiologia da Amazonia Ocidental and Fundacao de Amparo ao Desenvolvimento das Acoes Cientificas e Tecnologicas de Pesquisa (FAPERO)	This work was supported by Fundacao Oswaldo Cruz (FIOCRUZ) - http://portal.fiocruz.br, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) - http.//www.faperi.br, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - http://www.cnpq.br, Instituto Nacional de Epidemiologia da Amazonia Ocidental and Fundacao de Amparo ao Desenvolvimento das Acoes Cientificas e Tecnologicas de Pesquisa (FAPERO)- http://fapero.ro.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaui V, 2016, ASS ENDOBIONT DOUBLE, P213, DOI [10.1093/infdis/jiv354, DOI 10.1093/INFDIS/JIV354]; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Boite MC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001888; Bourreau E, 2016, J INFECT DIS, V213, P105, DOI 10.1093/infdis/jiv355; Brettmann EA, 2016, TILTING BALANCE RNA, P1, DOI [10.1073/pnas.1615085113, DOI 10.1073/PNAS.1615085113]; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Cantanhede LM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004079; Chouicha N, 1997, PARASITOLOGY, V115, P343, DOI 10.1017/S0031182097001376; CUPOLILLO E, 1993, T ROY SOC TROP MED H, V87, P116, DOI 10.1016/0035-9203(93)90451-U; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gandon S, 2008, J EVOLUTION BIOL, V21, P1861, DOI 10.1111/j.1420-9101.2008.01598.x; Ginouves M, 2016, AM J TROP MED HYG, V94, P102, DOI 10.4269/ajtmh.15-0419; Gomez P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2297; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; GRIMALDI G, 1991, AM J TROP MED HYG, V44, P645, DOI 10.4269/ajtmh.1991.44.645; Grybchuk D, 2018, P NATL ACAD SCI USA, V115, pE506, DOI 10.1073/pnas.1717806115; Hajjaran H, 2016, ARCH VIROL, V161, P3385, DOI 10.1007/s00705-016-3044-z; Hall T.A., 1999, BIOEDIT USER FRIENDL; Hartley MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005852; Hartley MA, 2014, TRENDS PARASITOL, V30, P412, DOI 10.1016/j.pt.2014.05.006; Hartley MA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00099; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; Kuhls K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002490; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Martinez E, 2001, T ROY SOC TROP MED H, V95, P375, DOI 10.1016/S0035-9203(01)90185-3; Ogg MM, 2003, AM J TROP MED HYG, V69, P309, DOI 10.4269/ajtmh.2003.69.309; Parmentier L, 2016, AM J TROP MED HYG, V94, P840, DOI 10.4269/ajtmh.15-0803; PATTERSON JL, 1990, EXP PARASITOL, V70, P111, DOI 10.1016/0014-4894(90)90091-P; Pereira LDR, 2013, MEM I OSWALDO CRUZ, V108, P665, DOI 10.1590/0074-0276108052013021; Romero GAS, 2002, ACTA TROP, V82, P25, DOI 10.1016/S0001-706X(02)00002-5; Salinas G, 1996, AM J TROP MED HYG, V54, P425, DOI 10.4269/ajtmh.1996.54.425; Sasaki A, 2000, P ROY SOC B-BIOL SCI, V267, P2183, DOI 10.1098/rspb.2000.1267; SCHEFFTER S, 1994, VIROLOGY, V199, P479, DOI 10.1006/viro.1994.1149; SCHEFFTER SM, 1995, VIROLOGY, V212, P84, DOI 10.1006/viro.1995.1456; STUART KD, 1992, P NATL ACAD SCI USA, V89, P8596, DOI 10.1073/pnas.89.18.8596; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; TARR PI, 1988, P NATL ACAD SCI USA, V85, P9572, DOI 10.1073/pnas.85.24.9572; Tirera S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005764; WEEKS R, 1992, J VIROL, V66, P1389, DOI 10.1128/JVI.66.3.1389-1393.1992; WHO, 2010, CONTR LEISHM M WHO E; WIDMER G, 1995, NUCLEIC ACIDS RES, V23, P2300, DOI 10.1093/nar/23.12.2300; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zangger H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002836; Zangger H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002006	46	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198727	10.1371/journal.pone.0198727	http://dx.doi.org/10.1371/journal.pone.0198727			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912912	gold, Green Published			2022-12-26	WOS:000435528600043
J	Hachicha, H; Mahfoudh, N; Fourati, H; Elloumi, N; Marzouk, S; Feki, S; Fakhfakh, R; Frikha, F; Ayadi, A; Maatoug, A; Gaddour, L; Hakim, F; Bahloul, Z; Makni, H; Masmoudi, H; Kammoun, A				Hachicha, Hend; Mahfoudh, Nadia; Fourati, Hajer; Elloumi, Nesrine; Marzouk, Sameh; Feki, Sawsan; Fakhfakh, Raouia; Frikha, Faten; Ayadi, Abir; Maatoug, Amira; Gaddour, Lilia; Hakim, Feiza; Bahloul, Zouheir; Makni, Hafedh; Masmoudi, Hatem; Kammoun, Arwa			HLA Class III: A susceptibility region to systemic lupus erythematosus in Tunisian population	PLOS ONE			English	Article							NECROSIS-FACTOR TNF; RHEUMATOID-ARTHRITIS; PEMPHIGUS FOLIACEUS; DIABETES-MELLITUS; GENE POLYMORPHISM; MICA POLYMORPHISM; ASSOCIATION; SLE; HLA-DRB1; ALLELES	Background and objectives Short tandem repeats (STR) are usually used as informative polymorphic markers for genetic mapping and for disease susceptibility analysis. The involvement of these microsatellite markers localized in the MHC region was reported in many auto-immune diseases. In this study we analyzed for the first time eight polymorphisms of microsatellite loci at the HLA region: D6S291, D6S273, TNFa, b and c, MICA, D6S265 and D6S276, in Tunisian systemic lupus erythematosus (SLE) patients. Materials and methods We performed a case control study in which the microsatellite loci were amplified using specific primers labeled with NED, VIC, PET or 6-FAM and analyzed using GeneScan software 3.7. For the statistical analysis, we used SPSS software and we performed a sub-haplotype scoring test using the haplo.stats software developed in the R language. Results We found that two mean associated regions existed; the most statistically significant encompassed the 3 TNF markers (p = 0.0003, OR = 19.34); the latter covered the DR region. In fact, when scoring haplotypes in 3 marker- sliding windows, the p value increased as we moved away from the TNF region and decreased again when we approached the DRB1 locus. We also established for the first time the negative association between alleles of D6S291 and SLE. The majority of clinical and serological correlations were noted with TNF alleles. Conclusion Our results confirm the association between TNF and DRB1 polymorphisms and SLE. The association between alleles of D6S291 and SLE needs however to be verified by the analysis of other markers beyond this region.	[Hachicha, Hend; Feki, Sawsan; Masmoudi, Hatem] Habib Bourguiba Univ Hosp, Dept Immunol, Sfax, Tunisia; [Hachicha, Hend; Fourati, Hajer; Elloumi, Nesrine; Feki, Sawsan; Fakhfakh, Raouia; Ayadi, Abir; Maatoug, Amira; Masmoudi, Hatem] Habib Bourguiba Univ Hosp, UR12SP14, Sfax, Tunisia; [Hachicha, Hend] Univ Sfax, Fac Med Sfax, Sfax, Tunisia; [Mahfoudh, Nadia; Gaddour, Lilia; Hakim, Feiza; Makni, Hafedh; Kammoun, Arwa] Hedi Chaker Univ Hosp, Histocompatibil Dept, Sfax, Tunisia; [Marzouk, Sameh; Frikha, Faten; Bahloul, Zouheir] Hedi Chaker Univ Hosp Sfax, Dept Internal Med, Sfax, Tunisia	Universite de Sfax; Hopital Habib Bourguiba; Universite de Sfax; Hopital Habib Bourguiba; Universite de Sfax; Universite de Sfax; Hopital Hedi Chaker; Universite de Sfax; Hopital Hedi Chaker	Hachicha, H (corresponding author), Habib Bourguiba Univ Hosp, Dept Immunol, Sfax, Tunisia.; Hachicha, H (corresponding author), Habib Bourguiba Univ Hosp, UR12SP14, Sfax, Tunisia.; Hachicha, H (corresponding author), Univ Sfax, Fac Med Sfax, Sfax, Tunisia.	hendhachicha@yahoo.fr	Masmoudi, Hatem/AAW-3448-2021; Hachicha, Hend/K-4589-2019	Hachicha, Hend/0000-0002-5819-2899; fakhfakh, raouia/0000-0001-5379-0622	Ministere de l'enseignement superieur et de la recherche scientifique of Tunisia	Ministere de l'enseignement superieur et de la recherche scientifique of Tunisia	This work was supported by a Grant from the "Ministere de l'enseignement superieur et de la recherche scientifique of Tunisia." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a Grant from the "Ministere de l'enseignement superieur et de la recherche scientifique of Tunisia".	Abida O, 2013, HUM IMMUNOL, V74, P104, DOI 10.1016/j.humimm.2012.10.013; Aringer M, 2013, CLIN IMMUNOL, V147, P216, DOI 10.1016/j.clim.2012.11.012; ARNETT FC, 1988, AM J MED, V85, P38, DOI 10.1016/0002-9343(88)90381-6; Barnetche T, 2006, TISSUE ANTIGENS, V68, P390, DOI 10.1111/j.1399-0039.2006.00693.x; Castano-Rodriguez N, 2008, AUTOIMMUN REV, V7, P322, DOI 10.1016/j.autrev.2007.12.002; DAlfonso S, 1996, TISSUE ANTIGENS, V47, P551, DOI 10.1111/j.1399-0039.1996.tb02598.x; Dalla-Costa R, 2010, HUM IMMUNOL, V71, P809, DOI 10.1016/j.humimm.2010.04.001; Fojtikova M, 2011, RHEUMATOL INT, V31, P1195, DOI 10.1007/s00296-010-1431-4; Gambelunghe G, 2005, RHEUMATOLOGY, V44, P287, DOI 10.1093/rheumatology/keh459; Gupta M, 2006, ANN NY ACAD SCI, V1079, P229, DOI 10.1196/annals.1375.036; Hachicha H, 2018, INT J HEALTH SCI-IJH, V12, P21; Hajeer AH, 1997, TISSUE ANTIGENS, V49, P222, DOI 10.1111/j.1399-0039.1997.tb02742.x; Lee EY, 2006, INT J IMMUNOGENET, V33, P211, DOI 10.1111/j.1744-313X.2006.00599.x; Louis E, 2000, CLIN EXP IMMUNOL, V119, P64, DOI 10.1046/j.1365-2249.2000.01106.x; Naves M, 1998, EUR J IMMUNOGENET, V25, P317, DOI 10.1046/j.1365-2370.1998.00110.x; Novota P, 2004, FOLIA BIOL-PRAGUE, V50, P21; Park YW, 2009, ARTHRITIS RHEUM-US, V60, P1753, DOI 10.1002/art.24556; POCIOT F, 1993, EUR J IMMUNOL, V23, P224, DOI 10.1002/eji.1830230135; Relle M, 2015, AUTOIMMUN REV, V14, P1005, DOI 10.1016/j.autrev.2015.07.003; Sanchez E, 2006, RHEUMATOLOGY, V45, P1096, DOI 10.1093/rheumatology/kel058; Shai R, 1999, HUM MOL GENET, V8.4, P639; Smerdel-Ramoya A, 2005, RHEUMATOLOGY, V44, P1368, DOI 10.1093/rheumatology/kei015; Tarassi K, 1998, CLIN EXP RHEUMATOL, V16, P66; Tsuchiya N, 2001, GENES IMMUN, V2, P317, DOI 10.1038/sj.gene.6363783; van der Linden MW, 2001, GENES IMMUN, V2, P373, DOI 10.1038/sj.gene.6363794; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Yoshida K, 2011, ARTHRITIS RHEUM-US, V63, P3058, DOI 10.1002/art.30501	27	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198549	10.1371/journal.pone.0198549	http://dx.doi.org/10.1371/journal.pone.0198549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912900	Green Published, gold, Green Submitted			2022-12-26	WOS:000435528600033
J	Federman, S; Donoghue, MJ; Daly, DC; Eaton, DAR				Federman, Sarah; Donoghue, Michael J.; Daly, Douglas C.; Eaton, Deren A. R.			Reconciling species diversity in a tropical plant Glade (Canarium, Burseraceae)	PLOS ONE			English	Article							MADAGASCAR; INFERENCE; TREES; INTROGRESSION; DELIMITATION; BIOGEOGRAPHY; PHYLOGENY; DISCOVERY; RADIATION; PROGRAM	The challenges associated with sampling rare species or populations can limit our ability to make accurate and informed estimates of biodiversity for clades or ecosystems. This may be particularly true for tropical trees, which tend to be poorly sampled, and are thought to harbor extensive cryptic diversity. Here, we integrate genomics, morphology, and geography to estimate the number of species in a Glade of dioecious tropical trees (Canarium L.; Burseraceae) endemic to Madagascar, for which previous taxonomic treatments have recognized between one and 33 species. By sampling genomic data from even a limited number of individuals per taxon, we were able to clearly reject both previous hypotheses, and support instead an intermediate number of taxa. We recognize at least six distinct clades based on genetic structure and species delimitation analyses that correspond clearly with geographic and discrete morphological differences. Two widespread clades co-occur broadly throughout eastern wet forests, one Glade is endemic to western dry forests, and several slightly admixed clades are more narrowly distributed in mountainous regions in the north. Multiple previously described taxa were recovered as paraphyletic in our analyses, some of which were associated with admixed individuals, suggesting that hybridization contributes to taxonomic difficulties in Canarium. An improved understanding of Canarium species diversity has important implications for conservation efforts and understanding the origins of diversity in Madagascar. Our study shows that even limited genomic sampling, when combined with geography and morphology, can greatly improve estimates of species diversity for difficult tropical clades.	[Federman, Sarah; Donoghue, Michael J.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Daly, Douglas C.] New York Bot Garden, Inst Systemat Bot, Bronx, NY 10458 USA; [Eaton, Deren A. R.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA	Yale University; New York Botanical Garden; Columbia University	Federman, S (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	sarah.federman@yale.edu		Eaton, Deren/0000-0002-5922-2770	Yale Pierce Fellowship; Yale Ender Fellowship; Yale Institute for Biospheric Studies grant; NSF Graduate Research Fellowship [1122492]	Yale Pierce Fellowship; Yale Ender Fellowship; Yale Institute for Biospheric Studies grant; NSF Graduate Research Fellowship(National Science Foundation (NSF))	This work was supported by Yale Pierce Fellowship; Yale Ender Fellowship (https://gsas.yale.edu/fellowships/john-f-enders-felloshipss-research-grants); Yale Institute for Biospheric Studies grant (https://yibs.yale.edu/), and NSF Graduate Research Fellowship 1122492. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Baum DA, 2007, TAXON, V56, P417, DOI 10.1002/tax.562013; Bebber DP, 2010, P NATL ACAD SCI USA, V107, P22169, DOI 10.1073/pnas.1011841108; Chifman J, 2014, BIOINFORMATICS, V30, P3317, DOI 10.1093/bioinformatics/btu530; Daly DC, 2015, ADANSONIA, V37, P277, DOI 10.5252/a2015n2a2; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Doledec S, 2000, ECOLOGY, V81, P2914, DOI 10.1890/0012-9658(2000)081[2914:NSICAA]2.0.CO;2; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Eaton DAR, 2017, SYST BIOL, V66, P399, DOI 10.1093/sysbio/syw092; Eaton DAR, 2015, EVOLUTION, V69, P2587, DOI 10.1111/evo.12758; Eaton DAR, 2014, BIOINFORMATICS, V30, P1844, DOI 10.1093/bioinformatics/btu121; Eaton DAR, 2013, SYST BIOL, V62, P689, DOI 10.1093/sysbio/syt032; Escudero M, 2014, MOL PHYLOGENET EVOL, V79, P359, DOI 10.1016/j.ympev.2014.06.026; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Federman S, 2016, P NATL ACAD SCI USA, V113, P5041, DOI 10.1073/pnas.1523825113; Federman S, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0483-1; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Godfrey LR, 2003, EVOL ANTHROPOL, V12, P252, DOI 10.1002/evan.10123; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Janssen T, 2008, EVOLUTION, V62, P1876, DOI 10.1111/j.1558-5646.2008.00408.x; Joppa LN, 2010, P ROY SOC LOND B BIO; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Leache AD, 2014, SYST BIOL, V63, P534, DOI 10.1093/sysbio/syu018; Leenhouts PW., 1959, BLUMEA, V9; MARTIN RD, 1972, PHILOS T ROY SOC B, V264, P295, DOI 10.1098/rstb.1972.0013; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; RAXWORTHY CJ, 1995, J ZOOL, V235, P525, DOI 10.1111/j.1469-7998.1995.tb01767.x; Ray N., 2001, INTERNET ARCHAEOLOGY, V11, P1, DOI [DOI 10.11141/IA.11.2, 10.11141/ia.11.2]; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; RIPLEY B, 2017, MASS SUPPORT FUNCTIO; Snir S, 2010, IEEE ACM T COMPUT BI, V7, P704, DOI 10.1109/TCBB.2008.133; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Sukumaran J, 2017, P NATL ACAD SCI USA, V114, P1607, DOI 10.1073/pnas.1607921114; ter Steege H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29549; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Yang ZH, 2015, CURR ZOOL, V61, P854, DOI 10.1093/czoolo/61.5.854; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239; Yoder AD, 2016, P NATL ACAD SCI USA, V113, P8049, DOI 10.1073/pnas.1601081113	47	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2018	13	6							e0198882	10.1371/journal.pone.0198882	http://dx.doi.org/10.1371/journal.pone.0198882			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5RI	29906281	Green Published, gold, Green Submitted			2022-12-26	WOS:000435439400008
J	Hu, WX; Wang, ZM; Zheng, HJ				Hu, Wenxin; Wang, Zhiming; Zheng, Hongjin			Mitochondrial accumulation of amyloid beta (A beta) peptides requires TOMM22 as a main A beta receptor in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						yeast; mitochondria; amyloid- (A); electron microscopy (EM); chromatography; protein-protein interaction; Ni-NTA conjugated nanogold; protein import; Tom22	TRANS-GOLGI NETWORK; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; IMPORT; TOM22; RECOGNITION; DYSFUNCTION; PREPROTEIN; NEURONS; NEURODEGENERATION	Mitochondrial accumulation of intracellular beta-amyloid (A beta) peptides is present in the brains of individuals with Alzheimer's disease (AD) as well as in related mouse models of AD. This accumulation is extremely toxic because A beta disrupts the normal functions of many mitochondrial proteins, resulting in significant mitochondrial dysfunction. Therefore, understanding the mitochondrial accumulation of A beta is useful for future pharmaceutical design of drugs to address mitochondrial dysfunction in AD. However, the detailed molecular mechanism of this accumulation process remains elusive. Here, using yeast mitochondria, we present direct experimental evidence suggesting that A beta is specifically recognized by translocase of outer mitochondrial membrane subunit 22 (Tom22 in yeast; TOMM22 in human), a noncanonical receptor within the mitochondrial protein import machinery, and that this recognition is critical for A beta accumulation in mitochondria. Furthermore, we found that residues 25-42 in the A beta peptide mediate the specific interaction with TOMM22. On the basis of our findings, we propose that cytosolic A beta is recognized by TOMM22; transferred to another translocase subunit, TOMM40; and transported through the TOMM channel into the mitochondria. Our results not only confirm that yeast mitochondria can be used as a model to study mitochondrial dysfunction caused by A beta peptides in AD but also pave the way for future studies of the molecular mechanism of mitochondrial A beta accumulation.	[Hu, Wenxin; Wang, Zhiming; Zheng, Hongjin] Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Mail Stop 8101, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Zheng, HJ (corresponding author), Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Mail Stop 8101, Aurora, CO 80045 USA.	hongjin.zheng@ucdenver.edu			Boettcher Foundation Webb-Waring Biomedical Research Award	Boettcher Foundation Webb-Waring Biomedical Research Award	This work was supported by the Boettcher Foundation Webb-Waring Biomedical Research Award (to H.Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Agostinho P, 2015, J ALZHEIMERS DIS, V45, P329, DOI 10.3233/JAD-142730; Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; BROOKSBANK BWL, 1984, DEV BRAIN RES, V16, P37, DOI 10.1016/0165-3806(84)90060-9; Cam JA, 2005, J BIOL CHEM, V280, P15464, DOI 10.1074/jbc.M500613200; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Cenini G, 2016, MOL BIOL CELL, V27, P3257, DOI 10.1091/mbc.E16-05-0313; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; Crouch PJ, 2008, INT J BIOCHEM CELL B, V40, P181, DOI 10.1016/j.biocel.2007.07.013; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; DuBoff B, 2013, TRENDS NEUROSCI, V36, P325, DOI 10.1016/j.tins.2013.03.002; Hernandez-Zimbron LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042344; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Hansson Petersen C. A., 2008, P NATL ACAD SCI USA, V105, P13145, DOI DOI 10.1073/PNAS.0806192105; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005; Keil U, 2004, J BIOL CHEM, V279, P50310, DOI 10.1074/jbc.M405600200; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Neupert W, 2015, J MOL BIOL, V427, P1135, DOI 10.1016/j.jmb.2015.02.001; Pagani Lucia, 2011, Int J Alzheimers Dis, V2011, P925050, DOI 10.4061/2011/925050; Pinho CM, 2014, BBA-BIOENERGETICS, V1837, P1069, DOI 10.1016/j.bbabio.2014.02.007; Poduslo JF, 2012, BIOCHEMISTRY-US, V51, P3993, DOI 10.1021/bi300275g; Rimmer KA, 2011, J MOL BIOL, V405, P804, DOI 10.1016/j.jmb.2010.11.017; Saitoh T, 2011, BIOCHEMISTRY-US, V50, P5487, DOI 10.1021/bi200470x; Schmidt C, 2008, MOL PSYCHIATR, V13, P953, DOI 10.1038/sj.mp.4002077; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Selfridge JE, 2013, NEUROBIOL DIS, V51, P3, DOI 10.1016/j.nbd.2011.12.057; Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123; Shiota T, 2011, P NATL ACAD SCI USA, V108, P15179, DOI 10.1073/pnas.1105921108; Sirk D, 2007, J NEUROCHEM, V103, P1989, DOI 10.1111/j.1471-4159.2007.04907.x; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; VANLOON APGM, 1986, CELL, V44, P801, DOI 10.1016/0092-8674(86)90846-9; Vivekanandan S, 2011, BIOCHEM BIOPH RES CO, V411, P312, DOI 10.1016/j.bbrc.2011.06.133; Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x; Wirths O, 2012, LIFE SCI, V91, P1148, DOI 10.1016/j.lfs.2012.02.001; Wu YK, 2006, NAT STRUCT MOL BIOL, V13, P589, DOI 10.1038/nsmb1106; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; YAMAGUCHI H, 1992, ACTA NEUROPATHOL, V85, P15, DOI 10.1007/BF00304629; Yamano K, 2008, J BIOL CHEM, V283, P3799, DOI 10.1074/jbc.M708339200	47	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12681	12689		10.1074/jbc.RA118.002713	http://dx.doi.org/10.1074/jbc.RA118.002713			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29925587	hybrid, Green Published			2022-12-26	WOS:000442203500003
J	Kummarapurugu, AB; Afosah, DK; Sankaranarayanan, NV; Gangji, RN; Zheng, S; Kennedy, T; Rubin, BK; Voynow, JA; Desai, UR				Kummarapurugu, Apparao B.; Afosah, Daniel K.; Sankaranarayanan, Nehru Viji; Gangji, Rahaman Navaz; Zheng, Shuo; Kennedy, Thomas; Rubin, Bruce K.; Voynow, Judith A.; Desai, Umesh R.			Molecular principles for heparin oligosaccharide-based inhibition of neutrophil elastase in cystic fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deoxyribonuclease (DNase); protease; cystic fibrosis; neutrophil; heparin; mucus; CF sputum; neutrophil elastase; competitive inhibition; DNA; ODSH	LUNG; INFLAMMATION; SECRETIONS; CLEARANCE; PROTEASES; CHILDREN	Cystic fibrosis (CF) is a multifactorial disease in which dysfunction of protease-antiprotease balance plays a key role. The current CF therapy relies on dornase , hypertonic saline, and antibiotics and does not address the high neutrophil elastase (NE) activity observed in the lung and sputum of CF patients. Our hypothesis is that variants of heparin, which potently inhibit NE but are not anticoagulant, would help restore the protease-antiprotease balance in CF. To realize this concept, we studied molecular principles governing the effectiveness of different heparins, especially 2-O,3-O-desulfated heparin (ODSH), in the presence of sputum components and therapeutic agents. Using sputa from CF patients and an NE activity assay, we found that heparins are ineffective if used in the absence of dornase. This is true even when mucolytics, such as DTT or N-acetylcysteine, were used. Computational modeling suggested that ODSH and DNA compete for binding to an overlapping allosteric site on NE, which reduces the anti-NE potential of ODSH. NE inhibition of both DNA and ODSH is chain length-dependent, but ODSH chains exhibit higher potency per unit residue length. Likewise, ODSH chains exhibit higher NE inhibition potential compared with DNA chains in the presence of saline. These studies suggest fundamental differences in DNA and ODSH recognition and inhibition of NE despite engaging overlapping sites and offer unique insights into molecular principles that could be used in developing antiprotease agents in the presence of current treatments, such as dornase and hypertonic saline.	[Kummarapurugu, Apparao B.; Zheng, Shuo; Rubin, Bruce K.; Voynow, Judith A.] Virginia Commonwealth Univ, Childrens Hosp Richmond, POB 980315, Richmond, VA 23298 USA; [Afosah, Daniel K.; Sankaranarayanan, Nehru Viji; Desai, Umesh R.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Afosah, Daniel K.; Sankaranarayanan, Nehru Viji; Gangji, Rahaman Navaz; Desai, Umesh R.] Virginia Commonwealth Univ, Inst Struct Biol Drug Discovery & Dev, Richmond, VA 23298 USA; [Kennedy, Thomas] Tulane Univ, Med Ctr, New Orleans, LA 70112 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Tulane University	Voynow, JA (corresponding author), Virginia Commonwealth Univ, Childrens Hosp Richmond, POB 980315, Richmond, VA 23298 USA.; Desai, UR (corresponding author), Virginia Commonwealth Univ, Inst Struct Biol Drug Discovery & Dev, Richmond, VA 23298 USA.	Judith.voynow@vcuhealth.org; urdesai@vcu.edu	Afosah, Daniel/GSD-8459-2022; Desai, Umesh/D-3741-2013	Desai, Umesh/0000-0002-1976-6597; Navaz Gangji, Rahaman/0000-0002-8160-3473	National Institutes of Health [HL107152]; CFF Research Grant [VOYNOW15IO]; Commonwealth Health Research Board Grant [236-14-14]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027411] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CFF Research Grant; Commonwealth Health Research Board Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL107152 (to U. R. D.) and CFF Research Grant VOYNOW15IO and Commonwealth Health Research Board Grant 236-14-14 (to J. A. V.). T. K. invented the chemical entity ODSH, was the scientific founder of Cantex Pharmaceuticals, and owns stock in Cantex. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Horani RA, 2013, J MED CHEM, V56, P867, DOI 10.1021/jm301338q; BELORGEY D, 1995, FEBS LETT, V361, P265, DOI 10.1016/0014-5793(95)00173-7; Bennett WD, 2015, J APPL PHYSIOL, V118, P1483, DOI 10.1152/japplphysiol.00404.2014; Boothello RS, 2015, METHODS MOL BIOL, V1229, P335, DOI 10.1007/978-1-4939-1714-3_27; Cantin AM, 1998, AM J RESP CRIT CARE, V157, P464, DOI 10.1164/ajrccm.157.2.9608033; CHERNICK WS, 1959, PEDIATRICS, V24, P739; Elias JA, 2015, FISHMANS PULMONARY D, P757; Gray RD, 2015, ANTIBIOTICS-BASEL, V4, P62, DOI 10.3390/antibiotics4010062; Griffin KL, 2014, AM J RESP CELL MOL, V50, P684, DOI 10.1165/rcmb.2013-0338RC; Henderson AG, 2014, J CLIN INVEST, V124, P3047, DOI 10.1172/JCI73469; Henry BL, 2007, J BIOL CHEM, V282, P31891, DOI 10.1074/jbc.M704257200; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; Kelly E, 2008, EXPERT OPIN THER TAR, V12, P145, DOI 10.1517/14728222.12.2.145 ; Kummarapurugu AB, 2018, AM J RESP CELL MOL, V58, P126, DOI 10.1165/rcmb.2017-0250LE; Markart P, 2010, J AEROSOL MED PULM D, V23, P161, DOI 10.1089/jamp.2009.0780; NADZIEJKO C, 1994, AM J RESP CELL MOL, V11, P103, DOI 10.1165/ajrcmb.11.1.7912511; NAVIA MA, 1989, P NATL ACAD SCI USA, V86, P7, DOI 10.1073/pnas.86.1.7; Paranjape SM, 2018, PAEDIATR RESPIR REV, V25, P64, DOI 10.1016/j.prrv.2017.03.001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramsey BW, 2017, AM J RESP CRIT CARE, V195, P1092, DOI 10.1164/rccm.201702-0266ED; Rao NV, 2010, AM J PHYSIOL-CELL PH, V299, pC97, DOI 10.1152/ajpcell.00009.2010; REDINI F, 1988, BIOCHEM J, V252, P515, DOI 10.1042/bj2520515; Sagel SD, 2012, AM J RESP CRIT CARE, V186, P857, DOI 10.1164/rccm.201203-0507OC; Sankaranarayanan NV, 2014, GLYCOBIOLOGY, V24, P1323, DOI 10.1093/glycob/cwu077; Sankaranarayanan NV, 2015, METHODS MOL BIOL, V1229, P289, DOI 10.1007/978-1-4939-1714-3_24; Sankarayanarayanan NV, 2017, ANGEW CHEM INT EDIT, V56, P2312, DOI 10.1002/anie.201609541; SEGEL IH, 1975, ENZYME KINETICS, P125; Sharma L, 2014, J IMMUNOTOXICOL, V11, P260, DOI 10.3109/1547691X.2013.839587; Sly PD, 2013, NEW ENGL J MED, V368, P1963, DOI 10.1056/NEJMoa1301725; Spencer JL, 2006, BIOCHEMISTRY-US, V45, P9104, DOI 10.1021/bi060338r; Taggart C, 2000, J BIOL CHEM, V275, P27258; Taggart CC, 2005, AM J RESP CRIT CARE, V171, P1070, DOI 10.1164/rccm.200407-881PP; Twigg MS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/293053; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412; van Zundert G. C., 2016, J MOL BIOL, V428, P720; Voynow JA, 1999, AM J PHYSIOL-LUNG C, V276, pL835; Voynow JA, 2008, INT J BIOCHEM CELL B, V40, P1238, DOI 10.1016/j.biocel.2008.03.003; Weldon S, 2009, J IMMUNOL, V183, P8148, DOI 10.4049/jimmunol.0901716; Xia BY, 2005, GLYCOBIOLOGY, V15, P747, DOI 10.1093/glycob/cwi061; Zheng S, 2017, AM J RESP CELL MOL, V56, P90, DOI 10.1165/rcmb.2016-0069OC	41	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12480	12490		10.1074/jbc.RA118.002644	http://dx.doi.org/10.1074/jbc.RA118.002644			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29903912	hybrid, Green Published			2022-12-26	WOS:000441408500014
J	Lu, GD; Jia, ZY; Zu, QQ; Zhang, JX; Zhao, LB; Shi, HB				Lu, Guangdong; Jia, Zhenyu; Zu, Qingquan; Zhang, Jinxing; Zhao, Linbo; Shi, Haibin			Inhibition of the cyclophilin A-CD147 interaction attenuates right ventricular injury and dysfunction after acute pulmonary embolism in rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; Western blot; cardiomyopathy; biotechnology; thrombosis; acute pulmonary embolism; CD147; cyclophilin A; EMMPRIN; right ventricular dysfunction; heart disease	ISCHEMIA-REPERFUSION INJURY; ACUTE MYOCARDIAL-INFARCTION; EARLY BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; SYSTOLIC FUNCTION; OXIDATIVE STRESS; CYCLOSPORINE-A; MATRIX; CD147; THROMBOEMBOLISM	Acute pulmonary embolism (APE)-induced inflammation contributes to cardiomyocyte injury and dysfunction in the right ventricle (RV) of the heart. The interactions of cyclophilin A with its ligand extracellular matrix metalloproteinase inducer (EMMPRIN or CD147) may be involved in this inflammatory process. To this end, here we induced APE by intravenous injections of microspheres in Sprague-Dawley rats. We found that after the APE, cyclophilin A and CD147 levels increased synchronously in RV tissue following APE and peaked at 24 h. The cyclophilin A inhibitor cyclosporine A attenuated the APE-induced cyclophilin A levels, and a monoclonal antibody of CD147 (anti-CD147) abrogated the elevation of CD147 in the RV but not the increase of cyclophilin A. Importantly, treatment with cyclosporine A, anti-CD147, or both attenuated APE-induced increases in RV systolic pressure, plasma cardiac troponin-I (cTnI) concentrations, the RV/left ventricle diameter ratio, and the Tei index, measured by echocardiography 24 h after APE induction. These beneficial effects were associated with reduced RV neutrophil infiltration and prevention of matrix metalloproteinase 9 (MMP-9) and MMP-2 activation. These findings suggested that inhibiting the cyclophilin A-CD147 interaction attenuates APE-associated RV cardiomyocyte injury and dysfunction by suppressing inflammation. We further proposed that cyclophilin A and CD147 might participate in APE-induced pathological processes by partly activating the ERK1/2 kinase-nuclear factor-B pathway. We conclude that the cyclophilin A-CD147 interaction may represent a potential therapeutic target for managing APE.	[Lu, Guangdong; Jia, Zhenyu; Zu, Qingquan; Zhang, Jinxing; Zhao, Linbo; Shi, Haibin] Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University	Shi, HB (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, Nanjing 210029, Jiangsu, Peoples R China.	shihb@njmu.edu.cn			National Natural Science Foundation of China [81271678]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 81271678. The authors declare that they have no conflicts of interest with the contents of this article.	Beauchesne PR, 2007, DRUG DEV IND PHARM, V33, P211, DOI 10.1080/03639040601155665; Cau SBA, 2013, CARDIOVASC DRUG THER, V27, P259, DOI 10.1007/s10557-013-6458-9; Cuadrado I, 2016, THERANOSTICS, V6, P545, DOI 10.7150/thno.13352; Dahhan T, 2016, CARDIOVASC ULTRASOUN, V14, DOI 10.1186/s12947-016-0087-y; Dai YX, 2014, BRAIN RES, V1556, P67, DOI 10.1016/j.brainres.2014.01.052; Dang BQ, 2015, CRIT CARE MED, V43, pE369, DOI 10.1097/CCM.0000000000001146; Dawar FU, 2017, J LEUKOCYTE BIOL, V102, P989, DOI 10.1189/jlb.3RU0317-090RR; Dawar FU, 2017, J LEUKOCYTE BIOL, V101, P823, DOI 10.1189/jlb.3RU1116-477R; Dixon CE, 2016, J NEUROTRAUM, V33, P553, DOI 10.1089/neu.2015.4122; Fortuna GM, 2007, INT J CARDIOL, V114, P22, DOI 10.1016/j.ijcard.2005.11.109; Heinzmann D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124606; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Jin R, 2017, STROKE, V48, P3356, DOI 10.1161/STROKEAHA.117.018839; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; Jones AE, 2003, AM J PHYSIOL-LUNG C, V284, pL1072, DOI 10.1152/ajplung.00283.2002; Kalt DA, 2017, LAB MED, V48, pE62, DOI 10.1093/labmed/lmx056; Kandasamy AD, 2010, CARDIOVASC RES, V85, P413, DOI 10.1093/cvr/cvp268; Konstantinides SV, 2016, J AM COLL CARDIOL, V67, P976, DOI 10.1016/j.jacc.2015.11.061; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Lalu MM, 2005, EUR HEART J, V26, P27, DOI 10.1093/eurheratj/ehi007; Malesevic M, 2013, J MED CHEM, V56, P7302, DOI 10.1021/jm4007577; Neto-Neves EM, 2013, J CELL MOL MED, V17, P1588, DOI 10.1111/jcmm.12163; Neto-Neves EM, 2011, CRIT CARE MED, V39, P349, DOI 10.1097/CCM.0b013e3181fa3dfe; Nigro P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.410; Park JH, 2008, INT J CARDIOL, V125, P319, DOI 10.1016/j.ijcard.2007.02.030; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Ramachandran S, 2012, PROTEOMICS, V12, P2808, DOI 10.1002/pmic.201100586; Satoh K, 2014, CIRC RES, V115, P738, DOI 10.1161/CIRCRESAHA.115.304563; Sawicki G, 2005, CIRCULATION, V112, P544, DOI 10.1161/CIRCULATIONAHA.104.531616; Seizer P, 2014, CARDIOVASC RES, V102, P17, DOI 10.1093/cvr/cvu035; Seizer P, 2011, ARTERIOSCL THROM VAS, V31, P1377, DOI 10.1161/ATVBAHA.111.225771; Seko Y, 2004, BIOCHEM BIOPH RES CO, V317, P162, DOI 10.1016/j.bbrc.2004.03.021; Shimokawa H, 2016, CIRC RES, V118, P352, DOI 10.1161/CIRCRESAHA.115.306532; Sousa-Santos O, 2012, N-S ARCH PHARMACOL, V385, P685, DOI 10.1007/s00210-012-0748-9; Souza-Costa DC, 2007, CRIT CARE MED, V35, P239, DOI 10.1097/01.CCM.0000251638.67104.C3; Sun SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102541; Watts JA, 2006, J MOL CELL CARDIOL, V41, P296, DOI 10.1016/j.yjmcc.2006.05.011; Yang Y, 2008, RHEUMATOLOGY, V47, P1299, DOI 10.1093/rheumatology/ken225; Zhang WC, 2017, TRANSPLANTATION, V101, P2862, DOI 10.1097/TP.0000000000001941	39	12	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12199	12208		10.1074/jbc.RA118.002845	http://dx.doi.org/10.1074/jbc.RA118.002845			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29914983	Green Published, hybrid			2022-12-26	WOS:000440803200018
J	Girousse, C; Roche, J; Guerin, C; Le Gouis, J; Balzegue, S; Mouzeyar, S; Bouzidi, MF				Girousse, Christine; Roche, Jane; Guerin, Claire; Le Gouis, Jacques; Balzegue, Sandrine; Mouzeyar, Said; Bouzidi, Mohamed Fouad			Coexpression network and phenotypic analysis identify metabolic pathways associated with the effect of warming on grain yield components in wheat	PLOS ONE			English	Article							HIGH-TEMPERATURE STRESS; HEAT-SHOCK PROTEINS; TRANSCRIPTOME ANALYSIS; CELL NUMBER; DROUGHT; REVEALS; TOLERANCE; RESPONSES; DURATION; ANTHESIS	Wheat grains are an important source of human food but current production amounts cannot meet world needs. Environmental conditions such as high temperature (above 30 degrees C) could affect wheat production negatively. Plants from two wheat genotypes have been subjected to two growth temperature regimes. One set has been grown at an optimum daily mean temperature of 19 degrees C while the second set of plants has been subjected to warming at 27 degrees C from two to 13 days after anthesis (daa). While warming did not affect mean grain number per spike, it significantly reduced other yield-related indicators such as grain width, length, volume and maximal cell numbers in the endosperm. Whole genome expression analysis identified 6,258 and 5,220 genes, respectively, whose expression was affected by temperature in the two genotypes. Co-expression analysis using WGCNA (Weighted Gene Co-expression Network Analysis) uncovered modules (groups of co-expressed genes) associated with agronomic traits. In particular, modules enriched in genes related to nutrient reservoir and endopeptidase inhibitor activities were found to be positively associated with cell numbers in the endosperm. A hypothetical model pertaining to the effects of warming on gene expression and growth in wheat grain is proposed. Under moderately high temperature conditions, network analyses suggest a negative effect of the expression of genes related to seed storage proteins and starch biosynthesis on the grain size in wheat.	[Girousse, Christine; Roche, Jane; Guerin, Claire; Le Gouis, Jacques; Mouzeyar, Said; Bouzidi, Mohamed Fouad] Univ Clermont Auvergne, INRA, GDEC, Clermont Ferrand, France; [Balzegue, Sandrine] INRA, Transcript Platform iPS2, Evry, France; [Balzegue, Sandrine] Univ Angers, AGROCAMPUS Ouest, INRA, IRHS,SFR QUASAV 4207, Beaucouze, France	INRAE; Universite Clermont Auvergne (UCA); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Institut Agro; Agrocampus Ouest; Universite d'Angers	Roche, J (corresponding author), Univ Clermont Auvergne, INRA, GDEC, Clermont Ferrand, France.	jane.roche@uca.fr	Jane, Roche/AAD-1355-2021	ROCHE, JANE/0000-0001-9270-3915	BreedWheat project [ANR-10-BTBR-0003]	BreedWheat project	This work was supported by the BreedWheat project (ANR-10-BTBR-0003).	Altenbach SB, 2012, J CEREAL SCI, V56, P39, DOI 10.1016/j.jcs.2011.12.012; Asseng S, 2017, GLOBAL CHANGE BIOL, V23, P2464, DOI 10.1111/gcb.13530; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; Boden SA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r65; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Calderini DF, 1999, J AGR SCI, V132, P453, DOI 10.1017/S0021859699006504; Capron D, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-35; Claeys H, 2014, PLANT PHYSIOL, V165, P519, DOI 10.1104/pp.113.234641; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dias AS, 2009, J AGRON CROP SCI, V195, P137, DOI 10.1111/j.1439-037X.2008.00347.x; Dupont FM, 2003, J CEREAL SCI, V38, P133, DOI 10.1016/S0733-5210(03)00030-4; Egli DB., 1998, SEED BIOL YIELD GRAI; Farooq M, 2011, CRIT REV PLANT SCI, V30, P491, DOI 10.1080/07352689.2011.615687; Ferris R, 1998, ANN BOT-LONDON, V82, P631, DOI 10.1006/anbo.1998.0740; Frank G, 2009, J EXP BOT, V60, P3891, DOI 10.1093/jxb/erp234; Hairat S, 2015, PLANT PHYSIOL BIOCH, V95, P65, DOI 10.1016/j.plaphy.2015.07.009; Hannah LC, 2005, MAYDICA, V50, P497; Jiao J, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.02067, 10.3389/fpls.2016.01387]; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Liu ZS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0511-8; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Mangelsen E, 2011, MOL PLANT, V4, P97, DOI 10.1093/mp/ssq058; Nadaud I, 2010, PROTEOMICS, V10, P2901, DOI 10.1002/pmic.200900792; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; NICOLAS ME, 1985, ANN BOT-LONDON, V55, P433, DOI 10.1093/oxfordjournals.aob.a086922; Olsen OA, 2001, ANNU REV PLANT PHYS, V52, P233, DOI 10.1146/annurev.arplant.52.1.233; Porter JR, 2005, PHILOS T R SOC B, V360, P2021, DOI 10.1098/rstb.2005.1752; Qin DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-432; Reynolds M, 2011, J EXP BOT, V62, P439, DOI 10.1093/jxb/erq311; RIJVEN AHG, 1966, EXP CELL RES, V41, P324, DOI 10.1016/S0014-4827(66)80140-4; Rimbert H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0186329; Ross G.J.S., 1984, COMPSTAT 1984, P458; Ruan YL, 2012, TRENDS PLANT SCI, V17, P656, DOI 10.1016/j.tplants.2012.06.005; Sekhon RS, 2014, PLANT PHYSIOL, V165, P658, DOI 10.1104/pp.114.235424; Semenov MA, 2014, J CEREAL SCI, V59, P245, DOI 10.1016/j.jcs.2014.01.006; Semenov MA, 2010, CLIM RES, V41, P1, DOI 10.3354/cr00836; SINGH BK, 1982, PLANT SCI LETT, V26, P273, DOI 10.1016/0304-4211(82)90101-8; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SOFIELD I, 1977, AUST J PLANT PHYSIOL, V4, P785, DOI 10.1071/PP9770785; Stone PJ, 1995, AUST J PLANT PHYSIOL, V22, P927, DOI 10.1071/PP9950927; Pinto RS, 2010, THEOR APPL GENET, V121, P1001, DOI 10.1007/s00122-010-1351-4; Tack J, 2015, P NATL ACAD SCI USA, V112, P6931, DOI 10.1073/pnas.1415181112; TASHIRO T, 1989, ANN BOT-LONDON, V64, P59, DOI 10.1093/oxfordjournals.aob.a087808; Triboi E, 1996, P 4 EUR SOC AGR C, p68 ; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wan YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-121; WARDLAW IF, 1989, AUST J AGR RES, V40, P15, DOI 10.1071/AR9890015; Xiong Y, 2015, CURR OPIN PLANT BIOL, V28, P83, DOI 10.1016/j.pbi.2015.09.006; Yu ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101914; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang XW, 2013, GENE, V530, P185, DOI 10.1016/j.gene.2013.08.048; Zhang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049652	53	11	11	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199434	10.1371/journal.pone.0199434	http://dx.doi.org/10.1371/journal.pone.0199434			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940014	gold, Green Published, Green Submitted			2022-12-26	WOS:000436088700017
J	Wang, L; Lu, YY; Li, RP; Zeng, L; Du, JL; Huang, X; Xu, YJ				Wang, Lei; Lu, Yongyue; Li, Ripeng; Zeng, Ling; Du, Junling; Huang, Xiong; Xu, Yijuan			Mental health effects caused by red imported fire ant attacks (Solenopsis invicta)	PLOS ONE			English	Article							CONSEQUENCES; INFESTATION; PREVALENCE; INDOORS	Susceptible individuals who have suffered painful stings caused by red imported fire ants, Solenopsis invicta, usually experience physical health effects such as fever, dizziness, generalized urticaria, or other systemic reactions such as anaphylactic shock. Whether S. invicta stings also have negative effects on mental health is not clear. In the present study, the psychological impact of S. invicta stings was evaluated using a questionnaire that included a previously published posttraumatic stress disorder (PTSD) checklist, the Patient Health Questionnaire 9-item (PHQ-9), the Generalized Anxiety Disorder 7-item (GAD-7) scale, the Beck Anxiety Inventory (BAI), and the Pittsburgh Sleep Quality Index, 5th scale (PSQI(5)). A total of 96 valid questionnaires were obtained; 37 participants were placed in the stung group, and 59 participants were placed in the unstung group. Our results showed that symptoms of anxiety, depression and sleep disturbances were not associated with S. invicta stings (for GAD-7 scale, Pearson Chi-Square test, chi(2) = 0.152, df = 1, P = 0.697; for the BAI, chi(2) = 2.252, df = 1, P = 0.133; for the PHQ-9, chi(2) = 0.098, df = 1, P = 0.754; for the PSQI(5), chi(2) = 0.536, df = 1, P = 0.453). In total, 2 of 83 individuals stung by S. invicta met the criteria (> 50) for PTSD. However, there was no significant difference on PTSD between those stung by S. invicta in the 30-day group and the over 30-day group (chi(2) = 0.318, df = 1, P = 0.573). Overall, our data do not show an effect of S. invicta stings on mental health as measured using a range of indicators.	[Wang, Lei; Lu, Yongyue; Zeng, Ling; Du, Junling; Xu, Yijuan] South China Agr Univ, Red Imported Fire Ant Res Ctr, Guangzhou, Guangdong, Peoples R China; [Li, Ripeng; Huang, Xiong] Guangzhou Med Univ, Affiliated Hosp, Guangzhou Huiai Hosp, Dept Adult Psychiat, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Guangzhou Medical University	Xu, YJ (corresponding author), South China Agr Univ, Red Imported Fire Ant Res Ctr, Guangzhou, Guangdong, Peoples R China.	xuyijuan@yahoo.com		Wang, Lei/0000-0001-8390-3448	Science Foundation for The Excellent Youth Scholars of Guangdong Province [Yq2013031]; National Key Research and Development Project [2016YFC1201204]	Science Foundation for The Excellent Youth Scholars of Guangdong Province; National Key Research and Development Project	This study was supported by the Science Foundation for The Excellent Youth Scholars of Guangdong Province (No. Yq2013031) and the National Key Research and Development Project (2016YFC1201204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Beck A.T., 2005, ANXIETY DISORDERS PH; Burrows S, 2013, AM J CASE REP, V14, P176, DOI 10.12659/AJCR.883926; Buysse D J, 1989, Psychiatry Res, V28, P193; Carnevale P, 1998, B SOC PATHOL EXOT, V91, P474; DESHAZO RD, 1984, J ALLERGY CLIN IMMUN, V74, P841, DOI 10.1016/0091-6749(84)90188-X; DESHAZO RD, 1994, J ALLERGY CLIN IMMUN, V93, P847, DOI 10.1016/0091-6749(94)90376-X; DESHAZO RD, 1995, SOUTHERN MED J, V88, P712, DOI 10.1097/00007611-199507000-00003; DeVellis R., 1991, SCALE DEV THEORY APP; Goddard J, 2012, AM J MED, V125, P101, DOI 10.1016/j.amjmed.2011.08.010; Haag-Wackernagel D, 2004, ANN AGR ENV MED, V11, P343; [黄国平 HUANG GuoPing], 2006, [中国心理卫生杂志, Chinese Mental Health Journal], V20, P28; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Nunnelee Janice D, 2005, RN, V68, P56; Paudel B, 2009, Nepal Med Coll J, V11, P52; Remling R., 2003, COMMON SKIN DIS CHIL, P13; Rieder E, 2012, PSYCHOSOMATICS, V53, P85, DOI 10.1016/j.psym.2011.08.001; Sigdel M R, 2013, J Nepal Health Res Counc, V11, P244; Silva L, 2008, INT J DERMATOL, V47, P249, DOI 10.1111/j.1365-4632.2008.03570.x; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Susser SR, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000838; Tschinkel W, 1993, BIOL POLLUTION CONTR; Tschinkel W., 2006, THE FIRE ANT; Weiss Daniel S., 1997, P399; Xu Y, 2014, J BIOSAFETY, V23, P75; Xu YJ, 2012, FLA ENTOMOL, V95, P961, DOI 10.1653/024.095.0421; Zeng L, 2005, MONITORING CONTROL R; Zhao Jing-Ni, 2015, Chinese Journal of Applied Entomology, V52, P1409, DOI 10.7679/j.issn.2095-1353.2015.169	29	0	1	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199424	10.1371/journal.pone.0199424	http://dx.doi.org/10.1371/journal.pone.0199424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK3YY	29940002	Green Published, gold, Green Submitted			2022-12-26	WOS:000436088700015
J	Li, XF; Zito, S; Sinclair, M; Phillips, CJC				Li, Xiaofei; Zito, Sarah; Sinclair, Michelle; Phillips, Clive J. C.			Perception of animal welfare issues during Chinese transport and slaughter of livestock by a sample of stakeholders in the industry	PLOS ONE			English	Article							STUDENTS ATTITUDES; QUESTIONNAIRES; PREFERENCES; SAFETY; VIEWS; MEAT	China is the world's biggest livestock producer, and has a rapidly expanding intensive livestock production in response to growing demand. The large size of the country and geographical dispersion of the livestock production systems means that animals are often transported long distances to slaughter. This study investigated perceptions of animal welfare issues by stakeholders in the Chinese transport and slaughter industry using utility scores and adaptive conjoint analysis. An initial workshop for experts in this field identified key concerns; these were then included in a questionnaire, which was distributed electronically to stakeholders. Stakeholders, particularly those with higher levels of education, were most concerned about the absence of pre-slaughter stunning and failure to maintain unconsciousness throughout the slaughter process. For all livestock species electrical stunning was considered the best method of stunning and blunt trauma the worst; for cattle and sheep stunning using a penetrating captive bolt was considered preferable to the use a percussive captive bolt. Other concerns considered very important were journey quality and livestock workers' experience and attitudes. Heat stress and closed-sided vehicles were of greater concern than cold stress. Loading facilities and journey length were considered of intermediate importance, while lairage and methods for catching chickens were of least concern. The importance of some welfare concerns, e.g. livestock having to remain standing during a journey, was more commonly recognised by stakeholders who reported a high level of knowledge and experience. Therefore, these welfare issues could be a focus for future training activities. Compared to respondents directly involved in livestock transport, respondents involved in teaching and researching within livestock production rated the presented animal welfare issues as more important. These results can be used to guide development of training programmes, animal welfare research, and certification and regulatory control to target challenges to animal welfare in livestock transport and slaughter in China.	[Li, Xiaofei; Zito, Sarah; Sinclair, Michelle; Phillips, Clive J. C.] Univ Queensland, Sch Vet Sci, Ctr Anim Welf & Eth, Gatton, Qld, Australia; [Zito, Sarah] Royal New Zealand Soc Prevent Cruelty Anim, Auckland, New Zealand	University of Queensland	Phillips, CJC (corresponding author), Univ Queensland, Sch Vet Sci, Ctr Anim Welf & Eth, Gatton, Qld, Australia.	c.phillips@uq.edu.au	Li, xiaofei/GXF-7187-2022		University of Queensland in Australia under World Organisation for Animal Health (OIE)'s David Bayvel Collaborating Centre for Animal Welfare and Bioethical Analysis; University Putra Malaysia under World Organisation for Animal Health (OIE)'s David Bayvel Collaborating Centre for Animal Welfare and Bioethical Analysis; New Zealand Government Ministry of Primary Industries; European Commission via OIE; World Animal Protection, Universiti Putra Malaysia (UPM); Malaysian Government Department of Veterinary Services via UPM; Australian Government Department of Agriculture, Fisheries and Food; World Animal Health Organization (OIE)	University of Queensland in Australia under World Organisation for Animal Health (OIE)'s David Bayvel Collaborating Centre for Animal Welfare and Bioethical Analysis; University Putra Malaysia under World Organisation for Animal Health (OIE)'s David Bayvel Collaborating Centre for Animal Welfare and Bioethical Analysis; New Zealand Government Ministry of Primary Industries; European Commission via OIE; World Animal Protection, Universiti Putra Malaysia (UPM); Malaysian Government Department of Veterinary Services via UPM; Australian Government Department of Agriculture, Fisheries and Food(Australian Government); World Animal Health Organization (OIE)	This work was supported by University of Queensland in Australia and University Putra Malaysia, under the framework of the World Organisation for Animal Health (OIE)'s David Bayvel Collaborating Centre for Animal Welfare and Bioethical Analysis. It was funded by the New Zealand Government Ministry of Primary Industries, the European Commission via OIE, World Animal Protection, Universiti Putra Malaysia (UPM), the Malaysian Government Department of Veterinary Services via UPM, and the Australian Government Department of Agriculture, Fisheries and Food. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was conducted as part of the 'Animal Welfare Standards Project' under the auspices of the World Animal Health Organization (OIE).	Abernethy J, 2008, IEEE T KNOWL DATA EN, V20, P145, DOI [10.1109/TKDE.2007.190632, 10.1109/TKDE.2007.1031]; Andreasen AR, 2008, STRATEGIC MARKETING; [Anonymous], 2007, ACA TECHN PAP; [Anonymous], 2016, INT US COUNTR; [Anonymous], 2018, INTENSIVE ANIMAL FAR; Balch O., 2014, CHINAS GROWING HUNGE; Beef2Live, 2014, CHIN BEEF WORLD REP; Blakeley DN, 2003, J CHINESE PHILOS, V30, P137, DOI 10.1111/1540-6253.00111; Blokhuis H, 2013, IMPROVING FARM ANIMAL WELFARE: SCIENCE AND SOCIETY WORKING TOGETHER: THE WELFARE QUALITY APPROACH, P1, DOI 10.3920/978-90-8686-770-7; Cartwright B., 2006, THESIS; Davey Gareth, 2006, Journal of Applied Animal Welfare Science, V9, P289, DOI 10.1207/s15327604jaws0904_4; Food and Agriculture Organization Corporate Statistical Database (FAOSTAT), 2014, LIV PRIM; Food and Agriculture Organization of the United Nations Statistic Division (FAOSTAT), LIV AN PROD CHIN; Food and Agriculture Organization of the United Nations Statistic Division (FAOSTAT), 2014, LIV AN PROD; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Government of the People's Republic of China, 2008, 525 ORD STAT COUNC P; HAMILTON MB, 2006, ONLINE SURVEY RESPON; Heleski CR, 2006, ANTHROZOOS, V19, P290, DOI 10.2752/089279306785415439; Heleski CR, 2004, J ANIM SCI, V82, P2806; Herzog HA, 2007, ANTHROZOOS, V20, P7, DOI 10.2752/089279307780216687; Howell J., 2009, RES PAPER SERIES CBC; Jiwen C., 2010, PREVENTION CRUELTY A; Lai J, 2018, FOOD CONTROL, V85, P423, DOI 10.1016/j.foodcont.2017.09.032; Li PJ, 2008, LONG DISTANCE TRANSPORT AND WELFARE OF FARM ANIMALS, P288, DOI 10.1079/9781845934033.0288; Li PJ, 2009, J AGR ENVIRON ETHIC, V22, P217, DOI 10.1007/s10806-008-9140-7; Lievaart JJ, 2011, J DAIRY SCI, V94, P3420, DOI 10.3168/jds.2010-3954; Lin J., 2016, LIVEST IND, P39; Ling RZ, 2016, ANIM WELFARE, V25, P377, DOI 10.7120/09627286.25.3.377; Liu C., 2003, COLL WOM STUDY, P5; Lohr C. A., 2012, THESIS; Long DB, 2014, CHINA HUSBANDARY J, V50, P69; Maertens M., 2006, AM AGR EC ASS ANN M; Mang P., 2005, MEAT HYGIENE, P33; National Health and Family Planning Commission of China, 2017, REP LEG INF DIS CHIN; Niu RY, 2006, PROGR VET MED, V27, P108; OIE World Organisation for Animal Health, 2016, INTR REC AN WELF; Orme B. K., SAWTOOTH SOFTWARE RE; Paul ES, 2000, VET REC, V146, P269, DOI 10.1136/vr.146.10.269; Phillips CJC, 2009, ANIMAL, V3, P1152, DOI 10.1017/S1751731109004479; Phillips CJC, 2005, J BIOL EDUC, V40, P17, DOI 10.1080/00219266.2005.9656004; Phillips C, 2011, ANIMALS-BASEL, V1, P7, DOI 10.3390/ani1010007; Pines MK, 2007, ANIM WELFARE, V16, P489; Robins A, 2011, WORLD POULTRY SCI J, V67, P351, DOI 10.1017/S0043933911000341; Rohlf VI, 2012, ANTHROZOOS, V25, P171, DOI 10.2752/175303712X13316289505341; RSPCA Australia, 2014, NEW PLANS EXP CATTL; SAFE: New Zealand Animal Rights, 2016, NZ AN RIGHTS AN SENT; Shi YD, 2016, PRODUCTS QUALITY; Simoes GS, 2009, BRAZ ARCH BIOL TECHN, V52, P195, DOI 10.1590/S1516-89132009000700025; Song W., 2015, AN LAW C; Standards of China Association for Standardization, 2014, 2352014C CAS; Su B, 2017, ANIM WELFARE, V26, P239, DOI 10.7120/09627286.26.2.239; The Organisation for Economic Co-operation and Development (OECD), 2014, AGR OUTP MEAT CONS; Thomas R, 2012, THESIS; Tiplady CM, 2013, J AGR ENVIRON ETHIC, V26, P869, DOI 10.1007/s10806-012-9412-0; Tobias M.C., 2012, ANIMAL RIGHTS CHINA; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; United Nations Devlopment Program, 2016, HUM DEV REP; Wang F, 2017, ANHUI J PREVENTIVE V, V23, P171; Weary DM, 2016, ANIMAL, V10, P309, DOI 10.1017/S1751731115001160; Wells DL, 1997, SOC ANIM, V5, P45, DOI 10.1163/156853097X00213; Whitford A., 2012, SYDNEY LAW REV, V34, P348; Xi C, 2017, P WORLD C FARM AN WE, P44; Xian SX, 2006, THESIS; Xiao JB, 2010, ANIM HUSB SEED SCI, V31, P100; Yang H, 2013, J ANIM BREED GENET, V130, P249, DOI 10.1111/jbg.12045; Yang Z., 2013, ASIAN SOCIAL SCI, V9, P136, DOI DOI 10.5539/ASS.V9N7P136; You XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109177; Yu Q, 2012, CHINA SWINE IND, P53; Zhang GH, 2011, GRASS IND HUSB, P51; Zito S, 2016, J APPL ANIM WELF SCI, V19, P126, DOI 10.1080/10888705.2015.1121145	71	15	15	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0197028	10.1371/journal.pone.0197028	http://dx.doi.org/10.1371/journal.pone.0197028			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933370	Green Published, gold, Green Submitted			2022-12-26	WOS:000436076600002
J	Danish, L; Imig, D; Allgower, F; Scheurich, P; Pollak, N				Danish, Lubna; Imig, Dirke; Allgoewer, Frank; Scheurich, Peter; Pollak, Nadine			Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps	PLOS ONE			English	Article							X-LINKED INHIBITOR; OUTER-MEMBRANE PERMEABILIZATION; CD95-MEDIATED APOPTOSIS; ADENOCARCINOMA CELLS; INTRINSIC APOPTOSIS; SYSTEMS-ANALYSIS; IN-VIVO; PROTEIN; BCL-2; DEATH	Dysregulation of the mitochondrial signaling pathway of apoptosis induction represents a major hurdle in tumor therapy. The objective of the presented work was to investigate the role of the intrinsic (mitochondrial) apoptotic pathway in the non-small lung cancer cell line NCI-H460 upon induction of apoptosis using the highly bioactive TRAIL derivative Db-scTRAIL. NCI-H460 cells were TRAIL sensitive but an only about 3 fold overexpression of Bcl-2 was sufficient to induce a highly TRAIL resistant phenotype, confirming that the mitochondrial pathway is crucial for TRAIL-induced apoptosis induction. TRAIL resistance was paralleled by a strong inhibition of caspase-8,-9 and -3 activities and blocked their full processing. Notably, especially the final cleavage steps of the initiator caspase-8 and the executioner caspase-3 were effectively blocked by Bcl-2 overexpression. Caspase-9 knockdown failed to protect NCI-H460 cells from TRAIL-induced cell death, suggesting a minor role of this initiator caspase in this apoptotic pathway. Rather, knockdown of the XIAP antagonist Smac resulted in enhanced caspase-3 degradation after stimulation of cells with TRAIL. Of note, downregulation of XIAP had only limited effects on TRAIL sensitivity of wild type NCI-H460 cells, but resensitized Bcl-2 overexpressing cells for TRAIL-induced apoptosis. In particular, XIAP knockdown in combination with TRAIL allowed the final cleavage step of caspase-3 to generate the catalytically active p17 fragment, whose production was otherwise blocked in Bcl-2 overexpressing cells. Together, our data strongly suggest that XIAP-mediated inhibition of final caspase-3 processing is the last and major hurdle in TRAIL-induced apoptosis in NCI-H460 cells, which can be overcome by Smac in a Bcl-2 level dependent manner. Quantitative investigation of the XIAP/Smac interplay using a mathematical model approach corroborates our experimental data strengthening the suggested roles of XIAP and Smac as critical determinants for TRAIL sensitivity.	[Danish, Lubna; Scheurich, Peter; Pollak, Nadine] Univ Stuttgart, Inst Cell Biol & Immunol, Stuttgart, Germany; [Imig, Dirke; Allgoewer, Frank; Pollak, Nadine] Univ Stuttgart, Inst Syst Theory & Automat Control, Stuttgart, Germany	University of Stuttgart; University of Stuttgart	Pollak, N (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, Stuttgart, Germany.; Pollak, N (corresponding author), Univ Stuttgart, Inst Syst Theory & Automat Control, Stuttgart, Germany.	Nadine.Pollak@izi.uni-stuttgart.de	Allgöwer, Frank/F-3909-2011	Allgöwer, Frank/0000-0002-3702-3658	Deutsche Forschungsgemeinschaft [SCHE 349/10-1]; Bundesministerium fur Bildung und Forschung, project "PREDICT"; German research foundation [SCHE 349/10-1]; German Federal Research and Education Ministry (BMBF)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung, project "PREDICT"(Federal Ministry of Education & Research (BMBF)); German research foundation(German Research Foundation (DFG)); German Federal Research and Education Ministry (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by Deutsche Forschungsgemeinschaft, grant SCHE 349/10-1, PS, www.dfg.de; and by Bundesministerium fur Bildung und Forschung, project "PREDICT", PS, www.bmbf.de.; The authors acknowledge funding from the German research foundation in the grant SCHE 349/10-1 and the German Federal Research and Education Ministry (BMBF) in the project "PREDICT," We further thank Beate Budai for expert technical assistance and Dr. Martin Siegemund for the Db-scTRAIL.	Abou el Hassan MAI, 2004, BRIT J CANCER, V91, P171, DOI 10.1038/sj.bjc.6601910; Aldridge BB, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.85; Anagnostou VK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-186; Apolinario RM, 1997, J CLIN ONCOL, V15, P2456, DOI 10.1200/JCO.1997.15.6.2456; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Bilim V, 2008, BRIT J CANCER, V98, P941, DOI 10.1038/sj.bjc.6604268; Brentnall M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-32; de Miguel D, 2016, CELL DEATH DIFFER, V23, P733, DOI 10.1038/cdd.2015.174; Deeks ED, 2016, DRUGS, V76, P979, DOI 10.1007/s40265-016-0596-x; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fakler M, 2009, BLOOD, V113, P1710, DOI 10.1182/blood-2007-09-114314; Ferreira CG, 2000, CANCER RES, V60, P7133; Ferreira KS, 2012, APOPTOSIS, V17, P503, DOI 10.1007/s10495-011-0691-0; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fulda S, 2015, SEMIN CELL DEV BIOL, V39, P132, DOI 10.1016/j.semcdb.2014.12.005; Hu Q, 2014, P NATL ACAD SCI USA, V111, P16254, DOI 10.1073/pnas.1418000111; Huang JQ, 2015, INT J CLIN EXP PATHO, V8, P11278; Huber HJ, 2007, BIOINFORMATICS, V23, P648, DOI 10.1093/bioinformatics/btl684; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Ichim G, 2015, MOL CELL, V57, P860, DOI 10.1016/j.molcel.2015.01.018; Jeon JH, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.129; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911; Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397; Lovric MM, 2010, ONCOGENE, V29, P5048, DOI 10.1038/onc.2010.242; Mazzocco K, 1996, APOPTOSIS, V1, P63; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Moller Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107165; Neumann S, 2014, J BIOL CHEM, V289, P16576, DOI 10.1074/jbc.M114.559468; Okada H, 2002, MOL CELL BIOL, V22, P3509, DOI 10.1128/MCB.22.10.3509-3517.2002; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ozoren N, 2002, NEOPLASIA, V4, P551, DOI 10.1038/sj.neo.7900270; PEZZELLA F, 1993, NEW ENGL J MED, V329, P690, DOI 10.1056/NEJM199309023291003; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523; Sakuma Y, 2011, ONCOL REP, V25, P661, DOI 10.3892/or.2010.1123; Samraj AK, 2006, J BIOL CHEM, V281, P29652, DOI 10.1074/jbc.M603487200; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schmid J, 2012, J BIOL CHEM, V287, P41546, DOI 10.1074/jbc.M112.411827; Shawgo ME, 2009, J BIOL CHEM, V284, P33447, DOI 10.1074/jbc.M109.032359; Shtivelman E, 2014, ONCOTARGET, V5, P1392, DOI 10.18632/oncotarget.1891; Siegemund M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.29; Skommer J, 2011, APOPTOSIS, V16, P619, DOI 10.1007/s10495-011-0593-1; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Sun SY, 2001, BIOCHEM BIOPH RES CO, V280, P788, DOI 10.1006/bbrc.2000.4218; Sun XM, 2002, J BIOL CHEM, V277, P11345, DOI 10.1074/jbc.M109893200; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Twiddy Davina, 2007, Biochem J, V405, pe1; Vogler M, 2008, CANCER RES, V68, P7956, DOI 10.1158/0008-5472.CAN-08-1296; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wieder T, 2001, BLOOD, V97, P1378, DOI 10.1182/blood.V97.5.1378; Wurstle ML, 2012, EXP CELL RES, V318, P1213, DOI 10.1016/j.yexcr.2012.02.013; Yang LL, 2003, CANCER RES, V63, P831	57	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198203	10.1371/journal.pone.0198203	http://dx.doi.org/10.1371/journal.pone.0198203			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927992	gold, Green Published, Green Submitted			2022-12-26	WOS:000435802500012
J	Fernandez-Fernandez, D; Cadaveira-Mosquera, A; Rueda-Ruzafa, L; Herrera-Perez, S; Veale, EL; Reboreda, A; Mathie, A; Lamas, JA				Fernandez-Fernandez, Diego; Cadaveira-Mosquera, Alba; Rueda-Ruzafa, Lola; Herrera-Perez, Salvador; Veale, Emma L.; Reboreda, Antonio; Mathie, Alistair; Lamas, J. Antonio			Activation of TREK currents by riluzole in three subgroups of cultured mouse nodose ganglion neurons	PLOS ONE			English	Article							RESISTANT SODIUM-CHANNELS; BACKGROUND K+ CHANNEL; DORSAL-ROOT GANGLIA; NEUROPROTECTIVE AGENT RILUZOLE; AMYOTROPHIC-LATERAL-SCLEROSIS; POLYUNSATURATED FATTY-ACIDS; VISCERAL SENSORY NEURONS; DOMAIN POTASSIUM CHANNEL; VAGAL AFFERENT NEURONS; SYMPATHETIC NEURONS	Two-pore domain potassium channels (K2P) constitute major candidates for the regulation of background potassium currents in mammalian cells. Channels of the TREK subfamily are also well positioned to play an important role in sensory transduction due to their sensitivity to a large number of physiological and physical stimuli (pH, mechanical, temperature). Following our previous report describing the molecular expression of different K2P channels in the vagal sensory system, here we confirm that TREK channels are functionally expressed in neurons from the mouse nodose ganglion (mNG). Neurons were subdivided into three groups (A, Ah and C) based on their response to tetrodotoxin and capsaicin. Application of the TREK subfamily activator riluzole to isolated mNG neurons evoked a concentration dependent outward current in the majority of cells from all the three subtypes studied. Riluzole increased membrane conductance and hyperpolarized the membrane potential by approximately 10 mV when applied to resting neurons. The resting potential was similar in all three groups, but C cells were clearly less excitable and showed smaller hyperpolarization-activated currents at -100 mV and smaller sustained currents at -30 mV. Our results indicate that the TREK subfamily of K2P channels might play an important role in the maintenance of the resting membrane potential in sensory neurons of the autonomic nervous system, suggesting its participation in the modulation of vagal reflexes.	[Fernandez-Fernandez, Diego; Cadaveira-Mosquera, Alba; Rueda-Ruzafa, Lola; Herrera-Perez, Salvador; Reboreda, Antonio; Lamas, J. Antonio] Univ Vigo, Fac Biol, Dept Funct Biol & Hlth Sci, CINBIO, Vigo, Galicia, Spain; [Veale, Emma L.; Mathie, Alistair] Univ Kent, Medway Sch Pharm, Chatham, Kent, England; [Reboreda, Antonio] Leibniz Inst Neurobiol, Dept Funct Architecture Memory, Magdeburg, Germany	Universidade de Vigo; CINBIO; University of Greenwich; University of Kent; Leibniz Institut fur Neurobiologie (LIN)	Fernandez-Fernandez, D; Lamas, JA (corresponding author), Univ Vigo, Fac Biol, Dept Funct Biol & Hlth Sci, CINBIO, Vigo, Galicia, Spain.	duegui@gmail.com; antoniolamas@uvigo.es	Veale, Emma/AAA-5022-2022; Rueda, Lola/AGQ-6540-2022; Fernandez-Fernandez, Diego/K-9149-2017; Herrera-Pérez, Salvador/Z-1882-2019; Lamas, J. Antonio/D-7208-2013; Mathie, Alistair/K-7198-2019	Veale, Emma/0000-0002-6778-9929; Fernandez-Fernandez, Diego/0000-0003-1431-3705; Herrera-Pérez, Salvador/0000-0002-0491-3718; Lamas, J. Antonio/0000-0002-4453-4595; Mathie, Alistair/0000-0001-6094-2890; , Lola/0000-0002-0151-8018; , IIS Galicia Sur/0000-0003-3812-7413	Spanish Government: Secretaria de Estado de Investigacion, Desarrollo e Innovacion (MINECO) [BFU2014-58999-P]; Galician Government: Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia [GPC2015/022]; European Regional Development Fund [FP7-316265-BIOCAPS]; BBSRC [BB/J000930/1] Funding Source: UKRI	Spanish Government: Secretaria de Estado de Investigacion, Desarrollo e Innovacion (MINECO); Galician Government: Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia; European Regional Development Fund(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants to J. A.L. from the Spanish Government: Secretaria de Estado de Investigacion, Desarrollo e Innovacion (MINECO, BFU2014-58999-P), Galician Government: Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia (GPC2015/022) and European Regional Development Fund (FP7-316265-BIOCAPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBUCKLE JB, 1995, NEUROSCI LETT, V185, P70, DOI 10.1016/0304-3940(94)11227-A; Bagriantsev SN, 2013, ACS CHEM BIOL, V8, P1841, DOI 10.1021/cb400289x; Bang H, 2000, J BIOL CHEM, V275, P17412, DOI 10.1074/jbc.M000445200; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; Bellingham MC, 2011, CNS NEUROSCI THER, V17, P4, DOI 10.1111/j.1755-5949.2009.00116.x; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; Berthoud HR, 2001, AM J PHYSIOL-REG I, V280, pR1371, DOI 10.1152/ajpregu.2001.280.5.R1371; Bielefeldt K, 2000, NEUROSCIENCE, V101, P727, DOI 10.1016/S0306-4522(00)00375-4; Bielefeldt K, 2006, AM J PHYSIOL-GASTR L, V291, pG987, DOI 10.1152/ajpgi.00080.2006; Black JA, 2004, PAIN, V108, P237, DOI 10.1016/j.pain.2003.12.035; Braun G, 2015, BRIT J PHARMACOL, V172, P1728, DOI 10.1111/bph.13019; Bushell T, 2002, BRIT J PHARMACOL, V135, P705, DOI 10.1038/sj.bjp.0704518; Cadaveira-Mosquera A, 2012, J MOL NEUROSCI, V48, P86, DOI 10.1007/s12031-012-9780-y; Cadaveira-Mosquera A, 2011, J NEUROSCI, V31, P1375, DOI 10.1523/JNEUROSCI.2791-10.2011; CAFFREY JM, 1992, BRAIN RES, V592, P283, DOI 10.1016/0006-8993(92)91687-A; Cheah BC, 2010, CURR MED CHEM, V17, P1942, DOI 10.2174/092986710791163939; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; COLERIDGE JCG, 1984, REV PHYSIOL BIOCH P, V99, P1, DOI 10.1007/BFb0027715; Cummins TR, 2009, NAT PROTOC, V4, P1103, DOI 10.1038/nprot.2009.91; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; Czirjak G, 2002, MOL ENDOCRINOL, V16, P621, DOI 10.1210/me.16.3.621; Dirajlal S, 2003, J NEUROPHYSIOL, V89, P513, DOI 10.1152/jn.00371.2002; Djillani A, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00643; Doan TN, 1999, J PHYSIOL-LONDON, V514, P125, DOI 10.1111/j.1469-7793.1999.125af.x; Duprat F, 2000, MOL PHARMACOL, V57, P906; ELLIOTT AA, 1993, J PHYSIOL-LONDON, V463, P39, DOI 10.1113/jphysiol.1993.sp019583; Enyeart JJ, 2002, J BIOL CHEM, V277, P49186, DOI 10.1074/jbc.M207233200; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; EVANS DHL, 1954, J ANAT, V88, P320; Fang X, 2005, J PHYSIOL-LONDON, V565, P927, DOI 10.1113/jphysiol.2005.086199; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; FUKUDA J, 1980, BRAIN RES, V202, P249, DOI 10.1016/S0006-8993(80)80055-2; GALLEGO R, 1978, J NEUROPHYSIOL, V41, P1217, DOI 10.1152/jn.1978.41.5.1217; Gu QH, 2012, EXP PHYSIOL, V97, P534, DOI 10.1113/expphysiol.2011.060764; Hajdu P, 2003, CARDIOVASC RES, V58, P46, DOI 10.1016/S0008-6363(02)00831-3; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P47, DOI 10.1113/jphysiol.1985.sp015574; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; IKEDA SR, 1986, J NEUROPHYSIOL, V55, P527, DOI 10.1152/jn.1986.55.3.527; Jones RCW, 2005, J NEUROSCI, V25, P10981, DOI 10.1523/JNEUROSCI.0703-05.2005; Kang D, 2008, BIOCHEM BIOPH RES CO, V367, P609, DOI 10.1016/j.bbrc.2008.01.008; Kang D, 2006, AM J PHYSIOL-CELL PH, V291, pC138, DOI 10.1152/ajpcell.00629.2005; Kennard LE, 2005, BRIT J PHARMACOL, V144, P821, DOI 10.1038/sj.bjp.0706068; Kollarik M, 2004, J PHYSIOL-LONDON, V555, P115, DOI 10.1113/jphysiol.2003.054890; Kollarik M, 2003, J PHYSIOL-LONDON, V551, P869, DOI 10.1113/jphysiol.2003.042028; Kwong K, 2008, J PHYSIOL-LONDON, V586, P1321, DOI 10.1113/jphysiol.2007.146365; Lamas JA, 2009, PFLUG ARCH EUR J PHY, V458, P589, DOI 10.1007/s00424-009-0648-0; Lamas JA, 1998, PFLUG ARCH EUR J PHY, V436, P429, DOI 10.1007/s004240050653; Lembrechts R, 2011, HISTOCHEM CELL BIOL, V136, P371, DOI 10.1007/s00418-011-0837-8; Lesage F, 2000, J BIOL CHEM, V275, P28398, DOI 10.1074/jbc.M002822200; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Li BY, 2007, J NEUROSCI METH, V164, P75, DOI 10.1016/j.jneumeth.2007.04.003; Li BY, 2002, J NEUROSCI METH, V115, P157, DOI 10.1016/S0165-0270(02)00010-9; Lozinsky I., 2012, MECH GATED CHANNELS, P35, DOI [10.1007/978-94-007-5073-9_2, DOI 10.1007/978-94-007-5073-9_2]; Lu XL, 2013, INT J BIOL SCI, V9, P716, DOI 10.7150/ijbs.7006; Ma RL, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00157; Maati HMO, 2012, NEUROPHARMACOLOGY, V62, P278, DOI 10.1016/j.neuropharm.2011.07.019; Maati HMO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025602; Magistretti J, 1998, BIOPHYS J, V74, P831, DOI 10.1016/S0006-3495(98)74007-X; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; MARSH SJ, 1987, NEUROSCIENCE, V23, P275, DOI 10.1016/0306-4522(87)90289-2; Mazella J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000355; Mazzone SB, 2016, PHYSIOL REV, V96, P975, DOI 10.1152/physrev.00039.2015; Meadows HJ, 2001, BRAIN RES, V892, P94, DOI 10.1016/S0006-8993(00)03239-X; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Pinto V, 2008, J NEUROPHYSIOL, V99, P617, DOI 10.1152/jn.00944.2007; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Richter JM, 2014, BRIT J PHARMACOL, V171, P158, DOI 10.1111/bph.12436; Romero M, 2004, EUR J NEUROSCI, V19, P2693, DOI 10.1111/j.1460-9568.2004.03363.x; Rong WF, 2004, J PHYSIOL-LONDON, V560, P867, DOI 10.1113/jphysiol.2004.071746; ROY ML, 1992, J NEUROSCI, V12, P2104; SARIA A, 1988, AM REV RESPIR DIS, V137, P1330, DOI 10.1164/ajrccm/137.6.1330; STANSFELD CE, 1985, J NEUROPHYSIOL, V54, P245, DOI 10.1152/jn.1985.54.2.245; Su X, 1999, AM J PHYSIOL-GASTR L, V277, pG1180, DOI 10.1152/ajpgi.1999.277.6.G1180; Talley EM, 2003, NEUROSCIENTIST, V9, P46, DOI 10.1177/1073858402239590; Tate S, 1998, NAT NEUROSCI, V1, P653, DOI 10.1038/3652; Tertyshnikova S, 2005, J PHARMACOL EXP THER, V313, P250, DOI 10.1124/jpet.104.078592; UNDEM BJ, 1993, J AUTONOM NERV SYST, V44, P17, DOI 10.1016/0165-1838(93)90375-5; Veale EL, 2014, MOL PHARMACOL, V85, P671, DOI 10.1124/mol.113.091199; Wladyka CL, 2006, J PHYSIOL-LONDON, V575, P175, DOI 10.1113/jphysiol.2006.113308; Yamamoto Y, 2009, NEUROSCI LETT, V454, P129, DOI 10.1016/j.neulet.2009.02.069; Zhao H, 2010, AM J PHYSIOL-GASTR L, V298, pG212, DOI 10.1152/ajpgi.00396.2009; Zhou YH, 2010, CLIN EXP PHARMACOL P, V37, P852, DOI 10.1111/j.1440-1681.2010.05396.x	83	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199282	10.1371/journal.pone.0199282	http://dx.doi.org/10.1371/journal.pone.0199282			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928032	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000435802500066
J	Liang, DC; Shao, H; Born, WK; O'Brien, RL; Kaplan, HJ; Sun, DM				Liang, Dongchun; Shao, Hui; Born, Willi K.; O'Brien, Rebecca L.; Kaplan, Henry J.; Sun, Deming			High level expression of A2ARs is required for the enhancing function, but not for the inhibiting function, of y delta T cells in the autoimmune responses of EAU	PLOS ONE			English	Article							ADENOSINE A(2A) RECEPTORS; HUMAN DENDRITIC CELLS; IMMUNE-RESPONSE; DOWN-REGULATION; FLOW-CYTOMETRY; TISSUE-DAMAGE; IN-VIVO; ACTIVATION; INFLAMMATION; UVEITIS	We previously reported that activated y delta T cells greatly enhance autoimmune responses, particularly the Th17 response. To determine the mechanisms involved, we made a series of comparisons between activated and non-activated y delta T cells. Our results showed that activated y delta T cells expressed greatly increased levels of A2A adenosine receptor (A2AR) and decreased amounts of CD73, as well as increased amounts of T cell activation markers such as CD69, CD44 and CD25. We show that A2AR is a major functional molecule in the enhancing activity of y delta T cells. A2AR(-/-) y delta T cells (isolated from A2AR(-/-) mouse), lost their Th17-enhancing activity as did A2AR(+/+) y delta T cells (isolated from wt-B6 mouse) after treatment with an A2AR antagonist. Since y delta T cells possess either an enhancing or an inhibiting effect, we also tested whether A2AR expression on y delta T cells is essential to their inhibiting effect. Our results showed that the inhibiting effect of A2AR(-/-)y delta T cells was as potent as that of A2AR(+/+) y6 T cells. In a previous report we showed that the expression of different levels of CD73 molecule allowed y delta T cells to adjust their suppressive activity; in the current study, we show that expression of increased amounts of A2AR allows y delta T cells to more effectively exert their enhancing function.	[Liang, Dongchun; Sun, Deming] Univ Calif Los Angeles, David Geffen Sch Med, Doheny Eye Inst, Los Angeles, CA 90095 USA; [Liang, Dongchun; Sun, Deming] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Shao, Hui; Kaplan, Henry J.] Univ Louisville, Dept Ophthalmol & Visual Sci, Kentucky Lions Eye Ctr, Louisville, KY 40292 USA; [Born, Willi K.; O'Brien, Rebecca L.] Natl Jewish Hlth, Dept Biomed Res, Denver, CO USA	Doheny Eye Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Louisville; National Jewish Health	Sun, DM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Doheny Eye Inst, Los Angeles, CA 90095 USA.; Sun, DM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA.	dsun@doheny.org		Sun, Deming/0000-0003-4851-0416	NIH [NIH/NEI/EY0022403, NIH/NEI/EY018827]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants NIH/NEI/EY0022403 and NIH/NEI/EY018827.	Alam MS, 2009, MUCOSAL IMMUNOL, V2, P232, DOI 10.1038/mi.2009.4; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Beavis PA, 2012, TRENDS IMMUNOL, V33, P231, DOI 10.1016/j.it.2012.02.009; Blackburn Michael R, 2009, Handb Exp Pharmacol, P215, DOI 10.1007/978-3-540-89615-9_8; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Cheng L, 2008, J NEUROIMMUNOL, V203, P3, DOI 10.1016/j.jneuroim.2008.06.007; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Csoka B, 2008, FASEB J, V22, P3491, DOI 10.1096/fj.08-107458; Cui Y, 2009, J IMMUNOL, V183, P560, DOI 10.4049/jimmunol.0900241; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Erdmann AA, 2005, BLOOD, V105, P4707, DOI 10.1182/blood-2004-04-1407; Feoktistov I, 1997, PHARMACOL REV, V49, P381; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Himer L, 2010, FASEB J, V24, P2631, DOI 10.1096/fj.10-155192; Huang S, 1997, BLOOD, V90, P1600, DOI 10.1182/blood.V90.4.1600.1600_1600_1610; Huang YF, 2015, J IMMUNOL, V195, P5572, DOI 10.4049/jimmunol.1501604; Jin DC, 2010, CANCER RES, V70, P2245, DOI 10.1158/0008-5472.CAN-09-3109; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; Koshiba M, 1999, MOL PHARMACOL, V55, P614; Lappas CM, 2005, EXPERT OPIN INV DRUG, V14, P797, DOI 10.1517/13543784.14.7.797; Lappas CM, 2005, J IMMUNOL, V174, P1073, DOI 10.4049/jimmunol.174.2.1073; Liang DC, 2017, J IMMUNOL, V198, P1429, DOI 10.4049/jimmunol.1601510; Liang DC, 2016, J IMMUNOL, V196, P2646, DOI 10.4049/jimmunol.1502294; Liang DC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150078; Liang DC, 2014, J IMMUNOL, V193, P5498, DOI 10.4049/jimmunol.1401959; Liang DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108932; Liang DC, 2013, J IMMUNOL, V191, P1118, DOI 10.4049/jimmunol.1300626; Liang DC, 2013, INVEST OPHTH VIS SCI, V54, P3493, DOI 10.1167/iovs.12-11432; Liang DC, 2012, J IMMUNOL, V188, P5785, DOI 10.4049/jimmunol.1200109; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Manohar M, 2012, J LEUKOCYTE BIOL, V92, P787, DOI 10.1189/jlb.0312121; Michel ML, 2012, P NATL ACAD SCI USA, V109, P17549, DOI 10.1073/pnas.1204327109; Mills JH, 2012, J IMMUNOL, V188, P5713, DOI 10.4049/jimmunol.1200545; Naganuma M, 2006, J IMMUNOL, V177, P2765, DOI 10.4049/jimmunol.177.5.2765; Nian H, 2011, INVEST OPHTH VIS SCI, V52, P5920, DOI 10.1167/iovs.10-6758; Nian H, 2010, INVEST OPHTH VIS SCI, V51, P4661, DOI 10.1167/iovs.09-5045; Odashima M, 2005, GASTROENTEROLOGY, V129, P26, DOI 10.1053/j.gastro.2005.05.032; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Panther E, 2001, FASEB J, V15, P1963, DOI 10.1096/fj.01-0169com; Paul S, 2014, J LEUKOCYTE BIOL, V97, P295; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Riol-Blanco L, 2010, J IMMUNOL, V184, P1710, DOI 10.4049/jimmunol.0902796; Schnurr M, 2005, BLOOD, V105, P1582, DOI 10.1182/blood-2004-05-1718; Sevigny CP, 2007, J IMMUNOL, V178, P4240, DOI 10.4049/jimmunol.178.7.4240; Sitkovsky MV, 2005, TRENDS IMMUNOL, V26, P299, DOI 10.1016/j.it.2005.04.004; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Xie KP, 1997, ONCOGENE, V15, P771, DOI 10.1038/sj.onc.1201239; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zhao RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155953; Zocchi C, 1996, J PHARMACOL EXP THER, V276, P398; Zuo AJ, 2012, MOL IMMUNOL, V50, P125, DOI 10.1016/j.molimm.2011.12.013	58	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199601	10.1371/journal.pone.0199601	http://dx.doi.org/10.1371/journal.pone.0199601			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928041	Green Published, gold			2022-12-26	WOS:000435802500115
J	Shankar, R; Rowe, C; Van Hoorn, A; Henley, W; Laugharne, R; Cox, D; Pande, R; Roy, A; Sander, JW				Shankar, Rohit; Rowe, Charles; Van Hoorn, Alje; Henley, William; Laugharne, Richard; Cox, David; Pande, Raj; Roy, Ashok; Sander, Josemir W.			Under representation of people with epilepsy and intellectual disability in research	PLOS ONE			English	Article							ADULTS; PREVALENCE	Purpose One quarter of people with epilepsy have an intellectual disability (ID) and one fifth of people with an ID have epilepsy. Both conditions are associated with higher levels of morbidity, stigma and premature mortality. There have been calls for action to promote more research in this group. We examined if this group are represented adequately in current research. Methods The proportion of research output in epilepsy conferences and publications relevant to ID and the proportion in ID conferences and publications on epilepsy for 2015-2016 were identified. As the percentage of children in the population with epilepsy is 17%, research output of this group was compared with the ID group. Recognised material was classified based on whether it applied to general epilepsy/ID research, children with epilepsy or people with epilepsy and ID. Data was analysed to determine the proportion of presented research specifically identifying people with epilepsy and ID. Results Fewer than 2% of presentations at epilepsy conferences specifically related to the ID and epilepsy group compared to 15% relating to children with epilepsy. Similarly only 1.4% of the research presented at major ID conferences related to those with people with epilepsy and ID. About 5% of published research in the field of epilepsy related to those with ID as compared with 24% for children with epilepsy. Twelve percent of published research in ID specifically identified epilepsy. Conclusion Publications and conference presentations, on the population with epilepsy and comorbid ID is under-represented. Increased research in this area might assist in improving the quality of care for this relatively neglected group.	[Shankar, Rohit; Rowe, Charles; Van Hoorn, Alje; Laugharne, Richard; Cox, David; Pande, Raj] Cornwall Partnership NHS Fdn Trust, Bodmin, Cornwall, England; [Shankar, Rohit; Henley, William; Laugharne, Richard] Univ Exeter, Med Sch, Exeter, Devon, England; [Roy, Ashok] Coventry & Warwickshire NHS Trust, Solihul, England; [Roy, Ashok] Royal Coll Psychiatrists, Chair Fac Psychiat Intellectual Disabil, London, England; [Sander, Josemir W.] Univ Coll London Hosp, Biomed Res Ctr, NIHR, UCL Inst Neurol, Queen Sq, London, England; [Sander, Josemir W.] Chalfont Ctr Epilepsy, Gerrards Cross, Bucks, England; [Sander, Josemir W.] SEIN, Heemstede, Netherlands	University of Exeter; University College London Hospitals NHS Foundation Trust; University of London; King's College London; University College London	Shankar, R (corresponding author), Cornwall Partnership NHS Fdn Trust, Bodmin, Cornwall, England.; Shankar, R (corresponding author), Univ Exeter, Med Sch, Exeter, Devon, England.	Rohit.shankar@nhs.ne	Sander, Josemir W/C-1576-2008; Roy, Ashok/AAF-6396-2020; Shankar, Rohit/HGU-4155-2022; Shankar, Rohit/I-9028-2019	Sander, Josemir W/0000-0001-6041-9661; Shankar, Rohit/0000-0002-1183-6933; Shankar, Rohit/0000-0002-1183-6933; Laugharne, Richard/0000-0001-9916-343X	GSK; Eisai Co.; UCB Pharma; UCB; Special Products; LivaNova; Desitin	GSK(GlaxoSmithKline); Eisai Co.(Eisai Co Ltd); UCB Pharma(UCB Pharma SA); UCB(UCB Pharma SA); Special Products; LivaNova; Desitin	JWS has received departmental research support from GSK, Eisai Co. and UCB Pharma. RS has received research support from UCB, Eisai Co., Special Products, LivaNova and Desitin. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Devinsky O, 2016, NEUROLOGY, V86, P779, DOI 10.1212/WNL.0000000000002253; Devinsky O, 2015, NEUROLOGY, V85, P1512, DOI 10.1212/WNL.0000000000002060; Doran Z, 2016, EUR J NEUROL, V23, P1152, DOI 10.1111/ene.13016; Glover G, 2013, IMPROVING HLTH LIVES; Joint Epilepsy Council of the UK and Ireland, 2011, EP PREV INC OTH STAT; Kerr M, 2014, EPILEPSIA, V55, P1902, DOI 10.1111/epi.12848; McGrother CW, 2006, SEIZURE-EUR J EPILEP, V15, P376, DOI 10.1016/j.seizure.2006.04.002; MENCAP, 2007, DEATH IND; Ring H., 2013, ADV CLIN NEUROSCIENC, V13, P14; Robertson J, 2015, SEIZURE-EUR J EPILEP, V29, P46, DOI 10.1016/j.seizure.2015.03.016; Zack MM, 2017, MMWR-MORBID MORTAL W, V66, P821, DOI 10.15585/mmwr.mm6631a1	12	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198261	10.1371/journal.pone.0198261	http://dx.doi.org/10.1371/journal.pone.0198261			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927966	gold, Green Submitted, Green Published			2022-12-26	WOS:000435802500013
J	Yang, TT; Ala, M; Zhang, YS; Wu, JB; Wang, AZ; Guan, DX				Yang, Tingting; Ala, Musa; Zhang, Yushu; Wu, Jiabing; Wang, Anzhi; Guan, Dexin			Characteristics of soil moisture under different vegetation coverage in Horqin Sandy Land, northern China	PLOS ONE			English	Article							LOESS PLATEAU; TEMPORAL STABILITY; WATER-BALANCE; DESERTIFICATION; RESTORATION; GRASSLAND; COMMUNITY; GROWTH; FOREST; ZONE	Vegetation restoration as an effective sand fixation measure has made great achievements in China. However, soil water conditions deteriorate with the development and maturity of sand-fixing vegetation. In this study, we investigated the relationship between soil water content (SWC) and vegetation coverage (VC) at different portion (top, middle and bottom) on ten sand dunes during the growing season (April to October) in Horqin Sandy Land, northern China. We analyzed the temporal and spatial variation characteristics of SWC under different VC. The results indicate that VC and soil water storage were negatively correlated. The effect of vegetation on soil water storage on the sand dunes was greater in the dry season than the wet season. The VC and coefficient of coefficient of SWC were positively correlated at the 20 to 140 cm soil depth. As VC increased, the effect of drought stress increased at the 20 to 200 cm soil depths. The VC and SWC were negatively correlated at all the three portions of the sand dunes. According to soil water conditions and the concept of wilting humidity at different VC, we found that the suitable VC values were less than 0.46, 0.52, and 0.71 at the top, middle and bottom of the sand dunes, respectively.	[Yang, Tingting; Ala, Musa; Wu, Jiabing; Wang, Anzhi; Guan, Dexin] Chinese Acad Sci, Inst Appl Ecol, Shenyang, Liaoning, Peoples R China; [Yang, Tingting] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Yushu] China Meteorol Adm, Inst Atmospher Environm, Shenyang, Liaoning, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China Meteorological Administration	Wang, AZ; Guan, DX (corresponding author), Chinese Acad Sci, Inst Appl Ecol, Shenyang, Liaoning, Peoples R China.	waz@iae.ac.cn; dxguan@iae.ac.cn			National Program on Key Basic Research Project of China [2013CB429902-2]; Key projects of the Chinese Academy of Sciences [KFZD-SW-305]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2015BAD07B050501]; National Natural Science Foundation of China [31670712]	National Program on Key Basic Research Project of China(National Basic Research Program of China); Key projects of the Chinese Academy of Sciences; National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was funded by: National Program on Key Basic Research Project of China, Number: 2013CB429902-2, Recipient: Anzhi Wang, http://www.973.gov.cn/English/Index.aspx; Key projects of the Chinese Academy of Sciences, Number: KFZD-SW-305, Recipient: Jiabing Wu, http://www.cas.cn/; National Key Technology Research and Development Program of the Ministry of Science and Technology of China, Number: 2015BAD07B050501, Recipient: Dexin Guan (http://www.most.gov.cn/); and the National Natural Science Foundation of China, Number: 31670712, Recipient: Musa Ala, http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BS, 2017, PLANT SOIL, V414, P379, DOI 10.1007/s11104-016-3138-0; Ali S, 2016, AGR WATER MANAGE, V178, P1, DOI 10.1016/j.agwat.2016.09.003; Becerril-Pina R, 2015, J ARID ENVIRON, V120, P4, DOI 10.1016/j.jaridenv.2015.04.006; Bu CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127394; Chang Z, 2014, ACTA BOT BOREALI OCC; Charbonnier F, 2013, AGR FOREST METEOROL, V181, P152, DOI 10.1016/j.agrformet.2013.07.010; Chen HS, 2008, J HYDROL, V360, P242, DOI 10.1016/j.jhydrol.2008.07.037; Chen LD, 2007, CATENA, V70, P200, DOI 10.1016/j.catena.2006.08.007; [崔利强 CUI Liqiang], 2010, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V24, P177; de Taf DS, 2017, MICROB ECOL, P1, DOI [10.1007/s00248-91'7-0999-6, DOI 10.1007/S00248-91'7-0999-6]; Deblauwe V, 2008, GLOBAL ECOL BIOGEOGR, V17, P715, DOI 10.1111/j.1466-8238.2008.00413.x; Du XC, 2011, ANN FOREST SCI, V68, P1197, DOI 10.1007/s13595-011-0104-0; Eldridge DJ, 1997, ARID SOIL RES REHAB, V11, P113, DOI 10.1080/15324989709381465; English NB, 2005, J ARID ENVIRON, V63, P324, DOI 10.1016/j.jaridenv.2005.03.013; Ensign KL, 2006, GEODERMA, V136, P788, DOI 10.1016/j.geoderma.2006.06.009; Fan JL, 2015, J HYDROL, V523, P475, DOI 10.1016/j.jhydrol.2015.01.064; Gao Y, 2002, J ARID ENVIRON, V52, P483, DOI 10.1006/jare.2002.1013; Garduno HR, 2010, J ARID ENVIRON, V74, P291, DOI 10.1016/j.jaridenv.2009.08.005; Ge XD, 2015, ECOL ECON, V119, P53, DOI 10.1016/j.ecolecon.2015.08.006; Hong li LI, 2006, J ARID LAND RESOURCE; Kolahchi Z, 2007, J ARID ENVIRON, V68, P624, DOI 10.1016/j.jaridenv.2006.06.010; Kong W, 2009, J ARID ENVIRON, V73, P306, DOI 10.1016/j.jaridenv.2008.10.003; Kremer RG, 1996, ECOL MODEL, V84, P151, DOI 10.1016/0304-3800(94)00140-5; Lamusa A, 2006, Ying Yong Sheng Tai Xue Bao, V17, P31; Legates DR, 2011, PROG PHYS GEOG, V35, P65, DOI 10.1177/0309133310386514; [李红丽 Li Hongli], 2006, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V20, P169; Li XR, 2004, J ARID ENVIRON, V57, P1, DOI 10.1016/S0140-1963(03)00089-2; Li YQ, 2010, B SOIL WATER CONSERV; Li ZH, 2015, SUSTAINABILITY-BASEL, V7, P3086, DOI 10.3390/su7033086; [梁超 LIANG Chao], 2011, [水土保持研究, Research of Soil and Water Conservation], V18, P103; [刘凯 Liu Kai], 2015, [土壤, Soils], V47, P765; Liu RT, 2009, EUR J SOIL BIOL, V45, P417, DOI 10.1016/j.ejsobi.2009.06.006; [刘新平 LIU Xinping], 2006, [干旱区地理, Arid Land Geography], V29, P523; Lv P, 2011, ENVIRON EARTH SCI, V66, P1791, DOI [10.1007/e12665-011-1402-4, DOI 10.1007/E12665-011-1402-4]; Maestre FT, 2010, ECOLOGY, V91, P3742, DOI 10.1890/10-0391.1; McGowan S, 2003, HOLOCENE, V13, P239, DOI 10.1191/0959683603hl610rp; Meng L, 2010, ADV MATER RES-SWITZ, V113-116, P1110, DOI 10.4028/www.scientific.net/AMR.113-116.1110; Mo KL, 2016, ECOHYDROLOGY, V9, P700, DOI 10.1002/eco.1668; Musa A, 2014, ECOL ENG, V64, P250, DOI 10.1016/j.ecoleng.2013.12.026; Niu C., 2015, SOLID EARTH, V7, P1979, DOI [10.5194/sed-7-1979-2015, 10.5194/seds7-1979-2015, DOI 10.5194/SEDS7-1979-2015]; Niu Cun-yang, 2013, Shengtaixue Zazhi, V32, P1980; Ozkan U, 2017, CATENA, V149, P158, DOI 10.1016/j.catena.2016.09.017; PATWARDHAN AS, 1990, J IRRIG DRAIN ENG, V116, P182, DOI 10.1061/(ASCE)0733-9437(1990)116:2(182); Piao S., 2005, GEOPHYS RES LETT, V32, DOI [10.1029/200461021'764, DOI 10.1029/200461021'764]; Qadir M, 2008, LAND DEGRAD DEV, V19, P214, DOI 10.1002/ldr.818; Schlesinger WH, 1996, ECOLOGY, V77, P364, DOI 10.2307/2265615; Sharma KD, 1994, SPATIOTEMPORAL VARIA; Shi XiaoHong, 2006, Journal of Yunnan Agricultural University, V21, P355; Su YZ, 2003, ECOL ENG, V20, P223, DOI 10.1016/S0925-8574(03)00042-9; Torres L, 2015, LAND DEGRAD DEV, V26, P433, DOI 10.1002/ldr.2392; Veron SR, 2010, J APPL ECOL, V47, P1233, DOI 10.1111/j.1365-2664.2010.01883.x; Vivoni ER, 2008, ECOHYDROLOGY, V1, P225, DOI 10.1002/eco.11; Wang TJ, 2015, J HYDROL, V521, P447, DOI 10.1016/j.jhydrol.2014.12.037; West NE, 2008, ADV ECOL RES, V20, P179, DOI [10.1016/SO065-25040860055-0, DOI 10.1016/SO065-25040860055-0]; Yan QL, 2011, J ENVIRON QUAL, V40, P815, DOI 10.2134/jeq2010.0137; Yang L, 2014, CATENA, V115, P123, DOI 10.1016/j.catena.2013.12.005; [移小勇 YI XiaoYong], 2006, [生态学报, Acta Ecologica Sinica], V26, P1200; Zhang J, 2007, J DESERT RES, V27; Zhang XF, 2013, J APPL MICROBIOL, V114, P1054, DOI 10.1111/jam.12106; Zhao C, 2004, J SOIL WATER CONSERV, V18; Zhao HL, 2014, GEODERMA, V223, P62, DOI 10.1016/j.geoderma.2014.01.026; Zhao Y, 2010, HYDROL PROCESS, V24, P2507, DOI 10.1002/hyp.7665; Zhuang WW, 2015, PLANT BIOLOGY, V17, P1165, DOI 10.1111/plb.12359; Zou XY, 2002, J ARID ENVIRON, V51, P183, DOI 10.1006/jare.2001.0943; Zuo X., 2008, ENVIRON GEOL, V58, P1227, DOI DOI 10.1007/S00254008-1617-1; Zuo XA, 2012, GEODERMA, V173, P1, DOI 10.1016/j.geoderma.2011.10.003	66	19	19	7	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198805	10.1371/journal.pone.0198805	http://dx.doi.org/10.1371/journal.pone.0198805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927951	Green Submitted, Green Published, gold			2022-12-26	WOS:000435802500030
J	Kweon, J; Kim, DE; Jang, AH; Kim, Y				Kweon, Jiyeon; Kim, Da-eun; Jang, An-Hee; Kim, Yongsub			CRISPR/Cas-based customization of pooled CRISPR libraries	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION; KINASE INHIBITORS; HUMAN-CELLS; GENOME; KNOCKOUT; SCREENS	Pooled CRISPR libraries are widely used in high-throughput screening to study various biological processes. Various pooled CRISPR libraries have been shared for CRISPR screens and useful tools have been developed to construct researcher's own libraries, however, many researchers are struggling to create their own pooled CRISPR libraries: it is a time-consuming, labor-intensive, and expensive process. In this study, we develop a simple method to customize conventional pooled CRISPR libraries using the CRISPR/Cas9 system. We show that conventional pooled CRISPR libraries can be modified by eliminating gRNAs that target positive genes, enabling the identification of unknown target genes in CRISPR screening. CRISPR/Cas9 system can be applied as a precise tool for customizing conventional pooled CRISPR libraries and will broaden the scope of high-throughput screening technology.	[Kweon, Jiyeon; Jang, An-Hee; Kim, Yongsub] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Biomed Sci, Seoul, South Korea; [Kweon, Jiyeon; Jang, An-Hee; Kim, Yongsub] Univ Ulsan, Coll Med, Stem Cell Immunomodulat Res Ctr, Seoul, South Korea; [Kim, Da-eun] Seoul Natl Univ, Dept Chem, Seoul, South Korea; [Kim, Da-eun] Ctr Genome Engn, IBS, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Seoul National University (SNU); Institute for Basic Science - Korea (IBS)	Kim, Y (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Biomed Sci, Seoul, South Korea.; Kim, Y (corresponding author), Univ Ulsan, Coll Med, Stem Cell Immunomodulat Res Ctr, Seoul, South Korea.	yongsub1.kim@gmail.com		Kim, Yongsub/0000-0002-9334-4333	National Research Foundation of Korea [2016R1D1A1A02937096, 2017M3A9B4062419, 2016R1A6A3A04009014]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by the National Research Foundation of Korea (2016R1D1A1A02937096, 2017M3A9B4062419, and 2016R1A6A3A04009014) (https://ernd.nrf.re.kr/).	Boehm JS, 2011, NAT REV GENET, V12, P487, DOI 10.1038/nrg3013; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Kim HS, 2017, J BIOL CHEM, V292, P10664, DOI 10.1074/jbc.M117.782425; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Klann TS, 2017, NAT BIOTECHNOL, V35, P561, DOI 10.1038/nbt.3853; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Kurata M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36199; Kweon J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01650-w; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu JY, 2016, NATURE, V534, P652, DOI 10.1038/nature18606; Wu P, 2015, TRENDS PHARMACOL SCI, V36, P422, DOI 10.1016/j.tips.2015.04.005; Xu JY, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2509385	22	3	3	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199473	10.1371/journal.pone.0199473	http://dx.doi.org/10.1371/journal.pone.0199473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924860	Green Published, Green Submitted, gold			2022-12-26	WOS:000435655600070
J	Chiang, YS; Huang, YF; Midha, MK; Chen, TH; Shiau, HC; Chiu, KP				Chiang, Yih-Shien; Huang, Yu-Feng; Midha, Mohit K.; Chen, Tzu-Han; Shiau, Hsin-Chieh; Chiu, Kuo-Ping			Single cell transcriptome analysis of MCF-7 reveals consistently and inconsistently expressed gene groups each associated with distinct cellular localization and functions	PLOS ONE			English	Article							CANCER	Single cell transcriptome (SCT) analysis provides superior resolution to illustrate tumor cell heterogeneity for clinical implications. We characterized four SCTs of MCF-7 using 143 housekeeping genes (HKGs) as control, of which lactate dehydrogenase B (LDHB) expression is silenced. These SCT libraries mapped to 11,423, 11,486, 10,380, and 11,306 RefSeq genes (UCSC), respectively. High consistency in HKG expression levels across all four SCTs, along with transcriptional silencing of LDHB, was observed, suggesting a high sensitivity and reproducibility of the SCT analysis. Cross-library comparison on expression levels by scatter plotting revealed a linear correlation and an 83-94% overlap in transcript isoforms and expressed genes were also observed. To gain insight of transcriptional diversity among the SCTs, expressed genes were split into consistently expressed (CE) (expressed in all SCTs) and inconsistently expressed (IE) (expressed in some but not all SCTs) genes for further characterization, along with the 142 expressed HKGs as a reference. Distinct transcriptional strengths were found among these groups, with averages of 1,612.0, 88.0 and 1.2 FPKM for HKGs, CE and IE, respectively. Comparison between CE and IE groups further indicated that expressions of CE genes vary more significantly than that of IE genes. Gene Ontology analysis indicated that proteins encoded by CE genes are mainly involved in fundamental intracellular activities, while proteins encoded by IE genes are mainly for extracellular activities, especially acting as receptors or ion channels. The diversified gene expressions, especially for those encoded by IE genes, may contribute to cancer drug resistance.	[Chiang, Yih-Shien; Huang, Yu-Feng; Midha, Mohit K.; Chen, Tzu-Han; Shiau, Hsin-Chieh; Chiu, Kuo-Ping] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Midha, Mohit K.; Chiu, Kuo-Ping] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei, Taiwan; [Chiu, Kuo-Ping] Natl Taiwan Univ, Coll Life Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University	Chiu, KP (corresponding author), Acad Sinica, Genom Res Ctr, Taipei, Taiwan.; Chiu, KP (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei, Taiwan.; Chiu, KP (corresponding author), Natl Taiwan Univ, Coll Life Sci, Taipei, Taiwan.	chiukp@gate.sinica.edu.tw	Midha, Mohit/AAD-9858-2019; midha, mohit/F-4848-2015; Huang, Yu-Feng/Y-5818-2019; Chiu, Kuo-Ping/AAG-8855-2020	Midha, Mohit/0000-0001-7554-4086; midha, mohit/0000-0001-7554-4086; Huang, Yu-Feng/0000-0001-5822-3635; Chiu, Kuo-Ping/0000-0001-9144-0674; Chiang, Yih-Shien/0000-0002-2631-2999	Academia Sinica and PI; Genomics Research Center, Academia Sinica	Academia Sinica and PI; Genomics Research Center, Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Summit Project provided by Academia Sinica and PI funding provided by Genomics Research Center, Academia Sinica. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Brown NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057697; Chiu KP, 2016, SER BIOENG, P347, DOI 10.1007/978-3-662-49118-8_13; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Ducasse M, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-60; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heng HHQ, 2009, J CELL PHYSIOL, V220, P538, DOI 10.1002/jcp.21799; Housman G, 2014, CANCERS, V6, P1769, DOI 10.3390/cancers6031769; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Liu Serena, 2016, F1000Res, V5, DOI 10.12688/f1000research.7223.1; Maekawa M, 2003, CLIN CHEM, V49, P1518, DOI 10.1373/49.9.1518; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Navin N, 2011, GENOME MED, V3, DOI 10.1186/gm247; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Y, 2015, MOL CELL, V58, P598, DOI 10.1016/j.molcel.2015.05.005; Watson J, 1987, MOL BIOL GENE, V1, P686	22	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199471	10.1371/journal.pone.0199471	http://dx.doi.org/10.1371/journal.pone.0199471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920548	Green Published, Green Submitted, gold			2022-12-26	WOS:000435541300047
J	Pusceddu, I; Kleber, M; Delgado, G; Herrmann, W; Marz, W; Herrmann, M				Pusceddu, Irene; Kleber, Marcus; Delgado, Graciela; Herrmann, Wolfgang; MaErz, Winfried; Herrmann, Markus			Telomere length and mortality in the Ludwigshafen Risk and Cardiovascular Health study	PLOS ONE			English	Article							HEART-DISEASE; ASSOCIATION	Introduction Short telomeres have been associated with adverse lifestyle factors, cardiovascular risk factors and age-related diseases, including cardiovascular disease (CVD), myocardial infarction, atherosclerosis, hypertension, diabetes, and also with mortality. However, previous studies report conflicting results. Objectives The aim of the present study has been to investigate the involvement of telomere length in all-cause and CVD mortality in subjects hospitalized for diagnostic coronary angiography of the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Methods Relative telomere length (RTL) was measured with a Q-PCR based method in 3,316 participants of the LURIC study. Age-corrected RTL was calculated as the ratio between RTL and age. Median follow-up was 9.9 years. Cox regression and Kaplan-Maier analyses were performed to evaluate the role of RTL for all-cause and cardiovascular mortality. Results RTL correlated negatively with age (r = -0.09; p<0.001). In surviving patients the correlation between age and RTL was statistically significant (r = -0.088; p<0.001), but not in patients who died during follow-up (r = -0.043; p = 0.20). Patients in quartiles 2 - 4 of RTL had a lower hazard ratio for all-cause mortality (HR: 0.822; 95% CI 0.712 - 0.915; p = 0.008) and CVDmortality (HR: 0.836; 95% CI 0.722 - 0.969; p = 0.017) when compared to those in the 1 st quartile. Adjustment for major cardiovascular risk factors did not change this result, however additional adjustment for age attenuated this effect. Patients in the 4 th quartile of age-corrected RTL compared to those in the 1 st quartile had a lower hazard ratio for all-cause mortality, even with adjustment for major cardiovascular risk factors. Conclusions The present study supports the hypothesis that short telomere length increases the risk of all-cause and CVD mortality. Age appears to be an important co-variate that explains a substantial fraction of this effect. It remains unclear whether short telomeres contribute directly to the increase in mortality or if they are simply a surrogate marker for other adverse processes of aging.	[Pusceddu, Irene; Herrmann, Markus] Hosp Bolzano, Lab Clin Pathol, Bolzano, Italy; [Kleber, Marcus; Delgado, Graciela; MaErz, Winfried] Heidelberg Univ, Med Fac Mannheim, Med Clin Nephrol Hypertensiol Rheumatol Endocrino, Mannheim, Germany; [Herrmann, Wolfgang] Univ Saarland, Dept Clin Chem, Homburg, Germany; [MaErz, Winfried; Herrmann, Markus] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [MaErz, Winfried] Synlab Holding Deutschland GmbH, Synlab Acad, Mannheim, Germany	Krankenhaus Bozen; Ruprecht Karls University Heidelberg; Saarland University; Medical University of Graz; SYNLAB Group	Herrmann, M (corresponding author), Hosp Bolzano, Lab Clin Pathol, Bolzano, Italy.; Herrmann, M (corresponding author), Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria.	markusherr@aol.com			European Union [LSHM-CT-2004-503485, 201668, 305739]; Wissenschaftsinitiative Oberrhein (Project Genetic Mechanisms of Cardiovascular Diseases); German Ministry of Education and Research (Project AtheroSysMed); Synlab Services GmbH	European Union(European Commission); Wissenschaftsinitiative Oberrhein (Project Genetic Mechanisms of Cardiovascular Diseases); German Ministry of Education and Research (Project AtheroSysMed); Synlab Services GmbH	LURIC has received funding from the 6th Framework Program (Integrated Project Bloodomics, Grant LSHM-CT-2004-503485) and 7th Framework Program (Integrated Projects AtheroRemo, Grant no. 201668, and RiskyCAD, Project no. 305739) of the European Union, the Wissenschaftsinitiative Oberrhein (Project Genetic Mechanisms of Cardiovascular Diseases), and the German Ministry of Education and Research (Project AtheroSysMed). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Furthermore, the funder "Synlab Services GmbH" provided support in the form of salaries for author W.M., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions section.	Alter BP, 2012, HAEMATOL-HEMATOL J, V97, P353, DOI 10.3324/haematol.2011.055269; Barbaro PM, 2015, BLOOD, V126, P4984; Bischoff C, 2006, EPIDEMIOLOGY, V17, P190, DOI 10.1097/01.ede.0000199436.55248.10; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Dean SG, 2017, AGING-US, V9, P1537, DOI 10.18632/aging.101246; Elbers CC, 2014, J GERONTOL A-BIOL, V69, P527, DOI 10.1093/gerona/glt121; Fitzpatrick AL, 2011, J GERONTOL A-BIOL, V66, P421, DOI 10.1093/gerona/glq224; Fyhrquist F, 2011, J Hum Hypertens, V25, P711, DOI 10.1038/jhh.2011.57; Goglin SE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160748; Madrid AS, 2016, CLIN CHEM, V62, P1140, DOI 10.1373/clinchem.2016.258566; Mons U, 2017, AM J EPIDEMIOL, V185, P1317, DOI 10.1093/aje/kww210; Morgan RG, 2014, J HYPERTENS, V32, P1293, DOI 10.1097/HJH.0000000000000157; Needham BL, 2015, EPIDEMIOLOGY, V26, P528, DOI 10.1097/EDE.0000000000000299; Peng H, 2016, AGING-US, V8, P1583, DOI 10.18632/aging.101013; Pusceddu I, 2016, EUR J NUTR, V55, P1863, DOI 10.1007/s00394-015-1003-1; Rode L, 2015, JNCI-J NATL CANCER I, V107, P1; Svensson J, 2014, EXP GERONTOL, V57, P6, DOI 10.1016/j.exger.2014.04.013; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; Willeit P, 2010, ARTERIOSCL THROM VAS, V30, P1649, DOI 10.1161/ATVBAHA.110.205492; Winkelmann B. R., 2001, PHARMACOGENOMICS S1, V2, P1; Yeh JK, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090058	22	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0198373	10.1371/journal.pone.0198373	http://dx.doi.org/10.1371/journal.pone.0198373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920523	Green Published, gold, Green Submitted			2022-12-26	WOS:000435541300005
J	Akoku, DA; Tihnje, MA; Vukugah, TA; Tarkang, EE; Mbu, RE				Akoku, Derick Akompab; Tihnje, Mbah Abena; Vukugah, Thomas Achombwom; Tarkang, Elvis Enowbeyang; Mbu, Robinson Enow			Socio-economic vulnerabilities and HIV: Drivers of transactional sex among female bar workers in Yaounde, Cameroon	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ALCOHOL-CONSUMPTION; BEER PROMOTERS; RISK-FACTORS; BEHAVIOR; PREVALENCE; INFECTION; HIV/AIDS; POVERTY; WOMEN	Introduction The purpose of this study was to examine the relationship between socio-demographic characteristics, risky sexual behaviour, alcohol use and transactional sex among female bar workers in Yaounde, Cameroon. Materials and methods A cross-sectional survey was conducted among a representative sample of 410 female bar workers, recruited through a modified version of venue-based cluster sampling technique from May to June 2017. Transactional sex was defined as having received money/gifts in exchange for sex with any sexual partner in the past 12 months. Logistic regression models were performed to identify the factors associated with transactional sex. The level of statistical significance was set at p< = 0.05. Results About 14.9% (n = 61) of respondents reported to have engaged in transactional sex, 83.7% (n = 338) had multiple sexual partners at the time of the study, 14.4% (n = 55) had sex with one or more of their male customers in the past 6 months. Almost 73.4% (n = 301) reported alcohol use. Of these, 37.2% (n = 112) were frequent alcohol consumers. About 17.6% (n = 72) reported to have had unprotected sex under the influence of alcohol in the past 6 months. Multivariate logistic regression analysis showed that those who engaged in transactional sex were more likely to have had sex with a male customer in the past 6 months (aOR = 7.34; 95% CI, 3.63-16.98), had sex under the influence of alcohol in the past 6 months (aOR = 2.42; 95% CI, 1.18-4.96) and frequent alcohol consumers (aOR = 2.06; 95%Cl, 1.04-4.10). Respondents who had their last sexual intercourse 4 weeks or more prior to the study (aOR = 0.26; 95% CI, 0.08-0.84) were less likely to have engaged in transactional sex. Conclusions Our study concludes that female bar workers are exposed to male customers and engage in risky sexual practices including transaction sex. Most of them also consume alcohol which increases their risk of HIV and STI acquisition. They are a high-risk group that need to be targeted with HIV prevention interventions.	[Akoku, Derick Akompab; Tihnje, Mbah Abena] Community Res & Training Inst, Yaounde, Cameroon; [Vukugah, Thomas Achombwom; Mbu, Robinson Enow] Minist Publ Hlth, Yaounde, Cameroon; [Tarkang, Elvis Enowbeyang] Univ Hlth & Allied Sci, Sch Publ Hlth, Ho, Ghana; [Mbu, Robinson Enow] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon	University of Yaounde I	Akoku, DA (corresponding author), Community Res & Training Inst, Yaounde, Cameroon.	derickakoku@gmail.com						Baliunas D, 2010, INT J PUBLIC HEALTH, V55, P159, DOI 10.1007/s00038-009-0095-x; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Bello B, 2012, BMC PUBLIC HEALTH, V17, P4350; Census Bureau, 2014, 3 NAT POP HOUS CENS; Choudhry V, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.27249; DHS-MICS, 2011, 2011 CAM DEM HLTH SU; Dijk M, 2014, BEER SELLING IND CAM; Family Health International (FHI) and Bureau of AIDS TB and STIs Department of Disease Control, 2008, AS EP MOD AEM PROJ H; Gerbi GB, 2009, J SUBST USE, V14, P90, DOI 10.1080/14659890802624261; Ghosh J, 2009, SOC SCI MED, V68, P638, DOI 10.1016/j.socscimed.2008.11.023; Gillespie S, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000300531.74730.72; Grumiau S., 2012, PROMOTING DECENCY RE; Hardee K, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18619; Hedden SL, 2011, J SUBST USE, V16, P57, DOI 10.3109/14659891003721141; Jewkes R., 2012, Journal of AIDS and Clinical Research, V3, P158; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kalichman SC, 2010, EUR J PUBLIC HEALTH, V20, P202, DOI 10.1093/eurpub/ckp127; Kim AA, 2005, SEX TRANSM DIS, V32, P745, DOI 10.1097/01.olq.0000175384.44106.be; Krishnan S, 2008, ANN NY ACAD SCI, V1136, P101, DOI 10.1196/annals.1425.013; Lama TT, 2016, PREV SCI, V17, P227, DOI 10.1007/s11121-015-0607-2; Leclerc-Madlala S, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000341774.86500.53; MacPherson EE, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17364; Magni S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145326; Norris AH, 2009, SOC SCI MED, V69, P1167, DOI 10.1016/j.socscimed.2009.07.015; Okigbo CLC, 2014, AFR J REPROD HEALTH, V18, P133; Onoya D, 2012, WOMEN HEALTH ISS, V22, pE277, DOI 10.1016/j.whi.2011.11.006; Pascoe SJS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115290; Ranganathan M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20749; Rehm J, 2012, ADDICTION, V107, P51, DOI 10.1111/j.1360-0443.2011.03621.x; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; Scott-Sheldon LAJ, 2016, AIDS BEHAV, V20, pS19, DOI 10.1007/s10461-015-1108-9; Shuper PA, 2010, ALCOHOL ALCOHOLISM, V45, P159, DOI 10.1093/alcalc/agp091; Singh K, 2011, AFR HEALTH SCI, V11, P204; Stoebenau Kirsten, 2011, Global Health, V7, P34, DOI 10.1186/1744-8603-7-34; Townsend L, 2011, AIDS BEHAV, V15, P132, DOI 10.1007/s10461-010-9680-5; Tumwesigye NM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1069; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; Wamoyi J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20992; Wamoyi J, 2011, ARCH SEX BEHAV, V40, P5, DOI 10.1007/s10508-010-9646-8; Wamoyi J, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-2; Webber G, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-21; Webber GC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-389; Woolf-King SE, 2011, ARCH SEX BEHAV, V40, P17, DOI 10.1007/s10508-009-9516-4; Zembe YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051998	44	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198853	10.1371/journal.pone.0198853	http://dx.doi.org/10.1371/journal.pone.0198853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ6XV	29912969	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600055
J	Binzer, SB; Lundgreen, RBC; Berge, T; Hansen, PJ; Vismann, B				Binzer, Sofie Bjornholt; Lundgreen, Regitze Benedicte Carlstedt; Berge, Terje; Hansen, Per Juel; Vismann, Bent			The blue mussel Mytilus edulis is vulnerable to the toxic dinoflagellate Karlodinium armiger-Adult filtration is inhibited and several life stages killed	PLOS ONE			English	Article							FAMILY KARENIACEAE GYMNODINIALES; ALFACS BAY; VENEFICUM; DINOPHYCEAE; GROWTH; SIZE; ICHTHYOTOXIN; KARLOTOXINS; MECHANISM; SURVIVAL	Blooms of the toxic dinoflagellates Karlodinium armiger and K. veneficum are frequently observed in Alfacs Bay, Spain, causing mass mortality to wild and farmed mussels. An isolate of K. armiger from Alfacs Bay was grown in the laboratory and exposed to adults, embryos and trochophore larvae of the blue mussel, Mytilus edulis. Adult mussels rejected to filter K. armiger at cell concentrations >1.5-10(3) cells ml(-1). Exposure of adult mussels (23-33 mm shell length) to a range of K. armiger cell concentrations led to mussel mortality with LC50 values of 9.4-10(3) and 6.1-10(3) cells ml(-1) after 24 and 48 h exposure to similar to 3.6-10(4) K. armiger cells ml(-1), respectively. Karlodinium armiger also affected mussel embryos and trochophore larvae and feeding by K. armigeron both embryos and larvae was observed under the microscope. Embryos exposed to low K. armiger cell concentrations suffered no measurable mortality. However, at higher K. armiger cell concentrations the mortality of the embryos increased significantly with cell concentration and reached 97% at 1.8-10(3) K. armiger cells ml(-1) after 29 h of exposure. Natural K. armiger blooms may not only have serious direct effects on benthic communities, but may also affect the recruitment of mussels in affected areas.	[Binzer, Sofie Bjornholt; Lundgreen, Regitze Benedicte Carlstedt; Berge, Terje; Hansen, Per Juel; Vismann, Bent] Univ Copenhagen, Marine Biol Sect, Dept Biol, Helsingor, Denmark; [Berge, Terje; Hansen, Per Juel] Univ Copenhagen, Ctr Ocean Life, Helsingor, Denmark	University of Copenhagen; University of Copenhagen	Vismann, B (corresponding author), Univ Copenhagen, Marine Biol Sect, Dept Biol, Helsingor, Denmark.	bvismann@bio.ku.dk	Hansen, Per Juel/AAX-6193-2020; Hansen, Per J/E-9969-2011; Vismann, Bent/L-2731-2014	Hansen, Per Juel/0000-0003-0228-9621; Hansen, Per J/0000-0003-0228-9621; Lundgreen, Regitze/0000-0002-0114-3754; Vismann, Bent/0000-0002-3613-6511	Willum Kann Rasmussen Foundation; Innovation Fund of Denmark via the project SAFEFISH [4097-00007B]	Willum Kann Rasmussen Foundation; Innovation Fund of Denmark via the project SAFEFISH	TB and PJH were supported by Willum Kann Rasmussen Foundation through the Ocean Life project, and PJH, SB and BV were also supported by the Innovation Fund of Denmark via the project SAFEFISH, project no: 4097-00007B (Innovation Fund Denmark; https://innovatiansfonden.dk/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT BC, 1957, J MAR BIOL ASSOC UK, V36, P169, DOI 10.1017/S0025315400017173; Adolf JE, 2009, J PHYCOL, V45, P176, DOI 10.1111/j.1529-8817.2008.00641.x; Andersen AJC, 2017, MAR DRUGS, V15, DOI 10.3390/md15090278; Bachvaroff TR, 2009, J PHYCOL, V45, P137, DOI 10.1111/j.1529-8817.2008.00629.x; BALLANTINE D, 1956, J MAR BIOL ASSOC UK, V35, P241, DOI 10.1017/S0025315400009097; Berge T, 2008, AQUAT MICROB ECOL, V50, P289, DOI 10.3354/ame01166; Berge T, 2008, AQUAT MICROB ECOL, V50, P279, DOI 10.3354/ame01165; Berge T, 2012, ISME J, V6, P1926, DOI 10.1038/ismej.2012.29; Bergholtz T, 2006, J PHYCOL, V42, P170, DOI 10.1111/j.1529-8817.2006.00172.x; Brand LE, 2012, HARMFUL ALGAE, V14, P156, DOI 10.1016/j.hal.2011.10.020; Brownlee EF, 2008, J SHELLFISH RES, V27, P581, DOI 10.2983/0730-8000(2008)27[581:ROCVGA]2.0.CO;2; Cai PJ, 2016, HARMFUL ALGAE, V58, P66, DOI 10.1016/j.hal.2016.08.001; Calbet A, 2011, HARMFUL ALGAE, V10, P654, DOI 10.1016/j.hal.2011.05.001; CECCHERELLI VU, 1984, MAR ECOL PROG SER, V16, P173, DOI 10.3354/meps016173; Chang FH, 2008, HARMFUL ALGAE, V7, P532, DOI 10.1016/j.hal.2007.11.004; Daugbjerg N, 2000, PHYCOLOGIA, V39, P302, DOI 10.2216/i0031-8884-39-4-302.1; De Salas MF, 2005, PHYCOLOGIA, V44, P640, DOI 10.2216/0031-8884(2005)44[640:KASNGD]2.0.CO;2; de Salas MF, 2008, J PHYCOL, V44, P241, DOI 10.1111/j.1529-8817.2007.00458.x; Deeds JR, 2006, AFR J MAR SCI, V28, P421, DOI 10.2989/18142320609504190; Deeds JR, 2015, AQUAT TOXICOL, V159, P148, DOI 10.1016/j.aquatox.2014.11.028; Fernandez-Tejedor Margarita, 2010, CIESM Workshop Monographs, V40, P83; Galimany E, 2008, HARMFUL ALGAE, V7, P91, DOI 10.1016/j.hal.2007.05.004; Garces E, 1999, J PLANKTON RES, V21, P1977, DOI 10.1093/plankt/21.10.1977; Garces E, 2006, J PHYCOL, V42, P1096, DOI 10.1111/j.1529-8817.2006.00270.x; Guallar C, 2016, ECOL MODEL, V338, P37, DOI 10.1016/j.ecolmodel.2016.07.009; Guillard RRL, 1975, CULTURE MARINE INVER, P46; Ichimi K, 2001, TOXICON, V39, P1917, DOI 10.1016/S0041-0101(01)00177-5; JONES HD, 1992, J EXP MAR BIOL ECOL, V155, P213, DOI 10.1016/0022-0981(92)90064-H; LESSER MP, 1993, J SHELLFISH RES, V12, P377; Li AS, 1999, AQUAT MICROB ECOL, V19, P163, DOI 10.3354/ame019163; Mafra LL, 2010, AQUAT TOXICOL, V100, P17, DOI 10.1016/j.aquatox.2010.07.002; Manning SR, 2010, MAR DRUGS, V8, P678, DOI 10.3390/md8030678; MOHLENBERG F, 1979, MAR BIOL, V54, P143, DOI 10.1007/BF00386593; Mooney BD, 2010, HARMFUL ALGAE, V9, P557, DOI 10.1016/j.hal.2010.04.005; Mooney BD, 2009, J PHYCOL, V45, P164, DOI 10.1111/j.1529-8817.2008.00630.x; Nezan E, 2014, HARMFUL ALGAE, V40, P75, DOI 10.1016/j.hal.2014.10.006; Nielsen LT, 2016, TOXICON, V117, P84, DOI 10.1016/j.toxicon.2016.03.021; NIELSEN MV, 1991, MAR BIOL, V108, P263, DOI 10.1007/BF01344341; Nielsen P, 2014, J SHELLFISH RES, V33, P457, DOI 10.2983/035.033.0214; Peng JN, 2010, J AM CHEM SOC, V132, P3277, DOI 10.1021/ja9091853; Place AR, 2006, AFR J MAR SCI, V28, P347, DOI 10.2989/18142320609504175; Place AR, 2012, HARMFUL ALGAE, V14, P179, DOI 10.1016/j.hal.2011.10.021; Pleissner Daniel, 2013, Journal of Marine Biology, P1; Poulsen LK, 2011, MAR ECOL PROG SER, V441, P65, DOI 10.3354/meps09357; Ramon M., 2005, Boletin Instituto Espanol de Oceanografia, V21, P361; Rasmussen SA, 2017, J NAT PROD, V80, P1287, DOI 10.1021/acs.jnatprod.6b00860; Rasmussen SA, 2016, J NAT PROD, V79, P2250, DOI 10.1021/acs.jnatprod.6b00345; RIISGARD HU, 1979, MAR BIOL, V52, P61, DOI 10.1007/BF00386858; Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100; SHILO M, 1967, BACTERIOL REV, V31, P180, DOI 10.1128/MMBR.31.3.180-193.1967; Shumway SE, 2006, HARMFUL ALGAE, V5, P442, DOI 10.1016/j.hal.2006.04.013; SHUMWAY SE, 1987, AQUAT TOXICOL, V10, P9, DOI 10.1016/0166-445X(87)90024-5; SHUMWAY SE, 1987, COMP BIOCHEM PHYS A, V87, P1021, DOI 10.1016/0300-9629(87)90031-4; Stoecker DK, 2008, MAR BIOL, V154, P81, DOI 10.1007/s00227-007-0901-z; Van Wagoner RM, 2008, TETRAHEDRON LETT, V49, P6457, DOI 10.1016/j.tetlet.2008.08.103; Vogelbein WK, 2002, NATURE, V418, P967, DOI 10.1038/nature01008; WINTER JE, 1973, MAR BIOL, V22, P317, DOI 10.1007/BF00391388; YEAGER DP, 1989, PHYSIOL ZOOL, V62, P888, DOI 10.1086/physzool.62.4.30157935	58	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199306	10.1371/journal.pone.0199306	http://dx.doi.org/10.1371/journal.pone.0199306			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912948	Green Submitted, Green Published, gold			2022-12-26	WOS:000435528600103
J	Zsila, A; Pagliassotti, D; Urban, R; Orosz, G; Kiraly, O; Demetrovics, Z				Zsila, Agnes; Pagliassotti, Dru; Urban, Robert; Orosz, Gabor; Kiraly, Orsolya; Demetrovics, Zsolt			Loving the love of boys: Motives for consuming yaoi media	PLOS ONE			English	Article							OF-FIT INDEXES; MEASUREMENT INVARIANCE; INTERNET; GIRLS	In recent years, yaoi has been increasingly popular among youth interested in Japanese media such as anime and manga. Yaoi is defined as commercial and fan-created media that thematically focus on the romantic love between two men, often in a sexually explicit way. Despite the widespread popularity of this Japanese subgenre, there is a lack of empirical studies on the motives for consuming yaoi media that analyze the full range of motives using reliable research methods. The present study aimed to explore and operationalize the motives for yaoi media consumption based on previous qualitative research (Pagliassotti, 2008). Using an online survey, 724 yaoi consumers (58% male; M-age = 30.1 years, SD = 10.4) completed the Yaoi Consumption Motives Questionnaire (YCMQ). According to confirmatory factor analyses, the bi-factor model of nine motives yielded closer fit to the data than the theoretically proposed, first-order ten-factor model and a second-order nine-factor model. The nine-factor YCMQ demonstrated strong psychometric properties in terms of factor structure, internal consistency, and measurement invariance. These results indicate that the 31-item YCMQ is an appropriate instrument to assess individuals' motives for consuming yaoi media.	[Zsila, Agnes; Urban, Robert; Orosz, Gabor; Kiraly, Orsolya; Demetrovics, Zsolt] Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary; [Zsila, Agnes] Eotvos Lorand Univ, Doctoral Sch Psychol, Budapest, Hungary; [Pagliassotti, Dru] Calif Lutheran Univ, Thousand Oaks, CA USA; [Orosz, Gabor] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University; California Lutheran University; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Zsila, A (corresponding author), Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary.; Zsila, A (corresponding author), Eotvos Lorand Univ, Doctoral Sch Psychol, Budapest, Hungary.	zsila.agnes@ppk.elte.hu	Demetrovics, Zsolt/F-8613-2010	Demetrovics, Zsolt/0000-0001-5604-7551	Hungarian National Research, Development and Innovation Office [K111938]; New National Excellence Program of the Ministry of Human Capacities [UNKP-17-3, UNKP-17-4]	Hungarian National Research, Development and Innovation Office; New National Excellence Program of the Ministry of Human Capacities	This study was supported by the Hungarian National Research, Development and Innovation Office (Grant number: K111938). Az and OK were supported by the UNKP-17-3 and UNKP-17-4 New National Excellence Program of the Ministry of Human Capacities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Y, 2010, BOYS LOVE MANGA ESSA, P44; [Anonymous], 2009, DISCOVER STAT USING; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Brown T.A., 2006, CONFIRMATORY FACTOR, V1st; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Chou Dienfang, 2010, J INTERCULTURAL COMM, V19, P78; Demetrovics Z, 2011, BEHAV RES METHODS, V43, P814, DOI 10.3758/s13428-011-0091-y; Fermin T., 2013, EJCJS, V13; Gerrig R.J., 2011, PSYCHOL LIFE, V2nd; Kamm B-O, TRANSFORMATIVE WORKS; Lilja M, 2017, CULTURE UNBOUND J CU, V8, P284; Madill A, 2010, GIRLS LOVE BOYS LOVE, VII; Marsh HW, 2009, STRUCT EQU MODELING, V16, P439, DOI 10.1080/10705510903008220; Martin F, 2012, INTER-ASIA CULT STUD, V13, P365, DOI 10.1080/14649373.2012.689707; McLelland M, 2005, AUST FEM LAW J, V23, P61, DOI 10.1080/13200968.2005.10854344; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Mizoguchi, 2003, US JAPAN WOMENS J S, V25, P49; Muthen B., 2010, MPLUS USERS GUIDE; Nagaike K, 2015, BOYS LOVE MANGA HIST, P119; Nagaike Kazumi, 2015, BOYS LOVE MANGA HIST, P189; Noh S., 1998, KOR SOC JOURN COMM S; Nunnally J.C, 1978, CLIN DIAGN MENT DISO, DOI DOI 10.1007/978-1-4684-2490-4_4; Pagliassotti D., 2010, BOYS LOVE MANGA ESSA, P59; Pagliassotti D, 2017, READING BOYS LOVE W; Pagliassotti D, 2008, PARTICIPATIONS, V5; Pagliassotti Dru, 2009, INTERSECTIONS GENDER, V20; Paul B, 2008, INT J SEX HEALTH, V20, P187, DOI 10.1080/19317610802240154; Peter J, 2006, COMMUN RES, V33, P178, DOI 10.1177/0093650205285369; Reise SP, 2012, MULTIVAR BEHAV RES, V47, P667, DOI 10.1080/00273171.2012.715555; Reise SP, 2010, J PERS ASSESS, V92, P544, DOI 10.1080/00223891.2010.496477; Suzuki K., 2015, BOYS LOVE MANGA HIST, P93; Thorn Matthew, 2004, FANNING FLAMES FANS, P169; van der Star A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2148-9; Vandenberg RJ, 2002, ORGAN RES METHODS, V5, P139, DOI 10.1177/1094428102005002001; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Vettehen PH, 2008, COMMUN RES, V35, P319, DOI 10.1177/0093650208315960; Weaver JB, 2003, PERS INDIV DIFFER, V35, P1427, DOI 10.1016/S0191-8869(02)00360-4; Welker J, 2006, SIGNS, V31, P841, DOI 10.1086/498987; Welker James., 2015, BOYS LOVE MANGA HIST, P42; Wood Andrea, 2006, WOMENS STUDIES Q, V34, P394; Xu Yanrui, 2013, J GRAPHIC NOVELS COM, V4, P30, DOI DOI 10.1080/21504857.2013.771378; Zhang CY, 2016, WOMEN STUD COMMUN, V39, P249, DOI 10.1080/07491409.2016.1190806	43	3	3	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198895	10.1371/journal.pone.0198895	http://dx.doi.org/10.1371/journal.pone.0198895			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ5MF	29902228	Green Published, gold, Green Submitted			2022-12-26	WOS:000435424900055
J	Fernandez-de Gortari, E; Espinoza-Fonseca, LM				Fernandez-de Gortari, Eli; Espinoza-Fonseca, L. Michel			Structural basis for relief of phospholamban-mediated inhibition of the sarcoplasmic reticulum Ca2+-ATPase at saturating Ca2+ conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium ATPase; calcium; sarcoplasmic reticulum (SR); membrane transport; molecular dynamics; cardiac muscle; inhibition mechanism; phospholamban; SERCA	PARTICLE MESH EWALD; CALCIUM-PUMP; MOLECULAR-DYNAMICS; MONOMERIC PHOSPHOLAMBAN; CONFORMATIONAL SWITCH; CRYSTAL-STRUCTURES; BINDING SITES; PHOSPHORYLATION; PROTEIN; SARCOLIPIN	Sarcoplasmic reticulum Ca2+-ATPase (SERCA) is critical for cardiac Ca2+ transport. Reversal of phospholamban (PLB)-mediated SERCA inhibition by saturating Ca2+ conditions operates as a physiological rheostat to reactivate SERCA function in the absence of PLB phosphorylation. Here, we performed extensive atomistic molecular dynamics simulations to probe the structural mechanism of this process. Simulation of the inhibitory complex at superphysiological Ca2+ concentrations ([Ca2+] = 10 mm) revealed that Ca2+ ions interact primarily with SERCA and the lipid headgroups, but not with PLB's cytosolic domain or the cytosolic side of the SERCA-PLB interface. At this [Ca2+], a single Ca2+ ion was translocated from the cytosol to the transmembrane transport sites. We used this Ca2+-bound complex as an initial structure to simulate the effects of saturating Ca2+ at physiological conditions ([Ca2+](total) approximate to 400 m). At these conditions, approximate to 30% of the Ca2+-bound complexes exhibited structural features consistent with an inhibited state. However, in approximate to 70% of the Ca2+-bound complexes, Ca2+ moved to transport site I, recruited Glu(771) and Asp(800), and disrupted key inhibitory contacts involving the conserved PLB residue Asn(34). Structural analysis showed that Ca2+ induces only local changes in interresidue inhibitory interactions, but does not induce repositioning or changes in PLB structural dynamics. Upon relief of SERCA inhibition, Ca2+ binding produced a site I configuration sufficient for subsequent SERCA activation. We propose that at saturating [Ca2+] and in the absence of PLB phosphorylation, binding of a single Ca2+ ion in the transport sites rapidly shifts the equilibrium toward a noninhibited SERCA-PLB complex.	[Fernandez-de Gortari, Eli; Espinoza-Fonseca, L. Michel] Univ Michigan, Dept Internal Med, Ctr Arrhythmia Res, Div Cardiovasc Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Espinoza-Fonseca, LM (corresponding author), Univ Michigan, Dept Internal Med, Ctr Arrhythmia Res, Div Cardiovasc Med, Ann Arbor, MI 48109 USA.	lmef@umich.edu		Espinoza-Fonseca, L. Michel/0000-0002-7356-5681	NIGMS, National Institutes of Health Grant [R01GM120142]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120142] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01GM120142 (to L. M. E.-F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akin BL, 2013, J BIOL CHEM, V288, P30181, DOI 10.1074/jbc.M113.501585; Akin BL, 2012, J BIOL CHEM, V287, P7582, DOI 10.1074/jbc.M111.334987; Asahi M, 1999, J BIOL CHEM, V274, P32855, DOI 10.1074/jbc.274.46.32855; Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; BALKE CW, 1994, J PHYSIOL-LONDON, V474, P447, DOI 10.1113/jphysiol.1994.sp020036; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; CARUGO O, 1993, J CHEM SOC DALTON, P2127, DOI 10.1039/dt9930002127; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Chen ZH, 2010, J BIOL CHEM, V285, P3253, DOI 10.1074/jbc.M109.080820; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Simone A, 2013, BIOCHEMISTRY-US, V52, P6684, DOI 10.1021/bi400517b; Deng H, 2006, PROTEINS, V64, P34, DOI 10.1002/prot.20973; Dong XQ, 2014, BIOCHEM BIOPH RES CO, V449, P196, DOI 10.1016/j.bbrc.2014.04.166; Dudev T, 1999, J PHYS CHEM A, V103, P8093, DOI 10.1021/jp991575p; Dudev T, 2004, J PHYS CHEM B, V108, P4546, DOI 10.1021/jp0310347; Dudev T, 2003, J AM CHEM SOC, V125, P3168, DOI 10.1021/ja0209722; Einholm AP, 2004, J BIOL CHEM, V279, P15888, DOI 10.1074/jbc.M400158200; Espinoza-Fonseca LM, 2015, BIOCHEM BIOPH RES CO, V463, P37, DOI 10.1016/j.bbrc.2015.05.012; Espinoza-Fonseca LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095979; Espinoza-Fonseca LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026936; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fernandez-De Gortari E, 2017, PHYS CHEM CHEM PHYS, V19, P10153, DOI 10.1039/c7cp00243b; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Gustavsson M, 2013, P NATL ACAD SCI USA, V110, P17338, DOI 10.1073/pnas.1303006110; Ha KN, 2007, J BIOL CHEM, V282, P37205, DOI 10.1074/jbc.M704056200; HOVEMADSEN L, 1993, AM J PHYSIOL, V264, pC677, DOI 10.1152/ajpcell.1993.264.3.C677; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; INESI G, 1980, J BIOL CHEM, V255, P3025; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; James ZM, 2012, BIOPHYS J, V103, P1370, DOI 10.1016/j.bpj.2012.08.032; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Karim CB, 2004, P NATL ACAD SCI USA, V101, P14437, DOI 10.1073/pnas.0402801101; Katz AK, 1996, J AM CHEM SOC, V118, P5752, DOI 10.1021/ja953943i; Kekenes-Huskey PM, 2012, PROTEIN SCI, V21, P1429, DOI 10.1002/pro.2129; Kimura Y, 1996, J BIOL CHEM, V271, P21726, DOI 10.1074/jbc.271.36.21726; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kirschenlohr HL, 2000, BIOCHEM J, V346, P385, DOI 10.1042/0264-6021:3460385; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; MARCUS Y, 1988, CHEM REV, V88, P1475, DOI 10.1021/cr00090a003; Metcalfe EE, 2005, BIOCHEMISTRY-US, V44, P4386, DOI 10.1021/bi047571e; Espinoza-Fonseca LM, 2015, BIOPHYS J, V108, P1697, DOI 10.1016/j.bpj.2015.03.004; Mintz E, 1997, BBA-BIOENERGETICS, V1318, P52, DOI 10.1016/S0005-2728(96)00132-6; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; NAYAL M, 1994, P NATL ACAD SCI USA, V91, P817, DOI 10.1073/pnas.91.2.817; Norimatsu Y, 2017, NATURE, V545, P193, DOI 10.1038/nature22357; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pal TK, 2008, J MOL GRAPH MODEL, V27, P20, DOI 10.1016/j.jmgm.2008.02.001; Paterlini MG, 2005, BIOPHYS J, V88, P3243, DOI 10.1529/biophysj.104.054460; Periasamy M, 2001, J MOL CELL CARDIOL, V33, P1053, DOI 10.1006/jmcc.2001.1366; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sabbah HN, 2014, ESC HEART FAIL, V1, P94, DOI 10.1002/ehf2.12013; Sande JB, 2002, CARDIOVASC RES, V53, P382, DOI 10.1016/S0008-6363(01)00489-8; SASAKI T, 1992, J BIOL CHEM, V267, P1674; Smolin N, 2015, J PHYS CHEM B, V119, P1407, DOI 10.1021/jp511433v; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Strock C, 1998, J BIOL CHEM, V273, P15104, DOI 10.1074/jbc.273.24.15104; Sugita Y, 2010, P NATL ACAD SCI USA, V107, P21465, DOI 10.1073/pnas.1015819107; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2013, CURR OPIN STRUC BIOL, V23, P507, DOI 10.1016/j.sbi.2013.06.005; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Traaseth NJ, 2006, J MOL BIOL, V358, P1041, DOI 10.1016/j.jmb.2006.02.047; Traaseth NJ, 2009, P NATL ACAD SCI USA, V106, P10165, DOI 10.1073/pnas.0904290106; Weber W, 2000, J PHYS CHEM B, V104, P3668, DOI 10.1021/jp9937757; WENDTGALLITELLI MF, 1991, J PHYSIOL-LONDON, V435, P349, DOI 10.1113/jphysiol.1991.sp018514; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Zamoon J, 2005, P NATL ACAD SCI USA, V102, P4747, DOI 10.1073/pnas.0406039102; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5	81	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12405	12414		10.1074/jbc.RA118.003752	http://dx.doi.org/10.1074/jbc.RA118.003752			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29934304	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000441408500008
J	Jamilloux, Y; Lagrange, B; Micco, A; Bourdonnay, E; Provost, A; Tallant, R; Henry, T; Martinon, F				Jamilloux, Yvan; Lagrange, Brice; Di Micco, Antonia; Bourdonnay, Emilie; Provost, Angelina; Tallant, Remy; Henry, Thomas; Martinon, Fabio			A proximity-dependent biotinylation (BioID) approach flags the p62/sequestosome-1 protein as a caspase-1 substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammasome; inflammation; autophagy; caspase-1 (CASP1); proteomics; proteolytic enzyme	INFLAMMASOME ACTIVATION; CELL-DEATH; SELECTIVE AUTOPHAGY; AIM2 INFLAMMASOME; IN-VITRO; INFECTION; CLEAVAGE; RECRUITMENT; SECRETION; MUTATION	The inflammasome is a major component of the innate immune system, and its main function is to activate caspase-1, a cysteine protease that promotes inflammation by inducing interleukin-1 (IL-1) maturation and release into the extracellular milieu. To prevent uncontrolled inflammation, this complex is highly regulated. When it is assembled, the inflammasome is insoluble, which has long precluded the analysis of its interactions with other proteins. Here we used the proximity-dependent biotinylation assay (BioID) to identify proteins associated with caspase-1 during inflammasome activation. Using the BioID in a cell-free system in which the inflammasome had been activated, we found that a caspase-1-biotin ligase fusion protein selectively labeled 111 candidates, including the p62/sequestosome-1 protein (p62). Using co-immunoprecipitation experiments, we demonstrated that p62 interacts with caspase-1. This interaction promoted caspase-1-mediated cleavage of p62 at Asp-329. Mechanistic and functional analyses revealed that caspase-1-mediated cleavage of p62 leads to loss of its interaction with the autophagosomal protein microtubule-associated protein 1 light chain 3 (LC3B). Strikingly, overexpression of a p62 N-terminal fragment generated upon caspase-1 cleavage decreased IL-1 release, whereas overexpression of p62's C-terminal portion enhanced IL-1 release, by regulating pro-IL1 levels. Overall, the overexpression of both fragments together decreased IL-1 release. Taken together, our results indicate that caspase-1-mediated p62 cleavage plays a complex role in balancing caspase-1-induced inflammation.	[Jamilloux, Yvan; Lagrange, Brice; Di Micco, Antonia; Bourdonnay, Emilie; Provost, Angelina; Tallant, Remy; Henry, Thomas; Martinon, Fabio] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Jamilloux, Yvan; Lagrange, Brice; Di Micco, Antonia; Bourdonnay, Emilie; Provost, Angelina; Tallant, Remy; Henry, Thomas; Martinon, Fabio] Univ Claude Bernard Lyon 1, Ecole Normale Super Lyon, Ctr Int Rech Infectiol, CNRS,INSERM,UMR5308,U1111, F-69007 Lyon, France; [Jamilloux, Yvan; Lagrange, Brice; Di Micco, Antonia; Bourdonnay, Emilie; Provost, Angelina; Tallant, Remy; Henry, Thomas; Martinon, Fabio] Univ Claude Bernard Lyon 1, Hosp Civils Lyon, Hop Croix Rousse, Dept Internal Med, F-69004 Lyon, France	University of Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Henry, T (corresponding author), Univ Claude Bernard Lyon 1, Ecole Normale Super Lyon, Ctr Int Rech Infectiol, CNRS,INSERM,UMR5308,U1111, F-69007 Lyon, France.; Martinon, F (corresponding author), Dept Biochem, Rm F404,Ch Boveresses 155,CP 51, CH-1066 Epalinges, Switzerland.	thomas.henry@inserm.fr; fabio.martinon@unil.ch	Martinon, Fabio/A-5575-2009; Jamilloux, Yvan/F-6601-2019; Henry, Thomas/G-3160-2013; Bourdonnay, Emilie/P-3115-2019	Martinon, Fabio/0000-0002-6969-822X; Jamilloux, Yvan/0000-0001-5249-3650; Henry, Thomas/0000-0002-0687-8565; Bourdonnay, Emilie/0000-0002-3579-5478; Lagrange, Brice/0000-0002-4131-5995	Fondation Innovations en Infectiologie; Foundation for the Development of Internal Medicine in Europe; Groupama Foundation; EC Seventh Framework Programme (FP7) Grants [311542, 281996]; Societe Nationale Francaise de Medecine Interne; poste d'accueil from INSERM	Fondation Innovations en Infectiologie; Foundation for the Development of Internal Medicine in Europe; Groupama Foundation; EC Seventh Framework Programme (FP7) Grants; Societe Nationale Francaise de Medecine Interne; poste d'accueil from INSERM	This work was supported by Fondation Innovations en Infectiologie, the Foundation for the Development of Internal Medicine in Europe, and the Groupama Foundation (to Y. J.), EC Seventh Framework Programme (FP7) Grants 311542 (to T. H.) and 281996 (to F. M.); the Societe Nationale Francaise de Medecine Interne, and by a poste d'accueil from INSERM (to Y. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Agard NJ, 2010, MOL CELL PROTEOMICS, V9, P880, DOI 10.1074/mcp.M900528-MCP200; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Bagnis Claude, 2009, V515, P151, DOI 10.1007/978-1-59745-559-6_10; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Chae JJ, 2015, ARTHRITIS RHEUMATOL, V67, P563, DOI 10.1002/art.38961; Chapman-Smith A, 1999, J NUTR, V129, p477S, DOI 10.1093/jn/129.2.477S; Cronan JE, 2005, J NUTR BIOCHEM, V16, P416, DOI 10.1016/j.jnutbio.2005.03.017; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Di Micco A, 2016, P NATL ACAD SCI USA, V113, pE4671, DOI 10.1073/pnas.1602419113; Druilhe A, 2001, CELL DEATH DIFFER, V8, P649, DOI 10.1038/sj.cdd.4400881; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Harris J, 2017, MOL IMMUNOL, V86, P10, DOI 10.1016/j.molimm.2017.02.013; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Jamilloux Y, 2016, METHODS MOL BIOL, V1417, P207, DOI 10.1007/978-1-4939-3566-6_14; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kwon K, 2000, PROTEIN SCI, V9, P1530, DOI 10.1110/ps.9.8.1530; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Liu T, 2016, CELL REP, V16, P1988, DOI 10.1016/j.celrep.2016.07.019; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Luschen S, 1998, BIOCHEM BIOPH RES CO, V253, P92, DOI 10.1006/bbrc.1998.9754; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Norman JM, 2010, AUTOPHAGY, V6, P1042, DOI 10.4161/auto.6.8.13337; Ohtsuka S, 2014, EUR J IMMUNOL, V44, P1084, DOI 10.1002/eji.201344091; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Saitoh T, 2016, J ALLERGY CLIN IMMUN, V138, P28, DOI 10.1016/j.jaci.2016.05.009; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shi J, 2014, CELL DEATH DIFFER, V21, P1432, DOI 10.1038/cdd.2014.58; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JY, 2013, AUTOPHAGY, V9, P1591, DOI 10.4161/auto.26059; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Thome M, 2001, J CELL BIOL, V152, P1115, DOI 10.1083/jcb.152.5.1115; Walsh JG, 2011, J BIOL CHEM, V286, P32513, DOI 10.1074/jbc.M111.225862; Wang LJ, 2012, MOL CELL PROTEOMICS, V11, P1230, DOI 10.1074/mcp.M112.020594; Wang YT, 2017, IMMUNITY, V46, P393, DOI 10.1016/j.immuni.2017.02.011; Wurzer B, 2015, ELIFE, V4, DOI 10.7554/eLife.08941; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057; Zhou Q, 2012, AM J HUM GENET, V91, P713, DOI 10.1016/j.ajhg.2012.08.006	47	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12563	12575		10.1074/jbc.RA117.000435	http://dx.doi.org/10.1074/jbc.RA117.000435			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29929983	Green Published, hybrid			2022-12-26	WOS:000441408500021
J	Zheng, WL; Lu, Y; Tian, SY; Ma, FG; Wei, YJ; Xu, SS; Li, Y				Zheng, Weili; Lu, Yi; Tian, Siyu; Ma, Fengge; Wei, Yijuan; Xu, Shuangshuang; Li, Yong			Structural insights into the heterodimeric complex of the nuclear receptors FXR and RXR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear receptor; dimerization; X-ray crystallography; drug discovery; receptor structure-function; translation regulation; structural biology; structural model; transcriptional coactivator; FXR RXR heterodimer	RETINOID-X-RECEPTOR; LIGAND-BINDING DOMAINS; BILE-ACIDS; CRYSTAL-STRUCTURE; AGONIST; ALPHA; IDENTIFICATION; COACTIVATORS; ACTIVATION; DISEASE	Farnesoid X receptor (FXR) is a member of the family of ligand-activated nuclear receptors. FXR plays critical roles in maintaining many metabolic pathways, including bile acid regulation and glucose and lipid homeostasis, and forms a heterodimeric complex with the retinoid X receptor (RXR). Despite the important roles of the FXR/RXR heterodimerization in human physiology, the molecular basis underlying the FXR/RXR interaction is still uncertain in the absence of a complex structure. Here, we report the heterodimeric structure of FXR and RXR in the presence of an FXR agonist (WAY-362450), RXR agonist (9-cis-retinoic acid), and a peptide derived from a steroid receptor coactivator (SRC2), revealing both unique and conserved modes for FXR heterodimerization. We found that the dimerization with RXR induced allosteric conformational changes on the coactivator-binding site of FXR. These changes enhanced the transcriptional activity of FXR by promoting the coactivator binding, thus suggesting a structural basis for the functional permissiveness of the FXR/RXR heterodimer complex. Furthermore, sequence analyses together with functional mutagenesis studies indicated that the helix H10 largely responsible for the dimerization is highly conserved and also critical for the FXR transcriptional activity. Our findings highlight the important roles of RXR heterodimerization in the nuclear receptor signaling, providing a potential framework to develop pharmaceutical agents in treating FXR/RXR-related diseases.	[Zheng, Weili; Lu, Yi; Tian, Siyu; Ma, Fengge; Wei, Yijuan; Xu, Shuangshuang; Li, Yong] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China	Xiamen University	Li, Y (corresponding author), Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China.; Zheng, WL (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	weilizheng1116@gmail.com; yongli@xmu.edu.cn	Zheng, Weili/J-6754-2019	Zheng, Weili/0000-0003-4644-0127; Lu, Yi/0000-0002-6504-9548	National Natural Science Foundation of China [31470726, 31770814, U1405220]; 111 Project of Ministry of Education of China [B06016]; National Science Foundation of China [J1310027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project of Ministry of Education of China(Ministry of Education, China - 111 Project); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31470726, 31770814, and U1405220; 111 Project of Ministry of Education of China Grant B06016; and National Science Foundation of China for Fostering Talents in Basic Research Grant J1310027. The authors declare that they have no conflicts of interest with the contents of this article.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chao EY, 2008, J MED CHEM, V51, P5758, DOI 10.1021/jm800612u; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez EJ, 2018, PHARMACOL THERAPEUT, V183, P152, DOI 10.1016/j.pharmthera.2017.10.014; Flatt B, 2009, J MED CHEM, V52, P904, DOI 10.1021/jm8014124; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Grober J, 1999, J BIOL CHEM, V274, P29749, DOI 10.1074/jbc.274.42.29749; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Jin LH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2924; Kojetin DJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9013; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mudaliar S, 2013, GASTROENTEROLOGY, V145, P574, DOI 10.1053/j.gastro.2013.05.042; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Ohno T, 2012, CANCER LETT, V323, P215, DOI 10.1016/j.canlet.2012.04.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pavlin MR, 2014, J BIOL CHEM, V289, P24771, DOI 10.1074/jbc.M114.575423; Putcha BDK, 2012, P NATL ACAD SCI USA, V109, P6084, DOI 10.1073/pnas.1119852109; Rizzo G, 2005, MOL PHARMACOL, V68, P551, DOI 10.1124/mol.105.012104; Rocchi S, 2001, MOL CELL, V8, P737, DOI 10.1016/S1097-2765(01)00353-7; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Svensson S, 2003, EMBO J, V22, P4625, DOI 10.1093/emboj/cdg456; Wallace BD, 2013, J MOL BIOL, V425, P2561, DOI 10.1016/j.jmb.2013.04.012; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang Q, 2004, MOL ENDOCRINOL, V18, P1376, DOI 10.1210/me.2003-0421; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu RX, 2004, MOL CELL, V16, P919, DOI 10.1016/j.molcel.2004.11.042; Yamada S, 2014, EXPERT OPIN THER PAT, V24, P443, DOI 10.1517/13543776.2014.880692; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	36	19	20	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12535	12541		10.1074/jbc.RA118.004188	http://dx.doi.org/10.1074/jbc.RA118.004188			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29934308	hybrid, Green Published			2022-12-26	WOS:000441408500019
J	Clancy, JW; Sheehan, CS; Tricarico, CJ; D'Souza-Schorey, C				Clancy, James W.; Sheehan, Cohn S.; Tricarico, Christopher J.; D'Souza-Schorey, Crislyn			Aberrant endocytosis leads to the loss of normal mitotic spindle orientation during epithelial glandular morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; epithelial cell; cell biology; cell polarity; cell sorting; membrane trafficking; morphogenesis; epithelial cyst; endocytosis; mitotic spindle; ARF6; extracellular signal regulated kinase; glandular epithelium; receptor internalization; cadherin; GTPase; cMet receptor	BREAST-CANCER INVASION; ARF6 ACTIVATION; SIGNALING PATHWAY; RAB35; RECEPTOR; CELLS; CDC42; ENDOSOMES; PROTEINS; ADHESION	Epithelial cells form tissues with many functions, including secretion and environmental separation and protection. Glandular epithelial tissues comprise cysts and tubules that are formed from a polarized, single-epithelial cell layer surrounding a central, fluid-filled lumen. The pathways regulating key processes in epithelial tissue morphogenesis such as mitotic spindle formation are incompletely understood, but are important to investigate, as their dysregulation is a signature of epithelial tumors. Here, we describe a signaling axis that manifests in a defect in mitotic spindle orientation during epithelial growth and cystogenesis. We found that activation of the small GTPase ADP-ribosylation factor 6 (ARF6) results in the sustained internalization of cell-surface components such as the cMet receptor and the cell-adhesion molecule E-cadherin. The spindle orientation defect arising from elevated levels of ARF6-GTP required an increase in cMet endocytosis, but was independent of E-cadherin internalization or elevated extracellular signal-regulated kinase (ERK) activity resulting from internalized receptor signaling on endosomes. Misorientation of the mitotic spindle resulted in the development of epithelial cysts with structural abnormalities, the most conspicuous of which was the presence of multiple intercellular lumens. Abnormal mitotic spindle orientation was necessary but insufficient to disrupt glandular development, as blocking the strong prosurvival signal resulting from ERK hyperactivation yielded structurally normal cysts despite continued manifestation of spindle orientation defects. Our findings highlight a previously unknown link between ARF6 activation, cMet receptor internalization, and mitotic spindle orientation during epithelial glandular morphogenesis.	[Clancy, James W.; Sheehan, Cohn S.; Tricarico, Christopher J.; D'Souza-Schorey, Crislyn] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	D'Souza-Schorey, C (corresponding author), Box 369,Galvin Life Sci Bldg, Notre Dame, IN 46556 USA.	cdsouzas@nd.edu		Clancy, James/0000-0001-7967-1111	NCI, National Institutes of Health [R01CA115316]; NATIONAL CANCER INSTITUTE [R01CA115316] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NCI, National Institutes of Health, Grant R01CA115316 (to C.D.-S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abella JV, 2005, MOL CELL BIOL, V25, P9632, DOI 10.1128/MCB.25.21.9632-9645.2005; Allaire PD, 2013, J CELL SCI, V126, P722, DOI 10.1242/jcs.112375; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Benard V, 2002, METHOD ENZYMOL, V345, P349; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Chesneau L, 2012, CURR BIOL, V22, P147, DOI 10.1016/j.cub.2011.11.058; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; den Elzen N, 2009, MOL BIOL CELL, V20, P3740, DOI 10.1091/mbc.E09-01-0023; Durgan J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.174235; Grossmann AH, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003398; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; Hanono A, 2006, J CELL BIOL, V175, P803, DOI 10.1083/jcb.200604046; Hao Y, 2010, CURR BIOL, V20, P1809, DOI 10.1016/j.cub.2010.09.032; Hommelgaard AM, 2004, MOL BIOL CELL, V15, P1557, DOI 10.1091/mbc.E03-08-0596; Hu ZZ, 2013, EXP CELL RES, V319, P1932, DOI 10.1016/j.yexcr.2013.05.028; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mitsushima M, 2009, MOL CELL BIOL, V29, P2816, DOI 10.1128/MCB.01713-08; Miyamotoa Y, 2014, MOL BIOL CELL, V25, P1532, DOI 10.1091/mbc.E13-10-0600; Monteleon CL, 2012, MOL BIOL CELL, V23, P4495, DOI 10.1091/mbc.E12-03-0246; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Pease JC, 2011, J CELL SCI, V124, P1007, DOI 10.1242/jcs.081406; Pellon-Cardenas O, 2013, MOL CELL BIOL, V33, P2963, DOI 10.1128/MCB.01698-12; Prigent M, 2003, J CELL BIOL, V163, P1111, DOI 10.1083/jcb.200305029; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Rahajeng J, 2012, TRAFFIC, V13, P82, DOI 10.1111/j.1600-0854.2011.01294.x; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Sabe H, 2009, TRAFFIC, V10, P982, DOI 10.1111/j.1600-0854.2009.00917.x; Sangar F, 2014, ONCOGENE, V33, P2758, DOI 10.1038/onc.2013.211; Tushir JS, 2010, MOL BIOL CELL, V21, P2355, DOI 10.1091/mbc.E09-09-0824; Uytterhoeven V, 2011, CELL, V145, P117, DOI 10.1016/j.cell.2011.02.039; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	42	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12095	12104		10.1074/jbc.RA117.001640	http://dx.doi.org/10.1074/jbc.RA117.001640			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29903910	Green Published, hybrid			2022-12-26	WOS:000440803200010
J	Debellut, F; Hendrix, N; Ortiz, JR; Lambach, P; Neuzil, KM; Bhat, N; Pecenka, C				Debellut, Frederic; Hendrix, Nathaniel; Ortiz, Justin R.; Lambach, Philipp; Neuzil, Kathleen M.; Bhat, Niranjan; Pecenka, Clint			Forecasting demand for maternal influenza immunization in low- and lower-middle-income countries	PLOS ONE			English	Article							GLOBAL PRODUCTION CAPACITY; SPONTANEOUS-ABORTION; FETAL-DEATH; VACCINE; PREGNANCY; INFANTS; STRATEGIES; OUTCOMES; SAFETY	Immunization of pregnant women against seasonal influenza remains limited in low- and lower-middle-income countries despite being recommended by the World Health Organization (WHO). The WHO/PATH Maternal Influenza Immunization Project was created to identify and address obstacles to delivering influenza vaccines to pregnant women in low resource setting. To gain a better understanding of potential demand from this target group, we developed a model simulating pregnant women populations eligible for vaccination during antenatal care (ANC) services in all low- and lower-middle-income countries. We assessed potential vaccine demand in the context of both seasonal and year-round vaccination strategies and identified the ways that immunization programs may be affected by availability gaps in supply linked to current vaccine production cycles and shelf life duration. Results of our analysis, which includes 54 eligible countries in 2015 for New Vaccine Support from Gavi, the Vaccine Alliance, suggest the demand for influenza vaccines could be 7.7 to 16.0 million doses in 2020, and 27.0 to 61.7 million doses by 2029. If current trends in production capacity and actual production of seasonal influenza vaccines were to continue, global vaccine supply would be sufficient to meet this additional demand-although a majority of countries would face implementation issues linked to timing of supply.	[Debellut, Frederic] PATH, Ctr Vaccine Innovat & Access, Geneva, Switzerland; [Hendrix, Nathaniel; Bhat, Niranjan; Pecenka, Clint] PATH, Ctr Vaccine Innovat & Access, Seattle, WA USA; [Ortiz, Justin R.; Neuzil, Kathleen M.] Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Lambach, Philipp] WHO, Initiat Vaccine Res, Geneva, Switzerland	University System of Maryland; University of Maryland Baltimore; World Health Organization	Debellut, F (corresponding author), PATH, Ctr Vaccine Innovat & Access, Geneva, Switzerland.	fdebellut@path.org		Ortiz, Justin/0000-0002-3138-5965; Debellut, Frederic/0000-0002-3027-2838	Bill and Melinda Gates Foundation [OPP1084288]; World Health Organization; Bill & Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); World Health Organization(World Health Organization); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was funded through a grant from the Bill and Melinda Gates Foundation (Investment ID: OPP1084288 to JO). Philipp Lambach and Justin R. Ortiz work for and receive salaries from the World Health Organization. The specific roles of these authors are articulated in the 'author contributions' section. The authors alone are responsible for the views expressed in this publication and they do not necessarily represent the decisions, policy or views of the World Health Organization. The work described is based on research funded by the Bill & Melinda Gates Foundation. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasinghe A, 2010, HUM VACCINES, V6, P745, DOI 10.4161/hv.6.9.12587; [Anonymous], 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.1.009, 10.5365/WPSAR.2013.4.1.009]; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P261; [Anonymous], 2012, WKLY EPIDEMIOL REC; Bratton KN, 2015, CLIN INFECT DIS, V60, pE11, DOI 10.1093/cid/ciu915; Cox N, 2014, B WORLD HEALTH ORGAN, V92, P311, DOI 10.2471/BLT.14.139428; Fell DB, 2015, BJOG-INT J OBSTET GY, V122, P17, DOI 10.1111/1471-0528.12977; Gavi, COUNTR EL SUPP; Gavi, MARK SHAP GOAL; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Gilchrist SAN, 2013, HEALTH POLICY PLANN, V28, P838, DOI 10.1093/heapol/czs123; Hirve S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153003; Keller-Stanislawski B, 2014, VACCINE, V32, P7057, DOI 10.1016/j.vaccine.2014.09.052; Lambach P, 2015, VACCINE, V33, P6493, DOI 10.1016/j.vaccine.2015.08.037; Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480; McLean KA, 2016, VACCINE, V34, P5410, DOI 10.1016/j.vaccine.2016.08.019; McMillan M, 2015, VACCINE, V33, P2108, DOI 10.1016/j.vaccine.2015.02.068; Newman L. P., GLOBAL INFLUENZA SEA; Ortiz JR, 2016, VACCINE, V34, P5400, DOI 10.1016/j.vaccine.2016.07.045; Partridge J, 2013, VACCINE, V31, P728, DOI 10.1016/j.vaccine.2012.10.111; Ropero-Alvarez AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-361; Steinhoff MC, 2014, LANCET, V383, P1611, DOI 10.1016/S0140-6736(14)60583-3; Tapia MD, 2016, LANCET INFECT DIS, V16, P1026, DOI 10.1016/S1473-3099(16)30054-8; WHO, EST DTP1 COV; WHO, 2008, TRAIN MIDL MAN MLM M; World Health Organization, 2006, GLOB PAND INFL ACT P; World Health Organization, 2012, REP 2 WHO CONS GLOB; World Health Organization, GLOB HLTH OBS DAT RE; World Health Organization (WHO), MAT INFL IMM GUID IN; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zuber PLF, 2009, VACCINE, V27, P410, DOI 10.1016/j.vaccine.2008.10.069	31	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199470	10.1371/journal.pone.0199470	http://dx.doi.org/10.1371/journal.pone.0199470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933402	gold, Green Published, Green Submitted			2022-12-26	WOS:000436076600026
J	Pitchford, JL; Garcia, M; Pulis, EE; Ambert, AM; Heaton, AJ; Solangi, M				Pitchford, Jonathan L.; Garcia, Michael; Pulis, Eric E.; Ambert, Ashley Milian; Heaton, Andrew J.; Solangi, Moby			Gauging the influence of increased search effort on reporting rates of bottlenose dolphin (Tursiops truncatus) strandings following the deepwater horizon oil spill	PLOS ONE			English	Article							POPULATIONS; ABUNDANCE; PATTERNS; CONTEXT; BAY	The co-occurrence of the Deepwater Horizon oil spill and the northern Gulf of Mexico cetacean Unusual Mortality Event have raised questions about the stability of inshore bottlenose dolphin (Tursiops truncatus) populations throughout the region. Several factors could have contributed to the ongoing event, but little attention has been paid to the potential effects of increased search effort and reporting of strandings associated with oil spill response activities, which were widespread for an extended period. This study quantified the influence of increased search effort by estimating the number of bottlenose dolphin strandings reported by oil spill responders and comparing monthly stranding rates with and without response related records. Results showed that response teams reported an estimated 58% of strandings during the Active Response period within the study area. Comparison of Poisson rates tests showed that when responder-influenced stranding records were removed, the monthly stranding rates from the Active Response period (May 2010 April 2014) were similar to the Post-Removal Actions Deemed Complete period (May 2013 March 2015) (e.g., p = 0.83 for remote areas in Louisiana). Further, analyses using the Getis-Ord Gi* spatial statistic showed that when response-related stranding reports were removed from the Active Response period, significant spatial clustering of strandings (p < 0.05) was reduced by 48% in coastal Louisiana. Collectively, these results suggest that increased search effort resulting from the Deepwater Horizon oil spill response throughout remote portions of the Unusual Mortality Event geographic region had the capacity to increase reporting and recovery of marine mammal strandings to unusually high levels. To better understand how stranding data relates to actual mortality, more work is needed to quantify dolphin population size, population trends, and carcass detection rates including the role of search effort. This is vital for understanding the status of a protected species within the northern Gulf of Mexico.	[Pitchford, Jonathan L.] Grand Bay Natl Estuarine Res Reserve, Moss Point, MS 39562 USA; [Pitchford, Jonathan L.; Pulis, Eric E.; Ambert, Ashley Milian; Heaton, Andrew J.; Solangi, Moby] Inst Marine Mammal Studies, Gulfport, MS 39503 USA; [Garcia, Michael] NOVACES LLC, New Orleans, LA USA; [Heaton, Andrew J.] Univ S Alabama, Mobile, AL USA	University of South Alabama	Pitchford, JL (corresponding author), Grand Bay Natl Estuarine Res Reserve, Moss Point, MS 39562 USA.; Pitchford, JL (corresponding author), Inst Marine Mammal Studies, Gulfport, MS 39503 USA.	jonathan.pitchford@dmr.ms.gov	Pulis, Eric/AAF-4312-2020	Pulis, Eric/0000-0002-1695-7953	BP Exploration & Production Inc ("BP"); Institute for Marine Mammal Studies (IMMS)	BP Exploration & Production Inc ("BP"); Institute for Marine Mammal Studies (IMMS)	This work was funded by BP Exploration & Production Inc ("BP") and the Institute for Marine Mammal Studies (IMMS). The funders provided support in the form of salaries for authors [MG, JP, EEP, AMA, AH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Balmer B. C., 2013, Marine Mammal Science, V29, pE114, DOI 10.1111/j.1748-7692.2012.00598.x; Balmer B. C., 2008, Journal of Cetacean Research and Management, V10, P157; Bump JK, 2009, ECOLOGY, V90, P3159, DOI 10.1890/09-0292.1; Byrd G. Vernon, 2009, Marine Ornithology, V37, P197; Carmichael RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041155; Carretta JV, 2016, MAR MAMMAL SCI, V32, P349, DOI 10.1111/mms.12264; Deepwater Horizon Natural Resource Damage Assessment Trustees, 2016, DEEPWATER HORIZON OI; Eleuterius CK, 1979, MASCP79009; Environmental Response Management Application, 2016, ENV RESPONSE MANAGEM; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gulf Coast EcosystemRestoration Council, 2016, IN RESP SPILL; Hubard Carrie W., 2004, Aquatic Mammals, V30, P299, DOI 10.1578/AM.30.2.2004.299; Huso MMP, 2010, ENVIRONMETRICS; Kuletz KJ, 2015, PROG OCEANOGR, V136, P175, DOI 10.1016/j.pocean.2015.05.012; Lane SM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1944; Litz JA, 2014, DIS AQUAT ORGAN, V112, P161, DOI 10.3354/dao02807; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; Miller C., 2003, THESIS; Miller LJ, 2013, AQUAT CONSERV, V23, P145, DOI 10.1002/aqc.2278; NOAA. National Oceanic and Atmospheric Administration, 2016, NAT MAR MAMM HLTH ST; Peltier H, 2012, ECOL INDIC, V18, P278, DOI 10.1016/j.ecolind.2011.11.014; Piza EL, 2012, USING POISSON NEGATI; Santos SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025383; Schwacke LH, 2014, ENVIRON SCI TECHNOL, V48, P93, DOI 10.1021/es403610f; United States Coast Guard, 2016, CG 611 MAN PROGR POL; Venn-Watson S, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0117248; Venn-Watson S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126538; Waring GT, 2014, 228 NOAA NMFSNE; Wells RS, 2015, MAR MAMMAL SCI, V31, P355, DOI 10.1111/mms.12142; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams R, 2011, CONSERV LETT, V4, P228, DOI 10.1111/j.1755-263X.2011.00168.x	31	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199214	10.1371/journal.pone.0199214	http://dx.doi.org/10.1371/journal.pone.0199214			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927976	gold, Green Published			2022-12-26	WOS:000435802500055
J	Ponce-de-Leon, A; Rodriguez-Noriega, E; Morfin-Otero, R; Cornejo-Juarez, DP; Tinoco, JC; Martinez-Gamboa, A; Gaona-Tapia, CJ; Guerrero-Almeida, ML; Martin-Onraet, A; Cervantes, JLV; Sifuentes-Osornio, J				Ponce-de-Leon, Alfredo; Rodriguez-Noriega, Eduardo; Morfin-Otero, Rayo; Cornejo-Juarez, Dora P.; Tinoco, Juan C.; Martinez-Gamboa, Areli; Gaona-Tapia, Carmen J.; Lourdes Guerrero-Almeida, M.; Martin-Onraet, Alexandra; Vallejo Cervantes, Jose Luis; Sifuentes-Osornio, Jose			Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; IN-VITRO SUSCEPTIBILITIES; ACINETOBACTER-BAUMANNII; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; EPIDEMIOLOGY; ENTEROBACTERIACEAE; WORLDWIDE; PROFILES; AMERICA	Antimicrobial resistance is an increasing worldwide concern, which poses unique challenges for the effective prevention and treatment of several infections, especially the ones triggered by organisms producing extended-spectrum P-lactamases (ESBL). Here, we present the surveillance results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) of Gram-negative bacilli isolated from intra-abdominal infections (IAI, n = 1,235) and urinary-tract infections (UTI, n = 2,682), collected in Mexico from 2009 to 2015. Susceptibility and ESBL status were determined according to the Clinical and Laboratory Standards Institute (CLSI) broth microdilution method. Both E. coli (57%) and K. pneumoniae (12%) were the most frequently reported organisms, as well as the ones with the highest prevalence of ESBL-producing isolates (54% and 39%, respectively). The overall prevalence of ESBL-producing organisms was higher in nosocomial infections than in community acquired infections (21% vs. 27%). The ESBL rates were 36% for IAI (953/2,682) and 37% for UTI (461/1,235). In addition, ertapenem, imipenem and amikacin were the antibiotics that mostly preserved bacterial susceptibility. Our results show consistency with global trends, although higher than the rates observed in Latin America.	[Ponce-de-Leon, Alfredo; Martinez-Gamboa, Areli; Gaona-Tapia, Carmen J.; Sifuentes-Osornio, Jose] Salvador Zubiran Natl Inst Med Sci & Nutr, Clin Microbiol Lab, Mexico City, DF, Mexico; [Ponce-de-Leon, Alfredo; Lourdes Guerrero-Almeida, M.; Sifuentes-Osornio, Jose] Salvador Zubiran Natl Inst Med Sci & Nutr, Dept Infect Dis, Mexico City, DF, Mexico; [Rodriguez-Noriega, Eduardo; Morfin-Otero, Rayo] Hosp Civil Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico; [Rodriguez-Noriega, Eduardo; Morfin-Otero, Rayo] Univ Guadalajara, Ctr Univ Ciencias Salud, Inst Patol Infecciosa & Expt, Guadalajara, Jalisco, Mexico; [Cornejo-Juarez, Dora P.; Martin-Onraet, Alexandra] Natl Canc Inst, Dept Infect Dis, Mexico City, DF, Mexico; [Tinoco, Juan C.] Hosp Gen Durango, Durango, Mexico; [Vallejo Cervantes, Jose Luis] MSD Mexico, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad de Guadalajara; Merck & Company	Sifuentes-Osornio, J (corresponding author), Salvador Zubiran Natl Inst Med Sci & Nutr, Clin Microbiol Lab, Mexico City, DF, Mexico.; Sifuentes-Osornio, J (corresponding author), Salvador Zubiran Natl Inst Med Sci & Nutr, Dept Infect Dis, Mexico City, DF, Mexico.	sifuentesosornio@gmail.com	Martin-Onraet, Alexandra/AAV-2671-2021; Morfín-Otero, Rayo/AAR-8027-2021	Martin-Onraet, Alexandra/0000-0002-8627-404X; Morfín-Otero, Rayo/0000-0001-9576-1950; Rodriguez-Noriega, Eduardo/0000-0002-1386-4815; Ponce-de-Leon, Alfredo/0000-0003-2640-2916; Sifuentes-Osornio, Jose/0000-0001-9584-1360	MSD	MSD	This study was funded by MSD. JLVC is employed by MSD Mexico. Medical writing was provided by MSD Mexico. MSD provided support in the form of salary for author JLVC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baquero F, 2009, SURG INFECT, V10, P99, DOI 10.1089/sur.2008.0020; Bouchillon SK, 2013, CLIN THER, V35, P872, DOI 10.1016/j.clinthera.2013.03.022; Cohen AE, 2006, AM J MED, V119, P958, DOI 10.1016/j.amjmed.2006.05.030; Alcantar-Curiel MD, 2014, ARCH MED RES, V45, P553, DOI 10.1016/j.arcmed.2014.10.006; Federacion D.P, 2014, REGL LEY GEN SAL MAT; Gales AC, 2012, DIAGN MICR INFEC DIS, V73, P354, DOI 10.1016/j.diagmicrobio.2012.04.007; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Hawser Stephen, 2012, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-642-28951-4_3; Hawser SP, 2010, SURG INFECT, V11, P371, DOI 10.1089/sur.2009.057; Hawser SP, 2009, ANTIMICROB AGENTS CH, V53, P3280, DOI 10.1128/AAC.00426-09; Hoban DJ, 2012, DIAGN MICR INFEC DIS, V74, P62, DOI 10.1016/j.diagmicrobio.2012.05.024; Hsueah PR, 2010, INT J ANTIMICROB AG, V36, P408, DOI 10.1016/j.ijantimicag.2010.07.002; Jean SS, 2016, INT J ANTIMICROB AG, V47, P328, DOI 10.1016/j.ijantimicag.2016.01.008; Kang CI, 2010, INT J ANTIMICROB AG, V36, P284, DOI 10.1016/j.ijantimicag.2010.05.009; KNOTHE H, 1983, INFECTION, V11, P315, DOI 10.1007/BF01641355; Kouchak F, 2012, IRAN J MED SCI, V37, P72; Lautenbach E, 2001, CLIN INFECT DIS, V33, P1288, DOI 10.1086/322667; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Morrissey I, 2013, PHARMACEUTICALS-BASE, V6, P1335, DOI 10.3390/ph6111335; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Paterson DL, 2005, J ANTIMICROB CHEMOTH, V55, P965, DOI 10.1093/jac/dki117; Perez F, 2013, CLEV CLIN J MED, V80, P225, DOI 10.3949/ccjm.80a.12182; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Rawat D, 2010, J GLOB INFECT DIS, V2, P263, DOI 10.4103/0974-777X.68531; Rodriguez-Bano J, 2010, CLIN INFECT DIS, V50, P40, DOI 10.1086/649537; Rossi F, 2006, J ANTIMICROB CHEMOTH, V58, P205, DOI 10.1093/jac/dkl199; Sader H S, 2000, Braz J Infect Dis, V4, P245; Salles MJC, 2013, EPIDEMIOL INFECT, V141, P2459, DOI 10.1017/S095026881300191X; Shaikh S, 2015, SAUDI J BIOL SCI, V22, P90, DOI 10.1016/j.sjbs.2014.08.002; Sotomayor de Zavaleta M, 2015, REV MEX UROL, V75, P1; Torres-Gonzalez P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139883; Villegas MV, 2011, BRAZ J INFECT DIS, V15, P34, DOI 10.1590/S1413-86702011000100007	32	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198621	10.1371/journal.pone.0198621	http://dx.doi.org/10.1371/journal.pone.0198621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927958	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500025
J	Vatavu, S; Lobont, OR; Para, I; Pelin, A				Vatavu, Sorana; Lobont, Oana-Ramona; Para, Iulia; Pelin, Andrei			Addressing oil price changes through business profitability in oil and gas industry in the United Kingdom	PLOS ONE			English	Article							GOVERNANCE; COMPANIES	In this paper, we investigate how crude oil price and volume traded affected the profitability of oil and gas companies in the United Kingdom (UK) since the financial crisis started in 2008. The study benefit from insights of the financial statements, to develop a model that focuses on how changes in oil price impact corporate performance. In order to observe the financial indicators that influence the performance, as well as the effects that changes in oil prices and demand of crude oil have on the profitability of oil and gas companies, we apply comparative regression analysis, including the generalised method of moments estimation technique for panel data set. The sample is consisting of 31 oil and gas companies in the UK, and the period analysed is 2006-2014. Results show that profitable oil and gas companies managed to face the drop in oil price and recover, characterized by significant cash flows and stock turnover, efficient use of assets, and high solvency rates. Although the oil price and volume traded do not significantly affect profitability and other financial ratios, if the oil price continues to decrease, it would permanently alter both the UK economy and oil and gas companies. In order to survive, companies make drastic cuts and defer essential investments, often at the long-term expense of asset performance. This study is important in a world where the energy consumption steadily grew over time. However, the renewable energy is cheaper and more environmentally friendly, and thus, countries where oil and gas industry is one of the most popular sectors face an economic decline. These results could be useful for investors, managers or decision makers, reclaiming strategic decisions in the current uncertain and volatile environment.	[Vatavu, Sorana; Lobont, Oana-Ramona] West Univ Timisoara, Fac Econ & Business Adm, Dept Finance, Timisoara, Romania; [Para, Iulia] West Univ Timisoara, Fac Econ & Business Adm, Dept Mkt & Int Business Relat, Timisoara, Romania; [Pelin, Andrei] West Univ Timisoara, Fac Econ & Business Adm, Dept Management, Timisoara, Romania	West University of Timisoara; West University of Timisoara; West University of Timisoara	Vatavu, S (corresponding author), West Univ Timisoara, Fac Econ & Business Adm, Dept Finance, Timisoara, Romania.	sorana.vatavu@yahoo.com	Iulia, Para/AAO-1320-2020; Lobont, Oana Ramona/AHA-3609-2022; Vatavu, Sorana/HDN-2055-2022; Lobont, Oana-Ramona/AAP-8584-2020	Iulia, Para/0000-0003-3322-6500; Lobont, Oana Ramona/0000-0002-2942-3715; Vatavu, Sorana/0000-0002-7966-3696				Asuquo AI., 2012, AM INT J CONT RES, V2, P168; Banerjee S.B., 2001, J CORPORATE CITIZENS, V1, P39; Brindescu- Olariu D., 2016, THEORETICAL APPL EC, V3, P257; Corduneanu C, 2010, EUROECONOMICA, V3, p51 ; Dayanandan A, 2011, INT REV FINANC ANAL, V20, P252, DOI 10.1016/j.irfa.2011.05.004; Diaz EM, 2017, FINANC RES LETT, V20, P75, DOI 10.1016/j.frl.2016.09.010; EITI, 2017, EXTR IND TRANSP IN W; Gompers P, 2003, Q J ECON, V118, P107, DOI 10.1162/00335530360535162; Kang WS, 2017, J INT MONEY FINANC, V70, P344, DOI 10.1016/j.jimonfin.2016.10.003; Liu J., 2017, IMPACT OIL PRICE CHA; Porter ME, 2006, HARVARD BUS REV, V84, P78; Ramos SB, 2011, ENERG ECON, V33, P525, DOI 10.1016/j.eneco.2010.10.005; Sovacool BK, 2016, WORLD DEV, V83, P179, DOI 10.1016/j.worlddev.2016.01.021; Sun CW, 2017, J CLEAN PROD, V154, P341, DOI 10.1016/j.jclepro.2017.03.222; Thomsen S, 2000, STRATEGIC MANAGE J, V21, P689, DOI 10.1002/(SICI)1097-0266(200006)21:6<689::AID-SMJ115>3.0.CO;2-Y; Van Alstine J, 2014, RESOUR POLICY, V40, P48, DOI 10.1016/j.resourpol.2014.01.002; Wolf C, 2009, ENERG POLICY, V37, P2642, DOI 10.1016/j.enpol.2009.02.041; Zhou DQ, 2016, APPL ENERG, V177, P117, DOI 10.1016/j.apenergy.2016.05.099	18	9	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199100	10.1371/journal.pone.0199100	http://dx.doi.org/10.1371/journal.pone.0199100			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK0LV	29928039	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500044
J	Zhou, YC; Fang, WH; Kao, TW; Wang, CC; Chang, YW; Peng, TC; Wu, CJ; Yang, HF; Chan, JYH; Chen, WL				Zhou, Yi-Chao; Fang, Wen-Hui; Kao, Tung-Wei; Wang, Chung-Ching; Chang, Yaw-Wen; Peng, Tao-Chun; Wu, Chen-Jung; Yang, Hui-Fang; Chan, James Yi-Hsin; Chen, Wei-Liang			Exploring the association between thyroid-stimulating hormone and metabolic syndrome: A large population-based study	PLOS ONE			English	Article							FREE THYROXINE CONCENTRATION; BODY-MASS INDEX; REFERENCE RANGE; SUBCLINICAL HYPOTHYROIDISM; WAIST CIRCUMFERENCE; ALCOHOL-CONSUMPTION; BLOOD-PRESSURE; OLDER-ADULTS; RISK-FACTORS; COMPONENTS	A growing amount of evidence suggests that thyroid-stimulating hormone (TSH) is associated with cardiometabolic risk. However, there have been few longitudinal studies. The aim of this study was to explore the causal relationship between TSH and metabolic syndrome (MetS) in a large population-based longitudinal study. From 2010 to 2016 at the Health Management Center at Tri-Service General Hospital, 25,121 eligible patients were enrolled in our cross-sectional analyses. Cox proportional hazard models were used to investigate the longitudinal association among hypertension (HTN), prediabetes (pre-DM), MetS, diabetes (DM) and TSH levels (N = 12,463). The average follow-up time was 7.2 years. In the cross-sectional analysis, the OR for MetS was 1.06 (95% CI = 1.03-1.09; P< 0.05), while the ORs for DM, pre-DM or HTN were not statistically significant (all P> 0.05). After dividing TSH levels into four quartiles, the ORs for the presence of MetS determined by comparing the highest TSH quartile with the lowest TSH quartile were 1.37 (95% CI = 1.18-1.60), 1.42 (95% CI = 1.20-1.67), and 1.44 (95% CI = 1.22-1.69) (all, P<0.05) in model 1, model 2 and model 3 respectively. The HR for the incidence of MetS was 1.33 (95% CI = 1.17-1.51; P < 0.05). Our study revealed that TSH levels had a strong association with incident MetS.	[Zhou, Yi-Chao; Fang, Wen-Hui; Kao, Tung-Wei; Wang, Chung-Ching; Chang, Yaw-Wen; Peng, Tao-Chun; Wu, Chen-Jung; Yang, Hui-Fang; Chan, James Yi-Hsin; Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan; [Zhou, Yi-Chao; Fang, Wen-Hui; Kao, Tung-Wei; Wang, Chung-Ching; Chang, Yaw-Wen; Peng, Tao-Chun; Wu, Chen-Jung; Yang, Hui-Fang; Chan, James Yi-Hsin; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Zhou, Yi-Chao; Fang, Wen-Hui; Kao, Tung-Wei; Wang, Chung-Ching; Chang, Yaw-Wen; Peng, Tao-Chun; Wu, Chen-Jung; Yang, Hui-Fang; Chan, James Yi-Hsin; Chen, Wei-Liang] Triserv Gen Hosp, Natl Def Med Ctr, Hlth Management Ctr, Dept Family & Community Med, Taipei, Taiwan; [Kao, Tung-Wei; Chang, Yaw-Wen; Peng, Tao-Chun; Wu, Chen-Jung; Yang, Hui-Fang; Chan, James Yi-Hsin; Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Wu, Chen-Jung] Taoyuan Armed Forces Gen Hosp, Dept Community Med, Div Family Med, Taoyuan, Taiwan; [Chan, James Yi-Hsin] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital; National Defense Medical Center	Chen, WL (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Hlth Management Ctr, Dept Family & Community Med, Taipei, Taiwan.; Chen, WL (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan.	weiliang0508@gmail.com	Peng, Tao‑Chun/AAY-7035-2020; Chang, Yaw-Wen/AAF-2630-2020	Chang, Yaw-Wen/0000-0002-8436-0518; Yang, Hui-Fang/0000-0001-6400-0462				Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Angelin B, 2010, CURR OPIN LIPIDOL, V21, P499, DOI 10.1097/MOL.0b013e3283402e9c; Asvold BO, 2007, EUR J ENDOCRINOL, V156, P181, DOI 10.1530/eje.1.02333; Asvold BO, 2007, J CLIN ENDOCR METAB, V92, P841, DOI 10.1210/jc.2006-2208; Aye M, 2012, SINGAP MED J, V53, P545; Baik I, 2008, AM J CLIN NUTR, V87, P1455, DOI 10.1093/ajcn/87.5.1455; Barzin M, 2011, ACTA PAEDIATR, V100, P722, DOI 10.1111/j.1651-2227.2011.02162.x; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Diez JJ, 2004, J CLIN ENDOCR METAB, V89, P4890, DOI 10.1210/jc.2003-032061; Dimitriadis G, 2006, J CLIN ENDOCR METAB, V91, P4930, DOI 10.1210/jc.2006-0478; Djousse L, 2004, OBES RES, V12, P1375, DOI 10.1038/oby.2004.174; Huber G, 2002, J CLIN ENDOCR METAB, V87, P3221, DOI 10.1210/jc.87.7.3221; Hwang LC, 2012, ASIA PAC J CLIN NUTR, V21, P227; Iqbal A, 2006, J HUM HYPERTENS, V20, P932, DOI 10.1038/sj.jhh.1002091; Kim HJ, 2016, ENDOCRINOL METAB, V31, P311, DOI 10.3803/EnM.2016.31.2.311; Lai YX, 2011, ENDOCR J, V58, P23, DOI 10.1507/endocrj.K10E-272; Lin SY, 2005, METABOLISM, V54, P1524, DOI 10.1016/j.metabol.2005.05.020; Maratou E, 2009, EUR J ENDOCRINOL, V160, P785, DOI 10.1530/EJE-08-0797; Mehran L, 2017, THYROID, V27, P886, DOI 10.1089/thy.2016.0557; Mehran L, 2014, THYROID, V24, P1566, DOI 10.1089/thy.2014.0103; Nestel P, 2007, ASIA PAC J CLIN NUTR, V16, P362; Owen PJD, 2006, J CLIN ENDOCR METAB, V91, P2126, DOI 10.1210/jc.2005-2108; Park SB, 2011, J KOREAN MED SCI, V26, P540, DOI 10.3346/jkms.2011.26.4.540; Roos A, 2007, J CLIN ENDOCR METAB, V92, P491, DOI 10.1210/jc.2006-1718; Ruhla S, 2010, CLIN ENDOCRINOL, V72, P696, DOI 10.1111/j.1365-2265.2009.03698.x; Ryan MC, 2008, AM J CARDIOL, V102, P40, DOI 10.1016/j.amjcard.2008.02.096; Sun K, 2014, CLIN NUTR, V33, P596, DOI 10.1016/j.clnu.2013.10.003; Syauqy A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020143; Tsou MT, 2014, INT J GERONTOL, V8, P127, DOI 10.1016/j.ijge.2013.10.006; Vieira BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163044; Wang FR, 2012, J CLIN ENDOCR METAB, V97, P2724, DOI 10.1210/jc.2012-1133; Waring AC, 2012, CLIN ENDOCRINOL, V76, P911, DOI 10.1111/j.1365-2265.2011.04328.x	35	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199209	10.1371/journal.pone.0199209	http://dx.doi.org/10.1371/journal.pone.0199209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928001	gold, Green Published, Green Submitted			2022-12-26	WOS:000435802500054
J	Li, YR; Zhao, LY; Yu, DM; Wang, ZH; Ding, GQ				Li, Yaru; Zhao, Liyun; Yu, Dongmei; Wang, Zhihong; Ding, Gangqiang			Metabolic syndrome prevalence and its risk factors among adults in China: A nationally representative cross-sectional study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; CARDIOVASCULAR-DISEASE; HEALTH; CONSUMPTION; OVERWEIGHT; OBESITY; TRENDS; STATES; FRUIT; KOREA	Objectives The aim of this study was to examine sex disparity in metabolic syndrome prevalence and its risk factors among Chinese adults. Methods Using the 2010 +/- 2012 China National Nutrition and Health Survey (CNNHS), a nationally representative cross-sectional study on nutrition and non-communicable chronic diseases, a total of 98,042 participants aged 18 years and older were included in the analysis. Dietary information was collected with a food frequency questionnaire (FFQ). Metabolic syndrome was defined according to the updated NCEP ATP III criteria. A multivariable logistic regression model was performed to examine the associations between sociodemographic and dietary factors with metabolic syndrome prevalence, and the results are presented using odd ratios (ORs) and 95% confidence intervals (CIs). Results The overall standardized prevalence of metabolic syndrome was 24.2% (24.6% in men and 23.8% in women). The metabolic syndrome prevalence was positively associated with age in men and women. The prevalence of metabolic syndrome was negatively associated with the physical activity level among men and inversely associated with the education level among women (P for trend < 0.01). Frequent consumption of fungi and algae was an underlying risk factor for metabolic syndrome in men, whereas frequent consumption of nuts and pork was associated with a decreased prevalence of metabolic syndrome in women. Conclusions The prevalence of metabolic syndrome in men was not different from that in women. There are sex-specific associations between multiple risk factors and metabolic syndrome.	[Li, Yaru; Zhao, Liyun; Yu, Dongmei; Wang, Zhihong; Ding, Gangqiang] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Ding, GQ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing, Peoples R China.	gangqiangding@163.com	ding, gangqiang/AHD-5012-2022		Special Fund for Health-scientific Research in the Public Interest from the National Health and Family Planning Commission of the People's Republic of China [20120212]; China National Nutrition and Health Survey [CHNNS2010-2012]	Special Fund for Health-scientific Research in the Public Interest from the National Health and Family Planning Commission of the People's Republic of China; China National Nutrition and Health Survey	This research was supported by the Special Fund for Health-scientific Research in the Public Interest (No. 20120212) from the National Health and Family Planning Commission of the People's Republic of China.; The authors would like to thank all the staffs and participants working for the China National Nutrition and Health Survey 2010-2012 (CHNNS2010-2012).	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Chen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053258; Chen W, 2017, CHIN CIRCUL J, P521; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Deshmukh Pradeep R, 2013, Indian J Community Med, V38, P33, DOI 10.4103/0970-0218.106625; Fisher SC, 2013, PREV MED, V56, P372, DOI 10.1016/j.ypmed.2013.02.015; Fujimoto WY, 2000, DIABETES RES CLIN PR, V50, pS73, DOI 10.1016/S0168-8227(00)00182-0; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Hou XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057319; Hu SS, 2012, BIOMED ENVIRON SCI, V25, P251, DOI 10.3967/0895-3988.2012.03.001; Kim HJ, 2014, INT J CARDIOL, V174, P64, DOI 10.1016/j.ijcard.2014.03.163; Kim Y, 2016, DIABETIC MED, V33, P428, DOI 10.1111/dme.12970; Kim YS, 2015, NUTRIENTS, V7, P2085, DOI 10.3390/nu7042085; Li R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2870-y; Li Yan-ping, 2006, Zhonghua Yufang Yixue Zazhi, V40, P273; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Lu JL, 2017, J CLIN ENDOCR METAB, V102, P507, DOI 10.1210/jc.2016-2477; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Park S, 2015, NUTRITION, V31, P111, DOI 10.1016/j.nut.2014.05.011; Prasad D S, 2012, J Cardiovasc Dis Res, V3, P204, DOI 10.4103/0975-3583.98895; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Song QB, 2015, DIABETES VASC DIS RE, V12, P189, DOI 10.1177/1479164114562410; Trumbo P, 2002, J AM DIET ASSOC, V102, P1621, DOI 10.1016/S0002-8223(02)90346-9; Wang PY, 2016, J DIABETES INVEST, V7, P56, DOI 10.1111/jdi.12376; Wu Y, 2015, NUTR METAB CARDIOVAS, V25, P140, DOI 10.1016/j.numecd.2014.10.004; Xi B, 2013, PREV MED, V57, P867, DOI 10.1016/j.ypmed.2013.09.023; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Yu SS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-877	32	82	93	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199293	10.1371/journal.pone.0199293	http://dx.doi.org/10.1371/journal.pone.0199293			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920555	Green Submitted, Green Published, gold			2022-12-26	WOS:000435541300032
J	Uhia, I; Priestman, M; Joyce, G; Krishnan, N; Shahrezaei, V; Robertson, BD				Uhia, Iria; Priestman, Miles; Joyce, Graham; Krishnan, Nitya; Shahrezaei, Vahid; Robertson, Brian D.			Analysis of ParAB dynamics in mycobacteria shows active movement of ParB and differential inheritance of ParA	PLOS ONE			English	Article							CHROMOSOME SEGREGATION; PROTEIN; GROWTH; LOCALIZATION; ASYMMETRY; PLASMID	Correct chromosomal segregation, coordinated with cell division, is crucial for bacterial survival, but despite extensive studies, the mechanisms underlying this remain incompletely understood in mycobacteria. We report a detailed investigation of the dynamic interactions between ParA and ParB partitioning proteins in Mycobacterium smegmatis using microfluidics and time-lapse fluorescence microscopy to observe both proteins simultaneously. During growth and division, ParB presents as a focused fluorescent spot that subsequently splits in two. One focus moves towards a higher concentration of ParA at the new pole, while the other moves towards the old pole. We show ParB movement is in part an active process that does not rely on passive movement associated with cell growth. In some cells, another round of ParB segregation starts before cell division is complete, consistent with initiation of a second round of chromosome replication. ParA fluorescence distribution correlates with cell size, and in sister cells, the larger cell inherits a local peak of concentrated ParA, while the smaller sister inherits more homogeneously distributed protein. Cells which inherit more ParA grow faster than their sister cell, raising the question of whether inheritance of a local concentration of ParA provides a growth advantage. Alterations in levels of ParA and ParB were also found to disturb cell growth.	[Uhia, Iria; Priestman, Miles; Joyce, Graham; Krishnan, Nitya; Robertson, Brian D.] Imperial Coll London, Dept Med, MRC, Ctr Mol Bacteriol & Infect, London, England; [Shahrezaei, Vahid] Imperial Coll London, Dept Math, London, England	Imperial College London; Imperial College London	Robertson, BD (corresponding author), Imperial Coll London, Dept Med, MRC, Ctr Mol Bacteriol & Infect, London, England.	b.robertson@imperial.ac.uk		Robertson, Brian D./0000-0001-5785-5307; Priestman, Miles/0000-0002-0811-354X; Shahrezaei, Vahid/0000-0002-4013-5458	Fundacion Alfonso Martin Escudero; Imperial College Trust [P08829]; Biotechnology and Biological Sciences Research Council Doctoral Training Partnership [BBSRC DTP1-BB/J014575/1]	Fundacion Alfonso Martin Escudero; Imperial College Trust; Biotechnology and Biological Sciences Research Council Doctoral Training Partnership(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	I.U. was funded by a postdoctoral fellowship from the Fundacion Alfonso Martin Escudero (2012 call) (http://www.fundarne.org/en/) and a grant from the Imperial College Trust (P08829) (https://www.imperial.ac.uk/adminservices/secretariat/secretariat/what-we-do/imperial-college-trust/). M.P. was funded by a Biotechnology and Biological Sciences Research Council Doctoral Training Partnership (BBSRC DTP1-BB/J014575/1) (tittp://www.bbsrc.ac.uk/skills/investing-doctoral-training/dtp/). The ONIX microfluidics platform was provided by an Imperial College Trust Collaborative Research Award (littps://www.imperial.ac.uk/admin-services/secretariat/secretariat/what-we-do/imperial-college-trust/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Casart Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-51; Chaudhuri BN, 2011, J MOL BIOL, V413, P901, DOI 10.1016/j.jmb.2011.08.002; Donovan C, 2010, J BACTERIOL, V192, P3441, DOI 10.1128/JB.00214-10; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Ginda K, 2017, MOL MICROBIOL, V105, P453, DOI 10.1111/mmi.13712; Ginda K, 2013, MOL MICROBIOL, V87, P998, DOI 10.1111/mmi.12146; Golding I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098102; Graham TGW, 2014, GENE DEV, V28, P1228, DOI 10.1101/gad.242206.114; Hartmans S, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P889, DOI 10.1007/0-387-30743-5_33; Hu LH, 2015, P NATL ACAD SCI USA, V112, pE7055, DOI 10.1073/pnas.1505147112; Jakimowicz D, 2002, MOL MICROBIOL, V45, P1365, DOI 10.1046/j.1365-2958.2002.03102.x; Jakimowicz D, 2007, MICROBIOL-SGM, V153, P4050, DOI 10.1099/mic.0.2007/011619-0; Joyce G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044582; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lim HC, 2014, ELIFE, V3, DOI 10.7554/eLife.02758; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; Maloney E, 2009, TUBERCULOSIS, V89, pS65, DOI 10.1016/S1472-9792(09)70015-0; Meniche X, 2014, P NATL ACAD SCI USA, V111, pE3243, DOI 10.1073/pnas.1402158111; Nisa S, 2010, J ANTIMICROB CHEMOTH, V65, P2347, DOI 10.1093/jac/dkq311; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Ptacin JL, 2010, CELL CYCLE, V9, P4033, DOI 10.4161/cc.9.20.13521; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Santi I, 2015, MBIO, V6, DOI 10.1128/mBio.01999-14; Santi I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3913; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seeliger JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029266; Singh B, 2013, MOL MICROBIOL, V88, P64, DOI 10.1111/mmi.12169; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Surovtsev IV, 2016, BIOPHYS J, V110, P2790, DOI 10.1016/j.bpj.2016.05.014; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; Trojanowski D, 2015, MBIO, V6, DOI 10.1128/mBio.02125-14; van Kessel JC, 2008, NAT REV MICROBIOL, V6, P851, DOI 10.1038/nrmicro2014; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Williams KJ, 2010, PLASMID, V64, P69, DOI 10.1016/j.plasmid.2010.04.003; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Zhang YJJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002946	41	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199316	10.1371/journal.pone.0199316	http://dx.doi.org/10.1371/journal.pone.0199316			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920558	Green Published, Green Submitted, gold			2022-12-26	WOS:000435541300034
J	Ullah, S; Daud, H; Cass, SC; Fanaee-T, H; Khalil, A				Ullah, Sami; Daud, Hanita; Cass, Sarat C.; Fanaee-T, Hadi; Khalil, Alamgir			An Eigenspace approach for detecting multiple space-time disease clusters: Application to measles hotspots detection in Khyber-Pakhtunkhwa, Pakistan	PLOS ONE			English	Article							CANCER; SURVEILLANCE	Identifying the abnormally high-risk regions in a spatiotemporal space that contains an unexpected disease count is helpful to conduct surveillance and implement control strategies. The EigenSpot algorithm has been recently proposed for detecting space-time disease clusters of arbitrary shapes with no restriction on the distribution and quality of the data, and has shown some promising advantages over the state-of-the-art methods. However, the main problem with the EigenSpot method is that it cannot be adapted to detect more than one spatiotemporal hotspot. This is an important limitation, since, in reality, we may have multiple hotspots, sometimes at the same level of importance. We propose an extension of the EigenSpot algorithm, called Multi-EigenSpot that is able to handle multiple hotspots by iteratively removing previously detected hotspots and re-running the algorithm until no more hotspots are found. In addition, a visualization tool (heatmap) has been linked to the proposed algorithm to visualize multiple clusters with different colors. We evaluated the proposed method using the monthly data on measles cases in Khyber-Pakhtunkhwa, Pakistan (Jan 2016-Dec 2016), and the efficiency was compared with the state-of-the-art methods: EigenSpot and Space-time scan statistic (SaTScan). The results showed the effectiveness of the proposed method for detecting multiple clusters in a spatiotemporal space.	[Ullah, Sami; Daud, Hanita; Cass, Sarat C.] Univ Teknol PETRONAS, Dept Fundamental & Appl Sci, Bandar Seri Iskandar, Tronoh Perak, Malaysia; [Fanaee-T, Hadi] Univ Oslo, Dept Biostat, Oslo, Norway; [Khalil, Alamgir] Univ Peshawar, Dept Stat, Peshawar, Pakistan	Universiti Teknologi Petronas; University of Oslo; University of Peshawar	Ullah, S (corresponding author), Univ Teknol PETRONAS, Dept Fundamental & Appl Sci, Bandar Seri Iskandar, Tronoh Perak, Malaysia.	sami.khan3891@gmail.com	Ullah, Sami/W-1593-2019; Fanaee-T, Hadi/O-4174-2016; Daud, Hanita/AAZ-3422-2020	Ullah, Sami/0000-0001-7371-7297; Fanaee-T, Hadi/0000-0001-8413-963X; 	Fundamental Research Grant Scheme (FRGS) from the Ministry of Education, Malaysia; Universiti Teknologi PETRONAS [0153AB-L19]	Fundamental Research Grant Scheme (FRGS) from the Ministry of Education, Malaysia; Universiti Teknologi PETRONAS	This research was supported by a Fundamental Research Grant Scheme (FRGS) from the Ministry of Education, Malaysia, with Universiti Teknologi PETRONAS cost center 0153AB-L19.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Ali S. S., 2016, Pakistan Journal of Public Health, V6, P36; Amin R, 2010, PEDIATR BLOOD CANCER, V54, P511, DOI 10.1002/pbc.22403; Assuncao R, 2009, COMPUT STAT DATA AN, V53, P2817, DOI 10.1016/j.csda.2008.10.032; BOSKP, 2016, DEV STAT KHYB PAKHT, P270; Costa MA, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-20; District heath Information System, 3 QUART REP 2016, pII; Dong W., 2012, P 2012 SIAM INT C DA, P732; Fanaee-T H, 2015, EXPERT SYST, V32, P454, DOI 10.1111/exsy.12088; Iyengar V.S., 2004, P 10 ACM SIGKDD INT, P587, DOI [DOI 10.1145/1014052.1014124, 10.1145/1014052.1014124]; Iyengar Vijay S, 2005, MMWR Suppl, V54, P71; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; Kulldorff M, 2012, SATSCAN SOFTWARE SPA; Mancuso M, 2016, DH'16: PROCEEDINGS OF THE 2016 DIGITAL HEALTH CONFERENCE, P91, DOI 10.1145/2896338.2896369; Neill DB, 2006, THESIS, P156; Riaz H, 2013, LANCET, V381, P189, DOI 10.1016/S0140-6736(13)60072-0; Takahashi K, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-14; Teleb N, 2014, MMWR-MORBID MORTAL W, V63, P511; Ullah S, 2017, GEOSPATIAL HEALTH, V12, P210, DOI 10.4081/gh.2017.567; Wang H, 2014, STAT PUBLIC POLICY, V1, P86, DOI 10.1080/2330443X.2014.960120; Weishan Dong, 2011, 2011 IEEE International Conference on Service Operations and Logistics and Informatics (SOLI), P231, DOI 10.1109/SOLI.2011.5986561; World Health Organization, 2016, MEASL SURV DAT; Wu XJ, 2015, INT J GEOGR INF SCI, V29, P624, DOI 10.1080/13658816.2014.994520; Zahoor MA, 2015, EXCLI J, V14, P504, DOI 10.17179/excli2015-170; Zhang ZK, 2010, J PROBAB STAT, V2010, DOI 10.1155/2010/642379	27	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199176	10.1371/journal.pone.0199176	http://dx.doi.org/10.1371/journal.pone.0199176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920540	Green Submitted, Green Published, gold			2022-12-26	WOS:000435541300022
J	Mazurenko, S; Bidmanova, S; Kotlanova, M; Damborsky, J; Prokop, Z				Mazurenko, Stanislav; Bidmanova, Sarka; Kotlanova, Marketa; Damborsky, Jiri; Prokop, Zbynek			Sensitive operation of enzyme-based biodevices by advanced signal processing	PLOS ONE			English	Article							SPHINGOMONAS-PAUCIMOBILIS UT26; HALOALKANE DEHALOGENASE; BIOSENSORS; CALIBRATION; SENSORS; EQUATION; TRENDS; TOXINS	Analytical devices that combine sensitive biological component with a physicochemical detector hold a great potential for various applications, e.g., environmental monitoring, food analysis or medical diagnostics. Continuous efforts to develop inexpensive sensitive biodevices for detecting target substances typically focus on the design of biorecognition elements and their physical implementation, while the methods for processing signals generated by such devices have received far less attention. Here, we present fundamental considerations related to signal processing in biosensor design and investigate how undemanding signal treatment facilitates calibration and operation of enzyme-based biodevices. Our signal treatment approach was thoroughly validated with two model systems: (i) a biodevice for detecting chemical warfare agents and environmental pollutants based on the activity of haloalkane dehalogenase, with the sensitive range for bis(2-chloroethyl) ether of 0.01-0.8 mM and (ii) a biodevice for detecting hazardous pesticides based on the activity of y-hexachlorocyclohexane dehydrochlorinase with the sensitive range for y-hexachlorocyclohexane of 0.01-0.3 mM. We demonstrate that the advanced signal processing based on curve fitting enables precise quantification of parameters important for sensitive operation of enzyme-based biodevices, including: (i) automated exclusion of signal regions with substantial noise, (ii) derivation of calibration curves with significantly reduced error, (iii) shortening of the detection time, and (iv) reliable extrapolation of the signal to the initial conditions. The presented simple signal curve fitting supports rational design of optimal system setup by explicit and flexible quantification of its properties and will find a broad use in the development of sensitive and robust biodevices.	[Mazurenko, Stanislav; Bidmanova, Sarka; Kotlanova, Marketa; Damborsky, Jiri; Prokop, Zbynek] Masaryk Univ, Loschmidt Labs, Dept Expt Biol, Brno, Czech Republic; [Mazurenko, Stanislav; Bidmanova, Sarka; Kotlanova, Marketa; Damborsky, Jiri; Prokop, Zbynek] Masaryk Univ, Res Ctr Tox Cpds Environm RECETOX, Brno, Czech Republic; [Bidmanova, Sarka; Damborsky, Jiri; Prokop, Zbynek] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic; [Kotlanova, Marketa] Enantis Sro, Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Prokop, Z (corresponding author), Masaryk Univ, Loschmidt Labs, Dept Expt Biol, Brno, Czech Republic.; Prokop, Z (corresponding author), Masaryk Univ, Res Ctr Tox Cpds Environm RECETOX, Brno, Czech Republic.; Prokop, Z (corresponding author), St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic.	zbynek@chemi.muni.cz	Prokop, Zbynek/H-5707-2012; Mazurenko, Stanislav/AGH-3241-2022; Damborsky, Jiri/H-3799-2012	Prokop, Zbynek/0000-0001-9358-4081; Mazurenko, Stanislav/0000-0003-3659-4819; Damborsky, Jiri/0000-0002-7848-8216; Nevolova, Sarka/0000-0002-7726-5272	RECETOX Research Infrastructure [LM2015051, CZ.02.1.01/0.0/0.0/16_013/0001761]; Programme CETOCOEN UPgrade [CZ.1.05/2.1.00/19.0382]; University spin-off Enantis	RECETOX Research Infrastructure; Programme CETOCOEN UPgrade; University spin-off Enantis	This research was supported by the RECETOX Research Infrastructure (LM2015051 and CZ.02.1.01/0.0/0.0/16_013/0001761) and Programme CETOCOEN UPgrade (CZ.1.05/2.1.00/19.0382). University spin-off Enantis provided support in the form of salaries for author MK, but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Achi F, 2015, SENSOR ACTUAT B-CHEM, V207, P413, DOI 10.1016/j.snb.2014.10.033; Bahadir EB, 2015, ANAL BIOCHEM, V478, P107, DOI 10.1016/j.ab.2015.03.011; Baronas R, 2013, CHEMOMETR INTELL LAB, V126, P108, DOI 10.1016/j.chemolab.2013.05.003; Bazin I, 2017, BIOSENS BIOELECTRON, V87, P285, DOI 10.1016/j.bios.2016.06.083; Bidmanova S, 2016, ANAL CHEM, V88, P6044, DOI 10.1021/acs.analchem.6b01272; Bidmanova S, 2016, BIOSENS BIOELECTRON, V84, P97, DOI 10.1016/j.bios.2015.12.010; Bidmanova S, 2012, SENSOR ACTUAT B-CHEM, V161, P93, DOI 10.1016/j.snb.2011.09.046; Bisswanger H., 2014, PERSPECT SCI, V1, P41, DOI DOI 10.1016/J.PISC.2014.02.005; Brown JQ, 2006, BIOSENS BIOELECTRON, V21, P1760, DOI 10.1016/j.bios.2005.08.013; D'Amico A, 2015, SENSOR ACTUAT B-CHEM, V207, P1060, DOI 10.1016/j.snb.2014.07.065; De Marco R, 2007, ELECTROANAL, V19, P1987, DOI 10.1002/elan.200703916; Farre M, 2009, TRAC-TREND ANAL CHEM, V28, P170, DOI 10.1016/j.trac.2008.09.018; Fernandez J, 2013, ENVIRON SCI POLLUT R, V20, P1937, DOI 10.1007/s11356-012-1433-8; Fonollosa J, 2015, SENSOR ACTUAT B-CHEM, V215, P618, DOI 10.1016/j.snb.2015.03.028; Geng ZY, 2015, SENSOR ACTUAT B-CHEM, V216, P321, DOI 10.1016/j.snb.2015.03.071; Gill A, 1996, J BIOTECHNOL, V48, P117, DOI 10.1016/0168-1656(96)01410-1; Golicnik M, 2011, BIOCHEM ENG J, V53, P234, DOI 10.1016/j.bej.2010.10.012; Gutfreund H., 1995, KINETICS LIFE SCI RE; Hu JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132098; Johnson KA, 2013, FEBS LETT, V587, P2753, DOI 10.1016/j.febslet.2013.07.012; Kmunicek J, 2005, BIOCHEMISTRY-US, V44, P3390, DOI 10.1021/bi047912o; Koudelakova T, 2013, BIOTECHNOL J, V8, P32, DOI 10.1002/biot.201100486; Kurganov BI, 2001, ANAL CHIM ACTA, V427, P11, DOI 10.1016/S0003-2670(00)01167-3; Mishra RK, 2017, ACS SENSORS, V2, P553, DOI 10.1021/acssensors.7b00051; Nagata Y, 1997, APPL ENVIRON MICROB, V63, P3707, DOI 10.1128/AEM.63.9.3707-3710.1997; Orellana G, 2008, CURR ANAL CHEM, V4, P273, DOI 10.2174/157341108785914871; Peng L, 2016, BIOSENS BIOELECTRON, V83, P169, DOI 10.1016/j.bios.2016.04.052; Raposo F, 2016, TRAC-TREND ANAL CHEM, V77, P167, DOI 10.1016/j.trac.2015.12.006; Reinstein J, 2013, ENCY BIOPHYSICS, P1213; Roda A, 2016, BIOSENS BIOELECTRON, V76, P164, DOI 10.1016/j.bios.2015.06.017; Rodriguez-Mozaz S, 2004, PURE APPL CHEM, V76, P723, DOI 10.1351/pac200476040723; Sharma H, 2013, SENSOR ACTUAT B-CHEM, V183, P535, DOI 10.1016/j.snb.2013.03.137; Su LA, 2011, BIOSENS BIOELECTRON, V26, P1788, DOI 10.1016/j.bios.2010.09.005; Wencel D, 2009, SENSOR ACTUAT B-CHEM, V139, P208, DOI 10.1016/j.snb.2008.12.066; Wolfbeis OS, 2005, J MATER CHEM, V15, P2657, DOI 10.1039/b501536g	35	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198913	10.1371/journal.pone.0198913	http://dx.doi.org/10.1371/journal.pone.0198913			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912920	Green Published, gold, Green Submitted			2022-12-26	WOS:000435528600061
J	Skinner, DZ; Bellinger, B; Hiscox, W; Helms, GL				Skinner, Daniel Z.; Bellinger, Brian; Hiscox, William; Helms, Gregory L.			Evidence of cyclical light/dark-regulated expression of freezing tolerance in young winter wheat plants	PLOS ONE			English	Article							CBF GENE FAMILY; COPY NUMBER VARIATION; COLD-ACCLIMATION; CIRCADIAN CLOCK; FROST TOLERANCE; PHOTOPERIODIC REGULATION; TRITICUM-MONOCOCCUM; HEXAPLOID WHEAT; LOCUS FR-A(M)2; AMINO-ACID	The ability of winter wheat (Triticum aestivum L.) plants to develop freezing tolerance through cold acclimation is a complex rait that responds to many environmental cues including day length and temperature. A large part of the freezing tolerance is conditioned by the C-repeat binding factor (CBF) gene regulon. We investigated whether the level of freezing tolerance of 12 winter wheat lines varied throughout the day and night in plants grown under a constant low temperature and a 12-hour photoperiod. Freezing tolerance was significantly greater (P<0.0001) when exposure to subfreezing temperatures began at the midpoint of the light period, or the midpoint of the dark period, compared to the end of either period, with an average of 21.3% improvement in survival. Thus, freezing survival was related to the photoperiod, but cycled from low, to high, to low within each 12-hour light period and within each 12-hour dark period, indicating ultradian cyclic variation of freezing tolerance. Quantitative real-time PCR analysis of expression levels of CBF genes 14 and 15 indicated that expression of these two genes also varied cyclically, but essentially 180 degrees out of phase with each other. Proton nuclear magnetic resonance analysis (H-1-NMR) showed that the chemical composition of the wheat plants' cellular fluid varied diurnally, with consistent separation of the light and dark phases of growth. A compound identified as glutamine was consistently found in greater concentration in a strongly freezing-tolerant wheat line, compared to moderately and poorly freezing-tolerant lines. The glutamine also varied in ultradian fashion in the freezing-tolerant wheat line, consistent with the ultradian variation in freezing tolerance, but did not vary in the less-tolerant lines. These results suggest at least two distinct signaling pathways, one conditioning freezing tolerance in the light, and one conditioning freezing tolerance in the dark; both are at least partially under the control of the CBF regulon.	[Skinner, Daniel Z.; Bellinger, Brian] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Skinner, Daniel Z.; Bellinger, Brian] ARS, USDA, Wheat Hlth Genet & Qual Res Unit, Pullman, WA 99164 USA; [Hiscox, William; Helms, Gregory L.] Washington State Univ, Ctr NMR Spect, Pullman, WA 99164 USA	Washington State University; United States Department of Agriculture (USDA); Washington State University	Skinner, DZ (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.; Skinner, DZ (corresponding author), ARS, USDA, Wheat Hlth Genet & Qual Res Unit, Pullman, WA 99164 USA.	dan.skinner@ars.usda.gov		Hiscox, William/0000-0002-3503-1654	US Department of Agriculture [2090-21000-030-00D]; USDA-ARS project [2090-21000-030-00D]	US Department of Agriculture(United States Department of Agriculture (USDA)); USDA-ARS project	This research was supported by US Department of Agriculture intramural project number 2090-21000-030-00D (DZS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by USDA-ARS project 2090-21000-030-00D.	Badawi M, 2007, MOL GENET GENOMICS, V277, P533, DOI 10.1007/s00438-006-0206-9; Bieniawska Z, 2008, PLANT PHYSIOL, V147, P263, DOI 10.1104/pp.108.118059; Brilli F, 2013, J EXP BOT, V64, P519, DOI 10.1093/jxb/ers353; Campoli C, 2009, MOL GENET GENOMICS, V282, P141, DOI 10.1007/s00438-009-0451-9; Carre IA, 2001, J BIOL RHYTHM, V16, P415, DOI 10.1177/074873001129002006; Charron JBF, 2005, PLANT PHYSIOL, V139, P2017, DOI 10.1104/pp.105.070466; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Dhillon T, 2013, THEOR APPL GENET, V126, P2777, DOI 10.1007/s00122-013-2171-0; Dong MA, 2011, P NATL ACAD SCI USA, V108, P7241, DOI 10.1073/pnas.1103741108; Feldman M, 2012, GENETICS, V192, P763, DOI 10.1534/genetics.112.146316; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Gattolin S, 2008, PLANT PHYSIOL, V147, P912, DOI 10.1104/pp.108.116079; Gierczik K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081828; Gusta LV, 2001, CAN J PLANT SCI, V81, P241, DOI 10.4141/P00-068; Juhasz Z, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0363-7; Kamada-Nobusada T, 2013, PLANT CELL PHYSIOL, V54, P1881, DOI 10.1093/pcp/pct127; Kan CC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1892-7; Knox AK, 2008, PLANT MOL BIOL, V67, P257, DOI 10.1007/s11103-008-9316-6; Knox AK, 2010, THEOR APPL GENET, V121, P21, DOI 10.1007/s00122-010-1288-7; Kosova K, 2008, BIOL PLANTARUM, V52, P601, DOI 10.1007/s10535-008-0120-6; Laudencia-Chingcuanco D, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/232530; Lee CM, 2012, P NATL ACAD SCI USA, V109, P15054, DOI 10.1073/pnas.1211295109; Limin AE, 2006, PLANTA, V224, P360, DOI 10.1007/s00425-006-0219-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd D, 2006, BIOL RHYTHM RES, V37, P281, DOI 10.1080/09291010600804379; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Millar AJ, 2003, J BIOL RHYTHM, V18, P217, DOI [10.1177/0748730403018003004, 10.1177/0748730403253383]; Miller AK, 2006, MOL GENET GENOMICS, V275, P193, DOI 10.1007/s00438-005-0076-6; Miranda RD, 2017, PLANT SIGNAL BEHAV, V12, DOI 10.1080/15592324.2017.1361075; Mohseni S, 2012, GENOME, V55, P865, DOI 10.1139/gen-2012-0112; Molina-Rueda JJ, 2015, PLANT PHYSIOL BIOCH, V94, P181, DOI 10.1016/j.plaphy.2015.06.009; NAGY F, 1993, P NATL ACAD SCI USA, V90, P6290, DOI 10.1073/pnas.90.13.6290; NAIDU BP, 1991, PHYTOCHEMISTRY, V30, P407, DOI 10.1016/0031-9422(91)83693-F; North HM, 2005, PLANT SCI, V169, P115, DOI 10.1016/j.plantsci.2005.03.002; Novak A, 2017, PLANT MOL BIOL REP, V35, P399, DOI 10.1007/s11105-017-1035-1; Novak A, 2016, J EXP BOT, V67, P1285, DOI 10.1093/jxb/erv526; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Saulescu N. N., 2001, APPL PHYSL WHEAT BRE, P111; Shabala S, 2003, PLANT SOIL, V255, P217, DOI 10.1023/A:1026198927712; Skinner DZ, 2008, CAN J PLANT SCI, V88, P885, DOI 10.4141/CJPS08007; Skinner DZ, 2008, PLANT BREEDING, V127, P228, DOI 10.1111/j.1439-0523.2007.01464.x; Skinner DZ, 2014, CROP SCI, V54, P1721, DOI 10.2135/cropsci2013.09.0604; Skinner DZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133166; Skinner DZ, 2010, PLANT SOIL, V332, P289, DOI 10.1007/s11104-010-0293-6; Skinner DZ, 2009, FUNCT INTEGR GENOMIC, V9, P513, DOI 10.1007/s10142-009-0126-y; Skinner JS, 2005, PLANT MOL BIOL, V59, P533, DOI 10.1007/s11103-005-2498-2; Snedecor G W, 1967, STAT METHODS, P327; Soltesz A, 2013, J EXP BOT, V64, P1849, DOI 10.1093/jxb/ert050; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Zhu J, 2014, THEOR APPL GENET, V127, P1183, DOI 10.1007/s00122-014-2290-2	50	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198042	10.1371/journal.pone.0198042	http://dx.doi.org/10.1371/journal.pone.0198042			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912979	Green Submitted, Green Published, gold			2022-12-26	WOS:000435528600016
J	Gade, PAV; Olsen, TB; Jensen, PO; Kolpen, M; Hoiby, N; Henneberg, KA; Sams, T				Gade, Peter Alexander Vistar; Olsen, Terkel Bo; Jensen, Peter Ostrup; Kolpen, Mette; Hoiby, Niels; Henneberg, Kaj-Age; Sams, Thomas			Modelling of ciprofloxacin killing enhanced by hyperbaric oxygen treatment in Pseudomonas aeruginosa PAO1 biofilms	PLOS ONE			English	Article							POLYMORPHONUCLEAR LEUKOCYTES; INFECTIONS; DIFFUSION; GROWTH; PENETRATION; TOLERANCE; TRANSPORT; LUNGS	Outline In chronic lung infections by Pseudomonas aeruginosa (PA) the bacteria thrive in biofilm structures protected from the immune system of the host and from antibiotic treatment. Increasing evidence suggests that the susceptibility of the bacteria to antibiotic treatment can be significantly enhanced by hyperbaric oxygen treatment. The aim of this study is to simulate the effect of ciprofloxacin treatment in a PAO1 biofilm model with aggregates in agarose when combined with hyperbaric oxygen treatment. This is achieved in a reaction-diffusion model that describes the combined effect of ciprofloxacin diffusion, oxygen diffusion and depletion, bacterial growth and killing, and adaptation of the bacteria to ciprofloxacin. In the model, the oxygen diffusion and depletion use a set of parameters derived from experimental results presented in this work. The part of the model describing ciprofloxacin killing uses parameter values from the literature in combination with our estimates (Jacobs, et al., 2016; Grillon, et al., 2016). Micro-respirometry experiments were conducted to determine the oxygen consumption in the P. aeruginosa strain PAO1. The parameters were validated against existing data from an HBOT experiment by Kolpen et al. (2017). The complete oxygen model comprises a reaction-diffusion equation describing the oxygen consumption by using a Michaelis-Menten reaction term. The oxygen model performed well in predicting oxygen concentrations in both time and depth into the biofilm. At 2.8 bar pure oxygen pressure, HBOT increases the penetration depth of oxygen into the biofilm almost by a of factor 4 in agreement with the scaling that follows from the stationary balance between the consumption term and diffusion term. Conclusion In the full reaction-diffusion model we see that hyperbaric oxygen treatment significantly increases the killing by ciprofloxacin in a PAO1 biofilm in alignment with the experimental results from Kolpen et al. (Kolpen, et al., 2017; Kolpen, et al. 2016). The enhanced killing, in turn, lowers the oxygen consumption in the outer layers of the biofilm, and leads to even deeper penetration of oxygen into the biofilm.	[Gade, Peter Alexander Vistar; Olsen, Terkel Bo; Henneberg, Kaj-Age; Sams, Thomas] Tech Univ Denmark, Dept Elect Engn, Biomed Engn, DK-2800 Lyngby, Denmark; [Gade, Peter Alexander Vistar; Olsen, Terkel Bo] Tech Univ Denmark, Dept Appl Math & Comp Sci, DK-2800 Lyngby, Denmark; [Jensen, Peter Ostrup; Kolpen, Mette; Hoiby, Niels] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; [Jensen, Peter Ostrup; Kolpen, Mette; Hoiby, Niels] Univ Copenhagen, Costerton Biofilm Ctr, Dept Immunol & Microbiol, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark	Technical University of Denmark; Technical University of Denmark; Rigshospitalet; University of Copenhagen; University of Copenhagen	Sams, T (corresponding author), Tech Univ Denmark, Dept Elect Engn, Biomed Engn, DK-2800 Lyngby, Denmark.	tsams@dtu.dk	Sams, Thomas/A-9781-2014; Henneberg, Kaj-Aage/AAM-3919-2020; Jensen, Peter Ostrup/HGD-7725-2022	Sams, Thomas/0000-0002-6316-2539; Henneberg, Kaj-Aage/0000-0001-9418-6587; Hoiby, Niels/0000-0002-1347-725X; Kolpen, Mette/0000-0001-5575-0384; Gade, Peter/0000-0002-8257-8804; Jensen, Peter Ostrup/0000-0003-1648-7186	University of Copenhagen, Center for Antimicrobial Research, UC-CARE [50061804231-F16]; Danish Council for Independent Research, Technology and Production Sciences, FTP [DFF-4184-00515]; Cystic Fibrosis Foundation, USA [HOIBY05A0]	University of Copenhagen, Center for Antimicrobial Research, UC-CARE; Danish Council for Independent Research, Technology and Production Sciences, FTP(Det Frie Forskningsrad (DFF)); Cystic Fibrosis Foundation, USA	This work was supported by grants from University of Copenhagen, Center for Antimicrobial Research, UC-CARE, http://uc-care.ku.dk, Award Number: 50061804231-F16 vertical bar Recipient: Mette Kolpen; Danish Council for Independent Research, Technology and Production Sciences, FTP, http:://dff.ufm.dk, Award Number: DFF-4184-00515 vertical bar Recipient: Peter Ostrup Jensen; and Cystic Fibrosis Foundation, USA, http://www.cff.org, Award Number: HOIBY05A0 vertical bar Recipient: Niels Hoiby. The funders played no role in experimental design, data analysis and interpretation, nor the decision to submit the work for publication.	Arai H, 2014, J BACTERIOL, V196, P4206, DOI 10.1128/JB.02176-14; Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Cao B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153616; Chmiel James F, 2014, Ann Am Thorac Soc, V11, P1120, DOI 10.1513/AnnalsATS.201402-050AS; Corless RM, 1996, ADV COMPUT MATH, V5, P329, DOI 10.1007/BF02124750; Cowley ES, 2015, MBIO, V6, DOI 10.1128/mBio.00767-15; Cunningham AB, 1995, WATER SCI TECHNOL, V32, P107, DOI 10.1016/0273-1223(96)00014-5; Davies JC, 2007, BMJ-BRIT MED J, V335, P1255, DOI 10.1136/bmj.39391.713229.AD; Dwyer DJ, 2015, ANNU REV PHARMACOL, V55, P313, DOI 10.1146/annurev-pharmtox-010814-124712; Fernandez-Barat L, 2017, J CYST FIBROS, V16, P222, DOI 10.1016/j.jcf.2016.08.005; Gregoire N, 2010, ANTIMICROB AGENTS CH, V54, P2379, DOI 10.1128/AAC.01478-08; Grillon A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156690; Han P, 1996, J PHYS CHEM-US, V100, P5597, DOI 10.1021/jp952903y; Hoegger MJ, 2014, SCIENCE, V345, P818, DOI 10.1126/science.1255825; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Jacobs M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004782; Jensen PO, 2017, APMIS, V125, P276, DOI 10.1111/apm.12668; KIESEWETTER S, 1993, NAT GENET, V5, P274, DOI 10.1038/ng1193-274; Kolpen M, 2014, CLIN EXP IMMUNOL, V177, P310, DOI 10.1111/cei.12318; Kolpen M, 2010, THORAX, V65, P57, DOI 10.1136/thx.2009.114512; Kolpen M, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01024-17, 10.1128/aac.01024-17]; Kolpen M, 2016, INT J ANTIMICROB AG, V47, P163, DOI 10.1016/j.ijantimicag.2015.12.005; Kolpen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084353; Kragh KN, 2014, INFECT IMMUN, V82, P4477, DOI 10.1128/IAI.01969-14; Line L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00554; Lobritz MA, 2015, P NATL ACAD SCI USA, V112, P8173, DOI 10.1073/pnas.1509743112; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Moser C, 2017, APMIS, V125, P320, DOI 10.1111/apm.12674; Roberts ME, 2004, ANTIMICROB AGENTS CH, V48, P48, DOI 10.1128/AAC.48.1.48-52.2004; SKEEL RD, 1990, SIAM J SCI STAT COMP, V11, P1, DOI 10.1137/0911001; Stewart PS, 2016, NPJ BIOFILMS MICROBI, V2, DOI 10.1038/npjbiofilms.2016.12; STEWART PS, 1994, ANTIMICROB AGENTS CH, V38, P1052, DOI 10.1128/AAC.38.5.1052; Stewart PS, 1996, ANTIMICROB AGENTS CH, V40, P2517, DOI 10.1128/AAC.40.11.2517; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; SUCI PA, 1994, ANTIMICROB AGENTS CH, V38, P2125, DOI 10.1128/AAC.38.9.2125; Tam VH, 2005, J ANTIMICROB CHEMOTH, V55, P699, DOI 10.1093/jac/dki086; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Williams HD, 2007, ADV MICROB PHYSIOL, V52, P1, DOI 10.1016/S0065-2911(06)52001-6; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870	42	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198909	10.1371/journal.pone.0198909	http://dx.doi.org/10.1371/journal.pone.0198909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902223	Green Submitted, Green Published, gold			2022-12-26	WOS:000435424900058
J	Grun, AY; App, CB; Breidenbach, A; Meier, J; Metreveli, G; Schaumann, GE; Manz, W				Gruen, Alexandra Y.; App, Constantin B.; Breidenbach, Andreas; Meier, Jutta; Metreveli, George; Schaumann, Gabriele E.; Manz, Werner			Effects of low dose silver nanoparticle treatment on the structure and community composition of bacterial freshwater biofilms	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; DIVERSITY; IMPACT; TOXICITY; ION; NANOMATERIALS; AGGREGATION; TOLERANCE; STABILITY; EXPOSURE	The application of engineered silver nanoparticles (AgNPs) in a considerable amount of registered commercial products inevitably will result in the continuous release of AgNPs into the natural aquatic environment. Therefore, native biofilms, as the prominent life form of microorganisms in almost all known ecosystems, will be subjected to AgNP exposure. Despite the exponentially growing research activities worldwide, it is still difficult to assess nanoparticle-mediated toxicity in natural environments. In order to obtain an ecotoxicologically relevant exposure scenario, we performed experiments with artificial stream mesocosm systems approaching low dose AgNP concentrations close to predicted environmental concentrations. Pregrown freshwater biofilms were exposed for 14 days to citrate-stabilized AgNPs at a concentration of 600 fag 1 ' in two commonly used sizes (30 and 70 nm). Sublethal effects of AgNP treatment were assessed with regard to biofilm structure by gravimetric measurements (biofilm thickness and density) and by two biomass parameters, chlorophyll a and protein content. The composition of bacterial biofilm communities was characterized by t RFLP fingerprinting combined with phylogenetic studies based on the 16S gene. After 14 days of treatment, the structural parameters of the biofilm such as thickness, density, and chlorophyll a and protein content were not statistically significantly changed by AgNP exposure. Furthermore, t RFLP fingerprint analysis showed that the bacterial diversity was not diminished by AgNPs, as calculated by Shannon Wiener and evenness indices. Nevertheless, t RFLP analysis also indicated that AgNPs led to an altered biofilm community composition as was shown by cluster analysis and multidimensional scaling (MDS) based on the Bray Curtis index. Sequence analysis of cloned 16S rRNA genes further revealed that changes in community composition were related with the displacement of putatively AgNP-sensitive bacterial taxa Actinobacteria, Chloroflexi, and Cyanobacteria by taxa known for their enhanced adaptability towards metal stress, such as Acidobacteria, Sphingomonadales, and Comamonadaceae. This measurable community shift, even after low dose AgNP treatment, causes serious concerns with respect to the broad application of AgNPs and their potentially adverse impact on the ecological function of lotic biofilms, such as biodegradation or biostabilization.	[Gruen, Alexandra Y.; App, Constantin B.; Breidenbach, Andreas; Meier, Jutta; Manz, Werner] Univ Koblenz Landau, Inst Integrated Nat Sci, Koblenz, Germany; [Metreveli, George; Schaumann, Gabriele E.] Univ Koblenz Landau, Inst Environm Sci, Grp Environm & Soil Chem, Landau, Germany	University of Koblenz & Landau; University of Koblenz & Landau	Manz, W (corresponding author), Univ Koblenz Landau, Inst Integrated Nat Sci, Koblenz, Germany.	manz@uni-koblenz.de	Schaumann, Gabriele E/B-4283-2015; Metreveli, George/AAQ-4102-2021	Schaumann, Gabriele E/0000-0003-1788-2751; Manz, Werner/0000-0002-4320-4236	German Research Foundation (DFG) [FOR 1536, BIOFILM MA3273/3-1, MASK SCHA849/16]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the German Research Foundation (DFG; Research unit INTERNANO: FOR 1536, subprojects BIOFILM MA3273/3-1 (WM); MASK SCHA849/16 (GS); www.dfg.de. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the German Research Foundation (DFG; Research unit INTERNANO: FOR 1536, subprojects BIOFILM MA3273/3-1 and MASK SCHA849/16). We thank S. Kleinsteuber, U. Lohse, and I. Fetzer from Helmholtz Centre for Environmental Research in Leipzig (UFZ). We thank D. Mewes (Institute for Integrated Natural Sciences, University of Koblenz-Landau, Koblenz, Germany) for help with chlorophyll a measurements. We thank K. Hoffmann and C. Sodemann for technical assistance.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Battin TJ, 2016, NAT REV MICROBIOL, V14, P251, DOI 10.1038/nrmicro.2016.15; Berg J, 2012, APPL ENVIRON MICROB, V78, P7438, DOI 10.1128/AEM.01071-12; BOENIGK J, 2014, PLOS ONE, V9; Bouskill NJ, 2010, ECOTOXICOLOGY, V19, P317, DOI 10.1007/s10646-009-0414-2; Bradford A, 2009, ENVIRON SCI TECHNOL, V43, P4530, DOI 10.1021/es9001949; Brummer IHM, 2003, APPL ENVIRON MICROB, V69, P4463, DOI 10.1128/AEM.69.8.4463-4473.2003; Canovas D, 2003, ENVIRON MICROBIOL, V5, P1242, DOI 10.1046/j.1462-2920.2003.00463.x; Chernousova S, 2013, ANGEW CHEM INT EDIT, V52, P1636, DOI 10.1002/anie.201205923; CHISTI Y, 1986, ENZYME MICROB TECH, V8, P194, DOI 10.1016/0141-0229(86)90087-6; Choi O, 2008, ENVIRON SCI TECHNOL, V42, P4583, DOI 10.1021/es703238h; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Critchley MM, 2004, J APPL MICROBIOL, V97, P590, DOI 10.1111/j.1365-2672.2004.02341.x; Das P, 2012, ENVIRON SCI TECHNOL, V46, P9120, DOI 10.1021/es3019918; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Fabrega J, 2011, CHEMOSPHERE, V85, P961, DOI 10.1016/j.chemosphere.2011.06.066; Gardener M., 2012, EXPLORING DATA LOOKI; Gerbersdorf SU, 2015, GEOBIOLOGY, V13, P68, DOI 10.1111/gbi.12115; Giese B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19275-4; Gil-Allue C, 2015, ENVIRON SCI TECHNOL, V49, P1165, DOI 10.1021/es5050166; Gottschalk F, 2013, ENVIRON POLLUT, V181, P287, DOI 10.1016/j.envpol.2013.06.003; Grun AY, 2016, ENVIRON SCI POLLUT R, V23, P24277, DOI 10.1007/s11356-016-7691-0; Hajipour MJ, 2012, TRENDS BIOTECHNOL, V30, P499, DOI 10.1016/j.tibtech.2012.06.004; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Kaegi R, 2013, WATER RES, V47, P3866, DOI 10.1016/j.watres.2012.11.060; Kaegi R, 2011, ENVIRON SCI TECHNOL, V45, P3902, DOI 10.1021/es1041892; Kang FX, 2014, ENVIRON SCI TECHNOL, V48, P316, DOI 10.1021/es403796x; Kroll A, 2016, ENVIRON SCI POLLUT R, V23, P4218, DOI 10.1007/s11356-015-4887-7; Lawrence JR, 2004, APPL ENVIRON MICROB, V70, P4326, DOI 10.1128/AEM.70.7.4326-4339.2004; LECHEVALIER HA, 1967, ANNU REV MICROBIOL, V21, P71, DOI 10.1146/annurev.mi.21.100167.000443; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Li J, 2015, ENVIRON SCI POLLUT R, V22, P10496, DOI 10.1007/s11356-015-4232-1; Li X, 2012, ENVIRON SCI TECHNOL, V46, P5378, DOI 10.1021/es204531y; Liu JY, 2010, ENVIRON SCI TECHNOL, V44, P2169, DOI 10.1021/es9035557; Lowry GV, 2012, ENVIRON SCI TECHNOL, V46, P6893, DOI 10.1021/es300839e; Matyar F, 2010, ENVIRON MONIT ASSESS, V167, P309, DOI 10.1007/s10661-009-1051-1; McAleece N., 1997, BIODIVERSITY PROFESS; Metreveli G, 2016, ENVIRON SCI-NANO, V3, P418, DOI 10.1039/c5en00152h; Metreveli G, 2015, SCI TOTAL ENVIRON, V535, P35, DOI 10.1016/j.scitotenv.2014.11.058; Mewes D, 2017, FRESHWATER BIOL, V62, P807, DOI 10.1111/fwb.12903; Moran AC, 2008, ENVIRON TOXICOL CHEM, V27, P2239, DOI 10.1897/08-112.1; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pillai S, 2014, P NATL ACAD SCI USA, V111, P3490, DOI 10.1073/pnas.1319388111; Pillai ZS, 2004, J PHYS CHEM B, V108, P945, DOI 10.1021/jp037018r; R Core Team, 2021, R LANGUAGE ENV STAT; Rajendhran J, 2011, MICROBIOL RES, V166, P99, DOI 10.1016/j.micres.2010.02.003; Schaumann GE, 2015, SCI TOTAL ENVIRON, V535, P3, DOI 10.1016/j.scitotenv.2014.10.035; Sheng GP, 2010, BIOTECHNOL ADV, V28, P882, DOI 10.1016/j.biotechadv.2010.08.001; Sheng ZY, 2011, WATER RES, V45, P6039, DOI 10.1016/j.watres.2011.08.065; Staudt C, 2004, BIOTECHNOL BIOENG, V88, P585, DOI 10.1002/bit.20241; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Vilchez R, 2007, MICROBIOL-SGM, V153, P325, DOI 10.1099/mic.0.2006/002139-0; Vilchez R, 2011, ECOTOXICOLOGY, V20, P779, DOI 10.1007/s10646-011-0629-x; Walker B., 2004, Ecology and Society, V9, P5; Ward NL, 2009, APPL ENVIRON MICROB, V75, P2046, DOI 10.1128/AEM.02294-08; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wirth SM, 2012, ENVIRON SCI TECHNOL, V46, P12687, DOI 10.1021/es301521p; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Yang Y, 2014, WATER RES, V48, P317, DOI 10.1016/j.watres.2013.09.046; Zhang JH, 1997, GENOME RES, V7, P649, DOI 10.1101/gr.7.6.649	65	16	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199132	10.1371/journal.pone.0199132	http://dx.doi.org/10.1371/journal.pone.0199132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902242	Green Submitted, Green Published, gold			2022-12-26	WOS:000435424900092
J	Lee, S; Axelsen, TV; Jesse, N; Pedersen, SF; Vahi, P; Boedtkjer, E				Lee, Soojung; Axelsen, Trine, V; Jesse, Nicolai; Pedersen, Stine F.; Vahi, Pernille; Boedtkjer, Ebbe			Na+,HCO3--cotransporter NBCn1 (Slc4a7) accelerates ErbB2-induced breast cancer development and tumor growth in mice	ONCOGENE			English	Article							INTRACELLULAR PH TRANSIENTS; EXPRESSION; CELLS; NHE1; MIGRATION; NA+; EPITHELIUM; EVOLUTION; ARTERIES; HYPOXIA	Metabolic acid production challenges cellular pH homeostasis in solid cancer tissue, and mechanisms of net acid extrusion represent promising new targets for breast cancer therapy. Here, we used genetically engineered mice to investigate the contribution of the Na+,HCO3--cotransporter NBCn1 (Slc4a7) to intracellular acid-base regulation in ErbB2-induced breast cancer tissue and the consequences of NBCn1 knockout for breast tumor development and growth. We demonstrate an approximately 2-fold increase of NBCn1 protein abundance in ErbB2-induced breast cancer tissue compared to normal breast tissue despite a 4-fold decrease in the NBCn1 mRNA level. In congruence, we show that NBCn1 facilitates net acid extrusion and elevates steady-state intracellular pH in breast cancer tissue. Disruption of NBCn1 expression delayed ErbB2-induced breast carcinogenesis from a median tumor-free survival of 9.5 months in wild-type mice to 12 months in NBCn1-knockout mice and decelerated the tumor growth rate by approximately 1/3. Glycolytic metabolism-evaluated based on the interstitial concentrations of lactate and glucose measured in microdialysates-was increased in breast cancer tissue compared to normal breast tissue, but was unaffected by NBCn1 knockout. Disruption of NBCn1 expression inhibited cell proliferation-evaluated by staining for the proliferative marker Ki67-particularly in central tumor areas with predicted increase in acid loading from glycolytic metabolism. In conclusion, NBCn1 regulates intracellular pH in ErbB2-induced breast cancer tissue by providing a pathway for cellular uptake of HCO3-, which can neutralize metabolic acidic waste products. Disrupting NBCn1 expression delays ErbB2-induced breast cancer development, inhibits cancer cell proliferation, and decelerates tumor growth.	[Lee, Soojung; Axelsen, Trine, V; Jesse, Nicolai; Boedtkjer, Ebbe] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Pedersen, Stine F.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Vahi, Pernille] Aarhus Univ Hosp, Dept Pathol, Aarhus, Denmark	Aarhus University; University of Copenhagen; Aarhus University	Boedtkjer, E (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	eb@biomed.au.dk	Pedersen, Stine Falsig/O-1133-2019; Boedtkjer, Ebbe/O-8449-2019	Pedersen, Stine Falsig/0000-0002-3044-7714; Boedtkjer, Ebbe/0000-0002-5078-9279	Danish Cancer Society [R42-A4273]; Novo Nordisk Foundation [NNF13OC0007393, NNF15OC0017344, NNF16OC0023194]; Danish Council for Independent Research [7025-00050B]	Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This work was supported by the Danish Cancer Society (grant no. R42-A4273 to EB), the Novo Nordisk Foundation (grant no. NNF13OC0007393 and NNF15OC0017344 to EB and grant no. NNF16OC0023194 to SFP), and the Danish Council for Independent Research (grant no. 7025-00050B to EB).	Aalkjaer C, 2014, COMPR PHYSIOL, V4, P1605, DOI 10.1002/cphy.c130005; Amith SR, 2017, SEMIN CANCER BIOL, V43, P35, DOI 10.1016/j.semcancer.2017.01.004; Andersen AP, 2018, INT J CANCER, V142, P2529, DOI 10.1002/ijc.31276; Boedtkjer E, 2006, CIRC RES, V98, P515, DOI 10.1161/01.RES.0000204750.04971.76; Boedtkjer E, 2012, CURR PHARM DESIGN, V18, P1345, DOI 10.2174/138161212799504830; Boedtkjer E, 2008, AM J PHYSIOL-CELL PH, V294, pC591, DOI 10.1152/ajpcell.00281.2007; Boedtkjer E, 2016, CARDIOVASC RES, V111, P227, DOI 10.1093/cvr/cvw079; Boedtkjer E, 2013, INT J CANCER, V132, P1288, DOI 10.1002/ijc.27782; Boedtkjer E, 2011, CIRCULATION, V124, P1819, DOI 10.1161/CIRCULATIONAHA.110.015974; Bonde L, 2017, ACTA PHYSIOL, V219, P227, DOI 10.1111/apha.12685; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; Bouzinova EV, 2005, AM J PHYSIOL-CELL PH, V289, pC1448, DOI 10.1152/ajpcell.00313.2005; Brockton NT, 2012, ORAL ONCOL, V48, P615, DOI 10.1016/j.oraloncology.2012.01.018; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Counillon L, 2016, BBA-MOL CELL RES, V1863, P2465, DOI 10.1016/j.bbamcr.2016.02.018; Damkier HH, 2006, AM J PHYSIOL-HEART C, V290, pH172, DOI 10.1152/ajpheart.00713.2005; Flinck M, 2018, ACTA PHYSIOL, V223, DOI 10.1111/apha.13068; Froelunde AS, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-0952-8; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gerweck LE, 1996, CANCER RES, V56, P1194; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Gorbatenko A, 2016, BIOCHEM J, V473, P4027, DOI 10.1042/BCJ20160054; Gorbatenko A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00130; Gorbatenko A, 2014, FASEB J, V28, P350, DOI 10.1096/fj.13-233288; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Helmlinger G, 2002, CLIN CANCER RES, V8, P1284; Landis MD, 2006, ONCOGENE, V25, P3325, DOI 10.1038/sj.onc.1209365; Larsen AM, 2012, CHEMMEDCHEM, V7, P1808, DOI 10.1002/cmdc.201200335; Lauritzen G, 2010, EXP CELL RES, V316, P2538, DOI 10.1016/j.yexcr.2010.06.005; Lee S, 2016, ONCOGENE, V35, P2112, DOI 10.1038/onc.2015.273; Lee S, 2015, PFLUG ARCH EUR J PHY, V467, P367, DOI 10.1007/s00424-014-1524-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McIntyre A, 2016, CANCER RES, V76, P3744, DOI 10.1158/0008-5472.CAN-15-1862; Morais-Santos F, 2015, ONCOTARGET, V6, P19177, DOI 10.18632/oncotarget.3910; Parakh S, 2017, CANCER TREAT REV, V59, P1, DOI 10.1016/j.ctrv.2017.06.005; Parks SK, 2015, J CELL PHYSIOL, V230, P1954, DOI 10.1002/jcp.24930; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Pedersen SF, 2006, PFLUG ARCH EUR J PHY, V452, P249, DOI 10.1007/s00424-006-0044-y; Rasmussen JK, 2018, J CEREBR BLOOD F MET, V38, P492, DOI 10.1177/0271678X17699224; Rodriguez-Enriquez S, 2008, J CELL PHYSIOL, V216, P189, DOI 10.1002/jcp.21392; Romero Q, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-341; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Rosner A, 2002, AM J PATHOL, V161, P1087, DOI 10.1016/S0002-9440(10)64269-1; Stransky L, 2016, PHYSIOL REV, V96, P1071, DOI 10.1152/physrev.00035.2015; Swietach P, 2008, J BIOL CHEM, V283, P20473, DOI 10.1074/jbc.M801330200; TRIVEDI B, 1966, J BIOL CHEM, V241, P4110; VAUPEL P, 1989, CANCER RES, V49, P6449	48	22	22	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 11	2018	37	41					5569	5584		10.1038/s41388-018-0353-6	http://dx.doi.org/10.1038/s41388-018-0353-6			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GW5QO	29907770				2022-12-26	WOS:000446991200007
J	Cho, HJ; Mook-Jung, I				Cho, Hyun Jin; Mook-Jung, Inhee			O-GlcNAcylation regulates endoplasmic reticulum exit sites through Sec31A modification in conventional secretory pathway	FASEB JOURNAL			English	Article						ER-Golgi; transport; COPII vesicles; ERES; ALG-2	BETA-N-ACETYLGLUCOSAMINE; GLCNAC TRANSFERASE; NUCLEOCYTOPLASMIC PROTEINS; COPII COAT; SUBSTRATE-SPECIFICITY; ALZHEIMER-DISEASE; VESICLE FORMATION; QUALITY-CONTROL; CELL BIOLOGY; SYNAPSIN I	The conventional secretory pathway is indispensable for eukaryotic cells. Newly synthesized membrane and secretory proteins are released from the endoplasmic reticulum (ER) through ER-derived vesicles to their appropriate destination. Vesicle formation is important for steady protein trafficking. O-GlcNAcylation (O-GlcNAc) is a unique protein glycosylation signature, whose dynamic regulation by O-GlcNAc transferase and O-GlcNAcase occurs exclusively for nuclear and cytoplasmic proteins. Because of this locally limited property, the role of O-GlcNAc in the conventional protein secretory pathway is unknown. We report that Sec31A on COPII vesicles, a specific coat-protein complex for anterograde trafficking in the ER-Golgi network, is O-GlcNAcylated on S964, which accelerates COPII vesicle formation through control of its binding affinity to apoptosis-linked gene 2, a calcium-binding protein. Together, O-GlcNAc on Sec31A regulates conventional secretory vesicle trafficking in the ER-Golgi network. These modifications accelerate COPII vesicle formation and accelerated anterograde transport of vesicles within the ER-Golgi networks.Cho, H. J., Mook-Jung, I. O-GlcNAcylation regulates endoplasmic reticulum exit sites through Sec31A modification in conventional secretory pathway.	[Cho, Hyun Jin; Mook-Jung, Inhee] Seoul Natl Univ, Dept Biochem & Biomed Sci, Coll Med, 28 Yungun Dong, Seoul 110799, South Korea	Seoul National University (SNU)	Mook-Jung, I (corresponding author), Seoul Natl Univ, Dept Biochem & Biomed Sci, Coll Med, 28 Yungun Dong, Seoul 110799, South Korea.	inhee@snu.ac.kr			National Research Foundation (NRF) [2015R1A2A1A05001794, 2014M3-C7A1046047, 2015M3C7A1028790]; Medical Research Council (MRC) [2011-0030738]; Basic Research Program grant from the NRF [2016R1A6A3A11930270]	National Research Foundation (NRF); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Basic Research Program grant from the NRF	The authors thank all members of the Alzlab (Seoul National University College of Medicine). This work was supported grants from the National Research Foundation (NRF; 2015R1A2A1A05001794, 2014M3-C7A1046047, 2015M3C7A1028790), Medical Research Council (MRC; 2011-0030738; to I.M.-J.) and a Basic Research Program grant from the NRF (2016R1A6A3A11930270 to H.J.C.). The authors declare no conflicts of interest.	Akimoto Yoshihiro, 2005, Medical Molecular Morphology, V38, P84, DOI 10.1007/s00795-004-0264-1; Alvarez C, 1999, J CELL BIOL, V147, P1205, DOI 10.1083/jcb.147.6.1205; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Barlowe CK, 2013, GENETICS, V193, P383, DOI 10.1534/genetics.112.142810; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Budnik A, 2009, FEBS LETT, V583, P3796, DOI 10.1016/j.febslet.2009.10.038; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Campsteijn C, 2016, CURR OPIN CELL BIOL, V41, P1, DOI 10.1016/j.ceb.2016.03.008; Carrillo LD, 2011, J BIOL CHEM, V286, P6650, DOI 10.1074/jbc.M110.191627; Cha MY, 2015, HUM MOL GENET, V24, P6492, DOI 10.1093/hmg/ddv358; Cho HJ, 2014, EMBO J, V33, P2314, DOI 10.15252/embj.201487807; Cole RN, 1999, J NEUROCHEM, V73, P418, DOI 10.1046/j.1471-4159.1999.0730418.x; Dudognon P, 2004, FEBS LETT, V561, P44, DOI 10.1016/S0014-5793(04)00109-7; Foerster S, 2014, BBA-MOL BASIS DIS, V1842, P1333, DOI 10.1016/j.bbadis.2014.05.014; Freeze HH, 2013, J BIOL CHEM, V288, P6936, DOI 10.1074/jbc.R112.429274; Fulop N, 2007, AM J PHYSIOL-CELL PH, V292, pC1370, DOI 10.1152/ajpcell.00422.2006; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Goulabchand R, 2014, AUTOIMMUN REV, V13, P742, DOI 10.1016/j.autrev.2014.02.005; Groves JA, 2013, CELL STRESS CHAPERON, V18, P535, DOI 10.1007/s12192-013-0426-y; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Helm JR, 2014, J BIOL CHEM, V289, P23609, DOI 10.1074/jbc.M114.561829; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Katoh K, 2003, J BIOL CHEM, V278, P39104, DOI 10.1074/jbc.M301604200; Kolarova M., 2012, INT J ALZHEIMERS DIS, V2012, P13; Koreishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054382; la Cour JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075309; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Levine CG, 2005, MOL BIOL CELL, V16, P279, DOI 10.1091/mbc.E04-06-0508; Lewis BA, 2013, BBA-GENE REGUL MECH, V1829, P1202, DOI 10.1016/j.bbagrm.2013.09.003; Li JJ, 2010, METHODS MOL BIOL, V600, P1, DOI 10.1007/978-1-60761-454-8_1; Lodish H, 2000, OVERVIEW SECRETORY P; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Maki M, 2011, SCI CHINA LIFE SCI, V54, P770, DOI 10.1007/s11427-011-4204-8; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Martinez MR, 2017, BIOCHEM SOC T, V45, P237, DOI 10.1042/BST20160153; Miller EA, 2013, CURR OPIN CELL BIOL, V25, P420, DOI 10.1016/j.ceb.2013.04.005; MOULLIER P, 1986, EUR J BIOCHEM, V161, P197, DOI 10.1111/j.1432-1033.1986.tb10142.x; Nagel AK, 2014, AMINO ACIDS, V46, P2305, DOI 10.1007/s00726-014-1827-7; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pathak S, 2015, NAT STRUCT MOL BIOL, V22, P744, DOI 10.1038/nsmb.3063; PERSECHINI A, 1989, TRENDS NEUROSCI, V12, P462, DOI 10.1016/0166-2236(89)90097-0; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; Sadoul R, 2006, BIOL CELL, V98, P69, DOI 10.1042/BC20050007; Salama NR, 1997, MOL BIOL CELL, V8, P205, DOI 10.1091/mbc.8.2.205; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Shibata H, 2015, J BIOL CHEM, V290, P4981, DOI 10.1074/jbc.M114.592089; Skorobogatko Y, 2014, J BIOL CHEM, V289, P3602, DOI 10.1074/jbc.M113.512814; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Sollner TH, 1996, EXPERIENTIA, V52, P1021; Stankewich MC, 2006, J CELL SCI, V119, P958, DOI 10.1242/jcs.02751; Szul T, 2011, PHYSIOLOGY, V26, P348, DOI 10.1152/physiol.00017.2011; Tan EP, 2013, J BIOL CHEM, V288, P27085, DOI 10.1074/jbc.M113.470187; Tarabykina S, 2004, FRONT BIOSCI-LANDMRK, V9, P1817, DOI 10.2741/1358; Theard D, 2007, MOL BIOL CELL, V18, P2313, DOI 10.1091/mbc.E06-11-1040; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; van Noort V, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.4; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Whelan SA, 2006, METHOD ENZYMOL, V415, P113, DOI 10.1016/S0076-6879(06)15008-9; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/NCHEMBIO.797, 10.1038/nchembio.797]; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara Natasha Elizabeth, 2004, Methods Mol Biol, V284, P175; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zachara NE, 2004, CURR ORG CHEM, V8, P369, DOI 10.2174/1385272043485873; Zanetti G, 2013, ELIFE, V2, DOI 10.7554/eLife.00951; Zeuschner D, 2006, NAT CELL BIOL, V8, P377, DOI 10.1038/ncb1371; Zhu YP, 2014, J BIOL CHEM, V289, P34472, DOI 10.1074/jbc.R114.601351	77	10	10	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4641	4657		10.1096/fj.201701523R	http://dx.doi.org/10.1096/fj.201701523R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913562				2022-12-26	WOS:000443817700003
J	Qin, X; Peterson, MR; Haller, SE; Cao, L; Thomas, DP; He, GL				Qin, Xing; Peterson, Matthew R.; Haller, Samantha E.; Cao, Li; Thomas, D. Paul; He, Guanglong			Caspase recruitment domain-containing protein 9 (CARD9) knockout reduces regional ischemia/reperfusion injury through an attenuated inflammatory response	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MESENCHYMAL STROMAL CELLS; INNATE IMMUNE-RESPONSES; MYOCARDIAL-INFARCTION; OXYGEN-CONSUMPTION; IN-VITRO; NEUTROPHILS; ACTIVATION; CONTRIBUTES; DYSFUNCTION	Ischemic heart disease remains a leading cause of morbidity and mortality in the United States. Interventional reperfusion induces further damage to the ischemic myocardium through neutrophil infiltration and acute inflammation. As caspase recruitment domain-containing protein 9 (CARD9) plays a critical role in innate immune response and inflammation, we hypothesized that CARD9 knockout would provide protection against ischemia and reperfusion (I/R) injury through attenuation of acute inflammatory responses. C57BL/6 wild-type (WT) and CARD9(-/-) mice were subjected to 45 min left anterior descending (LAD) coronary artery occlusion followed by 24-h reperfusion. Area at risk (AAR) and infarct size were measured by Evans blue and triphenyltetrazolium chloride (TTC) staining. Frozen heart sections were stained with anti-mouse GR-1 antibody to detect infiltrated neutrophils. Concentrations of cytokines/chemokines TNF-alpha, IL-6, CXCL-1 and MCP-1 were determined in heart tissue homogenate and serum by ELISA assay. Western immunoblotting analyses were performed to measure the phosphorylation of p38 MAPK. Our results indicate that following I/R, infarct size was significantly smaller in CARD9(-/-) mice compared to WT. The number of infiltrated neutrophils was significantly lower in CARD9(-/-) mice compared to WT. Levels of TNF-alpha, IL-6, CXCL-1 and MCP-1 were significantly reduced in heart tissue and serum from CARD9(-/-) mice compared to WT. CARD9(-/-) mice also exhibited significantly lower levels of phosphorylated p38 MAPK. Taken together, our results suggest that CARD9 knockout protects the heart from ischemia/reperfusion (I/R) injury, possibly through reduction of neutrophil infiltration and attenuation of CARD9-associated acute inflammatory signaling.	[Qin, Xing; Peterson, Matthew R.; Haller, Samantha E.; Cao, Li; He, Guanglong] Univ Wyoming, Sch Pharm, Coll Hlth Sci, Laramie, WY 82071 USA; [Qin, Xing] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian, Shaanxi, Peoples R China; [Cao, Li] Soochow Univ, Coll Pharmaceut Sci, Suzhou, Jiangsu, Peoples R China; [Thomas, D. Paul] Univ Wyoming, Div Kinesiol & Hlth, Coll Hlth Sci, Laramie, WY 82071 USA	University of Wyoming; Air Force Military Medical University; Soochow University - China; University of Wyoming	He, GL (corresponding author), Univ Wyoming, Sch Pharm, Coll Hlth Sci, Laramie, WY 82071 USA.	ghe@uwyo.edu		He, Guanglong/0000-0003-0093-2150	National Institute for General Medical Sciences (NIGMS) Institutional Development Awards (IDeA) Networks for Biomedical Excellence (INBRE) Program [2P20GM103432]; Diabetes Action Research and Education Foundation	National Institute for General Medical Sciences (NIGMS) Institutional Development Awards (IDeA) Networks for Biomedical Excellence (INBRE) Program; Diabetes Action Research and Education Foundation	This work was supported by National Institute for General Medical Sciences (NIGMS) Institutional Development Awards (IDeA) Networks for Biomedical Excellence (INBRE) Program: 2P20GM103432, and Diabetes Action Research and Education Foundation.	Ahn J, 2012, CURR HYPERTENS REP, V14, P510, DOI 10.1007/s11906-012-0309-0; Arslan F, 2011, NAT REV CARDIOL, V8, P292, DOI 10.1038/nrcardio.2011.38; Arwood MJ, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0586-5; Cao L, 2016, J MOL CELL CARDIOL, V92, P185, DOI 10.1016/j.yjmcc.2016.02.014; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Christia P, 2013, EUR J CLIN INVEST, V43, P986, DOI 10.1111/eci.12118; Crunkhorn S, 2007, J BIOL CHEM, V282, P15439, DOI 10.1074/jbc.M611214200; Ding HS, 2013, GENE, V527, P389, DOI 10.1016/j.gene.2013.05.041; DREYER WJ, 1992, CIRC RES, V71, P1518, DOI 10.1161/01.RES.71.6.1518; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Epelman S, 2015, NAT REV IMMUNOL, V15, P117, DOI 10.1038/nri3800; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Gwechenberger M, 1999, CIRCULATION, V99, P546, DOI 10.1161/01.CIR.99.4.546; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Hout GP, 2015, EXPERT OPINION THERA, p1 ; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Ibanez B, 2015, J AM COLL CARDIOL, V65, P1455, DOI 10.1016/j.jacc.2015.02.032; Ito S, 2015, STEM CELL RES, V14, P95, DOI 10.1016/j.scr.2014.11.007; Jang HR, 2015, NAT REV NEPHROL, V11, P88, DOI 10.1038/nrneph.2014.180; Jankovic N, 2015, AM J CLIN NUTR, V102, P745, DOI 10.3945/ajcn.114.095117; Jeong YJ, 2014, IMMUNOLOGY, V143, P269, DOI 10.1111/imm.12307; Kumphune S, 2012, EUR J CLIN PHARMACOL, V68, P513, DOI 10.1007/s00228-011-1193-2; Li X, 2013, CELL PHYSIOL BIOCHEM, V32, P1857, DOI 10.1159/000356618; Li YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114205; Liang P, 2015, MYCOPATHOLOGIA, V179, P347, DOI 10.1007/s11046-015-9877-2; Manning CN, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0059-4; Neri M, 2015, CURR VASC PHARMACOL, V13, P26, DOI 10.2174/15701611113119990003; Newburger PE, 2013, SEMIN HEMATOL, V50, P198, DOI 10.1053/j.seminhematol.2013.06.010; Raj P, 2015, ANN NY ACAD SCI, V1348, P55, DOI 10.1111/nyas.12828; Roth S, 2013, TRENDS IMMUNOL, V34, P243, DOI 10.1016/j.it.2013.02.006; Schofield ZV, 2013, SHOCK, V40, P463, DOI 10.1097/SHK.0000000000000044; Seropian IM, 2014, J AM COLL CARDIOL, V63, P1593, DOI 10.1016/j.jacc.2014.01.014; Sun M, 2004, CIRCULATION, V110, P3221, DOI 10.1161/01.CIR.0000147233.10318.23; Timmers L, 2012, CARDIOVASC RES, V94, P276, DOI 10.1093/cvr/cvs018; Tyagi S, 2000, J LEUKOCYTE BIOL, V68, P679; Vilahur G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00496; Xing ZZ, 2015, WORLD J GASTROENTERO, V21, P7165, DOI 10.3748/wjg.v21.i23.7165; Xu Y, 2008, J PHARMACOL EXP THER, V327, P402, DOI 10.1124/jpet.108.142372; Zhao X, 2005, CIRCULATION, V111, P2966, DOI 10.1161/CIRCULATIONAHA.104.527226; Zhu XH, 2007, ANTIOXID REDOX SIGN, V9, P447, DOI 10.1089/ars.2006.1389	40	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199711	10.1371/journal.pone.0199711	http://dx.doi.org/10.1371/journal.pone.0199711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940016	Green Submitted, Green Published, gold			2022-12-26	WOS:000436088700037
J	Chakravarthy, SK; Jayasudha, R; Ranjith, K; Dutta, A; Pinna, NK; Mande, SS; Sharma, S; Garg, P; Murthy, SI; Shivaji, S				Chakravarthy, Sama Kalyana; Jayasudha, Rajagopalaboopathi; Ranjith, Konduri; Dutta, Anirban; Pinna, Nishal Kumar; Mande, Sharmila S.; Sharma, Savitri; Garg, Prashant; Murthy, Somasheila, I; Shivaji, Sisinthy			Alterations in the gut bacterial microbiome in fungal Keratitis patients	PLOS ONE			English	Article							INTESTINAL MICROBIOME; COMMENSAL BACTERIA; REDUCED DIVERSITY; FECAL MICROBIOTA; MUCOSAL BARRIER; RISK-FACTORS; HUMAN HEALTH; DISEASE; AGE; DIAGNOSIS	Dysbiosis in the gut microbiome has been implicated in several diseases including autoimmune diseases, inflammatory diseases, cancers and mental disorders. Keratitis is an inflammatory disease of the eye significantly contributing to corneal blindness in the developing world. It would be worthwhile to investigate the possibility of dysbiosis in the gut microbiome being associated with Keratitis. Here, we have analyzed fungal and bacterial populations in stool samples through high-throughput sequencing of the ITS2 region for fungi and V3-V4 region of 16S rRNA gene for bacteria in healthy controls (HC, n = 31) and patients with fungal keratitis (FK, n = 32). Candida albicans (2 OTUs), Aspergillus (1 OTU) and 3 other denovo-OTUs were enriched in FK samples and an unclassified denovo-OTU was enriched in HC samples. However, the overall abundances of these ` discriminatory' OTUs were very low (< 0.001%) and not indicative of significant dysbiosis in the fungal community inhabiting the gut of FK patients. In contrast, the gut bacterial richness and diversity in FK patients was significantly decreased when compared to HC. 52 OTUs were significantly enriched in HC samples whereas only 5 OTUs in FK. The OTUs prominently enriched in HC were identified as Faecalibacterium prausnitzii, Bifidobacterium adolescentis, Lachnospira, Mitsuokella multacida, Bacteroides plebeius, Megasphaera and Lachnospiraceae. In FK samples, 5 OTUs affiliated to Bacteroides fragilis, Dorea, Treponema, Fusobacteriaceae, and Acidimicrobiales were significantly higher in abundance. The functional implications are that Faecalibacterium prausnitzii, an anti-inflammatory bacterium and Megasphaera, Mitsuokella multacida and Lachnospira are butyrate producers, which were enriched in HC patients, whereas Treponema and Bacteroides fragilis, which are pathogenic were abundant in FK patients, playing a potential pro-inflammatory role. Heatmap, PCoA plots and functional profiles further confirm the distinct patterns of gut bacterial composition in FK and HC samples. Our study demonstrates dysbiosis in the gut bacterial microbiomes of FK patients compared to HC. Further, based on inferred functions, it appears that dysbiosis in the gut of FK subjects is strongly associated with the disease phenotype with decrease in abundance of beneficial bacteria and increase in abundance of pro-inflammatory and pathogenic bacteria.	[Chakravarthy, Sama Kalyana; Jayasudha, Rajagopalaboopathi; Ranjith, Konduri; Sharma, Savitri; Shivaji, Sisinthy] LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Jhaveri Microbiol Ctr, Kallam Anji Reddy Campus, Hyderabad, India; [Dutta, Anirban; Pinna, Nishal Kumar; Mande, Sharmila S.] Tata Consultancy Serv Ltd, TCS Res, Biosci R&D Div, Pune, Maharashtra, India; [Garg, Prashant; Murthy, Somasheila, I] LV Prasad Eye Inst, Tej Kohli Cornea Inst, Kallam Anji Reddy Campus, Hyderabad, India	L. V. Prasad Eye Institute; Tata Sons; Tata Consultancy Services Limited (TCS); L. V. Prasad Eye Institute	Shivaji, S (corresponding author), LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Jhaveri Microbiol Ctr, Kallam Anji Reddy Campus, Hyderabad, India.	shivas@lvpei.org	Garg, Prashant/AAN-6793-2020; Dutta, Anirban/B-1519-2010	Garg, Prashant/0000-0003-4989-2815; Dutta, Anirban/0000-0002-8209-026X; Sama, Kalyana Chakravarthy/0000-0002-6823-276X	Department of Biotechnology, Ministry of Science and Technology [BT/PR12057/MED/12/676/2014]	Department of Biotechnology, Ministry of Science and Technology	Funded by Department of Biotechnology, Ministry of Science and Technology Award Number: BT/PR12057/MED/12/676/2014 Recipient: Sisinthy Shivaji. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas J, 2003, CLIN INFECT DIS, V36, P580, DOI 10.1086/367657; Afra K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-264; Aly AM, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0124-2; Andriessen EMMA, 2016, EMBO MOL MED, V8, P1366, DOI 10.15252/emmm.201606531; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arrazuria R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00446; Bajaj JS, 2014, J HEPATOL, V60, P940, DOI 10.1016/j.jhep.2013.12.019; Bharathi MJ, 2007, OPHTHAL EPIDEMIOL, V14, P61, DOI 10.1080/09286580601001347; BHUTE S, 2016, FRONT MICROBIOL, V7, DOI DOI 10.3389/FRNICH.2016.00660; Buentke E, 2002, J INVEST DERMATOL, V119, P850, DOI 10.1046/j.1523-1747.2002.00132.x; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chang Marilene Rodrigues, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P37, DOI 10.1590/S0036-46652007000100007; Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28484; Chen ML, 2016, MBIO, V7, DOI 10.1128/mBio.02210-15; Cheng MF, 2001, J CLIN MICROBIOL, V39, P1608, DOI 10.1128/JCM.39.4.1608-1611.2001; CHIRAMBO MC, 1986, B WORLD HEALTH ORGAN, V64, P567; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Dandona R, 2003, BRIT J OPHTHALMOL, V87, P133, DOI 10.1136/bjo.87.2.133; DANESHMEND TK, 1988, CLIN PHARMACOKINET, V14, P13, DOI 10.2165/00003088-198814010-00002; Dasgupta S, 2014, CELL HOST MICROBE, V15, P413, DOI 10.1016/j.chom.2014.03.006; de Paiva CS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23561; Dehingia M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18563; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feng C M, 1990, Zhonghua Yan Ke Za Zhi, V26, P151; Finkel-Jimenez B, 2002, J IMMUNOL, V168, P5746, DOI 10.4049/jimmunol.168.11.5746; Flemer B, 2017, GUT, V66, P633, DOI 10.1136/gutjnl-2015-309595; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Giloteaux L, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0171-4; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Gopinathan U, 2009, INDIAN J OPHTHALMOL, V57, P273, DOI 10.4103/0301-4738.53051; Gostincar C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-549; Gupta Noopur, 2013, Indian J Community Med, V38, P198, DOI 10.4103/0970-0218.120153; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Hartmann P, 2015, ALCOHOL CLIN EXP RES, V39, P763, DOI 10.1111/acer.12704; Hopkins MJ, 2001, GUT, V48, P198, DOI 10.1136/gut.48.2.198; Horai R, 2015, IMMUNITY, V43, P343, DOI 10.1016/j.immuni.2015.07.014; Jumas-Bilak E, 2007, INT J SYST EVOL MICR, V57, P2314, DOI 10.1099/ijs.0.64883-0; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kothavade RJ, 2010, J MED MICROBIOL, V59, P873, DOI 10.1099/jmm.0.013227-0; Kotzampassi Katerina, 2014, ISRN Obes, V2014, P651895, DOI 10.1155/2014/651895; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Kugadas A, 2017, INVEST OPHTH VIS SCI, V58, P4593, DOI 10.1167/iovs.17-22119; Kugadas A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005855; Kuntal BK, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1013-x; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lederberg J., 2001, SCIENTIST, V17; Leser T, 2016, C P IPC, V2016, P108; LEWIS JA, 1995, SOIL BIOL BIOCHEM, V27, P863, DOI 10.1016/0038-0717(95)00019-B; Lewis RE, 2011, CURR OPIN INFECT DIS, V24, pS14, DOI 10.1097/01.qco.0000399603.91138.e7; Li QR, 2014, J CLIN GASTROENTEROL, V48, P513, DOI 10.1097/MCG.0000000000000035; Liang H, 2018, INVEST OPHTH VIS SCI, V59; Lima IFN, 2015, CURR OPIN GASTROEN, V31, P30, DOI 10.1097/MOG.0000000000000136; Ling ZX, 2016, SCI REP-UK, V6, DOI 10.1038/srep30673; Lopetuso LR, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-23; Lukiw WJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01544; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Maharana PK, 2016, INDIAN J OPHTHALMOL, V64, P346, DOI 10.4103/0301-4738.185592; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Marks M, 2014, T ROY SOC TROP MED H, V108, P601, DOI 10.1093/trstmh/tru128; Martin R, 2014, INFLAMM BOWEL DIS, V20, P417, DOI 10.1097/01.MIB.0000440815.76627.64; Mayer EA, 2014, J NEUROSCI, V34, P15490, DOI 10.1523/JNEUROSCI.3299-14.2014; MODJO HS, 1986, PHYTOPATHOLOGY, V76, P688, DOI 10.1094/Phyto-76-688; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Motukupally SR, 2015, INDIAN J MED MICROBI, V33, P538, DOI 10.4103/0255-0857.167331; Nagpal S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148347; Nakamura YK, 2016, INVEST OPHTH VIS SCI, V57, P3747, DOI 10.1167/iovs.16-19733; Pacheco-Sanchez M, 2006, MYCOLOGIA, V98, P180, DOI 10.3852/mycologia.98.2.180; Pervez MM, 2010, J HEALTH POPUL NUTR, V28, P305; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rautaraya B, 2011, BMC OPHTHALMOL, V11, DOI 10.1186/1471-2415-11-39; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Remely M, 2014, GENE, V537, P85, DOI 10.1016/j.gene.2013.11.081; Richards JL, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.29; Rowan S, 2018, GUT MICROBES, V9, P452, DOI 10.1080/19490976.2018.1435247; Rowan S, 2017, P NATL ACAD SCI USA, V114, pE4472, DOI 10.1073/pnas.1702302114; Sam QH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020330; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Selander C, 2009, J IMMUNOL, V182, P4208, DOI 10.4049/jimmunol.0800885; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shareck J, 2011, EUKARYOT CELL, V10, P1004, DOI 10.1128/EC.05030-11; SHELLY SA, 2013, MICROBIOME, V1, P24, DOI DOI 10.1186/2049-2618-1-24; Shimizu J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153746; Shivaji S, 2017, GUT PATHOG, V9, DOI 10.1186/s13099-017-0163-3; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Srinivasan M, 1997, BRIT J OPHTHALMOL, V81, P965, DOI 10.1136/bjo.81.11.965; St Leger AJ, 2017, IMMUNITY, V47, P148, DOI 10.1016/j.immuni.2017.06.014; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Sun J, 2016, GENES DIS, V3, P130, DOI 10.1016/j.gendis.2016.03.004; Sun J, 2014, GENES DIS, V1, P132, DOI 10.1016/j.gendis.2014.08.001; Thomas PA, 2003, EYE, V17, P852, DOI 10.1038/sj.eye.6700557; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Versalovic J, 2017, CLIN CHEM, V63, P1674, DOI 10.1373/clinchem.2016.264473; Vilgalys R., 1994, Mycologia Helvetica, V6, P73; Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Yang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep27427; Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13; Zaleski A, 2013, PRZ GASTROENTEROL, V8, P350, DOI 10.5114/pg.2013.39917; Zarate-Blades CR, 2017, GUT MICROBES, V8, P59, DOI 10.1080/19490976.2016.1273996; Zinkernagel MS, 2017, SCI REP-UK, V7, DOI 10.1038/srep40826	111	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e99640	10.1371/journal.pone.0199640	http://dx.doi.org/10.1371/journal.pone.0199640			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933394	Green Published, Green Submitted, gold			2022-12-26	WOS:000436076600039
J	Karamaoun, C; Sobac, B; Mauroy, B; Van Muylem, A; Haut, B				Karamaoun, Cyril; Sobac, Benjamin; Mauroy, Benjamin; Van Muylem, Alain; Haut, Benoit			New insights into the mechanisms controlling the bronchial mucus balance	PLOS ONE			English	Article							AIRWAY SURFACE LIQUID; HUMAN RESPIRATORY-TRACT; HUMAN NASAL CAVITY; MUCOCILIARY CLEARANCE; CYSTIC-FIBROSIS; WATER TRANSPORT; HEAT-TRANSFER; HUMAN LUNG; TRACHEAL; TEMPERATURE	In this work, we aim to analyze and compare the mechanisms controlling the volume of mucus in the bronchial region of the lungs of a healthy human adult, at rest and in usual atmospheric conditions. This analysis is based on a balance equation for the mucus in an airway, completed by a computational tool aiming at characterizing the evaporation, during respiration, of the water contained in the bronchial mucus. An idealized representation of the lungs, based on Weibel's morphometric model, is used. The results indicate that the mechanisms controlling the volume of mucus in an airway depend on the localization of the airway in the bronchial region of the lungs. In the proximal generations, the volume of mucus in an airway is mainly controlled by the evaporation of the water it contains and the replenishment, with water, of the mucus layer by epithelial cells or the submucosal glands. Nevertheless, cilia beating in this part of the bronchial region remains of fundamental importance to transport the mucus and hence to eliminate dust and pathogens trapped in it. On the other hand, in the distal generations of the bronchial region, the volume of mucus in an airway is mainly controlled by the mucociliary transport and by the absorption of liquid by the epithelium. This absorption is a consequence of the mucus displacement by the cilia along generations with an interface between the epithelium and the airway surface layer of decreasing area. The numerical results obtained are in good agreement with previously published experimental data, thus validating our approach. We also briefly discuss how our results can improve the understanding and, possibly, the treatment of pulmonary diseases.	[Karamaoun, Cyril; Sobac, Benjamin; Haut, Benoit] Univ Libre Bruxelles, TIPs Transfers Interfaces & Proc, Brussels, Belgium; [Mauroy, Benjamin] Univ Cote Azur, UMR CNRS 7351, Lab JA Dieudonne, Nice, France; [Van Muylem, Alain] Univ Libre Bruxelles, Erasme Univ Hosp, Chest Dept, Brussels, Belgium	Universite Libre de Bruxelles; UDICE-French Research Universities; Universite Cote d'Azur; Universite Libre de Bruxelles	Sobac, B (corresponding author), Univ Libre Bruxelles, TIPs Transfers Interfaces & Proc, Brussels, Belgium.	bsobac@ulb.ac.be	Sobac, Benjamin/AAH-2849-2020	Haut, Benoit/0000-0002-3021-0207; Sobac, Benjamin/0000-0003-4263-3159; Karamaoun, Cyril/0000-0002-1884-176X	European Space Agency & Belgium Science Policy - Programme de developpement d'experiences scientifiques [4000109631]; Fonds de la Recherche Scientifique - Charge de Recherche; Agence Nationale de la Recherche, Projet VirtualChest [ANR-16-CE19-0014]; Idex UCA JEDI [ANR-15-IDEX-01]; ESA; BELSPO (ESA-ESTEC-PRODEX) [4000109631]; Fonds de la Recherche Scientifique-FNRS; French National Research Agency (ANR VirtualChest) [ANR-16-CE19-0014]; French National Research Agency (Idex UCA JEDI) [ANR-15-IDEX-01]	European Space Agency & Belgium Science Policy - Programme de developpement d'experiences scientifiques; Fonds de la Recherche Scientifique - Charge de Recherche; Agence Nationale de la Recherche, Projet VirtualChest; Idex UCA JEDI; ESA(European Space Agency); BELSPO (ESA-ESTEC-PRODEX); Fonds de la Recherche Scientifique-FNRS(Fonds de la Recherche Scientifique - FNRS); French National Research Agency (ANR VirtualChest); French National Research Agency (Idex UCA JEDI)	This work was supported by European Space Agency & Belgium Science Policy - Programme de developpement d'experiences scientifiques 4000109631 - CK AV BH (http://www.belspo.be/belspo/index_fr.stm); Fonds de la Recherche Scientifique - Charge de Recherche - BS (http://www.fnrs.be/); and Agence Nationale de la Recherche, Projet VirtualChest ANR-16-CE19-0014 and Idex UCA JEDI, ANR-15-IDEX-01 BM (http://www.agence-nationale-recherche.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the financial support of ESA and BELSPO (ESA-ESTEC-PRODEX arrangement 4000109631), Fonds de la Recherche Scientifique-FNRS (Postdoctoral Researcher position of BS) and the French National Research Agency (ANR VirtualChest, ANR-16-CE19-0014 and Idex UCA JEDI, ANR-15-IDEX-01).	Asgharian B, 2001, J AEROSOL SCI, V32, P817, DOI 10.1016/S0021-8502(00)00121-X; ASMUNDSSON T, 1970, AM REV RESPIR DIS, V102, P388; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; BOUCHER RC, 1981, J APPL PHYSIOL, V50, P613, DOI 10.1152/jappl.1981.50.3.613; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Cho H-J, 2011, PLOS ONE, V6, P1, DOI [10.1371/journal, DOI 10.1371/JOURNAL]; DAVISKAS E, 1990, J APPL PHYSIOL, V69, P362, DOI 10.1152/jappl.1990.69.1.362; Elad D, 2008, RESP PHYSIOL NEUROBI, V163, P121, DOI 10.1016/j.resp.2008.05.002; Elkins M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008816.pub2; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; FOSTER WM, 1980, J APPL PHYSIOL, V48, P965, DOI 10.1152/jappl.1980.48.6.965; HANNA LM, 1986, J BIOMECH ENG-T ASME, V108, P19, DOI 10.1115/1.3138574; Harkness LM, 2015, PHARMACOL THERAPEUT, V148, P17, DOI 10.1016/j.pharmthera.2014.11.010; Herschlag G, 2013, J THEOR BIOL, V325, P42, DOI 10.1016/j.jtbi.2013.01.023; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; INGENITO EP, 1986, J APPL PHYSIOL, V61, P2252, DOI 10.1152/jappl.1986.61.6.2252; IRAVANI J, 1976, PHARMACOL THER PT B, V2, P471, DOI 10.1016/0306-039X(76)90003-9; Joo NS, 2010, J CLIN INVEST, V120, P3161, DOI 10.1172/JCI43466; Joo NS, 2006, J BIOL CHEM, V281, P7392, DOI 10.1074/jbc.M512766200; Karamaoun C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00255; KILBURN KH, 1968, AM REV RESPIR DIS, V98, P449; Kilgour E, 2004, INTENS CARE MED, V30, P1491, DOI 10.1007/s00134-004-2235-3; Kim DW, 2017, COMPUT BIOL MED, V86, P18, DOI 10.1016/j.compbiomed.2017.04.018; King M, 2006, PAEDIATR RESPIR REV, V7, pS212, DOI 10.1016/j.prrv.2006.04.199; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; Leal J, 2017, INT J PHARMACEUT, V532, P555, DOI 10.1016/j.ijpharm.2017.09.018; Makinen TM, 2009, RESP MED, V103, P456, DOI 10.1016/j.rmed.2008.09.011; Mauroy B, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00214; Mauroy B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/056006; MCFADDEN ER, 1985, J APPL PHYSIOL, V58, P564, DOI 10.1152/jappl.1985.58.2.564; MCFADDEN ER, 1992, AM REV RESPIR DIS, V146, pS8, DOI 10.1164/ajrccm/146.5_Pt_2.S8; MCFADDEN ER, 1982, J CLIN INVEST, V69, P700, DOI 10.1172/JCI110498; Mercer RR, 1992, AM REV RESPIR DIS, P145; MILLER S, 1995, THORAX, V50, P165, DOI 10.1136/thx.50.2.165; MUSSATTO DJ, 1988, AM REV RESPIR DIS, V138, P775, DOI 10.1164/ajrccm/138.4.775; Norton MM, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011921; OBYRNE PM, 1982, AM REV RESPIR DIS, V125, P281; REGNIS JA, 1994, AM J RESP CRIT CARE, V150, P66, DOI 10.1164/ajrccm.150.1.8025774; Robinson M, 1996, AM J RESP CRIT CARE, V153, P1503, DOI 10.1164/ajrccm.153.5.8630593; Sanders N, 2009, ADV DRUG DELIVER REV, V61, P115, DOI 10.1016/j.addr.2008.09.011; Scherer P, 1985, HEAT TRANSFER MED BI, P287; Smith DJ, 2008, RESP PHYSIOL NEUROBI, V163, P178, DOI 10.1016/j.resp.2008.03.006; Sobac B, 2015, J COLLOID INTERF SCI, V438, P306, DOI 10.1016/j.jcis.2014.09.036; Tawhai MH, 2004, ANN BIOMED ENG, V32, P609, DOI 10.1023/B:ABME.0000019180.03565.7e; Tawhai MH, 2004, J APPL PHYSIOL, V97, P2310, DOI 10.1152/japplphysiol.00520.2004; TSAI CL, 1990, J APPL PHYSIOL, V69, P222, DOI 10.1152/jappl.1990.69.1.222; van Ertbruggen C, 2005, J APPL PHYSIOL, V98, P970, DOI 10.1152/japplphysiol.00795.2004; Warnock L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001401.pub3; Warren NJ, 2010, ANN BIOMED ENG, V38, P3535, DOI 10.1007/s10439-010-0111-6; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3; Weibel ER, 2005, RESP PHYSIOL NEUROBI, V148, P3, DOI 10.1016/j.resp.2005.03.005; West J. B., 2011, RESP PHYSL ESSENTIAL, V9th; Widdicombe JH, 2002, J ANAT, V201, P313, DOI 10.1046/j.1469-7580.2002.00098.x; Williams R, 1996, CRIT CARE MED, V24, P1920, DOI 10.1097/00003246-199611000-00025; YAGER D, 1994, J APPL PHYSIOL, V77, P2333, DOI 10.1152/jappl.1994.77.5.2333; YEATES DB, 1975, J APPL PHYSIOL, V39, P487, DOI 10.1152/jappl.1975.39.3.487	58	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199319	10.1371/journal.pone.0199319	http://dx.doi.org/10.1371/journal.pone.0199319			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933368	Green Published, Green Submitted, gold			2022-12-26	WOS:000436076600020
J	Nacher, M; Adenis, A; Huber, F; Hallet, E; Abboud, P; Mosnier, E; Bideau, B; Marty, C; Lucarelli, A; Morel, V; Lacapere, F; Epelboin, L; Couppie, P				Nacher, Mathieu; Adenis, Antoine; Huber, Florence; Hallet, Edouard; Abboud, Philippe; Mosnier, Emilie; Bideau, Bastien; Marty, Christian; Lucarelli, Aude; Morel, Vanessa; Lacapere, Francois; Epelboin, Loic; Couppie, Pierre			Estimation of the duration between HIV seroconversion and HIV diagnosis in different population groups in French Guiana: Strategic information to reduce the proportion of undiagnosed infections	PLOS ONE			English	Article							MARONI RIVER; ATTITUDES	Background Given the great efforts put into the strategic objective of reducing the proportion of HIV-infected patients that are undiagnosed, the aim of the present study was to review the temporal trends between 1997 and 2016 for median estimates of infection duration and median CD4 count at diagnosis for the main patient origins in French Guiana. Methods CD4 cell count at HIV sero-conversion and square root of CD4 cell decline were obtained using the CD4 decline in a cohort of HIV-infected persons in the UK, fitting random effect (slope and intercept) multilevel linear regression models. Multivariate analysis used robust regression for modeling the delay between estimated HIV seroconversion and diagnosis and quantile regression for CD4 at HIV diagnosis. Results The median interval between the estimated HIV seroconversion and HIV diagnosis was 8 years for patients fromBrazil, 4.5 years for those from Haiti, 6.6 years for those from Suriname, 3.3 years for patients from Guyana, and 3.1 years for French patients. A simple robust regression model with French patients as reference group adjusting for sex and age at the time of diagnosis showed that the interval was significantly longer for Brazilian (beta = +3.7 years, P = 0.001), Surinamese (beta = +4.2 years, P<0.0001), Haitian origins (beta = +1.5 years, P = 0.049) but not for those originating from Guyana (beta = -0.03 years, P = 0.9); Men independently had a longer interval than women (beta = +3.5 years, P<0.0001). Conclusions Despite great efforts in French Guiana regarding HIV testing both in terms of diversification and intensification we still need to tailor the offer to better reach the communities in need. These results should help authorities scale up and optimize initiatives to reduce the proportion of patients who are unaware of their infection. They also raise the question of the role of stigma and discrimination as a barrier to HIV testing in small communities, and further emphasize the importance of reducing it.	[Nacher, Mathieu; Adenis, Antoine] Ctr Hosp Cayenne, Ctr Invest Clin Antilles Guyane, INSERM 1424, Cayenne, French Guiana; [Nacher, Mathieu; Huber, Florence; Hallet, Edouard; Morel, Vanessa] Ctr Hosp Cayenne, COREVIH Guyane Coordinat Lutte VIH, Cayenne, French Guiana; [Abboud, Philippe; Epelboin, Loic] Ctr Hosp Cayenne, Dept Malad Infect & Trop, Cayenne, French Guiana; [Mosnier, Emilie; Bideau, Bastien] Ctr Hosp Cayenne, Dept Ctr Delocalises Prevent & Soins, Cayenne, French Guiana; [Marty, Christian] Croix Rouge Francaise Ctr Prevent Sante, Cayenne, French Guiana; [Lucarelli, Aude] Ctr Hosp Cayenne, Hop Jour Adultes, Cayenne, French Guiana; [Lacapere, Francois] Agence Reg Sante Guyane, Cayenne, French Guiana; [Couppie, Pierre] Ctr Hosp Cayenne, Serv Dermatol Venereol, Cayenne, French Guiana		Nacher, M (corresponding author), Ctr Hosp Cayenne, Ctr Invest Clin Antilles Guyane, INSERM 1424, Cayenne, French Guiana.; Nacher, M (corresponding author), Ctr Hosp Cayenne, COREVIH Guyane Coordinat Lutte VIH, Cayenne, French Guiana.	mathieu.nacher@ch-cayenne.fr	nacher, mathieu/AAH-4796-2021; MOSNIER, Emilie/GXV-4053-2022; Adenis, Antoine/AAI-1059-2021; Epelboin, LoÃc/AAP-6477-2020	nacher, mathieu/0000-0001-9397-3204; MOSNIER, Emilie/0000-0002-6004-3323; Adenis, Antoine/0000-0003-4000-4981; Epelboin, LoÃc/0000-0002-3481-5991; Huber, Florence/0000-0002-4340-0106				Alvarez-del Arco D, 2017, AIDS, V31, P1979, DOI 10.1097/QAD.0000000000001571; [Anonymous], 2017, EPIDEMIOLOGIE MALADI; Cazein F, 2016, B EPIDEMIOL HEBD, V41-42, P745; Cazein F., 2015, B EPIDEMIOL HEBD, V9, P152; Champenois K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-200; Collomb G, 2008, HIST IDENTITES LONGI; Douine M, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4557-4; Health Protection Agency Centre for Infections, 2008, LONG AN TRAJ CD4 CEL; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; MOSNIER E, 2015, BVS, V11, P10; Nacher M, 2005, AIDS, V19, P727, DOI 10.1097/01.aids.0000166096.69811.b7; Nacher M, 2010, INT J STD AIDS, V21, P359, DOI 10.1258/ijsa.2010.009570; Nacher M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192564; Pantazis N, 2019, STAT METHODS MED RES, V28, P1979, DOI 10.1177/0962280217746437; Pantazis N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032369; Pugliese P, 2009, HIV MED, V10, P504, DOI 10.1111/j.1468-1293.2009.00719.x; Rice BD, 2012, AIDS, V26, P1961, DOI 10.1097/QAD.0b013e3283578b80; Sangare I, 2017, PUBLIC HEALTH, V151, P23, DOI 10.1016/j.puhe.2017.06.002; Sidibe M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21133; van Melle A, 2015, AIDS CARE, V27, P1112, DOI 10.1080/09540121.2015.1032203; van Melle A, 2015, AIDS CARE, V27, P160, DOI 10.1080/09540121.2014.939607; Yazdanpanah Y, 2010, ANTIVIR THER, V15, P17, DOI 10.3851/IMP1526	22	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199267	10.1371/journal.pone.0199267	http://dx.doi.org/10.1371/journal.pone.0199267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933374	gold, Green Published, Green Submitted			2022-12-26	WOS:000436076600018
J	Yuan, BY; Nishiura, H				Yuan, Baoyin; Nishiura, Hiroshi			Estimating the actual importation risk of dengue virus infection among Japanese travelers	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; CLINICAL DENGUE; SEROPREVALENCE; CHILDREN; TRANSMISSION; AGE	Background Frequent international travel facilitates the global spread of dengue fever. Japan has experienced an increasing number of imported case notifications of dengue virus (DENV) infection, mostly arising from Japanese travelers visiting South and Southeast Asian countries. This has led an autochthonous dengue outbreak in 2014 in Japan. The present study aimed to infer the risk of DENV infection among Japanese travelers to Asian countries, thereby obtaining an actual estimate of the number of DENV infections among travelers. Methodology/Principal findings For eight destination countries (Indonesia, Philippines, Thailand, India, Malaysia, Vietnam, Sri Lanka, and Singapore), we collected age-dependent seroepidemiological data. We also retrieved the number of imported cases, who were notified to the Japanese government, as well as the total number of travelers to each destination. Using a mathematical model, we estimated the force of infection in each destination country with seroepidemiological data while jointly inferring the reporting coverage of DENV infections among Japanese travelers from datasets of imported cases and travelers. Assuming that travelers had a risk of infection that was identical to that of the local population during travel, the reporting coverage of dengue appeared to range from 0.6% to 4.3%. The risk of infection per journey ranged from 0.02% to 0.44%. Conclusions/Significance We found that the actual number of imported cases of DENV infection among Japanese travelers could be more than 20 times the notified number of imported cases. This finding may be attributed to the substantial proportion of asymptomatic and under-ascertained infections.	[Yuan, Baoyin; Nishiura, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Hyg, Sapporo, Hokkaido, Japan	Hokkaido University	Nishiura, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Hyg, Sapporo, Hokkaido, Japan.	nishiurah@med.hokudai.ac.jp	Yuan, Baoyin/AAR-5171-2020; Yuan, Baoyin/GNM-5458-2022		China Scholarship Council; Japan Agency for Medical Research and Development (AMED); Japanese Society for the Promotion of Science (JSPS) KAKENHI [16KT0130, 16K15356, 17H04701]; Japan Science and Technology Agency (JST) CREST program [JPMJCR1413]; Telecommunications Advancement Foundation	China Scholarship Council(China Scholarship Council); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japanese Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency (JST) CREST program; Telecommunications Advancement Foundation(Telecommunications Advancement Foundation)	BY received financial support from China Scholarship Council. HN received funding from the Japan Agency for Medical Research and Development (AMED), Japanese Society for the Promotion of Science (JSPS) KAKENHI (grant numbers 16KT0130, 16K15356 and 17H04701), and Japan Science and Technology Agency (JST) CREST program (JPMJCR1413) and the Telecommunications Advancement Foundation.	Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112; Egger JR, 2007, EMERG INFECT DIS, V13, P924, DOI 10.3201/eid1306.070008; Fukusumi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004924; Garg S, 2017, INT J INFECT DIS, V54, P25, DOI 10.1016/j.ijid.2016.10.030; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; HITT inception analysis Vietnam, 2013, HIGH IMP TOUR TRAIN; Infectious Disease Surveillance Center (IDSC), 2004, INF AG SURV REP IASR, V25, P26; Japan Travel Bureau Tourism Research and Consulting Co, 2017, JAP OV TRAV DEST VIS; Japan Travel Bureau Tourism Research and Consulting Co, 2017, TOUR STAT; Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103/141662, 10.3201/eid2103.141662]; Low SL, 2015, AM J TROP MED HYG, V93, P40, DOI 10.4269/ajtmh.14-0671; Malaysia Convention & Exhibition Bureau, 2013, VAL BUS TOUR MAL; Market Research Division Ministry of Tourism Government of India, 2017, IND TOUR STAT 2014; Muench H., CATALYTIC MODELS EPI, P8928; Muhammad Azami Nor Azila, 2011, BMC Res Notes, V4, P216, DOI 10.1186/1756-0500-4-216; Nakajima K, 2005, INF AG SURV REP IASR, V26, P306; Nakamura N, 2012, WEST PAC SURVEILL RE, V3, P39, DOI [10.5365/wpsar.2011.2.3.002, 10.5365/WPSAR.2011.2.3.002]; National Institute of Infectious Diseases, 2015, INFECT AGENT SURVEIL, V36, P33; Nishiura H., 2006, Dengue Bulletin, V30, P51; OECD, 2014, OECD TOURISM TRENDS, DOI [10.1787/TOUR-2014-EN, DOI 10.1787/TOUR-2014-EN, 10.1787/tour-2014-en]; Prayitno A, 2016, INT J INFECT DIS, V45, P242, DOI 10.1016/j.ijid.2016.02.543; Reiter P, 2010, EUROSURVEILLANCE, V15, P11; Research & International Relations Division Sri Lanka Tourism Development Authority, 2017, ANN STAT REP 2011 MO; Rodriguez-Barraquer I, 2014, AM J EPIDEMIOL, V179, P353, DOI 10.1093/aje/kwt256; Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384; Senate Economic Planning Office Philippines, 2014, TOUR GLANC; SenGupta A Members of the Core IPS Team, 2012, INT PASSENGER SURVEY; Singapore Tourism Board, 2015, TOUR SECT PERF 2015; Statistics Indonesia, 2017, ARR INT VIS IND NAT; Suzuki T, 2017, EMERG INFECT DIS, V23, P1758, DOI 10.3201/eid2310.171132; Takasaki Tomohiko, 2011, Trop Med Health, V39, P13, DOI 10.2149/tmh.2011-S07; Tam CC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002259; Taniguchi Kiyosu, 2008, Travel Med Infect Dis, V6, P349, DOI 10.1016/j.tmaid.2008.07.001; Thai KTD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001180; Thai KTD, 2005, TROP MED INT HEALTH, V10, P379, DOI 10.1111/j.1365-3156.2005.01388.x; Alera MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004337; Tourism Authority of Thailand Immigration Bureau Thailand, 2017, TOURISM STAT; United Nations Department of Economic and Social Affairs, 2015, UN WORLD POP PROSP 2; Vector-borne Virus Laboratory. National Institute of Infectious Diseases, 2017, INF DENG VIR INF; Visit Indonesia Tourism Officer Ministry of Tourism, 2017, FOR VIS IND; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI DOI 10.1038/NRMICRO1845; WHO, 2017, DENG SEV DENG; World Health Organization, 2009, DENGUE GUIDELINES DI	44	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0198734	10.1371/journal.pone.0198734	http://dx.doi.org/10.1371/journal.pone.0198734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924819	Green Submitted, gold, Green Published			2022-12-26	WOS:000435655600033
J	Zhou, JX; Li, S; Nie, GZ; Fan, XW; Tan, JX; Li, HY; Pang, XK				Zhou, Junxue; Li, Sha; Nie, Gaozhong; Fan, Xiwei; Tan, Jinxian; Li, Huayue; Pang, Xiaoke			Developing a database for pedestrians' earthquake emergency evacuation in indoor scenarios	PLOS ONE			English	Article							SOCIAL FORCE MODEL; HIGH-INTENSITY AREAS; BUILDING DAMAGE; PUBLIC RESPONSE; EXIT CHOICE; SIMULATION; BEHAVIOR; CALIBRATION	With the booming development of evacuation simulation software, developing an extensive database in indoor scenarios for evacuation models is imperative. In this paper, we conduct a qualitative and quantitative analysis of the collected videotapes and aim to provide a complete and unitary database of pedestrians' earthquake emergency response behaviors in indoor scenarios, including human-environment interactions. Using the qualitative analysis method, we extract keyword groups and keywords that code the response modes of pedestrians and construct a general decision flowchart using chronological organization. Using the quantitative analysis method, we analyze data on the delay time, evacuation speed, evacuation route and emergency exit choices. Furthermore, we study the effect of classroom layout on emergency evacuation. The database for indoor scenarios provides reliable input parameters and allows the construction of real and effective constraints for use in software and mathematical models. The database can also be used to validate the accuracy of evacuation models.	[Zhou, Junxue; Nie, Gaozhong; Fan, Xiwei; Pang, Xiaoke] China Earthquake Adm, Inst Geol, Beijing, Peoples R China; [Zhou, Junxue; Li, Sha; Tan, Jinxian] Earthquake Adm Guangxi Zhuang Autonomous Reg, Nanning, Peoples R China; [Li, Huayue] China Earthquake Networks Ctr, Beijing, Peoples R China	China Earthquake Administration	Li, S (corresponding author), Earthquake Adm Guangxi Zhuang Autonomous Reg, Nanning, Peoples R China.	lisha4340@163.com			Director Foundation of the Institute of Geology, China Earthquake Administration [IGCEA1522]; National Natural Science Foundation of China [41601390]; Key Programs of Large and Medium-sized Urban Earthquake Disaster Scene Building [2016QJGJ14]; China Earthquake Administration Special Project Surplus Fund (High Resolution Rapid Post-Earthquake Assessment Techniques)	Director Foundation of the Institute of Geology, China Earthquake Administration; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Programs of Large and Medium-sized Urban Earthquake Disaster Scene Building; China Earthquake Administration Special Project Surplus Fund (High Resolution Rapid Post-Earthquake Assessment Techniques)	This work was jointly supported by the Director Foundation of the Institute of Geology, China Earthquake Administration (Grant No. IGCEA1522), the National Natural Science Foundation of China (Grant No. 41601390), the Key Programs of Large and Medium-sized Urban Earthquake Disaster Scene Building (Grant No. 2016QJGJ14), and the China Earthquake Administration Special Project Surplus Fund (High Resolution Rapid Post-Earthquake Assessment Techniques).	Alexander D., 1990, INT J MASS EMERGENCI, V8, P5; An JW, 2015, NAT HAZARDS, V79, P511, DOI 10.1007/s11069-015-1859-7; Bemardini G, 2016, SAFETY SCI, V86, P273, DOI 10.1016/j.ssci.2016.03.010; Bernardini G, 2016, SAFETY SCI, V82, P77, DOI 10.1016/j.ssci.2015.09.001; Bourque L.B., 1993, LOMA PRIETA CALIFORN, pB3; Chen P, 2017, J ADV TRANSPORT, DOI 10.1155/2017/5202150; Chen X, 2012, COMPUT ENVIRON URBAN, V36, P207, DOI 10.1016/j.compenvurbsys.2011.11.002; Chen Y., 2016, THESIS, P3; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; D'Orazio M, 2014, SAFETY SCI, V62, P450, DOI 10.1016/j.ssci.2013.09.014; Dirk H. A., 1991, BEHAV SCI, V10, P1; Emily L, 2015, NAT HAZARDS, V80, P249, DOI [10.1007/s11069-015-1967-4, DOI 10.1007/S11069-015-1967-4]; Fahy R.F., 2001, P 2 INT S HUMAN BEHA, P175; Goltz JD, 2011, EARTHQ SPECTRA, V27, P487, DOI 10.1193/1.3575728; Goltz JD., 1992, INT J MASS EMERGENCI, V10, P43; Gong MS, 2015, NAT HAZARDS, V77, P847, DOI 10.1007/s11069-015-1631-z; He CR, 2011, NAT HAZARDS, V57, P435, DOI 10.1007/s11069-010-9624-4; He CR, 2011, NAT HAZARDS, V57, P279, DOI 10.1007/s11069-010-9612-8; Li CY, 2017, IEEE T VIS COMPUT GR, V23, P1388, DOI 10.1109/TVCG.2017.2656958; Li MF, 2015, SAFETY SCI, V79, P243, DOI 10.1016/j.ssci.2015.06.018; Lindell M. K., 2015, DISASTERS, DOI [DOI 10.1111/DISA.12133, 10.1111/DISA.12133]; Liu MX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180992; Liu X, 2009, PHYSICA A, V388, P2717, DOI 10.1016/j.physa.2009.03.017; Lovreglio R., 2017, LEAN COMP CONSTR C P, P381, DOI [10.24928/JC3-2017/0058, DOI 10.24928/JC3-2017/0058, https://doi.org/10.24928/JC3-2017/0058]; Lovreglio R, 2016, TRANSPORT RES A-POL, V92, P59, DOI 10.1016/j.tra.2016.06.018; Lovreglio R, 2016, SIMUL MODEL PRACT TH, V66, P226, DOI 10.1016/j.simpat.2016.03.006; Lovreglio R, 2016, SAFETY SCI, V82, P421, DOI 10.1016/j.ssci.2015.10.015; Nie G.Z., 2001, QUATERNARY SCI, V21, P249; Ohta Y., 1985, INT J MASS EMERGENCI, V3, P147; Prati G, 2012, DISASTERS, V36, P439, DOI 10.1111/j.1467-7717.2011.01264.x; Purser DA, 2001, SAFETY SCI, V38, P157, DOI 10.1016/S0925-7535(00)00066-7; Rosoff H, 2011, EARTHQ SPECTRA, V27, P597, DOI 10.1193/1.3574450; Shi L, 2009, BUILD ENVIRON, V44, P1724, DOI 10.1016/j.buildenv.2008.11.008; Teknomo K, 2001, 2001 IEEE WORKSHOP ON MULTI-OBJECT TRACKING, PROCEEDINGS, P11, DOI 10.1109/MOT.2001.937976; Wang JH, 2013, RISK ANAL, V33, P1553, DOI 10.1111/j.1539-6924.2012.01923.x; Wang L., 2016, CHINESE PHYS B, V25, DOI DOI 10.1088/1674-1056/25/11/118901; Wei BY, 2013, NAT HAZARDS, V69, P441, DOI 10.1007/s11069-013-0710-2; Wu SH, 2015, NAT HAZARDS, V77, P645, DOI 10.1007/s11069-015-1613-1; Xiao ML, 2017, NAT HAZARDS, V87, P1783, DOI 10.1007/s11069-017-2849-8; Xiao ML, 2016, B EARTHQ ENG, V14, P1757, DOI 10.1007/s10518-016-9887-6; Xu C, 2013, NAT HAZARDS, V69, P1459, DOI 10.1007/s11069-013-0757-0; Xu X, 2008, PHYSICA A, V387, P5567, DOI 10.1016/j.physa.2008.05.058; Yang T., 2011, THESIS, P9; Yang XL, 2011, PHYSICA A, V390, P2375, DOI 10.1016/j.physa.2010.10.019; Zeng WL, 2017, TRANSPORT RES C-EMER, V80, P37, DOI 10.1016/j.trc.2017.04.009; Zeng WL, 2014, PROCD SOC BEHV, V138, P521, DOI 10.1016/j.sbspro.2014.07.233; Zeng WL, 2014, TRANSPORT RES C-EMER, V40, P143, DOI 10.1016/j.trc.2014.01.007; Zhang J, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/06/P06004; Zheng XL, 2009, MODERN ED TECHNOLOGY, V19, P29; 宋卫国, 2008, [自然科学进展, Progress in Natural Science], V18, P552	50	13	13	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0197964	10.1371/journal.pone.0197964	http://dx.doi.org/10.1371/journal.pone.0197964			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ8QS	29924812	gold, Green Published, Green Submitted			2022-12-26	WOS:000435655600009
J	Szarkowska, A; Gerber-Moron, O				Szarkowska, Agnieszka; Gerber-Moron, Olivia			Viewers can keep up with fast subtitles: Evidence from eye movements	PLOS ONE			English	Article							HARD-OF-HEARING; TELEVISION PROGRAMS; READING PATTERNS; CAPTION RATE; COMPREHENSION; DEAF; ENJOYMENT; VERBATIM; TRACKING; ADULTS	People watch subtitled audiovisual materials more than ever before. With the proliferation of subtitled content, we are also witnessing an increase in subtitle speeds. However, there is an ongoing controversy about what optimum subtitle speeds should be. This study looks into whether viewers can keep up with increasingly fast subtitles and whether the way people cope with subtitled content depends on their familiarity with subtitling and on their knowledge of the language of the film soundtrack. We tested 74 English, Polish and Spanish viewers watching films subtitled at different speeds (12, 16 and 20 characters per second). The films were either in Hungarian, a language unknown to the participants (Experiment 1), or in English (Experiment 2). We measured viewers' comprehension, self-reported cognitive load, scene and subtitle recognition, preferences and enjoyment. By analyzing people's eye gaze, we were able to discover that most viewers could read the subtitles as well as follow the images, coping well even with fast subtitle speeds. Slow subtitles triggered more rereading, particularly in English clips, causing more frustration and less enjoyment. Faster subtitles with unreduced text were preferred in the case of English videos, and slower subtitles with text edited down in Hungarian videos. The results provide empirical grounds for revisiting current subtitling practices to enable more efficient processing of subtitled videos for viewers.	[Szarkowska, Agnieszka] UCL, Ctr Translat Studies, London, England; [Szarkowska, Agnieszka] Univ Warsaw, Inst Appl Linguist, Warsaw, Poland; [Gerber-Moron, Olivia] Univ Autonoma Barcelona, Fac Translat & Interpreting, Dept Translat & Interpreting & East Asian Studies, Barcelona, Spain	University of London; University College London; University of Warsaw; Autonomous University of Barcelona	Szarkowska, A (corresponding author), UCL, Ctr Translat Studies, London, England.; Szarkowska, A (corresponding author), Univ Warsaw, Inst Appl Linguist, Warsaw, Poland.	a.szarkowska@uw.edu.pl	Szarkowska, Agnieszka/Q-5177-2019; Gerber-Moron, Olivia/H-2372-2015	Szarkowska, Agnieszka/0000-0002-0048-993X; Gerber-Moron, Olivia/0000-0001-6513-3662	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant [702606]; "La Caixa" Foundation [E-08-2014-1306365]; Transmedia Catalonia Research Group [SGR2005/230]; Marie Curie fellowship; La Caixa foundation	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant; "La Caixa" Foundation(La Caixa Foundation); Transmedia Catalonia Research Group; Marie Curie fellowship(European Commission); La Caixa foundation(La Caixa Foundation)	The research reported here has been supported by a grant from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant Agreement No. 702606 and from "La Caixa" Foundation (E-08-2014-1306365) and Transmedia Catalonia Research Group (SGR2005/230). Marie Curie fellowship was awarded to A. Szarkowska for a two-year project to be conducted at University College London. The funding covered employment costs and the costs related to carrying out the study, incl. participant fees. O. Gerber-Moron was awarded the scholarship from La Caixa foundation for her PhD. She is also part of the Transmedia Catalonia research group. This funding was used to pay for Olivia's 5-month stay in London at UCL to help prepare materials, carry out the tests and do the data analysis.	Baker RG, 1985, SUBTITLING TELEVISIO; Baker Robert G., 1984, HDB TELEVISION SUBTI; BBC, 2017, BBC SUBT GUID; Bisson MJ, 2014, APPL PSYCHOLINGUIST, V35, P399, DOI 10.1017/S0142716412000434; BRAVERMAN BB, 1980, AM ANN DEAF, V125, P943, DOI 10.1353/aad.2012.1118; Burnham D, 2008, J DEAF STUD DEAF EDU, V13, P391, DOI 10.1093/deafed/enn003; Cambra C, 2008, AM ANN DEAF, V153, P425; Cintas JD, 2008, AUDIOVISUAL TRANSLATION: LANGUAGE TRANSFER ON SCREEN, P1, DOI 10.1057/9780230234581; Crystal D., 2012, ENGLISH GLOBAL LANGU, DOI [10.1017/CBO9781139196970, DOI 10.1017/CBO9781139196970]; d'Ydewalle G, 1999, J PSYCHOLINGUIST RES, V28, P227, DOI 10.1023/A:1023202130625; d'Ydewalle G., 1992, EYE MOVEMENTS VISUAL, P415, DOI DOI 10.1007/978-1-4612-2852-3_25; d'Ydewalle G., 1985, EYE MOVEMENTS HUMAN, P375; d'Ydewalle G, 2003, READING NATIVE FOREI, P671; De Linde Zoe., 1999, SEMIOTICS SUBTITLING; Dwyer T, 2017, SPEAKING SUBTITLES R; DYDEWALLE G, 1991, COMMUN RES, V18, P650, DOI 10.1177/009365091018005005; dYdewalle G, 1987, EYE MOVEMENTS PHYSL, DOI DOI 10.1016/B978-0-444-70113-8.50047-3; Eurostat, 2017, FOR LANG LEARN STAT; Ghia E., 2012, SUBTITLING MATTERS N; Holmqvist K., 2011, EYE TRACKING COMPREH; Ivarsson Jan., 1998, SUBTITLING; Jensema C, 1996, AM ANN DEAF, V141, P284, DOI 10.1353/aad.2012.0377; Jensema C, 1998, AM ANN DEAF, V143, P318, DOI 10.1353/aad.2012.0073; Jensema C. J, 1999, CAPTION SPEED VIEWER; Jensema CJ, 2000, AM ANN DEAF, V145, P275, DOI 10.1353/aad.2012.0093; Jensema CJ, 2000, AM ANN DEAF, V145, P464, DOI 10.1353/aad.2012.0144; Karamitroglou F., 1998, TRANSLATION J, V2, P1; Koolstra CeesM., 1999, COMMUNICATIONS-GER, V24, P407, DOI [10.1515/comm.1999.24.4.407, DOI 10.1515/COMM.1999.24.4.407]; Koolstra CM, 2002, EUR J COMMUN, V17, P325, DOI 10.1177/0267323102017003694; Kruger J. - L, 2015, REFRACTORY, V25; Kruger JL, 2014, J EYE MOVEMENT RES, V7; Luczak K, 2017, EFFECTS LANGUAGE SOU; Luyken Georg-Michael, 1991, OVERCOMING LANGUAGE; Ferriol JLM, 2013, QUADERNS, V20, P201; Ferriol JLM, 2012, ESTUD TRAD, V2, P47, DOI 10.5209/rev_ESTR.2012.v2.38977; Matamala A, 2017, BABEL-AMSTERDAM, V63, P423, DOI 10.1075/babel.63.3.07mat; Mayberry RI, 2011, J DEAF STUD DEAF EDU, V16, P164, DOI 10.1093/deafed/enq049; Mitterer H, 2009, PLOS ONE, V4, pA146, DOI 10.1371/journal.pone.0007785; Moran Siobhan., 2009, EFFECT LINGUISTIC VA; Munoz C, 2017, SYSTEM, V67, P77, DOI 10.1016/j.system.2017.04.015; Musselman C, 2000, J Deaf Stud Deaf Educ, V5, P9, DOI 10.1093/deafed/5.1.9; Muylaert W, 1983, THEORIE METHODEN MOD, P201; Netflix, 2016, TIM TEXT STYL GUID G; Neves J., 2008, J SPECIALISED TRANSL, V10, P128; Ofcom, 2017, OFC COD TEL ACC SERV, P1; Ofcom, 2005, SUBT ISS SPEED; Orrego-Carmona David., 2015, RECEPTION NONPROFESS; Perego E, 2018, TARGET-NETH, V30, P137, DOI 10.1075/target.16083.per; Perego E, 2016, ACROSS LANG CULT, V17, P205, DOI 10.1556/084.2016.17.2.4; Perego E, 2015, PERSPECT STUD TRANSL, V23, P1, DOI 10.1080/0907676X.2014.912343; Perego E, 2010, MEDIA PSYCHOL, V13, P243, DOI 10.1080/15213269.2010.502873; Raney A.A., 2010, HDB EMOTIONS MASS ME, P180; Raney AA, 2003, LEA COMMUN SER, P61; Robson G., 2004, CLOSED CAPTIONING HD; Romero-Fresco P, 2015, RECEPTION SUBTITLES; Romero-Fresco P, 2009, VIAL-VIGO INT J APPL, V6, P109; Romero-Fresco Pablo., 2015, RECEPTION SUBTITLES, P335; Ross NM, 2013, J VISION, V13, DOI 10.1167/13.4.1; Ryan RM, 2006, MOTIV EMOTION, V30, P347, DOI 10.1007/s11031-006-9051-8; RYAN RM, 1982, J PERS SOC PSYCHOL, V43, P450, DOI 10.1037/0022-3514.43.3.450; Sandford J., 2015, 306 BBC; Schilperoord J, 2005, J DEAF STUD DEAF EDU, V10, P402, DOI 10.1093/deafed/eni038; SHROYER EH, 1980, AM ANN DEAF, V125, P916, DOI 10.1353/aad.2012.1240; Szarkowska, 2016, REPORT RESULTS ONL 1; Szarkowska A, 2018, SURE PROJECT DATASET, DOI [10.18150/repod.4469278, DOI 10.18150/REPOD.4469278]; Szarkowska A, 2016, ACROSS LANG CULT, V17, P183, DOI 10.1556/084.2016.17.2.3; Szarkowska A, 2011, AM ANN DEAF, V156, P363, DOI 10.1353/aad.2011.0039; Tamborini R, 2010, J COMMUN, V60, P758, DOI 10.1111/j.1460-2466.2010.01513.x; Tveit Jan Emil, 2004, TRANSLATING TELEVISI; Tyler MD, 2013, DEAFNESS ED INT, V11, P152, DOI [10.1179/146431509790559606, DOI 10.1179/146431509790559606]; Wang HX, 2012, J VISION, V12, DOI [10.1167/12.1.16, 10.1167/12.6.26]; Winke P, 2013, MOD LANG J, V97, P254, DOI 10.1111/j.1540-4781.2013.01432.x	72	28	28	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199331	10.1371/journal.pone.0199331	http://dx.doi.org/10.1371/journal.pone.0199331			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ7CA	29920538	Green Published, Green Submitted, gold			2022-12-26	WOS:000435541300036
J	Muller, SF; Konig, A; Doring, B; Glebe, D; Geyer, J				Mueller, Simon F.; Koenig, Alexander; Doering, Barbara; Glebe, Dieter; Geyer, Joachim			Characterisation of the hepatitis B virus cross-species transmission pattern via Na+/taurocholate co-transporting polypeptides from 11 New World and Old World primate species	PLOS ONE			English	Article							TAUROCHOLATE COTRANSPORTING POLYPEPTIDE; TUPAIA HEPATOCYTES; WOOLLY MONKEY; ENTRY; INFECTION; ACID; NTCP; RECEPTOR	The hepatic Na+/taurocholate co-transporting polypeptide (NTCP in man, Ntcp in animals) is the high-affinity receptor for the hepatitis B (HBV) and hepatitis D (HDV) viruses. Species barriers for human HBV/HDV within the order Primates were previously attributed to Ntcp sequence variations that disable virus-receptor interaction. However, only a limited number of primate Ntcps have been analysed so far. In the present study, a total of 11 Ntcps from apes, Old and New World monkeys were cloned and expressed in vitro to characterise their interaction with HBV and HDV. All Ntcps showed intact bile salt transport. Human NTCP as well as the Ntcps from the great apes chimpanzee and orangutan showed transport-competing binding of HBV derived myr-preS1-peptides. In contrast, all six Ntcps from the group of Old World monkeys were insensitive to HBV myr-preS1-peptide binding and HBV/HDV infection. This is basically predetermined by the amino acid arginine at position 158 of all studied Old World monkey Ntcps. An exchange from arginine to glycine (as present in humans and great apes) at this position (R158G) alone was sufficient to achieve full transport-competing HBV myr-preS1-peptide binding and susceptibility for HBV/HDV infection. New World monkey Ntcps showed higher sequence heterogeneity, but in two cases with 158G showed transport-competing HBV myr-preS1-peptide binding, and in one case (Saimiri sciureus) even susceptibility for HBV/HDV infection. In conclusion, amino acid position 158 of NTCP/Ntcp is sufficient to discriminate between the HBV/HDV susceptible group of humans and great apes (158G) and the non-susceptible group of Old World monkeys (158R). In the case of the phylogenetically more distant New World monkey Ntcps amino acid 158 plays a significant, but not exclusive role.	[Mueller, Simon F.; Doering, Barbara; Geyer, Joachim] Justus Liebig Univ Giessen, Inst Pharmacol & Toxicol, Biomed Res Ctr Seltersberg, Giessen, Germany; [Koenig, Alexander; Glebe, Dieter] Justus Liebig Univ Giessen, Inst Med Virol, Biomed Res Ctr Seltersberg, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Geyer, J (corresponding author), Justus Liebig Univ Giessen, Inst Pharmacol & Toxicol, Biomed Res Ctr Seltersberg, Giessen, Germany.	Joachim.M.Geyer@vetmed.uni-giessen.de	Geyer, Joachim/AAQ-4593-2021	Geyer, Joachim/0000-0003-2663-1858; Muller, Simon/0000-0002-5429-0088	Deutsche Forschungsgemeinschaft DFG [Sonderforschungsbereich SFB1021/2]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	The study was supported in part by funding from the Deutsche Forschungsgemeinschaft DFG (http://www.dfg.de), Sonderforschungsbereich SFB1021/2 "RNA viruses: RNA metabolism, host response and pathogenesis", project B08 to JG and DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Anita Neubauer, Klaus Schuh, Regina Leidolf, and Sigrun Broehl for technical help. The study was supported in part by funding from the Deutsche Forschungsgemeinschaft (DFG), Sonderforschungsbereich SFB1021/2 "RNA viruses: RNA metabolism, host response and pathogenesis", project B08 to JG and DG.	Barrera A, 2004, J VIROL, V78, P5233, DOI 10.1128/JVI.78.10.5233-5243.2004; Blank A, 2016, J HEPATOL, V65, P483, DOI 10.1016/j.jhep.2016.04.013; Bonvicino CR, 2014, WORLD J GASTROENTERO, V20, P7665, DOI 10.3748/wjg.v20.i24.7665; Burwitz BJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01953-y; Doring B, 2012, CURR TOP MEMBR, V70, P105, DOI 10.1016/B978-0-12-394316-3.00004-1; Dupinay T, 2013, HEPATOLOGY, V58, P1610, DOI 10.1002/hep.26428; Fu LR, 2017, VIROLOGY, V505, P1, DOI 10.1016/j.virol.2017.02.006; Geyer J, 2006, N-S ARCH PHARMACOL, V372, P413, DOI 10.1007/s00210-006-0043-8; Geyer J, 2007, J BIOL CHEM, V282, P19728, DOI 10.1074/jbc.M702663200; Glebe D, 2005, GASTROENTEROLOGY, V129, P234, DOI 10.1053/j.gastro.2005.03.090; Glebe D, 2013, SEMIN LIVER DIS, V33, P103, DOI 10.1055/s-0033-1345717; Konig A, 2014, J HEPATOL, V61, P867, DOI 10.1016/j.jhep.2014.05.018; Lanford RE, 1998, P NATL ACAD SCI USA, V95, P5757, DOI 10.1073/pnas.95.10.5757; Lempp FA, 2017, HEPATOLOGY, V66, P703, DOI 10.1002/hep.29112; Li WH, 2016, J HEPATOL, V64, pS32, DOI 10.1016/j.jhep.2016.02.011; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Nkongolo S, 2014, J HEPATOL, V60, P723, DOI 10.1016/j.jhep.2013.11.022; Petzinger E, 1999, HEPATOLOGY, V30, P1257, DOI 10.1002/hep.510300529; Shimura S, 2017, J HEPATOL, V66, P685, DOI 10.1016/j.jhep.2016.11.009; Souza BFDD, 2018, J HEPATOL, V68, P1114, DOI 10.1016/j.jhep.2018.01.029; Sureau C, 2016, J HEPATOL, V64, pS102, DOI 10.1016/j.jhep.2016.02.013; WHO, 2017, WHO PUBLISHES LIST B; Yan H, 2013, J VIROL, V87, P7977, DOI 10.1128/JVI.03540-12; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Zhong GC, 2013, J VIROL, V87, P7176, DOI 10.1128/JVI.03533-12; Zhou XM, 2014, NATURE, V505, P569, DOI 10.1038/nature12811	26	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199200	10.1371/journal.pone.0199200	http://dx.doi.org/10.1371/journal.pone.0199200			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912972	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600087
J	Zhong, ZJ; Tu, R; Ou, HP; Yan, GW; Dan, JM; Xiao, QC; Wang, Y; Cao, SZ; Shen, LH; Deng, JL; Zuo, ZC; Ma, XP; Zhou, ZY; Liu, HF; Yu, SM; Ren, ZH; Hu, YC; Peng, GN				Zhong, Zhijun; Tu, Rui; Ou, Hongping; Yan, Guangwen; Dan, Jiaming; Xiao, Qicheng; Wang, Ya; Cao, Suizhong; Shen, Liuhong; Deng, Junliang; Zuo, Zhicai; Ma, Xiaoping; Zhou, Ziyao; Liu, Haifeng; Yu, Shumin; Ren, Zhihua; Hu, Yanchun; Peng, Guangneng			Occurrence and genetic characterization of Giardia duodenalis and Cryptosporidium spp. from adult goats in Sichuan Province, China	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; ENTEROCYTOZOON-BIENEUSI; HEILONGJIANG PROVINCE; ASSEMBLAGE E; SHEEP; PREVALENCE; LAMBS; INDIA; DAIRY; KIDS	Giardia duodenalis and Cryptosporidium spp. are common gastrointestinal protozoa in mammals. Many studies have been conducted on the distribution of G. duodenalis and Cryptosporidium spp. genotypes in sheep and cattle. However, in China, information about molecular characterization and genetic analysis of G. duodenalis and Cryptosporidium spp. in goats is limited. In this study, 342 fecal samples from adult goats were collected from 12 farms in Sichuan Province, China. The occurrence of G. duodenalis and Cryptosporidium spp. in adult goats was 14.9% (51/342) and 4.7% (16/342), respectively. All G. duodenalis were identified as assemblage E, with two novel genotypes (assemblages E17 and E18) being detected at the beta-giardin (bg) locus. Based on three loci-beta-giardin (bg), triose phosphate isomerase (tpi), and glutamate dehydrogenase (gdh)-multilocus sequence typing revealed three novel multilocus genotypes (MLGs) of assemblage E (MLG-E1, E2, E3 (sc)). Small Subunit (SSU) rRNA-based PCR identified two Cryptosporidium species, namely C. xiaoi (11/16) and C. suis (5/16). This study is not only the first to report C. suis infection in adult goats in China but is also the first to use the MLG approach to identify G. duodenalis in adult goats.	[Zhong, Zhijun; Tu, Rui; Dan, Jiaming; Xiao, Qicheng; Wang, Ya; Cao, Suizhong; Shen, Liuhong; Deng, Junliang; Zuo, Zhicai; Ma, Xiaoping; Zhou, Ziyao; Liu, Haifeng; Yu, Shumin; Ren, Zhihua; Hu, Yanchun; Peng, Guangneng] Sichuan Agr Univ, Key Lab Anim Dis & Human Hlth Sichuan Prov, Coll Vet Med, Chengdu, Sichuan, Peoples R China; [Ou, Hongping] Chengdu Agr Coll, Chengdu, Sichuan, Peoples R China; [Yan, Guangwen] Xichang Univ, Coll Anim Sci, Xichang, Peoples R China	Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University	Zhong, ZJ; Peng, GN (corresponding author), Sichuan Agr Univ, Key Lab Anim Dis & Human Hlth Sichuan Prov, Coll Vet Med, Chengdu, Sichuan, Peoples R China.	zhongzhijun488@126.com; pgn.sicau@163.com			National Key Research and Development Program of China [2016YFD0501009]; National Natural Science Foundation of China [31272620]; Chengdu Giant Panda Breeding Research Foundation [CPF2015-4]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chengdu Giant Panda Breeding Research Foundation	This work was supported by the National Key Research and Development Program of China (2016YFD0501009); the National Natural Science Foundation of China (31272620); and the Chengdu Giant Panda Breeding Research Foundation (CPF2015-4).	Abdel-Moein KA, 2016, PARASITOL RES, V115, P3197, DOI 10.1007/s00436-016-5081-7; Al-Habsi Khalid, 2017, Vet Parasitol Reg Stud Reports, V7, P32, DOI 10.1016/j.vprsr.2016.11.006; Caccio SM, 2008, INT J PARASITOL, V38, P1523, DOI 10.1016/j.ijpara.2008.04.008; CRISTANZIANO VD, 2014, INT PARASITOL, V63, P438, DOI DOI 10.1016/J.PARINT.2013.11.004; Daniels ME, 2015, AM J TROP MED HYG, V93, P596, DOI 10.4269/ajtmh.15-0111; Fayer R, 2004, VET PARASITOL, V126, P37, DOI 10.1016/j.vetpar.2004.09.004; Feng YY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01701; Geurden T, 2008, VET PARASITOL, V155, P142, DOI 10.1016/j.vetpar.2008.05.002; Gu You-fang, 2014, Chinese Journal of Parasitology and Parasitic Diseases, V32, P401; Jafari Hedieh, 2014, Journal of Parasitic Diseases, V38, P81, DOI 10.1007/s12639-012-0199-8; Jin Y, 2017, VET PARASITOL, V247, P70, DOI 10.1016/j.vetpar.2017.09.021; Li JQ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02004; Li JQ, 2015, J EUKARYOT MICROBIOL, V62, P833, DOI 10.1111/jeu.12269; Li W, 2015, VET PARASITOL, V208, P125, DOI 10.1016/j.vetpar.2015.01.014; Lim YAL, 2013, MOL CELL PROBE, V27, P28, DOI 10.1016/j.mcp.2012.08.006; Maurya PS, 2013, TROP ANIM HEALTH PRO, V45, P941, DOI 10.1007/s11250-012-0311-1; Mi RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111164; Peng XQ, 2016, INFECT GENET EVOL, V41, P26, DOI 10.1016/j.meegid.2016.03.021; Qi M, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1828-3; Quilez J, 2008, APPL ENVIRON MICROB, V74, P6026, DOI 10.1128/AEM.00606-08; Robertson ID, 2000, INT J PARASITOL, V30, P1369, DOI 10.1016/S0020-7519(00)00134-X; Robertson LJ, 2010, VET PARASITOL, V171, P140, DOI 10.1016/j.vetpar.2010.03.014; Robertson LJ, 2009, EPIDEMIOL INFECT, V137, P913, DOI 10.1017/S0950268809002295; Ruiz A, 2008, VET PARASITOL, V154, P137, DOI 10.1016/j.vetpar.2008.03.003; Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001; Squire SA, 2017, INFECT GENET EVOL, V55, P236, DOI 10.1016/j.meegid.2017.09.025; Tzanidakis N, 2014, PARASITE, V21, DOI 10.1051/parasite/2014048; Utaaker KS, 2017, ACTA VET SCAND, V59, DOI 10.1186/s13028-017-0354-4; Wang HY, 2016, INFECT GENET EVOL, V39, P330, DOI 10.1016/j.meegid.2016.02.006; Wang RJ, 2014, EXP PARASITOL, V142, P11, DOI 10.1016/j.exppara.2014.04.001; Wang SS, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2418-8; Wang XL, 2017, PARASITOL RES, V116, P2101, DOI 10.1007/s00436-017-5509-8; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Ye JB, 2015, VET PARASITOL, V210, P235, DOI 10.1016/j.vetpar.2015.04.011; Zhang WZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001826; Zhong ZJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184913	36	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199325	10.1371/journal.pone.0199325	http://dx.doi.org/10.1371/journal.pone.0199325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912930	Green Submitted, Green Published, gold			2022-12-26	WOS:000435528600104
J	Clos, M; Sommer, T; Schneider, SL; Rose, M				Clos, Mareike; Sommer, Tobias; Schneider, Signe L.; Rose, Michael			Enhanced transformation of incidentally learned knowledge into explicit memory by dopaminergic modulation	PLOS ONE			English	Article							PARKINSONS-DISEASE; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; PREDICTION ERRORS; DORSAL STRIATUM; HUMAN BRAIN; IN-VIVO; HALOPERIDOL; REWARD; IMPLICIT	During incidental learning statistical regularities are extracted from the environment without the intention to learn. Acquired implicit memory of these regularities can affect behavior in the absence of awareness. However, conscious insight in the underlying regularities can also develop during learning. Such emergence of explicit memory is an important learning mechanism that is assumed to involve prediction errors in the striatum and to be dopamine-dependent. Here we directly tested this hypothesis by manipulating dopamine levels during incidental learning in a modified serial reaction time task (SRTT) featuring a hidden regular sequence of motor responses in a placebo-controlled between-group study. Awareness for the sequential regularity was subsequently assessed using cued generation and additionally verified using free recall. The results demonstrated that dopaminergic modulation nearly doubled the amount of explicit sequence knowledge emerged during learning in comparison to the placebo group. This strong effect clearly argues for a causal role of dopamine-dependent processing for the development of awareness for sequential regularities during learning.	[Clos, Mareike; Sommer, Tobias; Schneider, Signe L.; Rose, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Martinistr 52, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Clos, M; Rose, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Martinistr 52, Hamburg, Germany.	m.clos@uke.de; rose@uke.de	Rose, Michael/AAI-6335-2021	Sommer, Tobias/0000-0002-3504-7357	Deutsche Forschungsgemeinschaft [SFB/Transregio 169 TPB3, DFG SO 952/3-1]; Bundesministerium fur Bildung, Wissenschaft, Forschung and Technologie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung, Wissenschaft, Forschung and Technologie	This work was supported by grants from the Deutsche Forschungsgemeinschaft (www.dfg.de; SFB/Transregio 169 TPB3 to MR and DFG SO 952/3-1 to TS) and Bundesministerium fur Bildung, Wissenschaft, Forschung and Technologie (https://www.bmbf.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB/Transregio 169 and DFG SO 952/3-1) and Bundesministerium fur Bildung, Wissenschaft, Forschung and Technologie. The authors are grateful to the University of Minnesota Center for Magnetic Resonance Research for providing the image reconstruction algorithm for the simultaneous multi-slice acquisitions. The authors declare no competing financial interests.	Axmacher N, 2010, NEURON, V65, P541, DOI 10.1016/j.neuron.2010.02.006; Baars BJ, 2005, PROG BRAIN RES, V150, P45, DOI 10.1016/S0079-6123(05)50004-9; Badgaiyan RD, 2008, NEUROREPORT, V19, P409, DOI 10.1097/WNR.0b013e3282f6435f; Beigi M, 2016, NEUROPSYCHOLOGIA, V93, P53, DOI 10.1016/j.neuropsychologia.2016.09.019; Berns GS, 1997, SCIENCE, V276, P1272, DOI 10.1126/science.276.5316.1272; Bestmann S, 2015, J COGNITIVE NEUROSCI, V27, P365, DOI 10.1162/jocn_a_00706; BOND A, 1974, BRIT J MED PSYCHOL, V47, P211, DOI 10.1111/j.2044-8341.1974.tb02285.x; Brovelli A, 2008, CEREB CORTEX, V18, P1485, DOI 10.1093/cercor/bhm198; Carbon M, 2003, HUM BRAIN MAPP, V19, P197, DOI 10.1002/hbm.10115; Chen YCI, 2005, PSYCHOPHARMACOLOGY, V180, P705, DOI 10.1007/s00213-004-2034-0; Cleeremans A., 2002, IMPLICIT LEARNING CO, P1; Clos M, 2018, BIORXIV, DOI [10.1101/274159, DOI 10.1101/274159]; Clos M, 2015, NEUROPSYCHOLOGIA, V72, P1, DOI 10.1016/j.neuropsychologia.2015.04.011; Daniel R, 2012, NEUROIMAGE, V59, P3457, DOI 10.1016/j.neuroimage.2011.11.058; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Del Arco A, 2009, J NEURAL TRANSM, V116, P941, DOI 10.1007/s00702-009-0243-8; Deserno L, 2015, P NATL ACAD SCI USA, V112, P1595, DOI 10.1073/pnas.1417219112; Diederen KMJ, 2017, J NEUROSCI, V37, P1708, DOI 10.1523/JNEUROSCI.1979-16.2016; Durschmid S, 2016, CEREB CORTEX, V26, P1168, DOI 10.1093/cercor/bhu304; Dugast C, 1997, N-S ARCH PHARMACOL, V355, P716, DOI 10.1007/PL00005004; Ferenczi EA, 2016, SCIENCE, V351, DOI 10.1126/science.aac9698; FERRARO FR, 1993, BRAIN COGNITION, V21, P163, DOI 10.1006/brcg.1993.1013; Ford CP, 2014, NEUROSCIENCE, V282, P13, DOI 10.1016/j.neuroscience.2014.01.025; Frank MJ, 2006, BEHAV NEUROSCI, V120, P497, DOI 10.1037/0735-7044.120.3.497; Garris PA, 2003, NEUROSCIENCE, V118, P819, DOI 10.1016/S0306-4522(03)00005-8; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Haider H, 2007, METHODS, V42, P49, DOI 10.1016/j.ymeth.2006.12.004; Haider H, 2009, PSYCHOL RES-PSYCH FO, V73, P817, DOI 10.1007/s00426-008-0199-6; Handley R, 2013, HUM BRAIN MAPP, V34, P272, DOI 10.1002/hbm.21436; Hazeltine E, 1997, BRAIN, V120, P123, DOI 10.1093/brain/120.1.123; JACKSON GM, 1995, NEUROPSYCHOLOGIA, V33, P577, DOI 10.1016/0028-3932(95)00010-Z; Jaworski JN, 2001, EUR J PHARMACOL, V418, P201, DOI 10.1016/S0014-2999(01)00936-0; Jocham G, 2011, J NEUROSCI, V31, P1606, DOI 10.1523/JNEUROSCI.3904-10.2011; Kahnt T, 2017, J NEUROSCI, V37, P1493, DOI 10.1523/JNEUROSCI.2827-16.2016; Kapur S, 1997, PSYCHOPHARMACOLOGY, V131, P148, DOI 10.1007/s002130050277; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Lohani S, 2017, MOL PSYCHIATR, V22, P585, DOI 10.1038/mp.2016.102; Menon M, 2007, BIOL PSYCHIAT, V62, P765, DOI 10.1016/j.biopsych.2006.10.020; MOGHADDAM B, 1990, J NEUROCHEM, V54, P1755, DOI 10.1111/j.1471-4159.1990.tb01230.x; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Niva Y, 2007, ANN NY ACAD SCI, V1104, P357, DOI 10.1196/annals.1390.018; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Oei NYL, 2012, NEUROPSYCHOPHARMACOL, V37, P1729, DOI 10.1038/npp.2012.19; Pehek EA, 1999, J PHARMACOL EXP THER, V289, P14; Peigneux P, 2000, HUM BRAIN MAPP, V10, P179, DOI 10.1002/1097-0193(200008)10:4<179::AID-HBM30>3.0.CO;2-H; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Pleger B, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000164; Rose M, 2011, J NEUROSCI, V31, P13739, DOI 10.1523/JNEUROSCI.3020-11.2011; Rose M, 2010, CEREB CORTEX, V20, P2787, DOI 10.1093/cercor/bhq025; Runger D, 2008, J EXP PSYCHOL LEARN, V34, P1011, DOI 10.1037/a0012942; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schwarz A, 2004, SYNAPSE, V54, P1, DOI 10.1002/syn.20055; Schwarze U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054324; Seth AK, 2006, P NATL ACAD SCI USA, V103, P10799, DOI 10.1073/pnas.0604347103; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Sharp ME, 2016, BRAIN, V139, P355, DOI 10.1093/brain/awv347; Shi WX, 1997, J NEUROSCI, V17, P7988; van der Schaaf ME, 2014, CEREB CORTEX, V24, P633, DOI 10.1093/cercor/bhs344; Wilkinson L, 2007, BRAIN RES, V1137, P117, DOI 10.1016/j.brainres.2006.12.051; Wilkinson L, 2009, NEUROPSYCHOLOGIA, V47, P2564, DOI 10.1016/j.neuropsychologia.2009.05.003; Willingham DB, 2002, J NEUROPHYSIOL, V88, P1451, DOI 10.1152/jn.2002.88.3.1451; Wunderlich K, 2012, NEURON, V75, P418, DOI 10.1016/j.neuron.2012.03.042; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006; Youngren KD, 1999, NEUROPSYCHOPHARMACOL, V20, P403, DOI 10.1016/S0893-133X(98)00082-7	68	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199013	10.1371/journal.pone.0199013	http://dx.doi.org/10.1371/journal.pone.0199013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ5MF	29902226	Green Published, Green Submitted, gold			2022-12-26	WOS:000435424900073
J	Rodriguez, R; Crane, BT				Rodriguez, Raul; Crane, Benjamin Thomas			Effect of vibration during visual-inertial integration on human heading perception during eccentric gaze	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; SPATIAL REFERENCE FRAMES; OPTIMAL CUE COMBINATION; SUPERIOR TEMPORAL AREA; SELF-MOTION PERCEPTION; VESTIBULAR INTEGRATION; BAYESIAN INTEGRATION; VERTICAL AXIS; SIGNALS; NEURONS	Heading direction is determined from visual and inertial cues. Visual headings use retinal coordinates while inertial headings use body coordinates. Thus during eccentric gaze the same heading may be perceived differently by visual and inertial modalities. Stimulus weights depend on the relative reliability of these stimuli, but previous work suggests that the inertial heading may be given more weight than predicted. These experiments only varied the visual stimulus reliability, and it is unclear what occurs with variation in inertial reliability. Five human subjects completed a heading discrimination task using 2s of translation with a peak velocity of 16cm/s. Eye position was +/- 25 degrees left/right with visual, inertial, or combined motion. The visual motion coherence was 50%. Inertial stimuli included 6 Hz vertical vibration with 0, 0.10, 0.15, or 0.20cm amplitude. Subjects reported perceived heading relative to the midline. With an inertial heading, perception was biased 3.6 degrees towards the gaze direction. Visual headings biased perception 9.6 degrees opposite gaze. The inertial threshold without vibration was 4.8 degrees which increased significantly to 8.8 degrees with vibration but the amplitude of vibration did not influence reliability. With visual-inertial headings, empirical stimulus weights were calculated from the bias and compared with the optimal weight calculated from the threshold. In 2 subjects empirical weights were near optimal while in the remaining 3 subjects the inertial stimuli were weighted greater than optimal predictions. On average the inertial stimulus was weighted greater than predicted. These results indicate multisensory integration may not be a function of stimulus reliability when inertial stimulus reliability is varied.	[Rodriguez, Raul; Crane, Benjamin Thomas] Univ Rochester, Dept Bioengn, Rochester, NY 14611 USA; [Crane, Benjamin Thomas] Univ Rochester, Dept Otolaryngol, Rochester, NY 14611 USA; [Crane, Benjamin Thomas] Univ Rochester, Dept Neurosci, Rochester, NY 14611 USA	University of Rochester; University of Rochester; University of Rochester	Crane, BT (corresponding author), Univ Rochester, Dept Bioengn, Rochester, NY 14611 USA.; Crane, BT (corresponding author), Univ Rochester, Dept Otolaryngol, Rochester, NY 14611 USA.; Crane, BT (corresponding author), Univ Rochester, Dept Neurosci, Rochester, NY 14611 USA.	craneb@gmail.com		Crane, Benjamin/0000-0002-8327-1257; Rodriguez, Raul/0000-0001-8402-6002	NIDCD [R01 DC013580]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013580] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This was funded by NIDCD R01 DC013580.; The authors would like to thank Kyle Critelli for technical assistance as well as editing the final paper. Grant support was provided by NIDCD R01 DC013580.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; ANDERSEN RA, 1983, J NEUROSCI, V3, P532; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; BENSON AJ, 1989, AVIAT SPACE ENVIR MD, V60, P205; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; Butler JS, 2015, EXP BRAIN RES, V233, P587, DOI 10.1007/s00221-014-4136-1; Butler JS, 2011, SEEING PERCEIVING, V24, P453, DOI 10.1163/187847511X588070; Butler JS, 2010, J VISION, V10, DOI 10.1167/10.11.23; Chen XD, 2014, J NEUROPHYSIOL, V112, P353, DOI 10.1152/jn.00057.2014; Chen XD, 2013, NEURON, V80, P1310, DOI 10.1016/j.neuron.2013.09.006; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Crane BT, 2017, J NEUROPHYSIOL, V118, P1609, DOI 10.1152/jn.00037.2017; Crane BT, 2014, JARO-J ASSOC RES OTO, V15, P87, DOI 10.1007/s10162-013-0423-y; Crane BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051383; Crane BT, 2012, EXP BRAIN RES, V223, P89, DOI 10.1007/s00221-012-3243-0; Crane BT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135539; Cuturi LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056862; de Winkel KN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169676; de Winkel KN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127104; de Winkel KN, 2010, J VISION, V10, DOI 10.1167/10.12.1; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fan RH, 2015, J NEUROSCI, V35, P16303, DOI 10.1523/JNEUROSCI.2903-15.2015; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; Fetsch CR, 2007, J NEUROSCI, V27, P700, DOI 10.1523/JNEUROSCI.3553-06.2007; Fetsch CR, 2013, NAT REV NEUROSCI, V14, P429, DOI 10.1038/nrn3503; Fetsch CR, 2012, NAT NEUROSCI, V15, P146, DOI 10.1038/nn.2983; Fetsch CR, 2010, EUR J NEUROSCI, V31, P1721, DOI 10.1111/j.1460-9568.2010.07207.x; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Flores A, 2016, NEUROSCIENCE, V322, P416, DOI 10.1016/j.neuroscience.2016.02.051; Gibson JJ, 1950, PERCEPTION VISUAL WO; Goel R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136335; Grabherr L, 2008, EXP BRAIN RES, V186, P677, DOI 10.1007/s00221-008-1350-8; Gu Y, 2006, J NEUROSCI, V26, P73, DOI 10.1523/JNEUROSCI.2356-05.2006; Gu Y, 2007, NAT NEUROSCI, V10, P1038, DOI 10.1038/nn1935; Gu Y, 2010, NEURON, V66, P596, DOI 10.1016/j.neuron.2010.04.026; Guedry F. E., 1974, VESTIBULAR SYSTEM PA, VVI, P3; Hillis JM, 2004, J VISION, V4, P967, DOI 10.1167/4.12.1; ISRAEL I, 1989, J NEUROPHYSIOL, V62, P247, DOI 10.1152/jn.1989.62.1.247; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Kolster H, 2010, J NEUROSCI, V30, P9801, DOI 10.1523/JNEUROSCI.2069-10.2010; LAND MF, 1992, NATURE, V359, P318, DOI 10.1038/359318a0; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Lee B, 2011, J NEUROPHYSIOL, V105, P60, DOI 10.1152/jn.00495.2009; MacNeilage PR, 2010, J NEUROSCI, V30, P9084, DOI 10.1523/JNEUROSCI.1304-10.2010; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Melcher D, 2011, PHILOS T R SOC B, V366, P468, DOI 10.1098/rstb.2010.0277; Odegaard B, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004649; Oruc I, 2003, VISION RES, V43, P2451, DOI 10.1016/S0042-6989(03)00435-8; Perry CJ, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00037; Roditi RE, 2012, EXP BRAIN RES, V219, P369, DOI 10.1007/s00221-012-3099-3; Roditi RE, 2012, JARO-J ASSOC RES OTO, V13, P381, DOI 10.1007/s10162-012-0318-3; Rosas P, 2005, J OPT SOC AM A, V22, P801, DOI 10.1364/JOSAA.22.000801; Takahashi K, 2007, J NEUROSCI, V27, P9742, DOI 10.1523/JNEUROSCI.0817-07.2007; TELFORD L, 1995, EXP BRAIN RES, V104, P502; ter Horst AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145015; Tian JR, 2005, ANN NY ACAD SCI, V1039, P489, DOI 10.1196/annals.1325.051; Valko Y, 2012, J NEUROSCI, V32, P13537, DOI 10.1523/JNEUROSCI.2157-12.2012; Wann JP, 2000, NAT NEUROSCI, V3, P647, DOI 10.1038/76602; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; Wilkie RM, 2003, J VISION, V3, P677, DOI 10.1167/3.11.3; Wuehr M, 2016, BRAIN STIMUL, V9, P109, DOI 10.1016/j.brs.2015.08.017; Wurtz RH, 2011, PHILOS T R SOC B, V366, P492, DOI 10.1098/rstb.2010.0186; Yang LH, 2017, ELIFE, V6, DOI 10.7554/eLife.29809; Yu XF, 2018, CEREB CORTEX, V28, P612, DOI 10.1093/cercor/bhw402	65	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199097	10.1371/journal.pone.0199097	http://dx.doi.org/10.1371/journal.pone.0199097			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902253	gold, Green Published, Green Submitted			2022-12-26	WOS:000435424900087
J	Schneider, JS				Schneider, Jay S.			Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease	PLOS ONE			English	Article							NIGROSTRIATAL DOPAMINERGIC-NEURONS; GM1 GANGLIOSIDE; STRIATAL DOPAMINE; MPTP; RECOVERY; MODEL; RESTORES; PRIMATES; PROMOTES; SYSTEM	Reduced expression of GM1 and other major brain gangliosides GD1a, GD1b and GT1b have been reported in Parkinson's disease (PD) brain. Mechanisms underlying these changes are unclear but may be due to a deficit in the ganglioside biosynthetic process. The present study examined the extent to which deficits in gene expression of key biosynthetic enzymes involved in synthesis of GM1 and GD1b (B3galt4) and GD1a and GT1 b (St3gal2) exist in neuromelanin-containing neurons in the PD substantia nigra (SN). In situ hybridization histochemistry was used to examine gene expression of B3GALT4 and ST3GAL2 in neuromelanin-containing neurons in the SN in 8 normal controls (61-92 yrs.) and 7 PD subjects (77-95 yrs). There was a significant decrease in both B3GALT4 and ST3GAL2 gene expression in residual neuromelanin-containing cells in the SN of PD patients compared to age-matched neurologically normal controls. These changes appeared to be cell-type specific as abundant B3GALT4 and ST3GAL2 gene expression was observed in non-neuromelanin containing neurons located outside of the SN in the PD brain. These data show that residual neuromelanin-containing neurons in the PD SN have decreased expression of the ganglioside biosynthetic genes B3GALT4 and ST3GAL2, consistent with previous reports of decreased levels of gangliosides GM1, GD1a, GD1b and GT1b in the PD SN. These changes may increase the vulnerability of these neurons to degeneration in response to a variety of potential stressors.	[Schneider, Jay S.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University	Schneider, JS (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	jay.schneider@jefferson.edu		Schneider, Jay/0000-0002-4565-146X	Qilu Pharmaceuticals, Inc.	Qilu Pharmaceuticals, Inc.	This work was funded by a grant from Qilu Pharmaceuticals, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant from Qilu Pharmaceuticals, Inc. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SK, 2014, MOVEMENT DISORD, V29, P518, DOI 10.1002/mds.25729; Aureli M, 2016, MOL NEUROBIOL, V53, P1824, DOI 10.1007/s12035-015-9136-z; Baba M, 1998, AM J PATHOL, V152, P879; Bartels T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103727; Doria M, 2016, FREE RADICAL BIO MED, V101, P393, DOI 10.1016/j.freeradbiomed.2016.10.008; Forsayeth J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00045; Hadaczek P, 2015, EXP NEUROL, V263, P177, DOI 10.1016/j.expneurol.2014.10.010; HADJICONSTANTINOU M, 1989, BRAIN RES, V484, P297, DOI 10.1016/0006-8993(89)90373-9; HADJICONSTANTINOU M, 1988, J NEUROCHEM, V51, P1190, DOI 10.1111/j.1471-4159.1988.tb03086.x; HADJICONSTANTINOU M, 1986, NEUROPHARMACOLOGY, V25, P1075; HAKOMORI S, 1993, BIOCHEM SOC T, V21, P583, DOI 10.1042/bst0210583; HERRERO MT, 1993, NEUROSCIENCE, V56, P965, DOI 10.1016/0306-4522(93)90142-3; JAGER WAD, 1969, ARCH NEUROL-CHICAGO, V21, P615; JONSSON G, 1984, J NEUROSCI RES, V12, P459, DOI 10.1002/jnr.490120229; Ledeen RW, 2015, TRENDS BIOCHEM SCI, V40, P407, DOI 10.1016/j.tibs.2015.04.005; Ledeen RW, 2002, NEUROCHEM RES, V27, P637, DOI 10.1023/A:1020224016830; ODERFELDNOWAK B, 1984, J NEUROSCI RES, V12, P409, DOI 10.1002/jnr.490120225; Pope-Coleman A, 1998, RESTOR NEUROL NEUROS, V12, P255; Proia RL, 2004, NAT GENET, V36, P1147, DOI 10.1038/ng1104-1147; RIEKKINEN P, 1975, ARCH NEUROL-CHICAGO, V32, P25, DOI 10.1001/archneur.1975.00490430047006; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sandhoff R, 2018, PROG MOL BIOL TRANSL, V156, P1, DOI 10.1016/bs.pmbts.2018.01.002; Schengrund CL, 2015, TRENDS BIOCHEM SCI, V40, P397, DOI 10.1016/j.tibs.2015.03.007; Schneider JS, 2015, J NEUROL SCI, V356, P118, DOI 10.1016/j.jns.2015.06.028; Schneider JS, 2013, J NEUROL SCI, V324, P140, DOI 10.1016/j.jns.2012.10.024; Schneider JS, 2010, J NEUROL SCI, V292, P45, DOI 10.1016/j.jns.2010.02.009; Schneider JS, 1998, NEUROLOGY, V50, P1630, DOI 10.1212/WNL.50.6.1630; SCHNEIDER JS, 1989, EXP NEUROL, V105, P177, DOI 10.1016/0014-4886(89)90117-9; SCHNEIDER JS, 1992, SCIENCE, V256, P843, DOI 10.1126/science.1350379; SCHNEIDER JS, 1995, J NEUROSCI RES, V42, P117, DOI 10.1002/jnr.490420113; Seyfried T.N, 2018, ASN NEURO; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Sonnino S, 2013, J NEUROCHEM, V124, P432, DOI 10.1111/jnc.12088; TILSON HA, 1988, J NEUROSCI RES, V19, P88, DOI 10.1002/jnr.490190112; Tseng EE, 1998, SURGERY, V124, P298, DOI 10.1016/S0039-6060(98)70134-5; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Wei JS, 2009, AUTOPHAGY, V5, P860, DOI 10.4161/auto.8825; Wu GS, 2012, J NEUROSCI RES, V90, P1997, DOI 10.1002/jnr.23090; Yates AJ, 1998, ANN NY ACAD SCI, V845, P57, DOI 10.1111/j.1749-6632.1998.tb09662.x; Yu RK, 2004, J LIPID RES, V45, P783, DOI 10.1194/jlr.R3000020-JLR200; Zhao HY, 2018, J CHROMATOGR B, V1081, P105, DOI 10.1016/j.jchromb.2018.01.025	41	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199189	10.1371/journal.pone.0199189	http://dx.doi.org/10.1371/journal.pone.0199189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902255	Green Published, Green Submitted, gold			2022-12-26	WOS:000435424900096
J	He, TL; Jin, M; Xu, CX; Ma, ZJ; Wu, FF; Zhang, XB				He, Tianliang; Jin, Min; Xu, Chenxi; Ma, Zhongjun; Wu, Fufang; Zhang, Xiaobo			The homeostasis-maintaining metabolites from bacterial stress response to bacteriophage infection suppress tumor metastasis	ONCOGENE			English	Article							MICROBIAL NATURAL-PRODUCTS; DEEP-SEA FUNGUS; DRUG DISCOVERY; CELL-PROLIFERATION; MARINE-ENVIRONMENT; HYDROTHERMAL VENTS; BREAST-CANCER; DIVERSITY; ORIGIN; GENOME	The antiviral metabolites from bacterial stress response to bacteriophage infection can maintain homeostasis of host cells, while metabolism disorder is a remarkable characteristic of tumorigenesis. In the aspect of metabolic homeostasis, therefore, the antiviral homeostasis-maintaining metabolites of bacteria may possess anti-tumor activity. However, this issue has not been addressed. Here we show that the homeostasis-challenged maintaining metabolites from deep-sea bacteriophage-challenged thermophile can suppress tumor metastasis. The results indicated that the metabolic profiles of the bacteriophage GVE2-infected and virus-free thermophile Geobacillus sp. E263 from a deep-sea hydrothermal vent were remarkably different. Thirteen metabolites were significantly elevated and two metabolites were downregulated in thermophile stress response to GVE2 infection. As an example, the upregulated L-norleucine was characterized. The data showed that L-norleucine had antiviral activity in thermophile. Furthermore, the in vitro and in vivo assays revealed that L-norleucine, as well as its derivative, significantly suppressed metastasis of gastric and breast cancer cells. L-norleucine interacted with hnRNPA2/B1 protein to inhibit the expressions of Twist1 and Snail, two inhibitors of E-cadherin, and promote the E-cadherin expression, leading to the inhibition of tumor metastasis. Therefore, our study presented that antiviral homeostasis-maintaining metabolites of microbes might be a promising source for anti-tumor drugs.	[He, Tianliang; Jin, Min; Xu, Chenxi; Zhang, Xiaobo] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Ma, Zhongjun] Zhejiang Univ, Inst Marine Biol & Nat Prod, Dept Ocean Sci & Engn, Hangzhou 310058, Zhejiang, Peoples R China; [Wu, Fufang] Fuyang Normal Univ, Sch Chem & Mat Engn, Fuyang 236037, Peoples R China	Zhejiang University; Zhejiang University; Fuyang Normal University	Zhang, XB (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	zxb0812@zju.edu.cn		He, Tianliang/0000-0003-4437-5309; Zhang, Xiaobo/0000-0003-4606-212X	China Ocean Mineral Resources R D Association [DY135-B-04]; National Program on the Key Basic Research Project [2015CB755903]	China Ocean Mineral Resources R D Association; National Program on the Key Basic Research Project	This work was supported by China Ocean Mineral Resources R & D Association (DY135-B-04) and National Program on the Key Basic Research Project (2015CB755903).	Ankrah NYD, 2014, ISME J, V8, P1089, DOI 10.1038/ismej.2013.216; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Brana AF, 2015, MICROB ECOL, V69, P512, DOI 10.1007/s00248-014-0508-0; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Cairns R, 2006, MOL CANCER RES, V4, P61, DOI 10.1158/1541-7786.MCR-06-0002; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Ciavardelli D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.285; Ferronato MJ, 2015, J STEROID BIOCHEM, V154, P285, DOI 10.1016/j.jsbmb.2015.09.009; Geuens T, 2016, HUM GENET, V135, P851, DOI 10.1007/s00439-016-1683-5; Gulder TAM, 2009, CURR OPIN MICROBIOL, V12, P252, DOI 10.1016/j.mib.2009.05.002; Hanaford AR, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-3090; He TL, 2016, MAR BIOTECHNOL, V18, P232, DOI 10.1007/s10126-015-9683-3; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jin M, 2015, APPL MICROBIOL BIOT, V99, P8101, DOI 10.1007/s00253-015-6674-2; Jin M, 2013, MICROBIOL-SGM, V159, P1597, DOI 10.1099/mic.0.067611-0; Katt WP, 2014, DRUG DISCOV TODAY, V19, P450, DOI 10.1016/j.drudis.2013.10.008; Knight V, 2003, APPL MICROBIOL BIOT, V62, P446, DOI 10.1007/s00253-003-1381-9; Krall AS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11457; Lam KS, 2007, TRENDS MICROBIOL, V15, P279, DOI 10.1016/j.tim.2007.04.001; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Li DH, 2007, ARCH PHARM RES, V30, P1051; Li DH, 2007, J ANTIBIOT, V60, P317, DOI 10.1038/ja.2007.40; Li X, 2005, TRENDS BIOTECHNOL, V23, P539, DOI 10.1016/j.tibtech.2005.08.006; Li Y, 2009, J NAT PROD, V72, P912, DOI 10.1021/np900116m; Liu B, 2006, CURR MICROBIOL, V53, P163, DOI 10.1007/s00284-005-0509-9; Loh TJ, 2015, ONCOL REP, V34, P1231, DOI 10.3892/or.2015.4110; Majeed R, 2012, J CANC SCI THER, V4; Martin W, 2008, NAT REV MICROBIOL, V6, P805, DOI 10.1038/nrmicro1991; Nastrucci C, 2012, RECENT PAT ANTI-CANC, V7, P218, DOI 10.2174/157489212799972963; NISHIO M, 1990, J GEN VIROL, V71, P61, DOI 10.1099/0022-1317-71-1-61; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pelaez F, 2006, BIOCHEM PHARMACOL, V71, P981, DOI 10.1016/j.bcp.2005.10.010; Pettit RK, 2011, MICROB BIOTECHNOL, V4, P471, DOI 10.1111/j.1751-7915.2010.00196.x; Qu XH, 2015, ONCOL LETT, V10, P1677, DOI 10.3892/ol.2015.3457; Remes C, 2012, BIOORG CHEM, V41-42, P6, DOI 10.1016/j.bioorg.2011.12.003; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Salomon CE, 2004, NAT PROD REP, V21, P105, DOI 10.1039/b301384g; Sana Theodore R, 2008, J Biomol Tech, V19, P258; Sanchez EL, 2015, VIROLOGY, V479, P609, DOI 10.1016/j.virol.2015.02.038; Shi F, 2018, ONCOTARGET, V9, P706, DOI 10.18632/oncotarget.23091; Simmons TL, 2008, P NATL ACAD SCI USA, V105, P4587, DOI 10.1073/pnas.0709851105; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tauler J, 2010, CANCER RES, V70, P7137, DOI 10.1158/0008-5472.CAN-10-0860; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wei DH, 2010, J VIROL, V84, P2365, DOI 10.1128/JVI.02182-09; Weitz Joshua S, 2012, F1000 Biol Rep, V4, P17; Xiong ZQ, 2013, MAR DRUGS, V11, P700, DOI 10.3390/md11030700; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	49	4	4	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 25	2018	37	43					5766	5779		10.1038/s41388-018-0376-z	http://dx.doi.org/10.1038/s41388-018-0376-z			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GY1KL	29925861				2022-12-26	WOS:000448288200005
J	Carion, TW; Greenwood, M; Ebrahim, AS; Jerome, A; Suvas, S; Gronert, K; Berger, EA				Carion, Thomas W.; Greenwood, Matthew; Ebrahim, Abdul Shukkur; Jerome, Andrew; Suvas, Susmit; Gronert, Karsten; Berger, Elizabeth A.			Immunoregulatory role of 15-lipoxygenase in the pathogenesis of bacterial keratitis	FASEB JOURNAL			English	Article						lipid mediators; resolution; ocular infection; inflammation	LIPID MEDIATORS; ANTIINFLAMMATORY CYTOKINES; INFLAMMATION; RESOLUTION; RECEPTOR; CIRCUITS; EYE; MECHANISMS; RESOLVINS; APOPTOSIS	Although autacoids primarily derived from the cyclooxygenase-2 and 5-lipoxygenase (LOX) pathways are essential mediators of inflammation, endogenous specialized proresolving mediators (SPMs) act as robust agonists of resolution. SPM biosynthesis is initiated by the conversion of arachidonic acid, eicosapentaenoic acid, and docosahexaenoic acid primarily via the 12/15-LOX pathway. Although 12/15-LOX activity is prominent in the cornea, the role of SPM pathway activation during infection remains largely unknown and is the focus of the current study. Pseudomonas keratitis was induced in resistant BALB/c and susceptible C57BL/6 (B6) mice. Biosynthetic pathways for proinflammatory autacoids and SPMs were assessed. Divergent lipid mediator profiles demonstrate the importance of 15-LOX pathways in the pathogenesis of ocular infectious disease. Results indicate that an imbalance of LOX enzymatic pathways contributes to susceptibility observed in B6 mice where deficient activation of SPM circuits, as indicated by reduced 15-hydroxy-eicosatetraenoic acid and 17-hydroxydocosahexaenoic acid levels, prevented transition toward resolution and led to chronic inflammation. In sharp contrast, BALB/c mice demonstrated a well-balanced axis of 5-LOX/12-LOX/15-LOX pathways, resulting in sufficient proresolving bioactive metabolite formation and immune homeostasis. Furthermore, a novel immunoregulatory role for 15-LOX was revealed in inflammatory cells (polymorphonuclear leukocytes and macrophages), which influenced phagocytic activity. These data provide evidence that SPM circuits are essential for host defense during bacterial keratitis.Carion, T. W., Greenwood, M., Ebrahim, A. S., Jerome, A., Suvas, S., Gronert, K., Berger, E. A. Immunoregulatory role of 15-lipoxygenase in the pathogenesis of bacterial keratitis.	[Carion, Thomas W.; Ebrahim, Abdul Shukkur; Jerome, Andrew; Suvas, Susmit; Berger, Elizabeth A.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield Ave,8263 Scott Hall, Detroit, MI 48201 USA; [Suvas, Susmit] Wayne State Univ, Sch Med, Dept Immunol & Microbiol, Detroit, MI 48201 USA; [Greenwood, Matthew; Gronert, Karsten] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Suvas, Susmit; Berger, Elizabeth A.] Kresge Eye Inst, Dept Ophthalmol, Detroit, MI USA	Wayne State University; Wayne State University; University of California System; University of California Berkeley	Berger, EA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield Ave,8263 Scott Hall, Detroit, MI 48201 USA.	eberger@med.wayne.edu	Berger, Elizabeth/W-6893-2019	Greenwood, Matthew/0000-0003-1471-7945; Jerome, Andrew/0000-0002-6748-8114	U.S. National Institutes of Health, National Eye Institute [R01 EY023226, P30EY004068, R01 EY026082]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY022417, R01EY023226, R01EY026082, P30EY004068] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by U.S. National Institutes of Health, National Eye Institute Grants R01 EY023226 (to E.A.B.), P30EY004068 (Core Grant), and R01 EY026082 (to K.G.), and by Research to Prevent Blindness. The authors declare no conflicts of interest.	Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Berger EA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003457; Berger EA, 2012, INVEST OPHTH VIS SCI, V53, P7432, DOI 10.1167/iovs.12-9894; Biteman B, 2007, FASEB J, V21, P2257, DOI 10.1096/fj.06-7918com; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Carion TW, 2015, INVEST OPHTH VIS SCI, V56, P6932, DOI 10.1167/iovs.15-17315; CHEN XS, 1994, J BIOL CHEM, V269, P13979; Chiang N, 2017, J IMMUNOL, V198, P842, DOI 10.4049/jimmunol.1601650; Chiang N, 2013, J IMMUNOL, V190, P6378, DOI 10.4049/jimmunol.1202969; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; COLOTTA F, 1992, BLOOD, V80, P2012; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Fredman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024422; Gao Y, 2015, J IMMUNOL, V195, P3086, DOI 10.4049/jimmunol.1500610; Gorham JD, 1996, P NATL ACAD SCI USA, V93, P12467, DOI 10.1073/pnas.93.22.12467; Gronert K, 2005, PROSTAG LEUKOTR ESS, V73, P221, DOI 10.1016/j.plefa.2005.05.009; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Hazlett LD, 2004, PROG RETIN EYE RES, V23, P1, DOI 10.1016/j.preteyeres.2003.10.002; HAZLETT LD, 1987, INVEST OPHTH VIS SCI, V28, P1978; Henriksson JT, 2009, INVEST OPHTH VIS SCI, V50, P3648, DOI 10.1167/iovs.08-2941; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Huang X, 2003, INVEST OPHTH VIS SCI, V44, P3409, DOI 10.1167/iovs.03-0162; Jhanji V, 2007, J CATARACT REFR SURG, V33, P1488, DOI 10.1016/j.jcrs.2007.04.015; Kenchegowda S, 2010, J LIPID RES, V51, P879, DOI 10.1194/jlr.R001347; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; Leedom AJ, 2010, AM J PATHOL, V176, P74, DOI 10.2353/ajpath.2010.090678; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Li HF, 1997, CURR EYE RES, V16, P214, DOI 10.1076/ceyr.16.3.214.15412; Li N, 2010, J OCUL PHARMACOL TH, V26, P431, DOI 10.1089/jop.2010.0019; Liclican EL, 2010, THESCIENTIFICWORLDJO, V10, P1029, DOI 10.1100/tsw.2010.99; LOTTI R, 1992, EYE, V6, P400, DOI 10.1038/eye.1992.82; Luo Yi, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0320s22; McClellan SA, 2003, J IMMUNOL, V170, P5219, DOI 10.4049/jimmunol.170.10.5219; Park SH, 2009, CORNEA, V28, P68, DOI 10.1097/ICO.0b013e318182259b; Rattanatam T, 2001, CORNEA, V20, P290, DOI 10.1097/00003226-200104000-00010; ROUX KH, 1995, PCR METH APPL, V4, pS185; Rudner XL, 2000, J IMMUNOL, V164, P6576, DOI 10.4049/jimmunol.164.12.6576; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2018, MOL ASPECTS MED, V64, P1, DOI 10.1016/j.mam.2017.08.002; Serhan CN, 2004, HISTOCHEM CELL BIOL, V122, P305, DOI 10.1007/s00418-004-0695-8; Serhan CN, 2003, J IMMUNOL, V171, P6856, DOI 10.4049/jimmunol.171.12.6856; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Szliter EA, 2007, J IMMUNOL, V178, P1105, DOI 10.4049/jimmunol.178.2.1105; Tanaka N, 2018, CIRC J, V82, P596, DOI 10.1253/circj.CJ-17-0294; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wang SB, 2012, FASEB J, V26, P1506, DOI 10.1096/fj.11-198036; Wei J, 2017, MOL ASPECTS MED, V58, P37, DOI 10.1016/j.mam.2017.03.006; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhou Z, 2008, INVEST OPHTH VIS SCI, V49, P4458, DOI 10.1167/iovs.08-1906	51	12	12	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5026	5038		10.1096/fj.201701502R	http://dx.doi.org/10.1096/fj.201701502R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913556	Bronze, Green Published			2022-12-26	WOS:000443817700033
J	Melkova, K; Zapletal, V; Jansen, S; Nomilner, E; Zachrdla, M; Hritz, J; Novacek, J; Zweckstetter, M; Jensen, MR; Blackledge, M; Zidek, L				Melkova, Katerina; Zapletal, Vojtech; Jansen, Severine; Nomilner, Erik; Zachrdla, Milan; Hritz, Jozef; Novacek, Jiri; Zweckstetter, Markus; Jensen, Malene R.; Blackledge, Martin; Zidek, Lukas			Functionally specific binding regions of microtubule-associated protein 2c exhibit distinct conformations and dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY DISORDERED PROTEINS; RESIDUAL DIPOLAR COUPLINGS; DENSITY-FUNCTION-ANALYSIS; BACKBONE DYNAMICS; ALPHA-SYNUCLEIN; PROLINE-RICH; NMR ANALYSIS; PHOSPHORYLATION; TAU; DOMAIN	Microtubule-associated protein 2c (MAP2c) is a 49-kDa intrinsically disordered protein regulating the dynamics of microtubules in developing neurons. MAP2c differs from its sequence homologue Tau in the pattern and kinetics of phosphorylation by cAMP-dependent protein kinase (PKA). Moreover, the mechanisms through which MAP2c interacts with its binding partners and the conformational changes and dynamics associated with these interactions remain unclear. Here, we used NMR relaxation and paramagnetic relaxation enhancement techniques to determine the dynamics and long-range interactions within MAP2c. The relaxation rates revealed large differences in flexibility of individual regions of MAP2c, with the lowest flexibility observed in the known and proposed binding sites. Quantitative conformational analyses of chemical shifts, small-angle X-ray scattering (SAXS), and paramagnetic relaxation enhancement measurements disclosed that MAP2c regions interacting with important protein partners, including Fyn tyrosine kinase, plectin, and PKA, adopt specific conformations. High populations of polyproline II and alpha-helices were found in Fyn- and plectin-binding sites of MAP2c, respectively. The region binding the regulatory subunit of PKA consists of two helical motifs bridged by a more extended conformation. Of note, although MAP2c and Tau did not differ substantially in their conformations in regions of high sequence identity, we found that they differ significantly in long-range interactions, dynamics, and local conformation motifs in their N-terminal domains. These results highlight that the N-terminal regions of MAP2c provide important specificity to its regulatory roles and indicate a close relationship between MAP2c's biological functions and conformational behavior.	[Melkova, Katerina; Zapletal, Vojtech; Jansen, Severine; Nomilner, Erik; Zachrdla, Milan; Hritz, Jozef; Novacek, Jiri; Zidek, Lukas] Masaryk Univ, Cent European Inst Technol, Kamenice 5, Brno 62500, Czech Republic; [Melkova, Katerina; Zapletal, Vojtech; Jansen, Severine; Nomilner, Erik; Zachrdla, Milan; Zidek, Lukas] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, Kamenice 5, Brno 62500, Czech Republic; [Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Fassberg 11, D-37077 Gottingen, Germany; [Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, Von Siebold Str 3a, D-37075 Gottingen, Germany; [Jensen, Malene R.; Blackledge, Martin] Univ Grenoble Alps, CNRS, CEA, F-38000 Grenoble, France; [Zachrdla, Milan] Ecole Normale Super, Dept Chim, 24 Rue Lhomond, F-75005 Paris, France	Masaryk University Brno; Masaryk University Brno; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); CEA; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Zidek, L (corresponding author), Masaryk Univ, Kamenice 5, CZ-62500 Brno, Czech Republic.	lzidek@chemi.muni.cz	Jansen, Severine/Q-6364-2019; Novacek, Jiri/AAQ-4739-2021; Zidek, Lukas/D-7112-2012; Hritz, Jozef/J-6887-2015; Novacek, Jiri/D-8551-2012; Zidek, Lukas/AAB-6109-2020	Novacek, Jiri/0000-0003-4013-3898; Zidek, Lukas/0000-0002-8013-0336; Hritz, Jozef/0000-0002-4512-9241; Novacek, Jiri/0000-0003-4013-3898; Zidek, Lukas/0000-0002-8013-0336	FRISBI [ANR-10-INSB-05-02]; GRAL [ANR-10-LABX- 49-01]; Ministry of Education, Youth, and Sports of the Czech Republic (MEYS CR) [LM2015043]; CESNET [LM2015042]; CERIT Scientific Cloud by MEYS CR [LM2015085]; IT4Innovations National Supercomputing Center [LM2015070]; MEYS CR	FRISBI; GRAL; Ministry of Education, Youth, and Sports of the Czech Republic (MEYS CR); CESNET; CERIT Scientific Cloud by MEYS CR; IT4Innovations National Supercomputing Center; MEYS CR	This work used the platforms of the Grenoble Instruct Center (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX- 49-01) within the Grenoble Partnership for Structural Biology (PSB). The CIISB research infrastructure project LM2015043 funded by the Ministry of Education, Youth, and Sports of the Czech Republic (MEYS CR) is gratefully acknowledged for the partial financial support of the measurements at the Josef Dadok National NMR Centre and Proteomics Core Facilities, CEITEC-Masaryk University. Computational resources were provided by CESNET (LM2015042) and the CERIT Scientific Cloud (LM2015085) under the program "Projects of Large Research, Development, and Innovations Infrastructures" funded by MEYS CR, and by the IT4Innovations National Supercomputing Center (LM2015070) under the program "Large Infrastructures for Research, Experimental Development, and Innovations" funded by MEYS CR. We thank G. Wiche for providing plasmids for protein expression, and M. Z. thanks E. Mandelkow and J. Biernat for useful discussions.	Abragam A., 1961, PRINCIPLES NUCLEAR M, P264; Ackmann M, 2000, J BIOL CHEM, V275, P30335, DOI 10.1074/jbc.M002590200; Alexa A, 2002, BIOCHEMISTRY-US, V41, P12427, DOI 10.1021/bi025916s; Barthe P, 1999, J BIOMOL NMR, V15, P271, DOI 10.1023/A:1008336418418; Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102; Bernado P, 2009, BIOPHYS J, V97, P2839, DOI 10.1016/j.bpj.2009.08.044; Bibow S, 2011, ANGEW CHEM INT EDIT, V50, P11520, DOI 10.1002/anie.201105493; BRANDT R, 1994, J BIOL CHEM, V269, P11776; BRUGG B, 1991, J CELL BIOL, V114, P735, DOI 10.1083/jcb.114.4.735; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P333, DOI 10.1016/B978-012164491-8/50007-5; Dehmelt L, 2005, GENOME BIOL, V6; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eyal E, 2004, J COMPUT CHEM, V25, P712, DOI 10.1002/jcc.10420; Ferrage F, 2012, METHODS MOL BIOL, V831, P141, DOI 10.1007/978-1-61779-480-3_9; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Gamblin TC, 1996, BIOCHEMISTRY-US, V35, P12576, DOI 10.1021/bi961135d; Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954; Gotz F, 2016, BIOCHEM J, V473, P1881, DOI 10.1042/BCJ20160242; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; Guo Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030163; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; ISHIMA R, 1995, BIOCHEMISTRY-US, V34, P3162, DOI 10.1021/bi00010a005; ISHIMA R, 1995, J MAGN RESON SER B, V108, P73, DOI 10.1006/jmrb.1995.1104; Jalava NS, 2007, INT J DEV NEUROSCI, V25, P121, DOI 10.1016/j.ijdevneu.2006.12.001; Jansen S, 2017, J BIOL CHEM, V292, P6715, DOI 10.1074/jbc.M116.771097; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Kaderavek P, 2014, J BIOMOL NMR, V58, P193, DOI 10.1007/s10858-014-9816-4; Kaneko T, 2008, FRONT BIOSCI-LANDMRK, V13, P4938, DOI 10.2741/3053; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; Kazimierczuk K, 2008, J MAGN RESON, V192, P123, DOI 10.1016/j.jmr.2008.02.003; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kowalewski A., 2006, NUCL SPIN RELAXATION, P127; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; Krizova H, 2004, J BIOMOL NMR, V28, P369, DOI 10.1023/B:JNMR.0000015404.61574.65; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Laurine E, 2003, J BIOL CHEM, V278, P29979, DOI 10.1074/jbc.M303242200; Lefevre JF, 1996, BIOCHEMISTRY-US, V35, P2674, DOI 10.1021/bi9526802; Liu F, 2005, J BIOL CHEM, V280, P1790, DOI 10.1074/jbc.M410775200; Malmendal A, 2003, BIOCHEM BIOPH RES CO, V301, P136, DOI 10.1016/S0006-291X(02)02989-3; Marsh JA, 2008, J AM CHEM SOC, V130, P7804, DOI 10.1021/ja802220c; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Medina MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019420; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Nodet G, 2009, J AM CHEM SOC, V131, P17908, DOI 10.1021/ja9069024; Novacek J, 2014, J MAGN RESON, V241, P41, DOI 10.1016/j.jmr.2013.12.008; Novacek J, 2013, J BIOMOL NMR, V56, P291, DOI 10.1007/s10858-013-9761-7; OBAR RA, 1989, NEURON, V3, P639, DOI 10.1016/0896-6273(89)90274-2; Ortega E, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.197467; Ozenne V, 2012, J AM CHEM SOC, V134, P15138, DOI 10.1021/ja306905s; Ozenne V, 2012, BIOINFORMATICS, V28, P1463, DOI 10.1093/bioinformatics/bts172; Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573; Redfield A., 1965, ADV MAGN RESON, V1, P1, DOI [10.1016/B978-1-4832-3114-3.50007-6, DOI 10.1016/B978-1-4832-3114-3.50007-6]; Reynolds JG, 2008, J BIOL CHEM, V283, P8070, DOI 10.1074/jbc.C700221200; Salmon L, 2010, J AM CHEM SOC, V132, P8407, DOI 10.1021/ja101645g; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Schwalbe M, 2014, STRUCTURE, V22, P238, DOI 10.1016/j.str.2013.10.020; Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6; Sibille N, 2012, PROTEINS, V80, P454, DOI 10.1002/prot.23210; Srb P, 2017, J BIOMOL NMR, V69, P133, DOI 10.1007/s10858-017-0138-1; Sundermann F, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2590-9; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tie L, 2008, J PROTEOME RES, V7, P1704, DOI 10.1021/pr700711s; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Valencia RG, 2013, MOL BIOL CELL, V24, P768, DOI 10.1091/mbc.E12-06-0488; VIERECK C, 1989, J NEUROSCI, V9, P3547; Vullo A, 2006, NUCLEIC ACIDS RES, V34, pW164, DOI 10.1093/nar/gkl166; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; WANGSNESS RK, 1953, PHYS REV, V89, P728, DOI 10.1103/PhysRev.89.728; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; WILLE H, 1992, J BIOL CHEM, V267, P10737; Xie C, 2015, J NEUROCHEM, V135, P19, DOI 10.1111/jnc.13228; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zamora-Leon SP, 2005, J BIOL CHEM, V280, P1962, DOI 10.1074/jbc.M411380200; Zamora-Leon SP, 2001, J BIOL CHEM, V276, P39950, DOI 10.1074/jbc.M107807200	85	9	9	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13297	13309		10.1074/jbc.RA118.001769	http://dx.doi.org/10.1074/jbc.RA118.001769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29925592	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000442730200027
J	Chan, EC; Ren, CG; Xie, ZH; Jude, J; Barker, T; Koziol-White, CA; Ma, M; Panettieri, RA; Wu, DQ; Rosenberg, HF; Druey, KM				Chan, Eunice C.; Ren, Chunguang; Xie, Zhihui; Jude, Joseph; Barker, Tolga; Koziol-White, Cynthia A.; Ma, Michelle; Panettieri, Reynold A.; Wu, Dianqing; Rosenberg, Helene F.; Druey, Kirk M.			Regulator of G protein signaling 5 restricts neutrophil chemotaxis and trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						regulator of G protein signaling; RGS; chemotaxis; neutrophil; inflammation; trafficking; GPCR; G protein-coupled receptor; leukocyte; innate immunity	RGS PROTEINS; TRANSENDOTHELIAL MIGRATION; ISCHEMIA-REPERFUSION; INFLAMMATION; ACTIVATION; ATHEROSCLEROSIS; EOSINOPHILS; INFECTION; TISSUE; CELLS	Neutrophils are white blood cells that are mobilized to damaged tissues and to sites of pathogen invasion, providing the first line of host defense. Chemokines displayed on the surface of blood vessels promote migration of neutrophils to these sites, and tissue- and pathogen-derived chemoattractant signals, including N-formylmethionylleucylphenylalanine (fMLP), elicit further migration to sites of infection. Although nearly all chemoattractant receptors use heterotrimeric G proteins to transmit signals, many of the mechanisms lying downstream of chemoattractant receptors that either promote or limit neutrophil motility are incompletely defined. Here, we show that regulator of G protein signaling 5 (RGS5), a protein that modulates G protein activity, is expressed in both human and murine neutrophils. We detected significantly more neutrophils in the airways of Rgs5(-/-) mice than WT counterparts following acute respiratory virus infection and in the peritoneum in response to injection of thioglycollate, a biochemical proinflammatory stimulus. RGS5-deficient neutrophils responded with increased chemotaxis elicited by the chemokines CXC motif chemokine ligand 1 (CXCL1), CXCL2, and CXCL12 but not fMLP. Moreover, adhesion of these cells was increased in the presence of both CXCL2 and fMLP. In summary, our results indicate that RGS5 deficiency increases chemotaxis and adhesion, leading to more efficient neutrophil mobilization to inflamed tissues in mice. These findings suggest that RGS5 expression and activity in neutrophils determine their migrational patterns in the complex microenvironments characteristic of inflamed tissues.	[Chan, Eunice C.; Xie, Zhihui; Barker, Tolga; Druey, Kirk M.] NIAID, Mol Signal Transduct Sect, NIH, Bethesda, MD 20892 USA; [Ma, Michelle; Rosenberg, Helene F.] NIAID, Inflammat Immunobiol Sect, NIH, Bethesda, MD 20892 USA; [Ren, Chunguang; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Jude, Joseph; Koziol-White, Cynthia A.; Panettieri, Reynold A.] Rutgers New Jersey Sch Med, Child Hlth Inst New Jersey, Rutgers Inst Translat Med & Sci, Newark, NJ 07103 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Yale University	Druey, KM (corresponding author), NIAID, NIH, 10 Ctr Dr,Rm 11N238A, Bethesda, MD 20892 USA.	kdruey@niaid.nih.gov	ren, Chunguang/L-9609-2019; panettieri, reynold/AAG-9485-2019		Intramural Research Program, NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000746, ZIAAI000943] Funding Source: NIH RePORTER	Intramural Research Program, NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program, NIAID, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alqinyah M, 2018, CELL SIGNAL, V42, P77, DOI 10.1016/j.cellsig.2017.10.007; Anger T, 2004, J BIOL CHEM, V279, P3906, DOI 10.1074/jbc.M309496200; Arnold C, 2018, FASEB J, V32, P2021, DOI 10.1096/fj.201700384RR; Ayres-Sander CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060025; Balenga NA, 2014, J ALLERGY CLIN IMMUN, V134, P451, DOI 10.1016/j.jaci.2014.01.019; Bansal G, 2008, J IMMUNOL, V181, P7882, DOI 10.4049/jimmunol.181.11.7882; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Burn T, 2017, CELL MOL LIFE SCI, V74, P1871, DOI 10.1007/s00018-016-2444-2; Call DR, 2001, AM J PATHOL, V158, P715, DOI 10.1016/S0002-9440(10)64014-X; Cho H, 2008, MOL CELL BIOL, V28, P2590, DOI 10.1128/MCB.01889-07; Cho H, 2012, MOL CELL BIOL, V32, P4561, DOI 10.1128/MCB.00651-12; Croft W, 2013, J BIOL CHEM, V288, P27327, DOI 10.1074/jbc.M113.497826; CYSTER JG, 1995, J EXP MED, V182, P581, DOI 10.1084/jem.182.2.581; de Oliveira S, 2016, NAT REV IMMUNOL, V16, P378, DOI 10.1038/nri.2016.49; DOERSCHUK CM, 1993, J APPL PHYSIOL, V74, P3040, DOI 10.1152/jappl.1993.74.6.3040; Domachowske JB, 2000, J IMMUNOL, V165, P2677, DOI 10.4049/jimmunol.165.5.2677; Druey KM, 2017, ADV IMMUNOL, V136, P315, DOI 10.1016/bs.ai.2017.05.001; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Gane J, 2012, THORAX, V67, P553, DOI 10.1136/thoraxjnl-2011-200088; Han JI, 2006, J LEUKOCYTE BIOL, V79, P1357, DOI 10.1189/jlb.1105693; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Heusinkveld LE, 2017, EXPERT OPIN ORPHAN D, V5, P813, DOI 10.1080/21678707.2017.1375403; Hirano Y, 2016, BIOL CHEM, V397, P497, DOI 10.1515/hsz-2015-0309; Holdfeldt A, 2017, J LEUKOCYTE BIOL, V102, P871, DOI 10.1189/jlb.2A0317-086RR; Hwang IY, 2010, GENES IMMUN, V11, P384, DOI 10.1038/gene.2010.27; Hwang IY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060139; Hyun YM, 2017, J LEUKOCYTE BIOL, V102, P617, DOI 10.1189/jlb.1RU1216-521R; Kehrl JH, 2016, BIOCHEM PHARMACOL, V114, P40, DOI 10.1016/j.bcp.2016.04.005; Khan SM, 2013, PHARMACOL REV, V65, P545, DOI 10.1124/pr.111.005603; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Laurent Paoline, 2017, Front Immunol, V8, P454, DOI 10.3389/fimmu.2017.00454; Lee JK, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0491-0; Lomakina EB, 2010, CELL MOL BIOENG, V3, P106, DOI 10.1007/s12195-009-0099-x; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; Miyamoto-Matsubara M, 2010, ANN NY ACAD SCI, V1200, P112, DOI 10.1111/j.1749-6632.2010.05507.x; Muller WA, 2016, IMMUNOL REV, V273, P61, DOI 10.1111/imr.12443; Naumenko V, 2018, CELL TISSUE RES, V371, P505, DOI 10.1007/s00441-017-2763-0; Patel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7614; Percopo CM, 2017, J LEUKOCYTE BIOL, V101, P321, DOI 10.1189/jlb.3A0416-166R; Percopo CM, 2015, ANTIVIR RES, V121, P109, DOI 10.1016/j.antiviral.2015.07.001; Percopo CM, 2014, METHODS MOL BIOL, V1178, P257, DOI 10.1007/978-1-4939-1016-8_22; Percopo CM, 2011, VIROLOGY, V416, P26, DOI 10.1016/j.virol.2011.04.010; Pero RS, 2007, P NATL ACAD SCI USA, V104, P4371, DOI 10.1073/pnas.0700185104; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Shankar SP, 2012, J IMMUNOL, V188, P6347, DOI 10.4049/jimmunol.1103781; Shen J, 2016, HUM PATHOL, V47, P121, DOI 10.1016/j.humpath.2015.09.013; Shi GX, 2007, J EXP MED, V204, P2705, DOI 10.1084/jem.20071267; Sprang SR, 2016, BIOPOLYMERS, V105, P449, DOI 10.1002/bip.22836; Surve CR, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad8163; Swamydas M., 2015, CURR PROTOC IMMUNOL, V110, P3, DOI DOI 10.1002/0471142735.im0320s110; Tamirisa P, 1999, CIRCULATION, V99, P441, DOI 10.1161/01.CIR.99.3.441; Wang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002980; Wang ZL, 2008, J CLIN INVEST, V118, P195, DOI 10.1172/JCI33139; Wang ZQ, 2016, BIOCHEM BIOPH RES CO, V473, P551, DOI 10.1016/j.bbrc.2016.03.114; Waugh JL, 2005, J COMP NEUROL, V481, P299, DOI 10.1002/cne.20372; Xie ZH, 2008, MOL CELL, V31, P660, DOI 10.1016/j.molcel.2008.06.024; Xie ZH, 2016, AAPS J, V18, P294, DOI 10.1208/s12248-015-9847-0; Yuan QY, 2017, CELL REP, V19, P2586, DOI 10.1016/j.celrep.2017.05.080; Zarbock A, 2007, BLOOD, V110, P3773, DOI 10.1182/blood-2007-06-094565	60	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12690	12702		10.1074/jbc.RA118.002404	http://dx.doi.org/10.1074/jbc.RA118.002404			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29929985	Green Published, hybrid			2022-12-26	WOS:000442203500004
J	Goya, S; Valinotto, LE; Tittarelli, E; Rojo, GL; Jodar, MSN; Greninger, AL; Zaiat, JJ; Marti, MA; Mistchenko, AS; Viegas, M				Goya, Stephanie; Valinotto, Laura E.; Tittarelli, Estefania; Rojo, Gabriel L.; Nabaes Jodar, Mercedes S.; Greninger, Alexander L.; Zaiat, Jonathan J.; Marti, Marcelo A.; Mistchenko, Alicia S.; Viegas, Mariana			An optimized methodology for whole genome sequencing of RNA respiratory viruses from nasopharyngeal aspirates	PLOS ONE			English	Article							PRIMER-AMPLIFICATION SISPA; IDENTIFICATION; INFECTIONS; DIVERSITY; DISCOVERY	Over the last decade, the number of viral genome sequences deposited in available databases has grown exponentially. However, sequencing methodology vary widely and many published works have relied on viral enrichment by viral culture or nucleic acid amplification with specific primers rather than through unbiased techniques such as metagenomics. The genome of RNA viruses is highly variable and these enrichment methodologies may be difficult to achieve or may bias the results. In order to obtain genomic sequences of human respiratory syncytial virus (HRSV) from positive nasopharyngeal aspirates diverse methodologies were evaluated and compared. A total of 29 nearly complete and complete viral genomes were obtained. The best performance was achieved with a DNase I treatment to the RNA directly extracted from the nasopharyngeal aspirate (NPA), sequence-independent single-primer amplification (SISPA) and library preparation performed with Nextera XT DNA Library Prep Kit with manual normalization. An average of 633,789 and 1,674,845 filtered reads per library were obtained with MiSeq and NextSeq 500 platforms, respectively. The higher output of NextSeq 500 was accompanied by the increasing of duplicated reads percentage generated during SISPA (from an average of 1.5% duplicated viral reads in MiSeq to an average of 74% in NextSeq 500). HRSV genome recovery was not affected by the presence or absence of duplicated reads but the computational demand during the analysis was increased. Considering that only samples with viral load >= E+06 copies/ml NPA were tested, no correlation between sample viral loads and number of total filtered reads was observed, nor with the mapped viral reads. The HRSV genomes showed a mean coverage of 98.46% with the best methodology. In addition, genomes of human metapneumovirus (HMPV), human rhinovirus (HRV) and human parainfluenza virus types 1-3 (HPIV1-3) were also obtained with the selected optimal methodology.	[Goya, Stephanie; Valinotto, Laura E.; Tittarelli, Estefania; Rojo, Gabriel L.; Nabaes Jodar, Mercedes S.; Mistchenko, Alicia S.; Viegas, Mariana] Ricardo Gutierrez Childrens Hosp, Buenos Aires, DF, Argentina; [Goya, Stephanie; Valinotto, Laura E.; Tittarelli, Estefania; Zaiat, Jonathan J.; Marti, Marcelo A.; Viegas, Mariana] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Nabaes Jodar, Mercedes S.] Minist Salud Ciudad Buenos Aires, Buenos Aires, DF, Argentina; [Greninger, Alexander L.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Zaiat, Jonathan J.; Marti, Marcelo A.] Argentine Bioinformat Platform BIA, Buenos Aires, DF, Argentina; [Mistchenko, Alicia S.] CIC, Buenos Aires, DF, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; Instituto Nacional de Saude Dr. Ricardo Jorge; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Washington; University of Washington Seattle	Viegas, M (corresponding author), Ricardo Gutierrez Childrens Hosp, Buenos Aires, DF, Argentina.; Viegas, M (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	viegasmariana@conicet.gov.ar		Goya, Stephanie/0000-0001-7479-3064; Valinotto, Laura/0000-0001-8723-5483; Greninger, Alexander/0000-0002-7443-0527	ANPCYT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Nacion, Argentina [PICT3446/14]	ANPCYT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Nacion, Argentina(ANPCyT)	This work was partially supported by ANPCYT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Nacion, Argentina (grant PICT3446/14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agoti CN, 2015, J VIROL, V89, P3444, DOI 10.1128/JVI.03391-14; Aljabr W, 2016, J VIROL, V90, P4876, DOI 10.1128/JVI.02349-15; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Baronti C, 2015, J VIROL METHODS, V226, P7, DOI 10.1016/j.jviromet.2015.09.004; Baym M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128036; Chrzastek K, 2017, VIROLOGY, V509, P159, DOI 10.1016/j.virol.2017.06.019; Conceicao-Neto N, 2015, SCI REP-UK, V5, DOI 10.1038/srep16532; Dimitrov KM, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0741-5; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; GARDNER PS, 1968, LANCET, V1, P597; Goya S, WHOLE GENOME SEQUENC; Grad YH, 2014, J VIROL, V88, P7286, DOI 10.1128/JVI.00038-14; Greninger AL, 2018, VIRUS RES, V244, P218, DOI 10.1016/j.virusres.2017.10.014; Greninger AL, 2017, J PEDIAT INF DIS SOC, V6, P168, DOI 10.1093/jpids/pix019; Greninger AL, 2017, J CLIN MICROBIOL, V55, P177, DOI 10.1128/JCM.01881-16; Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Houldcroft CJ, 2017, NAT REV MICROBIOL, V15, P183, DOI 10.1038/nrmicro.2016.182; Karron RA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8463; Kawada J, 2016, SCI REP-UK, V6, DOI 10.1038/srep33452; Kim C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021610; Levitz R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184318; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Madi N, 2018, J MED VIROL, V90, P412, DOI 10.1002/jmv.24984; Malboeuf CM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks794; Marston DA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-444; Parker J, 2017, J CLIN VIROL, V86, P20, DOI 10.1016/j.jcv.2016.11.010; Piedra FA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172953; Rebuffo-Scheer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025468; REYES GR, 1991, MOL CELL PROBE, V5, P473, DOI 10.1016/S0890-8508(05)80020-9; Rosseel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076144; Rosseel T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-463; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schobel SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26311; Suzuki T, 2017, J CLIN VIROL, V96, P67, DOI 10.1016/j.jcv.2017.10.001; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Xue KS, 2018, MSPHERE, V3, DOI 10.1128/mSphereDirect.00552-17	37	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199714	10.1371/journal.pone.0199714	http://dx.doi.org/10.1371/journal.pone.0199714			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940028	Green Published, gold, Green Submitted			2022-12-26	WOS:000436088700038
J	Richard, P; Walker, R; Alexandre, P				Richard, Patrick; Walker, Regine; Alexandre, Pierre			The burden of out of pocket costs and medical debt faced by households with chronic health conditions in the United States	PLOS ONE			English	Article							OREGON EXPERIMENT; CANCER-TREATMENT; CARE; COVERAGE; IMPACT; ADULTS; RETRANSFORMATION; EXPENSES; OUTCOMES; SHOCKS	Introduction To examine the relationship between chronic health conditions and out-of-pocket costs (OOPC) and medical debt. Methods Secondary data from the 2013 Panel Study of Income Dynamics (PSID) was used. Households whose head of household and spouse (for married households) were 18 to 64 years old were included. Results Households with 1 to 3 chronic conditions had higher odds of having any OOPC compared to households with no chronic conditions (AOR 1.74, 95% CI 1.39, 2.17) (p < .01). Households with 1 to 3 and 4 or more chronic health conditions were associated with higher odds of having any medical debt (AOR 2.24, 95% CI 1.75 to 2.87; AOR 5.04, 95% CI 3.04 to 8.34) compared to those with no chronic conditions (p < 0.01). Similarly, 1 to 3 and 4 or more chronic health conditions was associated with higher amounts of OOPC (Exponentiated Coefficient 1.18, 95% CI 1.03 to 1.36; Exponentiated Coefficient 1.56, 95% CI 1.17 to 2.07) and medical debt (Exponentiated Coefficient 1.69, 95% CI 1.23 to 2.34; Exponentiated Coefficient 2.73, 95% CI 1.19 to 6.25) compared to households with no chronic conditions (p < 0.05). Conclusions Findings from this study show that the presence of chronic health conditions impose a large financial burden on some households.	[Richard, Patrick] Uniformed Serv Univ Hlth Sci USU, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA; [Walker, Regine] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Alexandre, Pierre] Florida Atlantic Univ, Coll Business, Dept Hlth Adm, Boca Raton, FL 33431 USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; State University System of Florida; Florida Atlantic University	Richard, P (corresponding author), Uniformed Serv Univ Hlth Sci USU, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA.	patrick.richard@usuhs.edu		Richard, Patrick/0000-0002-0856-3911	USU/PMB Incoming Faculty Research Support Start-up Package Grant [C087328915]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069609] Funding Source: NIH RePORTER	USU/PMB Incoming Faculty Research Support Start-up Package Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by the USU/PMB Incoming Faculty Research Support Start-up Package (Grant # C087328915). Funding was received by P.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiarz P, 2013, HEALTH ECON, V22, P1177, DOI 10.1002/hec.2877; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Baicker K, 2011, NEW ENGL J MED, V365, P683, DOI 10.1056/NEJMp1108222; BECKETTI S, 1988, J LABOR ECON, V6, P472, DOI 10.1086/298192; Bernard DSM, 2011, J CLIN ONCOL, V29, P2821, DOI 10.1200/JCO.2010.33.0522; Beronio K, 2014, J BEHAV HEALTH SER R, V41, P410, DOI 10.1007/s11414-014-9412-0; Bestvina CM, 2014, FUTURE ONCOL, V10, P2189, DOI 10.2217/fon.14.130; Bradley CJ, 2013, J HEALTH ECON, V32, P833, DOI 10.1016/j.jhealeco.2013.06.008; Cameron A.C., 2008, MICROECONOMETRICS US; Chatterji P, 2011, J HEALTH ECON, V30, P858, DOI 10.1016/j.jhealeco.2011.06.006; Cohen RA, 2011, FINANCIAL BURDEN MED; Crook J., 2005, U EDINBURGH WORKING; Cunningham P., 2008, TRADE OFFS GETTING T; Davidoff AJ, 2013, CANCER-AM CANCER SOC, V119, P1257, DOI 10.1002/cncr.27848; De Nardi M, 2009, NATL BUREAU EC RES; Dobkin A, 2015, 22288 NAT BUR EC RES; Doty M.M., 2008, SEEING RED GROWING B; Dranove D, 2006, HEALTH AFFAIR, V25, pW74, DOI 10.1377/hlthaff.25.w74; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Fitzgerald J, 1998, ANAL SAMPLE ATTRITIO; Gross T, 2011, J PUBLIC ECON, V95, P767, DOI 10.1016/j.jpubeco.2011.01.012; Halpern MT, 2011, EPILEPSY BEHAV, V22, P483, DOI 10.1016/j.yebeh.2011.07.007; Himmelstein DU, 2009, AM J MED, V122, P741, DOI 10.1016/j.amjmed.2009.04.012; Jaspers L, 2015, EUR J EPIDEMIOL, V30, P163, DOI 10.1007/s10654-014-9983-3; Kim H, 2012, J CONSUM AFF, V46, P357, DOI 10.1111/j.1745-6606.2012.01236.x; Kircher SM, 2014, CANCER-AM CANCER SOC, V120, P3378, DOI 10.1002/cncr.28898; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Manning WG, 1998, J HEALTH ECON, V17, P283, DOI 10.1016/S0167-6296(98)00025-3; Mazumder B, 2014, EFFECTS MASSACHUSETT; Meraya AM, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140388; Moran JR, 2011, J HEALTH ECON, V30, P505, DOI 10.1016/j.jhealeco.2011.02.001; Mullahy J, 1998, J HEALTH ECON, V17, P247, DOI 10.1016/S0167-6296(98)00030-7; Ojeda VD, 2010, HEALTH ECON, V19, P396, DOI 10.1002/hec.1480; Paez KA, 2009, HEALTH AFFAIR, V28, P15, DOI 10.1377/hlthaff.28.1.15; Pollitz Karen, 2014, MED DEBT PEOPLE HLTH; PSID, 2015, PSID MAIN INT US MAN; Richard P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144075; Sambamoorthi U, 2015, EXPERT REV PHARM OUT, V15, P823, DOI 10.1586/14737167.2015.1091730; Tu Ha T, 2009, Track Rep, P1; Webb A, 2010, MUCH IS ENOUGH DISTR; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; Zafar SY, 2013, ONCOLOGIST, V18, P381, DOI 10.1634/theoncologist.2012-0279	42	21	21	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199598	10.1371/journal.pone.0199598	http://dx.doi.org/10.1371/journal.pone.0199598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK3YY	29940025	Green Published, gold, Green Submitted			2022-12-26	WOS:000436088700029
J	Takheaw, N; Laopajon, W; Surinkaew, S; Khummuang, S; Pata, S; Kasinrerk, W				Takheaw, Nuchjira; Laopajon, Witida; Surinkaew, Sirirat; Khummuang, Saichit; Pata, Supansa; Kasinrerk, Watchara			Ligation of Na, K ATPase beta 3 subunit on monocytes by a specific monoclonal antibody mediates T cell hypofunction	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; HUMAN DENDRITIC CELLS; SODIUM-PUMP; MOLECULAR-MECHANISMS; DOWN-REGULATION; ALPHA-SUBUNIT; EXPRESSION; DIFFERENTIATION; ACTIVATION; RESPONSES	T cells play a crucial role in orchestrating body immune responses. T cell hyperfunction, however, leads to inflammation and induction of autoimmune diseases. Understanding of T cell regulation mechanisms and successful modulation of T cell responses is beneficial in treatment of disease associated to T cell hyperresponsiveness. Our previous study indicated that monoclonal antibody (mAb) P-3E10, a mAb to Na, K ATPase beta 3 subunit, inhibited anti-CD3-induced PBMC proliferation. In the current study, we further investigated the mechanism of mAb P-3E10 in the induction of T cell hypofunction. We demonstrated that mAb P-3E10 decreased T cell proliferation and Th1, Th2 and Th17 cytokine production. Monocytes were the cells playing a key role in mediation of mAb P-3E10 induced T cell hypofunction. The inhibition of T cell activation by mAb P-3E10 required cell contact between monocytes and T cells. The mAb P-3E10 induced the down-expression level of MHC class II and CD86 and increased IL-6, IL-10 and TNF-alpha production of monocytes. We concluded that ligation of the Na, K ATPase beta 3 subunit on monocytes by mAb P-3E10 arbitrated T cell hypofunction. This mAb might be a promising novel immunotherapeutic antibody for the treatment of hyperresponsive T cell associated diseases.	[Takheaw, Nuchjira; Laopajon, Witida; Pata, Supansa; Kasinrerk, Watchara] Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, Div Clin Immunol, Chiang Mai, Thailand; [Laopajon, Witida; Surinkaew, Sirirat; Khummuang, Saichit; Pata, Supansa; Kasinrerk, Watchara] Chiang Mai Univ, Fac Associated Med Sci, Natl Ctr Genet Engn & Biotechnol, Natl Sci & Technol Dev Agcy,Biomed Technol Res Ct, Chiang Mai, Thailand	Chiang Mai University; Chiang Mai University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Pata, S; Kasinrerk, W (corresponding author), Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, Div Clin Immunol, Chiang Mai, Thailand.; Pata, S; Kasinrerk, W (corresponding author), Chiang Mai Univ, Fac Associated Med Sci, Natl Ctr Genet Engn & Biotechnol, Natl Sci & Technol Dev Agcy,Biomed Technol Res Ct, Chiang Mai, Thailand.	supansa_pata@hotmail.com; watchara_kasinrerk@hotmail.com		Takheaw, Nuchjira/0000-0002-7239-9482; Surinkaew, Sirirat/0000-0001-9161-8567	Thailand Research Fund (TRF) [RTA5980007]; TRF; Thailand Office of Higher Education Commission [MRG6080269]; Royal Golden Jubilee Ph.D. program [PHD/ 0121/2557]; Chiang Mai University	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); TRF(Thailand Research Fund (TRF)); Thailand Office of Higher Education Commission; Royal Golden Jubilee Ph.D. program(Thailand Research Fund (TRF)); Chiang Mai University	This work was supported by the Thailand Research Fund (TRF) Senior Research Scholar (RTA5980007) to WK; the TRF and the Thailand Office of Higher Education Commission (MRG6080269) to SP. NT is a doctoral candidate of the Royal Golden Jubilee Ph.D. program (PHD/ 0121/2557). SS is a post-doctoral fellowship supported by Chiang Mai University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARCY S, 1995, INT IMMUNOL, V7, P179, DOI 10.1093/intimm/7.2.179; Bennett J Claude, 2008, Arthritis Rheum, V58, pS53, DOI 10.1002/art.23045; Boyette LB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176460; Brossart P, 1998, BLOOD, V92, P4238, DOI 10.1182/blood.V92.11.4238.423k16_4238_4247; Chastain EML, 2011, BBA-MOL BASIS DIS, V1812, P265, DOI 10.1016/j.bbadis.2010.07.008; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chen LW, 2011, P NATL ACAD SCI USA, V108, P18778, DOI 10.1073/pnas.1018994108; Chiampanichayakul S, 2002, INT IMMUNOL, V14, P1407, DOI 10.1093/intimm/dxf112; Chiampanichayakul S, 2006, TISSUE ANTIGENS, V68, P509, DOI 10.1111/j.1399-0039.2006.00726.x; CHOW DC, 1995, J EXP BIOL, V198, P1; Chruewkamlow N, 2015, IMMUNOBIOLOGY, V220, P634, DOI 10.1016/j.imbio.2014.11.017; Creery WD, 1996, EUR J IMMUNOL, V26, P1273, DOI 10.1002/eji.1830260614; DING L, 1993, J IMMUNOL, V151, P1224; Dittel BN, 2008, BRAIN BEHAV IMMUN, V22, P421, DOI 10.1016/j.bbi.2007.11.010; Evans HG, 2009, P NATL ACAD SCI USA, V106, P6232, DOI 10.1073/pnas.0808144106; Gane JM, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1079851; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; Holmgren M, 2000, NATURE, V403, P898, DOI 10.1038/35002599; Horvatinovich JM, 2017, J IMMUNOL, V198, P2286, DOI 10.4049/jimmunol.1600802; Iwata Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/594809; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kong BS, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0961-z; Kriegel MA, 2008, INT IMMUNOL, V20, P601, DOI 10.1093/intimm/dxn019; Kumar A, 1999, CLIN EXP IMMUNOL, V117, P84; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135; MALEFYT RD, 1991, J EXP MED, V174, P915; Malik N, 1996, J BIOL CHEM, V271, P22754, DOI 10.1074/jbc.271.37.22754; MCDONOUGH AA, 1990, FASEB J, V4, P1598, DOI 10.1096/fasebj.4.6.2156741; Moudgil KD, 2011, J INTERF CYTOK RES, V31, P695, DOI 10.1089/jir.2011.0065; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; Ohno Y, 2016, CANCER IMMUNOL IMMUN, V65, P193, DOI 10.1007/s00262-015-1791-4; Pata Supansa, 2011, BMC Res Notes, V4, P293, DOI 10.1186/1756-0500-4-293; Patel VK, 2017, ATHEROSCLEROSIS, V263, P15, DOI 10.1016/j.atherosclerosis.2017.05.026; Pennock ND, 2013, ADV PHYSIOL EDUC, V37, P273, DOI 10.1152/advan.00066.2013; Podojil JR, 2008, ADV EXP MED BIOL, V640, P234, DOI 10.1007/978-0-387-09789-3_18; Podojil JR, 2009, IMMUNOL REV, V229, P337, DOI 10.1111/j.1600-065X.2009.00773.x; Poole JA, 2005, J ALLERGY CLIN IMMUN, V116, P780, DOI 10.1016/j.jaci.2005.07.007; Roberts CA, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00571; SHAMRAJ OI, 1994, P NATL ACAD SCI USA, V91, P12952, DOI 10.1073/pnas.91.26.12952; Sinistro A, 2008, CLIN VACCINE IMMUNOL, V15, P1851, DOI 10.1128/CVI.00184-08; Skapenko A, 2005, ARTHRITIS RES THER, V7, pS4, DOI 10.1186/ar1703; Stonehouse TJ, 1999, IMMUNOLOGY, V96, P35; Studer RA, 2011, PHYSIOL GENOMICS, V43, P844, DOI 10.1152/physiolgenomics.00002.2011; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Tokhtaeva E, 2012, J BIOL CHEM, V287, P26115, DOI 10.1074/jbc.M112.370734; Tono T, 2017, INFLAMM REGEN, V37, DOI 10.1186/s41232-017-0054-5; Uccioli L, 2010, DIABETES CARE, V33, P350, DOI 10.2337/dc09-1141; Vanhove B, 2017, ANTIBODIES, V6, DOI 10.3390/antib6040019; Waite JC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/819467; Wang XB, 2002, SCAND J IMMUNOL, V55, P53, DOI 10.1046/j.0300-9475.2001.01019.x; WANIDWORANUN C, 1993, J IMMUNOL, V151, P6853; Xiu B, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.56; Yang H, 2017, APMIS, V125, P24, DOI 10.1111/apm.12629; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Yoon BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109775; Ziegler-Heitbrock L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00423; Zola H, 2005, CELL RES, V15, P691, DOI 10.1038/sj.cr.7290338	58	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199717	10.1371/journal.pone.0199717	http://dx.doi.org/10.1371/journal.pone.0199717			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940031	gold, Green Published, Green Submitted			2022-12-26	WOS:000436088700039
J	Bohn, A; Braley, A; de la Vega, PR; Zevallos, JC; Barengo, NC				Bohn, Andrew; Braley, Alexander; de la Vega, Pura Rodriguez; Zevallos, Juan Carlos; Barengo, Noel C.			The association between race and survival in glioblastoma patients in the US: A retrospective cohort study	PLOS ONE			English	Article							MALIGNANT BRAIN-TUMOR; AGE-BASED DISPARITIES; CLINICAL-TRIALS; UNITED-STATES; RACIAL-DIFFERENCES; ELDERLY-PATIENTS; DIAGNOSIS; PARTICIPATION; RECEIPT	Background Glioblastoma is the most common primary brain cancer in adults with an incidence of 3.4 per 100,000, making up about 15% of all brain tumors. Inconsistent results have been published in regard differences in survival between white and black glioblastoma patients. The objective of this to study the association between race and in Glioblastoma patients in the USA during 2010-2014. Methods and findings The National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database were used to evaluate race/ethnicity (White non-Hispanic, Black non-Hispanic, Asian/ Pacific Islanders non-Hispanic (API)) and Hispanic) adults patients with first-time diagnosis of glioblastoma (International Classification of Diseases for Oncology, 3rd Edition [ICD-O3], codes C711-C714, and histology type 9440/3) from 2010-2014. The primary outcome was 3-year overall survival which was defined as months from diagnosis to death due to any cause and cancer, Kaplan-Meier (KM) and log-rank test were used to compare overall survival times across race groups. Cox proportional hazard models were used to determine the independent effect of race on 3-year survival. Age, gender, health insurance coverage, primary site, tumor size, extent of surgery and year of diagnosis were included in the adjusted model. The 3-year overall survival for API-non Hispanic (NH) patients decreased by 25% compared with White NH glioblastoma patients (hazard ratio (HR) 0.75; 95% confidence interval (CI) 0.62-0.90)) after adjusting for age, gender, health insurance, primary site, tumor size, and extent of the surgery. Black NH (HR 0.95; 95% CI 0.80-1.13) and Hispanic (HR 1.01, 95% CI 0.84-1.21) exhibited similar mortality risks compared with White NH patients. Conclusion Compared with White NH, API NH with glioblastoma have a better survival. The findings from this study can help increase the accuracy of the prognostic outlook for white, black and API patients with GBM.	[Bohn, Andrew; Braley, Alexander; de la Vega, Pura Rodriguez; Zevallos, Juan Carlos; Barengo, Noel C.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Med & Hlth Sci Res, Miami, FL 33199 USA	State University System of Florida; Florida International University	Barengo, NC (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Dept Med & Hlth Sci Res, Miami, FL 33199 USA.	nbarengo@fiu.edu		Braley, Alexander/0000-0002-1443-1472; Barengo, Noel C/0000-0003-0660-3091				Barnholtz-Sloan JS, 2007, J NEURO-ONCOL, V85, P171, DOI 10.1007/s11060-007-9405-4; Barnholtz-Sloan JS, 2003, CANCER-AM CANCER SOC, V98, P603, DOI 10.1002/cncr.11534; Barnholtz-Sloan JS, 2003, J NEUROSURG, V99, P458, DOI 10.3171/jns.2003.99.3.0458; Beaumont TL, 2007, J NEURO-ONCOL, V83, P39, DOI 10.1007/s11060-006-9295-x; Duggan Maire A, 2016, AM J SURG PATHOL, V40, pe94, DOI [10.1097/PAS.0000000000000749, DOI 10.1097/PAS.0000000000000749]; Farah P, 2016, J NEURO-ONCOL, V128, P419, DOI 10.1007/s11060-016-2127-8; Gittleman H, 2017, NEURO-ONCOLOGY, V19, P669, DOI 10.1093/neuonc/now208; Huang M C, 1996, Noshuyo Byori, V13, P11; Jagsi R, 2012, CANCER-AM CANCER SOC, V118, P333, DOI 10.1002/cncr.26295; MCLENDON RE, 1985, CANCER, V56, P894, DOI 10.1002/1097-0142(19850815)56:4<894::AID-CNCR2820560432>3.0.CO;2-#; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Pan IW, 2015, J CLIN NEUROSCI, V22, P1575, DOI 10.1016/j.jocn.2015.03.032; Rhome R, 2016, J NEURO-ONCOL, V128, P241, DOI 10.1007/s11060-016-2101-5; Robertson JT, 2002, BRIT J NEUROSURG, V16, P562; Shabihkhani M, 2017, J NEURO-ONCOL, V132, P351, DOI 10.1007/s11060-017-2377-0; Shah BK, 2016, ANTICANCER RES, V36, P4883, DOI 10.21873/anticanres.11052; Simpson JR, 1996, AM J CLIN ONCOL-CANC, V19, P114, DOI 10.1097/00000421-199604000-00005; Stewart JH, 2007, ANN SURG ONCOL, V14, P3328, DOI 10.1245/s10434-007-9500-y; Thakkar JP, 2014, CANCER EPIDEM BIOMAR, V23, P1985, DOI 10.1158/1055-9965.EPI-14-0275; THAKKAR JP, 2013, J CLIN ONCOL S, V31	22	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198581	10.1371/journal.pone.0198581	http://dx.doi.org/10.1371/journal.pone.0198581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927955	Green Submitted, Green Published, gold			2022-12-26	WOS:000435802500024
J	Vertz, J; Deblanc, D; Rhodin, M; Pfau, T				Vertz, Jodi; Deblanc, Diana; Rhodin, Marie; Pfau, Thilo			Effect of a unilateral hind limb orthotic lift on upper body movement symmetry in the trotting horse	PLOS ONE			English	Article							COMPENSATORY LOAD REDISTRIBUTION; INERTIAL SENSOR SYSTEM; FORELIMB LAMENESS; PELVIC MOVEMENT; GAIT ANALYSIS; FORCE PLATE; ASYMMETRY; QUANTIFICATION; IDENTIFICATION; TREADMILL	In trotting horses, movement asymmetry is associated with ground reaction force asymmetry. In humans, limb length differences influence contralateral force production. Here we investigate whether horses, in immediate reaction to limb length changes, show movement asymmetry adaptations consistent with reported force differences. Aim of this study was to quantify pelvic and compensatory head and withers movement asymmetry as a function of limb length changes after application of orthotic lifts. In this experimental study movement asymmetry of eleven trotting horses was calculated from vertical displacement of poll, withers, sacrum and left and right tuber coxae with inertial sensors. Horses were assessed in hand under 5 conditions (all with hind limb boots): without orthotic lifts, and with a 15mm or 30mm orthotic lift applied to the left hind or right hind. A linear mixed model investigated the influence of orthotic lift condition (P<0.05, pairwise posthoc Bonferroni correction). Pelvic movement asymmetry showed increased pelvic downward movement during stance of the shorter limb and increased pelvic upward movement during and after stance of the longer limb (P<0.001) with asymmetry changes of 3-7mm (4-10mm) for 15mm (30mm) lifts. Hip hike (tuber coxae movement asymmetry) was unaffected (P = 0.348). Head and withers movement asymmetry were affected less consistently (2 of 3 respectively 1 of 3 head or withers parameters). The small sample size of the study reduced generalizability, no direct force measurements were conducted and only immediate effects of orthotic lifts were assessed with no re-assessments days or weeks after. Conclusions about mechanical consequences (weight bearing, pushoff) are based on published movement-force associations. Pelvic movement asymmetry with an artificial change in limb length through application of an orthotic lift indicates increased weight support with the shorter limb and increased pushoff with the longer limb. This may be of relevance for the management of horses with different hoof shapes between contralateral limbs, for example some chronically lame horse.	[Vertz, Jodi] Hlth Hoofcare, Albuquerque, NM USA; [Vertz, Jodi] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Deblanc, Diana] Performance Equine Vet Serv, Peralta, NM USA; [Rhodin, Marie] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Pfau, Thilo] Royal Vet Coll, Dept Clin Sci & Serv, London, England	University of Edinburgh; Swedish University of Agricultural Sciences; University of London; University of London Royal Veterinary College	Pfau, T (corresponding author), Royal Vet Coll, Dept Clin Sci & Serv, London, England.	tpfau@rvc.ac.uk	Rhodin, Marie/AAD-7266-2020		FORMAS [2014-12003-28225-26]; Healthy Hoofcare	FORMAS(Swedish Research Council Formas); Healthy Hoofcare	Financial support provided by FORMAS grant 2014-12003-28225-26, http://www.formas.se/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Healthy Hoofcare provided support in the form of salaries for author JV and Performance Equine Veterinary Services for DD. These companies did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Bell RP, 2016, AM J VET RES, V77, P337, DOI 10.2460/ajvr.77.4.337; Buchner HHF, 1996, EQUINE VET J, V28, P71, DOI 10.1111/j.2042-3306.1996.tb01592.x; Geor R., 2008, EQUINE EXERCISE PHYS, P303; Greve L, 2017, VET J, V220, P95, DOI 10.1016/j.tvjl.2017.01.003; Keegan KG, 2010, EQUINE VET J, V42, P92, DOI 10.2746/042516409X479568; Keegan KG, 2012, AM J VET RES, V73, P368, DOI 10.2460/ajvr.73.3.368; Kramer J, 2004, AM J VET RES, V65, P741, DOI 10.2460/ajvr.2004.65.741; Maliye S, 2013, EQUINE VET J, V45, P26, DOI 10.1111/evj.12158; Maliye S, 2016, JAVMA-J AM VET MED A, V249, P940, DOI 10.2460/javma.249.8.940; Maliye S, 2015, VET J, V204, P208, DOI 10.1016/j.tvjl.2015.03.005; Marshall JF, 2012, EQUINE VET J, V44, P8, DOI 10.1111/j.2042-3306.2012.00611.x; MAY SA, 1987, EQUINE VET J, V19, P185, DOI 10.1111/j.2042-3306.1987.tb01371.x; McCracken MJ, 2012, EQUINE VET J, V44, P652, DOI 10.1111/j.2042-3306.2012.00571.x; McGuigan MP, 2003, J EXP BIOL, V206, P1325, DOI 10.1242/jeb.00254; Merkens H W, 1988, Equine Vet J Suppl, P99; Perttunen JR, 2004, SCAND J MED SCI SPOR, V14, P49, DOI 10.1111/j.1600-0838.2003.00307.x; Pfau T, 2005, J EXP BIOL, V208, P2503, DOI 10.1242/jeb.01658; Pfau T, 2018, EQUINE VET J, V50, P117, DOI 10.1111/evj.12705; Pfau T, 2016, VET REC, V179, DOI 10.1136/vr.103516; Pfau T, 2016, EQUINE VET EDUC, V28, P203, DOI 10.1111/eve.12400; Pfau T, 2014, EQUINE VET J, V46, P759, DOI 10.1111/evj.12220; Pfau T, 2012, AM J VET RES, V73, P1890, DOI 10.2460/ajvr.73.12.1890; Rhodin M, 2018, EQUINE VET J, V50, P818, DOI 10.1111/evj.12844; Rhodin M, 2013, VET J, V198, pE39, DOI 10.1016/j.tvjl.2013.09.031; Rhodin M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176253; Ross M., 2011, DIAGNOSIS MANAGEMENT, V2nd ed., P3; Ross M.W., 2011, DIAGNOSIS MANAGEMENT, P80; Starke SD, 2012, EQUINE VET J, V44, P657, DOI 10.1111/j.2042-3306.2012.00576.x; Starke SD, 2012, J BIOMECH, V45, P1522, DOI 10.1016/j.jbiomech.2012.03.014; van Weeren PR, 2017, EQUINE VET J, V49, P567, DOI 10.1111/evj.12715; Warner SM, 2010, EQUINE VET J, V42, P417, DOI 10.1111/j.2042-3306.2010.00200.x; Weishaupt MA, 2006, VET J, V171, P135, DOI 10.1016/j.tvjl.2004.09.004; Weishaupt MA, 2004, EQUINE VET J, V36, P727, DOI 10.2746/0425164044848244; White SC, 2004, CLIN ORTHOP RELAT R, P287, DOI 10.1097/01.blo.0000119460.33630.6d; Wiggers N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114836	35	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199447	10.1371/journal.pone.0199447	http://dx.doi.org/10.1371/journal.pone.0199447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928020	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000435802500095
J	Wu, ZD; Boke-Olen, N; Fensholt, R; Ardo, J; Eklundh, L; Lehsten, V				Wu, Zhendong; Boke-Olen, Niklas; Fensholt, Rasmus; Ardo, Jonas; Eklundh, Lars; Lehsten, Veiko			Effect of climate dataset selection on simulations of terrestrial GPP: Highest uncertainty for tropical regions	PLOS ONE			English	Article							NET ECOSYSTEM EXCHANGE; CARBON-CYCLE; VEGETATION DYNAMICS; NEXT-GENERATION; PLANT GEOGRAPHY; MODEL; ASSIMILATION; RESPIRATION; VARIABILITY; SEPARATION	Biogeochemical models use meteorological forcing data derived with different approaches (e.g. based on interpolation or reanalysis of observation data or a hybrid hereof) to simulate ecosystem processes such as gross primary productivity (GPP). This study assesses the impact of different widely used climate datasets on simulated gross primary productivity and evaluates the suitability of them for reproducing the global and regional carbon cycle as mapped from independent GPP data. We simulate GPP with the biogeochemical model LPJ-GUESS using six historical climate datasets (CRU, CRUNCEP, ECMWF, NCEP, PRINCETON, and WFDEI). The simulated GPP is evaluated using an observation-based GPP product derived from eddy covariance measurements in combination with remotely sensed data. Our results show that all datasets tested produce relatively similar GPP simulations at a global scale, corresponding fairly well to the observation-based data with a difference between simulations and observations ranging from -50 to 60 g m(-2) yr(-1). However, all simulations also show a strong underestimation of GPP (ranging from -533 to -870 g m(-2) yr(-1)) and low temporal agreement (r < 0.4) with observations over tropical areas. As the shortwave radiation for tropical areas was found to have the highest uncertainty in the analyzed historical climate datasets, we test whether simulation results could be improved by a correction of the tested shortwave radiation for tropical areas using a new radiation product from the International Satellite Cloud Climatology Project (ISCCP). A large improvement (up to 48%) in simulated GPP magnitude was observed with bias corrected shortwave radiation, as well as an increase in spatio-temporal agreement between the simulated GPP and observation based GPP. This study conducts a spatial inter-comparison and quantification of the performances of climate datasets and can thereby facilitate the selection of climate forcing data over any given study area for modelling purposes.	[Wu, Zhendong; Boke-Olen, Niklas; Ardo, Jonas; Eklundh, Lars; Lehsten, Veiko] Lund Univ, Dept Phys Geog & Ecosyst Sci, Lund, Sweden; [Wu, Zhendong; Fensholt, Rasmus] Univ Copenhagen, Dept Geosci & Nat Resource Management, Copenhagen, Denmark; [Lehsten, Veiko] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland	Lund University; University of Copenhagen; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Wu, ZD (corresponding author), Lund Univ, Dept Phys Geog & Ecosyst Sci, Lund, Sweden.; Wu, ZD (corresponding author), Univ Copenhagen, Dept Geosci & Nat Resource Management, Copenhagen, Denmark.	zhendong.wu@nateko.lu.se	Eklundh, Lars R/G-4253-2010; Boke-Olen, Niklas/AAQ-8047-2020; Fensholt, Rasmus/L-7951-2014	Eklundh, Lars R/0000-0001-7644-6517; Boke-Olen, Niklas/0000-0003-2441-7153; Ardo, Jonas/0000-0002-9318-0973; Wu, Zhendong/0000-0003-1435-9105; Fensholt, Rasmus/0000-0003-3067-4527	SATGUESS project - Lund University; Copenhagen University	SATGUESS project - Lund University; Copenhagen University	This article is funded by SATGUESS project which is my PhD project funded by Lund University and Copenhagen University. The funders Veiko Lehsten and Rasmus Fensholt are my supervisors, and they had role in study design, decision to publish and editing manuscript.	Ahlstrom A, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/12/1/014004; Ahlstrom A, 2015, SCIENCE, V348, P895, DOI 10.1126/science.aaa1668; Anav A, 2015, REV GEOPHYS, V53, P785, DOI 10.1002/2015RG000483; [Anonymous], [No title captured]; [Anonymous], 2007, TERRESTRIAL ECOSYSTE, DOI [10.1007/978-3-540-32730-1, DOI 10.1007/978-3-540-32730-1_15]; Ardo Jonas, 2015, Carbon Balance Manag, V10, P8; Barman R, 2014, GLOBAL CHANGE BIOL, V20, P1394, DOI 10.1111/gcb.12474; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Chen M, 2014, REMOTE SENS-BASEL, V6, P7136, DOI 10.3390/rs6087136; CHOU MD, 1992, J ATMOS SCI, V49, P762, DOI 10.1175/1520-0469(1992)049<0762:ASRMFU>2.0.CO;2; Cox P, 2008, SCIENCE, V321, P1642, DOI 10.1126/science.1158907; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Hungerford R. D., 1989, MTCLIM MOUNTAIN MICR; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; Jones C, 2013, J CLIMATE, V26, P4398, DOI 10.1175/JCLI-D-12-00554.1; Jones P. D., 2013, CRU TS3 21 CLIMATIC, DOI [10.5285/D0E1585D-3417-485F-87AE-4FCECF10A992, DOI 10.5285/D0E1585D-3417-485F-87AE-4FCECF10A992]; Jung M, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002915; Jung M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001566; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; Kowalczyk EA, 2013, AUST METEOROL OCEAN, V63, P65, DOI 10.22499/2.6301.005; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Lamarque JF, 2011, CLIMATIC CHANGE, V109, P191, DOI 10.1007/s10584-011-0155-0; Lasslop G, 2010, GLOBAL CHANGE BIOL, V16, P187, DOI 10.1111/j.1365-2486.2009.02041.x; Legates DR, 1999, WATER RESOUR RES, V35, P233, DOI 10.1029/1998WR900018; McGuire AD, 2012, BIOGEOSCIENCES, V9, P3185, DOI 10.5194/bg-9-3185-2012; Medany M, 2006, BACKGROUND PAPER IMP, P21; Mlawer EJ, 1997, J GEOPHYS RES-ATMOS, V102, P16663, DOI 10.1029/97JD00237; Moffat AM, 2007, AGR FOREST METEOROL, V147, P209, DOI 10.1016/j.agrformet.2007.08.011; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Murray-Tortarolo G, 2013, REMOTE SENS-BASEL, V5, P4819, DOI 10.3390/rs5104819; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Papale D, 2006, BIOGEOSCIENCES, V3, P571, DOI 10.5194/bg-3-571-2006; Parton WJ, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001193; PARTON WJ, 1993, GLOBAL BIOGEOCHEM CY, V7, P785, DOI 10.1029/93GB02042; Peterson TC, 1998, J GEOPHYS RES-ATMOS, V103, P25967, DOI 10.1029/98JD01168; Piao SL, 2013, GLOBAL CHANGE BIOL, V19, P2117, DOI 10.1111/gcb.12187; Poulter B, 2011, BIOGEOSCIENCES, V8, P2027, DOI 10.5194/bg-8-2027-2011; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Scheiter S, 2013, NEW PHYTOL, V198, P957, DOI 10.1111/nph.12210; Scherrer SC, 2011, INT J CLIMATOL, V31, P1518, DOI 10.1002/joc.2170; SCHIFFER RA, 1983, B AM METEOROL SOC, V64, P779; Schneider U., 2008, GLOBAL PRECIPITATION, V112; Sheffield J, 2006, J CLIMATE, V19, P3088, DOI 10.1175/JCLI3790.1; Simmons A, 2007, ECMWF NEWSL, V110, P25, DOI [10.21957/pocnex23c6, DOI 10.21957/POCNEX23C6]; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Sitch S, 2015, BIOGEOSCIENCES, V12, P653, DOI 10.5194/bg-12-653-2015; Smith B, 2014, BIOGEOSCIENCES, V11, P2027, DOI 10.5194/bg-11-2027-2014; Smith B, 2001, GLOBAL ECOL BIOGEOGR, V10, P621, DOI 10.1046/j.1466-822X.2001.00256.x; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P17, DOI 10.1038/NCLIMATE2067; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Weedon GP, 2011, J HYDROMETEOROL, V12, P823, DOI 10.1175/2011JHM1369.1; Weedon G.P., 2010, WATCH TECH REP, V22, P41; Wei Y, 2013, GEOSCI MODEL DEV DIS, V6, P5375, DOI DOI 10.5194/GMDD-6-5375-2013; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; Wramneby A, 2008, ECOL MODEL, V216, P277, DOI 10.1016/j.ecolmodel.2008.04.013; Wu ZD, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa6fd8; Zaehle S, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003522; Zhang YC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004457; Zhao M, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2004JG000004	64	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199383	10.1371/journal.pone.0199383	http://dx.doi.org/10.1371/journal.pone.0199383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928023	gold, Green Published			2022-12-26	WOS:000435802500081
J	Zhang, YJ; Li, DH; Wang, YY; Zhou, R; Wang, LH; Zhang, YX; Yu, JY; Gong, HH; You, J; Zhang, XR				Zhang, Yujuan; Li, Donghua; Wang, Yanyan; Zhou, Rong; Wang, Linhai; Zhang, Yanxin; Yu, Jingyin; Gong, Huihui; You, Jun; Zhang, Xiurong			Genome-wide identification and comprehensive analysis of the NAC transcription factor family in Sesamum indicum	PLOS ONE			English	Article							CUP-SHAPED-COTYLEDON; NO-APICAL-MERISTEM; FACTOR GENE FAMILY; LEAF SENESCENCE; CELL-DIVISION; ORYZA-SATIVA; ARABIDOPSIS; DROUGHT; EXPRESSION; SEQUENCE	The NAM, ATAF1/2, and CUC2 (NAC) family constitutes a large family of plant-specific transcription factors, involved in many aspects of physiological processes and a variety of abiotic stresses. There is little information concerning the NAC family in Sesamum indicum. In this study, 87 sesame NAC genes were identified and phylogenetically clustered into 12 groups with Arabidopsis NAC genes. A total of 83 SiNAC genes were distributed non-randomly on the 16 linkage groups in sesame. Four and 49 SiNACs were found to be tandemly and segmentally duplicated, respectively. Expression profiles of SiNAC genes in different tissues (root, stem, leaf, flower, seed, and capsule) and in response to drought and water-logging stresses by using RNA-seq data demonstrated that 23 genes were highly expressed in all tissues, 18 and 31 SiNACs respond strongly to drought and waterlogging stresses, respectively. In addition, the expression of 30 SiNAC genes distributed in different subgroups was analyzed with quantitative real-time RT-PCR under cold, osmotic, and salt stresses, revealed that their expression patterns vary in response to abiotic stresses. SiNAC genes displayed diverse expression patterns among the different tissues and stress treatments, suggested that their contribution to plant growth and development in sesame and multiple stress resistance in sesame. In this study, NAC transcription factors were analyzed in sesame and some specific candidate SiNAC genes in response to abiotic stress for functional study were identified. This study provides valuable information to deepen our understanding of the abiotic stress responses by NAC transcription factors in sesame.	[Zhang, Yujuan; Li, Donghua; Wang, Yanyan; Zhou, Rong; Wang, Linhai; Zhang, Yanxin; Yu, Jingyin; You, Jun; Zhang, Xiurong] Chinese Acad Agr Sci, Res Inst, Minist Agr Oil Crops, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China; [Zhang, Yujuan; Gong, Huihui] Shandong Acad Agr Sci, Cotton Res Ctr, Jinan, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shandong Academy of Agricultural Sciences	You, J; Zhang, XR (corresponding author), Chinese Acad Agr Sci, Res Inst, Minist Agr Oil Crops, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China.	junyou@caas.cn; zhangxr@oilcrops.cn	Wang, Yuan/HHC-1520-2022; Wang, Yin/HCI-9352-2022; wangwangwang, yuanyaun/HHN-6432-2022; wang, yan/GSE-6489-2022; Wang, Yanbo/HFZ-8018-2022	You, Jun/0000-0001-8927-1015	Opening Project of the Key Laboratory of Biology and Genetic Improvement of Oil Crops, Ministry of Agriculture, P. R. China [2017007]; China Agriculture Research System [CARS-14]; Agricultural Science and Technology Innovation Project of Chinese Academy of Agricultural Sciences [CAAS-ASTIP-2013-OCRI]; Opening Project of the Huanghuaihai Key Laboratory of Cotton Genetic Improvement and Cultivation Physiology, Ministry of Agriculture, P. R. China [2016KL03]; Central Public-interest Scientific Institution Basal Research Fund [1610172018007]; Natural Science Foundation of Shandong Province of China [ZR2018LC014]	Opening Project of the Key Laboratory of Biology and Genetic Improvement of Oil Crops, Ministry of Agriculture, P. R. China; China Agriculture Research System; Agricultural Science and Technology Innovation Project of Chinese Academy of Agricultural Sciences; Opening Project of the Huanghuaihai Key Laboratory of Cotton Genetic Improvement and Cultivation Physiology, Ministry of Agriculture, P. R. China; Central Public-interest Scientific Institution Basal Research Fund; Natural Science Foundation of Shandong Province of China(Natural Science Foundation of Shandong Province)	This study was funded by the Opening Project of the Key Laboratory of Biology and Genetic Improvement of Oil Crops, Ministry of Agriculture, P. R. China (2017007), China Agriculture Research System (CARS-14), the Agricultural Science and Technology Innovation Project of Chinese Academy of Agricultural Sciences (CAAS-ASTIP-2013-OCRI), the Opening Project of the Huanghuaihai Key Laboratory of Cotton Genetic Improvement and Cultivation Physiology, Ministry of Agriculture, P. R. China (2016KL03), the Central Public-interest Scientific Institution Basal Research Fund (1610172018007) and the Natural Science Foundation of Shandong Province of China (ZR2018LC014). The funding bodies did not participate in the design of the study, data analysis, or writing of the manuscript.	Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Aida M, 1999, DEVELOPMENT, V126, P1563; Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Balazadeh S, 2010, PLANT SIGNAL BEHAV, V5, P733, DOI 10.4161/psb.5.6.11694; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dossa K, 2017, GENOM DATA, V11, P122, DOI 10.1016/j.gdata.2017.01.003; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Guan QM, 2014, PLANT CELL, V26, P438, DOI 10.1105/tpc.113.118927; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hibara K, 2003, PLANT J, V36, P687, DOI 10.1046/j.1365-313X.2003.01911.x; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Kim MJ, 2012, BIOCHEM J, V448, P353, DOI 10.1042/BJ20120244; Kim SG, 2008, PLANT SIGNAL BEHAV, V3, P877, DOI 10.4161/psb.3.10.6247; Kim SG, 2010, GENOMICS, V95, P56, DOI 10.1016/j.ygeno.2009.09.003; Kim YS, 2006, PLANT CELL, V18, P3132, DOI 10.1105/tpc.106.043018; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee S, 2012, PLANT J, V70, P831, DOI 10.1111/j.1365-313X.2012.04932.x; Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922; Li DH, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1099-y; Li S, 2017, PLANT PHYSIOL, V173, P1520, DOI 10.1104/pp.17.00018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meshi T, 1995, PLANT CELL PHYSIOL, V36, P1405; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Miyake Y, 2005, J AGR FOOD CHEM, V53, P22, DOI 10.1021/jf048743h; Mmadi MA, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120362; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Park J, 2011, PLANT PHYSIOL, V156, P537, DOI 10.1104/pp.111.177071; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Rushton PJ, 2008, PLANT PHYSIOL, V147, P280, DOI 10.1104/pp.107.114041; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Seo PJ, 2008, TRENDS PLANT SCI, V13, P550, DOI 10.1016/j.tplants.2008.06.008; Shen JB, 2017, SCI REP-UK, V7, DOI 10.1038/srep40641; Shiriga K, 2014, META GENE, V2, P407, DOI 10.1016/j.mgene.2014.05.001; Singh AK, 2013, DNA RES, V20, P403, DOI 10.1093/dnares/dst019; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Wang LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149912; Wang LH, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r39; Wang N, 2013, PLANT CELL REP, V32, P61, DOI 10.1007/s00299-012-1340-y; Wang YP, 2013, BIOINFORMATICS, V29, P1458, DOI 10.1093/bioinformatics/btt150; Wei X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02586-3; Wei X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9609; Willemsen V, 2008, DEV CELL, V15, P913, DOI 10.1016/j.devcel.2008.09.019; Wu YR, 2009, CELL RES, V19, P1279, DOI 10.1038/cr.2009.108; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Yoon HK, 2008, MOL CELLS, V25, P438; You J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122027; Yu JY, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-3, 10.1186/1471-2199-15-20]; Yu XW, 2016, PLANT CELL REP, V35, P613, DOI 10.1007/s00299-015-1907-5; Yu YC, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2647-x; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhao X, 2016, GENE, V586, P158, DOI 10.1016/j.gene.2016.04.028; Zhong RQ, 2010, TRENDS PLANT SCI, V15, P625, DOI 10.1016/j.tplants.2010.08.007	69	16	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199262	10.1371/journal.pone.0199262	http://dx.doi.org/10.1371/journal.pone.0199262			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927997	gold, Green Submitted, Green Published			2022-12-26	WOS:000435802500064
J	Maher, RL; Johnston, MA; Brandt, ME; Smith, TB; Correa, AMS				Maher, Rebecca L.; Johnston, Michelle A.; Brandt, Marilyn E.; Smith, Tyler B.; Correa, Adrienne M. S.			Depth and coral cover drive the distribution of a coral macroborer across two reef systems	PLOS ONE			English	Article							POLYCHAETE SPIROBRANCHUS-GIGANTEUS; INTERNAL BIOEROSION; CALCIUM-CARBONATE; WATER-QUALITY; PORITES; FRAMEWORK; ISLAND; MACROBIOEROSION; ACCRETION; PATTERNS	Bioerosion, the removal of calcium carbonate from coral frameworks by living organisms, influences a variety of reef features, from their topographic complexity to the net balance of carbonate budgets. Little is known, however, about how macroborers, which bore into reef substrates leaving traces greater than 0.1 mm diameter, are distributed across coral reefs, particularly reef systems with high (>50%) stony coral cover or at mesophotic depths (>= 30 m). Here, we present an accurate and efficient method for quantifying macroborer densities from stony coral hosts via image analysis, using the bioeroding barnacle, Lithotrya dorsalis, and its host coral, Orbicella franksi, as a case study. We found that in 2014, L. dorsalis densities varied consistently with depth and host percent cover in two Atlantic reef systems: the Flower Garden Banks (FGB, northwest Gulf of Mexico) and the U.S. Virgin Islands (USVI). Although average barnacle density was nearly 4.5 times greater overall in the FGB than in the USVI, barnacle density decreased with depth in both reef regions. Barnacle density also scaled negatively with increasing coral cover in the study areas, suggesting that barnacle populations are not strictly space-limited in their distribution and settlement opportunities. Our findings suggest that depth and host coral cover, and potentially, local factors may strongly influence the abundance of macroborers, and thus the rate of CaCO3 loss, in a given reef system. Our image analysis method for quantifying macroborers can be standardized across historical and modern reef records to better understand how borers impact host growth and reef health.	[Maher, Rebecca L.; Correa, Adrienne M. S.] Rice Univ, BioSci Rice, Houston, TX 77005 USA; [Maher, Rebecca L.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Johnston, Michelle A.] NOAA, Flower Garden Banks Natl Marine Sanctuary, Galveston, TX USA; [Brandt, Marilyn E.; Smith, Tyler B.] Univ Virgin Isl, Ctr Marine & Environm Studies, 2 John Brewers Bay, St Thomas, VI USA	Rice University; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of the Virgin Islands	Maher, RL (corresponding author), Rice Univ, BioSci Rice, Houston, TX 77005 USA.; Maher, RL (corresponding author), Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA.	maherr@oregonstata.edu		Maher, Rebecca/0000-0003-3108-8503	National Science Foundation [BIO-OCE 1800914]; Virgin Islands Established Program [0814417, 1355437]; National Oceanic and Atmospheric Administration's Coral Reef Conservation Program	National Science Foundation(National Science Foundation (NSF)); Virgin Islands Established Program; National Oceanic and Atmospheric Administration's Coral Reef Conservation Program	A Sigma Xi Grants-in-Aid of Research award (to R.M.) supported this work, with additional support from the National Science Foundation (BIO-OCE 1800914 to A.M.S.C.), the Virgin Islands Established Program to Stimulate Competitive Research (VI-EPSCoR, National Science Foundation #0814417 and #1355437 (TBS)), and the National Oceanic and Atmospheric Administrations Coral Reef Conservation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson Richard B., 2005, Gulf of Mexico Science, V23, P84; Bak R.P.M., 1976, Netherlands J Sea Res, V10, P285, DOI 10.1016/0077-7579(76)90009-0; BAK RPM, 1994, CORAL REEFS, V13, P99, DOI 10.1007/BF00300768; Barkley HC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500328; CHAZOTTES V, 1995, PALAEOGEOGR PALAEOCL, V113, P189, DOI 10.1016/0031-0182(95)00043-L; Chen TR, 2013, CORAL REEFS, V32, P101, DOI 10.1007/s00338-012-0946-4; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Clarke A.M., 2008, STATE CORAL REEF ECO, P189; Cooper TF, 2008, MAR FRESHWATER RES, V59, P703, DOI 10.1071/MF08016; Crook ED, 2013, P NATL ACAD SCI USA, V110, P11044, DOI 10.1073/pnas.1301589110; DAI CF, 1995, ZOOL STUD, V34, P117; DeCarlo TM, 2015, GEOLOGY, V43, P7, DOI 10.1130/G36147.1; Ennis RS, 2016, MAR POLLUT BULL, V111, P418, DOI 10.1016/j.marpolbul.2016.07.033; Enochs IC, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1742; Floros CD, 2005, AQUAT CONSERV, V15, P289, DOI 10.1002/aqc.666; Fonseca AC, 2006, REV BIOL TROP, V54, P101; Glynn Peter W., 1997, P68; Goreau TF, 1963, MECH HARD TISSUE DES, P22; Guadayol O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085213; HIGHSMITH RC, 1980, J EXP MAR BIOL ECOL, V46, P177, DOI 10.1016/0022-0981(80)90030-1; Holmes KE, 2000, INVERTEBR BIOL, V119, P125; HUBBARD DK, 1990, J SEDIMENT PETROL, V60, P335; Hubbard DK, 2012, SPECIAL PUBLICATION, V98, P1; HUNTE W, 1990, MAR BIOL, V104, P87, DOI 10.1007/BF01313161; Jafari MA, 2016, MAR POLLUT BULL, V105, P586, DOI 10.1016/j.marpolbul.2015.11.048; Johnston MA, 2016, LONG TERM MONITORING; Johnston MA, 2013, LONG TERM MONITORING, V1; Johnston MA, 2015, LONG TERM MONITORING; Kennedy EV, 2013, CURR BIOL, V23, P912, DOI 10.1016/j.cub.2013.04.020; KIENE WE, 1994, CORAL REEFS, V13, P91, DOI 10.1007/BF00300767; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Le Grand HM, 2011, CORAL REEFS, V30, P97, DOI 10.1007/s00338-010-0670-x; Londono-Cruz E, 2003, MAR ECOL PROG SER, V265, P289, DOI 10.3354/meps265289; Macdonald IA, 2003, CORAL REEFS, V22, P523, DOI 10.1007/s00338-003-0340-3; MACGEACHY J K, 1976, Internationale Revue der Gesamten Hydrobiologie, V61, P715, DOI 10.1002/iroh.19760610602; Moore C.H, 1977, Proceedings int Coral Reef Symp, V3, P499; NEUMANN AC, 1966, LIMNOL OCEANOGR, V11, P92, DOI 10.4319/lo.1966.11.1.0092; Perry CT, 2008, EARTH-SCI REV, V86, P106, DOI 10.1016/j.earscirev.2007.08.006; Perry CT, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.2018; Perry CT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2409; ReakaKudla ML, 1996, CORAL REEFS, V15, P101; RISK MJ, 1978, REV BIOL TROP, V26, P85; Risk MJ, 1993, REEF MONITORING MALD, P66; SAMMARCO PW, 1990, MAR ECOL PROG SER, V59, P145, DOI 10.3354/meps059145; Schmahl George R., 2008, V1, P221, DOI 10.1007/978-1-4020-6847-8_6; Schonberg CHL, 2017, ICES J MAR SCI, V74, P895, DOI 10.1093/icesjms/fsw254; SCOFFIN TP, 1980, B MAR SCI, V30, P475; SCOTT PJB, 1988, CORAL REEFS, V7, P145, DOI 10.1007/BF00300974; Silbiger NJ, 2017, ECOLOGY, V98, P2547, DOI 10.1002/ecy.1946; Silbiger NJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153058; Smith TB, 2010, CORAL REEFS, V29, P289, DOI 10.1007/s00338-009-0575-8; Smith TB, 2008, MAR POLLUT BULL, V56, P1983, DOI 10.1016/j.marpolbul.2008.08.015; Smith TB, 2016, US VIRGIN ISLANDS TE; Smith TB, 2016, GLOBAL CHANGE BIOL, V22, P2756, DOI 10.1111/gcb.13175; Steneck Robert S., 1994, P220; Tribollet A, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P435, DOI 10.1007/978-94-007-0114-4_25; Weinstein DK, 2016, MAR ECOL PROG SER, V559, P45, DOI 10.3354/meps11883; Weinstein DK, 2015, SEDIMENT GEOL, V329, P177, DOI 10.1016/j.sedgeo.2015.07.003; Weinstein DK, 2014, GEOMORPHOLOGY, V222, P14, DOI 10.1016/j.geomorph.2014.03.005; Weinstein DK, MESOPHOTIC CORAL ECO	60	8	8	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199462	10.1371/journal.pone.0199462	http://dx.doi.org/10.1371/journal.pone.0199462			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924857	Green Submitted, Green Published, gold			2022-12-26	WOS:000435655600068
J	Perez-Rodriguez, A; Batlle, J; Corrales, I; Borras, N; Rodriguez-Trillo, A; Loures, E; Cid, AR; Bonanad, S; Cabrera, N; Moret, A; Parra, R; Mingot-Castellano, ME; Navarro, N; Altisent, C; Perez-Montes, R; Marcellini, S; Moreto, A; Herrero, S; Soto, I; Mosteirin, NF; Jimenez-Yuste, V; Alonso, N; Jacob, AD; Fontanes, E; Campos, R; Paloma, MJ; Bermejo, N; Berrueco, R; Mateo, J; Arribalzaga, K; Marco, P; Palomo, A; Quismondo, NC; Inigo, B; Nieto, MD; Vidal, R; Martinez, MP; Aguinaco, R; Tenorio, M; Ferreiro, M; Garcia-Frade, J; Rodriguez-Huerta, AM; Cuesta, J; Rodriguez-Gonzalez, R; Garcia-Candel, F; Dobon, M; Aguilar, C; Batlle, F; Vidal, F; Lopez-Fernandez, MF				Perez-Rodriguez, Almudena; Batlle, Javier; Corrales, Irene; Borras, Nina; Rodriguez-Trillo, Angela; Loures, Esther; Rosa Cid, Ana; Bonanad, Santiago; Cabrera, Noelia; Moret, Andres; Parra, Rafael; Eva Mingot-Castellano, Maria; Navarro, Nira; Altisent, Carmen; Perez-Montes, Rocio; Marcellini, Shally; Moreto, Ana; Herrero, Sonia; Soto, Inmaculada; Fernandez Mosteirin, Nuria; Jimenez-Yuste, Victor; Alonso, Nieves; de Andres Jacob, Aurora; Fontanes, Emilia; Campos, Rosa; Jose Paloma, Maria; Bermejo, Nuria; Berrueco, Ruben; Mateo, Jose; Arribalzaga, Karmele; Marco, Pascual; Palomo, Angeles; Castro Quismondo, Nerea; Inigo, Belen; del Mar Nieto, Maria; Vidal, Rosa; Paz Martinez, Maria; Aguinaco, Reyes; Tenorio, Maria; Ferreiro, Maria; Garcia-Frade, Javier; Maria Rodriguez-Huerta, Ana; Cuesta, Jorge; Rodriguez-Gonzalez, Ramon; Garcia-Candel, Faustino; Dobon, Manuela; Aguilar, Carlos; Batlle, Fernando; Vidal, Francisco; Fernanda Lopez-Fernandez, Maria			Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project	PLOS ONE			English	Article							MOLECULAR DIAGNOSIS; MUTATIONS; BINDING; DOMAIN; CLASSIFICATION; MANAGEMENT; CHALLENGE; FREQUENCY; VARIANT	The multimeric analysis (MA) of plasma von Willebrand factor (VWF) evaluates structural integrity and helps in the diagnosis of von Willebrand disease (VWD). This assay is a matter of controversy, being considered by some investigators cumbersome and only slightly informative. The centralised study 'Molecular and Clinical Profile of von Willebrand Disease in Spain (PCM-EVW-ES)' has been carried out by including the phenotypic assessment and the genetic analysis by next generation sequencing (NGS) of the VWF gene (VWF). The aim of the present study was to evaluate the role of MA to the diagnosis of these patients and their potential discrepancies. Two hundred and seventy out of 480 patients centrally diagnosed with VWD had normal multimers, 168 had abnormal multimers and 42 a total absence of multimers. VWF MA was of great significance in the diagnosis of 83 patients (17.3%), it was also of help in the diagnosis achieved in 365 additional patients (76%) and was not informative in 32 cases (6.7%). With regard to discrepancies, 110 out of 480 (23%) patients centrally diagnosed with VWD presented some kind of discordance between VWF: RCo/VWF: Ag and/or VWF: CB/VWF: Ag ratios, multimeric study and/or genetic results. The VWF MA was key in the presence of novel mutations as well as in cases with phenotypic discrepancies. A comparison between the contribution of MA and VWF:CB showed a clearly higher contribution of the former in the diagnostic process. These data seem to reinforce the relevance of the VWF MA in VWD diagnosis, despite all its limitations.	[Perez-Rodriguez, Almudena; Batlle, Javier; Rodriguez-Trillo, Angela; Loures, Esther; Fernanda Lopez-Fernandez, Maria] Complexo Hosp Univ A Coruna, Serv Hematol, INIBIC, La Coruna, Spain; [Corrales, Irene; Borras, Nina; Vidal, Francisco] Banc Sang & Teixits, Barcelona, Spain; [Corrales, Irene; Borras, Nina; Parra, Rafael; Vidal, Francisco] Univ Autonoma Barcelona VHIR UAB, Unitat Hemofilia, Vali Hebron Res Inst, Barcelona, Spain; [Rosa Cid, Ana; Bonanad, Santiago; Cabrera, Noelia; Moret, Andres] Univ Hosp, Serv Hematol, Valencia, Spain; [Rosa Cid, Ana; Bonanad, Santiago; Cabrera, Noelia; Moret, Andres] Politecn La Fe, Valencia, Spain; [Parra, Rafael; Altisent, Carmen] Hosp Univ Vall Hebron, Serv Hematol, Barcelona, Spain; [Eva Mingot-Castellano, Maria] Hosp Reg Univ Malaga, Serv Hematol, Malaga, Spain; [Navarro, Nira] Hosp Univ Dr Negrin, Serv Hematol, Las Palmas Gran Canaria, Spain; [Perez-Montes, Rocio] Hosp Univ Marques Valdecilla, Serv Hematol, Santander, Spain; [Marcellini, Shally] Serv Hematol Salud Castilla & Leon, Segovia, Spain; [Moreto, Ana] Hosp Univ Cruces, Serv Hematol, Baracaldo, Spain; [Herrero, Sonia] Hosp Univ Guadalajara, Serv Hematol, Guadalajara, Spain; [Soto, Inmaculada] Hosp Univ Cent Asturias, Serv Hematol, Oviedo, Spain; [Fernandez Mosteirin, Nuria] Hosp Univ Miguel Servet, Serv Hematol, Zaragoza, Spain; [Jimenez-Yuste, Victor] Hosp Univ La Paz, Serv Hematol, Madrid, Spain; [Alonso, Nieves] Hosp Infanta Cristina, Serv Hematol, Badajoz, Spain; [de Andres Jacob, Aurora] Complexo Hosp Univ Santiago Compostela, Serv Hematol, Santiago, Spain; [Fontanes, Emilia] Hosp Univ Lucus Augusti, Serv Hematol, Lugo, Spain; [Campos, Rosa] Hosp Jerez Frontera, Serv Hematol, Cadiz, Spain; [Jose Paloma, Maria] Hosp Virgen Camino, Serv Hematol, Pamplona, Spain; [Bermejo, Nuria] Hosp San Pedro Alcantara, Serv Hematol, Caceres, Spain; [Berrueco, Ruben] Hosp San Juan Dios, Serv Hematol, Barcelona, Spain; [Mateo, Jose] Hosp Sta Creu & St Pau, Serv Hematol, Barcelona, Spain; [Arribalzaga, Karmele] Hosp Univ Fdn Alcorcon, Serv Hematol, Madrid, Spain; [Marco, Pascual] Hosp Gen Alicante, Serv Hematol, Alicante, Spain; [Castro Quismondo, Nerea] Hosp Univ 12 Octubre, Serv Hematol, Madrid, Spain; [Inigo, Belen] Hosp Clin San Carlos, Serv Hematol, Madrid, Spain; [del Mar Nieto, Maria] Complejo Hosp Jaen, Serv Hematol, Jaen, Spain; [Vidal, Rosa] Fdn Jimenez Diaz, Serv Hematol, Madrid, Spain; [Paz Martinez, Maria] Hosp Nuestra Sra Sonsoles, Serv Hematol, Avila, Spain; [Aguinaco, Reyes] Hosp Joan 23, Serv Hematol, Tarragona, Spain; [Tenorio, Maria] Hosp Ramon & Cajal, Serv Hematol, Madrid, Spain; [Ferreiro, Maria] Hosp Montecelo, Serv Hematol, Pontevedra, Spain; [Garcia-Frade, Javier] Hosp Rio Hortega, Serv Hematol, Valladolid, Spain; [Maria Rodriguez-Huerta, Ana] Hosp Gregorio Maranon, Serv Hematol, Madrid, Spain; [Cuesta, Jorge] Hosp Virgen Salud, Serv Hematol, Toledo, Spain; [Rodriguez-Gonzalez, Ramon] Hosp Severo Ochoa, Serv Hematol, Madrid, Spain; [Garcia-Candel, Faustino] Hosp Univ Virgen Arrixaca, Serv Hematol, Murcia, Spain; [Dobon, Manuela] Hosp Lozano Blesa, Serv Hematol, Zaragoza, Spain; [Aguilar, Carlos] Hosp Santa Barbara, Serv Hematol, Soria, Spain; [Batlle, Fernando] Lapisoft Project SL, Dept Res, La Coruna, Spain; [Vidal, Francisco] GIBER Enfermedades Cardiovasc CIBERCV, Barcelona, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Universitari Vall d'Hebron; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Cruces; Central University Hospital Asturias; Miguel Servet University Hospital; Hospital Universitario La Paz; Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitario Lucus Augusti-Lugo; Hospital Virgen del Camino; Servicio Navarro de Salud - Osasunbidea; University of Barcelona; Alcorcon Foundation University Hospital; General University Hospital of Alicante; Hospital Universitario 12 de Octubre; Hospital Clinico San Carlos; Complejo Hospitalario de Jaen; Universitat Rovira i Virgili; Hospital Universitario Ramon y Cajal; Complexo Hospitalario Universitario de Pontevedra; Hospital del Rio Hortega; General University Gregorio Maranon Hospital; Complejo Hospitalario de Toledo; Severo Ochoa University Hospital; Hospital Clinico Universitario Virgen de la Arrixaca; Lozano Blesa University Clinical Hospital	Batlle, J (corresponding author), Complexo Hosp Univ A Coruna, Serv Hematol, INIBIC, La Coruna, Spain.	francisco.javier.batlle.fonrodona@sergas.es	Bermejo, Nuria/O-1913-2019; Iñigo, Belén/AAA-1162-2019; Soto-Ortega, Inmaculada/AAD-9244-2020; Tillo, Angela Rodriguez/H-2337-2017; Bonanad, Santiago/O-6683-2018; Jimenez-Yuste, Victor/C-3762-2013; de Batlle, Jordi/G-6724-2016	Bermejo, Nuria/0000-0002-9661-0318; Iñigo, Belén/0000-0001-6372-1970; Soto-Ortega, Inmaculada/0000-0001-6396-4411; Tillo, Angela Rodriguez/0000-0002-6213-0906; Bonanad, Santiago/0000-0002-8390-8211; Jimenez-Yuste, Victor/0000-0003-3937-3499; Berrueco, Ruben/0000-0002-1068-7489; Marco, Pascual/0000-0002-3412-7566; Alonso, Maria Nieves/0000-0003-2759-9220; Corrales Insa, Irene/0000-0002-0647-0340; BATLLE, JAVIER/0000-0002-7931-2546; de Batlle, Jordi/0000-0003-3500-6608; Mateo, Jose/0000-0002-4227-3256; Moret, Andres/0000-0003-2984-7646	Baxalta [H16-32544, H13-000845]; Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII), Spain [PI12/01494, PI15/01643, RD12/0042/0053]; Fondo Europeo de Desarrollo Regional (FEDER)	Baxalta; Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII), Spain; Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government)	Research Grants (H16-32544) and (H13-000845) were from Baxalta, now part of Shire, and grants (PI12/01494, PI15/01643 and RD12/0042/0053) from Ministerio de Economia y Competitividad (MINECO)-Instituto de Salud Carlos III (ISCIII), Spain. CIBERCV is an initiative of ISCIII co-financed by Fondo Europeo de Desarrollo Regional (FEDER) a way to build Europe.	Batlle J, 2008, J THROMB HAEMOST, V6, P388, DOI 10.1111/j.1538-7836.2007.02853.x; Batlle J, 1989, COAGULATION BLEEDING, P325; Batlle J, 2016, THROMB HAEMOSTASIS, V115, P40, DOI 10.1160/TH15-04-0282; Batlle J, 2011, SEMIN THROMB HEMOST, V37, P503, DOI 10.1055/s-0031-1281036; Borras N, 2017, HAEMATOLOGICA, V102, P2005, DOI 10.3324/haematol.2017.168765; Budde U, 2008, J THROMB HAEMOST, V6, P762, DOI 10.1111/j.1538-7836.2008.02945.x; Budde U, 2006, SEMIN THROMB HEMOST, V32, P514, DOI 10.1055/s-2006-947866; Casana P, 2006, HAEMATOLOGICA, V91, P1130; Casonato A, 1998, AM J CLIN PATHOL, V109, P347, DOI 10.1093/ajcp/109.3.347; Casonato A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179566; Castaman G, 2013, HAEMATOLOGICA, V98, P667, DOI 10.3324/haematol.2012.077263; Corrales I, 2012, HAEMATOL-HEMATOL J, V97, P1003, DOI 10.3324/haematol.2011.055285; Corrales I, 2009, THROMB HAEMOSTASIS, V101, P570, DOI 10.1160/TH08-08-0500; Costa-Pinto J, 2014, HAEMOPHILIA, V20, P559, DOI 10.1111/hae.12380; De Jong A, 2016, J THROMB HAEMOST, V14, P449, DOI 10.1111/jth.13243; Favaloro EJ, 2017, AM J HEMATOL, V92, P114, DOI 10.1002/ajh.24556; Flood VH, 2015, BLOOD, V125, P2297, DOI 10.1182/blood-2014-11-610824; Flood VH, 2014, SEMIN THROMB HEMOST, V40, P41, DOI 10.1055/s-0033-1363166; Flood VH, 2013, CLIN CHEM, V59, P684, DOI 10.1373/clinchem.2012.199000; Goodeve A, 2008, BLOOD, V111, P3299; Hamilton A, 2011, THROMB HAEMOSTASIS, V105, P501, DOI 10.1160/TH10-08-0523; HILBERT L, 1995, BLOOD, V86, P1010; Leebeek FWG, 2016, NEW ENGL J MED, V375, P2067, DOI 10.1056/NEJMra1601561; Legendre P, 2013, BLOOD, V121, P2135, DOI 10.1182/blood-2012-09-456038; Michiels JJ, 2017, CLIN APPL THROMB-HEM, V23, P518, DOI 10.1177/1076029616647157; Penas N, 2005, AM J HEMATOL, V80, P188, DOI 10.1002/ajh.20470; Perez-Rodriguez A, 2009, HAEMATOL-HEMATOL J, V94, P679, DOI 10.3324/haematol.2008.003301; Ruggeri ZM, 2003, J THROMB HAEMOST, V1, P1335, DOI 10.1046/j.1538-7836.2003.00260.x; RUGGERI ZM, 1981, BLOOD, V57, P1140; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; Schneppenheim R, 2010, BLOOD, V115, P4894, DOI 10.1182/blood-2009-07-226324; Sidonio RF, 2017, HAEMOPHILIA, V23, P743, DOI 10.1111/hae.13292; Veyradier A, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003038	33	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0197876	10.1371/journal.pone.0197876	http://dx.doi.org/10.1371/journal.pone.0197876			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924855	Green Submitted, Green Published, gold			2022-12-26	WOS:000435655600007
J	Dai, N; Yu, XL; Fan, QL; Yuan, FL; Liu, LL; Sun, YC				Dai, Ning; Yu, Xiaoling; Fan, Qilei; Yuan, Fulai; Liu, Lele; Sun, Yuchun			Complete denture tooth arrangement technology driven by a reconfigurable rule	PLOS ONE			English	Article							CAD/CAM	The conventional technique for the fabrication of complete dentures is complex, with a long fabrication process and difficult-to-control restoration quality. In recent years, digital complete denture design has become a research focus. Digital complete denture tooth arrangement is a challenging issue that is difficult to efficiently implement under the constraints of complex tooth arrangement rules and the patient's individualized functional aesthetics. The present study proposes a complete denture automatic tooth arrangement method driven by a reconfigurable rule; it uses four typical operators, including a position operator, a scaling operator, a posture operator, and a contact operator, to establish the constraint mapping association between the teeth and the constraint set of the individual patient. By using the process reorganization of different constraint operators, this method can flexibly implement different clinical tooth arrangement rules. When combined with a virtual occlusion algorithm based on progressive iterative Laplacian deformation, the proposed method can achieve automatic and individual tooth arrangement. Finally, the experimental results verify that the proposed method is flexible and efficient.	[Dai, Ning; Yu, Xiaoling; Fan, Qilei; Yuan, Fulai; Liu, Lele] Nanjing Univ Aeronaut & Astronaut, Coll Mech & Elect Engn, Nanjing, Jiangsu, Peoples R China; [Sun, Yuchun] Peking Univ, Sch & Hosp Stomatol, Fac Prosthodont, Ctr Digital Dent, Beijing, Peoples R China	Nanjing University of Aeronautics & Astronautics; Peking University	Dai, N (corresponding author), Nanjing Univ Aeronaut & Astronaut, Coll Mech & Elect Engn, Nanjing, Jiangsu, Peoples R China.; Sun, YC (corresponding author), Peking Univ, Sch & Hosp Stomatol, Fac Prosthodont, Ctr Digital Dent, Beijing, Peoples R China.	dai_ning@nuaa.edu.cn; polarshining@163.com	, 孙玉春/AAX-5280-2020	Ning, Dai/0000-0002-3377-9976	Natural Science Foundation of Jiangsu Province, China [BK20161487]; Six talent peaks project in Jiangsu Province, China [GDZB-034]; National Natural Science Foundation of China [81271181]; Fundamental Research Funds for the Central Universities [NS2017029]; Jiangsu Province science and technology support plan project,China [BE2016010-4]; Foundation of Graduate Innovation Center in NUAA [kfjj20170520]	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Six talent peaks project in Jiangsu Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Jiangsu Province science and technology support plan project,China; Foundation of Graduate Innovation Center in NUAA	This study was supported by the Natural Science Foundation of Jiangsu Province, China (No. BK20161487) to Ning Dai, Six talent peaks project in Jiangsu Province, China(No. GDZB-034) to Ning Dai, the National Natural Science Foundation of China (No.81271181) to Yuchun Sun, the Fundamental Research Funds for the Central Universities (No.NS2017029) to Ning Dai, the Jiangsu Province science and technology support plan project,China (No. BE2016010-4) to Ning Dai, and Foundation of Graduate Innovation Center in NUAA (NO.kfjj20170520) to Lele Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Natural Science Foundation of Jiangsu Province, China (No. BK20161487), Six talent peaks project in Jiangsu Province, China (No. GDZB-034), the National Natural Science Foundation of China (No.81271181),the Fundamental Research Funds for the Central Universities (No.NS2017029), Jiangsu Province science and technology support plan project, China (No. BE2016010-4) and Foundation of Graduate Innovation Center in NUAA (NO.kfjj20170520). The authors would also like to thank the anonymous reviewers whose comments and suggestions helped improve the original manuscript.	Ahmat M. M., 2016, ARPN J ENG APPL SCI, V11, P5269; Alexa M, 2003, VISUAL COMPUT, V19, P105, DOI 10.1007/s00371-002-0180-0; Baba NZ, 2016, CURR ORAL HLTH REP, V3, P203; Bidra AS, 2013, J PROSTHET DENT, V109, P361, DOI 10.1016/S0022-3913(13)60318-2; Busch M, 2006, Int J Comput Dent, V9, P113; Ebert J, 2009, J DENT RES, V88, P673, DOI 10.1177/0022034509339988; Goodacre CJ, 2012, J PROSTHET DENT, V107, P34, DOI 10.1016/S0022-3913(12)60015-8; Gottschalk S., 1996, Computer Graphics Proceedings. SIGGRAPH '96, P171, DOI 10.1145/237170.237244; Lipman Y., 2004, P EUROGRAPHICS ACM S, P179; Logozzo S, 2014, OPT LASER ENG, V54, P203, DOI 10.1016/j.optlaseng.2013.07.017; Lu P, 2001, Zhonghua Kou Qiang Yi Xue Za Zhi, V36, P139; Maeda Y, 1994, Int J Prosthodont, V7, P17; Schaefer O, 2014, J DENT, V42, P677, DOI 10.1016/j.jdent.2014.01.016; Sun YC, 2009, COMPUT METH PROG BIO, V93, P266, DOI 10.1016/j.cmpb.2008.10.003; Wimmer T, 2016, J PROSTHET DENT, V115, P541, DOI 10.1016/j.prosdent.2015.10.016; Zhang S, 2014, P 25 ANN INT SOL FRE, P991; Zhang YD, 2011, J MED SYST, V35, P1421, DOI 10.1007/s10916-009-9419-x; Zhao T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163934	18	6	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198252	10.1371/journal.pone.0198252	http://dx.doi.org/10.1371/journal.pone.0198252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912886	Green Submitted, Green Published, gold			2022-12-26	WOS:000435528600020
J	Jean, G; Lafage-Proust, MH; Souberbielle, JC; Lechevallier, S; Deleaval, P; Lorriaux, C; Hurot, JM; Mayor, B; Mehdi, M; Chazot, C				Jean, Guillaume; Lafage-Proust, Marie Helene; Souberbielle, Jean Claude; Lechevallier, Sylvain; Deleaval, Patrik; Lorriaux, Christie; Hurot, Jean Marc; Mayor, Brice; Mehdi, Manolie; Chazot, Charles			Severe secondary hyperparathyroidism in patients on haemodialysis is associated with a high initial serum parathyroid hormone and beta-CrossLaps level: Results from an incident cohort	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; MINERAL METABOLISM; BONE BIOMARKERS; CALCIUM; PROGRESSION; OUTCOMES; CARE; CALCIFICATION; PHOSPHORUS; MORTALITY	Background Secondary hyperparathyroidism (SHPT) is a frequent complication of renal disease and most commonly occurs in patients on haemodialysis (HD) with metabolic, vascular, endocrine, and bone complications. The aim of this study was to analyze the evolution of mineral metabolism parameters during the first 36 months of HD treatment and identify the initial factors associated with severe SHPT. Methods Serum parathyroid hormone (PTH), calcium and phosphate levels were measured monthly; bone-specific alkaline phosphatase (b-ALP) and beta-CrossLaps (CTX) were measured biannually. Severe SHPT was defined as the need for cinacalcet treatment. Patients with less than 24 months of follow-up were excluded. Results One hundred thirty-three incident HD patients were included. Baseline mean PTH was 275 +/- 210 pg/mL. After an initial drop at the third month (172 +/- 133 pg/mL), the serum PTH level progressively increased to the maximum at 36 months (367 +/- 254 pg/mL). This initial drop was associated with the initial correction of both hypocalcaemia and hyperphosphataemia. Serum CTX and b-ALP revealed no significant changes over time. Severe SHPT was observed in 18% of patients and was associated with higher mean calcaemia and phosphataemia. In logistic regression, the initial factors associated with the risk of severe SHPT were: female sex, higher baseline PTH and CTX values. A receiver operation characteristic curve analysis identified a cut-off value of >374 pg/mL for baseline PTH and >1.2 pg/L for CTX for increased risk of developing severe SHPT. The relative risk of developing severe SHPT was 3.7 (1.8-7.5, p = 0.002) for high baseline CTX, 4.9 (2.4-9.7, p = 0.001) for high baseline PTH, and 7.7 (3.6-16, p<0.0001) when both criteria were present. Conclusion After an initial drop, a progressive increase in the serum PTH level during the first 3 years of HD treatment was observed despite aggressive therapy. High baseline levels of PTH and CTX increased the risk of developing severe SHPT.	[Jean, Guillaume; Deleaval, Patrik; Lorriaux, Christie; Hurot, Jean Marc; Mayor, Brice; Mehdi, Manolie; Chazot, Charles] NEPHROCARE Tassin Charcot, Haemodialysis, Sainte Foy Les Lyon, France; [Lafage-Proust, Marie Helene; Chazot, Charles] CHU St Etienne, INSERM 890, St Etienne, France; [Souberbielle, Jean Claude; Chazot, Charles] Univ Paris 05, INSERM, U845, Paris, France; [Souberbielle, Jean Claude; Chazot, Charles] Hop Necker Enfants Malad, Serv Explorat Fonct, Paris, France; [Lechevallier, Sylvain; Chazot, Charles] CERBALLIANCE, Lab Biol Med Grand Vallon, Sainte Foy Les Lyon, France; [Chazot, Charles] F CRIN INI CRCT Cardiovasc & Renal Clin Trialists, Nancy, France	CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Jean, G (corresponding author), NEPHROCARE Tassin Charcot, Haemodialysis, Sainte Foy Les Lyon, France.	guillaume-jean-crat@wanadoo.fr		Lafage-Proust, Marie-Helene/0000-0002-2091-3961; Jean, guillaume/0000-0003-4757-9956	NEPHROCARE (Fresenius Medical Care France); CERBALLIANCE	NEPHROCARE (Fresenius Medical Care France); CERBALLIANCE	NEPHROCARE (Fresenius Medical Care France) and CERBALLIANCE provided support in the form of salaries for authors GJ, PD, CL, JMH, BM, MM, CC and SL but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio M, 2012, J RENAL NUTR, V22, pS22, DOI 10.1053/j.jrn.2011.09.006; Basile C, 2012, AM J KIDNEY DIS, V59, P92, DOI 10.1053/j.ajkd.2011.08.033; Chertow GM, 2002, KIDNEY INT, V62, P245, DOI 10.1046/j.1523-1755.2002.00434.x; Delanaye P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12808-3; Delanaye P, 2014, NEPHROL DIAL TRANSPL, V29, P997, DOI 10.1093/ndt/gft275; Felsenfeld AJ, 2015, SEMIN DIALYSIS, V28, P564, DOI 10.1111/sdi.12411; Figurek A, 2017, ROM J INTERN MED, V55, P222, DOI 10.1515/rjim-2017-0021; Fouque D, 2013, NEPHROL DIAL TRANSPL, V28, P360, DOI 10.1093/ndt/gfs404; Hansen D, 2011, KIDNEY INT, V80, P841, DOI 10.1038/ki.2011.226; Jamal SA, 2013, LANCET, V382, P1268, DOI 10.1016/S0140-6736(13)60897-1; Jean G, 2007, CLIN NEPHROL, V68, P63; Jean G, 2017, NEPHROL THER, V13, P470, DOI 10.1016/j.nephro.2017.02.009; Jean G, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0365-9; Jean G, 2013, NEPHROL THER, V9, P154, DOI 10.1016/j.nephro.2013.02.006; Jean G, 2013, NEPHROL DIAL TRANSPL, V28, P176, DOI 10.1093/ndt/gfs119; Jean G, 2012, NEPHRON CLIN PRACT, V120, pC132, DOI 10.1159/000334424; Kandula P, 2011, CLIN J AM SOC NEPHRO, V6, P50, DOI 10.2215/CJN.03940510; KDIGO C-M, 2009, KIDNEY INT S113, V76, pS1, DOI DOI 10.1038/KI.2009.188; Ketteler M, 2017, KIDNEY INT, V92, P26, DOI 10.1016/j.kint.2017.04.006; Kovesdy CP, 2008, KIDNEY INT, V73, P1296, DOI 10.1038/ki.2008.64; Liabeuf S, 2017, NEPHROL DIAL TRANSPL, V32, P1737, DOI 10.1093/ndt/gfw409; Lishmanov A, 2012, INT UROL NEPHROL, V44, P541, DOI 10.1007/s11255-010-9897-2; LLACH F, 1990, KIDNEY INT, V38, pS62; Moranne O, 2009, J AM SOC NEPHROL, V20, P164, DOI 10.1681/ASN.2008020159; QI QL, 1995, AM J KIDNEY DIS, V26, P622, DOI 10.1016/0272-6386(95)90599-5; Quarles LD, 2003, J AM SOC NEPHROL, V14, P575, DOI 10.1097/01.ASN.0000050224.03126.AD; Reichel H, 2004, NEPHRON CLIN PRACT, V98, pC112, DOI 10.1159/000081552; Rodriguez M, 2005, CALCIUM SENSING RECE, V288, pF253, DOI [10.1152/ajprenal.00302.2004, DOI 10.1152/AJPRENAL.00302.2004]; Schumock GT, 2008, CURR MED RES OPIN, V24, P3037, DOI 10.1185/03007990802437943 ; Souberbielle JC, 2006, KIDNEY INT, V70, P345, DOI 10.1038/sj.ki.5001606; Tentori F, 2015, CLIN J AM SOC NEPHRO, V10, P98, DOI 10.2215/CJN.12941213; Wolf M, 2010, J AM SOC NEPHROL, V21, P1427, DOI 10.1681/ASN.2009121293; Yan JF, 2015, INT UROL NEPHROL, V47, P701, DOI 10.1007/s11255-015-0917-0; Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x	34	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199140	10.1371/journal.pone.0199140	http://dx.doi.org/10.1371/journal.pone.0199140			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912988	gold, Green Published, Green Submitted			2022-12-26	WOS:000435528600080
J	Kim, S; Lee, Y; Kim, JW; Son, YJ; Ma, MJ; Um, JH; Kim, ND; Min, SH; Kim, DI; Kim, BB				Kim, Sunghwan; Lee, Younho; Kim, Jun Woo; Son, Young-Jin; Ma, Min Jung; Um, Jee-Hyun; Kim, Nam Doo; Min, Sang Hyun; Kim, Dong Il; Kim, Brian B.			Discovery of a novel potent peptide agonist to adiponectin receptor 1	PLOS ONE			English	Article							FATTY-ACID OXIDATION; CERAMIDASE ACTIVITY; INSULIN-RESISTANCE; OBESITY; ADIPOR1	Activation of adiponectin receptors (AdipoRs) by its natural ligand, adiponectin has been known to be involved in modulating critical metabolic processes such as glucose metabolism and fatty acid oxidation as demonstrated by a number of in vitro and in vivo studies over last two decades. These findings suggest that AdipoRs' agonists could be developed into a potential therapeutic agent for metabolic diseases, such as diabetes mellitus, especially for type II diabetes, a long-term metabolic disorder characterized by high blood sugar, insulin resistance, and relative lack of insulin. Because of limitations in production of biologically active adiponectin, adiponectin-mimetic AdipoRs' agonists have been suggested as alternative ways to expand the opportunity to develop anti-diabetic agents. Based on crystal structure of AdipoR1, we designed AdipoR1's peptide agonists using protein-peptide docking simulation and screened their receptor binding abilities and biological functions via surface plasmon resonance (SPR) and biological analysis. Three candidate peptides, BHD1028, BHD43, and BHD44 were selected and confirmed to activate AdipoR1-mediated signal pathways. In order to enhance the stability and solubility of peptide agonists, candidate peptides were PEGylated. PEGylated BHD 1028 exhibited its biological activity at nano-molar concentration and could be a potential therapeutic agent for the treatment of diabetes. Also, SPR and virtual screening techniques utilized in this study may potentially be applied to other peptide-drug screening processes against membrane receptor proteins.	[Kim, Sunghwan; Kim, Jun Woo; Son, Young-Jin; Ma, Min Jung; Kim, Nam Doo; Min, Sang Hyun] Daegu Gyeongbuk Med Innovat Fdn, New Drug Dev Ctr, Daegu, South Korea; [Kim, Sunghwan] Polus Inc, R&D Ctr, 32 Songdogwahak Ro, Incheon, South Korea; [Lee, Younho] Yonsei Univ, Coll Pharm, 85 Songdogwahak Ro, Incheon, South Korea; [Lee, Younho] Yonsei Univ, Yonsei Inst Pharmaceut Sci, 85 Songdogwahak Ro, Incheon, South Korea; [Son, Young-Jin] Samhyun Inc, Dept New Drug Discovery, Daegu, South Korea; [Um, Jee-Hyun] Dong A Univ, Dept Biochem, Coll Med, Busan, South Korea; [Kim, Dong Il] Inha Univ, Dept Biol Engn, Incheon, South Korea; [Kim, Brian B.] EncuraGen Inc, R&D Ctr, Anyang, Gyeonggi Do, South Korea	Yonsei University; Yonsei University; Dong A University; Inha University	Kim, BB (corresponding author), EncuraGen Inc, R&D Ctr, Anyang, Gyeonggi Do, South Korea.	bkim@encuragen.com		Lee, Younho/0000-0002-4235-1269; Son, Young-Jin/0000-0002-0405-0924; Kim, Sunghwan/0000-0002-1927-9617	EncuraGen	EncuraGen	For this study, EncuraGen provided financial support for study design, research materials, data collection, analysis and salary for author B.B.K. Polus Inc. and Samhyun Inc. provided support in the form of salaries for S.K and Y.J.S, respectively. The specific roles of these authors are articulated in the 'author contributions' section.	Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Di L, 2015, AAPS J, V17, P134, DOI 10.1208/s12248-014-9687-3; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Holland WL, 2013, SCIENCE, V342, P1460, DOI 10.1126/science.1249077; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Ma LM, 2017, J ENZYM INHIB MED CH, V32, P624, DOI 10.1080/14756366.2017.1284067; Mancia F, 2004, STRUCTURE, V12, P1355, DOI 10.1016/j.str.2004.06.012; Min XS, 2012, FEBS LETT, V586, P912, DOI 10.1016/j.febslet.2012.02.024; Na DH, 2005, PHARM RES-DORDR, V22, P743, DOI 10.1007/s11095-005-2590-y; Narasimhan ML, 2005, MOL CELL, V17, P171, DOI 10.1016/j.molcel.2004.11.050; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Otvos L, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00093; Otvos L, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-90; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Pauletti GM, 1997, ADV DRUG DELIVER REV, V27, P235, DOI 10.1016/S0169-409X(97)00045-8; Shi YK, 2014, LANCET, V383, P1947, DOI 10.1016/S0140-6736(14)60886-2; Sun L, 2017, ARTERIOSCL THROM VAS, V37, P1290, DOI 10.1161/ATVBAHA.117.309630; Tanabe H, 2015, NATURE, V520, P312, DOI 10.1038/nature14301; Tanabe Hiroaki, 2015, Journal of Structural and Functional Genomics, V16, P11, DOI 10.1007/s10969-014-9192-z; Vasiliauskaite-Brooks I, 2017, NATURE, V544, P120, DOI 10.1038/nature21714; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557	26	19	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199256	10.1371/journal.pone.0199256	http://dx.doi.org/10.1371/journal.pone.0199256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912982	Green Published, gold, Green Submitted			2022-12-26	WOS:000435528600096
J	O'Suilleabhain, PS; Howard, S; Hughes, BM				O'Suilleabhain, Paraic S.; Howard, Siobhan; Hughes, Brian M.			Openness to experience and stress responsivity: An examination of cardiovascular and underlying hemodynamic trajectories within an acute stress exposure	PLOS ONE			English	Article							BLOOD-PRESSURE REACTIONS; ALL-CAUSE MORTALITY; ACUTE PSYCHOLOGICAL STRESS; MODEL PERSONALITY-TRAITS; INDIVIDUAL-DIFFERENCES; 5-FACTOR MODEL; MENTAL STRESS; FOLLOW-UP; REACTIVITY; HYPERTENSION	The personality trait openness to experience has been implicated in health, and in particular cardiovascular wellbeing. In a sample of 62 healthy young female adults, the role of openness in cardiovascular responsivity during a stress exposure was examined. Traditionally, methodologies have averaged a stress exposure into a single reading. This may be limited in that it does not consider patterns of cardiovascular adaptation within a stress exposure. Continuous cardiovascular data were reduced to mean 10 second readings, with phases determined through examinations of shifts in responsivity between each 10 second pairing. Analyses revealed a significant linear interaction for openness across the entire exposure for systolic blood pressure, and cardiac output. A significant between-subjects effect for heart rate also emerged. Contrary to their lower counterparts, those highest in openness exhibited an increasingly myocardial hemodynamic response profile throughout the exposure. Comparisons of responsivity suggests adaptive stress response trajectories for those highest in openness. This study also provides evidence that an attenuation of myocardial responsivity may underpin blunted responsivity. This study provides a potential mechanism in reported openness-health associations.	[O'Suilleabhain, Paraic S.; Hughes, Brian M.] Natl Univ Ireland, Sch Psychol, Galway, Ireland; [Howard, Siobhan] Univ Limerick, Dept Psychol, Limerick, Ireland	Ollscoil na Gaillimhe-University of Galway; University of Limerick	O'Suilleabhain, PS (corresponding author), Natl Univ Ireland, Sch Psychol, Galway, Ireland.	paraic.osuilleabhain@nuigalway.ie	Howard, Siobhan/AAV-9968-2021	Howard, Siobhan/0000-0002-1689-0867	National University of Ireland, Galway	National University of Ireland, Galway	This work was supported by funding from the National University of Ireland, Galway. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, CARDIOVASCULAR PSYCH, DOI DOI 10.4324/9781315081762; Bibbey A, 2013, INT J PSYCHOPHYSIOL, V90, P28, DOI 10.1016/j.ijpsycho.2012.10.018; Buss DM, 2009, PERSPECT PSYCHOL SCI, V4, P359, DOI 10.1111/j.1745-6924.2009.01138.x; Carroll D, 2001, PSYCHOSOM MED, V63, P737, DOI 10.1097/00006842-200109000-00006; CARROLL D, 1995, BRIT MED J, V310, P771, DOI 10.1136/bmj.310.6982.771; Carroll D, 2012, PSYCHOPHYSIOLOGY, V49, P1444, DOI 10.1111/j.1469-8986.2012.01463.x; Carroll D, 2012, INT J PSYCHOPHYSIOL, V85, P270, DOI 10.1016/j.ijpsycho.2012.04.001; Chida Y, 2010, HYPERTENSION, V55, P1026, DOI 10.1161/HYPERTENSIONAHA.109.146621; Christenfeld N, 1998, ANN BEHAV MED, V20, P317, DOI 10.1007/BF02886381; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa PT, 2007, REVISED NEO PERSONAL; Everson SA, 1996, HYPERTENSION, V27, P1059, DOI 10.1161/01.HYP.27.5.1059; Feldman PJ, 1999, J PERS SOC PSYCHOL, V77, P370, DOI 10.1037/0022-3514.77.2.370; Ferguson E, 2012, BRIT J HEALTH PSYCH, V17, P85, DOI 10.1111/j.2044-8287.2011.02055.x; FRANKISH J, 1991, HEALTH PSYCHOL, V10, P224, DOI 10.1037/0278-6133.10.3.224; Goodwin RD, 2006, J HEALTH PSYCHOL, V11, P643, DOI 10.1177/1359105306066610; Guelen I, 2003, BLOOD PRESS MONIT, V8, P27, DOI 10.1097/00126097-200302000-00006; Higgins NM, 2012, ANXIETY STRESS COPIN, V25, P381, DOI 10.1080/10615806.2011.616956; Hughes BM, 2001, STUD PSYCHOL, V43, P3; Hughes BM, 2013, ENCY BEHAV MED, P235; Hughes BM, 2011, BIOL PSYCHOL, V86, P129, DOI 10.1016/j.biopsycho.2010.03.015; Ironson GH, 2008, PSYCHOSOM MED, V70, P245, DOI 10.1097/PSY.0b013e31816422fc; Iwasa H, 2008, AM J GERIAT PSYCHIAT, V16, P399, DOI 10.1097/JGP.0b013e3181662ac9; James JE, 2012, BIOL PSYCHOL, V90, P161, DOI 10.1016/j.biopsycho.2012.02.021; Jayasinghe SU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169746; JENNINGS JR, 1992, PSYCHOPHYSIOLOGY, V29, P742, DOI 10.1111/j.1469-8986.1992.tb02052.x; Jonassaint CR, 2007, PSYCHOSOM MED, V69, P319, DOI 10.1097/PSY.0b013e318052e27d; Jonassaint CR, 2010, ETHNIC DIS, V20, P11; Lee EM, 2014, INT J PSYCHOPHYSIOL, V92, P79, DOI 10.1016/j.ijpsycho.2014.03.001; Lee HB, 2014, PSYCHOSOMATICS, V55, P352, DOI 10.1016/j.psym.2013.11.004; Lu W, 2016, INT J PSYCHOPHYSIOL, V106, P135, DOI 10.1016/j.ijpsycho.2016.05.004; Markovitz JH, 1998, PSYCHOSOM MED, V60, P186, DOI 10.1097/00006842-199803000-00014; MATTHEWS KA, 1993, HYPERTENSION, V22, P479, DOI 10.1161/01.HYP.22.4.479; MCCRAE RR, 1991, PERS SOC PSYCHOL B, V17, P227, DOI 10.1177/014616729101700217; McCrare RR, 2010, NEO INVENTORIES NEO; Newman JD, 1999, PSYCHOSOM MED, V61, P243, DOI 10.1097/00006842-199903000-00017; O Suilleabhain PS, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13023; O'Suilleabhain PS, 2018, J PSYCHOSOM RES, V110, P32, DOI 10.1016/j.jpsychores.2018.04.013; Palatini P, 2009, CURR HYPERTENS REP, V11, P199, DOI 10.1007/s11906-009-0035-4; PENAZ J., 1973, DIG 10 INT C MED BIO, V104; Phillips AC, 2013, INT J PSYCHOPHYSIOL, V90, P1, DOI 10.1016/j.ijpsycho.2013.02.002; Phillips AC, 2011, BIOL PSYCHOL, V86, P95, DOI 10.1016/j.biopsycho.2010.03.003; Phillips AC, 2009, J PSYCHOSOM RES, V67, P37, DOI 10.1016/j.jpsychores.2008.12.002; Schutte Aletta E, 2003, Blood Press Monit, V8, P195; Sesker AA, 2016, PERSONAL MENT HEALTH, V10, P29, DOI 10.1002/pmh.1323; Suilleabhain PO, 2014, PSYCHONEUROENDOCRINO, V50, P209, DOI 10.1016/j.psyneuen.2014.08.018; Sutin AR, 2011, PSYCHOL AGING, V26, P994, DOI 10.1037/a0024276; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Taylor MD, 2009, PSYCHOSOM MED, V71, P631, DOI 10.1097/PSY.0b013e3181a65298; Torres SJ, 2014, OBESITY FACTS, V7, P339, DOI 10.1159/000369854; Treiber FA, 1997, INT J BEHAV MED, V4, P278, DOI 10.1207/s15327558ijbm0404_2; Turiano NA, 2012, J AGING HEALTH, V24, P654, DOI 10.1177/0898264311431303; Turner J. R., 1994, CARDIOVASCULAR REACT, DOI 10.1007/978-1-4757-9579-0; TURNER JR, 1986, INT J PSYCHOPHYSIOL, V3, P307, DOI 10.1016/0167-8760(86)90039-5; Weston SJ, 2015, SOC PSYCHOL PERS SCI, V6, P309, DOI 10.1177/1948550614553248; Williams PG, 2009, J RES PERS, V43, P777, DOI 10.1016/j.jrp.2009.06.003	57	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199221	10.1371/journal.pone.0199221	http://dx.doi.org/10.1371/journal.pone.0199221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ6XV	29912932	Green Submitted, Green Published, gold			2022-12-26	WOS:000435528600092
J	Hall, MK; Weidner, DA; Whitman, AA; Schwalbe, RA				Hall, M. Kristen; Weidner, Douglas A.; Whitman, Austin A.; Schwalbe, Ruth A.			Lack of complex type N-glycans lessens aberrant neuronal properties	PLOS ONE			English	Article							PROTEIN GLYCOSYLATION; RAT-LIVER; SWAINSONINE; OLIGOSACCHARIDES; INHIBITOR; CANCER; SWEET; ALK	Modifications in surface glycans attached to proteins via N-acetylglucosamine-beta 1-Nasparagine linkage have been linked to tumor development and progression. These modifications include complex N-glycans with high levels of branching, fucose and sialic acid residues. Previously, we silenced Mgat2 in neuroblastoma (NB) cells, which halted the conversion of hybrid type N-glycans to complex type, to generate a novel cell line, NB_1 (-Mgat2). By comparing the aberrant cell properties of the NB_1 (- Mgat2) cell line to the parental cell line (NB_1), we investigated the impact of eliminating complex type N-glycans on NB cell behavior. Further, the N-glycosylation pathway in the NB_1 (- Mgat2) cell line was rescued by transiently transfecting cells with Mgat2, thus creating the NB_1 (-/+Mgat2) cell line. Changes in the N-glycosylation pathway were verified by enhanced binding of E-PHA and L-PHA to proteins in the rescued cell line relative to those of the NB_1 (- Mgat2) cell line. Also, western blotting of total membranes from the rescued cell line ectopically expressing a voltage-gated K+ channel (Kv3.1b) revealed that N-glycans of Kv3.1b were processed to complex type. By employment of various cell lines, we demonstrated that reduction of the complex type N-glycans diminished anchorage-independent cell growth, and enhanced cell-cell interactions. Two independent cell invasion assays showed that cell invasiveness was markedly lessened by lowering the levels of complex type N-glycans while cell mobility was only slightly modified. Neurites of NB cells were shortened by the absence of complex type N-glycans. Cell proliferation was reduced in NB cells with lowered levels of complex type N-glycans which resulted from hindered progression through G1+Go phases of the cell cycle. Overall, our results illustrate that reducing the ratio of complex to hybrid types of N-glycans diminishes aberrant NB cell behavior and thereby has a suppressive effect in cell proliferation, and cell dissociation and invasion phases of NB.	[Hall, M. Kristen; Whitman, Austin A.; Schwalbe, Ruth A.] East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27858 USA; [Weidner, Douglas A.] East Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Schwalbe, RA (corresponding author), East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27858 USA.	schwalber@ecu.edu		Schwalbe, Ruth/0000-0002-6839-7863	Department of Biochemistry and Molecular Biology, Brody School of Medicine; Wooten Laboratory grant; Open Access Publishing Support Fund at ECU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM129679] Funding Source: NIH RePORTER	Department of Biochemistry and Molecular Biology, Brody School of Medicine; Wooten Laboratory grant; Open Access Publishing Support Fund at ECU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Department of Biochemistry and Molecular Biology, Brody School of Medicine (to R.A.S), Wooten Laboratory grant (to R.A.S), and Open Access Publishing Support Fund at ECU (to R.A.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Berens EB, 2015, JOVE-J VIS EXP, DOI 10.3791/53409; Berois N, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00114; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; Brooks NL, 2006, FEBS J, V273, P3287, DOI 10.1111/j.1742-4658.2006.05339.x; Carvalho S, 2016, TRENDS CANCER, V2, P519, DOI 10.1016/j.trecan.2016.08.003; Del Grosso F, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-525; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; GOSS PE, 1994, CANCER RES, V54, P1450; Goss PE, 1997, CLIN CANCER RES, V3, P1077; Hall MK, 2014, BBA-GEN SUBJECTS, V1840, P595, DOI 10.1016/j.bbagen.2013.10.025; Hall MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019317; Hall M Kristen, 2017, J Glycobiol, V6, DOI 10.4172/2168-958X.1000128; Hall MK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060925; Hall MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137138; Hall MK, 2014, FEBS OPEN BIO, V4, P892, DOI 10.1016/j.fob.2014.10.006; Hall MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075013; Ho WL, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0334-6; Hu YL, 2015, J PROTEOME RES, V14, P2074, DOI 10.1021/pr5011718; Inamori K, 2006, FEBS LETT, V580, P627, DOI 10.1016/j.febslet.2005.12.089; Martin G. Steven, 2003, Cancer Cell, V4, P167, DOI 10.1016/S1535-6108(03)00216-2; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; NARASIMHAN S, 1986, CARBOHYD RES, V149, P65, DOI 10.1016/S0008-6215(00)90370-7; Passoni L, 2009, CANCER RES, V69, P7338, DOI 10.1158/0008-5472.CAN-08-4419; Shaheen PE, 2005, INVEST NEW DRUG, V23, P577, DOI 10.1007/s10637-005-0793-z; Stanley P., 2017, ESSENTIALS GLYCOBIOL; TULSIANI DRP, 1983, ARCH BIOCHEM BIOPHYS, V224, P594, DOI 10.1016/0003-9861(83)90247-3; TULSIANI DRP, 1983, J BIOL CHEM, V258, P7578; Varki A K R, 2017, ESSNTIALS GLYCOBIOLO; You N, 2012, ONCOL REP, V28, P2091, DOI 10.3892/or.2012.2035	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199202	10.1371/journal.pone.0199202	http://dx.doi.org/10.1371/journal.pone.0199202			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902282	gold, Green Published, Green Submitted			2022-12-26	WOS:000435424900099
J	Martin-Fores, I; Acosta-Gallo, B; Castro, I; de Miguel, JM; del Pozo, A; Casado, MA				Martin-Fores, Irene; Acosta-Gallo, Belen; Castro, Isabel; de Miguel, Jose M.; del Pozo, Alejandro; Casado, Miguel A.			The invasiveness of Hypochaeris glabra (Asteraceae): Responses in morphological and reproductive traits for exotic populations	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; RAPID EVOLUTION; NATIVE RANGE; ADAPTATION; DISPERSAL; CLIMATE; PLANTS; ENVIRONMENT; STRATEGIES; COMMON	Scientists have been interested in many topics driven by biological invasions, such as shifts in the area of distribution of plant species and rapid evolution. Invasiveness of exotic plant species depends on variations on morphological and reproductive traits potentially associated with reproductive fitness and dispersal ability, which are expected to undergo changes during the invasion process. Numerous Asteraceae are invasive and display dimorphic fruits, resulting in a bet-hedging dispersal strategy -wind-dispersed fruits versus animal-dispersed fruits-. We explored phenotypic differentiation in seed morphology and reproductive traits of exotic (Chilean) and native (Spanish) populations of Hypochaeris glabra. We collected flower heads from five Spanish and five Chilean populations along rainfall gradients in both countries. We planted seeds from the ten populations in a common garden trial within the exotic range to explore their performance depending on the country of origin (native or exotic) and the environmental conditions at population origin (precipitation and nutrient availability). We scored plant biomass, reproductive traits and fruit dimorphism patterns. We observed a combination of bet-hedging strategy together with phenotypic differentiation. Native populations relied more on bet-hedging while exotic populations always displayed greater proportion of wind-dispersed fruits than native ones. This pattern may reflect a strategy that might entail a more efficient long distance dispersal of H. glabra seeds in the exotic range, which in turn can enhance the invasiveness of this species.	[Martin-Fores, Irene] CSIC, Natl Museum Nat Sci BGC MNCN, Dept Biogeog & Global Change, Madrid, Spain; [Martin-Fores, Irene; Acosta-Gallo, Belen; de Miguel, Jose M.; Casado, Miguel A.] Univ Complutense Madrid, Dept Ecol, Madrid, Spain; [Castro, Isabel] Autonomous Univ Madrid, Dept Ecol, Madrid, Spain; [del Pozo, Alejandro] Univ Talca, Fac Agr Sci, Talca, Chile	Consejo Superior de Investigaciones Cientificas (CSIC); Complutense University of Madrid; Autonomous University of Madrid; Universidad de Talca	Martin-Fores, I (corresponding author), CSIC, Natl Museum Nat Sci BGC MNCN, Dept Biogeog & Global Change, Madrid, Spain.; Martin-Fores, I (corresponding author), Univ Complutense Madrid, Dept Ecol, Madrid, Spain.	imfores@pdi.ucm.es	Martín-Forés, Irene/F-3544-2016; Acosta-Gallo, Belén/F-6846-2016; Garcinuño, José Manuel/ABC-4953-2021	Martín-Forés, Irene/0000-0003-3627-0347; Garcinuño, José Manuel/0000-0002-9781-0872; ACOSTA GALLO, BELEN/0000-0003-0861-6072	Spanish Ministry of Science and Innovation [CGL2009-08718]; Spanish Ministry of Education, Culture and Sport [AP2009-0518]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education, Culture and Sport(Spanish Government)	This research was funded by Spanish Ministry of Science and Innovation (CGL2009-08718) (MAC) (http://www.mineco.gob.es/) and the Spanish Ministry of Education, Culture and Sport (AP2009-0518) (IMF) (https://www.mecd.gob.es/portada-mecd/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by Spanish Ministry of Science and Innovation (CGL2009-08718; grant recipient: Miguel A. Casado) and the Spanish Ministry of Education, Culture and Sport (AP2009-0518; grant recipient: Irene Martin-Fores). We would like to acknowledge the assistance of the entire INIA-Cauquenes Institution in central Chile to carry out the common garden trial. Useful and constructive comments to the manuscript were provided by two anonymous referees.	BAKER GA, 1982, J ECOL, V70, P201, DOI 10.2307/2259873; Barrett S. C. H., 1990, Plant population genetics, breeding, and genetic resources., P254; Barton K, 2018, MUMIN MULTIMODEL INF; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Buswell JM, 2011, J ECOL, V99, P214, DOI 10.1111/j.1365-2745.2010.01759.x; Carboni Marta, 2015, Hacquetia, V14, P5, DOI 10.1515/hacq-2015-0017; Cheptou PO, 2008, P NATL ACAD SCI USA, V105, P3796, DOI 10.1073/pnas.0708446105; Colautti RI, 2013, SCIENCE, V342, P364, DOI 10.1126/science.1242121; Cox GM, 2006, ECOL MODEL, V198, P240, DOI 10.1016/j.ecolmodel.2006.04.016; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; DiTomaso JM, 2007, WEEDS CALIFORNIA OTH, V3488; Fuentes N, 2013, BIOL INVASIONS, V15, P847, DOI 10.1007/s10530-012-0334-6; Harper J. L, 1977, POPULATION BIOL PLAN; Herman JJ, 2014, EVOLUTION, V68, P632, DOI 10.1111/evo.12324; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hufbauer RA, 2012, EVOL APPL, V5, P89, DOI 10.1111/j.1752-4571.2011.00211.x; Imbert E, 1996, INT J PLANT SCI, V157, P309, DOI 10.1086/297350; Jimenez MA, 2016, J ARID ENVIRON, V126, P62, DOI 10.1016/j.jaridenv.2015.10.014; Kumschick S, 2013, J ECOL, V101, P378, DOI 10.1111/1365-2745.12044; Kuznetsova A., 2017, LMERTEST TESTS LINEA; Lande R, 2009, J EVOLUTION BIOL, V22, P1435, DOI 10.1111/j.1420-9101.2009.01754.x; Lande R, 2015, MOL ECOL, V24, P2038, DOI 10.1111/mec.13037; Leishman MR, 2014, J ECOL, V102, P1451, DOI 10.1111/1365-2745.12318; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Maron JL, 2007, EVOLUTION, V61, P1912, DOI 10.1111/j.1558-5646.2007.00153.x; Martin-Fores I, 2012, PASTOS, V42, P135; Martin-Fores I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01457-1; Martin-Fores I, 2015, BIOL INVASIONS, V17, P1425, DOI 10.1007/s10530-014-0805-z; Mazerolle M. C., 2013, AICCMODAVG MODEL SEL; Monty A, 2010, OIKOS, V119, P1563, DOI 10.1111/j.1600-0706.2010.17769.x; Moran EV, 2014, ECOL LETT, V17, P637, DOI 10.1111/ele.12262; Moravcova L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123634; Ninyerola M, 2005, ATLAS CLIMATICO DIGI; Parker JD, 2013, ECOLOGY, V94, P985, DOI 10.1890/12-1810.1; Pysek P, 1998, OIKOS, V82, P282, DOI 10.2307/3546968; Pysek P, 2008, ECOLOGICAL STUDIES A, V193; Pysek P, 2009, DIVERS DISTRIB, V15, P891, DOI 10.1111/j.1472-4642.2009.00602.x; R Core Team, 2013, R LANG ENV STAT COMP; Richardson DM, 2012, NEW PHYTOL, V196, P383, DOI 10.1111/j.1469-8137.2012.04292.x; Sadzawka A., 2006, SERIE ACTAS I INVEST, V34, P1; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; SANBI [South African National Biodiversity Institute], 2016, BOT DAT SO AFR BODAT; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Simons AM., 2011, P ROY SOC LOND B BIO; SORENSEN AE, 1978, NATURE, V276, P174, DOI 10.1038/276174a0; Turner KG, 2014, NEW PHYTOL, V202, P309, DOI 10.1111/nph.12634; Valery L, 2008, BIOL INVASIONS, V10, P1345, DOI 10.1007/s10530-007-9209-7; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Van Molken T, 2005, AM J BOT, V92, P432, DOI 10.3732/ajb.92.3.432; Wilson JRU, 2016, NEOBIOTA, P87, DOI 10.3897/neobiota.31.9185; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Zuur Alain F., 2009, P1	56	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198849	10.1371/journal.pone.0198849	http://dx.doi.org/10.1371/journal.pone.0198849			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902275	Green Submitted, Green Published, gold			2022-12-26	WOS:000435424900048
J	Nagappan-Chettiar, S; Johnson-Venkatesh, EM; Umemori, H				Nagappan-Chettiar, Sivapratha; Johnson-Venkatesh, Erin M.; Umemori, Hisashi			Tyrosine phosphorylation of the transmembrane protein SIRP: Sensing synaptic activity and regulating ectodomain cleavage for synapse maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurodevelopment; synapse; hippocampus; tyrosine; phosphorylation; shedding; immunoglobulin superfamily; neural activity; synaptogenesis	DEPENDENT PROTEOLYTIC CLEAVAGE; CELL-ADHESION; HIPPOCAMPAL-NEURONS; NEGATIVE REGULATION; ALPHA; ACTIVATION; RAT; DIFFERENTIATION; CIRCUITS; SHP-2	Synapse maturation is a neural activity-dependent process during brain development, in which active synapses preferentially undergo maturation to establish efficient neural circuits in the brain. Defects in this process are implicated in various neuropsychiatric disorders. We have previously reported that a postsynaptic transmembrane protein, signal regulatory protein- (SIRP), plays an important role in activity-dependently directing synapse maturation. In the presence of synaptic activity, the ectodomain of SIRP is cleaved and released and then acts as a retrograde signal to induce presynaptic maturation. However, how SIRP detects synaptic activity to promote its ectodomain cleavage and synapse maturation is unknown. Here, we show that activity-dependent tyrosine phosphorylation of SIRP is critical for SIRP cleavage and synapse maturation. We found that during synapse maturation and in response to neural activity, SIRP is highly phosphorylated on its tyrosine residues in the hippocampus, a structure critical for learning and memory. Tyrosine phosphorylation of SIRP was necessary for SIRP cleavage and presynaptic maturation, as indicated by the fact that a phosphorylation-deficient SIRP variant underwent much less cleavage and could not drive presynaptic maturation. However, SIRP phosphorylation did not affect its synaptic localization. Finally, we show that inhibitors of the Src and JAK kinase family suppress neural activity-dependent SIRP phosphorylation and cleavage. Together, our results indicate that SIRP phosphorylation serves as a mechanism for detecting synaptic activity and linking it to the ectodomain cleavage of SIRP, which in turn drives synapse maturation in an activity-dependent manner.	[Nagappan-Chettiar, Sivapratha; Johnson-Venkatesh, Erin M.; Umemori, Hisashi] Boston Childrens Hosp, Dept Neurol, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Nagappan-Chettiar, Sivapratha; Umemori, Hisashi] Harvard Med Sch, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Umemori, H (corresponding author), Harvard Med Sch, Boston Childrens Hosp, 300 Longwood Ave,Ctr Life Sci 13074, Boston, MA 02115 USA.	hisashi.umemori@childrens.harvard.edu		Nagappan Chettiar, Sivapratha/0000-0003-4371-8090; Umemori, Hisashi/0000-0001-7198-2062	National Institutes of Health [R01-NS092578, R01-MH111647]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH111647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01-NS092578 and R01-MH111647 (to H. U.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alblas J, 2005, MOL CELL BIOL, V25, P7181, DOI 10.1128/MCB.25.16.7181-7192.2005; Atapattu L, 2012, J CELL SCI, V125, P6084, DOI 10.1242/jcs.112631; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Bemben MA, 2014, NAT NEUROSCI, V17, P56, DOI 10.1038/nn.3601; Bian Z, 2016, P NATL ACAD SCI USA, V113, pE5434, DOI 10.1073/pnas.1521069113; BROWNING MD, 1985, J NEUROCHEM, V45, P11, DOI 10.1111/j.1471-4159.1985.tb05468.x; Chia PH, 2013, J CELL BIOL, V203, P11, DOI 10.1083/jcb.201307020; Chiba T, 2009, MOL PSYCHIATR, V14, P206, DOI 10.1038/mp.2008.105; Dabrowski A, 2015, DEVELOPMENT, V142, P1818, DOI 10.1242/dev.115568; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Galbaugh T, 2010, MOL CANCER RES, V8, P1413, DOI 10.1158/1541-7786.MCR-10-0130; Hamada J, 2004, FEBS LETT, V557, P204, DOI 10.1016/S0014-5793(03)01493-5; Hashimoto K, 2013, CELL MOL LIFE SCI, V70, P4667, DOI 10.1007/s00018-013-1405-2; Holm CK, 2016, BIOCHEM BIOPH RES CO, V478, P268, DOI 10.1016/j.bbrc.2016.07.048; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Johnson-Venkatesh EM, 2010, EUR J NEUROSCI, V32, P181, DOI 10.1111/j.1460-9568.2010.07338.x; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Kim J, 2010, J BIOL CHEM, V285, P22917, DOI 10.1074/jbc.M110.126649; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lipska BK, 2002, J NEUROSCI, V22, P2835, DOI 10.1523/JNEUROSCI.22-07-02835.2002; Liu SQ, 2005, J BIOL CHEM, V280, P39294, DOI 10.1074/jbc.M503866200; Londino JD, 2015, J BIOL CHEM, V290, P31113, DOI 10.1074/jbc.M115.682914; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Maruyama T, 2012, J NEUROCHEM, V121, P891, DOI 10.1111/j.1471-4159.2012.07748.x; Meyer F, 2012, NEUROPSYCHOPHARMACOL, V37, P2233, DOI 10.1038/npp.2012.74; Motegi S, 2003, EMBO J, V22, P2634, DOI 10.1093/emboj/cdg278; Nagappan-Chettiar S, 2017, NEUROSCI RES, V116, P60, DOI 10.1016/j.neures.2016.12.003; Nakahata Y, 2000, J NEUROCHEM, V74, P2436, DOI 10.1046/j.1471-4159.2000.0742436.x; Neznanov N, 2003, J BIOL CHEM, V278, P3809, DOI 10.1074/jbc.M210698200; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; Niimura M, 2005, J NEUROCHEM, V92, P1377, DOI 10.1111/j.1471-4159.2005.02977.x; Ohnishi H, 2010, J NEUROSCI, V30, P10472, DOI 10.1523/JNEUROSCI.0257-10.2010; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Penzes P, 2013, J NEUROCHEM, V126, P165, DOI 10.1111/jnc.12261; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Siddiqui TJ, 2011, CURR OPIN NEUROBIOL, V21, P132, DOI 10.1016/j.conb.2010.08.016; Smith RE, 2003, BLOOD, V102, P2532, DOI 10.1182/blood-2002-11-3596; Stofega MR, 2000, J BIOL CHEM, V275, P28222; Stofega MR, 1998, J BIOL CHEM, V273, P7112, DOI 10.1074/jbc.273.12.7112; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Takada T, 1998, J BIOL CHEM, V273, P9234, DOI 10.1074/jbc.273.15.9234; Tang GM, 2014, NEURON, V83, P1131, DOI 10.1016/j.neuron.2014.07.040; Terauchi A, 2016, ELIFE, V5, DOI 10.7554/eLife.12151; Terauchi A, 2015, J CELL SCI, V128, P281, DOI 10.1242/jcs.158337; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Timms JF, 1998, MOL CELL BIOL, V18, P3838, DOI 10.1128/MCB.18.7.3838; Toth AB, 2013, NAT NEUROSCI, V16, P1417, DOI 10.1038/nn.3516; Umemori H, 1999, ONCOGENE, V18, P7399, DOI 10.1038/sj.onc.1203152; Umemori H, 2008, J BIOL CHEM, V283, P34053, DOI 10.1074/jbc.M805729200; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Yasuda M, 2011, NEURON, V70, P1128, DOI 10.1016/j.neuron.2011.04.027; Zhao H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1131-2	60	2	2	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12026	12042		10.1074/jbc.RA117.001488	http://dx.doi.org/10.1074/jbc.RA117.001488			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29914984	Green Published, hybrid			2022-12-26	WOS:000440803200005
J	Walsh, TJ; Shores, MM; Krakauer, CA; Forsberg, CW; Fox, AE; Moore, KP; Korpak, A; Heckbert, SR; Zeliadt, SB; Kinsey, CE; Thompson, ML; Smith, NL; Matsumoto, AM				Walsh, Thomas J.; Shores, Molly M.; Krakauer, Chloe A.; Forsberg, Christopher W.; Fox, Alexandra E.; Moore, Kathryn P.; Korpak, Anna; Heckbert, Susan R.; Zeliadt, Steven B.; Kinsey, Chloe E.; Thompson, Mary Lou; Smith, Nicholas L.; Matsumoto, Alvin M.			Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels	PLOS ONE			English	Article							REPLACEMENT THERAPY; HYPOGONADAL MEN; ANDROGEN DEFICIENCY; OLDER MEN; PREVALENCE; METAANALYSIS; OUTCOMES; ANTIGEN; TRENDS; SAFETY	Purpose Testosterone treatment of men with low testosterone is common and, although relatively short-term, has raised concern regarding an increased risk of prostate cancer (CaP). We investigated the association between modest-duration testosterone treatment and incident aggressive CaP. Materials and methods Retrospective inception cohort study of male Veterans aged 40 to 89 years with a laboratory-defined low testosterone measurement from 2002 to 2011 and recent prostate specific antigen (PSA) testing; excluding those with recent testosterone treatment, prostate or breast cancer, high PSA or prior prostate biopsy. Histologically-confirmed incident aggressive prostate cancer or any prostate cancer were the primary and secondary outcomes, respectively. Results Of the 147,593 men included, 58,617 were treated with testosterone. 313 aggressive CaPs were diagnosed, 190 among untreated men (incidence rate (IR) 0.57 per 1000 person years, 95% CI 0.49-0.65) and 123 among treated men (IR 0.58 per 1000 person years; 95% CI 0.48-0.69). After adjusting for age, race, hospitalization during year prior to cohort entry, geography, BMI, medical comorbidities, repeated testosterone and PSA testing, testosterone treatment was not associated with incident aggressive CaP (HR 0.89; 95% CI 0.70-1.13) or any CaP (HR 0.90; 95% CI 0.81-1.01). No association between cumulative testosterone dose or formulation and CaP was observed. Conclusions Among men with low testosterone levels and normal PSA, testosterone treatment was not associated with an increased risk of aggressive or any CaP. The clinical risks and benefits of testosterone treatment can only be fully addressed by large, longer-term randomized controlled trials.	[Walsh, Thomas J.; Shores, Molly M.; Heckbert, Susan R.; Thompson, Mary Lou; Smith, Nicholas L.] Univ Washington, Seattle, WA 98195 USA; [Walsh, Thomas J.; Shores, Molly M.; Krakauer, Chloe A.; Forsberg, Christopher W.; Fox, Alexandra E.; Moore, Kathryn P.; Korpak, Anna; Zeliadt, Steven B.; Kinsey, Chloe E.; Thompson, Mary Lou; Smith, Nicholas L.; Matsumoto, Alvin M.] VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; [Heckbert, Susan R.; Smith, Nicholas L.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Matsumoto, Alvin M.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Matsumoto, Alvin M.] VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Group Health Cooperative; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Walsh, TJ (corresponding author), Univ Washington, Seattle, WA 98195 USA.; Walsh, TJ (corresponding author), VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA.	walsht@uw.edu	Matsumoto, Alvin/AAH-6096-2020		National Institutes of Health National Institute on Aging [R01 AG042934-01]; Department of Veterans Affairs, VA Health Services Research and Development Service, VA Information Resource Center; Seattle Epidemiologic Research and Information Center of the Cooperative Studies Program within the VA Office of Research and Development, Seattle, Washington [SDR 02-237, 98-004]; NATIONAL INSTITUTE ON AGING [R01AG042934] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Veterans Affairs, VA Health Services Research and Development Service, VA Information Resource Center; Seattle Epidemiologic Research and Information Center of the Cooperative Studies Program within the VA Office of Research and Development, Seattle, Washington; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research is supported by grant R01 AG042934-01, National Institutes of Health National Institute on Aging to T.W.; Supported by grant R01 AG042934-01, National Institutes of Health National Institute on Aging. Support for VA/CMS data provided by the Department of Veterans Affairs, VA Health Services Research and Development Service, VA Information Resource Center and by the Seattle Epidemiologic Research and Information Center of the Cooperative Studies Program within the VA Office of Research and Development, Seattle, Washington (Project Numbers SDR 02-237 and 98-004). The authors have no conflicts of interest to declare. This work was supported with resources and the use of facilities at the VA Puget Sound Health Care System. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.	Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Araujo AB, 2004, J CLIN ENDOCR METAB, V89, P5920, DOI 10.1210/jc.2003-031719; Araujo AB, 2007, J CLIN ENDOCR METAB, V92, P4241, DOI 10.1210/jc.2007-1245; Baillargeon J, 2015, J UROLOGY, V194, P1612, DOI 10.1016/j.juro.2015.05.099; BEHRE HM, 1994, CLIN ENDOCRINOL, V40, P341; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Calof OM, 2005, J GERONTOL A-BIOL, V60, P1451, DOI 10.1093/gerona/60.11.1451; Cui Y, 2014, PROSTATE CANCER P D, V17, P132, DOI 10.1038/pcan.2013.60; Feneley MR, 2012, J SEX MED, V9, P2138, DOI 10.1111/j.1743-6109.2012.02808.x; FOWLER JE, 1981, J UROLOGY, V126, P372, DOI 10.1016/S0022-5347(17)54531-0; Gould DC, 2006, BJU INT, V98, P1, DOI 10.1111/j.1464-410X.2006.06191.x; Haider A, 2015, J UROLOGY, V193, P80, DOI 10.1016/j.juro.2014.06.071; Handelsman DJ, 2013, MED J AUSTRALIA, V199, P548, DOI 10.5694/mja13.10111; Kaplan AL, 2013, UROLOGY, V82, P321, DOI 10.1016/j.urology.2013.03.049; Khera M, 2011, J UROLOGY, V186, P1005, DOI 10.1016/j.juro.2011.04.065; Layton JB, 2014, J CLIN ENDOCR METAB, V99, P835, DOI 10.1210/jc.2013-3570; Loeb S, 2017, J CLIN ONCOL, V35, P1430, DOI 10.1200/JCO.2016.69.5304; Fernandez-Balsells MM, 2010, J CLIN ENDOCR METAB, V95, P2560, DOI 10.1210/jc.2009-2575; Mulligan T, 2006, INT J CLIN PRACT, V60, P762, DOI 10.1111/j.1742-1241.2006.00992.x; Schneider HJ, 2009, CLIN ENDOCRINOL, V70, P446, DOI 10.1111/j.1365-2265.2008.03370.x; Shabsigh R, 2009, INT J IMPOT RES, V21, P9, DOI 10.1038/ijir.2008.31; Shah BR, 2005, J CLIN EPIDEMIOL, V58, P550, DOI 10.1016/j.jclinepi.2004.10.016; Sharifi N, 2010, ENDOCR-RELAT CANCER, V17, pR305, DOI 10.1677/ERC-10-0187; Sih R, 1997, J CLIN ENDOCR METAB, V82, P1661, DOI 10.1210/jc.82.6.1661; Wallis CJD, 2016, LANCET DIABETES ENDO, V4, P498, DOI 10.1016/S2213-8587(16)00112-1; Walsh TJ, 2015, ANDROLOGY-US, V3, P287, DOI 10.1111/andr.12014; Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101	28	19	19	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199194	10.1371/journal.pone.0199194	http://dx.doi.org/10.1371/journal.pone.0199194			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933385	Green Submitted, gold, Green Published			2022-12-26	WOS:000436076600016
J	Korhonen, K; Einio, E; Leinonen, T; Tarkiainen, L; Martikainen, P				Korhonen, Kaarina; Einio, Elina; Leinonen, Taina; Tarkiainen, Lasse; Martikainen, Pekka			Time-varying effects of socio-demographic and economic factors on the use of institutional long-term care before dementia-related death: A Finnish register-based study	PLOS ONE			English	Article							NURSING-HOME PLACEMENT; OLDER-PEOPLE; LIVING ARRANGEMENTS; ALZHEIMERS-DISEASE; INCIDENT DEMENTIA; RISK-FACTORS; FOLLOW-UP; PREDICTORS; PROXIMITY; FINLAND	Objectives The effects of socio-demographic and economic factors on institutional long-term care (LTC) among people with dementia remain unclear. Inconsistent findings may relate to time varying effects of these factors as dementia progresses. To clarify the question, we estimated institutional LTC trajectories by age, marital status and household income in the eight years preceding dementia-related and non-dementia-related deaths. Methods We assessed a population-representative sample of Finnish men and women for institutional LTC over an eight-year period before death. Deaths related to dementia and all other causes at the age of 70+ in 2001-2007 were identified from the Death Register. Dates in institutional LTC were obtained from national care registers. We calculated the average and time-varying marginal effects of age, marital status and household income on the estimated probability of institutional LTC use, employing repeated-measures logistic regression models with generalised estimating equations (GEE). Results The effects of age, marital status and household income on institutional LTC varied across the time before death, and the patterns differed between dementia-related and non-dementia-related deaths. Among people who died of dementia, being of older age, non-married and having a lower income predicted a higher probability of institutional LTC only until three to four years before death, after which the differences diminished or disappeared. Among women in particular, the probability of institutional LTC was nearly equal across age, marital status and income groups in the last year before dementia-related death. Among those who died from non-dementia-related causes, in contrast, the differences widened until death. Conclusions We show that individuals with dementia require intensive professional care at the end of life, regardless of their socio-demographic or economic resources. The results imply that the potential for extending community living for people with dementia is likely to be difficult through modification of their socio-demographic and economic environments.	[Korhonen, Kaarina; Einio, Elina; Tarkiainen, Lasse; Martikainen, Pekka] Univ Helsinki, Fac Social Sci, Populat Res Unit, Helsinki, Finland; [Einio, Elina] London Sch Econ & Polit Sci, Dept Social Policy, London, England; [Einio, Elina; Martikainen, Pekka] Max Planck Inst Demog Res, Rostock, Germany; [Leinonen, Taina] Finnish Inst Occupat Hlth, Helsinki, Finland; [Martikainen, Pekka] Stockholm Univ, Dept Publ Hlth Sci, Stockholm, Sweden	University of Helsinki; University of London; London School Economics & Political Science; Max Planck Society; Finnish Institute of Occupational Health; Stockholm University	Korhonen, K (corresponding author), Univ Helsinki, Fac Social Sci, Populat Res Unit, Helsinki, Finland.	karina.korhonen@helsinki.fi		Korhonen, Kaarina/0000-0001-8499-2008	Eino Jutikkala Fund; Academy of Finland; Strategic Research Council PROMEQ project [303615]; European Union Horizon2020 Programme [667661]	Eino Jutikkala Fund; Academy of Finland(Academy of Finland); Strategic Research Council PROMEQ project; European Union Horizon2020 Programme	This work was funded by the Eino Jutikkala Fund (KK) and Academy of Finland (PM). KK & PM were also funded by the Strategic Research Council PROMEQ project (#303615). PM was also supported by the European Union Horizon2020 Programme under grant agreement n 667661 (Promoting mental wellbeing in the ageing population-MINDMAP). The study does not necessarily reflect the Commission's views and in no way anticipates the Commission's future policy in this area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero-Torres H, 2001, J CLIN EPIDEMIOL, V54, P795, DOI 10.1016/S0895-4356(00)00371-1; Andel R, 2007, J AGING HEALTH, V19, P213, DOI 10.1177/0898264307299359; [Anonymous], 2013, OECD FRAMEWORK STAT, DOI [10.1787/9789264194830-en, DOI 10.1787/9789264194830-EN]; Brayne C, 2006, PLOS MED, V3, P1922, DOI 10.1371/journal.pmed.0030397; Eska K, 2013, DEMENT GER COGN D EX, V3, P426, DOI 10.1159/000355079; Garcia-Ptacek S, 2016, J AM GERIATR SOC, V64, pE137, DOI 10.1111/jgs.14421; Gaugler JE, 2005, J AM GERIATR SOC, V53, P2098, DOI 10.1111/j.1532-5415.2005.00495.x; Gaugler JE, 2003, GERONTOLOGIST, V43, P219, DOI 10.1093/geront/43.2.219; Gaugler JE, 2009, MED CARE, V47, P191, DOI 10.1097/MLR.0b013e31818457ce; Hakkinen U, 2008, HEALTH ECON POLICY L, V3, P165, DOI 10.1017/S174413310800443X; Heyman A, 1997, NEUROLOGY, V48, P1304, DOI 10.1212/WNL.48.5.1304; Huang S-W, 2015, MEDICINE, P94, DOI [10.1097/114D.0000000000002155, DOI 10.1097/114D.0000000000002155]; Johansson, 2010, 76 ENEPRI; Jones DS, 2016, NEW ENGL J MED, V374, P507, DOI 10.1056/NEJMp1514434; Knapp M., 2007, DEMENTIA UK FULL REP; Luppa M, 2012, DEMENT GERIATR COGN, V33, P282, DOI 10.1159/000339729; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Martikainen P, 2012, J EPIDEMIOL COMMUN H, V66, P1152, DOI 10.1136/jech-2011-200756; Martikainen P, 2009, GERONTOLOGIST, V49, P34, DOI 10.1093/geront/gnp013; McCann M, 2011, AGE AGEING, V40, P358, DOI 10.1093/ageing/afr031; Mittelman MS, 2006, NEUROLOGY, V67, P1592, DOI 10.1212/01.wnl.0000242727.81172.91; Murphy M, 2013, SOC SCI MED, V88, P39, DOI 10.1016/j.socscimed.2013.03.042; Nihtila E, 2007, POP STUD-J DEMOG, V61, P299, DOI 10.1080/00324720701524193; Nihtila EK, 2008, EUR J PUBLIC HEALTH, V18, P77, DOI 10.1093/eurpub/ckm025; Norton MC, 2009, J GERONTOL B-PSYCHOL, V64, P560, DOI 10.1093/geronb/gbp052; Peeters JM, 2010, BMC NURS, V9, DOI 10.1186/1472-6955-9-9; Prince M, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0188-8; Schulze J, 2015, SOC PSYCH PSYCH EPID, V50, P143, DOI 10.1007/s00127-014-0911-3; Smith GE, 2000, J AM GERIATR SOC, V48, P519, DOI 10.1111/j.1532-5415.2000.tb04998.x; Solomon A, 2014, ALZHEIMERS DEMENT, V10, P303, DOI 10.1016/j.jalz.2013.03.004; StataCorp, 2015, STAT SOFTW REL 14; Tarricone R, 2008, HOME CARE EUROPE SOL; Todd S, 2013, INT J GERIATR PSYCH, V28, P1109, DOI 10.1002/gps.3946; Twisk JWR, 2003, APPL LONGITUDINAL DA; van de Vorst IE, 2016, AM J EPIDEMIOL, V184, P219, DOI 10.1093/aje/kwv319; Wattmo C, 2011, GERONTOLOGIST, V51, P17, DOI 10.1093/geront/gnq050; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209	37	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199551	10.1371/journal.pone.0199551	http://dx.doi.org/10.1371/journal.pone.0199551			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK0LV	29928067	gold, Green Published, Green Submitted			2022-12-26	WOS:000435802500108
J	Paul, KK; Dhar-Chowdhury, P; Haque, CE; Al-Amin, HM; Goswami, DR; Kafi, MAH; Drebot, MA; Lindsay, LR; Ahsan, GU; Brooks, WA				Paul, Kishor Kumar; Dhar-Chowdhury, Parnali; Haque, C. Emdad; Al-Amin, Hasan Mohammad; Goswami, Doli Rani; Kafi, Mohammad Abdullah Heel; Drebot, Michael A.; Lindsay, L. Robbin; Ahsan, Gias Uddin; Brooks, W. Abdullah			Risk factors for the presence of dengue vector mosquitoes, and determinants of their prevalence and larval site selection in Dhaka, Bangladesh	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; RIO-DE-JANEIRO; CONTAINER PRODUCTIVITY; CULICIDAE; TRANSMISSION; PUPAL; ALBOPICTUS; URBANIZATION; ASSOCIATION; CHIKUNGUNYA	Dengue viruses are responsible for over 100 million infections a year worldwide and are a public health concern in Bangladesh. Although risk of transmission is high, data on vector population characteristics are scanty in Bangladesh; therefore, a comprehensive prediction of the patterns of local virus transmission is not possible. Recognizing these gaps, multi-year entomological surveys were carried out in Dhaka, where the disease is most frequently reported. The specific objectives of the present study are threefold: i) to determine the risk factors for the presence of Aedes mosquitoes; ii) to identify the types of most productive and key containers; and iii) to estimate the effects of climatic factors on Aedes abundance in the city of Dhaka, Bangladesh. Entomological surveys were conducted in 12 out of 90 wards in Dhaka. These wards were selected using a probability proportional sampling procedure during the monsoon seasons in 2011, 2012 and 2013 and in the dry season in 2012. All containers inside and around sampled households were inspected for mosquito larvae and pupae, and containers were classified according to their relative size, use pattern, and materials of construction. During the study period (2011-2013), 12,680 larvae and pupae were collected. About 82% of the identified immature mosquitoes were Aedes aegypti, while the remainder were Ae. albopictus and other mosquito species. The largest number of immature mosquitoes was collected from tires and refrigerator trays during 2011 and 2012 monsoon seasons. Conversely, plastic drums were the most productive during the 2012 dry and 2013 monsoon season. Vehicle parts and discarded construction materials were the most efficient producers of Aedes mosquitoes in all surveys. The presence of Aedes mosquitoes was significantly (p < 0.05) higher in low socio-economic zones of Dhaka. Container location, presence of vegetation, and availability of shade for containers were also significantly associated with finding immature Aedes mosquitoes, based on multivariable analysis after confounder adjustment. Rainfall, temperature, and relative humidity also significantly affected the mean abundance of mosquitoes. Proper use, disposal, and recycling of the containers that effectively produce large numbers of Aedesvector mosquitoes may decrease the risk of arboviral transmission.	[Paul, Kishor Kumar; Al-Amin, Hasan Mohammad; Goswami, Doli Rani; Kafi, Mohammad Abdullah Heel] Int Ctr Diarrhoea Dis Res Bangladesh, Infect Dis Div, Program Emerging Infect, Dhaka, Bangladesh; [Dhar-Chowdhury, Parnali; Haque, C. Emdad] Univ Manitoba, Nat Resources Inst, Winnipeg, MB, Canada; [Dhar-Chowdhury, Parnali; Drebot, Michael A.; Lindsay, L. Robbin] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Ahsan, Gias Uddin] North South Univ, Dept Publ Hlth, Dhaka, Bangladesh; [Brooks, W. Abdullah] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	International Centre for Diarrhoeal Disease Research (ICDDR); University of Manitoba; Public Health Agency of Canada; North South University (NSU); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Paul, KK (corresponding author), Int Ctr Diarrhoea Dis Res Bangladesh, Infect Dis Div, Program Emerging Infect, Dhaka, Bangladesh.	kishorpaul@icddrb.org	Ahsan, Gias U/AAN-8794-2020; Brooks, W. Abdullah/AAD-3876-2021; Paul, Kishor Kumar/V-6320-2019	Brooks, W. Abdullah/0000-0001-9871-5546; Paul, Kishor Kumar/0000-0002-6054-3571; Ahsan, Gias U/0000-0003-0737-5940; Haque, Emdad/0000-0001-8008-2496; Kafi, Mohammad Abdullah Heel/0000-0002-6437-0161	International Development Research Centre (IDRC), Ottawa, Canada [106040-001]; Government of Bangladesh; Government of Canada; Government of Sweden; Government of UK	International Development Research Centre (IDRC), Ottawa, Canada(CGIAR); Government of Bangladesh; Government of Canada(CGIAR); Government of Sweden; Government of UK	This work was funded by International Development Research Centre (IDRC), Ottawa, Canada (https://www.idrc.ca/) (Grant no. 106040-001) to CEH. In addition, the Government of Bangladesh, Canada, Sweden and the UK provided core/unrestricted funding support for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Tauhid U., 2007, Bangladesh Journal of Zoology, V35, P205; [Anonymous], 2016, DAILY STAR; Banerjee S, 2013, INDIAN J MED RES, V137, P549; Bang DYH, 1987, REV DHF SITUATION CO; Barrera R, 2006, AM J TROP MED HYG, V74, P290, DOI 10.4269/ajtmh.2006.74.290; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Chadee DD, 2009, TROP MED INT HEALTH, V14, P220, DOI 10.1111/j.1365-3156.2008.02216.x; Chaves LF, 2011, J APPL ENTOMOL, V135, P611, DOI 10.1111/j.1439-0418.2010.01580.x; Cheong WH, 1986, BULLETIN, V23, P155; de Brito Arduino M, 2014, J INSECTS, V2014, P9; Dhar-Chowdhury P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005475; Dhar-Chowdhury P, 2016, AM J TROP MED HYG, V94, P1223, DOI 10.4269/ajtmh.15-0639; Dhar-Chowdhury P, 2014, INT HEALTH, V6, P306, DOI 10.1093/inthealth/ihu032; Dickerson CZ, 2007, THESIS; Ferdousi Farhana, 2015, Tropical Medicine and Health, V43, P253, DOI 10.2149/tmh.2015-16; Focks D., 2003, REV ENTOMOLOGICAL SA; Focks D.A., 2006, TDRIRMDEN061, V31, P192; Garelli FM, 2009, J MED ENTOMOL, V46, P1176, DOI 10.1603/033.046.0528; Hammond SN, 2007, J MED ENTOMOL, V44, P851, DOI 10.1603/0022-2585(2007)44[851:COAADC]2.0.CO;2; Hii YL, 2009, GLOBAL HEALTH ACTION, V2, P124, DOI 10.3402/gha.v2i0.2036; Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003; Hossain MA, 2003, EMERG INFECT DIS, V9, P1411, DOI 10.3201/eid0911.030117; Hsieh YH, 2009, TROP MED INT HEALTH, V14, P628, DOI 10.1111/j.1365-3156.2009.02277.x; Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263; Jeffery JAL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039067; Khan M, 1986, DENGUE NEWS LETTER, V12; Khatun S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003907; KITTAYAPONG P, 1993, J MED ENTOMOL, V30, P601, DOI 10.1093/jmedent/30.3.601; Knudsen AB, 1997, ASSIGNMENT REPORT DE, P35; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; LEE H L, 1987, Tropical Biomedicine, V4, P111; Lee H. L., 1991, Tropical Biomedicine, V8, P157; Lee HL, 1990, J BIOSCIENCE, V1, P107; Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301; Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056; Malik A, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-5902-x; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123; Nasir-ud-din M., 1952, Pakistan Journal of Health, V2, P110; NEEDHAM RD, 1990, CAN GEOGR-GEOGR CAN, V34, P133, DOI 10.1111/j.1541-0064.1990.tb01258.x; Nguyen LAP, 2011, INT HEALTH, V3, P115, DOI 10.1016/j.inhe.2010.11.002; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Phuanukoonnon S, 2005, TROP MED INT HEALTH, V10, P755, DOI 10.1111/j.1365-3156.2005.01452.x; Regis LN, 2014, ACTA TROP, V137, P80, DOI 10.1016/j.actatropica.2014.04.010; RUSSELL PK, 1966, AM J TROP MED HYG, V15, P573, DOI 10.4269/ajtmh.1966.15.573; Saifur RGM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030919; Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113; Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001; Seng CM, 2009, TROP MED INT HEALTH, V14, P1233, DOI 10.1111/j.1365-3156.2009.02368.x; Sharmin S, 2015, T ROY SOC TROP MED H, V109, P619, DOI 10.1093/trstmh/trv067; Strickman D, 2003, AM J TROP MED HYG, V68, P209, DOI 10.4269/ajtmh.2003.68.209; Su Ming-Daw, 1994, Kaohsiung Journal of Medical Sciences, V10, pS94; Tsuzuki A, 2009, AM J TROP MED HYG, V80, P752, DOI 10.4269/ajtmh.2009.80.752; TunLin W, 1995, AM J TROP MED HYG, V53, P591, DOI 10.4269/ajtmh.1995.53.591; Ulibarri Gerard, 2016, F1000Res, V5, P598, DOI 10.12688/f1000research.8461.3; Ullah M, 2015, THE DAILY SUN; Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100; Wu PC, 2007, ACTA TROP, V103, P50, DOI 10.1016/j.actatropica.2007.05.014; Yunus EB, 2001, DENGUE OUT BREAK 200	63	28	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199457	10.1371/journal.pone.0199457	http://dx.doi.org/10.1371/journal.pone.0199457			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928055	Green Submitted, gold, Green Published			2022-12-26	WOS:000435802500099
J	Bhardwaj, A; Ghose, D; Thakur, KG; Dutta, D				Bhardwaj, Amit; Ghose, Debarghya; Thakur, Krishan Gopal; Dutta, Dipak			Escherichia coli beta-clamp slows down DNA polymerase I dependent nick translation while accelerating ligation	PLOS ONE			English	Article							CHROMOSOMAL REPLICATION MACHINE; ONE HOLOENZYME PARTICLE; III HOLOENZYME; SLIDING-CLAMP; STRUCTURAL-PROPERTIES; KLENOW FRAGMENT; RNA-POLYMERASE; E. COLI; MECHANISM; STRAND	The nick translation property of DNA polymerase I (Pol I) ensures the maturation of Okazaki fragments by removing primer RNAs and facilitating ligation. However, prolonged nick translation traversing downstream DNA is an energy wasting futile process, as Pol I simultaneously polymerizes and depolymerizes at the nick sites utilizing energy-rich dNTPs. Using an in vitro assay system, we demonstrate that the beta-clamp of the Escherichia coli replisome strongly inhibits nick translation on the DNA substrate. To do so, beta-clamp inhibits the strand displacement activity of Pol I by interfering with the interaction between the finger subdomain of Pol I and the downstream primer-template junction. Conversely, beta-clamp stimulates the 5' exonuclease property of Pol I to cleave single nucleotides or shorter oligonucleotide flaps. This single nucleotide flap removal at high frequency increases the probability of ligation between the upstream and downstream DNA strands at an early phase, terminating nick translation. Besides beta-clamp-mediated ligation helps DNA ligase to seal the nick promptly during the maturation of Okazaki fragments.	[Bhardwaj, Amit; Ghose, Debarghya; Thakur, Krishan Gopal; Dutta, Dipak] CSIR, Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Dutta, D (corresponding author), CSIR, Inst Microbial Technol, Chandigarh, India.	dutta@imtech.res.in		Thakur, Krishan/0000-0003-4500-2133	Science and Engineering Research Board, Department of Science and Technology, India [SR/S2/RJN-20/2012]	Science and Engineering Research Board, Department of Science and Technology, India	This work has been supported by Science and Engineering Research Board, Department of Science and Technology, India (Grant number # SR/S2/RJN-20/2012; http://www.serb.gov.in/rnf.php) to DD. AB is a senior research fellow of Indian Council of Medical Research, India. DG is a senior research fellow of Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie TR, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00562; Bertram JG, 1998, J BIOL CHEM, V273, P24564, DOI 10.1074/jbc.273.38.24564; BONNER CA, 1992, J BIOL CHEM, V267, P11431; BURGERS PMJ, 1981, P NATL ACAD SCI-BIOL, V78, P5391, DOI 10.1073/pnas.78.9.5391; de Saro FJL, 2001, P NATL ACAD SCI USA, V98, P8376, DOI 10.1073/pnas.121009498; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Duzen JIM, 2004, DNA REPAIR, V3, P301, DOI 10.1016/j.dnarep.2003.11.008; GEFTER ML, 1971, P NATL ACAD SCI USA, V68, P3150, DOI 10.1073/pnas.68.12.3150; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; HALL KB, 1991, BIOCHEMISTRY-US, V30, P10606, DOI 10.1021/bi00108a002; Hayner JN, 2013, J BIOL CHEM, V288, P1162, DOI 10.1074/jbc.M112.406231; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Hingorani MM, 1999, EMBO J, V18, P5131, DOI 10.1093/emboj/18.18.5131; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; HUGHES AJ, 1991, J BIOL CHEM, V266, P4568; Indiani C, 2005, MOL CELL, V19, P805, DOI 10.1016/j.molcel.2005.08.011; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; Kornberg A, 1992, DNA REPLICATION, V19; Langston LD, 2006, MOL CELL, V23, P155, DOI 10.1016/j.molcel.2006.05.034; Leu FP, 2003, MOL CELL, V11, P315, DOI 10.1016/S1097-2765(03)00042-X; Lewis JS, 2016, ENZYMES, V39, P31, DOI 10.1016/bs.enz.2016.04.001; Lovett Susan T, 2011, EcoSal Plus, V4, DOI 10.1128/ecosalplus.4.4.7; LUNDQUIST RC, 1982, CELL, V31, P53, DOI 10.1016/0092-8674(82)90404-4; MAKI H, 1988, J BIOL CHEM, V263, P6570; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; Moolman MC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6820; NAKTINIS V, 1995, J BIOL CHEM, V270, P13358, DOI 10.1074/jbc.270.22.13358; O'Donnell M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010108; OGAWA T, 1980, ANNU REV BIOCHEM, V49, P421, DOI 10.1146/annurev.bi.49.070180.002225; ONRUST R, 1995, J BIOL CHEM, V270, P13366, DOI 10.1074/jbc.270.22.13366; Patel PH, 2001, J MOL BIOL, V308, P823, DOI 10.1006/jmbi.2001.4619; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Pritchard AE, 2000, EMBO J, V19, P6536, DOI 10.1093/emboj/19.23.6536; RATMEYER L, 1994, BIOCHEMISTRY-US, V33, P5298, DOI 10.1021/bi00183a037; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Singh K, 2007, J BIOL CHEM, V282, P10594, DOI 10.1074/jbc.M611242200; Srivastava A, 2003, BIOCHEMISTRY-US, V42, P3645, DOI 10.1021/bi026699y; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; Su'etsugu M, 2011, MOL CELL, V41, P720, DOI 10.1016/j.molcel.2011.02.024; Sutton MD, 2010, BBA-PROTEINS PROTEOM, V1804, P1167, DOI 10.1016/j.bbapap.2009.06.010; Sutton MD, 1999, P NATL ACAD SCI USA, V96, P12373, DOI 10.1073/pnas.96.22.12373; Tougu K, 1996, J BIOL CHEM, V271, P21398, DOI 10.1074/jbc.271.35.21398; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Turner RM, 2003, BIOCHEMISTRY-US, V42, P2373, DOI 10.1021/bi026566c; Vaisman A, 2014, MUTAT RES-FUND MOL M, V761, P21, DOI 10.1016/j.mrfmmm.2014.01.005; Wagner J, 2000, EMBO REP, V1, P484; Wang TCV, 2005, BIOESSAYS, V27, P633, DOI 10.1002/bies.20233; Xu Y, 1997, J MOL BIOL, V268, P284, DOI 10.1006/jmbi.1997.0967; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029; Zhao GJ, 2014, ACTA BIOCH BIOPH SIN, V46, P659, DOI 10.1093/abbs/gmu050	53	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199559	10.1371/journal.pone.0199559	http://dx.doi.org/10.1371/journal.pone.0199559			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924849	Green Submitted, Green Published, gold			2022-12-26	WOS:000435655600075
J	Lorbeer, R; Grotz, A; Dorr, M; Volzke, H; Lieb, W; Kuhn, JP; Mensel, B				Lorbeer, Roberto; Grotz, Andreas; Doerr, Marcus; Volzke, Henry; Lieb, Wolfgang; Kuehn, Jens-Peter; Mensel, Birger			Reference values of vessel diameters, stenosis prevalence, and arterial variations of the lower limb arteries in a male population sample using contrast-enhanced MR angiography	PLOS ONE			English	Article							INTERMITTENT CLAUDICATION; COMPUTED-TOMOGRAPHY; GENERAL-POPULATION; POPLITEAL ARTERY; ASSOCIATION; COHORT; RISK; IDENTIFICATION; DETERMINANTS; MORTALITY	Introduction Morphological characterization of leg arteries is of significant importance to detect vascular remodeling triggered by atherosclerotic changes. We determined reference values of vessel diameters and assessed prevalence of stenosis and arterial variations of the lower limb arteries in a healthy male population sample. Methods Gadolinium-enhanced magnetic resonance angiography at 1.5 Tesla was performed in 756 male participants ( median age = 52 years, range = 21 +/- 82 years) of the population-based Study of Health in Pomerania. Vessel diameters were measured in 9 predefined segments of the pelvic and leg arteries and 95th percentiles were used for upper reference values of means of left and right side arteries. Results Reference values of vascular diameters decreased from proximal to distal arteries: common iliac = 1.18cm; internal iliac = 0.75cm; external iliac = 1.03cm; proximal femoral = 1.02cm; distal femoral = 0.77cm; popliteal = 0.69cm; anterior tibial = 0.42cm; posterior tibial = 0.38cm; fibular = 0.40cm. Body-surface area indexed reference values increased with age in all segments. A number of 53 subjects (7.0%) had at least one stenosis, mainly in the lower leg arteries anterior tibial (n = 28, 3.7%), posterior tibial (n = 18, 2.4%) and fibular (n = 20, 2.6%). The risk of stenosis increased considerably with age (odds ratio = 1.08; p<0.001). The most common arterial variant was type I-A in both legs (n = 620, 82%).	[Lorbeer, Roberto] Ludwig Maximilian Univ Hosp, Dept Radiol, Munich, Germany; [Lorbeer, Roberto; Volzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Grotz, Andreas; Kuehn, Jens-Peter; Mensel, Birger] Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Doerr, Marcus] Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany; [Doerr, Marcus; Volzke, Henry] DZHK German Ctr Cardiovasc Res, Greifswald, Germany; [Volzke, Henry] DZD German Ctr Diabet Res, Greifswald, Germany; [Lieb, Wolfgang] Christian Albrecht Univ, Inst Epidemiol, Kiel, Germany	University of Munich; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; German Centre for Cardiovascular Research; University of Kiel	Mensel, B (corresponding author), Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany.	menselb@uni-greifswald.de	Lieb, Wolfgang/AAC-7650-2022; Dörr, Marcus/F-1919-2010	Dörr, Marcus/0000-0001-7471-475X	Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403, 01ZZ0701, 03ZIK012]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania; Bayer Healthcare; German Federal Ministry of Education and Research; Ministry of Cultural Affairs of the German Federal State of Mecklenburg-West Pomerania [03I52061A]; DZHK (German Centre for Cardiovascular Research)	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs of the German Federal State of Mecklenburg-West Pomerania; DZHK (German Centre for Cardiovascular Research)	SHIP is part of the Community Medicine Research network of the University of Greifswald which is funded by the Federal Ministry of Education and Research (www.bmbf.de/en/index. html, 01ZZ9603, 01ZZ0103, 01ZZ0403, 01ZZ0701, 03ZIK012), the Ministry of Cultural Affairs (www, regierung-mv.de/Landesregerung/bm) as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania (www.regerung-mv.de/Landesregerung/sm). Whole-body MR imaging was supported by a joint grant from Siemens Healthcare, Erlangen, Germany, and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the 'Center of Knowledge Interchange' program of Siemens AG. Contrast-enhanced MRI research is part of the entire whole-body MRI study and was supported by Bayer Healthcare. Furthermore, this work is part of the research project Greifswald Approach to Individualized Medicine (GANI_MED). The GANI-MED (http.//www2.medizin.uni-grerfswald.de/gani_med/) consortium is funded by the German Federal Ministry of Education and Research as well as by the Ministry of Cultural Affairs of the German Federal State of Mecklenburg-West Pomerania (03I52061A). This study was further supported by the DZHK (German Centre for Cardiovascular Research, https//dzhk.de/en/).	Collins R, 2007, BMJ-BRIT MED J, V334, P1257, DOI 10.1136/bmj.39217.473275.55; Day CP, 2006, CLIN RADIOL, V61, P696, DOI 10.1016/j.crad.2006.03.014; Diehm C, 2009, CIRCULATION, V120, P2053, DOI 10.1161/CIRCULATIONAHA.109.865600; DUBOIS D, 1989, NUTRITION, V5, P303; Golledge J, 2007, J VASC SURG, V45, P40, DOI 10.1016/j.jvs.2006.09.006; Green DJ, 2010, ATHEROSCLEROSIS, V210, P525, DOI 10.1016/j.atherosclerosis.2010.01.048; Hegenscheid K, 2009, ROFO-FORTSCHR RONTG, V181, P748, DOI 10.1055/s-0028-1109510; Herborn CU, 2004, AM J ROENTGENOL, V182, P1427, DOI 10.2214/ajr.182.6.1821427; HOREJS D, 1988, J COMPUT ASSIST TOMO, V12, P602, DOI 10.1097/00004728-198807000-00011; Huber A, 2000, AM J ROENTGENOL, V175, P1291, DOI 10.2214/ajr.175.5.1751291; Jensen SA, 2005, VASC MED, V10, P257, DOI 10.1191/1358863x05vm635oa; Jensen SA, 2008, VASC MED, V13, P239, DOI 10.1177/1358863X08094800; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; Kalsch H, 2013, INT J CARDIOL, V163, P72, DOI 10.1016/j.ijcard.2011.05.039; Kieback AG, 2012, VASA, V41, P105, DOI 10.1024/0301-1526/a000172; KIM D, 1989, ANN SURG, V210, P776, DOI 10.1097/00000658-198912000-00014; Kollerits B, 2008, ATHEROSCLEROSIS, V198, P214, DOI 10.1016/j.atherosclerosis.2007.09.012; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lorbeer R, 2015, J VASC INTERV RADIOL, V26, P635, DOI 10.1016/j.jvir.2014.12.022; Macchi Claudio, 1994, Italian Journal of Anatomy and Embryology, V99, P157; Rogers IS, 2013, AM J CARDIOL, V111, P1510, DOI 10.1016/j.amjcard.2013.01.306; Sandgren T, 1999, J VASC SURG, V29, P503, DOI 10.1016/S0741-5214(99)70279-X; Sandgren T, 1998, J VASC SURG, V28, P284, DOI 10.1016/S0741-5214(98)70164-8; Sandhu GS, 2010, AM J ROENTGENOL, V195, P858, DOI 10.2214/AJR.09.3766; Suttmeyer B, 2016, BIOMED ENG-BIOMED TE, V61, P383, DOI 10.1515/bmt-2014-0181; Suttmeyer B, 2014, BIOMED ENG-BIOMED TE, V59, P29, DOI 10.1515/bmt-2013-0113; Szpinda M, 2005, Folia Morphol (Warsz), V64, P315; Alzamora MT, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-119; van Melick N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189876; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394	30	21	21	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0197559	10.1371/journal.pone.0197559	http://dx.doi.org/10.1371/journal.pone.0197559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924802	Green Published, Green Submitted, gold			2022-12-26	WOS:000435655600005
J	Alcaniz, M; Guillen, M; Santolino, M				Alcaniz, Manuela; Guillen, Montserrat; Santolino, Miguel			Prevalence of drug use among drivers based on mandatory, random tests in a roadside survey	PLOS ONE			English	Article							ALCOHOL-IMPAIRED DRIVERS; UNITED-STATES; RISK PERCEPTIONS; DRIVING BEHAVIOR; SPANISH DRIVERS; VEHICLE CRASHES; ILLICIT DRUGS; YOUNG-ADULTS; ORAL FLUID; DRINKING	Background In the context of road safety, this study aims to examine the prevalence of drug use in a random sample of drivers. Methods A stratified probabilistic sample was designed to represent vehicles circulating on non-urban roads. Random drug tests were performed during autumn 2014 on 521 drivers in Catalonia (Spain). Participation was mandatory. The prevalence of drug driving for cannabis, methamphetamines, amphetamines, cocaine, opiates and benzodiazepines was assessed. Results The overall prevalence of drug use is 16.4% (95% CI: 13.9; 18.9) and affects primarily younger male drivers. Drug use is similarly prevalent during weekdays and on weekends, but increases with the number of occupants. The likelihood of being positive for methamphetamines is significantly higher for drivers of vans and lorries. Conclusions Different patterns of use are detected depending on the drug considered. Preventive drug tests should not only be conducted on weekends and at night-time, and need to be reinforced for drivers of commercial vehicles. Active educational campaigns should focus on the youngest age-group of male drivers.	[Alcaniz, Manuela; Guillen, Montserrat; Santolino, Miguel] Univ Barcelona, Riskctr IREA, Dept Econometr, Barcelona, Spain	University of Barcelona	Santolino, M (corresponding author), Univ Barcelona, Riskctr IREA, Dept Econometr, Barcelona, Spain.	msantolino@ub.edu	Guillen, Montserrat/E-1407-2011; SANTOLINO, MIGUEL/G-3984-2014; SANTOLINO, MIGUEL/AAL-5858-2021	Guillen, Montserrat/0000-0002-2644-6268; SANTOLINO, MIGUEL/0000-0002-0286-3673; SANTOLINO, MIGUEL/0000-0002-0286-3673	Catalan Traffic Service; Spanish Ministry of Economy and Competitiveness [EC02015-66314-R, EC02016-76203-C2-2-P]	Catalan Traffic Service; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This study was supported by the Catalan Traffic Service and the Spanish Ministry of Economy and Competitiveness under Grants EC02015-66314-R and EC02016-76203-C2-2-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari P, 1998, NATL DRUG STRATEGY H, V6, P82; Alcaniz M, 2016, TRANSPORT RES F-TRAF, V42, P522, DOI 10.1016/j.trf.2016.09.031; Alcaniz M, 2014, ACCIDENT ANAL PREV, V65, P131, DOI 10.1016/j.aap.2013.12.021; [Anonymous], 2009, SAMPLING DESIGN ANAL; Asbridge M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e536; Ayuso M, 2016, RISKS, V4, DOI 10.3390/risks4020010; Begg DJ, 2004, ACCIDENT ANAL PREV, V36, P1067, DOI 10.1016/j.aap.2004.03.001; Behnood A, 2017, TRAFFIC INJ PREV, V18, P456, DOI 10.1080/15389588.2016.1262540; Beirness DJ, 2010, TRAFFIC INJ PREV, V11, P215, DOI 10.1080/15389581003735626; Bergen Gwen, 2011, Morbidity and Mortality Weekly Report, V60, P1351; Berning A, 2015, J DRUG ADDICT ED ERA; Blencowe T, 2011, FORENSIC SCI INT, V208, P173, DOI 10.1016/j.forsciint.2010.11.026; Brady JE, 2014, AM J EPIDEMIOL, V179, P692, DOI 10.1093/aje/kwt327; Calafat A, 2009, TRAFFIC INJ PREV, V10, P162, DOI 10.1080/15389580802597054; Callaghan RC, 2013, ACCIDENT ANAL PREV, V53, P149, DOI 10.1016/j.aap.2013.01.008; Cao LQ, 2012, J CRIM JUST, V40, P296, DOI 10.1016/j.jcrimjus.2012.04.002; Choi NG, 2016, GERONTOLOGIST, V56, P282, DOI 10.1093/geront/gnu070; Chulia H, 2016, J STUD ALCOHOL DRUGS, V77, P413, DOI 10.15288/jsad.2016.77.413; Couper FJ, 2014, J ANAL TOXICOL, V38, P569, DOI 10.1093/jat/bku090; Couper FJ, 2002, J FORENSIC SCI, V47, P562; de Castro A, 2014, DRUG TEST ANAL, V6, P1011, DOI 10.1002/dta.1605; Degenhardt L, 2006, INT J DRUG POLICY, V17, P41, DOI 10.1016/j.drugpo.2005.12.004; Domingo-Salvany A, 2017, FORENSIC SCI INT, V278, P253, DOI 10.1016/j.forsciint.2017.07.005; Elliot D., 1987, ALCOHOL DRUGS DRIV, V3, P31; Fergusson DM, 2006, ADDICTION, V101, P556, DOI 10.1111/j.1360-0443.2005.01322.x; Fierro I, 2015, INT J DRUG POLICY, V26, P794, DOI 10.1016/j.drugpo.2015.04.021; Gjerde H, 2008, ACCIDENT ANAL PREV, V40, P1765, DOI 10.1016/j.aap.2008.06.015; Gomez-Talegon T, 2012, FORENSIC SCI INT, V223, P106, DOI 10.1016/j.forsciint.2012.08.012; Huestis MA, 2015, ADDICTION, V110, P1697, DOI 10.1111/add.13041; Institoris L, 2013, FORENSIC SCI INT, V224, P37, DOI 10.1016/j.forsciint.2012.10.022; Kelley-Baker T, 2013, TRAFFIC INJ PREV, V14, P117, DOI 10.1080/15389588.2012.697229; Kelly E, 2004, DRUG ALCOHOL REV, V23, P319, DOI 10.1080/09595230412331289482; Kuypers KPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043496; Lacey JH, 2011, EVALUATION REV, V35, P319, DOI 10.1177/0193841X11422446; Li MC, 2012, EPIDEMIOL REV, V34, P65, DOI 10.1093/epirev/mxr017; Logan B, 2015, FINAL REPORT VERMONT; Longo MC, 2000, ACCIDENT ANAL PREV, V32, P613, DOI 10.1016/S0001-4575(99)00111-6; Moore C, 2013, J ANAL TOXICOL, V37, P305, DOI 10.1093/jat/bkt022; Ojaniemi KK, 2009, ACCIDENT ANAL PREV, V41, P191, DOI 10.1016/j.aap.2008.10.011; Palk G, 2011, TRANSPORT RES F-TRAF, V14, P147, DOI 10.1016/j.trf.2010.11.004; Perkins HW, 2010, ADDICT BEHAV, V35, P866, DOI 10.1016/j.addbeh.2010.05.004; Robertson AA, 2011, ACCIDENT ANAL PREV, V43, P1414, DOI 10.1016/j.aap.2011.02.017; SAS Institute Inc, 2009, SAS STAT SOFTW REL 9; Schulze H, 2012, DRUID FINAL REPORT W; Sweedler Barry M., 2009, P23, DOI 10.1007/978-3-7643-9923-8_2; Szwarcwald Célia Landmann, 2008, Rev. bras. epidemiol., V11, P38, DOI 10.1590/S1415-790X2008000500004; Tjaderborn M, 2016, DRUG ALCOHOL DEPEN, V161, P77, DOI 10.1016/j.drugalcdep.2016.01.031; Dols ST, 2010, ACCIDENT ANAL PREV, V42, P2024, DOI 10.1016/j.aap.2010.06.013; United Nations Office on Drugs and Crime, WORLD DRUG REP 2014; Valen A, 2017, FORENSIC SCI INT, V280, P15, DOI 10.1016/j.forsciint.2017.09.010; Vanlaar W, 2005, ACCIDENT ANAL PREV, V37, P391, DOI 10.1016/j.aap.2004.12.001; Vanlaar W, 2008, ACCIDENT ANAL PREV, V40, P1018, DOI 10.1016/j.aap.2007.11.007; Voas RB, 2013, DRUG ALCOHOL DEPEN, V132, P69, DOI 10.1016/j.drugalcdep.2013.01.014; Walsh JM, 2008, ADDICTION, V103, P1258, DOI 10.1111/j.1360-0443.2008.02277.x; Wong Kristin, 2014, Inj Epidemiol, V1, P26	55	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199302	10.1371/journal.pone.0199302	http://dx.doi.org/10.1371/journal.pone.0199302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ7CA	29920542	gold, Green Published			2022-12-26	WOS:000435541300033
J	Mikos, V; Yen, SC; Tay, A; Heng, CH; Chung, CLH; Liew, SHX; Tana, DML; Au, WL				Mikos, Val; Yen, Shih-Cheng; Tay, Arthur; Heng, Chun-Huat; Chung, Chloe Lau Ha; Liew, Sylvia Hui Xin; Tana, Dawn May Leng; Au, Wing Lok			Regression analysis of gait parameters and mobility measures in a healthy cohort for subject-specific normative values	PLOS ONE			English	Article							WALKING SPEED; ELDERLY-PEOPLE; OLDER-ADULTS; PARKINSON DISEASE; GO TEST; NORMALIZATION; COMMUNITY; PERFORMANCE; AGE; CLASSIFICATION	Background Deviation in gait performance from normative data of healthy cohorts is used to quantify gait ability. However, normative data is influenced by anthropometry and such differences among subjects impede accurate assessment. De-correlation of anthropometry from gait parameters and mobility measures is therefore desirable. Methods 87 (42 male) healthy subjects varying form 21 to 84 years of age were assessed on gait parameters (cadence, ankle velocity, stride time, stride length) and mobility measures (the 3-meter/7-meter Timed Up-and-Go, 10-meter Walk Test). Multiple linear regression models were derived for each gait parameter and mobility measure, with anthropometric measurements (age, height, body mass, gender) and self-selected walking speed as independent variables. The resulting models were used to normalize the gait parameters and mobility measures. The normalization's capability in de-correlating data and reducing data dispersion were evaluated. Results Gait parameters were predominantly influenced by height and walking speed, while mobility measures were affected by age and walking speed. Normalization de-correlated data from anthropometric measurements from Id < 0.74 to Id < 0.23, and reduced data dispersion by up to 69%. Conclusion Normalization of gait parameters and mobility measures through linear regression models augment the capability to compare subjects with varying anthropometric measurements.	[Mikos, Val; Yen, Shih-Cheng; Tay, Arthur; Heng, Chun-Huat] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore, Singapore; [Chung, Chloe Lau Ha; Liew, Sylvia Hui Xin] Tan Tock Seng Hosp, Dept Physiotherapy, Singapore, Singapore; [Tana, Dawn May Leng] Singapore Gen Hosp, Dept Physiotherapy, Singapore, Singapore; [Au, Wing Lok] Natl Neurosci Inst, Dept Neurol, Singapore, Singapore	National University of Singapore; Tan Tock Seng Hospital; Singapore General Hospital; National Neuroscience Institute (NNI)	Au, WL (corresponding author), Natl Neurosci Inst, Dept Neurol, Singapore, Singapore.	au.ming.lok@singhealth.com.sg	Yen, Shih-Cheng/AAU-6487-2021	Yen, Shih-Cheng/0000-0001-7723-0072; Tay, Arthur/0000-0002-3197-2369	Singapore Millennium Foundation Limited; National Medical Research Council of Singapore (Translational and Clinical Research Flagship Programme); NUS MOE Tier 1 grant [R263-000-A42-112]	Singapore Millennium Foundation Limited; National Medical Research Council of Singapore (Translational and Clinical Research Flagship Programme); NUS MOE Tier 1 grant	The study was supported by research grants from the Singapore Millennium Foundation Limited, the National Medical Research Council of Singapore (Translational and Clinical Research Flagship Programme), and NUS MOE Tier 1 grant no. R263-000-A42-112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by research grants from the Singapore Millennium Foundation Limited, the National Medical Research Council of Singapore (Translational and Clinical Research Flagship Programme), and NUS MOE Tier 1 grant no. R263-000-A42-112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Our gratitude goes to Alex Lim Lek Syn of the Movement Science Laboratory at Singapore General Hospital for generating the gait reports required for validation of our wearable system. Finally, we thank the engineers and final year projects students from ECE, NUS for their aid regarding data collection.	ANDRIACCHI TP, 1977, J BIOMECH, V10, P261, DOI 10.1016/0021-9290(77)90049-5; [Anonymous], 2000, FDN CLIN RES APPL PR; Bohannon Richard W, 2006, J Geriatr Phys Ther, V29, P64; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P49; Bohannon RW, 1996, J ORTHOP SPORT PHYS, V24, P86, DOI 10.2519/jospt.1996.24.2.86; Bowden MG, 2008, NEUROREHAB NEURAL RE, V22, P672, DOI 10.1177/1545968308318837; Callisaya ML, 2010, AGE AGEING, V39, P191, DOI 10.1093/ageing/afp250; Canning CG, 2015, NEUROLOGY, V84, P304, DOI 10.1212/WNL.0000000000001155; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Clark DJ, 2014, EXP GERONTOL, V55, P49, DOI 10.1016/j.exger.2014.03.019; Dixon PC, 2014, GAIT POSTURE, V40, P521, DOI 10.1016/j.gaitpost.2014.06.009; HOF AL, 1996, GAIT POSTURE, V4, P222; Hollman JH, 2011, GAIT POSTURE, V34, P111, DOI 10.1016/j.gaitpost.2011.03.024; Kamide N, 2011, GERIATR GERONTOL INT, V11, P445, DOI 10.1111/j.1447-0594.2011.00704.x; Kimura T, 2007, ANTHROPOL SCI, V115, P67, DOI 10.1537/ase.060309; KIRTLEY C, 1985, J BIOMED ENG, V7, P282, DOI 10.1016/0141-5425(85)90055-X; Lee WW, 2014, IEEE J BIOMED HEALTH, V18, P1839, DOI 10.1109/JBHI.2014.2301449; Novaes RD, 2011, REV BRAS FISIOTER, V15, P117, DOI 10.1590/S1413-35552011000200006; OBERG T, 1993, J REHABIL RES DEV, V30, P210; Oh-Park M, 2010, J AM GERIATR SOC, V58, P1512, DOI 10.1111/j.1532-5415.2010.02962.x; OMalley MJ, 1996, J BIOMECH, V29, P619, DOI 10.1016/0021-9290(95)00088-7; Paul SS, 2014, NEUROREHAB NEURAL RE, V28, P282, DOI 10.1177/1545968313508470; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Pondal Margarita, 2008, J Geriatr Phys Ther, V31, P57; Salbach NM, 2015, GAIT POSTURE, V41, P341, DOI 10.1016/j.gaitpost.2014.10.002; Samson MM, 2001, AGING CLIN EXP RES, V13, P16, DOI 10.1007/BF03351489; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Snijders AH, 2007, LANCET NEUROL, V6, P63, DOI 10.1016/S1474-4422(06)70678-0; Stansfield BW, 2003, GAIT POSTURE, V17, P81, DOI 10.1016/S0966-6362(02)00062-0; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Tay A, 2013, IEEE INT CONF CON AU, P1796; Thaweewannakij T, 2013, PHYS THER, V93, P1312, DOI 10.2522/ptj.20120411; Verlinden VJA, 2013, GAIT POSTURE, V37, P500, DOI 10.1016/j.gaitpost.2012.09.005; Wahid F, 2016, J APPL BIOMECH, V32, P128, DOI 10.1123/jab.2015-0035; Yau W, 2010, INT J STROKE; Zampieri C, 2010, J NEUROL NEUROSUR PS, V81, P171, DOI 10.1136/jnnp.2009.173740	36	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199215	10.1371/journal.pone.0199215	http://dx.doi.org/10.1371/journal.pone.0199215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ6XV	29912992	Green Submitted, Green Published, gold			2022-12-26	WOS:000435528600091
J	Sekihara, K; Saitoh, K; Yang, H; Kawashima, H; Kazuno, S; Kikkawa, M; Arai, H; Miida, T; Hayashi, N; Sasai, K; Tabe, Y				Sekihara, Kazumasa; Saitoh, Kaori; Yang, Haeun; Kawashima, Haruki; Kazuno, Saiko; Kikkawa, Mika; Arai, Hajime; Miida, Takashi; Hayashi, Nobuhiro; Sasai, Keisuke; Tabe, Yoko			Low-dose ionizing radiation exposure represses the cell cycle and protein synthesis pathways in in vitro human primary keratinocytes and U937 cell lines	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; PHOSPHATASE 2A; C-MYC; BYSTANDER RESPONSE; ONCOSTATIN-M; KINASE; GROWTH; MTOR; CANCER; ALPHA	The effects of the high-dose ionizing radiation used in radiotherapy have been thoroughly demonstrated in vitro and in vivo. However, the effects of low-dose ionizing radiation (LDIR) such as computed tomography-guided biopsies and X-ray fluoroscopy on skin cells remain controversial. This study investigated the molecular effects of LDIR on the human primary keratinocytes (HPKs) and U937 cells, monocytes-like cell lines. These cells were exposed to 0.1 Gray (Gy) X-ray as LDIR. The modulation of transcription was assessed using a cDNA array, and the protein expression after LDIR exposure was investigated using isobaric tags for relative and absolute quantification (iTRAQ) proteomic analysis at 24 hours. These effects were confirmed by immunoblotting analysis. The direct effects of LDIR on the U937 cells and HPKs and the bystander effects of irradiated HPKs on U937 cells were also investigated. LDIR downregulated c-Myc in both U937 cells and HPKs, and upregulated the p21(WAF1/CIP1) protein expression in U937 cells along with the activation of TGF beta and protein phosphatase 2A (PP2A). In HPKs, LDIR downregulated the mTOR signaling with repression of S6 and 4EBP1 activation. Similar changes were observed as bystander effects of LDIR. Our findings suggest that LDIR inhibits protein synthesis and induces the cytokines activation associated with inflammation via direct and bystander effects, which might recapitulate the effects of LDIR in inflammated skin structures.	[Sekihara, Kazumasa; Saitoh, Kaori; Yang, Haeun; Miida, Takashi; Tabe, Yoko] Juntendo Univ, Grad Sch Med, Dept Lab Med, Tokyo, Japan; [Sekihara, Kazumasa; Yang, Haeun] Juntendo Univ, Grad Sch Med, Leading Ctr Dev & Res Canc Med, Tokyo, Japan; [Kawashima, Haruki; Hayashi, Nobuhiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Life Sci & Technol, Tokyo, Japan; [Kazuno, Saiko; Kikkawa, Mika; Arai, Hajime] Juntendo Univ, Grad Sch Med, Lab Prote & Biomol Sci, Res Support Ctr, Tokyo, Japan; [Sasai, Keisuke] Juntendo Univ, Grad Sch Med, Dept Radiat Oncol, Tokyo, Japan; [Tabe, Yoko] Juntendo Univ, Grad Sch Med, Dept Next Generat Hematol Lab Med, Tokyo, Japan; [Sekihara, Kazumasa] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Kagoshima, Japan	Juntendo University; Juntendo University; Tokyo Institute of Technology; Juntendo University; Juntendo University; Juntendo University; Kagoshima University	Tabe, Y (corresponding author), Juntendo Univ, Grad Sch Med, Dept Lab Med, Tokyo, Japan.; Tabe, Y (corresponding author), Juntendo Univ, Grad Sch Med, Dept Next Generat Hematol Lab Med, Tokyo, Japan.	tabe@juntendo.ac.jp	Hayashi, Nobuhiro/F-6088-2011; Miida, Takashi/A-5589-2012	Hayashi, Nobuhiro/0000-0002-9950-094X; Miida, Takashi/0000-0002-4294-8030	Foundation of Strategic Research Projects in Private Universities from the MEXT, Japan [S1311011]	Foundation of Strategic Research Projects in Private Universities from the MEXT, Japan	This work was supported by the Foundation of Strategic Research Projects in Private Universities from the MEXT, Japan grant no. S1311011 to YT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albig W, 1997, GENOMICS, V40, P314, DOI 10.1006/geno.1996.4592; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; ASAMI O, 1984, J BIOCHEM-TOKYO, V95, P299, DOI 10.1093/oxfordjournals.jbchem.a134609; Asur R, 2010, MUTAGENESIS, V25, P271, DOI 10.1093/mutage/geq003; Bakin AV, 2002, J CELL SCI, V115, P3193; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Chou SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039679; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Deldicque L, 2005, EUR J APPL PHYSIOL, V94, P1, DOI 10.1007/s00421-004-1255-6; Du S, 2013, SEMIN RADIAT ONCOL, V23, P242, DOI 10.1016/j.semradonc.2013.05.001; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; El-Saghire H, 2013, INT J MOL MED, V32, P1407, DOI 10.3892/ijmm.2013.1514; Ewan KB, 2002, CANCER RES, V62, P5627; Gartel AL, 2003, EXP CELL RES, V283, P17, DOI 10.1016/S0014-4827(02)00020-4; Ghandhi SA, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-31; Glen A, 2008, J PROTEOME RES, V7, P897, DOI 10.1021/pr070378x; Goldberg Z, 2002, INT J ONCOL, V21, P337; Hall EJ, 2008, BRIT J RADIOL, V81, P362, DOI 10.1259/bjr/01948454; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Herbrich SM, 2013, J PROTEOME RES, V12, P594, DOI 10.1021/pr300624g; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Journy N, 2015, BRIT J CANCER, V112, P185, DOI 10.1038/bjc.2014.526; Jung P, 2009, CELL CYCLE, V8, P982, DOI 10.4161/cc.8.7.7949; Kent KD, 2003, IN VITRO CELL DEV-AN, V39, P388; Klokov D, 2013, ONCOGENE, V32, P479, DOI 10.1038/onc.2012.64; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; Leng SA, 2011, AM J ROENTGENOL, V197, pW97, DOI 10.2214/AJR.10.5057; Li YK, 2010, NEOPLASIA, V12, P848, DOI 10.1593/neo.10704; Longworth J, 2012, J PROTEOME RES, V11, P5959, DOI 10.1021/pr300692t; Lorimore SA, 2003, INT J RADIAT BIOL, V79, P15, DOI 10.1080/0955300021000045664; Lyng FM, 2006, RADIAT RES, V165, P400, DOI 10.1667/RR3527.1; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Martin M, 1997, ONCOGENE, V15, P981, DOI 10.1038/sj.onc.1201433; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; McNitt-Gray MF, 2002, RADIOGRAPHICS, V22, P1541, DOI 10.1148/rg.226025128; Mothersill C, 2001, RADIAT RES, V155, P759, DOI 10.1667/0033-7587(2001)155[0759:RIBEPH]2.0.CO;2; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; NAGASAWA H, 1992, CANCER RES, V52, P6394; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pernot E, 2012, MUTAT RES-REV MUTAT, V751, P258, DOI 10.1016/j.mrrev.2012.05.003; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Prise KM, 1998, INT J RADIAT BIOL, V74, P793, DOI 10.1080/095530098141087; Ronningen T, 2015, GENOME RES, V25, P1825, DOI 10.1101/gr.193748.115; SASAI K, 1990, CANCER CHEMOTH PHARM, V26, P112, DOI 10.1007/BF02897255; Schaper F, 2014, MOL MED, V20, P72, DOI 10.2119/molmed.2014.00019; Sekihara K, 2017, ONCOTARGET, V8, P34552, DOI 10.18632/oncotarget.16602; Shao C, 2008, ONCOGENE, V27, P434, DOI 10.1038/sj.onc.1210653; Shareef MM, 2007, CANCER RES, V67, P11811, DOI 10.1158/0008-5472.CAN-07-0722; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shivanna M, 2010, INVEST OPHTH VIS SCI, V51, P1575, DOI 10.1167/iovs.09-4343; SOWBY FD, 1978, RADIOLOGY, V129, P533, DOI 10.1148/129.2.533; Sulkava M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12421-4; Tabe Y, 2017, EXPERT OPIN THER TAR, V21, P705, DOI 10.1080/14728222.2017.1333600; Tabe Y, 2016, INT J RADIAT BIOL, V92, P24, DOI 10.3109/09553002.2015.1106021; Tabe Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137210; Takashima S, 1996, J BIOL CHEM, V271, P24901, DOI 10.1074/jbc.271.40.24901; Taki K, 2009, J RADIAT RES, V50, P241, DOI 10.1269/jrr.09011; Temme J, 2013, RADIAT RES, V179, P422, DOI 10.1667/RR3161.2; Toichi E, 2008, J INVEST DERMATOL, V128, P2705, DOI 10.1038/jid.2008.137; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Watt LF, 2017, BREAST CANCER RES TR, V166, P117, DOI 10.1007/s10549-017-4403-5; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Yu N, 2018, RADIAT RES, V189, P409, DOI 10.1667/RR14840.1; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	72	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199117	10.1371/journal.pone.0199117	http://dx.doi.org/10.1371/journal.pone.0199117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912936	Green Submitted, Green Published, gold			2022-12-26	WOS:000435528600076
J	Scherer, AN; Anand, NS; Koleske, AJ				Scherer, Alexander N.; Anand, Neha S.; Koleske, Anthony J.			Cortactin stabilization of actin requires actin-binding repeats and linker, is disrupted by specific substitutions, and is independent of nucleotide state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; ARP2/3 COMPLEX; ADP-ACTIN; FLUORESCENCE MICROSCOPY; PHOSPHORYLATION SITES; DENDRITIC SPINE; CAPPING PROTEIN; CELL MOTILITY; BARBED-END; FILAMENTS	The actin-binding protein cortactin promotes the formation and maintenance of actin-rich structures, including lamellipodial protrusions in fibroblasts and neuronal dendritic spines. Cortactin cellular functions have been attributed to its activation of the Arp2/3 complex, which stimulates actin branch nucleation, and to its recruitment of Rho family GTPase regulators. Cortactin also binds actin filaments and significantly slows filament depolymerization, but the mechanism by which it does so and the relationship between actin binding and stabilization are unclear. Here we elucidated the cortactin regions that are necessary and sufficient for actin filament binding and stabilization. Using actin cosedimentation assays, we found that the cortactin repeat region binds actin but that the adjacent linker region is required for binding with the same affinity as fulllength cortactin. Using total internal reflection fluorescence microscopy to measure the rates of single filament actin depolymerization, we observed that cortactin -actin interactions are sufficient to stabilize actin filaments. Moreover, conserved charged residues in repeat 4 were necessary for high-affinity actin binding, and substitution of these residues significantly impaired cortactin-mediated actin stabilization. Cortactin bound actin with higher affinity than did its paralog, hematopoietic cell-specific Lyn substrate 1 (HS1), and the effects on actin stability were specific to cortactin. Finally, cortactin stabilized A DP-actin filaments, indicating that the stabilization mechanism does not depend on the actin nucleotide state. Together, these results indicate that cortactin binding to actin is necessary and sufficient to stabilize filaments in a concentration-dependent manner, specific to conserved residues in the cortactin repeats, and independent of the actin nucleotide state.	[Scherer, Alexander N.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Anand, Neha S.; Koleske, Anthony J.] Yale Univ, Dept Mol Biophys & Biochem, 333 Cedar St, New Haven, CT 06520 USA; [Koleske, Anthony J.] Yale Univ, Dept Neurosci, 333 Cedar St, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Koleske, AJ (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 333 Cedar St, New Haven, CT 06520 USA.; Koleske, AJ (corresponding author), Yale Univ, Dept Neurosci, 333 Cedar St, New Haven, CT 06520 USA.	anthony.koleske@yale.edu	Anand, Neha/AAK-4151-2021	Scherer, Alexander/0000-0003-0114-9272	NINDS, National Institutes of Health [NS089662, NS105640]; NIMH, National Institutes of Health [MH115939]; NIGMS, National Institutes of Health [F30GM119198]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F30GM119198, T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH115939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS105640, R01NS089662] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health Grants NS089662 and NS105640 and NIMH, National Institutes of Health Grant MH115939 (to A.J.K.) and NIGMS, National Institutes of Health Award F30GM119198 (to A.N.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cherepanova O, 2006, J MOL BIOL, V356, P714, DOI 10.1016/j.jmb.2005.11.082; Citalan-Madrid AF, 2017, MUCOSAL IMMUNOL, V10, P1237, DOI 10.1038/mi.2016.136; Courtemanche N, 2015, J BIOL CHEM, V290, P4038, DOI 10.1074/jbc.M114.608117; Courtemanche N, 2013, BIOCHEMISTRY-US, V52, P6456, DOI 10.1021/bi400682n; Cowieson NP, 2008, J BIOL CHEM, V283, P16187, DOI 10.1074/jbc.M708917200; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Fujiwara I, 2007, P NATL ACAD SCI USA, V104, P8827, DOI 10.1073/pnas.0702510104; Galkin VE, 2002, NAT STRUCT BIOL, V9, P518, DOI 10.1038/nsb811; Galkin VE, 2008, J MOL BIOL, V376, P607, DOI 10.1016/j.jmb.2007.12.007; Ponce AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep29003; Hao JJ, 2005, J BIOL CHEM, V280, P37988, DOI 10.1074/jbc.M504552200; Helgeson LA, 2014, J BIOL CHEM, V289, P28856, DOI 10.1074/jbc.M114.587527; Helgeson LA, 2013, ELIFE, V2, DOI 10.7554/eLife.00884; Hering H, 2003, J NEUROSCI, V23, P11759; Hong NH, 2015, J CELL BIOL, V210, P753, DOI 10.1083/jcb.201412127; HUXLEY HE, 1967, J MOL BIOL, V30, P383, DOI 10.1016/S0022-2836(67)80046-9; Jegou A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001161; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Lapetina S, 2009, J CELL BIOL, V185, P503, DOI 10.1083/jcb.200809085; Li X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16959-1; Liang X, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00797-w; Lin YC, 2013, J NEUROSCI, V33, P1846, DOI 10.1523/JNEUROSCI.4284-12.2013; Lukoyanova N, 2002, CURR BIOL, V12, P383, DOI 10.1016/S0960-9822(02)00678-4; MacGrath SM, 2012, BIOCHEMISTRY-US, V51, P6644, DOI 10.1021/bi300722t; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Martin KH, 2006, J CELL SCI, V119, P2851, DOI 10.1242/jcs03034; Niedermayer T, 2012, P NATL ACAD SCI USA, V109, P10769, DOI 10.1073/pnas.1121381109; Oelkers JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019931; Oser M, 2010, J CELL SCI, V123, P3662, DOI 10.1242/jcs.068163; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Pant K, 2006, J MOL BIOL, V359, P840, DOI 10.1016/j.jmb.2006.03.065; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rosenberg BJ, 2017, MOL BIOL CELL, V28, P1347, DOI 10.1091/mbc.E16-12-0885; Schmoller KM, 2011, J STRUCT BIOL, V173, P350, DOI 10.1016/j.jsb.2010.09.003; Schnoor M, 2011, J EXP MED, V208, P1721, DOI 10.1084/jem.20101920; Shekhar S, 2017, CURR BIOL, V27, P1990, DOI 10.1016/j.cub.2017.05.036; Shekhar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9730; Shvetsov A, 2009, CELL MOTIL CYTOSKEL, V66, P90, DOI 10.1002/cm.20328; Sinha S, 2016, J CELL BIOL, V214, P197, DOI 10.1083/jcb.201601025; Smith MB, 2010, CYTOSKELETON, V67, P693, DOI 10.1002/cm.20481; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; Thomas SG, 2017, PLATELETS, V28, P372, DOI 10.1080/09537104.2016.1235688; Tseng QZ, 2012, P NATL ACAD SCI USA, V109, P1506, DOI 10.1073/pnas.1106377109; Uruno T, 2003, BIOCHEM J, V371, P485, DOI 10.1042/BJ20021791; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; van Rossum AGSH, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-15; van Rossum AGSH, 2003, J BIOL CHEM, V278, P45672, DOI 10.1074/jbc.M306688200; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	60	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13022	13032		10.1074/jbc.RA118.004068	http://dx.doi.org/10.1074/jbc.RA118.004068			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29929984	hybrid, Green Published			2022-12-26	WOS:000442730200005
J	van Rheenen, W; Diekstra, FP; Harschnitz, O; Westeneng, HJ; van Eijk, KR; Saris, CGJ; Groen, EJN; van Es, MA; Blauw, HM; van Vught, PWJ; Veldink, JH; van den Berg, LH				van Rheenen, Wouter; Diekstra, Frank P.; Harschnitz, Oliver; Westeneng, Henk-Jan; van Eijk, Kristel R.; Saris, Christiaan G. J.; Groen, Ewout J. N.; van Es, Michael A.; Blauw, Hylke M.; van Vught, Paul W. J.; Veldink, Jan H.; van den Berg, Leonard H.			Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study	PLOS ONE			English	Article							GENE-EXPRESSION; AXONAL-TRANSPORT; BREAST-CANCER; ALS; MUTATIONS; SIGNATURE; DIAGNOSIS; DISRUPT; TDP-43	The biological pathways involved in amyotrophic lateral sclerosis (ALS) remain elusive and diagnostic decision-making can be challenging. Gene expression studies are valuable in overcoming such challenges since they can shed light on differentially regulated pathways and may ultimately identify valuable biomarkers. This two-stage transcriptome-wide study, including 397 ALS patients and 645 control subjects, identified 2,943 differentially expressed transcripts predominantly involved in RNA binding and intracellular transport. When batch effects between the two stages were overcome, three different models (support vector machines, nearest shrunken centroids, and LASSO) discriminated ALS patients from control subjects in the validation stage with high accuracy. The models' accuracy reduced considerably when discriminating ALS from diseases that mimic ALS clinically (N = 75), nor could it predict survival. We here show that whole blood transcriptome profiles are able to reveal biological processes involved in ALS. Also, this study shows that using these profiles to differentiate between ALS and mimic syndromes will be challenging, even when taking batch effects in transcriptome data into account.	[van Rheenen, Wouter; Diekstra, Frank P.; Harschnitz, Oliver; Westeneng, Henk-Jan; van Eijk, Kristel R.; Saris, Christiaan G. J.; Groen, Ewout J. N.; van Es, Michael A.; Blauw, Hylke M.; van Vught, Paul W. J.; Veldink, Jan H.; van den Berg, Leonard H.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol, Utrecht, Netherlands; [Harschnitz, Oliver; Groen, Ewout J. N.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands; [Saris, Christiaan G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Nijmegen Neuromuscular Ctr, Nijmegen, Netherlands; [Groen, Ewout J. N.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Groen, Ewout J. N.] Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; University of Edinburgh; University of Edinburgh	van den Berg, LH (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol, Utrecht, Netherlands.	L.H.vandenBerg@umcutrecht.nl	Groen, Ewout JN/L-5081-2016; van+Es, Michael/AAC-5772-2021; Saris, C.G.J./L-4623-2015	Groen, Ewout JN/0000-0002-2330-9444; Harschnitz, Oliver/0000-0001-6496-881X; van Rheenen, Wouter/0000-0002-5860-1533; van Es, Michael/0000-0002-7709-5883	European Community's Health Seventh Framework Programme (FP7) [259867]; ZONMW, under the frame of E-Rare-2; ERA-Net for Research on Rare Diseases (PYRAMID)	European Community's Health Seventh Framework Programme (FP7); ZONMW, under the frame of E-Rare-2; ERA-Net for Research on Rare Diseases (PYRAMID)	The research leading to these results has received funding from the European Community's Health Seventh Framework Programme (FP7/2007-2013) under grant agreement n 259867 to LHvdB. This project was supported by ZONMW, under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases (PYRAMID) to JHV.	Al-Chalabi A, 2010, J NEUROL NEUROSUR PS, V81, P1324, DOI 10.1136/jnnp.2010.207464; Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Blauw HM, 2012, NEUROLOGY, V78, P776, DOI 10.1212/WNL.0b013e318249f697; Bowser R, 2011, NAT REV NEUROL, V7, P631, DOI 10.1038/nrneurol.2011.151; Brooks BR, 2000, WORLD FEDERATION NEU, P293; Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Groen EJN, 2013, HUM MOL GENET, V22, P3690, DOI 10.1093/hmg/ddt222; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huisman MHB, 2011, J NEUROL NEUROSUR PS, V82, P1165, DOI 10.1136/jnnp.2011.244939; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Li JP, 2012, NEUROBIOL AGING, V33, P1833, DOI 10.1016/j.neurobiolaging.2011.04.007; Li P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143045; Marinkovic P, 2012, P NATL ACAD SCI USA, V109, P4296, DOI 10.1073/pnas.1200658109; Meyer D, 2006, J STAT SOFTW; Mitchell JD, 2010, AMYOTROPH LATERAL SC, V11, P537, DOI 10.3109/17482968.2010.495158; Mizielinska S, 2014, CURR OPIN NEUROL, V27, P515, DOI 10.1097/WCO.0000000000000130; Morotz GM, 2012, HUM MOL GENET, V21, P1979, DOI 10.1093/hmg/dds011; Otto M, 2012, AMYOTROPH LATERAL SC, V13, P1, DOI 10.3109/17482968.2011.627589; Raman R, 2015, NEUROPATH APPL NEURO, V41, P201, DOI 10.1111/nan.12147; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Ryberg H, 2010, MUSCLE NERVE, V42, P104, DOI 10.1002/mus.21683; Saris CGJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-405; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Tao ZT, 2015, HUM MOL GENET, V24, P2426, DOI 10.1093/hmg/ddv005; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Verstraete E, 2012, J NEUROL NEUROSUR PS, V83, P383, DOI 10.1136/jnnp-2011-300909; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5	41	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0198874	10.1371/journal.pone.0198874	http://dx.doi.org/10.1371/journal.pone.0198874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29939990	Green Published, gold, Green Submitted			2022-12-26	WOS:000436088700006
J	Platko, K; Lebeau, P; Austin, RC				Platko, Khrystyna; Lebeau, Paul; Austin, Richard C.			MAPping the kinase landscape of macrophage activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ARLTS1; CANCER	ARL11 is a tumor suppressor gene with established pro-apoptotic properties, but its function beyond this role is poorly understood. A new analysis of macrophage activation has identified ARL11 as a novel regulator of a mitogen-activated protein kinase (MAPK). These findings expand on the function of ARL11 beyond its tumor suppressor activity and highlight a novel role as a regulator of macrophage activation and inflammatory response.	[Platko, Khrystyna; Lebeau, Paul; Austin, Richard C.] McMaster Univ, St Josephs Healthcare Hamilton, Dept Med, Div Nephrol, Hamilton, ON L8N 4A6, Canada; [Platko, Khrystyna; Lebeau, Paul; Austin, Richard C.] Hamilton Ctr Kidney Res, Hamilton, ON L8N 4A6, Canada; [Austin, Richard C.] Hamilton Hlth Sci, Thrombosis & Atherosclerosis Res Inst TaARI, Hamilton, ON L8L 2X2, Canada; [Austin, Richard C.] McMaster Univ, Hamilton, ON L8L 2X2, Canada; [Austin, Richard C.] Heart & Stroke Fdn Ontario, Ottawa, ON, Canada; [Austin, Richard C.] St Josephs Healthcare, Div Nephrol, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Austin, RC (corresponding author), 50 Charlton Ave E,Rm T-3313, Hamilton, ON L8N 4A6, Canada.	austinr@taari.ca			Heart and Stroke Foundation of Ontario [T-6146]; Heart and Stroke Foundation of Canada [G-13-0003064, G-15-0009389]; Canadian Institutes of Health Research [74477]; St. Joseph's Healthcare Hamilton; Canadian Institutes of Health Research Team Grant in Thromboembolism [FRN-79846]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); St. Joseph's Healthcare Hamilton; Canadian Institutes of Health Research Team Grant in Thromboembolism(Canadian Institutes of Health Research (CIHR))	This work was supported in part by research grants from the Heart and Stroke Foundation of Ontario (T-6146), the Heart and Stroke Foundation of Canada (G-13-0003064 and G-15-0009389), and the Canadian Institutes of Health Research (74477) (to R.C.A.). Financial support from St. Joseph's Healthcare Hamilton and the Canadian Institutes of Health Research Team Grant in Thromboembolism (FRN-79846) is acknowledged. The authors declare that they have no conflicts of interest with the contents of this article.	Arya SB, 2018, J BIOL CHEM, V293, P9892, DOI 10.1074/jbc.RA117.000727; Calin GA, 2005, NEW ENGL J MED, V352, P1667, DOI 10.1056/NEJMoa042280; Lioberas J, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00028; Siltanen S, 2008, EUR J HUM GENET, V16, P983, DOI 10.1038/ejhg.2008.43; WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955; Yendamuri S, 2008, CANCER LETT, V264, P11, DOI 10.1016/j.canlet.2008.02.021; Yendamuri S, 2007, CANCER RES, V67, P7738, DOI 10.1158/0008-5472.CAN-07-1481	7	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9910	9911		10.1074/jbc.H118.003380	http://dx.doi.org/10.1074/jbc.H118.003380			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29934367	Green Published, hybrid			2022-12-26	WOS:000436102300031
J	Lafort, Y; Couto, A; Sunderbrink, U; Hoek, R; Shargie, E; Zhao, J; Viisainen, K; Simwaka, B				Lafort, Yves; Couto, Aleny; Sunderbrink, Ute; Hoek, Roxanne; Shargie, Estifanos; Zhao, Jinkou; Viisainen, Kirsi; Simwaka, Bertha			Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; PATIENT RETENTION; HIV CARE; RISK-FACTORS; PROGRAMS; SURVIVAL; TRENDS; INCOME	Background Retention in anti-retroviral therapy (ART) presents a challenge in sub-Saharan Africa. In Mozambique, after roll-out to peripheral facilities, the 12-month retention rate was reported mostly from sites with an electronic patient tracking system (EPTS), representing only 65% of patients. We conducted a nationally representative study, compared 12-month retention at EPTS and non-EPTS sites, and its predictors. Methods Applying a proportionate to population size sampling strategy, we obtained a nationally representative sample of patients who initiated ART between January 2013 and June 2014. We calculated weighted proportions of the patients' status at 12 months after ART initiation, and 12-month incidence of lost to follow-up (LTFU) and death. We assessed determinants of LTFU and death by calculating adjusted hazard ratios (AHR) through multivariate cox-proportional hazard models. Results Among 19,297 patients sampled, 54.3% were still active, 33.1% LTFU, 2.0% dead, 2.6% transferred-out and 8.0% had unknown status, 12 months after ART initiation. Total attrition rate (LTFU or dead) was 45.5/100PY, higher at facilities without EPTS (51.8/100PY) than with EPTS (37.7/100PY). Clinical stage IV (AHR = 1.7), CD4 count <= 150 (AHR = 1.3) and being pregnant (AHR = 1.6) were significantly associated with LTFU. Clinical stage III or IV (AHR = 2.1 and 3.8), CD4 count <= 150 (AHR = 3.0), not being pregnant (AHR = 3.0), and ART regimens with stavudine (AHR = 4.28) were significantly associated with deaths. Patients enrolled in adherence support groups were 4.6 times less likely to be LTFU, but the number (n = 174) was too small to be significant (p = 0.273). Conclusion Retention in ART was substantially lower at non-EPTS sites. EPTS should be expanded to all ART sites to facilitate comprehensive routine monitoring of retention in care. Retention in Mozambique is low and needs to be improved, especially among pregnant women and patients with advanced disease at ART initiation. The effect of ART adherence support groups needs to be further monitored.	[Lafort, Yves; Sunderbrink, Ute] GFA Consulting, Hamburg, Germany; [Lafort, Yves] Univ Ghent, Int Ctr Reprod Hlth, Ghent, Belgium; [Couto, Aleny; Hoek, Roxanne] Minist Hlth, Maputo, Mozambique; [Shargie, Estifanos; Zhao, Jinkou; Viisainen, Kirsi; Simwaka, Bertha] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland	Ghent University	Lafort, Y (corresponding author), GFA Consulting, Hamburg, Germany.; Lafort, Y (corresponding author), Univ Ghent, Int Ctr Reprod Hlth, Ghent, Belgium.	yves.lafor@telent.be	Fazli, Ghazal/AAE-8320-2022	Zhao, Jinkou/0000-0001-9184-3385	Global Fund to Fight AIDS, Tuberculosis and Malaria	Global Fund to Fight AIDS, Tuberculosis and Malaria	The research was funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria (https://www.theglobalfund.org/en/). Four of the authors are employees of the funding agency (ES, JZ, KV and BS). The objective of the study was to provide relevant information to the Mozambican national HIV programme to improve the Global Fund funded antiretrovial therapy programme. The role of the Global Fund authors was to assist in the design of the study protocol, revise the study report and provide feedback on the manuscript. GFA Consulting provided support in the form of salaries for authors YL and US, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abuogi LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156506; Auld AF, 2016, JAIDS-J ACQ IMM DEF, V73, pE11, DOI 10.1097/QAI.0000000000001137; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Boyles TH, 2011, PLOS ONE, V6, DOI [10.1097/QAD.0b013e32830ebcee, DOI 10.1097/QAD.0B013E32830EBCEE]; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Dalhatu I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165528; Decroo T, 2014, TROP MED INT HEALTH, V19, P514, DOI 10.1111/tmi.12278; Farahani M, 2016, AIDS, V30, P477, DOI 10.1097/QAD.0000000000000921; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Jobarteh K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166444; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Lambdin BH, 2013, JAIDS-J ACQ IMM DEF, V62, pE146, DOI 10.1097/QAI.0b013e3182840d4e; McNairy ML, 2015, JAIDS-J ACQ IMM DEF, V70, pE44, DOI 10.1097/QAI.0000000000000745; McNairy ML, 2013, JAIDS-J ACQ IMM DEF, V62, pE70, DOI 10.1097/QAI.0b013e318278bcb0; Melaku Z, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1776-4; Mutasa-Apollo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086305; Palladino C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082718; Pati R, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18490; Plano de Acelerac E da Resposta ao HIV e SIDA, 2013, MOC 2013 2015; Principal Recipient, 2016, GLOB FUND HIV GRANT; Rasschaert F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091544; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; SIDA Relato A rio do Progresso Moc E ambique, 2016, MAP MOC REP MOC CONS; UNAIDS, 2016, COUNTR FACTSH MOZ 20; UNAIDS, 2016, GLOB AIDS UPD; Velen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064459	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198916	10.1371/journal.pone.0198916	http://dx.doi.org/10.1371/journal.pone.0198916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927961	Green Published, Green Submitted, gold			2022-12-26	WOS:000435802500033
J	Yip, HYK; Tan, CW; Hirokawa, Y; Burgess, AW				Yip, Hon Yan Kelvin; Tan, Chin Wee; Hirokawa, Yumiko; Burgess, Antony Wilks			Colon organoid formation and cryptogenesis are stimulated by growth factors secreted from myofibroblasts	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; STEM-CELLS; CRYPT FISSION; IN-VITRO; TGF-BETA; HYPERPLASTIC POLYPS; COLORECTAL ADENOMAS; FACTOR RECEPTOR; MICE; HISTOGENESIS	Although small intestinal epithelial stem cells form crypts when using intestinal culture conditions, colon stem cells usually form colonospheres. Colon mesenchymal cell feeder layers can stimulate colon crypts to form organoids and produce crypts. We have investigated whether conditioned medium from colon mesenchymal cells can also stimulate colonosphere and organoid cryptogenesis. We prepared conditioned medium (CM) from WEHIYH2 cells (mouse colon myofibroblasts); the CM stimulated both colonosphere formation and organoid cryptogenesis in vitro. The colon organoid-stimulating factors in WEHI-YH2 CM are inactivated by heating and trypsin digestion and proteins can be concentrated by ultrafiltration. Both the colonosphere- and organoid cryptogenesis-stimulatory effects of the CM are independent of canonical Wnt and Notch signaling. In contrast, bone morphogenetic protein 4 (BMP4) abolishes colonosphere formation and organoid cryptogenesis. The Transforming Growth Factor beta (TGF beta) Type I receptor kinase inhibitor (A83-01) stimulates colonosphere formation, whereas the Epidermal Growth Factor receptor (EGFR) kinase inhibitor (AG1478) reduces the formation of colonospheres, but in the presence of EGF, a "just-right" concentration of AG1478 increases colon organoid cryptogenesis.	[Yip, Hon Yan Kelvin; Tan, Chin Wee; Hirokawa, Yumiko; Burgess, Antony Wilks] Walter & Eliza Hall Inst Med Res, Struct Biol, Parkville, Vic, Australia; [Yip, Hon Yan Kelvin; Tan, Chin Wee; Burgess, Antony Wilks] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Burgess, Antony Wilks] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Parkville, Vic, Australia; [Yip, Hon Yan Kelvin] Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia; [Yip, Hon Yan Kelvin] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Walter & Eliza Hall Institute; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Monash University; Monash University	Tan, CW; Burgess, AW (corresponding author), Walter & Eliza Hall Inst Med Res, Struct Biol, Parkville, Vic, Australia.; Tan, CW; Burgess, AW (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.; Burgess, AW (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Parkville, Vic, Australia.	cwtan@wehi.edu.au; tburgess@wehi.edu.au	Yip, Hon Yan Kelvin/ABE-4686-2021; Tan, Chin Wee/B-1584-2015	Yip, Hon Yan Kelvin/0000-0002-6281-6852; Tan, Chin Wee/0000-0001-9695-7218	Ludwig Institute for Cancer Research; National Health and Medical Research Council (NHMRC) [GNT1029628, 487922]; Operational Infrastructure Support Program by the Victorian Government, Australia; Melbourne International Research Scholarship; Melbourne International Fee Remission Scholarship	Ludwig Institute for Cancer Research; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Operational Infrastructure Support Program by the Victorian Government, Australia; Melbourne International Research Scholarship; Melbourne International Fee Remission Scholarship	This work was supported by the Ludwig Institute for Cancer Research, the National Health and Medical Research Council (NHMRC) Project Grant GNT1029628 and, Program Grant #487922, and funds from the Operational Infrastructure Support Program provided by the Victorian Government, Australia. The funders had no role on the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The manuscript is solely the responsibility of the institutions and individual authors and does not reflect the views of the NHMRC. H.Y.K.Y was supported by the Melbourne International Research Scholarship and Melbourne International Fee Remission Scholarship.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Abud HE, 2005, EXP CELL RES, V303, P252, DOI 10.1016/j.yexcr.2004.10.006; Ahmad AA, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-9; ARAKI K, 1995, GASTROENTEROLOGY, V109, P1468, DOI 10.1016/0016-5085(95)90632-0; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Batts LE, 2006, DEV DYNAM, V235, P1563, DOI 10.1002/dvdy.20741; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Bjerknes M, 1997, AM J PATHOL, V150, P833; Dehmer JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027070; DiMarco RL, 2014, INTEGR BIOL-UK, V6, P127, DOI 10.1039/c3ib40188j; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Flentjar N, 2007, GASTROENTEROLOGY, V132, P1410, DOI 10.1053/j.gastro.2007.02.054; Fre S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025785; Furukawa K, 2011, BIOCHEM BIOPH RES CO, V405, P521, DOI 10.1016/j.bbrc.2011.01.045; GABRIEL A, 1992, ANAT REC, V234, P281, DOI 10.1002/ar.1092340214; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Gardiner BS, 2016, COMPUT METHOD BIOMEC, V19, P1160, DOI 10.1080/10255842.2015.1115022; Gierdalski M, 2003, CEREB CORTEX, V13, P572, DOI 10.1093/cercor/13.6.572; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hirokawa Y, 2014, AM J PHYSIOL-GASTR L, V306, pG547, DOI 10.1152/ajpgi.00267.2013; Iavarone A, 1997, NATURE, V387, P417; In JG, 2016, NAT REV GASTRO HEPAT, V13, P633, DOI 10.1038/nrgastro.2016.142; Jung P, 2015, STEM CELL REP, V5, P979, DOI 10.1016/j.stemcr.2015.10.003; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kim TH, 2012, P NATL ACAD SCI USA, V109, P3932, DOI 10.1073/pnas.1113890109; King JB, 2012, AM J PHYSIOL-GASTR L, V303, pG443, DOI 10.1152/ajpgi.00087.2012; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Lebenthal E., 1989, HUMAN GASTROINTESTIN; Mahe MM, 2015, JOVE-J VIS EXP, DOI 10.3791/52483; MASKENS AP, 1978, ACTA ANAT, V100, P17; May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; PARK HS, 1995, AM J PATHOL, V147, P1416; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Powell DW, 2005, AM J PHYSIOL-GASTR L, V289, pG2, DOI 10.1152/ajpgi.00075.2005; Preston SL, 2003, CANCER RES, V63, P3819; Ramalingam S, 2012, AM J PHYSIOL-GASTR L, V302, pG10, DOI 10.1152/ajpgi.00277.2011; Reynolds A, 2014, GUT, V63, P610, DOI 10.1136/gutjnl-2012-304067; Rothenberg ME, 2012, GASTROENTEROLOGY, V142, P1195, DOI 10.1053/j.gastro.2012.02.006; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shaker A, 2010, J CLIN INVEST, V120, P2081, DOI 10.1172/JCI40676; Stelzner M, 2012, AM J PHYSIOL-GASTR L, V302, pG1359, DOI 10.1152/ajpgi.00493.2011; Suzuki A, 2010, LAB INVEST, V90, P1425, DOI 10.1038/labinvest.2010.150; Tan CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11036; Tan CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078519; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Wasan HS, 1998, J PATHOL, V185, P246; Wiener Z, 2014, P NATL ACAD SCI USA, V111, pE2229, DOI 10.1073/pnas.1406444111; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Wong WM, 2002, GUT, V50, P212, DOI 10.1136/gut.50.2.212; Yamada Y, 2013, DIGEST DIS SCI, V58, P1207, DOI 10.1007/s10620-012-2515-7; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695	63	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199412	10.1371/journal.pone.0199412	http://dx.doi.org/10.1371/journal.pone.0199412			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928021	gold, Green Published			2022-12-26	WOS:000435802500084
J	McHugh, DR; Steele, MS; Valerio, DM; Miron, A; Mann, RJ; LePage, DF; Conlon, RA; Cotton, CU; Drumm, ML; Hodges, CA				McHugh, Daniel R.; Steele, Miarasa S.; Valerio, Dana M.; Miron, Alexander; Mann, Rachel J.; LePage, David F.; Conlon, Ronald A.; Cotton, Calvin U.; Drumm, Mitchell L.; Hodges, Craig A.			A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies	PLOS ONE			English	Article							INTESTINAL-OBSTRUCTION SYNDROME; CONDUCTANCE REGULATOR PROTEIN; DUCHENNE MUSCULAR-DYSTROPHY; CHLORIDE TRANSPORT; IN-VITRO; CFTR POTENTIATOR; SEVERE PHENOTYPE; GROWTH FAILURE; STOP MUTATIONS; PHASE-3 TRIAL	Nonsense mutations are present in 10% of patients with CF, produce a premature termination codon in CFTR mRNA causing early termination of translation, and lead to lack of CFTR function. There are no currently available animal models which contain a nonsense mutation in the endogenous Cftr locus that can be utilized to test nonsense mutation therapies. In this study, we create a CF mouse model carrying the G542X nonsense mutation in Cftr using CRISPR/Cas9 gene editing. The G542X mouse model has reduced Cftr mRNA levels, demonstrates absence of CFTR function, and displays characteristic manifestations of CF mice such as reduced growth and intestinal obstruction. Importantly, CFTR restoration is observed in G542X intestinal organoids treated with G418, an aminoglycoside with translational readthrough capabilities. The G542X mouse model provides an invaluable resource for the identification of potential therapies of CF nonsense mutations as well as the assessment of in vivo effectiveness of these potential therapies targeting nonsense mutations.	[McHugh, Daniel R.; Miron, Alexander; Mann, Rachel J.; LePage, David F.; Conlon, Ronald A.; Drumm, Mitchell L.; Hodges, Craig A.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [McHugh, Daniel R.; Steele, Miarasa S.; Valerio, Dana M.; Cotton, Calvin U.; Drumm, Mitchell L.; Hodges, Craig A.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Cotton, Calvin U.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Hodges, CA (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.; Hodges, CA (corresponding author), Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA.	craig.hodges@case.edu		Hodges, Craig/0000-0003-3332-9024	Cystic Fibrosis Foundation Therapeutics	Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation)	This work was supported by grants from the Cystic Fibrosis Foundation Therapeutics (Hodges 15XX0 to CAH and Conlon 15XX0 to RAC, https://www.cff.org/ CFF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baradaran-Heravi A, 2017, P NATL ACAD SCI USA, V114, P3479, DOI 10.1073/pnas.1620982114; Benhabiles H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187930; Bidou L, 2012, TRENDS MOL MED, V18, P679, DOI 10.1016/j.molmed.2012.09.008; Brady KG, 2001, AM J PHYSIOL-LUNG C, V281, pL1173, DOI 10.1152/ajplung.2001.281.5.L1173; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; CLEGHORN GJ, 1986, LANCET, V1, P8; Colombo C, 2011, J CYST FIBROS, V10, pS24, DOI 10.1016/S1569-1993(11)60005-2; De Lisle RC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009753; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Delaney SJ, 1996, EMBO J, V15, P955, DOI 10.1002/j.1460-2075.1996.tb00432.x; Du M, 2002, J MOL MED, V80, P595, DOI 10.1007/s00109-002-0363-1; Du M, 2008, P NATL ACAD SCI USA, V105, P2064, DOI 10.1073/pnas.0711795105; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gonzalez-Hilarion S, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-58; Hagemeijer MC, 2018, J CYST FIBROS, V17, pS46, DOI 10.1016/j.jcf.2017.10.017; HASTY P, 1995, SOMAT CELL MOLEC GEN, V21, P177, DOI 10.1007/BF02254769; Heier CR, 2009, HUM MOL GENET, V18, P1310, DOI 10.1093/hmg/ddp030; Hobbs CA, 2013, J PHYSIOL-LONDON, V591, P4377, DOI 10.1113/jphysiol.2012.240861; Hodges CA, 2008, GENESIS, V46, P546, DOI 10.1002/dvg.20433; Hodges CA, 2011, AM J PHYSIOL-GASTR L, V301, pG528, DOI 10.1152/ajpgi.00052.2011; Howard M, 1996, NAT MED, V2, P467, DOI 10.1038/nm0496-467; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408; Keeling KM, 2014, ANNU REV GENOM HUM G, V15, P371, DOI 10.1146/annurev-genom-091212-153527; Kelley TJ, 1997, AM J PHYSIOL-LUNG C, V273, pL1065, DOI 10.1152/ajplung.1997.273.5.L1065; Kerem E, 2008, LANCET, V372, P719, DOI 10.1016/S0140-6736(08)61168-X; Kerem E, 2014, LANCET RESP MED, V2, P539, DOI 10.1016/S2213-2600(14)70100-6; KOLLER BH, 1991, P NATL ACAD SCI USA, V88, P10730, DOI 10.1073/pnas.88.23.10730; Kyle UG, 2015, NUTR CLIN PRACT, V30, P227, DOI 10.1177/0884533614555234; Lai HC, 1999, AM J CLIN NUTR, V69, P531; Liang F, 2017, SLAS TECHNOL, V22, P315, DOI 10.1177/2472630317692561; Livraghi A, 2007, TOXICOL PATHOL, V35, P116, DOI 10.1080/01926230601060025; Malik V, 2010, ANN NEUROL, V67, P771, DOI 10.1002/ana.22024; McDonald CM, 2017, LANCET, V390, P1489, DOI 10.1016/S0140-6736(17)31611-2; McElroy SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001593; Mutyam V, 2016, AM J RESP CRIT CARE, V194, P1092, DOI 10.1164/rccm.201601-0154OC; Nakajima K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34703; Nudelman I, 2010, BIOORGAN MED CHEM, V18, P3735, DOI 10.1016/j.bmc.2010.03.060; ONEAL WK, 1993, HUM MOL GENET, V2, P1561, DOI 10.1093/hmg/2.10.1561; Pattison AM, 2016, INFECT IMMUN, V84, P3083, DOI 10.1128/IAI.00639-16; Perez B, 2012, MOL SYNDROMOL, V3, P230, DOI 10.1159/000343086; Pillarisetti N, 2011, AM J RESP CRIT CARE, V184, P75, DOI 10.1164/rccm.201011-1892OC; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; Rowntree RK, 2003, ANN HUM GENET, V67, P471, DOI 10.1046/j.1469-1809.2003.00028.x; Sandoval RM, 2006, J AM SOC NEPHROL, V17, P2697, DOI 10.1681/ASN.2005101124; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Scaparrotta A, 2012, J PEDIATR ENDOCR MET, V25, P393, DOI 10.1515/jpem-2012-0012; SCHLOESSER M, 1991, J MED GENET, V28, P878, DOI 10.1136/jmg.28.12.878; Schmid-Burgk JL, 2014, GENOME RES, V24, P1719, DOI 10.1101/gr.176701.114; Sermet-Gaudelus I, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-5; Sermet-Gaudelus I, 2010, AM J RESP CRIT CARE, V182, P1262, DOI 10.1164/rccm.201001-0137OC; Singh Vikesh K, 2017, J Cyst Fibros, V16 Suppl 2, pS70, DOI 10.1016/j.jcf.2017.06.011; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Sun L, 2012, NAT GENET, V44, P562, DOI 10.1038/ng.2221; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; van Heeckeren AM, 2004, AM J PHYSIOL-LUNG C, V287, pL944, DOI 10.1152/ajplung.00387.2003; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170; Xue XP, 2014, AM J RESP CELL MOL, V50, P805, DOI 10.1165/rcmb.2013-0282OC; ZEIHER BG, 1995, J CLIN INVEST, V96, P2051, DOI 10.1172/JCI118253	64	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199573	10.1371/journal.pone.0199573	http://dx.doi.org/10.1371/journal.pone.0199573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924856	Green Published, Green Submitted, gold			2022-12-26	WOS:000435655600076
J	Pinder, AC; Manimekalan, A; Knight, JDM; Krishnankutty, P; Britton, JR; Philip, S; Dahanukar, N; Raghavan, R				Pinder, Adrian C.; Manimekalan, Arunachalam; Knight, J. D. Marcus; Krishnankutty, Prasannan; Britton, J. Robert; Philip, Siby; Dahanukar, Neelesh; Raghavan, Rajeev			Resolving the taxonomic enigma of the iconic game fish, the hump-backed mahseer from the Western Ghats biodiversity hotspot, India	PLOS ONE			English	Article							BARBUS-MUSSULLAH SYKES; TELEOSTEI CYPRINIDAE; ALIGNMENT	Growing to lengths and weights exceeding 1.5 m and 45 kg, the hump-backed mahseer fish of the Western Ghats biodiversity hotspot, India, is an iconic, mega-faunal species that is globally recognized as a premier freshwater game fish. Despite reports of their high extinction risk, conservation approaches are currently constrained by their lack of valid taxonomic identity. Using an integrative approach, incorporating morphology, molecular analysis and historical photographs, this fish can now be revealed to be conspecific with Tor remadevii, a species lacking a common name, that was initially, but poorly, described in 2007 from the River Pambar, a tributary of the River Cauvery in Kerala. Currently known to be endemic and restricted to the River Cauvery basin in the Western Ghats, T. remadevii is distinguished from congeners by its prominent hump originating above the pre-opercle and extending to the origin of the dorsal fin, a well-developed mandible resulting in a terminal or slightly superior mouth position, and the dorsal orientation of the eyes. While body colouration varies (silver, bronze, greenish) and is not considered a reliable diagnostic character, orange coloration of the caudal fin (sometimes extending to all fins) is considered a consistent characteristic. Having been first brought to the attention of the scientific community in 1849, and the recreational angling (game fishing) community in 1873, it has taken over 150 years to finally provide this iconic fish with a valid scientific name. This taxonomic clarity should now assist development and delivery of urgent conservation actions commensurate with their extinction risk.	[Pinder, Adrian C.; Britton, J. Robert] Bournemouth Univ, Fac Sci & Technol, Poole, Dorset, England; [Pinder, Adrian C.; Raghavan, Rajeev] Freshwater Biol Assoc, Mahseer Trust, Wareham, Dorset, England; [Manimekalan, Arunachalam] Bharathiar Univ, Dept Environm Sci, Coimbatore, Tamil Nadu, India; [Knight, J. D. Marcus] Govt India, India Minist Environm Forest & Climate Change, New Delhi, India; [Krishnankutty, Prasannan] Mahatma Gandhi Coll, Dept Zool, Thiruvananthapuram, Kerala, India; [Philip, Siby] Nirmalagiri Coll, Dept Zool, Kannur, India; [Dahanukar, Neelesh] Indian Inst Sci Educ & Res, Pune, Maharashtra, India; [Dahanukar, Neelesh; Raghavan, Rajeev] ZOO, Coimbatore, Tamil Nadu, India; [Raghavan, Rajeev] Kerala Univ Fisheries & Ocean Studies Kochi, Dept Fisheries Resource Management, Kochi, Kerala, India	Bournemouth University; Freshwater Biological Association (FBA); Bharathiar University; Indian Institute of Science Education & Research (IISER) Pune; Kerala University of Fisheries & Ocean Studies	Pinder, AC (corresponding author), Bournemouth Univ, Fac Sci & Technol, Poole, Dorset, England.; Pinder, AC (corresponding author), Freshwater Biol Assoc, Mahseer Trust, Wareham, Dorset, England.	apinder@bournemouth.ac.uk	Arunachalam, Manimekalan/AAU-2686-2021; Dahanukar, Neelesh/B-2816-2012; Arunachalam, Manimekalan/GNW-4712-2022; Raghavan, Rajeev/ABD-8719-2021; Britton, Robert/B-5040-2009	Arunachalam, Manimekalan/0000-0002-6050-5233; Dahanukar, Neelesh/0000-0001-7162-9023; Britton, Robert/0000-0003-1853-3086; Pinder, Adrian/0000-0002-2175-9337	Mohammed Bin Zayed Species Conservation Fund [14258705]; Critical Ecosystem Partnership Fund - Western Ghats Small Grants Program; Tata Power Company Limited; Mahseer Trust under the Kaveri Mission initiative; Inspire Faculty Fellowship Program of the Department of Science and Technology (DST), Government of India [IFA12-LSBM-21]	Mohammed Bin Zayed Species Conservation Fund; Critical Ecosystem Partnership Fund - Western Ghats Small Grants Program; Tata Power Company Limited; Mahseer Trust under the Kaveri Mission initiative; Inspire Faculty Fellowship Program of the Department of Science and Technology (DST), Government of India	Field work was supported by the Mohammed Bin Zayed Species Conservation Fund (Project No 14258705) and Critical Ecosystem Partnership Fund - Western Ghats Small Grants Program (to RR), The Tata Power Company Limited and the Mahseer Trust under the Kaveri Mission initiative (to AP), Inspire Faculty Fellowship Program (IFA12-LSBM-21) of the Department of Science and Technology (DST), Government of India (to ND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Anvar, 2013, Journal of Threatened Taxa, V5, P4569; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armbruster JW, 2012, ZOOTAXA, P8; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Carrizo SF, 2017, BIOSCIENCE, V67, P919, DOI 10.1093/biosci/bix099; Chen ZM, 2004, ENVIRON BIOL FISH, V70, P185; Chernomor O, 2016, SYST BIOL, V65, P997, DOI 10.1093/sysbio/syw037; Day F., 1878, FISHES INDIA BEING 4; Doornik JA, 2008, OXFORD B ECON STAT, V70, P927, DOI 10.1111/j.1468-0084.2008.00537.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eschmeyer W.N., 2017, CATALOG FISHES GENER; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harris R. J., 2001, PRIMER MULTIVARIATE, V3rd; He FZ, 2017, WIRES WATER, V4, DOI 10.1002/wat2.1208; Hora S. L., 1943, JOUR BOMBAY NAT HIST SOC, V44, P164; Hora S. L., 1943, JOUR BOMBAY NAT HIST SOC, V44, P1; Huberty C. J., 2006, APPL MANOVA DISCRIMI, V2; Jayaram K. C., 1997, Journal of the Bombay Natural History Society, V94, P48; Jerdon T., 1849, MADRAS J LIT SCI, V15, P149; Jung SB, 2012, MY ADVENTURES ANGLIN; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Knight JDM, 2014, ZOOTAXA, V3821, P280, DOI 10.11646/zootaxa.3821.2.8; Knight JDM, 2013, ZOOTAXA, V3750, P201, DOI 10.11646/zootaxa.3750.3.1; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurup B. Madhusoodana, 2010, Journal of the Bombay Natural History Society, V107, P227; Kurup BM, 2007, P INT S MAHS 29 30 M; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Last P.R., 2008, DESCRIPTIONS NEW AUS, P283; Menon A. G. K., 1992, Journal of the Bombay Natural History Society, V89, P210; Nguyen TTT, 2008, MOL PHYLOGENET EVOL, V48, P1223, DOI 10.1016/j.ympev.2008.01.006; Pinder AC, 2015, AQUAT CONSERV, V25, P829, DOI 10.1002/aqc.2543; Pinder AC, 2015, ENDANGER SPECIES RES, V28, P11, DOI 10.3354/esr00673; Pinder AC, 2013, CURR SCI INDIA, V104, P1472; Raghavan R, 2013, CURR SCI INDIA, V104, P1277; Rambaut A., 2009, FIGTREE V1 3 1; Sen TK, 1982, 39 REC ZOOL SURV IND; SPENCE REGINALD, 1932, JOUR BOMBAY NAT HIST SOC, V36, P29; Stewart DJ, 2013, COPEIA, P470, DOI 10.1643/CI-12-017; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thomas H.S., 1873, THE ROD IN INDIA; Wild Life, 1977, WILDLIFE J WILDLIFE, V1977, P1	41	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199328	10.1371/journal.pone.0199328	http://dx.doi.org/10.1371/journal.pone.0199328			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924871	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000435655600063
J	Amorim, PF; Costa, WJEM				Amorim, Pedro F.; Costa, Wilson J. E. M.			Multigene phylogeny supports diversification of four-eyed fishes and one-sided livebearers (Cyprinodontiformes: Anablepidae) related to major South American geological events	PLOS ONE			English	Article							TELEOSTEI CYPRINODONTIFORMES; JENYNSIA-MULTIDENTATA; MASS EXTINCTION; MIOCENE; MARINE; WATER; BIOGEOGRAPHY; KILLIFISHES; EVOLUTION; POSITION	The high diversity of Neotropical fishes has been attributed to major South American palaeogeographic events, such as Andean uplift, rise of the Isthmus of Panama and marine transgressions. However, the unavailability of temporal information about evolution and diversification of some fish groups prevents the establishment of robust hypotheses about correlations between species diversification and proposed palaeogeographical events. One example is the Anablepidae, a family of teleost fishes found mostly in coastal habitats of Central and South America, but also in some inner river basins of South America. Historical aspects of the distribution patterns of the Anablepidae were never analysed and no accurate estimation of time of its origin and diversification is presently available. A multi-gene analysis was performed to estimate Anablepidae phylogenetic position, age and biogeography, comprising seven nuclear genes. The suborder Cyprinodontoidei was recovered in three major clades, one comprising all the Old World Cyprinodontoidei and two comprising New World lineages. Anablepidae was recovered as the sister group of the New World Poeciliidae, with the Amazonian genus Fluviphylax as their sister group. The ages found for the origin and diversification of Cyprinodontiformes were congruent with the pattern recorded for other vertebrate groups, with an origin anterior to the Cretaceous-Paleogene (K-Pg) transition and diversification during the Paleogene. The age estimated for the split between the Atlantic and Pacific lineages of Anableps was congruent with the rise of Panamanian Isthmus. The results suggest Miocene marine transgressions as determinant to the current distribution of Jenynsia.	[Amorim, Pedro F.; Costa, Wilson J. E. M.] Univ Fed Rio de Janeiro, Inst Biol, Lab Systemat & Evolut Teleost Fishes, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Amorim, PF (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Lab Systemat & Evolut Teleost Fishes, Rio De Janeiro, RJ, Brazil.	pedro_f_a@hotmail.com	Amorim, Pedro/AAJ-9021-2021; Costa, Wilson/A-9283-2013	Costa, Wilson/0000-0002-0428-638X; Amorim, Pedro/0000-0001-7029-0275	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [307349/2015-2]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [2016006328]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The funders for the development of the study were provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br)) (307349/2015-2) for WJEMC, and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (http://www.faperj.br)(2016006328) for PFA.	Aguilera G, 2005, ZOOTAXA, P29, DOI 10.11646/zootaxa.1096.1.3; Aguilera G, 2013, NEOTROP ICHTHYOL, V11, P565, DOI 10.1590/S1679-62252013000300009; Amorim PF, 2018, J FISH BIOL, V92, P1312, DOI 10.1111/jfb.13587; [Anonymous], 2014, TRACER V1 6; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; BAUGHMAN JL, 1947, COPEIA, P200, DOI 10.2307/1438859; Betancur-R Ricardo, 2013, PLoS Curr, V5, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; Bisazza A, 2000, ETHOLOGY, V106, P961, DOI 10.1046/j.1439-0310.2000.00620.x; Bloom DD, 2017, J BIOGEOGR, V44, P1927, DOI 10.1111/jbi.12954; Bloom DD, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P137; Bogan Sergio, 2009, Pap. Avulsos Zool. (São Paulo), V49, P81, DOI 10.1590/S0031-10492009000500001; Braganca PHN, 2018, ZOOSYST EVOL, V94, P137, DOI 10.3897/zse.94.22173; Calvino P, 2016, J FISH BIOL, V88, P1236, DOI 10.1111/jfb.12895; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Collins PA, 2011, J CRUSTACEAN BIOL, V31, P179, DOI 10.1651/10-3306.1; Costa WJEM, 2012, VERTEBR ZOOL, V62, P371; Costa WJEM, 2011, CYBIUM, V35, P181; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Freyhof J, 2017, ZOOTAXA, V4294, P573, DOI 10.11646/zootaxa.4294.5.6; Friedman M, 2010, P ROY SOC B-BIOL SCI, V277, P1675, DOI 10.1098/rspb.2009.2177; Garman S.W., 1895, MEM MUS COMP ZOOL, V19, P1; Gaudant Jean, 2009, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V111A, P281; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Ghedotti Michael J., 1998, P561; Ghedotti MJ, 2000, ZOOL J LINN SOC-LOND, V130, P1, DOI 10.1006/zjls.1999.0213; Heath TA, 2012, SYST BIOL, V61, P793, DOI 10.1093/sysbio/sys032; Hrbek T, 2007, MOL PHYLOGENET EVOL, V43, P986, DOI 10.1016/j.ympev.2006.06.009; Iturralde-Vinent MA, 1999, B AM MUS NAT HIST, P1; Kellner AWA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081386; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Latrubesse EM, 2007, J S AM EARTH SCI, V23, P61, DOI 10.1016/j.jsames.2006.09.021; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Longrich NR, 2012, P NATL ACAD SCI USA, V109, P21396, DOI 10.1073/pnas.1211526110; Longrich NR, 2011, P NATL ACAD SCI USA, V108, P15253, DOI 10.1073/pnas.1110395108; Lovejoy NR, 2006, J S AM EARTH SCI, V21, P5, DOI 10.1016/j.jsames.2005.07.009; Lovejoy NR, 1998, NATURE, V396, P421, DOI 10.1038/24757; Lundberg John G., 1998, P13; Marshall LG, 1996, SCIENCE, V273, P123; MEYER A, 1993, P ROY SOC LOND B BIO, V254, P153, DOI DOI 10.1098/RSPB.1993.0140; MILLER RR, 1979, COPEIA, P82; Montoya-Burgos JI, 2003, MOL ECOL, V12, P1855, DOI 10.1046/j.1365-294X.2003.01857.x; Murase Atsunobu, 2014, Check List, V10, P1401; Near TJ, 2013, P NATL ACAD SCI USA, V110, P12738, DOI 10.1073/pnas.1304661110; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Oliveira RRD, 2016, J FISH BIOL, V89, P959, DOI 10.1111/jfb.13013; Owens GL, 2012, BIOL LETTERS, V8, P86, DOI 10.1098/rsbl.2011.0582; Owens GL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005970; Parenti LR, 1981, B AM MUS NAT HIST, V168, P335, DOI DOI 10.1080/00222930210135631; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Parker Alex, 1997, P163, DOI 10.1016/B978-012417540-2/50012-9; Pohl M, 2015, VERTEBR ZOOL, V65, P37; Reznick DN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172546; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSEN DE, 1975, SYST ZOOL, V24, P431, DOI 10.2307/2412905; Sandrini JZ, 2013, AQUAT TOXICOL, V130, P171, DOI 10.1016/j.aquatox.2013.01.006; Sferco E, PAP PALAEONTOL; Sivasundar A, 2001, MOL ECOL, V10, P407, DOI 10.1046/j.1365-294x.2001.01194.x; Swamynathan SK, 2003, FASEB J, V17, P1996, DOI 10.1096/fj.03-0122com; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turner CL, 1940, J MORPHOL, V67, P91, DOI 10.1002/jmor.1050670104; Turner CL, 1940, J MORPHOL, V67, P291, DOI 10.1002/jmor.1050670205; Wainwright PC, 2012, SYST BIOL, V61, P1001, DOI 10.1093/sysbio/sys060; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P323; Wesselingh FP., 2002, CAINOZOIC RES, V1, P35; WHITE ERROL IVOR, 1927, ANN & MAG NAT HIST, V20, P519; Wible JR, 2007, NATURE, V447, P1003, DOI 10.1038/nature05854; Yu Y, 2015, MOL PHYLOGENET EVOL, V87, P46, DOI 10.1016/j.ympev.2015.03.008; Zwickl D. J, 2006, GENETIC ALGORITHM AP	71	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199201	10.1371/journal.pone.0199201	http://dx.doi.org/10.1371/journal.pone.0199201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912943	Green Submitted, Green Published, gold			2022-12-26	WOS:000435528600088
J	Cheng, XL; Yuan, LX; Nizamani, MM; Zhu, ZX; Friedman, CR; Wang, HF				Cheng, Xia-Lan; Yuan, Lang-Xing; Nizamani, Mir Mohammad; Zhu, Zhi-Xin; Friedman, Cynthia Ross; Wang, Hua-Feng			Taxonomic and phylogenetic diversity of vascular plants at Ma'anling volcano urban park in tropical Haikou, China: Reponses to soil properties	PLOS ONE			English	Article							BIODIVERSITY; FORESTS; VEGETATION; COMMUNITIES; PHOSPHORUS; RECREATION; SUCCESSION; NUTRIENTS; PATTERNS; ECOLOGY	Anthropogenic processes and socio-economic factors play important roles in shaping plant diversity in urban parks. To investigate how plant diversity of Ma'anling urban volcano park in Hainan Province, China respond to these factors, we carried out a field investigation on the taxonomic and phylogenetic diversity of vascular plants and soil properties in this area. We found 284 species of vascular plants belonging to 88 families and 241 genera, which included 194 native species, 23 invasive species, 31 naturalized species, 40 cultivars, and 4 rare / endangered plant species. Tree composition and richness significantly varied between different vegetation formations (plantation, secondary forest, and abandoned land). Plant species richness and community composition were significantly affected by elevation (El), soil water content (WC), total soil nitrogen (TN) and soil organic matter (SOM). There were significant diversity differences between plantations and abandoned lands, but not between the plantations and secondary forests. The flora in the study site was tropical in nature, characterized by pantropic distributions. Compared to adjacent areas, floristic composition in the study site was most similar to that of Guangdong, followed by that of Vietnam. Our study revealed the diversity patterns of volcanic plants and provided the basis for future planning of plant conservation, such as preserving plant species, maintaining plant habitats, and coordinating plant management in this region.	[Cheng, Xia-Lan; Yuan, Lang-Xing; Nizamani, Mir Mohammad; Zhu, Zhi-Xin; Wang, Hua-Feng] Hainan Univ, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Inst Trop Agr & Forestry, Haikou, Hainan, Peoples R China; [Friedman, Cynthia Ross] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	Hainan University; University of British Columbia	Wang, HF (corresponding author), Hainan Univ, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Inst Trop Agr & Forestry, Haikou, Hainan, Peoples R China.	wanghuafeng2012@foxmail.com		, Hua-Feng/0000-0003-3331-2898; Nizamani, Mir Muhammad/0000-0002-8709-9212	National Natural Scientific Foundation of China [31660055, 31660074]; Hainan University [kyqd1633, kyqd (zr)1840]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Hainan University	This study was funded by National Natural Scientific Foundation of China (31660055 and 31660074) and the start-up fund from Hainan University [(kyqd1633) and kyqd (zr)1840]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the editor and two reviewers for their constructive suggestions and comments, which improved the manuscript. We also thank Dr. Xiaojing Wei for proofreading the manuscript. This study was funded by National Natural Scientific Foundation of China (31660055 and 31660074) and the start-up fund from Hainan University [(kyqd1633) and kyqd (zr) 1840].	Ballantyne M, 2014, LANDSCAPE URBAN PLAN, V130, P112, DOI 10.1016/j.landurbplan.2014.07.004; Beckage B, 2000, CAN J FOREST RES, V30, P1617, DOI 10.1139/cjfr-30-10-1617; Bordewich M, 2009, APPL MATH LETT, V22, P638, DOI 10.1016/j.aml.2008.05.004; BORMANN BT, 1990, J ECOL, V78, P561, DOI 10.2307/2260884; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cavender-Bares J, 2012, ECOLOGY, V93, pS52, DOI 10.1890/11-0502.1; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chen XH, 2014, CHINESE J TROPICAL C; Chi XL, 2014, BASIC APPL ECOL, V15, P416, DOI 10.1016/j.baae.2014.07.003; Christ C, 2003, TOURISM BIODIVERSITY; Costello EK, 2009, APPL ENVIRON MICROB, V75, P735, DOI 10.1128/AEM.01469-08; Daufresne T, 2005, P NATL ACAD SCI USA, V102, P9212, DOI 10.1073/pnas.0406427102; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fang YT, 2008, BIOGEOSCIENCES, V5, P339, DOI 10.5194/bg-5-339-2008; Flora of China Committee, 2013, FLORA CHINA; Fournier B, 2017, AGR ECOSYST ENVIRON, V242, P43, DOI 10.1016/j.agee.2017.03.021; Gautam MK, 2016, ACTA OECOL, V75, P43, DOI 10.1016/j.actao.2016.06.010; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Grishin SY, 1996, VEGETATIO, V127, P129, DOI 10.1007/BF00044637; Gulezian PZ, 2010, LANDSCAPE URBAN PLAN, V95, P161, DOI 10.1016/j.landurbplan.2009.12.013; Hansen J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080954, 10.1371/journal.pone.0081648]; Hardtle W, 2003, FOREST ECOL MANAG, V182, P327, DOI 10.1016/S0378-1127(03)00091-4; HEDLEY MJ, 1982, SOIL SCI SOC AM J, V46, P970, DOI 10.2136/sssaj1982.03615995004600050017x; Hercock M., 1999, Environmentalist, V19, P259, DOI 10.1023/A:1026406912992; Huang JH, 2003, CHINESE BIODIVERSITY; Huston M.A., 1994, BIOL DIVERSITY; Ingram JC, 2008, ENCY ECOLOGY; Jiang Y, 2016, PLANT SOIL, V403, P21, DOI 10.1007/s11104-015-2723-y; Kelly CL, 2010, ECOLOGICAL MANAGEMEN, V4, P37; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; [孔凡洲 Kong Fanzhou], 2012, [海洋科学, Marine Sciences], V36, P57; Laliberte E, 2013, TRENDS ECOL EVOL, V28, P331, DOI 10.1016/j.tree.2013.02.008; Lambers H, 2015, CURR OPIN PLANT BIOL, V25, P23, DOI 10.1016/j.pbi.2015.04.002; [李建武 Li Jianwu], 2012, [地球与环境, Earth and Environment], V40, P491; Liu L, 2012, SOIL BIOL BIOCHEM, V44, P31, DOI 10.1016/j.soilbio.2011.08.017; [刘永贤 Liu Yongxian], 2014, [生态学报, Acta Ecologica Sinica], V34, P5229; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lu S.G., 2007, PTERIDOLOGY; Lu XK, 2009, PEDOSPHERE, V19, P189, DOI 10.1016/S1002-0160(09)60108-9; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Miller TE, 2005, AM NAT, V165, P439, DOI 10.1086/428681; Mo Jiangming, 2003, Forest Ecology and Management, V175, P573, DOI 10.1016/S0378-1127(02)00220-7; Monz CA, 2010, ENVIRON MANAGE, V45, P551, DOI 10.1007/s00267-009-9406-5; Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155; NAKASHIZUKA T, 1993, J VEG SCI, V4, P537, DOI 10.2307/3236081; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Obase K, 2007, MYCORRHIZA, V17, P209, DOI 10.1007/s00572-006-0097-y; Oldeland J, 2010, REMOTE SENS ENVIRON, V114, P1155, DOI 10.1016/j.rse.2010.01.003; Organization WT, 2010, TOUR BIOD ACH COMM G; Osborne OG, 2017, NEW PHYTOL; Pec GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124691; Pickering CM, 2007, J ENVIRON MANAGE, V85, P791, DOI 10.1016/j.jenvman.2006.11.021; Rankin BL, 2015, J ENVIRON MANAGE, V154, P293, DOI 10.1016/j.jenvman.2014.10.035; REJMANEK M, 1982, AM MIDL NAT, V108, P194, DOI 10.2307/2425309; Roberts MR, 2002, FOREST ECOL MANAG, V155, P17, DOI 10.1016/S0378-1127(01)00544-8; Samardzija M, 2018, VETERINARSKA STANICA, V1, P61; Schmincke H-U, 2004, VOLCANISM; Schuettpelz E, 2009, P NATL ACAD SCI USA, V106, P11200, DOI 10.1073/pnas.0811136106; Singh R, 2017, ECOL ENG, V103, P226, DOI 10.1016/j.ecoleng.2017.04.020; Soliveres S, 2012, OIKOS, V121, P1638, DOI 10.1111/j.1600-0706.2011.20309.x; The State Forestry Bureau, 1999, AN METH FOR SOIL FOR; Tiessen H., 1993, SOIL SAMPLING METHOD, P75, DOI [10.1201/9781420005271.ch25, DOI 10.1201/9781420005271.CH25]; Tilman D., 1982, Monographs in Population Biology, pi; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Wang S, 2015, CHINESE J TROPICAL C; Wang Xi-Xi, 2016, Chinese Journal of Plant Ecology, V40, P469, DOI 10.17521/cjpe.2016.0021; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Webb CO, 2006, ECOLOGY, V87, pS1, DOI 10.1890/0012-9658(2006)87[1:IPICE]2.0.CO;2; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wei L, 2016, FOREST ECOL MANAG, V379, P173, DOI 10.1016/j.foreco.2016.08.020; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Williams-Linera G, 2016, REV MEX BIODIVERS, V87, P1265, DOI 10.1016/j.rmb.2016.09.003; [吴虹玥 Wu Hongyue], 2004, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V13, P40; Wu Z.Y., 2006, AREAL TYPES SEED PLA; Wu Zheng-Yi, 2003, Acta Botanica Yunnanica, V25, P245; Wu ZY, 2011, BIODIVERS SCI, V19, P1; Xie Z, 2014, SOIL BIOL BIOCHEM, V77, P89, DOI 10.1016/j.soilbio.2014.06.024; Xu Yuanjie, 2017, Biodiversity Science, V25, P23, DOI 10.17520/biods.2016199; Yang J, 2017, LANDSCAPE URBAN PLAN, V162, P92, DOI 10.1016/j.landurbplan.2017.02.003; Yang X, 2000, CHINESE J ECOL, V19; Yang XB, 2016, CHECKLIST PLANT SPEC; Yang XB, 2011, HAINAN ISLAND FOREST; Zhai DL, 2012, J ENVIRON MANAGE, V96, P64, DOI 10.1016/j.jenvman.2011.10.011; Zhang CB, 2010, BIORESOURCE TECHNOL, V101, P1686, DOI 10.1016/j.biortech.2009.10.001; Zhong Lei, 2015, Biodiversity Science, V23, P619; Zhu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151941	87	4	6	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198517	10.1371/journal.pone.0198517	http://dx.doi.org/10.1371/journal.pone.0198517			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ6XV	29912898	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600032
J	Horsington, J; Nfon, C; Bittner, H; Durr, PA; Singanallur, N; Alexandersen, S; Vosloo, W				Horsington, Jacquelyn; Nfon, Charles; Bittner, Hilary; Durr, Peter A.; Singanallur, Nagendrakumar; Alexandersen, Soren; Vosloo, Wilna			The protective capacity of high payload FMDV A22 IRQ vaccine in sheep against direct-contact challenge with a heterologous, contemporary FMDV A strain from South East Asia	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; EMERGENCY VACCINATION; SUBCLINICAL INFECTION; CARRIER STATE; HIGH-POTENCY; CLINICAL-PROTECTION; CATTLE; PIGS; TRANSMISSION; PERSISTENCE	Foot-and-mouth disease (FMD) is an acute, highly contagious viral disease of domestic and wild cloven-hoofed animals, caused by FMD virus (FMDV). An FMD outbreak can cause major production losses and have significant implications for trade. Vaccination can assist in controlling the disease, and emergency vaccination using high antigen payload vaccines (>6 PD50/dose) is considered an important control approach in the event of an outbreak. In recent years there has been a divergence of serotype A viruses in South East Asia (SEA) into several distinct genetic and antigenic clusters. Numerous variants were found to poorly match serotype A vaccines commonly included in international antigen banks. This study examined the ability of single vaccination with high-potency monovalent A22 IRQ vaccine to protect sheep following challenge with the A/VIT/15/2012 strain, just four days following vaccination. The vaccine proved effective at limiting clinical disease but did not prevent infection.	[Horsington, Jacquelyn; Durr, Peter A.; Singanallur, Nagendrakumar; Vosloo, Wilna] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Nfon, Charles; Bittner, Hilary] Canadian Food Inspect Agcy, Natl Centres Anim Dis, Winnipeg, MB, Canada; [Alexandersen, Soren] Geelong Ctr Emerging Infect Dis, Geelong, Vic, Australia; [Alexandersen, Soren] Deakin Univ Geelong, Geelong, Vic, Australia; [Alexandersen, Soren] Univ Hosp Geelong, Barwon Hlth, Geelong, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Canadian Food Inspection Agency; Deakin University; Geelong Hospital	Horsington, J (corresponding author), CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia.	jacquelyn.horsington@csiro.au	Alexandersen, Soren/N-1598-2019; Durr, Peter/O-2948-2014; Singanallur, Nagendrakumar Balasubramanian/G-9349-2013	Alexandersen, Soren/0000-0002-5039-3178; Durr, Peter/0000-0003-0851-5300; Singanallur, Nagendrakumar Balasubramanian/0000-0002-0523-3853; Horsington, Jacquelyn/0000-0001-7124-3104	Animal Health Australia on behalf of Cattle Council of Australia; Australian Dairy Farmers; Australian Lot Feeders Association; Wool Producers Australia; Sheepmeat Council of Australia; Australian Pork Limited; Goat Industry Council of Australia; Australian Government [P.PSH 0652]; CFIA-NCAD	Animal Health Australia on behalf of Cattle Council of Australia; Australian Dairy Farmers; Australian Lot Feeders Association; Wool Producers Australia; Sheepmeat Council of Australia; Australian Pork Limited(Australian Pork Limited); Goat Industry Council of Australia; Australian Government(Australian GovernmentCGIAR); CFIA-NCAD	Funding was provided in part by producer levies held by Animal Health Australia on behalf of Cattle Council of Australia, Australian Dairy Farmers, Australian Lot Feeders Association, Wool Producers Australia, Sheepmeat Council of Australia, Australian Pork Limited and the Goat Industry Council of Australia. The AHA industry funds are matched through the Meat and Livestock Australia Donor Company by the Australian Government under MLA Project P.PSH 0652. The work was supported by in-kind contributions by the CFIA-NCAD in the form of facilities and support staff.; The work was supported by in-kind contributions by the CFIA-NCAD in the form of facilities and support staff. We therefore acknowledge Dr. Valerie Smid and the NCFAD animal care team for veterinary and animal care services; Kate Hole, Melissa Goolia and Tim Salo of the NCFAD Vesicular Disease Unit for technical help.	Aggarwal N, 2002, VACCINE, V20, P2508, DOI 10.1016/S0264-410X(02)00178-0; Alexandersen S, 2002, J GEN VIROL, V83, P1915, DOI 10.1099/0022-1317-83-8-1915; Alexandersen S, QUANTITIES INFECT VI, DOI [10.1099/0022-1317-83-8-1915, DOI 10.1099/0022-1317-83]; Barnett PV, 2004, VACCINE, V22, P1221, DOI 10.1016/j.vaccine.2003.09.024; Barnett PV, 2002, VACCINE, V20, P3197, DOI 10.1016/S0264-410X(02)00242-6; BROOKSBY JB, 1982, INTERVIROLOGY, V18, P1, DOI 10.1159/000149299; BURROWS R, 1968, J HYG-CAMB, V66, P633, DOI 10.1017/S0022172400028369; CARTWRIGHT B, 1982, RES VET SCI, V32, P338, DOI 10.1016/S0034-5288(18)32391-9; Cox SJ, 2007, VACCINE, V25, P7687, DOI 10.1016/j.vaccine.2007.07.067; Cox SJ, 2009, VET RES, V40, DOI 10.1051/vetres:2008051; Cox SJ, 2006, VACCINE, V24, P3184, DOI 10.1016/j.vaccine.2006.01.037; Cox SJ, 1999, VACCINE, V17, P1858, DOI 10.1016/S0264-410X(98)00486-1; de Rueda CB, 2015, VET RES, V46, DOI 10.1186/s13567-015-0156-5; Dias CCA, 2011, J INTERF CYTOK RES, V31, P227, DOI 10.1089/jir.2010.0055; DOEL TR, 1994, VACCINE, V12, P592, DOI 10.1016/0264-410X(94)90262-3; DONALDSON AI, 1992, VET REC, V131, P114, DOI 10.1136/vr.131.6.114; Eble PL, 2006, VACCINE, V24, P1274, DOI 10.1016/j.vaccine.2005.09.040; Golde WT, 2005, VACCINE, V23, P5775, DOI 10.1016/j.vaccine.2005.07.043; Horsington J, 2015, VACCINE, V33, P422, DOI 10.1016/j.vaccine.2014.11.043; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; LaRocco M, 2015, J CLIN MICROBIOL, V53, P755, DOI 10.1128/JCM.03220-14; LaRocco M, 2013, J CLIN MICROBIOL, V51, P1714, DOI 10.1128/JCM.03370-12; Ludi AB, 2014, J GEN VIROL, V95, P384, DOI 10.1099/vir.0.057521-0; Mackay DKJ, 2001, J VIROL METHODS, V97, P33, DOI 10.1016/S0166-0934(01)00333-0; Madhanmohan M, 2012, RES VET SCI, V93, P1050, DOI 10.1016/j.rvsc.2011.10.006; Madhanmohan M, 2010, VET RES COMMUN, V34, P285, DOI 10.1007/s11259-010-9353-x; McFadden AMJ, 2015, TRANSBOUND EMERG DIS, V62, pE45, DOI 10.1111/tbed.12208; Mittal M, 2005, ARCH VIROL, V150, P911, DOI 10.1007/s00705-004-0469-6; Moniwa M, 2012, J COMP PATHOL, V147, P330, DOI 10.1016/j.jcpa.2012.01.010; Nagendrakumar SB, 2011, VACCINE, V29, P1906, DOI 10.1016/j.vaccine.2010.12.127; Parida S, 2008, VACCINE, V26, P3469, DOI 10.1016/j.vaccine.2008.04.026; Ramanoon SZ, 2013, TROP ANIM HEALTH PRO, V45, P373, DOI 10.1007/s11250-012-0226-x; SALT JS, 1993, BRIT VET J, V149, P207, DOI 10.1016/S0007-1935(05)80168-X; Salt JS, 1998, VACCINE, V16, P746, DOI 10.1016/S0264-410X(97)86180-4; Stenfeldt C, 2015, VET MICROBIOL, V178, P50, DOI 10.1016/j.vetmic.2015.04.004; Vosloo W, 2002, REV SCI TECH OIE, V21, P437, DOI 10.20506/rst.21.3.1349	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0195302	10.1371/journal.pone.0195302	http://dx.doi.org/10.1371/journal.pone.0195302			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912868	gold, Green Submitted, Green Published			2022-12-26	WOS:000435528600005
J	Marco-Jimenez, F; Baselga, M; Vicente, JS				Marco-Jimenez, Francisco; Baselga, Manuel; Salvador Vicente, Jose			Successful re-establishment of a rabbit population from embryos vitrified 15 years ago: The importance of biobanks in livestock conservation	PLOS ONE			English	Article							CRYOPRESERVED CONTROL POPULATION; LITTER SIZE; GENETIC RESPONSE; STORAGE TIME; GROWTH-RATE; IN-VIVO; VITRIFICATION; SELECTION; SURVIVAL; BANKING	Genetic resource banks (GRB) are a valuable tool for maintaining genetic variability and preserving breeds from pathogens or catastrophe, enabling us to assess and correct breeding schemes, minimizing the impact of genetic drift and facilitating diffusion. This study tests their efficiency in re-establishing two extinct populations of a synthetic rabbit line selected for daily weight gain, using vitrified embryos from two generations (18th and 36th) separated by 15 years of genetic selection. The effect of long-term storage of vitrified embryos in liquid nitrogen was also evaluated. A total of 516 vitrified embryos using the same protocol were transferred into 54 recipients. The embryos had been maintained in liquid nitrogen during 2 different periods, (i) 1 year (301 embryos and 26 transfers, 36th generation) and (ii) 15 years (259 embryos and 28 transfers, 18th generation). A total of 80.0% (8/10 to 18th) and 60.0% (9/15 to 36th) of the foundational sire families were eventually re-established. Over approximately one year, animals within each population were crossed to produce the next generation and re-establish the original population size. Our study demonstrated that our GRB of embryos vitrified 15 years ago is a successful strategy to re-establish rabbit populations to continue the breeding programme.	[Marco-Jimenez, Francisco; Baselga, Manuel; Salvador Vicente, Jose] Univ Politecn Valencia, Inst Sci & Anim Technol, Lab Biotecnol Reprod, Valencia, Spain	Universitat Politecnica de Valencia	Marco-Jimenez, F (corresponding author), Univ Politecn Valencia, Inst Sci & Anim Technol, Lab Biotecnol Reprod, Valencia, Spain.	fmarco@dca.upv.es	Jiménez, Francisco Marco/I-7126-2012	Jiménez, Francisco Marco/0000-0002-5226-4118	Spanish Research project [AGL2014-53405-C2-1-P]; Generalitat Valenciana research program [Prometeo II 2014/036]	Spanish Research project(Spanish Government); Generalitat Valenciana research program	This research was supported by the projects: Spanish Research project AGL2014-53405-C2-1-P Comision Interministerial de Ciencia y Tecnologia (CICYT) and Generalitat Valenciana research program (Prometeo II 2014/036) (FMJ, MB and JSV).	Agca Y, 2012, THERIOGENOLOGY, V78, P1653, DOI 10.1016/j.theriogenology.2012.08.012; Alminana C, 2015, ANIM REPROD, V12, P418; Amstislavsky S.Ya., 2013, RUSS J GENET, V3, P305; APELO CL, 1989, JPN J VET RES, V37, P49; Baselga M, 1989, MEJORA GENETICA CONE; BESENFELDER U, 1993, J REPROD FERTIL, V99, P53, DOI 10.1530/jrf.0.0990053; Bielanski A, 2012, THERIOGENOLOGY, V77, P467, DOI 10.1016/j.theriogenology.2011.07.043; Bielanski A, 2003, CRYOBIOLOGY, V46, P146, DOI 10.1016/S0011-2240(03)00020-8; Bouzat JL, 2010, CONSERV GENET, V11, P463, DOI 10.1007/s10592-010-0049-0; Cicerone MT, 1996, J CHEM PHYS, V104, P7210, DOI 10.1063/1.471433; Scholz EC, 2012, CURRENT FRONTIERS IN CRYOPRESERVATION, P105; ESTANY J, 1992, GENET SEL EVOL, V24, P527, DOI 10.1051/gse:19920604; ESTANY J, 1989, LIVEST PROD SCI, V21, P67, DOI 10.1016/0301-6226(89)90021-3; Fang Y, 2014, CRYOLETTERS, V35, P232; Fogarty NM, 2000, REPROD FERT DEVELOP, V12, P31, DOI 10.1071/RD00020; Garcia ML, 2002, LIVEST PROD SCI, V74, P45, DOI 10.1016/S0301-6226(01)00280-9; Garcioa ML, 2000, VITRIFIED EMBRYOS TR, P139; Holt WV, 1996, J ZOOL, V238, P531, DOI 10.1111/j.1469-7998.1996.tb05411.x; Joly T, 1997, THESIS; Joly T, 1998, GENET SEL EVOL, V30, pS259, DOI 10.1051/gse:19980715; Kasai M., 1992, BIOL REPROD, V39, P284; Lavara R, 2011, THERIOGENOLOGY, V76, P652, DOI 10.1016/j.theriogenology.2011.03.018; Liebermann J, 2002, REPRODUCTION, V124, P483, DOI 10.1530/rep.0.1240483; Lin TA, 2011, THERIOGENOLOGY, V75, P760, DOI 10.1016/j.theriogenology.2010.10.018; Lopez-Bejar M, 2002, THERIOGENOLOGY, V58, P1541, DOI 10.1016/S0093-691X(02)01045-2; Mara L, 2013, ANIM REPROD SCI, V138, P25, DOI 10.1016/j.anireprosci.2013.02.006; Marco-Jimenez F, 2013, THERIOGENOLOGY, V79, P1124, DOI 10.1016/j.theriogenology.2013.02.008; Marco-Jimenez F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148661; Martinez EA, 2016, THERIOGENOLOGY, V85, P152, DOI 10.1016/j.theriogenology.2015.06.002; Matsumoto H, 2001, CRYOBIOLOGY, V42, P139, DOI 10.1006/cryo.2001.2309; Men H, 2012, THERIOGENOLOGY, V78, P1720, DOI 10.1016/j.theriogenology.2012.06.003; Moce ML, 2010, THERIOGENOLOGY, V73, P704, DOI 10.1016/j.theriogenology.2009.11.010; Mozdarani H, 2007, BIOL RES, V40, P299, DOI [/S0716-97602007000400004, 10.4067/S0716-97602007000400004]; Naturil-Alfonso C, 2015, REPROD DOMEST ANIM, V50, P312, DOI 10.1111/rda.12493; Ragab M, 2015, J ANIM BREED GENET, V132, P68, DOI 10.1111/jbg.12110; Rall W F, 2000, ILAR J, V41, P221; Riggs R, 2010, FERTIL STERIL, V93, P109, DOI 10.1016/j.fertnstert.2008.09.084; Sanchez-Osorio J, 2010, THERIOGENOLOGY, V74, P486, DOI 10.1016/j.theriogenology.2010.03.003; Santacreu MA, 2005, J ANIM SCI, V83, P2303; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; TESTART J, 1987, FERTIL STERIL, V48, P107; Vajta G, 2006, THERIOGENOLOGY, V65, P236, DOI 10.1016/j.theriogenology.2005.09.026; Vicente JS, 2012, THERIOGENOLOGY, V77, P81, DOI 10.1016/j.theriogenology.2011.07.019; Vicente JS, 2003, REPROD NUTR DEV, V43, P137, DOI 10.1051/rnd:2003011; VICENTE JS, 1994, THERIOGENOLOGY, V42, P1205, DOI 10.1016/0093-691X(94)90869-9; Vicente JS, 1999, REPROD NUTR DEV, V42, P1205	46	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199234	10.1371/journal.pone.0199234	http://dx.doi.org/10.1371/journal.pone.0199234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912976	gold, Green Published, Green Submitted			2022-12-26	WOS:000435528600095
J	Feito, Y; Hoffstetter, W; Serafini, P; Mangine, G				Feito, Yuri; Hoffstetter, Wade; Serafini, Paul; Mangine, Gerald			Changes in body composition, bone metabolism, strength, and skill-specific performance resulting from 16-weeks of HIFT	PLOS ONE			English	Article							MINERAL DENSITY; PHYSICAL-ACTIVITY; AEROBIC CAPACITY; LONG-TERM; INTENSITY; EXERCISE; FITNESS; ADULTS; FORCE; POWER	High Intensity Functional Training (HIFT) is a training modality, characterized by multimodal exercises performed at high-intensity. Little is known about the training adaptations that occur as a prolonged training program. The purpose of this study was to examine changes in body composition, bone metabolism, strength, and skill-specific performance over 16-weeks of HIFT. Twenty-six recreationally active adult males (n = 9; 34.2 +/- 9.1 y; 91.5 +/- 17.7 kg; 178.5 +/- 5.4 cm) and females (n =17 = 36.4 +/- 7.9 y; 91.5 +/- 17.7 kg; 162.9 +/- 7.0 cm) completed pre and post training assessments of body composition (Dual-Energy X-Ray Absorptiometry) and performance measures. Performance was assessed using three HIFT workouts (WOD 1-3) to assess strength, skill, and metabolic performance. Aside from the body composition measurements, all assessments were carried out at the local training facility. Training included participation in HIFT a minimum of twice a week for 16-weeks. Repeated measures analysis of variance revealed a significant gender x time interaction in Bone Mineral Content (BMC) (p = 0.027), where improvements favored women (1.0% +/- 1.1%, p = 0.004) over men (-0.1% + 0.8%, p = 0.625). Further, region-specific analysis indicated that women (2.5% +/- 3.0%, p < 0.005) experienced greater improvements in the trunk compared to men (-0.3% +/- 1.8%, p = 0.621), while changes in leg BMC were comparable between women (0.8% +/- 1.0%, p < 0.001) and men (0.3% +/- 0.6%, p < 0.001). Although no other interactions were observed, significant performance improvements were noted for all participants in WOD 1 (18.3% +/- 16.8%), absolute 5RM (14.4% +/- 9.7%), relative 5RM (15.4% +/- 9.2%), WOD 2 (5.7% +/- 6.5%), and WOD 3 (-17.3% +/- 14.7%). These data indicate that 16-weeks of HIFT resulted in positive outcomes in strength, metabolic conditioning performance, and body composition.	[Feito, Yuri; Hoffstetter, Wade; Serafini, Paul; Mangine, Gerald] Kennesaw State Univ, Dept Exercise Sci & Sport Management, Kennesaw, GA 30144 USA	University System of Georgia; Kennesaw State University	Feito, Y (corresponding author), Kennesaw State Univ, Dept Exercise Sci & Sport Management, Kennesaw, GA 30144 USA.	yfeito@kennesaw.edu	Feito, Yuri/D-8255-2013	Feito, Yuri/0000-0001-6790-6294	WellStar College of Health & Human Services at Kennesaw State University	WellStar College of Health & Human Services at Kennesaw State University	This study was partially funded by a professional development grant provided by the Dean of the WellStar College of Health & Human Services at Kennesaw State University to Yuri Feito. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abe T, 2000, EUR J APPL PHYSIOL O, V81, P174, DOI 10.1007/s004210050027; Alharbi M, 2017, EUR J CARDIOVASC NUR, V16, P309, DOI 10.1177/1474515116666475; American College of Sports Medicine, 2013, ACSMS GUIDELINES EXE; Bellar D, 2015, BIOL SPORT, V32, P315, DOI 10.5604/20831862.1174771; Buckley S, 2015, APPL PHYSIOL NUTR ME, V40, P1157, DOI 10.1139/apnm-2015-0238; Butcher SJ, 2015, OPEN ACCESS J SPORTS, V6, P241, DOI 10.2147/OAJSM.S88265; Caserotti P, 2008, SCAND J MED SCI SPOR, V18, P773, DOI 10.1111/j.1600-0838.2007.00732.x; Chen TC, 2011, EUR J APPL PHYSIOL, V111, P211, DOI 10.1007/s00421-010-1648-7; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; CONROY BP, 1993, MED SCI SPORT EXER, V25, P1103; CrossFit Inc, 2017, CROSSFIT TRAIN LEV 1; Eather N, 2016, J SPORT SCI, V34, P209, DOI 10.1080/02640414.2015.1045925; Fujimura R, 1997, J BONE MINER RES, V12, P656, DOI 10.1359/jbmr.1997.12.4.656; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; GARHAMMER J, 1991, INT J SPORT BIOMECH, V7, P3, DOI 10.1123/ijsb.7.1.3; Glassman G., 2002, CROSSFIT J; GRANHED H, 1987, SPINE, V12, P146, DOI 10.1097/00007632-198703000-00010; Haff GG, 2015, ESSENTIALS STRENGTH, V4th; Haff GG., 2016, ESSENTIALS STRENGTH, P583; Heinrich KM, 2015, EUR J CANCER CARE, V24, P812, DOI 10.1111/ecc.12338; Heinrich KM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-789; Heinrich KM, 2012, MIL MED, V177, P1125, DOI 10.7205/MILMED-D-12-00143; Jager R, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0177-8; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; KARLSSON MK, 1995, CALCIFIED TISSUE INT, V57, P325, DOI 10.1007/BF00302066; Kohrt WM, 2004, MED SCI SPORT EXER, V36, P1985, DOI 10.1249/01.MSS.0000142662.21767.58; Macaluso A, 2004, EUR J APPL PHYSIOL, V91, P450, DOI 10.1007/s00421-003-0991-3; Mazzetti SA, 2000, MED SCI SPORT EXER, V32, P1175, DOI 10.1097/00005768-200006000-00023; Murawska-Cialowicz E, 2015, J PHYSIOL PHARMACOL, V66, P811; Ratamess NA, 2008, J STRENGTH COND RES, V22, P103, DOI 10.1519/JSC.0b013e31815f29cc; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Riggs BL, 2005, J BONE MINER RES, V20, P177, DOI 10.1359/JBMR.041114; Robling AG, 2002, J BONE MINER RES, V17, P1545, DOI 10.1359/jbmr.2002.17.8.1545; Serafini PR, 2018, J STRENGTH COND RES, V32, P3474, DOI 10.1519/JSC.0000000000001843; Sheppard JM, 2016, ESSENTIALS STRENGTH, P447; Sperandei S, 2016, J SCI MED SPORT, V19, P916, DOI 10.1016/j.jsams.2015.12.522; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Tsuzuku S, 1998, CALCIFIED TISSUE INT, V63, P283, DOI 10.1007/s002239900527; VIRVIDAKIS K, 1990, INT J SPORTS MED, V11, P244, DOI 10.1055/s-2007-1024800; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	40	34	34	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2018	13	6							e0198324	10.1371/journal.pone.0198324	http://dx.doi.org/10.1371/journal.pone.0198324			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5RI	29906290	Green Published, gold, Green Submitted			2022-12-26	WOS:000435439400005
J	Michalski, MN; Williams, BO				Michalski, Megan N.; Williams, Bart O.			A quest for clarity in bone erosion: The role of sequestosome 1 in Paget's disease of bone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							MUTATION; P62; OSTEOCLASTOGENESIS; INCREASES; DOMAIN	Alterations in the SQSTM1 gene are a putative cause of Paget's disease of bone, yet results are conflicting about how these mutations impact osteoclasts, the cell type believed to be the main pathological contributor. In this issue of JBC, Zach et al. provide important new evidence that the protein encoded by SQSTM1, p62, negatively regulates osteoclastogenesis and demonstrate that aged p62-deficient mice develop bone phenotypes similar to those of Paget's disease. These findings help to clarify the role of this important protein and present new opportunities to interrogate bone biology.	[Michalski, Megan N.; Williams, Bart O.] Van Andel Res Inst, Ctr Canc & Cell Biol, Grand Rapids, MI 49503 USA	Van Andel Institute	Williams, BO (corresponding author), Van Andel Res Inst, 333 Bostwick NE, Grand Rapids, MI 49503 USA.	bart.williams@vai.org		Williams, Bart/0000-0002-5261-5301	NIAMS NIH HHS [R01 AR053293] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053293] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Chang KH, 2014, CELL REP, V9, P2084, DOI 10.1016/j.celrep.2014.11.031; Daroszewska A, 2011, HUM MOL GENET, V20, P2734, DOI 10.1093/hmg/ddr172; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Galson Deborah L, 2014, J Bone Metab, V21, P85, DOI 10.11005/jbm.2014.21.2.85; Hiruma Y, 2008, HUM MOL GENET, V17, P3708, DOI 10.1093/hmg/ddn266; Kurihara N, 2007, J CLIN INVEST, V117, P133, DOI 10.1172/JCI28267; Rea SL, 2006, J BONE MINER RES, V21, P1136, DOI 10.1359/JBMR.060405; Tan A, 2014, QJM-INT J MED, V107, P865, DOI 10.1093/qjmed/hcu075; Yip KHM, 2006, AM J PATHOL, V169, P503, DOI 10.2353/ajpath.2006.050960; Zach F, 2018, J BIOL CHEM, V293, P9530, DOI 10.1074/jbc.RA118.002449	10	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9542	9543		10.1074/jbc.H118.003689	http://dx.doi.org/10.1074/jbc.H118.003689			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29907733	Green Published, hybrid			2022-12-26	WOS:000435441400036
J	Thibault, G; Gholizadeh, H; Sinitski, E; Baddour, N; Lemaire, ED				Thibault, Gabrielle; Gholizadeh, Hossein; Sinitski, Emily; Baddour, Natalie; Lemaire, Edward D.			Effects of the unity vacuum suspension system on transtibial gait for simulated non-level surfaces	PLOS ONE			English	Article							DESTABILIZING ROCK SURFACE; DYNAMIC STABILITY; ELEVATED VACUUM; LIMB VOLUME; AMPUTEES; WALKING; SUCTION; STRATEGIES; TREADMILL; TERRAIN	Walking on various surfaces encountered in everyday life requires lower limb prosthesis users to continually adapt their movement patterns. Elevated vacuum suspension systems could improve transtibial amputee gait on non-level surfaces; however, research is lacking to guide clinical practice. Twelve transtibial amputees were fitted with the Ossur sleeveless vacuum suspension system (Unity). After a one month accommodation period, the CAREN-Extended system was used to evaluate gait on a self-paced treadmill when walking with continuous perturbations (medial-lateral translations, rolling hills, simulated uneven ground) with an active or inactive vacuum suspension system. Significant differences between active and inactive vacuum conditions (p<0.05) were found for some temporal-spatial and kinematic gait parameters, but the differences were small and not considered clinically significant. Our findings suggest that potential vacuum pump failures would not immediately affect gait performance in a moderately high functioning amputee population. However, residual limb volume changes over time due to the removal of elevated vacuum may adversely affect socket fit, leading to greater gait differences and reduced quality of life.	[Thibault, Gabrielle; Gholizadeh, Hossein; Sinitski, Emily; Lemaire, Edward D.] Ottawa Hosp Rehabil Ctr, Ctr Rehabil Res & Dev, Ottawa, ON, Canada; [Sinitski, Emily] Canadian Forces Hlth Serv, Ottawa, ON, Canada; [Baddour, Natalie] Univ Ottawa, Fac Engn, Dept Mech Engn, Ottawa, ON, Canada; [Lemaire, Edward D.] Univ Ottawa, Fac Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Gholizadeh, H (corresponding author), Ottawa Hosp Rehabil Ctr, Ctr Rehabil Res & Dev, Ottawa, ON, Canada.	hgholizadeh@ohri.ca	Baddour, Natalie/A-4018-2008; Gholizadeh, Hossein/G-4838-2010	Baddour, Natalie/0000-0002-7025-7501; Gholizadeh, Hossein/0000-0001-5847-7985; Lemaire, Edward/0000-0003-4693-2623	Mitacs [IT05713]	Mitacs	This project was funded by Mitacs. Application Ref. IT05713.	Astrom I, 2004, PROSTHET ORTHOT INT, V28, P28; Beil TL, 2002, J REHABIL RES DEV, V39, P693; Board WJ, 2001, PROSTHET ORTHOT INT, V25, P202, DOI 10.1080/03093640108726603; Darter BJ, 2015, PROSTHET ORTHOT INT; FILLAUER CE, 1989, J PROSTHET ORTHOT, V1, P92, DOI 10.1097/00008526-198901000-00007; Gates DH, 2012, GAIT POSTURE, V36, P33, DOI 10.1016/j.gaitpost.2011.12.019; Gates DH, 2012, GAIT POSTURE, V35, P36, DOI 10.1016/j.gaitpost.2011.08.001; Gholizadeh H, 2016, CLIN BIOMECH, V37, P108, DOI 10.1016/j.clinbiomech.2016.06.005; Gholizadeh H, 2014, CLIN BIOMECH, V29, P87, DOI 10.1016/j.clinbiomech.2013.10.013; Klute GK, 2011, ARCH PHYS MED REHAB, V92, P1570, DOI 10.1016/j.apmr.2011.05.019; Ferreira AEK, 2015, GAIT POSTURE, V41, P683, DOI 10.1016/j.gaitpost.2015.01.026; MacLellan MJ, 2006, EXP BRAIN RES, V173, P521, DOI 10.1007/s00221-006-0399-5; Marigold DS, 2008, GAIT POSTURE, V27, P689, DOI 10.1016/j.gaitpost.2007.09.005; Marigold DS, 2002, J NEUROPHYSIOL, V88, P339, DOI 10.1152/jn.00691.2001; Samitier CB, 2016, PROSTHET ORTHOT INT, V40, P83, DOI 10.1177/0309364614546927; Sanders JE, 2011, J REHABIL RES DEV, V48, P949, DOI 10.1682/JRRD.2010.09.0189; Sinitski EH, 2014, TRANSTIBIAL AMPUTEE; Sinitski EH, 2015, J REHABIL RES DEV, V52, P221, DOI 10.1682/JRRD.2013.11.0244; Sinitski EH, 2015, GAIT POSTURE, V41, P568, DOI 10.1016/j.gaitpost.2014.12.016; Wilken JM, 2012, GAIT POSTURE, V35, P301, DOI 10.1016/j.gaitpost.2011.09.105; Xu H, 2017, CLIN BIOMECH, V43, P95, DOI 10.1016/j.clinbiomech.2017.02.008	21	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199181	10.1371/journal.pone.0199181	http://dx.doi.org/10.1371/journal.pone.0199181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902256	Green Submitted, Green Published, gold			2022-12-26	WOS:000435424900095
J	Sioud, M; Westby, P; Vasovic, V; Floisand, Y; Peng, Q				Sioud, Mouldy; Westby, Phuong; Vasovic, Vlada; Floisand, Yngvar; Peng, Qian			Development of a new high-affinity human antibody with antitumor activity against solid and blood malignancies	FASEB JOURNAL			English	Article						immunotherapy; targeted therapy; phage display; immune effector cells	IMMUNE-CHECKPOINT BLOCKADE; CANCER-THERAPY; RITUXIMAB; CELLS; DIFFERENTIATION; EXPRESSION; CHALLENGES; STRATEGIES; LYMPHOMA; PROTEINS	mAbs have emerged as a promising strategy for the treatment of cancer. However, in several malignancies, no effective antitumor mAbs are yet available. Identifying therapeutic mAbs that recognize common tumor antigens could render the treatment widely applicable. Here, a human single-chain variable fragment (scFv) antibody library was sequentially affinity selected against a panel of human cancer cell lines and an antibody fragment (named MS5) that bound to solid and blood cancer cells was identified. The MS5 scFv was fused to the human IgG1 Fc domain to generate an antibody (MS5-Fc fusion) that induced antibody-dependent cellular cytotoxicity and phagocytosis of cancer cells by macrophages. In addition, the MS5-Fc antibody bound to primary leukemia cells and induced antibody-dependent cellular cytotoxicity. In the majority of analyzed cancer cells, the MS5-Fc antibody induced cell surface redistribution of the receptor complexes, but not internalization, thus maximizing the accessibility of the IgG1 Fc domain to immune effector cells. In vitro stability studies showed that the MS5-Fc antibody was stable after 6 d of incubation in human serum, retaining approximate to 60% of its initial intact form. After intravenous injections, the antibody localized into tumor tissues and inhibited the growth of 3 different human tumor xenografts (breast, lymphoma, and leukemia). These antitumor effects were associated with tumor infiltration by macrophages and NK cells. In the Ramos B-cell lymphoma xenograft model, the MS5-Fc antibody exhibited a comparable antitumor effect as rituximab, a chimeric anti-CD20 IgG1 mAb. These results indicate that human antibodies with pan-cancer abilities can be generated from phage display libraries, and that the engineered MS5-Fc antibody could be an attractive agent for further clinical investigation.Sioud, M., Westby, P., Vasovic, V., FlOisand, Y., Peng, Q. Development of a new high-affinity human antibody with antitumor activity against solid and blood malignancies.	[Sioud, Mouldy; Westby, Phuong] Univ Hosp, Radiumhosp, Rikshosp, Dept Canc Immunol, Oslo, Norway; [Vasovic, Vlada; Peng, Qian] Univ Hosp, Radiumhosp, Rikshosp, Dept Pathol, Oslo, Norway; [Floisand, Yngvar] Univ Hosp, Radiumhosp, Rikshosp, Dept Hematol, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Sioud, M (corresponding author), Oslo Univ Hosp, N-0340 Oslo, Norway.	mouldy.sioud@rr-research.no		Vasovic, Vlada/0000-0001-8985-1992	Norwegian Cancer Society [182593]	Norwegian Cancer Society(Norwegian Cancer Society)	The authors thank the excellent technical assistance from Anne Mobergslien (Department of Cancer Immunology, Oslo University Hospital). They also thank Linn A. Rosenberg (Department of Cancer Immunology, Oslo University Hospital) for helping with the preparation of recombinant proteins, Ingrid Kjonstad (Department of Cancer Immunology, Oslo University Hospital) for analyzing the antibody stability, Dr. Morten Oksvold (Department of Pathology, Oslo University Hospital) for assisting with the confocal microscopic images, Dr. Hans-Petter Hersleth (Department of Biosciences, Oslo University) for assisting with size-exclusion chromatography analysis, and Dr. Anne Dybwad (Norwegian Medicines Agency, Oslo, Norway) for critical reading of the manuscript. This work was funded by the Norwegian Cancer Society (Grant 182593) awarded to M.S. The authors declare no conflicts of interest.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Anthony D, 2014, FASEB J, V28, P3867, DOI 10.1096/fj.14-250332; BATOR JM, 1989, J IMMUNOL METHODS, V125, P167, DOI 10.1016/0022-1759(89)90090-2; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Beers SA, 2010, BLOOD, V115, P5191, DOI 10.1182/blood-2010-01-263533; BIRNIE GD, 1988, BRIT J CANCER, V58, P41; Broussas Matthieu, 2013, Methods Mol Biol, V988, P305, DOI 10.1007/978-1-62703-327-5_19; Cohnen A, 2013, BLOOD, V122, P1411, DOI 10.1182/blood-2012-07-441832; Davis TA, 2000, J CLIN ONCOL, V18, P3135, DOI 10.1200/JCO.2000.18.17.3135; Farkona S, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0623-5; Frenzel A, 2016, MABS-AUSTIN, V8, P1177, DOI 10.1080/19420862.2016.1212149; Glassman Patrick M., 2014, Cancer Biology Medicine, V11, P20, DOI 10.7497/j.issn.2095-3941.2014.01.002; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; Hatjiharissi E, 2007, BLOOD, V110, P2561, DOI 10.1182/blood-2007-01-070656; Herter S, 2013, MOL CANCER THER, V12, P2031, DOI 10.1158/1535-7163.MCT-12-1182; Hourigan CS, 2013, NAT REV CLIN ONCOL, V10, P460, DOI 10.1038/nrclinonc.2013.100; Inoue Y, 2017, CANCER SCI, V108, P455, DOI 10.1111/cas.13162; Jager V, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-52; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Leone P, 2013, JNCI-J NATL CANCER I, V105, P1172, DOI 10.1093/jnci/djt184; Lim SH, 2011, BLOOD, V118, P2530, DOI 10.1182/blood-2011-01-330357; McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825; Mhyre AJ, 2009, BLOOD, V113, P649, DOI 10.1182/blood-2008-04-152686; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Musto P, 2011, EXPERT OPIN BIOL TH, V11, P551, DOI 10.1517/14712598.2011.567262; O'Reilly MK, 2009, TRENDS PHARMACOL SCI, V30, P240, DOI 10.1016/j.tips.2009.02.005; Parslow AC, 2016, BIOMEDICINES, V4, DOI 10.3390/biomedicines4030014; Pitt JM, 2016, IMMUNITY, V44, P1255, DOI 10.1016/j.immuni.2016.06.001; Rey-Giraud F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042656; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Roberts CJ, 2011, INT J PHARMACEUT, V418, P318, DOI 10.1016/j.ijpharm.2011.03.064; Said JW, 2013, MODERN PATHOL, V26, pS42, DOI 10.1038/modpathol.2012.178; Seidel UJE, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00076; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sioud M, 2007, EUR J IMMUNOL, V37, P2834, DOI 10.1002/eji.200737112; Sioud M, 2018, SCAND J IMMUNOL, V87, DOI 10.1111/sji.12643; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Strohl WR, 2018, PROTEIN CELL, V9, P86, DOI 10.1007/s13238-017-0457-8; Strohl WR, 2009, CURR OPIN BIOTECH, V20, P685, DOI 10.1016/j.copbio.2009.10.011; Tsirigotis P, 2016, ANN MED, V48, P428, DOI 10.1080/07853890.2016.1186827; Unverdorben F, 2016, MABS-AUSTIN, V8, P120, DOI 10.1080/19420862.2015.1113360	41	5	5	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5063	5077		10.1096/fj.201701544R	http://dx.doi.org/10.1096/fj.201701544R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913558				2022-12-26	WOS:000443817700036
J	Jain, P; Malakar, B; Khan, MZ; Lochab, S; Singh, A; Nandicoori, VK				Jain, Preeti; Malakar, Basanti; Khan, Mehak Zahoor; Lochab, Savita; Singh, Archana; Nandicoori, Vinay Kumar			Delineating FtsQ-mediated regulation of cell division in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell division; Mycobacterium tuberculosis; phosphorylation; mycobacteria; protein kinase; FtsQ; regulation; dcw operon; divisome; septation	PENICILLIN-BINDING PROTEIN-3; ESCHERICHIA-COLI DIVISOME; OUTER-MEMBRANE PROTEINS; BACILLUS-SUBTILIS; TRIMERIC COMPLEX; IN-VITRO; Z RING; GROWTH; DIVIB; KINASE	Identifying and characterizing the individual contributors to bacterial cellular elongation and division will improve our understanding of their impact on cell growth and division. Here, we delineated the role of ftsQ, a terminal gene of the highly conserved division cell wall (dcw) operon, in growth, survival, and cell length maintenance in the human pathogen Mycobacterium tuberculosis (Mtb). We found that FtsQ overexpression significantly increases the cell length and number of multiseptate cells. FtsQ depletion in Mtb resulted in cells that were shorter than WT cells during the initial growth stages (4 days after FtsQ depletion) but were longer than WT cells at later stages (10 days after FtsQ depletion) and compromised the survival in vitro and in differentiated THP1 macrophages. Overexpression of N- and C-terminal FtsQ regions altered the cell length, and the C-terminal domain alone complemented the FtsQ depletion phenotype. MS analyses suggested robust FtsQ phosphorylation on Thr-24, and although phosphoablative and -mimetic mutants rescued the FtsQ depletion-associated cell viability defects, they failed to complement the cell length defects. MS and coimmunoprecipitation experiments identified 63 FtsQ-interacting partners, and we show that the interaction of FtsQ with the recently identified cell division protein SepIVA is independent of FtsQ phosphorylation and suggests a role of FtsQ in modulating cell division. FtsQ exhibited predominantly septal localization in both the presence and absence of SepIVA. Our results suggest a role for FtsQ in modulating the length, division, and survival of Mtb cells both in vitro and in the host.	[Jain, Preeti; Malakar, Basanti; Khan, Mehak Zahoor; Lochab, Savita; Nandicoori, Vinay Kumar] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India; [Singh, Archana] CSIR, Inst Genom & Integrat Biol, New Delhi 110025, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	vinaykn@nii.ac.in		Khan, Mehak Zahoor/0000-0002-2780-4119; Singh, Archana/0000-0003-1388-9489; Nandicoori, Vinay/0000-0002-5682-4178	Department of Science and Technology, Government of India [EMR/2014/000877]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by Department of Science and Technology, Government of India Grant EMR/2014/000877 (to V. K. N.). The authors declare that they have no conflicts of interest with the contents of this article. This article contains Table S1.	Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Arora D, 2018, J BIOL CHEM, V293, P6497, DOI 10.1074/jbc.M117.811190; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; BOTTA GA, 1981, J BACTERIOL, V145, P333, DOI 10.1128/JB.145.1.333-340.1981; Buddelmeijer N, 1998, J BACTERIOL, V180, P6107; Busiek KK, 2014, MOL MICROBIOL, V92, P1212, DOI 10.1111/mmi.12623; CARSON MJ, 1991, J BACTERIOL, V173, P2187, DOI 10.1128/JB.173.7.2187-2195.1991; Chawla Y, 2014, J BIOL CHEM, V289, P13858, DOI 10.1074/jbc.M114.563536; Cho H, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.172, 10.1038/nmicrobiol.2016.172]; D'Ulisse V, 2007, MICROBIOL-SGM, V153, P124, DOI 10.1099/mic.0.2006/000265-0; DAI K, 1992, J BACTERIOL, V174, P6145, DOI 10.1128/JB.174.19.6145-6151.1992; Dai K, 1996, J BACTERIOL, V178, P1328, DOI 10.1128/jb.178.5.1328-1334.1996; Daniel RA, 2000, MOL MICROBIOL, V36, P278, DOI 10.1046/j.1365-2958.2000.01857.x; Datta P, 2002, J BIOL CHEM, V277, P24983, DOI 10.1074/jbc.M203847200; Datta P, 2006, MOL MICROBIOL, V62, P1655, DOI 10.1111/j.1365-2958.2006.05491.x; DeJesus MA, 2017, MBIO, V8, DOI 10.1128/mBio.02133-16; DEWAR SJ, 1992, J BACTERIOL, V174, P6314, DOI 10.1128/JB.174.19.6314-6316.1992; Du SS, 2017, MOL MICROBIOL, V105, P177, DOI 10.1111/mmi.13696; Du SS, 2016, P NATL ACAD SCI USA, V113, pE5052, DOI 10.1073/pnas.1606656113; Dziadek J, 2002, MICROBIOL-SGM, V148, P961, DOI 10.1099/00221287-148-4-961; England K, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-79; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Fortuin S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00006; Gerding MA, 2009, J BACTERIOL, V191, P7383, DOI 10.1128/JB.00811-09; Ghosh J, 2009, P NATL ACAD SCI USA, V106, P10781, DOI 10.1073/pnas.0904104106; Glas M, 2015, J BIOL CHEM, V290, P21498, DOI 10.1074/jbc.M115.654756; Goehring NW, 2007, J BACTERIOL, V189, P633, DOI 10.1128/JB.00991-06; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Gupta S, 2015, MICROBIOL-SGM, V161, P1627, DOI 10.1099/mic.0.000108; Haeusser DP, 2016, NAT REV MICROBIOL, V14, P305, DOI 10.1038/nrmicro.2016.26; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Jain P, 2014, MBIO, V5, DOI 10.1128/mBio.01245-14; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Katis VL, 1999, J BACTERIOL, V181, P2710, DOI 10.1128/JB.181.9.2710-2718.1999; Kaval KG, 2012, VIRULENCE, V3, P406, DOI [10.4161/viru.20747, 10.1111/j.1365-2958.2012.07969.x]; Khan MZ, 2017, J BIOL CHEM, V292, P16093, DOI 10.1074/jbc.M117.797563; Kieser KJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005010; Lee JJ, 2014, NEW MICROBIOL, V37, P525; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Liu B, 2015, MOL MICROBIOL, V95, P945, DOI 10.1111/mmi.12906; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Mannik J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006638; Masson S, 2009, J BIOL CHEM, V284, P27687, DOI 10.1074/jbc.M109.019471; Mavrici D, 2014, P NATL ACAD SCI USA, V111, P8037, DOI 10.1073/pnas.1321812111; Nagarajan SN, 2015, J BIOL CHEM, V290, P9626, DOI 10.1074/jbc.M114.611822; Noirclerc-Savoye M, 2005, MOL MICROBIOL, V55, P413, DOI 10.1111/j.1365-2958.2004.04408.x; Ortiz C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184184; Pandey AK, 2009, TUBERCULOSIS, V89, P12, DOI 10.1016/j.tube.2008.07.007; Pichoff S, 2015, MOL MICROBIOL, V95, P971, DOI 10.1111/mmi.12907; Plocinski P, 2012, J BACTERIOL, V194, P6398, DOI 10.1128/JB.01005-12; Plocinski P, 2011, J BACTERIOL, V193, P3246, DOI 10.1128/JB.00188-11; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Priyadarshini R, 2006, J BACTERIOL, V188, P5345, DOI 10.1128/JB.00476-06; Rajanala K, 2014, J CELL SCI, V127, P3505, DOI 10.1242/jcs.149112; Ramos A, 2003, MICROBIOL-SGM, V149, P3531, DOI 10.1099/mic.0.26653-0; Rego EH, 2017, NATURE, V546, P153, DOI 10.1038/nature22361; RICARD M, 1973, J BACTERIOL, V116, P314, DOI 10.1128/JB.116.1.314-322.1973; Rico AI, 2013, J BIOL CHEM, V288, P20830, DOI 10.1074/jbc.R113.479519; Robson SA, 2006, P NATL ACAD SCI USA, V103, P6700, DOI 10.1073/pnas.0601397103; Rowland SL, 2010, J BACTERIOL, V192, P6116, DOI 10.1128/JB.00783-10; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Sackett MJ, 1998, MOL MICROBIOL, V28, P421, DOI 10.1046/j.1365-2958.1998.00753.x; Samten B, 2016, TUBERCULOSIS, V101, pS99, DOI 10.1016/j.tube.2016.09.017; Sanchez-Pulido L, 2003, TRENDS BIOCHEM SCI, V28, P523, DOI 10.1016/j.tibs.2003.08.003; Sharma AK, 2016, J BIOL CHEM, V291, P24215, DOI 10.1074/jbc.M116.754531; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Singh B, 2013, MOL MICROBIOL, V88, P64, DOI 10.1111/mmi.12169; Soderstrom B, 2014, MOL MICROBIOL, V92, P1, DOI 10.1111/mmi.12534; Song H, 2008, TUBERCULOSIS, V88, P526, DOI 10.1016/j.tube.2008.02.004; Soni V, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005235; SPRATT BG, 1977, J BACTERIOL, V131, P293, DOI 10.1128/JB.131.1.293-305.1977; Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Thompson LS, 2006, J BACTERIOL, V188, P7677, DOI 10.1128/JB.01072-06; Tiwari D, 2009, J BIOL CHEM, V284, P27467, DOI 10.1074/jbc.M109.036095; Tsang MJ, 2015, MOL MICROBIOL, V95, P925, DOI 10.1111/mmi.12905; Ursinus A, 2004, J BACTERIOL, V186, P6728, DOI 10.1128/JB.186.20.6728-6737.2004; van den Ent F, 2008, MOL MICROBIOL, V68, P110, DOI 10.1111/j.1365-2958.2008.06141.x; Verma R, 2017, J PROTEOME RES, V16, P1632, DOI 10.1021/acs.jproteome.6b00983; Wu KJ, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00649-17; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002; Zhang YJJ, 2013, CELL, V155, P1296, DOI 10.1016/j.cell.2013.10.045	88	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12331	12349		10.1074/jbc.RA118.003628	http://dx.doi.org/10.1074/jbc.RA118.003628			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29903917	Green Published, hybrid			2022-12-26	WOS:000441408500003
J	Seren, S; Abouzaid, MR; Eulenberg-Gustavus, C; Hirschfeld, J; Soliman, HN; Jerke, U; N'Guessan, K; Dallet-Choisy, S; Lesner, A; Lauritzen, C; Schacher, B; Eickholz, P; Nagy, N; Szell, M; Croix, C; Viaud-Massuard, MC; Aldosari, AA; Ragunatha, S; Mostafa, MI; Giampieri, F; Battino, M; Cornillier, H; Lorette, G; Stephan, JL; Goizet, C; Pedersen, J; Gauthier, F; Jenne, DE; Marchand-Adam, S; Chapple, IL; Kettritz, R; Korkmaz, B				Seren, Seda; Abouzaid, Maha Rashed; Eulenberg-Gustavus, Claudia; Hirschfeld, Josefine; Soliman, Hala Nasr; Jerke, Uwe; N'Guessan, Koffi; Dallet-Choisy, Sandrine; Lesner, Adam; Lauritzen, Conni; Schacher, Beate; Eickholz, Peter; Nagy, Nikoletta; Szell, Marta; Croix, Cecile; Viaud-Massuard, Marie-Claude; Aldosari, Abdullah Al Farraj; Ragunatha, Shivanna; Mostafa, Mostafa Ibrahim; Giampieri, Francesca; Battino, Maurizio; Cornillier, Helene; Lorette, Gerard; Stephan, Jean-Louis; Goizet, Cyril; Pedersen, John; Gauthier, Francis; Jenne, Dieter E.; Marchand-Adam, Sylvain; Chapple, Iain L.; Kettritz, Ralph; Korkmaz, Brice			Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protease; protease inhibitor; neutrophil; aminopeptidase; antigen; autoimmune disease; genetic disease; proteinase 3; cathepsin C; granulomatosis with polyangiitis; Papillon-Lefevre syndrome	PAPILLON-LEFEVRE-SYNDROME; ANCA-ASSOCIATED VASCULITIDES; NEUTROPHIL SERINE PROTEASES; WEGENERS AUTOANTIGEN; MOLECULAR ANALYSIS; HUMAN-DISEASES; MUTATIONS; ELASTASE; CELLS; BINDING	Membrane-bound proteinase 3 (PR3(m)) is the main target antigen of anti-neutrophil cytoplasmic autoantibodies (ANCA) in granulomatosis with polyangiitis, a systemic small-vessel vasculitis. Binding of ANCA to PR3(m) triggers neutrophil activation with the secretion of enzymatically active PR3 and related neutrophil serine proteases, thereby contributing to vascular damage. PR3 and related proteases are activated from pro-forms by the lysosomal cysteine protease cathepsin C (CatC) during neutrophil maturation. We hypothesized that pharmacological inhibition of CatC provides an effective measure to reduce PR3(m) and therefore has implications as a novel therapeutic approach in granulomatosis with polyangiitis. We first studied neutrophilic PR3 from 24 patients with Papillon-Lefevre syndrome (PLS), a genetic form of CatC deficiency. PLS neutrophil lysates showed a largely reduced but still detectable (0.5-4%) PR3 activity when compared with healthy control cells. Despite extremely low levels of cellular PR3, the amount of constitutive PR3(m) expressed on the surface of quiescent neutrophils and the typical bimodal membrane distribution pattern were similar to what was observed in healthy neutrophils. However, following cell activation, there was no significant increase in the total amount of PR3(m) on PLS neutrophils, whereas the total amount of PR3(m) on healthy neutrophils was significantly increased. We then explored the effect of pharmacological CatC inhibition on PR3 stability in normal neutrophils using a potent cell-permeable CatC inhibitor and a CD34(+) hematopoietic stem cell model. Human CD34(+) hematopoietic stem cells were treated with the inhibitor during neutrophil differentiation over 10 days. We observed strong reductions in PR3(m), cellular PR3 protein, and proteolytic PR3 activity, whereas neutrophil differentiation was not compromised.	[Seren, Seda; N'Guessan, Koffi; Dallet-Choisy, Sandrine; Gauthier, Francis; Marchand-Adam, Sylvain; Korkmaz, Brice] INSERM, U1100, Ctr Etude Pathol Resp, F-37000 Tours, France; [Seren, Seda; N'Guessan, Koffi; Dallet-Choisy, Sandrine; Gauthier, Francis; Marchand-Adam, Sylvain; Korkmaz, Brice] Univ Tours, F-37000 Tours, France; [Abouzaid, Maha Rashed; Mostafa, Mostafa Ibrahim] Natl Res Ctr, Dept Orodent Genet, Cairo 12622, Egypt; [Soliman, Hala Nasr] Natl Res Ctr, Dept Med Mol Genet, Cairo 12622, Egypt; [Eulenberg-Gustavus, Claudia; Jerke, Uwe; Kettritz, Ralph] Charite & Max Delbruck Ctr Mol Med Helmholtz Gemi, Expt & Clin Res Ctr, D-13125 Berlin, Germany; [Hirschfeld, Josefine; Chapple, Iain L.] Univ Birmingham, Coll Med & Dent Sci, Periodontal Res Grp, Inst Clin Sci, Birmingham B5 7EG, W Midlands, England; [Hirschfeld, Josefine; Chapple, Iain L.] Birmingham Community Hlth Trust, Birmingham B5 7EG, W Midlands, England; [Lesner, Adam] Univ Gdansk, Fac Chem, PL-80309 Gdansk, Poland; [Lauritzen, Conni; Pedersen, John] Unizyme Labs AS, DK-2970 Horsholm, Denmark; [Schacher, Beate; Eickholz, Peter] Goethe Univ Frankfurt, Dept Periodontol, D-60323 Frankfurt, Germany; [Nagy, Nikoletta; Szell, Marta] Univ Szeged, Dept Med Genet, H-6720 Szeged, Hungary; [Croix, Cecile; Viaud-Massuard, Marie-Claude] CNRS, UMR Genet Immunotherapie Chim & Canc 7292, F-37000 Tours, France; [Croix, Cecile; Viaud-Massuard, Marie-Claude] Univ Tours, F-37000 Tours, France; [Aldosari, Abdullah Al Farraj] King Saud Univ, Coll Dent, Dept Prosthet Dent Sci, Riyadh 12372, Saudi Arabia; [Ragunatha, Shivanna] ESIC Med Coll, Dept Dermatol Venereol & Leprosy, Bengaluru 560010, Karnataka, India; [Ragunatha, Shivanna] PGIMSR Rajajinagar, Bengaluru 560010, Karnataka, India; [Giampieri, Francesca; Battino, Maurizio] Univ Politecn Marche, Dept Clin Sci, I-60121 Ancona, Italy; [Cornillier, Helene] Univ Tours, CHU Tours, Serv Dermatol, F-37000 Tours, France; [Lorette, Gerard] Univ Tours, INRA, UMR 1282, Lab Virol & Immunol Mol, F-37000 Tours, France; [Stephan, Jean-Louis] CHU St Etienne, Serv Hematol Immunol & Rhumatol Pediat, St Priest En Jarez, France; [Goizet, Cyril] Pellegrin Hosp, MRGM Lab, INSERM, U1211,Rare Dis Genet & Metab, F-33000 Bordeaux, France; [Goizet, Cyril] Univ Bordeaux, F-33000 Bordeaux, France; [Jenne, Dieter E.] German Ctr Lung Res DZL, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, D-81377 Munich, Germany; [Jenne, Dieter E.] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Kettritz, Ralph] Charite, Med Dept, Div Nephrol & Intens Care Med, D-10117 Berlin, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); University of Birmingham; Fahrenheit Universities; University of Gdansk; Goethe University Frankfurt; Szeged University; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; King Saud University; Marche Polytechnic University; CHU Tours; Universite de Tours; INRAE; Universite de Tours; CHU de St Etienne; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Korkmaz, B (corresponding author), Univ Tours, INSERM, U1100, CEPR,Fac Med, 10 Bld, F-37032 Tours, France.	brice.korkmaz@inserm.fr	GOIZET, Cyril/M-4576-2014; Giampieri, Francesca/I-1911-2015; Chapple, Iain L C/T-2986-2017; Hirschfeld, Josefine/AAD-3604-2022; Nagy, Nikoletta/AAJ-6631-2020; Battino, Maurizio/E-6103-2012; Lesner, Adam/M-2732-2019; Jenne, Dieter Erich/AAP-1414-2020; Shivanna, Ragunatha/ABD-6583-2021	GOIZET, Cyril/0000-0002-1913-889X; Giampieri, Francesca/0000-0002-8151-9132; Chapple, Iain L C/0000-0003-2697-7082; Hirschfeld, Josefine/0000-0001-8512-7411; Nagy, Nikoletta/0000-0001-8576-7953; Battino, Maurizio/0000-0002-7250-1782; Shivanna, Ragunatha/0000-0002-9774-1272; KORKMAZ, BRICE/0000-0002-5159-8706; Kettritz, Ralph/0000-0001-5821-6718; Soliman, Hala/0000-0001-8783-9869; Abouzaid, Maha/0000-0002-9986-425X; marchand-adam, sylvain/0000-0002-9522-3738; Seren, Seda/0000-0002-7263-485X; Jerke, Uwe/0000-0001-6887-8010; Lesner, Adam/0000-0001-8335-3431	European Union's Horizon 2020 research and innovation program [668036]; "Ministere de l'Enseignement Superieur et de la Recherche," the "Region Centre-Val de Loire" (Project BPCO-Lyse); "Alexandre von Humboldt Foundation" (2016, Comprehensive Pneumology Center, Munich)	European Union's Horizon 2020 research and innovation program; "Ministere de l'Enseignement Superieur et de la Recherche," the "Region Centre-Val de Loire" (Project BPCO-Lyse); "Alexandre von Humboldt Foundation" (2016, Comprehensive Pneumology Center, Munich)	This work was supported by the "Ministere de l'Enseignement Superieur et de la Recherche," the "Region Centre-Val de Loire" (Project BPCO-Lyse). This project has received funding from the European Union's Horizon 2020 research and innovation program under Grant Agreement 668036 (RELENT). The authors declare that they have no conflicts of interest with the contents of this article. Responsibility for the information and views set out in this article lies entirely with the authors.; Recipient of a short-term institutional research training grant from the "Alexandre von Humboldt Foundation" (2016, Comprehensive Pneumology Center, Munich).	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Attucci S, 2002, BIOCHEM J, V366, P965, DOI 10.1042/BJ20020321; Bullon P, 2014, J EUR ACAD DERMATOL, V28, P1049, DOI 10.1111/jdv.12265; Bullon P, 2018, J ALLERGY CLIN IMMUN, V142, P1131, DOI 10.1016/j.jaci.2018.01.018; Campbell EJ, 2000, J IMMUNOL, V165, P3366, DOI 10.4049/jimmunol.165.6.3366; Chaigne B, 2016, PRESSE MED, V45, pE171, DOI 10.1016/j.lpm.2016.05.003; Dahl SW, 2001, BIOCHEMISTRY-US, V40, P1671, DOI 10.1021/bi001693z; Essawi M, 1997, DIS MARKERS, V13, P99; Eulenberg-Gustavus C, 2017, J EXP MED, V214, P2089, DOI 10.1084/jem.20161093; Goldmann WH, 1999, EUR J BIOCHEM, V261, P155, DOI 10.1046/j.1432-1327.1999.00259.x; GORLIN RJ, 1964, J PEDIATR-US, V65, P895, DOI 10.1016/S0022-3476(64)80014-7; GREENE LJ, 1963, J BIOL CHEM, V238, P2054; Guarino C, 2017, BIOCHEM PHARMACOL, V131, P52, DOI 10.1016/j.bcp.2017.02.009; Guarino C, 2014, J BIOL CHEM, V289, P31777, DOI 10.1074/jbc.M114.591339; HALBWACHSMECARELLI L, 1995, FEBS LETT, V374, P29, DOI 10.1016/0014-5793(95)01073-N; Hamon Y, 2016, J BIOL CHEM, V291, P8486, DOI 10.1074/jbc.M115.707109; Hamon Y, 2016, FEBS J, V283, P498, DOI 10.1111/febs.13605; Hart T C, 1994, Periodontol 2000, V6, P88, DOI 10.1111/j.1600-0757.1994.tb00029.x; Hart TC, 1999, J MED GENET, V36, P881; Hinkofer LC, 2013, J BIOL CHEM, V288, P26635, DOI 10.1074/jbc.M113.495770; Hong Y, 2012, J AM SOC NEPHROL, V23, P49, DOI 10.1681/ASN.2011030298; Jenne DE, 2006, CLIN NEPHROL, V66, P153; JENNE DE, 1990, NATURE, V346, P520, DOI 10.1038/346520a0; Jerke U, 2015, KIDNEY INT, V88, P764, DOI 10.1038/ki.2015.159; Kallenberg CGM, 2015, CLIN EXP RHEUMATOL, V33, pS11; Kantari C, 2011, J LEUKOCYTE BIOL, V90, P941, DOI 10.1189/jlb.1210695; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kettritz R, 2012, CLIN EXP IMMUNOL, V169, P220, DOI 10.1111/j.1365-2249.2012.04615.x; Kettritz R, 2016, IMMUNOL REV, V273, P232, DOI 10.1111/imr.12441; Korkmaz B, 2005, AM J RESP CELL MOL, V32, P553, DOI 10.1165/rcmb.2004-0374OC; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2007, J BIOL CHEM, V282, P1989, DOI 10.1074/jbc.M608700200; Korkmaz B, 2018, PHARMACOL THERAPEUT, V190, P202, DOI 10.1016/j.pharmthera.2018.05.011; Korkmaz B, 2016, PHARMACOL REV, V68, P603, DOI 10.1124/pr.115.012104; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Korkmaz B, 2008, J BIOL CHEM, V283, P35976, DOI 10.1074/jbc.M806754200; Legowska M, 2016, ARCH BIOCHEM BIOPHYS, V612, P91, DOI 10.1016/j.abb.2016.10.007; Martin KR, 2016, J BIOL CHEM, V291, P10476, DOI 10.1074/jbc.M115.698639; Martinho S, 2017, ARCH PEDIATRIE, V24, P360, DOI 10.1016/j.arcped.2017.01.013; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Millet A, 2013, ANN RHEUM DIS, V72, P1273, DOI 10.1136/annrheumdis-2013-203255; Molgaard A, 2007, BIOCHEM J, V401, P645, DOI 10.1042/BJ20061389; Nagy N, 2014, MOL GENET GENOM MED, V2, P217, DOI 10.1002/mgg3.61; Noack B, 2008, J CLIN PERIODONTOL, V35, P311, DOI 10.1111/j.1600-051X.2008.01201.x; Pagnoux C, 2016, EUR J RHEUMATOL, V3, P122, DOI 10.5152/eurjrheum.2015.0043; Perera NC, 2013, J IMMUNOL, V191, P2700, DOI 10.4049/jimmunol.1301293; Pham CTN, 2004, J IMMUNOL, V173, P7277, DOI 10.4049/jimmunol.173.12.7277; Ragunatha S, 2015, PEDIATR DERMATOL, V32, P292, DOI 10.1111/pde.12357; Roberts H, 2016, J LEUKOCYTE BIOL, V100, P433, DOI 10.1189/jlb.5A1015-489R; Schacher B, 2006, J CLIN PERIODONTOL, V33, P829, DOI 10.1111/j.1600-051X.2006.00992.x; Schonermarck U, 2015, NEPHROL DIAL TRANSPL, V30, pi46, DOI 10.1093/ndt/gfu398; Schreiber A, 2005, J AM SOC NEPHROL, V16, P2216, DOI 10.1681/ASN.2004070609; Schreiber A, 2003, J AM SOC NEPHROL, V14, P68, DOI 10.1097/01.ASN.0000040751.83734.D1; Schreiber A, 2017, P NATL ACAD SCI USA, V114, pE9618, DOI 10.1073/pnas.1708247114; Selvaraju Veeriah, 2003, BMC Med Genet, V4, P5, DOI 10.1186/1471-2350-4-5; Soliman H., 2015, EGYPTIAN J MED HUMAN, V16, P239, DOI [10.1016/j.ejmhg.2015.03.002, DOI 10.1016/J.EJMHG.2015.03.002]; Sorensen OE, 2014, J CLIN INVEST, V124, P4539, DOI 10.1172/JCI76009; Thieblemont N, 2016, SEMIN IMMUNOL, V28, P159, DOI 10.1016/j.smim.2016.03.004; Toomes C, 1999, NAT GENET, V23, P421, DOI 10.1038/70525; Turk D, 2001, EMBO J, V20, P6570, DOI 10.1093/emboj/20.23.6570; Yates M, 2017, CLIN MED, V17, P60, DOI 10.7861/clinmedicine.17-1-60	61	18	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12415	12428		10.1074/jbc.RA118.001922	http://dx.doi.org/10.1074/jbc.RA118.001922			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29925593	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000441408500009
J	Bertalovitz, AC; Badhey, MLO; McDonald, TV				Bertalovitz, Alexander C.; Badhey, Marika L. Osterbur; McDonald, Thomas, V			Synonymous nucleotide modification of the KCNH2 gene affects both mRNA characteristics and translation of the encoded hERG ion channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						genetic polymorphism; genetic disease; potassium channel; protein synthesis; mRNA; transcription; translation; hERG	LONG-QT-SYNDROME; POTASSIUM CHANNEL; CIRCULAR-DICHROISM; QUALITY-CONTROL; SECONDARY STRUCTURE; CODON OPTIMALITY; CLICK CHEMISTRY; EMBL-EBI; TRAFFICKING; DECAY	Synonymous nucleotide variation is increasingly recognized as a factor than can affect protein expression, but the underlying mechanisms are incompletely understood. Here, we investigated whether synonymous changes could affect expression of the potassium voltage-gated channel subfamily H member 2 (KCNH2) gene, encoding the human ether-a-go-go-related gene (hERG) ion channel, which is linked to hereditary cardiac arrhythmia. We examined a previously described synthetic version (hERG-codon modified (CM)) with synonymous substitutions designed to reduce GC content, rare codons, and mRNA secondary structure relative to the native construct (hERG-NT). hERG-CM exhibited lower protein expression than hERG-NT in HEK293T cells. We found that the steady-state abundance of hERG-NT mRNA was greater than hERG-CM because of an enhanced transcription rate and increased mRNA stability for hERG-NT. Translation of hERG-CM was independently reduced, contributing to the overall greater synthesis of hERG-NT channel protein. This was partially offset, however, by a higher aggregation of a newly synthesized hERG-NT channel, resulting in nonfunctional protein. Regional mRNA analyses of chimeras of hERG-NT and hERG-CM revealed that synonymous changes in the 5 segments of the coding region had the greatest influence on hERG synthesis at both the mRNA and protein levels. Taken together, these results indicate that synonymous nucleotide variations within the coding region, particularly in the 5 region of the hERG mRNA, can affect both transcription and translation. These findings support the notion that greater attention should be given to the effects of synonymous genetic variation when analyzing hERG DNA sequences in the study of hereditary cardiac disease.	[Bertalovitz, Alexander C.; Badhey, Marika L. Osterbur; McDonald, Thomas, V] Albert Einstein Coll Med, Dept Mol Pharmacol, Dept Med, Div Cardiol, Bronx, NY 10461 USA; [Bertalovitz, Alexander C.; McDonald, Thomas, V] Univ S Florida, Morsani Coll Med, Dept Cardiovasc Sci, Tampa, FL 33612 USA	Yeshiva University; Albert Einstein College of Medicine; State University System of Florida; University of South Florida	McDonald, TV (corresponding author), Univ S Florida, Morsani Coll Med, Dept Cardiovasc Sci, Tampa, FL 33612 USA.	thomasmcdonald@health.usf.edu		McDonald, Thomas/0000-0002-6075-0888	National Institutes of Health from NHLBI [R01HL118437, F30HL126283]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL126283, R01HL118437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01HL118437 and F30HL126283 from NHLBI. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badhey MLO, 2017, J CARDIOVASC ELECTR, V28, P1070, DOI 10.1111/jce.13259; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Bentele K, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.32; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Cleary MD, 2005, NAT BIOTECHNOL, V23, P232, DOI 10.1038/nbt1061; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Foo B, 2016, J PHYSIOL-LONDON, V594, P2469, DOI 10.1113/JP270531; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HASHIZUME H, 1967, J BIOCHEM, V61, P738, DOI 10.1093/oxfordjournals.jbchem.a128608; Huch S, 2014, WIRES RNA, V5, P747, DOI 10.1002/wrna.1244; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; IVANOV VI, 1973, BIOPOLYMERS, V12, P89, DOI 10.1002/bip.1973.360120109; JOHNSON WC, 1972, BIOPOLYMERS, V11, P225, DOI 10.1002/bip.1972.360110117; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keller SH, 2005, CELL BIOCHEM BIOPHYS, V43, P365, DOI 10.1385/CBB:43:3:365; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Lamothe SM, 2018, FASEB J, V32, P1933, DOI 10.1096/fj.201700832R; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Manganas LN, 2001, J BIOL CHEM, V276, P49427, DOI 10.1074/jbc.M109325200; Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Miller MR, 2009, NAT METHODS, V6, P439, DOI [10.1038/nmeth.1329, 10.1038/NMETH.1329]; Moric-Janiszewska E, 2012, CARDIOL J, V19, P159, DOI 10.5603/CJ.2012.0028; Newman ZR, 2016, P NATL ACAD SCI USA, V113, pE1362, DOI 10.1073/pnas.1518976113; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; PURVIS IJ, 1987, J MOL BIOL, V193, P413, DOI 10.1016/0022-2836(87)90230-0; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Radhakrishnan A, 2016, CELL, V167, P122, DOI 10.1016/j.cell.2016.08.053; Radhakrishnan A, 2016, J MOL BIOL, V428, P3558, DOI 10.1016/j.jmb.2016.05.025; Roy B, 2013, TRENDS GENET, V29, P691, DOI 10.1016/j.tig.2013.09.002; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SHARP PM, 1987, MOL BIOL EVOL, V4, P222; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simms CL, 2017, MOL CELL, V68, P361, DOI 10.1016/j.molcel.2017.08.019; Simms CL, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1366; Smith JL, 2013, AM J PHYSIOL-CELL PH, V305, pC919, DOI 10.1152/ajpcell.00406.2012; Sroubek J, 2013, FASEB J, V27, P3039, DOI 10.1096/fj.12-227009; Tester David J, 2014, Methodist Debakey Cardiovasc J, V10, P29; Thomas D, 2003, CARDIOVASC RES, V60, P235, DOI 10.1016/j.cardiores.2003.08.002; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Trudeau MC, 1996, SCIENCE, V272, P1087; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Tuller T, 2015, NUCLEIC ACIDS RES, V43, P13, DOI 10.1093/nar/gku1313; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Um SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000933; Walker VE, 2007, J BIOL CHEM, V282, P23509, DOI 10.1074/jbc.M701006200; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Wang SR, 2008, BIOORG MED CHEM LETT, V18, P6505, DOI 10.1016/j.bmcl.2008.10.047; WILLIAMS AL, 1986, NUCLEIC ACIDS RES, V14, P6649, DOI 10.1093/nar/14.16.6649; Young JC, 2014, DIS MODEL MECH, V7, P319, DOI 10.1242/dmm.014001; Zamft B, 2012, P NATL ACAD SCI USA, V109, P8948, DOI 10.1073/pnas.1205063109; Zhou T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048541; Zhou ZP, 2018, ELIFE, V7, DOI [10.7554/eLife.33569.001, 10.7554/eLife.33569]	60	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12120	12136		10.1074/jbc.RA118.001805	http://dx.doi.org/10.1074/jbc.RA118.001805			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29907571	Green Published, hybrid			2022-12-26	WOS:000440803200012
J	Patel, S; Barkell, AM; Gupta, D; Strong, SL; Bruton, S; Muskett, FW; Addis, PW; Renshaw, PS; Slocombe, PM; Doyle, C; Clargo, A; Taylor, RJ; Prosser, CE; Henry, AJ; Robinson, MK; Waters, LC; Holdsworth, G; Carr, MD				Patel, Saleha; Barkell, Alice M.; Gupta, Deepti; Strong, Sarah L.; Bruton, Shaun; Muskett, Frederick W.; Addis, Philip W.; Renshaw, Philip S.; Slocombe, Patrick M.; Doyle, Carl; Clargo, Alison; Taylor, Richard J.; Prosser, Christine E.; Henry, Alistair J.; Robinson, Martyn K.; Waters, Lorna C.; Holdsworth, Gill; Carr, Mark D.			Structural and functional analysis of Dickkopf 4 (Dkk4): New insights into Dkk evolution and regulation of Wnt signaling by Dkk and Kremen proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cooperativity; nuclear magnetic resonance (NMR); Wnt signaling; cell surface receptor; structural biology; protein structure; protein-protein interaction; Dkk4; Kremen1; LRP6	TORSION ANGLE DYNAMICS; NMR CHEMICAL-SHIFTS; N-TERMINAL DOMAIN; SECONDARY-STRUCTURE; TISSUE INHIBITOR; MATRIX-METALLOPROTEINASE; COMPLEX-FORMATION; LRP6; BINDING; FAMILY	Dickkopf (Dkk) family proteins are important regulators of Wnt signaling pathways, which play key roles in many essential biological processes. Here, we report the first detailed structural and dynamics study of a full-length mature Dkk protein (Dkk4, residues 19-224), including determination of the first atomic-resolution structure for the N-terminal cysteine-rich domain (CRD1) conserved among Dkk proteins. We discovered that CRD1 has significant structural homology to the Dkk C-terminal cysteine-rich domain (CRD2), pointing to multiple gene duplication events during Dkk family evolution. We also show that Dkk4 consists of two independent folded domains (CRD1 and CRD2) joined by a highly flexible, nonstructured linker. Similarly, the N-terminal region preceding CRD1 and containing a highly conserved NXI(R/K) sequence motif was shown to be dynamic and highly flexible. We demonstrate that Dkk4 CRD2 mediates high-affinity binding to both the E1E2 region of low-density lipoprotein receptor-related protein 6 (LRP6 E1E2) and the Kremen1 (Krm1) extracellular domain. In contrast, the N-terminal region alone bound with only moderate affinity to LRP6 E1E2, consistent with binding via the conserved NXI(R/K) motif, but did not interact with Krm proteins. We also confirmed that Dkk and Krm family proteins function synergistically to inhibit Wnt signaling. Insights provided by our integrated structural, dynamics, interaction, and functional studies have allowed us to refine the model of synergistic regulation of Wnt signaling by Dkk proteins. Our results indicate the potential for the formation of a diverse range of ternary complexes comprising Dkk, Krm, and LRP5/6 proteins, allowing fine-tuning of Wnt-dependent signaling.	[Patel, Saleha; Barkell, Alice M.; Strong, Sarah L.; Bruton, Shaun; Muskett, Frederick W.; Addis, Philip W.; Renshaw, Philip S.; Prosser, Christine E.; Waters, Lorna C.; Carr, Mark D.] Univ Leicester, Leicester Inst Struct & Chem Biol, Lancaster Rd, Leicester LE1 7HB, Leics, England; [Patel, Saleha; Barkell, Alice M.; Strong, Sarah L.; Bruton, Shaun; Muskett, Frederick W.; Addis, Philip W.; Renshaw, Philip S.; Waters, Lorna C.; Carr, Mark D.] Univ Leicester, Dept Mol & Cell Biol, Lancaster Rd, Leicester LE1 7HB, Leics, England; [Gupta, Deepti; Slocombe, Patrick M.; Doyle, Carl; Clargo, Alison; Taylor, Richard J.; Prosser, Christine E.; Henry, Alistair J.; Robinson, Martyn K.; Holdsworth, Gill] UCB, 208 Bath Rd, Slough SL1 3WE, Berks, England	University of Leicester; University of Leicester; UCB Pharma SA	Waters, LC; Carr, MD (corresponding author), Univ Leicester, Leicester Inst Struct & Chem Biol, Lancaster Rd, Leicester LE1 7HB, Leics, England.; Holdsworth, G (corresponding author), 208 Bath Rd, Slough SL1 3WE, Berks, England.	lw83@le.ac.uk; gill.holdsworth@ucb.com; mdc12@le.ac.uk	Renshaw, Perry/O-1384-2018	Carr, Mark/0000-0002-3939-0996; Addis, Philip/0000-0003-1185-651X	CASE Ph.D. studentships from the Biotechnology and Biological Sciences Research Council (BBSRC); UCB; MRC [MC_U117533887] Funding Source: UKRI	CASE Ph.D. studentships from the Biotechnology and Biological Sciences Research Council (BBSRC); UCB(UCB Pharma SA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by CASE Ph.D. studentships from the Biotechnology and Biological Sciences Research Council (BBSRC) in partnership with UCB.	Ahn VE, 2011, DEV CELL, V21, P862, DOI 10.1016/j.devcel.2011.09.003; Aravind L, 1998, CURR BIOL, V8, pR477, DOI 10.1016/S0960-9822(98)70309-4; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barkell AM, 2015, BIOMOL NMR ASSIGN, V9, P147, DOI 10.1007/s12104-014-9562-2; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Broadhurst RW, 1995, BIOCHEMISTRY-US, V34, P16608, DOI 10.1021/bi00051a008; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P405, DOI 10.1016/B978-012164491-8/50008-7; Chen LJ, 2008, J BIOL CHEM, V283, P23364, DOI 10.1074/jbc.M802375200; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; Chouhan S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27558; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fedi P, 1999, J BIOL CHEM, V274, P19465, DOI 10.1074/jbc.274.27.19465; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hafsa NE, 2015, NUCLEIC ACIDS RES, V43, pW370, DOI 10.1093/nar/gkv494; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holdsworth G, 2012, J BIOL CHEM, V287, P26464, DOI 10.1074/jbc.M112.350108; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mishra SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052190; Muskett FW, 1998, J BIOL CHEM, V273, P21736, DOI 10.1074/jbc.273.34.21736; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Sima J, 2016, DEVELOPMENT, V143, P4723, DOI 10.1242/dev.143909; Sitar T, 2006, P NATL ACAD SCI USA, V103, P13028, DOI 10.1073/pnas.0605652103; Sun SJ, 2015, J BIOMOL NMR, V62, P105, DOI 10.1007/s10858-015-9923-x; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; Williamson RA, 1999, J BIOL CHEM, V274, P37226, DOI 10.1074/jbc.274.52.37226; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Zebisch M, 2016, STRUCTURE, V24, P1599, DOI 10.1016/j.str.2016.06.020; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004; Zhu SY, 2003, FASEB J, V17, P1765, DOI 10.1096/fj.02-1044fje; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027	44	14	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12149	12166		10.1074/jbc.RA118.002918	http://dx.doi.org/10.1074/jbc.RA118.002918			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29925589	Green Published, hybrid			2022-12-26	WOS:000440803200014
J	Chen, FP; Chien, MH; Chen, HY; Ng, YT				Chen, Fang-Ping; Chien, Mei-Hua; Chen, Huang-Yang; Ng, Yuet-Tong			Effects of phthalates on normal human breast cells co-cultured with different fibroblasts	PLOS ONE			English	Article							IN-VITRO; ESTROGEN-RECEPTOR; PROLIFERATION; CANCER; IMPACT; GROWTH; ESTERS; TISSUE; ASSAY	Whether or not phthalates play a role in breast carcinogenesis remains to be determined. The goal of this study was to explore the effects of phthalates on the growth of normal MCF-10A breast cells modulated by breast fibroblasts. Fibroblasts were derived from normal mammary tissue adjacent to both estrogen receptor (ER) positive and negative primary breast cancers, which were grown separately from nontumorigenic MCF-10A epithelial cells. MCF-10A co-culture cells were treated with 10 nM 17 beta-estradiol (E-2), Butyl benzyl phthalate (BBP), di(n-butyl) phthalate (DBP), and di(20ethylhexyl) phthalate (DEHP) (10 and 100 nM). After incubation for 120 hours, the cells were harvested and extracted for MTT assay. Western blot analysis was used to evaluate the proliferative pathway proteins and the effects on ER alpha. Only fibroblasts from ER (+) breast cancer significantly stimulated proliferation of MCF-10A cells. Exposure of the co-culture to E-2, BBP, DBP, DEHP, and E-2 combined with one of these phthalates resulted in significantly increased cell proliferation, as well as proliferating cell nuclear antigen (PCNA) and ER a expressions. The present study demonstrates that phthalates express a significant influence in fibroblast +/- epithelial interactions, similarly to the effects of E-2 on breast cells. The effects of phthalates on normal breast cells depend upon ER modulating actions. In breast carcinogenesis, phthalates should be considered as having endocrine disrupting potential, even at low concentrations.	[Chen, Fang-Ping; Chien, Mei-Hua] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Keelung, Taiwan; [Chen, Fang-Ping] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan; [Chen, Huang-Yang] Chang Gung Mem Hosp, Dept Gen Surg, Keelung, Taiwan; [Ng, Yuet-Tong] Chang Gung Mem Hosp, Dept Anesthesiol, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chen, FP (corresponding author), Chang Gung Mem Hosp, Dept Obstet & Gynecol, Keelung, Taiwan.; Chen, FP (corresponding author), Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan.	fangping@cgmh.org.tw			Taiwan's National Science Council [NMRPD1F1231]; Clinical Monitoring Research Program at Keelung Chang Gung Memorial Hospital [CMRPG2E0361]	Taiwan's National Science Council; Clinical Monitoring Research Program at Keelung Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	We declare that our study received research grants from Taiwan's National Science Council (grant no.: NMRPD1F1231) and the Clinical Monitoring Research Program at Keelung Chang Gung Memorial Hospital (grant no.: CMRPG2E0361). The funders played no role in our research, including study design, data collection, data analysis, manuscript preparation, and decision to submit for publication consideration.	Bass JJ, 2017, SCAND J MED SCI SPOR, V27, P4, DOI 10.1111/sms.12702; Brophy JT, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-87; Chen FP, 2014, CLIMACTERIC, V17, P377, DOI 10.3109/13697137.2013.865720; Chen FP, 2014, CLIMACTERIC, V17, P682, DOI 10.3109/13697137.2014.937688; Chen FP, 2016, TAIWAN J OBSTET GYNE, V55, P826, DOI 10.1016/j.tjog.2015.11.003; Gache C, 1998, IN VITRO CELL DEV-AN, V34, P347; Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802; Hsieh TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042750; JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434; Kunz-Schughart LA, 2002, HISTOL HISTOPATHOL, V17, P623, DOI 10.14670/HH-17.623; Kunz-Schughart LA, 2002, HISTOL HISTOPATHOL, V17, P599, DOI 10.14670/HH-17.599; Lopez-Carrillo L, 2010, ENVIRON HEALTH PERSP, V118, P539, DOI 10.1289/ehp.0901091; McBryan J, 2008, J MAMMARY GLAND BIOL, V13, P159, DOI 10.1007/s10911-008-9075-7; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Okubo T, 2003, BIOL PHARM BULL, V26, P1219; Pilat MJ, 1996, BREAST CANCER RES TR, V37, P253, DOI 10.1007/BF01806507; Proia DA, 2006, NAT PROTOC, V1, P206, DOI 10.1038/nprot.2006.31; Rajapakse N, 2002, ENVIRON HEALTH PERSP, V110, P917, DOI 10.1289/ehp.02110917; Sadlonova A, 2005, BREAST CANCER RES, V7, pR46, DOI 10.1186/bcr949; vanRoozendaal KEP, 1996, INT J CANCER, V65, P120, DOI 10.1002/(SICI)1097-0215(19960103)65:1<120::AID-IJC20>3.0.CO;2-J; Zacharewski TR, 1998, TOXICOL SCI, V46, P282, DOI 10.1006/toxs.1998.2505; ZAJCHOWSKI DA, 1993, CANCER RES, V53, P5004	22	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199596	10.1371/journal.pone.0199596	http://dx.doi.org/10.1371/journal.pone.0199596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940022	Green Published, Green Submitted, gold			2022-12-26	WOS:000436088700028
J	Chen, YY; Wu, Y; Zhu, BT; Zhang, GY; Wei, N				Chen, Yingying; Wu, Ying; Zhu, Baotong; Zhang, Guanyu; Wei, Na			Co-fermentation of cellobiose and xylose by mixed culture of recombinant Saccharomyces cerevisiae and kinetic modeling	PLOS ONE			English	Article							BUTANOL-ETHANOL PRODUCTION; ALCOHOLIC FERMENTATION; BIOFUEL PRODUCTION; ZYMOMONAS-MOBILIS; YEAST; CONSUMPTION; GLUCOSE; BIOMASS; OVEREXPRESSION; HYDROLYSATE	Efficient conversion of cellulosic sugars in cellulosic hydrolysates is important for economically viable production of biofuels from lignocellulosic biomass, but the goal remains a critical challenge. The present study reports a new approach for simultaneous fermentation of cellobiose and xylose by using the co-culture consisting of recombinant Saccharomyces cerevisiae specialist strains. The co-culture system can provide competitive advantage of modularity compared to the single culture system and can be tuned to deal with fluctuations in feedstock composition to achieve robust and cost-effective biofuel production. This study characterized fermentation kinetics of the recombinant cellobiose-consuming S. cerevisiae strain EJ2, xylose-consuming S. cerevisiae strain SR8, and their co-culture. The motivation for kinetic modeling was to provide guidance and prediction of using the co-culture system for simultaneous fermentation of mixed sugars with adjustable biomass of each specialist strain under different substrate concentrations. The kinetic model for the co-culture system was developed based on the pure culture models and incorporated the effects of product inhibition, initial substrate concentration and inoculum size. The model simulations were validated by results from independent fermentation experiments under different substrate conditions, and good agreement was found between model predictions and experimental data from batch fermentation of cellobiose, xylose and their mixtures. Additionally, with the guidance of model prediction, simultaneous co-fermentation of 60 g/L cellobiose and 20 g/L xylose was achieved with the initial cell densities of 0.45 g dry cell weight /L for EJ2 and 0.9 g dry cell weight /L SR8. The results demonstrated that the kinetic modeling could be used to guide the design and optimization of yeast co-culture conditions for achieving simultaneous fermentation of cellobiose and xylose with improved ethanol productivity, which is critically important for robust and efficient renewable biofuel production from lignocellulosic biomass.	[Chen, Yingying; Wu, Ying; Zhu, Baotong; Wei, Na] Univ Notre Dame, Dept Civil & Environm Engn & Earth Sci, Notre Dame, IN 46556 USA; [Zhang, Guanyu] Univ Pittsburgh, Dept Civil & Environm Engn, Pittsburgh, PA USA	University of Notre Dame; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wei, N (corresponding author), Univ Notre Dame, Dept Civil & Environm Engn & Earth Sci, Notre Dame, IN 46556 USA.	NWei@nd.edu	chen, ying/HHS-8254-2022	Zhu, Baotong/0000-0002-5516-5780	University of Notre Dame; ND Center for Environmental Science and Technology Predoctoral Fellowship Program; Patrick and Jana Eilers Graduate Student Fellowship for Energy-Related Research.	University of Notre Dame; ND Center for Environmental Science and Technology Predoctoral Fellowship Program; Patrick and Jana Eilers Graduate Student Fellowship for Energy-Related Research.	This work was supported by funds from the University of Notre Dame. Y.C. thankfully acknowledges support from the ND Center for Environmental Science and Technology Predoctoral Fellowship Program and Patrick and Jana Eilers Graduate Student Fellowship for Energy-Related Research.	Almeida JRM, 2011, BIOTECHNOL J, V6, P286, DOI 10.1002/biot.201000301; Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186; Ariyajaroenwong P, 2016, J TAIWAN INST CHEM E, V66, P210, DOI 10.1016/j.jtice.2016.06.023; Fazzini RAB, 2010, ENVIRON MICROBIOL, V12, P2436, DOI 10.1111/j.1462-2920.2010.02217.x; Buijs NA, 2013, CURR OPIN CHEM BIOL, V17, P480, DOI 10.1016/j.cbpa.2013.03.036; Chen YL, 2011, J IND MICROBIOL BIOT, V38, P581, DOI 10.1007/s10295-010-0894-3; Chen YY, 2016, APPL ENVIRON MICROB, V82, P2156, DOI 10.1128/AEM.03718-15; Chen YY, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-015-0418-5; Fu N, 2008, WORLD J MICROB BIOT, V24, P1091, DOI 10.1007/s11274-007-9613-2; Fu N, 2009, ENZYME MICROB TECH, V45, P210, DOI 10.1016/j.enzmictec.2009.04.006; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; Ghaly AE, 1997, BIOMASS BIOENERG, V12, P461, DOI 10.1016/S0961-9534(97)00012-3; Gu SY, 2014, IEEE INT CONF DISTR, P119, DOI 10.1109/DCOSS.2014.34; Guan WJ, 2018, IND ENG CHEM RES, V57, P775, DOI 10.1021/acs.iecr.7b03953; Guan WJ, 2016, BIORESOURCE TECHNOL, V200, P713, DOI 10.1016/j.biortech.2015.10.102; Ha SJ, 2011, APPL ENVIRON MICROB, V77, P5822, DOI 10.1128/AEM.05228-11; Ha SJ, 2011, P NATL ACAD SCI USA, V108, P504, DOI 10.1073/pnas.1010456108; Hahn-Hagerdal B, 2006, TRENDS BIOTECHNOL, V24, P549, DOI 10.1016/j.tibtech.2006.10.004; Hahn-Hagerdal B, 2007, APPL MICROBIOL BIOT, V74, P937, DOI 10.1007/s00253-006-0827-2; Hanly TJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-44; Hanly TJ, 2012, APPL MICROBIOL BIOT, V93, P2529, DOI 10.1007/s00253-011-3628-1; Hanly TJ, 2011, BIOTECHNOL BIOENG, V108, P376, DOI 10.1002/bit.22954; Hong KK, 2012, CELL MOL LIFE SCI, V69, P2671, DOI 10.1007/s00018-012-0945-1; Huang C, 2015, IEEE INT CONF MOB, P154, DOI 10.1109/MASS.2015.39; Huang C, 2015, IEEE TRUST BIG, P72, DOI 10.1109/Trustcom.2015.564; Huffer S, 2012, TRENDS BIOTECHNOL, V30, P538, DOI 10.1016/j.tibtech.2012.07.002; Ingledew WM, 1999, ALCOHOL TXB, P49; Isikgor FH, 2015, POLYM CHEM-UK, V6, P4497, DOI 10.1039/c5py00263j; Jeffries TW, 2006, CURR OPIN BIOTECH, V17, P320, DOI 10.1016/j.copbio.2006.05.008; Katahira S, 2006, APPL MICROBIOL BIOT, V72, P1136, DOI 10.1007/s00253-006-0402-x; Kim SR, 2012, TRENDS BIOTECHNOL, V30, P274, DOI 10.1016/j.tibtech.2012.01.005; Kim SR, 2013, PLOS ONE; Krishnan MS, 1999, APPL BIOCHEM BIOTECH, V77-9, P373, DOI 10.1385/ABAB:78:1-3:373; Latif F, 2001, BIORESOURCE TECHNOL, V77, P57, DOI 10.1016/S0960-8524(00)00134-6; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Madhavan A, 2009, APPL MICROBIOL BIOT, V82, P1037, DOI 10.1007/s00253-008-1818-2; MALESZKA R, 1982, APPL ENVIRON MICROB, V44, P909, DOI 10.1128/AEM.44.4.909-912.1982; Margeot A, 2009, CURR OPIN BIOTECH, V20, P372, DOI 10.1016/j.copbio.2009.05.009; Moyses DN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030207; Nevoigt E, 2008, MICROBIOL MOL BIOL R, V72, P379, DOI 10.1128/MMBR.00025-07; Oh EJ, 2016, APPL ENVIRON MICROB, V82, P3631, DOI 10.1128/AEM.00410-16; Oliveira S.C., 2016, J BIOPROCESS BIOTECH, V6, P266, DOI [10.4172/2155-9821.1000266, DOI 10.4172/2155-9821.1000266]; Patle S, 2007, BIOTECHNOL LETT, V29, P1839, DOI 10.1007/s10529-007-9493-4; Ramon-Portugal F, 2004, BIOTECHNOL LETT, V26, P1671, DOI 10.1007/s10529-004-3520-5; Sathesh-Prabu C, 2011, BIORESOURCE TECHNOL, V102, P2788, DOI 10.1016/j.biortech.2010.11.097; Somerville C, 2006, SCIENCE, V312, P1277, DOI 10.1126/science.1130034; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; van Maris AJA, 2006, ANTON LEEUW INT J G, V90, P391, DOI 10.1007/s10482-006-9085-7; Wang D, 2014, IEEE COMMUN MAG, V52, P36, DOI 10.1109/MCOM.2014.6871667; Wang J, 2007, FIBROCYTES NEW INSIG, P75; Wei N, 2013, NAT COMMUN, V4; Wei N, 2015, ACS SYNTH BIOL; Wei N, 2013, TRENDS BIOTECHNOL, V31, P70, DOI 10.1016/j.tibtech.2012.10.009; Zhou H, 2012, METAB ENG, V14, P611, DOI 10.1016/j.ymben.2012.07.011	56	16	16	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199104	10.1371/journal.pone.0199104	http://dx.doi.org/10.1371/journal.pone.0199104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940003	Green Submitted, Green Published, gold			2022-12-26	WOS:000436088700009
J	Kotilainen, T; Robson, TM; Hernandez, R				Kotilainen, Titta; Robson, T. Matthew; Hernandez, Ricardo			Light quality characterization under climate screens and shade nets for controlled-environment agriculture	PLOS ONE			English	Article							RADIATION; SOLAR; MICROCLIMATE; RESPONSES; POSTHARVEST; PARAMETERS; GROWTH; CROPS; RED	Climate screens are typically used inside glass greenhouses to improve control of humidity and temperature, and thus reduce energy expenditure. Shade nets are more appropriate to use, either with or without polyethylene cladding, at locations less-reliant on climate control, but where protection against hail, wind and excessive solar radiation might be needed. In addition, insect screens and nets can be employed to hinder insect pests and other invertebrates entering either type of production environment, and to keep invertebrates used in pest management contained inside. Screens and nets both transmit sunlight in a wave-length-specific manner, giving them the potential to affect plant morphology and physiology. Screens and nets of various colours and nominal shading factors have been described and studied; however, detailed measurements of their spectral characteristics are scarce. We measured solar spectral photon-irradiance and its attenuation by climate screens, shade nets, insect nets, greenhouse glass, and polyethylene covers. Our aim was to elucidate the effects of different patterns, colours, and shading factors, on light quality in production environments. Our measurements reveal that there are large differences both in the fraction of global irradiance attenuated and spectral ratios received under materials that are otherwise superficially similar in terms of their appearance and texture. We suggest that the type of spectral characterization that we performed is required to fully interpret the results of research examining plant responses to different types of screen and net. These data on spectral irradiance would benefit material manufacturers, researchers, growers, and horticultural consultants, enabling material selection to better match the solutions sought by growers and their desired outcomes regarding plant performance.	[Kotilainen, Titta; Robson, T. Matthew] Univ Helsinki, Fac Biol & Environm Sci, Viikki Plant Sci Ctr ViPS, Organismal & Evolutionary Biol, Helsinki, Finland; [Hernandez, Ricardo] NC State Univ, Dept Hort Sci, Raleigh, NC USA	University of Helsinki; University of North Carolina; North Carolina State University	Kotilainen, T (corresponding author), Univ Helsinki, Fac Biol & Environm Sci, Viikki Plant Sci Ctr ViPS, Organismal & Evolutionary Biol, Helsinki, Finland.	titta.kotilainen@helsinki.fi	Robson, Thomas Matthew/J-3381-2012	Robson, Thomas Matthew/0000-0002-8631-796X; Kotilainen, Titta/0000-0002-2822-9734; Hernandez, Ricardo/0000-0001-9739-4349	Academy of Finland [304653]; USDA National Institute of Food and Agriculture [107454]	Academy of Finland(Academy of Finland); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This research was funded by the Academy of Finland (Decision No. 304653 to T.M. R.): http://webfocus.aka.fi/ibi_apps/WFServlet?IBIF_ex=x_HakKuvaus2&CLICKED_ON=&HAKNRO1=304653&UILANG=en&IBIAPP_app=aka_ext&TULOSTE=HTML and by the USDA National Institute of Food and Agriculture (Decision No. 107454 to R.H.): https://portal.nifa.usda.gov/web/crisprojectpages/1007454-improving-sustainability-by-evaluating-novel-technologies-and-techniques-that-increase-energy-afficiency-in-horticulture-production-systems.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahemd HA, 2016, SCI HORTIC-AMSTERDAM, V201, P36, DOI 10.1016/j.scienta.2016.01.030; Aphalo P., 2016, CHECK ARRAY SPECTROM; Aphalo PJ, 2017, UV-B RADIATION AND PLANT LIFE: MOLECULAR BIOLOGY TO ECOLOGY, P10, DOI 10.1079/9781780648590.0010; Aphalo PJ, 2012, VISIBLE HDB BEST PRA; Aphalo PJ., 2015, UV4PLANTS B, V2015, P21; Arthurs S. P., 2013, HortScience, V48, P975; Ben-Yakir D, 2008, ACTA HORTIC, V770, P205, DOI 10.17660/ActaHortic.2008.770.24; Both AJ, 2017, HORTTECHNOLOGY, V27, P544, DOI [10.21273/HORTTECH03648-16, 10.21273/horttech03648-16]; Cascone G, 2005, ACTA HORTIC, P693, DOI 10.17660/ActaHortic.2005.691.85; Castellano S, 2008, APPL ENG AGRIC, V24, P799; Castilla N, 2013, GREENHOUSE TECHNOLOGY AND MANAGEMENT, 2ND EDITION, P1, DOI [10.1079/9781780641034.0000, 10.1079/9781780641034.0001]; Castronuovo D., 2017, Acta Horticulturae, P373, DOI 10.17660/actahortic.2017.1170.46; Cope KR, 2013, HORTSCIENCE, V48, P504, DOI 10.21273/HORTSCI.48.4.504; Demotes-Mainard S, 2016, ENVIRON EXP BOT, V121, P4, DOI 10.1016/j.envexpbot.2015.05.010; Diaz-Perez JC, 2014, HORTSCIENCE, V49, P891, DOI 10.21273/HORTSCI.49.7.891; Elad Y, 2007, PHYTOPARASITICA, V35, P285, DOI 10.1007/BF02981163; Emde C, 2016, GEOSCI MODEL DEV, V9, P1647, DOI 10.5194/gmd-9-1647-2016; Hernandez R, 2014, SCI HORTIC-AMSTERDAM, V173, P92, DOI 10.1016/j.scienta.2014.04.035; Hickman G. W., 2017, INT GREENHOUSE VEGET; Hideg E, 2017, UV-B RADIATION AND PLANT LIFE: MOLECULAR BIOLOGY TO ECOLOGY, P90, DOI 10.1079/9781780648590.0090; Ilic ZS, 2017, ENVIRON EXP BOT, V139, P79, DOI 10.1016/j.envexpbot.2017.04.006; Ilic ZS, 2015, J SCI FOOD AGR, V95, P2660, DOI 10.1002/jsfa.7000; ISO, 2007, SPAC ENV NAT ART PRO; Marcel AK, 2012, PHYSIOL PLANTARUM, V145, P501, DOI 10.1111/j.1399-3054.2012.01656.x; Jenkins GI, 2009, ANNU REV PLANT BIOL, V60, P407, DOI 10.1146/annurev.arplant.59.032607.092953; Kitta E, 2014, BIOSYST ENG, V122, P115, DOI 10.1016/j.biosystemseng.2014.04.001; Kittas C, 1999, J AGR ENG RES, V73, P341, DOI 10.1006/jaer.1999.0420; Kittas C, 2012, J HORTIC SCI BIOTECH, V87, P7, DOI 10.1080/14620316.2012.11512822; Lindfors A, 2009, PHOTOCHEM PHOTOBIOL, V85, P1233, DOI 10.1111/j.1751-1097.2009.00578.x; NIJSKENS J, 1985, AGR FOREST METEOROL, V35, P229, DOI 10.1016/0168-1923(85)90086-3; R Core Team, 2020, R LANG ENV STAT COMP; Robson TM, 2015, PLANT CELL ENVIRON, V38, P856, DOI 10.1111/pce.12374; Seckmeyer G, 2008, PHOTOCHEM PHOTOBIOL, V84, P172, DOI 10.1111/j.1751-1097.2007.00216.x; Sellaro R, 2010, PLANT PHYSIOL, V154, P401, DOI 10.1104/pp.110.160820; Siipola SM, 2015, PLANT CELL ENVIRON, V38, P941, DOI 10.1111/pce.12403; SMITH H, 1982, ANNU REV PLANT PHYS, V33, P481, DOI 10.1146/annurev.pp.33.060182.002405; Tanny J, 2013, BIOSYST ENG, V114, P26, DOI 10.1016/j.biosystemseng.2012.10.008; Teramura A.H., 1986, STRATOSPHERIC OZONE, P327, DOI [10.1007/978-3-642-70090-3_25, DOI 10.1007/978-3-642-70090-3_25]; Tinyane PP, 2013, SCI HORTIC-AMSTERDAM, V161, P340, DOI 10.1016/j.scienta.2013.06.024; Verdaguer D, 2017, PLANT SCI, V255, P72, DOI 10.1016/j.plantsci.2016.11.014; Wang YH, 2015, PLANT GROWTH REGUL, V77, P147, DOI 10.1007/s10725-015-0046-x; Wargent J, 2017, UV-B RADIATION AND PLANT LIFE: MOLECULAR BIOLOGY TO ECOLOGY, P162, DOI 10.1079/9781780648590.0162; Wargent JJ, 2011, PLANT CELL ENVIRON, V34, P1401, DOI 10.1111/j.1365-3040.2011.02342.x	43	19	20	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199628	10.1371/journal.pone.0199628	http://dx.doi.org/10.1371/journal.pone.0199628			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940006	Green Published, gold, Green Submitted			2022-12-26	WOS:000436088700030
J	Miyazawa, H; Ookawara, S; Ito, K; Ueda, Y; Yanai, K; Ishii, H; Mutsuyoshi, Y; Kitano, T; Shindo, M; Aomatsu, A; Hirai, K; Hoshino, T; Morishita, Y				Miyazawa, Haruhisa; Ookawara, Susumu; Ito, Kiyonori; Ueda, Yuichiro; Yanai, Katsunori; Ishii, Hiroki; Mutsuyoshi, Yuko; Kitano, Taisuke; Shindo, Mitsutoshi; Aomatsu, Akinori; Hirai, Keiji; Hoshino, Taro; Morishita, Yoshiyuki			Association of cerebral oxygenation with estimated glomerular filtration rate and cognitive function in chronic kidney disease patients without dialysis therapy	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; LONG-TERM HEMODIALYSIS; MINI-MENTAL-STATE; IMPAIRMENT; SATURATION; PRESSURE; DEMENTIA; OXIMETRY; FEASIBILITY; INSTRUMENTS	Background A decline in estimated glomerular filtration rate (eGFR) is reportedly associated with increased prevalence rates of cognitive impairment. However, data concerning the association between the cerebral saturation of oxygen (rSO(2)) and cognitive function of patients with chronic kidney disease (CKD) is limited. This study aimed to (i) elucidate the clinical factors associating with cerebral rSO(2) and (ii) investigate the association between cerebral rSO(2) and cognitive assessment in CKD patients. Methods A total of 40 CKD patients not requiring dialysis (26 men and 14 women; mean age, 61.0 +/- 2.7 years) were recruited. The numbers of patients at each CKD stage were as follows: G1, 5; G2, 8; G3a, 6; G3b, 5; G4, 11; and G5, 5. Cerebral rSO(2) was monitored at the forehead using the oxygen saturation monitor INVOS 5100C. The cognitive function of each patient was confirmed using the Mini-Mental State Examination (MMSE). Results Cerebral rSO(2) levels were significantly higher in CKD patients than in hemodialysis patients (63.8 +/- 1.5% vs. 44.9 +/- 2.2%, p < 0.001). Multiple regression analysis showed that cerebral rSO(2) was independently associated with eGFR (standardized coefficient: 0.530), serum albumin concentration (standardized coefficient: 0.365), and serum sodium concentration (standardized coefficient: 0.224). Furthermore, MMSE showed a significantly positive correlation with cerebral rSO(2) (r = 0.624, p < 0.001). Conclusions Cerebral rSO(2) was affected by eGFR and serum albumin and sodium concentrations in CKD patients. Furthermore, cerebral rSO(2) monitoring, which reflected MMSE scores, might be a useful method for assessing cognitive function in CKD patients.	[Miyazawa, Haruhisa; Ookawara, Susumu; Ito, Kiyonori; Ueda, Yuichiro; Yanai, Katsunori; Ishii, Hiroki; Mutsuyoshi, Yuko; Kitano, Taisuke; Shindo, Mitsutoshi; Aomatsu, Akinori; Hirai, Keiji; Hoshino, Taro; Morishita, Yoshiyuki] Jichi Med Univ, Saitama Med Ctr, Dept Integrated Med 1, Div Nephrol, Saitama, Japan	Jichi Medical University	Ookawara, S (corresponding author), Jichi Med Univ, Saitama Med Ctr, Dept Integrated Med 1, Div Nephrol, Saitama, Japan.	su-ooka@hb.tp1.jp			Japanese Association of Dialysis Physicians (JADP) [2017-9]; Kidney Foundation, Japan [JKFB 17-4]	Japanese Association of Dialysis Physicians (JADP); Kidney Foundation, Japan(Kidney Foundation, Japan)	This work was supported by a grant from the Japanese Association of Dialysis Physicians (JADP Grant 2017-9) and a grant from The Kidney Foundation, Japan (JKFB 17-4) to SO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calderon-Arnulphi M, 2007, J NEUROSURG, V106, P283, DOI 10.3171/jns.2007.106.2.283; Cheng Z, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050291; Chung MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178977; Fan HR, 2017, INT UROL NEPHROL, V49, P859, DOI 10.1007/s11255-017-1542-x; Fang YF, 2014, KIDNEY INT, V85, P142, DOI 10.1038/ki.2013.271; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Holsinger T, 2007, JAMA-J AM MED ASSOC, V297, P2391, DOI 10.1001/jama.297.21.2391; HONGO K, 1995, NEUROL RES, V17, P89, DOI 10.1080/01616412.1995.11740293; Hoshino T, 2014, NEPHRON CLIN PRACT, V126, P57, DOI 10.1159/000358432; Hyttel-Sorensen S, 2011, BIOMED OPT EXPRESS, V2, P3047, DOI 10.1364/BOE.2.003047; Ismail Z, 2010, INT J GERIATR PSYCH, V25, P111, DOI 10.1002/gps.2306; Ito K, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2852514; Ito K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117474; Kikuchi H, 2017, CLIN EXP NEPHROL, V21, P55, DOI 10.1007/s10157-016-1251-2; Kozniewska E, 2001, Med Sci Monit, V7, P641; KOZNIEWSKA E, 1995, CIRC RES, V76, P551, DOI 10.1161/01.RES.76.4.551; Kurella M, 2004, KIDNEY INT, V66, P2361, DOI 10.1111/j.1523-1755.2004.66024.x; Lemmers PMA, 2008, PEDIATRICS, V121, P142, DOI 10.1542/peds.2007-0925; Li LC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/131263; Maslehaty Homajoun, 2012, ISRN Neurol, V2012, P907187, DOI 10.5402/2012/907187; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McCusker K, 2006, PERFUSION-UK, V21, P149, DOI 10.1191/0267659106pf863oa; Miyazawa H, 2016, WORLD J NEPHROL, V6, P524; Murayama H, 2017, JPAD-J PREV ALZHEIM, V4, P93, DOI 10.14283/jpad.2016.113; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ono M, 2013, CRIT CARE MED, V41, P464, DOI 10.1097/CCM.0b013e31826ab3a1; Ookawara S, 2001, NEPHRON, V87, P27, DOI 10.1159/000045881; Ookawara S, 2018, J ARTIF ORGANS, V21, P86, DOI 10.1007/s10047-017-0978-1; Ookawara S, 2014, THER APHER DIAL, V18, P202, DOI 10.1111/1744-9987.12070; Parnia S, 2014, CRIT CARE MED, V42, P930, DOI 10.1097/CCM.0000000000000047; Prohovnik I, 2007, J CEREBR BLOOD F MET, V27, P1861, DOI 10.1038/sj.jcbfm.9600478; Renneboog B, 2006, AM J MED, V119, DOI [DOI 10.1016/J.AMJMED.2005.09.026, 10.1016/j.amjmed.2005.09.026]; Schmitz J, 2014, PHYSIOL MEAS, V35, P1349, DOI 10.1088/0967-3334/35/7/1349; Tadic M, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0386-0; Tamura MK, 2008, AM J KIDNEY DIS, V52, P227, DOI 10.1053/j.ajkd.2008.05.004; Tamura MK, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0226-6; Tamura MK, 2011, CLIN J AM SOC NEPHRO, V6, P248, DOI 10.2215/CJN.02660310; Tamura MK, 2011, KIDNEY INT, V79, P14, DOI 10.1038/ki.2010.336; Tariq SH, 2006, AM J GERIAT PSYCHIAT, V14, P900, DOI 10.1097/01.JGP.0000221510.33817.86; Tobias JD, 2006, EXPERT REV MED DEVIC, V3, P235, DOI 10.1586/17434440.3.2.235; Watzman HM, 2000, ANESTHESIOLOGY, V93, P947, DOI 10.1097/00000542-200010000-00012	42	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199366	10.1371/journal.pone.0199366	http://dx.doi.org/10.1371/journal.pone.0199366			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940017	Green Published, gold, Green Submitted			2022-12-26	WOS:000436088700012
J	Chang, M; Chang, YJ; Chao, PY; Yu, Q				Chang, Ming; Chang, Yaw-Jen; Chao, Pei Yu; Yu, Qing			Exosome purification based on PEG-coated Fe3O4 nanoparticles	PLOS ONE			English	Article							MICROVESICLES; ABLATION; CELLS	Cancer cells secrete many exosomes, which facilitate metastasis and the later growth of cancer. For early cancer diagnosis, the detection of exosomes is a crucial step. Exosomes exist in biological fluid, such as blood, which contains various proteins. It is necessary to remove the proteins in the biological fluid to avoid test interference. This paper presented a novel method for exosome isolation using Fe3O4 magnetic nanoparticles (MNPs), which were synthesized using the chemical co-precipitation method and then coated with polyethylene glycol (PEG). The experimental results showed that the diameter of the PEG-coated Fe3O4 nanoparticles was about 20 nm, while an agglomerate of MNPs reached hundreds of nanometers in size. In the protein removal experiments, fetal bovine serum (FBS) was adopted as the analyte for bioassays of exosome purification. PEG-coated Fe3O4 MNPs reduced the protein concentration in FBS to 39.89% of the original solution. By observing a particle size distribution of 30 similar to 200 nm (the size range of various exosomes), the exosome concentrations were kept the same before and after purification. In the gel electrophoresis experiments, the bands of CD63 (similar to 53 kDa) and CD9 (similar to 22 kDa) revealed that exosomes existed in FBS as well as in the purified solution. However, the bands of the serum albumins (similar to 66 kDa) and the various immunoglobulins (around 160 similar to 188 kDa) in the purified solution's lane explained that most proteins in FBS were removed by PEG-coated Fe3O4 MNPs. When purifying exosomes from serum, protein removal is critical for further exosome investigation. The proposed technique provides a simple and effective method to remove proteins in the serum using the PEG-coated Fe3O4 MNPs.	[Chang, Ming; Yu, Qing] Huaqiao Univ, Key Lab Proc Monitoring & Syst Optimizat Mech & E, Xiamen, Peoples R China; [Chang, Ming; Chang, Yaw-Jen; Chao, Pei Yu] Chung Yuan Christian Univ, Dept Mech Engn, Taoyuan, Taiwan	Huaqiao University; Chung Yuan Christian University	Chang, YJ (corresponding author), Chung Yuan Christian Univ, Dept Mech Engn, Taoyuan, Taiwan.	justin@cycu.edu.tw	chao, P/GSD-8001-2022		Research Foundation for Advanced Talents of Huaqiao University [16BS504]; Promotion Program for Young and Middleaged Teacher in Science and Technology Research of Huaqiao University [ZQN-PY304]	Research Foundation for Advanced Talents of Huaqiao University; Promotion Program for Young and Middleaged Teacher in Science and Technology Research of Huaqiao University	This research was financially supported by the Research Foundation for Advanced Talents of Huaqiao University under Grant No. 16BS504 and Promotion Program for Young and Middleaged Teacher in Science and Technology Research of Huaqiao University under Grant No. ZQN-PY304. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Bobrie A, 2012, CANCER RES, V72, P4920, DOI 10.1158/0008-5472.CAN-12-0925; Caradec J, 2014, CLIN BIOCHEM, V47, P1286, DOI 10.1016/j.clinbiochem.2014.06.011; Chang M, 2015, MATERIALS, V8, P7813, DOI 10.3390/ma8115429; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Folkman J., 2003, HOLLAND FREI CANC ME; Gabayno JLF, 2015, NANOSCALE, V7, P3947, DOI 10.1039/c4nr06143h; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hosseini-Beheshti E, 2016, ONCOTARGET, V7, P14639, DOI 10.18632/oncotarget.7052; Johnsen KB, 2014, BBA-REV CANCER, V1846, P75, DOI 10.1016/j.bbcan.2014.04.005; Kalra H, 2013, PROTEOMICS, V13, P3354, DOI 10.1002/pmic.201300282; Liga A, 2015, LAB CHIP, V15, P2388, DOI 10.1039/c5lc00240k; Liu Y, 2016, CELL RES, V26, P149, DOI 10.1038/cr.2015.153; Minciacchi VR, 2015, SEMIN CELL DEV BIOL, V40, P41, DOI 10.1016/j.semcdb.2015.02.010; Munson Phillip, 2015, Medicines (Basel), V2, P310; Peterson MF, 2015, METHODS, V87, P31, DOI 10.1016/j.ymeth.2015.04.015; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Schulz WA., 2007, MOL BIOL HUMAN CANC; Soung YH, 2016, BMB REP, V49, P18, DOI 10.5483/BMBRep.2016.49.1.239; Sun J, 2007, J BIOMED MATER RES A, V80A, P333, DOI 10.1002/jbm.a.30909; Taylor DD, 2015, METHODS, V87, P3, DOI 10.1016/j.ymeth.2015.02.019; Zhang X, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0181-x	25	28	29	8	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199438	10.1371/journal.pone.0199438	http://dx.doi.org/10.1371/journal.pone.0199438			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933408	gold, Green Published, Green Submitted			2022-12-26	WOS:000436076600025
J	Choi, KS; Kwak, M; Lee, B; Park, S				Choi, Kyoung Su; Kwak, Myounghai; Lee, Byoungyoon; Park, Seonjoo			Complete chloroplast genome of Tetragonia tetragonioides: Molecular phylogenetic relationships and evolution in Caryophyllales	PLOS ONE			English	Article							PLASTID GENOME; INDEPENDENT TRANSFERS; INVERTED REPEAT; WEB SERVERS; DNA; SEQUENCES; MITOCHONDRIAL; REDUCTION; PATTERNS; NUCLEUS	The chloroplast genome of Tetragonia tetragonioides (Aizoaceae; Caryophyllales) was sequenced to provide information for studies on phylogeny and evolution within Caryophyllales. The chloroplast genome of Tetragonia tetragonioides is 149,506 bp in length and includes a pair of inverted repeats (IRs) of 24,769 bp that separate a large single copy (LSC) region of 82,780 bp and a small single copy (SSC) region of 17,188 bp. Comparative analysis of the chloroplast genome showed that Caryphyllales species have lost many genes. In particular, the rpl2 intron and infA gene were not found in T. tetragonioides, and core Caryophyllales lack the rpl2 intron. Phylogenetic analyses were conducted using 55 genes in 16 complete chloroplast genomes. Caryophyllales was found to divide into two clades; core Caryophyllales and noncore Caryophyllales. The genus Tetragonia is closely related to Mesembryanthemum. Comparisons of the synonymous (Ks), nonsynonymous (Ka), and Ka/Ks substitution rates revealed that nonsynonymous substitution rates were lower than synonymous substitution rates and that Ka/Ks rates were less than 1. The findings of the present study suggest that most genes are a purified selection.	[Choi, Kyoung Su] Korea Forest Serv, Div Forest Biodivers, Korea Natl Arboretum, Pochen, South Korea; [Kwak, Myounghai; Lee, Byoungyoon] Natl Inst Biol Resources Korea, Plant Resources Div, Incheon, South Korea; [Park, Seonjoo] Yeungnam Univ, Dept Life Sci, Gyongsan, Gyeongbuk, South Korea	Korea National Arboretum; Yeungnam University	Park, S (corresponding author), Yeungnam Univ, Dept Life Sci, Gyongsan, Gyeongbuk, South Korea.	sjpark01@ynu.ac.kr		park, seonjoo/0000-0001-6494-3460	National Institute of Biological Resources of Korea [NBR201631201]	National Institute of Biological Resources of Korea	This work was supported by a National Institute of Biological Resources of Korea (NBR201631201), website: https://www.nibr.go.kr/main/main.jsp.	Angiosperm Phylogeny Group (APG), 2001, ANGIOSPERM PHYLOGENY; Brockington SF, 2009, INT J PLANT SCI, V170, P627, DOI 10.1086/597785; Chen ZW, 2017, MOL PHYLOGENET EVOL, V112, P268, DOI 10.1016/j.ympev.2017.04.014; Choi KS, 2016, FRONT PLANT SCI, V7, DOI [10.3359/fpls.2016.00355, 10.3389/fpls.2016.00355]; Choi KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138727; Choi KS, 2015, GENE, V572, P214, DOI 10.1016/j.gene.2015.07.020; Blazier J, 2011, PLANT MOL BIOL, V76, P263, DOI 10.1007/s11103-011-9753-5; CLEGG MT, 1994, P NATL ACAD SCI USA, V91, P6795, DOI 10.1073/pnas.91.15.6795; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; DOWNIE SR, 1991, EVOLUTION, V45, P1245, DOI [10.2307/2409731, 10.1111/j.1558-5646.1991.tb04390.x]; DOWNIE SR, 1994, SYST BOT, V19, P236, DOI 10.2307/2419599; Drummond A., 2011, GENEIOUS V 5 5; Guisinger MM, 2008, PNAS, V105, P47; Ivanova Z, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00204; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jansen RK, 2011, MOL BIOL EVOL, V28, P835, DOI 10.1093/molbev/msq261; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Klak C, 2003, AM J BOT, V90, P1433, DOI 10.3732/ajb.90.10.1433; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Samigullin TH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150718; Sanderson MJ, 2015, AM J BOT, V102, P1115, DOI 10.3732/ajb.1500184; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Sloan DB, 2014, MOL PHYLOGENET EVOL, V72, P82, DOI 10.1016/j.ympev.2013.12.004; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; THOMAS F, 1988, NUCLEIC ACIDS RES, V16, P2461, DOI 10.1093/nar/16.6.2461; Wicke S, 2013, PLANT CELL, V25, P3711, DOI 10.1105/tpc.113.113373; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Zeng SY, 2017, GENES-BASEL, V8, DOI 10.3390/genes8030103	33	7	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199626	10.1371/journal.pone.0199626	http://dx.doi.org/10.1371/journal.pone.0199626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933404	Green Published, gold, Green Submitted			2022-12-26	WOS:000436076600037
J	Gallo, J; Svoboda, M; Zapletalova, J; Proskova, J; Juranova, J				Gallo, Jiri; Svoboda, Michal; Zapletalova, Jana; Proskova, Jitka; Juranova, Jarmila			Serum IL-6 in combination with synovial IL-6/CRP shows excellent diagnostic power to detect hip and knee prosthetic joint infection	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PERIPROSTHETIC INFECTION; FLUID INTERLEUKIN-6; INFLAMMATORY MARKER; ARTHROPLASTY; BIOMARKERS; ACCURACY; REVISION; FAILURE; TESTS	Background The diagnosis of prosthetic joint infection (PJI) is still a challenge in some patients after total joint replacement. Interleukin-6 (IL-6) strongly participates in the arrangement of the host bacteria response. Therefore, increased levels of IL-6 should accompany every PJI. Purpose The aim of the study was to show diagnostic characteristics of serum IL-6 for the diagnosis of prosthetic joint infection (PJI). We also compared the diagnostic values of serum IL-6 with synovial IL-6 (sIL-6)and synovial C-reactive protein (sCRP). Study design We performed a prospective study of 240 patients in whom serum IL-6 was determined before total hip (n = 124) or knee (n =116) reoperations. The PJI diagnosis was based on the MSIS (Musculoskeletal Infection Society) criteria (2011). Receiver operating characteristic plots were constructed for IL-6, sIL-6, and sCRP. Results PJI was diagnosed in 93 patients, and aseptic revision was diagnosed in 147 patients. The AUC (area under curve) for IL-6 was 0.938 (95% CI; 0.904-0.971). The optimal IL-6 cut-off value for PJI was 12.55 ng/L. Positive and negative likelihood ratios for IL-6 were 8.24 (95% CI; 4.79-14.17) and 0.15 (95% CI; 0.09-0.26), respectively. The optimal sIL-6 and sCRP cut-off values were 20,988 ng/L and 8.80 mg/L, respectively. Positive and negative likelihood ratios for sIL-6 were 40.000 (95% CI; 5.7-280.5) and 0.170 (95% CI; 0.07-0.417), respectively. Negative likelihood ratio for sCRP was 0.083 (95% CI; 0.022-0.314). Conclusions The present study identified the cut-off values for serum/synovial IL-6 and synovial CRP for diagnostics of PJI at the site of THA and TKA and separately for each site. The diagnostic odds ratio for serum/synovial IL-6 and synovial CRP is very good. Simultaneous positivity of serum IL-6 either with synovial IL-6 or synovial CRP almost excludes false negative detection of PJI at the site of interest.	[Gallo, Jiri; Svoboda, Michal] Palacky Univ Olomouc, Teaching Hosp Olomouc, Fac Med, Dept Orthopaed, Olomouc, Czech Republic; [Zapletalova, Jana] Palacky Univ Olomouc, Fac Med, Dept Med Biophys, Olomouc, Czech Republic; [Proskova, Jitka] Teaching Hosp Olomouc, Dept Clin Biochem, Olomouc, Czech Republic; [Juranova, Jarmila] Palacky Univ Olomouc, Teaching Hosp Olomouc, Fac Med, Dept Hematooncol, Olomouc, Czech Republic	Palacky University Olomouc; University Hospital Olomouc; Palacky University Olomouc; University Hospital Olomouc; Palacky University Olomouc; University Hospital Olomouc; University Hospital Plzen	Gallo, J (corresponding author), Palacky Univ Olomouc, Teaching Hosp Olomouc, Fac Med, Dept Orthopaed, Olomouc, Czech Republic.	jiri.gallo@volny.cz		Gallo, Jiri/0000-0002-7424-8653	Agency of Health Research, Ministry of Health Czech Republic [VES 17-29680A]	Agency of Health Research, Ministry of Health Czech Republic	The corresponding author received grant support from the Agency of Health Research, Ministry of Health Czech Republic project No. VES 17-29680A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SS, 2016, KNEE SURG SPORT TR A, V24, P3064, DOI 10.1007/s00167-016-4230-y; Atkins BL, 1998, J CLIN MICROBIOL, V36, P2932, DOI 10.1128/JCM.36.10.2932-2939.1998; Berbari E, 2010, J BONE JOINT SURG AM, V92A, P2102, DOI 10.2106/JBJS.I.01199; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Bottner F, 2007, J BONE JOINT SURG BR, V89B, P94, DOI 10.1302/0301-620X.89B1.17485; Buttaro MA, 2010, CLIN ORTHOP RELAT R, V468, P3263, DOI 10.1007/s11999-010-1451-0; De Vecchi E, 2016, CLIN MICROBIOL INFEC, V22, P555, DOI 10.1016/j.cmi.2016.03.020; Deirmengian C, 2014, CLIN ORTHOP RELAT R, V472, P3254, DOI 10.1007/s11999-014-3543-8; Deirmengian C, 2014, J BONE JOINT SURG AM, V96A, P1439, DOI 10.2106/JBJS.M.01316; Deirmengian C, 2010, CLIN ORTHOP RELAT R, V468, P2017, DOI 10.1007/s11999-010-1298-4; Deirmengian CA, 2016, J ARTHROPLASTY, V31, pS152, DOI 10.1016/j.arth.2016.01.060; Dendukuri N, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5779; Di Cesare PE, 2005, J BONE JOINT SURG AM, V87A, P1921, DOI 10.2106/JBJS.D.01803; Elgeidi A, 2014, INT ORTHOP, V38, P2591, DOI 10.1007/s00264-014-2475-y; Ettinger M, 2015, CLIN INFECT DIS, V61, P332, DOI 10.1093/cid/civ286; Frangiamore SJ, 2016, CLIN ORTHOP RELAT R, V474, P1630, DOI 10.1007/s11999-016-4710-x; Frangiamore SJ, 2015, J BONE JOINT SURG AM, V97A, P63, DOI 10.2106/JBJS.N.00104; Gallo J, 2008, NEW MICROBIOL, V31, P97; Gallo J, 2017, BIOMED PAP, V161, P310, DOI 10.5507/bp.2017.021; Gollwitzer H, 2013, J BONE JOINT SURG AM, V95A, P644, DOI 10.2106/JBJS.L.00205; Gundtoft PH, 2017, DAN MED J, V64; Holinka J, 2011, J ORTHOP RES, V29, P617, DOI 10.1002/jor.21286; Jacovides CL, 2011, J ARTHROPLASTY, V26, P99, DOI 10.1016/j.arth.2011.03.025; Le DH, 2014, CLIN ORTHOP RELAT R, V472, P2197, DOI 10.1007/s11999-014-3540-y; Lee YS, 2017, J BONE JOINT SURG AM, V99, P2077, DOI [10.2106/JBJS.17.00123, 10.2106/jbjs.17.00123]; Lenski M, 2014, J ARTHROPLASTY, V29, P1105, DOI 10.1016/j.arth.2014.01.014; Luo JQ, 2013, COMMUN STAT-SIMUL C, V42, P1213, DOI 10.1080/03610918.2012.661906; Mesquida M, 2017, AUTOIMMUN REV, V16, P1079, DOI 10.1016/j.autrev.2017.08.002; MIRRA JM, 1976, CLIN ORTHOP RELAT R, P221; Mustafa RA, 2017, J CLIN EPIDEMIOL, V92, P18, DOI 10.1016/j.jclinepi.2017.09.003; Nilsdotter-Augustinsson A, 2007, ACTA ORTHOP, V78, P629, DOI 10.1080/17453670710014329; Parvizi J, 2014, J ARTHROPLASTY, V29, P1331, DOI 10.1016/j.arth.2014.03.009; Parvizi J, 2012, CLIN ORTHOP RELAT R, V470, P54, DOI 10.1007/s11999-011-1991-y; Randau TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089045; Ronde-Oustau C, 2014, ORTHOP TRAUMATOL-SUR, V100, P217, DOI 10.1016/j.otsr.2013.10.017; Shahi A, 2017, J ARTHROPLASTY, V32, pS232, DOI 10.1016/j.arth.2017.06.005; Tetreault MW, 2014, CLIN ORTHOP RELAT R, V472, P3997, DOI 10.1007/s11999-014-3828-y; Ugras AA, 2011, KNEE, V18, P113, DOI 10.1016/j.knee.2010.03.004; Wimmer MD, 2016, TECHNOL HEALTH CARE, V24, P927, DOI 10.3233/THC-161247; Wirtz DC, 2000, INT ORTHOP, V24, P194, DOI 10.1007/s002640000136; Worthington T, 2010, BRIT J BIOMED SCI, V67, P71, DOI 10.1080/09674845.2010.11730294; Xie K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01713-4; Yi PH, 2015, CLIN ORTHOP RELAT R, V473, P498, DOI 10.1007/s11999-014-3902-5	43	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199226	10.1371/journal.pone.0199226	http://dx.doi.org/10.1371/journal.pone.0199226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927991	gold, Green Published, Green Submitted			2022-12-26	WOS:000435802500056
J	Gialamas, A; Kinnell, A; Mittinty, MN; Davison, B; Singh, G; Lynch, J				Gialamas, Angela; Kinnell, Angela; Mittinty, Murthy N.; Davison, Belinda; Singh, Gurmeet; Lynch, John			Association of anthropometric measures and cardiovascular risk factors in children and adolescents: Findings from the Aboriginal Birth Cohort study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BLOOD-PRESSURE; LEG LENGTH; PUBERTAL CHANGES; FETAL ORIGINS; ADULT HEALTH; TRUNK LENGTH; FOLLOW-UP; HEIGHT; CHILDHOOD	This study examined the association of anthropometric measures including height, leg length, trunk length and body mass index (BMI) at 11 and 18 years with systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol, low-density lipoprotein cholesterol (LDL-c) and high-density lipoprotein cholesterol (HDL-c) at 11 and 18 years. We analysed data from 661 participants from the Aboriginal Birth Cohort study a longitudinal study based in the Northern Territory, Australia. Associations between anthropometric measures and cardiovascular risk factors were investigated in linear regression analyses adjusted for confounding, with imputation for missing data. In adjusted analyses, increasing leg length [males: 0.47mmHg/cm (0.23, 0.72); females: 0.50mmHg/cm (0.18, 0.83)], trunk length [males: 0.50mmHg/cm (0.28, 0.73); females: 0.57mmHg/cm (0.33, 0.81)] and height [males: 0.32mmHg/cm (0.16, 0.48); females: 0.32mmHg/cm (0.12, 0.52)] at 11 years was associated with higher SBP at 11 years. When these exposures were measured at 18 years the effect on SBP at 18 years had attenuated, and only increased trunk length was associated with higher SBP at 18 years for both sexes [males: 0.46mmHg/cm (0.05, 0.87); females: 0.69mmHg/cm (0.30, 1.08)]. We observed little association between height, leg length and trunk length and DBP, total cholesterol, LDL-c and HDL-c. Increased BMI was associated with elevated SBP and DBP at 11 and 18 years. Our findings suggest that height, leg length, and trunk length measured at 11 and 18 years was generally not associated with cardiovascular risk factors at 11 and 18 years. However, greater childhood BMI was associated with higher blood pressure and this association persisted into adolescence. This study contributes to the limited body of evidence on the association between measures of early anthropometry and cardiovascular risk among the Australian Aboriginal population.	[Gialamas, Angela; Kinnell, Angela; Mittinty, Murthy N.; Lynch, John] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia; [Davison, Belinda; Singh, Gurmeet] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia; [Lynch, John] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Adelaide; Charles Darwin University; Menzies School of Health Research; University of Bristol	Gialamas, A (corresponding author), Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia.	angela.gialamas@adelaide.edu.cn			National Health and Medical Research Council of Australia [631947, 1044639]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a National Health and Medical Research Council of Australia (https://www.nhmrc.gov.au/) Program Grant (grant number 631947) and a National Health and Medical Research Council of Australia Project Grant (grant number 1044639). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW,, 2020, AB TORR STRAIT ISL H; Australian Bureau of Statistics, 2006, NAT HLTH SURV SUMM R; Australian Bureau of Statistics, 1988, CENS 86 AUSTR PROF S; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Batty GD, 2009, ECON HUM BIOL, V7, P137, DOI 10.1016/j.ehb.2009.06.004; Bogin B, 2010, INT J ENV RES PUB HE, V7, P1047, DOI 10.3390/ijerph7031047; Cunningham J, 1998, OVERWEIGHT OBESITY I; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dobbins TA, 2012, MED J AUSTRALIA, V197, P291, DOI 10.5694/mja11.11331; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Fraser A, 2008, J EPIDEMIOL COMMUN H, V62, P48, DOI 10.1136/jech.2006.053181; FRIEDEMANN C, 2012, BMJ-BRIT MED J, V25, P345; Fujita Y, 2010, PEDIATR INT, V52, P689, DOI 10.1111/j.1442-200X.2010.03093.x; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gunnarsdottir I, 2002, AM J CLIN NUTR, V76, P1290, DOI 10.1093/ajcn/76.6.1290; Gunnell DJ, 1998, J EPIDEMIOL COMMUN H, V52, P142, DOI 10.1136/jech.52.3.142; Kouda K, 2003, INT J EPIDEMIOL, V32, P1105, DOI 10.1093/ije/dyg207; Langenberg C, 2003, J HYPERTENS, V21, P537, DOI 10.1097/00004872-200303000-00019; Larkins N, 2017, J HYPERTENS, V35, P1801, DOI 10.1097/HJH.0000000000001401; Lawlor DA, 2004, HEART, V90, P745, DOI 10.1136/hrt.2003.019950; Lawrance M, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-31; Little R.J.A., 2002, STAT ANAL MISSING DA; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Lynch J, 2005, ANNU REV PUBL HEALTH, V26, P1, DOI 10.1146/annurev.publhealth.26.021304.144505; Markey PG, 1998, TRENDS HLTH MOTHERS; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Nordestgaard BG, 2016, EUR HEART J, V37, P1944, DOI 10.1093/eurheartj/ehw152; Regnault N, 2014, INT J EPIDEMIOL, V43, P149, DOI 10.1093/ije/dyt248; Rogol AD, 2000, AM J CLIN NUTR, V72, p521S, DOI 10.1093/ajcn/72.2.521S; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Sayers S, 2009, PAEDIATR PERINAT EP, V23, P548, DOI 10.1111/j.1365-3016.2009.01071.x; Sayers Susan M, 2003, BMC Int Health Hum Rights, V3, P1, DOI 10.1186/1472-698X-3-1; Shankar RR, 2005, J CLIN ENDOCR METAB, V90, P163, DOI 10.1210/jc.2004-0926; Silventoinen K, 2006, AM J EPIDEMIOL, V163, P615, DOI 10.1093/aje/kwj081; Skinner AC, 2015, NEW ENGL J MED, V373, P1307, DOI 10.1056/NEJMoa1502821; Smith GD, 2001, J EPIDEMIOL COMMUN H, V55, P867, DOI 10.1136/jech.55.12.867; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Timpson NJ, 2009, HYPERTENSION, V54, P84, DOI 10.1161/HYPERTENSIONAHA.109.130005; Wadsworth MEJ, 1997, PAEDIATR PERINAT EP, V11, P2, DOI 10.1046/j.1365-3016.1997.d01-7.x; Wells JCK, 2014, INT J OBESITY, V38, P930, DOI 10.1038/ijo.2014.24; Whitley E, 2012, J EPIDEMIOL COMMUN H, V66, P18, DOI 10.1136/jech.2009.104216; Wong SN, 2006, BLOOD PRESS MONIT, V11, P281, DOI 10.1097/01.mbp.0000209082.09623.b4; World Health Organization, GROWTH REF DAT 5 19; Yeung SLA, 2016, SCI REP-UK, V6, DOI 10.1038/srep38420	49	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199280	10.1371/journal.pone.0199280	http://dx.doi.org/10.1371/journal.pone.0199280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927998	Green Published, gold			2022-12-26	WOS:000435802500065
J	Moreno, RL; Williams, K; Jones, KL; Ribera, AB				Moreno, Rosa L.; Williams, Kristina; Jones, Kenneth L.; Ribera, Angeles B.			Investigation of Islet2a function in zebrafish embryos: Mutants and morphants differ in morphologic phenotypes and gene expression	PLOS ONE			English	Article							MOTOR-NEURON; IDENTIFIED MOTONEURONS; AXONAL OUTGROWTH; PROTEIN; TRANSCRIPTION; DIFFERENTIATION; SPECIFICATION; DESIGN; GROWTH; IMAGE	Zebrafish primary motor neurons differ from each other with respect to morphology, muscle targets and electrophysiological properties. For example, CaP has 2-3-fold larger densities of both inward and outward currents than do other motor neurons. We tested whether the transcription factor Islet2a, uniquely expressed in CaP, but not other primary motor neurons, plays a role in specifying its stereotypic electrophysiological properties. We used both TALEN-based gene editing and antisense morpholino approaches to disrupt Islet2a function. Our electrophysiology results do not support a specific role for Islet2a in determining CaP's unique electrical properties. However, we also found that the morphological phenotypes of CaP and a later-born motor neuron differed between islet2a mutants and morphants. Using microarrays, we tested whether the gene expression profiles of whole embryo morphants, mutants and controls also differed. Morphants had 174 and 201 genes that were differentially expressed compared to mutants and controls, respectively. Further, islet2a was identified as a differentially expressed gene. To examine how mutation of islet2a affected islet gene expression specifically in CaPs, we performed RNA in situ hybridization. We detected no obvious differences in expression of isletl, islet2a, or islet2b in CaPs of mutant versus sibling control embryos. However, immunolabeling studies revealed that an Islet protein persisted in CaPs of mutants, albeit at a reduced level compared to controls. While we cannot exclude requirement for some Islet protein, we conclude that differentiation of the CaP's stereotypic large inward and outward currents does not have a specific requirement for Islet2a.	[Moreno, Rosa L.; Williams, Kristina; Ribera, Angeles B.] Univ Colorado, Dept Physiol & Biophys, Sch Med, Aurora, CO 80045 USA; [Jones, Kenneth L.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Ribera, AB (corresponding author), Univ Colorado, Dept Physiol & Biophys, Sch Med, Aurora, CO 80045 USA.	angie.ribera@ucdenver.edu	Jones, Kenneth/GXF-4945-2022	Ribera, Angie/0000-0002-0966-5856	 [R01NS086839]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086839, P30NS048154] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by R01NS086839 (www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel B, 1995, DEVELOPMENT, V121, P4117; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; Eisen JS, 2001, NAT NEUROSCI, V4, P1065, DOI 10.1038/nn742; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; Eve AMJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172227; Fashena D, 1999, J COMP NEUROL, V406, P415, DOI 10.1002/(SICI)1096-9861(19990412)406:3<415::AID-CNE9>3.0.CO;2-2; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Francius C, 2014, CELL MOL LIFE SCI, V71, P813, DOI 10.1007/s00018-013-1398-x; Gerety SS, 2011, DEV BIOL, V350, P279, DOI 10.1016/j.ydbio.2010.11.030; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Hutchinson SA, 2006, DEVELOPMENT, V133, P2137, DOI 10.1242/dev.02355; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; Jowett T, 1999, METHOD CELL BIOL, V59, P63; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; KORZH V, 1993, DEVELOPMENT, V118, P417; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; Lawson ND, 2016, TRENDS CELL BIOL, V26, P77, DOI 10.1016/j.tcb.2015.11.005; Liu C, 2012, DEVELOPMENT, V139, P4591, DOI 10.1242/dev.083055; Ma AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065259; Meng AM, 1997, P NATL ACAD SCI USA, V94, P6267, DOI 10.1073/pnas.94.12.6267; Moreno RL, 2017, JOVE-J VIS EXP, DOI 10.3791/55507; Moreno RL, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-19; Moreno RL, 2009, J NEUROPHYSIOL, V102, P2477, DOI 10.1152/jn.00446.2009; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Neff KL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-1; Novak Alicia E., 2003, Methods in Cell Science, V25, P79, DOI 10.1023/B:MICS.0000006894.43940.b1; Novodvorsky P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141611; Olesnicky E, 2010, GENESIS, V48, P656, DOI 10.1002/dvg.20673; Pittman AJ, 2008, DEVELOPMENT, V135, P2865, DOI 10.1242/dev.025049; Place ES, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171143; Plazas PV, 2013, P NATL ACAD SCI USA, V110, P1524, DOI 10.1073/pnas.1213048110; Rikin A, 2010, J VIS EXP; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Santiago C, 2017, CELL REP, V18, P1646, DOI 10.1016/j.celrep.2017.01.041; Sato-Maeda M, 2008, DEVELOPMENT, V135, P323, DOI 10.1242/dev.007559; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Segawa H, 2001, NEURON, V30, P423, DOI 10.1016/S0896-6273(01)00283-5; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Song MR, 2009, DEVELOPMENT, V136, P2923, DOI 10.1242/dev.037986; Stifani N, 2014, FRONT CELL NEUROSCI, V8, P1, DOI 10.3389/fncel.2014.00293; Tallafuss A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2215-8; Tamme Richard, 2002, BMC Dev Biol, V2, P9, DOI 10.1186/1471-213X-2-9; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Uemura O, 2005, DEV BIOL, V278, P587, DOI 10.1016/j.ydbio.2004.11.031; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; Witzel HR, 2017, SCI REP-UK, V7, DOI 10.1038/srep41043; Wolfram V, 2014, J NEUROSCI, V34, P2538, DOI 10.1523/JNEUROSCI.4511-13.2014; Wolfram V, 2012, NEURON, V75, P663, DOI 10.1016/j.neuron.2012.06.015; Zannino DA, 2009, J NEUROSCI, V29, P2322, DOI 10.1523/JNEUROSCI.3755-08.2009	61	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199233	10.1371/journal.pone.0199233	http://dx.doi.org/10.1371/journal.pone.0199233			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927984	Green Published, Green Submitted, gold			2022-12-26	WOS:000435802500060
J	Vilanova, E; Ramirez-Angulo, H; Torres-Lezama, A; Aymard, G; Gamez, L; Duran, C; Hernandez, L; Herrera, R; van der Heijden, G; Phillips, OL; Ettl, GJ				Vilanova, Emilio; Ramirez-Angulo, Hirma; Torres-Lezama, Armando; Aymard, Gerardo; Gamez, Luis; Duran, Cristabel; Hernandez, Lionel; Herrera, Rafael; van der Heijden, Geertje; Phillips, Oliver L.; Ettl, Gregory J.			Environmental drivers of forest structure and stem turnover across Venezuelan tropical forests	PLOS ONE			English	Article							TREE MORTALITY; ABOVEGROUND BIOMASS; WOOD PRODUCTIVITY; SPATIAL-PATTERNS; CARBON STORAGE; LIFE ZONES; AMAZON; DYNAMICS; DENSITY; RATES	Using data from 50 long-term permanent plots from across Venezuelan forests in northern South America, we explored large-scale patterns of stem turnover, aboveground biomass (AGB) and woody productivity (AGWP), and the relationships between them and with potential climatic drivers. We used principal component analysis coupled with generalized least squares models to analyze the relationship between climate, forest structure and stem dynamics. Two major axes associated with orthogonal temperature and moisture gradients effectively described more than 90% of the environmental variability in the dataset. Average turnover was 1.91 0.10% year(-1) with mortality and recruitment being almost identical, and close to average rates for other mature tropical forests. Turnover rates were significantly different among regions (p < 0.001), with the lowland forests in Western alluvial plains being the most dynamic, and Guiana Shield forests showing the lowest turnover rates. We found a weak positive relationship between AGB and AGWP, with Guiana Shield forests having the highest values for both variables (204.8 +/- 14.3 Mg C ha(-1) and 3.27 +/- 0.27 Mg C ha(-1) year(-1) respectively), but AGB was much more strongly and negatively related to stem turnover. Our data suggest that moisture is a key driver of turnover, with longer dry seasons favoring greater rates of tree turnover and thus lower biomass, having important implications in the context of climate change, given the increases in drought frequency in many tropical forests. Regional variation in AGWP among Venezuelan forests strongly reflects the effects of climate, with greatest woody productivity where both precipitation and temperatures are high. Overall, forests in wet, low elevation sites and with slow turnover stored the greatest amounts of biomass. Although faster stand dynamics are closely associated with lower carbon storage, stem-level turnover rates and woody productivity did not show any correlation, indicating that stem dynamics and carbon dynamics are largely decoupled from one another.	[Vilanova, Emilio; Ramirez-Angulo, Hirma; Torres-Lezama, Armando; Gamez, Luis] Univ Los Andes, Inst Invest Desarrollo Forestal INDEFOR, Merida, Venezuela; [Vilanova, Emilio; Ettl, Gregory J.] Univ Washington, SEFS, Seattle, WA 98195 USA; [Aymard, Gerardo] Univ Expt Llanos Ezequiel Zamora UNELLEZ, Portuguese, Venezuela; [Duran, Cristabel] Univ Freiburg, Inst Forest Sci, Fac Environm & Nat Resources, Freiburg, Germany; [Hernandez, Lionel] UNEG, Bolivar, Venezuela; [Herrera, Rafael] Inst Venezolano Invest Cient, Ctr Ecol, Caracas, Venezuela; [Herrera, Rafael] Univ Vienna, Dept Geog & Reg Res Geoecol, Vienna, Austria; [van der Heijden, Geertje] Univ Nottingham, Sch Geog, Nottingham, England; [Phillips, Oliver L.] Univ Leeds, Sch Geog, Leeds, W Yorkshire, England	University of Los Andes Venezuela; University of Washington; University of Washington Seattle; University of Freiburg; Venezuelan Institute Science Research; University of Vienna; University of Nottingham; University of Leeds	Vilanova, E (corresponding author), Univ Los Andes, Inst Invest Desarrollo Forestal INDEFOR, Merida, Venezuela.; Vilanova, E (corresponding author), Univ Washington, SEFS, Seattle, WA 98195 USA.	vilanova@uw.edu	Phillips, Oliver/A-1523-2011; van der Heijden, Geertje/AAB-4102-2019; Vilanova, Emilio/AAG-9543-2020; Aymard, Gerardo/ABE-9203-2020	Phillips, Oliver/0000-0002-8993-6168; van der Heijden, Geertje/0000-0002-2110-5173; Vilanova, Emilio/0000-0001-6289-5127; Aymard, Gerardo/0000-0001-9405-0508; Hernandez, Lionel/0000-0002-7279-1003	"Consejo de Desarrollo Cientifico Humanistico, Tecnologico y de las Artes" at Universidad de Los Andes, Venezuela; Amazon Forest Inventory Network (RAINFOR) project; Natural Environment Research Council [NE/D005590/1, NE/I028122/1]; Gordon and Betty Moore Foundation; ERC Advanced Grant [291585]; Anne McLaren fellowship from the University of Nottingham, UK; Corkery Family Fund from University of Washington; Center for Sustainable Forestry at Pack Forest from University of Washington; Natural Environment Research Council [NE/B504630/1, NE/D010306/1, NE/B503384/1, NE/I02982X/1] Funding Source: researchfish; NERC [NE/I02982X/1, NE/D010306/1] Funding Source: UKRI	"Consejo de Desarrollo Cientifico Humanistico, Tecnologico y de las Artes" at Universidad de Los Andes, Venezuela; Amazon Forest Inventory Network (RAINFOR) project; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); ERC Advanced Grant(European Research Council (ERC)); Anne McLaren fellowship from the University of Nottingham, UK; Corkery Family Fund from University of Washington(University of Washington); Center for Sustainable Forestry at Pack Forest from University of Washington; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	HRA and ATL received funding support from the "Consejo de Desarrollo Cientifico Humanistico, Tecnologico y de las Artes" (http://www2.ula.ve/cdcht/) at Universidad de Los Andes, Venezuela for data collection during the early 1990s. All authors acknowledge funding from the Amazon Forest Inventory Network (RAINFOR) project for fieldwork and data collection between 2004 and 2016. The RAINFOR forest monitoring network in Venezuela has been supported by the Natural Environment Research Council (http://www.nerc.ac.uk/) (grants NE/D005590/1 and NE/I028122/1) and the Gordon and Betty Moore Foundation (https://www.moore.org/). OLP is supported by an ERC Advanced Grant (291585) and is a Royal Society-Wolfson Research Merit Award holder. GvdH is supported by an Anne McLaren fellowship from the University of Nottingham, UK. EV received funding support from the Corkery Family Fund and the Center for Sustainable Forestry at Pack Forest (http://www.packforest.org/), both from University of Washington (http://www.washington.edu/).	Alvarez-Davila E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171072; Baez S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126594; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Baraloto C, 2011, GLOBAL CHANGE BIOL, V17, P2677, DOI 10.1111/j.1365-2486.2011.02432.x; Barton K., 2022, MULTIMODEL INFERENCE; Bevilacqua M.P., 2002, STATE VENEZUELAS FOR; Bispo PD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152009; Brienen RJW, 2015, NATURE, V519, P344, DOI 10.1038/nature14283; CAREY EV, 1994, BIOTROPICA, V26, P255, DOI 10.2307/2388846; Castanho ADA, 2013, BIOGEOSCIENCES, V10, P2255, DOI 10.5194/bg-10-2255-2013; Cavanaugh KC, 2014, GLOBAL ECOL BIOGEOGR, V23, P563, DOI 10.1111/geb.12143; Chao KJ, 2008, J ECOL, V96, P281, DOI 10.1111/j.1365-2745.2007.01343.x; Chao KJ, 2009, J VEG SCI, V20, P260, DOI 10.1111/j.1654-1103.2009.05755.x; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; CUEVAS E, 1986, OECOLOGIA, V68, P466, DOI 10.1007/BF01036756; Delaney M, 1997, J TROP ECOL, V13, P697, DOI 10.1017/S0266467400010877; Delaney M, 1998, BIOTROPICA, V30, P2, DOI 10.1111/j.1744-7429.1998.tb00364.x; Delbart N, 2010, BIOGEOSCIENCES, V7, P3027, DOI 10.5194/bg-7-3027-2010; Doughty CE, 2018, BIOTROPICA, V50, P16, DOI 10.1111/btp.12504; Feldpausch TR, 2016, GLOBAL BIOGEOCHEM CY, V30, P964, DOI 10.1002/2015GB005133; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Girardin CAJ, 2014, PLANT ECOL DIVERS, V7, P161, DOI 10.1080/17550874.2013.820806; Gotelli N, 2004, PRIMER ECOLOGICAL ST, P381; Greenwood S, 2017, ECOL LETT, V20, P539, DOI 10.1111/ele.12748; Hammond D. S., 2005, Tropical forests of the Guiana shield: ancient forests in a modern world, DOI 10.1079/9780851995366.0000; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hernandez L, 2012, REV BIOL TROP, V60, P11; HERRERA R, 1978, INTERCIENCIA, V3, P223; Houghton RA, 2012, BIOGEOSCIENCES, V9, P5125, DOI 10.5194/bg-9-5125-2012; Huber O, 2001, BIODIVERS CONSERV, V10, P1627, DOI 10.1023/A:1012042628406; Huber O., 2010, LIBRO ROJO ECOSISTEM, P29; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Johnson MO, 2016, GLOBAL CHANGE BIOL, V22, P3996, DOI 10.1111/gcb.13315; Kammesheidt L, 2001, FOREST ECOL MANAG, V148, P1, DOI 10.1016/S0378-1127(00)00529-6; Keeling HC, 2007, GLOBAL ECOL BIOGEOGR, V16, P618, DOI 10.1111/j.1466-8238.2007.00314.x; Le Quere C, 2016, EARTH SYST SCI DATA, V8, P605, DOI 10.5194/essd-8-605-2016; Lewis SL, 2004, J ECOL, V92, P929, DOI 10.1111/j.0022-0477.2004.00923.x; Lopez-Gonzalez G, 2011, J VEG SCI, V22, P610, DOI 10.1111/j.1654-1103.2011.01312.x; Malhi Y, 2002, J VEG SCI, V13, P439, DOI 10.1111/j.1654-1103.2002.tb02068.x; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Malhi Y, 2012, J ECOL, V100, P65, DOI 10.1111/j.1365-2745.2011.01916.x; Marimon BS, 2014, PLANT ECOL DIVERS, V7, P281, DOI 10.1080/17550874.2013.818072; Marvin DC, 2014, P NATL ACAD SCI USA, V111, pE5224, DOI 10.1073/pnas.1412999111; McCune B, 2002, STRUCTURAL EQUATION, DOI [10.1016/50022-0981(03)00091-1, DOI 10.1016/50022-0981(03)00091-1]; Meir P, 2015, NEW PHYTOL, V207, P28, DOI 10.1111/nph.13382; Mitchard ETA, 2014, GLOBAL ECOL BIOGEOGR, V23, P935, DOI 10.1111/geb.12168; Nepstad D, 2014, SCIENCE, P344; Oksanen F, 2017, PACKAGE VEGAN, DOI [10.1093/molbev/msv334, DOI 10.1093/MOLBEV/MSV334]; Pacheco-Angulo C, 2017, FORESTS, V8, DOI 10.3390/f8080291; Pan YD, 2013, ANNU REV ECOL EVOL S, V44, P593, DOI 10.1146/annurev-ecolsys-110512-135914; Peacock J, 2007, J VEG SCI, V18, P535, DOI 10.1111/j.1654-1103.2007.tb02568.x; Pearson TRH, 2017, CARBON BAL MANAGE, V12, DOI 10.1186/s13021-017-0072-2; Phillips O, 2016, FIELD MANUAL PLOT ES; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Phillips OL, 2008, PHILOS T R SOC B, V363, P1819, DOI 10.1098/rstb.2007.0033; Phillips OL, 2017, CARBON BAL MANAGE, V12, DOI 10.1186/s13021-016-0069-2; Phillips OL, 2010, NEW PHYTOL, V187, P631, DOI 10.1111/j.1469-8137.2010.03359.x; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Pillet M, 2018, J ECOL, V106, P1165, DOI 10.1111/1365-2745.12876; Pinheiro J, R PACKAGE VERSION; Quesada CA, 2012, BIOGEOSCIENCES, V9, P2203, DOI 10.5194/bg-9-2203-2012; Quesada CA, 2011, BIOGEOSCIENCES, V8, P1415, DOI 10.5194/bg-8-1415-2011; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez Angulo H, 2010, REV FOR VENEZ, V54, P207, DOI [10.1079/9780851995366.0000, DOI 10.1079/9780851995366.0000]; Ramirez-Angulo H, 2002, ECOTROPICOS, V15, P177; Rodig E, 2017, GLOBAL ECOL BIOGEOGR, V26, P1292, DOI 10.1111/geb.12639; Schargel R., 2015, CATALOG ANOTADO ILUS, P15; SHEIL D, 1995, FOREST ECOL MANAG, V77, P11, DOI 10.1016/0378-1127(95)03583-V; Slik JWF, 2015, P NATL ACAD SCI USA, V112, P7472, DOI 10.1073/pnas.1423147112; Spracklen DV, 2014, BIOGEOSCIENCES, V11, P2741, DOI 10.5194/bg-11-2741-2014; Stegen JC, 2011, GLOBAL ECOL BIOGEOGR, V20, P744, DOI 10.1111/j.1466-8238.2010.00645.x; Stephenson NL, 2011, ECOL MONOGR, V81, P527, DOI 10.1890/10-1077.1; Stephenson NL, 2005, ECOL LETT, V8, P524, DOI 10.1111/j.1461-0248.2005.00746.x; STEYERMARK J. A., 1961, BOL SOC VENEZOLANA CIENC NAT, V22, P291; Strassburg B. B. N., 2012, IUFRO World Series, V31, P83; Sullivan MJP, 2017, SCI REP-UK, V7, DOI 10.1038/srep39102; SWAINE MD, 1987, J TROP ECOL, V3, P359, DOI 10.1017/S0266467400002339; Talbot J, 2014, FOREST ECOL MANAG, V320, P30, DOI 10.1016/j.foreco.2014.02.021; Torres-Lezama A., 2002, Revista Forestal Venezolana, V46, P63; van der Sande MT, 2017, BIOTROPICA, V49, P593, DOI 10.1111/btp.12453; Veillon J.P., 1985, REV FORESTAL VENEZOL, V19, P1; Wagner FH, 2016, BIOGEOSCIENCES, V13, P2537, DOI 10.5194/bg-13-2537-2016; Whittaker RH, 1973, BROOKH S BIOL, P392; Zhang QY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169770; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014	88	18	19	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198489	10.1371/journal.pone.0198489	http://dx.doi.org/10.1371/journal.pone.0198489			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927972	Green Published, Green Submitted, gold			2022-12-26	WOS:000435802500022
J	Dzogang, F; Lightman, S; Cristianini, N				Dzogang, Fabon; Lightman, Stafford; Cristianini, Nello			Diurnal variations of psychometric indicators in Twitter content	PLOS ONE			English	Article							RHYTHMS; MOOD; WORK	The psychological state of a person is characterised by cognitive and emotional variables which can be inferred by psychometric methods. Using the word lists from the Linguistic Inquiry and Word Count, designed to infer a range of psychological states from the word usage of a person, we studied temporal changes in the average expression of psychological traits in the general population. We sampled the contents of Twitter in the United Kingdom at hourly intervals for a period of four years, revealing a strong diurnal rhythm in most of the psychometric variables, and finding that two independent factors can explain 85% of the variance across their 24-h profiles. The first has peak expression time starting at 5am/6am, it correlates with measures of analytical thinking, with the language of drive (e.g power, and achievement), and personal concerns. It is anticorrelated with the language of negative affect and social concerns. The second factor has peak expression time starting at 3am/4am, it correlates with the language of existential concerns, and anticorrelates with expression of positive emotions. Overall, we see strong evidence that our language changes dramatically between night and day, reflecting changes in our concerns and underlying cognitive and emotional processes. These shifts occur at times associated with major changes in neural activity and hormonal levels.	[Dzogang, Fabon; Cristianini, Nello] Univ Bristol, Intelligent Syst Lab, Bristol, Avon, England; [Lightman, Stafford] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England	University of Bristol; University of Bristol	Cristianini, N (corresponding author), Univ Bristol, Intelligent Syst Lab, Bristol, Avon, England.	nello.cristianini@bristol.ac.uk		, Fabon/0000-0001-9614-1876	European Research Council [339365]; ERC Advanced Grant ThinkBIG	European Research Council(European Research Council (ERC)European Commission); ERC Advanced Grant ThinkBIG	European Research Council Advanced Grant 339365 "ThinkBIG" granted to NC supported NC and FD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NC and FD were supported by the ERC Advanced Grant ThinkBIG. The authors would like to express their appreciation to Prof. James Pennebaker who has provided insightful comments as well as encouragement.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Bamman D, 2014, J SOCIOLING, V18, P135, DOI 10.1111/josl.12080; Bechtel W, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00118; DZOGANG F, 2017, BRAIN NEUROSCIENCE A, V0001; Dzogang F, 2017, LECT NOTES COMPUT SC, V10584, P63, DOI 10.1007/978-3-319-68765-0_6; Dzogang F, 2012, BIOMED INFORM INSIGH, V5, P129, DOI 10.4137/BII.S8973; Dzogang Fabon, 2016, 2016 IEEE INT C DAT; Gimpel K., 2011, P ACL, P42; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Knutsson U, 1997, J CLIN ENDOCR METAB, V82, P536, DOI 10.1210/jc.82.2.536; Krishnan HC, 2015, LEARN MEMORY, V22, P426, DOI 10.1101/lm.038877.115; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Leung M, 2016, CANCER EPIDEM BIOMAR, V25, P830, DOI 10.1158/1055-9965.EPI-15-1178; Lever J, 2017, NAT METHODS, V14, P641, DOI 10.1038/nmeth.4346; Malek ZS, 2007, ENDOCRINOLOGY, V148, P5165, DOI 10.1210/en.2007-0526; MARTIN KF, 1991, PHARMACOL THERAPEUT, V51, P421, DOI 10.1016/0163-7258(91)90069-X; McClung CA, 2011, EUR NEUROPSYCHOPHARM, V21, pS683, DOI 10.1016/j.euroneuro.2011.07.008; Pennebaker JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115844; Pennebaker JamesW., 2015, DEV PSYCHOMETRIC PRO, DOI DOI 10.15781/T29G6Z; Piantadosi ST, 2014, PSYCHON B REV, V21, P1112, DOI 10.3758/s13423-014-0585-6; Stirman SW, 2001, PSYCHOSOM MED, V63, P517; Takase K, 2014, SCI REP-UK, V4, DOI 10.1038/srep03738; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Watson D, 1997, J PERS ASSESS, V68, P267, DOI 10.1207/s15327752jpa6802_4	24	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0197002	10.1371/journal.pone.0197002	http://dx.doi.org/10.1371/journal.pone.0197002			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ8QS	29924814	Green Published, Green Submitted, gold			2022-12-26	WOS:000435655600003
J	Hobson, JJ; Gallegos, AS; Atha, BW; Kelly, JP; Lein, CD; VanOrsdel, CE; Weldon, JE; Hemm, MR				Hobson, Jessica J.; Gallegos, Austin S.; Atha, Benjamin W., III; Kelly, John P.; Lein, Christina D.; VanOrsdel, Cailtin E.; Weldon, John E.; Hemm, Matthew R.			Investigation of amino acid specificity in the CydX small protein shows sequence plasticity at the functional level	PLOS ONE			English	Article							CYTOCHROME BD OXIDASE; ESCHERICHIA-COLI; MEMBRANE-PROTEINS; GENE; GENOMICS; COMPLEX; SITE	Small proteins are a new and expanding area of research. Many characterized small proteins are composed of a single hydrophobic a-helix, and the functional requirements of their limited amino acid sequence are not well understood. One hydrophobic small protein, CydX, has been shown to be a component of the cytochrome bd oxidase complex in Escherichia coli, and is required for enzyme function. To investigate small protein sequence specificity, an alanine scanning mutagenesis on the small protein CydX was conducted using mutant alleles expressed from the E. co/ichromosome at the wild-type locus. The resulting mutant strains were assayed for CydX function. No single amino acid was required to maintain wildtype resistance to P-mercaptoethanol. However, substitutions of 10-amino acid blocks indicated that the N-terminus of the protein was required for wild-type CydX activity. A series of double mutants showed that multiple mutations at the N-terminus led to beta-mercaptoethanol sensitivity in vivo. Triple mutants showed both in vivo and in vitro phenotypes. Together, these data provide evidence suggesting a high level of functional plasticity in CydX, in which multiple amino acids may work cooperatively to facilitate CydX function.	[Hobson, Jessica J.; Gallegos, Austin S.; Atha, Benjamin W., III; Kelly, John P.; Lein, Christina D.; VanOrsdel, Cailtin E.; Weldon, John E.; Hemm, Matthew R.] Towson Univ, Dept Biol Sci, Towson, MD 21252 USA; [Hobson, Jessica J.] Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Chapel Hill, NC USA	University System of Maryland; Towson University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Hemm, MR (corresponding author), Towson Univ, Dept Biol Sci, Towson, MD 21252 USA.	mhemm@towson.edu		Hobson, Jessica/0000-0002-1896-0339; Weldon, John/0000-0002-6516-9064; Atha III, Benjamin/0000-0002-1492-9406	National Institute of Allergy and Infectious Diseases, National Institute of Health [R15, 1R15A1094548-01]; Undergraduate Research Grants from the Fisher College of Science and Mathematics; Undergraduate Research Grants from Towson University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI094548] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Undergraduate Research Grants from the Fisher College of Science and Mathematics; Undergraduate Research Grants from Towson University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by an R15 grant (1R15A1094548-01) from the National Institute of Allergy and Infectious Diseases, National Institute of Health. It was also supported by funds to the Jess and Mildred Fisher Endowed Chair of Biological Sciences at Towson University (M.R.H.). Students were supported by Undergraduate Research Grants from the Fisher College of Science and Mathematics and from Towson University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by an R15 grant (1R15A1094548-01) from the National Institute of Allergy and Infectious Diseases, National Institute of Health. It was also supported by funds to the Jess and Mildred Fisher Endowed Chair of Biological Sciences at Towson University (M.R.H.). Students were supported by Undergraduate Research Grants from the Fisher College of Science and Mathematics and from Towson University. We would like to thank John Biondo and Bradley Stansbury for help with experiments, and Dr. Gisela Storz for helpful comments and discussions about the project and the manuscript. We would also like to thank Jacqueline Thompson for her substantial logistical help throughout the project.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alix E, 2008, EMBO J, V27, P546, DOI 10.1038/sj.emboj.7601983; Allen RJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-946; ANRAKU Y, 1987, TRENDS BIOCHEM SCI, V12, P262, DOI 10.1016/0968-0004(87)90131-9; Axe DD, 1996, P NATL ACAD SCI USA, V93, P5590, DOI 10.1073/pnas.93.11.5590; Basrai MA, 1997, GENOME RES, V7, P768, DOI 10.1101/gr.7.8.768; Chen HJ, 2015, BBA-GEN SUBJECTS, V1850, P318, DOI 10.1016/j.bbagen.2014.10.005; COTTER PA, 1990, J BACTERIOL, V172, P6333, DOI 10.1128/jb.172.11.6333-6338.1990; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DiMaio D, 2014, ANNU REV MICROBIOL, V68, P21, DOI 10.1146/annurev-micro-091313-103727; Duval M, 2017, CURR OPIN MICROBIOL, V39, P81, DOI 10.1016/j.mib.2017.09.010; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Garbis S, 2005, J CHROMATOGR A, V1077, P1, DOI 10.1016/j.chroma.2005.04.059; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Heim EN, 2015, P NATL ACAD SCI USA, V112, pE4717, DOI 10.1073/pnas.1514230112; HEINZ DW, 1992, P NATL ACAD SCI USA, V89, P3751, DOI 10.1073/pnas.89.9.3751; HELLINGA HW, 1992, BIOCHEMISTRY-US, V31, P11203, DOI 10.1021/bi00160a034; Hemm MR, 2008, MOL MICROBIOL, V70, P1487, DOI 10.1111/j.1365-2958.2008.06495.x; Hobbs EC, 2012, P NATL ACAD SCI USA, V109, P16696, DOI 10.1073/pnas.1210093109; Hoeser J, 2014, FEBS LETT, V588, P1537, DOI 10.1016/j.febslet.2014.03.036; Huang CS, 2017, NATURE, V546, P681, DOI 10.1038/nature22970; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; Ladoukakis E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r118; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Satheshkumar PS, 2013, VIROLOGY, V444, P148, DOI 10.1016/j.virol.2013.06.003; Savard J, 2006, CELL, V126, P559, DOI 10.1016/j.cell.2006.05.053; Schroedel Andrea, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-10; Storz G, 2014, ANNU REV BIOCHEM, V83, P753, DOI 10.1146/annurev-biochem-070611-102400; Sun YH, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00047; VanOrsdel CE, 2013, J BACTERIOL, V195, P3640, DOI 10.1128/JB.00324-13; Wang J, 2003, NAT REV GENET, V4, P741, DOI 10.1038/nrg1160	33	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198699	10.1371/journal.pone.0198699	http://dx.doi.org/10.1371/journal.pone.0198699			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912917	Green Submitted, Green Published, gold			2022-12-26	WOS:000435528600042
J	Wang, L; Cui, SF; Liu, ZC; Ping, Y; Qiu, JP; Geng, XQ				Wang, Lei; Cui, Sufen; Liu, Zhicheng; Ping, Yong; Qiu, Jiangping; Geng, Xueqing			Inhibition of mitochondria! respiration under hypoxia and increased antioxidant activity after reoxygenation of Tribolium castaneum	PLOS ONE			English	Article							OXIDATIVE STRESS; DROSOPHILA-MELANOGASTER; LOW-OXYGEN; EXPERIMENTAL SELECTION; METABOLIC DEPRESSION; CELLULAR ADAPTATION; LOCUSTA-MIGRATORIA; HYPOBARIC HYPOXIA; ANOXIA TOLERANCE; TENEBRIO-MOLITOR	Regulating the air in low-oxygen environments protects hermetically stored grains from storage pests damage. However, pests that can tolerate hypoxic stress pose a huge challenge in terms of grain storage. We used various biological approaches to determine the fundamental mechanisms of Tribolium castaneum to cope with hypoxia. Our results indicated that limiting the available oxygen to T. castaneum increased glycolysis and inhibited the Krebs cycle, and that accumulated pyruvic acid was preferentially converted to lactic acid via anaerobic metabolism. Mitochondrial aerobic respiration was markedly suppressed for beetles under hypoxia, which also might have led to mitochondrial autophagy. The enzymatic activity of citrate synthase decreased in insects under hypoxia but recovered within 12 h, which suggested that the beetles recovered from the hypoxia. Moreover, hypoxia-reperfusion resulted in severe oxidative damage to insects, and antioxidant levels increased to defend against the high level of reactive oxygen species. In conclusion, our findings show that mitochondria were the main target in T. castaneum in response to low oxygen. The beetles under hypoxia inhibited mitochondrial respiration and increased antioxidant activity after reoxygenation. Our research advances the field of pest control and makes it possible to develop more efficient strategies for hermetic storage.	[Wang, Lei; Cui, Sufen; Liu, Zhicheng; Qiu, Jiangping; Geng, Xueqing] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China; [Ping, Yong] Shanghai Jiao Tong Univ, Bio X Inst, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Geng, XQ (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China.	xqgeng@sjtu.edu.cn			Shanghai Jiao Tong University foundation [Agri-X 2016007]; Shanghai Jiao Tong University Agri-X fund [AgriX 2016007]	Shanghai Jiao Tong University foundation; Shanghai Jiao Tong University Agri-X fund	The research was supported by grants from the Shanghai Jiao Tong University foundation to XQG (Grant No. Agri-X 2016007). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The sequencing service was provided by Personal Biotechnology Co., Ltd., Shanghai, China. The research was supported by grants from Shanghai Jiao Tong University Agri-X fund (Grant No. AgriX 2016007).	Acin-Perez R, 2014, CELL METAB, V19, P1020, DOI 10.1016/j.cmet.2014.04.015; Ali SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036801; Altincicek B, 2008, DEV COMP IMMUNOL, V32, P585, DOI 10.1016/j.dci.2007.09.005; Azad P, 2012, G3-GENES GENOM GENET, V2, P1169, DOI 10.1534/g3.112.003681; Azad P, 2011, FREE RADICAL BIO MED, V51, P530, DOI 10.1016/j.freeradbiomed.2011.05.005; Bar-Or D, 2001, BIOCHEM BIOPH RES CO, V284, P856, DOI 10.1006/bbrc.2001.5042; Barbehenn RV, 2002, J CHEM ECOL, V28, P1329, DOI 10.1023/A:1016288201110; Bosco G, 2015, ARCH INSECT BIOCHEM, V88, P222, DOI 10.1002/arch.21217; Calabrese EJ, 2007, TOXICOL APPL PHARM, V222, P122, DOI 10.1016/j.taap.2007.02.015; Calabrese EJ, 2016, PHARMACOL RES, V110, P242, DOI 10.1016/j.phrs.2015.12.021; Callier V, 2015, J EXP BIOL, V218, P2927, DOI 10.1242/jeb.125849; Cavallaro MC, 2014, ANN ENTOMOL SOC AM, V107, P1081, DOI 10.1603/AN14035; Cheng WN, 2013, J INSECT PHYSIOL, V59, P1160, DOI 10.1016/j.jinsphys.2013.08.009; Chua YL, 2010, J BIOL CHEM, V285, P31277, DOI 10.1074/jbc.M110.158485; CORDIS GA, 1995, J MOL CELL CARDIOL, V27, P1645, DOI 10.1016/S0022-2828(95)90656-8; Cordis GA, 1998, J MOL CELL CARDIOL, V30, P1939, DOI 10.1006/jmcc.1998.0752; Soares JBRC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120600; CZYZYKKRZESKA MF, 1994, J BIOL CHEM, V269, P760; CZYZYKKRZESKA MF, 1992, J NEUROCHEM, V58, P1538, DOI 10.1111/j.1471-4159.1992.tb11376.x; DONAHAYE E, 1990, PHYTOPARASITICA, V18, P189, DOI 10.1007/BF02980989; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gelfi C, 2004, FASEB J, V18, P612, DOI 10.1096/fj.03-1077fje; Gleixner E, 2008, FEBS J, V275, P5108, DOI 10.1111/j.1742-4658.2008.06642.x; Gorr TA, 2006, J INSECT PHYSIOL, V52, P349, DOI 10.1016/j.jinsphys.2006.01.002; Greenberg S, 1996, J INSECT PHYSIOL, V42, P991, DOI 10.1016/S0022-1910(96)00071-6; Greenlee KJ, 1998, J EXP BIOL, V201, P2843; Grieshaber M K, 1994, Rev Physiol Biochem Pharmacol, V125, P43, DOI 10.1007/BFb0030909; Harrison J, 2006, RESP PHYSIOL NEUROBI, V154, P4, DOI 10.1016/j.resp.2006.02.008; Harrison JF, 2015, INTEGR COMP BIOL, V55, P802, DOI 10.1093/icb/icv055; Harrison JF, 2015, PHYSIOL BIOCHEM ZOOL, V88, P455, DOI 10.1086/682216; Harrison JF, 2011, ANNU REV PHYSIOL, V73, P95, DOI 10.1146/annurev-physiol-012110-142155; HEACOCK CS, 1990, BRIT J CANCER, V62, P217, DOI 10.1038/bjc.1990.264; Hermes-Lima M, 1998, COMP BIOCHEM PHYS B, V120, P437, DOI 10.1016/S0305-0491(98)10053-6; Hermes-Lima M, 2015, FREE RADICAL BIO MED, V89, P1122, DOI 10.1016/j.freeradbiomed.2015.07.156; Hoback WW, 2012, CELL ORIG LIFE EXTRE, V21, P169; Hoback WW, 1998, AM MIDL NAT, V140, P27, DOI 10.1674/0003-0031(1998)140[0027:SOIAAB]2.0.CO;2; Hoback WW, 2000, J COMP PHYSIOL B, V170, P307, DOI 10.1007/s003600000104; Hoback WW, 2001, J INSECT PHYSIOL, V47, P533, DOI 10.1016/S0022-1910(00)00153-0; Hoback WW, 2012, ECOLOGICAL EXPT EXPO, P167; HOCHACHKA PW, 1993, CAN J ZOOL, V71, P1267, DOI 10.1139/z93-173; Irvine KD, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019224; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Gutierrez-Avino FJ, 2009, EMBO REP, V10, P1051, DOI 10.1038/embor.2009.140; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; King AM, 2015, ANNU REV ENTOMOL, V60, P59, DOI 10.1146/annurev-ento-011613-162107; Kolsch G, 2002, J INSECT PHYSIOL, V48, P143, DOI 10.1016/S0022-1910(01)00158-5; Lee SJ, 2008, MOL BIOL CELL, V19, P4051, DOI 10.1091/mbc.E08-03-0265; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; LOUDON C, 1989, J EXP BIOL, V147, P217; LOUDON C, 1988, J INSECT PHYSIOL, V34, P97, DOI 10.1016/0022-1910(88)90160-6; Lyakhovich VV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P962, DOI 10.1134/S0006297906090033; Ma J, 2012, CANCER-AM CANCER SOC, V118, P4105, DOI 10.1002/cncr.27393; Magalhaes J, 2005, J APPL PHYSIOL, V99, P1247, DOI 10.1152/japplphysiol.01324.2004; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Mani M. S., 1968, ECOLOGY BIOGEOGRAPHY, P71; Marelja Z, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00050; Matsuzawa A, 2005, ANTIOXID REDOX SIGN, V7, P472, DOI 10.1089/ars.2005.7.472; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Phillips TW, 2010, ANNU REV ENTOMOL, V55, P375, DOI 10.1146/annurev.ento.54.110807.090451; Powell-Coffman JA, 2010, TRENDS ENDOCRIN MET, V21, P435, DOI 10.1016/j.tem.2010.02.006; Reisch AS, 2007, METHOD CELL BIOL, V80, P199, DOI 10.1016/S0091-679X(06)80010-5; Reynolds ER, 2004, J NEUROBIOL, V58, P503, DOI 10.1002/neu.10297; RUUGE EK, 1991, AM J PHYSIOL, V261, P81, DOI 10.1152/ajplung.1991.261.4.L81; Santos DE, 2016, INSECT BIOCHEM MOLEC, V73, P1, DOI 10.1016/j.ibmb.2016.04.001; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schonenberger MJ, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00042; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; SNYDER GK, 1980, J INSECT PHYSIOL, V26, P699, DOI 10.1016/0022-1910(80)90043-8; SODERSTROM EL, 1990, J ECON ENTOMOL, V83, P472, DOI 10.1093/jee/83.2.472; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Vrailas-Mortimer A, 2011, DEV CELL, V21, P783, DOI 10.1016/j.devcel.2011.09.002; Wang L, 2015, INSECT MOL BIOL, V24, P634, DOI 10.1111/imb.12189; Wang PH, 1998, P NATL ACAD SCI USA, V95, P4556, DOI 10.1073/pnas.95.8.4556; Wang Y, 2001, FREE RADICAL BIO MED, V31, P1448, DOI 10.1016/S0891-5849(01)00728-6; WEGENER G, 1995, THERMOCHIM ACTA, V251, P209, DOI 10.1016/0040-6031(94)02009-D; Wegener G., 1987, P369; WEGENER G, 1993, SURVIVING HYPOXIA ME, P417; Weisbrot-Lefkowitz M, 1998, MOL BRAIN RES, V53, P333, DOI 10.1016/S0169-328X(97)00313-6; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhao DJ, 2012, J INSECT PHYSIOL, V58, P1424, DOI 10.1016/j.jinsphys.2012.08.006; Zhou D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000490; Zhou D, 2013, ANNU REV GENOM HUM G, V14, P25, DOI 10.1146/annurev-genom-091212-153439; Zhou D, 2011, P NATL ACAD SCI USA, V108, P2349, DOI 10.1073/pnas.1010643108; Zhou D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000221; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345	88	13	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199056	10.1371/journal.pone.0199056	http://dx.doi.org/10.1371/journal.pone.0199056			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902250	gold, Green Published, Green Submitted			2022-12-26	WOS:000435424900083
J	Spurthi, KM; Sarikhani, M; Mishra, S; Desingu, PA; Yadav, S; Rao, S; Maity, S; Tamta, AK; Kumar, S; Majumdar, S; Jain, A; Raghuraman, A; Khan, D; Singh, I; Samuel, RJ; Ramachandra, SG; Nandi, D; Sundaresan, NR				Spurthi, Kondapalli Mrudula; Sarikhani, Mohsen; Mishra, Sneha; Desingu, Perumal Arumugam; Yadav, Shikha; Rao, Swathi; Maity, Sangeeta; Tamta, Ankit Kumar; Kumar, Shweta; Majumdar, Shamik; Jain, Aditi; Raghuraman, Aishwarya; Khan, Danish; Singh, Ishwar; Samuel, Rosa J.; Ramachandra, Subbaraya G.; Nandi, Dipankar; Sundaresan, Nagalingam R.			Toll-like receptor 2 deficiency hyperactivates the FoxO1 transcription factor and induces aging-associated cardiac dysfunction in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC HEART-FAILURE; NECROSIS-FACTOR-ALPHA; KAPPA-B; MYOCARDIAL-INFARCTION; ENDOGENOUS LIGANDS; STEM-CELLS; TLR2; MACROPHAGES; ACTIVATION; POLYMORPHISMS	Toll-like receptors (TLRs) are a family of pattern-recognition receptors involved in innate immunity. Previous studies have shown that TLR2 inhibition protects the heart from acute stress, including myocardial infarction and doxorubicin-induced cardiotoxicity in animal models. However, the role of TLR2 in the development of aging-associated heart failure is not known. In this work, we studied aging-associated changes in structure and function of TLR2-deficient mice hearts. Whereas young TLR2-KO mice did not develop marked cardiac dysfunction, 8- and 12-month-old TLR2-KO mice exhibited spontaneous adverse cardiac remodeling and cardiac dysfunction in an age-dependent manner. The hearts of the 8-month-old TLR2-KO mice had increased fibrosis, cell death, and reactivation of fetal genes. Moreover, TLR2-KO hearts displayed reduced infiltration by macrophages, increased numbers of myofibroblasts and atrophic cardiomyocytes, and higher levels of the atrophy-related ubiquitin ligases MuRF-1 and atrogin-1. Mechanistically, TLR2 deficiency impaired the PI3K/Akt signaling pathway, leading to hyperactivation of the transcription factor Forkhead box protein O1 (FoxO1) and, in turn, to elevated expression of FoxO1 target genes involved in the regulation of muscle wasting and cell death. AS1842856-mediated chemical inhibition of FoxO1 reduced the expression of the atrophy-related ubiquitin ligases and significantly reversed the adverse cardiac remodeling while improving the contrastile functions in the TLR2-KO mice. Interestingly, TLR2 levels decreased in hearts of older mice, and the activation of TLR1/2 signaling improved cardiac functions in these mice. These findings suggest that TLR2 signaling is essential for protecting the heart against aging-associated adverse remodeling and contractile dysfunction in mice.	[Spurthi, Kondapalli Mrudula; Sarikhani, Mohsen; Mishra, Sneha; Desingu, Perumal Arumugam; Rao, Swathi; Maity, Sangeeta; Tamta, Ankit Kumar; Kumar, Shweta; Raghuraman, Aishwarya; Khan, Danish; Singh, Ishwar; Sundaresan, Nagalingam R.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bengaluru 560012, Karnataka, India; [Yadav, Shikha; Majumdar, Shamik] Indian Inst Sci, Dept Biochem, Bengaluru 560012, Karnataka, India; [Jain, Aditi; Nandi, Dipankar] Indian Inst Sci, Ctr Biosyst Sci & Engn, Bengaluru 560012, Karnataka, India; [Samuel, Rosa J.; Ramachandra, Subbaraya G.] Indian Inst Sci, Cent Anim Facil, Bengaluru 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Sundaresan, NR (corresponding author), Indian Inst Sci, Div Biol Sci, Dept Microbiol & Cell Biol, SB-02, Bengaluru 560012, Karnataka, India.	rsundaresan@iisc.ac.in	Jain, Aditi/AAD-8922-2019; Majumdar, Shamik/ABE-2032-2021; Desingu, Perumal/AGH-9777-2022; Desingu, P./AGM-5446-2022; Nandi, Dipankar/O-1363-2019	Majumdar, Shamik/0000-0002-3458-816X; Desingu, P./0000-0003-4395-4472; Nandi, Dipankar/0000-0002-5221-9712; Maity, Sangeeta/0000-0003-4426-1715				Ackers-Johnson M, 2016, CIRC RES, V119, P909, DOI 10.1161/CIRCRESAHA.116.309202; Agius E, 2009, J EXP MED, V206, P1929, DOI 10.1084/jem.20090896; Agrawal A, 2007, J IMMUNOL, V178, P6912, DOI 10.4049/jimmunol.178.11.6912; Albert EJ, 2008, J LEUKOCYTE BIOL, V83, P833, DOI 10.1189/jlb.0807557; Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Balistreri CR, 2004, JAMA-J AM MED ASSOC, V292, P2339, DOI 10.1001/jama.292.19.2339; Battiprolu PK, 2012, J CLIN INVEST, V122, P1109, DOI 10.1172/JCI60329; Boehm O, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-33; Bozkurt B, 1998, CIRCULATION, V97, P1382, DOI 10.1161/01.CIR.97.14.1382; Bualeong T, 2016, J NEGAT RESULTS BIOM, V15, DOI 10.1186/s12952-016-0050-3; Calvano JE, 2006, CLIN IMMUNOL, V121, P186, DOI 10.1016/j.clim.2006.05.012; Chao W, 2009, AM J PHYSIOL-HEART C, V296, pH1, DOI 10.1152/ajpheart.00995.2008; Chen B, 2016, CIRC RES, V119, P776, DOI 10.1161/CIRCRESAHA.116.309624; Chen Q, 2017, CELL PHYSIOL BIOCHEM, V42, P427, DOI 10.1159/000477591; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Connell PS, 2012, J VET CARDIOL, V14, P31, DOI 10.1016/j.jvc.2011.11.003; Cuevas CD, 2014, J VIROL, V88, P7703, DOI 10.1128/JVI.00050-14; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Erridge C, 2003, J EXP MED, V197, P1787, DOI 10.1084/jem.20022078; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Favre J, 2007, ARTERIOSCL THROM VAS, V27, P1064, DOI 10.1161/ATVBAHA.107.140723; Fernandez-Ruiz I, 2016, NAT REV CARDIOL, V13, P503, DOI [10.1038/nrcardio.2016.127, 10.1038/nrcardio.2016.58]; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Frantz S, 2001, J BIOL CHEM, V276, P5197, DOI 10.1074/jbc.M009160200; Frantz S, 2007, NAT CLIN PRACT CARD, V4, P444, DOI 10.1038/ncpcardio0938; Gage JR, 2004, NEUROIMMUNOMODULAT, V11, P173, DOI 10.1159/000076766; Galasso G, 2010, EUR HEART J, V31, P733; Gautam JK, 2006, J BIOL CHEM, V281, P30132, DOI 10.1074/jbc.M602057200; Ha TZ, 2011, ANTIOXID REDOX SIGN, V15, P1875, DOI 10.1089/ars.2010.3723; Hattori Y, 1997, BIOCHEM MOL BIOL INT, V41, P979; Herman AC, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.45; Higashikuni Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000267; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Jain A, 2017, INT J CARDIOL, V232, P160, DOI 10.1016/j.ijcard.2017.01.036; Kajstura J, 1996, AM J PHYSIOL-HEART C, V271, pH1215, DOI 10.1152/ajpheart.1996.271.3.H1215; Kong KF, 2008, J VIROL, V82, P7613, DOI 10.1128/JVI.00618-08; Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999; Lin J, 2008, EXP GERONTOL, V43, P296, DOI 10.1016/j.exger.2007.12.005; Lu C, 2011, J IMMUNOL, V187, P1458, DOI 10.4049/jimmunol.1003428; Lu L, 2017, CLIN EXP PHARMACOL P, V44, P55, DOI 10.1111/1440-1681.12753; Ma YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040763; Mann DL, 2011, CIRC RES, V108, P1133, DOI 10.1161/CIRCRESAHA.110.226936; Marmiroli S, 1998, FEBS LETT, V438, P49, DOI 10.1016/S0014-5793(98)01270-8; Massari P, 2006, J IMMUNOL, V176, P2373, DOI 10.4049/jimmunol.176.4.2373; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Menon R, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00196; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Mishra S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23669-9; Molnar A, 2006, MOL MED, V12, P143, DOI 10.2119/2006-00043.Molnar; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Park SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08502; Pinto AR, 2014, AGING-US, V6, P399, DOI 10.18632/aging.100669; Pop-Moldovan AL, 2017, CANCER GENE THER, V24, P203, DOI 10.1038/cgt.2017.4; Pourrajab Fatemeh, 2015, Mol Cell Ther, V3, P4, DOI 10.1186/s40591-015-0041-7; Ramos GC, 2017, P NATL ACAD SCI USA, V114, pE2420, DOI 10.1073/pnas.1621047114; Richter V, 2003, GERONTOLOGY, V49, P293, DOI 10.1159/000071710; Ronnebaum SM, 2010, ANNU REV PHYSIOL, V72, P81, DOI 10.1146/annurev-physiol-021909-135931; Salvador AM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003126; Sandor F, 2003, J CELL BIOL, V162, P1099, DOI 10.1083/jcb.200304093; Schippers EF, 2004, CYTOKINE, V26, P16, DOI 10.1016/j.cyto.2003.12.003; Shaw AC, 2011, AGEING RES REV, V10, P346, DOI 10.1016/j.arr.2010.10.007; Shechter R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01254; Shishido T, 2003, CIRCULATION, V108, P2905, DOI 10.1161/01.CIR.0000101921.93016.1C; Sloane JA, 2010, NEUROMOL MED, V12, P149, DOI 10.1007/s12017-009-8094-x; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Sussman M, 2007, TRENDS CARDIOVAS MED, V17, P235, DOI 10.1016/j.tcm.2007.08.003; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Tamura Y, 2012, CURR MOL MED, V12, P1198, DOI 10.2174/156652412803306710; Tang AH, 2007, J LEUKOCYTE BIOL, V82, P282, DOI 10.1189/jlb.1206752; Timmerman KL, 2011, J APPL PHYSIOL, V110, P869, DOI 10.1152/japplphysiol.00072.2011; Toth MJ, 2011, J APPL PHYSIOL, V110, P892, DOI 10.1152/japplphysiol.00545.2010; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van Duin D, 2007, J IMMUNOL, V178, P970, DOI 10.4049/jimmunol.178.2.970; Wang L, 2014, CARDIOVASC RES, V101, P383, DOI 10.1093/cvr/cvt258; Weinberger T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00107; Yadav S, 2018, FREE RADICAL BIO MED, V116, P73, DOI 10.1016/j.freeradbiomed.2017.12.032; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x	81	18	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13073	13089		10.1074/jbc.RA118.001880	http://dx.doi.org/10.1074/jbc.RA118.001880			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29929978	Green Published, hybrid			2022-12-26	WOS:000442730200009
J	Sananes, A; Cohen, I; Shahar, A; Hockla, A; De Vita, E; Miller, AK; Radisky, ES; Papo, N				Sananes, Amiram; Cohen, Itay; Shahar, Anat; Hockla, Alexandra; De Vita, Elena; Miller, Aubry K.; Radisky, Evette S.; Papo, Niv			A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein engineering; directed evolution; proteolysis; protease inhibitor; X-ray crystallography; cell invasion; enzyme inhibition; selective binding; yeast surface display	MESSENGER-RNA EXPRESSION; OVARIAN-CANCER; SUBSTRATE-SPECIFICITY; CLINICAL-SIGNIFICANCE; PROTEASE INHIBITORS; ALZHEIMERS-DISEASE; SERUM BIOMARKER; EMERGING ROLES; RESIDENCE TIME; UP-REGULATION	Human tissue kallikrein (KLK) proteases are hormone-like signaling molecules with important functions in cancer pathophysiology. KLK-related peptidase 6 (KLK6), specifically, is highly up-regulated in several types of cancer, where its increased activity promotes cancer invasion and metastasis. This characteristic suggests KLK6 as an attractive target for therapeutic interventions. However, inhibitors that specifically target KLK6 have not yet been reported, possibly because KLK6 shares a high sequence homology and structural similarity with other serine proteases and resists inhibition by many polypeptide inhibitors. Here, we present an innovative combinatorial approach to engineering KLK6 inhibitors via flow cytometry-based screening of a yeast-displayed mutant library of the human amyloid precursor protein Kunitz protease inhibitor domain (APPI), an inhibitor of other serine proteases, such as anionic and cationic trypsins. On the basis of this screening, we generated APPI(M17L,I18F,S19F,F34V) (APPI-4M), an APPI variant with a KLK6 inhibition constant (K-i) of 160 pm and a turnover time of 10 days. To the best of our knowledge, APPI-4M is the most potent KLK6 inhibitor reported to date, displaying 146-fold improved affinity and 13-fold improved proteolytic stability compared with WT APPI (APPI(WT)). We further demonstrate that APPI-4M acts as a functional inhibitor in a cell-based model of KLK6-dependent breast cancer invasion. Finally, the crystal structures of the APPI(WT)/KLK6 and APPI-4M/KLK6 complexes revealed the structural and mechanistic bases for the improved KLK6 binding and proteolytic resistance of APPI-4M. We anticipate that APPI-4M will have substantial translational potential as both imaging agent and therapeutic.	[Sananes, Amiram; Cohen, Itay; Papo, Niv] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel; [Sananes, Amiram; Cohen, Itay; Papo, Niv] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Shahar, Anat] NIBN, IL-84105 Beer Sheva, Israel; [Hockla, Alexandra; Radisky, Evette S.] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [De Vita, Elena; Miller, Aubry K.] German Canc Res Ctr, Canc Drug Dev Grp, Neuenheimer Feld 280, D-69120 Heidelberg, Germany	Ben Gurion University; Ben Gurion University; Mayo Clinic; Helmholtz Association; German Cancer Research Center (DKFZ)	Papo, N (corresponding author), Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.; Papo, N (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel.	papo@bgu.ac.il	Miller, Aubry/AAO-3863-2020; Radisky, Evette S/C-8526-2012; De Vita, Elena/AAV-3670-2021	Radisky, Evette S/0000-0003-3121-109X; De Vita, Elena/0000-0003-4707-8342	European Research Council [336041]; Prostate Cancer Foundation; DKFZ-MOST [GR2495]; United States-Israel Binational Science Foundation; National Institutes of Health [R01CA154387]; NATIONAL CANCER INSTITUTE [R01CA154387] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Prostate Cancer Foundation; DKFZ-MOST; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the European Research Council "Ideas Program" ERC-2013-StG Contract Grant 336041, the Prostate Cancer Foundation (to N.P.), and the DKFZ-MOST Contract Grant GR2495 (to N.P. and A.K.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by United States-Israel Binational Science Foundation.; Supported by National Institutes of Health Grant R01CA154387.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angelini A, 2015, METHODS MOL BIOL, V1319, P3, DOI 10.1007/978-1-4939-2748-7_1; Ashby EL, 2010, BRAIN RES, V1363, P1, DOI 10.1016/j.brainres.2010.09.017; Avgeris M, 2010, BIOL CHEM, V391, P505, DOI 10.1515/BC.2010.056; Bando Y, 2018, GLIA, V66, P359, DOI 10.1002/glia.23249; Bayes A, 2004, BIOL CHEM, V385, P517, DOI 10.1515/BC.2004.061; Bernett MJ, 2002, J BIOL CHEM, V277, P24562, DOI 10.1074/jbc.M202392200; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Bradshaw JM, 2015, NAT CHEM BIOL, V11, P525, DOI [10.1038/NCHEMBIO.1817, 10.1038/nchembio.1817]; Caliendo G, 2012, J MED CHEM, V55, P6669, DOI 10.1021/jm300407t; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Christodoulou S, 2014, TUMOR BIOL, V35, P4673, DOI 10.1007/s13277-014-1612-y; Cohen I, 2016, BIOCHEM J, V473, P1329, DOI 10.1042/BJ20151410; Copeland RA, 2016, NAT REV DRUG DISCOV, V15, P87, DOI 10.1038/nrd.2015.18; Copeland RA, 2010, EXPERT OPIN DRUG DIS, V5, P305, DOI 10.1517/17460441003677725; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; de Veer SJ, 2017, J INVEST DERMATOL, V137, P430, DOI 10.1016/j.jid.2016.09.017; de Veer SJ, 2016, BIOL CHEM, V397, P1237, DOI 10.1515/hsz-2016-0112; de Veer SJ, 2015, J MED CHEM, V58, P8257, DOI 10.1021/acs.jmedchem.5b01148; Diamandis EP, 2003, J CLIN ONCOL, V21, P1035, DOI 10.1200/JCO.2003.02.022; EDWARDS PR, 1995, ANAL BIOCHEM, V231, P210, DOI 10.1006/abio.1995.1522; Ehrenfeld P, 2014, ANTICANCER RES, V34, P6925; Emami N, 2007, MOL ONCOL, V1, P269, DOI 10.1016/j.molonc.2007.09.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghosh MC, 2004, TUMOR BIOL, V25, P193, DOI 10.1159/000081102; Gomis-Ruth FX, 2002, J BIOL CHEM, V277, P27273, DOI 10.1074/jbc.M201534200; Gooljarsingh LT, 2006, P NATL ACAD SCI USA, V103, P7625, DOI 10.1073/pnas.0602650103; Hebb Andrea L O, 2010, Curr Drug Discov Technol, V7, P137; Henkhaus RS, 2008, BIOL CHEM, V389, P757, DOI 10.1515/BC.2008.087; Heuze-Vourc'h N, 2009, J CELL MOL MED, V13, P4014, DOI 10.1111/j.1582-4934.2009.00763.x; Hoffman BR, 2002, BRIT J CANCER, V87, P763, DOI 10.1038/sj.bjc.6600533; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katz BA, 1998, NATURE, V391, P608, DOI 10.1038/35422; Katz BA, 2001, CHEM BIOL, V8, P1107, DOI 10.1016/S1074-5521(01)00084-9; Kim JT, 2011, CANCER-AM CANCER SOC, V117, P2608, DOI 10.1002/cncr.25841; KITAGUCHI N, 1990, BIOCHIM BIOPHYS ACTA, V1038, P105, DOI 10.1016/0167-4838(90)90017-A; Klucky B, 2007, CANCER RES, V67, P8198, DOI 10.1158/0008-5472.CAN-07-0607; Kolin DL, 2014, BIOL CHEM, V395, P1087, DOI 10.1515/hsz-2014-0143; Kontos CK, 2012, CLIN CHEM LAB MED, V50, P1877, DOI 10.1515/cclm-2012-0247; Kountourakis P, 2008, CANCER SCI, V99, P2224, DOI 10.1111/j.1349-7006.2008.00942.x; Krenzer S, 2011, J INVEST DERMATOL, V131, P2281, DOI 10.1038/jid.2011.190; Krishnan R, 1998, BIOCHEMISTRY-US, V37, P12094, DOI 10.1021/bi980840e; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Liebeschuetz JW, 2002, J MED CHEM, V45, P1221, DOI 10.1021/jm010944e; Liebler DC, 2005, NAT REV DRUG DISCOV, V4, P410, DOI 10.1038/nrd1720; LONGAS MO, 1980, BIOCHEM J, V189, P481, DOI 10.1042/bj1890481; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Magklara A, 2003, BIOCHEM BIOPH RES CO, V307, P948, DOI 10.1016/S0006-291X(03)01271-3; Mange A, 2016, J PROTEOMICS, V142, P114, DOI 10.1016/j.jprot.2016.04.050; Marceau F, 2004, NAT REV DRUG DISCOV, V3, P845, DOI 10.1038/nrd1522; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melnikova VO, 2008, CANCER MICROENVIRON, V1, P103, DOI 10.1007/s12307-008-0002-7; Michel N, 2014, BIOL CHEM, V395, P1015, DOI 10.1515/hsz-2014-0124; Nagahara H, 2005, CLIN CANCER RES, V11, P6800, DOI 10.1158/1078-0432.CCR-05-0943; Ogawa K, 2005, CLIN CANCER RES, V11, P2889, DOI 10.1158/1078-0432.CCR-04-2281; Oikonomopoulou K, 2010, BIOL CHEM, V391, P299, DOI 10.1515/BC.2010.038; Otlewski J, 2005, EMBO J, V24, P1303, DOI 10.1038/sj.emboj.7600611; Patra K, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0336-4; Petraki CD, 2006, TUMOR BIOL, V27, P1, DOI 10.1159/000090150; Prassas I, 2015, NAT REV DRUG DISCOV, V14, P183, DOI 10.1038/nrd4534; Prezas P, 2006, BIOL CHEM, V387, P807, DOI 10.1515/BC.2006.102; Radisky ES, 2004, BIOCHEMISTRY-US, V43, P13648, DOI 10.1021/bi048797k; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh MA, 2011, BIOCHEM J, V440, P95, DOI 10.1042/BJ20110788; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; Scarisbrick IA, 2012, BRAIN PATHOL, V22, P709, DOI 10.1111/j.1750-3639.2012.00577.x; Scarisbrick IA, 2012, BIOL CHEM, V393, P355, DOI 10.1515/hsz-2011-0241; Shan SJC, 2007, BRIT J CANCER, V96, P362, DOI 10.1038/sj.bjc.6603556; Sidiropoulos KG, 2016, MOL ONCOL, V10, P993, DOI 10.1016/j.molonc.2016.03.008; SMITH RP, 1990, SCIENCE, V248, P1126, DOI 10.1126/science.2111585; Sotiropoulou G, 2012, TRENDS PHARMACOL SCI, V33, P623, DOI 10.1016/j.tips.2012.09.005; Swedberg JE, 2010, BIOL CHEM, V391, P357, DOI 10.1515/BC.2010.037; Tatebe H, 2010, NEUROSCI RES, V67, P341, DOI 10.1016/j.neures.2010.04.008; Vakrakou A, 2014, BIOL CHEM, V395, P1105, DOI 10.1515/hsz-2014-0166; White NMA, 2009, CANCER BIOMARK, V5, P279, DOI 10.3233/CBM-2009-0113; Wilczynska M, 1997, NAT STRUCT BIOL, V4, P354, DOI 10.1038/nsb0597-354; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang K, 2013, CHEM BIOL, V20, P92, DOI 10.1016/j.chembiol.2012.10.020	82	13	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12663	12680		10.1074/jbc.RA117.000871	http://dx.doi.org/10.1074/jbc.RA117.000871			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29934309	hybrid, Green Published			2022-12-26	WOS:000442203500002
J	Ali, S; Malik, MZ; Singh, SS; Chirom, K; Ishrat, R; Singh, RKB				Ali, Shahnawaz; Malik, Md Zubbair; Singh, Soibam Shyamchand; Chirom, Keilash; Ishrat, Romana; Singh, R. K. Brojen			Exploring novel key regulators in breast cancer network	PLOS ONE			English	Article							COMMUNITY STRUCTURE; IDENTIFICATION; ORGANIZATION; BIOLOGY; CENTRALITY; APOPTOSIS; GENES; POWER	The breast cancer network constructed from 70 experimentally verified genes is found to follow hierarchical scale free nature with heterogeneous modular organization and diverge leading hubs. The topological parameters (degree distributions, clustering co-efficient, connectivity and centralities) of this network obey fractal rules indicating absence of centrality lethality rule, and efficient communication among the components. From the network theoretical approach, we identified few key regulators out of large number of leading hubs, which are deeply rooted from top to down of the network, serve as backbone of the network, and possible target genes. However, p53, which is one of these key regulators, is found to be in low rank and keep itself at low profile but directly cross-talks with important genes BRCA2 and BRCA3. The popularity of these hubs gets changed in unpredictable way at various levels of organization thus showing disassortive nature. The local community paradigm approach in this network shows strong correlation of nodes in majority of modules/sub-modules (fast communication among nodes) and weak correlation of nodes only in few modules/sub-modules (slow communication among nodes) at various levels of network organization.	[Ali, Shahnawaz; Malik, Md Zubbair; Ishrat, Romana] Jamia Millie Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India; [Ali, Shahnawaz; Malik, Md Zubbair; Singh, Soibam Shyamchand; Chirom, Keilash; Singh, R. K. Brojen] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India	Jamia Millia Islamia; Jawaharlal Nehru University, New Delhi	Singh, RKB (corresponding author), Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India.	brojen@jnu.ac.in	Ali, Shahnawaz/K-5884-2015; Malik, Md. Zubbair/GPT-6580-2022; Malik, Zubbair/AAY-8558-2020	Ali, Shahnawaz/0000-0002-7601-4762; Malik, Md. Zubbair/0000-0001-6693-0401; 	Indian Council of Medical Research under SRF (Senior Research Fellowship); UPOE-II (UGC), New Delhi, India [101]	Indian Council of Medical Research under SRF (Senior Research Fellowship); UPOE-II (UGC), New Delhi, India	SA and MZM are financially supported by Indian Council of Medical Research under SRF (Senior Research Fellowship) and R.K.B.S by UPOE-II (UGC) (101), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad FK, 2012, J BIOMED INFORM, V45, P350, DOI 10.1016/j.jbi.2011.11.015; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A., 2007, LARGE SCALE STRUCTUR, P67, DOI 10.1142/9789812771681_0005; Barzel B, 2013, NAT PHYS, V9, P673, DOI [10.1038/nphys2741, 10.1038/NPHYS2741]; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Borgatti SP, 2006, SOC NETWORKS, V28, P466, DOI 10.1016/j.socnet.2005.11.005; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Cai QY, 2014, NAT GENET, V46, P886, DOI 10.1038/ng.3041; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Cannistraci CV, 2013, SCI REP-UK, V3, DOI 10.1038/srep01613; Canright G, 2004, SCI COMPUT PROGRAM, V53, P195, DOI 10.1016/j.scico.2003.12.008; Canright Geoffrey S., 2006, ComPlexUs, V3, P131, DOI 10.1159/000094195; Chand Y, 2012, BIOINFORMATION, V8, P1132, DOI 10.6026/97320630081132; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Dittrich MT, 2008, BIOINFORMATICS, V24, pI223, DOI 10.1093/bioinformatics/btn161; Emmert-Streib F, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00015; Fatouros M, 2008, ANN SURG ONCOL, V15, P21, DOI 10.1245/s10434-007-9612-4; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hamed M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S5-S2; Hernandez-Toro J, 2007, BIOINFORMATICS, V23, P2495, DOI 10.1093/bioinformatics/btm373; Heylighen F., 2001, ENCY LIFE SUPPORT SY; Holland J.H., 1995, HIDDEN ORDERHOW ADAP; Holland JH., 1975, Q REV BIOL; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kauffman Stuart A., 1993; Liu J, 2015, CANCER LETT, V356, P197, DOI 10.1016/j.canlet.2013.12.025; Lubin A, 2014, INT J MOL SCI, V15, P141, DOI 10.3390/ijms15010141; Macedo GS, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.AM2016-100; Malik MZ, 2017, MOL BIOSYST, V13, P350, DOI 10.1039/c6mb00525j; Malik MZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40596; Mandelbrot BB, 1997, 1164 SAUD SCH BUS; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mason O, 2007, IET SYST BIOL, V1, P89, DOI 10.1049/iet-syb:20060038; Murphy JA, 2013, LANCET ONCOL, V14, pE262, DOI 10.1016/S1470-2045(13)70047-0; Nafis S, 2016, MOL BIOSYST, V12, P3357, DOI 10.1039/c6mb00526h; Nafis S, 2015, BRIEF BIOINFORM, V16, P675, DOI 10.1093/bib/bbu036; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Peng XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130743; Pieroni E, 2008, PROTEOMICS, V8, P799, DOI 10.1002/pmic.200700767; Prigogine I., 1984, ORDER OUT CHAOS; Raj U, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03534-x; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Synnott NC, 2017, INT J CANCER, V140, P234, DOI 10.1002/ijc.30425; Traag VA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02930; Traag VA, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016114; van der Hage JA, 2001, J CLIN ONCOL, V19, P4224, DOI 10.1200/JCO.2001.19.22.4224; Weterings E, 2016, DNA REPAIR, V43, P98, DOI 10.1016/j.dnarep.2016.03.014; Woods SJ, 2015, BBA-GENE REGUL MECH, V1849, P821, DOI 10.1016/j.bbagrm.2014.10.007; Wu M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-547; Zhou TB, 2013, J RECEPT SIG TRANSD, V33, P28, DOI 10.3109/10799893.2012.752006	58	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198525	10.1371/journal.pone.0198525	http://dx.doi.org/10.1371/journal.pone.0198525			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927945	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500023
J	Sljivic, A; Kleut, MP; Bukumiric, Z; Celic, V				Sljivic, Aleksandra; Kleut, Milena Pavlovic; Bukumiric, Zoran; Celic, Vera			Association between right ventricle two- and three-dimensional echocardiography and exercise capacity in patients with reduced left ventricular ejection fraction	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; LONGITUDINAL STRAIN; SPECKLE TRACKING; INDEPENDENT PREDICTOR; MAGNETIC-RESONANCE; EUROPEAN-SOCIETY; PROGNOSTIC VALUE; PATHOPHYSIOLOGY; GUIDELINES; CARDIOLOGY	Introduction Echocardiography represents the most commonly performed noninvasive cardiac imaging test for patients with heart failure (HF). The aim of this study was to assess the relationship between exercise capacity parameters (peak oxygen consumption (VO2) and the minute ventilation-carbon dioxide production relationship (VE/VCO2)), two-dimensional speckle tracking echocardiography (2D-STE) and three-dimensional echocardiography (3DE) imaging of right ventricular (RV) function in HF patients with reduced ejection fraction (EF). Material and methods This cross-sectional study included 54 patients with diagnosed ischemic LV systolic dysfunction (HF with reduced EF <40%) divided in subgroups based on the proposed values of the analyzed cardiopulmonary exercise testing (CPET) variables: VO2 peak <= 15 ml/kg/min, VO2 peak > 15 ml/kg/min, VE/VCO2 slope < 36 and VE/VCO2 slope >= 36. All patients underwent a physical examination, laboratory testing, conventional echocardiography, 2D-STE, 3DE, and CPET. Results RV fractional area change (FAC), 2D RV global longitudinal strain (GLS), 3D RV EF were significantly decreased, and RV basal diameter (BD), systolic pulmonary artery pressure (SPAP), tricuspid annular plane systolic excursion (TAPSE), ratio between tricuspid flow and tissue Doppler derived e' of the lateral tricuspid annulus (TV E/e') were significantly increased in the subgroups of subjects with a worse VO2 peak and VE/VCO2 slope values. There was a significant positive correlation between the peak VO2 values and TAPSE, 2D RV GLS, 3D RV SV, and 3D RV EF as well as a significantly inverse correlation with VE/VCO2 slope. Conclusions The observed significant correlation between the examined parameters suggests that 2D RV GLS and 3D RV EF, SV are associated with exercise capacity in patients with reduced HF.	[Sljivic, Aleksandra; Kleut, Milena Pavlovic; Celic, Vera] Univ Clin Hosp Ctr Dr Dragisa Misovic Dedinje, Dept Cardiol, Belgrade, Serbia; [Bukumiric, Zoran] Univ Belgrade, Fac Med, Inst Med Stat & Informat, Belgrade, Serbia; [Celic, Vera] Univ Belgrade, Fac Med, Belgrade, Serbia	University of Belgrade; University of Belgrade	Sljivic, A (corresponding author), Univ Clin Hosp Ctr Dr Dragisa Misovic Dedinje, Dept Cardiol, Belgrade, Serbia.	sljivic0809@gmail.com						Abraham Jacob, 2009, Heart Fail Clin, V5, P191, DOI 10.1016/j.hfc.2008.11.002; Apostolakis S, 2012, CARDIOLOGY, V121, P263, DOI 10.1159/000338705; Arena R, 2007, CIRCULATION, V115, P2410, DOI 10.1161/CIRCULATIONAHA.107.686576; Badano Luigi P, 2012, J Cardiovasc Ultrasound, V20, P1, DOI 10.4250/jcu.2012.20.1.1; BAKER BJ, 1984, AM J CARDIOL, V54, P596, DOI 10.1016/0002-9149(84)90256-X; Ben-Gal T, 2000, TRANSPLANT P, V32, P743, DOI 10.1016/S0041-1345(00)00965-9; Bjornstad H, 2001, EUR HEART J, V22, P37; Cahalin LP, 2013, HEART FAIL REV, V18, P79, DOI 10.1007/s10741-012-9332-0; Cameli M, 2013, AM J CARDIOL, V112, P1778, DOI 10.1016/j.amjcard.2013.07.046; CLARK AL, 1994, CIRCULATION, V89, P2062, DOI 10.1161/01.CIR.89.5.2062; Cornelis J, 2015, INT J CARDIOL, V182, P476, DOI 10.1016/j.ijcard.2015.01.029; Corra U, 2014, EUR J HEART FAIL, V16, P929, DOI 10.1002/ejhf.156; D'Andrea A, 2011, J CARD FAIL, V17, P309, DOI 10.1016/j.cardfail.2010.11.005; Damman K, 2010, J REN CARE, V36, P18, DOI 10.1111/j.1755-6686.2010.00172.x; de Groote P, 1998, J AM COLL CARDIOL, V32, P948, DOI 10.1016/S0735-1097(98)00337-4; DISALVO TG, 1995, J AM COLL CARDIOL, V25, P1143, DOI 10.1016/0735-1097(94)00511-N; Garcia-Martin A, 2016, CARDIOL J, V23, P189, DOI 10.5603/CJ.a2015.0079; Ghio S, 2013, EUR J HEART FAIL, V15, P408, DOI 10.1093/eurjhf/hfs208; Guarracino F, 2005, Minerva Anestesiol, V71, P307; Guazzi M, 2013, INT J CARDIOL, V169, P379, DOI 10.1016/j.ijcard.2013.09.014; Guazzi M, 2013, AM J PHYSIOL-HEART C, V305, pH1373, DOI 10.1152/ajpheart.00157.2013; Hacker M, 2003, J NUCL CARDIOL, V10, P644, DOI 10.1016/S1071-3581(03)00659-7; Haddad F, 2008, CIRCULATION, V117, P1717, DOI 10.1161/CIRCULATIONAHA.107.653584; Huang YT, 2016, SCI REP-UK, V6, DOI 10.1038/srep29590; Kalogeropoulos Andreas P, 2011, Congest Heart Fail, V17, P189, DOI 10.1111/j.1751-7133.2011.00234.x; Kjaergaard J, 2006, EUR J ECHOCARDIOGR, V7, P430, DOI 10.1016/j.euje.2005.10.009; Kossaify A, 2015, CLIN MED INSIGHTS-CA, V9, P65, DOI 10.4137/CMC.S27462; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Leong DP, 2012, ECHOCARDIOGR-J CARD, V29, P455, DOI 10.1111/j.1540-8175.2011.01594.x; Lindqvist P, 2003, Eur J Echocardiogr, V4, P29, DOI 10.1053/euje.2002.0177; Lu KJ, 2015, ECHOCARDIOGR-J CARD, V32, P966, DOI 10.1111/echo.12783; Malhotra R, 2016, JACC-HEART FAIL, V4, P607, DOI 10.1016/j.jchf.2016.03.022; Metra M, 2012, EUR HEART J, V33, P2135, DOI 10.1093/eurheartj/ehs205; Meyer P, 2010, CIRCULATION, V121, P252, DOI 10.1161/CIRCULATIONAHA.109.887570; PATTERSON JA, 1972, AM J CARDIOL, V30, P757, DOI 10.1016/0002-9149(72)90151-8; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Puwanant S, 2009, EUR J ECHOCARDIOGR, V10, P733, DOI 10.1093/ejechocard/jep052; Rubis P, 2010, EUR J HEART FAIL, V12, P260, DOI 10.1093/eurjhf/hfp200; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Salerno G, 2011, J CARDIOVASC MED, V12, P625, DOI 10.2459/JCM.0b013e328349a268; Savarese G, 2014, JACC-HEART FAIL, V2, P148, DOI 10.1016/j.jchf.2013.11.007; Sorrentino R, 2016, RES REP CLIN CARDIOL, V7, P147, DOI 10.2147/RRCC.S107374; SZLACHCIC J, 1985, AM J CARDIOL, V55, P1037, DOI 10.1016/0002-9149(85)90742-8; Tadic M, 2017, ARCH CARDIOVASC DIS, V110, P562, DOI 10.1016/j.acvd.2017.05.002; Timmers L, 2012, CARDIOVASC RES, V94, P276, DOI 10.1093/cvr/cvs018; Vizzardi E, 2014, HELL J CARDIOL, V55, P150; Witte KKA, 2004, HEART, V90, P1144, DOI 10.1136/hrt.2003.025684	47	3	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199439	10.1371/journal.pone.0199439	http://dx.doi.org/10.1371/journal.pone.0199439			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928010	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500092
J	Miller, CA; Taboue, GCT; Ekane, MMP; Robak, M; Clee, PRS; Richards-Zawacki, C; Fokam, EB; Fuashi, NA; Anthony, NM				Miller, Courtney A.; Taboue, Geraud Canis Tasse; Ekane, Mary M. P.; Robak, Matthew; Clee, Paul R. Sesink; Richards-Zawacki, Corinne; Fokam, Eric B.; Fuashi, Nkwatoh Athanasius; Anthony, Nicola M.			Distribution modeling and lineage diversity of the chytrid fungus Batrachochytrium dendrobatidis (Bd) in a central African amphibian hotspot	PLOS ONE			English	Article							HIGH PREVALENCE; CHYTRIDIOMYCOSIS; PATHOGEN; FROGS; DISEASE; MONTANE; DETERMINANTS; TEMPERATURE; INFECTION; HIGHLANDS	The amphibian disease chytridiomycosis in amphibians is caused by the chytrid fungus Batrachochytrium dendrobatidis (Bd) and has resulted in dramatic declines and extinctions of amphibian populations worldwide. A hypervirulent, globally-dispersed pandemic lineage (Bd-GPL) is thought to be largely responsible for population declines and extinctions, although numerous endemic lineages have also been found. Recent reports of amphibian declines have been linked to the emergence of Bd in Cameroon, a major hotspot of African amphibian diversity. However, it is not known whether Bd-GPL or other lineages have been found in this region. This study therefore aims to examine Bd lineage diversity in the region and predict the distribution of this pathogen under current and future climate conditions using data from this study and from historical records. Almost 15% (52/360) of individuals tested positive for Bd using a standard quantitative PCR diagnostic. Infected amphibians were found at all eight sites sampled in this study. Species distribution models generated in BIOMOD2 indicate that areas with highest predicted environmental suitability occur in the Cameroon highlands and several protected areas throughout the country. These areas of high environmental suitability for Bd are projected to shift or decrease in size under future climate change. However, montane regions with high amphibian diversity are predicted to remain highly suitable. Phylogenetic analysis of the ITS sequences obtained from a set of positive Bd samples indicate that most fall within the Bd-GPL lineage while the remainder group with isolates from either Brazil or South Korea. Although more in depth phylogenetic analyses are needed, identification of Bd-GPL lineages in areas of high amphibian diversity emphasizes the need to continue to monitor for Bd and develop appropriate conservation strategies to prevent its further spread.	[Miller, Courtney A.; Anthony, Nicola M.] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA; [Taboue, Geraud Canis Tasse; Ekane, Mary M. P.; Fokam, Eric B.; Fuashi, Nkwatoh Athanasius] Univ Buea, Dept Zool & Anim Physiol, Buea, Cameroon; [Taboue, Geraud Canis Tasse] Inst Geol & Min Res, Yaounde, Cameroon; [Robak, Matthew] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Clee, Paul R. Sesink] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Richards-Zawacki, Corinne] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	University of Louisiana System; University of New Orleans; Tulane University; Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Miller, CA (corresponding author), Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA.	camille3@uno.edu	Fokam, Eric Bertrand/GPS-7655-2022; Anthony, Nicola/AAI-7280-2021	Fokam, Eric Bertrand/0000-0003-4531-3580; 	International Herpetological Symposium (CAM); Tulane Graduate Student fund; US National Science Foundation Partnerships for International Research and Education (PIRE) [OISE 1243524]	International Herpetological Symposium (CAM); Tulane Graduate Student fund; US National Science Foundation Partnerships for International Research and Education (PIRE)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The laboratory procedures and materials for data analysis in the current project was funded by the International Herpetological Symposium (CAM), http://www.internationalherpetologicalsymposium.com, and the Tulane Graduate Student fund. Field work and sample collection was supported by a separate ongoing project funded under the US National Science Foundation Partnerships for International Research and Education (PIRE) Grant (OISE 1243524), http://www.nsf.gov. The funders had no role in study design, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Amiet J., 2008, THREATENED AMPHIBIAN, P16; Andre SE, 2008, J WILDLIFE DIS, V44, P716, DOI 10.7589/0090-3558-44.3.716; Annis SL, 2004, J WILDLIFE DIS, V40, P420, DOI 10.7589/0090-3558-40.3.420; Balaz V, 2012, HERPETOL J, V22, P191; Bataille A, 2013, MOL ECOL, V22, P4196, DOI 10.1111/mec.12385; Bell RC, 2011, ECOHEALTH, V8, P116, DOI 10.1007/s10393-010-0364-4; Berger L, 2016, FUNGAL ECOL, V19, P89, DOI 10.1016/j.funeco.2015.09.007; Bergl RA, 2007, BIOL CONSERV, V134, P195, DOI 10.1016/j.biocon.2006.08.013; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Clare FC, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0454; Conradie Werner, 2016, Herpetological Review, V47, P42; Conradie Werner, 2011, Herpetological Review, V42, P369; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Doherty-Bone TM, 2013, DIS AQUAT ORGAN, V102, P187, DOI 10.3354/dao02557; Doherty-Bone TM, 2008, HERPETOL J, V18, P115; El Mouden E. H., 2011, Herpetological Review, V42, P71; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gaertner JP, 2009, ECOHEALTH, V6, P20, DOI 10.1007/s10393-009-0229-x; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Goldberg TL, 2007, J WILDLIFE DIS, V43, P521, DOI 10.7589/0090-3558-43.3.521; Gower DJ, 2013, ECOHEALTH, V10, P173, DOI 10.1007/s10393-013-0831-9; Gower DJ, 2012, HERPETOL J, V22, P225; Greenbaum E, 2015, HERPETOL J, V25, P91; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HASTIE T, 1994, J AM STAT ASSOC, V89, P1255, DOI 10.2307/2290989; Hastie T., 1986, STAT SCI, V1, P297; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirschfeld M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155129; Hofer U, 2000, J TROP ECOL, V16, P517, DOI 10.1017/S0266467400001553; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Hydeman ME, 2017, ECOL EVOL, V7, P7729, DOI 10.1002/ece3.3309; Hydeman Marina E., 2013, Herpetological Review, V44, P254; Imasuen Abigail A., 2011, Herpetological Review, V42, P379; James TY, 2015, ECOL EVOL, V5, P4079, DOI 10.1002/ece3.1672; Jarvis A, 2008, CGIAR CSI CONS SPAT, P1; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kielgast J, 2010, ANIM CONSERV, V13, P36, DOI 10.1111/j.1469-1795.2009.00297.x; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Leroy B, 2016, ECOGRAPHY, V39, P599, DOI 10.1111/ecog.01388; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Murray KA, J APPL ECOL, V201, P163; Murray KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061061; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; O'Hanlon SJ, 2018, SCIENCE, V360, P621, DOI 10.1126/science.aar1965; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Penner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056236; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillott AD, 2013, CONSERV BIOL, V27, P1058, DOI 10.1111/cobi.12073; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez J, 2008, HIGH RESOLUTION STAT; Reeder Natalie M.M., 2011, Herpetology Notes, V4, P83; Ridgeway G., 1999, COMPUT SCI STAT, P172; Robak MJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00410; Roedder Dennis, 2009, Diversity, V1, P52; Rodder D, 2010, DIS AQUAT ORGAN, V92, P201, DOI 10.3354/dao02197; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Scherer R., 2016, PROPCIS VARIOUS CONF; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Seimon TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118543; Sesink Clee PR, 2017, THESIS; Sonn JM, 2017, ECOHEALTH, V14, P762, DOI 10.1007/s10393-017-1269-2; Tarrant J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069591; Thomson DM, 2005, CONSERV BIOL, V19, P917, DOI 10.1111/j.1523-1739.2005.004108.x; Thuiller W., 2014, GLOBAL CHANGE BIOL, V9, P1353; Toham AK, 2006, VISION BIODIVERSITY; Van Rooij P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0266-0; Voyles J, 2018, SCIENCE, V359, P1517, DOI 10.1126/science.aao4806; Voyles J, 2014, ECOL EVOL, V4, P3633, DOI 10.1002/ece3.1199; Wake DB, 2012, SCIENCE, V335, P1052, DOI 10.1126/science.1218364; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Wombwell Louise E., 2014, THESIS; Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361	84	13	13	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199288	10.1371/journal.pone.0199288	http://dx.doi.org/10.1371/journal.pone.0199288			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924870	Green Published, Green Submitted, gold			2022-12-26	WOS:000435655600057
J	Verma, R; Venkatareddy, M; Kalinowski, A; Li, T; Kukla, J; Mollin, A; Cara-Fuentes, G; Patel, SR; Garg, P				Verma, Rakesh; Venkatareddy, Madhusudan; Kalinowski, Anne; Li, Theodore; Kukla, Joanna; Mollin, Ashomathi; Cara-Fuentes, Gabriel; Patel, Sanjeevkumar R.; Garg, Puneet			Nephrin is necessary for podocyte recovery following injury in an adult mature glomerulus	PLOS ONE			English	Article							HUMAN DIABETIC-NEPHROPATHY; SLIT-DIAPHRAGM PROTEIN; NEPHROTIC SYNDROME; ANGIOTENSIN-II; ACTIN POLYMERIZATION; KIDNEY-DISEASE; EXPRESSION; GENE; ENDOCYTOSIS; GLOMERULOSCLEROSIS	Nephrin (Nphs1) is an adhesion protein that is expressed at the podocyte intercellular junction in the glomerulus. Nphs1 mutations in humans or deletion in animal genetic models results in a developmental failure of foot process formation. A number of studies have shown decrease in expression of nephrin in various proteinuric kidney diseases as well as in animal models of glomerular disease. Decrease in nephrin expression has been suggested to precede podocyte loss and linked to the progression of kidney disease. Whether the decrease in expression of nephrin is related to loss of podocytes or lead to podocyte detachment is unclear. To answer this central question we generated an inducible model of nephrin deletion (Nphs1 (Tam-Cre)) in order to lower nephrin expression in healthy adult mice. Following tamoxifen-induction there was a 75% decrease in nephrin expression by 14 days. The Nphs1 Tam-Cre mice had normal foot process ultrastructure and intact filtration barriers up to 4 +/- 6 weeks post-induction. Despite the loss of nephrin expression, the podocyte number and density remained unchanged during the initial period. Unexpectedly, nephrin expression, albeit at low levels persisted at the slit diaphragm up to 16 +/- 20 weeks post-tamoxifen induction. The mice became progressively proteinuric with glomerular hypertrophy and scarring reminiscent of focal and segmental glomerulosclerosis at 20 weeks. Four week-old Nphs1 knockout mice subjected to protamine sulfate model of podocyte injury demonstrated failure to recover from foot process effacement following heparin sulfate. Similarly, Nphs1 knockout mice failed to recover following nephrotoxic serum (NTS) with persistence of proteinuria and foot process effacement. Our results suggest that as in development, nephrin is necessary for maintenance of a healthy glomerular filter. In contrast to the developmental phenotype, lowering nephrin expression in a mature glomerulus resulted in a slowly progressive disease that histologically resembles FSGS a disease linked closely with podocyte depletion. Podocytes with low levels of nephrin expression are both susceptible and unable to recover following perturbation. Our results suggest that decreased nephrin expression independent of podocyte loss occurring as an early event in proteinuric kidney diseases might play a role in disease progression.	[Verma, Rakesh; Venkatareddy, Madhusudan; Kalinowski, Anne; Li, Theodore; Patel, Sanjeevkumar R.; Garg, Puneet] Univ Michigan, Div Nephrol, Sch Med, Ann Arbor, MI 48109 USA; [Kukla, Joanna] Wayne State Univ, Sch Med, Detroit, MI USA; [Mollin, Ashomathi] Univ Toledo, 2801 W Bancroft St, Toledo, OH 43606 USA; [Cara-Fuentes, Gabriel] Motts Children Hosp, Div Pediat Nephrol, Ann Arbor, MI USA; [Patel, Sanjeevkumar R.; Garg, Puneet] VAMC, Vet Adm, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; Wayne State University; University System of Ohio; University of Toledo	Garg, P (corresponding author), Univ Michigan, Div Nephrol, Sch Med, Ann Arbor, MI 48109 USA.; Garg, P (corresponding author), VAMC, Vet Adm, Ann Arbor, MI 48105 USA.	pungarg@umich.edu		Cara-Fuentes, Gabriel/0000-0002-4164-3251; Garg, Puneet/0000-0001-7439-459X	NIDDK [DK097027]; SP [DK082409]; University of Michigan's George M. O'Brien Translational Research Core Center [P30 DK0801943]; MDTRC Cell and Molecular Biology Core [P60 DK020572]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD028820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK081943, R01DK097027, P30DK020572] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); SP; University of Michigan's George M. O'Brien Translational Research Core Center; MDTRC Cell and Molecular Biology Core; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants to PG from NIDDK (DK097027) and SP (DK082409). Support was also obtained from the University of Michigan's George M. O'Brien Translational Research Core Center Grant P30 DK0801943 and MDTRC Cell and Molecular Biology Core Grant P60 DK020572. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Aaltonen P, 2001, LAB INVEST, V81, P1185, DOI 10.1038/labinvest.3780332; Benigni A, 2004, KIDNEY INT, V65, P2193, DOI 10.1111/j.1523-1755.2004.00636.x; Benigni A, 2001, J AM SOC NEPHROL, V12, P941, DOI 10.1681/ASN.V125941; Bonnet F, 2001, DIABETOLOGIA, V44, P874; Chugh S, 2001, KIDNEY INT, V59, P601, DOI 10.1046/j.1523-1755.2001.059002601.x; Ding F, 2017, KIDNEY INT; Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023; Doublier S, 2001, AM J PATHOL, V158, P1723, DOI 10.1016/S0002-9440(10)64128-4; Dumont V, 2017, FASEB J, V31, P3978, DOI 10.1096/fj.201601265R; Furness PN, 1999, NEPHROL DIAL TRANSPL, V14, P1234, DOI 10.1093/ndt/14.5.1234; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Garg P, 2010, J BIOL CHEM, V285, P22676, DOI 10.1074/jbc.M110.122929; Goerge B, 2012, J CLIN INVESTIGATION; Guan N, 2003, PEDIATR NEPHROL, V18, P1122, DOI 10.1007/s00467-003-1240-z; Huh W, 2002, NEPHROL DIAL TRANSPL, V17, P478, DOI 10.1093/ndt/17.3.478; Jia JY, 2008, AM J NEPHROL, V28, P500, DOI 10.1159/000113538; Jim B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036041; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JJ, 2007, J AM SOC NEPHROL, V18, P2303, DOI 10.1681/ASN.2006101145; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; Konigshausen E, 2016, SCI REP-UK, V6, DOI 10.1038/srep39513; Langham RG, 2002, DIABETOLOGIA, V45, P1572, DOI 10.1007/s00125-002-0946-y; Li XZ, 2015, J AM SOC NEPHROL, V26, P2361, DOI 10.1681/ASN.2014040405; Luimula P, 2000, KIDNEY INT, V58, P1461, DOI 10.1046/j.1523-1755.2000.00308.x; Majumder S, 2018, J CLIN INVEST, V128, P483, DOI 10.1172/JCI95946; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nishizono R, 2017, J AM SOC NEPHROL; Patrakka J, 2001, J AM SOC NEPHROL, V12, P289, DOI 10.1681/ASN.V122289; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Satoh D, 2014, J BIOCHEM, V156, P115, DOI 10.1093/jb/mvu022; Soda K, 2013, CURR OPIN NEPHROL HY, V22, P432, DOI 10.1097/MNH.0b013e3283624820; Srivastava T, 2001, PEDIATR NEPHROL, V16, P1022, DOI 10.1007/s004670100018; Teng B, 2016, DIABETES, V65, P3667, DOI 10.2337/db16-0081; Topham PS, 1999, J CLIN INVEST, V104, P1549, DOI 10.1172/JCI7707; Toyoda M, 2004, NEPHROL DIAL TRANSPL, V19, P380, DOI 10.1093/ndt/gfg545; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2016, MOL CELL BIOL, V36, P596, DOI 10.1128/MCB.00956-15; Wang JR, 2010, GENESIS, V48, P446, DOI 10.1002/dvg.20635; Wang SX, 2002, KIDNEY INT, V61, P141, DOI 10.1046/j.1523-1755.2002.00114.x; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Yanagita M, 2002, J CLIN INVEST, V110, P239, DOI 10.1172/JCI200214861; Yuan HP, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134946; Yuan HP, 2002, AM J PHYSIOL-RENAL, V282, pF585, DOI 10.1152/ajprenal.00290.2001	46	29	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0198013	10.1371/journal.pone.0198013	http://dx.doi.org/10.1371/journal.pone.0198013			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924795	gold, Green Submitted, Green Published			2022-12-26	WOS:000435655600010
J	Groszyk, J; Yanushevska, Y; Zielezinski, A; Nadolska-Orczyk, A; Karlowski, WM; Orczyk, W				Groszyk, Jolanta; Yanushevska, Yuliya; Zielezinski, Andrzej; Nadolska-Orczyk, Anna; Karlowski, Wojciech M.; Orczyk, Waclaw			Annotation and profiling of barley GLYCOGEN SYNTHASE3/Shaggy-like genes indicated shift in organ-preferential expression	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE; ARABIDOPSIS-THALIANA; GSK3/SHAGGY-LIKE KINASE; GSK3-LIKE KINASES; MULTIGENE FAMILY; CELL EXPANSION; PLANTS; RICE; BRASSINOSTEROIDS; INHIBITION	GLYCOGEN SYNTHASE KINASE3/Shaggy-like kinases (GSKs) represent a highly conserved group of proteins found in all eukaryotes. In plants they are encoded by multigene families and integrate signaling of brassinosteroids, auxin and abscisic acid in wide range of physiological and developmental processes with a strong impact on plant responses to environmental and biotic factors. Based on comprehensively studied structures of 10 Arabidopsis thaliana GSKgenes and encoded proteins we report identification and phylogenetic reconstruction of 7 transcriptionally active GSKgenes in barley. We re-evaluated annotation of the GSKgenes in the current barley genome (Hv_IBSC_PGSB_v2) and provided data that a single gene annotated in the previous barley genome ensemble should be retained in the current one. The novel structure of another GSK, predicted in Hv_IBSC_PGSB_v2 to encode both GSK and amine oxidase domains, was proposed and experimentally confirmed based on the syntenic region in Brachypodium distachyon. The genes were assigned to 4 groups based on their encoded amino acid sequences and protein kinase domains. The analysis confirmed high level of conservation of functional protein domains and motifs among plant GSKs and the identified barley orthologs. Each of the seven identified HvGSK genes was expressed indicating semi-constitutive regulation in all tested organs and developmental stages. Regulation patterns of GSKs from the indicated groups showed a shift in organ-preferential expression in A. thaliana and barley illustrating diversification of biological roles of individual HvGSKs in different plant species.	[Groszyk, Jolanta; Yanushevska, Yuliya; Orczyk, Waclaw] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Genet Engn, Radzikow, Blonie, Poland; [Zielezinski, Andrzej; Karlowski, Wojciech M.] Adam Mickiewicz Univ, Inst Mol Biol & Biotechnol, Dept Computat Biol, Fac Biol, Poznan, Poland; [Nadolska-Orczyk, Anna] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Funct Genom, Radzikow, Blonie, Poland	Institute of Plant Breeding & Acclimatization; Adam Mickiewicz University; Institute of Plant Breeding & Acclimatization	Orczyk, W (corresponding author), Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Genet Engn, Radzikow, Blonie, Poland.	w.orczyk@ihar.edu.pl	Zielezinski, Andrzej/I-1342-2018	Zielezinski, Andrzej/0000-0002-8096-3776; Kloc, Yuliya/0000-0001-6837-2255; Nadolska-Orczyk, Anna/0000-0001-6127-3860; Groszyk, Jolanta/0000-0002-2517-8142; Karlowski, Wojciech/0000-0002-8086-5404	National Science Center (NCN) [UMO-2014/13/B/NZ9/02381]	National Science Center (NCN)	The research was financed by National Science Center (NCN) grant No: UMO-2014/13/B/NZ9/02381 (WO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Charrier B, 2002, PLANT PHYSIOL, V130, P577, DOI 10.1104/pp.009175; Che RH, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.195, 10.1038/nplants.2015.195]; Cho H, 2014, NAT CELL BIOL, V16, P66, DOI 10.1038/ncb2893; Choe S, 2002, PLANT PHYSIOL, V130, P1506, DOI 10.1104/pp.010496; Claisse G, 2007, PLANT MOL BIOL, V64, P113, DOI 10.1007/s11103-007-9138-y; Dal Santo S, 2012, PLANT CELL, V24, P3380, DOI 10.1105/tpc.112.101279; De Rybel B, 2009, CHEM BIOL, V16, P594, DOI 10.1016/j.chembiol.2009.04.008; Dornelas MC, 1998, GENE, V212, P249, DOI 10.1016/S0378-1119(98)00147-4; Dornelas MC, 1999, PLANT MOL BIOL, V39, P137, DOI 10.1023/A:1006102812280; Dornelas MC, 2000, PLANT J, V21, P419, DOI 10.1046/j.1365-313x.2000.00691.x; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gudesblat GE, 2012, NAT CELL BIOL, V14, P548, DOI 10.1038/ncb2471; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Jiang YH, 2012, PLANT J, V70, P398, DOI 10.1111/j.1365-313X.2011.04877.x; Jonak C, 2002, TRENDS PLANT SCI, V7, P457, DOI 10.1016/S1360-1385(02)02331-2; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kempa S, 2007, PLANT J, V49, P1076, DOI 10.1111/j.1365-313X.2006.03025.x; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Kim TW, 2012, NATURE, V482, P419, DOI 10.1038/nature10794; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Koh S, 2007, PLANT MOL BIOL, V65, P453, DOI 10.1007/s11103-007-9213-4; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li JM, 2002, SCIENCE, V295, P1299; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; Locascio A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00412; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Perez-Perez JM, 2002, DEV BIOL, V242, P161, DOI 10.1006/dbio.2001.0543; Piao HL, 1999, PLANT PHYSIOL, V119, P1527, DOI 10.1104/pp.119.4.1527; Qi XS, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-143; Rapacz M, 2012, ACTA PHYSIOL PLANT, V34, P1723, DOI 10.1007/s11738-012-0967-1; Rozhon W, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-172; Rozhon W, 2010, PLANT J, V62, P215, DOI 10.1111/j.1365-313X.2010.04145.x; Saidi Y, 2012, TRENDS PLANT SCI, V17, P39, DOI 10.1016/j.tplants.2011.10.002; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Stampfl H, 2016, PLANT PHYSIOL, V171, P1366, DOI 10.1104/pp.15.01741; Tavares R, 2002, PLANT MOL BIOL, V50, P261, DOI 10.1023/A:1016009831678; Tichtinsky G, 1998, BBA-GENE STRUCT EXPR, V1442, P261, DOI 10.1016/S0167-4781(98)00187-0; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Yan ZY, 2009, PLANT PHYSIOL, V150, P710, DOI 10.1104/pp.109.138099; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Yoo MJ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-3; Youn JH, 2013, MOL CELLS, V36, P564, DOI 10.1007/s10059-013-0266-8; Zielezinski A, 2017, BIOINFORMATICS, V33, P1224, DOI 10.1093/bioinformatics/btw825; Zielezinski A, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0533-2	47	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199364	10.1371/journal.pone.0199364	http://dx.doi.org/10.1371/journal.pone.0199364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920545	gold, Green Published, Green Submitted			2022-12-26	WOS:000435541300039
J	Melliger, RL; Braschler, B; Rusterholz, HP; Baur, B				Melliger, Ramona Laila; Braschler, Brigitte; Rusterholz, Hans-Peter; Baur, Bruno			Diverse effects of degree of urbanisation and forest size on species richness and functional diversity of plants, and ground surface-active ants and spiders	PLOS ONE			English	Article							CARABID BEETLE ASSEMBLAGES; HABITAT FRAGMENTATION; URBAN; GRADIENT; BIODIVERSITY; ECOLOGY; AREA; SOIL; CONSERVATION; COMMUNITIES	Urbanisation is increasing worldwide and is regarded a major driver of environmental change altering local species assemblages in urban green areas. Forests are one of the most frequent habitat types in urban landscapes harbouring many native species and providing important ecosystem services. By using a multi-taxa approach covering a range of trophic ranks, we examined the influence of degree of urbanisation and forest size on the species richness and functional diversity of plants, and ground surface-active ants and spiders. We conducted field surveys in twenty-six forests in the urban region of Basel, Switzerland. We found that a species' response to urbanisation varied depending on trophic rank, habitat specificity and the diversity indices used. In plants, species richness decreased with degree of urbanisation, whereas that of both arthropod groups was not affected. However, ants and spiders at higher trophic rank showed greater shifts in species composition with increasing degree of urbanisation, and the percentage of forest specialists in both arthropod groups increased with forest size. Local abiotic site characteristics were also crucial for plant species diversity and species composition, while the structural diversity of both leaf litter and vegetation was important for the diversity of ants and spiders. Our results highlight that even small urban forests can harbour a considerable biodiversity including habitat specialists. Nonetheless, urbanisation directly and indirectly caused major shifts in species composition. Therefore, special consideration needs to be given to vulnerable species, including those with special habitat requirements. Locally adapted management practices could be a step forward to enhance habitat quality in a way to maximize diversity of forest species and thus ensure forest ecosystem functioning; albeit large-scale factors also remain important.	[Melliger, Ramona Laila; Braschler, Brigitte; Rusterholz, Hans-Peter; Baur, Bruno] Univ Basel, Sect Conservat Biol, Dept Environm Sci, Basel, Switzerland	University of Basel	Braschler, B (corresponding author), Univ Basel, Sect Conservat Biol, Dept Environm Sci, Basel, Switzerland.	brigitte.braschler@unibas.ch	Braschler, Brigitte/N-6953-2017	Braschler, Brigitte/0000-0003-0088-3651	Stadtgartnerei Basel (BBaur); Stiftung Emilia Guggenheim-Schnurr (BBraschler); Basler Stiftung fur biologische Forschung (BBraschler)	Stadtgartnerei Basel (BBaur); Stiftung Emilia Guggenheim-Schnurr (BBraschler); Basler Stiftung fur biologische Forschung (BBraschler)	Stadtgartnerei Basel (BBaur), Stiftung Emilia Guggenheim-Schnurr (BBraschler), and Basler Stiftung fur biologische Forschung (BBraschler) provided funding for the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaruikka D, 2002, J INSECT CONSERV, V6, P195, DOI 10.1023/A:1024432830064; Allen S. E., 1974, Chemical analysis of ecological materials.; Anderson M. J., 2005, PERMANOVA FORTRAN CO; Aubin I, 2013, BIODIVERS CONSERV, V22, P2957, DOI 10.1007/s10531-013-0565-6; Bengtsson J, 1998, APPL SOIL ECOL, V9, P137, DOI 10.1016/S0929-1393(98)00067-5; Bolger DT, 2000, ECOL APPL, V10, P1230, DOI 10.1890/1051-0761(2000)010[1230:AIUHFI]2.0.CO;2; Bolund P, 1999, ECOL ECON, V29, P293, DOI 10.1016/S0921-8009(99)00013-0; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Braun-Blanquet J., 1964, PFLANZENSOZIOLOGIE G, DOI 10.1007/978-3-7091-8110-2; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Burnand J., 1999, WALDSTANDORTE BEIDER, V72; Cameron GN, 2015, URBAN ECOSYST, V18, P1051, DOI 10.1007/s11252-015-0472-6; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Concepcion ED, 2015, OIKOS, V124, P1571, DOI 10.1111/oik.02166; Croci S, 2008, LANDSCAPE ECOL, V23, P1171, DOI 10.1007/s10980-008-9257-0; Cvejic R, 2015, D3 1 TYPOLOGY URBAN, V3; Deichsel Ralf, 2006, Urban Ecosystems, V9, P161, DOI 10.1007/s11252-006-8588-3; Delarze R., 2015, LEBENSRAUME SCHWEIZ, V3rd; Didham RK, 1996, TRENDS ECOL EVOL, V11, P255, DOI 10.1016/0169-5347(96)20047-3; Fujita A, 2008, ENTOMOL SCI, V11, P39, DOI 10.1111/j.1479-8298.2007.00243.x; Gaublomme E, 2008, BIOL CONSERV, V141, P2585, DOI 10.1016/j.biocon.2008.07.022; Gibb H, 2002, BIOL CONSERV, V106, P91, DOI 10.1016/S0006-3207(01)00232-4; Gibbs JP, 2001, ECOL APPL, V11, P79, DOI 10.1890/1051-0761(2001)011[0079:HFAACC]2.0.CO;2; Godefroid S, 2003, GLOBAL ECOL BIOGEOGR, V12, P287, DOI 10.1046/j.1466-822X.2003.00035.x; Godefroid S, 2007, LANDSCAPE ECOL, V22, P1227, DOI 10.1007/s10980-007-9102-x; Godinez-Alvarez H, 2009, ECOL INDIC, V9, P1001, DOI 10.1016/j.ecolind.2008.11.011; Grime J. P., 1979, Plant strategies and vegetation processes.; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Gyenizse P., 2014, LANDSC AMP ENV, V8, P78; Hanggi A, 1995, LEBENSRAUME MITTELEU; Hobbs ER, 1988, LANDSCAPE ECOL, V1, P141, DOI 10.1007/BF00162740; Holt RD, 1999, ECOLOGY, V80, P1495, DOI 10.2307/176542; Horak J, 2018, URBAN ECOSYST, V21, P263, DOI 10.1007/s11252-017-0712-z; Horvath R, 2012, ECOL RES, V27, P1069, DOI 10.1007/s11284-012-0988-7; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Ivanov K, 2010, BIODIVERS CONSERV, V19, P3917, DOI 10.1007/s10531-010-9937-3; Klotz S., 2002, SCHRIFTENREIHE VEGET; Kowarik I, 2016, URBAN FOR URBAN GREE, V19, P68, DOI 10.1016/j.ufug.2016.06.023; Kuhn I, 2004, EVOL ECOL RES, V6, P749; Laliberte E., 2014, FD MEASURING FUNCTIO, V1, P1; Lizee MH, 2011, ECOL INDIC, V11, P353, DOI 10.1016/j.ecolind.2010.06.003; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; Magura T, 2004, LANDSCAPE ECOL, V19, P747, DOI 10.1007/s10980-005-1128-4; Magura T, 2010, LANDSCAPE ECOL, V25, P621, DOI 10.1007/s10980-009-9445-6; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Maximo Heros J, 2014, BMC Res Notes, V7, P554, DOI 10.1186/1756-0500-7-554; McDonnell MJ, 2008, LANDSCAPE ECOL, V23, P1143, DOI 10.1007/s10980-008-9253-4; McIntyre NE, 2001, LANDSCAPE URBAN PLAN, V52, P257, DOI 10.1016/S0169-2046(00)00122-5; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Melliger RL, 2017, URBAN FOR URBAN GREE, V28, P88, DOI 10.1016/j.ufug.2017.10.009; Melliger RL, 2017, URBAN ECOSYST, V20, P1095, DOI 10.1007/s11252-017-0662-5; Miyashita T, 1998, BIOL CONSERV, V86, P357, DOI 10.1016/S0006-3207(98)00025-1; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Muller-Schneider P., 1986, VERBREITUNGSBIOLOGIE; Nentwig W., 2020, SPIDERS EUROPE, V12, DOI [10.24436/1, DOI 10.24436/1]; Niemela J, 1999, BIODIVERS CONSERV, V8, P119, DOI 10.1023/A:1008817325994; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pickett STA, 2011, J ENVIRON MANAGE, V92, P331, DOI 10.1016/j.jenvman.2010.08.022; Roberts M.J., 1987, SPIDERS GREAT BRITAI, V2; Roberts MJ, 1985, SPIDERS GREAT BRITAI, V1; Rota E, 2015, URBAN ECOSYST, V18, P715, DOI 10.1007/s11252-014-0425-5; Schuler J, 2015, BAUMBEWOHNENDE AMEIS; SEIFERT B, 2007, AMEISEN MITTEL NORDE; Sitko J, 2014, J HELMINTHOL, V88, P97, DOI 10.1017/S0022149X12000818; Sparks DL, 1996, METHODS SOIL ANAL 3, DOI [10.2136/sssabookser5.3.c32, DOI 10.2136/SSSABOOKSER5.3.C32]; Steffan-Dewenter I, 2003, CONSERV BIOL, V17, P1036, DOI 10.1046/j.1523-1739.2003.01575.x; Sukopp H., 1998, URBAN ECOL, P3, DOI DOI 10.1007/978-3-642-88583-9_1; Vallet J, 2010, BIODIVERS CONSERV, V19, P3375, DOI 10.1007/s10531-010-9901-2; Vergnes A, 2014, BIODIVERS CONSERV, V23, P1859, DOI 10.1007/s10531-014-0689-3; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Ward PS, 2016, ZOOTAXA, V4072, P343, DOI 10.11646/zootaxa.4072.3.4	74	38	39	5	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199245	10.1371/journal.pone.e0199245	http://dx.doi.org/10.1371/journal.pone.e0199245			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920553				2022-12-26	WOS:000435541300029
J	Zhang, ZW; Sun, H; Gao, SB; Jin, SH				Zhang, Zhengwei; Sun, He; Gao, Shangbing; Jin, Shenghua			Self-recovery reversible image watermarking algorithm	PLOS ONE			English	Article							FRAGILE WATERMARKING; TAMPERING DETECTION	The integrity of image content is essential, although most watermarking algorithms can achieve image authentication but not automatically repair damaged areas or restore the original image. In this paper, a self-recovery reversible image watermarking algorithm is proposed to recover the tampered areas effectively. First of all, the original image is divided into homogeneous blocks and non-homogeneous blocks through multi-scale decomposition, and the feature information of each block is calculated as the recovery watermark. Then, the original image is divided into 4x4 non-overlapping blocks classified into smooth blocks and texture blocks according to image textures. Finally, the recovery watermark generated by homogeneous blocks and error-correcting codes is embedded into the corresponding smooth block by mapping; watermark information generated by non-homogeneous blocks and error-correcting codes is embedded into the corresponding non-embedded smooth block and the texture block via mapping. The correlation attack is detected by invariant moments when the watermarked image is attacked. To determine whether a sub-block has been tampered with, its feature is calculated and the recovery watermark is extracted from the corresponding block. If the image has been tampered with, it can be recovered. The experimental results show that the proposed algorithm can effectively recover the tampered areas with high accuracy and high quality. The algorithm is characterized by sound visual quality and excellent image restoration.	[Zhang, Zhengwei; Gao, Shangbing; Jin, Shenghua] Huaiyin Inst Technol, Fac Comp & Software Engn, Huaian, Jiangsu, Peoples R China; [Zhang, Zhengwei; Sun, He] PLA Univ Sci & Technol, Coll Command Informat Syst, Nanjing, Jiangsu, Peoples R China	Huaiyin Institute of Technology; Army Engineering University of PLA	Zhang, ZW (corresponding author), Huaiyin Inst Technol, Fac Comp & Software Engn, Huaian, Jiangsu, Peoples R China.; Zhang, ZW (corresponding author), PLA Univ Sci & Technol, Coll Command Informat Syst, Nanjing, Jiangsu, Peoples R China.	zzw49010650@sina.com			"333" project in Jiangsu province [BRA2016454]; Huaian Natural Science Research Program [HAB201704]	"333" project in Jiangsu province; Huaian Natural Science Research Program	This work is supported by "333" project in Jiangsu province (BRA2016454). At the same time this work is also supported by the Huaian Natural Science Research Program (No. HAB201704).	Benrhouma O, 2015, NONLINEAR DYNAM, V79, P1817, DOI 10.1007/s11071-014-1777-3; Bravo-Solorio S, 2011, SIGNAL PROCESS, V91, P728, DOI 10.1016/j.sigpro.2010.07.019; Chang CC, 2008, PATTERN RECOGN, V41, P654, DOI 10.1016/j.patcog.2007.06.003; Che Shengbing, 2010, Journal of Multimedia, V5, P290, DOI 10.4304/jmm.5.3.290-297; Choi KC, 2015, MULTIMED TOOLS APPL, V74, P1961, DOI 10.1007/s11042-013-1732-1; Dadkhah S, 2014, SIGNAL PROCESS-IMAGE, V29, P1197, DOI 10.1016/j.image.2014.09.001; Deng XH, 2013, J NANOSCI NANOTECHNO, V13, P2099, DOI 10.1166/jnn.2013.6872; Dong Rong Pan Yumin Tian Xuan, 2012, J HUAZHONG U SCI TEC, V40, P67; Fridrich J, 1999, IEEE INT C IM PROC K, V3, P792; [高振宇 GAO Zhen-yu], 2010, [中国图象图形学报, Journal of Image and Graphics], V15, P129; Huo YR, 2014, MULTIMED TOOLS APPL, V72, P123, DOI 10.1007/s11042-012-1317-4; Jiang N, 2015, INT J THEOR PHYS, V54, P1021, DOI 10.1007/s10773-014-2294-3; Kim HS, 2003, IEEE T CIRC SYST VID, V13, P766, DOI 10.1109/TCSVT.2003.815955; Kim KS, 2011, COMPUT VIS IMAGE UND, V115, P1308, DOI 10.1016/j.cviu.2011.05.001; Li CL, 2015, MULTIMED TOOLS APPL, V74, P10581, DOI 10.1007/s11042-014-2188-7; Liu Quan, 2007, Journal of China Institute of Communications, V28, P104; Mao Yun, 2012, INT J ANTENN PROPAG, V2012, P1; Muntean M, 2014, IEEE INT CONF AUTO, DOI 10.1109/AQTR.2014.6857838; Pei T, 2012, GEOINFORMATICA, V16, P625, DOI 10.1007/s10707-012-0165-8; Qin C, 2013, SIGNAL PROCESS, V93, P933, DOI 10.1016/j.sigpro.2012.11.013; Qin C, 2012, SIGNAL PROCESS, V92, P1137, DOI 10.1016/j.sigpro.2011.11.013; Sachnev V, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-89; Wang Guodong, 2007, Journal of Southeast University (Natural Science Edition), V37, P211; Wang JT, 2014, 2014 INTERNATIONAL SYMPOSIUM ON COMPUTER, CONSUMER AND CONTROL (IS3C 2014), P1095, DOI 10.1109/IS3C.2014.285; Wu CF, 2000, IEEE T CONSUM ELECTR, V46, P1, DOI 10.1109/30.826373; Zhang Hong-bin, 2004, Acta Electronica Sinica, V32, P196; Zhang XP, 2011, IEEE T IMAGE PROCESS, V20, P485, DOI 10.1109/TIP.2010.2066981; Zhang XP, 2008, IEEE T MULTIMEDIA, V10, P1490, DOI 10.1109/TMM.2008.2007334	28	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199143	10.1371/journal.pone.0199143	http://dx.doi.org/10.1371/journal.pone.0199143			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920528	Green Published, gold, Green Submitted			2022-12-26	WOS:000435541300020
J	Bayer, L; Gumpel, J; Hause, G; Muller, M; Grunwald, T				Bayer, Lea; Guempel, Jessica; Hause, Gerd; Mueller, Martin; Grunwald, Thomas			Non-human papillomaviruses for gene delivery in vitro and in vivo	PLOS ONE			English	Article							DNA VACCINES; IMMUNOGENICITY; IMMUNIZATION; ENHANCEMENT; POTENCY; MUCOSAL; HEPARIN; PROTEIN; MODEL	Papillomavirus capsids are known to have the ability to package DNA plasmids and deliver them both in vitro and in vivo. Of all known papillomavirus types, human papillomaviruses (HPVs) are by far the most intensely studied. Although HPVs work well as gene transfer vectors, their use is limited as most individuals are exposed to this virus either through a HPV vaccination or natural infection. To circumvent these constraints, we produced pseudovirions (PsVs) of ten non-human papillomavirus types and tested their transduction efficiencies in vitro. PsVs based on Macaca fascicularis papillomavirus-11 and Puma concolor papillomavirus-1 were further tested in vivo. Intramuscular transduction by PsVs led to months-long expression of a reporter plasmid, indicating that PsVs have potential as gene delivery vectors.	[Bayer, Lea; Guempel, Jessica; Grunwald, Thomas] Fraunhofer Inst Cell Therapy & Immunol IZI, Dept Immunol, Leipzig, Germany; [Hause, Gerd] Martin Luther Univ Halle Wittenberg, Biozentrum, Halle, Saale, Germany; [Mueller, Martin] German Canc Res Ctr, Heidelberg, Germany	Fraunhofer Gesellschaft; Martin Luther University Halle Wittenberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Grunwald, T (corresponding author), Fraunhofer Inst Cell Therapy & Immunol IZI, Dept Immunol, Leipzig, Germany.	thomas.grunwald@izi.fraunhofer.de	Grunwald, Thomas/J-7728-2015	Bayer, Lea/0000-0002-8516-0745	 [600253]		This work was supported by the Fraunhofer Society with the Internal Programs under grant Discover No. 600253.	Buck C. B., 2006, HUMAN PAPILLOMAVIRUS, P445; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Buck Christopher B, 2007, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2601s37; Caputo A, 2003, VACCINE, V21, P1103, DOI 10.1016/S0264-410X(02)00555-8; Cerqueira C, 2017, MOL THER-METH CLIN D, V5, P165, DOI 10.1016/j.omtm.2017.04.005; Cerqueira C, 2013, CELL MICROBIOL, V15, P1818, DOI 10.1111/cmi.12150; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Dey AK, 2011, EXPERT REV VACCINES, V10, P227, DOI 10.1586/ERV.10.142; Duarte Djane B, 2016, Curr Protoc Pharmacol, V72, DOI 10.1002/0471141755.ph0506s72; Dupuis M, 2000, J IMMUNOL, V165, P2850, DOI 10.4049/jimmunol.165.5.2850; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; Graham BS, 2010, MUCOSAL IMMUNOL, V3, P475, DOI 10.1038/mi.2010.31; Grunwald T, 2015, CLIN EXP VACCINE RES, V4, P1, DOI 10.7774/cevr.2015.4.1.1; Horvath CAJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-11; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; Kasturi SP, 2006, J CONTROL RELEASE, V113, P261, DOI 10.1016/j.jcornel.2006.04.006; Kines RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120797; Kines RC, 2009, P NATL ACAD SCI USA, V106, P20458, DOI 10.1073/pnas.0908502106; Knuschke T, 2013, J IMMUNOL, V190, P6221, DOI 10.4049/jimmunol.1202654; Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x; Locher CP, 2003, IMMUNOL LETT, V90, P67, DOI 10.1016/j.imlet.2003.02.001; Merck, 2015, MERCKS 9 VAL HPV VAC; MULLER M, 1995, J VIROL, V69, P948; Otten G, 2004, VACCINE, V22, P2489, DOI 10.1016/j.vaccine.2003.11.073; Peachman KK, 2003, METHODS, V31, P232, DOI 10.1016/S1046-2023(03)00137-3; Rector A, 2013, VIROLOGY, V445, P213, DOI 10.1016/j.virol.2013.05.007; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; RODEN RBS, 1994, J VIROL, V68, P7260, DOI 10.1128/JVI.68.11.7260-7266.1994; Romani N, 2010, IMMUNOL CELL BIOL, V88, P424, DOI 10.1038/icb.2010.39; Schiller John T, 2010, Gynecol Oncol, V118, pS12, DOI 10.1016/j.ygyno.2010.04.004; Stang A, 2005, J CLIN MICROBIOL, V43, P716, DOI 10.1128/JCM.43.2.716-720.2005; STEINBERG BM, 1989, J VIROL, V63, P957, DOI 10.1128/JVI.63.2.957-960.1989; Ternette N, 2007, VACCINE, V25, P7271, DOI 10.1016/j.vaccine.2007.07.025; VINEGAR R, 1987, FASEB J, V46, P118; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; Zhao QJ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-52	37	2	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198996	10.1371/journal.pone.0198996	http://dx.doi.org/10.1371/journal.pone.0198996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912929	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600066
J	Chen, XL; Li, XG; Zhao, W; Li, TJ; Ouyang, Q				Chen, Xianli; Li, Xiaoguang; Zhao, Wei; Li, Tiejun; Ouyang, Qi			Parameter sensitivity analysis for a stochastic model of mitochondrial apoptosis pathway	PLOS ONE			English	Article							SYSTEMS BIOLOGY; BCL-2; ACTIVATION; MUTATIONS	Understanding how gene alterations induce oncogenesis plays an important role in cancer research and may be instructive for cancer prevention and treatment. We conducted a parameter sensitivity analysis to the mitochondrial apoptosis model. Both a nonlinear bifurcation analysis of the deterministic dynamics and energy barrier analysis of the corresponding stochastic models were performed. We found that the parameter sensitivity ranking according to the change of the bifurcation-point locations in deterministic models and the change of the barrier heights from a living to death state of the cell in stochastic models are highly correlated. For the model we considered, in combination with previous knowledge that the parameters significantly affecting the system's bifurcation point are strongly associated with frequently mutated oncogenic genes, we conclude that the energy barrier height can be used as indicator of oncogenesis as well as bifurcation point. We provide a possible mechanism that may help elucidate the logic of cancer initiation from the view of stochastic dynamics and energy landscape. And we show the equivalence of energy barrier height and bifurcation-point location in determining the parameter sensitivity spectrum for the first time.	[Chen, Xianli; Ouyang, Qi] Peking Univ, State Key Lab Artificial Microstruct & Mesoscop P, Dept Phys, Beijing, Peoples R China; [Li, Xiaoguang] Hunan Normal Univ, Coll Math & Compute Sci, Changsha, Hunan, Peoples R China; [Li, Xiaoguang] Beijing Computat Sci Res Ctr, Beijing, Peoples R China; [Zhao, Wei; Ouyang, Qi] Peking Univ, Ctr Quantitat Biol, Beijing, Peoples R China; [Zhao, Wei; Ouyang, Qi] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Li, Tiejun] Peking Univ, LMAM, Beijing, Peoples R China; [Li, Tiejun] Peking Univ, Sch Math Sci, Beijing, Peoples R China	Peking University; Hunan Normal University; Chinese Academy of Engineering Physics; Beijing Computational Science Research Center (CSRC); Peking University; Peking University; Peking University; Peking University	Ouyang, Q (corresponding author), Peking Univ, State Key Lab Artificial Microstruct & Mesoscop P, Dept Phys, Beijing, Peoples R China.; Ouyang, Q (corresponding author), Peking Univ, Ctr Quantitat Biol, Beijing, Peoples R China.; Ouyang, Q (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.; Li, TJ (corresponding author), Peking Univ, LMAM, Beijing, Peoples R China.; Li, TJ (corresponding author), Peking Univ, Sch Math Sci, Beijing, Peoples R China.	tieli@math.pku.edu.cn; qi@pku.edu.cn			Natural Science Foundation of China [11434001, 91530322]; Ministry of Science and Technology of the Peoples Republic of China;  [2012AA02A702]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the Peoples Republic of China(Ministry of Science and Technology, China); 	This work is partially supported by Natural Science Foundation of China whose URL is http://www.nsfc.gov.cn/. The grant numbers are 11434001 (QO) and 91530322 (TL). This work is also supported by Ministry of Science and Technology of the Peoples Republic of China whose URL is http://www.most.gov.cn. The corresponding grant number is 2012AA02A702 (QO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Bokov P M, 2012, SCI TECHNOLOGY NUCL, V2012, P1; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003451; Chen XL, 2016, J THEOR BIOL, V404, P120, DOI 10.1016/j.jtbi.2016.05.010; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Elkholi R, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-16; Freidlin M. I., 1984, RANDOM PERTURBATIONS; Ge H, 2012, INT J MOD PHYS B, V26, DOI 10.1142/S0217979212300125; Heymann M, 2008, COMMUN PUR APPL MATH, V61, P1052, DOI 10.1002/cpa.20238; Homma T, 1996, RELIAB ENG SYST SAFE, V52, P1, DOI 10.1016/0951-8320(96)00002-6; Huang S, 2009, SEMIN CELL DEV BIOL, V20, P869, DOI 10.1016/j.semcdb.2009.07.003; IKEGAKI N, 1994, CANCER RES, V54, P6; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; KURTZ TG, 1972, J CHEM PHYS, V57, P2976, DOI 10.1063/1.1678692; Li CH, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0774; Lopez J, 2015, BRIT J CANCER, V112, P957, DOI 10.1038/bjc.2015.85; Lv C, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004156; Lv C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088167; Monni O, 1997, BLOOD, V90, P1168, DOI 10.1182/blood.V90.3.1168.1168_1168_1174; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; Pe'er D, 2011, CELL, V144, P864, DOI 10.1016/j.cell.2011.03.001; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Sarosiek KA, 2016, FEBS J, V283, P3523, DOI 10.1111/febs.13714; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Stites EC, 2007, SCIENCE, V318, P463, DOI 10.1126/science.1144642; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; TALKNER P, 1987, J STAT PHYS, V48, P231, DOI 10.1007/BF01010408; Zhao LJ, 2015, P NATL ACAD SCI USA, V112, pE4046, DOI 10.1073/pnas.1502126112; Zhou JX, 2012, J R SOC INTERFACE, V9, P3539, DOI 10.1098/rsif.2012.0434; Zi Z, 2011, IET SYST BIOL, V5, P336, DOI 10.1049/iet-syb.2011.0015	35	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198579	10.1371/journal.pone.0198579	http://dx.doi.org/10.1371/journal.pone.0198579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912904	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600035
J	Kantarek, Z; Masojc, P; Bienias, A; Milczarski, P				Kantarek, Zuzanna; Masojc, Piotr; Bienias, Anna; Milczarski, Pawel			Identification of a novel, dominant dwarfing gene (Ddw4) and its effect on morphological traits of rye	PLOS ONE			English	Article							PLANT HEIGHT; LINKAGE MAPS; BARLEY; QTLS; LOCALIZATION; POPULATION; MARKERS; RICE; ARM	Shortening rye stems to improve lodging resistance is among the major tasks awaiting breeders of this cereal. The most straightforward way to achieve this goal is the implementation of a dominant dwarfing gene into high yielding cultivars. The choice of dominant dwarfing genes in rye is limited to Ddw1 and Ddw3 loci, which are well characterized with respect to map position and tightly linked molecular markers on the long arms of chromosomes 5RL and 1RL, respectively. This paper reports on the identification and preliminary characterization of a novel dominant dwarfing gene, Ddw4, from line S44. This was mapped within the centromeric region of chromosome 3R. The Ddw4 gene is sensitive to exogenous gibberellin. Its introduction into the rye populational cultivar Dankowskie Amber decreased plant height by c. 54% without any negative effects on spike length and number of kernels per spike. Further genetic studies are needed to determine the perspectives for application of the newly detected dwarfing gene into breeding programs for short-stem rye.	[Kantarek, Zuzanna; Masojc, Piotr; Bienias, Anna; Milczarski, Pawel] West Pomeranian Univ Technol, Dept Genet Plant Breeding & Biotechnol, Slowackiego 17, Szczecin, Poland	West Pomeranian University of Technology	Milczarski, P (corresponding author), West Pomeranian Univ Technol, Dept Genet Plant Breeding & Biotechnol, Slowackiego 17, Szczecin, Poland.	pawel.milczarski@zut.edu.pl	Masojć, Piotr/J-4795-2016; Milczarski, Paweł/M-6657-2016	Milczarski, Paweł/0000-0003-2622-8938; Masojc, Piotr/0000-0002-3376-5988; Bienias, Anna/0000-0002-4573-0619	National Centre for Research and Development [PBS1/68/5/2012]; West Pomeranian University of Technology, Szczecin [518-07-017-3171-01/18]	National Centre for Research and Development(National Centre for Research & Development, Poland); West Pomeranian University of Technology, Szczecin	This work was financially supported by the National Centre for Research and Development, Project No. PBS1/68/5/2012, http:/www.ncbr.gov.pl/programy-krajowe/program-badan-stosowanych/, Pawet Milczarski. This work was financially supported in part by the West Pomeranian University of Technology, Szczecin, project 518-07-017-3171-01/18, Piotr Masojc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARUA UM, 1993, GENOME, V36, P1080, DOI 10.1139/g93-143; Bienias A., 2017, THESIS; Borner A, 1996, EUPHYTICA, V89, P69, DOI 10.1007/BF00015721; Cao G, 2001, THEOR APPL GENET, V103, P153, DOI 10.1007/s001220100536; Cui F, 2011, THEOR APPL GENET, V122, P1517, DOI 10.1007/s00122-011-1551-6; DEVRIES JN, 1984, Z PFLANZENZUCHT, V92, P117; Jia QJ, 2009, FUNCT INTEGR GENOMIC, V9, P255, DOI 10.1007/s10142-009-0120-4; Kicherer S, 2000, THEOR APPL GENET, V100, P881, DOI 10.1007/s001220051365; Korzun V, 1996, THEOR APPL GENET, V92, P1073, DOI 10.1007/BF00224051; Korzun V, 1998, THEOR APPL GENET, V96, P1104, DOI 10.1007/s001220050845; LAURIE DA, 1993, PLANT BREEDING, V111, P198, DOI 10.1111/j.1439-0523.1993.tb00630.x; Li HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120558; Li HH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1424-5; Masojc P, 2009, EUPHYTICA, V170, P123, DOI 10.1007/s10681-009-9952-1; Masojc P, 2017, J APPL GENET, V58, P297, DOI 10.1007/s13353-017-0396-3; Masojc P, 2011, J APPL GENET, V52, P153, DOI 10.1007/s13353-010-0025-x; Masojc P, 2009, MOL BREEDING, V23, P75, DOI 10.1007/s11032-008-9215-1; Melz G., 1989, THESIS; Miedaner T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-706; Mikolajczak K, 2017, J APPL GENET, V58, P23, DOI 10.1007/s13353-016-0358-1; Milczarski P, 2016, J APPL GENET, V57, P439, DOI 10.1007/s13353-016-0347-4; Milczarski P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189912; Milczarski P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028495; Myskow B, 2014, J APPL GENET, V55, P15, DOI 10.1007/s13353-013-0186-5; Myskow B, 2012, MOL BREEDING, V30, P367, DOI 10.1007/s11032-011-9627-1; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Stojalowski S, 2015, EUPHYTICA, V201, P43, DOI 10.1007/s10681-014-1173-6; Tenhola-Roininen T, 2010, EUPHYTICA, V172, P303, DOI 10.1007/s10681-009-9982-8; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; WORLAND AJ, 1986, EUPHYTICA, V35, P857, DOI 10.1007/BF00028593	31	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199335	10.1371/journal.pone.0199335	http://dx.doi.org/10.1371/journal.pone.0199335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912949	Green Published, gold, Green Submitted			2022-12-26	WOS:000435528600105
J	De Smedt, T; Merrall, E; Macina, D; Perez-Vilar, S; Andrews, N; Bollaerts, K				De Smedt, Tom; Merrall, Elizabeth; Macina, Denis; Perez-Vilar, Silvia; Andrews, Nick; Bollaerts, Kaatje			Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectiveness	PLOS ONE			English	Article							MULTIPLE-IMPUTATION; PERTUSSIS; IMMUNIZATION; SENSITIVITY; EFFICACY; SAFETY; TRIAL	Background Studies of vaccine effectiveness (VE) rely on accurate identification of vaccination and cases of vaccine-preventable disease. In practice, diagnostic tests, clinical case definitions and vaccination records often present inaccuracies, leading to biased VE estimates. Previous studies investigated the impact of non-differential disease misclassification on VE estimation. Methods We explored, through simulation, the impact of non-differential and differential disease- and exposure misclassification when estimating VE using cohort, case-control, test-negative case-control and case-cohort designs. The impact of misclassification on the estimated VE is demonstrated for VE studies on childhood seasonal influenza and pertussis vaccination. We additionally developed a web-application graphically presenting bias for user-selected parameters. Results Depending on the scenario, the misclassification parameters had differing impacts. Decreased exposure specificity had greatest impact for influenza VE estimation when vaccination coverage was low. Decreased exposure sensitivity had greatest impact for pertussis VE estimation for which high vaccination coverage is typically achieved. The impact of the exposure misclassification parameters was found to be more noticeable than that of the disease misclassification parameters. When misclassification is limited, all study designs perform equally. In case of substantial (differential) disease misclassification, the test-negative design performs worse. Conclusions Misclassification can lead to significant bias in VE estimates and its impact strongly depends on the scenario. We developed a web-application for assessing the potential (joint) impact of possibly differential disease- and exposure misclassification that can be modified by users to their own study scenario. Our results and the simulation tool may be used to guide better design, conduct and interpretation of future VE studies.	[De Smedt, Tom; Bollaerts, Kaatje] P95 Epidemiol & Pharmacovigilance, Leuven, Belgium; [Merrall, Elizabeth] GSK Vaccines, Amsterdam, Netherlands; [Macina, Denis] Sanofi Pasteur, Lyon, France; [Perez-Vilar, Silvia] FISABIO Publ Hlth, Valencia, Spain; [Perez-Vilar, Silvia] Erasmus Univ, Med Ctr, Rotterdam, Netherlands; [Andrews, Nick] Publ Hlth England, Stat Modelling & Econ Dept, London, England	GlaxoSmithKline; Erasmus University Rotterdam; Erasmus MC; Public Health England	Bollaerts, K (corresponding author), P95 Epidemiol & Pharmacovigilance, Leuven, Belgium.	Kaatje.Bollaerts@p-95.com	Perez-Vilar, Silvia/H-4372-2016	Perez-Vilar, Silvia/0000-0003-1272-1502	Innovative Medicines Initiative (IMI) Joint Undertaking through the ADVANCE project [115557]; IMI	Innovative Medicines Initiative (IMI) Joint Undertaking through the ADVANCE project; IMI	This research was funded by the Innovative Medicines Initiative (IMI) Joint Undertaking through the ADVANCE project [No 115557]. The IMI is a joint initiative (public-private partnership) of the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) to improve the competitive situation of the European Union in the field of pharmaceutical research. The IMI provided support in the form of salaries for TDS and KB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work by EM and DM was covered by EFPIA's in-kind contribution to IMI projects. SPV and NA did not receive any financial compensation for their contribution to this research. The specific roles of these authors are articulated in the 'author contributions' section.	Allaire JJ, 2016, SHINY WEB APPL FRAME; Cole SR, 2006, INT J EPIDEMIOL, V35, P1074, DOI 10.1093/ije/dyl097; COPELAND KT, 1977, AM J EPIDEMIOL, V105, P488, DOI 10.1093/oxfordjournals.aje.a112408; Edwards JK, 2013, AM J EPIDEMIOL, V177, P904, DOI 10.1093/aje/kws340; FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742; FLEGAL KM, 1986, AM J EPIDEMIOL, V123, P736, DOI 10.1093/oxfordjournals.aje.a114294; Foppa IM, 2013, VACCINE, V31, P3104, DOI 10.1016/j.vaccine.2013.04.026; Fox MP, 2005, INT J EPIDEMIOL, V34, P1370, DOI 10.1093/ije/dyi184; Funk Michele Jonsson, 2014, Curr Epidemiol Rep, V1, P175; Gibbons CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-147; Goldstein ND, 2016, AM J EPIDEMIOL, V183, P1063, DOI 10.1093/aje/kwv273; Gustafson P., 2003, MEASUREMENT ERROR MI, DOI DOI 10.1201/9780203502761; Gustafsson L, 1996, NEW ENGL J MED, V334, P349, DOI 10.1056/NEJM199602083340602; HALLORAN ME, 1991, AM J EPIDEMIOL, V133, P323, DOI 10.1093/oxfordjournals.aje.a115884; Hanquet G, 2013, VACCINE, V31, P5634, DOI 10.1016/j.vaccine.2013.07.006; Jackson ML, 2015, VACCINE, V33, P1313, DOI 10.1016/j.vaccine.2015.01.069; Jurek AM, 2008, INT J EPIDEMIOL, V37, P382, DOI 10.1093/ije/dym291; Kuchenhoff' H, 2006, BIOMETRICS, V62, P85, DOI 10.1111/j.1541-0420.2005.00396.x; Lash TL, 2009, APPL QUANTITATIVE BI; Lyles RH, 2011, EPIDEMIOLOGY, V22, P589, DOI 10.1097/EDE.0b013e3182117c85; MacLehose RF, 2009, EPIDEMIOLOGY, V20, P27, DOI 10.1097/EDE.0b013e31818ab3b0; McNeil MM, 2014, VACCINE, V32, P5390, DOI 10.1016/j.vaccine.2014.07.073; Mereckiene J, 2014, EUROSURVEILLANCE, V19, P29, DOI 10.2807/1560-7917.ES2014.19.16.20780; Messer K, 2008, STAT MED, V27, P6332, DOI 10.1002/sim.3458; Nguyen M, 2012, PHARMACOEPIDEM DR S, V21, P291, DOI 10.1002/pds.2323; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Ozasa K, 2008, VACCINE, V26, P6462, DOI 10.1016/j.vaccine.2008.06.039; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Skowronski DM, 2013, EURO SURVEILL, V18; Stehr K, 1998, PEDIATRICS, V101, P1, DOI 10.1542/peds.101.1.1; WHO/UNICEF, 2016, EST NAT IMM COV; Zhang LJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001478.pub6	33	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2018	13	6							e0199180	10.1371/journal.pone.0199180	http://dx.doi.org/10.1371/journal.pone.0199180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5RI	29906276	Green Published, gold			2022-12-26	WOS:000435439400013
J	del Monte, A; Arroyo, AB; Andres-Manzano, MJ; Garcia-Barbera, N; Caleprico, MS; Vicente, V; Roldan, V; Gonzalez-Conejero, R; Martinez, C; Andres, V				del Monte, Alberto; Arroyo, Ana B.; Andres-Manzano, Maria J.; Garcia-Barbera, Nuria; Caleprico, Maria S.; Vicente, Vicente; Roldan, Vanessa; Gonzalez-Conejero, Rocio; Martinez, Constantino; Andres, Vicente			miR-146a deficiency in hematopoietic cells is not involved in the development of atherosclerosis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MICRORNAS; MICE; MACROPHAGES; INFLAMMATION; INHIBITION; ACTIVATION; EXPRESSION; PROTECTS; BIOLOGY	Background Atherosclerosis involves activation of the IRAK1/TRAF6/NF-kappa B inflammatory cascade, which is negatively regulated by miR146a. Previous studies showed that the TT genotype of rs2431697, located near the miR-146a gene, drives lower miR-146a transcription and predicts adverse cardiovascular events in anticoagulated atrial fibrillation patients. Moreover, systemic miR-146a administration protects mice from atherosclerosis. Here we evaluated the ability of miR-146a expression in the hematopoietic component to regulate atherosclerosis in low-density lipoprotein receptor-null mice (LdIr(-/-)). Methods and results Lethally-irradiated LdIr(-/-)mice transplanted with bone marrow from wild-type or miR-146a-null mice were fed an atherogenic diet for 8 and 20 weeks. Irak1, Traf6 and MIR146A expression were quantified in thoracic aorta by qRT-PCR and Western blot. Aortic plaque size and composition were characterized by Oil-Red staining and immunohistochemistry and leukocyte recruitment by intravital microscopy. Blood cell counts were similar in fat-fed Ldir(-/-)mice with or without hematopoietic miR-146a expression. However, plasma cholesterol decreased in fat-fed Ldir(-/-)mice transplanted with bone marrow deficient for miR-146a. Finally, aortic atherosclerosis burden and recruitment of leukocytes into the vessel wall were undistinguishable between the two groups, despite higher levels of Irak1 and Traf6 mRNA and protein in the aorta of fat-fed mice lacking hematopoietic miR-146a expression. Conclusions miR-146a deficiency exclusively in hematopoietic cells modulates cholesterol levels in plasma and the expression of its targets in the artery wall of fat-fed LdIr(-/-)mice, but does not 16 accelerate atherosclerosis. Atheroprotection upon systemic miR-146a administration may therefore be caused by specific effects on vascular cells.	[del Monte, Alberto; Andres-Manzano, Maria J.; Caleprico, Maria S.; Andres, Vicente] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain; [del Monte, Alberto; Andres-Manzano, Maria J.; Andres, Vicente] CIBER Enfermedades Cardiovasc CIBER CV, Murcia, Spain; [Arroyo, Ana B.; Garcia-Barbera, Nuria; Vicente, Vicente; Roldan, Vanessa; Gonzalez-Conejero, Rocio; Martinez, Constantino] Univ Murcia, IMIB Arrixaca, Ctr Reg Hemodonac, Serv Hematol & Oncol Med,Hosp Univ Morales Mesegu, Murcia, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia	Andres, V (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain.; Andres, V (corresponding author), CIBER Enfermedades Cardiovasc CIBER CV, Murcia, Spain.; Gonzalez-Conejero, R; Martinez, C (corresponding author), Univ Murcia, IMIB Arrixaca, Ctr Reg Hemodonac, Serv Hematol & Oncol Med,Hosp Univ Morales Mesegu, Murcia, Spain.	rocio.gonzalez@carm.es; constant@um.es; vandres@cnic.es	Andres, Vicente/I-6440-2014; Vicente, Vicente/L-6185-2019; Rodríguez, Ana Belén Arroyo/AAF-4759-2021; Martinez, Constantino/R-8972-2019; Roldan, Vanessa/I-5858-2019; Del Monte Monge, Alberto/AAB-6859-2021; Gonzalez-Conejero, Rocio/H-9254-2017	Andres, Vicente/0000-0002-0125-7209; Vicente, Vicente/0000-0002-4278-3264; Rodríguez, Ana Belén Arroyo/0000-0002-0150-2331; Roldan, Vanessa/0000-0002-4945-6602; Del Monte Monge, Alberto/0000-0002-6382-9639; Martinez, Constantino/0000-0002-2976-2354; Gonzalez-Conejero, Rocio/0000-0002-4772-9822	Institute de Salud Carlos III [PI14/00253, RD12/0042/0050, RD12/0042/0028, CIBERCV CB16/11/00405]; Fondo Europeo de Desarrollo Regional (FEDER) [PI14/00253, RD12/0042/0050, RD12/0042/0028, CIBERCV CB16/11/00405]; Fundacion Seneca [19873/GERM/15]; Spanish Ministerio de Economia, lndustria y Competitividad (MEIC) [BES-2014-06779]; Sociedad Espanola de Trombosis y Hemostasia (SETH); Ministerio de Economia, Industria y Competitividad (MEIC); Pro-CNIC Foundation; Severo Ochoa Center of Excellence [SEV-2015-0505]	Institute de Salud Carlos III(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Fundacion Seneca(Fundacion Seneca); Spanish Ministerio de Economia, lndustria y Competitividad (MEIC); Sociedad Espanola de Trombosis y Hemostasia (SETH); Ministerio de Economia, Industria y Competitividad (MEIC); Pro-CNIC Foundation; Severo Ochoa Center of Excellence(Spanish Government)	This study was supported by research grants from the Institute de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER) [PI14/00253, Red RIC (RD12/0042/0050 and RD12/0042/0028), CIBERCV CB16/11/00405] and 19873/GERM/15 (Fundacion Seneca). A.D.M. has a predoctoral contract from the Spanish Ministerio de Economia, lndustria y Competitividad (MEIC) (BES-2014-06779) and A.B.A. has a research fellowship from Sociedad Espanola de Trombosis y Hemostasia (SETH). The CNIC is supported by the Ministerio de Economia, Industria y Competitividad (MEIC) and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou L, 2015, TRENDS MOL MED, V21, P307, DOI 10.1016/j.molmed.2015.02.003; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Cheng HS, 2017, CIRC RES, V121, P354, DOI 10.1161/CIRCRESAHA.116.310529; Cheng HS, 2013, EMBO MOL MED, V5, P1017, DOI 10.1002/emmm.201202318; Diez-Juan A, 2001, FASEB J, V15, P1989, DOI 10.1096/fj.01-0130com; Feinberg MW, 2016, CIRC RES, V118, P703, DOI 10.1161/CIRCRESAHA.115.306300; Fuster JJ, 2011, ARTERIOSCL THROM VAS, V31, P2455, DOI 10.1161/ATVBAHA.111.235580; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.212; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Li K, 2015, CIRC RES, V117, pe1, DOI 10.1161/CIRCRESAHA.117.305844; Lin N, 2017, EXP THER MED, V14, P5087, DOI 10.3892/etm.2017.5121; Lofgren SE, 2012, GENES IMMUN, V13, P268, DOI 10.1038/gene.2011.84; Lu H, 2015, ARTERIOSCL THROM VAS, V35, P485, DOI 10.1161/ATVBAHA.115.305380; Ma ST, 2016, SCI REP-UK, V6, DOI 10.1038/srep22910; McManus DD, 2015, NAT REV CARDIOL, V12, P711, DOI 10.1038/nrcardio.2015.101; Murphy AJ, 2016, EUR HEART J, V37, P1113, DOI 10.1093/eurheartj/ehv718; Pello OM, 2011, IMMUNOBIOLOGY, V216, P1172, DOI 10.1016/j.imbio.2011.05.010; Perez-Sanchez C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31375; Polykratis A, 2012, CIRCULATION, V126, P1739, DOI 10.1161/CIRCULATIONAHA.112.100339; Rius C, 2015, METHODS MOL BIOL, V1339, P357, DOI 10.1007/978-1-4939-2929-0_26; Roldan V, 2014, THROMB HAEMOSTASIS, V112, P781, DOI 10.1160/TH14-01-0092; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; Soehnlein O, 2015, THROMB HAEMOSTASIS, V114, P866, DOI 10.1160/TH15-08-0623; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tiyerili V, 2016, INT J CARDIOL, V204, P29, DOI 10.1016/j.ijcard.2015.11.128; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064; Xiang YZ, 2015, BLOOD, V125, P3377, DOI 10.1182/blood-2015-01-620278	32	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198932	10.1371/journal.pone.0198932	http://dx.doi.org/10.1371/journal.pone.0198932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902229	Green Submitted, Green Published, gold			2022-12-26	WOS:000435424900064
J	Kong, FW; Pham, T; Martin, C; Elefteriades, J; McKay, R; Primiano, C; Sun, W				Kong, Fanwei; Thuy Pham; Martin, Caitlin; Elefteriades, John; McKay, Raymond; Primiano, Charles; Sun, Wei			Finite element analysis of annuloplasty and papillary muscle relocation on a patient-specific mitral regurgitation model	PLOS ONE			English	Article							VALVE REPAIR; RING	Objectives Functional mitral regurgitation (FMR) is a significant complication of left ventricle (LV) dysfunction associated with poor prognosis and commonly treated by undersized ring annuloplasty. This study aimed to quantitatively simulate the treatment outcomes and mitral valve (MV) biomechanics following ring annulopalsty and papillary muscle relocation (PMR) procedures for a FMR patient. Methods We utilized a validated finite element model of the left heart for a patient with severe FMR and LV dilation from our previous study and simulated virtual ring annuloplasty procedures with various sizes of Edwards Classic and GeoForm annuloplasty rings. The model included detailed geometries of the left ventricle, mitral valve, and chordae tendineae, and incorporated age- and gender- matched nonlinear, anisotropic hyperelastic tissue material properties, and simulated chordal tethering at diastole due to LV dilation. Results Ring annuloplasty with either the Classic or GeoForm ring improved leaflet coaptation and increased the total leaflet closing force while increased posterior mitral leaflet (PML) stresses and strains. Classic rings resulted in larger coaptation forces and areas compared to GeoForm rings. The PMR procedure further improved the leaflet coaptation, decreased the PML stress and strain for both ring shapes and all sizes in this patient model. Conclusions This study demonstrated that a rigorously developed patient-specific computational model can provide useful insights into annuloplasty repair techniques for the treatment of FMR patients and could potentially serve as a tool to assist in pre-operative planning for MV repair surgical or interventional procedures.	[Kong, Fanwei; Thuy Pham; Martin, Caitlin; Sun, Wei] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Kong, Fanwei; Thuy Pham; Martin, Caitlin; Sun, Wei] Emory Univ, Atlanta, GA 30322 USA; [Elefteriades, John] Yale Univ, Aort Inst Yale New Haven Hosp, New Haven, CT USA; [McKay, Raymond; Primiano, Charles] Hartford Hosp, Dept Cardiol, Hartford, CT 06115 USA	University System of Georgia; Georgia Institute of Technology; Emory University; Yale University; Hartford Hospital	Sun, W (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.; Sun, W (corresponding author), Emory Univ, Atlanta, GA 30322 USA.	wei.sun@bme.gatech.edu			NIH [HL104080, HL127570]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL127570, R01HL104080] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the NIH HL104080 and HL127570 grants. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the NIH HL104080 and HL127570 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Acker MA, 2014, NEW ENGL J MED, V370, P23, DOI 10.1056/NEJMoa1312808; Al-Amri HS, 2011, J SAUDI HEART ASSOC, V23, P125, DOI 10.1016/j.jsha.2011.04.001; Borghetti V, 2000, EUR J CARDIO-THORAC, V17, P431, DOI 10.1016/S1010-7940(00)00344-4; Choi A, 2016, INT J NUMERICAL METH; Choi A, 2014, BIO-MED MATER ENG, V24, P341, DOI 10.3233/BME-130816; De Bonis M, 2011, EUR J CARDIO-THORAC, V40, P488, DOI 10.1016/j.ejcts.2010.11.048; Fattouch K, 2014, J THORAC CARDIOV SUR, V148, P1947, DOI 10.1016/j.jtcvs.2014.02.047; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Goldstein D, 2016, NEW ENGL J MED, V374, P344, DOI 10.1056/NEJMoa1512913; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Kuwahara E, 2006, CIRCULATION, V114, pI529, DOI 10.1161/CIRCULATIONAHA.105.000729; Maisano F, 2005, ANN THORAC SURG, V79, P1268, DOI 10.1016/j.athoracsur.2004.04.014; Matsunaga A, 2004, J HEART VALVE DIS, V13, P390; McGee EC, 2004, J THORAC CARDIOV SUR, V128, P916, DOI 10.1016/j.jtcvs.2004.07.037; Pantoja JL, 2014, ANN THORAC SURG, V98, P1355, DOI 10.1016/j.athoracsur.2014.04.077; Peeler BB, OPERATIVE TECHNIQUES, V10, P113; Sharma A, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0813-6; Stevanella M., 2011, CARDIOVASCUL ENG TEC, V2, P66, DOI 10.1007/s13239-010-0032-4; Pham T, 2017, CARDIOVASC ENG TECHN, V8, P3, DOI 10.1007/s13239-016-0291-9; Timek TA, 2014, J THORAC CARDIOV SUR, V148, P1951, DOI 10.1016/j.jtcvs.2014.02.051; Votta E, 2008, PHILOS T R SOC A, V366, P3411, DOI 10.1098/rsta.2008.0095; Votta E, 2007, ANN THORAC SURG, V84, P92, DOI 10.1016/j.athoracsur.2007.03.040; Wang Q, 2013, ANN BIOMED ENG, V41, P142, DOI 10.1007/s10439-012-0620-6; Wenk JF, 2010, ANN THORAC SURG, V89, P1546, DOI 10.1016/j.athoracsur.2010.02.036; Wu AH, 2005, J AM COLL CARDIOL, V45, P381, DOI 10.1016/j.jacc.2004.09.073	25	14	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198331	10.1371/journal.pone.0198331	http://dx.doi.org/10.1371/journal.pone.0198331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902273	Green Published, Green Submitted, gold			2022-12-26	WOS:000435424900020
J	Hamann, I; Krys, D; Glubrecht, D; Bouvet, V; Marshall, A; Vos, L; Mackey, JR; Wuest, M; Wuest, F				Hamann, Ingrit; Krys, Daniel; Glubrecht, Darryl; Bouvet, Vincent; Marshall, Alison; Vos, Larissa; Mackey, John R.; Wuest, Melinda; Wuest, Frank			Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancereffects of hypoxia	FASEB JOURNAL			English	Article						glucose metabolism; fructose metabolism; positron emission tomography	POSITRON-EMISSION-TOMOGRAPHY; BIOLOGICAL MARKER EXPRESSION; GLUCOSE TRANSPORTERS; F-18-FLUORODEOXYGLUCOSE UPTAKE; FLUORODEOXYGLUCOSE UPTAKE; INDUCIBLE FACTOR-1-ALPHA; F-18-FDG UPTAKE; CYTOCHALASIN-B; CANCER; FRUCTOSE	Elevated growth in breast cancer (BC) activates hypoxia-inducible factor (HIF1) and downstream, facilitative glucose transporter 1 (GLUT1), which can be visualized with 2-deoxy-2-[F-18]fluoro-d-glucose ([F-18]FDG). GLUT5 (fructose) and GLUT2 (glucose/fructose) might provide alternative targets for BC imaging as to why effects of hypoxia on GLUT1/2/5 levels and function were examined in human BC models. GLUT1/2/5 and HIF1 mRNA was analyzed in BC patient biopsies. In MCF10A, MCF7, and MDA-MB231 cells, [F-18]FDG, 6-deoxy-6-[F-18]fluoro-d-fructose (6-[F-18]FDF) and [F-18]-fluoroazomycin arabinoside were used in radiotracer experiments, whereas GLUT1/2/5 mRNA was analyzed with real-time PCR and protein levels determined via Western blot/immunohistochemistry. Positron emission tomography imaging was performed in MCF7 and MDA-MB231 tumor-bearing mice. Glucose/fructose/cytochalasin B reduced cellular 6-[F-18]FDF uptake by 50%, indicating functional involvement of GLUT2. With GLUT5 staining lower than GLUT1, 6-[F-18]FDF revealed lower uptake than [F-18]FDG [standardized uptake value (SUV)(6-[)(18)(F]FDF, 120 min) 0.77 +/- 0.06 vs. SUV[F]FDG, 120 min18 1.08 +/- 0.07] in MDA-MB231 tumors and was blocked by 20% with cytochalasin B after 10 min. Whereas correspondence between 6-[F-18]FDF uptake and GLUT5 protein was low, high GLUT2 levels were detected in all cell lines and tumor models. Besides GLUT1, GLUT5 seems to be regulated under hypoxia on the molecular and functional level. Additionally, results strongly support a functional involvement of GLUT2 in fructose metabolism, possibly by compensating for the weaker expression and function of GLUT5 in BC.Hamann, I., Krys, D., Glubrecht, D., Bouvet, V., Marshall, A., Vos, L., Mackey, J. R., Wuest, M., Wuest, F. Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancereffects of hypoxia.	[Hamann, Ingrit; Krys, Daniel; Glubrecht, Darryl; Bouvet, Vincent; Marshall, Alison; Vos, Larissa; Mackey, John R.; Wuest, Melinda; Wuest, Frank] Univ Alberta, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada	University of Alberta	Wuest, F (corresponding author), Univ Alberta, Dept Oncol, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	wuest@ualberta.ca			Alberta Cancer Foundation (ACF); Canadian Breast Cancer Foundation (CBCF); Dianne and Irving Kipnes Foundation; ACF	Alberta Cancer Foundation (ACF); Canadian Breast Cancer Foundation (CBCF); Dianne and Irving Kipnes Foundation; ACF(United States Department of Health & Human Services)	The authors thank Dr. John Wilson, David Clendening, and Blake Lazurko (Edmonton PET Center) for [<SUP>18</SUP>F] production on a biomedical cyclotron. The authors thank Angela Westover, Jeff McPherson, and Kristan Nagy-Colombo [Edmonton Radiopharmaceutical Center (ERC), Edmonton, AB, Canada] for production and availability of clinical PET radiotracer [<SUP>18</SUP>F]FDG. The authors greatly acknowledge Ali Akbari (Edmonton PET Center) for preparation of [<SUP>18</SUP>F]FAZA. The authors thank Dan McGinn (Vivarium of the Cross Cancer Institute, Edmonton, AB, Canada) for supporting the animal work and Hans-Soenke Jans (University of Alberta) for technical support of the preclinical imaging facility. The authors thank Dr. Frederick West (Department of Chemistry, University of Alberta) for providing a labeling precursor for the synthesis of radiotracer 6-[<SUP>18</SUP>F]FDF. I.H. thanks the Alberta Cancer Foundation (ACF) for a postdoctoral fellowship award. The authors also gratefully acknowledge the Dianne and Irving Kipnes Foundation, ACF, and the Canadian Breast Cancer Foundation (CBCF) for supporting this work. The authors declare no conflicts of interest.	Barron CC, 2016, METABOLISM, V65, P124, DOI 10.1016/j.metabol.2015.10.007; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Bourgeois AC, 2013, RADIOL CLIN N AM, V51, P781, DOI 10.1016/j.rcl.2013.06.003; Bouvet V, 2014, AM J NUCL MED MOLEC, V4, P248; Chapman DW, 2014, EJNMMI RES, V4, DOI 10.1186/s13550-014-0027-5; Cheng JY, 2013, J NUCL MED, V54, P333, DOI 10.2967/jnumed.112.111963; COLVILLE CA, 1993, BIOCHEM J, V290, P701, DOI 10.1042/bj2900701; Concha II, 1997, BLOOD, V89, P4190, DOI 10.1182/blood.V89.11.4190; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008; Godoy A, 2006, J CELL PHYSIOL, V207, P614, DOI 10.1002/jcp.20606; Gowrishankar G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026902; HAMACHER K, 1986, J NUCL MED, V27, P235; Jadvar H, 2009, J NUCL MED, V50, P1820, DOI 10.2967/jnumed.108.054098; JONES MN, 1980, FEBS LETT, V115, P1, DOI 10.1016/0014-5793(80)80713-7; JUNG CY, 1977, J BIOL CHEM, V252, P5456; Kaira K, 2014, LUNG CANCER, V83, P197, DOI 10.1016/j.lungcan.2013.11.025; Kaira K, 2013, ANTICANCER RES, V33, P4219; Kapoor K, 2016, P NATL ACAD SCI USA, V113, P4711, DOI 10.1073/pnas.1603735113; Kent C, 2015, CLIN BREAST CANCER, V15, P403, DOI 10.1016/j.clbc.2015.06.008; Krzeslak A, 2012, PATHOL ONCOL RES, V18, P721, DOI 10.1007/s12253-012-9500-5; Lachaal M, 2000, BBA-BIOMEMBRANES, V1466, P379, DOI 10.1016/S0005-2736(00)00205-4; Lin YC, 2017, CLIN OTOLARYNGOL, V42, P608, DOI 10.1111/coa.12783; Lopci E, 2014, AM J NUCL MED MOLEC, V4, P365; Vercher-Conejero JL, 2015, DIAGNOSTICS, V5, P61, DOI 10.3390/diagnostics5010061; Mano Y, 2014, AM J CLIN PATHOL, V142, P391, DOI 10.1309/AJCPG8AFJ5NRKLLM; McManus J, 2015, MOL BIOSYST, V11, P2680, DOI 10.1039/c5mb00310e; Park SI, 2013, ONKOLOGIE, V36, P169, DOI 10.1159/000349944; Pinheiro C, 2011, HISTOL HISTOPATHOL, V26, P1279, DOI 10.14670/HH-26.1279; Reischl G, 2005, APPL RADIAT ISOTOPES, V62, P897, DOI 10.1016/j.apradiso.2004.12.004; Sato-Tadano A, 2013, CANCER SCI, V104, P1380, DOI 10.1111/cas.12238; Semenza GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI 10.1016/j.bbamcr.2015.05.036; Semenza GL, 2012, TRENDS MOL MED, V18, P534, DOI 10.1016/j.molmed.2012.08.001; Smith TAD, 2013, NUCL MED BIOL, V40, P858, DOI 10.1016/j.nucmedbio.2013.05.006; SOULE HD, 1990, CANCER RES, V50, P6075; Tanasova M, 2013, CHEMBIOCHEM, V14, P1263, DOI 10.1002/cbic.201300164; Tian M, 2012, ACAD RADIOL, V19, P420, DOI 10.1016/j.acra.2011.12.006; Trayner BJ, 2009, BIOORGAN MED CHEM, V17, P5488, DOI 10.1016/j.bmc.2009.06.034; van den Beucken T, 2011, RADIOTHER ONCOL, V99, P379, DOI 10.1016/j.radonc.2011.05.058; Vermeulen JF, 2013, CELL ONCOL, V36, P333, DOI 10.1007/s13402-013-0138-4; Wood IS, 2007, BIOCHEM BIOPH RES CO, V361, P468, DOI 10.1016/j.bbrc.2007.07.032; Wuest M, 2018, MOL PHARMACOL, V93, P79, DOI 10.1124/mol.117.110007; Wuest M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0609-9; Wuest M, 2013, J LABELLED COMPD RAD, V56, P244, DOI 10.1002/jlcr.2997; Wuest M, 2011, NUCL MED BIOL, V38, P461, DOI 10.1016/j.nucmedbio.2010.11.004; ZamoraLeon SP, 1996, P NATL ACAD SCI USA, V93, P1847, DOI 10.1073/pnas.93.5.1847	47	42	45	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5104	5118		10.1096/fj.201800360R	http://dx.doi.org/10.1096/fj.201800360R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913554	Bronze			2022-12-26	WOS:000443817700039
J	Brown, CW; Amante, JJ; Mercurio, AM				Brown, Caitlin W.; Amante, John J.; Mercurio, Arthur M.			Cell clustering mediated by the adhesion protein PVRL4 is necessary for alpha 6 beta 4 integrin-promoted ferroptosis resistance in matrix-detached cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; cell death; cell-cell interaction; extracellular matrix; integrin; ferroptosis; glutathione peroxidase 4; lipid peroxidation	EXTRACELLULAR-MATRIX; CANCER-CELLS; SURVIVAL; DEATH	Ferroptosis is an iron-dependent form of programmed cell death characterized by the accumulation of lipid-targeting reactive oxygen species that kill cells by damaging their plasma membrane. The lipid repair enzyme GSH peroxidase 4 (GPX4) protects against this oxidative damage and enables cells to resist ferroptosis. Recent work has revealed that matrix-detached carcinoma cells can be susceptible to ferroptosis and that they can evade this fate through the signaling properties of the alpha 6 beta 4 integrin, which sustains GPX4 expression. Although these findings on ferroptosis are provocative, they differ from those in previous studies indicating that matrix-detached cells are prone to apoptosis via a process referred to as anoikis. In an effort to reconcile these discrepant findings, here we observed that matrix-detached epithelial and carcinoma cells cluster spontaneously via a mechanism that involves the cell adhesion protein PVRL4 (also known as Nectin-4). We found that this clustering process allows these cells to survive by stimulating a PVRL4/alpha 6 beta 4/Src signaling axis that sustains GPX4 expression and buffers against lipid peroxidation. In the absence of alpha 6 beta 4, PVRL4-mediated clustering induced an increase in lipid peroxidation that was sufficient for triggering ferroptosis. When the clustering was inhibited, single cells did not exhibit a significant increase in lipid peroxidation in the absence of alpha 6 beta 4, and they were more susceptible to apoptosis than to ferroptosis. These results indicate that ferroptosis induction depends on cell clustering in matrix-detached cells that lack alpha 6 beta 4 and imply that the fate of matrix-detached cells can be determined by the state of their cell-cell interactions.	[Brown, Caitlin W.; Amante, John J.; Mercurio, Arthur M.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Mercurio, AM (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA.	arthur.mercurio@umassmed.edu		Amante, John/0000-0002-8777-6551	Department of Defense [W81XWH-17-1-0009]; American Cancer Society [130451-PF-17-105-01-CSM]	Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society)	This work was supported by Department of Defense Grant W81XWH-17-1-0009. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by American Cancer Society Grant 130451-PF-17-105-01-CSM.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Brown CW, 2017, J CELL BIOL, V216, P4287, DOI 10.1083/jcb.201701136; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Hawk MA, 2018, NAT CELL BIOL, V20, P272, DOI 10.1038/s41556-018-0034-2; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pavlova NN, 2013, ELIFE, V2, DOI 10.7554/eLife.00358; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rayavarapu RR, 2015, J BIOL CHEM, V290, P8722, DOI 10.1074/jbc.M114.612754; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Viswanathan VS, 2017, NATURE, V547, P453, DOI 10.1038/nature23007; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010	18	28	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12741	12748		10.1074/jbc.RA118.003017	http://dx.doi.org/10.1074/jbc.RA118.003017			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29934307	hybrid, Green Published			2022-12-26	WOS:000442203500008
J	Gross, C; Saponaro, A; Santoro, B; Moroni, A; Thiel, G; Hamacher, K				Gross, Christine; Saponaro, Andrea; Santoro, Bina; Moroni, Anna; Thiel, Gerhard; Hamacher, Kay			Mechanical transduction of cytoplasmic-to-transmembrane-domain movements in a hyperpolarization-activated cyclic nucleotide-gated cation channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						potassium channel; protein conformation; computational biology; cyclic AMP (cAMP); protein dynamic; anisotropic network model; cAMP dependent gating; HCN1 channel; linear response theory	VOLTAGE-SENSING MECHANISM; PACEMAKER CHANNELS; STRUCTURAL BASIS; CAMP MODULATION; MOLECULAR-BASIS; HCN CHANNELS; BINDING; LINKER; PROTEINS; DYNAMICS	Hyperpolarization-activated cyclic nucleotide-gated cation (HCN) channels play a critical role in the control of pacemaking in the heart and repetitive firing in neurons. In HCN channels, the intracellular cyclic nucleotide-binding domain (CNBD) is connected to the transmembrane portion of the channel (TMPC) through a helical domain, the C-linker. Although this domain is critical for mechanical signal transduction, the conformational dynamics in the C-linker that transmit the nucleotide-binding signal to the HCN channel pore are unknown. Here, we use linear response theory to analyze conformational changes in the C-linker of the human HCN1 protein, which couple cAMP binding in the CNBD with gating in the TMPC. By applying a force to the tip of the so-called elbow of the C-linker, the coarse-grained calculations recapitulate the same conformational changes triggered by cAMP binding in experimental studies. Furthermore, in our simulations, a displacement of the C-linker parallel to the membrane plane (i.e. horizontally) induced a rotational movement resulting in a distinct tilting of the transmembrane helices. This movement, in turn, increased the distance between the voltage-sensing S4 domain and the surrounding transmembrane domains and led to a widening of the intracellular channel gate. In conclusion, our computational approach, combined with experimental data, thus provides a more detailed understanding of how cAMP binding is mechanically coupled over long distances to promote voltage-dependent opening of HCN channels.	[Gross, Christine; Hamacher, Kay] Tech Univ Darmstadt, Computat Biol & Simulat Grp, D-64287 Darmstadt, Germany; [Thiel, Gerhard] Tech Univ Darmstadt, Dept Biol, Membrane Biophys, D-64287 Darmstadt, Germany; [Saponaro, Andrea; Moroni, Anna] Univ Milan, Dept Biosci, I-20133 Milan, Italy; [Santoro, Bina] Columbia Univ, Dept Neurosci, New York, NY 10032 USA	Technical University of Darmstadt; Technical University of Darmstadt; University of Milan; Columbia University	Thiel, G (corresponding author), Tech Univ Darmstadt, Dept Biol, Schnittspahnstr 3, D-64287 Darmstadt, Germany.	thiel@bio.tu-darmstadt.de	moroni, anna/H-2097-2014; Saponaro, Andrea/AAD-1005-2019	moroni, anna/0000-0002-1860-406X; Saponaro, Andrea/0000-0001-5035-5174; Hamacher, Kay/0000-0002-6921-8345; Santoro, Bina/0000-0002-4277-1992; Thiel, Gerhard/0000-0002-2335-1351	Ministry of Higher Education, Research and the Arts (HMWK) of the Hessen State in LOEWE Project iNAPO; European Reseach Council (ERC) under the European Union [695078]; National Institutes of Health [R01 NS036658]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036658] Funding Source: NIH RePORTER	Ministry of Higher Education, Research and the Arts (HMWK) of the Hessen State in LOEWE Project iNAPO; European Reseach Council (ERC) under the European Union; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Ministry of Higher Education, Research and the Arts (HMWK) of the Hessen State in LOEWE Project iNAPO, by the European Reseach Council (ERC) under the European Union's Horizon 2020 Research and Innovation Program Grant 695078 noMAGIC ERC 2015AdG, and by National Institutes of Health Grant R01 NS036658 (to B. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Aman TK, 2017, BIOPHYS J, V112, p249A, DOI 10.1016/j.bpj.2016.11.1362; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bell DC, 2004, J GEN PHYSIOL, V123, P5, DOI 10.1085/jgp.200308918; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Biel S, 2016, PFLUG ARCH EUR J PHY, V468, P1663, DOI 10.1007/s00424-016-1870-1; Chen S, 2007, J GEN PHYSIOL, V129, P175, DOI 10.1085/jgp.200609585; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; Das A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003521; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gross C, 2017, J CHEM INF MODEL, V57, P243, DOI 10.1021/acs.jcim.6b00556; Hamacher K, 2006, J CHEM THEORY COMPUT, V2, P873, DOI 10.1021/ct050247s; Hamacher K, 2006, PLOS COMPUT BIOL, V2, P80, DOI 10.1371/journal.pcbi.0020010; Hamacher K, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016703; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Ikeguchi M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.078102; Ishii TM, 2001, J PHYSIOL-LONDON, V537, P93, DOI 10.1111/j.1469-7793.2001.0093k.x; Jager S, 2016, LECT N BIOINFORMAT, V9838, P197, DOI 10.1007/978-3-319-43681-4_16; James ZM, 2018, J GEN PHYSIOL, V150, P225, DOI 10.1085/jgp.201711898; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; Keskin O, 1998, PROTEIN SCI, V7, P2578, DOI 10.1002/pro.5560071211; Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022; Kwan DCH, 2012, J GEN PHYSIOL, V140, P279, DOI 10.1085/jgp.201210838; Lee CH, 2017, CELL, V168, P111, DOI 10.1016/j.cell.2016.12.023; Li MH, 2017, NATURE, V542, P60, DOI 10.1038/nature20819; Lolicato M, 2014, NAT CHEM BIOL, V10, P457, DOI [10.1038/NCHEMBIO.1521, 10.1038/nchembio.1521]; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; Moore EH, 1920, B AM MATH SOC, V26, P394, DOI 10.1090/S0002-9904-1920-03322-7; Penrose R., 1955, MATH P CAMBRIDGE PHI, V51, P406, DOI [10.1017/S0305004100030401, DOI 10.1017/S0305004100030401]; Postea O, 2011, NAT REV DRUG DISCOV, V10, P903, DOI 10.1038/nrd3576; Prole DL, 2006, J GEN PHYSIOL, V128, P273, DOI 10.1085/jgp.200609590; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Saponaro A, 2014, P NATL ACAD SCI USA, V111, P14577, DOI 10.1073/pnas.1410389111; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Stieber J, 2003, J BIOL CHEM, V278, P33672, DOI 10.1074/jbc.M305318200; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Thon S, 2015, BIOPHYS J, V109, P2268, DOI 10.1016/j.bpj.2015.08.054; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Tsang SY, 2004, J BIOL CHEM, V279, P43752, DOI 10.1074/jbc.M408747200; Tsang SY, 2004, BIOCHEM BIOPH RES CO, V322, P652, DOI 10.1016/j.bbrc.2004.07.167; Vemana S, 2004, J GEN PHYSIOL, V123, P21, DOI 10.1085/jgp.200308916; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Wang J, 2001, J GEN PHYSIOL, V118, P237, DOI 10.1085/jgp.118.3.237; Weissgraeber S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40168; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070; Wu SJ, 2012, J GEN PHYSIOL, V140, P29, DOI 10.1085/jgp.201110749; Wu SJ, 2011, BIOPHYS J, V100, P1226, DOI 10.1016/j.bpj.2011.01.034; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	56	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12908	12918		10.1074/jbc.RA118.002139	http://dx.doi.org/10.1074/jbc.RA118.002139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29936413	Green Published, hybrid			2022-12-26	WOS:000442203500022
J	Lemus, MR; Roussarie, E; Hammad, N; Mougeolle, A; Ransac, S; Issa, R; Mazat, JP; Uribe-Carvajal, S; Rigoulet, M; Devin, A				Lemus, Monica Rosas; Roussarie, Elodie; Hammad, Noureddine; Mougeolle, Alexis; Ransac, Stephane; Issa, Razanne; Mazat, Jean-Pierre; Uribe-Carvajal, Salvador; Rigoulet, Michel; Devin, Anne			The role of glycolysis-derived hexose phosphates in the induction of the Crabtree effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; respiration; respiratory chain; yeast; glycolysis; Crabtree effect; fructose1; 6-bisphosphate; glucose-6-phosphate; oxidative phosphorylation	SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL BIOGENESIS; ENERGY-METABOLISM; RESPIRATION; CELLS; PHOSPHORYLATION; OVEREXPRESSION; CARDIOMYOCYTES; MEMBRANE; KINETICS	Evidence for the Crabtree effect was first reported by H. Crabtree in 1929 and is defined as the glucose-induced decrease of cellular respiratory flux. This effect was observed in tumor cells and was not detected in most non-tumor cells. A number of hypotheses on the mechanism underlying the Crabtree effect have been formulated. However, to this day, no consensual mechanism for this effect has been described. In a previous study on isolated mitochondria, we have proposed that fructose-1,6-bisphosphate (F1,6bP), which inhibits the respiratory chain, induces the Crabtree effect. Using whole cells from the yeast Saccharomyces cerevisiae as a model, we show here not only that F1,6bP plays a key role in the process but that glucose-6-phosphate (G6P), a hexose that has an effect opposite to that of F1,6bP on the regulation of the respiratory flux, does as well. Thus, these findings reveal that the Crabtree effect strongly depends on the ratio between these two glycolysis-derived hexose phosphates. Last, in silico modeling of the Crabtree effect illustrated the requirement of an inhibition of the respiratory flux by a coordinated variation of glucose-6-phosphate and fructose-1,6-bisphosphate to fit the respiratory rate decrease observed upon glucose addition to cells. In summary, we conclude that two glycolysis-derived hexose phosphates, G6P and F1,6bP, play a key role in the induction of the Crabtree effect.	[Lemus, Monica Rosas; Roussarie, Elodie; Hammad, Noureddine; Mougeolle, Alexis; Ransac, Stephane; Issa, Razanne; Mazat, Jean-Pierre; Rigoulet, Michel; Devin, Anne] Univ Bordeaux, IBGC, UMR 5095, F-33077 Bordeaux, France; [Lemus, Monica Rosas; Roussarie, Elodie; Hammad, Noureddine; Mougeolle, Alexis; Ransac, Stephane; Issa, Razanne; Mazat, Jean-Pierre; Rigoulet, Michel; Devin, Anne] CNRS, UMR 5095, Inst Biochim & Genet Cellulaires, 1 Rue Camille St Saens, F-33077 Bordeaux, France; [Uribe-Carvajal, Salvador] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Universidad Nacional Autonoma de Mexico	Devin, A (corresponding author), CNRS, UMR 5095, Inst Biochim & Genet Cellulaires, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	anne.devin@ibgc.cnrs.fr		, Stephane Ransac/0000-0003-2597-4584	CNRS (Conseil National de la Recherche Scientifique); Comite de Dordogne and Gironde de la Ligue Nationale Contre le Cancer; Fondation ARC pour la recherche sur le Cancer; Plan Cancer 2014-2019 [BIO 2014 06]; French Association against Myopathies; European Commission	CNRS (Conseil National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Comite de Dordogne and Gironde de la Ligue Nationale Contre le Cancer; Fondation ARC pour la recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Plan Cancer 2014-2019; French Association against Myopathies; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the CNRS (Conseil National de la Recherche Scientifique), the Comite de Dordogne and Gironde de la Ligue Nationale Contre le Cancer, The Fondation ARC pour la recherche sur le Cancer, the Plan Cancer 2014-2019 number BIO 2014 06, the French Association against Myopathies, and the European Commission (to H.N.). The authors declare that they have no conflicts of interest with the contents of this article. This publication reflects the view only of the authors and the European Commission cannot be held responsible for any use which may be made of the information contained therein.	Aiston S, 1999, J BIOL CHEM, V274, P24559, DOI 10.1074/jbc.274.35.24559; Anmann T, 2006, BBA-BIOENERGETICS, V1757, P1597, DOI 10.1016/j.bbabio.2006.09.008; Averet N, 1998, MOL CELL BIOCHEM, V184, P67, DOI 10.1023/A:1006830810440; Chevtzoff C, 2010, J BIOL CHEM, V285, P1733, DOI 10.1074/jbc.M109.019570; Cornish-Bowden A, 2014, BIOCHIMIE, V107, P161, DOI 10.1016/j.biochi.2014.09.018; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; DEWINDE JH, 1993, PROG NUCLEIC ACID RE, V46, P51, DOI 10.1016/S0079-6603(08)61018-1; Diaz-Ruiz R, 2008, J BIOL CHEM, V283, P26948, DOI 10.1074/jbc.M800408200; Eimre M, 2008, BBA-BIOENERGETICS, V1777, P514, DOI 10.1016/j.bbabio.2008.03.019; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; KOOBS DH, 1972, SCIENCE, V178, P127, DOI 10.1126/science.178.4057.127; Loret MO, 2007, YEAST, V24, P47, DOI 10.1002/yea.1435; Rodriguez-Enriquez S, 2001, EUR J BIOCHEM, V268, P2512, DOI 10.1046/j.1432-1327.2001.02140.x; SAKS V, 1995, BIOCHEM BIOPH RES CO, V208, P919, DOI 10.1006/bbrc.1995.1422; Smallbone K, 2013, FEBS LETT, V587, P2832, DOI 10.1016/j.febslet.2013.06.043; Sumner JB, 1944, SCIENCE, V100, P413, DOI 10.1126/science.100.2601.413; SUSSMAN I, 1980, BIOCHIM BIOPHYS ACTA, V591, P209, DOI 10.1016/0005-2728(80)90153-X; van Maris AJA, 2001, FEMS YEAST RES, V1, P139, DOI 10.1016/S1567-1356(01)00022-8; VEECH RL, 1979, J BIOL CHEM, V254, P6538; WEINHOUSE S, 1972, CANCER RES, V32, P2007; Wojtczak L, 1999, EUR J BIOCHEM, V263, P495, DOI 10.1046/j.1432-1327.1999.00522.x; ZIZI M, 1994, J BIOL CHEM, V269, P1614	23	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12843	12854		10.1074/jbc.RA118.003672	http://dx.doi.org/10.1074/jbc.RA118.003672			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29907566	Green Published, hybrid			2022-12-26	WOS:000442203500017
J	Andra, KK; Dorsey, S; Royer, CA; Menon, AK				Andra, Kiran K.; Dorsey, Savanna; Royer, Catherine A.; Menon, Anant K.			Structural mapping of fluorescently-tagged, functional nhTMEM16 scramblase in a lipid bilayer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence resonance energy transfer (FRET); liposome; ion channel; glycerophospholipid; membrane reconstitution; calcium; ACP tag; dithionite; fluorescence lifetime imaging (FLIM); MCP tag; scramblase	BOUND IMMUNOGLOBULIN-E; LIFETIME IMAGING MICROSCOPY; ACTIVATED CHLORIDE CHANNEL; RESONANCE ENERGY-TRANSFER; E-RECEPTOR COMPLEX; PLASMA-MEMBRANE; PHASOR APPROACH; CRYO-EM; CELLS; SURFACE	Most members of the TransMEMbrane protein 16 (TMEM16) family are Ca2+-regulated scramblases that facilitate the bidirectional movement of phospholipids across membranes necessary for diverse physiological processes. The nhTMEM16 scramblase (from the fungus Nectria hematococca) is a homodimer with a large cytoplasmic region and a hydrophilic, membrane-exposed groove in each monomer. The groove provides the transbilayer conduit for lipids, but the mechanism by which Ca2+ regulates it is not clear. Because fusion of large protein tags at either the N or C terminus abolishes nhTMEM16 activity, we hypothesized that its cytoplasmic portion containing both termini may regulate lipid translocation via a Ca2+-dependent conformational change. To test this hypothesis, here we used fluorescence methods to map key distances within the nhTMEM16 homodimer and between its termini and the membrane. To this end, we developed functional nhTMEM16 variants bearing an acyl carrier protein (ACP) tag at one or both of the termini. These constructs were fluorescently labeled by ACP synthase-mediated insertion of CoA-conjugated fluorophores and reconstituted into vesicles containing fluorescent lipids to obtain the distance of closest approach between the labeled tag and the membrane via FRET. Fluorescence lifetime measurements with phasor analysis were used to determine the distance between the N and C termini of partnering monomers in the nhTMEM16 homodimer. We now report that the measured distances do not vary significantly between Ca2+-replete and EGTA-treated samples, indicating that whereas the cytoplasmic portion of the protein is important for function, it does not appear to regulate scramblase activity via a detectable conformational change.	[Andra, Kiran K.; Menon, Anant K.] Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA; [Dorsey, Savanna; Royer, Catherine A.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA	Cornell University; Rensselaer Polytechnic Institute	Menon, AK (corresponding author), Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA.	akm2003@med.cornell.edu	Menon, Anant/AAN-8663-2021; Royer, Catherine A/E-5266-2016	Menon, Anant/0000-0001-6924-2698; Royer, Catherine A/0000-0002-2670-3391; Andra, Kiran K/0000-0003-2204-0911	National Institutes of Health [R01 GM106717]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM106717 (to A. K. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BAIRD B, 1985, BIOCHEMISTRY-US, V24, P6252, DOI 10.1021/bi00343a032; Bethel NP, 2016, P NATL ACAD SCI USA, V113, P14049, DOI 10.1073/pnas.1607574113; Bevers EM, 2016, PHYSIOL REV, V96, P605, DOI 10.1152/physrev.00020.2015; Brunner JD, 2016, CURR OPIN STRUC BIOL, V39, P61, DOI 10.1016/j.sbi.2016.05.020; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Dang SY, 2017, NATURE, V552, P426, DOI 10.1038/nature25024; Day RN, 2014, METHODS, V66, P200, DOI 10.1016/j.ymeth.2013.06.017; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Dixon JM, 2005, PHOTOCHEM PHOTOBIOL, V81, P212, DOI 10.1562/2004-11-06-TSN-361.1; Goren MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6115; Gyobu S, 2017, P NATL ACAD SCI USA, V114, P6274, DOI 10.1073/pnas.1703391114; HOLOWKA D, 1983, BIOCHEMISTRY-US, V22, P3475, DOI 10.1021/bi00283a026; HOLOWKA D, 1983, BIOCHEMISTRY-US, V22, P3466, DOI 10.1021/bi00283a025; Jiang T, 2017, ELIFE, V6, DOI 10.7554/eLife.28671; Johnsson N, 2005, CHEMBIOCHEM, V6, P47, DOI 10.1002/cbic.200400290; Kobayashi T, 2018, CURR BIOL, V28, pR386, DOI 10.1016/j.cub.2018.01.007; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lee BC, 2016, BIOPHYS J, V111, P1919, DOI 10.1016/j.bpj.2016.09.032; Lee SY, 2009, J MOL BIOL, V387, P1055, DOI 10.1016/j.jmb.2009.02.034; Malvezzi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3367; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Montigny C, 2016, BBA-MOL CELL BIOL L, V1861, P767, DOI 10.1016/j.bbalip.2015.12.020; Pandey K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16842-z; Paulino C, 2017, NATURE, V552, P421, DOI 10.1038/nature24652; Paulino C, 2017, ELIFE, V6, DOI 10.7554/eLife.26232; Ploier B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12832; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Pomorski TG, 2016, PROG LIPID RES, V64, P69, DOI 10.1016/j.plipres.2016.08.003; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Saha J, 2015, SPECTROCHIM ACTA A, V149, P143, DOI 10.1016/j.saa.2015.04.027; SHAKLAI N, 1977, BIOCHEMISTRY-US, V16, P5585, DOI 10.1021/bi00644a031; Stringari C, 2011, P NATL ACAD SCI USA, V108, P13582, DOI 10.1073/pnas.1108161108; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Szmacinski H, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.4.046017; Vogel SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049593; Whitlock JM, 2017, ANNU REV PHYSIOL, V79, P119, DOI 10.1146/annurev-physiol-022516-034031; Wielandt AG, 2015, J BIOL CHEM, V290, P16281, DOI 10.1074/jbc.M114.617746; Ziomkiewicz I, 2013, CYTOM PART A, V83, P794, DOI 10.1002/cyto.a.22311	39	6	6	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12248	12258		10.1074/jbc.RA118.003648	http://dx.doi.org/10.1074/jbc.RA118.003648			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29903908	hybrid, Green Published			2022-12-26	WOS:000440803200022
J	Crux, S; Herms, J; Dorostkar, MM				Crux, Sophie; Herms, Jochen; Dorostkar, Mario M.			Tcf4 regulates dendritic spine density and morphology in the adult brain	PLOS ONE			English	Article							TRANSGENIC MICE; NEUROPSYCHIATRIC DISORDERS; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; IN-VIVO; MEMORY; GENE; HIPPOCAMPUS; GSK3-BETA; VARIANTS	Tcf4 is a transcription factor which regulates neurogenesis and neuronal migration in the brain. In humans, loss of function of Tcf4 leads to the rare neurodevelopmental disorder Pitt-Hopkins syndrome, which is characterized by intellectual disability, developmental delay and autistic behavior. We analyzed the consequences of functional loss of Tcf4 on dendritic spines in mature principal neurons. To this end, we crossed mice in which the DNA-binding domain of the Tcf4 gene is flanked by LoxP sites to mice expressing tamoxifen-inducible cre recombinase in a sparse subset of fluorescently labelled neurons (SlickV line). This resulted in a mouse model with an inducible functional knockout of Tcf4 in a subset of cortical and hippocampal neurons, in which we analyzed dendritic spines, which are the morphological correlate of excitatory postsynapses. Heterozygous as well as homozygous loss of Tcf4 led to a reduction in the number of dendritic spines in the cortex as well as in the hippocampus. This was accompanied by morphological changes of dendritic spines. These results suggest that Tcf4 is involved in synaptic plasticity in mature neurons, and functional loss of Tcf4 may contribute to the neurological symptoms in Pitt-Hopkins syndrome.	[Crux, Sophie; Herms, Jochen] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Crux, Sophie; Herms, Jochen] Ludwig Maximilians Univ Munchen, Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Herms, Jochen; Dorostkar, Mario M.] Ludwig Maximilians Univ Munchen, Ctr Neuropathol, Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich	Dorostkar, MM (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Neuropathol, Munich, Germany.	mario.dorostkar@med.uni-muenchen.de	Dorostkar, Mario/AAF-6399-2020	Dorostkar, Mario/0000-0001-8037-4907	Friedrich-Baur-Stiftung [11/17]	Friedrich-Baur-Stiftung	MMD received a grant from the Friedrich-Baur-Stiftung (Ref. Nr. 11/17; http://www.klinikum.uni-muenchen.de/Friedrich-Baur-Institut/de/institutt/friedrich_baur_stittung/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Bergqvist I, 2000, EUR J IMMUNOL, V30, P2857, DOI 10.1002/1521-4141(200010)30:10<2857::AID-IMMU2857>3.0.CO;2-G; Brzozka MM, 2016, EUR ARCH PSY CLIN N, V266, P505, DOI 10.1007/s00406-015-0643-8; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dewachter I, 2009, NEUROBIOL DIS, V35, P193, DOI 10.1016/j.nbd.2009.04.003; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flora A, 2007, P NATL ACAD SCI USA, V104, P15382, DOI 10.1073/pnas.0707456104; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Gipson CD, 2017, GENES BRAIN BEHAV, V16, P101, DOI 10.1111/gbb.12324; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hayashi Y, 2005, NEURON, V46, P529, DOI 10.1016/j.neuron.2005.05.006; Herms J, 2016, ANNU REV PATHOL-MECH, V11, P221, DOI 10.1146/annurev-pathol-012615-044216; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Kawanishi Y, 1999, J HUM GENET, V44, P428, DOI 10.1007/s100380050196; Kennedy AJ, 2016, CELL REP, V16, P2666, DOI 10.1016/j.celrep.2016.08.004; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Merk DJ, 2018, DEV CELL, V44, P709, DOI 10.1016/j.devcel.2018.02.012; Navarrete K, 2013, AM J MED GENET B, V162B, P1, DOI 10.1002/ajmg.b.32109; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Ochs SM, 2015, MOL PSYCHIATR, V20, P482, DOI 10.1038/mp.2014.55; Ochs SM, 2014, SPINEMINER; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Powell LM, 2008, CURR OPIN GENET DEV, V18, P411, DOI 10.1016/j.gde.2008.07.012; Quednow BB, 2014, CELL MOL LIFE SCI, V71, P2815, DOI 10.1007/s00018-013-1553-4; Saarikettu J, 2004, J BIOL CHEM, V279, P41004, DOI 10.1074/jbc.M408120200; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; SCHEFF SW, 1990, NEUROBIOL AGING, V11, P29, DOI 10.1016/0197-4580(90)90059-9; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Smillie Karen Janet, 2011, Int J Alzheimers Dis, V2011, P263673, DOI 10.4061/2011/263673; Spittaels K, 2002, NEUROSCIENCE, V113, P797, DOI 10.1016/S0306-4522(02)00236-1; Sweatt JD, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.32; Thaxton C, 2018, J NEUROSCI, V38, P918, DOI 10.1523/JNEUROSCI.1305-17.2017; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Yuste R, 2013, ANNU REV NEUROSCI, V36, P429, DOI 10.1146/annurev-neuro-062111-150455	41	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199359	10.1371/journal.pone.0199359	http://dx.doi.org/10.1371/journal.pone.0199359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933371	Green Submitted, Green Published, gold			2022-12-26	WOS:000436076600021
J	Barcelona, PF; Galan, A; Nedev, H; Jian, YF; Sarunic, MV; Saragovi, HU				Barcelona, Pablo F.; Galan, Alba; Nedev, Hinyu; Jian, Yifan; Sarunic, Marinko, V; Saragovi, H. Uri			The route of administration influences the therapeutic index of an anti-proNGF neutralizing mAb for experimental treatment of Diabetic Retinopathy	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; DRUG-DELIVERY; SUBCONJUNCTIVAL INJECTION; NEURODEGENERATIVE PATHOLOGIES; OCULAR DISTRIBUTION; IN-VIVO; INTRAVITREAL; GLAUCOMA; RABBITS; P75(NTR)	Many neurodegenerative retinal diseases are treated with monoclonal antibodies (mAb) delivered by invasive intravitreal injection (IVT). In Diabetic Retinopathy there is a scarcity of effective agents that can be delivered using non-invasive methods, and there are significant challenges in the validation of novel therapeutic targets. ProNGF represents a potential novel target, and IVT administration of a function-blocking anti-proNGF mAb is therapeutic in a mouse model of DR. We therefore compared invasive IVT to less invasive systemic intravenous (IV) and local subconjunctival (SCJ) administration, for therapy of Diabetic Retinopathy. The IV and SCJ routes are safe, afford sustained pharmacokinetics and tissue penetration of anti-proNGF mAb, and result in long-term therapeutic efficacy that blocks retinal inflammation, edema, and neuronal death. SCJ may be a more convenient and less invasive approach for ophthalmic use and may enable reduced frequency of intervention for the treatment of retinal pathologies.	[Barcelona, Pablo F.; Galan, Alba; Nedev, Hinyu; Saragovi, H. Uri] Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ, Canada; [Barcelona, Pablo F.; Galan, Alba; Nedev, Hinyu; Saragovi, H. Uri] McGill Univ, Ctr Translat Res, Montreal, PQ, Canada; [Barcelona, Pablo F.; Saragovi, H. Uri] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Jian, Yifan; Sarunic, Marinko, V] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC, Canada; [Saragovi, H. Uri] McGill Univ, Dept Ophthalmol, Montreal, PQ, Canada; [Saragovi, H. Uri] McGill Univ, Integrated Program Neurosci, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; Simon Fraser University; McGill University; McGill University	Saragovi, HU (corresponding author), Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ, Canada.; Saragovi, HU (corresponding author), McGill Univ, Ctr Translat Res, Montreal, PQ, Canada.; Saragovi, HU (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.; Saragovi, HU (corresponding author), McGill Univ, Dept Ophthalmol, Montreal, PQ, Canada.; Saragovi, HU (corresponding author), McGill Univ, Integrated Program Neurosci, Montreal, PQ, Canada.	uri.saragovi@mcgill.ca	Barcelona, Pablo Federico/AAJ-8440-2020	Sarunic, Marinko/0000-0002-5636-9056; Barcelona, Pablo/0000-0001-8248-2282; Jian, Yifan/0000-0001-7988-7385	Foundation Fighting Blindness of Canada; Canadian Institutes of Health Research	Foundation Fighting Blindness of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Foundation Fighting Blindness of Canada grant to HUS and a Canadian Institutes of Health Research grant to HUS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agard E, 2015, CAN J OPHTHALMOL, V50, P127, DOI 10.1016/j.jcjo.2014.11.004; Ambati J, 2000, INVEST OPHTH VIS SCI, V41, P1181; Ambati J, 2000, INVEST OPHTH VIS SCI, V41, P1186; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Bai YJ, 2010, J BIOL CHEM, V285, P39392, DOI 10.1074/jbc.M110.147801; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P6639, DOI 10.1167/iovs.10-5431; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P4722, DOI 10.1167/iovs.09-5032; Baker CW, 2016, CURR OPIN OPHTHALMOL, V27, P210, DOI 10.1097/ICU.0000000000000262; Barcelona PF, 2016, J NEUROSCI, V36, P8826, DOI 10.1523/JNEUROSCI.4278-15.2016; Barcelona PF, 2015, MOL CELL BIOL, V35, P3396, DOI 10.1128/MCB.00544-15; Binet F, 2013, CELL METAB, V17, P353, DOI 10.1016/j.cmet.2013.02.003; Cerani A, 2013, CELL METAB, V18, P505, DOI 10.1016/j.cmet.2013.09.003; Dejda A, 2014, J CLIN INVEST, V124, P4807, DOI 10.1172/JCI76492; di Lauro R, 2010, GRAEF ARCH CLIN EXP, V248, P785, DOI 10.1007/s00417-010-1303-3; Edelhauser HF, 2010, INVEST OPHTH VIS SCI, V51, P5403, DOI 10.1167/iovs.10-5392; Falavarjani KG, 2013, EYE, V27, P787, DOI 10.1038/eye.2013.107; Galan A, 2017, INVEST OPHTH VIS SCI, V58, P2852, DOI 10.1167/iovs.16-20988; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; Goldblum D, 2002, ANTIMICROB AGENTS CH, V46, P3719, DOI 10.1128/AAC.46.12.3719-3723.2002; Heng LZ, 2013, DIABETIC MED, V30, P640, DOI 10.1111/dme.12089; Hosseini K, 2008, J OCUL PHARMACOL TH, V24, P301, DOI 10.1089/jop.2007.0117; Hughes GA, 2005, NANOMED-NANOTECHNOL, V1, P22, DOI 10.1016/j.nano.2004.11.009; Janoria KG, 2007, EXPERT OPIN DRUG DEL, V4, P371, DOI 10.1517/17425247.4.4.371; Jian YF, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.5.056007; Kessner R, 2014, EUR J OPHTHALMOL, V24, P918, DOI 10.5301/ejo.5000473; Kim SH, 2008, PHARM RES-DORDR, V25, P512, DOI 10.1007/s11095-007-9408-z; Lee TWY, 2001, J OCUL PHARMACOL TH, V17, P565, DOI 10.1089/10807680152729257; Li J, 2011, APPL OPTICS, V50, P1832, DOI 10.1364/AO.50.001832; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Nomoto H, 2009, INVEST OPHTH VIS SCI, V50, P4807, DOI 10.1167/iovs.08-3148; Penha FM, 2011, EXPERT OPIN DRUG MET, V7, P1021, DOI 10.1517/17425255.2011.585970; Platon-Corchado M, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.306; Regnier A, 2008, AM J VET RES, V69, P410, DOI 10.2460/ajvr.69.3.410; Simo R, 2014, DIABETES CARE, V37, P893, DOI 10.2337/dc13-2002; Suzuki Takashi, 2008, Journal of Infection and Chemotherapy, V14, P204, DOI 10.1007/s10156-008-0612-5; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Tyagi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048188; Veves A, 2001, J CLIN INVEST, V107, P1215, DOI 10.1172/JCI13038; Voss K, 2015, J CONTROL RELEASE, V214, P1, DOI 10.1016/j.jconrel.2015.06.035; Wang Jia-Kang, 2015, Eye Sci, V30, P176; Weijtens O, 1999, AM J OPHTHALMOL, V128, P192, DOI 10.1016/S0002-9394(99)00129-4; Wu LW, 2008, RETINA-J RET VIT DIS, V28, P314, DOI 10.1097/IAE.0b013e31814cf03e; Yang Y, 2015, RETINA-J RET VIT DIS, V35, P2440, DOI 10.1097/IAE.0000000000000726	43	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199079	10.1371/journal.pone.0199079	http://dx.doi.org/10.1371/journal.pone.0199079			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927948	Green Published, Green Submitted, gold			2022-12-26	WOS:000435802500041
J	Diniz, IM; Guerra, AA; de Lemos, LLP; Souza, KM; Godman, B; Bennie, M; Wettermark, B; Acurcio, FD; Alvares, J; Andrade, EIG; Cherchiglia, ML; de Araujo, VE				Diniz, Isabela Maia; Guerra Jr, Augusto Afonso; Pires de Lemos, Livia Lovato; Souza, Kathiaja M.; Godman, Brian; Bennie, Marion; Wettermark, Bjorn; Acurcio, Francisco de Assis; Alvares, Juliana; Gurgel Andrade, Eli Iola; Cherchiglia, Mariangela Leal; de Araujo, Vania Eloisa			The long-term costs for treating multiple sclerosis in a 16-year retrospective cohort study in Brazil	PLOS ONE			English	Article							QUALITY-OF-LIFE; DISABILITY	Background Multiple Sclerosis (MS) is a disease that appreciably impacts on the quality of life of patients and is associated with high expenditure. MS is a chronic multifactorial disease, characterized by inflammation, demyelination and axonal loss. The Brazilian public health system provides pharmacological treatment as well as hospital and outpatient care for patients with relapsing-remitting and secondary progressive multiple sclerosis. However, we are not aware of any previous publications assessing total direct medical costs in patients with a long follow-up within the Brazilian healthcare system. Consequently, the objective is to analyze public spending on patients with MS to guide stakeholders in future investment and disinvestment decisions. Methods and findings We retrospectively analyzed public Brazilian spending on patients with MS between 2000 and 2015 using the patient-centered registry of all patients in the public health system (SUS) obtained through deterministic-probabilistic record linkage of the Outpatient Information System, Hospital Information System and Mortality Information Systems in Brazil. Descriptive data analysis and a multiple linear regression model was performed to evaluate the associations between the mean annual cost per patient and the clinical and demographic variables. The suitability of the model was verified from a residue analysis and the level of significance adopted was 5%. Results 28,401 patients were identified and subsequently 23,082 patients were analyzed. The majority of the patients were female (73.3%), lived in the southeast region (58.9%), had a mean age of 36.8 (+/- 12.2) years and started treatment using one of the interferons beta (78.9%). The total direct medical cost spending in the sixteen years of the follow-up was US $ 2,308,393,465.60, and the mean annual expenditure per patient was US $ 13,544.40 (+/- 4,607.05). In the best fit model (p <0.001), approximately 40% of the variability of the mean annual cost per patient was explained by the region of residence; medication used (intention to treat); if the patient was a non-exclusive user of medicines, i.e., used SUS for other procedures other than high-cost medicines; year of treatment start; and presence of events (death; Relapse; change of treatment and/or comorbidity). Conclusions In the public health system of Brazil, disease modifying therapies currently represent almost all of the total direct costs of multiple sclerosis treatment. Around the world, new and emerging health technologies to treat of MS impose a challenge to health budgets, highlighting the need for cost-effectiveness studies comparing these technologies to those already available. Our regression model may help in this process, and calls attention to the need to access the real world performance of new therapies available in SUS, with the potential for disinvestment and/or price reductions if needed.	[Diniz, Isabela Maia; Guerra Jr, Augusto Afonso; Pires de Lemos, Livia Lovato; Acurcio, Francisco de Assis; Alvares, Juliana; de Araujo, Vania Eloisa] Univ Fed Minas Gerais, Fac Farm, SUS Collaborating Ctr Technol Assessment & Excell, Belo Horizonte, MG, Brazil; [Diniz, Isabela Maia; Guerra Jr, Augusto Afonso; Acurcio, Francisco de Assis; Alvares, Juliana; Gurgel Andrade, Eli Iola; Cherchiglia, Mariangela Leal] Univ Fed Minas Gerais, Fac Farm, Programa Posgrad Medicamentos & Assistencia Farma, Belo Horizonte, MG, Brazil; [Pires de Lemos, Livia Lovato; Acurcio, Francisco de Assis; Gurgel Andrade, Eli Iola; Cherchiglia, Mariangela Leal] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Saude Publ, Belo Horizonte, MG, Brazil; [Souza, Kathiaja M.] Minist Saude, Secretaria Ciencia Tecnol & Insumos Estrateg, Dept Gestao & Incorp Tecnol Saude, Esplanade Minist Bloco G, Brasilia, DF, Brazil; [Souza, Kathiaja M.] Univ Fed Sao Paulo, Programa Posgrad Saude Baseada Evidencias, Sao Paulo, SP, Brazil; [Godman, Brian; Bennie, Marion] Strathclyde Univ, Strathclyde Inst Pharm & Biomed Sci, Pharmacoepidemiol, Glasgow, Lanark, Scotland; [Godman, Brian; Wettermark, Bjorn] Karolinska Inst, Div Clin Pharmacol, Stockholm, Sweden; [Wettermark, Bjorn] Karolinska Inst, Karolinska Univ Hosp, Div Clin Pharmacol, Stockholm, Sweden	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Sao Paulo (UNIFESP); University of Strathclyde; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Diniz, IM (corresponding author), Univ Fed Minas Gerais, Fac Farm, SUS Collaborating Ctr Technol Assessment & Excell, Belo Horizonte, MG, Brazil.; Diniz, IM (corresponding author), Univ Fed Minas Gerais, Fac Farm, Programa Posgrad Medicamentos & Assistencia Farma, Belo Horizonte, MG, Brazil.	beladiz@gmail.com	Cherchiglia, Mariangela/Z-3216-2019; Alvares-Teodoro, Juliana/AAY-8801-2020; araujo, Vania/ABD-2986-2020; Godman, Brian/R-8897-2019; Alvares-Teodoro, Juliana/O-3943-2018; Andrade, Eli Iola Gurgel/AAP-9854-2021; Acurcio, Francisco A/G-2583-2012; Guerra, Augusto Afonso/AAS-6584-2020	Cherchiglia, Mariangela/0000-0001-5622-567X; Alvares-Teodoro, Juliana/0000-0002-0210-0721; Alvares-Teodoro, Juliana/0000-0002-0210-0721; Acurcio, Francisco A/0000-0002-5880-5261; Guerra, Augusto Afonso/0000-0001-5256-0577; Lemos, Livia/0000-0002-8921-515X				Agencia Nacional de Saude Suplementar Ministerio da Saude Republica Federative do Brasil, 2016, CAD INF SAUD SUPL BE, P65; Aitken M., 2016, MED USE SPENDING US; Benedict RHB, 2005, J NEUROL SCI, V231, P29, DOI 10.1016/j.jns.2004.12.009; Browne P, 2014, NEUROLOGY, V83, P1022, DOI 10.1212/WNL.0000000000000768; Cherchiglia Mariângela Leal, 2007, Rev. bras. estud. popul., V24, P163, DOI 10.1590/S0102-30982007000100010; Curkendall SM, 2011, CLIN THER, V33, P914, DOI 10.1016/j.clinthera.2011.05.049; da Silva NL, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1352-3; Ernstsson O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159129; Garattini L, 2015, PHARMACOECONOMICS, V33, P1241, DOI 10.1007/s40273-015-0322-7; Godman B., 2014, J PHARM CARE HLTH SY, V1, P1, DOI DOI 10.4172/JPCHS.1000113; Guerra AA, 2017, INT J TECHNOL ASSESS, V33, P279, DOI 10.1017/S0266462317000423; Hauser S, 2012, HARRISONS PRINCIPLES; Hawton AJ, 2016, EUR J HEALTH ECON, V17, P875, DOI 10.1007/s10198-015-0728-3; Jick SS, 2014, J NEUROL, V261, P1508, DOI 10.1007/s00415-014-7370-3; Kobelt G, 2006, NEUROLOGY, V66, P1696, DOI 10.1212/01.wnl.0000218309.01322.5c; Kobelt G, 2017, MULT SCLER J, V23, P1123, DOI 10.1177/1352458517694432; Kolasa K, 2013, PRZEGL EPIDEMIOL, V67, P157; Kolasa Katarzyna, 2013, Przegl Epidemiol, V67, P75; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Moccia M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169489; Pereira ABCND, 2015, MULT SCLER RELAT DIS, V4, P572, DOI 10.1016/j.msard.2015.08.004; Oliveira Lilian Ribeiro de, 2016, BAR, Braz. Adm. Rev., V13, pe140120, DOI 10.1590/1807-7692bar2016140120; Palmer AJ, 2013, MULT SCLER J, V19, P1640, DOI 10.1177/1352458513488230; Patti F, 2011, NEUROL SCI, V32, P787, DOI 10.1007/s10072-011-0499-2; Pereira R, 2017, INT J POPULATION DAT, V1, P1, DOI [10.23889/ijpds.v1i1.225, DOI 10.23889/IJPDS.V1I1.225]; de Lemos LLP, 2018, PHARMACOECONOMICS, V36, P161, DOI 10.1007/s40273-017-0579-0; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Prescott JD, 2007, J MANAGE CARE PHARM, V13, P44, DOI 10.18553/jmcp.2007.13.1.44; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rudick RA, 2008, CNS DRUGS, V22, P827, DOI 10.2165/00023210-200822100-00004; World Bank, INT COMP PROGR DAT; Ysrraelit MC, 2018, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00729	33	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199446	10.1371/journal.pone.0199446	http://dx.doi.org/10.1371/journal.pone.0199446			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928006	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000435802500094
J	Nakai, H; Itatani, T; Horiike, R; Kyota, K; Tsukasaki, K				Nakai, Hisao; Itatani, Tomoya; Horiike, Ryo; Kyota, Kaoru; Tsukasaki, Keiko			Tsunami evacuation simulation using geographic information systems for homecare recipients depending on electric devices	PLOS ONE			English	Article							GIS; DISASTER	Tsunamis cause direct damage to property and destroy infrastructure. In addition, power outages can lead to death, especially for patients who rely on medical equipment requiring a power supply. Recently, Nankai Trough Earthquakes have been predicted, and much effort has been put into developing countermeasures in Japan. Kochi City on Shikoku Island is expected to suffer in the event of a large tsunami. The present study identifies individuals living in Kochi who need evacuation assistance and depend on electrical medical devices, simulates evacuation behavior and inundation during a tsunami using a geographic information system (GIS), and considers the usefulness of such a GIS. We asked caregivers, including visiting nurses, to introduce us to homecare recipients who rely on a ventilator, an endotracheal suction device, or other medical devices requiring electric power. We received introductions to 52 homecare recipients. Using a GIS, we plotted the area of predicted inundation and the locations of homecare recipients, nursing stations, and welfare evacuation shelters. We predicted evacuation routes, and then analyzed the time difference between the time required for evacuation and tsunami arrival at a welfare evacuation shelter. To measure the effects of the main parameters, we conducted both one-way and multi way sensitivity analysis. In the event of a tsunami, eight of the homecare recipients living in the forecasted inundation areas in Kochi may face delayed evacuation. Among homecare recipients facing a high possibility of escape delay, 95.2% lived more than 1,800 m from the nearest welfare evacuation shelter. We found that individual evacuation behavior can be simulated by specifying the residence of a homecare recipient and the evacuation route using a GIS.	[Nakai, Hisao] Kanazawa Med Univ, Nursing Dept, Kanazawa, Ishikawa, Japan; [Itatani, Tomoya; Kyota, Kaoru; Tsukasaki, Keiko] Kanazawa Univ, Doctoral Course, Div Hlth Sci, Grad Sch Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Horiike, Ryo] Hlth Policy Dept, Med Policy Sect, Kochi, Kochi, Japan	Kanazawa Medical University; Kanazawa University	Itatani, T (corresponding author), Kanazawa Univ, Doctoral Course, Div Hlth Sci, Grad Sch Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan.	itatani@staff.kanazawa-u.ac.jp			 [10708986]		This study was funded by a Grant-in-Aid for Challenging Exploratory Research (project no.: 10708986, 2015-2017) to HN.	[Anonymous], 2011, 24JIKAN HOUM BIS AR; [Anonymous], 2015, 2015 ZENK GAIR KOUTS; Central Disaster Management Bureau Cabinet Office Governmnet Japan, DAM EST NANK TROUGH; Centre for Research on the Epidemiology of Disasters CRED, 1996, POV DEATH DIS MORT; CRED, 2016, TSUN DIS RISK 2016; Curtis AB, 2013, PUBLIC HEALTH REP, V128, P212, DOI 10.1177/003335491312800311; Fleten S., 2016, P 2016 13 INT C EUR, P1; Furumura T, 2011, J GEOPHYS RES, V116, P1; Holt James B, 2008, Prev Chronic Dis, V5, pA97; Ishida Tomoyuki, 2014, J INTERNET SERVICES, V4, P40; Jacqueline WC, 2012, DISASTER MED, V6, P163; Japan Fire and Disaster Management Agency, 2017, 2011 HIG NI TSUIT 20; Kafi KM, 2016, ASIAN J APPL SCI, V4, P63; Kato T, 2011, EARTH PLANETS SPACE, V63, pE5, DOI 10.5047/eps.2011.05.001; Kawai J, 2015, PROCEDIA COMPUT SCI, V72, P329, DOI 10.1016/j.procs.2015.12.147; Kawai M, 2012, IRYO, V66, P475; Kim S, 2016, EARTH PLANETS SPACE, V68, DOI 10.1186/s40623-016-0438-9; Loke AY, 2012, GERIATR GERONTOL INT, V12, P524, DOI 10.1111/j.1447-0594.2011.00778.x; Mace SE, 2017, SOUTH MED J, V110, P509, DOI 10.14423/SMJ.0000000000000679; Malik S, 2017, DISASTER MED PUBLIC, P1; Mikami A., 2012, HIST EARTHQUAKE, V27, P27; Mikami T, 2012, P JSCE EARTHQ ENG S, P1; Ministry of Health Labor and Welfare, TEID NI KAK ZAIT EN; Ministry of Health Labor and Welfare Health Insurance Bureau, 2012, HEISEI24NENDO SHINR; Ministry of Land Infrastructure Transport and Tourism, NAT LAND NUM INF DOW; Ministry of Land Infrastructure Transport and Tourism, TSUN WO SOUT HIN HIN; Morita T, 2017, J EPIDEMIOL COMMUN H, V71, P974, DOI 10.1136/jech-2016-208652; Nakai H, 2016, J JAPAN SOC DISASTER, V17, P30; Prefecture Kochi, TSUNAMI SHINSUI YOSO; Prefecture Kochi, SHINDO BUNPUZU SAIDA; Ronan KR, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0589-6; Shepard CW, 2011, PUBLIC HEALTH REP, V126, P741; Sullivan HT, 2011, GEOTECH GEOL ENG, V29, P225, DOI 10.1007/s10706-010-9363-z; Suppasri A, 2013, PURE APPL GEOPHYS, V170, P993, DOI 10.1007/s00024-012-0511-7; Vatenmacher M, 2017, ENVIRON MANAGE, V59, P762, DOI 10.1007/s00267-017-0828-1; Waring S, 2005, INT J HYG ENVIR HEAL, V208, P109, DOI 10.1016/j.ijheh.2005.01.020; Wood N, 2014, INT J DISAST RISK RE, V9, P68, DOI 10.1016/j.ijdrr.2014.04.009	37	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199252	10.1371/journal.pone.0199252	http://dx.doi.org/10.1371/journal.pone.0199252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK0LV	29927985	gold, Green Submitted, Green Published			2022-12-26	WOS:000435802500063
J	Nacarino-Meneses, C; Kohler, M				Nacarino-Meneses, Carmen; Kohler, Meike			Limb bone histology records birth in mammals	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; ASIATIC WILD ASS; GROWTH-RATES; POSTNATAL-GROWTH; AGE; SKELETOCHRONOLOGY; POPULATION; PATTERNS; EXTANT; FOSSIL	The annual cyclicality of cortical bone growth marks (BGMs) allows reconstruction of some important life history traits, such as longevity, growth rate or age at maturity. Little attention has been paid, however, to non-cyclical BGMs, though some record key life history events such as hatching (egg-laying vertebrates), metamorphosis (amphibians), or weaning (suggested for Microcebus and the hedgehog). Here, we investigate the relationship between non-cyclical BGMs and a stressful biological event in mammals: the moment of birth. In the present study, we histologically examine ontogenetic series of femora, tibiae and metapodia in several extant representatives of the genus Equus (E. hemionus, E. quagga and E. grevyi). Our analysis reveals the presence of a non-cyclical growth mark that is deposited around the moment of birth, analogous to the neonatal line described for teeth. We therefore refer to it as neonatal line. The presence of this feature within the bone cross-section agrees with a period of growth arrest in newborn foals regulated by the endocrine system. The neonatal line is accompanied by modifications in bone tissue type and vascularization, and has been identified in all bones studied and at different ontogenetic ages. Our discovery of a non-cyclical BGM related to the moment of birth in mammals is an important step towards the histological reconstruction of life histories in extant and fossil equids.	[Nacarino-Meneses, Carmen; Kohler, Meike] Inst Catala Paleontol Miguel Crusafont ICP, Dept Evolutionary Paleobiol, Campus Univ Autonoma Barcelona, Barcelona, Spain; [Kohler, Meike] ICREA, Barcelona, Spain	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); ICREA	Nacarino-Meneses, C (corresponding author), Inst Catala Paleontol Miguel Crusafont ICP, Dept Evolutionary Paleobiol, Campus Univ Autonoma Barcelona, Barcelona, Spain.	carmen.nacarino@icp.cat	Nacarino-Meneses, Carmen/ABI-6198-2020	Nacarino-Meneses, Carmen/0000-0003-2123-8758; Kohler, Meike/0000-0002-6816-6651	Spanish Ministry of Economy and Competitiveness [CGL-2015-63777, BES-2013-066335]; Government of Catalonia [2014-SGR-1207]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Government of Catalonia(Generalitat de Catalunya)	This work has received the support from the Spanish Ministry of Economy and Competitiveness (CGL-2015-63777, PI: M.K.) and the Government of Catalonia (2014-SGR-1207, PI: M.K.; CERCA Programme, M.K.). C.N.-M. is supported with a FPI grant from the Spanish Ministry of Economy and Competitiveness (BES-2013-066335). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amprino R., 1947, ARCH BIOL SCI, V58, P315; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; [Anonymous], 1999, WALKERS MAMMALS WORL; Bruce RC, 2006, J HERPETOL, V40, P85, DOI 10.1670/42-05N.1; Buchanan CR, 1992, HORMONAL CONTROL BON, V6, P53; Calder WA., 1984, SIZE FUNCTION LIFE H; Carlson S.J., 1990, SKELETAL BIOMINERALI, P235; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; CASTANET J, 1991, Amphibia-Reptilia, V12, P81, DOI 10.1163/156853891X00356; Castanet J, 2006, CR PALEVOL, V5, P629, DOI 10.1016/j.crpv.2005.10.006; Castanet J, 2004, J ZOOL, V263, P31, DOI 10.1017/S0952836904004844; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Castanet J., 1993, BONE, P245; Chinsamy A, 2008, S AFR J SCI, V104, P311; Chinsamy A, 2006, ACTA PALAEONTOL POL, V51, P325; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Churcher C.S., 1993, Mammalian Species, V453, P1; Cubo J, 2012, PALEOBIOLOGY, V38, P335, DOI 10.1666/08093.1; Currey JD, 2002, STRUCTURE MECH BONES, DOI [10.1016/B978-0-12-801238-3.037600, DOI 10.1016/B978-0-12-801238-3.037600]; Curtin AJ, 2012, J VERTEBR PALEONTOL, V32, P939, DOI 10.1080/02724634.2012.672388; Damuth J., 1990, BODY SIZE MAMMALIAN; de Margerie E, 2004, J EXP BIOL, V207, P869, DOI 10.1242/jeb.00841; de Margerie E, 2002, J ANAT, V201, P521, DOI 10.1046/j.1469-7580.2002.00118.x; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; Dytham C., 2011, CHOOSING USING STAT; Ento K, 2002, ZOOL SCI, V19, P241, DOI 10.2108/zsj.19.241; Ernest SKM, 2003, ECOLOGY, V84, P3402, DOI 10.1890/02-9002; Esteban A, 2002, AMPHIBIA-REPTILIA, V23, P249; Esteban M, 1999, ANN ZOOL FENN, V36, P53; Fellows I, 2012, J STAT SOFTW, V49, P1; Fowden AL, 2012, EQUINE VET J, V44, P130, DOI 10.1111/j.2042-3306.2011.00505.x; Francillon-Vieillot H., 1990, P471; HEMELAAR A, 1985, Amphibia-Reptilia, V6, P323, DOI 10.1163/156853885X00326; Hugi J, 2012, J HERPETOL, V46, P312, DOI 10.1670/11-071; Huttenlocker AK, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P13; Jakob C, 2002, AMPHIBIA-REPTILIA, V23, P407, DOI 10.1163/15685380260462329; Jordana X, 2016, CR PALEVOL, V15, P255, DOI 10.1016/j.crpv.2015.03.008; Kaczensky P., 2015, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2015-4.RLTS.T7951A45171204.en, DOI 10.2305/IUCN.UK.2015-4.RLTS.T7951A45171204.EN]; Khonsue W, 2001, ZOOL SCI, V18, P597, DOI 10.2108/zsj.18.597; Kim HY, 2013, BONE RES, V1, DOI 10.4248/BR201302004; King S.R.B., 2019, IUCN RED LIST THREAT, V2016, DOI [DOI 10.2305/IUCN.UK.2016-2.RLTS.T41013A45172424.EN, 10.2305/IUCN.UK.2016-2.RLTS.T41013A45172424.en]; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Kohler M., ISLANDS EVOLUTION; Kohler M, 2009, P NATL ACAD SCI USA, V106, P20354, DOI 10.1073/pnas.0813385106; Lamm ET, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P55; Lee AH, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P217; Lkhagvasuren Davaa, 2013, Journal of Species Research, V2, P85; Marin-Moratalla N, 2014, BIOL J LINN SOC, V112, P678, DOI 10.1111/bij.12302; Marin-Moratalla N, 2013, MAMM BIOL, V78, P422, DOI 10.1016/j.mambio.2013.07.079; Martin RB, 1998, SKELETAL TISSUE MECH; Martinez-Maza C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103708; Messer NT, 1998, P AM ASS EQUINE PRAC, V44, P248; Moncunill-Sole B, 2016, CR PALEVOL, V15, P227, DOI 10.1016/j.crpv.2015.04.004; MORRIS PA, 1970, J ZOOL, V161, P277; Nacarino-Meneses C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16227-2; Nacarino-Meneses C, 2016, PEERJ, V4, DOI 10.7717/peerj.2580; Nacarino-Meneses C, 2016, CR PALEVOL, V15, P267, DOI 10.1016/j.crpv.2015.02.005; Olgun K, 2005, AMPHIBIA-REPTILIA, V26, P223, DOI 10.1163/1568538054253465; Orlandi-Oliveras G, 2016, CR PALEVOL, V15, P238, DOI 10.1016/j.crpv.2015.05.001; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; PENZHORN B L, 1982, Koedoe, P89; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Prondvai E, 2014, BIOL J LINN SOC, V112, P799, DOI 10.1111/bij.12323; Rogers KC, 2016, SCIENCE, V352, P450, DOI 10.1126/science.aaf1509; Rubenstein D.I., 2016, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2016-3.RLTS.T7950A89624491.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T7950A89624491.EN]; Schoepke K., 2012, Erforschung Biologischer Ressourcen der Mongolei, V12, P77; SCHOUR ISAAC, 1936, JOUR AMER DENTAL ASSOC, V23, P1946; Silver I. A., 1963, P250; Sinsch U, 2015, HERPETOL J, V25, P5; Smith TM, 2006, J ANAT, V208, P125, DOI 10.1111/j.1469-7580.2006.00500.x; SMUTS G L, 1974, Journal of the Southern African Wildlife Management Association, V4, P103; Stearns S.C., 1992, pi; STEWART F, 1993, J ENDOCRINOL, V138, P81, DOI 10.1677/joe.0.1380081; STOVER SM, 1992, J ANAT, V181, P455; Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155; Tafforeau P, 2007, PALAEOGEOGR PALAEOCL, V246, P206, DOI 10.1016/j.palaeo.2006.10.001; Turner-Walker G., 2008, ADV HUMAN PALAEOPATH, DOI 10.1002/9780470724187.ch7; WEBER DF, 1971, AM J ANAT, V132, P375, DOI 10.1002/aja.1001320307; Woodward HN, 2015, PALEOBIOLOGY, V41, P503, DOI 10.1017/pab.2015.19; Woodward HN, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P195; ZUCKERMAN S, 1953, P ZOOL SOC LOND, V122, P827	81	19	19	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0198511	10.1371/journal.pone.0198511	http://dx.doi.org/10.1371/journal.pone.0198511			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924818	Green Published, Green Submitted, gold			2022-12-26	WOS:000435655600026
J	Rothen, J; Murie, C; Carnes, J; Anupama, A; Abdulla, S; Chemba, M; Mpina, M; Tanner, M; Sim, BKL; Hoffmann, SL; Gottardo, R; Daubenberger, C; Stuart, K				Rothen, Julian; Murie, Carl; Carnes, Jason; Anupama, Atashi; Abdulla, Salim; Chemba, Mwajuma; Mpina, Maxmillian; Tanner, Marcel; Sim, B. Kim Lee; Hoffmann, Stephen L.; Gottardo, Raphael; Daubenberger, Claudia; Stuart, Ken			Whole blood transcriptome changes following controlled human malaria infection in malaria pre-exposed volunteers correlate with parasite prepatent period	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM SPOROZOITES; HUMAN CHALLENGE MODEL; PFSPZ VACCINE; RNA-SEQ; IMMUNE-RESPONSES; PROTECTION; EXPRESSION; INOCULATION; EFFICACY; IMMUNIZATION	Malaria continues to be one of mankind's most devastating diseases despite the many and varied efforts to combat it. Indispensable for malaria elimination and eventual eradication is the development of effective vaccines. Controlled human malaria infection (CHMI) is an invaluable tool for vaccine efficacy assessment and investigation of early immunological and molecular responses against Plasmodium falciparum infection. Here, we investigated gene expression changes following CHMI using RNA-Seq. Peripheral blood samples were collected in Bagamoyo, Tanzania, from ten adults who were injected intradermally (ID) with 2.5x10(4) aseptic, purified, cryopreserved P. falciparum sporozoites (Sanaria (R) PfSPZ Challenge). A total of 2,758 genes were identified as differentially expressed following CHMI. Transcriptional changes were most pronounced on day 5 after inoculation, during the clinically silent liver phase. A secondary analysis, grouping the volunteers according to their prepatent period duration, identified 265 genes whose expression levels were linked to time of blood stage parasitemia detection. Gene modules associated with these 265 genes were linked to regulation of transcription, cell cycle, phosphatidylinositol signaling and erythrocyte development. Our study showed that in malaria pre-exposed volunteers, parasite prepatent period in each individual is linked to magnitude and timing of early gene expression changes after ID CHMI.	[Rothen, Julian; Mpina, Maxmillian; Tanner, Marcel; Daubenberger, Claudia] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Rothen, Julian; Mpina, Maxmillian; Tanner, Marcel; Daubenberger, Claudia] Univ Basel, Basel, Switzerland; [Murie, Carl; Gottardo, Raphael] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Carnes, Jason; Anupama, Atashi; Stuart, Ken] Ctr Infect Dis Res, Seattle, WA USA; [Abdulla, Salim; Chemba, Mwajuma; Mpina, Maxmillian] Ifakara Hlth Inst, Bagamoyo Res & Training Ctr, Bagamoyo, Tanzania; [Sim, B. Kim Lee; Hoffmann, Stephen L.] Sanaria Inc, Rockville, MD USA	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Fred Hutchinson Cancer Center; Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); Ifakara Health Institute; Sanaria Inc.	Rothen, J (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland.; Rothen, J (corresponding author), Univ Basel, Basel, Switzerland.	julian.rothen@unibas.ch	Gottardo, Raphael/HCH-3169-2022	Carnes, Jason/0000-0001-7302-1935; Rothen, Julian/0000-0003-0770-1689; Gottardo, Raphael/0000-0002-3867-0232; Daubenberger, Claudia/0000-0001-7136-0642	National Institutes of Health - Human Immunology Project Consortium [U19A1089986]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089986] Funding Source: NIH RePORTER	National Institutes of Health - Human Immunology Project Consortium; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health - Human Immunology Project Consortium grant (number: U19A1089986) to KS. Authors KLS and SH are affiliated with the commercial company Sanaria Inc., the manufacturer of PfSPZ Challenge. The funders provided support in the form of salaries for authors KLS, SH and KS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; [Anonymous], WORLD MAL REP 2017; Berman JD, 2001, T ROY SOC TROP MED H, V95, P429, DOI 10.1016/S0035-9203(01)90206-8; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Douglas AD, 2013, J INFECT DIS, V208, P340, DOI 10.1093/infdis/jit156; Dunachie S, 2015, VACCINE, V33, P5321, DOI 10.1016/j.vaccine.2015.07.087; Epstein JE, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89154; Hodgson SH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00686; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110; Kazmin D, 2017, P NATL ACAD SCI USA, V114, P2425, DOI 10.1073/pnas.1621489114; Kublin JG, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aad9099; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Lyke KE, 2017, P NATL ACAD SCI USA, V114, P2711, DOI 10.1073/pnas.1615324114; Miller JL, 2014, CELL REP, V7, P436, DOI 10.1016/j.celrep.2014.03.018; Mordmuller B, 2017, NATURE, V542, P445, DOI 10.1038/nature21060; Obiero JM, 2015, INFECT IMMUN, V83, P2185, DOI 10.1128/IAI.03069-14; Ockenhouse CF, 2006, INFECT IMMUN, V74, P5561, DOI 10.1128/IAI.00408-06; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roestenberg M, 2012, J INFECT DIS, V206, P319, DOI 10.1093/infdis/jis355; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Shekalaghe S, 2014, AM J TROP MED HYG, V91, P471, DOI 10.4269/ajtmh.14-0119; Shen L., 2013, R PACKAGE VERSION, V1, P2013; Sissoko MS, 2017, LANCET INFECT DIS, V17, P498, DOI [10.1016/S1473-3099(17)30104-4, 10.1016/s1473-3099(17)30104-4]; Spring M, 2014, J INFECT DIS, V209, P540, DOI 10.1093/infdis/jiu063; Spring M, 2013, VACCINE, V31, P4975, DOI 10.1016/j.vaccine.2013.08.007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teirlinck AC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002389; Tran TM, 2016, SCI REP-UK, V6, DOI 10.1038/srep31291; Vahey MT, 2010, J INFECT DIS, V201, P580, DOI 10.1086/650310; van den Berg RA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00557; van Wolfswinkel ME, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2108-1; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Yamagishi J, 2014, GENOME RES, V24, P1433, DOI 10.1101/gr.158980.113; Zhu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20498	43	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199392	10.1371/journal.pone.0199392	http://dx.doi.org/10.1371/journal.pone.0199392			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920562	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000435541300043
J	Lumbantoruan, C; Kermode, M; Giyai, A; Ang, A; Kelaher, M				Lumbantoruan, Christina; Kermode, Michelle; Giyai, Aloisius; Ang, Agnes; Kelaher, Margaret			Understanding women's uptake and adherence in Option B plus for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PMTCT PROGRAM; BARRIERS; INVOLVEMENT; OUTCOMES; REASONS; LEVEL; CARE	Background Despite a more proactive approach to reducing new HIV infections in infants through lifelong treatment (Option B+ policy) for infected pregnant women, prevention of mother-to-child transmission of HIV (PMTCT) has not been fully effective in Papua, Indonesia. Mother-tochild transmission (MTCT) is the second greatest risk factor for HIV infection in the community, and an elimination target of <1% MTCT has not yet been achieved. The purpose of this study was to improve understanding of the implementation of Option B+ for PMTCT in Papua through investigation of facilitators and barriers to women's uptake and adherence to antiretroviral therapy (ART) in the program. This information is vital for improving program outcomes and success of program scale up in similar settings in Papua. Methods In-depth interviews were conducted with 20 women and 20 PMTCT health workers at two main referral hospitals for PMTCT in Papua. Development of interview guides was informed by the socio-ecological framework. Qualitative data were managed with NVivo11 software and themes were analysed using template analysis. Factors influencing women's uptake and adherence in Option B+ for PMTCT were identified through final analysis of key themes. Results Factors that motivated PMTCT uptake and adherence were good quality post-test HIV counselling, belief in the efficacy of antiretroviral (ARV) attained through personal or peer experiences, and a partner who did not prevent women from seeking PMTCT care. Key barriers for PMTCT participation included doubts about ARV efficacy, particularly for asymptomatic women, unsupportive partners who actively prevented women from seeking treatment, and women's concerns about community stigma and discrimination. Conclusions Results suggest that PMTCT program success is determined by facilitators and barriers from across the spectrum of the socio-ecological model. While roll out of Option B+ as current national policy for pregnant women in Papua has improved detection and enrolment of HIV-positive women, health facilities need to address various existing and potential issues to ensure long-term adherence of women beyond the current PMTCT program, including during pregnancy, childbirth and breastfeeding.	[Lumbantoruan, Christina; Kelaher, Margaret] Univ Melbourne, Ctr Hlth Policy, Melbourne, Vic, Australia; [Lumbantoruan, Christina; Kermode, Michelle] Univ Melbourne, Nossal Inst Global Hlth, Melbourne, Vic, Australia; [Giyai, Aloisius; Ang, Agnes] Papua Prov Hlth Off, Prov Hlth Off, Jayapura, Papua, Indonesia	University of Melbourne; University of Melbourne	Lumbantoruan, C (corresponding author), Univ Melbourne, Ctr Hlth Policy, Melbourne, Vic, Australia.; Lumbantoruan, C (corresponding author), Univ Melbourne, Nossal Inst Global Hlth, Melbourne, Vic, Australia.	christina.dolarosa@gmail.com		kelaher, Margaret/0000-0002-9899-858X; Lumbantoruan, Christina/0000-0003-2672-1351	Department of Foreign Affairs and Trade Australia [14/04320]; Ministry of Finance, Republic of Indonesia [PRJ-4591/LPDP.3/2016]; Indonesian Ministry of Home Affairs; Sub-Directorate HIV AIDS of the Indonesian Ministry of Health; Papua Provincial Health Office; Jayapura Hospital; Abepura Hospital	Department of Foreign Affairs and Trade Australia; Ministry of Finance, Republic of Indonesia; Indonesian Ministry of Home Affairs; Sub-Directorate HIV AIDS of the Indonesian Ministry of Health; Papua Provincial Health Office; Jayapura Hospital; Abepura Hospital	CL received research funding from Department of Foreign Affairs and Trade Australia; grant number: 14/04320; http://australiaawards.gov.au and Ministry of Finance, Republic of Indonesia; grant number: PRJ-4591/LPDP.3/2016; http://www.lpdp.kemenkeu go.id. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Indonesian Ministry of Home Affairs, Sub-Directorate HIV AIDS of the Indonesian Ministry of Health, Papua Provincial Health Office, Jayapura Hospital, and Abepura Hospital for supporting and approving the research permit. Authors also thank HIV positive women and health workers for their voluntary participations in this study that made production of this manuscript possible. We hope they will benefit from this study.	Atanga PN, 2017, TROP MED INT HEALTH, V22, P161, DOI 10.1111/tmi.12816; Brooks J, 2015, QUAL RES PSYCHOL, V12, P202, DOI 10.1080/14780887.2014.955224; Butt L, 2013, CULT MED PSYCHIAT, V37, P179, DOI 10.1007/s11013-012-9299-2; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Ebuy H, 2015, INT J INFECT DIS, V33, P123, DOI 10.1016/j.ijid.2014.12.026; Flax V.L., 2017, PLOS ONE, V12; Gourlay A, 2015, SEXUALLY TRANSMITTED; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hardon A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-26; Hardon AP, 2009, SOC SCI MED, V69, P838, DOI 10.1016/j.socscimed.2009.05.043; Hodgson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111421; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Ismaili H, 2011, ETHIOP J HEALTH DEV, V25, P126; Karutu CK, 2016, UNDERSTANDING BARRIE, P290; Kebaabetswe PM, 2007, AIDS CARE, V19, P355, DOI 10.1080/09540120600942407; Kementerian Dalam Negeri Republik Indonesia, 2018, PROF DAER PROV PAP; Kementerian Kesehatan Republic of Indonesia, 2016, PROF KES IND TAH 201; Kementerian Kesehatan Republik Indonesia, 2015, PED MAN PROGR PENC P; Kementerian Kesehatan Republik Indonesia, 2013, RENC AKS NAS PENC PE; Kementerian Kesehatan Republik Indonesia, 2014, PROF KES IND 2013; Kementerian Kesehatan Republik Indonesia, 2014, PED PEL PENC PEN HIV; Kementerian Kesehatan Republik Indonesia, 2015, RENC AKS NAS PENG HI; Kementerian Kesehatan Republik Indonesia, 2015, LAP PERK HIV AIDS TR; Kementerian Kesehatan Republik Indonesia, 2014, RINGK EKS DAT DAN IN; Kim MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148466; Landes M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3380-7; McLean E, 2017, SEXUALLY TRANSMITTED, P93; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Ministry of Health Republic of Indonesia, 2007, RISK BEH HIV PREV TA; Morfaw F, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-5; Nachega JB, 2016, PATIENT PREFER ADHER, V10, P683, DOI 10.2147/PPA.S100002; Nkuoh GN, 2013, J MIDWIFERY WOM HEAL, V58, P83, DOI 10.1111/j.1542-2011.2012.00208.x; Oktavia M, 2012, RETROVIROLOGY, P9; Puttkammer N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173123; Rosenberg NE, 2017, AJAR-AFR J AIDS RES, V16, P215, DOI 10.2989/16085906.2017.1362017; Rujumba J, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-189; Salem G, 2017, PLOS ONE, V12; Sarker Malabika, 2009, East Afr J Public Health, V6, P280; Theilgaard ZP, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-28; Trisnawati LM, 2015, INDONESIAN HLTH POLI, V1, P8; Turan B, 2017, AIDS BEHAV, V21, P283, DOI 10.1007/s10461-016-1451-5; Turan JM, 2013, AIDS BEHAV, V17, P2528, DOI 10.1007/s10461-013-0446-8; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369; Vieira N, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0427-6; Wold B, 2012, ECOLOGICAL PERSPECTI; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2014, GLOB GUID CRIT PROC; World Health Organization, 2010, PMTCT STRAT VIS 2010; World Health Organization, 2021, ANT DRUGS TREAT PREG	50	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198329	10.1371/journal.pone.0198329	http://dx.doi.org/10.1371/journal.pone.0198329			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ6XV	29912960	Green Published, gold			2022-12-26	WOS:000435528600023
J	Sato, M; Yamashita, O; Sato, MA; Miyawaki, Y				Sato, Masashi; Yamashita, Okito; Sato, Masa-aki; Miyawaki, Yoichi			Information spreading by a combination of MEG source estimation and multivariate pattern classification	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; OBJECT RECOGNITION; HUMAN BRAIN; TEMPORAL CORTEX; INVERSE PROBLEM; EEG DATA; TIME; CATEGORY; NETWORKS; LEAKAGE	To understand information representation in human brain activity, it is important to investigate its fine spatial patterns at high temporal resolution. One possible approach is to use source estimation of magnetoencephalography (MEG) signals. Previous studies have mainly quantified accuracy of this technique according to positional deviations and dispersion of estimated sources, but it remains unclear how accurately MEG source estimation restores information content represented by spatial patterns of brain activity. In this study, using simulated MEG signals representing artificial experimental conditions, we performed MEG source estimation and multivariate pattern analysis to examine whether MEG source estimation can restore information content represented by patterns of cortical current in source brain areas. Classification analysis revealed that the corresponding artificial experimental conditions were predicted accurately from patterns of cortical current estimated in the source brain areas. However, accurate predictions were also possible from brain areas whose original sources were not defined. Searchlight decoding further revealed that this unexpected prediction was possible across wide brain areas beyond the original source locations, indicating that information contained in the original sources can spread through MEG source estimation. This phenomenon of "information spreading" may easily lead to false-positive interpretations when MEG source estimation and classification analysis are combined to identify brain areas that represent target information. Real MEG data analyses also showed that presented stimuli were able to be predicted in the higher visual cortex at the same latency as in the primary visual cortex, also suggesting that information spreading took place. These results indicate that careful inspection is necessary to avoid false-positive interpretations when MEG source estimation and multivariate pattern analysis are combined.	[Sato, Masashi; Miyawaki, Yoichi] Univ Electrocommun, Grad Sch Informat & Engn, Tokyo, Japan; [Sato, Masashi] Japan Soc Promot Sci, Tokyo, Japan; [Yamashita, Okito; Sato, Masa-aki] Adv Telecommun Res Inst Int, Neural Informat Anal Labs, Kyoto, Japan; [Yamashita, Okito] CiNet, Brain Funct Imaging Technol Grp, Osaka, Japan; [Yamashita, Okito] RIKEN, Ctr Adv Intelligence Project, Tokyo, Japan; [Miyawaki, Yoichi] JST, PRESTO, Tokyo, Japan	University of Electro-Communications - Japan; Japan Society for the Promotion of Science; Advanced Telecommunications Research Institute International; National Institute of Information & Communications Technology (NICT) - Japan; RIKEN; Japan Science & Technology Agency (JST)	Miyawaki, Y (corresponding author), Univ Electrocommun, Grad Sch Informat & Engn, Tokyo, Japan.; Miyawaki, Y (corresponding author), JST, PRESTO, Tokyo, Japan.	yoichi.miyawaki@uec.ac.jp	Yamashita, Okito/ABW-9839-2022	Miyawaki, Yoichi/0000-0001-9581-926X; Yamashita, Okito/0000-0002-6039-3657	JSPS KAKENHI [JP16H01541, JP17H01755, JP26120514]; MIC SCOPE [141203025]; JST PRESTO [JPMJPR1778]; KDDI Foundation; Narishige Neuroscience Research Foundation; Naito Foundation; Yazaki Memorial Foundation for Science and Technology, JSPS KAKENHI [JP16J00417]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MIC SCOPE; JST PRESTO(Japan Science & Technology Agency (JST)); KDDI Foundation(KDDI Corporation); Narishige Neuroscience Research Foundation; Naito Foundation(Naito Memorial Foundation); Yazaki Memorial Foundation for Science and Technology, JSPS KAKENHI	This work was supported by JSPS KAKENHI (JP16H01541, JP17H01755 and JP26120514), MIC SCOPE (141203025), JST PRESTO (JPMJPR1778), the KDDI Foundation, the Narishige Neuroscience Research Foundation, the Naito Foundation, and the Yazaki Memorial Foundation for Science and Technology to Yoichi Miyawaki, JSPS KAKENHI (JP16J00417) to Masashi Sato, and a contract research 173 with NICT to Masa-aki Sato. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookes MJ, 2012, NEUROIMAGE, V63, P910, DOI 10.1016/j.neuroimage.2012.03.048; Carlson T, 2013, J VISION, V13, DOI 10.1167/13.10.1; Carlson TA, 2011, J VISION, V11, DOI 10.1167/11.10.9; Cichy RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27755; Cichy RM, 2014, NAT NEUROSCI, V17, P455, DOI 10.1038/nn.3635; Clarke A, 2015, CEREB CORTEX, V25, P3602, DOI 10.1093/cercor/bhu203; Clarke A, 2014, J NEUROSCI, V34, P4766, DOI 10.1523/JNEUROSCI.2828-13.2014; Colclough GL, 2015, NEUROIMAGE, V117, P439, DOI 10.1016/j.neuroimage.2015.03.071; Contini EW, 2017, NEUROPSYCHOLOGIA, V105, P165, DOI 10.1016/j.neuropsychologia.2017.02.013; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cottereau B, 2007, NEUROIMAGE, V38, P439, DOI 10.1016/j.neuroimage.2007.07.046; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; de Cheveigne A, 2007, J NEUROSCI METH, V165, P297, DOI 10.1016/j.jneumeth.2007.06.003; de Peralta-Menendez RG, 1998, IEEE T BIO-MED ENG, V45, P440, DOI 10.1109/10.664200; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Fukushima M, 2015, NEUROIMAGE, V105, P408, DOI 10.1016/j.neuroimage.2014.09.066; Ghaoui L., 2010, SAFE FEATURE ELIMINA; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Gohel B, 2018, COMPUT BIOL MED, V93, P106, DOI 10.1016/j.compbiomed.2017.12.020; Gramfort A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-45; Grave de Peralta-Menendez R., 1996, BRAIN TOPOGRAPHY, V9, P117, DOI [10.1007/BF01200711, DOI 10.1007/BF01200711]; Grootswagers T, 2017, J COGNITIVE NEUROSCI, V29, P677, DOI 10.1162/jocn_a_01068; Grova C, 2006, NEUROIMAGE, V29, P734, DOI 10.1016/j.neuroimage.2005.08.053; Haibo He, 2009, IEEE Transactions on Knowledge and Data Engineering, V21, P1263, DOI 10.1109/TKDE.2008.239; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hauk O, 2011, NEUROIMAGE, V54, P1966, DOI 10.1016/j.neuroimage.2010.09.053; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2015, NEURON, V87, P257, DOI 10.1016/j.neuron.2015.05.025; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Kajihara S, 2004, BRAIN TOPOGR, V17, P13, DOI 10.1023/B:BRAT.0000047333.10619.eb; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Koh KM, 2007, J MACH LEARN RES, V8, P1519; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2013, TRENDS COGN SCI, V17, P401, DOI 10.1016/j.tics.2013.06.007; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Kybic J, 2005, IEEE T MED IMAGING, V24, P12, DOI 10.1109/TMI.2004.837363; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; MACKAY DJC, 1992, NEURAL COMPUT, V4, P415, DOI [10.1162/neco.1992.4.3.415, 10.1162/neco.1992.4.3.448]; MATSUURA K, 1995, IEEE T BIO-MED ENG, V42, P608, DOI 10.1109/10.387200; Miyawaki Y, 2008, NEURON, V60, P915, DOI 10.1016/j.neuron.2008.11.004; Molins A, 2008, NEUROIMAGE, V42, P1069, DOI 10.1016/j.neuroimage.2008.05.064; Neal Radford M, 1996, BAYESIAN LEARNING NE; Ohata R, 2016, SCI REP-UK, V6, DOI 10.1038/srep27416; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Ramkumar P, 2016, NEUROIMAGE, V134, P295, DOI 10.1016/j.neuroimage.2016.03.027; Saito T., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0UMAL.P0NE.0137923; Sato M, 2004, NEUROIMAGE, V23, P806, DOI 10.1016/j.neuroimage.2004.06.037; Sato M, 2017, PRNI, V2017, DOI [10.1109/PRNI.2017.7981509, DOI 10.1109/PRNI.2017.7981509]; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sharon D, 2007, NEUROIMAGE, V36, P1225, DOI 10.1016/j.neuroimage.2007.03.066; Simanova I, 2015, J COGNITIVE NEUROSCI, V27, P35, DOI 10.1162/jocn_a_00690; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Uutela K, 1999, NEUROIMAGE, V10, P173, DOI 10.1006/nimg.1999.0454; van de Nieuwenhuijzen ME, 2013, NEUROIMAGE, V83, P1063, DOI 10.1016/j.neuroimage.2013.07.075; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Wardle SG, 2016, NEUROIMAGE, V132, P59, DOI 10.1016/j.neuroimage.2016.02.019; Yoshor D, 2007, CEREB CORTEX, V17, P2293, DOI 10.1093/cercor/bhl138; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	65	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198806	10.1371/journal.pone.0198806	http://dx.doi.org/10.1371/journal.pone.0198806			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ6XV	29912968	Green Submitted, gold, Green Published			2022-12-26	WOS:000435528600049
J	Kawatsu, L; Uchimura, K; Ohkado, A; Kato, S				Kawatsu, Lisa; Uchimura, Kazuhiro; Ohkado, Akihiro; Kato, Seiya			A combination of quantitative and qualitative methods in investigating risk factors for lost to follow-up for tuberculosis treatment in Japan - Are physicians and nurses at a particular risk?	PLOS ONE			English	Article							TREATMENT FAILURE; RETREATMENT	Background The treatment success rate of pulmonary tuberculosis (PTB) patients aged 64 years and below in Japan, a tuberculosis (TB) middle-burden country with a notification of 13.9 per 100,000 populations in 2016, has been fluctuating around 70% for some years. In order to improve treatment outcome, it is critical to address those lost to follow-up (LTFU). The objective of the study therefore was to describe the characteristics of, and analyze the risk factors for those LTFU among pulmonary TB patients aged between 15 and 64, and discuss policy implications. Methods The study used a mixed method of quantitative and qualitative approach, and was conducted in two phases. The first involved analysis of cohort data from the national TB surveillance of PTB patients newly notified between 1 January 2006 and 31 December 2015. The second phase involved focus group (FGD) discussions with public health nurses, who are responsible for supporting TB patients' adherence to medication, on the possible reasons why some patients become lost to follow-up. Results Analysis of the surveillance data suggested that among all patients, positive sputum smear (adjusted odds ratio, [aOR] 0.52, 95% confidence interval [CI] 0.47-0.58) and cavitary lesion on chest x-ray (aOR 0.79, 95%CI 0.72-0.85) decreased the risk, while not requiring hospitalization increased the risk of LTFU (aOR 1.46, 95%CI 1.33-1.60). Among females, being a physician (aOR 2.07 95%CI 1.23-3.48) and nurse (aOR 1.18, 95%CI 1.91-1.37) were identified as additional risk factors for LTFU. The analysis of focus group discussions revealed three possible themes which may be useful in understanding why nurses and physicians were at a higher risk of becoming LTFU-firstly, the possibility that physicians and nurses were finding it difficult to make medication taking a routine, secondly, their low risk perception towards TB is affecting their adherence behavior, and thirdly, their unwillingness to accept DOTS was increasing their risk of becoming LTFU. Conclusions The analysis of surveillance data and FGD transcripts indicated that patient education for those starting their treatment as an outpatient, and establishing DOTS that is both acceptable and realistic to physicians and nurses, may be two issues which need to be addressed urgently.	[Kawatsu, Lisa; Uchimura, Kazuhiro; Ohkado, Akihiro] Japan AntiTB Assoc RIT JATA, Res Inst TB, Dept Epidemiol & Clin Res, Tokyo, Japan; [Kato, Seiya] Japan AntiTB Assoc RIT JATA, Res Inst TB, Tokyo, Japan		Kawatsu, L (corresponding author), Japan AntiTB Assoc RIT JATA, Res Inst TB, Dept Epidemiol & Clin Res, Tokyo, Japan.	kawatsu@jata.or.jp	Ohkado, Akihiro/HGF-2977-2022		Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development [18fk0108041h0002]	Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	The study was supported by the Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development (Grant number: 18fk0108041h0002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], TUB JAP ANN REP 2016; Becerra MC, 2000, INT J TUBERC LUNG D, V4, P108; Bischoff WE, 2000, ARCH INTERN MED, V160, P1017, DOI 10.1001/archinte.160.7.1017; Borgdorff MW, 1993, EUR RESPIR J, V16, P209; Chiang CY, 2004, J FORMOS MED ASSOC, V103, P411; Comolet TM, 1998, INT J TUBERC LUNG D, V2, P891; DEMISSIE M, 1994, ETHIOPIAN MED J, V32, P97; Doebbeling BN, 1992, NEW ENGL J MED, P32788; Dooley KE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-140; Ishizaka T, 2010, JAPANESE J INFECT PR, V25, P290; Liam CK, 1999, INT J TUBERC LUNG D, V3, P300; LoBue PA, 1998, CHEST, V113, P1184, DOI 10.1378/chest.113.5.1184; LUND S, 1994, AM J INFECT CONTROL, V22, P352, DOI 10.1016/0196-6553(94)90034-5; Matsumoto Kenji, 2014, Kekkaku, V89, P593; MORI T, 1992, TUBERCLE LUNG DIS, V73, P225, DOI 10.1016/0962-8479(92)90091-W; Mulenga C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-756; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Naing Nyi Nyi, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P369; Nuwaha F, 1997, INT J TUBERC LUNG D, V1, P181; Rabahi Marcelo Fouad, 2002, Braz J Infect Dis, V6, P63, DOI 10.1590/S1413-86702002000200002; RamphalNaley L, 1996, AM J INFECT CONTROL, V24, P243, DOI 10.1016/S0196-6553(96)90056-5; Tekle B, 2002, INT J TUBERC LUNG D, V6, P573; Tsuda Yuko, 2015, Kekkaku, V90, P387; Uplekar M, 2000, GENDER TUBERCULOSIS; World Health Organization, 2013, DEFINITIONS REPORTIN	25	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2018	13	6							e0198075	10.1371/journal.pone.0198075	http://dx.doi.org/10.1371/journal.pone.0198075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5RI	29906287	gold, Green Submitted, Green Published			2022-12-26	WOS:000435439400003
J	Yu, DW; Ding, XH; Liu, ZX; Wu, XY; Zhu, YM; Wei, HM; Chong, HH; Cui, S; He, YX				Yu, Danwei; Ding, Xiaohui; Liu, Zixuan; Wu, Xiyuan; Zhu, Yuanmei; Wei, Huanmian; Chong, Huihui; Cui, Sheng; He, Yuxian			Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial-approved membrane fusion inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); HIV-1; host-pathogen interaction; AIDS; antiviral agent; drug resistance; gp41; fusion inhibitor; sifuvirtide	IMMUNODEFICIENCY-VIRUS TYPE-1; GP41 6-HELIX BUNDLE; T HOOK STRUCTURE; ENVELOPE GLYCOPROTEIN; CONFORMATIONAL-CHANGES; PHENOTYPIC RESISTANCE; PEPTIDE INHIBITORS; ATOMIC-STRUCTURE; CORE STRUCTURE; COILED-COIL	Host cell infection with HIV-1 requires fusion of viral and cell membranes. Sifuvirtide (SFT) is a peptide-based HIV-1 fusion inhibitor approved for phase III clinical trials in China. Here, we focused on characterizing HIV-1 variants highly resistant to SFT to gain insight into the molecular resistance mechanism. Three primary substitutions (V38A, A47I, and Q52R) located at the inhibitor-binding site of HIV-1's envelope protein (Env) and one secondary substitution (N126K) located at the C-terminal heptad repeat region of the viral protein gp41, which is part of the envelope, conferred high SFT resistance and cross-resistance to the anti-HIV-1 drug T20 and the template peptide C34. Interestingly, SFT's resistance profile could be dramatically improved with an M-T hook structure-modified SFT (MTSFT) and with short-peptide inhibitors that mainly target the gp41 pocket (2P23 and its lipid derivative LP-19). We found that the V38A and Q52R substitutions reduce the binding stabilities of SFT, C34, and MTSFT, but they had no effect on the binding of 2P23 and LP-19; in sharp contrast, the A47I substitution enhanced fusion inhibitor binding. Furthermore, the primary resistance substitutions impaired Env-mediated membrane fusion and cell entry and changed the conformation of the gp41 core structure. Importantly, whereas the V38A and Q52R sub-stitutions disrupted the N-terminal helix of gp41, a single A47I substitution greatly enhanced its thermostability. Taken together, our results provide crucial structural insights into the mechanism of HIV-1 resistance to gp41-dependent fusion inhibitors, which may inform the development of additional anti-HIV drugs.	[Yu, Danwei; Ding, Xiaohui; Liu, Zixuan; Wu, Xiyuan; Zhu, Yuanmei; Wei, Huanmian; Chong, Huihui; Cui, Sheng; He, Yuxian] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Yu, Danwei; Ding, Xiaohui; Liu, Zixuan; Wu, Xiyuan; Zhu, Yuanmei; Wei, Huanmian; Chong, Huihui; He, Yuxian] Chinese Acad Med Sci, Ctr AIDS Res, Beijing 100730, Peoples R China; [Yu, Danwei; Ding, Xiaohui; Liu, Zixuan; Wu, Xiyuan; Zhu, Yuanmei; Wei, Huanmian; Chong, Huihui; He, Yuxian] Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	He, YX (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.; He, YX (corresponding author), Chinese Acad Med Sci, Ctr AIDS Res, Beijing 100730, Peoples R China.; He, YX (corresponding author), Peking Union Med Coll, Beijing 100730, Peoples R China.	yhe@ipbcams.ac.cn	Sheng, CUI/M-6405-2013; Cui, Sheng/AAQ-1721-2020	Sheng, CUI/0000-0001-6329-3582; yu, danwei/0000-0002-2379-2210	Natural Science Foundation of China [81630061, 81473255]; CAMS Innovation Fund for Medical Sciences Grant [2017-I2M-1-014]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Sciences Grant	This work was supported by Natural Science Foundation of China Grants 81630061 and 81473255 and CAMS Innovation Fund for Medical Sciences Grant 2017-I2M-1-014. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn KW, 2017, J BIOL CHEM, V292, P16498, DOI 10.1074/jbc.M117.791731; Baldwin CE, 2004, J VIROL, V78, P12428, DOI 10.1128/JVI.78.22.12428-12437.2004; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chong H., 2017, J VIROL, V91; Chong HH, 2015, AIDS, V29, P13, DOI 10.1097/QAD.0000000000000498; Chong HH, 2014, J ANTIMICROB CHEMOTH, V69, P2759, DOI 10.1093/jac/dku183; Chong HH, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-40; Chong HH, 2013, FASEB J, V27, P1203, DOI 10.1096/fj.12-222547; Chong HH, 2012, J BIOL CHEM, V287, P34558, DOI 10.1074/jbc.M112.390393; Chong HH, 2012, J BIOL CHEM, V287, P20281, DOI 10.1074/jbc.M112.354126; Chong HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032599; De Feo CJ, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0086-8; Dimitrov AS, 2005, BIOCHEMISTRY-US, V44, P12471, DOI 10.1021/bi051092d; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eggink D, 2008, J VIROL, V82, P6678, DOI 10.1128/JVI.00352-08; Eggink D, 2016, J VIROL, V90, P10587, DOI 10.1128/JVI.01616-16; Eggink D, 2011, J VIROL, V85, P10785, DOI 10.1128/JVI.05331-11; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Eggink D, 2009, J BIOL CHEM, V284, P26941, DOI 10.1074/jbc.M109.004416; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; He YX, 2008, J VIROL, V82, P6349, DOI 10.1128/JVI.00319-08; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; He YX, 2013, CURR PHARM DESIGN, V19, P1800, DOI 10.2174/1381612811319100004; Ishikawa H, 2012, PROTEIN ENG DES SEL, V25, P813, DOI 10.1093/protein/gzs051; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; Johnson WE, 2001, J VIROL, V75, P11426, DOI 10.1128/JVI.75.23.11426-11436.2001; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kondo N, 2010, J BIOL CHEM, V285, P14681, DOI 10.1074/jbc.M109.067090; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Li J, 2009, IMMUNOBIOLOGY, V214, P51, DOI 10.1016/j.imbio.2008.04.005; Liu ZH, 2011, J BIOL CHEM, V286, P3277, DOI 10.1074/jbc.M110.199323; Nameki D, 2005, J VIROL, V79, P764, DOI 10.1128/JVI.79.2.764-770.2005; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Poveda E, 2004, J MED VIROL, V74, P21, DOI 10.1002/jmv.20141; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Sackett K, 2006, J BIOL CHEM, V281, P21755, DOI 10.1074/jbc.M603135200; Shimane K, 2013, ANTIMICROB AGENTS CH, V57, P4035, DOI 10.1128/AAC.00237-13; Shimura K, 2010, J BIOL CHEM, V285, P39471, DOI 10.1074/jbc.M110.145789; Sista PR, 2004, AIDS, V18, P1787, DOI 10.1097/00002030-200409030-00007; Steffen I, 2010, CURR PHARM DESIGN, V16, P1143, DOI 10.2174/138161210790963751; Steger HK, 2006, J BIOL CHEM, V281, P25813, DOI 10.1074/jbc.M601457200; Su Y, 2015, J VIROL, V89, P12467, DOI 10.1128/JVI.01741-15; Su Y, 2015, J VIROL, V89, P5801, DOI 10.1128/JVI.00373-15; Svicher V, 2009, ANTIMICROB AGENTS CH, V53, P2816, DOI 10.1128/AAC.01067-08; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Wang W, 2011, J VIROL, V85, P12929, DOI 10.1128/JVI.05391-11; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wu X., 2018, J VIROL, V92; Xiong SW, 2017, J VIROL, V91, DOI 10.1128/JVI.01839-16; Yao X, 2012, J BIOL CHEM, V287, P26618, DOI 10.1074/jbc.M112.381079; Yao X, 2012, J BIOL CHEM, V287, P6788, DOI 10.1074/jbc.M111.317883	57	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12703	12718		10.1074/jbc.RA118.003538	http://dx.doi.org/10.1074/jbc.RA118.003538			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29929981	Green Published, hybrid			2022-12-26	WOS:000442203500005
J	Kuo, IC; Lin, HYH; Niu, SW; Lee, JJ; Chiu, YW; Hung, CC; Hwang, SJ; Chen, HC				Kuo, I-Ching; Lin, Hugo You-Hsien; Niu, Sheng-Wen; Lee, Jia-Jung; Chiu, Yi-Wen; Hung, Chi-Chih; Hwang, Shang-Jyh; Chen, Hung-Chun			Anemia modifies the prognostic value of glycated hemoglobin in patients with diabetic chronic kidney disease	PLOS ONE			English	Article							3RD NATIONAL-HEALTH; GLYCEMIC CONTROL; MELLITUS; ALBUMIN; A1C; NEPHROPATHY; ASSOCIATION; PREVALENCE; INSUFFICIENCY; EPIDEMIOLOGY	A common complication of chronic kidney disease (CKD), anemia can influence glycated hemoglobin (HbA1c) levels. In diabetic patients, anemia occurs earlier and with higher severity over the course of CKD stages. To elucidate the effect of hemoglobin (Hb) on the predictive value of HbA1c, we enrolled 1558 diabetic patients with stages 3-4 CKD, categorized according to baseline Hb and HbA1c quartiles. Linear regression revealed that higher HbA1c correlated significantly with higher Hb in the Hb < 10 g/dL group (beta = 0.146, P = 0.004). A fully-adjusted Cox regression model revealed worse clinical outcomes in patients with higher HbA1c quartiles in the Hb >= 10 g/dL group. Hazard ratios for end-stage renal disease (ESRD), all-cause mortality, and composite endpoint (cardiovascular events and all-cause mortality) in patients with Hb >= 10 g/dL and the highest HbA1c quartile were 1.92 (95% confidence interval [CI], 1.17 - 3.15), 1.76 (95% CI, 1.02 - 3.03), and 1.54 (95% CI, 1.03 - 2.31), respectively. By contrast, HbA1c was not associated with clinical outcomes in the Hb < 10 g/dL group. In conclusion, in stages 3-4 diabetic CKD, higher HbA1c is associated with a higher risk of poor clinical outcomes in patients with Hb >= 10 g/dL.	[Kuo, I-Ching; Lin, Hugo You-Hsien; Niu, Sheng-Wen] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Kuo, I-Ching; Niu, Sheng-Wen] Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan; [Lin, Hugo You-Hsien] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Lee, Jia-Jung; Chiu, Yi-Wen; Hung, Chi-Chih; Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Chiu, Yi-Wen; Hwang, Shang-Jyh; Chen, Hung-Chun] Kaohsiung Med Univ, Coll Med, Fac Renal Care, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Hung, CC; Chen, HC (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan.; Chen, HC (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Renal Care, Kaohsiung, Taiwan.	chichi@cc.kmu.edu.tw; chenhc@kmu.edu.tw						Agarwal R, 2011, AM J NEPHROL, V34, P32, DOI 10.1159/000328737; Al-Khoury S, 2006, DIABETOLOGIA, V49, P1183, DOI 10.1007/s00125-006-0254-z; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Ansari A, 2003, AM J KIDNEY DIS, V41, P523, DOI 10.1053/ajkd.2003.50114; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Bosman DR, 2001, DIABETES CARE, V24, P495, DOI 10.2337/diacare.24.3.495; Chen CW, 2017, CLIN CHEM, V63, P477, DOI 10.1373/clinchem.2016.258319; Craig KJ, 2005, DIABETES CARE, V28, P1118, DOI 10.2337/diacare.28.5.1118; Deray G, 2004, AM J NEPHROL, V24, P522, DOI 10.1159/000081058; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El-Achkar TM, 2005, KIDNEY INT, V67, P1483, DOI 10.1111/j.1523-1755.2005.00226.x; FLUCKIGER R, 1981, NEW ENGL J MED, V304, P823, DOI 10.1056/NEJM198104023041406; Freedman BI, 2010, AM J NEPHROL, V31, P375, DOI 10.1159/000287561; Grossman C, 2014, DIABETES-METAB RES, V30, P291, DOI 10.1002/dmrr.2491; HOWARD RL, 1991, KIDNEY INT, V40, P923, DOI 10.1038/ki.1991.295; Hsu CC, 2006, AM J KIDNEY DIS, V48, P727, DOI 10.1053/j.ajkd.2006.07.018; Hsu CY, 2002, J AM SOC NEPHROL, V13, P504, DOI 10.1681/ASN.V132504; Hwang SJ, 2010, NEPHROL DIAL TRANSPL, V25, P2616, DOI 10.1093/ndt/gfq308; Kalantar-Zadeh K, 2007, DIABETES CARE, V30, P1049, DOI 10.2337/dc06-2127; Kim IY, 2015, NEPHROLOGY, DOI [10.1111/nep.12508, DOI 10.1111/NEP.12508]; Kondaveeti SB, 2013, J CLIN DIAGN RES, V7, P1280, DOI 10.7860/JCDR/2013/5145.3117; Kuo IC, 2016, SCI REP-UK, V6, DOI 10.1038/srep20028; Locatelli F, 2006, NEPHROL DIAL TRANSPL, V21, P991, DOI 10.1093/ndt/gfk011; Loutradis Charalampos, 2016, World J Nephrol, V5, P358, DOI 10.5527/wjn.v5.i4.358; Ly J, 2004, AM J KIDNEY DIS, V44, P715, DOI 10.1053/j.ajkd.2004.06.018; Mc Causland FR, 2016, AM J KIDNEY DIS, V68, P873, DOI 10.1053/j.ajkd.2016.07.022; Mehdi U, 2009, DIABETES CARE, V32, P1320, DOI 10.2337/dc08-0779; Mohanram A, 2008, KIDNEY INT, V73, P630, DOI 10.1038/sj.ki.5002746; Molnar MZ, 2011, NEPHROL DIAL TRANSPL, V26, P2000, DOI 10.1093/ndt/gfq690; Murea M, 2012, AM J NEPHROL, V36, P488, DOI 10.1159/000343920; Ng JM, 2010, DIABETES CARE, V33, P2310, DOI 10.2337/dc10-0917; Oh SW, 2011, NEPHROL DIAL TRANSPL, V26, P2238, DOI 10.1093/ndt/gfq707; Park SB, 2017, J DIABETES COMPLICAT, V31, P1041, DOI 10.1016/j.jdiacomp.2017.01.014; Ravanan R, 2007, DIABETOLOGIA, V50, P26, DOI 10.1007/s00125-006-0514-y; Shurraw S, 2011, ARCH INTERN MED, V171, P1920, DOI 10.1001/archinternmed.2011.537; Spallone V, 2004, DIABETIC MED, V21, P1174, DOI 10.1111/j.1464-5491.2004.01306.x; Speeckaert M, 2014, NEPHROL DIAL TRANSPL, V29, P2167, DOI 10.1093/ndt/gfu006; Standl E, 2011, DIABETES CARE, V34, pS120, DOI 10.2337/dc11-s206; Thomas MC, 2004, NEPHROL DIAL TRANSPL, V19, P1792, DOI 10.1093/ndt/gfh248; Thomas MC, 2006, AM J KIDNEY DIS, V48, P537, DOI 10.1053/j.ajkd.2006.06.011; Vanholder R, 2016, LANCET DIABETES ENDO, V4, P360, DOI 10.1016/S2213-8587(16)00033-4	41	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199378	10.1371/journal.pone.0199378	http://dx.doi.org/10.1371/journal.pone.0199378			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933406	Green Published, gold, Green Submitted			2022-12-26	WOS:000436076600022
J	Boos, CJ; Basso, M; O'Hara, JP; Vincent, E; Mellor, A; Sevier, L; Abdul-Razakq, H; Cooke, M; Barlow, M; Woods, DR				Boos, Christopher J.; Basso, Malcolm; O'Hara, John P.; Vincent, Emma; Mellor, Adrian; Sevier, Luke; Abdul-Razakq, Humayra; Cooke, Mark; Barlow, Matt; Woods, David R.			The relationship between anxiety and acute mountain sickness	PLOS ONE			English	Article							HIGH-ALTITUDE; TRAIT ANXIETY; SYMPTOMS; DISORDERS; INVENTORY; ILLNESS; ONSET	Introduction Whilst the link between physical factors and risk of high altitude (HA)-related illness and acute mountain sickness (AMS) have been extensively explored, the influence of psychological factors has been less well examined. In this study we aimed to investigate the relationship between 'anxiety and AMS risk during a progressive ascent to very HA. Methods Eighty health adults were assessed at baseline (848m) and over 9 consecutive altitudes during a progressive trek to 5140m. HA-related symptoms (Lake Louise [LLS] and AMS-C Scores) and state anxiety (State-Trait-Anxiety-Score [STAI Y-1]) were examined at each altitude with trait anxiety (STAI Y-2) at baseline. Results The average age was 32.1 +/- 8.3 years (67.5% men). STAI Y-1 scores fell from 848m to 3619m, before increasing to above baseline scores (848m) at >= 4072m (p = 0.01). STAI Y-1 scores correlated with LLS (r = 0.31; 0.24-0.3; P<0.0001) and AMS-C Scores (r = 0.29; 0.22-0.35; P<0.0001). There was significant main effect for sex (higher STAI Y-1 scores in women) and altitude with no sex-x-altitude interaction on STAI Y-1 Scores. Independent predictors of significant state anxiety included female sex, lower age, higher heart rate and increasing LLS and AMS-C scores (p<0.0001). A total of 38/80 subjects (47.5%) developed AMS which was mild in 20 (25%) and severe in 18 (22.5%). Baseline STAI Y-2 scores were an independent predictor of future severe AMS (B = 1.13; 1.009-1.28; p = 0.04; r(2) = 0.23) and STAI Y-1 scores at HA independently predicted AMS and its severity. Conclusion Trait anxiety at low altitude was an independent predictor of future severe AMS development at HA. State anxiety at HA was independently associated with AMS and its severity.	[Boos, Christopher J.; Sevier, Luke; Abdul-Razakq, Humayra] Poole Hosp NHS Fdn Trust, Dept Cardiol, Poole, Dorset, England; [Boos, Christopher J.] Bournemouth Univ, Dept Postgrad Med Educ, Bournemouth, Dorset, England; [Boos, Christopher J.; O'Hara, John P.; Mellor, Adrian; Cooke, Mark; Barlow, Matt; Woods, David R.] Leeds Beckett Univ, Res Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England; [Basso, Malcolm; Mellor, Adrian; Woods, David R.] Tees Esk & Wear Valleys NHS Trust, Middlesbrough, Cleveland, England; [Vincent, Emma; Mellor, Adrian] Def Med Serv, Lichfield, England; [Mellor, Adrian] James Cook Univ Hosp, Middlesbrough, Cleveland, England; [Woods, David R.] Northumbria & Newcastle NHS Trusts, Wansbeck Gen & Royal Victoria Infirm, Newcastle, NSW, Australia; [Woods, David R.] Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England	Bournemouth University; Leeds Beckett University; James Cook University Hospital; Newcastle University - UK	Boos, CJ (corresponding author), Poole Hosp NHS Fdn Trust, Dept Cardiol, Poole, Dorset, England.; Boos, CJ (corresponding author), Bournemouth Univ, Dept Postgrad Med Educ, Bournemouth, Dorset, England.; Boos, CJ (corresponding author), Leeds Beckett Univ, Res Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England.	christopherboos@hotmail.com		Barlow, Matthew/0000-0001-7291-9516; Dervin, Humayra/0000-0002-0356-9919				Ahmad S, 2017, PAK J MED SCI, V33, P231, DOI 10.12669/pjms.331.11393; Bartsch P, 2013, NEW ENGL J MED, V368, P2294, DOI 10.1056/NEJMcp1214870; Beidleman BA, 2007, HIGH ALT MED BIOL, V8, P192, DOI 10.1089/ham.2007.1016; Betz ME, 2011, SUICIDE LIFE-THREAT, V41, P562, DOI 10.1111/j.1943-278X.2011.00054.x; Bian SZ, 2016, PHYSIOL BEHAV, V167, P202, DOI 10.1016/j.physbeh.2016.09.008; Bian SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142375; Boos CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152868; Boos CJ, 2014, CLIN RES CARDIOL, V103, P291, DOI 10.1007/s00392-013-0654-2; BORTNER RW, 1969, J CHRON DIS, V22, P87, DOI 10.1016/0021-9681(69)90061-7; Dong JQ, 2013, PHYSIOL BEHAV, V112, P23, DOI 10.1016/j.physbeh.2013.02.001; Donzuso G, 2014, BRAIN BEHAV, V4, P504, DOI 10.1002/brb3.232; Fagenholz PJ, 2007, WILD ENVIRON MED, V18, P312, DOI 10.1580/07-WEME-BR-102R1.1; Guo L, 2015, EXP THER MED, V10, P907, DOI 10.3892/etm.2015.2611; Guo WY, 2017, CEPHALALGIA, V37, P336, DOI 10.1177/0333102416646761; Julian LJ, 2011, ARTHRIT CARE RES, V63, pS467, DOI 10.1002/acr.20561; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; KNIGHT RG, 1983, BRIT J CLIN PSYCHOL, V22, P245, DOI 10.1111/j.2044-8260.1983.tb00610.x; Leshem E, 2008, J TRAVEL MED, V15, P315, DOI 10.1111/j.1708-8305.2008.00229.x; MacInnis MJ, 2016, HIGH ALT MED BIOL, V17, P281, DOI 10.1089/ham.2016.0024; MacInnis MJ, 2015, HIGH ALT MED BIOL, V16, P290, DOI 10.1089/ham.2015.0065; Mellor A, 2017, J ROY ARMY MED CORPS, V163, P371, DOI 10.1136/jramc-2016-000700; MISSOUM G, 1992, INT J SPORTS MED, V13, pS37, DOI 10.1055/s-2007-1024587; Nicolas M, 1999, J ENVIRON PSYCHOL, V19, P407, DOI 10.1006/jevp.1999.0139; Niedermeier M, 2017, PHYSIOL BEHAV, V171, P187, DOI 10.1016/j.physbeh.2017.01.004; Oliver SJ, 2012, J TRAVEL MED, V19, P210, DOI 10.1111/j.1708-8305.2012.00609.x; Remes O, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.497; Roth WT, 2002, DEPRESS ANXIETY, V16, P51, DOI 10.1002/da.10059; Schulte-van Maaren YWM, 2013, J AFFECT DISORDERS, V150, P1008, DOI 10.1016/j.jad.2013.05.031; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Sracic MK, 2014, MIL MED, V179, P559, DOI 10.7205/MILMED-D-13-00359; Sutton J., 1992, HYPOXIA MOUNTAIN MED, P327	31	25	31	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0197147	10.1371/journal.pone.0197147	http://dx.doi.org/10.1371/journal.pone.0197147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK0LV	29927953	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000435802500003
J	Kang, SJ; Choi, SM; Choi, JA; Choi, JU; Oh, TH; Kim, SE; Kim, UJ; Won, EJ; Jang, HC; Park, KH; Shin, JH; Kweon, SS; Jung, SI				Kang, Seung Ji; Choi, Su-Mi; Choi, Jin-A; Choi, Jin Un; Oh, Tae-Hoon; Kim, Seong Eun; Kim, Uh Jin; Won, Eun Jeong; Jang, Hee-Chang; Park, Kyung-Hwa; Shin, Jong Hee; Kweon, Sun-Seog; Jung, Sook-In			Factors affecting the clinical relevance of Corynebacterium striatum isolated from blood cultures	PLOS ONE			English	Article							TOF-MASS-SPECTROMETRY; LEVEL DAPTOMYCIN RESISTANCE; 16S RIBOSOMAL-RNA; NOSOCOMIAL OUTBREAK; IDENTIFICATION; INFECTION; STRAINS; RPOB; ENDOCARDITIS; EMERGENCE	This study aimed to identify clinical or microbiological factors affecting the clinical relevance of Corynebacterium striatum isolated from blood cultures. A total of 64 isolates from 51 patients identified as C. striatum by matrix assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and 16S rRNA gene sequencing were assessed. More than two blood cultures were positive in 25 (48.1%) patients. Diabetes, solid tumor, and a history of previous exposure to antibiotics were more common in patients with multiple positive blood cultures. Charlson comorbidity scores were also higher, and more isolates were recovered after 48 hours of hospital stay in patients with multiple positive blood cultures. Strains recovered from patients with multiple positive blood cultures produced significantly more biofilm. Based on multilocus sequence typing (MLST), sequence type (ST) 20 (31.3%) was the most dominant, followed by ST2 (20.3%) and ST23 (10.9%). There was no relationship between the number of positive blood culture sets and sequence typing. In multivariate analyses, Carlson comorbidity score (odds ratio [OR], 1.91; 95% confidence interval [CI], 1.09-3.36; P = 0.03) and biofilm formation were associated with multiple positive blood cultures (OR, 17.43; 95% CI, 3.71-81.91; P = 0.03). This study provides evidence that the biofilm phenotype could contribute to determining the clinical significance of C. striatum in patients with severe underlying conditions. The predominance of certain STs suggests the relatedness of C. striatum infection and the nosocomial environment.	[Kang, Seung Ji; Choi, Su-Mi; Choi, Jin-A; Oh, Tae-Hoon; Kim, Seong Eun; Kim, Uh Jin; Jang, Hee-Chang; Park, Kyung-Hwa; Jung, Sook-In] Chonnam Natl Univ, Dept Internal Med, Med Sch, Gwangju, South Korea; [Choi, Jin Un; Won, Eun Jeong; Shin, Jong Hee] Chonnam Natl Univ, Dept Lab Med, Med Sch, Gwangju, South Korea; [Kweon, Sun-Seog] Chonnam Natl Univ, Dept Prevent Med, Med Sch, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University	Jung, SI (corresponding author), Chonnam Natl Univ, Dept Internal Med, Med Sch, Gwangju, South Korea.	sijung@chonnam.ac.kr	Kweon, Sun-Seog/AAZ-4732-2021; Won, Eun Jeong/AGX-7670-2022	Kweon, Sun-Seog/0000-0003-2378-8550; Kim, Seong Eun/0000-0003-0162-6155; Won, Eun Jeong/0000-0002-8750-4257	National Research Foundation of Korea [NRF-2013R1A1A3010554]; Chonnam National University Hospital Biomedical Research Institute [HCRI18013-1]	National Research Foundation of Korea(National Research Foundation of Korea); Chonnam National University Hospital Biomedical Research Institute	This work was supported by a grant from the National Research Foundation of Korea (http://www.nrf.re.kr/eng/main), (NRF-2013R1A1A3010554 [to SIJ]) and Chonnam National University Hospital Biomedical Research Institute (http://cnuhcrin.com/website2012/eng/), (HCRI18013-1 [to SJK]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibi S, 2015, PATHOL BIOL, V63, P153, DOI 10.1016/j.patbio.2015.07.007; Bernard K, 2012, J CLIN MICROBIOL, V50, P3152, DOI 10.1128/JCM.00796-12; Brandenburg AH, 1996, J CLIN MICROBIOL, V34, P2089, DOI 10.1128/JCM.34.9.2089-2094.1996; Campanile F, 2009, EMERG INFECT DIS, V15, P75, DOI 10.3201/eid1501.080804; Cherifi S, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-20; COWLING P, 1993, J INFECTION, V26, P335, DOI 10.1016/0163-4453(93)95823-2; de Arriba JJ, 2002, J INFECTION, V44, P193, DOI 10.1053/jinf.2001.0927; de Souza C, 2015, MEM I OSWALDO CRUZ, V110, P242, DOI 10.1590/0074-02760140373; Fernandez-Ayala M, 2001, AM J MED, V111, P167, DOI 10.1016/S0002-9343(01)00739-2; Gomila M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-52; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Hindler J, 2015, METH ANT DIL DISK SU; Iaria C, 2007, J HOSP INFECT, V67, P102, DOI 10.1016/j.jhin.2007.07.002; Ishiwada N, 2016, J INFECT CHEMOTHER, V22, P790, DOI 10.1016/j.jiac.2016.08.009; Jenkins A, 2015, MBIO, V6, DOI 10.1128/mBio.02272-14; Khamis A, 2005, J CLIN MICROBIOL, V43, P1934, DOI 10.1128/JCM.43.4.1934-1936.2005; Khamis A, 2004, J CLIN MICROBIOL, V42, P3925, DOI 10.1128/JCM.42.9.3925-3931.2004; LEONARD RB, 1994, J CLIN MICROBIOL, V32, P164, DOI 10.1128/JCM.32.1.164-169.1994; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin MC, 2003, J MED MICROBIOL, V52, P599, DOI 10.1099/jmm.0.05102-0; MARTINEZMARTINEZ L, 1995, J CLIN MICROBIOL, V33, P1318; MARTINEZMARTINEZ L, 1995, J CLIN MICROBIOL, V33, P2458; McMullen AR, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01111-17, 10.1128/aac.01111-17]; Mushtaq A, 2016, DIAGN MICR INFEC DIS, V85, P372, DOI 10.1016/j.diagmicrobio.2016.04.013; Neemuchwala A, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.01776-17, 10.1128/aac.01776-17]; Nudel K, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2017.12.024; Oliva A, 2010, J CLIN MICROBIOL, V48, P4669, DOI 10.1128/JCM.01532-10; Papadimitriou-Olivgeris M, 2015, J MED MICROBIOL, V64, P1270, DOI 10.1099/jmm.0.000151; Baio PVP, 2013, MEM I OSWALDO CRUZ, V108, P23, DOI 10.1590/S0074-02762013000100004; Petti C, 2008, MM18A CLIN LAB STAND; Qin L, 2017, JPN J INFECT DIS, V70, P152, DOI [10.7883/yoken.JJID.2015.530, 10.7883/yoken.jjid.2015.530]; Renom F, 2014, New Microbes New Infect, V2, P106, DOI 10.1002/nmi2.48; Renom F, 2007, J CLIN MICROBIOL, V45, P2064, DOI 10.1128/JCM.00152-07; Sperandei S, 2014, BIOCHEM MEDICA, V24, P12, DOI 10.11613/BM.2014.003; Tarr P E, 2003, Transpl Infect Dis, V5, P53; TeKippe EM, 2014, EUR J CLIN MICROBIOL, V33, P2199, DOI 10.1007/s10096-014-2188-6; Tran TT, 2012, ANTIMICROB AGENTS CH, V56, P3461, DOI 10.1128/AAC.00046-12; Verroken A, 2014, CLIN MICROBIOL INFEC, V20, P44, DOI 10.1111/1469-0691.12197; Werth BJ, 2016, MICROB DRUG RESIST, V22, P233, DOI 10.1089/mdr.2015.0208; Yang HS, 2015, ANN LAB MED, V35, P548, DOI 10.3343/alm.2015.35.5.548	40	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e019954	10.1371/journal.pone.0199454	http://dx.doi.org/10.1371/journal.pone.0199454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928059	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500098
J	Thongprayoon, C; Cheungpasitporn, W; Mao, MA; Sakhuja, A; Kashani, K				Thongprayoon, Charat; Cheungpasitporn, Wisit; Mao, Michael A.; Sakhuja, Ankit; Kashani, Kianoush			U-shape association of serum albumin level and acute kidney injury risk in hospitalized patients	PLOS ONE			English	Article							SURVIVAL; HYPOALBUMINEMIA; METAANALYSIS; RESUSCITATION; PREDICTOR; SURGERY	Background While an association between hypoalbuminemia and increased risk of acute kidney injury (AKI) is well-established, the risk of AKI development and its severity among patients with elevated serum albumin is unclear. The aim of this study was to evaluate the risk of AKI in hospitalized patients stratified by various admission serum albumin levels. Methods This single-center retrospective study was conducted at a tertiary referral hospital. All adult hospitalized patients who had admission albumin levels available between January 2009 and December 2013 were enrolled. Admission albumin was categorized based on its distribution into six groups (<= 2.4, 2.5-2.9, 3.0-3.4, 3.5-3.9, 4.0-4.4, and >= 4.5 mg/dL). The primary outcome was the incidence of hospital-acquired AKI (HAKI). Logistic regression analysis was performed to obtain the odds ratio of AKI for various admission albumin strata using the albumin 3.5 to 3.9 mg/dL (lowest incidence of AKI) as the reference group. Results Of the total 9,552 studied patients, HAKI occurred in 1,556 (16.3%) patients. The incidence of HAKI among patients with admission albumin (<= 2.4, 2.5-2.9, 3.0-3.4, 3.5-3.9, 4.0-4.4, and >= 4.5 mg/dL was 18.3%, 14.3%, 15.5%, 14.2%, 16.7%, and 26.0%, respectively. After adjusting for potential confounders, admission serum albumin levels <= 2.4 and >= 4.5 mg/dL were associated with an increased risk of HAKI with odds ratios of 1.52 (95% CI 1.18-1.94) and 2.16 (95% CI 1.74-2.69), respectively. While stage 1 HAKI was significantly more frequent among patients with admission albumin >= 4.5 mg/dL (23.0% vs. 11.6%, P<0.001), incidence of stage 3 HAKI was higher in those with albumin <= 2.4 mg/dL (2.8% vs 0.3%, P<0.001). Conclusion Admission serum albumin levels <= 2.4 and >= 4.5 mg/dL were associated with an increased risk for HAKI. Patients with admission albumin >= 4.5 mg/dL had HAKI with a lower intensity when compared with those who had admission albumin levels <= 2.4 mg/dL.	[Thongprayoon, Charat] Bassett Med Ctr, Dept Internal Med, Cooperstown, NY USA; [Cheungpasitporn, Wisit] Univ Mississippi, Med Ctr, Dept Internal Med, Div Nephrol, Jackson, MS 39216 USA; [Mao, Michael A.; Kashani, Kianoush] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Sakhuja, Ankit; Kashani, Kianoush] Mayo Clin, Dept Med, Div Pulm & Crit Care Med, Rochester, MN 55905 USA	University of Mississippi; University of Mississippi Medical Center; Mayo Clinic; Mayo Clinic	Kashani, K (corresponding author), Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN 55905 USA.; Kashani, K (corresponding author), Mayo Clin, Dept Med, Div Pulm & Crit Care Med, Rochester, MN 55905 USA.	kashani.kianoush@mayo.edu	Thongprayoon, Charat/J-4184-2019; Cheungpasitporn, Wisit/H-8194-2019	Thongprayoon, Charat/0000-0002-8313-3604; Cheungpasitporn, Wisit/0000-0001-9954-9711				Asher V, 2012, MED ONCOL, V29, P2005, DOI 10.1007/s12032-011-0019-5; Berbel MN, 2011, REV ASSOC MED BRAS, V57, P600, DOI 10.1590/S0104-42302011000500022; Blunt MC, 1998, ANAESTHESIA, V53, P755, DOI 10.1046/j.1365-2044.1998.00488.x; BURLESON RL, 1978, ARCH SURG-CHICAGO, V113, P688; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Cheng XC, 2015, EUR J CARDIO-THORAC, V47, P958, DOI 10.1093/ejcts/ezu330; CONTRERAS AM, 1994, REV INVEST CLIN, V46, P37; Delaney AP, 2011, CRIT CARE MED, V39, P386, DOI 10.1097/CCM.0b013e3181ffe217; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; DOWEIKO JP, 1991, JPEN-PARENTER ENTER, V15, P207, DOI 10.1177/0148607191015002207; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; FLECK A, 1985, LANCET, V1, P781; Garg AX, 2014, JAMA-J AM MED ASSOC, V312, P2254, DOI 10.1001/jama.2014.15284; GERKENS JF, 1990, EUR J PHARMACOL, V177, P119, DOI 10.1016/0014-2999(90)90261-4; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Igleslas J, 1999, AM J PHYSIOL-RENAL, V277, pF711, DOI 10.1152/ajprenal.1999.277.5.F711; Jellinge ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105983; Kashani K, 2017, CLIN CHEM LAB MED, V55, P1074, DOI 10.1515/cclm-2016-0973; KAYSEN GA, 1989, KIDNEY INT, V36, pS168; Lee EH, 2016, ANESTHESIOLOGY, V124, P1001, DOI 10.1097/ALN.0000000000001051; Lee EH, 2012, INTENS CARE MED, V38, P1478, DOI 10.1007/s00134-012-2599-8; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu M, 2012, EUR J HEART FAIL, V14, P39, DOI 10.1093/eurjhf/hfr154; Lyons O, 2010, EUR J INTERN MED, V21, P17, DOI 10.1016/j.ejim.2009.10.010; Margarson MP, 1998, ANAESTHESIA, V53, P789, DOI 10.1046/j.1365-2044.1998.00438.x; Marrero JA, 2010, ONCOLOGIST, V15, P23, DOI 10.1634/theoncologist.2010-S4-23; Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X; Mutlu EA, 2006, SCAND J GASTROENTERO, V41, P759, DOI 10.1080/00365520500442625; Namendys-Silva SA, 2011, AM J HOSP PALLIAT ME, V28, P253, DOI 10.1177/1049909110384841; Nie SS, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5605634; Parikh CR, 2016, KIDNEY INT, V89, P1372, DOI 10.1016/j.kint.2016.02.027; POCKAJ BA, 1994, J IMMUNOTHER, V15, P22, DOI 10.1097/00002371-199401000-00003; Pulimood TB, 2000, CRIT CARE, V4, P151, DOI 10.1186/cc688; REINHARDT GF, 1980, JPEN-PARENTER ENTER, V4, P357, DOI 10.1177/0148607180004004357; Sang BH, 2015, CRIT CARE MED, V43, P2552, DOI 10.1097/CCM.0000000000001279; Sung J, 2004, AM SURGEON, V70, P1099; Tanriverdi O, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0282-3; Thongprayoon C, 2018, J NEPHROL, V31, P241, DOI 10.1007/s40620-017-0442-6; Thongprayoon C, 2016, CLIN KIDNEY J, V9, P560, DOI 10.1093/ckj/sfw055; Thongprayoon C, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-176; Vincent JL, 2009, BEST PRACT RES-CLIN, V23, P183, DOI 10.1016/j.bpa.2008.11.004; Wegman DH, 2018, SCAND J WORK ENV HEA, V44, P16, DOI 10.5271/sjweh.3659; Wiedermann CJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9308; Wiedermann CJ, 2010, INTENS CARE MED, V36, P1657, DOI 10.1007/s00134-010-1928-z; Wilkes MM, 2001, ANN INTERN MED, V135, P149, DOI 10.7326/0003-4819-135-3-200108070-00007; Wilson FP, 2015, LANCET, V385, P1966, DOI 10.1016/S0140-6736(15)60266-5; Yacoub R, 2013, AM J KIDNEY DIS, V62, P1077, DOI 10.1053/j.ajkd.2013.04.018; Yu MY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180750; Zamlauski-Tucker M, 1988, Ren Physiol, V10, P352; Zavada J, 2010, NEPHROL DIAL TRANSPL, V25, P3911, DOI 10.1093/ndt/gfp766; Zuk A, 2016, ANNU REV MED, V67, P293, DOI 10.1146/annurev-med-050214-013407	51	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199153	10.1371/journal.pone.0199153	http://dx.doi.org/10.1371/journal.pone.0199153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927987	Green Submitted, gold, Green Published			2022-12-26	WOS:000435802500049
J	Park, JW; Koh, DH; Jang, WS; Lee, JY; Cho, KS; Ham, WS; Rha, KH; Jung, WH; Hong, SJ; Choi, YD				Park, Jae Won; Koh, Dong Hoon; Jang, Won Sik; Lee, Joo Yong; Cho, Kang Su; Ham, Won Sik; Rha, Koon Ho; Jung, Woo Hee; Hong, Sung Joon; Choi, Young Deuk			Age-adjusted Charlson Comorbidity Index as a prognostic factor for radical prostatectomy outcomes of very high-risk prostate cancer patients	PLOS ONE			English	Article							LONG-TERM SURVIVAL; QUALITY-OF-LIFE; MEN; VALIDATION; MORTALITY; IMPACT; SCORE	Purpose Prostate cancer (PC) is a devastating and heterogeneous condition with diverse treatment options. When selecting treatments for patients with very high-risk PC, clinicians must consider patient comorbidities. We investigated the efficacy of the age-adjusted Charlson Comorbidity Index (ACCI) as a prognostic factor for patient outcomes after radical prostatectomy (RP). Materials and methods We retrospectively investigated the medical records of PC patients at our institution who underwent RP from 1992 to 2010. Very high-risk PC was defined according to National Comprehensive Cancer Network guidelines. Patients with incomplete medical records or who had received neoadjuvant therapy were excluded. Preoperative comorbidity was evaluated by the ACCI, and the prognostic efficacy of the ACCI was analyzed using univariable and multivariable Cox regression, competing risk regression model and Kaplan-Meier curves. Results Our final analysis included 228 men with a median age of 66 years (interquartile range 62-71) and median prostate specific antigen of 10.7 ng/mL. There were 41 (18%) patients with an ACCI score >3 and 88 (38.6%) patients with a biopsy Gleason score >8. Preoperative evaluation revealed that 159 patients (69.7%) had a non-organ confined tumor (>= T3). Following RP, 8-year prostate cancer-specific survival (PCSS) and overall survival (OS) rates were 91.6% and 83.4%, respectively. Competing risk regression analysis revealed that ACCI was significantly associated with other-cause survival and OS (p<0.05). Conclusion The ACCI is an effective prognostic factor for other-cause survival and OS in very high-risk PC patients. RP should be considered carefully for patients with an ACCI score >3.	[Park, Jae Won] Ilsan Hosp, Natl Hlth Insurance Serv, Dept Urol, Goyang, South Korea; [Koh, Dong Hoon; Jang, Won Sik; Lee, Joo Yong; Cho, Kang Su; Ham, Won Sik; Rha, Koon Ho; Hong, Sung Joon; Choi, Young Deuk] Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol, Seoul, South Korea; [Jung, Woo Hee] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea	National Health Insurance Service; NHIS Ilsan Hospital; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Choi, YD (corresponding author), Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol, Seoul, South Korea.	youngd74@yuhs.ac	; Lee, Joo Yong/C-3851-2013	Jang, Won Sik/0000-0002-9082-0381; Lee, Joo Yong/0000-0002-3470-1767; Choi, Young Deuk/0000-0002-8545-5797; Rha, Koon Ho/0000-0001-8588-7584; Ham, Won Sik/0000-0003-2246-8838; Cho, Kang Su/0000-0002-3500-8833; Hong, Sung Joon/0000-0001-9869-065X				Albertsen PC, 2011, J CLIN ONCOL, V29, P1335, DOI 10.1200/JCO.2010.31.2330; Alibhai SMH, 2008, CANCER, V112, P1043, DOI 10.1002/cncr.23269; Berglund A, 2011, J UROLOGY, V185, P833, DOI 10.1016/j.juro.2010.10.061; Casey JT, 2009, J ENDOUROL, V23, P1519, DOI 10.1089/end.2009.0388; Chang CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148076; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Froehner M, 2008, UROLOGY, V72, P1252, DOI 10.1016/j.urology.2008.05.037; Jeldres C, 2008, EUR UROL, V54, P107, DOI 10.1016/j.eururo.2007.10.038; Jespersen CG, 2015, SCAND J UROL, V49, P366, DOI 10.3109/21681805.2015.1026936; Kastner C, 2006, PROSTATE CANCER P D, V9, P270, DOI 10.1038/sj.pcan.4500889; Koo KC, 2014, PROSTATE INT, V2, P127, DOI 10.12954/PI.14050; Lee JY, 2016, J CANCER RES CLIN, V142, P849, DOI 10.1007/s00432-015-2093-0; Lee JY, 2014, YONSEI MED J, V55, P316, DOI 10.3349/ymj.2014.55.2.316; Loeb S, 2010, UROLOGY, V76, P710, DOI 10.1016/j.urology.2009.09.014; Lunardi P, 2017, WORLD J UROL, V35, P587, DOI 10.1007/s00345-016-1900-9; Lund L, 2008, UROLOGY, V72, P1258, DOI 10.1016/j.urology.2007.12.018; National Cancer Institute, SEER CANC STAT REV; National Comprehensive Cancer Network, 2021, CENTRAL NERVOUS SYST; Oderda M, 2012, BJU INT, V110, pE192, DOI 10.1111/j.1464-410X.2012.10942.x; Piccirillo JF, 2004, JAMA-J AM MED ASSOC, V291, P2441, DOI 10.1001/jama.291.20.2441; Pompe RS, 2017, J UROLOGY, V198, P354, DOI 10.1016/j.juro.2017.02.070; Post PN, 2001, BJU INT, V87, P821, DOI 10.1046/j.1464-410x.2001.02189.x; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Stattin P, 2017, EUR UROL, V72, P125, DOI [10.1016/j.eururo.2016.07.023, 10.1016/j.eururo.2017.06.036]; Wei JT, 2002, J CLIN ONCOL, V20, P557, DOI 10.1200/JCO.20.2.557; Willis DL, 2012, BJU INT, V109, P898, DOI 10.1111/j.1464-410X.2011.10551.x; Zumsteg ZS, 2017, BJU INT, V120, pE87, DOI 10.1111/bju.13903	30	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199365	10.1371/journal.pone.0199365	http://dx.doi.org/10.1371/journal.pone.0199365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924851	gold, Green Published			2022-12-26	WOS:000435655600065
J	Su, JR; Ng, C; Lewis, PW; Cano, MV				Su, John R.; Ng, Carmen; Lewis, Paige W.; Cano, Maria V.			Adverse events after vaccination among HIV-positive persons, 1990-2016	PLOS ONE			English	Article							RECOMMENDED IMMUNIZATION SCHEDULE; INVASIVE PNEUMOCOCCAL DISEASE; CLINICAL-PRACTICE GUIDELINE; AGED 19 YEARS; ADVISORY-COMMITTEE; UNITED-STATES; RISK-FACTORS; INFLUENZA VACCINE; INFECTED ADULTS; VIRUS	Human immunodeficiency virus (HIV) causes immune dysregulation, potentially affecting response to vaccines in infected persons. We investigated if unexpected adverse events (AEs) or unusual patterns of AEs after vaccination were reported among HIV-positive persons. We searched for domestic reports among HIV-positive persons to the Vaccine Adverse Event Reporting System (VAERS) during 1990-2016. We analyzed reports by age group (< 19 and >= 19 years), sex, serious or non-serious status, live vaccine type (live versus inactivated), AEs reported, and CD4 counts. Of 532,235 reports received, 353 (0.07%) described HIV-positive persons, of whom 67% were aged >= 19 years, and 57% were male; most reports (75%) were non-serious. The most commonly reported inactivated vaccines were pneumococcal polysaccharide (27%) and inactivated influenza (27%); the mostly reported common live virus vaccines were combination measles, mumps, and rubella (8%) and varicella (6%). Injection site reactions were commonly reported (39%). Of 67 reports with CD4 counts available, 41 (61%) described persons immunocompromised at time of vaccination (CD4 count < 500 cells/mm 3), and differed from overall reports only in that varicella was the most common live virus vaccine (4 reports). Of 22 reports describing failure to protect against infection, 6 described persons immunocompromised at time of vaccination, among whom varicella vaccine was most common (3 reports). Of 66 reports describing live virus vaccines, 7 described persons with disseminated infection: 6 had disseminated varicella, 3 of whom had vaccine strain varicella-zoster virus. Of 18 reported deaths, 7 resulted from disseminated infection: 6 were among immunocompromised persons, 1 of whom had vaccine strain varicella-zoster virus. We identified no unexpected or unusual patterns of AEs among HIV-positive persons. These data reinforce current vaccine recommendations for this risk group. However, healthcare providers should know their HIV-positive patients' immune status because immunocompromising conditions can potentially increase the risk of rare, but severe, AEs following vaccination with live virus vaccines.	[Su, John R.; Ng, Carmen; Lewis, Paige W.; Cano, Maria V.] Ctr Dis Control & Prevent, Immunizat Safety Off, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Su, JR (corresponding author), Ctr Dis Control & Prevent, Immunizat Safety Off, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.	ezu2@cdc.gov		Ng, Carmen/0000-0003-4219-3907				Amendola A, 2002, VACCINE, V20, P3720, DOI 10.1016/S0264-410X(02)00357-2; Barry PM, 2006, AIDS, V20, P437, DOI 10.1097/01.aids.0000206507.54901.84; Beck James M, 2005, Proc Am Thorac Soc, V2, P423, DOI 10.1513/pats.200507-077JS; Boasso A, 2009, J INTERN MED, V265, P78, DOI 10.1111/j.1365-2796.2008.02043.x; Boschini A, 2006, J MED VIROL, V78, P1218, DOI 10.1002/jmv.20684; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention, HIV INF AD VACC 2017; Centers for Disease Control and Prevention, 2016, VACC INF STAT IVSS; Centers for Disease Control and Prevention, 2016, OPP INF; Centers for Disease Control and Prevention, 2016, HIV SURVEILLANCE REP, V27; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P1007; CHADWICK EG, 1994, PEDIATR INFECT DIS J, V13, P206, DOI 10.1097/00006454-199403000-00008; Corti M, 2011, REV SOC BRAS MED TRO, V44, P784, DOI 10.1590/S0037-86822011000600026; Dworkin MS, 2001, CLIN INFECT DIS, V32, P794, DOI 10.1086/319218; Ehresman K., 1999, Morbidity and Mortality Weekly Report, V48, P577; Falco V, 2006, VACCINE, V24, P2567, DOI 10.1016/j.vaccine.2005.12.021; Geretti AM, 2010, CURR OPIN INFECT DIS, V23, P32, DOI 10.1097/QCO.0b013e328334fec4; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1168, DOI 10.1093/cid/ciu558; Kim DK, 2017, MMWR-MORBID MORTAL W, V66, P136, DOI 10.15585/mmwr.mm6605e2; Kim DK, 2016, MMWR-MORBID MORTAL W, V65, P88, DOI 10.15585/mmwr.mm6504a5; Kim HN, 2009, INT J STD AIDS, V20, P595, DOI 10.1258/ijsa.2009.009126; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Lau YF, 2017, HUM VACC IMMUNOTHER, V13, P551, DOI 10.1080/21645515.2016.1246636; Lechiche C, 2006, SCAND J INFECT DIS, V38, P929, DOI 10.1080/00365540600561785; Lin JC, 2001, ARCH INTERN MED, V161, P441, DOI 10.1001/archinte.161.3.441; Lowes R., 2017, MEDSCAPE MED NEWS; Maves RC, 2014, J CLIN VIROL, V59, P63, DOI 10.1016/j.jcv.2013.10.027; National Institute of Health, 2015, GUID PREV TREATM OPP; Robinson CL, 2017, MMWR-MORBID MORTAL W, V66, P134, DOI 10.15585/mmwr.mm6605e1; Robinson CL, 2016, MMWR-MORBID MORTAL W, V65, P86, DOI 10.15585/mmwr.mm6504a4; RODRIGUEZBARRADAS MC, 1992, J INFECT DIS, V165, P553, DOI 10.1093/infdis/165.3.553; Rubin LG, 2014, CLIN INFECT DIS, V58, pE44, DOI [10.1093/cid/cit816, 10.1093/cid/cit684]; Shimabukuro TT, 2015, VACCINE, V33, P4398, DOI 10.1016/j.vaccine.2015.07.035; U.S. Department of Health and Human Services, 2013, GUID PREV TREATM OPP; Vigano A, 2008, JAIDS-J ACQ IMM DEF, V48, P289, DOI 10.1097/QAI.0b013e3181632cda; WILFERT CM, 1995, CLIN INFECT DIS, V21, pS134, DOI 10.1093/clinids/21.Supplement_1.S134; Winsett RE, 2016, IDCases, V6, P97, DOI 10.1016/j.idcr.2016.09.010; Wolfe S, 2015, EPIDEMIOLOGY PREVENT; World Health Organization, 2016, CONGUID UANT DRU	39	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199229	10.1371/journal.pone.0199229	http://dx.doi.org/10.1371/journal.pone.0199229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920551	gold, Green Submitted, Green Published			2022-12-26	WOS:000435541300026
J	Thiboonboon, K; Kulpeng, W; Teerawattananon, Y				Thiboonboon, Kittiphong; Kulpeng, Wantanee; Teerawattananon, Yot			An economic analysis of chromosome testing in couples with children who have structural chromosome abnormalities	PLOS ONE			English	Article							COST-EFFECTIVENESS; LIFE EXPECTANCY; SEARCH	Background Structural chromosome abnormalities can cause significant negative reproductive outcomes as they typically result in morbidity and mortality of newborns. The prevalence of structural chromosomal abnormalities in live births is at least 0.05%, of which many of them have parental origins. It is uncommon to predict structural chromosome abnormalities at birth in the first child but it is possible to prevent repeated abnormalities through screening and diagnostic programmes. This study will provide an economic analysis of the prenatal detection of these abnormalities. Methods A cost-benefit analysis using a decision analytic model was employed to compare the status quo (doing nothing) with two interventional strategies. The first strategy (Strategy I) is preconceptional screening plus amniocentesis, and the second strategy (Strategy II) is amniocentesis alone. The monetary values in Thai baht (THB) were adjusted to international dollars (I$) using purchasing power parity (PPP) (I$1 = THB 17.60 for the year 2013). The robustness of the results was tested by applying a probabilistic sensitivity analysis. Results Both diagnostic strategies can reduce approximately 10.7 +/- 11.1 births with abnormal chromosomes per 1,000 diagnosed couples. The benefit cost ratios were 1.62 for Strategy I and 1.24 for Strategy II. Net present values per 1,000 diagnoses in couples were I$ 464,000 for Strategy I and I$ 267,000 for Strategy II. The probabilistic sensitivity analysis suggested that the cost-benefit analysis was sufficiently robust, confirming that both strategies provided higher benefits than costs. Conclusions Since the benefits of both diagnostic strategies exceeded their costs, both strategies are economical +/- with Strategy I being more economically attractive. Strategy I is superior toStrategy II because it decreases the risk of normal children potentially dying from the amniocentesis process.	[Thiboonboon, Kittiphong; Kulpeng, Wantanee; Teerawattananon, Yot] Minist Publ Hlth, Dept Hlth, Hlth Intervent & Technol Assessment Program, Muang, Nonthaburi, Thailand; [Thiboonboon, Kittiphong] Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW, Australia	Ministry of Public Health - Thailand; University of Technology Sydney	Thiboonboon, K (corresponding author), Minist Publ Hlth, Dept Hlth, Hlth Intervent & Technol Assessment Program, Muang, Nonthaburi, Thailand.; Thiboonboon, K (corresponding author), Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW, Australia.	kittiphong.thiboonboon@uts.edu.au		Teerawattananon, Yot/0000-0003-2217-2930; Thiboonboon, Kittiphong/0000-0003-3922-4362	National Health Security Office (NHSO); Thailand Research Fund (TRF) [RTA5980011]	National Health Security Office (NHSO); Thailand Research Fund (TRF)(Thailand Research Fund (TRF))	This project is supported by the National Health Security Office (NHSO). The Health Intervention and Technology Assessment Program (HITAP) is funded by the Thailand Research Fund (TRF) under a grant for Senior Research Scholar (RTA5980011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings, interpretations, and conclusions expressed in this article do not necessarily reflect the views of the funding agencies.; This project is supported by the National Health Security Office (NHSO). The Health Intervention and Technology Assessment Program (HITAP) is funded by the Thailand Research Fund (TRF) under a grant for Senior Research Scholar (RTA5980011). The findings, interpretations, and conclusions expressed in this article do not necessarily reflect the views of the funding agencies.	[Anonymous], 1976, JAMA-J AM MED ASSOC, V236, P1471; [Anonymous], 2012, REP CONS PRIC IND TH; [Anonymous], 2018, REAL GDP GROWTH WORL; BAIRD PA, 1988, LANCET, V2, P1354; Berer M, 2017, HEALTH HUM RIGHTS, V19, P13; BOUE A, 1984, PRENATAL DIAG, V4, P45, DOI 10.1002/pd.1970040705; [Bureau international du travail Bureau of S International Labour O], 2003, STAT EMPL UN UND EC; Centers for Disease Control and Prevention, 1995, CHOR VILL SAMPL AMN; Chaiyakunapruk Nathom, 2008, J Med Assoc Thai, V91 Suppl 2, pS16; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Drummond M, 2009, VALUE HEALTH, V12, P409, DOI 10.1111/j.1524-4733.2008.00489.x; Eiben B, 2005, LANCET, V366, P1161, DOI 10.1016/S0140-6736(05)67473-9; Franssen MTM, 2006, BMJ-BRIT MED J, V332, P759, DOI 10.1136/bmj.38735.459144.2F; Ganiats TG, 1996, MED DECIS MAKING, V16, P45, DOI 10.1177/0272989X9601600112; Gekas J, 2011, EUR J HUM GENET, V19, P3, DOI 10.1038/ejhg.2010.138; Grimshaw G M, 2003, Health Technol Assess, V7, P1; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; JACOBS PA, 1992, J MED GENET, V29, P103, DOI 10.1136/jmg.29.2.103; Jaruratanasirikul Somchit, 2004, Journal of the Medical Association of Thailand, V87, P1199; Lamlertkittikul Surachai, 2007, Journal of the Medical Association of Thailand, V90, P1970; Leung WC, 2004, PRENATAL DIAG, V24, P790, DOI 10.1002/pd.985; Manopunya M, 2008, THAI J OBSTET GYNAEC, V16, P163; Moatti JP, 1999, HEALTH CARE ANAL, V7, P153, DOI 10.1023/A:1009437104347; Mohara A, 2012, J COMP EFFECT RES, V1, P137, DOI [10.2217/CER.12.10, 10.2217/cer.12.10]; MOONEY GH, 1980, J MED ETHICS, V6, P177, DOI 10.1136/jme.6.4.177; Pattanaphesaj J, 2012, J HEALTH SCI, V21, P667; Permsuwan Unchalee, 2008, J Med Assoc Thai, V91 Suppl 2, pS53; Petrou S, 2000, J MED SCREEN, V7, P59, DOI 10.1136/jms.7.2.59; Petrou S, 2001, HEALTH ECON, V10, P775, DOI 10.1002/hec.636; Pitukkijronnakorn S, 2011, ARCH GYNECOL OBSTET, V284, P793, DOI 10.1007/s00404-010-1727-3; Rodriguez-Caballero A, 2010, MED ORAL PATOL ORAL, V15, pE473, DOI 10.4317/medoral.15.e473; Shaffer LG, 2005, GENET MED, V7, P650, DOI 10.1097/01.gim.0000186545.83160.1e; Shannon NL, 2001, J MED GENET, V38, P674, DOI 10.1136/jmg.38.10.674; Suwanrath C, 1999, THAI J OBSTET GYNECO, V11, P105; Theisen A, 2010, APPL CLIN GENET, V3, P159, DOI 10.2147/TACG.S8884; van Leeuwen M, 2013, HUM REPROD, V28, P1737, DOI 10.1093/humrep/det067; von Mehren M, 2012, J NATL COMPR CANC NE, V10, P951, DOI 10.6004/jnccn.2012.0099; Wattanasirichaigoon D, 2013, RAMA NURS I, V19, P206; World DataBank, 2013, WORLD DEV IND DAT	39	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199318	10.1371/journal.pone.0199318	http://dx.doi.org/10.1371/journal.pone.0199318			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ7CA	29920550	Green Published, gold, Green Submitted			2022-12-26	WOS:000435541300035
J	Ushijima, B; Richards, GP; Watson, MA; Schubiger, CB; Hase, CC				Ushijima, Blake; Richards, Gary P.; Watson, Michael A.; Schubiger, Carla B.; Hase, Claudia C.			Factors affecting infection of corals and larval oysters by Vibrio coralliilyticus	PLOS ONE			English	Article							MANNOSE-SENSITIVE HEMAGGLUTININ; OUTER-MEMBRANE PROTEIN; CRASSOSTREA-GIGAS; BILE RESISTANCE; CLIMATE-CHANGE; POCILLOPORA-DAMICORNIS; SCLERACTINIAN CORAL; VIRULENCE FACTOR; TOXR REGULON; CHOLERAE	The bacterium Vibrio coralliilyticus can threaten vital reef ecosystems by causing disease in a variety of coral genera, and, for some strains, increases in virulence at elevated water temperatures. In addition, strains of V. coralliilyticus (formally identified as V. tubiashil) have been implicated in mass mortalities of shellfish larvae causing significant economic losses to the shellfish industry. Recently, strain BAA-450, a coral pathogen, was demonstrated to be virulent towards larval Pacific oysters (Crassostrea gigas). However, it is unclear whether other coral-associated V. coralliilyticus strains can cause shellfish mortalities and if infections are influenced by temperature. This study compared dose dependence, temperature impact, and gross pathology of four V. coralliilyticus strains (BAA-450, OCNO08, OCNO14 and RE98) on larval degrees C. gigas raised at 23 degrees C and 27 degrees C, and evaluated whether select virulence factors are required for shellfish infections as they are for corals. All strains were infectious to larval oysters in a dose-dependent manner with OCNO14 being the most pathogenic and BAA-450 being the least. At 27 C, higher larval mortalities (p < 0.05) were observed for all V. coralliilyticus strains, ranging from 38.8-93.7%. Gross pathological changes to the velum and cilia occurred in diseased larvae, but there were no distinguishable differences between oysters exposed to different V. coralliilyticus strains or temperatures. Additionally, in OCNO08, the predicted transcriptional regulator ToxR and the outer membrane protein OmpU were important for coral and oyster disease, while mannose sensitive hemagglutinin type IV pili were required only for coral infection. This study demonstrated that multiple coral pathogens can infect oyster larvae in a temperature-dependent manner and identified virulence factors required for infection of both hosts.	[Ushijima, Blake; Schubiger, Carla B.; Hase, Claudia C.] Oregon State Univ, Carlson Coll Vet Med, Corvallis, OR 97331 USA; [Richards, Gary P.; Watson, Michael A.] ARS, USDA, Dover, DE USA	Oregon State University; United States Department of Agriculture (USDA)	Ushijima, B (corresponding author), Oregon State Univ, Carlson Coll Vet Med, Corvallis, OR 97331 USA.	ushijimb@oregonstate.edu		Richards, Gary/0000-0003-1068-0874; Ushijima, Blake/0000-0002-1053-5207; Schubiger, Carla/0000-0002-6433-3125	USDA; ARS in-house [CRIS 8072-42000-081-00D]; Department of Clinical Veterinary Medicine	USDA(United States Department of Agriculture (USDA)); ARS in-house; Department of Clinical Veterinary Medicine	This work was supported by USDA, ARS in-house funding under CRIS 8072-42000-081-00D (G.P.R.) and internal funding provided by the Department of Clinical Veterinary Medicine at OSU (C.C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker-Austin C, 2016, EMERG INFECT DIS, V22, P1216, DOI [10.3201/eid2207.151996, 10.32032/eid2207.151996]; Baker-Austin C, 2013, NAT CLIM CHANGE, V3, P73, DOI [10.1038/nclimate1628, 10.1038/NCLIMATE1628]; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Brown T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067246; Burge CA, 2014, ANNU REV MAR SCI, V6, P249, DOI 10.1146/annurev-marine-010213-135029; Cesar Herman S. J., 2004, Pacific Science, V58, P231, DOI 10.1353/psc.2004.0014; Chiavelli DA, 2001, APPL ENVIRON MICROB, V67, P3220, DOI 10.1128/AEM.67.7.3220-3225.2001; Duperthuy M, 2011, P NATL ACAD SCI USA, V108, P2993, DOI 10.1073/pnas.1015326108; Duperthuy M, 2010, ENVIRON MICROBIOL, V12, P951, DOI 10.1111/j.1462-2920.2009.02138.x; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; Elston RA, 2008, DIS AQUAT ORGAN, V82, P119, DOI 10.3354/dao01982; Estes RM, 2004, DIS AQUAT ORGAN, V58, P223, DOI 10.3354/dao058223; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Friedlander A., 2008, STATE CORAL REEF ECO, P222; Gay M, 2004, DIS AQUAT ORGAN, V59, P49, DOI 10.3354/dao059049; Goo SY, 2006, INFECT IMMUN, V74, P5586, DOI 10.1128/IAI.00171-06; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Hasegawa H, 2008, APPL ENVIRON MICROB, V74, P4101, DOI 10.1128/AEM.00061-08; Hasegawa H, 2009, APPL ENVIRON MICROB, V75, P7602, DOI 10.1128/AEM.01016-09; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Karunasagar I, 2003, J APPL MICROBIOL, V95, P338, DOI 10.1046/j.1365-2672.2003.01984.x; Kesarcodi-Watson A, 2009, J FISH DIS, V32, P499, DOI 10.1111/j.1365-2761.2009.01006.x; Kimes NE, 2012, ISME J, V6, P835, DOI 10.1038/ismej.2011.154; Kvennefors ECE, 2012, MICROB ECOL, V63, P605, DOI 10.1007/s00248-011-9946-0; Le Roux F, 2007, APPL ENVIRON MICROB, V73, P777, DOI 10.1128/AEM.02147-06; Le Roux F, 2009, ENVIRON MICROBIOL, V11, P1959, DOI 10.1111/j.1462-2920.2009.01918.x; Lee SE, 2000, J BACTERIOL, V182, P3405, DOI 10.1128/JB.182.12.3405-3415.2000; LIN Z, 1993, J BACTERIOL, V175, P3844, DOI 10.1128/JB.175.12.3844-3855.1993; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Lovatelli A, 2004, HATCHERY CULTURE BIV; Martin JP, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00159; Mathur J, 2004, INFECT IMMUN, V72, P3577, DOI 10.1128/IAI.72.6.3577-3583.2004; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Nissimov J, 2009, FEMS MICROBIOL LETT, V292, P210, DOI 10.1111/j.1574-6968.2009.01490.x; Nyholm SV, 2009, ENVIRON MICROBIOL, V11, P483, DOI 10.1111/j.1462-2920.2008.01788.x; Park DK, 2006, J BACTERIOL, V188, P2214, DOI 10.1128/JB.188.6.2214-2221.2006; Paz S, 2007, ENVIRON RES, V103, P390, DOI 10.1016/j.envres.2006.07.002; PETERSON KM, 1988, INFECT IMMUN, V56, P2822, DOI 10.1128/IAI.56.11.2822-2829.1988; Provenzano D, 2000, P NATL ACAD SCI USA, V97, P10220, DOI 10.1073/pnas.170219997; Provenzano D, 2000, INFECT IMMUN, V68, P1491, DOI 10.1128/IAI.68.3.1491-1497.2000; Raina JB, 2016, PEERJ, V4, DOI 10.7717/peerj.2275; Richards GP, 2015, APPL ENVIRON MICROB, V81, P292, DOI 10.1128/AEM.02930-14; Rypien KL, 2010, ENVIRON MICROBIOL, V12, P28, DOI 10.1111/j.1462-2920.2009.02027.x; Santos ED, 2011, ISME J, V5, P1471, DOI 10.1038/ismej.2011.19; SPERANDIO V, 1995, INFECT IMMUN, V63, P4433, DOI 10.1128/IAI.63.11.4433-4438.1995; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sussman M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004511; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Tirado MC, 2010, FOOD RES INT, V43, P1745, DOI 10.1016/j.foodres.2010.07.003; Tirape A, 2007, DEV COMP IMMUNOL, V31, P859, DOI 10.1016/j.dci.2007.01.005; Ushijima B, 2016, ENVIRON MICROBIOL, V18, P4055, DOI 10.1111/1462-2920.13428; Ushijima B, 2014, APPL ENVIRON MICROB, V80, P2102, DOI 10.1128/AEM.03463-13; Ushijima B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046717; van de Water JAJM, 2018, MOL ECOL, V27, P1065, DOI 10.1111/mec.14489; Vezzulli L, 2016, P NATL ACAD SCI USA, V113, pE5062, DOI 10.1073/pnas.1609157113; Vezzulli L, 2010, ENVIRON MICROBIOL, V12, P2007, DOI 10.1111/j.1462-2920.2010.02209.x; Vidal-Dupiol J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107672; Vidal-Dupiol J, 2011, J BIOL CHEM, V286, P22688, DOI 10.1074/jbc.M110.216358; Vidal-Dupiol J, 2011, J EXP BIOL, V214, P1533, DOI 10.1242/jeb.053165; Wang SY, 2002, J BACTERIOL, V184, P1630, DOI 10.1128/JB.184.6.1630-1639.2002; Watnick PI, 1999, J BACTERIOL, V181, P3606, DOI 10.1128/JB.181.11.3606-3609.1999; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wells Sue, 2006, FRONT LINE SHORELINE; Welsh RM, 2017, PEERJ, V5, DOI 10.7717/peerj.3315; Whitaker WB, 2010, APPL ENVIRON MICROB, V76, P4720, DOI 10.1128/AEM.00474-10	71	15	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199475	10.1371/journal.pone.0199475	http://dx.doi.org/10.1371/journal.pone.0199475			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920567	Green Submitted, gold, Green Published			2022-12-26	WOS:000435541300048
J	Ban, EZ; Lye, MS; Chong, PP; Yap, YY; Lim, SYC; Rahman, HA				Ban, Eng-Zhuan; Lye, Munn-Sann; Chong, Pei Pei; Yap, Yoke-Yeow; Lim, Siew Ying Crystale; Rahman, Hejar Abdul			Association of hOGG1 Ser326Cys, ITGA2 C807T, TNF-A-308G > A and XPD Lys751Gln polymorphisms with the survival of Malaysian NPC patients	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; SQUAMOUS-CELL CARCINOMA; NECROSIS-FACTOR-ALPHA; GENE POLYMORPHISMS; NASOPHARYNGEAL CARCINOMA; ALPHA(2)BETA(1) INTEGRIN; NUCLEOTIDE POLYMORPHISMS; TUMOR ANGIOGENESIS; TNF-ALPHA; OGG1 GENE	Background Nasopharyngeal carcinoma is a rare form of cancer across the world except in certain areas such as Southern China, Hong Kong and Malaysia. NPC is considered a relatively radiosensitive tumor and patients diagnosed at early stages tend to survive longer compared to those with advanced disease. Given that early symptoms of NPC are non-specific and that the nasopharynx is relatively inaccessible, less invasive screening methods such as biomarker screening might be the key to improve NPC survival and management. A number of genes with their respective polymorphisms have been shown in past studies to be associated with survival of various cancers. hOGG1 and XPD genes encode for a DNA glycosylase and a DNA helicase respectively; both are proteins that are involved in DNA repair. ITGA2 is the alpha subunit of the transmembrane receptor integrin and is mainly responsible for cell-cell and cell-extracellular matrix interaction. TNF-alpha is a cytokine that is released by immune cells during inflammation. Methods Restriction fragment length polymorphism-polymerase chain reaction (RFLP-PCR) was used to genotype all the aforementioned gene polymorphisms. Kaplan-Meier survival function, log-rank test and Cox regression were used to investigate the effect of gene polymorphisms on the all-cause survival of NPC. Results NPC cases carrying T/T genotype of ITGA2 C807T have poorer all-cause survival compared to those with C/C genotypes, with an adjusted HR of 2.06 (95% CI = 1.14-3.72) in individual model. The 5-year survival rate of C/C carriers was 55% compared to those with C/T and T/T where the survival rates were 50% and 43%, respectively. Conclusion The finding from the present study showed that ITGA2 C807T polymorphism could be potentially useful as a prognostic biomarker for NPC. However, the prognostic value of ITGA2 C807T polymorphism has to be validated by well-designed further studies with larger patient numbers.	[Ban, Eng-Zhuan; Lye, Munn-Sann; Rahman, Hejar Abdul] Univ Putra Malaysia, Dept Community Hlth, Fac Med & Hlth Sci, Serdang, Malaysia; [Chong, Pei Pei] Univ Putra Malaysia, Dept Biomed Sci, Fac Med & Hlth Sci, Serdang, Malaysia; [Yap, Yoke-Yeow] Univ Putra Malaysia, Dept Otorhinolaryngol, Fac Med & Hlth Sci, Serdang, Malaysia; [Lim, Siew Ying Crystale] UCSI Univ, Fac Sci Appl, Cheras, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; UCSI University	Lye, MS (corresponding author), Univ Putra Malaysia, Dept Community Hlth, Fac Med & Hlth Sci, Serdang, Malaysia.	lyems9@yahoo.com	Lim, Crystale Siew Ying/W-1295-2019; Chong, Pei Pei/AAP-4227-2021; Chong, Pei pei/G-1367-2018	Lim, Crystale Siew Ying/0000-0002-0517-0610; Chong, Pei Pei/0000-0002-8229-3593; Chong, Pei pei/0000-0002-8229-3593	Science Fund from the Ministry of Science, Technology and Innovation, Malaysia [04-11-08-625FR]	Science Fund from the Ministry of Science, Technology and Innovation, Malaysia	The study was funded solely by the Science Fund from the Ministry of Science, Technology and Innovation, Malaysia as declared in the submission system (04-11-08-625FR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2007, IMMUNOL REV, V218, P29, DOI 10.1111/j.1600-065X.2007.00531.x; ALBELDA SM, 1990, CANCER RES, V50, P6757; Banescu C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/213790; Ben Nasr H, 2008, CLIN CHIM ACTA, V395, P124, DOI 10.1016/j.cca.2008.05.022; Boiteux S, 2000, ARCH BIOCHEM BIOPHYS, V377, P1, DOI 10.1006/abbi.2000.1773; BREUSS JM, 1995, J CELL SCI, V108, P2241; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Chen J, 2003, CELL CYCLE, V2, P503, DOI 10.4161/cc.2.6.558; Chen J, 2011, WORLD J GASTROENTERO, V17, P2860, DOI 10.3748/wjg.v17.i23.2860; Chen L, 2012, RADIOTHER ONCOL, V104, P331, DOI 10.1016/j.radonc.2011.10.009; Chen RW, 2015, ONCOTARGETS THER, V8, P2835, DOI 10.2147/OTT.S90430; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Coleman WB, 2001, MOL BASIS HUMAN CANC; CONRAD PA, 1993, J CELL BIOL, V120, P1381, DOI 10.1083/jcb.120.6.1381; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Ding W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135128; Elahi A, 2002, CARCINOGENESIS, V23, P1229, DOI 10.1093/carcin/23.7.1229; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Farnebo L, 2015, DNA REPAIR, V31, P64, DOI 10.1016/j.dnarep.2015.05.003; FitzGerald LM, 2009, EUR J HUM GENET, V17, P368, DOI 10.1038/ejhg.2008.171; Forman D, 2014, CANC INCIDENCE 5 CON, VX; Garmy-Susini Barbara, 2008, Lymphatic Research and Biology, V6, P155, DOI 10.1089/lrb.2008.1011; Gerger A, 2009, INT J COLORECTAL DIS, V24, P159, DOI 10.1007/s00384-008-0587-9; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Ha YS, 2011, ANN SURG ONCOL, V18, P1775, DOI 10.1245/s10434-010-1500-7; Hall CL, 2008, NEOPLASIA, V10, P797, DOI 10.1593/neo.08380; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hofmann G, 2011, ANTICANCER RES, V31, P1373; Huang CG, 2012, MOL BIOL REP, V39, P709, DOI 10.1007/s11033-011-0789-z; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Juszczynski P, 2002, BLOOD, V100, P3037, DOI 10.1182/blood-2002-02-0654; Kam MKM, 2004, INT J RADIAT ONCOL, V60, P1440, DOI 10.1016/j.ijrobp.2004.05.022; Kozlova NI, 2007, EXCLI J, V6, P145; Kritzik M, 1998, BLOOD, V92, P2382, DOI 10.1182/blood.V92.7.2382; Kroeger KR, 1996, BIOCHEM MOL BIOL INT, V40, P43; Langsenlehner U, 2006, BREAST CANCER RES TR, V97, P67, DOI 10.1007/s10549-005-9089-4; Lech-Maranda E, 2013, GENE CHROMOSOME CANC, V52, P287, DOI 10.1002/gcc.22028; Li DH, 2007, INT J CANCER, V120, P1748, DOI 10.1002/ijc.22301; Lye MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130530; Makni L, 2016, META GENE, V10, P90, DOI 10.1016/j.mgene.2016.02.003; Min HQ, 1998, STUDY NASOPHARYNGEAL, P6; Nash HM, 1997, CHEM BIOL, V4, P693, DOI 10.1016/S1074-5521(97)90225-8; Pare L, 2008, BRIT J CANCER, V99, P1050, DOI 10.1038/sj.bjc.6604671; Park HB, 2004, BIOCHEM J, V378, P559, DOI 10.1042/BJ20031392; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Ramirez NE, 2011, J CLIN INVEST, V121, P226, DOI 10.1172/JCI42328; Rathinam R, 2010, CANCER METAST REV, V29, P223, DOI 10.1007/s10555-010-9211-x; Robertson JH, 2009, CLIN EXP METASTAS, V26, P769, DOI 10.1007/s10585-009-9276-5; Salles G, 1996, BRIT J HAEMATOL, V93, P352, DOI 10.1046/j.1365-2141.1996.5181059.x; SANCAR A, 1994, SCIENCE, V266, P1954, DOI 10.1126/science.7801120; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Shen J, 2007, CANCER, V109, P574, DOI 10.1002/cncr.22417; Spano JP, 2003, EUR J CANCER, V39, P2121, DOI 10.1016/S0959-8049(03)00367-8; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Swenberg JA, 2011, TOXICOL SCI, V120, pS130, DOI 10.1093/toxsci/kfq371; Tarabar O, 2014, INT J CLIN ONCOL, V19, P186, DOI 10.1007/s10147-013-0531-z; Tengstrom M, 2014, ACTA ONCOL, V53, P769, DOI 10.3109/0284186X.2014.892210; Tiseo M, 2012, LUNG CANCER, V78, P92, DOI 10.1016/j.lungcan.2012.07.009; TRACEY KJ, 1988, J EXP MED, V167, P1211, DOI 10.1084/jem.167.3.1211; Tripepi G, 2010, NEPHRON CLIN PRACT, V115, pC94, DOI 10.1159/000312871; Ward MH, 2000, INT J CANCER, V86, P603, DOI 10.1002/(SICI)1097-0215(20000601)86:5&lt;603::AID-IJC1&gt;3.0.CO;2-H; Warzocha K, 1998, BLOOD, V91, P3574; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Xie H, 2013, BREAST, V22, P707, DOI 10.1016/j.breast.2012.12.016; Yu X, 2000, J CELL SCI, V113, P2139; Yuan T, 2012, DIGEST DIS SCI, V57, P2451, DOI 10.1007/s10620-012-2192-6; Zainal Ariffin O, 2011, NATL CANC REPORT 200; Zhang ZH, 2008, BLOOD, V111, P1980, DOI 10.1182/blood-2007-06-094680; Zhu QY, 2010, CLIN CHIM ACTA, V411, P179, DOI 10.1016/j.cca.2009.10.024; ZUTTER MM, 1995, P NATL ACAD SCI USA, V92, P7411, DOI 10.1073/pnas.92.16.7411	73	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198332	10.1371/journal.pone.0198332	http://dx.doi.org/10.1371/journal.pone.0198332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912899	gold, Green Published, Green Submitted			2022-12-26	WOS:000435528600024
J	Moretti, IF; Franco, DG; Galatro, TFD; Marie, SKN				Moretti, Isabele Fattori; Franco, Daiane Gil; de Almeida Galatro, Thais Fernanda; Nagahashi Marie, Suely Kazue			Plasmatic membrane toll-like receptor expressions in human astrocytomas	PLOS ONE			English	Article							NF-KAPPA-B; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; GLIOBLASTOMA; PTEN; INHIBITORS; NECROSIS; CANCER; PHOSPHORYLATION; PROGRESSION	Toll-like receptors (TLRs) are the first to identify disturbances in the immune system, recognizing pathogens such as bacteria, fungi, and viruses. Since the inflammation process plays an important role in several diseases, TLRs have been considered potential therapeutic targets, including treatment for cancer. However, TLRs' role in cancer remains ambiguous. This study aims to analyze the expression levels of plasmatic cell membrane TLRs (TLR1, TLR2, TLR4, TLR5, and TLR6) in human astrocytomas the most prevalent tumors of CNS different grades (II-IV). We demonstrated that TLR expressions were higher in astrocytoma samples compared to non-neoplastic brain tissue. The gene and protein expressions were observed in GBM cell lines U87MG and A172, proving their presence in the tumor cells. Associated expressions between the known heterodimers TLR1-TLR2 were found in all astrocytoma grades. In GBMs, the mesenchymal subtype showed higher levels of TLR expressions in relation to classical and proneural subtypes. A strong association of TLRs with the activation of cell cycle process and signaling through canonical, inflammasome and ripoptosome pathways was observed by in silico analysis, further highlighting TLRs as interesting targets for cancer treatment.	[Moretti, Isabele Fattori; Franco, Daiane Gil; de Almeida Galatro, Thais Fernanda; Nagahashi Marie, Suely Kazue] Univ Sao Paulo, Fac Med FMUSP, Dept Neurol, Lab Mol & Cellular Biol LIM 15, Sao Paulo, Brazil	Universidade de Sao Paulo	Moretti, IF (corresponding author), Univ Sao Paulo, Fac Med FMUSP, Dept Neurol, Lab Mol & Cellular Biol LIM 15, Sao Paulo, Brazil.	isabelemoretti@usp.br	Oba-Shinjo, Sueli M./C-4017-2012; Moretti, Isabele/HGF-1356-2022; Marie, Suely Kazue Nagahashi/D-1870-2012	Oba-Shinjo, Sueli M./0000-0002-1650-5973; Moretti, Isabele/0000-0002-3079-4273; Marie, Suely Kazue Nagahashi/0000-0003-4419-7928	Sao Paulo Research Foundation (FAPESP) [2013/06315-3, 2013/02162-8, 2014/50137-5, 2016/14695-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [NUFFIC 062/15]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [305730/2015-0]; Fundacao Faculdade de Medicina	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Faculdade de Medicina	This work was supported by Sao Paulo Research Foundation (FAPESP, http://www.fapesp.br/), grants 2013/06315-3 (SKNM), 2013/02162-8 (SKNM), 2014/50137-5 (SKNM), and 2016/14695-9 (IFM); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br/) grant number NUFFIC 062/15 (SKNM); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br/) grant number 305730/2015-0; Fundacao Faculdade de Medicina.	Ahn SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24552; Aksoy E, 2012, NAT IMMUNOL, V13, P1045, DOI 10.1038/ni.2426; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Brescia P, 2013, STEM CELLS, V31, P857, DOI 10.1002/stem.1317; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Che FY, 2017, ONCOTARGET, V8, P53495, DOI 10.18632/oncotarget.18586; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; da Silva R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119781; Das A, 2016, TUMOR BIOL, V37, P7525, DOI 10.1007/s13277-015-4621-6; David A, 2017, HAEMATOLOGICA, V102, P883, DOI 10.3324/haematol.2016.156281; Galatro TFD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061605; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Fenton TR, 2012, P NATL ACAD SCI USA, V109, P14164, DOI 10.1073/pnas.1211962109; Fisher DT, 2014, SEMIN IMMUNOL, V26, P38, DOI 10.1016/j.smim.2014.01.008; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Friedmann-Morvinski D, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501292; Galatro Thais F, 2017, MedicalExpress (São Paulo, online), V4, pM170505, DOI 10.5935/medicalexpress.2017.05.05; Guo BC, 2016, SCI REP-UK, V6, DOI 10.1038/srep36107; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Gupta P, 2013, CELL SIGNAL, V25, P682, DOI 10.1016/j.cellsig.2012.12.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lewis AM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-48; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Marie SKN, 2008, INT J CANCER, V122, P807, DOI 10.1002/ijc.23189; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Najjar M, 2016, IMMUNITY, V45, P46, DOI 10.1016/j.immuni.2016.06.007; Newton K, 2016, CELL DEATH DIFFER, V23, P1565, DOI 10.1038/cdd.2016.46; Oba-Shinjo SM, 2005, MOL BRAIN RES, V140, P25, DOI 10.1016/j.molbrainres.2005.06.015; Oliva-Gonzalez C, 2017, TOXICOL LETT, V280, P92, DOI 10.1016/j.toxlet.2017.08.013; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Ping PH, 2016, ARCH BIOCHEM BIOPHYS, V604, P20, DOI 10.1016/j.abb.2016.06.001; Pradere JP, 2014, ONCOGENE, V33, P3485, DOI 10.1038/onc.2013.302; Qin ZH, 2007, ACTA PHARMACOL SIN, V28, P1859, DOI 10.1111/j.1745-7254.2007.00741.x; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Raza SA, 2002, NEUROSURGERY, V51, P2, DOI 10.1097/00006123-200207000-00002; Sarrazy V, 2011, CANCER LETT, V311, P195, DOI 10.1016/j.canlet.2011.07.018; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schratt G, 2001, MOL CELL BIOL, V21, P2933, DOI 10.1128/MCB.21.8.2933-2943.2001; Singh AR, 2014, EXP CELL RES, V327, P78, DOI 10.1016/j.yexcr.2014.05.016; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stupp R, 2005, ANN ONCOL, V16, P949; Tan YH, 2015, IMMUNITY, V43, P909, DOI 10.1016/j.immuni.2015.10.008; Thuringer D, 2011, J BIOL CHEM, V286, P3418, DOI 10.1074/jbc.M110.154823; Turner DA, 2010, J CELL SCI, V123, P2834, DOI 10.1242/jcs.069641; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang F, 2015, AM J TRANSL RES, V7, P607; Wang QH, 2017, CANCER CELL, V32, P42, DOI 10.1016/j.ccell.2017.06.003; Yin HK, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/9687052	58	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199211	10.1371/journal.pone.0199211	http://dx.doi.org/10.1371/journal.pone.0199211			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912993	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600090
J	Shinde, RN; Kumar, GS; Eqbal, S; Sobhia, ME				Shinde, Ranajit Nivrutti; Kumar, G. Siva; Eqbal, Shahbaz; Sobhia, M. Elizabeth			Screening and identification of potential PTP1B allosteric inhibitors using in silico and in vitro approaches	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; MOLECULAR-DYNAMICS SIMULATIONS; SIGNAL-TRANSDUCTION; NEGATIVE REGULATOR; INSULIN; 1B; LIGANDS; MODEL; STATE	Protein tyrosine phosphatase 1B (PTP1B) is a validated therapeutic target for Type 2 diabetes due to its specific role as a negative regulator of insulin signaling pathways. Discovery of active site directed PTP1B inhibitors is very challenging due to highly conserved nature of the active site and multiple charge requirements of the ligands, which makes them non-selective and non-permeable. Identification of the PTP1B allosteric site has opened up new avenues for discovering potent and selective ligands for therapeutic intervention. Interactions made by potent allosteric inhibitor in the presence of PTP1B were studied using Molecular Dynamics (MD). Computationally optimized models were used to build separate pharmacophore models of PTP1B and TCPTP, respectively. Based on the nature of interactions the target residues offered, a receptor based pharmacophore was developed. The pharmacophore considering conformational flexibility of the residues was used for the development of pharmacophore hypothesis to identify potentially active inhibitors by screening large compound databases. Two pharmacophore were successively used in the virtual screening protocol to identify potential selective and permeable inhibitors of PTP1B. Allosteric inhibition mechanism of these molecules was established using molecular docking and MD methods. The geometrical criteria values confirmed their ability to stabilize PTP1B in an open conformation. 23 molecules that were identified as potential inhibitors were screened for PTP1 B inhibitory activity. After screening, 10 molecules which have good permeability values were identified as potential inhibitors of PTP1B. This study confirms that selective and permeable inhibitors can be identified by targeting allosteric site of PTP1B.	[Shinde, Ranajit Nivrutti; Kumar, G. Siva; Eqbal, Shahbaz; Sobhia, M. Elizabeth] Natl Inst Pharmaceut Educ & Res, Dept Pharmacoinformat, Sas Nagar, Punjab, India; [Shinde, Ranajit Nivrutti] SVKMs NMIMS, Sch Pharm & Technol Management, Shirpur, Maharashtra, India	National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali); SVKM's NMIMS (Deemed to be University)	Sobhia, ME (corresponding author), Natl Inst Pharmaceut Educ & Res, Dept Pharmacoinformat, Sas Nagar, Punjab, India.	mesophia@niper.ac.in			NIPER; SAS Nagar; Ministry of chemical and fertilizers, Government of India	NIPER; SAS Nagar; Ministry of chemical and fertilizers, Government of India	The work is supported by the NIPER, SAS Nagar and Ministry of chemical and fertilizers, Government of India. The funders had no role in study design, data collection, and analysis, decision to publish or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; BARFORD D, 1995, NAT STRUCT BIOL, V2, P1043, DOI 10.1038/nsb1295-1043; Barnum D, 1996, J CHEM INF COMP SCI, V36, P563, DOI 10.1021/ci950273r; Barr K, 2004, COMPOUNDS MODULATE A; Baskaran SK, 2012, J CHEM INF MODEL, V52, P2004, DOI 10.1021/ci200581g; Bharatham K, 2008, J COMPUT AID MOL DES, V22, P925, DOI 10.1007/s10822-008-9229-0; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/nchem.1243, 10.1038/NCHEM.1243]; Brandao TAS, 2010, J BIOL CHEM, V285, P15874, DOI 10.1074/jbc.M109.066951; Byon JCH, 1998, MOL CELL BIOCHEM, V182, P101, DOI 10.1023/A:1006868409841; Cereto-Massague A, 2012, BIOINFORMATICS, V28, P1661, DOI 10.1093/bioinformatics/bts249; Chen J, 2006, J CHEM INF MODEL, V46, P2684, DOI 10.1021/ci600246s; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cui W, 2013, J CHEM INF MODEL, V53, P1157, DOI 10.1021/ci300526u; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Dixon SL, 2006, J COMPUT AID MOL DES, V20, P647, DOI 10.1007/s10822-006-9087-6; Dube N, 2005, BBA-PROTEINS PROTEOM, V1754, P108, DOI 10.1016/j.bbapap.2005.07.030; Ehrlich P, 1909, BER DTSCH CHEM GES, V42, P17, DOI 10.1002/cber.19090420105; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Hendriks WJAJ, 2013, FEBS J, V280, P708, DOI 10.1111/febs.12000; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Iversen LF, 2002, J BIOL CHEM, V277, P19982, DOI 10.1074/jbc.M200567200; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kamerlin SCL, 2006, BIOCHEM BIOPH RES CO, V345, P1161, DOI 10.1016/j.bbrc.2006.04.181; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Lee JY, 2008, B KOREAN CHEM SOC, V29, P1479; Li HS., 2000, PRINCIPLES TECHNIQUE; Li S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097668; Liu F, 1996, J BIOL CHEM, V271, P31290, DOI 10.1074/jbc.271.49.31290; Kamerlin SCL, 2007, BIOCHEM BIOPH RES CO, V356, P1011, DOI 10.1016/j.bbrc.2007.03.093; Montalibet J, 2006, J BIOL CHEM, V281, P5258, DOI 10.1074/jbc.M511546200; Nan F, 2008, SHANGHAI I MAT MED C; Olmez EO, 2011, J BIOMOL STRUCT DYN, V28, P675, DOI 10.1080/07391102.2011.10508599; Ortuso F, 2006, BIOINFORMATICS, V22, P1449, DOI 10.1093/bioinformatics/btl115; Peters GH, 2000, BIOPHYS J, V78, P2191, DOI 10.1016/S0006-3495(00)76768-3; Peters GH, 1999, BIOPHYS J, V77, P505, DOI 10.1016/S0006-3495(99)76907-9; Richmond NJ, 2006, J COMPUT AID MOL DES, V20, P567, DOI 10.1007/s10822-006-9082-y; Shinde RN, 2013, J MOL GRAPH MODEL, V45, P98, DOI 10.1016/j.jmgm.2013.08.001; Singh U, 2013, MOL SIMULAT, V39, P385, DOI 10.1080/08927022.2012.731506; Tang YB, 2013, BIOORG MED CHEM LETT, V23, P2313, DOI 10.1016/j.bmcl.2013.02.073; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wermuth CG, 1998, ANNU REP MED CHEM, V33, P385, DOI DOI 10.1016/S0065-7743(08)61101-X; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X	51	17	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199020	10.1371/journal.pone.0199020	http://dx.doi.org/10.1371/journal.pone.0199020			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912965	Green Published, gold, Green Submitted			2022-12-26	WOS:000435528600068
J	Onishi, Y; Yamanaka, T; Okumura, T; Kawagucci, S; Watanabe, HK; Ohara, Y				Onishi, Yuji; Yamanaka, Toshiro; Okumura, Tomoyo; Kawagucci, Shinsuke; Watanabe, Hiromi Kayama; Ohara, Yasuhiko			Evaluation of nutrient and energy sources of the deepest known serpentinite-hosted ecosystem using stable carbon, nitrogen, and sulfur isotopes	PLOS ONE			English	Article							VENT; SUBDUCTION; SEA; FRACTIONATION; COMMUNITIES; HYDROGEN; DELTA-N-15; BACTERIA; METHANE; NITRATE	The Shinkai Seep Field (SSF) in the southern Mariana forearc discovered in 2010 is the deepest (similar to 5,700 m in depth) known serpentinite-hosted ecosystem dominated by a vesicomyid clam, Calyptogena (Abyssogena) mariana. The pioneering study presumed that the animal communities are primary sustained by reducing fluid originated from the serpentinization of mantle peridotite. For understanding the nutrient and energy sources for the SSF community, this study conducted four expeditions to the SSF and collected additional animal samples such as polychaetes and crustaceans as well as sediments, fragments of chimneys developing on fissures of serpentinized peridotite, seeping fluid on the chimneys, and pore water within the chimneys. Geochemical analyses of seeping fluids on the chimneys and pore water of the chimneys revealed significantly high pH (similar to 10) that suggest subseafloor serpentinization controlling fluid chemistry. Stable isotope systematics (carbon, nitrogen, and sulfur) among animals, inorganic molecules, and environmental organic matter suggest that the SSF animal community mostly relies on the chemosynthetic production while some organisms appear to partly benefit from photosynthetic production despite the great depth of SSF.	[Onishi, Yuji; Yamanaka, Toshiro] Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, Okayama, Okayama, Japan; [Okumura, Tomoyo; Kawagucci, Shinsuke; Ohara, Yasuhiko] Japan Agcy Marine Earth Sci & Technol, Dept Subsurface Geobiol Anal & Res D SUGAR, Yokosuka, Kanagawa, Japan; [Watanabe, Hiromi Kayama] Japan Agcy Marine Earth Sci & Technol, Dept Marine Biodivers Res, Yokosuka, Kanagawa, Japan; [Ohara, Yasuhiko] Hydrog & Oceanog Dept Japan, Chiyoda Ku, Tokyo, Japan; [Yamanaka, Toshiro] Tokyo Univ Marine Sci & Technol, Sch Marine Resource & Environm, Minato Ku, Tokyo, Japan; [Okumura, Tomoyo] Kochi Univ, Ctr Adv Marine Core Res, Nanko Ku, Kochi, Japan	Okayama University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Tokyo University of Marine Science & Technology; Kochi University	Onishi, Y (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Kita Ku, Okayama, Okayama, Japan.	sc20505@s.okayama-u.ac.jp	kawagucci, shinsuke/H-6047-2013; YAMANAKA, Toshiro/B-2644-2011; Kawagucci, Shinsuke/O-7813-2019	kawagucci, shinsuke/0000-0002-7807-024X; YAMANAKA, Toshiro/0000-0002-6807-6904; Onishi, Yuji/0000-0002-5614-8464; Watanabe, Hiromi/0000-0001-5031-9018	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan through Special Coordination Funds 'TAIGA' project [20109005, 16H06347, 15H05468]; Japan Science and Technology Agency of CREST program, Japan [JPMJCR11A2]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan through Special Coordination Funds 'TAIGA' project; Japan Science and Technology Agency of CREST program, Japan	This study was partly supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT; http//www.mext.go.jp/en/) of Japan through Special Coordination Funds 'TAIGA' project (20109005; T.Y.), Kiban-S (16H06347; Y. O.) and a grant-in aids for Young Scientists (15H05468; T. O.), and Japan Science and Technology Agency (JST; http://www.jst.go.jp/ kisoken/crest/en/index.html) of CREST program (JPMJCR11A2; T. Y.), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; Becker EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074459; Beinart RA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2811; Berndt ME, 1996, GEOLOGY, V24, P351, DOI 10.1130/0091-7613(1996)024<0351:ROCDSO>2.3.CO;2; BOULEGUE J, 1987, EARTH PLANET SC LETT, V83, P343, DOI 10.1016/0012-821X(87)90076-8; Bradley AS, 2010, EARTH PLANET SC LETT, V297, P34, DOI 10.1016/j.epsl.2010.05.034; Bradley AS, 2009, GEOCHIM COSMOCHIM AC, V73, P102, DOI 10.1016/j.gca.2008.10.005; BROOKS JM, 1987, SCIENCE, V238, P1138, DOI 10.1126/science.238.4830.1138; Cavanaugh CM, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P475, DOI 10.1007/0-387-30741-9_18; Chen C, 2018, J MAR BIOL ASSOC UK, V98, P439, DOI 10.1017/S0025315416001648; COVENEY RM, 1987, AAPG BULL, V71, P39; Deines P, 1980, HDB ENV ISOTOPE GEOC, DOI DOI 10.1016/B978-0-444-41780-0.50015-8; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; FISHER CR, 1994, MAR ECOL PROG SER, V103, P45, DOI 10.3354/meps103045; FISHER CR, 1990, REV AQUAT SCI, V2, P399; FISHER CR, 1988, DEEP-SEA RES, V35, P1811, DOI 10.1016/0198-0149(88)90051-9; FRY B, 1983, NATURE, V306, P51, DOI 10.1038/306051a0; FRY B, 1984, CONTRIB MAR SCI, V27, P13; GEARING J N, 1991, P201; GEARING JN, 1984, GEOCHIM COSMOCHIM AC, V48, P1089, DOI 10.1016/0016-7037(84)90199-6; Gieskes J. M., 1991, ODP, P1, DOI 10.2973/odp.tn.15.1991; Goericke R., 1994, STABLE ISOTOPES ECOL, P187; Hugler M, 2011, ANNU REV MAR SCI, V3, P261, DOI 10.1146/annurev-marine-120709-142712; Hulme SM, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002674; Jacob U, 2005, MAR ECOL PROG SER, V287, P251, DOI 10.3354/meps287251; JANECKY DR, 1986, GEOCHIM COSMOCHIM AC, V50, P1357, DOI 10.1016/0016-7037(86)90311-X; KAPLAN IR, 1964, J GEN MICROBIOL, V34, P195, DOI 10.1099/00221287-34-2-195; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; KENNICUTT MC, 1992, CHEM GEOL, V101, P293, DOI 10.1016/0009-2541(92)90009-T; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Lang SQ, 2012, GEOCHIM COSMOCHIM AC, V92, P82, DOI 10.1016/j.gca.2012.06.006; LEE S, 1987, APPL ENVIRON MICROB, V53, P1298, DOI 10.1128/AEM.53.6.1298-1303.1987; Levin L, 1997, J MAR RES, V55, P595, DOI 10.1357/0022240973224337; Macko S.A., 1984, ORG GEOCHEM, V6, P787, DOI DOI 10.1016/0146-6380(84)90100-1; Maruo M, 2006, ANAL SCI, V22, P1175, DOI 10.2116/analsci.22.1175; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Minami T, 2005, GEOARCHAEOLOGY, V20, P79, DOI 10.1002/gea.20035; Miyazaki J, 2017, FRONT EARTH SC-SWITZ, V5, DOI 10.3389/feart.2017.00045; Mizota Chitoshi, 1999, Benthos Research, V54, P81; Mottl M. J., 1997, JAMSTEC J DEEP SEA R, V13, P103; Mottl MJ, 2004, GEOCHIM COSMOCHIM AC, V68, P4915, DOI 10.1016/j.gca.2004.05.037; Nakaseama M, 2008, RESOUR GEOL, V58, P289, DOI 10.1111/j.1751-3928.2008.00062.x; Nelson D.C., 1995, DEEP SEA HYDROTHERMA, P125; Nishi E, 2014, P BIOL SOC WASH, V126, P287, DOI 10.2988/0006-324X-126.4.287; Ohara Y, 2012, P NATL ACAD SCI USA, V109, P2831, DOI 10.1073/pnas.1112005109; Okumura T, 2016, GEOCHEM GEOPHY GEOSY, V17, P3775, DOI 10.1002/2016GC006449; Okumura T, 2016, PROG EARTH PLANET SC, V3, DOI 10.1186/s40645-016-0088-3; Okutani Takashi, 2013, Venus (Tokyo), V71, P39; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; RAU GH, 1982, DEEP-SEA RES, V29, P1035, DOI 10.1016/0198-0149(82)90026-7; RAU GH, 1990, DEEP-SEA RES, V37, P1669, DOI 10.1016/0198-0149(90)90070-C; REES CE, 1978, GEOCHIM COSMOCHIM AC, V42, P377, DOI 10.1016/0016-7037(78)90268-5; RUBY EG, 1987, APPL ENVIRON MICROB, V53, P1940, DOI 10.1128/AEM.53.8.1940-1943.1987; SAINO T, 1989, PALAEOGEOGR PALAEOCL, V71, P169, DOI 10.1016/0031-0182(89)90036-9; Sasaki T, 2010, TOP GEOBIOL, V33, P169, DOI 10.1007/978-90-481-9572-5_7; SCHOELL M, 1983, AAPG BULL, V67, P2225; Stern RJ, 2014, ISL ARC, V23, P368, DOI 10.1111/iar.12088; STEVENS TO, 1995, SCIENCE, V270, P450, DOI 10.1126/science.270.5235.450; STEVENS TO, 1993, MICROB ECOL, V25, P35, DOI 10.1007/BF00182128; Thiel V, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00423; Tsunogai U., 2003, CHIKYUKAGAKU, V37, P101, DOI DOI 10.14934/CHIKYUKAGAKU.37.101; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD, P424; VONHUENE R, 1991, REV GEOPHYS, V29, P279, DOI 10.1029/91RG00969; Voss M, 2001, DEEP-SEA RES PT I, V48, P1905, DOI 10.1016/S0967-0637(00)00110-2; Yamanaka T, 2003, GEOMICROBIOL J, V20, P185, DOI 10.1080/01490450303876; Yamanaka T, 1999, GEOCHEM J, V33, P89, DOI 10.2343/geochemj.33.89; Yamanaka T, 2015, SUBSEAFLOOR BIOSPHER, DOI [10.1007/978-4-431-54865-2_10, DOI 10.1007/978-4-431-54865-2_10]; Yamanaka Toshiro, 2001, Venus the Japanese Journal of Malacology, V60, P71	69	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2018	13	6							e0199000	10.1371/journal.pone.0199000	http://dx.doi.org/10.1371/journal.pone.0199000			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5RI	29906282	Green Published, gold, Green Submitted			2022-12-26	WOS:000435439400010
J	Bloise, N; Petecchia, L; Ceccarelli, G; Fassina, L; Usai, C; Bertoglio, F; Balli, M; Vassalli, M; De Angelis, MGC; Gavazzo, P; Imbriani, M; Visai, L				Bloise, Nora; Petecchia, Loredana; Ceccarelli, Gabriele; Fassina, Lorenzo; Usai, Cesare; Bertoglio, Federico; Balli, Martina; Vassalli, Massimo; De Angelis, Maria Gabriella Cusella; Gavazzo, Paola; Imbriani, Marcello; Visai, Livia			The effect of pulsed electromagnetic field exposure on osteoinduction of human mesenchymal stem cells cultured on nano-TiO2 surfaces	PLOS ONE			English	Article							OSTEOGENIC DIFFERENTIATION; BONE TISSUE; NANOSTRUCTURED TIO2; STIMULATION; PROLIFERATION; OSTEOBLASTS; TOPOGRAPHY; DEPOSITION; ADHESION	Human bone marrow-derived mesenchymal stem cells (hBM-MSCs) are considered a great promise in the repair and regeneration of bone. Considerable efforts have been oriented towards uncovering the best strategy to promote stem cells osteogenic differentiation. In previous studies, hBM-MSCs exposed to physical stimuli such as pulsed electromagnetic fields (PEMFs) or directly seeded on nanostructured titanium surfaces (TiO2) were shown to improve their differentiation to osteoblasts in osteogenic condition. In the present study, the effect of a daily PEMF-exposure on osteogenic differentiation of hBM-MSCs seeded onto nanostructured TiO2 (with clusters under 100 nm of dimension) was investigated. TiO2-seeded cells were exposed to PEMF (magnetic field intensity: 2 mT; intensity of induced electric field: 5 my; frequency: 75 Hz) and examined in terms of cell physiology modifications and osteogenic differentiation. Results showed that PEMF exposure affected TiO2-seeded cells osteogenesis by interfering with selective calcium-related osteogenic pathways, and greatly enhanced hBM-MSCs osteogenic features such as the expression of early/late osteogenic genes and protein production (e.g., ALP, COL-I, osteocalcin and osteopontin) and ALP activity. Finally, PEMF-treated cells resulted to secrete into conditioned media higher amounts of BMP-2, DCN and COL-I than untreated cell cultures. These findings confirm once more the osteoinductive potential of PEMF, suggesting that its combination with TiO2 nanostructured surface might be a great option in bone tissue engineering applications.	[Bloise, Nora; Bertoglio, Federico; Visai, Livia] Univ Pavia, DMM, CHT, INSTM Unit, Pavia, Italy; [Bloise, Nora; Bertoglio, Federico; Imbriani, Marcello; Visai, Livia] IRCCS, Dept Occupat Med Toxicol & Environm Risks, Ist Clin Sci Maugeri, Pavia, Italy; [Petecchia, Loredana; Usai, Cesare; Vassalli, Massimo; Gavazzo, Paola] CNR, Inst Biophys, Genoa, Italy; [Ceccarelli, Gabriele; Balli, Martina; De Angelis, Maria Gabriella Cusella; Imbriani, Marcello] Univ Pavia, CHT, Dept Publ Hlth Expt Med & Forens, Human Anat Unit, Pavia, Italy; [Fassina, Lorenzo] Univ Pavia, CHT, Dept Elect Comp & Biomed Engn, Pavia, Italy	University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Pavia; University of Pavia	Bloise, N (corresponding author), Univ Pavia, DMM, CHT, INSTM Unit, Pavia, Italy.; Bloise, N (corresponding author), IRCCS, Dept Occupat Med Toxicol & Environm Risks, Ist Clin Sci Maugeri, Pavia, Italy.	nora.bloise@unipv.it; livia.visai@unipv.it	Vassalli, Massimo/F-6762-2011; Fassina, Lorenzo/K-9283-2015; Visai, Livia/R-7397-2017; Imbriani, Marcello/AAB-1171-2021	Vassalli, Massimo/0000-0002-3063-4376; Fassina, Lorenzo/0000-0002-5587-4632; Visai, Livia/0000-0003-1181-3632; Imbriani, Marcello/0000-0002-2752-1565; Gavazzo, Paola/0000-0002-2016-4702; Usai, Cesare/0000-0001-8863-7759; Balli, Martina/0000-0003-0791-2021	Compagnia di San Paolo; INAIL grant entitled "Effetti dei campi elettromagnetici sulla salute umana: modelli sperimentali in vitro"; COST Action "European network for innovative uses of EMFs in biomedical applications" [BM1309 EMF-MED]; COST Action, "Modelling Nanomaterial Toxicity" [MODENA TD 1204]	Compagnia di San Paolo(Compagnia di San Paolo); INAIL grant entitled "Effetti dei campi elettromagnetici sulla salute umana: modelli sperimentali in vitro"; COST Action "European network for innovative uses of EMFs in biomedical applications"; COST Action, "Modelling Nanomaterial Toxicity"	This study was supported by the Compagnia di San Paolo to CU, an INAIL grant entitled "Effetti dei campi elettromagnetici sulla salute umana: modelli sperimentali in vitro" (2011), COST Action grant BM1309 EMF-MED "European network for innovative uses of EMFs in biomedical applications" (2014-2019), and a COST Action grant MODENA TD 1204, "Modelling Nanomaterial Toxicity" (2012-2016).	Addison WN, 2015, BONE, V71, P244, DOI 10.1016/j.bone.2014.11.003; Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009; Au HTH, 2007, BIOMATERIALS, V28, P4277, DOI 10.1016/j.biomaterials.2007.06.001; Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045; Bagheri L, 2018, J TISSUE ENG REGEN M, V12, P304, DOI 10.1002/term.2455; Bernardo ME, 2007, J CELL PHYSIOL, V211, P121, DOI 10.1002/jcp.20911; Bloise N, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.128006; Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1007/s00223-001-1114-y; Carbone R, 2006, BIOMATERIALS, V27, P3221, DOI 10.1016/j.biomaterials.2006.01.056; Ceccarelli G, 2013, BIORESEARCH OPEN ACC, V2, P283, DOI 10.1089/biores.2013.0016; Chen WQ, 2014, NANO TODAY, V9, P759, DOI 10.1016/j.nantod.2014.12.002; Cristofaro F, 2018, NANOSCALE, V10, P8689, DOI 10.1039/c8nr00677f; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Ding S, 2017, BIOTECHNOL BIOENG, V114, P260, DOI 10.1002/bit.26075; Diniz P, 2002, BIOELECTROMAGNETICS, V23, P398, DOI 10.1002/bem.10032; Fassina L, 2009, TISSUE ENG PART C-ME, V15, P233, DOI 10.1089/ten.tec.2008.0398; Gardin C, 2016, STEM CELL REV REP, V12, P543, DOI 10.1007/s12015-016-9669-1; Gittens RA, 2014, ACTA BIOMATER, V10, P3363, DOI 10.1016/j.actbio.2014.03.037; Gorodzha SN, 2017, COLLOID SURFACE B, V160, P48, DOI 10.1016/j.colsurfb.2017.09.004; Hale LV, 2000, CALCIFIED TISSUE INT, V67, P80, DOI 10.1007/s00223001101; Hofer HR, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0394-0; Jansen JHW, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-188; Kim S, 2014, ACTA BIOMATER, V10, P5021, DOI 10.1016/j.actbio.2014.08.028; Kulkarni M, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/6/062002; Mangano C, 2010, BIOMATERIALS, V31, P3543, DOI 10.1016/j.biomaterials.2010.01.056; Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109; Maziarz A, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0312-5; Paino F, 2017, CLIN SCI, V131, P699, DOI 10.1042/CS20170047; Petecchia L, 2017, EXP CELL RES, V358, P111, DOI 10.1016/j.yexcr.2017.06.008; Petecchia L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13856; Poundarik AA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19253-w; Qiu JC, 2016, SMALL, V12, P1770, DOI 10.1002/smll.201503946; de Vasconcellos LMR, 2016, LASER MED SCI, V31, P899, DOI 10.1007/s10103-016-1930-y; Saino E, 2011, EUR CELLS MATER, V21, P59, DOI 10.22203/eCM.v021a05; Schwartz Z, 2008, J ORTHOP RES, V26, P1250, DOI 10.1002/jor.20591; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Sun LY, 2010, BIOELECTROMAGNETICS, V31, P209, DOI 10.1002/bem.20550; Tirino V, 2011, STEM CELL REV REP, V7, P608, DOI 10.1007/s12015-011-9235-9; Tsai MT, 2007, BIOELECTROMAGNETICS, V28, P519, DOI 10.1002/bem.20336; Unal M, 2018, CURR OSTEOPOROS REP, V16, P205, DOI 10.1007/s11914-018-0433-0; Vercellino M, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6070124; Vigano M, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0496-5; Wang TT, 2017, BIOELECTROMAGNETICS, V38, P63, DOI 10.1002/bem.22018; Yang YG, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0547-5; Zohar R, 1998, EUR J ORAL SCI, V106, P401, DOI 10.1111/j.1600-0722.1998.tb02206.x	46	23	23	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199046	10.1371/journal.pone.0199046	http://dx.doi.org/10.1371/journal.pone.0199046			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902240	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000435424900079
J	Kim, MC; Yun, SC; Lee, SO; Choi, SH; Kim, YS; Woo, JH; Kim, SH				Kim, Min-Chul; Yun, Sung-Cheol; Lee, Sang-Oh; Choi, Sang-Ho; Kim, Yang Soo; Woo, Jun Hee; Kim, Sung-Han			Statins increase the risk of herpes zoster: A propensity score-matched analysis	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; POPULATION-BASED COHORT; MORTALITY; INFLUENZA; VACCINE; CHOLESTEROL; PRAVASTATIN; THERAPY; DISEASE; SEPSIS	Objectives Statins, which are lipid-lowering agents, have anti-inflammatory and immunomodulatory properties that may affect the occurrence of various infectious diseases. We assessed whether statins increase the risk of herpes zoster (HZ) with propensity score-matching. Methods The study was based on the National Health Insurance database and its subset database of the "medical check-up" population of South Korea. These cohorts consist of about one million and 570,000 people, respectively, representative of the entire population of South Korea. We identified 103,930 statin users and 430,685 non-statin users. After propensity score-matching, 25,726 statin users and the same number of non-statin users were finally analyzed. The development of HZ was monitored in these matched pairs over the 11 years from 2003 to 2013. Results Statin users had a significantly higher risk of HZ than non-statin users: hazard ratio (HR) 1.25 (95% CI, 1.15 to 1.37) (p < .0001). The risk of HZ associated with statins was especially high in the elderly: HR 1.39 (95% CI, 1.12 to 1.73) in the over 70-year-olds (p = 0.003) and HR 1.18 (95% CI, 1.00 to 1.39) in the 60-to-69-year-olds (p = 0.056). Furthermore, there was a significant p for trend in terms of cumulative dose effect between the risk of HZ and the duration of statin use (p < .0001). Conclusions These epidemiologic findings provide strong evidence for an association between HZ and statin use, and suggest that unnecessary statins should be avoided.	[Kim, Min-Chul] Chung Ang Univ Hosp, Dept Internal Med, Div Infect Dis, Seoul, South Korea; [Yun, Sung-Cheol] Univ Ulsan, Asan Med Ctr, Clin Epidemiol & Biostat, Coll Med, Seoul, South Korea; [Lee, Sang-Oh; Choi, Sang-Ho; Kim, Yang Soo; Woo, Jun Hee; Kim, Sung-Han] Univ Ulsan, Asan Med Ctr, Dept Infect Dis, Coll Med, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kim, SH (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Infect Dis, Coll Med, Seoul, South Korea.	kimsunghanmd@hotmail.com	Lee, Sang-Oh/AGV-5413-2022	Lee, Sang-Oh/0000-0003-1381-8787; Kim, Sung-Han/0000-0002-6596-8253	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C1763]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant no. HI15C1763).	Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Antoniou T, 2014, CLIN INFECT DIS, V58, P350, DOI 10.1093/cid/cit745; Black S, 2016, J INFECT DIS, V213, P1224, DOI 10.1093/infdis/jiv456; Caporaso NE, 2012, NEW ENGL J MED, V367, P1848, DOI 10.1056/NEJMe1210002; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; Chen HH, 2015, EUR J CLIN MICROBIOL, V34, P1451, DOI 10.1007/s10096-015-2372-3; Chopra V, 2012, AM J MED, V125, P1111, DOI 10.1016/j.amjmed.2012.04.011; Chung SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111268; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Del Pozo JL, 2010, CLIN INFECT DIS, V50, P121, DOI 10.1086/649005; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; Fedson DS, 2006, CLIN INFECT DIS, V43, P199, DOI 10.1086/505116; Forero-Pena DA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/167086; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Gupta R, 2007, JAMA-J AM MED ASSOC, V297, P1455, DOI 10.1001/jama.297.13.1455; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Irwin MR, 2013, CLIN INFECT DIS, V56, P1085, DOI 10.1093/cid/cis1208; Kawai K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004833; Kim MC, 2017, J AM COLL CARDIOL, V70, P295, DOI 10.1016/j.jacc.2017.05.015; Kwon SU, 2016, CLIN MICROBIOL INFEC, V22, P542, DOI 10.1016/j.cmi.2016.03.003; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Lee KJ, 2010, CLIN EXP IMMUNOL, V161, P298, DOI 10.1111/j.1365-2249.2010.04170.x; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Makris D, 2011, CRIT CARE MED, V39, P2440, DOI 10.1097/CCM.0b013e318225742c; Matthews A, 2016, BRIT J DERMATOL, V175, P1183, DOI 10.1111/bjd.14815; McLean HQ, 2016, J INFECT DIS, V214, P1150, DOI 10.1093/infdis/jiw335; Mullooly JP, 2005, EPIDEMIOL INFECT, V133, P245, DOI 10.1017/S095026880400281X; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Novack V, 2012, CAN MED ASSOC J, V184, pE367, DOI 10.1503/cmaj.111017; Omer SB, 2016, J INFECT DIS, V213, P1216, DOI 10.1093/infdis/jiv457; Papazian L, 2013, JAMA-J AM MED ASSOC, V310, P1692, DOI 10.1001/jama.2013.280031; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; Pursnani A, 2017, J CLIN ONCOL, V35, P2927, DOI 10.1200/JCO.2016.71.3594; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Strandberg TE, 2014, CLIN INFECT DIS, V58, P1042, DOI 10.1093/cid/ciu030; Terblanche M, 2007, LANCET INFECT DIS, V7, P358, DOI 10.1016/S1473-3099(07)70111-1; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Thomsen RW, 2008, ARCH INTERN MED, V168, P2081, DOI 10.1001/archinte.168.19.2081; Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286; van den Hoek HL, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7281; Yende S, 2011, CRIT CARE MED, V39, P1871, DOI 10.1097/CCM.0b013e31821b8290	44	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198263	10.1371/journal.pone.0198263	http://dx.doi.org/10.1371/journal.pone.0198263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902266	Green Published, gold, Green Submitted			2022-12-26	WOS:000435424900018
J	Yuan, JM; Ng, WH; Lam, PYP; Wang, Y; Xia, HP; Yap, JJ; Guan, SP; Lee, ASG; Wang, M; Baccarini, M; Hu, JC				Yuan, Jimin; Ng, Wan Hwa; Lam, Paula Y. P.; Wang, Yu; Xia, Hongping; Yap, Jiajun; Guan, Shou Ping; Lee, Ann S. G.; Wang, Mei; Baccarini, Manuela; Hu, Jiancheng			The dimer-dependent catalytic activity of RAF family kinases is revealed through characterizing their oncogenic mutants	ONCOGENE			English	Article							LANGERHANS CELL HISTIOCYTOSIS; B-RAF; PROTEIN-KINASES; WILD-TYPE; ACTIVATION MECHANISM; INHIBITOR RESISTANCE; METASTATIC MELANOMA; MAPK PATHWAY; GENE FUSIONS; C-RAF	Although extensively studied for three decades, the molecular mechanisms that regulate the RAF/MEK/ERK kinase cascade remain ambiguous. Recent studies identified the dimerization of RAF as a key event in the activation of this cascade. Here, we show that in-frame deletions in the beta 3-alpha C loop activate ARAF as well as BRAF and other oncogenic kinases by enforcing homodimerization. By characterizing these RAF mutants, we find that ARAF has less allosteric and catalytic activity than the other two RAF isoforms, which arises from its non-canonical APE motif. Further, these RAF mutants exhibit a strong oncogenic potential, and a differential inhibitor resistance that correlates with their dimer affinity. Using these unique mutants, we demonstrate that active RAFs, including the BRAF(V600E) mutant, phosphorylate MEK in a dimer-dependent manner. This study characterizes a special category of oncogenic kinase mutations, and elucidates the molecular basis that underlies the differential ability of RAF isoforms to stimulate MEK-ERK pathway. Further, this study reveals a unique catalytic feature of RAF family kinases that can be exploited to control their activities for cancer therapies.	[Yuan, Jimin; Ng, Wan Hwa; Lam, Paula Y. P.; Wang, Yu; Xia, Hongping; Yap, Jiajun; Guan, Shou Ping; Hu, Jiancheng] Div Cellular & Mol Res, Singapore, Singapore; [Lam, Paula Y. P.; Wang, Mei; Hu, Jiancheng] Duke NUS Med Sch, Canc & Stem Cell Program, 8 Coll Rd, Singapore 169857, Singapore; [Lee, Ann S. G.] Natl Canc Ctr Singapore, Div Med Sci, 11 Hosp Dr, Singapore 169610, Singapore; [Lee, Ann S. G.] Duke NUS Med Sch, Off Clin & Acad Fac Affairs, 8 Coll Rd, Singapore 169857, Singapore; [Lee, Ann S. G.] Natl Univ Singapore, Dept Physiol, 2 Med Dr, Singapore 117597, Singapore; [Baccarini, Manuela] Univ Vienna, Max F Perutz Labs, Doktor Bohr Gasse 9, A-1030 Vienna, Austria	National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore; National University of Singapore; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Hu, JC (corresponding author), Div Cellular & Mol Res, Singapore, Singapore.; Hu, JC (corresponding author), Duke NUS Med Sch, Canc & Stem Cell Program, 8 Coll Rd, Singapore 169857, Singapore.	hu.jiancheng@nccs.com.sg	Hu, Jiancheng/ABE-8133-2021; XIA, HONGPING/AAK-7100-2020; Baccarini, Manuela/B-6481-2014	Hu, Jiancheng/0000-0003-1615-0030; Baccarini, Manuela/0000-0002-3033-391X; Wang, Mei/0000-0001-6887-6840	NCCRF startup grant (NCCRF-SUG-JH); NCCRF bridging grant [NCCRF-YR2016-JUL-BG1]; NMRC seeding grants [NCCSPG-YR2015-JUL-14, NCCSPG-YR2016-JAN-17]; Duke-NUS Khoo Bridge Funding Award [Duke-NUS-KBrFA/2017/0003]; Asia Fund Cancer Research [AFCR2017/2019-JH]; SHF Research Grant [SHF/FG692S/2016]	NCCRF startup grant (NCCRF-SUG-JH); NCCRF bridging grant; NMRC seeding grants; Duke-NUS Khoo Bridge Funding Award; Asia Fund Cancer Research; SHF Research Grant	We thank the laboratories of Dr. Hui, Dr. Sabapathy, Dr. Virshup, and Dr. Anand for their help in experimental technologies. We also thank Dr. Andrey Shaw and Dr. Susan Taylor for their assistances. This study is supported by NCCRF startup grant (NCCRF-SUG-JH), NCCRF bridging grant (NCCRF-YR2016-JUL-BG1), NMRC seeding grants (NCCSPG-YR2015-JUL-14 and NCCSPG-YR2016-JAN-17), and Duke-NUS Khoo Bridge Funding Award (Duke-NUS-KBrFA/2017/0003), Asia Fund Cancer Research (AFCR2017/2019-JH) and SHF Research Grant (SHF/FG692S/2016).	Baccarini M, 2005, FEBS LETT, V579, P3271, DOI 10.1016/j.febslet.2005.03.024; Beenstock J, 2016, TRENDS BIOCHEM SCI, V41, P938, DOI 10.1016/j.tibs.2016.08.006; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chakraborty R, 2016, BLOOD, V128, P2533, DOI 10.1182/blood-2016-08-733790; Chen SH, 2016, CANCER DISCOV, V6, P300, DOI 10.1158/2159-8290.CD-15-0896; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Cseh B, 2014, FEBS LETT, V588, P2398, DOI 10.1016/j.febslet.2014.06.025; Desideri E, 2015, CELL, V161, P967, DOI 10.1016/j.cell.2015.04.045; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Diedrich B, 2017, EMBO J, V36, P646, DOI 10.15252/embj.201694732; Estep AL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001279; Fabrini R, 2009, BIOCHEMISTRY-US, V48, P10473, DOI 10.1021/bi901238t; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Foster SA, 2016, CANCER CELL, V29, P477, DOI 10.1016/j.ccell.2016.02.010; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Haling JR, 2014, CANCER CELL, V26, P402, DOI 10.1016/j.ccr.2014.07.007; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hibino K, 2009, BIOPHYS J, V97, P1277, DOI 10.1016/j.bpj.2009.05.048; Hu JC, 2008, MOL IMMUNOL, V45, P1825, DOI 10.1016/j.molimm.2007.11.002; Hu J, 2015, MOL CELL BIOL, V35, P264, DOI 10.1128/MCB.00943-14; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Hu JC, 2011, P NATL ACAD SCI USA, V108, P6067, DOI 10.1073/pnas.1102554108; Jain P, 2017, ONCOGENE, V36, P6348, DOI 10.1038/onc.2017.276; Jesenberger V, 2001, J EXP MED, V193, P353, DOI 10.1084/jem.193.3.353; Jin T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01274-0; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kumar-Sinha C, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0252-1; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Lavoie H, 2014, TRENDS BIOCHEM SCI, V39, P475, DOI 10.1016/j.tibs.2014.08.004; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Luo ZJ, 1996, NATURE, V383, P181, DOI 10.1038/383181a0; Mooz J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005484; Nan XL, 2015, P NATL ACAD SCI USA, V112, P7996, DOI 10.1073/pnas.1509123112; Nelson DS, 2014, BLOOD, V123, P3152, DOI 10.1182/blood-2013-06-511139; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rebocho AP, 2013, ONCOGENE, V32, P3207, DOI 10.1038/onc.2012.330; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Rizos H, 2014, CLIN CANCER RES, V20, P1965, DOI 10.1158/1078-0432.CCR-13-3122; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roring M, 2012, EMBO J, V31, P2629, DOI 10.1038/emboj.2012.100; Ross JS, 2016, INT J CANCER, V138, P881, DOI 10.1002/ijc.29825; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shaw AS, 2014, MOL CELL BIOL, V34, P1538, DOI 10.1128/MCB.00057-14; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; Taylor SS, 2013, BIOCHEM SOC T, V41, P981, DOI 10.1042/BST20130120; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Thevakumaran N, 2015, NAT STRUCT MOL BIOL, V22, P37, DOI 10.1038/nsmb.2924; Valley CC, 2015, MOL BIOL CELL, V26, P4087, DOI 10.1091/mbc.E15-05-0269; Wan LX, 2017, CANCER DISCOV, V7, P424, DOI 10.1158/2159-8290.CD-16-0647; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang XX, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005147; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yang J, 2012, J MOL BIOL, V415, P666, DOI 10.1016/j.jmb.2011.11.035	61	22	23	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 25	2018	37	43					5719	5734		10.1038/s41388-018-0365-2	http://dx.doi.org/10.1038/s41388-018-0365-2			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GY1KL	29930381	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000448288200002
J	Desta, KT; Masango, TE; Nkosi, ZZ				Desta, Kassaye Tekie; Masango, T. E.; Nkosi, Zerish Zethu			Performance of the National Tuberculosis Control Program in the post conflict Liberia	PLOS ONE			English	Article							GHANA; DETERMINANTS; DIAGNOSIS; QUALITY; TB	Background Tuberculosis is a major public health problem in Liberia. According to the World Health Organization (WHO), the incidence of tuberculosis in Liberia is significantly increasing from year to year. However, little is known about the performance of the programme and the challenges after the 14 years of civil war which ended in 2003. The purpose of the study was to evaluate the performance of the TB programme of Liberia. Methods The study utilised mixed research design; both quantitative and qualitative methods were used in this study conducted from 2013 to 2014. For the quantitative part of the study, a questionnaire, laboratory performance and eleven years TB programme data (2003-2013) were used. For the performance of tuberculosis laboratory testing, all the 107 functional tuberculosis microscopy centers in Liberia were included. For the qualitative part of the study, an interview of 10 informants and two focus group discussions (FGDs) were also conducted, each comprising of eight people. Themes and subthemes emerged from the two FGDs. Data was analysed in line with the Donabedian model. Quantitative findings were analysed and presented using both descriptive and inferential statistics. Results The study findings pointed out that there was overall improvement in the performance of the tuberculosis control programme in Liberia from 2003 to 2013. The percentage of cured patients was 60% in 2005 and 62% in 2013. Percentage of treatment completed was 16% in 2005 and 21% in 2013. The case detection rate was 57% and treatment success rate 80% in 2013. The default rate was 11% in 2013. Of the 139 participants, 120 (86%) completed TB treatment while 19 (14%) did not. Conclusion Between 2003 and 2013, the National Leprosy and Tuberculosis Control Programme (NLTCP) succeeded in restoring the TB services and improving some of the TB treatment outcomes including the Directly observed treatment short courses(DOTS) coverage. Despite these improvements, the TB treatment, laboratory services and human resource capacity lagged behind. The TB programme of Liberia needs to develop new strategies to address its challenges.	[Desta, Kassaye Tekie; Masango, T. E.; Nkosi, Zerish Zethu] Univ South Africa, Dept Hlth Studies, Pretoria, South Africa	University of South Africa	Desta, KT (corresponding author), Univ South Africa, Dept Hlth Studies, Pretoria, South Africa.	kassayetek@gmail.com	Nkosi, Zethu/AAG-3980-2020	Desta, Kassaye Tekie/0000-0002-2124-8289				Addo KK, 2006, INT J TUBERC LUNG D, V10, P812; Amo-Adjei J, 2014, GLOB PUBLIC HEALTH, V9, P299, DOI 10.1080/17441692.2014.880500; Bagchi S, 2010, INT J PREVENTIVE MED, V1, P223; Bruce N, 2008, QUANTITATIVE METHODS, P1, DOI DOI 10.1002/9780470725337; Bulage L, 2014, QUALITY TUBERCULOSIS, P1; Daniel O J, 2006, Niger J Med, V15, P63; Dheeraj Gupta, 2004, Indian Journal of Tuberculosis, V51, P27; Dodor E A, 2012, Ghana Med J, V46, P211; Dodor EA, 2005, T ROY SOC TROP MED H, V99, P827, DOI 10.1016/j.trstmh.2005.06.011; Donabedian A, 2003, INTRO QUALITY ASSURA, P1; Gerald L, 2010, PRINCIPLES PRACTICE, P1; Gosoniu GD, 2008, INT J TUBERC LUNG D, V12, P848; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Harper M, 2003, T ROY SOC TROP MED H, V97, P506, DOI 10.1016/S0035-9203(03)80007-X; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Inotu A, 2014, J TUBERCULOSIS RES, V2, P30, DOI [10.4236/jtr.2014.21004, DOI 10.4236/JTR.2014.21004]; James M., 2012, CURRICULUM PEDAGOGY, P1; Khan MA, 2005, HEALTH POLICY PLANN, V20, P354, DOI 10.1093/heapol/czi047; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Leprosy National & TB Control Programme, 2009, MAN NAT TUB LEPR PRO, P1; LoBiondo-Wood G, 2005, NURSING RES METHODS, P277; Mature B, 2011, BMC PUBLIC HEALTH, V11, P6; Mauch V, 2010, HEALTH POLICY, V96, P118, DOI 10.1016/j.healthpol.2010.01.003; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Mubashir Z., 2013, J ASS CHEST PHYS JAC, V2, P45; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Narasimhan P, 2013, PULM MED, V2013, P1, DOI DOI 10.1155/2013/828939; Padmapriyadarsini C, 2011, INDIAN J MED RES, V134, P850, DOI 10.4103/0971-5916.92630; Patrick K, 2011, GLOBAL J HLTH SCI, V3, P110; Suleiman MMA, 2009, SCAND J PUBLIC HEALT, V37, P101, DOI 10.1177/1403494808097172; Wanyeki I, 2006, SOC SCI MED, V63, P501, DOI 10.1016/j.socscimed.2005.12.015; Wasonga J., 2006, INT C DRUG THER HIV, P310; World Health Organization, 2012, TUB GLOB REP; World Health Organization, 2006, GLOB PLAN STOP TB 20	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199474	10.1371/journal.pone.0199474	http://dx.doi.org/10.1371/journal.pone.0199474			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK3YY	29940012	Green Submitted, gold, Green Published			2022-12-26	WOS:000436088700020
J	Bernat, P; Nykiel-Szymanska, J; Stolarek, P; Slaba, M; Szewczyk, R; Rozalska, S				Bernat, Przemyslaw; Nykiel-Szymanska, Justyna; Stolarek, Pauline; Slaba, Miroslawa; Szewczyk, Rafal; Rozalska, Sylwia			2,4-dichlorophenoxyacetic acid-induced oxidative stress: Metabolome and membrane modifications in Umbelopsis isabellina, a herbicide degrader	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; CUNNINGHAMELLA-ECHINULATA; MORTIERELLA-ISABELLINA; SACCHAROMYCES-CEREVISIAE; LIQUID-CHROMATOGRAPHY; SUPEROXIDE-DISMUTASE; LIPID-ACCUMULATION; 2,4-D; SPHINGOLIPIDS; ADAPTATION	The study reports the response to herbicide of the 2,4-dichlorophenoxyacetic acid (2,4-D)-degrading fungal strain Umbelopsis isabellina. A comparative analysis covered 41 free amino acids as well as 140 lipid species of fatty acids, phospholipids, acylglycerols, sphingolipids, and sterols. 2,4-D presence led to a decrease in fungal catalase activity, associated with a higher amount of thiobarbituric acid-reactive substances (TBARS). Damage to cells treated with the herbicide resulted in increased membrane permeability and decreased membrane fluidity. Detailed lipidomic profiling showed changes in the fatty acids composition such as an increase in the level of linoleic acid (C18: 2). Moreover, an increase in the phosphatidylethanolamine/phosphatidylcholine ratio was observed. Analysis of fungal lipid profiles revealed that the presence of 2,4-D was accompanied by the accumulation of triacylglycerols, a decrease in ergosterol content, and a considerable rise in the level of sphingolipid ceramides. In the exponential phase of growth, increased levels of leucine, glycine, serine, asparagine, and hydroxyproline were found. The results obtained in our study confirmed that in the cultures of U. isabellina oxidative stress was caused by 2,4-D. The herbicide itself forced changes not only to membrane lipids but also to neutral lipids and amino acids, as the difference of tested compounds profiles between 2,4-D D containing and control samples was consequently lower as the pesticide degradation progressed. The presented findings may have a significant impact on the basic understanding of 2,4-D biodegradation and may be applied for process optimization on metabolomic and lipidomic levels.	[Bernat, Przemyslaw; Nykiel-Szymanska, Justyna; Stolarek, Pauline; Slaba, Miroslawa; Szewczyk, Rafal; Rozalska, Sylwia] Univ Lodz, Fac Biol & Environm Protect, Dept Ind Microbiol & Biotechnol, Lodz, Poland	University of Lodz	Bernat, P (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Ind Microbiol & Biotechnol, Lodz, Poland.	przemyslaw.bernat@biol.uni.lodz.pl	Szewczyk, Rafal/GPC-8085-2022; Bernat, Przemysław/Y-7387-2019; Różalska, Sylwia/C-3746-2017; Nykiel-Szymanska, Justyna/N-6907-2018	Szewczyk, Rafal/0000-0002-4631-6081; Bernat, Przemysław/0000-0002-5589-1555; Różalska, Sylwia/0000-0003-1695-5154; Stolarek, Paulina/0000-0001-9904-9688; Slaba, Miroslawa/0000-0002-1337-8905; Nykiel-Szymanska, Justyna/0000-0002-3502-8711	National Science Centre, Poland [2015/19/B/ NZ9/00167]	National Science Centre, Poland(National Science Centre, Poland)	This study was supported by the National Science Centre, Poland (Project No. 2015/19/B/ NZ9/00167), grant recipient -PB.	[Anonymous], 2016, BIORESOURCE TECHNOL, V200, P223, DOI [10.1016/j.biortech.2015.10.034, DOI 10.1016/J.BIORTECH.2015.10.034]; [Anonymous], 2013, J HAZARD MATER, V246-247, P277; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Benndorf D, 2004, MICROBIOL-SGM, V150, P1005, DOI 10.1099/mic.0.26774-0; Bernat P, 2014, ENVIRON SCI POLLUT R, V21, P4228, DOI 10.1007/s11356-013-2375-5; Bhat SV, 2015, CHEMOSPHERE, V135, P453, DOI 10.1016/j.chemosphere.2014.12.035; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bukowska B, 2008, FOOD CHEM TOXICOL, V46, P359, DOI 10.1016/j.fct.2007.08.011; Busi R, 2018, PEST MANAG SCI, V74, P2265, DOI 10.1002/ps.4823; Chatzifragkou A, 2010, EUR J LIPID SCI TECH, V112, P1048, DOI 10.1002/ejlt.201000027; Cho YS, 2000, CURR MICROBIOL, V41, P33, DOI 10.1007/s002840010087; Demir M, 2013, BIORESOURCE TECHNOL, V128, P365, DOI 10.1016/j.biortech.2012.10.078; Deng CB, 2016, BIOORG MED CHEM LETT, V26, P3195, DOI 10.1016/j.bmcl.2016.04.031; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Fakas S, 2008, J APPL MICROBIOL, V105, P1062, DOI 10.1111/j.1365-2672.2008.03839.x; Fakas S, 2007, ENZYME MICROB TECH, V40, P1321, DOI 10.1016/j.enzmictec.2006.10.005; Fakas S, 2006, APPL MICROBIOL BIOT, V73, P676, DOI 10.1007/s00253-006-0506-3; Fakas S, 2009, BIORESOURCE TECHNOL, V100, P6118, DOI 10.1016/j.biortech.2009.06.015; Fakas S, 2008, EUR J LIPID SCI TECH, V110, P1062, DOI 10.1002/ejlt.200800025; Flis VV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135084; Folch J., 1957, J BIOL CHEM, V199, P833; Gao ZH, 2015, J ASIAN NAT PROD RES, V17, P1059, DOI 10.1080/10286020.2015.1054377; Gardeli C, 2017, J APPL MICROBIOL, V123, P1461, DOI 10.1111/jam.13587; Gonod LV, 2006, FEMS MICROBIOL ECOL, V58, P529, DOI 10.1111/j.1574-6941.2006.00159.x; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Halford NG, 2015, J EXP BOT, V66, P1145, DOI 10.1093/jxb/eru473; Ichihara K, 2010, J LIPID RES, V51, P635, DOI 10.1194/jlr.D001065; Jo C, 1998, POULTRY SCI, V77, P475, DOI 10.1093/ps/77.3.475; Kuchar L, 2016, ADV CLIN CHEM, V77, P177, DOI 10.1016/bs.acc.2016.06.004; KUHRY JG, 1983, CELL BIOPHYS, V5, P129, DOI 10.1007/BF02796139; Kumar A, 2014, BIOL PLANTARUM, V58, P733, DOI 10.1007/s10535-014-0435-4; KUTNEY JP, 1985, APPL ENVIRON MICROB, V49, P96, DOI 10.1128/AEM.49.1.96-100.1985; Lastovetsky OA, 2016, P NATL ACAD SCI USA, V113, P15102, DOI 10.1073/pnas.1615148113; Liao RS, 1999, ANTIMICROB AGENTS CH, V43, P1034, DOI 10.1128/AAC.43.5.1034; Lindberg L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073936; Mansour MMF, 2000, BIOL PLANTARUM, V43, P491, DOI 10.1023/A:1002873531707; Mithila J, 2011, WEED SCI, V59, P445, DOI 10.1614/WS-D-11-00062.1; Nykiel-Szymanska J, 2018, ENVIRON SCI POLLUT R, V25, P2738, DOI 10.1007/s11356-017-0571-4; Papanikolaou S, 2017, EUR J LIPID SCI TECH, V119, DOI 10.1002/ejlt.201600507; Piotrowska A, 2016, CHEMOSPHERE, V144, P107, DOI 10.1016/j.chemosphere.2015.08.067; Prado R., 2009, REPOS U CORUNA; Siewiera P, 2015, INT BIODETER BIODEGR, V104, P258, DOI 10.1016/j.ibiod.2015.06.014; Simoes T, 2003, APPL ENVIRON MICROB, V69, P4019, DOI 10.1128/AEM.69.7.4019-4028.2003; Singh A, 2017, J LIPID RES, V58, P2017, DOI [10.1194/jlr.M078600, 10.1194/jlr.m078600]; Slaba M, 2015, BIORESOURCE TECHNOL, V197, P404, DOI 10.1016/j.biortech.2015.08.045; Todorova D, 2008, J APPL MICROBIOL, V104, P178, DOI 10.1111/j.1365-2672.2007.03538.x; Vamvakaki AN, 2010, ENG LIFE SCI, V10, P348, DOI 10.1002/elsc.201000063; VENKATESWERLU G, 1986, CAN J MICROBIOL, V32, P654, DOI 10.1139/m86-122; Viegas CA, 2005, BIOCHEM BIOPH RES CO, V330, P271, DOI 10.1016/j.bbrc.2005.02.158; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028319; Wells GB, 1998, J BIOL CHEM, V273, P7235, DOI 10.1074/jbc.273.13.7235; Xia JM, 2011, BIOTECHNOL BIOENG, V108, P12, DOI 10.1002/bit.22910; Xiao L, 2017, J AGR FOOD CHEM, V65, P7345, DOI 10.1021/acs.jafc.7b02140; Yun Jung-Mi, 2012, Prev Nutr Food Sci, V17, P158, DOI 10.3746/pnf.2012.17.2.158; Zawadzka K, 2017, CHEMOSPHERE, V183, P18, DOI 10.1016/j.chemosphere.2017.05.088	56	26	26	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199677	10.1371/journal.pone.0199677	http://dx.doi.org/10.1371/journal.pone.0199677			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933393	gold, Green Published, Green Submitted			2022-12-26	WOS:000436076600041
J	Kavanagh, N; O'Brien, FJ; Kerrigan, SW				Kavanagh, Nicola; O'Brien, Fergal J.; Kerrigan, Steve W.			Staphylococcus aureus protein A causes osteoblasts to hyper-mineralise in a 3D extra-cellular matrix environment	PLOS ONE			English	Article							MODELS; BINDING; OSTEOCLASTOGENESIS; FIBRONECTIN; MANAGEMENT; SCAFFOLDS; MIGRATION; BEHAVIOR; TISSUES	Osteomyelitis is an inflammatory bone infection that is caused most commonly by the opportunistic pathogen Staphylococcus aureus. Research into staphylococcal induced bone infection is typically conducted using traditional 2D in vitro culture settings, which is not fully representative of the dynamic in vivo environment. In this study we utilised a collagen glycosaminoglycan scaffold, previously developed for bone tissue engineering, as a representative 3D model of infection. The scaffold resisted degradation and retained its pore structure, which is important for cellular function and survival, when seeded with both cells and bacteria. Using this model, we showed that in the presence of S. aureus, osteoblast proliferation was reduced over 21 days. Interestingly however these cells were more metabolically active compared to the uninfected cells and demonstrated increased mineralisation. Protein A (SpA) is a virulence factor found on the surface of S. aureus and has been shown to interact with osteoblasts. When SpA was removed from the surface of S. aureus, the osteoblasts show comparable activity with the uninfected cells demonstrating the importance of SpA in the interaction between bone cells and S. aureus. Our results suggest that infected osteoblasts are capable of over-compensating for bone loss and bone destruction by increasing mineralisation in a 3D environment, key elements required for ensuring bone strength. It also reinforces our previously established result that S. aureus SpA is a critical mediator in osteomyelitis and might be a potential novel drug target to treat osteomyelitis by preventing the interaction between S. aureus and osteoblasts.	[Kavanagh, Nicola; Kerrigan, Steve W.] Royal Coll Surgeons Ireland, Irish Ctr Vasc Biol, Cardiovasc Infect Res Grp, Dublin, Ireland; [Kavanagh, Nicola; O'Brien, Fergal J.; Kerrigan, Steve W.] Royal Coll Surgeons Ireland, Dept Anat, Tissue Engn Res Grp, Dublin, Ireland; [O'Brien, Fergal J.] Trinity Coll Dublin, Trinity Ctr Bioengn, Trinity Biomed Sci Inst, Dublin, Ireland; [O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Adv Mat & Bioengn Res AMBER Ctr, Dublin, Ireland; [O'Brien, Fergal J.] Trinity Coll Dublin, Dublin, Ireland; [Kerrigan, Steve W.] Royal Coll Surgeons Ireland, Sch Pharm & Mol & Cellular Therapeut, Dublin, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Trinity College Dublin; Royal College of Surgeons - Ireland; Trinity College Dublin; Royal College of Surgeons - Ireland	Kerrigan, SW (corresponding author), Royal Coll Surgeons Ireland, Irish Ctr Vasc Biol, Cardiovasc Infect Res Grp, Dublin, Ireland.; Kerrigan, SW (corresponding author), Royal Coll Surgeons Ireland, Dept Anat, Tissue Engn Res Grp, Dublin, Ireland.; Kerrigan, SW (corresponding author), Royal Coll Surgeons Ireland, Sch Pharm & Mol & Cellular Therapeut, Dublin, Ireland.	skerrigan@rcsi.ie	O'Brien, Fergal/F-9485-2011	O'Brien, Fergal/0000-0003-2030-8005	Science Foundation Ireland Research Frontiers Programme [BMT/2008/1709]; Irish Research Council [GOIP/2013/1171]	Science Foundation Ireland Research Frontiers Programme(Science Foundation Ireland); Irish Research Council(Irish Research Council for Science, Engineering and Technology)	This work was supported by a grant from the Science Foundation Ireland Research Frontiers Programme awarded to SWK. (no.BMT/2008/1709) and Irish Research Council awarded to NK, SWK (GOIP/2013/1171).; This work was supported by a grant from the Science Foundation Ireland Research Frontiers Programme awarded to SWK. (no.BMT/2008/1709) and Irish Research Council awarded to NK, SWK (GOIP/2013/1171).	Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Balcerzak M, 2003, ACTA BIOCHIM POL, V50, P1019; Birt MC, 2017, J ORTHOP, V14, P45, DOI 10.1016/j.jor.2016.10.004; Bouchoucha Sami, 2012, Tunis Med, V90, P473; Brown AE, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00507; Cassat JE, 2013, CELL HOST MICROBE, V13, P759, DOI 10.1016/j.chom.2013.05.003; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Claro T, 2013, MICROBIOL-SGM, V159, P147, DOI 10.1099/mic.0.063016-0; Claro T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018748; Fitzgerald KA, 2016, INT J PHARMACEUT, V511, P1058, DOI 10.1016/j.ijpharm.2016.07.079; Fitzgerald KA, 2015, J CONTROL RELEASE, V215, P39, DOI 10.1016/j.jconrel.2015.07.020; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Gu L, 2016, NAT REV CANCER, V16, P56, DOI 10.1038/nrc.2015.3; Hardcastle SA, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2014.119; Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598; Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]; Haugh MG, 2010, TISSUE ENG PART C-ME, V16, P887, DOI 10.1089/ten.TEC.2009.0422; Ignat'eva NY, 2007, J ANAL CHEM+, V62, P51, DOI 10.1134/S106193480701011X; Imamura Y, 2015, ONCOL REP, V33, P1837, DOI 10.3892/or.2015.3767; Kafienah W, 2003, METH MOL B, V238, P217; Keogh MB, 2010, ACTA BIOMATER, V6, P4305, DOI 10.1016/j.actbio.2010.06.001; Keogh MB, 2010, CELL TISSUE RES, V340, P169, DOI 10.1007/s00441-010-0939-y; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Lavery L A, 1995, J Foot Ankle Surg, V34, P61; Levine SM, 2003, RADIOGRAPHICS, V23, P157, DOI 10.1148/rg.231015088; Lew DP, 1997, NEW ENGLAND J MED, V336; Massey RC, 2001, CELL MICROBIOL, V3, P839, DOI 10.1046/j.1462-5822.2001.00157.x; Bertelli AM, 2016, BBA-MOL BASIS DIS, V1862, P1975, DOI 10.1016/j.bbadis.2016.07.016; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Mouzopoulos G, 2011, INJURY, V42, pS18, DOI 10.1016/S0020-1383(11)70128-0; O'Leary C, 2016, BIOMATERIALS, V85, P111, DOI 10.1016/j.biomaterials.2016.01.065; Ohbayashi T, 2011, MICROBIOL-SGM, V157, P786, DOI 10.1099/mic.0.044503-0; Otto Michael, 2010, Expert Rev Dermatol, V5, P183, DOI 10.1586/edm.10.6; Patel Mitul, 2009, Semin Plast Surg, V23, P148, DOI 10.1055/s-0029-1214167; Penn-Barwell JG, 2013, BONE JOINT J, V95B, P101, DOI 10.1302/0301-620X.95B1.30580; Popov L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00041; Reizner W, 2014, EUR CELLS MATER, V27, P196, DOI 10.22203/eCM.v027a15; Ryan AJ, 2016, DRUG DISCOV TODAY, V21, P1437, DOI 10.1016/j.drudis.2016.04.014; Waarsing JH, 2006, J ORTHOP RES, V24, P926, DOI 10.1002/jor.20063; Walter G, 2012, DTSCH ARZTEBL INT, V109, P257, DOI [10.3238/arztebl.012.0257, 10.3238/arztebl.2012.0257]; Wang Y, 2017, J CELL PHYSIOL, V232, P2396, DOI 10.1002/jcp.25774; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863; Widaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040586	43	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198837	10.1371/journal.pone.0198837	http://dx.doi.org/10.1371/journal.pone.0198837			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927956	Green Published, Green Submitted, gold			2022-12-26	WOS:000435802500031
J	Kowarski, K; Delarue, J; Martin, B; O'Brien, J; Meade, R; Cadhla, OO; Berrow, S				Kowarski, Katie; Delarue, Julien; Martin, Bruce; O'Brien, Joanne; Meade, Rossa; Cadhla, Oliver O.; Berrow, Simon			Signals from the deep: Spatial and temporal acoustic occurrence of beaked whales off western Ireland	PLOS ONE			English	Article							BOTTLE-NOSED WHALES; MARINE PROTECTED AREA; HYPEROODON-AMPULLATUS; ZIPHIUS-CAVIROSTRIS; NORTH-ATLANTIC; MESOPLODON-DENSIROSTRIS; FORAGING ACTIVITY; DIVING BEHAVIOR; CEPHALOPODS; STRANDINGS	Little is known of the spatio-temporal occurrence of beaked whales off western Ireland, limiting the ability of Regulators to implement appropriate management and conservation measures. To address this knowledge gap, static acoustic monitoring was carried out using eight fixed bottom-mounted autonomous acoustic recorders: four from May to December 2015 on Ireland's northern slope and four from March to November 2016 on the western and southern slopes. Recorders ran for 205 to 230 days, resulting in 4.09 TB of data sampled at 250 kHz which could capture beaked whale acoustic signals. Zero-crossing-based automated detectors identified beaked whale clicks. A sample of detections was manually validated to evaluate and optimize detector performance. Analysis confirmed the occurrence of Sowerby's and Cuvier's beaked whales and Northern bottlenose whales. Northern bottlenose whale clicks occurred in late summer and autumn, but were too few to allow further analysis. Cuvier's and Sowerby's clicks occurred at all stations throughout the monitoring period. There was a significant effect of month and station (latitude) on the mean daily number of click detections for both species. Cuvier's clicks were more abundant at lower latitudes while Sowerby's were greater at higher latitudes, particularly in the spring, suggesting a spatial segregation between species, possibly driven by prey preference. Cuvier's occurrence increased in late autumn 2015 off northwest Porcupine Bank, a region of higher relative occurrence for each species. Seismic airgun shots, with daily sound exposure levels as high as 175 dB re 1 mu Pa-2.s, did not appear to impact the mean daily number of Cuvier's or Sowerby's beaked whale click detections. This work provides insight into the significance of Irish waters for beaked whales and highlights the importance of using acoustics for beaked whale monitoring.	[Kowarski, Katie; Delarue, Julien; Martin, Bruce] JASCO Appl Sci, Dartmouth, NS, Canada; [O'Brien, Joanne; Meade, Rossa; Berrow, Simon] Galway Mayo Inst Technol, Marine & Freshwater Res Ctr, Galway, Ireland; [Cadhla, Oliver O.] Natl Pk & Wildlife Serv, Dept Culture Heritage & Gaeltacht, Dublin, Ireland	Galway Mayo Institute of Technology	Kowarski, K (corresponding author), JASCO Appl Sci, Dartmouth, NS, Canada.	Katie.Kowarski@jasco.com		O'Brien, Joanne/0000-0003-0296-2660; Kowarski, Katie/0000-0002-1325-8321	Department of Communications, Climate Action and Environment; Department of Culture, Heritage and the Gaeltacht under Ireland's ObSERVE Programme; JASCO	Department of Communications, Climate Action and Environment; Department of Culture, Heritage and the Gaeltacht under Ireland's ObSERVE Programme; JASCO	This study is part of the ObSERVE Acoustic project that was initiated and funded by the Department of Communications, Climate Action and Environment in partnership with the Department of Culture, Heritage and the Gaeltacht under Ireland's ObSERVE Programme. The Galway-Mayo Institute of Technology (GMIT) is the lead organization in ObSERVE. JASCO Applied Sciences was contracted by GMIT to provide acoustic recorders, analysis services, and to prepare a final report, but did not have any additional role in the study design, data collection, or decision to publish. JASCO provided internal funding in the form of salaries for authors (KK, JD, and BM) to prepare the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aguilar de Soto N, 2004, ACOUSTIC SURVEYS CET, VIII; Aguilar de Soto N, 2004, CETACEANS SEA BIRDS, VIII; Arbelo M, 2008, BIOACOUSTICS, V17, P294; Au WWL, 2013, J ACOUST SOC AM, V133, P3119, DOI 10.1121/1.4798360; Baumann-Pickering S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086072; Baumann-Pickering S, 2013, J ACOUST SOC AM, V134, P2293, DOI 10.1121/1.4817832; Benjaminsen T., 1979, Behavior of Marine Animals, V3, P143; Berrow S., 2001, P115; Berrow S., 2010, IRISH CETACEAN REV 2; BRUTON T, 1989, Irish Naturalists' Journal, V23, P156; Canadas A, 2002, DEEP-SEA RES PT I, V49, P2053, DOI 10.1016/S0967-0637(02)00123-1; Cholewiak D, 2013, J ACOUST SOC AM, V134, P3905, DOI 10.1121/1.4823843; Clarke MR, 2006, OCEANIC CEPHALOPOD D; Collins MA, 2002, B MAR SCI, V71, P239; Collins MA, 2001, J MAR BIOL ASSOC UK, V81, P105, DOI 10.1017/S0025315401003459; Couzens D, 2017, BRITAINS MAMMALS FIE; Cox T. M., 2005, Journal of Cetacean Research and Management, V7, P177; D'Amico Angela, 2009, Aquatic Mammals, V35, P452, DOI 10.1578/AM.35.4.2009.452; Davis J., 2006, P 23 INT C MACH LEAR, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; de Pontual H, 2012, J FISH BIOL, V81, P728, DOI 10.1111/j.1095-8649.2012.03345.x; DeRuiter SL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0223; Edds-Walton Peggy L., 1997, Bioacoustics, V8, P47; England G., 2001, JOINT INTERIM REPORT; Evans P. G. H., 1986, ANAL CETACEAN SIGHTI; Evans PG, 2003, P WORKSH HELD ECS 17; Evans PGH, 1992, STATUS REV CETACEANS; Falcone EA, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170629; Fernandez A, 2005, VET PATHOL, V42, P446, DOI 10.1354/vp.42-4-446; Fernandez A, 2006, REP U LAS PALMAS GRA, P24; Fernandez R, 2014, J MAR BIOL ASSOC UK, V94, P1109, DOI 10.1017/S002531541300180X; Filadelfo Ronald, 2009, Aquatic Mammals, V35, P435, DOI 10.1578/AM.35.4.2009.435; Finneran JJ, 2016, TECHNICAL REPORT; Frantzis A, 1998, NATURE, V392, P29, DOI 10.1038/32068; Gibson DI, 1998, J ZOOL, V244, P563, DOI 10.1111/j.1469-7998.1998.tb00061.x; Gillespie D, 2009, J ACOUST SOC AM, V125, P3428, DOI 10.1121/1.3110832; Giorli G, 2016, J ACOUST SOC AM, V140, P2333, DOI 10.1121/1.4964105; Giorli G, 2016, DEEP-SEA RES PT I, V107, P1, DOI 10.1016/j.dsr.2015.10.002; Giorli G, 2015, J ACOUST SOC AM, V137, P2495, DOI 10.1121/1.4919291; Hammond P.S., 2009, CETACEAN OFFSHORE DI; Hastie LC, 2009, OCEANOGR MAR BIOL, V47, P111; Hooker SK, 2009, RESP PHYSIOL NEUROBI, V167, P235, DOI 10.1016/j.resp.2009.04.023; Hooker SK, 1999, P ROY SOC B-BIOL SCI, V266, P671, DOI 10.1098/rspb.1999.0688; Hooker SK, 2002, BIOL CONSERV, V104, P51, DOI 10.1016/S0006-3207(01)00153-7; IUCN, 2021, WIKIPEDIA; Jefferson T.A., 2015, COMPREHENSIVE GUIDE; Johnsen E, 2007, ICES J MAR SCI, V64, P1202, DOI 10.1093/icesjms/fsm110; Johnston DW, 2008, BIOL LETTERS, V4, P208, DOI 10.1098/rsbl.2007.0614; Law RJ, 1997, MAR POLLUT BULL, V34, P208, DOI 10.1016/S0025-326X(96)00148-8; LU CC, 1975, J MAR BIOL ASSOC UK, V55, P143, DOI 10.1017/S0025315400015800; Lynn P, 2016, BREANANN SURVEY MARI; Mackey M, 2011, SEA678 DATA REPORT O; MacLeod C. D., 2005, Journal of Cetacean Research and Management, V7, P309; MacLeod CD, 2003, J MAR BIOL ASSOC UK, V83, P651, DOI 10.1017/S0025315403007616h; MacLeod Colin D., 2004, Journal of Cetacean Research and Management, V6, P79; Macleod D, 2000, MAMMAL REV, V30, P1; Martin B, 2013, P M AC, V19, P9, DOI [10.1121/1.4800967, DOI 10.1121/1.4800967]; Martin B, 2013, P M AC; Martin SB, 2017, J ACOUST SOC AM, V142, P3331, DOI 10.1121/1.5014049; Martin V, 2011, AQUAT MAMM, V37, P512, DOI 10.1578/AM.37.4.2011.512; McCauley RD, 2015, OFFSHORE IRISH NOISE; McGovern B, 2018, J MAR BIOL ASSOC UK, V98, P977, DOI 10.1017/S0025315416001594; Moore JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052770; Moulins A, 2007, J MAR BIOL ASSOC UK, V87, P177, DOI 10.1017/S0025315407055002; Munger LM, 2008, MAR MAMMAL SCI, V24, P795, DOI 10.1111/j.1748-7692.2008.00219.x; NASH R D M, 1982, Marine Ecology, V3, P161, DOI 10.1111/j.1439-0485.1982.tb00381.x; New LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068725; NMFS, 2016, NOAA TECHNICAL MEMOR, P178; OBrien J, 2009, BIOL ENV P ROYAL IRI; OCadhla O, 2004, CETACEAN DISTRIBUTIO, VII; Pereira JN, 2011, DEEP-SEA RES PT I, V58, P1084, DOI 10.1016/j.dsr.2011.08.004; Powers D. M, 2011, ARXIV201016061; Reda I, 2004, NRELTP56034302; Roch MA, 2011, J ACOUST SOC AM, V130, P2212, DOI 10.1121/1.3624821; Rogan E, 2017, DISTRIBUTION ABUNDAN; Rogan E., 2011, SC63SM19 IWC; ROSEN MJ, 2000, EUROPEAN RES CETACEA, V13, P383; Santos Begona M., 2005, Phuket Marine Biological Center Research Bulletin, V66, P291; Santos MB, 2001, J MAR BIOL ASSOC UK, V81, P687, DOI 10.1017/S0025315401004386; Soto NA, 2006, MAR MAMMAL SCI, V22, P690, DOI 10.1111/j.1748-7692.2006.00044.x; Spitz J, 2011, DEEP-SEA RES PT I, V58, P273, DOI 10.1016/j.dsr.2010.12.009; Stanistreet J.E., 2017, CAN J FISH AQUAT SCI, V00, P1; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Tyack PL, 2000, SPR HDB AUD, V12, P156; Vines J, 2014, RPS ENERGY; Wahlberg M, 2011, J ACOUST SOC AM, V130, P3077, DOI 10.1121/1.3641434; Wall D, 2013, ATLAS DISTRIBUTION R; Wall Ded, 2006, BIOL ENV P ROYAL IRI; Ward J, 2008, PASSIVE ACOUSTIC DET; WENZ GM, 1962, J ACOUST SOC AM, V34, P1936, DOI 10.1121/1.1909155; Whitehead H, 1997, MAR MAMMAL SCI, V13, P173, DOI 10.1111/j.1748-7692.1997.tb00625.x; Wiggins Sean M., 2005, Aquatic Mammals, V31, P161, DOI 10.1578/AM.31.2.2005.161; Wimmer T, 2004, CAN J ZOOL, V82, P1782, DOI 10.1139/Z04-168; Zar JH, 1999, BIOSTATISTICAL ANAL; Zimmer WMX, 2008, J ACOUST SOC AM, V124, P2823, DOI 10.1121/1.2988277; Zimmer WMX, 2007, MAR MAMMAL SCI, V23, P888, DOI 10.1111/j.1748-7692.2007.00152.x; Zimmer WMX, 2005, J ACOUST SOC AM, V117, P3919, DOI 10.1121/1.1910225	96	19	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199431	10.1371/journal.pone.0199431	http://dx.doi.org/10.1371/journal.pone.0199431			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928009	Green Submitted, Green Published, gold			2022-12-26	WOS:000435802500090
J	Bruno, AE; Charbonneau, P; Newman, J; Snell, EH; So, DR; Vanhoucke, V; Watkins, CJ; Williams, S; Wilson, J				Bruno, Andrew E.; Charbonneau, Patrick; Newman, Janet; Snell, Edward H.; So, David R.; Vanhoucke, Vincent; Watkins, Christopher J.; Williams, Shawn; Wilson, Julie			Classification of crystallization outcomes using deep convolutional neural networks	PLOS ONE			English	Article							PROTEIN-CRYSTALLIZATION; VISUAL ANALYSIS; TRAINING SET; IMAGES; TEXTURE	The Machine Recognition of Crystallization Outcomes (MARCO) initiative has assembled roughly half a million annotated images of macromolecular crystallization experiments from various sources and setups. Here, state-of-the-art machine learning algorithms are trained and tested on different parts of this data set. We find that more than 94% of the test images can be correctly labeled, irrespective of their experimental origin. Because crystal recognition is key to high-density screening and the systematic analysis of crystallization experiments, this approach opens the door to both industrial and fundamental research applications.	[Bruno, Andrew E.] SUNY Buffalo, Ctr Computat Res, Buffalo, NY USA; [Charbonneau, Patrick] Duke Univ, Dept Chem, Durham, NC 27706 USA; [Charbonneau, Patrick] Duke Univ, Dept Phys, Durham, NC 27706 USA; [Newman, Janet] CSIRO, Collaborat Crystallisat Ctr, Parkville, Vic, Australia; [Snell, Edward H.] Hauptman Woodward Med Res Inst, Buffalo, NY USA; [Snell, Edward H.] SUNY Buffalo, Dept Mat Design & Innovat, Buffalo, NY USA; [So, David R.; Vanhoucke, Vincent] Google Inc, Google Brain, Mountain View, CA 94043 USA; [Watkins, Christopher J.] CSIRO, IM&T Sci Comp, Clayton, Vic, Australia; [Williams, Shawn] GlaxoSmithKline Inc, Platform Technol & Sci, Collegeville, PA USA; [Wilson, Julie] Univ York, Dept Math, York, N Yorkshire, England	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Duke University; Duke University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Google Incorporated; Commonwealth Scientific & Industrial Research Organisation (CSIRO); GlaxoSmithKline; University of York - UK	Vanhoucke, V (corresponding author), Google Inc, Google Brain, Mountain View, CA 94043 USA.	vanhoucke@google.com	Snell, Edward/G-2055-2018; Newman, Janet M/D-1857-2011	Snell, Edward/0000-0001-8714-3191; Newman, Janet M/0000-0003-2666-3219; Wilson, Julie/0000-0002-5171-8480; Vanhoucke, Vincent/0000-0003-0544-2791; Charbonneau, Patrick/0000-0001-7174-0821	National Science Foundation [NSF DMR-1749374]	National Science Foundation(National Science Foundation (NSF))	PC acknowledges support from National Science Foundation Grant no. NSF DMR-1749374. VV and DRS are employed by Google Inc., and SPW is employed by GlaxoSmithKline Inc. These funders provided support in the form of salaries for authors VV, DRS, and SPW, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Additionally, GlaxoSmithKline provided data for the study which is freely available from the MARCO site (https://marco.ccr.buffalo.edu/).	Abadi M., 2016, TENSORFLOW LARGE SCA; Altan I, 2016, ARCH BIOCHEM BIOPHYS, V602, P12, DOI 10.1016/j.abb.2016.01.004; Angermueller C, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156651; Berg A., 2010, LARGE SCALE VISUAL R; Bern M., 2007, J APPL CRYSTALLOGR, V37, P279, DOI DOI 10.1107/S0021889804001'761; Bottou L, 2010, COMPSTAT'2010: 19TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL STATISTICS, P177, DOI 10.1007/978-3-7908-2604-3_16; Bousmalis Konstantinos, 2016, ADV NEURAL INFORM PR; Buchala S, 2008, ACTA CRYSTALLOGR D, V64, P823, DOI 10.1107/S0907444908014273; Chayen NE, 2004, CURR OPIN STRUC BIOL, V14, P577, DOI 10.1016/j.sbi.2004.08.002; Cumbaa CA, 2003, ACTA CRYSTALLOGR D, V59, P1619, DOI 10.1107/S0907444903015130; Cumbaa Christian, 2005, Journal of Structural and Functional Genomics, V6, P195, DOI 10.1007/s10969-005-5243-9; Cumbaa Christian A., 2010, Journal of Structural and Functional Genomics, V11, P61, DOI 10.1007/s10969-009-9076-9; Dean J., 2012, P 25 INT C NEURAL IN, DOI DOI 10.5555/2999134.2999271; Fazio Vincent J, 2015, Methods Mol Biol, V1261, P141, DOI 10.1007/978-1-4939-2230-7_8; Fusco D, 2016, COLLOID SURFACE B, V137, P22, DOI 10.1016/j.colsurfb.2015.07.023; Fusco D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101123; Ganin Yaroslav, 2015, INT C MACH LEARN, P1180; Golovin D, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1487, DOI 10.1145/3097983.3098043; Hargreaves D., COMMUNICATION; Harrison S, 2017, FUTURE MED CHEM, V9, P533, DOI 10.4155/fmc-2017-0025; Hung J, SPIE, V9034, P14; Kawabata K, 2008, SENSOR REV, V28, P242, DOI 10.1108/02602280810882607; Kotseruba Y, 2012, J PHYS CONF SER, V341, DOI 10.1088/1742-6596/341/1/012027; Krause J, 2017, ARXIV171001711CSCV; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Liu R, 2008, ACTA CRYSTALLOGR D, V64, P1187, DOI 10.1107/S090744490802982X; Liu Y, 2017, COMMUN MATH BIOL NEU, DOI 10.1080/10408398.2017.1329704; McPherson A., 1999, CRYSTALLIZATION BIOL; Mele K, 2014, J APPL CRYSTALLOGR, V47, P1097, DOI 10.1107/S1600576714009728; Mele K, 2014, CRYST GROWTH DES, V14, P261, DOI 10.1021/cg4014569; Newman J, 2012, ACTA CRYSTALLOGR F, V68, P253, DOI 10.1107/S1744309112002618; Newman J, 2011, METHODS, V55, P73, DOI 10.1016/j.ymeth.2011.04.004; Ng JT, 2016, ACTA CRYSTALLOGR D, V72, P224, DOI 10.1107/S2059798315024687; Pan S, 2006, ACTA CRYSTALLOGR D, V62, P271, DOI 10.1107/S0907444905041648; Po MJ, 2008, IEEE ENG MED BIO, P1926, DOI 10.1109/IEMBS.2008.4649564; Rawat W, 2017, NEURAL COMPUT, V29, P2352, DOI [10.1162/NECO_a_00990, 10.1162/neco_a_00990]; Rosa N, ACTA CRYST F; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Saitoh K, 2005, ACTA CRYSTALLOGR D, V61, P873, DOI 10.1107/S0907444905007948; Silberman N, 2017, TENSORFLOW SLIM IMAG; Smilkov D, 2017, ARXIV170603825CSLG; Snell EH, 2008, ACTA CRYSTALLOGR D, V64, P1131, DOI 10.1107/S0907444908028059; Snell EH, 2008, ACTA CRYSTALLOGR D, V64, P1123, DOI 10.1107/S0907444908028047; Snell EH, 2008, ACTA CRYSTALLOGR D, V64, P1240, DOI 10.1107/S0907444908032411; Spraggon G, 2002, ACTA CRYSTALLOGR D, V58, P1915, DOI 10.1107/S0907444902016840; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Szegedy C, 2017, ARXIV160207261CSCV; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Thielmann Yvonne, 2012, Journal of Structural and Functional Genomics, V13, P63, DOI 10.1007/s10969-011-9118-y; Tieleman T, 2012, RMSPROP DIVIDE GRADI, P31; Vallotton P, 2010, J APPL CRYSTALLOGR, V43, P1548, DOI 10.1107/S0021889810040963; Vanhoucke V., 2018, MARCOREPOSITORY TENS; Watkins C., 2018, C4 C3 CLASSIFIER PIP, DOI [10.4225/08/5a97375e6c0aa, DOI 10.4225/08/5A97375E6C0AA]; Wilson J., ADV DATA MINING APPL, P459; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yann MLJ, 2016, AAAI CONF ARTIF INTE, P1373; Zhang SH, 2017, J CRYST GROWTH, V472, P18, DOI 10.1016/j.jcrysgro.2017.01.026; Zoph B, 2017, ARXIV170707012CSCV	60	41	42	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0198883	10.1371/journal.pone.0198883	http://dx.doi.org/10.1371/journal.pone.0198883			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924841	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000435655600035
J	Lucas, SEM; Zhou, T; Blackburn, NB; Mills, RA; Ellis, J; Leo, P; Souzeau, E; Ridge, B; Charlesworth, JC; Lindsay, R; Craig, JE; Burdon, KP				Lucas, Sionne E. M.; Zhou, Tiger; Blackburn, Nicholas B.; Mills, Richard A.; Ellis, Jonathan; Leo, Paul; Souzeau, Emmanuelle; Ridge, Bronwyn; Charlesworth, Jac C.; Lindsay, Richard; Craig, Jamie E.; Burdon, Kathryn P.			Rare, potentially pathogenic variants in 21 keratoconus candidate genes are not enriched in cases in a large Australian cohort of European descent	PLOS ONE			English	Article							POSTERIOR POLYMORPHOUS DYSTROPHY; AUTOSOMAL-DOMINANT KERATOCONUS; GENOME-WIDE ASSOCIATION; VSX1 GENE; FAMILIAL KERATOCONUS; MUTATIONAL ANALYSIS; CORNEAL THICKNESS; SEQUENCE VARIANTS; LINKAGE SCAN; LOCUS	Many genes have been suggested as candidate genes for keratoconus based on their function, their proximity to associated polymorphisms or due to the identification of putative causative variants within the gene. However, very few of these genes have been assessed for rare variation in keratoconus more broadly. In contrast, VSX1 and SOD1 have been widely assessed, however, the vast majority of studies have been small and the findings conflicting. In a cohort of Australians of European descent, consisting of 385 keratoconus cases and 396 controls, we screened 21 keratoconus candidate genes: BANP, CAST, COL4A3, COL4A4, COL5A1, FOXO1, FNDC3B, HGF, IL1A, IL1B, ILRN, IMMP2L, MPDZ, NFIB, RAB3GAP1, RAD51, RXRA, SLC4A11, SOD1, TF and VSX1. The candidate genes were sequenced in these individuals by either whole exome sequencing or targeted gene sequencing. Variants were filtered to identify rare (minor allele frequency <1%), potentially pathogenic variants. A total of 164 such variants were identified across the two groups with no variants fulfilling these criteria in cases in IL1RN, BANP, IL1B, RAD51 or SOD1. The frequency of variants was compared between cases and controls using chi-square or Fishers' Exact tests for each gene with at least one rare potentially pathogenic variant identified in the case cohort. The number of rare potentially pathogenic variants per gene ranged from three (RXRA) to 102 (MPDZ), however for all genes, there was no difference in the frequency between the cases and controls. We conclude that rare potentially pathogenic variation in the 21 candidate genes assessed do not play a major role in keratoconus susceptibility and pathogenesis.	[Lucas, Sionne E. M.; Blackburn, Nicholas B.; Charlesworth, Jac C.; Burdon, Kathryn P.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Zhou, Tiger; Mills, Richard A.; Souzeau, Emmanuelle; Ridge, Bronwyn; Craig, Jamie E.] Flinders Univ S Australia, Dept Ophthalmol, Adelaide, SA, Australia; [Blackburn, Nicholas B.] Univ Texas Rio Grande Valley, Sch Med, Dept Human Genet, South Texas Diabet & Obes Inst, Brownsville, TX USA; [Ellis, Jonathan] Queensland Univ Technol, Brisbane, Qld, Australia; [Ellis, Jonathan] Princess Alexandra Hosp, Translat Res Inst, Brisbane, Qld, Australia; [Leo, Paul] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Lindsay, Richard] Richard Lindsay & Associates, East Melbourne, Vic, Australia	University of Tasmania; Menzies Institute for Medical Research; Flinders University South Australia; University of Texas System; University of Texas Rio Grande Valley; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Burdon, KP (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.	kathryn.burdon@utas.edu.au	Ellis, Jonathan J/F-2920-2010; Souzeau, Emmanuelle/AAB-5608-2022; Blackburn, Nicholas B./G-5114-2014; Leo, Paul/R-4464-2019; Blackburn, Nicholas B./GLQ-6342-2022; Burdon, Kathryn/AAD-2334-2022; Burdon, Kathryn/A-5026-2009; Lucas, Sionne E M/J-7035-2015; Charlesworth, Jac/J-7661-2014	Ellis, Jonathan J/0000-0003-0410-5064; Souzeau, Emmanuelle/0000-0002-2015-6577; Blackburn, Nicholas B./0000-0002-9774-1539; Blackburn, Nicholas B./0000-0002-9774-1539; Burdon, Kathryn/0000-0001-8217-1249; Burdon, Kathryn/0000-0001-8217-1249; Lucas, Sionne E M/0000-0003-0104-5406; Mills, Richard/0000-0002-7386-2571; Ellis, Jonathan/0000-0003-0218-546X; Craig, Jamie/0000-0001-9955-9696; Charlesworth, Jac/0000-0001-6201-3518	National Health and Medical Research Council (NHMRC) of Australia Centre for Research Excellence [GNT1023911]; NHMRC; NHMRC Practitioner Fellowship; Australian Government Research Training Program Scholarship; Pennicott Foundation; Richard Lindsay and Associates	National Health and Medical Research Council (NHMRC) of Australia Centre for Research Excellence(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Pennicott Foundation; Richard Lindsay and Associates	This work was funded in part by a National Health and Medical Research Council (NHMRC) of Australia Centre for Research Excellence (GNT1023911). KPB is supported by a Senior Research Fellowship from the NHMRC and JEC by an NHMRC Practitioner Fellowship. SEM Lucas is supported by the Australian Government Research Training Program Scholarship and the Pennicott Foundation. Dr. Richard Lindsay currently receives salary from Richard Lindsay and Associates, a specialist contact lens practice.	Abu-Amero KK, 2011, MOL VIS, V17, P822; Abu-Amero KK, 2011, MOL VIS, V17, P667; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Muammar AM, 2015, OPHTHALMIC GENET, V36, P373, DOI 10.3109/13816810.2014.889173; Aldave AJ, 2006, INVEST OPHTH VIS SCI, V47, P2820, DOI 10.1167/iovs.05-1530; Bardak H, 2016, Genet Mol Res, V15, DOI 10.4238/gmr15049024; BECHARA SJ, 1991, AM J OPHTHALMOL, V112, P729, DOI 10.1016/S0002-9394(14)77284-8; Bisceglia L, 2005, INVEST OPHTH VIS SCI, V46, P39, DOI 10.1167/iovs.04-0533; Bisceglia L, 2009, INVEST OPHTH VIS SCI, V50, P1081, DOI 10.1167/iovs.08-2382; BLAIR SD, 1992, CORNEA, V11, P255; Brancati F, 2004, J MED GENET, V41, P188, DOI 10.1136/jmg.2003.012872; Burdon KP, 2008, HUM GENET, V124, P379, DOI 10.1007/s00439-008-0555-z; Burdon KP, 2011, INVEST OPHTH VIS SCI, V52, P8514, DOI 10.1167/iovs.11-8261; Bykhovskaya Y, 2015, OPHTHALMIC GENET, V36, P244, DOI 10.3109/13816810.2013.848908; Czugala M, 2012, EUR J HUM GENET, V20, P389, DOI 10.1038/ejhg.2011.203; Dash DP, 2010, EYE, V24, P1085, DOI 10.1038/eye.2009.217; Dash D, 2006, MOL VIS, V12, P499; De Bonis P, 2011, MOL VIS, V17, P2482; Dehkordi FA, 2013, ACTA CYTOL, V57, P646, DOI 10.1159/000353297; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DRIVER PJ, 1994, AM J OPHTHALMOL, V118, P256, DOI 10.1016/S0002-9394(14)72911-3; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Eran P, 2008, OPHTHALMIC GENET, V29, P53, DOI 10.1080/13816810802008242; Fullerton J, 2002, HUM GENET, V110, P462, DOI 10.1007/s00439-002-0705-7; Gajecka M, 2009, INVEST OPHTH VIS SCI, V50, P1531, DOI 10.1167/iovs.08-2173; GASSET AR, 1974, AM J OPHTHALMOL, V78, P535, DOI 10.1016/0002-9394(74)90249-9; Godefrooij DA, 2017, AM J OPHTHALMOL, V175, P169, DOI 10.1016/j.ajo.2016.12.015; Bae HA, 2013, INVEST OPHTH VIS SCI, V54, P5132, DOI 10.1167/iovs.13-12377; Hameed A, 2000, INVEST OPHTH VIS SCI, V41, P629; Hao XD, 2015, OPHTHALMIC GENET, V36, P132, DOI 10.3109/13816810.2015.1005317; Hayashi T, 2000, GENOMICS, V67, P128, DOI 10.1006/geno.2000.6248; HEON E, 1995, HUM MOL GENET, V4, P485, DOI 10.1093/hmg/4.3.485; Heon E, 2002, HUM MOL GENET, V11, P1029, DOI 10.1093/hmg/11.9.1029; Hughes AE, 2003, INVEST OPHTH VIS SCI, V44, P5063, DOI 10.1167/iovs.03-0399; Hughes AE, 2011, AM J HUM GENET, V89, P628, DOI 10.1016/j.ajhg.2011.09.014; Hutchings H, 2005, J MED GENET, V42, P88, DOI 10.1136/jmg.2004.022103; Jeoung JW, 2012, CORNEA, V31, P746, DOI 10.1097/ICO.0b013e3181e16dd0; Karolak JA, 2016, OPHTHALMIC GENET, V37, P37, DOI 10.3109/13816810.2014.926375; Kelly BJ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0577-x; KENNEDY RH, 1986, AM J OPHTHALMOL, V101, P267, DOI 10.1016/0002-9394(86)90817-2; Kim SH, 2008, MOL VIS, V14, P2109; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kymes SM, 2004, AM J OPHTHALMOL, V138, P527, DOI 10.1016/j.ajo.2004.04.031; Lechner J, 2013, INVEST OPHTH VIS SCI, V54, P5266, DOI 10.1167/iovs.13-12035; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H., 2013, 313033997 ARXIV; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XH, 2006, INVEST OPHTH VIS SCI, V47, P3791, DOI 10.1167/iovs.06-0214; Li XH, 2013, CORNEA, V32, P696, DOI 10.1097/ICO.0b013e3182821c1c; Li XH, 2012, HUM MOL GENET, V21, P421, DOI 10.1093/hmg/ddr460; Liskova P, 2007, MOL VIS, V13, P1887; Liskova P, 2010, ARCH OPHTHALMOL-CHIC, V128, P1191, DOI 10.1001/archophthalmol.2010.200; Lu Y, 2013, NAT GENET, V45, P155, DOI 10.1038/ng.2506; Lucas SEM, 2017, INVEST OPHTH VIS SCI, V58, P6248, DOI 10.1167/iovs.17-22417; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mok JW, 2008, J HUM GENET, V53, P842, DOI 10.1007/s10038-008-0319-6; Moschos MM, 2015, OPHTHALMIC GENET, V36, P213, DOI 10.3109/13816810.2013.843712; Nejabat Mahmood, 2017, J Ophthalmic Vis Res, V12, P135, DOI 10.4103/jovr.jovr_97_16; Ng JB, 2016, CLIN LAB, V62, P1731, DOI 10.7754/Clin.Lab.2016.160144; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nowak DM, 2013, INVEST OPHTH VIS SCI, V54, P2207, DOI 10.1167/iovs.13-11592; Paliwal P, 2011, MOL VIS, V17, P481; Paliwal P, 2009, MOL VIS, V15, P2475; Pearson AR, 2000, EYE, V14, P625, DOI 10.1038/eye.2000.154; Rosenfeld JA, 2011, AM J MED GENET A, V155A, P1906, DOI 10.1002/ajmg.a.34100; Saee-Rad S, 2011, MOL VIS, V17, P3128; Sahebjada S, 2013, INVEST OPHTH VIS SCI, V54, P8224, DOI 10.1167/iovs.13-12982; Sahebjada S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084067; Semina EV, 2000, GENOMICS, V63, P289, DOI 10.1006/geno.1999.6093; Shetty R, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0178-x; Stabuc-Silih M, 2009, MOL VIS, V15, P2848; Stabuc-Silih M, 2010, CORNEA, V29, P172, DOI 10.1097/ICO.0b013e3181aebf7a; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Synowiec E, 2013, DIS MARKERS, V2013, P353, DOI 10.1155/2013/851817; Tang YMG, 2005, GENET MED, V7, P397, DOI 10.1097/01.GIM.0000170772.41860.54; Tang YMG, 2008, CORNEA, V27, P189, DOI 10.1097/ICO.0b013e31815a50e7; Tanwar M, 2010, MOL VIS, V16, P2395; Tyynismaa H, 2002, INVEST OPHTH VIS SCI, V43, P3160; Udar N, 2006, INVEST OPHTH VIS SCI, V47, P3345, DOI 10.1167/iovs.05-1500; Verma Anshuman, 2013, BMC Res Notes, V6, P103, DOI 10.1186/1756-0500-6-103; Vincent AL, 2013, MOL VIS, V19, P852; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang YN, 2013, OPHTHALMIC GENET, V34, P160, DOI 10.3109/13816810.2012.743569; WEISSMAN BA, 1989, OPTOMETRY VISION SCI, V66, P243, DOI 10.1097/00006324-198904000-00012; Wojcik KA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/247438; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	86	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199178	10.1371/journal.pone.0199178	http://dx.doi.org/10.1371/journal.pone.0199178			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924831	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000435655600053
J	Eastlack, SC; Dong, SL; Mo, YY; Alahari, SK				Eastlack, Steven C.; Dong, Shengli; Mo, Yin Y.; Alahari, Suresh K.			Expression of long noncoding RNA MALAT1 correlates with increased levels of Nischarin and inhibits oncogenic cell functions in breast cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSIVE FUNCTION; LUNG-CANCER; DOWN-REGULATION; GASTRIC-CANCER; METASTASIS; PROMOTES; PROLIFERATION; MIGRATION; PATHWAY	Malat1 is a long noncoding RNA with a wide array of functions, including roles in regulating cancer cell migration and metastasis. However, the nature of its involvement in control of these oncogenic processes is incompletely understood. In the present study, we investigate the role of Malat1 and the effects of Malat1 KO in a breast cancer cell model. Our selection of Malat1 as the subject of inquiry followed initial screening experiments seeking to identify IncRNAs which are altered in the presence or absence of Nischarin, a gene of interest previously discovered by our lab. Nischarin is a well characterized tumor suppressor protein and actively represses cell proliferation, migration, and invasion in breast cancer. Our microarray screen for IncRNAs revealed multiple IncRNAs to be significantly elevated in cells ectopically expressing Nischarin compared to control cancer cells, which have only marginal Nisch expression. Using these cells, we assess how the link between Nischarin and Malat1 affects cancer cell function, finding that Malat1 confers an inhibitory effect on cell growth and migration which is lost following Malat1 KO, but in a Nisch-dependent context. Specifically, Malat1 KO in the background of low Nischarin expression had a limited effect on cell functions, while Malat1 KO in cells with high levels of Nischarin led to significant increases in cell proliferation and migration. In summary, this project provides further clarity concerning the function of Malat1, specifically in breast cancer, while also indicating that the Nischarin expression context is an important factor in the determining how Malat1 activity is governed in breast cancer.	[Eastlack, Steven C.; Dong, Shengli; Alahari, Suresh K.] LSUHSC Sch Med, Dept Biochem & Mol Biol, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA; [Mo, Yin Y.] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Mississippi; University of Mississippi Medical Center	Alahari, SK (corresponding author), LSUHSC Sch Med, Dept Biochem & Mol Biol, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA.	salaha@lsuhsc.edu	Mo, Yin-Yuan/R-8255-2019					Alahari SV, 2016, INT REV CEL MOL BIO, V324, P229, DOI 10.1016/bs.ircmb.2016.01.004; Alahari SK, 2000, J CELL BIOL, V151, P1141, DOI 10.1083/jcb.151.6.1141; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Baranwal S, 2011, J NATL CANCER I, V103, P1513, DOI 10.1093/jnci/djr350; Chou JJ, 2016, BIOCHEM BIOPH RES CO, V472, P262, DOI 10.1016/j.bbrc.2016.02.102; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Han Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.407; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Jadaliha M, 2016, ONCOTARGET, V7, P40418, DOI 10.18632/oncotarget.9622; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Ji Q, 2014, BRIT J CANCER, V111, P736, DOI 10.1038/bjc.2014.383; Jin C, 2016, TUMOR BIOL, V37, P7383, DOI 10.1007/s13277-015-4605-6; Johnson R, 2009, RNA, V15, P85, DOI 10.1261/rna.1127009; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Lai MC, 2012, MED ONCOL, V29, P1810, DOI 10.1007/s12032-011-0004-z; Latorre E, 2016, CANCER RES, V76, P2626, DOI 10.1158/0008-5472.CAN-15-2018; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pang EJ, 2015, TUMOR BIOL, V36, P2403, DOI 10.1007/s13277-014-2850-8; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Shen LQ, 2015, J NEURO-ONCOL, V121, P101, DOI 10.1007/s11060-014-1613-0; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Song HJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-225; Wu XS, 2014, CANCER BIOL THER, V15, P806, DOI 10.4161/cbt.28584; Xu SP, 2015, INT J CLIN EXP PATHO, V8, P4881; Yang F, 2012, FEBS J, V279, P3159, DOI 10.1111/j.1742-4658.2012.08694.x	28	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198945	10.1371/journal.pone.0198945	http://dx.doi.org/10.1371/journal.pone.0198945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912916	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600064
J	Tran, TD; Kwon, YK				Tien-Dzung Tran; Kwon, Yung-Keun			Hierarchical closeness-based properties reveal cancer survivability and biomarker genes in molecular signaling networks	PLOS ONE			English	Article							CELL LUNG-CANCER; COMPLEX NETWORKS; BLADDER-CANCER; KRAS MUTATIONS; PATIENT SURVIVABILITY; EGFR MUTATIONS; MELANOMA; IDENTIFICATION; ROBUSTNESS; CARCINOMA	Specific molecular signaling networks underlie different cancer types and quantitative analyses on those cancer networks can provide useful information about cancer treatments. Their structural metrics can reveal survivability of cancer patients and be used to identify biomarker genes for early cancer detection. In this study, we devised a novel structural metric called hierarchical closeness (HC) entropy and found that it was negatively correlated with 5-year survival rates. We also made an interesting observation that a network of higher HC entropy was likely to be more robust against mutations. This finding suggested that cancers of high HC entropy tend to be incurable because their signaling networks are robust to perturbations caused by treatment. We also proposed a novel core identification method based on the reachability factor in the HC measure. The cores were permitted to decompose such that the negative relationship between HC entropy and cancer survival rate was consistently conserved in every core level. Interestingly, we observed that many promising biomarker genes for early cancer detection reside in the innermost core of a signaling network. Taken together, the proposed analyses of the hierarchical structure of cancer signaling networks may be useful in developing future novel cancer treatments.	[Tien-Dzung Tran] Hanoi Univ Ind, Complex Syst & Bioinformat Lab, Hanoi, Vietnam; [Kwon, Yung-Keun] Univ Ulsan, Sch IT Convergence, Ulsan, South Korea; [Tien-Dzung Tran] Hanoi Univ Ind, Dept Software Engn, Fac Informat & Commun Technol, Hanoi, Vietnam	Hanoi University of Industry (HaUI); University of Ulsan; Hanoi University of Industry (HaUI)	Tran, TD (corresponding author), Hanoi Univ Ind, Complex Syst & Bioinformat Lab, Hanoi, Vietnam.; Kwon, YK (corresponding author), Univ Ulsan, Sch IT Convergence, Ulsan, South Korea.; Tran, TD (corresponding author), Hanoi Univ Ind, Dept Software Engn, Fac Informat & Commun Technol, Hanoi, Vietnam.	trantd.vn@gmail.com; kwonyk@ulsan.ac.kr	Tien-Dzung, Tran/O-6538-2014	Tien-Dzung, Tran/0000-0002-7966-6838	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A1A09060910]; Hanoi University of Industry, Viet Nam	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Hanoi University of Industry, Viet Nam	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A09060910) (https://www.nrf.re.kr/). This work was supported by the Research Fund 2017 of the Hanoi University of Industry, Viet Nam (https://www.haui.edu.vn/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acencio ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077521; Ahmed HA, 2015, COMPUT BIOL CHEM, V59, P32, DOI 10.1016/j.compbiolchem.2015.08.008; Arakelyan A, 2013, BIOINFORMATICS, V29, P518, DOI 10.1093/bioinformatics/bts730; Bae NC, 2007, CANCER GENET CYTOGEN, V173, P107, DOI 10.1016/j.cancergencyto.2006.10.007; Balasenthil S, 2011, CANCER PREV RES, V4, P137, DOI 10.1158/1940-6207.CAPR-10-0025; Banerji CRS, 2013, SCI REP-UK, V3, DOI 10.1038/srep03039; Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138; Bansal S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-405; Barjaktarovic Z, 2013, RADIAT ENVIRON BIOPH, V52, P87, DOI 10.1007/s00411-012-0439-4; Batagelj V., 2003, CORR TECH REP 031004, VDS; Bianconi G, 2008, ENTROPY RANDOMIZED N, V81, DOI [10.1209/0295-5075/81/28005, DOI 10.1209/0295-5075/81/28005]; Bianconi G, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016114; Bianconi G, 2009, P NATL ACAD SCI USA, V106, P11433, DOI 10.1073/pnas.0811511106; Breitkreutz D, 2012, P NATL ACAD SCI USA, V109, P9209, DOI 10.1073/pnas.1201416109; Buschges R, 1999, BRAIN PATHOL, V9, P435; Garrido-Castro AC, 2013, TRANSL LUNG CANCER R, V2, P122, DOI 10.3978/j.issn.2218-6751.2013.02.02; Cicenas J, 2017, MED ONCOL, V34, DOI 10.1007/s12032-016-0879-9; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Cranford JA, 2009, J STUD ALCOHOL DRUGS, P86, DOI 10.15288/jsads.2009.s16.86; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Della Rossa F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01467; Dumenil C, 2015, LUNG CANCER, V90, P561, DOI 10.1016/j.lungcan.2015.10.012; Emerson Arnold I, 2015, J Clin Bioinforma, V5, P1, DOI 10.1186/s13336-015-0016-6; Estrada E, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016103; Fumia HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069008; Gaughan EM, 2013, LUNG CANCER, V79, P193, DOI 10.1016/j.lungcan.2012.12.002; Gfeller D, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056135; Hayes MP, 2009, GYNECOL ONCOL, V113, P370, DOI 10.1016/j.ygyno.2008.12.021; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Holme P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016605; Iliopoulos D, 2005, ONCOGENE, V24, P1625, DOI 10.1038/sj.onc.1208398; Isaac AE, 2015, J BIOSCIENCES, V40, P683, DOI 10.1007/s12038-015-9554-0; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jin G, 2010, LUNG CANCER, V69, P279, DOI 10.1016/j.lungcan.2009.11.012; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kwon YK, 2008, BIOINFORMATICS, V24, P987, DOI 10.1093/bioinformatics/btn060; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Leslie KK, 2012, GYNECOL ONCOL, V127, P345, DOI 10.1016/j.ygyno.2012.07.127; Liu JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104028; Liu W, 2014, SCI REP-UK, V4, DOI 10.1038/srep05739; Longo DM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-113; Lu YY, 2014, MOL BIOSYST, V10, P1117, DOI 10.1039/c3mb70474b; Malliaros FD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19307; Mao CQ, 2014, MOL THER, V22, P964, DOI 10.1038/mt.2014.18; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Maslov S, 2005, CORRELATION PROFILES, P168, DOI [10.1002/3527602755, DOI 10.1002/3527602755.CH8]; McCarron SL, 2003, INT J CANCER, V107, P673, DOI 10.1002/ijc.11448; Narang V, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004504; Netto GJ, 2012, NAT REV UROL, V9, P41, DOI 10.1038/nrurol.2011.193; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Reichardt J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.218701; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Robinson LF, 2010, NEUROIMAGE, V49, P1581, DOI 10.1016/j.neuroimage.2009.08.061; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Roy J, 2014, BRIEF BIOINFORM, V15, P612, DOI 10.1093/bib/bbs083; Sathe A, 2016, J UROLOGY, V195, P771, DOI 10.1016/j.juro.2015.08.082; Takemoto K, 2013, BIOSYSTEMS, V113, P149, DOI 10.1016/j.biosystems.2013.06.003; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; Tian TH, 2011, INTEGR BIOL-UK, V3, P17, DOI 10.1039/c0ib00046a; Tran TD, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0771; Tran TD, 2014, COMPUT BIOL CHEM, V53, P191, DOI 10.1016/j.compbiolchem.2014.08.023; Verma T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10441; Voliotis M, 2014, P NATL ACAD SCI USA, V111, pE326, DOI 10.1073/pnas.1314446111; Waclaw B, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046114; Weng L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-39; West J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00802; Wiencke JK, 2004, NAT REV CANCER, V4, P79, DOI 10.1038/nrc1257; Willem P, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-205; Zhang T, 2014, ACTA BIOCH BIOPH SIN, V46, P1072, DOI 10.1093/abbs/gmu105; Zhang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085170; Zhao J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-311; Zhu PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23078	76	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199109	10.1371/journal.pone.0199109	http://dx.doi.org/10.1371/journal.pone.0199109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912931	Green Submitted, gold, Green Published			2022-12-26	WOS:000435528600075
J	Garg, N; Whiteley, M				Garg, Neha; Whiteley, Marvin			The chemical topology of a bacterial swarm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PSEUDOMONAS-AERUGINOSA	Microbes respond to antibiotics by initiating a suite of defense mechanisms, including the production of small-molecule effectors. However, it is not well-known how these defenses vary according to the particular effector or antibiotic and bacterial state, due in part to the challenges of monitoring small molecules in complex environments. A new study uses state-of-the-art imaging techniques to track the location of secreted small molecules produced by a bacterial swarm in response to different antibiotics, providing unexpected insights into the spatial heterogeneity of bacterial stress responses.	[Garg, Neha] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Whiteley, Marvin] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Garg, Neha; Whiteley, Marvin] Emory Childrens Cyst Fibrosis Ctr, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Garg, N (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	neha.garg@chemistry.gatech.edu	Garg, Neha/L-3120-2018	Garg, Neha/0000-0002-2760-7123	Georgia Institute of Technology (Georgia Tech); National Institutes of Health [R01GM116547-01A1, 1R01DE023193-01]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116547] Funding Source: NIH RePORTER	Georgia Institute of Technology (Georgia Tech); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by start-up funds from the Georgia Institute of Technology (Georgia Tech) and National Institutes of Health Grants R01GM116547-01A1 and 1R01DE023193-01. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Davies SK, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00211-17; Garg N, 2017, CELL HOST MICROBE, V22, P705, DOI 10.1016/j.chom.2017.10.001; Jorth P, 2015, CELL HOST MICROBE, V18, P307, DOI 10.1016/j.chom.2015.07.006; Lepine F, 2004, J AM SOC MASS SPECTR, V15, P862; Morales-Soto N, 2018, J BIOL CHEM, V293, P9544, DOI 10.1074/jbc.RA118.002605; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Quinn RA, 2016, ISME J, V10, P1483, DOI 10.1038/ismej.2015.207; Szamosvari D, 2017, ANGEW CHEM INT EDIT, V56, P7271, DOI 10.1002/anie.201702944	8	0	0	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9553	9554		10.1074/jbc.H118.003178	http://dx.doi.org/10.1074/jbc.H118.003178			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29907734	Green Published, hybrid			2022-12-26	WOS:000435441400038
J	Bednarz, VN; Naumann, MS; Cardini, U; van Hoytema, N; Rix, L; Al-Rshaidat, MMD; Wild, C				Bednarz, Vanessa N.; Naumann, Malik S.; Cardini, Ulisse; van Hoytema, Nanne; Rix, Laura; Al-Rshaidat, Mamoon M. D.; Wild, Christian			Contrasting seasonal responses in dinitrogen fixation between shallow and deep-water colonies of the model coral Stylophora pistillata in the northern Red Sea	PLOS ONE			English	Article							NITROGEN-FIXATION; N-2 FIXATION; MONTASTRAEA-CAVERNOSA; ZOOXANTHELLATE CORAL; DISSOLVED-OXYGEN; GULF; TEMPERATURE; MUCUS; LIGHT; METABOLISM	Tropical corals are often associated with dinitrogen (N-2)-fixing bacteria (diazotrophs), and seasonal changes in key environmental parameters, such as dissolved inorganic nitrogen (DIN) availability and seawater temperature, are known to affect N-2 fixation in coral-microbial holobionts. Despite, then, such potential for seasonal and depth-related changes in N-2 fixation in reef corals, such variation has not yet been investigated. Therefore, this study quantified seasonal (winter vs. summer) N-2 fixation rates associated with the reef-building coral Stylophora pistillata collected from depths of 5, 10 and 20 m in the northern Gulf of Aqaba (Red Sea). Findings revealed that corals from all depths exhibited the highest N-2 fixation rates during the oligotrophic summer season, when up to 11% of their photo-metabolic nitrogen demand (CPND) could be met by N-2 fixation. While N-2 fixation remained seasonally stable for deep corals (20 m), it significantly decreased for the shallow corals (5 and 10 m) during the DIN-enriched winter season, accounting for less than 2% of the corals' CPND. This contrasting seasonal response in N-2 fixation across corals of different depths could be driven by 1) release rates of coral-derived organic matter, 2) the community composition of the associated diazotrophs, and/or 3) nutrient acquisition by the Symbiodinium community.	[Bednarz, Vanessa N.; Naumann, Malik S.; Cardini, Ulisse; van Hoytema, Nanne; Rix, Laura; Wild, Christian] Leibniz Ctr Trop Marine Res ZMT, Coral Reef Ecol Grp, Bremen, Germany; [Bednarz, Vanessa N.] Ctr Sci Monaco, Marine Dept, Municipality Of Monaco, Monaco; [Cardini, Ulisse] Staz Zool Anton Dohrn, Integrat Marine Ecol Dept, Naples, Italy; [Rix, Laura] GEOMAR Helmholtz Ctr Ocean Res, Marine Microbiol RD3, Kiel, Germany; [Al-Rshaidat, Mamoon M. D.] Marine Sci Stn, Lab Mol Microbial Ecol, Aqaba, Jordan; [Al-Rshaidat, Mamoon M. D.] Univ Jordan, Dept Biol Sci, Mol & Microbial Ecol, Amman, Jordan; [Wild, Christian] Univ Bremen, Fac Biol & Chem, Marine Ecol Grp, Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Stazione Zoologica Anton Dohrn di Napoli; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Jordan; University of Bremen	Bednarz, VN (corresponding author), Leibniz Ctr Trop Marine Res ZMT, Coral Reef Ecol Grp, Bremen, Germany.; Bednarz, VN (corresponding author), Ctr Sci Monaco, Marine Dept, Municipality Of Monaco, Monaco.	vbednarz@centrescientifique.mc	Rix, Laura/B-3121-2019; Cardini, Ulisse/I-3735-2013; Rix, Laura/U-6264-2019; Naumann, Malik/A-3607-2011; Al-Rshaidat, Mamoon/C-6549-2015	Rix, Laura/0000-0002-1888-6597; Cardini, Ulisse/0000-0002-0816-6158; van Hoytema, Nanne/0000-0002-6116-2770; Naumann, Malik/0000-0002-6870-291X; Al-Rshaidat, Mamoon/0000-0003-3047-5608	German Research Foundation [Wi 2677/9-1]; German Leibniz Association; Evangelisches Studienwerk Villigst e.V.	German Research Foundation(German Research Foundation (DFG)); German Leibniz Association; Evangelisches Studienwerk Villigst e.V.	This work was funded by the German Research Foundation [grant number Wi 2677/9-1 to C.W.] with support of the German Leibniz Association and a PhD stipend from Evangelisches Studienwerk Villigst e.V. to V.N.B.	Ainsworth TD, 2015, ISME J, V9, P2261, DOI 10.1038/ismej.2015.39; Alamaru A, 2009, GEOCHIM COSMOCHIM AC, V73, P5333, DOI 10.1016/j.gca.2009.06.018; Allers E, 2008, APPL ENVIRON MICROB, V74, P3274, DOI 10.1128/AEM.01870-07; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 1974, HELGOLANDER WISSENSC, V26, P238; Baker DM, 2013, ISME J, V7, P1248, DOI 10.1038/ismej.2013.12; Bednarz VN, 2017, MBIO, V8, DOI 10.1128/mBio.02058-16; Bednarz VN, 2015, MAR ECOL PROG SER, V519, P141, DOI 10.3354/meps11091; Benavides M, 2016, J EXP BIOL, V219, P2608, DOI 10.1242/jeb.139451; Breitbarth E, 2007, BIOGEOSCIENCES, V4, P53, DOI 10.5194/bg-4-53-2007; Breitbarth E, 2004, LIMNOL OCEANOGR-METH, V2, P282, DOI 10.4319/lom.2004.2.282; Bythell JC, 2011, J EXP MAR BIOL ECOL, V408, P88, DOI 10.1016/j.jembe.2011.07.028; Camps M, 2016, AQUAT MICROB ECOL, V77, P51, DOI 10.3354/ame01787; Capone D.G., 1993, HDB METHODS AQUATIC, P621, DOI 10.1201/9780203752746-74; Cardini U, 2016, ECOSYSTEMS, V19, P771, DOI 10.1007/s10021-016-9966-1; Cardini U, 2016, ENVIRON MICROBIOL, V18, P2620, DOI 10.1111/1462-2920.13385; Cardini U, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2257; Cardini U, 2014, ECOL EVOL, V4, P1706, DOI 10.1002/ece3.1050; Carlson DF, 2014, DEEP-SEA RES PT I, V84, P1, DOI 10.1016/j.dsr.2013.10.004; Charpy L, 2007, AQUAT MICROB ECOL, V47, P73, DOI 10.3354/ame047073; Chen CP, 2011, ISME J, V5, P728, DOI 10.1038/ismej.2010.151; Clarke K.R., 2006, PRIMER VERSION 6 USE; CROSSLAND CJ, 1987, CORAL REEFS, V6, P35, DOI 10.1007/BF00302210; Diazotrophs C., 2017, FRONT MAR SCI, V4, P10; Dubinsky Z., 1994, Pacific Science, V48, P313; Dubinsky Z, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P107, DOI 10.1007/978-94-007-0114-4_8; Ezzat L, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00102; Falkowski P. G., 1983, NITROGEN MARINE ENV, P839; GALLON JR, 1992, NEW PHYTOL, V122, P571; Gallon JR, 2001, PLANT SOIL, V230, P39, DOI 10.1023/A:1004640219659; GATTUSO JP, 1990, LIMNOL OCEANOGR, V35, P1796, DOI 10.4319/lo.1990.35.8.1796; Haas AF, 2014, PEERJ, V2, DOI 10.7717/peerj.235; Lampert-Karako S, 2008, AQUAT CONSERV, V18, P1039, DOI 10.1002/aqc.927; Leal MC, 2015, J EXP BIOL, V218, P858, DOI 10.1242/jeb.115519; Lema KA, 2012, APPL ENVIRON MICROB, V78, P3136, DOI 10.1128/AEM.07800-11; Lesser MP, 2007, MAR ECOL PROG SER, V346, P143, DOI 10.3354/meps07008; Lesser MP, 2018, ISME J, V12, P813, DOI 10.1038/s41396-017-0008-6; Lesser MP, 2010, ECOLOGY, V91, P990, DOI 10.1890/09-0313.1; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Manaspah R, 2006, OCEANOLOGIA, V48, P237; Mass T, 2007, MAR ECOL PROG SER, V334, P93, DOI 10.3354/meps334093; Mulholland MR, 2004, AQUAT MICROB ECOL, V37, P85, DOI 10.3354/ame037085; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Naumann MS, 2010, CORAL REEFS, V29, P649, DOI 10.1007/s00338-010-0612-7; Naumann MS, 2009, CORAL REEFS, V28, P109, DOI 10.1007/s00338-008-0459-3; Naumann MS, 2012, J MARINE SYST, V105, P20, DOI 10.1016/j.jmarsys.2012.05.007; PAULSON CA, 1977, J PHYS OCEANOGR, V7, P952, DOI 10.1175/1520-0485(1977)007<0952:IMITUO>2.0.CO;2; Pernice M, 2015, ENVIRON MICROBIOL, V17, P3570, DOI 10.1111/1462-2920.12518; RAHAV O, 1989, PROC R SOC SER B-BIO, V236, P325, DOI 10.1098/rspb.1989.0026; Rasheed M, 2003, CORAL REEFS, V22, P167, DOI 10.1007/s00338-003-0300-y; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; SHASHAR N, 1994, MAR ECOL PROG SER, V111, P259, DOI 10.3354/meps111259; Silverman J, 2007, BIOGEOCHEMISTRY, V84, P67, DOI 10.1007/s10533-007-9075-5; Tanaka Y, 2015, ECOL MODEL, V309, P163, DOI 10.1016/j.ecolmodel.2015.04.017; Tremblay P, 2014, CORAL REEFS, V33, P1, DOI 10.1007/s00338-013-1100-7; Tremblay P, 2015, J EXP BIOL, V218, P1223, DOI 10.1242/jeb.115303; Tremblay P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044672; Wang JT, 1999, MAR BIOL, V135, P219, DOI 10.1007/s002270050619; Wild C, 2005, MAR ECOL PROG SER, V287, P87, DOI 10.3354/meps287087; Wilson ST, 2012, APPL ENVIRON MICROB, V78, P6516, DOI 10.1128/AEM.01146-12; Winters G, 2009, MAR ECOL PROG SER, V384, P107, DOI 10.3354/meps08036	61	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199022	10.1371/journal.pone.0199022	http://dx.doi.org/10.1371/journal.pone.0199022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902263	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000435424900076
J	Rajasekaran, R; Felser, A; Nuoffer, JM; Dufour, JF; St-Pierre, MV				Rajasekaran, Raviprasadh; Felser, Andrea; Nuoffer, Jean-Marc; Dufour, Jean-Francois; St-Pierre, Marie V.			The histidine triad nucleotide-binding protein 2 (HINT-2) positively regulates hepatocellular energy metabolism	FASEB JOURNAL			English	Article						hepatic steatosis; lysine hyperacetylation; mitochondrial respiration; bioenergetics	PYRUVATE-DEHYDROGENASE COMPLEX; NONALCOHOLIC FATTY LIVER; RESPIRATORY-CHAIN; HEPATIC STEATOSIS; MITOCHONDRIAL DYSFUNCTION; PERMEABILIZED CELLS; STRESS; MECHANISM; OXYGEN; GENE	The histidine triad nucleotide-binding protein 2 (HINT-2) is a mitochondrial adenosine phosphoramidase expressed in hepatocytes. The phenotype of Hint2 knockout (Hint2(-/-)) mice includes progressive hepatic steatosis and lysine hyperacetylation of mitochondrial proteins, which are features of respiratory chain malfunctions. We postulated that the absence of HINT-2 induces a defect in mitochondria bioenergetics. Isolated Hint2(-/-) hepatocytes produced less ATP and generated a lower mitochondrial membrane potential than did Hint2(+/+) hepatocytes. In extracellular flux analyses with glucose, the basal, ATP-linked, and maximum oxygen consumption rates (OCRs) were decreased in Hint2(-/-) hepatocytes and in HepG2 cells lacking HINT-2. Conversely, in HINT-2 overexpressing SNU-449 and HepG2 cells, the basal, ATP-linked, and maximum OCRs were increased. Similarly, with palmitate, basal and maximum OCRs were decreased in Hint2(-/-) hepatocytes, but they were increased in HINT-2 overexpressing HepG2 cells. When assayed with radiolabeled substrate, palmitate oxidation was reduced by 25% in Hint2(-/-) mitochondria. In respirometry assays, complex I- and II-driven, coupled and uncoupled respirations and complex IV KCN-sensitive respiration were reduced in Hint2(-/-) mitochondria. Furthermore, HINT-2 associated with cardiolipin and glucose-regulated protein 75 kDa. Our study shows decreased electron transfer and oxidative phosphorylation capacity in the absence of HINT-2. The bioenergetics deficit accumulated over time in hepatocytes lacking HINT-2 likely leads to the secondary outcome of steatosis.Rajasekaran, R., Felser, A., Nuoffer, J.-M., Dufour, J.-F., St-Pierre, M. V. The histidine triad nucleotide-binding protein 2 (HINT-2) positively regulates hepatocellular energy metabolism.	[Rajasekaran, Raviprasadh; Dufour, Jean-Francois; St-Pierre, Marie V.] Univ Bern, Dept Biomed Res, Bern, Switzerland; [Felser, Andrea; Nuoffer, Jean-Marc] Univ Bern, Univ Inst Clin Chem, Bern, Switzerland; [Dufour, Jean-Francois] Univ Hosp Bern, Univ Clin Visceral Surg & Med, Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Dufour, JF (corresponding author), Univ Hosp Bern, Dept Visceral Surg & Med, 35 Murtenstr,Freiburgstr 4, CH-3010 Bern, Switzerland.	jean-francois.dufour@dbmr.unibe.ch	Dufour, Jean Francois Jacques/AAL-9866-2020; Nuoffer, Jean-Marc/C-8936-2009	Dufour, Jean Francois Jacques/0000-0002-8062-1346; 	Swiss National Foundation [31003A_160001]; IndoSwiss Grant from the Swiss National Foundation [IZLIZ3_156447]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); IndoSwiss Grant from the Swiss National Foundation	The authors acknowledge the services provided by Sophie Braga Lagache (Laboratory of Mass Spectrometry and Proteomics, Department for BioMedical Research, University of Bern), who processed the immunoprecipitated samples and identified the proteins subject to lysine acetylation. The authors acknowledge the technical help provided by David Belet and Philipp Kellmann (Department for Biomedical Research, University of Bern), who managed the animal breeding and care and performed hepatocyte isolation and HPLC measurements. Financial support was provided by Grant 31003A_160001 awarded by the Swiss National Foundation, and IndoSwiss Grant IZLIZ3_156447 from the Swiss National Foundation. The authors declare no conflicts of interest.	Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Bieganowski P, 2002, J BIOL CHEM, V277, P10852, DOI 10.1074/jbc.M111480200; Bottinger L, 2013, MOL BIOL CELL, V24, P2609, DOI 10.1091/mbc.E13-02-0106; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO;2-8; Estan MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115250; Felser A, 2014, TOXICOLOGY, V323, P1, DOI 10.1016/j.tox.2014.05.011; Fouque F, 2003, PEDIATR RES, V53, P793, DOI 10.1203/01.PDR.0000057987.46622.64; Gnaiger E., 2014, MITOCHONDRIAL PATHWA, P19; Goncalves LA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-169; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Huebner K, 2011, ADV ENZYME REGUL, V51, P208, DOI 10.1016/j.advenzreg.2010.09.003; Ibdah JA, 2005, GASTROENTEROLOGY, V128, P1381, DOI 10.1053/j.gastro.2005.02.001; Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004; Lampl T, 2015, JOVE-J VIS EXP, DOI 10.3791/52076; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Leveen P, 2011, HEPATOLOGY, V53, P437, DOI 10.1002/hep.24031; Liu ZQ, 2015, BIOCHIMIE, V116, P52, DOI 10.1016/j.biochi.2015.06.023; Maize KM, 2013, FEBS J, V280, P3389, DOI 10.1111/febs.12330; Makrecka-Kuka M, 2015, BIOMOLECULES, V5, P1319, DOI 10.3390/biom5031319; Martin J, 2006, GASTROENTEROLOGY, V130, P2179, DOI 10.1053/j.gastro.2006.03.024; Martin J, 2016, AM J PHYSIOL-GASTR L, V310, pG497, DOI 10.1152/ajpgi.00178.2015; Martin J, 2013, HEPATOLOGY, V57, P2037, DOI 10.1002/hep.26060; Munnik Teun, 2013, Methods Mol Biol, V1009, P253, DOI 10.1007/978-1-62703-401-2_23; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pfleger J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.202; Planas-Iglesias J, 2015, BIOPHYS J, V109, P1282, DOI 10.1016/j.bpj.2015.07.034; Rahman M, 2014, J CELL BIOL, V206, P289, DOI 10.1083/jcb.201404118; Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Schroder T, 2016, MOL METAB, V5, P283, DOI 10.1016/j.molmet.2016.01.010; Schwab MA, 2005, CLIN CHEM, V51, P151, DOI 10.1373/clinchem.2004.033852; Schwall CT, 2012, BBA-BIOENERGETICS, V1817, P1588, DOI 10.1016/j.bbabio.2012.04.015; Shinmura K, 2011, CIRC RES, V109, P396, DOI 10.1161/CIRCRESAHA.111.243097; Sriskanthadevan S, 2015, BLOOD, V125, P2120, DOI 10.1182/blood-2014-08-594408; Stehling O, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011312; Stockwin LH, 2010, INT J CANCER, V127, P2510, DOI 10.1002/ijc.25499; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; van Zutphen T, 2016, J HEPATOL, V65, P1198, DOI 10.1016/j.jhep.2016.05.046; Wagner GR, 2012, HUM MOL GENET, V21, P2688, DOI 10.1093/hmg/dds095; WASSERMAN DH, 1991, AM J PHYSIOL, V260, pE811, DOI 10.1152/ajpendo.1991.260.6.E811; Weiske J, 2006, J BIOL CHEM, V281, P27356, DOI 10.1074/jbc.M513452200; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Xu LJ, 2009, J CEREBR BLOOD F MET, V29, P365, DOI 10.1038/jcbfm.2008.125; Zhou X, 2013, BIOCHEMISTRY-US, V52, P3588, DOI 10.1021/bi301616c	48	6	7	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5143	5161		10.1096/fj.201701429R	http://dx.doi.org/10.1096/fj.201701429R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913563	Bronze			2022-12-26	WOS:000443817700042
J	Liu, XJ; Xue, RY; Yang, CT; Gu, JX; Chen, S; Zhang, S				Liu, Xijun; Xue, Ruyi; Yang, Caiting; Gu, Jianxin; Chen, She; Zhang, Si			Cholestasis-induced bile acid elevates estrogen level via farnesoid X receptor-mediated suppression of the estrogen sulfotransferase SULT1E1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; cAMP response element-binding protein (CREB); estrogen receptor; bile acid; nuclear receptor	BREAST-CANCER; POSTMENOPAUSAL WOMEN; NUCLEAR RECEPTORS; LIVER-DISEASE; SEX-HORMONES; MURINE MODEL; MOUSE-LIVER; FXR; MICE; ALPHA	The liver is the main site of estrogen metabolism, and liver disease is usually associated with an abnormal estrogen status. However, little is known about the mechanism underlying this connection. Here, we investigated the effects of bile acid (BA)-activated farnesoid X receptor (FXR) on the metabolism of 17 beta-estradiol (E2) during blockage of bile flow (cholestasis). Correlations between BA levels and E2 concentrations were established in patients with cholestasis, and hepatic expression profiles of key genes involved in estrogen metabolism were investigated in both WT and FXR-/- mice. We found that the elevated E2 level positively correlated with BA concentrations in the patients with cholestasis. We further observed that bile duct ligation (BDL) increases E2 levels in mouse serum, and this elevation effect was alleviated by deleting the FXR gene. Of note, FXR down-regulated the expression of hepatic sulfotransferase SULT1E1, the primary enzyme responsible for metabolic estrogen inactivation. At the molecular level, we found that FXR competes with the protein acetylase CREB-binding protein (CBP) for binding to the transcription factor hepatocyte nuclear factor 4 alpha (HNF4 alpha). This competition decreased HNF4 alpha acetylation and nuclear retention, which, in turn, repressed HNF4 alpha-dependent SULT1E1 gene transcription. These findings suggest that cholestasis induces BA-activated FXR activity, leading to downstream inhibition of SULT1E1 and hence impeding hepatic degradation of estrogen.	[Liu, Xijun; Yang, Caiting; Gu, Jianxin; Chen, She; Zhang, Si] Fudan Univ, Zhongshan Hosp, Sch Basic Med Sci,Minist Publ Hlth, Dept Biochem & Mol Biol,Key Lab Glycoconjugate Re, Shanghai 200032, Peoples R China; [Xue, Ruyi] Fudan Univ, Zhongshan Hosp, Shanghai Inst Liver Dis, Dept Gastroenterol & Hepatol, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Chen, S; Zhang, S (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, 130 Dong An Rd, Shanghai 200032, Peoples R China.	shechen@fudan.edu.cn; zhangsi@fudan.edu.cn	zhang, si/AAG-9094-2021	Xue, Ruyi/0000-0002-5710-0091; zhang, Si/0000-0002-5682-4995	National Natural Science Foundation of China [81573423, 81770137, 81371268, 81772615, 81572308, 81600309]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Natural Science Foundation of China Grants 81573423, 81770137 (to S. Z.), 81371268, 81772615 (to S. C.), 81572308 (to R. Y. X.), and 81600309 (to X. J. L.). The authors declare that they have no conflicts of interest with the contents of this article.	BECKER U, 1991, HEPATOLOGY, V13, P865, DOI 10.1016/0270-9139(91)90255-T; BECKER U, 1993, DAN MED BULL, V40, P447; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Cariou B, 2007, TRENDS PHARMACOL SCI, V28, P236, DOI 10.1016/j.tips.2007.03.002; Chung SH, 2010, TRENDS ENDOCRIN MET, V21, P504, DOI 10.1016/j.tem.2010.03.005; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Costarelli V, 2002, EUR J CLIN NUTR, V56, P925, DOI 10.1038/sj.ejcn.1601396; de Ronde W, 2009, CLIN ENDOCRINOL, V71, P874, DOI 10.1111/j.1365-2265.2009.03573.x; Devine A, 2005, OSTEOPOROSIS INT, V16, P216, DOI 10.1007/s00198-004-1674-6; Fiorucci S, 2007, TRENDS MOL MED, V13, P298, DOI 10.1016/j.molmed.2007.06.001; Flatt B, 2009, J MED CHEM, V52, P904, DOI 10.1021/jm8014124; Freeman EW, 2006, ARCH GEN PSYCHIAT, V63, P375, DOI 10.1001/archpsyc.63.4.375; Gadaleta RM, 2010, BBA-MOL CELL BIOL L, V1801, P683, DOI 10.1016/j.bbalip.2010.04.006; Gambino YP, 2012, BBA-MOL CELL RES, V1823, P900, DOI 10.1016/j.bbamcr.2012.01.015; GLUUD C, 1988, DAN MED BULL, V35, P564; Hageman J, 2010, ARTERIOSCL THROM VAS, V30, P1519, DOI 10.1161/ATVBAHA.109.197897; Hoekstra M, 2012, MOL CELL ENDOCRINOL, V362, P69, DOI 10.1016/j.mce.2012.05.010; Kakuta Y, 1998, BIOCHEM PHARMACOL, V55, P313, DOI 10.1016/S0006-2952(97)00465-6; Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249; Kodama S, 2011, NUCLEIC ACIDS RES, V39, P8392, DOI 10.1093/nar/gkr458; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; LONGCOPE C, 1969, J CLIN INVEST, V48, P2191, DOI 10.1172/JCI106185; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; McNeilly AD, 2010, J HEPATOL, V52, P705, DOI 10.1016/j.jhep.2009.10.037; Milona A, 2010, HEPATOLOGY, V52, P1341, DOI 10.1002/hep.23849; Murphy E, 2011, CIRC RES, V109, P687, DOI 10.1161/CIRCRESAHA.110.236687; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Stedman C, 2004, J BIOL CHEM, V279, P11336, DOI 10.1074/jbc.M310258200; Sun ZC, 2012, BIOCHEM BIOPH RES CO, V423, P775, DOI 10.1016/j.bbrc.2012.06.035; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Tong MH, 2005, NAT MED, V11, P153, DOI 10.1038/nm1184; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wu WB, 2014, BIOCHEM BIOPH RES CO, V443, P68, DOI 10.1016/j.bbrc.2013.11.057; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398; Xu YL, 2012, CANCER SCI, V103, P1000, DOI 10.1111/j.1349-7006.2012.02258.x; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yamamoto Y, 2006, J BIOL CHEM, V281, P16625, DOI 10.1074/jbc.M602723200; Zhang SW, 2009, J HEPATOL, V51, P380, DOI 10.1016/j.jhep.2009.03.025; Zhang SW, 2009, BIOCHEM BIOPH RES CO, V379, P476, DOI 10.1016/j.bbrc.2008.12.117	40	20	23	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12759	12769		10.1074/jbc.RA118.001789	http://dx.doi.org/10.1074/jbc.RA118.001789			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29929982	hybrid, Green Published			2022-12-26	WOS:000442203500010
J	Cai, QC; Fan, QP; Buechlein, A; Miller, D; Nephew, KP; Liu, S; Wan, J; Xu, Y				Cai, Qingchun; Fan, Qipeng; Buechlein, Aaron; Miller, David; Nephew, Kenneth P.; Liu, Sheng; Wan, Jun; Xu, Yan			Changes in mRNA/protein expression and signaling pathways in in vivo passaged mouse ovarian cancer cells	PLOS ONE			English	Article							STEM-CELLS; TUMOR MICROENVIRONMENT; GENE-EXPRESSION; BREAST-CANCER; MODELS; DESMOPLAKIN; STATISTICS; METABOLISM; RESISTANCE; PROGNOSIS	The cure rate for late stage epithelial ovarian cancer (EOC) has not significantly improved over several decades. New and more effective targets and treatment modalities are urgently needed. RNA-seq analyses of a syngeneic EOC cell pair, representing more and less aggressive tumor cells in vivo were conducted. Bioinformatics analyses of the RNA-seq data and biological signaling and function studies have identified new targets, such as ZIP4 in EOC. Many up-regulated tumor promoting signaling pathways have been identified which are mainly grouped into three cellular activities: 1) cell proliferation and apoptosis resistance; 2) cell skeleton and adhesion changes; and 3) carbohydrate metabolic reprograming. Unexpectedly, lipid metabolism has been the major down-regulated signaling pathway in the more aggressive EOC cells. In addition, we found that hypoxic responsive genes were at the center stage of regulation and detected functional changes were related to cancer stem cell-like activities. Moreover, our genetic, cellular, biochemical, and lipidomic analyses indicated that cells grown in 2D vs. 3D, or attached vs. suspended had dramatic changes. The important clinical implications of peritoneal cavity floating tumor cells are supported by the data proved in this work. Overall, the RNA-seq data provide a landscape of gene expression alterations during tumor progression.	[Cai, Qingchun; Fan, Qipeng; Xu, Yan] Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA; [Buechlein, Aaron; Miller, David; Nephew, Kenneth P.] Indiana Univ Sch Med, Med Sci, Bloomington, IN USA; [Liu, Sheng; Wan, Jun] Indiana Univ, Simon Canc Ctr, Collaborat Core Canc Bioinformat, Indianapolis, IN 46204 USA; [Liu, Sheng; Wan, Jun] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Xu, Y (corresponding author), Indiana Univ Sch Med, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA.	xu2@iu.edu	Wan, Jun/AAN-1337-2020	Wan, Jun/0000-0001-9286-6562; Xu, Yan/0000-0001-8445-7996	National Institutes of Health [R01 155145]; Mary Fendrich-Hulman Charitable Trust Fund; Walther Cancer Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary Fendrich-Hulman Charitable Trust Fund; Walther Cancer Foundation	This work is supported in part by the National Institutes of Health (R01 155145 to YX); and the Mary Fendrich-Hulman Charitable Trust Fund to YX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The bioinformatics analysis was done by the Collaborative Core for Cancer Bioinformatics (C3B) shared by IU Simon Cancer Center (P30CA082709) and Purdue University Center for Cancer Research (P30CA023168). The C3B is currently supported by the Walther Cancer Foundation.	Ajdukovic J., 2016, Experimental Oncology, V38, P9; Baert T, 2017, GYNECOL ONCOL REP, V19, P57, DOI 10.1016/j.gore.2017.01.002; Balbay MD, 1999, CLIN CANCER RES, V5, P783; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Braicu EI, 2017, ONCOTARGET, V8, P102912, DOI 10.18632/oncotarget.22076; Cai Q, 2015, ONCOGENE, V34, P3315, DOI 10.1038/onc.2014.264; Cai QC, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.969634; Chen PX, 2015, PATHOL ONCOL RES, V21, P1133, DOI 10.1007/s12253-015-9943-6; Chen XX, 2013, HUM PATHOL, V44, P2373, DOI 10.1016/j.humpath.2013.05.001; Chen X, 2010, ONCOTARGET, V1, P210, DOI 10.18632/oncotarget.127; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Donninger H, 2016, SEMIN CELL DEV BIOL, V58, P86, DOI 10.1016/j.semcdb.2016.06.007; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Englert-Golon M, 2017, ONCOL LETT, V14, P3401, DOI 10.3892/ol.2017.6590; Fan Q, 2017, J OBSTET GYNECOLOG; Fan QP, 2017, ONCOTARGET, V8, P90090, DOI 10.18632/oncotarget.21435; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Fong MY, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-12; Galgano MT, 2009, HUM PATHOL, V40, P1434, DOI 10.1016/j.humpath.2009.02.008; Greenaway J, 2008, GYNECOL ONCOL, V108, P385, DOI 10.1016/j.ygyno.2007.10.035; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heinaniemi M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r147; Hobbs RP, 2012, J INVEST DERMATOL, V132, P482, DOI 10.1038/jid.2011.318; Jemal A, 2018, J CLIN ONCOL, V36, P14, DOI 10.1200/JCO.2017.73.7932; Jung SG, 2010, CANCER SCI, V101, P1977, DOI 10.1111/j.1349-7006.2010.01641.x; Kim KS, 2006, CANCER RES, V66, P7983, DOI 10.1158/0008-5472.CAN-05-4381; Kiuru M, 2017, LAB INVEST, V97, P146, DOI 10.1038/labinvest.2016.142; Klymenko Y, 2017, CANCERS, V9, DOI 10.3390/cancers9080104; Li H, 2010, FASEB J, V24, P4103, DOI 10.1096/fj.10-161356; Li H, 2009, MOL CANCER THER, V8, P1692, DOI 10.1158/1535-7163.MCT-08-1106; Li P, 2017, ONCOL LETT, V14, P6611, DOI 10.3892/ol.2017.7062; Li YY, 2018, BIOCHEM BIOPH RES CO, V495, P1081, DOI 10.1016/j.bbrc.2017.11.117; Luo ZY, 2016, CANCER LETT, V377, P174, DOI 10.1016/j.canlet.2016.04.038; Lupia M, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0638-3; MacDonagh L, 2017, ONCOTARGET, V8, P72544, DOI 10.18632/oncotarget.19881; MacLean JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156109; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Miller DFB, 2013, METHODS, V63, P126, DOI 10.1016/j.ymeth.2013.03.023; Min HY, 2018, BIOMOL THER, V26, P45, DOI 10.4062/biomolther.2017.211; Odunsi K, 2017, ANN ONCOL, V28, P1, DOI 10.1093/annonc/mdx444; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Pearce OMT, 2018, CANCER DISCOV, V8, P304, DOI 10.1158/2159-8290.CD-17-0284; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Pizzuti L, 2018, J CELL PHYSIOL, V233, P1396, DOI 10.1002/jcp.26023; Ray U, 2018, FEBS J, V285, P432, DOI 10.1111/febs.14281; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Rudlowski C, 2004, ONCOLOGY-BASEL, V66, P404, DOI 10.1159/000079489; Saw YT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-329; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sobolik-Delmaire T, 2006, J BIOL CHEM, V281, P16962, DOI 10.1074/jbc.M600570200; Tania M, 2010, CURR ONCOL, V17, P6; Tjhay F, 2015, CANCER SCI, V106, P1421, DOI 10.1111/cas.12765; Van Wyhe RD, 2017, BREAST CANCER-TARGET, V9, P559, DOI 10.2147/BCTT.S148080; Varas-Godoy M, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/5263974; Walton J, 2016, CANCER RES, V76, P6118, DOI 10.1158/0008-5472.CAN-16-1272; Walton JB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17119-1; Wang HC, 2014, CLIN CHIM ACTA, V436, P243, DOI 10.1016/j.cca.2014.06.005; Woopen H, 2014, J GYNECOL ONCOL, V25, P221, DOI 10.3802/jgo.2014.25.3.221; Xie WM, 2017, ONCOTARGET, V8, P41508, DOI 10.18632/oncotarget.17242; YU DH, 1993, CANCER RES, V53, P891; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhao ZW, 2016, LIPIDS, V51, P179, DOI 10.1007/s11745-015-4108-7; Zhu ZQ, 2007, BIOCHEM BIOPH RES CO, V358, P66, DOI 10.1016/j.bbrc.2007.04.096	67	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0197404	10.1371/journal.pone.0197404	http://dx.doi.org/10.1371/journal.pone.0197404			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927933	Green Published, Green Submitted, gold			2022-12-26	WOS:000435802500005
J	Gagliardi, M; Bifone, A				Gagliardi, Mariacristina; Bifone, Angelo			Ring-opening copolymerization thermodynamics and kinetics of gamma-vaIeroIactone/epsilon-caprolactone	PLOS ONE			English	Article							EPSILON-CAPROLACTONE; POLYMERIZATION; BUTYROLACTONE; VALEROLACTONE; DEGRADATION	The general misconception that gamma-lactones are not thermodynamically polymerizable has limited the development of all gamma-lactone-based copolymers. A few studies have reported copolymerization of these five-membered cyclic esters with more reactive monomers, yet a systematic investigation of kinetics and thermodynamics is still lacking. To explore the feasibility of the reaction, we combined equilibrium and non-isothermal syntheses for the copolymerization of gamma-valerolactone with epsilon-caprolactone, initiated with methoxy polyethyleneglycol and catalyzed by Tin(II) 2-ethylhexanoate. Here, we present the polymerization kinetic and thermodynamic parameters for different monomer ratios in the reaction feed. We observed the dependency of enthalpy and entropy of polymerization upon monomer ratio changes, and estimated a linear increase in the activation energy by increasing the gamma-valerolactone fraction in the starting monomer mixture. Our data demonstrate that gamma-valerolactone can copolymerize with epsilon-caprolactone, but only under specific conditions. The reaction parameters determined in this study will enable preparation of additional gamma-valerolactone-based copolymers and development of a family of degradable materials with improved properties in respect to commonly used polyesters.	[Gagliardi, Mariacristina] Ist Italiano Tecnol, Ctr Micro Biorobot SSSA, Viale Rinaldo Piaggio 34, I-56025 Pontedera, Italy; [Bifone, Angelo] Ist Italiano Tecnol, Ctr Neurosci & Cognit Syst UNITN, Corso Bettini 31, I-38068 Rovereto, Italy	Istituto Italiano di Tecnologia - IIT; Istituto Italiano di Tecnologia - IIT	Gagliardi, M (corresponding author), Ist Italiano Tecnol, Ctr Micro Biorobot SSSA, Viale Rinaldo Piaggio 34, I-56025 Pontedera, Italy.	mariacristina_gagliardi@hotmail.it	Gagliardi, Mariacristina/S-5931-2019; Gagliardi, Mariacristina/K-9439-2013	Gagliardi, Mariacristina/0000-0002-5860-3141; Gagliardi, Mariacristina/0000-0002-5860-3141				Aleman C, 2009, J ORG CHEM, V74, P6237, DOI 10.1021/jo9010969; Bhaw-Luximon A, 2006, MACROMOL SYMP, V231, P60, DOI 10.1002/masy.200551306; Chen HL, 2013, INORG CHEM COMMUN, V35, P247, DOI 10.1016/j.inoche.2013.06.048; Chen TN, 2011, POLYM CHEM-UK, V2, P1190, DOI 10.1039/c1py00067e; Cockburn RA, 2010, MACROMOL CHEM PHYS, V211, P501, DOI 10.1002/macp.200900553; Duda A, 2005, MACROMOL SYMP, V224, P71, DOI 10.1002/masy.200550607; Duda A., 2009, THERMODYNAMICS KINET; Gagliardi M, 2016, MAT SCI ENG C-MATER, V59, P488, DOI 10.1016/j.msec.2015.10.054; Gagliardi M, 2015, J POLYM RES, V22, DOI 10.1007/s10965-015-0661-2; GMELIN E, 1995, PURE APPL CHEM, V67, P1789, DOI 10.1351/pac199567111789; Haba O, 2014, POLYM J, V46, P89, DOI 10.1038/pj.2013.70; Hong M, 2017, MACROMOLECULES, V50, P8469, DOI 10.1021/acs.macromol.7b02174; Hong M, 2016, NAT CHEM, V8, P42, DOI [10.1038/NCHEM.2391, 10.1038/nchem.2391]; Hong M, 2014, MACROMOLECULES, V47, P3614, DOI 10.1021/ma5007717; Houk KN, 2008, J ORG CHEM, V73, P2674, DOI 10.1021/jo702567v; Hsiao HC, 2016, J ORGANOMET CHEM, V804, P35, DOI 10.1016/j.jorganchem.2015.12.030; Koyama N, 1997, MACROMOLECULES, V30, P826, DOI 10.1021/ma961195r; Lebedev B. V., 1996, RUSS CHEM REV+, V65, P1063, DOI DOI 10.1070/13019960165N12ABEH000246; Lee CW, 1998, EUR POLYM J, V34, P117, DOI 10.1016/S0014-3057(98)80001-3; Libiszowski J, 2004, MACROMOLECULES, V37, P52, DOI 10.1021/ma030244e; Limwanich W, 2015, INT J CHEM KINET, V47, P734, DOI 10.1002/kin.20944; Limwanich W, 2015, THERMOCHIM ACTA, V599, P1, DOI 10.1016/j.tca.2014.11.001; Limwanich W, 2015, J THERM ANAL CALORIM, V119, P567, DOI 10.1007/s10973-014-4111-x; Meelua W, 2012, J POLYM RES, V19, DOI 10.1007/s10965-011-9799-8; Mehta R, 2007, POLYM-PLAST TECHNOL, V46, P257, DOI 10.1080/03602550601153083; Moore T, 2005, BIOMATERIALS, V26, P3771, DOI 10.1016/j.biomaterials.2004.10.002; Muzaiyanah AR, 2013, APPL BIOCHEM BIOTECH, V170, P1194, DOI 10.1007/s12010-013-0247-6; Nakayama A, 1996, J ENVIRON POLYM DEGR, V4, P205, DOI 10.1007/BF02067454; Olsen P, 2016, BIOMACROMOLECULES, V17, P3995, DOI 10.1021/acs.biomac.6b01375; Olsen P, 2016, BIOMACROMOLECULES, V17, P699, DOI 10.1021/acs.biomac.5b01698; Peng WF, 2018, THERMOCHIM ACTA, V659, P27, DOI 10.1016/j.tca.2017.09.020; Puaux JP, 2007, MACROMOL SYMP, V259, P318, DOI 10.1002/masy.200751336; Rydz J, 2015, INT J MOL SCI, V16, P564, DOI 10.3390/ijms16010564; Saiyasombat W, 1998, POLYMER, V39, P5581, DOI 10.1016/S0032-3861(97)10370-6; Schneiderman DK, 2016, MACROMOLECULES, V49, P2419, DOI 10.1021/acs.macromol.6b00211; Sestak J, 2017, J THERM ANAL CALORIM, V127, P1117, DOI 10.1007/s10973-015-4998-x; SZYMANSKI R, 1992, PROG POLYM SCI, V17, P917, DOI 10.1016/0079-6700(92)90013-O; Tanadchangsaeng N, 2013, J APPL POLYM SCI, V129, P2004, DOI 10.1002/app.38906; Tsou AH, 2017, POLYMER, V111, P115, DOI 10.1016/j.polymer.2017.01.045; Vert M, 2012, PURE APPL CHEM, V84, P377, DOI 10.1351/PAC-REC-10-12-04; Vyazovkin S, 2017, MACROMOL RAPID COMM, V38, DOI 10.1002/marc.201600615	41	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199231	10.1371/journal.pone.0199231	http://dx.doi.org/10.1371/journal.pone.0199231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927986	Green Published, Green Submitted, gold			2022-12-26	WOS:000435802500059
J	Tromeur, C; Jais, X; Mercier, O; Couturaud, F; Montani, D; Savale, L; Jevnikar, M; Weatherald, J; Sitbon, O; Parent, F; Fabre, D; Mussot, S; Dartevelle, P; Humbert, M; Simonneau, G; Fadel, E				Tromeur, Cecile; Jais, Xavier; Mercier, Olaf; Couturaud, Francis; Montani, David; Savale, Laurent; Jevnikar, Mitja; Weatherald, Jason; Sitbon, Olivier; Parent, Florence; Fabre, Dominique; Mussot, Sacha; Dartevelle, Philippe; Humbert, Marc; Simonneau, Gerald; Fadel, Elie			Factors predicting outcome after pulmonary endarterectomy	PLOS ONE			English	Article							INTERNATIONAL PROSPECTIVE REGISTRY; LONG-TERM OUTCOMES; HYPERTENSION; THROMBOENDARTERECTOMY; EXPERIENCE; HEMODYNAMICS; DIFFUSION; DIAGNOSIS; CAPACITY	Objective Few studies have reported predictive factors of outcome after pulmonary endarterectomy (PEA) in chronic thromboembolic pulmonary hypertension. The purpose of this study was to determine factors influencing mortality and predictors of hemodynamic improvement after PEA. Methods A total of 383 consecutive patients who underwent PEA between January 2005 and December 2009 were retrospectively reviewed. Among them, 150 were fully reevaluated 7.5 +/- 1 months after PEA by NYHA class, 6-minute walk distance (6MWD), percentage of predicted carbon monoxide transfer factor (TLCO) and right heart catheterisation. Results Mortality rates at 1 month, 1 year and 3 years were 2.8%, 6.9% and 7.5%, respectively. Preoperative pulmonary vascular resistance (PVR) independently predicted 1-month, 1- and 3-year mortality and age predicted mortality at 1 year and 3 years. Significant improvement in NYHA class and 6MWD were observed and PVR decreased from 773 +/- 353 to 307 +/- 221 dyn. sec.cm(-5) (p<0.001). In 96 patients (64%), PVR decreased by at least 50% and/or was reduced to lower than 250 dyn.sec.cm(-5). Preoperative cardiac output (CO) and TLCO predicted hemodynamic improvement. Conclusion PEA is associated with an excellent long-term survival and a marked improvement in clinical status and hemodynamics. Some preoperative factors including PVR, CO and TLCO can predict postoperative outcomes.	[Tromeur, Cecile; Couturaud, Francis] European Brittany Univ, Brest, France; [Tromeur, Cecile; Couturaud, Francis] Univ Hosp Ctr La Cavale Blanche, Dept Internal Med & Chest Dis, Brest, France; [Tromeur, Cecile; Couturaud, Francis] GETBO, CIC INSERM 1412, EA 3878, Brest, France; [Jais, Xavier; Mercier, Olaf; Montani, David; Savale, Laurent; Jevnikar, Mitja; Weatherald, Jason; Sitbon, Olivier; Parent, Florence; Fabre, Dominique; Mussot, Sacha; Dartevelle, Philippe; Humbert, Marc; Simonneau, Gerald; Fadel, Elie] Univ Paris Saclay, Univ Paris Sud, Fac Med, Le Kremlin Bicetre, France; [Jais, Xavier; Montani, David; Savale, Laurent; Jevnikar, Mitja; Weatherald, Jason; Sitbon, Olivier; Parent, Florence; Humbert, Marc; Simonneau, Gerald] Hop Bicetre, Serv Pneumol, Ctr Reference Hypertens Pulm, AP HP, Le Kremlin Bicetre, France; [Jais, Xavier; Mercier, Olaf; Montani, David; Savale, Laurent; Jevnikar, Mitja; Weatherald, Jason; Sitbon, Olivier; Parent, Florence; Fabre, Dominique; Mussot, Sacha; Dartevelle, Philippe; Humbert, Marc; Simonneau, Gerald; Fadel, Elie] Hop Marie Lannelongue, INSERM UMR S 999, Le Plessis Robinson, France; [Mercier, Olaf; Fabre, Dominique; Mussot, Sacha; Dartevelle, Philippe; Fadel, Elie] Hop Marie Lannelongue, Serv Chirurg Thorac & Vasc & Transplantat Cardiop, Le Plessis Robinson, France; [Weatherald, Jason] Univ Calgary, Dept Med, Div Respirol, Calgary, AB, Canada	Universite de Bretagne Occidentale; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Hopital Marie Lannelongue; University of Calgary	Tromeur, C (corresponding author), European Brittany Univ, Brest, France.; Tromeur, C (corresponding author), Univ Hosp Ctr La Cavale Blanche, Dept Internal Med & Chest Dis, Brest, France.; Tromeur, C (corresponding author), GETBO, CIC INSERM 1412, EA 3878, Brest, France.	tromeurcecile@gmail.com	Savale, Laurent/AAJ-9781-2020; Humbert, Marc/AAC-8459-2019; Sitbon, Olivier/I-3623-2019; David, Montani/I-6885-2019; Humbert, Marc/ABD-5112-2021; Simonneau, Gerald/ABE-6614-2020; Mussot, S/AAL-7512-2020; Couturaud, Francis/Q-1366-2019	Humbert, Marc/0000-0003-0703-2892; Sitbon, Olivier/0000-0002-1942-1951; David, Montani/0000-0002-9358-6922; Mussot, S/0000-0002-4669-7216; Couturaud, Francis/0000-0002-1855-8032; JAIS, XAVIER/0000-0002-4104-7994; tromeur, cecile/0000-0001-9161-7521; Mercier, Olaf/0000-0002-4760-6267; Jevnikar, Mitja/0000-0003-0727-6790; Weatherald, Jason/0000-0002-0615-4575				Bernstein RJ, 1996, CHEST, V110, P1430, DOI 10.1378/chest.110.6.1430; Bonderman D, 2007, CIRCULATION, V115, P2153, DOI 10.1161/CIRCULATIONAHA.106.661041; Cannon JE, 2016, CIRCULATION, V133, P1761, DOI 10.1161/CIRCULATIONAHA.115.019470; Condliffe R, 2009, EUR RESPIR J, V33, P332, DOI 10.1183/09031936.00092008; Condliffe R, 2008, AM J RESP CRIT CARE, V177, P1122, DOI 10.1164/rccm.200712-1841OC; Corsico AG, 2008, AM J RESP CRIT CARE, V178, P419, DOI 10.1164/rccm.200801-101OC; Dartevelle P, 2004, EUR RESPIR J, V23, P637, DOI 10.1183/09031936.04.00079704; Delcroix M, 2016, CIRCULATION, V133, P859, DOI 10.1161/CIRCULATIONAHA.115.016522; Dorfmuller P, 2014, EUR RESPIR J, V44, P1275, DOI 10.1183/09031936.00169113; Fedullo PF, 2000, SEMIN RESP CRIT CARE, V21, P563; Freed DH, 2011, J THORAC CARDIOV SUR, V141, P383, DOI 10.1016/j.jtcvs.2009.12.056; Galie N, 2015, EUR RESPIR J, V46, P903, DOI 10.1183/13993003.01032-2015; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Inami T, 2016, CIRCULATION, V134, P2030, DOI 10.1161/CIRCULATIONAHA.116.024201; Jamieson SW, 2003, ANN THORAC SURG, V76, P1457, DOI 10.1016/S0003-4975(03)00828-2; Jensen KW, 2009, CIRCULATION, V120, P1248, DOI 10.1161/CIRCULATIONAHA.109.865881; Kim NH, 2013, J AM COLL CARDIOL, V62, pD92, DOI 10.1016/j.jacc.2013.10.024; Kunihara T, 2011, EUR J CARDIO-THORAC, V40, P154, DOI 10.1016/j.ejcts.2010.10.043; Madani MM, 2012, ANN THORAC SURG, V94, P97, DOI 10.1016/j.athoracsur.2012.04.004; Mayer E, 2011, J THORAC CARDIOV SUR, V141, P702, DOI 10.1016/j.jtcvs.2010.11.024; Nagaya N, 2003, CHEST, V123, P338, DOI 10.1378/chest.123.2.338; Piazza G, 2011, NEW ENGL J MED, V364, P351, DOI 10.1056/NEJMra0910203; Reesink HJ, 2010, J THORAC CARDIOV SUR, V139, P85, DOI 10.1016/j.jtcvs.2009.03.053; Saouti N, 2009, EUR J CARDIO-THORAC, V35, P947, DOI 10.1016/j.ejcts.2009.01.023; Skoro-Sajer N, 2014, THORAX, V69, P116, DOI 10.1136/thoraxjnl-2013-203746; Steenhuis LH, 2000, EUR RESPIR J, V16, P276, DOI 10.1034/j.1399-3003.2000.16b15.x; Suda R, 2017, RESPIROLOGY, V22, P179, DOI 10.1111/resp.12883; Suntharalingam J, 2007, THORAX, V62, P617, DOI 10.1136/thx.2006.070680; Tscholl D, 2001, EUR J CARDIO-THORAC, V19, P771, DOI 10.1016/S1010-7940(01)00686-8; Zoia MC, 2002, THORAX, V57, P608, DOI 10.1136/thorax.57.7.608	30	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198198	10.1371/journal.pone.0198198	http://dx.doi.org/10.1371/journal.pone.0198198			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927944	Green Published, Green Submitted, gold			2022-12-26	WOS:000435802500011
J	Flatau, L; Reitt, M; Duttge, G; Lenk, C; Zoll, B; Poser, W; Weber, A; Heilbronner, U; Rietschel, M; Strohmaier, J; Kesberg, R; Nagel, J; Schulze, TG				Flatau, Laura; Reitt, Markus; Duttge, Gunnar; Lenk, Christian; Zoll, Barbara; Poser, Wolfgang; Weber, Alexandra; Heilbronner, Urs; Rietschel, Marcella; Strohmaier, Jana; Kesberg, Rebekka; Nagel, Jonas; Schulze, Thomas G.			Genomic information and a person's right not to know: A closer look at variations in hypothetical informational preferences in a German sample	PLOS ONE			English	Article							INCIDENTAL FINDINGS; PUBLIC-ATTITUDES; CLINICAL EXOME; GENETICS PROFESSIONALS; PERSPECTIVES; DISEASE; RETURN; RISK; RECOMMENDATIONS; PARTICIPANTS	In clinical practice and in research, there is an ongoing debate on how to return incidental and secondary findings of genetic tests to patients and research participants. Previous investigations have found that most of the people most of the time are in favor of full disclosure of results. Yet, the option to reject disclosure, based on the so-called right not to know, can be valuable especially for some vulnerable subgroups of recipients. In the present study we investigated variations in informational preferences in the context of genetic testing in a large and diverse German sample. This survey examined health care professionals, patients, participants of genetic counseling sessions and members of the general population (N = 518). Survey participants were assessed regarding their openness to learning about findings under various hypothetical scenarios, as well as their attitudes about the doctor-patient-relationship in a disclosure situation and about informational transfer to third parties. While the majority of participants wanted to learn about their findings, the extent of support of disclosure varied with features of the hypothetical diagnostic scenarios (e.g., controllability of disease; abstract vs. concrete scenario description) and demographic characteristics of the subjects. For example, subjects with higher levels of education were more selective with regards to the kind of information they want to receive than those with lower levels of education. We discuss implications of these findings for the debate about the right not to know and for the clinical practice of informed consent procedures.	[Flatau, Laura; Heilbronner, Urs; Schulze, Thomas G.] Ludwig Maximilians Univ Munchen, Inst Psychiat Phen & Genom, Munich, Germany; [Reitt, Markus; Poser, Wolfgang; Schulze, Thomas G.] Univ Gottingen, Inst Psychiat & Psychotherapy, Gottingen, Germany; [Duttge, Gunnar; Weber, Alexandra] Univ Gottingen, Ctr Med Law, Gottingen, Germany; [Lenk, Christian] Ulm Univ, Inst Hist Theory & Eth Med, Ulm, Germany; [Zoll, Barbara] Univ Gottingen, Inst Human Genet, Gottingen, Germany; [Rietschel, Marcella; Strohmaier, Jana] Cent Inst Mental Hlth, Mannheim, Germany; [Kesberg, Rebekka] Ulm Univ, Inst Psychol & Educ, Ulm, Germany; [Nagel, Jonas] Univ Gottingen, Dept Psychol, Gottingen, Germany	University of Munich; University of Gottingen; University of Gottingen; Ulm University; University of Gottingen; Central Institute of Mental Health; Ulm University; University of Gottingen	Flatau, L (corresponding author), Ludwig Maximilians Univ Munchen, Inst Psychiat Phen & Genom, Munich, Germany.	laura.flatau@med.uni-muenchen.de	Heilbronner, Urs/GXF-9880-2022	Kesberg, Rebekka/0000-0002-2240-2401; Heilbronner, Urs/0000-0001-7135-762X	German Federal Ministry of Education and Science (Bundesministerium fur Bildung und Forschung) [01GP1205]; Dr. Lisa Oehler Foundation, Kassel, Germany	German Federal Ministry of Education and Science (Bundesministerium fur Bildung und Forschung); Dr. Lisa Oehler Foundation, Kassel, Germany	The project was supported by the German Federal Ministry of Education and Science (Bundesministerium fur Bildung und Forschung), grant number: 01GP1205 (www.gesundheitsforschung-bmbf.de/de/diagnostikverfahren-2650.php). Thomas G. Schulze was supported by the Dr. Lisa Oehler Foundation, Kassel, Germany (www.lei-lookup.com/#!recordPopup;lei=967600LKEFSZ4L8DIV92;tab=0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnoy S, 2007, GENET TEST, V11, P187, DOI 10.1089/gte.2006.0509; Berkman BE, 2014, AM J BIOETHICS, V14, P28, DOI 10.1080/15265161.2014.880313; Bertier G, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0213-6; Bevan JL, 2012, NURS ETHICS, V19, P819, DOI 10.1177/0969733011433924; Biesecker LG, 2012, GENET MED, V14, P393, DOI 10.1038/gim.2011.78; Bollinger JM, 2012, GENET MED, V14, P451, DOI 10.1038/gim.2011.66; Bui ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101111; Christenhusz GM, 2013, EUR J HUM GENET, V21, P248, DOI 10.1038/ejhg.2012.130; Christensen KD, 2013, PERS MED, V10, P377, DOI [10.2217/PME.13.24, 10.2217/pme.13.24]; Clift KE, 2015, APPL TRANSL GENOM, V4, P38, DOI 10.1016/j.atg.2015.02.005; Condit CM, 2010, ANNU REV GENOM HUM G, V11, P339, DOI 10.1146/annurev-genom-082509-141740; Creighton S, 2003, CLIN GENET, V63, P462, DOI 10.1034/j.1399-0004.2003.00093.x; Evans JP, 2012, GENET MED, V14, P358, DOI 10.1038/gim.2012.8; Facio FM, 2013, EUR J HUM GENET, V21, P261, DOI 10.1038/ejhg.2012.179; Gigerenzer G, 2017, PSYCHOL REV, V124, P179, DOI 10.1037/rev0000055; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Gross M, 2015, ROUTLEDGE INT HDB SE, Vxvii, P408; Henneman L, 2006, GENET TEST, V10, P139, DOI 10.1089/gte.2006.10.139; Henneman L, 2013, EUR J HUM GENET, V21, P793, DOI 10.1038/ejhg.2012.271; Hertwig R, 2016, PERSPECT PSYCHOL SCI, V11, P359, DOI 10.1177/1745691616635594; Husedzinovic A, 2015, EUR J HUM GENET, V23, P1607, DOI 10.1038/ejhg.2015.27; Jallinoja P, 2000, J HEALTH COMMUN, V5, P29, DOI 10.1080/10810730050019546; Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190; Lanzerath D, 2014, SCHRIFTENREIHE HANS, V26, P146; Lemke AA, 2013, CLIN GENET, V84, P230, DOI 10.1111/cge.12060; Lohn Z, 2014, J GENET COUNS, V23, P463, DOI 10.1007/s10897-013-9604-4; Lohn Z, 2013, AM J MED GENET A, V161A, P542, DOI 10.1002/ajmg.a.35794; Makeeva OA, 2010, PERS MED, V7, P291, DOI [10.2217/pme.10.23, 10.2217/PME.10.23]; Melnyk D, 2012, ANN BEHAV MED, V44, P216, DOI 10.1007/s12160-012-9382-5; Meulenkamp TM, 2012, EUR J HUM GENET, V20, P258, DOI 10.1038/ejhg.2011.216; Middleton A, 2016, EUR J HUM GENET, V24, P21, DOI 10.1038/ejhg.2015.58; O'Daniel J, 2011, PUBLIC HEALTH GENOM, V14, P346, DOI 10.1159/000324933; O'Neill SC, 2015, PUBLIC HEALTH GENOM, V18, P104, DOI 10.1159/000370101; Ramoni RB, 2013, GENET MED, V15, P882, DOI 10.1038/gim.2013.58; Sanderson SC, 2016, EUR J HUM GENET, V24, P14, DOI 10.1038/ejhg.2015.118; Swartling U, 2007, EUR J HUM GENET, V15, P556, DOI 10.1038/sj.ejhg.5201786; Townsend A, 2012, AM J MED GENET A, V158A, P2519, DOI 10.1002/ajmg.a.35554; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yaniv I., 2004, RISK DECISION POLICY, V9, P317, DOI DOI 10.1080/14664530490896573	40	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							0198249	10.1371/journal.pone.0198249	http://dx.doi.org/10.1371/journal.pone.0198249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924808	Green Submitted, Green Published, gold			2022-12-26	WOS:000435655600014
J	Johnson, ZI; Jones, JD; Mukherjee, A; Rena, D; Feghali-Bostwick, C; Conley, YP; Yates, CC				Johnson, Zariel I.; Jones, Jacqueline D.; Mukherjee, Angana; Rena, Dianxu; Feghali-Bostwick, Carol; Conley, Yvette P.; Yates, Cecelia C.			Novel classification for global gene signature model for predicting severity of systemic sclerosis	PLOS ONE			English	Article							ONCOSTATIN-M; SKIN FIBROSIS; LUNG-DISEASE; SERUM-LEVELS; EXPRESSION; ACTIVATION; DEPOSITION; RECEPTOR; PROTEIN; RNA	Progression of systemic scleroderma (SSc), a chronic connective tissue disease that causes a fibrotic phenotype, is highly heterogeneous amongst patients and difficult to accurately diagnose. To meet this clinical need, we developed a novel three-layer classification model, which analyses gene expression profiles from SSc skin biopsies to diagnose SSc severity. Two SSc skin biopsy microarray datasets were obtained from Gene Expression Omnibus. The skin scores obtained from the original papers were used to further categorize the data into subgroups of low(< 18) and high (>= 18) severity. Data was pre-processed for normalization, background correction, centering and scaling. A two-layered cross-validation scheme was employed to objectively evaluate the performance of classification models of unobserved data. Three classification models were used: support vector machine, random forest, and naive Bayes in combination with feature selection methods to improve performance accuracy. For both input datasets, random forest classifier combined with correlation-based feature selection (CFS) method and naive Bayes combined with CFS or support vector machine based recursive feature elimination method yielded the best results. Additionally, we performed a principal component analysis to show that low and high severity groups are readily separable by gene expression signatures. Ultimately, we found that our novel classification prediction model produced global gene signatures that significantly correlated with skin scores. This study represents the first report comparing the performance of various classification prediction models for gene signatures from SSc patients, using current clinical diagnostic factors. In summary, our three-classification model system is a powerful tool for elucidating gene signatures from SSc skin biopsies and can also be used to develop a prognostic gene signature for SSc and other fibrotic disorders.	[Johnson, Zariel I.; Conley, Yvette P.; Yates, Cecelia C.] Univ Pittsburgh, Sch Nursing, Dept Hlth Promot & Dev, Pittsburgh, PA 15261 USA; [Jones, Jacqueline D.; Mukherjee, Angana] Troy Univ, Dept Biol & Environm Sci, Troy, AL USA; [Rena, Dianxu] Univ Pittsburgh, Sch Nursing, Hlth & Community Syst, Pittsburgh, PA 15261 USA; [Feghali-Bostwick, Carol] Univ South Carolina, Dept Rheumatol & Immunol, Charleston, SC USA; [Conley, Yvette P.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Yates, Cecelia C.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Troy University System; Troy University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yates, CC (corresponding author), Univ Pittsburgh, Sch Nursing, Dept Hlth Promot & Dev, Pittsburgh, PA 15261 USA.; Yates, CC (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	yatescc@upmc.edu		Conley, Yvette/0000-0002-1784-6067; Yates, Cecelia/0000-0002-8240-7773	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [AR068317]; School of Nursing, University of Pittsburgh Genomics of Patient Outcomes Hub; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR060297] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); School of Nursing, University of Pittsburgh Genomics of Patient Outcomes Hub; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number AR068317 to CCY. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This publication was also supported by the School of Nursing, University of Pittsburgh Genomics of Patient Outcomes Hub to CCY and YPC.	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Assassi S, 2013, ARTHRITIS RHEUM-US, V65, P2917, DOI 10.1002/art.38101; Bamber B, 1998, J MOL MED-JMM, V76, P61, DOI 10.1007/s109-1998-8105-3; Chakraborty D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01236-6; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Diboun I, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-252; Dobrota R, 2016, ANN RHEUM DIS, V75, P1743, DOI 10.1136/annrheumdis-2015-208024; Dospinescu P, 2013, CURR OPIN RHEUMATOL, V25, P179, DOI 10.1097/BOR.0b013e32835cfc2d; Elhai M, 2013, ANN RHEUM DIS, V72, P1217, DOI 10.1136/annrheumdis-2012-202657; Gazel A, 2006, J INVEST DERMATOL, V126, P2647, DOI 10.1038/sj.jid.5700461; Gerlicz Z, 2014, DERMATOLOGY, V228, P233, DOI 10.1159/000357806; GRUSCHWITZ MS, 1995, ARTHRITIS RHEUM, V38, P184, DOI 10.1002/art.1780380206; Hasegawa M, 1998, J RHEUMATOL, V25, P308; Hesselstrand R, 2012, RHEUMATOLOGY, V51, P915, DOI 10.1093/rheumatology/ker442; Johnson SR, 2017, CURR OPIN RHEUMATOL, V29, P568, DOI 10.1097/BOR.0000000000000443; Krzyszczak ME, 2011, CLIN RHEUMATOL, V30, P1333, DOI 10.1007/s10067-011-1751-0; Kumanovics G, 2017, RHEUMATOLOGY, V56, pV53, DOI 10.1093/rheumatology/kex202; Lakota K, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3827; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Liaw A., 2002, R NEWS, P2; Liu W, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-182; Martin P, 2012, AUTOIMMUN REV, V11, P827, DOI 10.1016/j.autrev.2012.02.017; Mathai SC, 2011, EXPERT REV RESP MED, V5, P267, DOI [10.1586/ERS.11.18, 10.1586/ers.11.18]; Michalska-Jakubus M, 2011, RHEUMATOLOGY, V50, P746, DOI 10.1093/rheumatology/keq392; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Nagata T, 2003, ARTERIOSCL THROM VAS, V23, P588, DOI 10.1161/01.ATV.0000060891.31516.24; Pedroza M, 2018, RHEUMATOLOGY, V57, P1838, DOI 10.1093/rheumatology/kex347; Reveille John D, 2003, Curr Rheumatol Rep, V5, P160, DOI 10.1007/s11926-003-0045-1; Rychli K, 2010, J THROMB HAEMOST, V8, P596, DOI 10.1111/j.1538-7836.2010.03741.x; Sargent JL, 2011, EXPERT REV CLIN IMMU, V7, P463, DOI [10.1586/ECI.11.41, 10.1586/eci.11.41]; Shand L, 2007, ARTHRITIS RHEUM-US, V56, P2422, DOI 10.1002/art.22721; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; Steen V, 2003, ANN RHEUM DIS, V62, P97, DOI 10.1136/ard.62.2.97; Steen VD, 2008, RHEUM DIS CLIN N AM, V34, P1, DOI 10.1016/j.rdc.2007.12.001; Steen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068; Tsujino K, 2012, AM J RESP CRIT CARE, V186, P170, DOI 10.1164/rccm.201201-0117OC; Weihs C, 2005, ST CLASS DAT ANAL, P335; Wong S, 2014, LAB INVEST, V94, P1003, DOI 10.1038/labinvest.2014.81; Yao LB, 1996, J EXP MED, V184, P81, DOI 10.1084/jem.184.1.81; Zhang HY, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-298	40	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199314	10.1371/journal.pone.0199314	http://dx.doi.org/10.1371/journal.pone.0199314			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924864	Green Submitted, Green Published, gold			2022-12-26	WOS:000435655600060
J	Hassan, A; Mustapha, GU; Lawal, BB; Na'uzo, AM; Ismail, R; Oboma, EWE; Oyebanji, O; Agenyi, J; Thomas, C; Balogun, MS; Dalhat, MM; Nguku, P; Ihekweazu, C				Hassan, Assad; Mustapha, G. U.; Lawal, Bola B.; Na'uzo, Aliyu M.; Ismail, Raji; Oboma, Eteng Womi-Eteng; Oyebanji, Oyeronke; Agenyi, Jeremiah; Thomas, Chima; Balogun, Muhammad Shakir; Dalhat, Mahmood M.; Nguku, Patrick; Ihekweazu, Chikwe			Time delays in the response to the Neisseria meningitidis serogroup C outbreak in Nigeria-2017	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; MENINGOCOCCAL MENINGITIS; NATIONAL SURVEILLANCE; EPIDEMIC MENINGITIS; NIGER	Background Nigeria reports high rates of mortality linked with recurring meningococcal meningitis outbreaks within the African meningitis belt. Few studies have thoroughly described the response to these outbreaks to provide strong and actionable public health messages. We describe how time delays affected the response to the 2016/2017 meningococcal meningitis outbreak in Nigeria. Methods Using data from Nigeria Centre for Disease Control (NCDC), National Primary Health Care Development Agency (NPHCDA), World Health Organisation (WHO), and situation reports of rapid response teams, we calculated attack and death rates of reported suspected meningococcal meningitis cases per week in Zamfara, Sokoto and Yobe states respectively, between epidemiological week 49 in 2016 and epidemiological week 25 in 2017. We identified when alert and epidemic thresholds were crossed and determined when the outbreak was detected and notified in each state. We examined response activities to the outbreak. Results There were 12,535 suspected meningococcal meningitis cases and 877 deaths (CFR: 7.0%) in the three states. It took an average time of three weeks before the outbreaks were detected and notified to NCDC. Four weeks after receiving notification, an integrated response coordinating centre was set up by NCDC and requests for vaccines were sent to International Coordinating Group (ICG) on vaccine provision. While it took ICG one week to approve the requests, it took an average of two weeks for approximately 41% of requested vaccines to arrive. On the average, it took nine weeks from the date the epidemic threshold was crossed to commencement of reactive vaccination in the three states. Conclusion There were delays in detection and notification of the outbreak, in coordinating response activities, in requesting for vaccines and their arrival from ICG, and in initiating reactive vaccination. Reducing these delays in future outbreaks could help decrease the morbidity and mortality linked with meningococcal meningitis outbreaks.	[Hassan, Assad; Mustapha, G. U.; Lawal, Bola B.; Na'uzo, Aliyu M.; Ismail, Raji; Balogun, Muhammad Shakir; Dalhat, Mahmood M.; Nguku, Patrick] Nigeria Field Epidemiol & Lab Training Programme, Abuja, Nigeria; [Hassan, Assad; Mustapha, G. U.; Oboma, Eteng Womi-Eteng; Oyebanji, Oyeronke; Agenyi, Jeremiah; Ihekweazu, Chikwe] Nigeria Ctr Dis Control, Abuja, Nigeria; [Thomas, Chima] WHO, Borno, Nigeria	World Health Organization	Hassan, A (corresponding author), Nigeria Field Epidemiol & Lab Training Programme, Abuja, Nigeria.; Hassan, A (corresponding author), Nigeria Ctr Dis Control, Abuja, Nigeria.	hssnassad@yahoo.com	BALOGUN, MUHAMMAD/ABH-4227-2020; Oyebanji, Oyeronke/GWD-1355-2022	BALOGUN, MUHAMMAD/0000-0002-4846-9698; Hassan, Assad/0000-0002-8860-5578; Mamman Na'uzo, Aliyu/0000-0002-0048-2228; Lawal, Bola Biliaminu/0000-0001-5239-9023; Raji, Ismail/0000-0002-1113-0877	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Aku FY, 2017, MMWR-MORBID MORTAL W, V66, P806, DOI 10.15585/mmwr.mm6630a2; Asiedu-bekoe F, 2017, INT J TROPICAL DIS H, V22, P1; Bassey BE, 2016, INT J INFECT DIS, V43, P62, DOI 10.1016/j.ijid.2015.12.016; Chippaux JP, 2008, J INFECT DEV COUNTR, V2, P335, DOI 10.3855/jidc.193; Hearld LR, 2015, HLTH CARE MANAGE REV, V40; Heymann DL, 2004, EMERG INFECT DIS, V10, P173, DOI 10.3201/eid1002.031038; Javier F, 2015, INT HEAL, V7, P226; LaForce FM, 2009, VACCINE, V27, pB13, DOI 10.1016/j.vaccine.2009.04.062; Leake JAD, 2002, B WORLD HEALTH ORGAN, V80, P342; Lewis R, 2001, LANCET, V358, P287, DOI 10.1016/S0140-6736(01)05484-8; Mohammed I, 2000, T ROY SOC TROP MED H, V94, P265, DOI 10.1016/S0035-9203(00)90316-X; Mohammed I, 2017, PATHOG GLOB HEALTH, V111, P1, DOI 10.1080/20477724.2016.1274068; Paireau J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001577; Report of World Health Organization, 2001, INT COORD GROUP ICG; Sidikou F, 2016, LANCET INFECT DIS, V16, P1288, DOI 10.1016/S1473-3099(16)30253-5; Trotter CL, 2015, VACCINE, V33, P6212, DOI 10.1016/j.vaccine.2015.09.107; WEC, 2017, WORLD EN TRIL IND 20, P145; WHO-AFRO, 2009, STANDARD OPERATING P; World Health Organisation, 2015, MAN MEN EP AFR QUICK; World Health Organisation, 2016, REV INT COORD GROUP	20	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199257	10.1371/journal.pone.0199257	http://dx.doi.org/10.1371/journal.pone.0199257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920549	Green Published, Green Submitted, gold			2022-12-26	WOS:000435541300030
J	Al-Harrasi, A; Rehman, NU; Khan, AL; Al-Broumi, M; Al-Amri, I; Hussain, J; Hussain, H; Csuk, R				Al-Harrasi, Ahmed; Rehman, Najeeb Ur; Khan, Abdul Latif; Al-Broumi, Muhammed; Al-Amri, Issa; Hussain, Javid; Hussain, Hidayat; Csuk, Rene			Chemical, molecular and structural studies of Boswellia species: beta-Boswellia Aldehyde and 3-epi-11 beta-Dihydroxy BA as precursors in biosynthesis of boswellic acids	PLOS ONE			English	Article							OLEO-GUM-RESIN; PENTACYCLIC TRITERPENE ACIDS; ACETYL-11-KETO-BETA-BOSWELLIC ACID; ALTERNATIVE METHOD; SACRA FLUECK; FRANKINCENSE; SERRATA; EXTRACT; AKBA; QUANTIFICATION	The distribution and biosynthesis of boswellic acids (BAs) is scarce in current literature. Present study aims to elucidate the BAs biosynthetic and its diversity in the resins of Boswellia sacra and Boswellia papyrifera. Results revealed the isolation of new (3 beta, 11 beta-dihydroxy BA) and recently known (as new source, beta-boswellic aldehyde) precursors from B. sacra resin along with alpha-amyrin. Following this, a detailed nomenclature of BAs was elucidated. The quantification and distribution of amyrins (3-epi-alpha-amyrin, beta-amyrin and alpha-amyrin) and BAs in different Boswellia resins showed highest amyrin and BAs in B. sacra as compared with B. serrata and B. papyrifera. Distribution of BAs significantly varied in the resin of B. sacra collected from dry mountains than coastal trees. In B. sacra, high content of a-amyrin was found in the roots but it lacked beta-amyrin and BAs. The leaf part showed traces of beta-ABA and AKBA but was deficient in amyrins. This was further confirmed by lack of transcript accumulation of amyrin-related biosynthesis gene in leaf part. In contrast, the stem showed presence of all six BAs which are attributed to existence of resin-secretory canals. In conclusion, the boswellic acids are genus-specific chemical constituents for Boswellia species albeit the variation of the amounts among different Boswellia species and grades.	[Al-Harrasi, Ahmed; Rehman, Najeeb Ur; Khan, Abdul Latif; Al-Broumi, Muhammed; Al-Amri, Issa; Hussain, Hidayat] Univ Nizwa, Nat & Med Sci Res Ctr, Birkat Al Mauz, Nizwa, Oman; [Hussain, Javid] Univ Nizwa, Dept Biol Sci & Chem, Birkat Al Mauz, Nizwa, Oman; [Csuk, Rene] Martin Luther Univ Halle Wittenberg, Organ Chem, Halle, Saale, Germany	University of Nizwa; University of Nizwa; Martin Luther University Halle Wittenberg	Al-Harrasi, A (corresponding author), Univ Nizwa, Nat & Med Sci Res Ctr, Birkat Al Mauz, Nizwa, Oman.	aharrasi@unizwa.edu.om	Hussain, Hidayat/I-4527-2016; Hussain, Javid/AAC-5053-2020; Csuk, René/L-1549-2015; Lee, In-Jung/GLS-0432-2022; Al-Amri, Issa/AFQ-0570-2022	Hussain, Hidayat/0000-0002-8654-8127; Csuk, René/0000-0001-7911-290X; Lee, In-Jung/0000-0001-7154-4820; Al-Amri, Issa/0000-0002-8238-8074; Khan, Abdul Latif/0000-0001-9700-8903; Hussain, Hazrat/0000-0001-9101-515X	Oman Research Council (TRC) [ORG/HSS/14/004, ORG/EBR/15/007]	Oman Research Council (TRC)	The authors would like to thank The Oman Research Council (TRC) for the generous support through the project ORG/HSS/14/004 and ORG/EBR/15/007 to AA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank The Oman Research Council (TRC) for the generous support through the project ORG/HSS/14/004 and ORG/EBR/15/007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors wish to acknowledge the Prof. Byung-Wook Yun for helping the RT-PCR related work.	Abe I, 2007, NAT PROD REP, V24, P1311, DOI 10.1039/b616857b; Addisalem AB, 2016, FOREST ECOL MANAG, V360, P253, DOI 10.1016/j.foreco.2015.10.038; Al-Harrasi A, 2017, SPECTROCHIM ACTA A, V184, P277, DOI 10.1016/j.saa.2017.05.018; Al-Harrasi A, 2014, ASIAN PAC J TROP MED, V7, pS485, DOI 10.1016/S1995-7645(14)60279-0; Al-Harrasi A, 2013, BIOCHEM SYST ECOL, V51, P113, DOI 10.1016/j.bse.2013.08.026; Al-Harrasi A, 2013, TROP J PHARM RES, V12, P597, DOI 10.4314/tjpr.v12i4.23; Al-Harrasi A, 2013, CHEM BIODIVERS, V10, P1501, DOI 10.1002/cbdv.201200231; Ammon H P T, 2002, Wien Med Wochenschr, V152, P373, DOI 10.1046/j.1563-258X.2002.02056.x; Asad M, 2016, PHARM BIOL, V54, P225, DOI 10.3109/13880209.2015.1028553; Asad M, 2015, AFR J TRADIT COMPLEM, V12, P1, DOI 10.4314/ajtcam.v12i2.1; Asif M, 2014, PAK J PHARM SCI, V27, P1811; Badria FA, 2003, Z NATURFORSCH C, V58, P505; Banno N, 2006, J ETHNOPHARMACOL, V107, P249, DOI 10.1016/j.jep.2006.03.006; Basar S., 2005, THESIS; Belsner K, 2003, MAGN RESON CHEM, V41, P115, DOI 10.1002/mrc.1138; BETON JL, 1956, J CHEM SOC, P2904, DOI 10.1039/jr9560002904; Chen GYJ, 2000, J PHYTOPATHOL, V148, P57, DOI 10.1111/j.1439-0434.2000.tb04625.x; Coppi A, 2010, GENET RESOUR CROP EV, V57, P1041, DOI 10.1007/s10722-010-9546-8; Cseke Leland J., 2006, P1; Culioli G, 2003, PHYTOCHEMISTRY, V62, P537, DOI 10.1016/S0031-9422(02)00538-1; Dekebo A, 2002, B CHEM SOC ETHIOPIA, V16, P87; Eschenmoser A, 2005, HELV CHIM ACTA, V88, P3011, DOI 10.1002/hlca.200590245; ESCHENMOSER A, 1955, HELV CHIM ACTA, V38, P1890, DOI 10.1002/hlca.19550380728; Eshete A, 2012, FOREST ECOL MANAG, V274, P136, DOI 10.1016/j.foreco.2012.02.024; Farah M.H., 2008, NON TIMBER FOREST PR; Fatcorusso E, 1985, PHYTOCHEMISTRY, V24, P1035; Greve HL, 2017, PLANTA MED, V83, P1214, DOI 10.1055/s-0043-116943; Hammer K, 2009, GENET RESOUR CROP EV, V56, P547, DOI 10.1007/s10722-008-9385-z; Henkel A, 2012, BIOCHEM PHARMACOL, V83, P115, DOI 10.1016/j.bcp.2011.09.026; Hussain H, 2017, EXPERT OPIN THER PAT, V27, P81, DOI 10.1080/13543776.2017.1235156; Johann J, 2003, EUR J ORG CHEM, V2003, P4752; Khan AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169794; Kreck C, 1998, INTERNIST PRAX, P857; Lemenih M, 2003, J ARID ENVIRON, V55, P465, DOI 10.1016/S0140-1963(03)00053-3; Lima FV, 2005, J BRAZIL CHEM SOC, V16, P578, DOI 10.1590/S0103-50532005000400014; MAHAJAN B, 1995, PHYTOCHEMISTRY, V39, P453, DOI 10.1016/0031-9422(95)99386-3; Manguro LOA, 2016, B CHEM SOC ETHIOPIA, V30, P317, DOI 10.4314/bcse.v30i2.16; Manguro LOA, 2016, J ASIAN NAT PROD RES, V18, P854, DOI 10.1080/10286020.2016.1165674; Mannino G, 2016, MOLECULES, V21, DOI 10.3390/molecules21101329; Mengistu T, 2012, FOREST ECOL MANAG, V278, P1, DOI 10.1016/j.foreco.2012.04.029; Ni X, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-253; Pan YN, 2015, J ETHNOPHARMACOL, V172, P118, DOI 10.1016/j.jep.2015.06.029; PARDHY RS, 1978, INDIAN J CHEM B, V16, P174; PARDHY RS, 1978, INDIAN J CHEM B, V16, P176; Peckys DB, 2013, SCI REP-UK, V3, DOI 10.1038/srep02626; Poeckel D, 2006, MOL PHARMACOL, V70, P1071, DOI 10.1124/mol.106.024836; PROIETTI G, 1981, PLANTA MED, V41, P417, DOI 10.1055/s-2007-971743; Olate VR, 2014, MOLECULES, V19, P6489, DOI 10.3390/molecules19056489; Raffaelli M., 2006, Webbia, V61, P245; Raffaelli M., 2003, Webbia, V58, P133; Reddy VLN, 2003, CHEM PHARM BULL, V51, P1081, DOI 10.1248/cpb.51.1081; Rees A, 1995, NEW PLANTSMAN, V2, P55; Rehman NU, 2018, PHYTOCHEM ANALYSIS, V29, P137, DOI 10.1002/pca.2721; Reising K, 2005, ANAL CHEM, V77, P6640, DOI 10.1021/ac0506478; Roy NK, 2016, CANCER LETT, V377, P74, DOI 10.1016/j.canlet.2016.04.017; Ruzicka L, 1939, HELV CHIM ACTA, V22, P948, DOI 10.1002/hlca.193902201121; Ruzicka L, 1940, HELV CHIM ACTA, V23, P132, DOI 10.1002/hlca.19400230115; Sailer ER, 1998, EUR J BIOCHEM, V256, P364, DOI 10.1046/j.1432-1327.1998.2560364.x; Schweizer S, 2000, J NAT PROD, V63, P1058, DOI 10.1021/np000069k; Schweizer S, 2000, PLANTA MED, V66, P781, DOI 10.1055/s-2000-9614; Shah BA, 2007, BIOORG MED CHEM LETT, V17, P6411, DOI 10.1016/j.bmcl.2007.10.011; Shah BA, 2009, NAT PROD REP, V26, P72, DOI 10.1039/b809437n; Shen T, 2008, CHEM BIODIVERS, V5, P540, DOI 10.1002/cbdv.200890051; SINGH SK, 1991, J NAT PROD, V54, P755, DOI 10.1021/np50075a003; Tadesse W, 2007, INVEST AGRAR-SIST R, V16, P211, DOI 10.5424/srf/2007163-01010; Tolera M, 2013, FOREST ECOL MANAG, V304, P65, DOI 10.1016/j.foreco.2013.04.036; Tolera M, 2013, ANN BOT-LONDON, V111, P61, DOI 10.1093/aob/mcs236; Verhoff M, 2014, J NAT PROD, V77, P1445, DOI 10.1021/np500198g; Winterstein A, 1932, H-S Z PHYSIOL CHEM, V208, P9, DOI 10.1515/bchm2.1932.208.1-3.9; Wolfram R.K., 2017, MEDITERR J CHEM, V6, P142; Yassin N., 2013, J ARAB SOC MED RES, V8, P1; Zaki AA, 2014, CHIN J NAT MEDICINES, V12, P345, DOI 10.1016/S1875-5364(14)60042-X; Zhao M, 2006, J NAT PROD, V69, P1164, DOI 10.1021/np0680073	73	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198666	10.1371/journal.pone.0198666	http://dx.doi.org/10.1371/journal.pone.0198666			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912889	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600040
J	Stukel, MR; Decima, M; Kelly, TB				Stukel, Michael R.; Decima, Moira; Kelly, Thomas B.			A new approach for incorporating N-15 isotopic data into linear inverse ecosystem models with Markov Chain Monte Carlo sampling	PLOS ONE			English	Article							FOOD-WEB ANALYSIS; EQUATORIAL PACIFIC; TROPHIC POSITION; MIXING MODELS; CARBON FLOWS; NITROGEN; MARINE; INFORMATION; PARTICLES; BIOMASS	Oceanographic field programs often use delta N-15 biogeochemical measurements and in situ rate measurements to investigate nitrogen cycling and planktonic ecosystem structure. However, integrative modeling approaches capable of synthesizing these distinct measurement types are lacking. We develop a novel approach for incorporating delta N-15 isotopic data into existing Markov Chain Monte Carlo (MCMC) random walk methods for solving linear inverse ecosystem models. We test the ability of this approach to recover food web indices (nitrate uptake, nitrogen fixation, zooplankton trophic level, and secondary production) derived from forward models simulating the planktonic ecosystems of the California Current and Amazon River Plume. We show that the MCMC with delta N-15 approach typically does a better job of recovering ecosystem structure than the standard MCMC or L-2 minimum norm (L2MN) approaches, and also outperforms an L2MN with delta N-15 approach. Furthermore, we find that the MCMC with delta N-15 approach is robust to the removal of input equations and hence is well suited to typical pelagic ecosystem studies for which the system is usually vastly under-constrained. Our approach is easily extendable for use with delta C-13 isotopic measurements or variable carbon:nitrogen stoichiometry.	[Stukel, Michael R.; Kelly, Thomas B.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Stukel, Michael R.] Florida State Univ, Ctr Ocean Atmospher Predict Studies, Tallahassee, FL 32306 USA; [Decima, Moira] Natl Inst Water & Atmospher Res NIWA, Wellington, New Zealand	State University System of Florida; Florida State University; State University System of Florida; Florida State University; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Stukel, MR (corresponding author), Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA.; Stukel, MR (corresponding author), Florida State Univ, Ctr Ocean Atmospher Predict Studies, Tallahassee, FL 32306 USA.	mstukel@fsu.edu	Kelly, Thomas/AAW-5785-2020	Kelly, Thomas/0000-0001-6285-1925; Stukel, Michael/0000-0002-7696-6739	National Science Foundation [OCE-1637632]; National Oceanic and Atmospheric Administration's RESTORE Program Grant [NOAA-NOS-NCCOS-2017-2004875]	National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration's RESTORE Program Grant	Funding to support this work came from two sources: A National Science Foundation grant to the California Current Ecosystem Long-Term Ecological Research Program (OCE-1637632). https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=11696. A National Oceanic and Atmospheric Administration's RESTORE Program Grant to M. Stukel (Project Title: Effects of nitrogen sources and plankton food-web dynamics on habitat quality for the larvae of Atlantic bluefin tuna in the Gulf of Mexico) under federal funding opportunity NOAA-NOS-NCCOS-2017-2004875. https://restoreactscienceprogram.noaa.gov/funded-projects/bluefin-tuna-larvae. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTABET MA, 1988, DEEP-SEA RES, V35, P535, DOI 10.1016/0198-0149(88)90130-6; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; Casciotti KL, 2016, ANNU REV MAR SCI, V8, P379, DOI 10.1146/annurev-marine-010213-135052; CHECKLEY DM, 1985, J PLANKTON RES, V7, P553, DOI 10.1093/plankt/7.4.553; CHRISTENSEN V, 1992, ECOL MODEL, V61, P169, DOI 10.1016/0304-3800(92)90016-8; Conroy BJ, 2016, LIMNOL OCEANOGR, V61, P825, DOI 10.1002/lno.10261; Decima M, 2017, LIMNOLOGY OCEANOGRAP, DOI [10.1002/lno.10567, DOI 10.1002/LNO.10567]; Dore JE, 2002, LIMNOL OCEANOGR, V47, P1595, DOI 10.4319/lo.2002.47.6.1595; Eldridge PM, 2005, MAR ECOL PROG SER, V303, P73, DOI 10.3354/meps303073; Fawcett SE, 2011, NAT GEOSCI, V4, P717, DOI [10.1038/ngeo1265, 10.1038/NGEO1265]; FRY B, 1994, MAR ECOL PROG SER, V112, P201, DOI 10.3354/meps112201; Fry B., 1989, STABLE ISOTOPES ECOL, P196, DOI [DOI 10.1007/978-1-4612-3498-2, DOI 10.1007/978-1-4612-3498-2_12]; Goericke R, 2011, CAL COOP OCEAN FISH, V52, P198; Goes JI, 2014, PROG OCEANOGR, V120, P29, DOI 10.1016/j.pocean.2013.07.010; Gontikaki E, 2011, PROG OCEANOGR, V91, P245, DOI 10.1016/j.pocean.2010.12.014; Gutierrez-Rodriguez A, 2014, LIMNOL OCEANOGR, V59, P1590, DOI 10.4319/lo.2014.59.5.1590; JACKSON GA, 1992, PROG OCEANOGR, V30, P223, DOI 10.1016/0079-6611(92)90014-Q; Johnson GA, 2009, ECOL MODEL, V220, P3448, DOI 10.1016/j.ecolmodel.2009.08.003; Kadoya T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041057; Kishi MJ, 2007, ECOL MODEL, V202, P12, DOI 10.1016/j.ecolmodel.2006.08.021; Kishi MJ, 2011, J OCEANOGR, V67, P3, DOI 10.1007/s10872-011-0009-4; Knapp AN, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002320; Knapp AN, 2016, P NATL ACAD SCI USA, V113, P4398, DOI 10.1073/pnas.1515641113; Kones JK, 2006, J MARINE SYST, V60, P153, DOI 10.1016/j.jmarsys.2005.12.002; Kones JK, 2009, ECOL MODEL, V220, P370, DOI 10.1016/j.ecolmodel.2008.10.012; Landry MR, 2009, PROG OCEANOGR, V83, P208, DOI 10.1016/j.pocean.2009.07.026; Lassalle G, 2014, PROG OCEANOGR, V120, P205, DOI 10.1016/j.pocean.2013.09.002; Li QP, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001111; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Niquil N, 1998, MAR ECOL PROG SER, V165, P17, DOI 10.3354/meps165017; Pacella SR, 2013, ECOL MODEL, V267, P127, DOI 10.1016/j.ecolmodel.2013.07.018; Parnell AC, 2013, ENVIRONMETRICS, V24, P387, DOI 10.1002/env.2221; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; RAU GH, 1990, MAR ECOL PROG SER, V59, P33, DOI 10.3354/meps059033; Richardson TL, 2004, DEEP-SEA RES PT I, V51, P1245, DOI 10.1016/j.dsr.2004.05.005; Sailley SF, 2013, MAR ECOL PROG SER, V492, P253, DOI 10.3354/meps10534; Saint-Beat B, 2013, ECOL MODEL, V258, P53, DOI 10.1016/j.ecolmodel.2013.01.023; Sara G, 2007, J APPL ICHTHYOL, V23, P122, DOI 10.1111/j.1439-0426.2006.00829.x; Sigman DM, 2001, ANAL CHEM, V73, P4145, DOI 10.1021/ac010088e; Soetaert K, 2009, R PACKAGE VERSION; Soetaert K, 2015, PACKAGE LIMSOLVE; Steele JH, 2009, J MARINE SYST, V76, P186, DOI 10.1016/j.jmarsys.2008.05.012; Stergiou KI, 2001, REV FISH BIOL FISHER, V11, P217, DOI 10.1023/A:1020556722822; Stock BC, 2016, ECOLOGY, V97, P2562, DOI 10.1002/ecy.1517; Stukel MR, 2015, J GEOPHYS RES-OCEANS, V120, P7208, DOI 10.1002/2015JC011264; Stukel MR, 2014, BIOGEOSCIENCES, V11, P3259, DOI 10.5194/bg-11-3259-2014; Stukel MR, 2012, J MARINE SYST, V91, P20, DOI 10.1016/j.jmarsys.2011.09.004; Stukel MR, 2010, LIMNOL OCEANOGR, V55, P2669, DOI 10.4319/lo.2010.55.6.2669; Subramaniam A, 2008, P NATL ACAD SCI USA, V105, P10460, DOI 10.1073/pnas.0710279105; Van den Meersche K., 2009, J STAT SOFTW, V30, P1, DOI [DOI 10.18637/JSS.V030.C01, 10.1002/wics.10., DOI 10.18637/jss.v030.c01]; van Oevelen D, 2006, J MAR RES, V64, P453, DOI 10.1357/002224006778189581; van Oevelen D, 2012, LIMNOL OCEANOGR, V57, P645, DOI 10.4319/lo.2012.57.2.0645; van Oevelen D, 2010, ECOSYSTEMS, V13, P32, DOI 10.1007/s10021-009-9297-6; van Oevelen D, 2009, LIMNOL OCEANOGR, V54, P1829, DOI 10.4319/lo.2009.54.6.1829; Vander Zanden MJ, 1997, CAN J FISH AQUAT SCI, V54, P1142, DOI 10.1139/cjfas-54-5-1142; Vezina A.F., 1989, Coastal and Estuarine Studies, P62; Vezina AF, 2004, PROG OCEANOGR, V60, P321, DOI 10.1016/j.pocean.2004.02.012; Vezina AF, 2003, J MARINE SYST, V40, P55, DOI 10.1016/S0924-7963(03)00013-7; VEZINA AF, 1988, MAR ECOL PROG SER, V42, P269, DOI 10.3354/meps042269; Weber SC, 2017, LIMNOL OCEANOGR, V62, P618, DOI 10.1002/lno.10448; White AE, 2013, PROG OCEANOGR, V109, P1, DOI 10.1016/j.pocean.2012.09.002; Yoshikawa C, 2005, J OCEANOGR, V61, P921, DOI 10.1007/s10872-006-0010-5	63	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199123	10.1371/journal.pone.0199123	http://dx.doi.org/10.1371/journal.pone.0199123			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912928	gold, Green Submitted, Green Published			2022-12-26	WOS:000435528600077
J	Zheng, R; Hill, D; Hedden, D; Mahood, J; Moreau, M; Southon, S; Lou, E				Zheng, Rui; Hill, Doug; Hedden, Douglas; Mahood, James; Moreau, Marc; Southon, Sarah; Lou, Edmond			Factors influencing spinal curvature measurements on ultrasound images for children with adolescent idiopathic scoliosis (AIS)	PLOS ONE			English	Article							VERTEBRAL ROTATION; PREVIOUS RADIOGRAPHS; CORONAL CURVATURE; RELIABILITY; ACCURACY; VALIDITY; SYSTEM	The measurements of spinal curvatures using the ultrasound (US) imaging method on children with scoliosis have been comparable with radiography. However, factors influencing the reliability and accuracy of US measurement have not been studied. The purpose of this study is to investigate the effects of curve features and patients' demographics on US measurements and to determine which factors influence the reliability and accuracy. Two hundred children with scoliosis were recruited and scanned with US by one experienced operator and three trainees. One experienced rater measured the proxy Cobb angles from US images twice one week apart and compared the results with clinical radiographic records. The correlation and accuracy between the US and radiographic measurements were subdivided by different curve severities, curve types, subjects' weight status and US acquisition experiences. A total of 326 and 313 curves were recognized from radiographs and US images, respectively. The mean Cobb angles of the 13 missing curves were 17.4 +/- 7.4 degrees and 11 at the thoracic region. Among the 16 curves showing large discrepancy (>= 6 degrees) between US and radiographic measurements, 7 were main thoracic and 6 were lumbar curves. Twelve had axial vertebral rotation (AVR) greater than 8 degrees. The US scans performed by the experienced operator showed fewer large discrepancy curves, smaller difference and higher correlation than the scans from the trainees (3%, 1.7 +/- 1.5 degrees, 0.95 vs 6%, 2.4 +/- 1.8 degrees, 0.90). Only 4% missing and 5% large discrepancy curves were demonstrated for US measurements in comparison to radiography. The missing curves were mainly caused by small severity and in the upper spinal region. There was a higher chance of the large discrepancy curves in the main thoracic and lumbar regions with AVR>8 degrees. A skilled operator acquired better US images and led to more accurate measurements especially for those subjects with larger curvatures, AVR and body mass index (BMI).	[Zheng, Rui] ShanghaiTech Univ, Sch Informat Sci & Technol, Shanghai, Peoples R China; [Hill, Doug; Hedden, Douglas; Mahood, James; Moreau, Marc; Southon, Sarah; Lou, Edmond] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Lou, Edmond] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada	ShanghaiTech University; University of Alberta; University of Alberta	Lou, E (corresponding author), Univ Alberta, Dept Surg, Edmonton, AB, Canada.; Lou, E (corresponding author), Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada.	elou@ualbert.ca		Lou, Edmond/0000-0002-7531-8377	Edmonton Orthopedic Research Committee, Division of Orthopedic Surgery, University of Alberta [RES0023645]	Edmonton Orthopedic Research Committee, Division of Orthopedic Surgery, University of Alberta	This research was supported by Edmonton Orthopedic Research Committee, Division of Orthopedic Surgery, University of Alberta (RES0023645 to EL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brink RC, 2018, SPINE J, V18, P979, DOI 10.1016/j.spinee.2017.10.012; Burwell R G, 2002, Stud Health Technol Inform, V91, P262; Burwell R G, 2002, Stud Health Technol Inform, V91, P246; Chen W., 2012, OPEN J ACOUST, V2, P95, DOI DOI 10.4236/OJA.2012.23011; Chen W, 2016, EUR SPINE J, V25, P3265, DOI 10.1007/s00586-016-4492-6; Chen W, 2013, J CHILD ORTHOP, V7, P521, DOI 10.1007/s11832-013-0539-y; Cheung CWJ, 2015, IEEE T MED IMAGING, V34, P1760, DOI 10.1109/TMI.2015.2390233; Cheung CWJ, 2013, IEEE ENG MED BIO, P6474, DOI 10.1109/EMBC.2013.6611037; Cheung CWJ, 2010, IFMBE PROC, V31, P584, DOI 10.1007/978-3-642-14515-5_149; Cobb J., 1948, AM ACADEMY ORTHOPAED, V5, P261; Currier D, 1990, ELEMENTS RES PHYS TH; Ilharreborde B, 2013, EUR SPINE J, V22, P2382, DOI 10.1007/s00586-013-2776-7; MORRISSY RT, 1990, J BONE JOINT SURG AM, V72A, P320, DOI 10.2106/00004623-199072030-00002; Standring S, 2005, GRAYS ANATOMY ANATOM, V39th; SUZUKI S, 1989, J BONE JOINT SURG BR, V71, P252, DOI 10.1302/0301-620X.71B2.2647754; Ungi T, 2014, ULTRASOUND MED BIOL, V40, P447, DOI 10.1016/j.ultrasmedbio.2013.09.021; Van Goethem J, 2007, NEUROIMAG CLIN N AM, V17, P105, DOI 10.1016/j.nic.2006.12.001; Vo QN, 2015, SCOLIOSIS SPINAL DIS, V10, DOI 10.1186/1748-7161-10-S2-S7; Wang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135264; Wang Q, 2016, ULTRASOUND MED BIOL, V42, P1473, DOI 10.1016/j.ultrasmedbio.2016.02.011; Webb Andrew G, 2003, INTRO BIOMEDICAL IMA; Young M, 2015, EUR SPINE J, V24, P1427, DOI 10.1007/s00586-015-3855-8; Zheng R, 2018, EUR SPINE J, V27, P2114, DOI 10.1007/s00586-017-5457-0; Zheng R, 2017, ULTRASOUND MED BIOL, V43, P934, DOI 10.1016/j.ultrasmedbio.2017.01.017; Zheng R, 2016, SPINE, V41, P404, DOI 10.1097/BRS.0000000000001244; Zheng Rui, 2015, Spine Deform, V3, P151, DOI 10.1016/j.jspd.2014.08.008; Zheng YP, 2016, SCOLIOSIS SPINAL DIS, V11, DOI 10.1186/s13013-016-0074-y	28	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198792	10.1371/journal.pone.0198792	http://dx.doi.org/10.1371/journal.pone.0198792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912905	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600047
J	Zhao, CW; Daley, MJ; Pruszynski, JA				Zhao, Charlie W.; Daley, Mark J.; Pruszynski, J. Andrew			Neural network models of the tactile system develop first-order units with spatially complex receptive fields	PLOS ONE			English	Article							SOMATOSENSORY CORTEX; REPRESENTATION; ORIENTATION; HAND; MECHANORECEPTORS; DISCRIMINATION; RECOGNITION; MECHANISMS; PATTERNS; ENDINGS	First-order tactile neurons have spatially complex receptive fields. Here we use machine-learning tools to show that such complexity arises for a wide range of training sets and network architectures. Moreover, we demonstrate that this complexity benefits network performance, especially on more difficult tasks and in the presence of noise. Our work suggests that spatially complex receptive fields are normatively good given the biological constraints of the tactile periphery.	[Zhao, Charlie W.; Daley, Mark J.; Pruszynski, J. Andrew] Western Univ, Dept Comp Sci, London, ON, Canada; [Zhao, Charlie W.] Yale Univ, Sch Med, New Haven, CT USA; [Daley, Mark J.] Western Univ, Dept Biol, London, ON, Canada; [Daley, Mark J.] Western Univ, Dept Actuarial Sci & Stat, London, ON, Canada; [Daley, Mark J.] Vector Inst, London, ON, Canada; [Daley, Mark J.; Pruszynski, J. Andrew] Western Univ, Brain & Mind Inst, London, ON, Canada; [Pruszynski, J. Andrew] Western Univ, Dept Physiol & Pharmacol, London, ON, Canada; [Pruszynski, J. Andrew] Western Univ, Dept Psychol, London, ON, Canada; [Pruszynski, J. Andrew] Western Univ, Roberts Res Inst, London, ON, Canada; [Pruszynski, J. Andrew] Umea Univ, Dept Integrat Med Biol, Umea, Sweden	Western University (University of Western Ontario); Yale University; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Umea University	Pruszynski, JA (corresponding author), Western Univ, Dept Comp Sci, London, ON, Canada.; Pruszynski, JA (corresponding author), Western Univ, Brain & Mind Inst, London, ON, Canada.; Pruszynski, JA (corresponding author), Western Univ, Dept Physiol & Pharmacol, London, ON, Canada.; Pruszynski, JA (corresponding author), Western Univ, Dept Psychol, London, ON, Canada.; Pruszynski, JA (corresponding author), Western Univ, Roberts Res Inst, London, ON, Canada.; Pruszynski, JA (corresponding author), Umea Univ, Dept Integrat Med Biol, Umea, Sweden.	andrew.pruszynski@uwo.ca	Pruszynski, J. Andrew/E-4522-2011; Daley, Mark/AAS-7366-2020	Pruszynski, J. Andrew/0000-0003-0786-0081; Daley, Mark/0000-0002-6939-9772; Zhao, Charlie Weige/0000-0002-8670-0985	Canadian Institutes of Health Research [3531979]; Natural Science and Engineering Research Council of Canada; Canada Research Chairs Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs Program(Canada Research Chairs)	This work was supported by the Canadian Institutes of Health Research (Foundation Grant to JAP: 3531979) and the Natural Science and Engineering Research Council of Canada (Discovery Grant to MJD). JAP received a salary award from the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Canadian Institutes of Health Research (Foundation Grant to JAP: 3531979) and the Natural Science and Engineering Research Council of Canada (Discovery Grant to MJD). JAP received a salary award from the Canada Research Chairs Program.	Bensmaia SJ, 2008, J NEUROSCI, V28, P776, DOI 10.1523/JNEUROSCI.4162-07.2008; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2008, CR MATH, V346, P589, DOI 10.1016/j.crma.2008.03.014; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; CAUNA N, 1959, J COMP NEUROL, V113, P169, DOI 10.1002/cne.901130202; CAUNA N, 1956, AM J ANAT, V99, P315, DOI 10.1002/aja.1000990206; Dodson MJ, 1998, J NEUROSCI, V18, P521; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Fitzgerald PJ, 2006, J NEUROSCI, V26, P6473, DOI 10.1523/JNEUROSCI.5057-05.2006; Friedman RM, 2002, J NEUROSCI, V22, P9556; JOHANSSON RS, 1978, J PHYSIOL-LONDON, V281, P101, DOI 10.1113/jphysiol.1978.sp012411; JOHNSON KO, 1981, J NEUROPHYSIOL, V46, P1177, DOI 10.1152/jn.1981.46.6.1177; JOHNSON KO, 1981, J PHYSIOL-LONDON, V310, P117, DOI 10.1113/jphysiol.1981.sp013540; Lemme A, EFFICIENT ONLINE LEA; Nolano M, 2003, ANN NEUROL, V54, P197, DOI 10.1002/ana.10615; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; PETER G, 1986, J APPL PHYSIOL, V60, P1107, DOI 10.1152/jappl.1986.60.4.1107; PHILLIPS JR, 1990, EXP BRAIN RES, V81, P589, DOI 10.1007/BF02423508; PHILLIPS JR, 1988, P NATL ACAD SCI USA, V85, P1317, DOI 10.1073/pnas.85.4.1317; Pruszynski JA, 2018, ELIFE, V7, DOI 10.7554/eLife.31200; Pruszynski JA, 2016, CURR BIOL, V26, P788, DOI 10.1016/j.cub.2016.01.027; Pruszynski JA, 2014, NAT NEUROSCI, V17, P1404, DOI 10.1038/nn.3804; Saal HP, 2017, P NATL ACAD SCI USA, V114, pE5693, DOI 10.1073/pnas.1704856114; Tong J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00579; VEGABERMUDEZ F, 1991, J NEUROPHYSIOL, V65, P531, DOI 10.1152/jn.1991.65.3.531; WHEAT HE, 1995, J NEUROSCI, V15, P5582; Yamins DLK, 2014, P NATL ACAD SCI USA, V111, P8619, DOI 10.1073/pnas.1403112111; Yau JM, 2009, P NATL ACAD SCI USA, V106, P16457, DOI 10.1073/pnas.0904186106	28	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199196	10.1371/journal.pone.0199196	http://dx.doi.org/10.1371/journal.pone.0199196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902277	gold, Green Published, Green Submitted			2022-12-26	WOS:000435424900098
J	Vassilakos, G; Lei, HQ; Yang, Y; Puglise, J; Matheny, M; Durzynska, J; Ozery, M; Bennett, K; Spradlin, R; Bonanno, H; Park, S; Ahima, RS; Barton, ER				Vassilakos, Georgios; Lei, Hanqin; Yang, Yun; Puglise, Jason; Matheny, Michael; Durzynska, Julia; Ozery, Matan; Bennett, Katherine; Spradlin, Ray; Bonanno, Heather; Park, Soohyun; Ahima, Rexford S.; Barton, Elisabeth R.			Deletion of muscle IGF-I transiently impairs growth and progressively disrupts glucose homeostasis in male mice	FASEB JOURNAL			English	Article						exercise intolerance; diabetes; force generation	SKELETAL-MUSCLE; INSULIN-RESISTANCE; VIRAL EXPRESSION; BODY GROWTH; HYPERTROPHY; INACTIVATION; RECEPTORS; HORMONE; METABOLISM; ACTIVATION	Insulin-like growth factors (IGFs) are essential for local skeletal muscle growth and organismal physiology, but these actions are entwined with glucose homeostasis through convergence with insulin signaling. The objective of this work was to determine whether the effects of IGF-I on growth and metabolism could be separated. We generated muscle-specific IGF-I-deficient (MID) mice that afford inducible deletion of Igf1 at any age. After Igf1 deletion at birth or in young adult mice, evaluations of muscle physiology and glucose homeostasis were performed up to 16 wk of age. MID mice generated at birth had lower muscle and circulating IGF-I, decreased muscle and body mass, and impaired muscle force production. Eight-wk-old male MID had heightened insulin levels with trends of elevated fasting glucose. This phenotype progressed to impaired glucose handling and increased fat deposition without significant muscle mass loss at 16 wk of age. The same phenotype emerged in 16-wk-old MID mice induced at 12 wk of age, compounded with heightened muscle fatigability and exercise intolerance. We assert that muscle IGF-I independently modulates anabolism and metabolism in an age-dependent manner, thus positioning muscle IGF-I maintenance to be critical for both muscle growth and metabolic homeostasis.Vassilakos, G., Lei, H., Yang, Y., Puglise, J., Matheny, M., Durzynska, J., Ozery, M., Bennett, K., Spradlin, R., Bonanno, H., Park, S., Ahima, R. S., Barton, E. R. Deletion of muscle IGF-I transiently impairs growth and progressively disrupts glucose homeostasis in male mice.	[Vassilakos, Georgios; Lei, Hanqin; Puglise, Jason; Durzynska, Julia; Ozery, Matan; Bennett, Katherine; Spradlin, Ray; Barton, Elisabeth R.] Univ Florida, Coll Hlth & Human Performance, Appl Physiol & Kinesiol, Canc & Genet Res Complex,1864 Stadium Rd,124 FLG, Gainesville, FL 32611 USA; [Yang, Yun; Matheny, Michael; Barton, Elisabeth R.] Univ Florida, Coll Med, Pharmacol & Therapeut, Canc & Genetics Res Complex, Gainesville, FL USA; [Bonanno, Heather] Univ Florida, Anim Care Serv, Canc & Genetics Res Complex, Gainesville, FL USA; [Yang, Yun] Sichuan Univ, West China Hosp, West China Sch Med, Gastrointestinal Surg, Chengdu, Sichuan, Peoples R China; [Durzynska, Julia] Adam Mickiewicz Univ, Inst Expt Biol, Mol Virol, Poznan, Poland; [Park, Soohyun] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Houston, TX 77030 USA; [Ahima, Rexford S.] Johns Hopkins Univ, Div Endocrinol Diabet & Metab, Baltimore, MD USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Sichuan University; Adam Mickiewicz University; University of Texas System; University of Texas Health Science Center Houston; Johns Hopkins University	Barton, ER (corresponding author), Univ Florida, Coll Hlth & Human Performance, Appl Physiol & Kinesiol, Canc & Genet Res Complex,1864 Stadium Rd,124 FLG, Gainesville, FL 32611 USA.	erbarton@ufl.edu	Ahima, Rexford/W-1394-2019; Durzyńska, Julia/ABB-1942-2020	Durzyńska, Julia/0000-0002-8767-3755; park, soohyun/0000-0001-9847-9985	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [P30-DK19525]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR057363, AR052646]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the Penn Mouse Phenotyping, Physiology and Metabolism (MPPM) Core (Philadelphia, PA, USA) for treadmill exercise testing and Insmed, Inc. (Monmouth Junction, NJ, USA) for providing mecasermin rinfabate (Iplex). The research was supported, in part, by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant P30-DK19525; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR057363 (to E.R.B.) and AR052646 to the Physiological Assessment Core of the Paul D. Wellstone Muscular Dystrophy Cooperative Research Center. The authors declare no conflicts of interest.	Adams GR, 1998, J APPL PHYSIOL, V84, P1716, DOI 10.1152/jappl.1998.84.5.1716; Ashpole NM, 2017, GEROSCIENCE, V39, P129, DOI 10.1007/s11357-017-9971-0; Bailyes EM, 1997, BIOCHEM J, V327, P209, DOI 10.1042/bj3270209; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Barton ER, 2006, APPL PHYSIOL NUTR ME, V31, P791, DOI 10.1139/h06-054; Barton ER, 2012, FASEB J, V26, P3691, DOI 10.1096/fj.11-203026; Barton ER, 2006, J APPL PHYSIOL, V100, P1778, DOI 10.1152/japplphysiol.01405.2005; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Barton-Davis ER, 1999, ACTA PHYSIOL SCAND, V167, P301; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; BRISMAR K, 1994, J CLIN ENDOCR METAB, V79, P872, DOI 10.1210/jc.79.3.872; Cheng CM, 2000, P NATL ACAD SCI USA, V97, P10236, DOI 10.1073/pnas.170008497; Clemmons DR, 2012, ENDOCRIN METAB CLIN, V41, P425, DOI 10.1016/j.ecl.2012.04.017; Clemmons DR, 2004, HORM RES, V62, P77, DOI 10.1159/000080763; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; Durzynska J, 2013, ENDOCRINOLOGY, V154, P1215, DOI 10.1210/en.2012-1992; Entingh-Pearsall A, 2016, J BIOL CHEM, V291, P22339, DOI 10.1074/jbc.A116.313201; Federici M, 1998, J CLIN ENDOCR METAB, V83, P2911, DOI 10.1210/jc.83.8.2911; Fernandez AM, 2002, J CLIN INVEST, V109, P347, DOI 10.1172/JCI200213503; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; KLIP A, 1990, DIABETES CARE, V13, P228, DOI 10.2337/diacare.13.3.228; Laron Z, 2001, J CLIN PATHOL-MOL PA, V54, P311; Lee S, 2004, J APPL PHYSIOL, V96, P1097, DOI 10.1152/japplphysiol.00479.2003; Liu JL, 1998, MOL ENDOCRINOL, V12, P1452, DOI 10.1210/me.12.9.1452; Lu YR, 2004, DIABETES, V53, P3131, DOI 10.2337/diabetes.53.12.3131; Lui JC, 2008, AM J PHYSIOL-REG I, V295, pR189, DOI 10.1152/ajpregu.00182.2008; Mavalli MD, 2010, J CLIN INVEST, V120, P4007, DOI 10.1172/JCI42447; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Moorwood C, 2013, JOVE-J VIS EXP, DOI 10.3791/50036; Morissette MR, 2009, AM J PHYSIOL-CELL PH, V297, pC1124, DOI 10.1152/ajpcell.00043.2009; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nakamura A, 2015, REGEN THER, V2, P49, DOI 10.1016/j.reth.2015.11.001; NIELSEN JH, 1989, MOL ENDOCRINOL, V3, P165, DOI 10.1210/mend-3-1-165; Ning Y, 2006, MOL ENDOCRINOL, V20, P2173, DOI 10.1210/me.2005-0196; O'Neill BT, 2016, J CLIN INVEST, V126, P3433, DOI 10.1172/JCI86522; O'Neill BT, 2015, CELL REP, V11, P1220, DOI 10.1016/j.celrep.2015.04.037; Rao PC, 2009, DEV NEUROBIOL, V69, P401, DOI 10.1002/dneu.20714; Rehfeldt C, 2010, AM J PHYSIOL-ENDOC M, V299, pE287, DOI 10.1152/ajpendo.00492.2009; Saengsirisuwan V, 2009, METABOLISM, V58, P38, DOI 10.1016/j.metabol.2008.08.004; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Sheffield-Moore M, 2004, TRENDS ENDOCRIN MET, V15, P110, DOI 10.1016/j.tem.2004.02.009; Shi J, 2011, DEV CELL, V21, P835, DOI 10.1016/j.devcel.2011.09.011; Siddle Kenneth, 2012, Front Endocrinol (Lausanne), V3, P34, DOI 10.3389/fendo.2012.00034; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Sjogren K, 2001, DIABETES, V50, P1539, DOI 10.2337/diabetes.50.7.1539; Slaaby R, 2015, SCI REP-UK, V5, DOI 10.1038/srep07911; Smith LR, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-21; Spangenburg EE, 2012, MED SCI SPORT EXER, V44, P1653, DOI 10.1249/MSS.0b013e31825871fa; Stevens-Lapsley JE, 2010, AM J PHYSIOL-ENDOC M, V299, pE730, DOI 10.1152/ajpendo.00230.2010; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Wilcox Gisela, 2005, Clin Biochem Rev, V26, P19; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Zhao AZ, 1997, P NATL ACAD SCI USA, V94, P3223, DOI 10.1073/pnas.94.7.3223	57	19	20	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					181	194		10.1096/fj.201800459R	http://dx.doi.org/10.1096/fj.201800459R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29932867	Green Published			2022-12-26	WOS:000457401500015
J	Jain, P; Sethi, SC; Pratyusha, VA; Garai, P; Naqvi, N; Sing, S; Pawar, K; Puri, N; Komath, SS				Jain, Priyanka; Sethi, Subhash Chandra; Pratyusha, Vavilala A.; Garai, Pramita; Naqvi, Nilofer; Sing, Sonali; Pawar, Kalpana; Puri, Niti; Komath, Sneha Sudha			Ras signaling activates glycosylphosphatidylinositol (GPI) anchor biosynthesis via the GPI-N-acetylglucosaminyltransferase (GPI-GnT) in Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Candida albicans; glycosylphosphatidylinositol (GPI anchor); macrophage; endoplasmic reticulum (ER); Saccharomyces cerevisiae; phagocytosis; plasma membrane; p38 MAPK; CaGpi2; GPI anchor biosynthesis pathway; hyphal morphogenesis; macrophage-mediated killing; Ras signaling	SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; INITIAL ENZYME; 1ST STEP; PIG-P; ERGOSTEROL BIOSYNTHESIS; MAMMALIAN-CELLS; 4TH MANNOSE; YEAST RAS; PROTEIN	The ability of Candida albicans to switch between yeast to hyphal form is a property that is primarily associated with the invasion and virulence of this human pathogenic fungus. Several glycosylphosphatidylinositol (GPI)-anchored proteins are expressed only during hyphal morphogenesis. One of the major pathways that controls hyphal morphogenesis is the Ras-signaling pathway. We examine the cross-talk between GPI anchor biosynthesis and Ras signaling in C. albicans. We show that the first step of GPI biosynthesis is activated by Ras in C. albicans. This is diametrically opposite to what is reported in Saccharomyces cerevisiae. Of the two C. albicans Ras proteins, CaRas1 alone activates GPI-GnT activity; activity is further stimulated by constitutively activated CaRas1. CaRas1 localized to the cytoplasm or endoplasmic reticulum (ER) is sufficient for GPI-GnT activation. Of the six subunits of the GPI-N-acetylglucosaminyltransferase (GPI-GnT) that catalyze the first step of GPI biosynthesis, CaGpi2 is the key player involved in activating Ras signaling and hyphal morphogenesis. Activation of Ras signaling is independent of the catalytic competence of GPI-GnT. This too is unlike what is observed in S. cerevisiae where multiple subunits were identified as inhibiting Ras2. Fluorescence resonance energy transfer (FRET) studies indicate a specific physical interaction between CaRas1 and CaGpi2 in the ER, which would explain the ability of CaRas1 to activate GPI-GnT. CaGpi2, in turn, promotes activation of the Ras-signaling pathway and hyphal morphogenesis. The Cagpi2 mutant is also more susceptible to macrophage-mediated killing, and macrophage cells show better survival when co-cultured with Cagpi2.	[Jain, Priyanka; Sethi, Subhash Chandra; Pratyusha, Vavilala A.; Garai, Pramita; Naqvi, Nilofer; Sing, Sonali; Pawar, Kalpana; Puri, Niti; Komath, Sneha Sudha] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Komath, SS (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	sskomath@mail.jnu.ac.in	Pratyusha, Vavilala/AAE-6436-2021; KOMATH, SNEHA SUDHA/AAE-6359-2020	KOMATH, SNEHA SUDHA/0000-0002-0491-7102; GARAI, PRAMITA/0000-0001-7936-8921; pawar, Kalpana/0000-0002-5369-9121; Pratyusha, Vavilala/0000-0002-2048-5047	Council of Scientific and Industrial Research; University Grants Commission, India; Department of Biotechnology (DBT); DBT India [BT/PR3749/BRB/10/986/2011]; Department of Science and Technology (DST) India [SB/SO/BB-011/2014]; DST under Promotion of University Research and Scientific Excellence Grant DST-PURSE [SR/PURSE/PHASE 2/11 (C)]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, India(University Grants Commission, India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); DBT India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST) India(Department of Science & Technology (India)); DST under Promotion of University Research and Scientific Excellence Grant DST-PURSE	Supported by Senior and Junior Research Fellowships from the Council of Scientific and Industrial Research and University Grants Commission, India.; Recipient of salary through a Department of Biotechnology (DBT)-funded research grant of S. S. K.; Recipient of funding from DBT India Grant BT/PR3749/BRB/10/986/2011, Department of Science and Technology (DST) India Grant SB/SO/BB-011/2014, and an umbrella grant to the School of Life Sciences from the DST under Promotion of University Research and Scientific Excellence Grant DST-PURSE No. SR/PURSE/PHASE 2/11 (C).	Ahmad MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035305; Ashraf M, 2011, J BIOL CHEM, V286, P2543, DOI 10.1074/jbc.C110.178343; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Care RS, 1999, MOL MICROBIOL, V34, P792, DOI 10.1046/j.1365-2958.1999.01641.x; Castillon GA, 2011, MOL BIOL CELL, V22, P2924, DOI 10.1091/mbc.E11-04-0294; Diezmann S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002562; Feng QH, 1999, J BACTERIOL, V181, P6339, DOI 10.1128/JB.181.20.6339-6346.1999; Gerami-Nejad M, 2004, YEAST, V21, P429, DOI 10.1002/yea.1080; Grimme SJ, 2001, J BIOL CHEM, V276, P27731, DOI 10.1074/jbc.M101986200; Heilmann CJ, 2011, MICROBIOL-SGM, V157, P2297, DOI 10.1099/mic.0.049395-0; Hohn C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004314; Hong YJ, 1999, J BIOL CHEM, V274, P35099, DOI 10.1074/jbc.274.49.35099; Ihara S, 2017, J CELL SCI, V130, P602, DOI 10.1242/jcs.196717; Ikeda A, 2016, YEAST, V33, P37, DOI 10.1002/yea.3138; Inglis DO, 2013, EUKARYOT CELL, V12, P1316, DOI 10.1128/EC.00094-13; Kajiwara K, 2008, MOL BIOL CELL, V19, P2069, DOI 10.1091/mbc.E07-08-0740; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; Leberer E, 2001, MOL MICROBIOL, V42, P673, DOI 10.1046/j.1365-2958.2001.02672.x; Maeda Y, 1998, EMBO J, V17, P4920, DOI 10.1093/emboj/17.17.4920; Martinez-Lopez R, 2004, MICROBIOL-SGM, V150, P3341, DOI 10.1099/mic.0.27320-0; Murakami Y, 2005, MOL BIOL CELL, V16, P5236, DOI 10.1091/mbc.E05-08-0743; Newman HA, 2005, EUKARYOT CELL, V4, P1801, DOI 10.1128/EC.4.11.1801-1807.2005; Nobile CJ, 2012, CELL, V148, P126, DOI 10.1016/j.cell.2011.10.048; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Phan VT, 2010, MOL CELL BIOL, V30, P2264, DOI 10.1128/MCB.01450-08; Piispanen AE, 2013, MOL MICROBIOL, V89, P166, DOI 10.1111/mmi.12268; Piispanen AE, 2011, EUKARYOT CELL, V10, P1473, DOI 10.1128/EC.05153-11; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Pratyusha VA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23187-8; Richard M, 2002, MOL MICROBIOL, V44, P841, DOI 10.1046/j.1365-2958.2002.02926.x; Richard ML, 2007, EUKARYOT CELL, V6, P119, DOI 10.1128/EC.00297-06; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shapiro RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044734; Sobering AK, 2004, CELL, V117, P637, DOI 10.1016/j.cell.2004.05.003; Sobering AK, 2003, MOL CELL BIOL, V23, P4983, DOI 10.1128/MCB.23.14.4983-4990.2003; Taron BW, 2004, J BIOL CHEM, V279, P36083, DOI 10.1074/jbc.M405081200; Uppuluri P, 2009, FUTURE MICROBIOL, V4, P1235, DOI 10.2217/FMB.09.85; Victoria GS, 2012, BIOCHEM J, V443, P619, DOI 10.1042/BJ20120143; Victoria GS, 2010, MICROBIOL-SGM, V156, P3041, DOI 10.1099/mic.0.039628-0; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Watanabe R, 2000, EMBO J, V19, P4402, DOI 10.1093/emboj/19.16.4402; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Yadav A, 2014, GLYCOCONJUGATE J, V31, P497, DOI 10.1007/s10719-014-9536-8; Yadav B, 2014, J BIOL CHEM, V289, P3365, DOI 10.1074/jbc.M113.528802; Zhao RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009934; Zhu Y, 2009, MOL MICROBIOL, V74, P862, DOI 10.1111/j.1365-2958.2009.06898.x	49	10	11	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12222	12238		10.1074/jbc.RA117.001225	http://dx.doi.org/10.1074/jbc.RA117.001225			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29907567	Green Published, hybrid			2022-12-26	WOS:000440803200020
J	Nafade, V; Nash, M; Huddart, S; Pande, T; Gebreselassie, N; Lienhardt, C; Pai, M				Nafade, Vaidehi; Nash, Madlen; Huddart, Sophie; Pande, Tripti; Gebreselassie, Nebiat; Lienhardt, Christian; Pai, Madhukar			A bibliometric analysis of tuberculosis research, 2007-2016	PLOS ONE			English	Article							PUBLICATIONS	Background Tuberculosis (TB) research is a key component of the End TB Strategy. To track research output, we conducted a bibliometric analysis of TB research from the past decade. Methods The Web of Science database was searched for publications from January 2007 to December 2016 with "tuberculosis" in the title. References were analysed using the R bibliometrix package. A year-stratified 5% random subset was drawn to extract funding sources and identify research areas. Findings The annual growth rate of publications was 7.3%, and was highest (13.1%) among Brazil, Russia, India, China and South Africa (BRICS). The USA was the most productive country, with 18.4% of references, followed by India (9.7%), China (7.3%), England (6.5%), and South Africa (3.9%). In the subset analysis, the most common research area was 'fundamental research' (33.8%). Frequently acknowledged funders were US and EU-based, with China and India emerging as top funders. Collaborations appeared more frequently between high-income countries and low/medium income countries (LMICs), with fewer collaborations among LMICs. Conclusion The past decade has seen a continued increase in TB publications. While USA continues to dominate research output and funding, BRICS countries have emerged as major research producers and funders. Collaborations among BRICS would enhance future TB research productivity.	[Nafade, Vaidehi; Nash, Madlen; Huddart, Sophie; Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Nafade, Vaidehi; Nash, Madlen; Huddart, Sophie; Pande, Tripti; Pai, Madhukar] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada; [Gebreselassie, Nebiat; Lienhardt, Christian] WHO, Global TB Programme, Geneva, Switzerland	McGill University; McGill University; World Health Organization	Pai, M (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Pai, M (corresponding author), McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada.	madhikar.pai@mcgill.ca	Lienhardt, Christian/AAU-4969-2021; PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021; Huddart, Sophie/AAF-8844-2020	Lienhardt, Christian/0000-0003-0233-893X; PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Huddart, Sophie/0000-0001-6425-3371; Gebreselassie, Nebiat/0000-0002-8795-7483	World Health Organization (WHO)	World Health Organization (WHO)(World Health Organization)	This study was commissioned and funded by the World Health Organization (WHO) and WHO staff were involved in conceptualization and supervision of the project. This analysis was originally prepared as part of a policy paper released at the WHO global ministerial conference on ending tuberculosis in the sustainable development era, held in Moscow, Russia, in November 2017.	Aria M, 2017, J INFORMETR, V11, P959, DOI 10.1016/j.joi.2017.08.007; Badenhorst A, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010504; Bai J, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0182-1; Chen LM, 2015, INT J TUBERC LUNG D, V19, P717, DOI 10.5588/ijtld.14.0925; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Frick M., 2017, 2016 REPORT TUBERCUL; Fullman N, 2017, LANCET, V390, P1423, DOI 10.1016/S0140-6736(17)32336-X; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Glynn RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013902; Gupta BM, 2011, COLLNET J SCIENTOMET, V5, P33, DOI 10.1080/09737766.2011.10700901; Michalopoulos A, 2005, CHEST, V128, P3993, DOI 10.1378/chest.128.6.3993; Ramos JM, 2008, INT J TUBERC LUNG D, V12, P1461; Soteriades ES, 2006, BMC PUBLIC HLTH, V6; Sumathipala Athula, 2004, BMC Med Ethics, V5, pE5; Sweileh WM, 2017, MULTIDISCIP RESP MED, V11, DOI 10.1186/s40248-016-0081-0; Wang YG, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004250; WHO, 2011, INT ROADM TUB RES; WHO, 2017, GLOB TUB REP 2017; World Health Organization, 2014, 67 WORLD HLTH ASS 20; Ye H, 2017, BIOMED RES-INDIA, V28, P3322; Zhang YG, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000004822, 10.1097/md.0000000000004822]	21	45	47	8	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199706	10.1371/journal.pone.0199706	http://dx.doi.org/10.1371/journal.pone.0199706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940004	Green Published, Green Submitted, gold			2022-12-26	WOS:000436088700036
J	Torra, J; Recasens, J; Royo-Esnal, A				Torra, Joel; Recasens, Jordi; Royo-Esnal, Aritz			Seedling emergence response of rare arable plants to soil tillage varies by species	PLOS ONE			English	Article							CEREAL FIELDS; AGRICULTURAL INTENSIFICATION; GERMINATION; CONSERVATION; LIGHT; WEEDS; DIVERSITY; MANAGEMENT; OPTIONS; SYSTEMS	Very little information is available on emergence of rare arable plants (RAP) in relation to soil disturbance and seed burial conditions in Europe. This information is essential to design conservation and soil management strategies to prevent the decline of these species in agroecosystems. The objective of this research was to investigate the effect of soil cultivation with burial time on the emergence and seed persistence of RAP. Seeds of 30 RAP species were collected from Spanish arable fields and subjected to two tillage treatments: (a) no soil disturbance, and (b) autumnal soil disturbance down to 10 cm depth every year. The treatments simulated no-till and tilled (disking), respectively. In plots under no-till, RAP seeds were sown at 1-cm depth. In the tilled plots, seeds were sown homogeneously mixed in the top 1-10 cm of soil. The trial was established every two consecutive seasons, and each trial was maintained for two years. Annual cumulative plant emergence was calculated each year; whereas the first trial was monitored for a third year to estimate seed longevity using a persistence index. The response in emergence of the 30 RAP to annual tillage varied among species. With burial time (number of years), higher emergence was observed for seeds sown in tilled soil. This was true across all species, and with strong season effects. The persistence index was correlated with seed weight, species with bigger seeds had low persistence indices while no pattern was observed for small seeded species. Most RAP species, particularly those with high persistence, showed induction of secondary dormancy processes, highlighting the importance of tillage to promote RAP emergence, and hence, seed bank replenishment. Therefore, as time passes the absence of soil tillage may represent a driver of RAP seed bank decline for those species with secondary dormancy processes. In conclusion, it is important to design soil management strategies, such as regular tillage to promote emergence, on a species basis to preserve RAP in Europe.	[Torra, Joel; Recasens, Jordi; Royo-Esnal, Aritz] Univ Lleida, Agrotecnio, ETSEA, Grp Malherbol & Ecol Vegetal,Dept HBJ, Lleida, Spain	Universitat de Lleida	Torra, J (corresponding author), Univ Lleida, Agrotecnio, ETSEA, Grp Malherbol & Ecol Vegetal,Dept HBJ, Lleida, Spain.	joel@hbj.udl.cat	Torra, Joel/B-3959-2011; Recasens, Jordi/B-3970-2011; Royo-Esnal, Aritz/B-4174-2011	Torra, Joel/0000-0002-8666-6780; Recasens, Jordi/0000-0002-8799-9958; Royo-Esnal, Aritz/0000-0003-2534-8372	Ministerio de Educacion y Ciencia de Espana [AGL2007-60828, AGL2010- 22084-C02-01]	Ministerio de Educacion y Ciencia de Espana(Spanish Government)	This work was supported by the Ministerio de Educacion y Ciencia de Espana (AGL2007-60828 and AGL2010- 22084-C02-01).	Albrecht H, 2016, BOT LETT, V163, P389, DOI 10.1080/23818107.2016.1237886; Baraibar B, 2017, WEED SCI, V65, P515, DOI 10.1614/WS-D-16-00031.1; Baraibar B, 2011, APPL SOIL ECOL, V51, P60, DOI 10.1016/j.apsoil.2011.08.012; Batlla D, 2007, ANN BOT-LONDON, V99, P915, DOI 10.1093/aob/mcm029; Batlla D, 2014, WEED BIOL MANAG, V14, P77, DOI 10.1111/wbm.12039; Borza JK, 2007, WEED TECHNOL, V21, P518, DOI 10.1614/WT-06-110; Botto JF, 2000, AUST J PLANT PHYSIOL, V27, P463; Cirujeda A, 2011, AGRON SUSTAIN DEV, V31, P675, DOI 10.1007/s13593-011-0030-4; Colbach N, 2005, WEED RES, V45, P2, DOI 10.1111/j.1365-3180.2004.00428.x; Dorado J, 1999, WEED SCI, V47, P67, DOI 10.1017/S0043174500090676; Fried G, 2009, BIOL CONSERV, V142, P238, DOI 10.1016/j.biocon.2008.09.029; Gaba S, 2017, WEED RES, V57, P123, DOI 10.1111/wre.12245; Guillemin JP, 2013, WEED RES, V53, P76, DOI 10.1111/wre.12000; Plaza EH, 2011, AGR ECOSYST ENVIRON, V140, P102, DOI 10.1016/j.agee.2010.11.016; Hyvonen T, 2002, PLANT ECOL, V159, P73, DOI 10.1023/A:1015580722191; Lal R., 2004, SOILS PLANTS ENV; Longas MM, 2016, WEED RES, V56, P462, DOI 10.1111/wre.12229; Marshall EJP, 2003, WEED RES, V43, P77, DOI 10.1046/j.1365-3180.2003.00326.x; Milberg P, 2000, SEED SCI RES, V10, P99, DOI 10.1017/S0960258500000118; Morris NL, 2010, SOIL TILL RES, V108, P1, DOI 10.1016/j.still.2010.03.004; Nichols V, 2015, FIELD CROP RES, V183, P56, DOI 10.1016/j.fcr.2015.07.012; Noronha A, 1997, ANN BOT-LONDON, V80, P795, DOI 10.1006/anbo.1997.0520; Pinke G, 2014, J VEG SCI, V25, P978, DOI 10.1111/jvs.12151; Recasens J, 2016, WEED RES, V56, P31, DOI 10.1111/wre.12185; Rotches-Ribalta R, 2016, WEED RES, V56, P114, DOI 10.1111/wre.12191; Rotches-Ribalta R, 2015, APPL VEG SCI, V18, P423, DOI 10.1111/avsc.12154; Rotches-Ribalta R, 2015, ECOTOXICOLOGY, V24, P991, DOI 10.1007/s10646-015-1440-x; Rotches-Ribalta R, 2015, AGR ECOSYST ENVIRON, V203, P55, DOI 10.1016/j.agee.2015.01.022; Royo-Esnal A, 2015, WEED RES, V55, P387, DOI 10.1111/wre.12154; Royo-Esnal A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146079; Royo-Esnal A, 2015, IND CROP PROD, V66, P161, DOI 10.1016/j.indcrop.2014.12.010; Saatkamp A, 2011, PLANT SOIL, V349, P331, DOI 10.1007/s11104-011-0878-8; Saatkamp A, 2011, ANN BOT-LONDON, V107, P415, DOI 10.1093/aob/mcq255; Saatkamp A, 2009, ANN BOT-LONDON, V104, P715, DOI 10.1093/aob/mcp148; Sole-Senan XO, 2014, AGR ECOSYST ENVIRON, V185, P221, DOI 10.1016/j.agee.2014.01.003; Storkey J, 2012, P ROY SOC B-BIOL SCI, V279, P1421, DOI 10.1098/rspb.2011.1686; Storkey J, 2010, WEED SCI, V58, P39, DOI 10.1614/WS-09-096.1; Torra J, 2015, WEED RES, V55, P503, DOI 10.1111/wre.12162; Torra J, 2016, WEED SCI, V64, P248, DOI 10.1614/WS-D-15-00127.1; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Walker KJ, 2007, BIOL CONSERV, V136, P260, DOI 10.1016/j.biocon.2006.11.026; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/	42	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199425	10.1371/journal.pone.0199425	http://dx.doi.org/10.1371/journal.pone.0199425			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940041	Green Published, gold, Green Submitted			2022-12-26	WOS:000436088700016
J	Klejnstrupl, NR; Buhl-Wiggers, J; Jones, S; Rand, J				Klejnstrupl, Ninja Ritter; Buhl-Wiggers, Julie; Jones, Sam; Rand, John			Early life malaria exposure and academic performance	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; SRI-LANKA; EDUCATIONAL-ATTAINMENT; COGNITIVE PERFORMANCE; DOUBLE-BLIND; PANEL-DATA; CHILDREN; IMPACT; HEALTH; SCHOOLCHILDREN	Malaria is a major cause of morbidity and mortality in sub-Saharan Africa. It is also a dynamic contributor to poverty through its effects on children's cognitive development. This paper examines the degree to which malaria in early childhood impacts on educational achievement in later childhood. The substantial decline in malaria in the region over recent years allows an assessment of its impact to be made. Focusing on Tanzania, we combine data from the Malaria Atlas Project and the 2010-2014 Uwezo household surveys (N = 246,325). We relate the district-level risk of malaria in a child's year of birth to his/her performance in tests of acquired cognitive skills (literacy and numeracy). For causal identification, we rely on differences across districts in the pace of decline in malaria prevalence occurring over the last 15 years. We control for time-invariant district level, age, birth cohort and survey year effects, as well as district-level trends and individual and household-specific factors. In addition, we use sibling variation in birth-year exposure to malaria to strengthen our identification. A ten percentage-point decrease in malaria prevalence in birth year is associated with a 0.06 standard deviation (p = 0.000) increase in English literacy achievement. This estimate is comparable in magnitude to education intervention programs with very large effects. Our results are robust to a large number of sensitivity analyses. We find no statistically significant effects of birth-year malaria exposure on attainments in numeracy and Kiswahili, and we argue that this is probably attributable to strong ceiling effects in these test scores. We conclude that in Tanzania malaria is an important factor in geographical variation in English literacy. This indicates that malaria is a significant public health challenge to educational achievement in this country, and probably in other regions with malaria.	[Klejnstrupl, Ninja Ritter] Univ Copenhagen, Dept Food & Resource Econ, Copenhagen, Denmark; [Buhl-Wiggers, Julie] Copenhagen Business Sch, Copenhagen, Denmark; [Jones, Sam; Rand, John] Univ Copenhagen, Dept Econ, Copenhagen, Denmark	University of Copenhagen; Copenhagen Business School; University of Copenhagen	Klejnstrupl, NR (corresponding author), Univ Copenhagen, Dept Food & Resource Econ, Copenhagen, Denmark.	nrk@ifro.ku.dk	Jones, Sam/S-7369-2019; Klejnstrup, Ninja Ritter/F-4821-2015	Klejnstrup, Ninja Ritter/0000-0001-9214-6119	Ulla og Mogens Folmer Andersens Fond [100041-1]	Ulla og Mogens Folmer Andersens Fond	NRK received financial support for this study from Ulla og Mogens Folmer Andersens Fond (J.nr. 100041-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie A, 2017, EC MATH STAT; ACER, 2015, REP CONC VAL INT REL; Afnan-Holmes H, 2015, LANCET GLOB HEALTH, V3, pE396, DOI 10.1016/S2214-109X(15)00059-5; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Bangirana P, 2014, CLIN INFECT DIS, V59, P336, DOI 10.1093/cid/ciu293; Barofsky J, 2015, J HEALTH ECON, V44, P118, DOI 10.1016/j.jhealeco.2015.08.002; Barreca AI, 2010, J HUM RESOUR, V45, P865; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bleakley H, 2010, AM ECON J-APPL ECON, V2, P1, DOI 10.1257/app.2.2.1; Carter JA, 2005, TROP MED INT HEALTH, V10, P3, DOI 10.1111/j.1365-3156.2004.01345.x; Chang S, 2014, ECON DEV CULT CHANGE, V62, P519, DOI 10.1086/675434; Christensen SS, 2015, T ROY SOC TROP MED H, V109, P233, DOI 10.1093/trstmh/trv005; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; Cutler D, 2010, AM ECON J-APPL ECON, V2, P72, DOI 10.1257/app.2.2.72; Das M, 1999, J ECON BEHAV ORGAN, V40, P409, DOI 10.1016/S0167-2681(99)00062-1; DEATON A, 1985, J ECONOMETRICS, V30, P109, DOI 10.1016/0304-4076(85)90134-4; Eppig C, 2010, P ROY SOC B-BIOL SCI, V277, P3801, DOI 10.1098/rspb.2010.0973; Fernando D, 2006, AM J TROP MED HYG, V74, P386, DOI 10.4269/ajtmh.2006.74.386; Fernando D, 2003, T ROY SOC TROP MED H, V97, P161, DOI 10.1016/S0035-9203(03)90107-6; Fernando D, 2003, T ROY SOC TROP MED H, V97, P633, DOI 10.1016/S0035-9203(03)80093-7; Fernando SD, 2003, AM J TROP MED HYG, V69, P582, DOI 10.4269/ajtmh.2003.69.582; Fernando SD, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-366; Fink G, 2015, DO IT WELL NOT ALL M; Guimaraes P, 2010, STATA J, V10, P628, DOI 10.1177/1536867X1101000406; Henderson V, 2011, AM ECON REV, V101, P194, DOI 10.1257/aer.101.3.194; Holding PA, 2001, AM J TROP MED HYG, V64, P68, DOI 10.4269/ajtmh.2001.64.68; John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709; Kihara M, 2006, TROP MED INT HEALTH, V11, P386, DOI 10.1111/j.1365-3156.2006.01579.x; Kremer M, 2013, SCIENCE, V340, P297, DOI 10.1126/science.1235350; Lucas AM, 2010, AM ECON J-APPL ECON, V2, P46, DOI 10.1257/app.2.2.46; McEwan PJ, 2015, REV EDUC RES, V85, P353, DOI 10.3102/0034654314553127; Nankabirwa J, 2013, AM J TROP MED HYG, V88, P1102, DOI 10.4269/ajtmh.12-0633; Rawlings SB, 2016, ECON DEV CULT CHANGE, V64, P509, DOI 10.1086/684965; Tatem AJ, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-11; Thuilliez J, 2010, SOC SCI MED, V71, P324, DOI 10.1016/j.socscimed.2010.02.027; Venkataramani AS, 2012, J HEALTH ECON, V31, P767, DOI 10.1016/j.jhealeco.2012.06.003; Victora CG, 2006, B WORLD HEALTH ORGAN, V84, P792, DOI 10.2471/BLT.06.030502	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199542	10.1371/journal.pone.0199542	http://dx.doi.org/10.1371/journal.pone.0199542			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK3VI	29933388	gold, Green Published, Green Submitted			2022-12-26	WOS:000436076600032
J	Costa, GB; Gilbert, A; Monroe, B; Blanton, J; Ngam, SN; Recuenco, S; Wallace, R				Costa, Galileu Barbosa; Gilbert, Amy; Monroe, Benjamin; Blanton, Jesse; Ngam, Sali Ngam; Recuenco, Sergio; Wallace, Ryan			The influence of poverty and rabies knowledge on healthcare seeking behaviors and dog ownership, Cameroon	PLOS ONE			English	Article							CANINE RABIES; VACCINATION COVERAGE; POPULATION; AFRICA; ECOLOGY; DEMOGRAPHY; ATTITUDES; DEATHS; MANAGEMENT; TANZANIA	Background Rabies is a fatal encephalitis caused by lyssaviruses, with most human cases worldwide resulting from rabid dog bites. Although effective animal and human vaccines have been available for over 100 years, control efforts have not been adequately implemented on the global scale and rabies remains one of the greatest global zoonotic threats to human health. We conducted a knowledge, attitudes and practices survey in Northern Cameroon to describe dog ownership characteristics, rates of dog bites, and post-bite healthcare seeking behaviors. Methods The survey was performed in four rural Cameroonian communities. A structured community-based questionnaire was conducted over a 20-day period in April 2010, and focused on socio-economic factors correlated with gaps in rabies knowledge. Information pertaining to socio-demographics, as well as attitudes and practices with regard to animal bites and bite treatment practices were recorded. Characteristics of dog ownership such as dog confinement, resources provided to dogs, and dog vaccination status were examined. Human to dog ratios were compared on a linear scale to poverty scores by community. When applicable, 2-tailed Chi-square tests or Fisher's exact tests were calculated to determine relationships between variables. We also used One-way Analysis of Variance (ANOVA) to identify associations between rabies knowledge and wealth with dog ownership, dog vaccination, and human healthcare seeking behaviors. Independent variables were evaluated using multivariate logistic regression analysis. Results A total of 208 households were enrolled. Respondents were predominantly male (68.3%), with a median age of 43.6 years. Eighty-four households (39.9%) reported owning a total of 141 dogs (human dog ratio 10.4:1). The majority of dogs (61%) were allowed to roam freely. A history of rabies vaccination was reported for 30.8% of owned dogs. Respondents reported 11 bites during the two years preceding the survey (annual bite incidence was 2.6% [95% CI 1.4%-4.6%]). Only one person (9.1%) received rabies post-exposure prophylaxis (PEP), and none described symptoms of clinical illness consistent with rabies. Respondents who indicated that they would seek medical care and PEP after a dog bite had higher average wealth and rabies knowledge index scores (p = 0.01 and 0.04, respectively). Respondents who indicated that they would seek care from a traditional healer had significantly lower wealth scores, but not significantly different knowledge scores (p < 0.01 and p = 0.49, respectively). Conclusions In the communities evaluated, the majority of dogs were allowed to roam freely and had no history of rabies vaccination; factors that favor enzootic transmission of canine rabies virus. We also identified a strong relationship between poverty and dog ownership. Bite events were relatively common among respondents, and very few victims reported utilizing health services to treat wounds. Increased wealth and knowledge were significantly associated with increased likelihood that a respondent would seek medical care and post-exposure prophylaxis. These findings indicate the need for educational outreach to raise awareness of dog rabies and proper prevention measures.	[Costa, Galileu Barbosa; Gilbert, Amy; Monroe, Benjamin; Blanton, Jesse; Recuenco, Sergio; Wallace, Ryan] Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA; [Costa, Galileu Barbosa] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil; [Gilbert, Amy] US Anim & Plant Hlth Inspect Serv, Natl Wildlife Res Ctr, USDA, Wildlife Serv, Ft Collins, CO USA; [Ngam, Sali Ngam] Lab Natl Vet LANAVET, Garoua, Cameroon; [Recuenco, Sergio] Natl Ctr Publ Hlth, Inst Nacl Salud, Lima, Peru	Centers for Disease Control & Prevention - USA; Universidade Federal de Minas Gerais; United States Department of Agriculture (USDA); Instituto Nacional de Salud - Peru	Costa, GB (corresponding author), Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA.; Costa, GB (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.	nfe8@cdc.gov	Costa, Galileu Barbosa/M-5768-2019; Costa, Galileu/C-3319-2014	Costa, Galileu/0000-0001-7360-6722; Gilbert, Amy T./0000-0002-8256-0081	USAID Emerging Pandemic Threats program	USAID Emerging Pandemic Threats program(United States Agency for International Development (USAID))	Funding for fieldwork was provided by USAID Emerging Pandemic Threats program, as part of an award to the CDC Center for Global Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MCGP, 2005, REV SAUDE PUBL, V39, P891, DOI 10.1590/S0034-89102005000600004; [Anonymous], J CAMEROON ACAD SCI; Awah Ndukum J., 2002, Tropical Veterinarian, V20, P162; Birhane MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004486; DEBALOGH KKIM, 1993, ONDERSTEPOORT J VET, V60, P437; Dodet B, 2015, INT HEALTH, V7, P4, DOI 10.1093/inthealth/ihu071; Dodet B, 2009, VACCINE, V27, P5027, DOI [10.1016/j.vaccine.2009.06.030, 10.1016/j.vaccine.2009.02.012]; Flores-Ibarra M, 2004, PREV VET MED, V62, P79, DOI 10.1016/j.prevetmed.2003.10.002; Fooks AR, 2014, LANCET, V384, P1389, DOI 10.1016/S0140-6736(13)62707-5; Frey J, 2013, TROP MED INT HEALTH, V18, P1555, DOI 10.1111/tmi.12202; Hampson K, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000339; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Kisiel LM, 2016, PREV VET MED, V135, P37, DOI 10.1016/j.prevetmed.2016.10.021; Knobel DL, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-5; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Kongkaew W, 2004, PREV VET MED, V65, P105, DOI 10.1016/j.prevetmed.2004.05.009; Leung T, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00052; Nel LH, 2007, CURR TOP MICROBIOL, V315, P161; Ratsitorahina M, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-21; RAUTENBACH GH, 1991, J S AFR VET ASSOC, V62, P158; Rinzin K, 2016, PREV VET MED, V126, P39, DOI 10.1016/j.prevetmed.2016.01.030; Robinson Laura E., 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P250; Sadeuh-Mba SA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006041; Sadeuh-Mba Serge Alain, 2014, BMC Res Notes, V7, P905, DOI 10.1186/1756-0500-7-905; Sambo M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003310; Schildecker S, 2016, TRANSBOUND EMERG DIS; Suzuki K, 2008, ZOONOSES PUBLIC HLTH, V55, P177, DOI 10.1111/j.1863-2378.2008.01114.x; Tack DM, 2013, JAVMA-J AM VET MED A, V242, P1279, DOI 10.2460/javma.242.9.1279; Taylor LH, 2017, ACTA TROP, V165, P133, DOI 10.1016/j.actatropica.2015.12.007; Tenzin T, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2393-x; Tenzin T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003784; Wallace RM, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00009; Wallace RM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004245; Wallace RM, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0306-2; World Health Organization, WHO EXP CONS RAB	35	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0197330	10.1371/journal.pone.0197330	http://dx.doi.org/10.1371/journal.pone.0197330			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927935	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500004
J	Huminiecki, L				Huminiecki, Lukasz			Modelling of the breadth of expression from promoter architectures identifies pro housekeeping transcription factors	PLOS ONE			English	Article							RNA-POLYMERASE-II; GENE-EXPRESSION; C-FOS; GROWTH; REGRESSION; SELECTION; CHROMATIN; ENHANCER; COMPLEX; PROTEIN	Understanding how regulatory elements control mammalian gene expression is a challenge of post-genomic era. We previously reported that size of proximal promoter architecture predicted the breadth of expression (fraction of tissues in which a gene is expressed). Herein, the contributions of individual transcription factors (TFs) were quantified. Several technologies of statistical modelling were utilized and compared: tree models, generalized linear models (GLMs, without and with regularization), Bayesian GLMs and random forest. Both linear and non-linear modelling strategies were explored. Encouragingly, different models led to similar statistical conclusions and biological interpretations. The majority of ENCODE TFs correlated positively with housekeeping expression, a minority correlated negatively. Thus, housekeeping expression can be understood as a cumulative effect of many types of TF binding sites. This is accompanied by the exclusion of fewer types of binding sites for TFs which are repressors, or support cell lineage commitment or temporarily inducible or spatially-restricted expression.	[Huminiecki, Lukasz] Polskiej Akad Nauk, Inst Genetyki & Hodowli Zwierzat, Jastrzeloiec, Magdalenka, Poland	Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences	Huminiecki, L (corresponding author), Polskiej Akad Nauk, Inst Genetyki & Hodowli Zwierzat, Jastrzeloiec, Magdalenka, Poland.	l.huminiecki@ighz.pl		Huminiecki, Lukasz/0000-0003-1943-4450	Polish National Science Centre grant POLONEZ 2 [2016/21/P/NZ2/03926]	Polish National Science Centre grant POLONEZ 2	LH was funded to perform this work by the Polish National Science Centre grant POLONEZ 2 (grant number 2016/21/P/NZ2/03926).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Arora S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r166; Birve A, 2001, DEVELOPMENT, V128, P3371; Borsos BN, 2017, SCI REP-UK, V7, DOI 10.1038/srep40960; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; BRAVO R, 1986, EMBO J, V5, P695, DOI 10.1002/j.1460-2075.1986.tb04269.x; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Breiman L., 1984, CLASSIFICATION REGRE, Vx, DOI [10.1101/gr.136184.111, DOI 10.1101/GR.136184.111]; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; CLARKSON DB, 1993, ACM T MATH SOFTWARE, V19, P484, DOI 10.1145/168173.168412; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Crawley MJ, 2007, R BOOK, pviii, DOI [10.1006/bbrc.1999.0880, DOI 10.1006/BBRC.1999.0880]; David Allis C., 2007, EPIGENETICS-US; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Fisher WW, 2012, P NATL ACAD SCI USA, V109, P21330, DOI 10.1073/pnas.1209589110; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Gelman A., BAYESIAN DATA ANAL, VThird; Gelman A, 2015, J EDUC BEHAV STAT, V40, P530, DOI 10.3102/1076998615606113; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hastie TJ, 1992, STAT MODELS S; Hoang T, 2016, CURR TOP DEV BIOL, V118, P163, DOI 10.1016/bs.ctdb.2016.01.004; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; HU ED, 1994, EMBO J, V13, P3094, DOI 10.1002/j.1460-2075.1994.tb06608.x; Hughey JJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv229; Huminiecki L, 2017, TRENDS BIOTECHNOL, V35, P530, DOI 10.1016/j.tibtech.2017.03.007; Hurst LD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002315; Hurst LD, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0413-3; Kokubo H, 1999, BIOCHEM BIOPH RES CO, V260, P459, DOI 10.1006/bbrc.1999.0880; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Littlewood TD, 2012, CELL, V151, P11, DOI 10.1016/j.cell.2012.09.006; MEHTA CR, 1986, ACM T MATH SOFTWARE, V12, P154, DOI 10.1145/6497.214326; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Neter J., 1996, APPL LINEAR STAT MOD, pxv; Neuman E, 1996, GENE, V173, P163, DOI 10.1016/0378-1119(96)00184-9; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Pagel JI, 2011, INDIAN J BIOCHEM BIO, V48, P226; Park J, 2012, HUM MOL GENET, V21, P46, DOI 10.1093/hmg/ddr436; Pon JR, 2016, ONCOTARGET, V7, P2297, DOI 10.18632/oncotarget.6223; PTASHNE M, 2002, GENES SIGNALS; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Reese JC, 2003, CURR OPIN GENET DEV, V13, P114, DOI 10.1016/S0959-437X(03)00013-3; Ripley B. D., 1996, PATTERN RECOGNITION; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; THOMPSON CB, 1992, MOL CELL BIOL, V12, P1043, DOI 10.1128/MCB.12.3.1043; THOMPSON NE, 1989, J BIOL CHEM, V264, P11511; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Valle-Garcia D, 2016, EPIGENETICS-US, V11, P398, DOI 10.1080/15592294.2016.1169351; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Venables WN., 2002, MODERN APPL STAT S, V4; White RJ, 2011, NAT REV GENET, V12, P459, DOI 10.1038/nrg3001; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	62	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198961	10.1371/journal.pone.0198961	http://dx.doi.org/10.1371/journal.pone.0198961			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928029	gold, Green Published, Green Submitted			2022-12-26	WOS:000435802500038
J	Corredor, AP; Gonzalez, J; Baquero, LA; Curtidor, H; Olaya-Galan, NN; Patarroyo, MA; Gutierrez, MF				Patricia Corredor, Adriana; Gonzalez, Janneth; Alfredo Baquero, Luis; Curtidor, Hernando; Nathalia Olaya-Galan, Nury; Alfonso Patarroyo, Manuel; Fernanda Gutierrez, Maria			In silico and in vitro analysis of boAP3d1 protein interaction with bovine leukaemia virus gp51	PLOS ONE			English	Article							RECEPTOR-BINDING DOMAIN; CELL-RECEPTOR; COG DATABASE; DNA; CLASSIFICATION; LYMPHOCYTES; INFECTION; MODEL; SHEEP; SU	The envelope glycoprotein 51 (gp51) is essential for bovine leukaemia virus (BLV) entry to bovine B-lymphocytes. Although the bovine adaptor protein 3 complex subunit delta-1 (boAP3D1) has been proposed as the potential receptor, the specific ligand-receptor interaction has not yet been completely defined and boAP3D1 receptor and gp51 3D structures have not been determined. This study was thus aimed at a functional annotation of boAP3D1 cellular adaptor protein and BLV gp51 and, proposing a reliable model for gp51-AP3D1 interaction using bioinformatics tools. The boAP3D1 receptor interaction patterns were calculated based on models of boAP3D1 receptor and gp51 complexes' 3D structures, which were constructed using homology techniques and data-driven docking strategy. The results showed that the participation of 6 key amino acids (aa) on gp51 (Asn170, Trp127, His115, Ala97, Ser98 and Glu128) and 4 aa on AP3D1 (Lys925, Asp807, Asp695 and Arg800) was highly probable in the interaction between gp51 and BLVR domains. Three gp51 recombinant peptides were expressed and purified to validate these results: the complete domain (rgp51), the N-terminal portion (rNgp51) and the C-terminal fragment (rCgp51); and binding assays to Madin-Darby bovine kidney (MDBK) cells were then carried out with each recombinant. It was found that rNgp51 preferentially bound to MDBK cells, suggesting this domain's functional role during invasion. The rNgp51-MDBK cell interaction was sensitive to trypsin (98% reduction) and chymotrypsin treatment (80% reduction). These results highlighted that the N terminal portion of gp51 interacted in vitro with the AP3D1 receptor and provides a plausible in silico interaction model.	[Patricia Corredor, Adriana; Nathalia Olaya-Galan, Nury; Fernanda Gutierrez, Maria] Univ Javeriana, Virol Lab, Bogota, Colombia; [Gonzalez, Janneth] Univ Javeriana, Sci Fac, Nutr & Biochem Dept, Bogota, Colombia; [Alfredo Baquero, Luis; Curtidor, Hernando; Alfonso Patarroyo, Manuel] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia; [Curtidor, Hernando; Alfonso Patarroyo, Manuel] Univ Rosario, Sch Med & Hlth Sci, Basic Sci Dept, Bogota, Colombia; [Nathalia Olaya-Galan, Nury] Univ Rosario, PhD Programme Biomed & Biol Sci, Bogota, Colombia	Pontificia Universidad Javeriana; Pontificia Universidad Javeriana; Universidad del Rosario; Universidad del Rosario	Gutierrez, MF (corresponding author), Univ Javeriana, Virol Lab, Bogota, Colombia.; Gonzalez, J (corresponding author), Univ Javeriana, Sci Fac, Nutr & Biochem Dept, Bogota, Colombia.	janneth.gonzalez@javeriana.edu.co; mfgutier@javeriana.edu.co	Curtidor, Hernando/I-7997-2016; GONZALEZ, JANNETH/AAB-9948-2020; Olaya-Galan, Nury-Nathalia/P-8079-2019; Solanki, Divyang/Q-2061-2019; Gutierrez, Maria/AAF-2966-2019; Patarroyo, Manuel A/I-8046-2016	Curtidor, Hernando/0000-0002-6556-7812; GONZALEZ, JANNETH/0000-0003-4482-256X; Olaya-Galan, Nury-Nathalia/0000-0002-4282-4951; Patarroyo, Manuel A/0000-0002-4751-2500; Baquero, Luis Alfredo/0000-0003-0889-0573; Corredor Figueroa, Adriana Patricia/0000-0001-9839-6151; Gutierrez, Maria Fernanda/0000-0003-0767-3737	Colciencias PUJ grants [657/2014]; Molecular Biology and Immunology Department from the Fundacion Instituto de Inmunologia de Colombia (FIDIC); Receptor-Ligand Department from the Fundacion Instituto de Inmunologia de Colombia (FIDIC)	Colciencias PUJ grants; Molecular Biology and Immunology Department from the Fundacion Instituto de Inmunologia de Colombia (FIDIC); Receptor-Ligand Department from the Fundacion Instituto de Inmunologia de Colombia (FIDIC)	This work was partly supported by Colciencias PUJ grants, as part of call 657/2014 for projects granted to Maria Fernanda Gutierrez, as well as the Molecular Biology and Immunology Department and the Receptor-Ligand Department from the Fundacion Instituto de Inmunologia de Colombia (FIDIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAN J, 1993, J VIROL, V67, P1050, DOI 10.1128/JVI.67.2.1050-1057.1993; BAN J, 1994, ARCH VIROL, V138, P379, DOI 10.1007/BF01379141; Barez PY, 2015, VIRUSES-BASEL, V7, P6080, DOI 10.3390/v7112929; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Buehring GC, 2003, AIDS RES HUM RETROV, V19, P1105, DOI 10.1089/088922203771881202; BUEHRING GC, 1994, LAB INVEST, V71, P359; Buehring GC, 2014, EMERG INFECT DIS, V20, P772, DOI 10.3201/eid2005.131298; Burny A, 1987, ENZOOTIC BOVINE LEUK, pxvi; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; de Brogniez A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040088; Dodonova SO, 2015, SCIENCE, V349, P195, DOI 10.1126/science.aab1121; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GIOVANNA M., 2013, OPEN J MED MICROBIOL, V3, P84, DOI [https://doi.org/10.4236/ojmm.2013.31013, DOI 10.4236/OJMM.2013.31013]; Hemmatzadeh F, 2015, VET RES COMMUN, V39, P97, DOI 10.1007/s11259-015-9629-2; Johnston ER, 2000, J VIROL, V74, P2930, DOI 10.1128/JVI.74.6.2930-2935.2000; Johnston ER, 2002, J VIROL, V76, P10861, DOI 10.1128/JVI.76.21.10861-10872.2002; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; KETTMANN R, 1984, LEUKEMIA RES, V8, P937, DOI 10.1016/0145-2126(84)90047-X; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lamb D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001268; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lubec G, 2005, PROG NEUROBIOL, V77, P90, DOI 10.1016/j.pneurobio.2005.10.001; Manel N, 2005, ONCOGENE, V24, P6016, DOI 10.1038/sj.onc.1208972; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Meirom R, 1997, VET IMMUNOL IMMUNOP, V59, P113, DOI 10.1016/S0165-2427(97)00056-1; MSD, 2014, OV BOV LEUK; Obal G, 2015, SCIENCE, V349, P95, DOI 10.1126/science.aaa5182; Olaya N, 2016, J MED SURG PATHOLOGY, V1, P2; Olaya-Galan NN, 2017, EPIDEMIOL INFECT, V145, P3125, DOI [10.1017/S0950268817002229, 10.1017/s0950268817002229]; D'Angelino RHR, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/425646; Rao V.S., 2011, J BIOINFORM SEQUENCE, V2, P89, DOI DOI 10.5897/JBSA; Rizzo G, 2016, VET MICROBIOL, V197, P21, DOI 10.1016/j.vetmic.2016.10.024; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Singh S, 2001, J BIOL CHEM, V276, P17111, DOI 10.1074/jbc.M101531200; SLAVIKOVA K, 1986, NEOPLASMA, V33, P671; Suzuki T, 2003, J GEN VIROL, V84, P1309, DOI 10.1099/vir.0.18763-0; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Gusteren WF, 1987, GRONINGEN MOL SIMULA, DOI [10.1110/ps.0217002, DOI 10.1110/PS.0217002]; Wadood A., 2013, OA DRUG DES DELIV, V1, P3, DOI DOI 10.13172/2054-4057-1-1-1119; WILLEMS L, 1993, J VIROL, V67, P4078, DOI 10.1128/JVI.67.7.4078-4085.1993; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	45	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199397	10.1371/journal.pone.0199397	http://dx.doi.org/10.1371/journal.pone.0199397			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928016	Green Published, Green Submitted, gold			2022-12-26	WOS:000435802500082
J	Valevicius, AM; Boser, QA; Lavoie, EB; Murgatroyd, GS; Pilarski, PM; Chapman, CS; Vette, AH; Hebert, JS				Valevicius, Aida M.; Boser, Quinn A.; Lavoie, Ewen B.; Murgatroyd, Glyn S.; Pilarski, Patrick M.; Chapman, Craig S.; Vette, Albert H.; Hebert, Jacqueline S.			Characterization of normative hand movements during two functional upper limb tasks	PLOS ONE			English	Article							UPPER-EXTREMITY; KINEMATIC MEASURES; PERFORMANCE; GRASP; RELIABILITY; STROKE; REACH; HEMIPARESIS; CHILDREN; ARM	Background Dexterous hand function is crucial for completing activities of daily living (ADLs), which typically require precise hand-object interactions. Kinematic analyses of hand trajectory, hand velocity, and grip aperture provide valuable mechanistic insights into task performance, but there is a need for standardized tasks representative of ADLs that are amenable to motion capture and show consistent performance in non-disabled individuals. Our objective was to develop two standardized functional upper limb tasks and to quantitatively characterize the kinematics of normative hand movement. Methods Twenty non-disabled participants were recruited to perform two tasks: the Pasta Box Task and Cup Transfer Task. A 12-camera motion capture system was used to collect kinematic data from which hand movement and grip aperture measures were calculated. Measures reported for reach-grasp and transport-release segments were hand distance travelled, hand trajectory variability, movement time, peak and percent-to-peak hand velocity, number of movement units, peak and percent-to-peak grip aperture, and percent-to-peak hand deceleration. A between-session repeatability analysis was conducted on 10 participants. Results Movement times were longer for transport-release compared to reach-grasp for every movement. Hand and grip aperture measures had low variability, with 55 out of 63 measures showing good repeatability (ICC > 0.75). Cross-body movements in the Pasta Box Task had longer movement times and reduced percent-to-peak hand velocity values. The Cup Transfer Task showed decoupling of peak grip aperture and peak hand deceleration for all movements. Movements requiring the clearing of an obstacle while transporting an object displayed a double velocity peak and typically a longer deceleration phase. Discussion Normative hand kinematics for two standardized functional tasks challenging various aspects of hand-object interactions important for ADLs showed excellent repeatability. The consistency in normative task performance across a variety of task demands shows promise as a potential outcome assessment for populations with upper limb impairment.	[Valevicius, Aida M.; Boser, Quinn A.; Vette, Albert H.; Hebert, Jacqueline S.] Univ Alberta, Fac Med & Dent, Dept Biomed Engn, Edmonton, AB, Canada; [Lavoie, Ewen B.; Chapman, Craig S.] Univ Alberta, Fac Kinesiol Sport & Recreat, Edmonton, AB, Canada; [Murgatroyd, Glyn S.; Vette, Albert H.; Hebert, Jacqueline S.] Alberta Hlth Serv, Glenrose Rehabil Hosp, Edmonton, AB, Canada; [Pilarski, Patrick M.; Hebert, Jacqueline S.] Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB, Canada; [Vette, Albert H.] Univ Alberta, Fac Engn, Dept Mech Engn, Edmonton, AB, Canada	University of Alberta; University of Alberta; Alberta Health Services (AHS); University of Alberta; University of Alberta	Hebert, JS (corresponding author), Univ Alberta, Fac Med & Dent, Dept Biomed Engn, Edmonton, AB, Canada.; Hebert, JS (corresponding author), Alberta Hlth Serv, Glenrose Rehabil Hosp, Edmonton, AB, Canada.; Hebert, JS (corresponding author), Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB, Canada.	jhebert@ualberta.ca	Hebert, Jacqueline/E-1881-2016	Hebert, Jacqueline/0000-0003-0788-0568	Defense Advanced Research Projects Agency (DARPA) BTO through the DARPA Contracts Management Office [N66001-15-C-4015]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04666, RGPIN-2014-05248]	Defense Advanced Research Projects Agency (DARPA) BTO through the DARPA Contracts Management Office(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was sponsored by the Defense Advanced Research Projects Agency (DARPA) BTO under the auspices of Dr. Doug Weber and Dr. Al Emondi through the DARPA Contracts Management Office; Grant/Contract No. N66001-15-C-4015 (JSH). Partial funding support was also received through Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (RGPIN-2014-04666; RGPIN-2014-05248) (AHV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEND W, 1982, BRAIN, V105, P331, DOI 10.1093/brain/105.2.331; Alt Murphy M, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-18; Alt Murphy M, 2015, PHYS THER REV, V20, P137, DOI 10.1179/1743288X15Y.0000000002; Alt Murphy M, 2011, NEUROREHAB NEURAL RE, V25, P71, DOI 10.1177/1545968310370748; Bouwsema H, 2012, J REHABIL RES DEV, V49, P1331, DOI 10.1682/JRRD.2011.09.0179; Bouwsema H, 2010, CLIN BIOMECH, V25, P523, DOI 10.1016/j.clinbiomech.2010.02.011; Butler EE, 2010, GAIT POSTURE, V32, P301, DOI 10.1016/j.gaitpost.2010.05.013; Chapman CS, 2008, EXP BRAIN RES, V191, P83, DOI 10.1007/s00221-008-1499-1; Cirstea MC, 2003, EXP BRAIN RES, V151, P289, DOI 10.1007/s00221-003-1438-0; Claxton LJ, 2003, PSYCHOL SCI, V14, P354, DOI 10.1111/1467-9280.24421; Cuijpers RH, 2004, J NEUROPHYSIOL, V91, P2598, DOI 10.1152/jn.00644.2003; Reyes-Guzman ADL, 2014, CLIN BIOMECH, V29, P719, DOI 10.1016/j.clinbiomech.2014.06.013; FISK JD, 1985, EXP BRAIN RES, V60, P159; Gates DH, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.015487; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; Hebert JS, 2014, J REHABIL RES DEV, V51, P919, DOI 10.1682/JRRD.2013.10.0228; Hebert JS, 2012, J REHABIL RES DEV, V49, P1163, DOI 10.1682/JRRD.2011.10.0207; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Jaspers E, 2011, GAIT POSTURE, V33, P279, DOI 10.1016/j.gaitpost.2010.11.021; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; Jongbloed-Pereboom M, 2013, AM J OCCUP THER, V67, P312, DOI 10.5014/ajot.2013.006643; Lang CE, 2005, EXP BRAIN RES, V166, P126, DOI 10.1007/s00221-005-2350-6; Light CM, 2002, ARCH PHYS MED REHAB, V83, P776, DOI 10.1053/apmr.2002.32737; Lindner HYN, 2009, J REHABIL MED, V41, P467, DOI 10.2340/16501977-0361; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; Madeleine P, 2010, ACTA PHYSIOL, V199, P1, DOI 10.1111/j.1748-1716.2010.02145.x; Major MJ, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-132; Marteniuk RC, 1987, CAN J PSYCHOL, V41; MARTENIUK RG, 1990, HUM MOVEMENT SCI, V9, P149, DOI 10.1016/0167-9457(90)90025-9; Mateo S, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/1743-0003-12-9; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Metzger AJ, 2012, ARCH PHYS MED REHAB, V93, P2029, DOI 10.1016/j.apmr.2012.03.011; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Nowak DA, 2008, NEUROSCI BIOBEHAV R, V32, P1439, DOI 10.1016/j.neubiorev.2008.05.021; Petuskey K, 2007, GAIT POSTURE, V25, P573, DOI 10.1016/j.gaitpost.2006.06.006; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; PRABLANC C, 1979, BIOL CYBERN, V35, P183, DOI 10.1007/BF00337063; Resnik L, 2013, ARCH PHYS MED REHAB, V94, P488, DOI 10.1016/j.apmr.2012.10.004; Schaefer SY, 2012, MOTOR CONTROL, V16, P245, DOI 10.1123/mcj.16.2.245; Schneiberg S, 2010, DEV MED CHILD NEUROL, V52, pe167, DOI 10.1111/j.1469-8749.2010.03635.x; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; Thrope G, 1989, STANDARDIZED OBJECT; Valyear KF, 2011, EXP BRAIN RES, V212, P125, DOI 10.1007/s00221-011-2705-0; van Andel CJ, 2008, GAIT POSTURE, V27, P120, DOI 10.1016/j.gaitpost.2007.03.002; van Vliet PM, 2007, ARCH PHYS MED REHAB, V88, P1325, DOI 10.1016/j.apmr.2007.06.769; Vanezis A, 2015, GAIT POSTURE, V41, P431, DOI 10.1016/j.gaitpost.2014.11.007; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Winter DA, 1979, BIOMECHANICS HUMAN M, P32; Wu C-Y, 1998, SCANDINAVIAN J OCCUP, V5, P83; Wu CY, 1998, AM J OCCUP THER, V52, P447, DOI 10.5014/ajot.52.6.447; Zackowski KM, 2002, EXP BRAIN RES, V146, P511, DOI 10.1007/s00221-002-1191-9	52	22	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199549	10.1371/journal.pone.0199549	http://dx.doi.org/10.1371/journal.pone.0199549			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK0LV	29928022	gold, Green Submitted, Green Published			2022-12-26	WOS:000435802500107
J	Park, S; Burke, RE; Kareva, T; Kholodilov, N; Aime, P; Franke, TF; Levy, O; Greene, LA				Park, Soyeon; Burke, Robert E.; Kareva, Tatyana; Kholodilov, Nikolai; Aime, Pascaline; Franke, Thomas F.; Levy, Oren; Greene, Lloyd A.			Context-dependent expression of a conditionally-inducible form of active Akt	PLOS ONE			English	Article							PROTEIN-KINASE B; NERVE GROWTH-FACTOR; PARKINSONS-DISEASE; PC12 CELLS; PHEOCHROMOCYTOMA CELLS; SIGNALING PATHWAY; NEURON DEATH; RODENT MODEL; ACTIVATION; SYSTEM	Akt kinases are key signaling components in proliferation-competent and post-mitotic cells. Here, we sought to create a conditionally-inducible form of active Akt for both in vitro and in vivo applications. We fused a ligand-responsive Destabilizing Domain (DD) derived from E. coli dihydrofolate reductase to a constitutively active mutant form of Akt1, Akt(E40K). Prior work indicated that such fusion proteins may be stabilized and induced by a ligand, the antibiotic Trimethoprim (TMP). We observed dose-dependent, reversible induction of both total and phosphorylated/active DD-Akt(E40K) by TMP across several cellular backgrounds in culture, including neurons. Phosphorylation of FoxO4, an Akt substrate, was significantly elevated after DD-Akt(E40K) induction, indicating the induced protein was functionally active. The induced Akt(E40K) protected cells from apoptosis evoked by serum deprivation and was neuroprotective in two cellular models of Parkinson's disease (6-OHDA and MPP+ exposure). There was no significant protection without induction. We also evaluated Akt (E40K) induction by TMP in mouse substantia nigra and striatum after neuronal delivery via an AAV1 adeno-associated viral vector. While there was significant induction in striatum, there was no apparent induction in substantia nigra. To explore the possible basis for this difference, we examined DD-Akt(E40K) induction in cultured ventral midbrain neurons. Both dopaminergic and non-dopaminergic neurons in the cultures showed DD-Akt(E40K) induction after TMP treatment. However, basal DD-Akt(E40K) expression was 3-fold higher for dopaminergic neurons, resulting in a significantly lower induction by TMP in this population. Such findings suggest that dopaminergic neurons may be relatively inefficient in protein degradation, a property that could relate to their lack of apparent DD-Akt(E40K) induction in vivo and to their selective vulnerability in Parkinson's disease. In summary, we generated an inducible, biologically active form of Akt. The degree of inducibility appears to reflect cellular context that will inform the most appropriate applications for this and related reagents.	[Park, Soyeon] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Burke, Robert E.; Aime, Pascaline; Greene, Lloyd A.] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10027 USA; [Burke, Robert E.; Kareva, Tatyana; Kholodilov, Nikolai; Levy, Oren] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA; [Kareva, Tatyana; Franke, Thomas F.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Aime, Pascaline] Regeneron Pharmaceut, Tarrytown, NY USA	Columbia University; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; Regeneron	Greene, LA (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10027 USA.	lag3@cumc.columbia.edu	Levey, Allan/F-2104-2011; Core, Vector/CAF-4832-2022	Levey, Allan/0000-0002-3153-502X; Kareva, Tatyana/0000-0002-6625-0243; Greene, Lloyd/0000-0002-3225-5521	National Institutes of Health/National Institute of Neurological Disorders and Stroke [2R01NS072050, 2R01NS033689]; US Department of Defense [W81XVVH-12-1-0051]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033689, R01NS072050] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants 2R01NS072050 and 2R01NS033689 from the National Institutes of Health/National Institute of Neurological Disorders and Stroke (https://www.ninds.nih.gov/) to L.A.G. and W81XVVH-12-1-0051 from the US Department of Defense (https://www.defense.gov) to R.E.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168182; Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; BARLING RWA, 1978, J ANTIMICROB CHEMOTH, V4, P203, DOI 10.1093/jac/4.3.203; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Cederfjall E, 2015, MOL THER, V23, P896, DOI 10.1038/mt.2015.8; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Deneka AY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176747; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Grau Cristina Malagelada, 2012, Methods Mol Biol, V846, P201, DOI 10.1007/978-1-61779-536-7_18; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Greene LA, 2011, CELL MOL NEUROBIOL, V31, P969, DOI 10.1007/s10571-011-9671-8; Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102; Hartl FU, 2017, ANNU REV BIOCHEM, V86, P21, DOI 10.1146/annurev-biochem-061516-044518; HARTLEY A, 1994, J NEUROCHEM, V63, P1987; Howell KR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175993; Hsu JH, 2002, ONCOGENE, V21, P1391, DOI 10.1038/sj/onc/1205194; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Kim SR, 2011, ANN NEUROL, V70, P110, DOI 10.1002/ana.22383; Li WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133165; Liu J, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00177; Liu P, 2014, ANGEW CHEM INT EDIT, V53, P10049, DOI 10.1002/anie.201403463; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Malagelada C, 2008, J NEUROSCI, V28, P14363, DOI 10.1523/JNEUROSCI.3928-08.2008; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Nolting S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182852; Park A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095101; Quintino L, 2013, MOL THER, V21, P2169, DOI 10.1038/mt.2013.169; Rakhit R, 2014, CHEM BIOL, V21, P1238, DOI 10.1016/j.chembiol.2014.08.011; Rao SAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063164; RAYPORT S, 1992, J NEUROSCI, V12, P4264; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Song ZQ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00128; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Tai K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046269; Timmons S, 2009, NEUROSCI LETT, V467, P30, DOI 10.1016/j.neulet.2009.09.055; WALKINSHAW G, 1994, NEUROSCIENCE, V63, P975, DOI 10.1016/0306-4522(94)90566-5; Wang DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160159; Wang L, 2017, J MOL NEUROSCI, V61, P379, DOI 10.1007/s12031-016-0872-y; Wang SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0164281; Wert MM, 2000, BIOCHEM J, V352, P175, DOI 10.1042/0264-6021:3520175; Zdychova J, 2005, PHYSIOL RES, V54, P1, DOI 10.33549/physiolres.930582; Zeng BY, 2005, MECH AGEING DEV, V126, P760, DOI 10.1016/j.mad.2005.01.008; Zheng WH, 2012, BRAIN RES, V1470, P145, DOI 10.1016/j.brainres.2012.06.032; Zhu QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118737	60	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0197899	10.1371/journal.pone.0197899	http://dx.doi.org/10.1371/journal.pone.0197899			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920520	gold, Green Published, Green Submitted			2022-12-26	WOS:000435541300003
J	Mashari, A; Montealegre-Gallegos, M; Jeganathan, J; Yeh, L; Hiansen, JQ; Meineri, M; Mahmood, F; Matyal, R				Mashari, Azad; Montealegre-Gallegos, Mario; Jeganathan, Jelliffe; Yeh, Lu; Hiansen, Joshua Qua; Meineri, Massimiliano; Mahmood, Feroze; Matyal, Robina			Low-cost three-dimensional printed phantom for neuraxial anesthesia training: Development and comparison to a commercial model	PLOS ONE			English	Article							ACCIDENTAL DURAL PUNCTURE; ULTRASOUND PHANTOM; MEDICAL-EDUCATION; SIMULATION; SURGERY	Neuraxial anesthesia (spinal and epidural anesthesia) procedures have significant learning curves and have been traditionally taught at the bed side, exposing patients to the increased risk associated with procedures done by novices. Simulation based medical education allows trainees to repeatedly practice and hone their skills prior to patient interaction. Widespread adoption of simulation-based medical education for procedural teaching has been slow due to the expense and limited variety of commercially available phantoms. Free/Libre/open-source (FLOS) software and desktop 3D printing technologies has enabled the fabrication of low-cost, patient-specific medical phantoms. However, few studies have evaluated the performance of these devices compared to commercially available phantoms. This paper describes the fabrication of a low-cost 3D printed neuraxial phantom based on computed tomorography (CT) scan data, and expert validation data comparing this phantom to a commercially available model. Methods Anonymized CT DICOM data was segmented to create a 3D model of the lumbar spine. The 3D model was modified, placed inside a digitally designed housing unit and fabricated on a desktop 3D printer using polylactic acid (PLA) filament. The model was filled with an echogenic solution of gelatin with psyllium fiber. Twenty-two staff anesthesiologists performed a spinal and epidural on the 3D printed simulator and a commercially available Simulab phantom. Participants evaluated the tactile and ultrasound imaging fidelity of both phantoms via Likert-scale questionnaire. Results The 3D printed neuraxial phantom cost $13 to print and required 25 hours of non-supervised printing and 2 hours of assembly time. The 3D printed phantom was found to be less realistic to surface palpation than the Simulab phantom due to fragility of the silicone but had significantly better fidelity for loss of resistance, dural puncture and ultrasound imaging than the Simulab phantom. Conclusion Low-cost neuraxial phantoms with fidelity comparable to commercial models can be produced using CT data and low-cost infrastructure consisting of FLOS software and desktop 3D printers.	[Mashari, Azad; Hiansen, Joshua Qua; Meineri, Massimiliano] Toronto Gen Hosp, Dept Anesthesia & Pain Management, Toronto, ON, Canada; [Mashari, Azad; Meineri, Massimiliano] Univ Toronto, Fac Med, Toronto, ON, Canada; [Mashari, Azad; Montealegre-Gallegos, Mario; Jeganathan, Jelliffe; Yeh, Lu; Mahmood, Feroze; Matyal, Robina] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA; [Yeh, Lu] Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, Groningen, Netherlands	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Groningen	Mashari, A (corresponding author), Toronto Gen Hosp, Dept Anesthesia & Pain Management, Toronto, ON, Canada.; Mashari, A (corresponding author), Univ Toronto, Fac Med, Toronto, ON, Canada.; Mashari, A (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA.	azad.mashari@mail.utoronto.ca	Mashari, Azad/S-3096-2018	Mashari, Azad/0000-0002-8403-1271	Foundation for Anesthesia Education and Research (FAER); Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston; Peter Munk Cardiac Center Foundation, Toronto General Hospital	Foundation for Anesthesia Education and Research (FAER); Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston; Peter Munk Cardiac Center Foundation, Toronto General Hospital	This research project was supported by a Foundation for Anesthesia Education and Research (FAER) grant; by the Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston; and by the Peter Munk Cardiac Center Foundation, Toronto General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini R, 2015, WORLD J EMERG MED, V6, P225, DOI 10.5847/wjem.j.1920-8642.2015.03.012; Aydin A, 2016, NAT REV UROL, V13, P503, DOI 10.1038/nrurol.2016.147; BUDE RO, 1995, J CLIN ULTRASOUND, V23, P271, DOI 10.1002/jcu.1870230413; Chao I, 2017, ANAESTHESIA; De Winter J., 2010, PRACTICAL ASSESS RES, V15, P11, DOI [10.7275/bj1p-ts64, DOI 10.7275/BJ1P-TS64]; Gleeson CM, 1998, INT J OBSTET ANESTH, V7, P242, DOI 10.1016/S0959-289X(98)80046-0; Jeganathan J, 2017, REG ANESTH ACUTE PAI, P42; Maran NJ, 2003, MED EDUC, V37, P22, DOI 10.1046/j.1365-2923.37.s1.9.x; Morehouse H, 2007, J ULTRAS MED, V26, P1123, DOI 10.7863/jum.2007.26.8.1123; Morrow DS, 2016, J ULTRAS MED, V35, P831, DOI 10.7863/ultra.15.04085; Nazarnia S, 2017, SEMIN CARDIOTHORAC V, V21, P81, DOI 10.1177/1089253216655874; Norman G, 2010, ADV HEAL SCI ED; Pinzon D, 2016, SURG INNOV, P1; Rodriguez-Paz JM, 2009, QUAL SAF HEALTH CARE, V18, P63, DOI 10.1136/qshc.2007.023903; Sprigge JS, 2008, ANAESTHESIA, V63, P36, DOI 10.1111/j.1365-2044.2007.05285.x; STRIDE PC, 1993, ANAESTHESIA, V48, P247, DOI 10.1111/j.1365-2044.1993.tb06913.x; Sullivan G. M., 2013, J GRAD MED ED; van der Wiel SE, 2016, BEST PRACT RES CL GA, V30, P375, DOI 10.1016/j.bpg.2016.04.004; Vetter MH, 2015, J SURG ONCOL, V112, P684, DOI 10.1002/jso.24006; West SJ, 2014, REGION ANESTH PAIN M, V39, P429, DOI 10.1097/AAP.0000000000000136; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zendejas B, 2016, SURG ENDOSC, V30, P512, DOI 10.1007/s00464-015-4233-7; Ziv A, 2005, MED TEACH, V27, P193, DOI 10.1080/01421590500126718; Ziv A, 2000, MED TEACH, V22, P489, DOI 10.1080/01421590050110777; Ziv Amitai, 2006, Simul Healthc, V1, P252, DOI 10.1097/01.SIH.0000242724.08501.63	25	16	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0191664	10.1371/journal.pone.0191664	http://dx.doi.org/10.1371/journal.pone.0191664			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912877	Green Published, gold, Green Submitted			2022-12-26	WOS:000435528600001
J	Cheng, YJ; Zhao, XZ; Chen, YL; Li, YH; Jia, RL; Zhu, L; Huang, CB; Sun, XL; Deng, HT; Li, ZG				Cheng, Yongjing; Zhao, Xiaozhen; Chen, Yuling; Li, Yuhui; Jia, Rulin; Zhu, Lei; Huang, Cibo; Sun, Xiaolin; Deng, Haiteng; Li, Zhanguo			Circulating immune complexome analysis identified anti-tubulin-alpha-1c as an inflammation associated autoantibody with promising diagnostic value for Behcet's Disease	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; PROTEOMIC SURVEILLANCE; K-ALPHA-1 TUBULIN; ANTIBODIES; REJECTION; PROTEINS; INSIGHTS; ANTIGEN; SERA	Background Behcet's disease (BD) is a chronic, multisystem-involved vasculitis and its pathogenesis remains elusive. No specific serological markers for BD diagnosis have been established. Identification of novel diagnostic biomarkers will be helpful in timely diagnostic and treatment for Behcet's disease. Objective To screen novel autoantigens or autoantibodies with potential diagnostic value in circulating immune complexes (CICs) from BD patients. Methods A proteomic strategy for immune complexome analysis was developed, in which CICs were separated from serum sample of 10 BD patients and 10 healthy controls and then subjected to Orbitrap mass spectrometry for autoantigen profiling. Anti-tubulin-alpha-1c antibody levels were further determined by enzyme-linked immunosorbent assay (ELISA) in sera of patients with BD, systemic lupus erythematosus (SLE), recurrent aphthous ulcers (RAU), ANCA associated systemic vasculitis (AASV), Takayasu's arteritis (TA) and 59 healthy controls. Result A total of 17 potential antigens were identified in CICs from BD patients, but not in HC. The autoantibody to one of the identified antigens, tubulin-alpha-1c, was significantly increased in BD patients compared with that in healthy and disease controls. The sensitivity and specificity of tubulin-alpha-lc antibody in the diagnosis of BD in this study were 61.36% and 88.4%, respectively. Further analysis demonstrated that anti-tubulin-alpha-1c was associated with complications of deep venous thrombosis and erythema nodosum in BD. The levels of antitubulin-alpha-1c were also significantly correlated with the BD inflammation and disease activity markers ESR, CRP and BVAS. Conclusion Anti-tubulin-alpha-1c antibody is a promising biomarker in diagnosis and severity evaluation of BD and in indicating the risk of deep venous thrombosis and erythema nodosum. The immune complexome analysis by proteomic CIC autoantigen screening is a feasible way of identifying novel biomarkers in BD.	[Cheng, Yongjing; Zhao, Xiaozhen; Li, Yuhui; Jia, Rulin; Zhu, Lei; Sun, Xiaolin; Li, Zhanguo] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China; [Cheng, Yongjing; Zhao, Xiaozhen; Li, Yuhui; Jia, Rulin; Zhu, Lei; Sun, Xiaolin; Li, Zhanguo] Beijing Key Lab Rheumatism Mech & Immune Diag, Beijing, Peoples R China; [Cheng, Yongjing; Huang, Cibo] Beijing Hosp, Natl Ctr Gerontol, Dept Rheumatol & Immunol, Beijing, Peoples R China; [Chen, Yuling; Deng, Haiteng] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing, Peoples R China	Peking University; Beijing Hospital; Tsinghua University	Sun, XL (corresponding author), Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China.; Sun, XL (corresponding author), Beijing Key Lab Rheumatism Mech & Immune Diag, Beijing, Peoples R China.; Deng, HT (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing, Peoples R China.	sunxiaolin_sxl@126.com; dengh@biomed.tsinghua.edu.cn	Sun, Xiaolin/AAD-8492-2022	Sun, Xiaolin/0000-0001-9709-1532; Zhao, Xhaozhen/0000-0002-9733-057X; Deng, Haiteng/0000-0001-9496-1280	National Natural Science Foundation of China [3040290,, 81471601, 81671602]; Beijing Sci-Tech Program [Z171100000417007]; Peking University Clinical Medicine + X Project for Joint Investigation of Youth and Beijing Nova Program [Z171100001117025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Sci-Tech Program; Peking University Clinical Medicine + X Project for Joint Investigation of Youth and Beijing Nova Program	This work was supported by funding from National Natural Science Foundation of China (3040290, 81471601 and 81671602)(YC, XS), Beijing Sci-Tech Program (Z171100000417007) (ZL), Peking University Clinical Medicine + X Project for Joint Investigation of Youth and Beijing Nova Program (Z171100001117025) (XS). The funders of this study had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript. Competing interests: The authorsr This work was supported by funding from National Natural Science Foundation of China (3040290, 81471601 and 81671602), Beijing Sci-Tech Program (Z171100000417007), Peking University Clinical Medicine + X Project for Joint Investigation of Youth and Beijing Nova Program (Z171100001117025).	ABDALLAH MA, 1995, INT J DERMATOL, V34, P841, DOI 10.1111/j.1365-4362.1995.tb04418.x; Alpsoy E, 2016, J DERMATOL, V43, P620, DOI 10.1111/1346-8138.13381; Ambrose N, 2015, CLIN EXP IMMUNOL, V181, P427, DOI 10.1111/cei.12655; Aylett CHS, 2011, INT REV CEL MOL BIO, V292, P1, DOI 10.1016/B978-0-12-386033-0.00001-3; CERVERA R, 1994, ANN RHEUM DIS, V53, P265, DOI 10.1136/ard.53.4.265; Chen SF, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0656-8; Cheon JH, 2015, CURR OPIN RHEUMATOL, V27, P24, DOI 10.1097/BOR.0000000000000125; Cho SB, 2010, CLIN EXP RHEUMATOL, V28, pS31; Davatchi F, 2010, CLIN RHEUMATOL, V29, P823, DOI 10.1007/s10067-010-1430-6; de Chambrun MP, 2012, AUTOIMMUN REV, V11, P687, DOI 10.1016/j.autrev.2011.11.026; Dinc A, 2003, CLIN EXP RHEUMATOL, V21, pS27; Goers TA, 2008, J IMMUNOL, V180, P4487, DOI 10.4049/jimmunol.180.7.4487; HEIN S, 1995, J THORAC CARDIOV SUR, V110, P89, DOI 10.1016/S0022-5223(05)80013-3; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Keller M, 2005, J IMMUNOL, V175, P7678, DOI 10.4049/jimmunol.175.11.7678; Lee KH, 2003, ARTHRITIS RHEUM, V48, P2025, DOI 10.1002/art.11074; LUQMANI RA, 1994, Q J MED, V87, P671; Mohammad A, 2013, RHEUMATOLOGY, V52, P304, DOI 10.1093/rheumatology/kes249; Mor F, 2002, EUR J IMMUNOL, V32, P356, DOI 10.1002/1521-4141(200202)32:2<356::AID-IMMU356>3.0.CO;2-9; Ndhlovu M, 2011, BRAIN BEHAV IMMUN, V25, P279, DOI 10.1016/j.bbi.2010.09.019; Ohyama K, 2011, CLIN CHEM, V57, P905, DOI 10.1373/clinchem.2010.157776; Ooka S, 2010, MICROBIOL IMMUNOL, V54, P354, DOI 10.1111/j.1348-0421.2010.00215.x; Ozoran K, 1996, RHEUMATOL INT, V15, P221, DOI 10.1007/BF00290374; Praprotnik S, 2001, ARTHRITIS RHEUM-US, V44, P1484, DOI 10.1002/1529-0131(200107)44:7<1484::AID-ART269>3.0.CO;2-Q; RAO K, 1989, TRANSPLANTATION, V48, P1018, DOI 10.1097/00007890-198912000-00025; Shaker O, 2007, BRIT J DERMATOL, V156, P32, DOI 10.1111/j.1365-2133.2006.07536.x; SILMAN AJ, 1990, LANCET, V335, P1078; Tanaka Y, 2006, MICROBIOL IMMUNOL, V50, P117, DOI 10.1111/j.1348-0421.2006.tb03776.x; Tiriveedhi V, 2013, J HEART LUNG TRANSPL, V32, P807, DOI 10.1016/j.healun.2013.06.003; Van Steendam K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3070; Yoshioka T, 2014, CLIN EXP RHEUMATOL, V32, pS9; Zheng Wen-jie, 2005, Zhonghua Nei Ke Za Zhi, V44, P910	32	8	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199047	10.1371/journal.pone.0199047	http://dx.doi.org/10.1371/journal.pone.0199047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902281	gold, Green Published, Green Submitted			2022-12-26	WOS:000435424900080
J	Wang, C; Aleksandrov, AA; Yang, ZR; Forouhar, F; Proctor, EA; Kota, P; An, JL; Kaplan, A; Khazanov, N; Boel, G; Stockwell, BR; Senderowitz, H; Dokholyan, NV; Riordan, JR; Brouillette, CG; Hunt, JF				Wang, Chi; Aleksandrov, Andrei A.; Yang, Zhengrong; Forouhar, Farhad; Proctor, Elizabeth A.; Kota, Pradeep; An, Jianli; Kaplan, Anna; Khazanov, Netaly; Boel, Gregory; Stockwell, Brent R.; Senderowitz, Hanoch; Dokholyan, Nikolay V.; Riordan, John R.; Brouillette, Christie G.; Hunt, John F.			Ligand binding to a remote site thermodynamically corrects the F508del mutation in the human cystic fibrosis transmembrane conductance regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cystic fibrosis; cystic fibrosis transmembrane conductance regulator (CFTR); thermodynamics; protein aggregation; fluorescence resonance energy transfer (FRET); high-throughput screening (HTS); calorimetry; isothermal titration calorimetry (ITC); electrophysiology; deoxythymidine; F508del mutation	DISCRETE MOLECULAR-DYNAMICS; NUCLEOTIDE-BINDING; CONFORMATIONAL MATURATION; ENDOPLASMIC-RETICULUM; DELTA-F508 MUTATION; THERMAL-STABILITY; CHLORIDE CHANNEL; WILD-TYPE; CFTR; PROTEIN	Many disease-causing mutations impair protein stability. Here, we explore a thermodynamic strategy to correct the disease-causing F508del mutation in the human cystic fibrosis transmembrane conductance regulator (hCFTR). F508del destabilizes nucleotide-binding domain 1 (hNBD1) in hCFTR relative to an aggregation-prone intermediate. We developed a fluorescence self-quenching assay for compounds that prevent aggregation of hNBD1 by stabilizing its native conformation. Unexpectedly, we found that dTTP and nucleotide analogs with exocyclic methyl groups bind to hNBD1 more strongly than ATP and preserve electrophysiological function of full-length F508del-hCFTR channels at temperatures up to 37 degrees C. Furthermore, nucleotides that increase open-channel probability, which reflects stabilization of an interdomain interface to hNBD1, thermally protect full-length F508del-hCFTR even when they do not stabilize isolated hNBD1. Therefore, stabilization of hNBD1 itself or of one of its interdomain interfaces by a small molecule indirectly offsets the destabilizing effect of the F508del mutation on full-length hCFTR. These results indicate that high-affinity binding of a small molecule to a remote site can correct a disease-causing mutation. We propose that the strategies described here should be applicable to identifying small molecules to help manage other human diseases caused by mutations that destabilize native protein conformation.	[Wang, Chi; Forouhar, Farhad; Kaplan, Anna; Boel, Gregory; Stockwell, Brent R.; Hunt, John F.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Aleksandrov, Andrei A.; Proctor, Elizabeth A.; Kota, Pradeep; Dokholyan, Nikolay V.; Riordan, John R.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Yang, Zhengrong; An, Jianli; Brouillette, Christie G.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA; [Khazanov, Netaly; Senderowitz, Hanoch] Bar Ilan Univ, Dept Chem, IL-5290002 Ramat Gan, Israel; [Yang, Zhengrong] Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, Birmingham, AL 35294 USA; [Forouhar, Farhad] Columbia Univ, Irving Canc Res Ctr, New York, NY 10032 USA; [Proctor, Elizabeth A.] Penn State Univ, Dept Neurosurg, Hershey, PA 17033 USA; [Proctor, Elizabeth A.] Penn State Univ, Dept Pharmacol, Hershey, PA 17033 USA; [Kota, Pradeep] NCI Frederick, Lab Cell & Dev Signaling, NIH, Frederick, MD 21702 USA; [Boel, Gregory] Univ Paris Diderot, CNRS UMR8261, Sorbonne Paris Cite, Inst Biol Physicochim, 13 Rue Pierre & Marie Curie, F-75005 Paris, France	Columbia University; Columbia University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Alabama System; University of Alabama Birmingham; Bar Ilan University; University of Alabama System; University of Alabama Birmingham; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Hunt, JF (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	jfh21@columbia.edu	Boel, Gregory/N-4623-2016; Stockwell, Brent R/AAE-7200-2019; Proctor, Elizabeth A./K-2350-2012; Dokholyan, Nikolay/B-2238-2009	Boel, Gregory/0000-0001-9900-6493; Stockwell, Brent R/0000-0002-3532-3868; Proctor, Elizabeth A./0000-0002-7627-2198; Dokholyan, Nikolay/0000-0002-8225-4025	Cystic Fibrosis Foundation Therapeutics Inc. as part of the CFTR 3D Structure Consortium [HUNT13XX0]; NATIONAL CANCER INSTITUTE [P01CA087497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123247, T32GM008281, R01GM114015] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation Therapeutics Inc. as part of the CFTR 3D Structure Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from Cystic Fibrosis Foundation Therapeutics Inc. to H. S., J. R. R., C. G. B., and J. F. H. as part of the CFTR 3D Structure Consortium, including grant HUNT13XX0. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alapi E.M., 2006, ANALOGUE BASED DRUG, P441, DOI [10.1002/3527608001.ch23, DOI 10.1002/3527608001.CH23]; Aleksandrov AA, 2002, FEBS LETT, V518, P183, DOI 10.1016/S0014-5793(02)02698-4; Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Aleksandrov AA, 2009, J PHYSIOL-LONDON, V587, P2875, DOI 10.1113/jphysiol.2009.170258; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Aleksandrov L, 2001, J BIOL CHEM, V276, P12918, DOI 10.1074/jbc.M100515200; Aleksandrov LA, 2015, PROTEIN EXPRES PURIF, V116, P159, DOI 10.1016/j.pep.2015.09.018; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Bagdany M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00444-4; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; BALDWIN RL, 1991, CIBA F SYMP, V161, P190; BARRICK D, 1993, PROTEIN SCI, V2, P869, DOI 10.1002/pro.5560020601; Bompadre SG, 2005, J GEN PHYSIOL, V125, P361, DOI 10.1085/jgp.200409227; Bompadre SG, 2005, J GEN PHYSIOL, V125, P377, DOI 10.1085/jgp.200409228; Boyle MP, 2014, LANCET RESP MED, V2, P527, DOI 10.1016/S2213-2600(14)70132-8; CARSON MR, 1995, J BIOL CHEM, V270, P20466, DOI 10.1074/jbc.270.35.20466; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Chung WJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163615; Corradi V, 2015, J BIOL CHEM, V290, P22891, DOI 10.1074/jbc.M115.665125; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; Daughdrill GW, 2005, PROTEIN FOLDING HANDBOOK; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; DOBSON CM, 1994, CURR BIOL, V4, P636, DOI 10.1016/S0960-9822(00)00141-X; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Dong Q, 2012, P NATL ACAD SCI USA, V109, P917, DOI 10.1073/pnas.1120065109; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Eckford PDW, 2014, CHEM BIOL, V21, P666, DOI 10.1016/j.chembiol.2014.02.021; Eckhardt B.J., 2017, INFECT DIS-NOR, P1293; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; Freire E, 2015, THERMODYNAMICS KINET, P1, DOI 10.1002/9783527673025.ch1; Frizzell RA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009563; FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; GRIKO YV, 1988, J MOL BIOL, V202, P127, DOI 10.1016/0022-2836(88)90525-6; Hall JD, 2016, PROTEIN SCI, V25, P360, DOI 10.1002/pro.2821; Hassell AM, 2007, ACTA CRYSTALLOGR D, V63, P72, DOI 10.1107/S0907444906047020; He LH, 2015, J MOL BIOL, V427, P106, DOI 10.1016/j.jmb.2014.07.026; He LH, 2013, FASEB J, V27, P536, DOI 10.1096/fj.12-216119; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hudson RP, 2017, MOL PHARMACOL, V92, P124, DOI 10.1124/mol.117.108373; HUGHSON FM, 1991, BIOCHEMISTRY-US, V30, P4113, DOI 10.1021/bi00231a001; Hunt JF, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009514; INGRAM VM, 1957, NATURE, V180, P326, DOI 10.1038/180326a0; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; JENG MF, 1990, BIOCHEMISTRY-US, V29, P10433, DOI 10.1021/bi00498a001; John DM, 2000, PROTEIN SCI, V9, P1416, DOI 10.1110/ps.9.7.1416; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Liang F, 2012, PEDIATR PULM, V47, P224; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Loo TW, 2010, BIOCHEMISTRY-US, V49, P6352, DOI 10.1021/bi100807h; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Matsumura Y, 2013, J BIOL CHEM, V288, P31069, DOI 10.1074/jbc.M113.479345; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Meng X, 2017, J BIOL CHEM, V292, P3706, DOI 10.1074/jbc.M116.751537; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Moro WB, 2009, BIOORG MED CHEM LETT, V19, P2001, DOI 10.1016/j.bmcl.2009.02.034; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pendergast W, 2001, BIOORG MED CHEM LETT, V11, P157, DOI 10.1016/S0960-894X(00)00612-0; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; PRIVALOV PL, 1989, ANNU REV BIOPHYS BIO, V18, P47, DOI 10.1146/annurev.biophys.18.1.47; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Rahman KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074574; Rakoczy EP, 2011, J MOL BIOL, V405, P584, DOI 10.1016/j.jmb.2010.11.003; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; RIORDAN JR, 1989, SCIENCE, V245, P1066; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; Sampson HM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-11; Sampson HM, 2011, CHEM BIOL, V18, P231, DOI 10.1016/j.chembiol.2010.11.016; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Shirvanyants D, 2012, J PHYS CHEM B, V116, P8375, DOI 10.1021/jp2114576; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vaccaro JA, 2000, ANTIMICROB AGENTS CH, V44, P217, DOI 10.1128/AAC.44.1.217-221.2000; Valastyan JS, 2014, DIS MODEL MECH, V7, P9, DOI 10.1242/dmm.013474; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Yin SY, 2010, METHODS MOL BIOL, V634, P189, DOI 10.1007/978-1-60761-652-8_14; Yin SY, 2009, P NATL ACAD SCI USA, V106, P16622, DOI 10.1073/pnas.0906146106; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhou Z, 2005, J PHYSIOL-LONDON, V569, P447, DOI 10.1113/jphysiol.2005.095083	106	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2018	293	46					17685	17704		10.1074/jbc.RA117.000819	http://dx.doi.org/10.1074/jbc.RA117.000819			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HA6SG	29903914	Green Published, hybrid			2022-12-26	WOS:000450409500003
J	Henderson, AM; Tai, DC; Aleliunas, RE; Aljaadi, AM; Glier, MB; Xu, EE; Miller, JW; Verchere, CB; Green, TJ; Devlin, AM				Henderson, Amanda M.; Tai, Daven C.; Aleliunas, Rika E.; Aljaadi, Abeer M.; Glier, Melissa B.; Xu, Eric E.; Miller, Joshua W.; Verchere, C. Bruce; Green, Tim J.; Devlin, Angela M.			Maternal folic acid supplementation with vitamin B-12 deficiency during pregnancy and lactation affects the metabolic health of adult female offspring but is dependent on offspring diet	FASEB JOURNAL			English	Article						adiposity; developmental programming; folate; glucose homeostasis; maternal diet	HIGH-FAT DIET; INSULIN-RESISTANCE; DNA METHYLATION; FOLATE CONCENTRATIONS; CANADIAN WOMEN; BETA-CELLS; FORTIFICATION; MICE; POPULATION; DISEASE	Epidemiologic studies have reported relationships between maternal high folate and/or low B-12 status during pregnancy and greater adiposity and insulin resistance in children. The goal of this study was to determine the effects of maternal folic acid supplementation (10 mg/kg diet), with (50 g/kg diet) and without B-12, on adult female offspring adiposity and glucose homeostasis. Female C57BL/6J mice were fed 1 of 3 diets from weaning and throughout breeding, pregnancy, and lactation: control (2 mg/kg diet folic acid, 50 g/kg diet B-12), supplemental folic acid with no B-12 (SFA-B-12), or supplemental folic acid with adequate B-12 (SFA+B-12). Female offspring were weaned onto the control diet or a Western diet (45% energy fat, 2 mg/kg diet folic acid, 50 g/kg diet B-12) for 35 wk. After weaning, control diet-fed offspring with SFA-B-12 dams had fasting hyperglycemia, glucose intolerance, lower cell mass, and greater islet hepatocyte nuclear factor 1 homeobox and nuclear receptor subfamily 1 group H member 3 mRNA than did offspring from control dams. In Western diet-fed offspring, those with SFA-B-12 dams had lower fasting blood glucose and plasma insulin concentrations, and were smaller than control offspring. Our findings suggest that maternal folic acid supplementation with B-12 deficiency during pregnancy/lactation programs the metabolic health of adult female offspring but is dependent on offspring diet.Henderson, A. M., Tai, D. C., Aleliunas, R. E., Aljaadi, A. M., Glier, M. B., Xu, E. E., Miller, J. W., Verchere, C. B., Green, T. J., Devlin, A. M. Maternal folic acid supplementation with vitamin B-12 deficiency during pregnancy and lactation affects the metabolic health of adult female offspring but is dependent on offspring diet.	[Henderson, Amanda M.; Glier, Melissa B.; Verchere, C. Bruce; Devlin, Angela M.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Henderson, Amanda M.; Tai, Daven C.; Aleliunas, Rika E.; Aljaadi, Abeer M.; Glier, Melissa B.; Xu, Eric E.; Verchere, C. Bruce; Devlin, Angela M.] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Aljaadi, Abeer M.] Univ British Columbia, Dept Food Nutr & Hlth, Vancouver, BC, Canada; [Xu, Eric E.] Univ British Columbia, Dept Surg, Vancouver, BC, Canada; [Henderson, Amanda M.; Tai, Daven C.; Aleliunas, Rika E.; Aljaadi, Abeer M.; Glier, Melissa B.; Xu, Eric E.; Verchere, C. Bruce; Devlin, Angela M.] British Columbia Childrens Hosp, Res Inst, Vancouver, BC, Canada; [Miller, Joshua W.] Rutgers Univ State Univ New Jersey, Dept Nutr Sci, New Brunswick, NJ USA; [Green, Tim J.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; BC Childrens Hospital; University of British Columbia; Rutgers State University New Brunswick; South Australian Health & Medical Research Institute (SAHMRI)	Devlin, AM (corresponding author), Childrens Hosp Res Inst, A4-194,950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	adevlin@bcchr.ubc.ca	Green, Tim/AAA-8601-2019	Green, Tim/0000-0002-0667-4300; Devlin, Angela/0000-0002-1390-6587	Natural Sciences and Engineering Council of Canada (NSERC); Canadian Institutes of Health Research operating grant; NSERC Canada Graduate Scholarship Master's Program award; University of British Columbia Doctoral Fellowship; British Columbia Children's Hospital Research Institute	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research operating grant(Canadian Institutes of Health Research (CIHR)); NSERC Canada Graduate Scholarship Master's Program award; University of British Columbia Doctoral Fellowship; British Columbia Children's Hospital Research Institute	The authors thank Eugene Wang and Jesse Olson for assistance with animal husbandry; Nolan Chem for assistance with experiments on IGF-1; Mitsushiro Komba and Dr. Michal Simon for assistance with Seahorse experiments; and Galina Soukacheva for assistance with islet isolation (all from the British Columbia Children's Hospital Research Institute). This work was funded by a Natural Sciences and Engineering Council of Canada (NSERC) discovery grant (to A.M.D.) and a Canadian Institutes of Health Research operating grant (to A.M.D.). A.M.H. was supported by an NSERC Canada Graduate Scholarship Master's Program award. M.B.G. was supported by a University of British Columbia Doctoral Fellowship. A.M.D. and C.B.V. were supported by Investigator Grants from the British Columbia Children's Hospital Research Institute. The authors declare no conflicts of interest.	Alejandro EU, 2014, J CLIN INVEST, V124, P4395, DOI 10.1172/JCI74237; Aleliunas RE, 2016, J NUTR, V146, P688, DOI 10.3945/jn.115.227629; Atta CAM, 2016, AM J PUBLIC HEALTH, V106, pE24, DOI 10.2105/AJPH.2015.302902; Bahous RH, 2017, HUM MOL GENET, V26, P888, DOI 10.1093/hmg/ddx004; Berryman DE, 2013, NAT REV ENDOCRINOL, V9, P346, DOI 10.1038/nrendo.2013.64; Cho CE, 2013, EPIGENETICS-US, V8, P710, DOI 10.4161/epi.24948; Christensen KE, 2015, AM J CLIN NUTR, V101, P646, DOI 10.3945/ajcn.114.086603; Colapinto CK, 2011, CAN MED ASSOC J, V183, pE100, DOI 10.1503/cmaj.100568; Cordero P, 2014, J DEV ORIG HLTH DIS, V5, P385, DOI 10.1017/S204017441400035X; De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; Dumortier O, 2014, DIABETES, V63, P3416, DOI 10.2337/db13-1431; FELL D, 1985, J CHROMATOGR, V345, P150, DOI 10.1016/0378-4347(85)80146-8; Garcia-Arevalo M, 2016, ENDOCRINOLOGY, V157, P4158, DOI 10.1210/en.2016-1390; Ghosh S, 2011, J BIOL CHEM, V286, P42483, DOI 10.1074/jbc.M111.304592; Glier MB, 2014, MOL NUTR FOOD RES, V58, P172, DOI 10.1002/mnfr.201200636; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; Hoile SP, 2012, BRIT J NUTR, V108, P852, DOI 10.1017/S0007114511006155; Huang YF, 2014, INT J MOL SCI, V15, P6298, DOI 10.3390/ijms15046298; Keating E, 2015, J ENDOCRINOL, V224, P245, DOI 10.1530/JOE-14-0448; Kelly KB, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100594; Krishnaveni GV, 2014, DIABETOLOGIA, V57, P110, DOI 10.1007/s00125-013-3086-7; Kumar KA, 2013, J NUTR BIOCHEM, V24, P25, DOI 10.1016/j.jnutbio.2012.01.004; Liu SL, 2016, CIRCULATION, V134, P647, DOI 10.1161/CIRCULATIONAHA.116.022126; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luco RF, 2006, DIABETES, V55, P2202, DOI 10.2337/db05-1534; MacFarlane AJ, 2011, AM J CLIN NUTR, V94, P1079, DOI 10.3945/ajcn.111.020230; McKay JA, 2014, MOL NUTR FOOD RES, V58, P1087, DOI 10.1002/mnfr.201300615; Meng ZX, 2012, DIABETOLOGIA, V55, P1733, DOI 10.1007/s00125-012-2516-2; MILLER JW, 1994, AM J CLIN NUTR, V59, P1033, DOI 10.1093/ajcn/59.5.1033; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Page R, 2017, AM J CLIN NUTR, V105, P1101, DOI 10.3945/ajcn.116.137968; Paniz C, 2017, J NUTR, V147, P1684, DOI 10.3945/jn.117.247445; Pfeiffer CM, 2007, AM J CLIN NUTR, V86, P718, DOI 10.1093/ajcn/86.3.718; Pfeiffer CM, 2005, AM J CLIN NUTR, V82, P442, DOI 10.1093/ajcn/82.2.442; Plesner A, 2005, DIABETES, V54, P2533, DOI 10.2337/diabetes.54.9.2533; Plumptre L, 2015, AM J CLIN NUTR, V102, P848, DOI 10.3945/ajcn.115.110783; Ray JG, 2008, QJM-INT J MED, V101, P475, DOI 10.1093/qjmed/hcn031; Rodriguez-Trejo A, 2012, AM J PHYSIOL-ENDOC M, V302, pE1431, DOI 10.1152/ajpendo.00619.2011; Roman-Garcia P, 2014, J CLIN INVEST, V124, P2988, DOI 10.1172/JCI72606; Sabet JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151579; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selhub J, 2016, BIOCHIMIE, V126, P71, DOI 10.1016/j.biochi.2016.04.010; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Stewart CP, 2011, J NUTR, V141, P1912, DOI 10.3945/jn.111.144717; [Subcommittee on Laboratory Animal Nutrition National Research Council (US)], 1995, NUTR REQ LAB AN, P80; Swisa A, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00021; Wilson RD, 2015, J OBSTET GYNAECOL CA, V37, P534, DOI 10.1016/S1701-2163(15)30230-9; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y	50	17	18	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5039	5050		10.1096/fj.201701503RR	http://dx.doi.org/10.1096/fj.201701503RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913560				2022-12-26	WOS:000443817700034
J	Cheng, ZS; Thomas, PW; Ju, LC; Bergstrom, A; Mason, K; Clayton, D; Miller, C; Bethel, CR; VanPelt, J; Tierney, DL; Page, RC; Bonomo, RA; Fast, W; Crowder, MW				Cheng, Zishuo; Thomas, Pei W.; Ju, Lincheng; Bergstrom, Alexander; Mason, Kelly; Clayton, Delaney; Miller, Callie; Bethel, Christopher R.; VanPelt, Jamie; Tierney, David L.; Page, Richard C.; Bonomo, Robert A.; Fast, Walter; Crowder, Michael W.			Evolution of New Delhi metallo-beta-lactamase (NDM) in the clinic: Effects of NDM mutations on stability, zinc affinity, and mono-zinc activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; antibiotics; metalloenzyme; enzyme kinetics; protein evolution; enzyme mutation; Co(II)-substituted enzyme; metallo--lactamase; NDM-1	VARIANTS REVEALS DIFFERENCES; ANTIBIOTIC-RESISTANCE; PROTEIN STABILITY; UNITED-STATES; INHIBITION; NMR	Infections by carbapenem-resistant Enterobacteriaceae are difficult to manage owing to broad antibiotic resistance profiles and because of the inability of clinically used -lactamase inhibitors to counter the activity of metallo--lactamases often harbored by these pathogens. Of particular importance is New Delhi metallo--lactamase (NDM), which requires a di-nuclear zinc ion cluster for catalytic activity. Here, we compare the structures and functions of clinical NDM variants 1-17. The impact of NDM variants on structure is probed by comparing melting temperature and refolding efficiency and also by spectroscopy (UV-visible, H-1 NMR, and EPR) of di-cobalt metalloforms. The impact of NDM variants on function is probed by determining the minimum inhibitory concentrations of various antibiotics, pre-steady-state and steady-state kinetics, inhibitor binding, and zinc dependence of resistance and activity. We observed only minor differences among the fully loaded di-zinc enzymes, but most NDM variants had more distinguishable selective advantages in experiments that mimicked zinc scarcity imposed by typical host defenses. Most NDM variants exhibited improved thermostability (up to approximate to 10 degrees C increased T-m) and improved zinc affinity (up to approximate to 10-fold decreased K-d,K- Zn2). We also provide first evidence that some NDM variants have evolved the ability to function as mono-zinc enzymes with high catalytic efficiency (NDM-15, ampicillin: k(cat)/K-m = 5 x 10(6) m(-1) s(-1)). These findings reveal the molecular mechanisms that NDM variants have evolved to overcome the combined selective pressures of -lactam antibiotics and zinc deprivation.	[Cheng, Zishuo; Bergstrom, Alexander; Mason, Kelly; Clayton, Delaney; Miller, Callie; VanPelt, Jamie; Tierney, David L.; Page, Richard C.; Crowder, Michael W.] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA; [Thomas, Pei W.; Fast, Walter] Univ Texas Austin, Coll Pharm, Div Chem Biol & Med Chem, Austin, TX 78712 USA; [Thomas, Pei W.; Fast, Walter] Univ Texas Austin, LaMontagne Ctr Infect Dis, Austin, TX 78712 USA; [Ju, Lincheng] China Med Univ, Shengjing Hosp, Dept Urol, Shenyang 110004, Liaoning, Peoples R China; [Bethel, Christopher R.; Bonomo, Robert A.] Case Western Reserve Univ, Cleveland Vet Adm Med Ctr VAMC, Ctr Antimicrobial Resistance & Epidemiol CARES, Res Serv,Louis Stokes Cleveland Dept Vet Affairs, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Cleveland Vet Adm Med Ctr VAMC, Ctr Antimicrobial Resistance & Epidemiol CARES, Dept Med, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Cleveland Vet Adm Med Ctr VAMC, Ctr Antimicrobial Resistance & Epidemiol CARES, Dept Mol Biol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Cleveland Vet Adm Med Ctr VAMC, Ctr Antimicrobial Resistance & Epidemiol CARES, Dept Microbiol Biochem Prote & Bioinformat, Cleveland, OH 44106 USA	University System of Ohio; Miami University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; China Medical University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Fast, W (corresponding author), Univ Texas Austin, Coll Pharm, Div Chem Biol & Med Chem, Austin, TX 78712 USA.; Fast, W (corresponding author), Univ Texas Austin, LaMontagne Ctr Infect Dis, Austin, TX 78712 USA.; Tierney, DL; Page, RC; Crowder, MW (corresponding author), Miami Univ, Dept Chem & Biochem, Hughes Labs 160, 651 E High St, Oxford, OH 45056 USA.; Bonomo, RA (corresponding author), Dept Med, Cleveland, OH 44106 USA.; Bonomo, RA (corresponding author), Dept Pharmacol, Cleveland, OH 44106 USA.; Bonomo, RA (corresponding author), Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.; Bonomo, RA (corresponding author), Dept Biochem Prote & Bioinformat, Cleveland, OH 44106 USA.; Bonomo, RA (corresponding author), CWRU, Cleveland VAMC, Ctr Antimicrobial Resistance & Epidemiol, Cleveland, OH 44106 USA.	dtierney@miamioh.edu; pagerc@miamioh.edu; robert.bonomo@va.gov; walt.fast@austin.utexas.edu; crowdemw@miamioh.edu	Cheng, Zishuo/AAD-6861-2020		National Institutes of Health from NIGMS [GM111926, R01AI100560, R01AI063517, R01AI072219]; NIAID, National Science Foundation [CHE-1509285]; Robert A. Welch Foundation [F-1572]; Miami University through the Robert H. and Nancy J. Blayney Professorship; Cleveland Department of Veterans Affairs Award [1I01BX001974]; Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development; Geriatric Research Education and Clinical Center [VISN 10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100560, R01AI072219, R01AI063517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111926] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001974] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID, National Science Foundation; Robert A. Welch Foundation(The Welch Foundation); Miami University through the Robert H. and Nancy J. Blayney Professorship; Cleveland Department of Veterans Affairs Award; Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development; Geriatric Research Education and Clinical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grants GM111926 (to W. F., R. A. B., M. W. C., D. L. T., and R. P.), R01AI100560 (to R. A. B.), R01AI063517 (to R. A. B.), and R01AI072219 (to R. A. B.) from NIGMS and NIAID, National Science Foundation Grant CHE-1509285 (to M. W. C. and D. L. T.), Robert A. Welch Foundation Award F-1572 (to W. F.), Miami University through the Robert H. and Nancy J. Blayney Professorship (to R. C. P.), funds and/or facilities provided by the Cleveland Department of Veterans Affairs Award 1I01BX001974 (to R. A. B.), the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development, and the Geriatric Research Education and Clinical Center VISN 10 (to R. A. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bahr G, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01849-17; Brown NG, 2010, J MOL BIOL, V404, P832, DOI 10.1016/j.jmb.2010.10.008; Castanheira M, 2011, ANTIMICROB AGENTS CH, V55, P1274, DOI 10.1128/AAC.01497-10; Chen X, 2013, ANAL CHEM, V85, P7957, DOI 10.1021/ac401732d; CLSI, 2015, PERF STAND ANT SUSC; Crowder MW, 2006, ACCOUNTS CHEM RES, V39, P721, DOI 10.1021/ar0400241; Cunden LS, 2018, BIOCHEMISTRY-US, V57, P1673, DOI 10.1021/acs.biochem.7b01305; Goldenzweig A, 2018, ANNU REV BIOCHEM, V87, P105, DOI 10.1146/annurev-biochem-062917-012102; Gonzalez LJ, 2016, NAT CHEM BIOL, V12, P516, DOI [10.1038/nchembio.2083, 10.1038/NCHEMBIO.2083]; Hemmingsen L, 2001, J AM CHEM SOC, V123, P10329, DOI 10.1021/ja0112240; Huang WZ, 1997, P NATL ACAD SCI USA, V94, P8801, DOI 10.1073/pnas.94.16.8801; King DT, 2012, J AM CHEM SOC, V134, P11362, DOI 10.1021/ja303579d; Llarrull LI, 2008, J AM CHEM SOC, V130, P15842, DOI 10.1021/ja801168r; Makena A, 2016, ANTIMICROB AGENTS CH, V60, P1377, DOI 10.1128/AAC.01768-15; Makena A, 2015, J ANTIMICROB CHEMOTH, V70, P463, DOI 10.1093/jac/dku403; Orellano EG, 1998, BIOCHEMISTRY-US, V37, P10173, DOI 10.1021/bi980309j; Patel MP, 2015, ANTIMICROB AGENTS CH, V59, P6741, DOI 10.1128/AAC.00618-15; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Riley EA, 2006, INORG CHEM, V45, P10016, DOI 10.1021/ic061207h; Solomon SL, 2014, AM FAM PHYSICIAN, V89, P938; Stewart AC, 2017, ACS INFECT DIS, V3, P927, DOI 10.1021/acsinfecdis.7b00128; TEALE FWJ, 1960, BIOCHEM J, V76, P381, DOI 10.1042/bj0760381; Thomas PW, 2011, BIOCHEMISTRY-US, V50, P10102, DOI 10.1021/bi201449r; Wang ZG, 1998, J AM CHEM SOC, V120, P10788, DOI 10.1021/ja982621m; Woodworth KR, 2018, MMWR-MORBID MORTAL W, V67, P396, DOI 10.15585/mmwr.mm6713e1; Yang H, 2014, BIOCHEM J, V464, P271, DOI 10.1042/BJ20140364; Yang H, 2014, J AM CHEM SOC, V136, P7273, DOI 10.1021/ja410376s; Yang H, 2012, BIOCHEMISTRY-US, V51, P3839, DOI 10.1021/bi300056y	28	60	62	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12606	12618		10.1074/jbc.RA118.003835	http://dx.doi.org/10.1074/jbc.RA118.003835			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29909397	hybrid, Green Published			2022-12-26	WOS:000441408500024
J	Assali, DR; Hsu, CT; Gunapala, KM; Aguayo, A; McBurney, M; Steele, AD				Assali, Dina R.; Hsu, Cynthia T.; Gunapala, Keith M.; Aguayo, Antonio; McBurney, Michael; Steele, Andrew D.			Food anticipatory activity on a calorie-restricted diet is independent of Sirt1	PLOS ONE			English	Article							CIRCADIAN CLOCK; GENE; BRAIN; MICE; PGC-1-ALPHA; HOMEOSTASIS; METABOLISM; EXPRESSION; DIFFERENCE; RESPONSES	A number of studies have demonstrated that the Sirtuin family member, Sirt1, is a key integrator of growth, metabolism, and lifespan. Sirt1 directly interacts with and deacetylates key regulators of the circadian clock, positioning it to be an important link between feeding and circadian rhythms. In fact, one study suggests that Sirt1 is necessary for behavioral anticipation of limited daily food availability, a circadian process termed food anticipatory activity (FAA). In their study, mice overexpressing Sirt1 had enhanced FAA, while mice lacking Sirt1 had little to no FAA. Based on the supposition that Sirt1 was indeed required for FAA, we sought to use Sirt1 deletion to map the neural circuitry responsible for FAA. We began by inactivating Sirt1 using the cell-type specific Cre-driver lines proopiomelanocortin, but after observing no effect on body weight loss or FAA we then moved on to more broadly neuronal Cre drivers Ca2+/calmodulin-dependent protein kinase II and nestin. As neither of these neuronal deletions of Sirt1 had impaired FAA, we then tested 1) a broad postnatal tamoxifen-inducible deletion, 2) a complete, developmental knockout of Sirt1, and 3) a gene replacement, catalytically inactive, form of Sirt1; but all of these mice had FAA similar to controls. Therefore, our findings suggest that FAA is completely independent of Sirt1.	[Assali, Dina R.; Aguayo, Antonio; Steele, Andrew D.] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA; [Hsu, Cynthia T.; Gunapala, Keith M.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [McBurney, Michael] Univ Ottawa, Dept Med, Ottawa, ON, Canada	California State University System; California State Polytechnic University Pomona; California Institute of Technology; University of Ottawa	Steele, AD (corresponding author), Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA.	adsteele@cpp.edu			Ellison Medical Foundation; Caltech Board Fellows in Brain Circuitry Program; Klarman Family Foundation; Eli and Edythe Broad Foundation; National Institute of General Medical Sciences of the National Institutes of Health [SC3GM125570]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM125570] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); Caltech Board Fellows in Brain Circuitry Program; Klarman Family Foundation; Eli and Edythe Broad Foundation; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ADS received salary support from from the Ellison Medical Foundation and the Caltech Board Fellows in Brain Circuitry Program. This work was also supported by the Klarman Family Foundation and the Eli and Edythe Broad Foundation to ADS. Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number SC3GM125570. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191373; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Cakir I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008322; Canto C, 2009, TRENDS ENDOCRIN MET, V20, P325, DOI 10.1016/j.tem.2009.03.008; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Caron AZ, 2014, FASEB J, V28, P1306, DOI 10.1096/fj.13-243568; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Gunapala KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018377; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hsu CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015429; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Li ZG, 2015, HORM BEHAV, V70, P38, DOI 10.1016/j.yhbeh.2015.02.004; Libert S, 2011, CELL, V147, P1459, DOI 10.1016/j.cell.2011.10.054; McBurney Michael W, 2013, Genes Cancer, V4, P125, DOI 10.1177/1947601912474893; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Michalik M, 2015, BEHAV NEUROSCI, V129, P351, DOI 10.1037/bne0000058; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger Ralph E, 2009, J Circadian Rhythms, V7, P11, DOI 10.1186/1740-3391-7-11; Mistlberger Ralph E, 2009, J Circadian Rhythms, V7, P3, DOI 10.1186/1740-3391-7-3; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Noriega LG, 2011, EMBO REP, V12, P1069, DOI 10.1038/embor.2011.151; Orozco-Solis R, 2015, ENDOCRINOLOGY, V156, P2174, DOI 10.1210/en.2014-1805; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Ramadori G, 2008, J NEUROSCI, V28, P9989, DOI 10.1523/JNEUROSCI.3257-08.2008; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Satoh A, 2010, J NEUROSCI, V30, P10220, DOI 10.1523/JNEUROSCI.1385-10.2010; Seifert EL, 2012, FASEB J, V26, P555, DOI 10.1096/fj.11-193979; Sittig LJ, 2016, NEURON, V91, P1253, DOI 10.1016/j.neuron.2016.08.013; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X	47	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199586	10.1371/journal.pone.0199586	http://dx.doi.org/10.1371/journal.pone.0199586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940007	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000436088700027
J	Castillo, E; Morales, DP; Garcia, A; Parrilla, L; Ruiz, VU; Alvarez-Bermejo, JA				Castillo, Encarnacion; Morales, Diego P.; Garcia, Antonio; Parrilla, Luis; Ruiz, Victor U.; Alvarez-Bermejo, Jose A.			A clustering-based method for single-channel fetal heart rate monitoring	PLOS ONE			English	Article							ECG EXTRACTION; ABDOMINAL ECG; DECOMPOSITION; ALGORITHMS; DISEASE; SIGNALS	Non-invasive fetal electrocardiography (ECG) is based on the acquisition of signals from abdominal surface electrodes. The composite abdominal signal consists of the maternal electrocardiogram along with the fetal electrocardiogram and other electrical interferences. These recordings allow for the acquisition of valuable and reliable information that helps ensure fetal well-being during pregnancy. This paper introduces a procedure for fetal heart rate extraction from a single-channel abdominal ECG signal. The procedure is composed of three main stages: a method based on wavelet for signal denoising, a new clustering-based methodology for detecting fetal QRS complexes, and a final stage to correct false positives and false negatives. The novelty of the procedure thus relies on using clustering techniques to classify singularities from the abdominal ECG into three types: maternal QRS complexes, fetal QRS complexes, and noise. The amplitude and time distance of all the local maxima followed by a local minimum were selected as features for the clustering classification. A wide set of real abdominal ECG recordings from two different databases, providing a large range of different characteristics, was used to illustrate the efficiency of the proposed method. The accuracy achieved shows that the proposed technique exhibits a competitve performance when compared to other recent works in the literature and a better performance over threshold-based techniques.	[Castillo, Encarnacion; Morales, Diego P.; Garcia, Antonio; Parrilla, Luis; Ruiz, Victor U.] Univ Granada, Dept Elect & Comp Technol, Campus Univ Fuentenueva, Granada, Spain; [Alvarez-Bermejo, Jose A.] Univ Almeria, Dept Informat, Almeria, Spain	University of Granada; Universidad de Almeria	Castillo, E (corresponding author), Univ Granada, Dept Elect & Comp Technol, Campus Univ Fuentenueva, Granada, Spain.	ecastillo@ditec.ugr.es	García, Antonio/C-6070-2012; Bermejo, José Antonio Álvarez/M-1691-2014; Castillo, Encarnacion/D-9975-2012; Morales, Diego P./E-1005-2012	García, Antonio/0000-0003-3533-4660; Bermejo, José Antonio Álvarez/0000-0002-5815-7858; Castillo, Encarnacion/0000-0001-6476-8105; Morales, Diego P./0000-0002-3294-8934	Banco Santander and Centro Mixto UGR-MADOC through project SIMMA [2/16]; Spain's Ministerio de Educacion, Cultura y Deporte (Programa Estatal de Promocion del Talento y su Empleabilidad en I+D+i, Subprograma Estatal de Movilidad, within Plan Estatal de Investigacion Cientifica y Tecnica y de Innovacion) under a "Salvador de Mad [PRX17/00287]	Banco Santander and Centro Mixto UGR-MADOC through project SIMMA; Spain's Ministerio de Educacion, Cultura y Deporte (Programa Estatal de Promocion del Talento y su Empleabilidad en I+D+i, Subprograma Estatal de Movilidad, within Plan Estatal de Investigacion Cientifica y Tecnica y de Innovacion) under a "Salvador de Mad	This work has been partially funded by Banco Santander and Centro Mixto UGR-MADOC through project SIMMA (code 2/16). The contribution of Antonio Garcia has been partially funded by Spain's Ministerio de Educacion, Cultura y Deporte (Programa Estatal de Promocion del Talento y su Empleabilidad en I+D+i, Subprograma Estatal de Movilidad, within Plan Estatal de Investigacion Cientifica y Tecnica y de Innovacion 2013-2016) under a "Salvador de Madariaga" grant (PRX17/00287).	Abdulhay E.W., 2014, BIOMEDICAL SCI, V2, P53, DOI DOI 10.12691/BSE-2-3-2; Addison PS, 2005, PHYSIOL MEAS, V26, pR155, DOI 10.1088/0967-3334/26/5/R01; Aggarwal CC, 2014, CH CRC DATA MIN KNOW, P1; Almeida R, 2014, PHYSIOL MEAS, V35, P1723, DOI 10.1088/0967-3334/35/8/1723; Alvarez P, 2017, CLASSIFICATION ALGOR, P524, DOI [10.1007/978-3-319-56148-6_47, DOI 10.1007/978-3-319-56148-6_47]; Andreotti F, 2014, PHYSIOL MEAS, V35, P1551, DOI 10.1088/0967-3334/35/8/1551; [Anonymous], 2013, OBSTET GYNAECOL REPR, DOI DOI 10.1016/J.OGRM.2013.06.003; [Anonymous], 2013, NONINVASIVE FETAL EC; [Anonymous], 2011, CLUSTER ANAL; Arya B, 2015, PEDIATR CARDIOL, V36, P1042, DOI 10.1007/s00246-015-1118-4; Asgari S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175139; Behar J, 2014, ANN BIOMED ENG, V42, P1340, DOI 10.1007/s10439-014-0993-9; Bin Queyam A, 2017, TECHNOLOGIES, V5, DOI 10.3390/technologies5040068; Castillo E, 2013, DIGIT SIGNAL PROCESS, V23, P1897, DOI 10.1016/j.dsp.2013.07.010; Castillo E, 2013, PROCEEDINGS IWBBIO 2013: INTERNATIONAL WORK-CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING, P491; Castillo E, 2013, J APPL MATH, DOI 10.1155/2013/763903; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; ICHINO M, 1994, IEEE T SYST MAN CYB, V24, P698, DOI 10.1109/21.286391; Jezewski J, 2012, BIOMED ENG-BIOMED TE, V57, P383, DOI 10.1515/bmt-2011-0130; Kanjilal PP, 1997, IEEE T BIO-MED ENG, V44, P51, DOI 10.1109/10.553712; Karvounis EC, 2009, IEEE T BIO-MED ENG, V56, P1394, DOI 10.1109/TBME.2009.2014691; Kimura Y., 2012, OPEN MED DEVICES J, V4, P7, DOI [10.2174/1875181401204010007, DOI 10.2174/1875181401204010007]; Lee KJ, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16071020; Little TD, CLUSTERING CLASSIFIC, DOI [10.1093/oxfordhb/9780199934898.001.0001/oxfordhb-9780199934898-e-024, DOI 10.1093/OXFORDHB/9780199934898.001.0001/OXFORDHB-9780199934898-E-024]; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Morales DP, 2013, MED ENG PHYS, V35, P1005, DOI 10.1016/j.medengphy.2012.09.011; Murtagh F, 2012, WIRES DATA MIN KNOWL, V2, P86, DOI 10.1002/widm.53; Nanda SJ, 2014, SWARM EVOL COMPUT, V16, P1, DOI 10.1016/j.swevo.2013.11.003; Open Data Commons Legal tools for Open Data, OP DAT COMM LEG TOOL; Panigrahy D, 2017, AUSTRALAS PHYS ENG S, V40, P191, DOI 10.1007/s13246-017-0527-5; Ruys TPE, 2013, J CARDIOL, V61, P107, DOI 10.1016/j.jjcc.2012.11.001; Su L., 2017, FRONT APPL MATH STAT, V3; Verdurmen KMJ, 2016, INT J GYNECOL OBSTET, V135, P129, DOI 10.1016/j.ijgo.2016.05.010; Wu J., 2012, ADV K MEANS CLUSTERI; Yazdani H., 2016, 3 INT C ART INT PATT, P1; Zhang NN, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17030457	36	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199308	10.1371/journal.pone.0199308	http://dx.doi.org/10.1371/journal.pone.0199308			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933366	Green Published, gold, Green Submitted			2022-12-26	WOS:000436076600019
J	Liu, YY; Li, ZL; Pan, M				Liu, Yuyang; Li, Zhaoliang; Pan, Mao			A high-temperature plugging system for offshore heavy oil thermal recovery	PLOS ONE			English	Article								There are many heavy oil reservoirs in offshore oilfields in China. Steam and multiple thermal fluid stimulation technologies are of increasing interest and have been applied to an increasing number of projects. During the stimulation or displacement of heavy oil reservoirs during thermal recovery, several factors, such as reservoir heterogeneity, are prone to cause channeling phenomena and affect the thermal recovery effect of steam stimulation. According to the unique requirements for the stimulation of multiple thermal fluids for offshore heavy oil, this study used transmission, blocking and relieving, heat resistance and a comprehensive evaluation of parallel sand tube experiments to conduct a screening evaluation of plugging systems for the stimulation of multiple thermal fluids, screen out a commonly used plugging agent in the current stage and propose corresponding guidance for the selection basis. The results show that foam, gel, foam gel and temperature-sensitive gel systems have a good transmission performance, whereas the oil sludge exhibits a poorer performance. The phenolic resin system exhibits great plugging properties, followed by oily sludge, temperature-sensitive gel, gel, foam gel and foam. Considering about washing resistance properties, phenolic resin system shows the best quality, followed by oily sludge and temperature-sensitive gel. The oily sludge system brings the best performance in plugging a high-permeability channel than phenolic resin gel and temperature-sensitive gel.	[Liu, Yuyang; Pan, Mao] Peking Univ, Sch Earth & Space Sci, Beijing, Peoples R China; [Liu, Yuyang; Pan, Mao] Peking Univ, Inst Oil & Gas, Beijing, Peoples R China; [Li, Zhaoliang] China Aero Geophys Survey, Beijing, Peoples R China; [Li, Zhaoliang] Remote Sensing Ctr Land & Resources, Beijing, Peoples R China; [Li, Zhaoliang] Minist Land & Resources, Key Lab Airborne Geophys & Remote Sensing Geol, Beijing, Peoples R China	Peking University; Peking University; Ministry of Natural Resources of the People's Republic of China	Li, ZL (corresponding author), China Aero Geophys Survey, Beijing, Peoples R China.; Li, ZL (corresponding author), Remote Sensing Ctr Land & Resources, Beijing, Peoples R China.; Li, ZL (corresponding author), Minist Land & Resources, Key Lab Airborne Geophys & Remote Sensing Geol, Beijing, Peoples R China.	lizhliang@petrochina.com.cn		LIU, Yuyang/0000-0002-6182-3786	Major National Science and Technology Projects of China [2017ZX05013-002]	Major National Science and Technology Projects of China	The work is supported by the funding of the Major National Science and Technology Projects of China (2017ZX05013-002) and the funding is granted to Prof. Mao Pan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Chuanfeng Z, 2008, J OIL GAS TECHNOLOGY, V30, P53; Fan Z, 2000, SPE INT C HLTH SAF E; Fansheng B, 2008, J LIAONING TU NATURA, V27, P677; Guofeng C, 2005, CHINA OFFSHORE OIL G, V17, P31; Haijun W, 2015, FAULT BLOCK OIL GAS, V22, P206; Hu SB, 2014, PETROL SCI TECHNOL, V32, P2458, DOI 10.1080/10916466.2013.841199; Jie J, 2014, NATURAL GAS OIL, V32, P45; Jie J, 2015, OFFSHORE OIL, V35, P38; Kang X., 2011, SPE ENH OIL REC C; Lin Chengyan, 2010, J OIL GAS TECHNOLOGY, P1; Lu Qiong, 2015, SPE AS PAC ENH OIL R; Pan G.M., 2016, P ANN TECHNICAL C EX; Qing YCW, 2012, OIL DRILLING PRODUCT, V34, P79; Shen Dehuang, 2014, Special Oil & Gas Reservoirs, V21, P134, DOI 10.3969/j.issn.1006-6535.2014.04.033; Srivastava P, 2010, SPE ANN TECHN C EXH; Sun YT, 2014, 24 INT OC POL ENG C; [吴刚 Wu Gang], 2012, [石油钻采工艺, Oil Drilling & Production Technology], V34, P100; Wu Z, 2015, PETROL SCI TECHNOL, V33, P1215, DOI 10.1080/10916466.2015.1057591; [彭仕宓 Peng Shimi], 2007, [石油学报, Acta Petrolei Sinica], V28, P79; Yingying W, 2012, FINE SPECIALTY CHEM, V20, P48; Zhang G, 2017, SPE IATMI AS PAC OIL; [张烈辉 ZHANG Lie-hui], 2009, [西南石油大学学报．自然科学版, Journal of Southwest Petroleum University], V31, P178; [赵东锋 Zhao Dongfeng], 2013, [油气地质与采收率, Petroleum Geology and Recovery Efficiency], V20, P65; [赵修太 Zhao Xiutai], 2012, [应用化工, Applied Chemical Industry], V41, P137	25	3	3	7	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199709	10.1371/journal.pone.0199709	http://dx.doi.org/10.1371/journal.pone.0199709			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933409	Green Published, Green Submitted, gold			2022-12-26	WOS:000436076600043
J	Semenova, O; Lightbody, G; O'Toole, JM; Boylan, G; Dempsey, E; Temko, A				Semenova, Oksana; Lightbody, Gordon; O'Toole, John M.; Boylan, Geraldine; Dempsey, Eugene; Temko, Andriy			Coupling between mean blood pressure and EEG in preterm neonates is associated with reduced illness severity scores	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; INFORMATION-THEORETIC MEASURES; FRACTIONAL OXYGEN EXTRACTION; CEREBRAL ELECTRICAL-ACTIVITY; MUTUAL INFORMATION; PREMATURE-INFANTS; GESTATIONAL-AGE; ACTIVITY TRANSIENTS; SPECTRAL-ANALYSIS; TRANSFER ENTROPY	Hypotension or low blood pressure (BP) is a common problem in preterm neonates and has been associated with adverse short and long-term neurological outcomes. Deciding when and whether to treat hypotension relies on an understanding of the relationship between BP and brain functioning. This study aims to investigate the interaction (coupling) between BP and continuous multichannel unedited EEG recordings in preterm infants less than 32 weeks of gestational age. The EEG was represented by spectral power in four frequency sub-bands: 0.3 +/- 3 Hz, 3 +/- 8 Hz, 8 +/- 15 Hz and 15 +/- 30 Hz. BP was represented as mean arterial pressure (MAP). The level of coupling between the two physiological systems was estimated using linear and nonlinear methods such as correlation, coherence and mutual information. Causality of interaction was measured using transfer entropy. The illness severity was represented by the clinical risk index for babies (CRIB II score) and contrasted to the computed level of interaction. It is shown here that correlation and coherence, which are linear measures of the coupling between EEG and MAP, do not correlate with CRIB values, whereas adjusted mutual information, a nonlinear measure, is associated with CRIB scores (r = -0.57, p = 0.003). Mutual information is independent of the absolute values of MAP and EEG powers and quantifies the level of coupling between the short-term dynamics in both signals. The analysis indicated that the dominant causality is from changes in EEG producing changes in MAP. Transfer entropy (EEG to MAP) is associated with the CRIB score (0.3 +/- 3 Hz: r = 0.428, p = 0.033, 3 +/- 8 Hz: r = 0.44, p = 0.028, 8 +/- 15 Hz: r = 0.416, p = 0.038) and indicates that a higher level of directed coupling from brain activity to blood pressure is associated with increased illness in preterm infants. This is the first study to present the nonlinear measure of interaction between brain activity and blood pressure and to demonstrate its relation to the initial illness severity in the preterm infant. The obtained results allow us to hypothesise that the normal wellbeing of a preterm neonate can be characterised by a nonlinear coupling between brain activity and MAP, whereas the presence of weak coupling with distinctive directionality of information flow is associated with an increased mortality rate in preterms.	[Semenova, Oksana; Lightbody, Gordon; Temko, Andriy] Univ Coll Cork, Dept Elect & Elect Engn, Cork, Ireland; [Semenova, Oksana; Lightbody, Gordon; O'Toole, John M.; Boylan, Geraldine; Dempsey, Eugene; Temko, Andriy] Univ Coll Cork, Irish Ctr Fetal & Neonatal Translat Res, Cork, Ireland; [O'Toole, John M.; Boylan, Geraldine; Dempsey, Eugene] Univ Coll Cork, Dept Pediat & Child Hlth, Cork, Ireland	University College Cork; University College Cork; University College Cork	Semenova, O (corresponding author), Univ Coll Cork, Dept Elect & Elect Engn, Cork, Ireland.; Semenova, O (corresponding author), Univ Coll Cork, Irish Ctr Fetal & Neonatal Translat Res, Cork, Ireland.	o.semenova@umail.ucc.ie	Dempsey, Eugene/AAG-3037-2021; Dempsey, Eugene Michael/H-8051-2015; Temko, Andriy/A-8503-2015	Boylan, Geraldine/0000-0003-0920-5291; Dempsey, Eugene Michael/0000-0002-6266-3462; Temko, Andriy/0000-0001-6548-0971	Science Foundation Ireland (SFI) Centers Program Award [SFI 12/RC/2272]; Science Foundation Ireland [15/SIRG/3580]	Science Foundation Ireland (SFI) Centers Program Award(Science Foundation Ireland); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This research was supported by a Science Foundation Ireland (SFI) Centers Program Award (SFI 12/RC/2272) to GB. JMOT received financial support from Science Foundation Ireland (15/SIRG/3580).	BELL AH, 1991, J CLIN NEUROPHYSIOL, V8, P312, DOI 10.1097/00004691-199107010-00007; Caicedo A, 2016, ADV EXP MED BIOL, V923, P143, DOI 10.1007/978-3-319-38810-6_19; Dempsey EM, 2007, J PERINATOL, V27, P469, DOI 10.1038/sj.jp.7211774; Dempsey EM, 2006, J PERINATOL, V26, P677, DOI 10.1038/sj.jp.7211579; Dempsey EM, 2009, ARCH DIS CHILD-FETAL, V94, pF241, DOI 10.1136/adc.2007.124263; Dempsey EM, 2015, ARCH DIS CHILD-FETAL, V100, pF380, DOI 10.1136/archdischild-2015-308667; Dorling JS, 2005, ARCH DIS CHILD-FETAL, V90, pF11, DOI 10.1136/adc.2003.048488; Doyle LW, 2003, PEDIATRICS, V111, P252, DOI 10.1542/peds.111.2.252; Gagliardi L, 2004, ARCH DIS CHILD-FETAL, V89, pF419, DOI 10.1136/adc.2003.031286; Hallberg B, 2010, ACTA PAEDIATR, V99, P531, DOI 10.1111/j.1651-2227.2009.01653.x; Jayasinghe D, 2003, PEDIATR RES, V54, P848, DOI 10.1203/01.PDR.0000088071.30873.DA; Jeong J, 2001, CLIN NEUROPHYSIOL, V112, P827, DOI 10.1016/S1388-2457(01)00513-2; Katura T, 2006, NEUROIMAGE, V31, P1592, DOI 10.1016/j.neuroimage.2006.02.010; Kistner A, 2000, PEDIATR NEPHROL, V15, P215, DOI 10.1007/s004670000473; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Laughon M, 2007, PEDIATRICS, V119, P273, DOI 10.1542/peds.2006-1138; LEVENE M, 1992, ARCH DIS CHILD-FETAL, V67, P1221; Lindner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-119; Lizier JT, 2014, FRONT ROBOT AI, DOI 10.3389/frobt.2014.00011; Lizier JT, 2012, INFORM SCIENCES, V208, P39, DOI 10.1016/j.ins.2012.04.016; Lizier JT, 2011, J COMPUT NEUROSCI, V30, P85, DOI 10.1007/s10827-010-0271-2; Mangia S, 2009, J CEREBR BLOOD F MET, V29, P441, DOI 10.1038/jcbfm.2008.134; Na SH, 2002, CLIN NEUROPHYSIOL, V113, P1954, DOI 10.1016/S1388-2457(02)00197-9; Netoff TI, 2006, HDB TIME SERIES ANAL, P265, DOI DOI 10.1002/9783527609970.CH11; Niemarkt HJ, 2011, PEDIATR RES, V70, P529, DOI 10.1203/PDR.0b013e31822d748b; Nosek BA, 2014, SOC PSYCHOL-GERMANY, V45, P137, DOI 10.1027/1864-9335/a000192; Okumura A, 2006, PEDIATR NEUROL, V34, P30, DOI 10.1016/j.pediatrneurol.2005.06.005; OMBONI S, 1993, HYPERTENSION, V22, P26, DOI 10.1161/01.HYP.22.1.26; Parry G, 2003, LANCET, V361, P1789, DOI 10.1016/S0140-6736(03)13397-1; Pavlidis E, 2017, ACTA PAEDIATR, V106, P1394, DOI 10.1111/apa.13956; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Pfurtscheller G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043640; Pikovsky A., SYNCHRONIZATION UNIV; Pompe B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051122; Ragwitz M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056201; Roche-Labarbe N, 2007, NEUROIMAGE, V36, P718, DOI 10.1016/j.neuroimage.2007.04.002; Roulston MS, 1997, PHYSICA D, V110, P62, DOI 10.1016/S0167-2789(97)00117-6; Shah D, 2013, PEDIATR RES, V74, P314, DOI 10.1038/pr.2013.104; SHAW JC, 1981, J MED ENG TECHNOL, V5, P279, DOI 10.3109/03091908109009362; Siewert-Delle A, 1998, AM J HYPERTENS, V11, P946, DOI 10.1016/S0895-7061(98)00090-9; Steinbrink J, 2006, MAGN RESON IMAGING, V24, P495, DOI 10.1016/j.mri.2005.12.034; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Synnes AR, 2001, J PEDIATR-US, V138, P525, DOI 10.1067/mpd.2001.111822; Tataranno ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124623; Tokariev A, 2012, NEUROIMAGE, V60, P1562, DOI 10.1016/j.neuroimage.2011.12.080; Tolonen M, 2007, NEUROSCIENCE, V145, P997, DOI 10.1016/j.neuroscience.2006.12.070; Vanhatalo S, 2005, EUR J NEUROSCI, V22, P2799, DOI 10.1111/j.1460-9568.2005.04459.x; Vesoulis ZA, 2017, J APPL PHYSIOL, V123, P55, DOI 10.1152/japplphysiol.00205.2017; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Victor S, 2006, PEDIATR RES, V59, P314, DOI 10.1203/01.pdr.0000199525.08615.1f; Victor S, 2006, PEDIATR RES, V60, P456, DOI 10.1203/01.pdr.0000238379.67720.19; Vinh NX, 2010, J MACH LEARN RES, V11, P2837; Wagenmakers EJ, 2012, PERSPECT PSYCHOL SCI, V7, P632, DOI 10.1177/1745691612463078; WEINDLING AM, 1989, ARCH DIS CHILD-FETAL, V64, P444, DOI 10.1136/adc.64.4_Spec_No.444; West CR, 2006, PEDIATR RES, V59, P610, DOI 10.1203/01.pdr.0000203095.06442.ad; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809; Wollstadt P, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005511; Yamada T, 2012, PRACTICAL GUIDE CLIN	58	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199587	10.1371/journal.pone.0199587	http://dx.doi.org/10.1371/journal.pone.0199587			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933403	Green Submitted, Green Published, gold			2022-12-26	WOS:000436076600035
J	Lazaro-Cote, A; Sadoul, B; Jackson, LJ; Vijayan, MM				Lazaro-Cote, Analisa; Sadoul, Bastien; Jackson, Leland J.; Vijayan, Mathilakath M.			Acute stress response of fathead minnows caged downstream of municipal wastewater treatment plants in the Bow River, Calgary	PLOS ONE			English	Article							ACUTE HANDLING DISTURBANCE; RAINBOW-TROUT; 3-SPINED STICKLEBACKS; ENVIRONMENTAL LEVELS; GLYCOGEN-METABOLISM; PIMEPHALES-PROMELAS; EFFLUENT EXPOSURE; CORTISOL; FISH; PHARMACEUTICALS	We examined whether exposure to municipal wastewater effluent (MWWE) compromised the stress performance of laboratory-reared fathead minnows (Pimephales promelas) in a field setting. Adult minnows were caged at two sites upstream and three sites downstream of wastewater treatments plants (WWTPs) discharging MWWE into the Bow River, Calgary, Alberta, Canada. At each site one group of fish was sampled after a 26 day exposure to MWWE, while another group was subjected to 1-min air exposure followed by 60-min confinement and then sampled. Fish morphometrics and proximate composition were measured, and whole-body cortisol, glucose and lactate levels assessed as markers of the stress response. The whole-body protein, glycogen and lipid content were higher at the site closest to a WWTP outfall relative to the other downstream and upstream sites. There were no significant differences in whole-body cortisol levels in minnows sampled at sites either upstream or downstream of WWTPs. Acute stressor exposure significantly elevated whole-body cortisol levels in all groups, and this response was not modified by the location of the sampling sites. The whole-body metabolite profile, including glucose and lactate levels, were significantly higher in fish caged immediately downstream from WWTP inputs relative to upstream sites. There was an acute-stressor-mediated increase in whole-body lactate, but not glucose, levels and this response was independent of sampling site. The results reveal that the capacity to evoke an acute stress response was not compromised in fathead minnows caged for 26 days downstream of WWTPs in the Bow River. However, there were changes in the whole-body proximate composition and metabolite levels immediately downstream from the WWTP outfall suggesting greater accumulation of energy stores in these fish. Taken together, our results suggest that environmental factors in addition to contaminants, including higher water temperature and nutrient availability, influence the impact of MWWEs on fish stress performance.	[Lazaro-Cote, Analisa; Sadoul, Bastien; Jackson, Leland J.; Vijayan, Mathilakath M.] Univ Calgary, Dept Biol Sci, Calgary, AB, Canada	University of Calgary	Vijayan, MM (corresponding author), Univ Calgary, Dept Biol Sci, Calgary, AB, Canada.	matt.vijayan@ucalgary.ca	ANIKUZHIYIL, ANISH/Y-8609-2018; Vijayan, Mathilakath/AAC-2190-2020	ANIKUZHIYIL, ANISH/0000-0001-9686-1283; Sadoul, Bastien/0000-0001-5968-3983				Al-Habsi AA, 2016, COMP BIOCHEM PHYS B, V199, P87, DOI 10.1016/j.cbpb.2015.11.009; Arlos MJ, 2015, WATER RES, V72, P40, DOI 10.1016/j.watres.2014.11.008; Askey PJ, 2007, ECOL FRESHW FISH, V16, P343, DOI 10.1111/j.1600-0633.2007.00221.x; Barton BA, 2002, BIOLOGICAL INDICATORS OF AQUATIC ECOSYSTEM STRESS, P111; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergmeyer HU, 1983, METHODS ENZYMATIC AN; Best C, 2017, SCI REP-UK, V7, DOI 10.1038/srep40905; Best C, 2014, AQUAT TOXICOL, V155, P190, DOI 10.1016/j.aquatox.2014.06.014; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Chen M, 2006, WATER QUAL RES J CAN, V41, P351, DOI 10.2166/wqrj.2006.039; Chung CWY, 2013, THESIS; Corcoran J, 2010, CRIT REV TOXICOL, V40, P287, DOI 10.3109/10408440903373590; Duffy WG, 1998, CAN J FISH AQUAT SCI, V55, P15, DOI 10.1139/cjfas-55-1-15; Faught E, 2016, COMP BIOCHEM PHYS B, V199, P136, DOI 10.1016/j.cbpb.2016.06.012; Faught E, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160032; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gracia-Lor E, 2010, J CHROMATOGR A, V1217, P622, DOI 10.1016/j.chroma.2009.11.090; Gravel A, 2007, AQUAT TOXICOL, V85, P87, DOI 10.1016/j.aquatox.2007.07.001; Hemming JM, 2004, ECOTOX ENVIRON SAFE, V57, P303, DOI 10.1016/S0147-6513(03)00025-3; HOLCOMBE GW, 1982, ENVIRON POLLUT A, V29, P167, DOI 10.1016/0143-1471(82)90161-1; Hontela A, 2008, ADRENAL TOXICOLOGY, P233; Ings JS, 2012, COMP BIOCHEM PHYS C, V156, P67, DOI 10.1016/j.cbpc.2012.04.002; Ings JS, 2012, AQUAT TOXICOL, V108, P53, DOI 10.1016/j.aquatox.2011.09.009; Ings JS, 2011, ENVIRON SCI TECHNOL, V45, P2368, DOI 10.1021/es103122g; Ings JS, 2011, AQUAT TOXICOL, V103, P85, DOI 10.1016/j.aquatox.2011.02.013; Iwama George K., 2006, P319; Jobling S, 2003, PURE APPL CHEM, V75, P2219, DOI 10.1351/pac200375112219; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Lajeunesse A, 2008, ANAL CHEM, V80, P5325, DOI 10.1021/ac800162q; Lajeunesse A, 2012, WATER RES, V46, P5600, DOI 10.1016/j.watres.2012.07.042; Melnyk-Lamont N, 2014, ENVIRON SCI TECHNOL, V48, P13434, DOI 10.1021/es504331n; Metcalfe CD, 2003, ENVIRON TOXICOL CHEM, V22, P2881, DOI 10.1897/02-627; Miller JL, 2014, ENVIRON TOXICOL, V29, P54, DOI 10.1002/tox.20772; MILLIGAN CL, 1993, J EXP BIOL, V180, P175; Milligan CL, 2003, J EXP BIOL, V206, P3167, DOI 10.1242/jeb.00538; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; MUNKITTRICK KR, 1991, ENVIRON TOXIC WATER, V6, P35, DOI 10.1002/tox.2530060105; Nesan D, 2016, SCI REP-UK, V6, DOI 10.1038/srep22582; Philip AM, 2018, DEV COMP IMMUNOL, V79, P67, DOI 10.1016/j.dci.2017.10.009; Pottinger TG, 2010, J FISH BIOL, V76, P601, DOI 10.1111/j.1095-8649.2009.02516.x; Pottinger TG, 2016, GEN COMP ENDOCR, V230, P29, DOI 10.1016/j.ygcen.2016.03.022; Pottinger TG, 2016, ECOTOXICOLOGY, V25, P538, DOI 10.1007/s10646-016-1612-3; Pottinger TG, 2013, AQUAT TOXICOL, V126, P382, DOI 10.1016/j.aquatox.2012.09.002; Ramsay JM, 2009, AQUACULTURE, V297, P157, DOI 10.1016/j.aquaculture.2009.08.035; Sadoul B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13301-7; Sandhu N, 2014, AQUAT TOXICOL, V146, P20, DOI 10.1016/j.aquatox.2013.10.010; Schreck CB, 2016, FISH PHYSIOL, V35, P1, DOI 10.1016/B978-0-12-802728-8.00001-1; The City of Calgary, 2011, STORMWATER MANAGEMEN; Vieno NM, 2005, ENVIRON SCI TECHNOL, V39, P8220, DOI 10.1021/es051124k; Vijayan MM, 2010, FISH DISEASES AND DISORDERS, VOL 2: NON-INFECTIOUS DISORDERS, 2ND EDITION, P182, DOI 10.1079/9781845935535.0182; Vijayan MM, 2006, TOXICOL SCI, V91, P431, DOI 10.1093/toxsci/kfj154; VIJAYAN MM, 1992, CAN J FISH AQUAT SCI, V49, P2260, DOI 10.1139/f92-247; WARES WD, 1979, COMP BIOCHEM PHYS A, V62, P351, DOI 10.1016/0300-9629(79)90070-7; Westerbeek-Vopicka K, 2009, WATER QUAL RES J CAN, V44, P81	54	7	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198177	10.1371/journal.pone.0198177	http://dx.doi.org/10.1371/journal.pone.0198177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927929	Green Submitted, gold, Green Published			2022-12-26	WOS:000435802500009
J	Liesmaa, I; Paakkanen, R; Jarvinen, A; Valtonen, V; Lokki, ML				Liesmaa, Inka; Paakkanen, Riitta; Jarvinen, Asko; Valtonen, Ville; Lokki, Marja-Liisa			Clinical features of patients with homozygous complement C4A or C4B deficiency	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RECURRENT RESPIRATORY-INFECTIONS; RP-C4-CYP21-TNX RCCX MODULES; COPY-NUMBER VARIATION; COMPONENT C4A; RISK-FACTORS; HLA SYSTEM; 2 PARTS; DISEASE; GENE	Introduction Homozygous deficiencies of complement C4A or C4B are detected in 1-10% of populations. In genome-wide association studies C4 deficiencies are missed because the genetic variation of C4 is complex. There are no studies where the clinical presentation of these patients is analyzed. This study was aimed to characterize the clinical features of patients with homozygous C4A or C4B deficiency. Material and methods Thirty-two patients with no functional C4A, 87 patients with no C4B and 120 with normal amount of C4 genes were included. C4A and C4B numbers were assessed with genomic quantitative real-time PCR. Medical history was studied retrospectively from patients' files. Results Novel associations between homozygous C4A deficiency and lymphoma, coeliac disease and sarcoidosis were detected. These conditions were present in 12.5%, (4/32 in patients vs. 0.8%, 1/120, in controls, OR = 17.00, 95%Cl = 1.83-158.04, p = 0.007), 12.5% (4/32 in patients vs. 0%, 0/120 in controls, OR = 1.14, 95%Cl = 1.00-1.30, p = 0.002) and 12.5%, respectively (4/32 in patients vs. 2.5%, 3/120 in controls, OR = 5.571, 95%Cl = 1.79-2.32, p = 0.036). In addition, C4A and C4B deficiencies were both associated with adverse drug reactions leading to drug discontinuation (34.4%, 11/32 in C4A-deficient patients vs. 14.2%, 17/120 in controls, OR = 3.174, 95%Cl = 1.30-7.74, p = 0.009 and 28.7%, 25/87 in C4B-deficient patients, OR = 2.44, 95%Cl = 1.22-4.88, p = 0.010). Conclusion This reported cohort of homozygous deficiencies of C4A or C4B suggests that C4 deficiencies may have various unrecorded disease associations. C4 gene should be considered as a candidate gene in studying these selected disease associations.	[Liesmaa, Inka; Jarvinen, Asko; Valtonen, Ville] Univ Helsinki, Inflammat Ctr, Div Infect Dis, Helsinki, Finland; [Liesmaa, Inka; Paakkanen, Riitta; Jarvinen, Asko; Valtonen, Ville] Helsinki Univ Hosp, Helsinki, Finland; [Paakkanen, Riitta; Lokki, Marja-Liisa] Univ Helsinki, Transplantat Lab, Medicum, Helsinki, Finland; [Paakkanen, Riitta] Univ Helsinki, Dept Med, Div Cardiol, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki	Liesmaa, I (corresponding author), Univ Helsinki, Inflammat Ctr, Div Infect Dis, Helsinki, Finland.; Liesmaa, I (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	inka.liesmaa@hus.fi		Liesmaa, Inka/0000-0001-9300-1886				Blanchong CA, 2000, J EXP MED, V191, P2183, DOI 10.1084/jem.191.12.2183; Boteva L, 2012, AM J HUM GENET, V90, P445, DOI 10.1016/j.ajhg.2012.01.012; Boteva L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022128; Candore Giuseppina, 2002, Autoimmunity Reviews, V1, P29, DOI 10.1016/S1568-9972(01)00004-0; Chung EK, 2002, AM J HUM GENET, V71, P810, DOI 10.1086/342778; CHUNG EK, 2005, CURR PROTOC IMMUNOL; DANGEL AW, 1994, IMMUNOGENETICS, V40, P425; Grunewald J, 2009, AM J RESP CRIT CARE, V179, P307, DOI 10.1164/rccm.200807-1082OC; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Ittiprasert W, 2005, J AUTOIMMUN, V25, P77, DOI 10.1016/j.jaut.2005.04.004; Jaatinen T, 1999, HUM IMMUNOL, V60, P707, DOI 10.1016/S0198-8859(99)00047-6; Kainulainen L, 2012, HUM IMMUNOL, V73, P498, DOI 10.1016/j.humimm.2012.02.015; Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006; Klein J, 2000, NEW ENGL J MED, V343, P782, DOI 10.1056/NEJM200009143431106; Lipsker D, 2010, LUPUS, V19, P1096, DOI 10.1177/0961203310373370; Lokki ML, 1999, J IMMUNOL, V162, P3687; Man XY, 2003, ANN RHEUM DIS, V62, P71, DOI 10.1136/ard.62.1.71; Margery-Muir AA, 2014, ARTHRITIS RHEUMATOL, V66, P2512, DOI 10.1002/art.38680; Mostafa GA, 2010, J NEUROIMMUNOL, V223, P115, DOI 10.1016/j.jneuroim.2010.03.025; Mougey R, 2010, Immunohematology, V26, P30; Paakkanen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038813; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rigby WFC, 2012, ARTHRITIS RHEUM-US, V64, P1338, DOI 10.1002/art.33472; RITTNER C, 1984, TISSUE ANTIGENS, V23, P130; Samano Eliana Sueco Tibana, 2004, Rev. Hosp. Clin., V59, P138, DOI 10.1590/S0041-87812004000300009; Sane J, 2012, CLIN INFECT DIS, V55, P358, DOI 10.1093/cid/cis405; Saxena K, 2009, MOL IMMUNOL, V46, P1289, DOI 10.1016/j.molimm.2008.11.018; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Senbagavalli P, 2011, HUM IMMUNOL, V72, P173, DOI 10.1016/j.humimm.2010.11.002; Seppanen M, 2006, CLIN EXP IMMUNOL, V145, P219, DOI 10.1111/j.1365-2249.2006.03134.x; Skattum L, 2011, MOL IMMUNOL, V48, P1643, DOI 10.1016/j.molimm.2011.05.001; Soto K, 2010, CLIN IMMUNOL, V137, P166, DOI 10.1016/j.clim.2010.06.003; Szalai C, 2002, J MED GENET, V39, P46, DOI 10.1136/jmg.39.1.46; Szilagyi A, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-1; Szilagyi A, 2008, CYTOGENET GENOME RES, V123, P118, DOI 10.1159/000184699; Wahrmann M, 2011, J AM SOC NEPHROL, V22, P367, DOI 10.1681/ASN.2010050513; Wennerstrom A, 2012, HUM IMMUNOL, V73, P93, DOI 10.1016/j.humimm.2011.10.016; Wouters D, 2009, MOL IMMUNOL, V46, P592, DOI 10.1016/j.molimm.2008.07.028; Wu YL, 2009, GENES IMMUN, V10, P433, DOI 10.1038/gene.2009.10; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; YU CY, 1986, EMBO J, V5, P2873, DOI 10.1002/j.1460-2075.1986.tb04582.x; YU CY, 1991, J IMMUNOL, V146, P1057; Zhang ZH, 2005, LANCET, V366, P556, DOI 10.1016/S0140-6736(05)67099-7	43	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199305	10.1371/journal.pone.0199305	http://dx.doi.org/10.1371/journal.pone.0199305			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928053	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500070
J	Inguva, V; Kathuria, SV; Bilsel, O; Perot, BJ				Inguva, Venkatesh; Kathuria, Sagar V.; Bilsel, Osman; Perot, Blair James			Computer design of microfluidic mixers for protein/RNA folding studies	PLOS ONE			English	Article							TURBULENCE MODELS; MICROSECOND; VISCOSITY; KINETICS; FLOW	Kinetic studies of biological macromolecules increasingly use microfluidic mixers to initiate and monitor reaction progress. A motivation for using microfluidic mixers is to reduce sample consumption and decrease mixing time to microseconds. Some applications, such as small-angle x-ray scattering, also require large (>10 micron) sampling areas to ensure high signal-to-noise ratios and to minimize parasitic scattering. Chaotic to marginally turbulent mixers are well suited for these applications because this class of mixers provides a good middle ground between existing laminar and turbulent mixers. In this study, we model various chaotic to marginally turbulent mixing concepts such as flow turning, flow splitting, and vortex generation using computational fluid dynamics for optimization of mixing efficiency and observation volume. Design iterations show flow turning to be the best candidate for chaotic/marginally turbulent mixing. A qualitative experimental test is performed on the finalized design with mixing of 10 M urea and water to validate the flow turning unsteady mixing concept as a viable option for RNA and protein folding studies. A comparison of direct numerical simulations (DNS) and turbulence models suggests that the applicability of turbulence models to these flow regimes may be limited.	[Inguva, Venkatesh; Perot, Blair James] Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA; [Kathuria, Sagar V.; Bilsel, Osman] Univ Massachusetts, Dept Biochem & Mol Pharmacol, Med Sch, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Worcester	Inguva, V (corresponding author), Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA.	vinguva@engin.umass.edu	Perot, Blair/Q-6493-2019	Perot, Blair/0000-0002-3279-1981; Bilsel, Osman/0000-0003-0414-3060	National Science Foundation Instrument Development Biological Research Award [1353942]	National Science Foundation Instrument Development Biological Research Award	This work was supported by National Science Foundation Instrument Development Biological Research Award No. 1353942 (OB, BJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, TURBULENT FLOWS, DOI DOI 10.1017/CBO9780511840531; Ansys I. CFD, 2015, ICEM CFD THEOR GUID; Arai M, 2011, J MOL BIOL, V410, P329, DOI 10.1016/j.jmb.2011.04.057; Arasa K., 2013, AM J BIOMED ENG, V3, P91, DOI [DOI 10.5923/J.AJBE.20130304.02, 10.5923/j.ajbe.20130304.02]; Bellouard Y, 2004, OPT EXPRESS, V12, P2120, DOI 10.1364/OPEX.12.002120; Bergeaud V, 2010, SOFTWARE INTEGRATION; Bilsel O, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1834698; Bringer MR, 2004, PHILOS T R SOC A, V362, P1087, DOI 10.1098/rsta.2003.1364; Chen DL, 2005, J AM CHEM SOC, V127, P9672, DOI 10.1021/ja052279v; COURANT R, 1967, IBM J RES DEV, V11, P215, DOI 10.1147/rd.112.0215; Gobby D, 2001, J MICROMECH MICROENG, V11, P126, DOI 10.1088/0960-1317/11/2/307; Gruber MF, 2011, J MEMBRANE SCI, V379, P488, DOI 10.1016/j.memsci.2011.06.022; Henderson A., 2004, THE PARAVIEW GUIDE; Hertzog DE, 2004, ANAL CHEM, V76, P7169, DOI 10.1021/ac048661s; Hills RD, 2010, J MOL BIOL, V398, P332, DOI 10.1016/j.jmb.2010.03.001; Jasak H., 2007, INT WORKSH COUPL MET, V1000, P1; Jiang X., 2016, NUMERICAL TECHNIQUES; KAWAHARA K, 1966, J BIOL CHEM, V241, P3228; Knight JB, 1998, PHYS REV LETT, V80, P3863, DOI 10.1103/PhysRevLett.80.3863; Lapidus LJ, 2007, BIOPHYS J, V93, P218, DOI 10.1529/biophysj.106.103077; Launder B. E., 1974, Letters in Heat and Mass Transfer, V1, P131, DOI 10.1016/0094-4548(74)90150-7; Lei Z, 2017, THERMAL SCI, V21; Liu P, 2016, THERM SCI, V20, P967, DOI 10.2298/TSCI1603967L; MENTER FR, 1994, AIAA J, V32, P1598, DOI 10.2514/3.12149; Park HY, 2006, ANAL CHEM, V78, P4465, DOI 10.1021/ac060572n; Paul E. L., 2003, HDB IND MIXING SCI P; REGENFUSS P, 1985, REV SCI INSTRUM, V56, P283, DOI 10.1063/1.1138345; Riegel J, 2012, ABOUT FREECAD; Seed WA., 2012, MECH CIRCULATION; Shastry MCR, 1998, BIOPHYS J, V74, P2714, DOI 10.1016/S0006-3495(98)77977-9; Shastry MCR, 1998, NAT STRUCT BIOL, V5, P385, DOI 10.1038/nsb0598-385; SHIH TH, 1995, COMPUT FLUIDS, V24, P227, DOI 10.1016/0045-7930(94)00032-T; Song H, 2003, APPL PHYS LETT, V83, P4664, DOI 10.1063/1.1630378; Spalart PR, 2007, AIAA J, V45, P2544, DOI 10.2514/1.29373; SPALART PR, 1994, RECH AEROSPATIALE, P5; Wilcox D., 2013, BASIC FLUID MECH; Wu Y, 2008, P NATL ACAD SCI USA, V105, P13367, DOI 10.1073/pnas.0802788105; Wu Y, 2007, J MOL BIOL, V366, P1624, DOI 10.1016/j.jmb.2006.12.005	38	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0198534	10.1371/journal.pone.0198534	http://dx.doi.org/10.1371/journal.pone.0198534			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924842	Green Submitted, Green Published, gold			2022-12-26	WOS:000435655600027
J	Lee, CG; Lee, J; Lee, M				Lee, Cha Gon; Lee, Jeehun; Lee, Munhyang			Multi-gene panel testing in Korean patients with common genetic generalized epilepsy syndromes	PLOS ONE			English	Article							CACNA1H; ASSOCIATION; VARIANTS; EXOME	Genetic heterogeneity of common genetic generalized epilepsy syndromes is frequently considered. The present study conducted a focused analysis of potential candidate or susceptibility genes for common genetic generalized epilepsy syndromes using multi-gene panel testing with next-generation sequencing. This study included patients with juvenile myoclonic epilepsy, juvenile absence epilepsy, and epilepsy with generalized tonic-clonic seizures alone. We identified pathogenic variants according to the American College of Medical Genetics and Genomics guidelines and identified susceptibility variants using case-control association analyses and family analyses for familial cases. A total of 57 patients were enrolled, including 51 sporadic cases and 6 familial cases. Twenty-two pathogenic and likely pathogenic variants of 16 different genes were identified. CACNA1H was the most frequently observed single gene. Variants of voltage-gated Ca2+ channel genes, including CACNA1A, CACNA1G, and CACNA1H were observed in 32% of variants (n = 7/22). Analyses to identify susceptibility variants using case-control association analysis indicated that KCNMA1 c. 400G>C was associated with common genetic generalized epilepsy syndromes. Only 1 family (family A) exhibited a candidate pathogenic variant p.(Arg788His) on CACNA1H, as determined via family analyses. This study identified candidate genetic variants in about a quarter of patients (n = 16/57) and an average of 2.8 variants was identified in each patient. The results reinforced the polygenic disorder with very high locus and allelic heterogeneity of common GGE syndromes. Further, voltage-gated Ca2+ channels are suggested as important contributors to common genetic generalized epilepsy syndromes. This study extends our comprehensive understanding of common genetic generalized epilepsy syndromes.	[Lee, Cha Gon] Eulji Univ, Nowon Eulji Med Ctr, Dept Pediat, Seoul, South Korea; [Lee, Jeehun; Lee, Munhyang] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea	Eulji University; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, J (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea.	jhlee0101@skku.edu		lee, cha gon/0000-0001-7294-229X	EMBRI Grant from the Eulji University [2016EMBRISN0001]; Basic Science Research Program through the National Research Foundation of Korea from the Ministry of Education [NRF-2017R1D1A1B03034685]	EMBRI Grant from the Eulji University; Basic Science Research Program through the National Research Foundation of Korea from the Ministry of Education(Ministry of Education (MOE), Republic of Korea)	This research was supported by an EMBRI Grant (2016EMBRISN0001) from the Eulji University and a grant of the Basic Science Research Program through the National Research Foundation of Korea (NRF-2017R1D1A1B03034685) from the Ministry of Education.	Allen AS, 2017, LANCET NEUROL, V16, P135, DOI 10.1016/S1474-4422(16)30359-3; Becker Felicitas, 2017, Epilepsia Open, V2, P334, DOI 10.1002/epi4.12068; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Berkovic SF, 1998, ANN NEUROL, V43, P435, DOI 10.1002/ana.410430405; Chen YC, 2003, ANN NEUROL, V54, P239, DOI 10.1002/ana.10607; Chioza B, 2006, EPILEPSY RES, V69, P177, DOI 10.1016/j.eplepsyres.2006.01.009; Delgado-Escueta AV, 2013, EPILEPSY BEHAV, V28, pS52, DOI 10.1016/j.yebeh.2012.06.033; dos Santos BP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179629; Eckle VS, 2014, J PHYSIOL-LONDON, V592, P795, DOI 10.1113/jphysiol.2013.264176; Heinzen EL, 2012, AM J HUM GENET, V91, P293, DOI 10.1016/j.ajhg.2012.06.016; Helbig I, 2013, EPILEPSY BEHAV, V28, pS66, DOI 10.1016/j.yebeh.2012.07.005; Heron SE, 2007, ANN NEUROL, V62, P560, DOI 10.1002/ana.21169; Liang JM, 2006, NEUROSCI LETT, V406, P27, DOI 10.1016/j.neulet.2006.06.073; Marini C, 2004, EPILEPSIA, V45, P467, DOI 10.1111/j.0013-9580.2004.46803.x; Noebels JL, 2012, JASPERS BASIC MECH E, DOI [10.1002/epi4.1206810.1002/epi4.12068, DOI 10.1002/EPI4.1206810.1002/EPI4.12068]; Nordli DR, 2005, EPILEPSIA, V46, P48, DOI 10.1111/j.1528-1167.2005.00313.x; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Steffens M, 2012, HUM MOL GENET, V21, P5359, DOI 10.1093/hmg/dds373; Sun Y, 2015, HUM MUTAT, V36, P648, DOI 10.1002/humu.22783; Winawer MR, 2005, NEUROLOGY, V65, P523, DOI 10.1212/01.wnl.0000172920.34994.63	20	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199321	10.1371/journal.pone.0199321	http://dx.doi.org/10.1371/journal.pone.0199321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924869	Green Submitted, Green Published, gold			2022-12-26	WOS:000435655600061
J	Um, SB; Yeom, H; Kim, NH; Kim, HC; Lee, HK; Suh, I				Um, Sun-Bi; Yeom, Hyungseon; Kim, Na Hyun; Kim, Hyeon Chang; Lee, Hyung Keun; Suh, Ii			Association between dry eye symptoms and suicidal ideation in a Korean adult population	PLOS ONE			English	Article							QUALITY-OF-LIFE; CHRONIC PAIN; RISK-FACTORS; NATIONAL-HEALTH; PREVALENCE; DISEASE; IMPACT; DEPRESSION; QUESTIONNAIRE; REPEATABILITY	Purpose This study assessed the association of dry eyes with depression and suicidal ideation in a Korean adult population. Methods Data from 16408 participants (6972 men and 9436 women) aged >= 19 years included in the fifth Korea National Health and Nutrition Examination Survey, conducted from 2010 +/- 2012, were analyzed. For dry eyes, surveys of previous diagnosis of dry eye disease (DED) by an ophthalmologist and experience of subjective dry eye symptoms were separately used. Diagnosis of depression and suicidal ideation were obtained via responses to an interviewer-assisted questionnaire, and questions were asked in a closed-ended response format. Logistic regression was used to examine the associations between dry eyes, depression, and suicidal ideation. Results DED diagnosis exhibited an odds ratio (OR) of 1.32 (95% confidence interval [CI] 1.11-1.57) for depression and 1.24 (95% CI 1.05-1.48) for suicidal ideation compared to those without DED, after adjusting for sex, age, education, occupation, household income, body mass index, smoking behavior, alcohol consumption, physical activity, hypertension, diabetes, dyslipidemia, thyroid diseases, major cardiovascular disease, and cancer. Similarly, the adjusted OR (95% CI) of dry eye symptoms was 1.50 (95% CI 1.30-1.73) for depression and 1.47 (95% CI 1.27-1.70) for suicidal ideation. Conclusion Our findings suggest that dry eyes (either DED diagnosis or dry eye symptoms) may be associated with the prevalence of depression and suicidal ideation in the Korean adult population.	[Um, Sun-Bi; Kim, Na Hyun] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea; [Yeom, Hyungseon; Kim, Hyeon Chang; Suh, Ii] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Lee, Hyung Keun] Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, HC (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	hckim@yuhs.ac	Kim, Hyeon Chang/F-8796-2019	Kim, Hyeon Chang/0000-0001-7867-1240; Suh, Il/0000-0002-9689-7849	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0055]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C0055) (HCK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayaki M, 2015, NEUROPSYCH DIS TREAT, V11, P889, DOI 10.2147/NDT.S81515; Bernert Rebecca A, 2007, Neuropsychiatr Dis Treat, V3, P735; Cheatle MD, 2014, J FAM PRACTICE, V63, pS6; Chia EM, 2003, CLIN EXP OPHTHALMOL, V31, P229, DOI 10.1046/j.1442-9071.2003.00634.x; Chung JH, 2014, J PSYCHOSOM RES, V77, P457, DOI 10.1016/j.jpsychores.2014.08.008; Fine PG, 2011, PAIN MED, V12, P996, DOI 10.1111/j.1526-4637.2011.01187.x; Foulks GN, 2015, OCUL SURF, V13, P118, DOI 10.1016/j.jtos.2014.12.001; Galor A, 2011, AM J OPHTHALMOL, V152, P377, DOI 10.1016/j.ajo.2011.02.026; Gulati A, 2006, AM J OPHTHALMOL, V142, P125, DOI 10.1016/j.ajo.2006.02.038; Hyon Joon Young, 2014, Korean J Ophthalmol, V28, P197, DOI 10.3341/kjo.2014.28.3.197; Kim JH, 2012, J GERONTOL NURS, V38, P48, DOI 10.3928/00989134-20121003-01; Kim KW, 2011, INVEST OPHTH VIS SCI, V52, P7954, DOI 10.1167/iovs.11-8050; Kim SW, 2013, J KOREAN MED SCI, V28, P345, DOI 10.3346/jkms.2013.28.3.345; Kim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117929; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Labbe A, 2013, BRIT J OPHTHALMOL, V97, P1399, DOI 10.1136/bjophthalmol-2013-303838; Le QH, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-22; Lee AJ, 2002, BRIT J OPHTHALMOL, V86, P1347, DOI 10.1136/bjo.86.12.1347; Lekhanont K, 2006, CORNEA, V25, P1162, DOI 10.1097/01.ico.0000244875.92879.1a; Li MY, 2011, CURR EYE RES, V36, P1, DOI 10.3109/02713683.2010.519850; Lin PY, 2003, OPHTHALMOLOGY, V110, P1096, DOI 10.1016/S0161-6420(03)00262-8; Lucas M, 2013, J AFFECT DISORDERS, V151, P1053, DOI 10.1016/j.jad.2013.08.033; McCall WV, 2011, SLEEP, V34, P1149, DOI 10.5665/SLEEP.1222; Mertzanis P, 2005, INVEST OPHTH VIS SCI, V46, P46, DOI 10.1167/iovs.03-0915; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060; Moss SE, 2008, OPTOMETRY VISION SCI, V85, P668, DOI 10.1097/OPX.0b013e318181a947; Moss SE, 2000, ARCH OPHTHALMOL-CHIC, V118, P1264; Nichols KK, 2002, CORNEA, V21, P578, DOI 10.1097/00003226-200208000-00009; Nock MK, 2013, JAMA PSYCHIAT, V70, P300, DOI 10.1001/2013.jamapsychiatry.55; Oden NL, 1998, ADV EXP MED BIOL, V438, P807; Ohayon MM, 2003, ARCH GEN PSYCHIAT, V60, P39, DOI 10.1001/archpsyc.60.1.39; Oquendo MA, 2008, PSYCHIAT CLIN N AM, V31, pXIII, DOI 10.1016/j.psc.2008.03.001; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Pigeon WR, 2012, METAANALYSIS SLEEP D, DOI [10.4088/JCP.11r07586, DOI 10.4088/JCP.11R07586]; Pompili M, 2009, PSYCHOSOMATICS, V50, P16, DOI 10.1176/appi.psy.50.1.16; Pouyeh B, 2012, AM J OPHTHALMOL, V153, P1061, DOI 10.1016/j.ajo.2011.11.030; Racine M, 2014, CLIN J PAIN, V30, P371, DOI 10.1097/AJP.0b013e31829e9d4d; Ratcliffe GE, 2008, CLIN J PAIN, V24, P204, DOI 10.1097/AJP.0b013e31815ca2a3; Ro Junsoo, 2015, J Prev Med Public Health, V48, P28, DOI 10.3961/jpmph.14.030; Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103; Schiffman RM, 2003, OPHTHALMOLOGY, V110, P1412, DOI 10.1016/S0161-6420(03)00462-7; Subramaniam M, 2014, ANN ACAD MED SINGAP, V43, P412; Tang NKY, 2006, PSYCHOL MED, V36, P575, DOI 10.1017/S0033291705006859; Tounaka K, 2014, TOHOKU J EXP MED, V233, P215, DOI 10.1620/tjem.233.215; Um SB, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-31; Vehof J, 2014, BRIT J OPHTHALMOL, V98, P1712, DOI 10.1136/bjophthalmol-2014-305201; Viso E, 2009, OPHTHAL EPIDEMIOL, V16, P15, DOI 10.1080/09286580802228509; Wen W, 2012, CORNEA, V31, P686, DOI 10.1097/ICO.0b013e3182261590; World Health Organization, 2014, PREV SUIC GLOB IMP 2; Yoon CG, 2015, J OCCUP HEALTH, V57, P222, DOI 10.1539/joh.14-0237-OA	50	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199131	10.1371/journal.pone.0199131	http://dx.doi.org/10.1371/journal.pone.0199131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ8QS	29924835	Green Published, gold			2022-12-26	WOS:000435655600049
J	Sample, SJ; Racette, MA; Hans, EC; Volstad, NJ; Schaefer, SL; Bleedorn, JA; Little, JP; Waller, KR; Hao, ZL; Block, WF; Muir, P				Sample, Susannah J.; Racette, Molly A.; Hans, Eric C.; Volstad, Nicola J.; Schaefer, Susan L.; Bleedorn, Jason A.; Little, Jeffrey P.; Waller, Kenneth R., III; Hao, Zhengling; Block, Walter F.; Muir, Peter			Use of a platelet-rich plasma-collagen scaffold as a bioenhanced repair treatment for management of partial cruciate ligament rupture in dogs	PLOS ONE			English	Article							CONTRALATERAL STIFLE JOINT; LABRADOR-RETRIEVERS; LEVELING OSTEOTOMY; RISK-FACTORS; IN-VITRO; SYNOVITIS; OSTEOARTHRITIS; DISEASE; ACL; PROGRESSION	Dogs are commonly affected with cruciate ligament rupture (CR) and associated osteoarthritis (OA), and frequently develop a second contralateral CR. Platelet rich plasma (PRP) is a component of whole blood that contains numerous growth factors, which in combination with a collagen scaffold may act to promote bioenhanced primary repair of ligament. This study tested the hypothesis that treatment of partial stable CR stifles with an intra-articular collagen scaffold and PRP would decrease the disease progression, synovitis and risk of complete CR over a 12-month study period. We conducted a prospective cohort study of 29 client-owned dogs with an unstable stifle due to complete CR and stable contralateral stifle with partial CR. All dogs were treated with tibial plateau leveling osteotomy (TPLO) on the unstable stifle and a single intra-articular application of PRP-collagen in the stable partial CR stifle. Dogs were evaluated at the time of diagnosis, and at 10-weeks and 12-months after treatment. We evaluated correlation between both development of complete CR and time to complete CR with diagnostic tests including bilateral stifle radiographs, 3.0 Tesla magnetic resonance (MR) imaging, and bilateral stifle arthroscopy. Additionally, histologic evaluation of synovial biopsies, C-reactive protein (CRP) concentrations in serum and synovial fluid, and synovial total nucleated cell count, were determined. Results indicated that a single application of PRP-collagen in partial CR stifles of client owned dogs is not an effective disease-modifying therapy for the prevention of progression to complete CR. Radiographic effusion, arthroscopic evaluation of cranial cruciate ligament (CrCL) damage, and MR assessment of ligament fiber tearing in partial CR stifles correlated with progression to complete CR over the 12-month follow-up period. We determined that the best predictive model for development of complete CR in PRP-collagen treated partial CR stifles included variables from multiple diagnostic modalities.	[Sample, Susannah J.; Racette, Molly A.; Hans, Eric C.; Volstad, Nicola J.; Schaefer, Susan L.; Bleedorn, Jason A.; Little, Jeffrey P.; Waller, Kenneth R., III; Hao, Zhengling] Univ Wisconsin, Sch Vet Med, Dept Surg Sci, Comparat Orthopaed Res Lab, Madison, WI 53706 USA; [Block, Walter F.; Muir, Peter] Univ Wisconsin, Dept Med Phys, Sch Med & Publ Hlth, 1530 Med Sci Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Muir, P (corresponding author), Univ Wisconsin, Dept Med Phys, Sch Med & Publ Hlth, 1530 Med Sci Ctr, Madison, WI 53706 USA.	peter.muir@wisc.edu	Fiumefreddo, Andrea/T-2977-2019; Bleedorn, Jason A/AAE-2115-2019; Muir, Peter/AAH-8057-2021	Bleedorn, Jason A/0000-0003-2987-7722; Muir, Peter/0000-0003-0028-6005; Hans, Eric/0000-0001-7488-9728	American Kennel Club Canine Health Foundation [0176]; National Institutes of Health [T32 OD 10999, K01OD0197343]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019743] Funding Source: NIH RePORTER	American Kennel Club Canine Health Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by the American Kennel Club Canine Health Foundation (01762), http://www.akcchf.org. Molly A. Racette also received funding from the National Institutes of Health (T32 OD 10999), https://www.nih.gov. Susannah J. Sample also received funding from the National Institutes of Health (K01OD0197343), https://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayral X, 1996, BAILLIERE CLIN RHEUM, V10, P477, DOI 10.1016/S1521-6942(96)80009-X; Baker LA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173810; Bergh MS, 2014, J AM ANIM HOSP ASSOC, V50, P315, DOI 10.5326/JAAHA-MS-6356; Bleedorn JA, 2011, VET SURG, V40, P531, DOI 10.1111/j.1532-950X.2011.00841.x; Bresnihan B, 1998, BRIT J RHEUMATOL, V37, P636; Buote N, 2009, VET SURG, V38, P481, DOI 10.1111/j.1532-950X.2009.00532.x; Cabrera SY, 2008, JAVMA-J AM VET MED A, V232, P889, DOI 10.2460/javma.232.6.889; Cheng MY, 2012, J ORTHOP RES, V30, P79, DOI 10.1002/jor.21496; Chuang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106389; de Bruin T, 2007, VET REC, V161, P745, DOI 10.1136/vr.161.22.745; DOVERSPIKE M, 1993, J AM ANIM HOSP ASSOC, V29, P167; Dusick A, 2014, VET J, V202, P550, DOI 10.1016/j.tvjl.2014.08.010; Erne JB, 2009, JAVMA-J AM VET MED A, V235, P386, DOI 10.2460/javma.235.4.386; Fazio CG, 2018, VET RADIOL ULTRASOUN, V59, P64, DOI 10.1111/vru.12567; Fuller MC, 2014, JAVMA-J AM VET MED A, V244, P328, DOI 10.2460/javma.244.3.328; Girling SL, 2006, J SMALL ANIM PRACT, V47, P708, DOI 10.1111/j.1748-5827.2006.00150.x; GOLDBERG VM, 1982, J BONE JOINT SURG AM, V64, P900, DOI 10.2106/00004623-198264060-00014; Grierson J, 2011, VET COMP ORTHOPAED, V24, P192, DOI 10.3415/VCOT-10-03-0030; Guthrie JW, 2012, J SMALL ANIM PRACT, V53, P273, DOI 10.1111/j.1748-5827.2011.01202.x; Hayashi K, 2003, VET SURG, V32, P269, DOI 10.1053/jvet.2003.50023; Innes JF, 2004, VET RADIOL ULTRASOUN, V45, P143, DOI 10.1111/j.1740-8261.2004.04024.x; Ionescu LC, 2012, ACTA BIOMATER, V8, P3687, DOI 10.1016/j.actbio.2012.06.005; Jin XZ, 2015, ANN RHEUM DIS, V74, P703, DOI 10.1136/annrheumdis-2013-204494; Joshi SM, 2009, AM J SPORT MED, V37, P2401, DOI 10.1177/0363546509339915; Kim SE, 2011, AM J VET RES, V72, P410, DOI 10.2460/ajvr.72.3.410; Krenn V, 2006, HISTOPATHOLOGY, V49, P358, DOI 10.1111/j.1365-2559.2006.02508.x; Little JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097329; Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037; McNulty AL, 2008, BIORHEOLOGY, V45, P487, DOI 10.3233/BIR-2008-0489; Might KR, 2013, VET SURG, V42, P392, DOI 10.1111/j.1532-950X.2012.01064.x; MOORE KW, 1995, AUST VET J, V72, P281, DOI 10.1111/j.1751-0813.1995.tb03555.x; Muir P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025331; Murray MM, 2009, CLIN SPORT MED, V28, P51, DOI 10.1016/j.csm.2008.08.005; Murray MM, 2009, J ORTHOP RES, V27, P639, DOI 10.1002/jor.20796; Murray MM, 2007, J ORTHOP RES, V25, P81, DOI 10.1002/jor.20282; Murray MM, 2006, J ORTHOP RES, V24, P820, DOI 10.1002/jor.20073; Murray MM, 2003, J ORTHOPAED RES, V21, P238, DOI 10.1016/S0736-0266(02)00142-0; Provenzano PP, 2002, J APPL PHYSIOL, V92, P362, DOI 10.1152/jappl.2002.92.1.362; Racette M, 2016, VET J, V209, P150, DOI 10.1016/j.tvjl.2015.10.055; Ragetly CA, 2011, VET SURG, V40, P327, DOI 10.1111/j.1532-950X.2010.00787.x; Reif U, 2004, VET SURG, V33, P368, DOI 10.1111/j.1532-950X.2004.04053.x; Sample SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178086; SCAVELLI TD, 1990, J AM VET MED ASSOC, V196, P1135; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Sumner JP, 2010, VET SURG, V39, P936, DOI 10.1111/j.1532-950X.2010.00738.x; Wilke VL, 2002, J AM VET MED ASSOC, V221, P1426, DOI 10.2460/javma.2002.221.1426	46	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0197204	10.1371/journal.pone.0197204	http://dx.doi.org/10.1371/journal.pone.0197204			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920524	gold, Green Submitted, Green Published			2022-12-26	WOS:000435541300001
J	Srinivas, SP; Goyal, A; Talele, DP; Mahadik, S; Sudhir, RR; Murthy, PP; Ranganath, S; Kompella, UB; Padmanabhan, P				Srinivas, Sangly P.; Goyal, Arushi; Talele, Deepti P.; Mahadik, Sanjay; Sudhir, Rachapalle Reddi; Murthy, P. Pavani; Ranganath, Sudhir; Kompella, Uday B.; Padmanabhan, Prema			Corneal epithelial permeability to fluorescein in humans by a multi-drop method	PLOS ONE			English	Article							MONTE-CARLO SIMULATIONS; BARRIER FUNCTION; TEAR FILM; OCULAR SURFACE; PHOTOREFRACTIVE KERATECTOMY; ARTIFICIAL TEARS; FLUOROPHOTOMETRY; PENETRATION; DISRUPTION; PHARMACOKINETICS	Purpose The permeability of the corneal epithelium to fluorescein P-dc is an indicator of the health of the ocular surface. It can be measured in a clinical setting by determining the accumulation of fluorescein in the stroma following administration of the dye on the ocular surface. Here we demonstrate a new multi-drop method for the measurement of Pdc by a spot fluorometer. Methods Twenty-nine healthy participants were recruited for this study. First, a probe-drop of fluorescein (0.35%, 2 mu L) was instilled on the conjunctiva. The clearance of the dye from the tears was immediately measured using the fluorometer. Following this, two loading drops (2%; 6 mu L each) were administered 10 min apart. Fifteen minutes later, the ocular surface was washed and fluorescence from the stroma F-s was measured. Permeability was calculated using P-dc = (Q x F-s)/(2 x AUC), where Q is the stromal thickness and AUC is the area under the fluorescence vs. time curve for the loading drops. Results After the probe drop, the tear fluorescence followed an exponential decay (elimination rate constant; kd = 0.41 +/- 0.28 per min; 49 eyes of 29 subjects), but the increase in Fs was negligible. However, after the loading drops, the measured Fs was similar to 20-fold higher than the autofluorescence and could be recorded at a high signal to noise ratio (SNR > 40). The intrasubject variability of kd was insignificant. Since fluorescein undergoes concentration quenching at > 0.5%, the value of AUC for the loading drops was estimated by scaling the AUC of the probe drop. The calculated Pdc was 0.54 +/- 0.54 nm/sec (n = 49). A Monte Carlo simulation of the model for the multi-drop protocol confirmed the robustness of the estimated P-dc. Conclusions The new multi-drop method can be used in place of the single-drop approach. It can overcome a lack of sensitivity in fluorometers of high axial resolution. The P-dc estimated by the multi-drop method is 11-fold higher than previously reported but closer to the value reported for other drugs with equivalent octanol/water partition coefficient.	[Srinivas, Sangly P.] Indiana Univ, Sch Optometry, Bloomington, IN 47405 USA; [Goyal, Arushi; Talele, Deepti P.; Mahadik, Sanjay; Sudhir, Rachapalle Reddi; Murthy, P. Pavani; Padmanabhan, Prema] Sankara Nethralaya, Dept Cornea & Refract Surg, Madras, Tamil Nadu, India; [Ranganath, Sudhir] Siddaganga Inst Technol, Dept Chem Engn, Tumkur, India; [Kompella, Uday B.] Univ Colorado, Pharmaceut Sci, Anschutz Med Campus, Aurora, CO USA	Indiana University System; Indiana University Bloomington; Siddaganga Institute of Technology; University of Colorado System; University of Colorado Anschutz Medical Campus	Srinivas, SP (corresponding author), Indiana Univ, Sch Optometry, Bloomington, IN 47405 USA.	srnivas@indiana.edu	srinivas, sangly/M-1223-2019		Obama Singh Initiative (United States-India Education Foundation); NIH [P30EY019008, R01EY022097]; Indiana Clinical and Translational Sciences Institute	Obama Singh Initiative (United States-India Education Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana Clinical and Translational Sciences Institute	SPS and PP were jointly funded by Obama Singh Initiative (United States-India Education Foundation; 2014). Institution of SPS received NIH grant core grant P30EY019008. SPS received a research grant from Indiana Clinical and Translational Sciences Institute. UAB received NIH grant R01EY022097. All the funding or sources of support received during this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bai YQ, 2017, PROG RETIN EYE RES, V58, P28, DOI 10.1016/j.preteyeres.2017.02.002; Bardag-Gorce F, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/4805986; BENEDETTO DA, 1984, ARCH OPHTHALMOL-CHIC, V102, P410; Benitez-del-Castillo JM, 2002, ADV EXP MED BIOL, V506, P703; BOETS EPM, 1988, CURR EYE RES, V7, P511, DOI 10.3109/02713688809031805; BOOT JP, 1991, GRAEF ARCH CLIN EXP, V229, P533, DOI 10.1007/BF00203316; Bradley JS, 2010, PEDIATR INFECT DIS J, V29, P1043, DOI 10.1097/INF.0b013e3181f42a53; Braun RJ, 2015, PROG RETIN EYE RES, V45, P132, DOI 10.1016/j.preteyeres.2014.11.001; Bron AJ, 2015, PROG RETIN EYE RES, V44, P36, DOI 10.1016/j.preteyeres.2014.10.001; BRUBAKER RF, 1985, OPHTHALMOLOGY, V92, P884; Brubaker RF, 1990, NONINVASIVE DIAGNOST, P248, DOI 10.1002/jps.22694; CARLSON KH, 1988, EXP EYE RES, V47, P27, DOI 10.1016/0014-4835(88)90021-8; CHANG SW, 1995, OPHTHALMIC RES, V27, P74, DOI 10.1159/000267600; Cunha-Vaz JG, 2004, EXP EYE RES, V78, P715, DOI 10.1016/S0014-4835(03)00213-6; CUNHAVAZ JG, 1993, INT OPHTHALMOL, V17, P147, DOI 10.1007/BF00942929; De Bruyn T, 2011, J PHARM SCI-US, V100, P5018, DOI 10.1002/jps.22694; DEKRUIJF EJFM, 1987, CURR EYE RES, V6, P1327, DOI 10.3109/02713688708997558; DelMonte DW, 2011, J CATARACT REFR SURG, V37, P588, DOI 10.1016/j.jcrs.2010.12.037; Dokoumetzidis A, 2005, BASIC CLIN PHARMACOL, V96, P200, DOI 10.1111/j.1742-7843.2005.pto960309.x; Edwards A, 2001, PHARMACEUT RES, V18, P1497, DOI 10.1023/A:1013061926851; Fahim Magid M, 2006, BMC Ophthalmol, V6, P20, DOI 10.1186/1471-2415-6-20; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; Gekka M, 2004, CORNEA, V23, P35, DOI 10.1097/00003226-200401000-00006; GOBBELS M, 1991, GRAEF ARCH CLIN EXP, V229, P345, DOI 10.1007/BF00170693; GOBBELS M, 1989, GRAEF ARCH CLIN EXP, V227, P142, DOI 10.1007/BF02169787; GOBBELS M, 1989, GRAEF ARCH CLIN EXP, V227, P139, DOI 10.1007/BF02169786; GRAY JR, 1985, GRAEF ARCH CLIN EXP, V222, P225, DOI 10.1007/BF02133684; Gupta C, 2012, PHARM RES-DORDR, V29, P3325, DOI 10.1007/s11095-012-0824-3; Gupta C, 2010, PHARM RES-DORDR, V27, P699, DOI 10.1007/s11095-010-0066-1; Hamalainen KM, 1997, INVEST OPHTH VIS SCI, V38, P627; Hayashi Y, 2016, INT MED CASE REP J, V9, DOI 10.2147/IMCRJ.S103299; Hutcheon AEK, 2007, EXP EYE RES, V84, P32, DOI 10.1016/j.exer.2006.08.011; JONES DP, 1982, J BIOMED ENG, V4, P113, DOI 10.1016/0141-5425(82)90071-1; Joshi A, 1996, INVEST OPHTH VIS SCI, V37, P1008; Kasnavia T, 1999, GROUND WATER, V37, P376, DOI 10.1111/j.1745-6584.1999.tb01114.x; Kimura K, 2009, INVEST OPHTH VIS SCI, V50, P597, DOI 10.1167/iovs.08-2606; Kimura K, 2008, INVEST OPHTH VIS SCI, V49, P565, DOI 10.1167/iovs.07-0419; King-Smith PE, 2013, INVEST OPHTH VIS SCI, V54, P6003, DOI 10.1167/iovs.13-12628; Kinoshita S, 2001, PROG RETIN EYE RES, V20, P639, DOI 10.1016/S1350-9462(01)00007-6; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Leong YY, 2015, OCUL SURF, V13, P103, DOI 10.1016/j.jtos.2014.10.003; Leung TN, 2014, INVEST OPHTH VIS SCI, V55, P5718, DOI 10.1167/iovs.14-14259; Li WY, 2013, CONTACT LENS ANTERIO, V36, P215, DOI 10.1016/j.clae.2013.02.006; Li Y, 2005, TOXICOL SCI, V88, P434, DOI 10.1093/toxsci/kfi319; Lin Meng C, 2007, Eye Contact Lens, V33, P378, DOI 10.1097/ICL.0b013e318157d7c9; Lin MC, 2014, INVEST OPHTH VIS SCI, V55, P776, DOI 10.1167/iovs.13-13508; Lin Meng C, 2003, Cont Lens Anterior Eye, V26, P11, DOI 10.1016/S1367-0484(02)00088-7; MAURICE D M, 1980, International Ophthalmology Clinics, V20, P21, DOI 10.1097/00004397-198002030-00005; Maurice D.M., 1984, HDB EXPT PHARM, V69, P19; MAURICE DM, 1993, INT OPHTHALMOL CLIN, V33, P81, DOI 10.1097/00004397-199303340-00009; MAURICE DM, 1992, J PHARM SCI, V81, P615, DOI 10.1002/jps.2600810704; MCCAREY BE, 1995, CURR EYE RES, V14, P505, DOI 10.3109/02713689509003762; McCarey BE, 1997, CURR EYE RES, V16, P44, DOI 10.1076/ceyr.16.1.44.5120; McNamara NA, 1998, OPTOMETRY VISION SCI, V75, P316, DOI 10.1097/00006324-199805000-00020; McNamara NA, 1997, INVEST OPHTH VIS SCI, V38, P1830; McNamara NA, 1999, AM J OPHTHALMOL, V127, P153, DOI 10.1016/S0002-9394(98)00342-0; Mokhtarzadeh M, 2011, INVEST OPHTH VIS SCI, V52, P2127, DOI 10.1167/iovs.10-6489; Mun EA, 2014, MOL PHARMACEUT, V11, P3556, DOI 10.1021/mp500332m; MUNNERLYN CR, 1985, GRAEF ARCH CLIN EXP, V222, P209, DOI 10.1007/BF02133676; Nejima R, 2005, AM J OPHTHALMOL, V139, P64, DOI 10.1016/j.ajo.2004.08.039; Nelson J D, 1995, Trans Am Ophthalmol Soc, V93, P709; Oba Y, 2012, GEOCHEM J, V46, P517, DOI 10.2343/geochemj.2.0226; Pflugfelder SC, 2005, AM J PATHOL, V166, P61, DOI 10.1016/S0002-9440(10)62232-8; Polunin GS, 1999, J REFRACT SURG, V15, pS221; Prausnitz MR, 1998, J PHARM SCI, V87, P1479, DOI 10.1021/js9802594; RAMSELAAR JAM, 1988, CURR EYE RES, V7, P947, DOI 10.3109/02713688808997251; Roberts JA, 2011, J ANTIMICROB CHEMOTH, V66, P227, DOI 10.1093/jac/dkq449; Savitsky DZ, 2009, J REFRACT SURG, V25, P366, DOI 10.3928/1081597X-20090401-12; Shimazaki J, 1999, CORNEA, V18, P559, DOI 10.1097/00003226-199909000-00008; SRINIVAS SP, 1994, CURR EYE RES, V13, P281, DOI 10.3109/02713689408995789; SRINIVAS SP, 1992, IEEE T BIO-MED ENG, V39, P1283, DOI 10.1109/10.184704; Suzuki K, 2000, INVEST OPHTH VIS SCI, V41, P2495; Tanihara H, 1997, AM J OPHTHALMOL, V123, P487, DOI 10.1016/S0002-9394(14)70174-6; Urtti A, 2006, ADV DRUG DELIVER REV, V58, P1131, DOI 10.1016/j.addr.2006.07.027; VANBEST JA, 1995, GRAEF ARCH CLIN EXP, V233, P582, DOI 10.1007/BF00404710; Willcox MDP, 2017, OCUL SURF, V15, P366, DOI 10.1016/j.jtos.2017.03.006; Yeh TN, 2013, INVEST OPHTH VIS SCI, V54, P3902, DOI 10.1167/iovs.13-11874; Yokoi Norihiko, 2005, Semin Ophthalmol, V20, P63, DOI 10.1080/08820530590931124; Zhang WS, 2004, J CONTROL RELEASE, V99, P241, DOI 10.1016/j.jconrel.2004.07.001	79	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0198831	10.1371/journal.pone.0198831	http://dx.doi.org/10.1371/journal.pone.0198831			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920519	gold, Green Published, Green Submitted			2022-12-26	WOS:000435541300011
J	Kint, S; De Spiegelaere, W; De Kesel, J; Vandekerckhove, L; Van Criekinge, W				Kint, Sam; De Spiegelaere, Ward; De Kesel, Jonas; Vandekerckhove, Linos; Van Criekinge, Wim			Evaluation of bisulfite kits for DNA methylation profiling in terms of DNA fragmentation and DNA recovery using digital PCR	PLOS ONE			English	Article							PROSTATE-CANCER; CLINICAL VALIDATION; ANTIGEN RECURRENCE; COLORECTAL-CANCER; CPG METHYLATION; DE-NOVO; ASSAY; TRANSCRIPTION; GENOME; HIV-1	DNA methylation is one of the most important epigenetic modifications in the regulation of gene transcription. The current gold standard to study this modification is bisulfite sequencing. Although multiple commercial bisulfite treatment kits provide good conversion efficiencies, DNA loss and especially DNA fragmentation remain troublesome. This hampers DNA methylation profiling of long DNA sequences. Here, we explored the performance of twelve commercial bisulfite kits by an in-depth comparison of DNA fragmentation using gel electrophoresis, qPCR and digital PCR, DNA recovery by spectroscopic measurements and digital PCR and conversion efficiency by next generation sequencing. The results show a clear performance difference between the bisulfite kits, and depending on the specific goal of the study, the most appropriate kit might differ. Moreover, we demonstrated that digital PCR is a valuable method to monitor both DNA fragmentation as well as DNA recovery after bisulfite treatment.	[Kint, Sam; Van Criekinge, Wim] Univ Ghent, Fac Biosci Engn, Dept Data Anal & Math Modelling, Ghent, Belgium; [Kint, Sam; Vandekerckhove, Linos] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, HIV Cure Res Ctr, Ghent, Belgium; [Kint, Sam; Vandekerckhove, Linos] Ghent Univ Hosp, Ghent, Belgium; [De Spiegelaere, Ward] Univ Ghent, Fac Vet Med, Dept Morphol, Merelbeke, Belgium; [De Kesel, Jonas] Univ Ghent, Fac Biosci Engn, Dept Biotechnol, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University	Kint, S (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Data Anal & Math Modelling, Ghent, Belgium.; Kint, S (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, HIV Cure Res Ctr, Ghent, Belgium.; Kint, S (corresponding author), Ghent Univ Hosp, Ghent, Belgium.	Sam.Kint@UGent.be	De Spiegelaere, Ward/C-6245-2008; Vandekerckhove, Linos/J-6420-2013	De Spiegelaere, Ward/0000-0003-2097-8439; Vandekerckhove, Linos/0000-0002-8600-1631; Kint, Sam/0000-0002-6719-2903; De Kesel, Jonas/0000-0002-4943-645X	Research Foundation Flanders [1802019N, 12G9716N]; HIVERA: EURECA [ERANET 01K11307A]	Research Foundation Flanders(FWO); HIVERA: EURECA	Linos Vandekerckhove is funded by the Research Foundation Flanders (www.fwo.be, Grant number 1802019N). Ward De Spiegelaere was a post-doctoral fellow at the Research Foundation Flanders (www.fwo.be, Grant number 12G9716N. Additionally, this work was supported by HIVERA: EURECA, ERANET 01K11307A.	Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Banez LL, 2010, J UROLOGY, V184, P149, DOI 10.1016/j.juro.2010.03.012; BEDNARIK DP, 1987, J VIROL, V61, P1253, DOI 10.1128/JVI.61.4.1253-1257.1987; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; Bryzgunova O., 2013, EUR J MOL BIOL, V1, P1, DOI 10.11648/j.ejmb.20130101.11; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chavez L, 2011, METHODS, V53, P47, DOI 10.1016/j.ymeth.2010.05.009; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; Darst Russell P, 2010, Curr Protoc Mol Biol, VChapter 7, DOI 10.1002/0471142727.mb0709s91; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Dietrich D, 2013, J MOL DIAGN, V15, P270, DOI 10.1016/j.jmoldx.2012.11.002; Ehrich M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1134; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fuso A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118318; Genereux DP, 2009, NUCLEIC ACIDS RES, V37, P5235, DOI 10.1093/nar/gkp637; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65; GUTEKUNST KA, 1993, J ACQ IMMUN DEF SYND, V6, P541; Hayatsu H, 2008, MUTAT RES-REV MUTAT, V659, P77, DOI 10.1016/j.mrrev.2008.04.003; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Holmes EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093933; Izzi Benedetta, 2014, Med Epigenet, V2, P28; Jang HS, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060148; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; Kneip C, 2011, J THORAC ONCOL, V6, P1632, DOI 10.1097/JTO.0b013e318220ef9a; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Leontiou CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135058; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Li YY, 2011, METHODS MOL BIOL, V791, P11, DOI 10.1007/978-1-61779-316-5_2; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Milavetz BI, 2015, METHODS MOL BIOL, V1238, P569, DOI 10.1007/978-1-4939-1804-1_30; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pelizzola M, 2011, FEBS LETT, V585, P1994, DOI 10.1016/j.febslet.2010.10.061; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; RAIZIS AM, 1995, ANAL BIOCHEM, V226, P161, DOI 10.1006/abio.1995.1204; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; Schatz P, 2010, J MOL DIAGN, V12, P345, DOI 10.2353/jmoldx.2010.090088; SCHULZEFORSTER K, 1990, BIOCHEM BIOPH RES CO, V168, P141, DOI 10.1016/0006-291X(90)91685-L; Sharma G, 2016, SCI REP-UK, V6, DOI 10.1038/srep25006; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Stewart GD, 2013, J UROLOGY, V189, P1110, DOI 10.1016/j.juro.2012.08.219; Tanaka K, 2007, BIOORG MED CHEM LETT, V17, P1912, DOI 10.1016/j.bmcl.2007.01.040; Trejbalova K, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0185-6; Trypsteen W, 2016, J VIRUS ERAD, V2, P162; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni012; Vynck M, 2016, MOL DIAGN THER, V20, P437, DOI 10.1007/s40291-016-0224-1; Weiss G, 2009, J UROLOGY, V181, P1678, DOI 10.1016/j.juro.2008.11.120; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wojdacz TK, 2008, NAT PROTOC, V3, P1903, DOI 10.1038/nprot.2008.191; Zhang YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10806	53	38	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199091	10.1371/journal.pone.0199091	http://dx.doi.org/10.1371/journal.pone.0199091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902267	Green Submitted, Green Published, gold			2022-12-26	WOS:000435424900085
J	Lahlou, H; Lopez-Juarez, A; Fontbonne, A; Nivet, E; Zine, A				Lahlou, Hanae; Lopez-Juarez, Alejandra; Fontbonne, Arnaud; Nivet, Emmanuel; Zine, Azel			Modeling human early otic sensory cell development with induced pluripotent stem cells	PLOS ONE			English	Article							INNER-EAR; HAIR-CELLS; DIFFERENTIATION; FATE; EXPRESSION; GENERATION; INDUCTION; SPECIFICATION; MORPHOGENESIS; REGENERATION	The inner ear represents a promising system to develop cell-based therapies from human induced pluripotent stem cells (hiPSCs). In the developing ear, Notch signaling plays multiple roles in otic region specification and for cell fate determination. Optimizing hiPSC induction for the generation of appropriate numbers of otic progenitors and derivatives, such as hair cells, may provide an unlimited supply of cells for research and cell-based therapy. In this study, we used monolayer cultures, otic-inducing agents, Notch modulation, and marker expression to track early and otic sensory lineages during hiPSC differentiation. Otic/placodal progenitors were derived from hiPSC cultures in medium supplemented with FGF3/FGF10 for 13 days. These progenitor cells were then treated for 7 days with retinoic acid (RA) and epidermal growth factor (EGF) or a Notch inhibitor. The differentiated cultures were analyzed in parallel by qPCR and immunocytochemistry. After the 13 day induction, hiPSC-derived cells displayed an upregulated expression of a panel of otic/placodal markers. Strikingly, a subset of these induced progenitor cells displayed key-otic sensory markers, the percentage of which was increased in cultures under Notch inhibition as compared to RA/EGF-treated cultures. Our results show that modulating Notch pathway during in vitro differentiation of hiPSC-derived otic/placodal progenitors is a valuable strategy to promote the expression of human otic sensory lineage genes.	[Lahlou, Hanae; Lopez-Juarez, Alejandra; Fontbonne, Arnaud; Zine, Azel] Aix Marseille Univ, CNRS, LNIA UMR 7260, Marseille, France; [Nivet, Emmanuel] Aix Marseille Univ, CNRS, NICN UMR 7259, Marseille, France; [Zine, Azel] Univ Montpellier, Fac Pharm, Montpellier, France; [Lahlou, Hanae] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Zine, A (corresponding author), Aix Marseille Univ, CNRS, LNIA UMR 7260, Marseille, France.; Zine, A (corresponding author), Univ Montpellier, Fac Pharm, Montpellier, France.	azel.zine@univ-amu.fr	Nivet, Emmanuel/C-2729-2014; Lopez Juarez, Silvia Alejandra/D-2617-2017	Nivet, Emmanuel/0000-0001-7903-4059; LAHLOU, HANAE/0000-0001-8384-9795; Lopez Juarez, Silvia Alejandra/0000-0001-9443-6531	European Community's Seventh Framework Programme [603029]; La Fondation Pour l'Audition	European Community's Seventh Framework Programme; La Fondation Pour l'Audition	The research leading to these results has received funding from the European Community's Seventh Framework Programme under grant agreement No. 603029 (Project OTOSTEM). "La Fondation Pour l'Audition" provided support for the final year Ph.D. fellowship rewarded to HL." The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud N, 2016, J TISSUE ENG REGEN M, V11, P1132; Abdolazimi Y, 2016, DEVELOPMENT, V143, P841, DOI 10.1242/dev.129320; Agrup C, 2007, J NEUROL NEUROSUR PS, V78, P114, DOI 10.1136/jnnp.2006.092064; Alvarez Y, 2003, DEVELOPMENT, V130, P6329, DOI 10.1242/dev.00881; Appler JM, 2011, PROG NEUROBIOL, V93, P488, DOI 10.1016/j.pneurobio.2011.01.004; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Basch ML, 2016, ELIFE, V5, DOI 10.7554/eLife.19921; Bouchard M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-89; Brigande JV, 2009, NAT NEUROSCI, V12, P679, DOI 10.1038/nn.2311; Chen JC, 2013, HEARING RES, V297, P3, DOI 10.1016/j.heares.2012.11.018; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; Christophorou NAD, 2010, DEV BIOL, V345, P180, DOI 10.1016/j.ydbio.2010.07.007; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; Costa A, 2015, DEVELOPMENT, V142, P1948, DOI 10.1242/dev.119149; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; Doetzlhofer A, 2004, DEV BIOL, V272, P432, DOI 10.1016/j.ydbio.2004.05.013; Ealy M, 2016, P NATL ACAD SCI USA, V113, P8508, DOI 10.1073/pnas.1605537113; Hans S, 2007, DEVELOPMENT, V134, P2449, DOI 10.1242/dev.000448; Jahan I, 2015, BIOESSAYS, V37, P1016, DOI 10.1002/bies.201500044; Jayasena CS, 2008, DEVELOPMENT, V135, P2251, DOI 10.1242/dev.017905; Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kiernan AE, 2013, SEMIN CELL DEV BIOL, V24, P470, DOI 10.1016/j.semcdb.2013.04.002; Koch U, 2013, DEVELOPMENT, V140, P689, DOI 10.1242/dev.080614; Koehler KR, 2017, NAT BIOTECHNOL, V35, P583, DOI 10.1038/nbt.3840; Koehler KR, 2013, NATURE, V500, P217, DOI 10.1038/nature12298; Kozuka K, 2017, STEM CELL REP, V9, P1976, DOI 10.1016/j.stemcr.2017.10.013; Ladher RK, 2010, DEVELOPMENT, V137, P1777, DOI 10.1242/dev.040055; Li HW, 2003, P NATL ACAD SCI USA, V100, P13495, DOI 10.1073/pnas.2334503100; Liu XP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11508; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lleras-Forero L, 2012, CURR OPIN GENET DEV, V22, P315, DOI 10.1016/j.gde.2012.05.003; McCarroll MN, 2012, DEVELOPMENT, V139, P2740, DOI 10.1242/dev.076075; Mizutari K, 2013, NEURON, V77, P58, DOI 10.1016/j.neuron.2012.10.032; Mulvaney J, 2012, JARO-J ASSOC RES OTO, V13, P281, DOI 10.1007/s10162-012-0317-4; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Ouji Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.56; Padanad MS, 2011, DEV BIOL, V351, P90, DOI 10.1016/j.ydbio.2010.12.036; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Rana NA, 2011, CURR OPIN STRUC BIOL, V21, P583, DOI 10.1016/j.sbi.2011.08.008; Romand R, 2006, J NEUROBIOL, V66, P687, DOI 10.1002/neu.20244; Ronaghi M, 2014, STEM CELLS DEV, V23, P1275, DOI 10.1089/scd.2014.0033; Rossi AM, 2017, DEV CELL, V40, P513, DOI 10.1016/j.devcel.2017.03.010; Ryals BM, 1998, SCIENCE, V240, P774; Savary E, 2008, MECH DEVELOP, V125, P674, DOI 10.1016/j.mod.2008.05.001; Schimmang T, 2007, INT J DEV BIOL, V51, P473, DOI 10.1387/ijdb.072334ts; Shi FX, 2007, EUR J NEUROSCI, V26, P3016, DOI 10.1111/j.1460-9568.2007.05909.x; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tateya T, 2011, DEV BIOL, V352, P329, DOI 10.1016/j.ydbio.2011.01.038; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Ulvestad M, 2013, BIOCHEM PHARMACOL, V86, P691, DOI 10.1016/j.bcp.2013.06.029; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Van Winkle AP, 2012, CELLS TISSUES ORGANS, V196, P34, DOI 10.1159/000330691; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Zine A, 2000, DEVELOPMENT, V127, P3373; Zine A, 1998, NEUROREPORT, V9, P263, DOI 10.1097/00001756-199801260-00016; Zine A, 2003, MOL NEUROBIOL, V27, P223, DOI 10.1385/MN:27:2:223; Zine A, 2001, J NEUROSCI, V21, P4712, DOI 10.1523/JNEUROSCI.21-13-04712.2001; Zine A, 2014, STEM CELLS BIOL REG, P111, DOI 10.1007/978-1-4614-9569-7_6	61	14	15	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198954	10.1371/journal.pone.0198954	http://dx.doi.org/10.1371/journal.pone.0198954			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902227	Green Published, Green Submitted, gold			2022-12-26	WOS:000435424900067
J	Poitevin, P; Thebault, J; Schone, BR; Jolivet, A; Lazure, P; Chauvaud, L				Poitevin, Pierre; Thebault, Julien; Schoene, Bernd R.; Jolivet, Aurelie; Lazure, Pascal; Chauvaud, Laurent			Ligament, hinge, and shell cross-sections of the Atlantic surfclam (Spisula solidissima): Promising marine environmental archives in NE North America	PLOS ONE			English	Article							BOTTOM WATER TEMPERATURE; GROWTH-RATE; CLAM; BIVALVIA; OXYGEN; OCEAN; AGE; POPULATIONS; ISOTOPES	The Atlantic surfclam (Spisula solidissima) is a commercially important species in North American waters, undergoing biological and ecological shifts. These are attributed, in part, to environmental modifications in its habitat and driven by climate change. Investigation of shell growth patterns, trace elements, and isotopic compositions require an examination of growth lines and increments preserved in biogenic carbonates. However, growth pattern analysis of S. solidissima is challenging due to multiple disturbance lines caused by environmental stress, erosion in umbonal shell regions, and constraints related to sample size and preparation techniques. The present study proposes an alternative method for describing chronology. First, we analyzed growth patterns using growth lines within the shell and hinge. To validate the assumption of annual periodicity of growth line formation, we analyzed the oxygen isotope composition of the outer shell layer of two specimens (46 degrees 54'20 '' N; 56 degrees 18'58 '' W). Maximum delta O-18(shell) values occurred at the exact same location as internal growth lines in both specimens, confirming that they are formed annually and that growth ceases during winter. Next, we used growth increment width data to build a standardized growth index (SGI) time-series (25-year chronology) for each of the three parts of the shell. Highly significant correlations were found between the three SGI chronologies (p < 0.001; 0.55 < tau < 0.68) of all specimens. Thus, ligament growth lines provide a new method of determining ontogenetic age and growth rate in S. solidissima. In a biogeographic approach, the shell growth performance of S. solidissima in Saint-Pierre and Miquelon was compared to those in other populations along its distribution range in order to place this population in a temporal and regional context.	[Poitevin, Pierre; Thebault, Julien; Chauvaud, Laurent] Univ Bretagne Occidentale, Lab Sci Environm Marin, CNRS, IRD,Ifremer,UB0 UMR6539, Plouzane, France; [Schoene, Bernd R.] Johannes Gutenberg Univ Mainz, Inst Geosci, Johann Joachim Becher Weg 21, Mainz, Germany; [Jolivet, Aurelie] Technopole Brest Iroise, TBM Environm Somme, Plouzane, France; [Lazure, Pascal] Ifremer, CNRS, Lab Oceanog Phys & Spatiale, IRD,UB0,UMR6523, Plouzane, France	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Johannes Gutenberg University of Mainz; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale	Poitevin, P (corresponding author), Univ Bretagne Occidentale, Lab Sci Environm Marin, CNRS, IRD,Ifremer,UB0 UMR6539, Plouzane, France.	poitevin.pierre@gmail.com	Thébault, Julien/F-6198-2011; Lazure, Pascal/L-4596-2015	Thébault, Julien/0000-0002-3111-4428; Lazure, Pascal/0000-0003-2794-8785; Jolivet, Aurelie/0000-0001-5415-3326; Schone, Prof. Dr. Bernd R./0000-0002-6879-1633; Poitevin, Pierre/0000-0002-0592-7126	EC2CO program MATISSE of the CNRS INSU; Cluster of Excellence LabexMER; LIA BeBEST CNRS INEE; French Ministry of Higher Education and Research grant	EC2CO program MATISSE of the CNRS INSU; Cluster of Excellence LabexMER; LIA BeBEST CNRS INEE; French Ministry of Higher Education and Research grant	This work was supported by the EC2CO program MATISSE of the CNRS INSU, the Cluster of Excellence LabexMER, and the LIA BeBEST CNRS INEE. This research was carried out as part of the Ph.D. thesis of Pierre Poitevin for the University of Western Brittany with a French Ministry of Higher Education and Research grant. the funder (TBM environnement/Som me) provided support in the form of salaries for the author Aurelie Jolivet (A.J.) and the specific roles of this author are articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE W G JR, 1980, Proceedings National Shellfisheries Association, V70, P207; [Anonymous], 2021, LANG ENV STAT COMP; Belding D. L., 1910, REP COMM FISH GAME M; Brey T., 2001, POPULATION DYNAMICS; Brulotte S, 2016, SECR CAN CONSULT SCI; Cargnelli L. M., 1999, NOAA TECH MEMO NMFS, V142; CERRATO RM, 1992, MAR BIOL, V114, P581, DOI 10.1007/BF00357255; Chute AS, 2016, J SHELLFISH RES, V35, P729, DOI 10.2983/035.035.0402; Fan C, 2011, PALAEOGEOGR PALAEOCL, V299, P437, DOI 10.1016/j.palaeo.2010.11.022; Fay C. W., 1983, FWSOBS821113; Fullenbach CS, 2015, CHEM GEOL, V417, P341, DOI 10.1016/j.chemgeo.2015.10.030; Gaspar MB, 1995, SCI MAR, V59, P87; Gendron L, 1988, RAP MANUS CAN SCI HA, V1993; Goodwin DH, 2003, PALAIOS, V18, P110, DOI 10.1669/0883-1351(2003)18<110:RAFOOI>2.0.CO;2; GROSSMAN EL, 1986, CHEM GEOL, V59, P59, DOI 10.1016/0168-9622(86)90057-6; Hare MP, 2005, MAR BIOL, V146, P707, DOI 10.1007/s00227-004-1471-y; Heilmayer O, 2005, POLAR BIOL, V28, P523, DOI 10.1007/s00300-005-0716-7; Ivany LC, 2003, PALAIOS, V18, P126, DOI 10.1669/0883-1351(2003)18<126:USIDTR>2.0.CO;2; JONES DS, 1983, J EXP MAR BIOL ECOL, V73, P225, DOI 10.1016/0022-0981(83)90049-7; JONES DS, 1978, MAR BIOL, V47, P63, DOI 10.1007/BF00397019; Kerswill C. J., 1944, FISH RES BD CANADA PROGR REPTS, V35, P18; LeGrande AN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026011; MARSH M, 1976, J ULTRA MOL STRUCT R, V54, P445, DOI 10.1016/S0022-5320(76)80028-7; Marzec RJ, 2010, J SHELLFISH RES, V29, P117, DOI 10.2983/035.029.0104; Merrill A. S., 1961, FISH B, V65, P299; Munroe DM, 2016, ESTUAR COAST SHELF S, V170, P112, DOI 10.1016/j.ecss.2016.01.009; Munroe DM, 2013, FISH OCEANOGR, V22, P220, DOI 10.1111/fog.12016; Narvaez DA, 2015, J MARINE SYST, V141, P136, DOI 10.1016/j.jmarsys.2014.08.007; Northeast Fisheries Science Center (NEFSC), 2013, 13 10 NOAA FISH; OWEN G, 1953, NATURE, V171, P73, DOI 10.1038/171073a0; Pauly D., 1984, FISHBYTE, V2, P21; Pauly D., 1979, GILL SIZE TEMPERATUR, V6, P1, DOI [10.3289/ifm_ber_63, DOI 10.3289/IFM.BER.63, DOI 10.3289/IFM_BER_63]; Roberts G, 1981, CAN MANUSCR REP FISH, V1607; Ropes J. W, 1970, Proc. natn. Shellfish. Ass., V60, P99; Ropes J.W., 1979, Bulletin of the American Malacological Union Incorporated, V1979, P58; Ropes J.W., 1987, P517; Ropes J. W., 1979, OXYGEN DEPLETION ASS, P263; Ropes J. W, 1988, AGE DETERMINATION ME, P125; Schone BR, 2013, GLOBAL PLANET CHANGE, V111, P199, DOI 10.1016/j.gloplacha.2013.09.013; SEPHTON T W, 1990, Journal of Shellfish Research, V9, P177; Sharp Z, 2006, PRINCIPLES STABLE IS, P120; SKELTON PW, 1979, PALEOBIOLOGY, V5, P90, DOI 10.1017/S0094837300006394; Stecher HA, 1996, GEOCHIM COSMOCHIM AC, V60, P3445, DOI 10.1016/0016-7037(96)00179-2; Steinhardt J, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00176; Taylor J. D., 1969, Bulletin of the British Museum (Natural History) Zoology, P1; Weinberg J. R., 2006, ATLANTIC SURFCLAM S; Weinberg JR, 2005, ICES J MAR SCI, V62, P1444, DOI 10.1016/j.icesjms.2005.04.020; Weinberg JR, 2002, AM FISH S S, V32, P131; Weinberg JR, 1996, MAR BIOL, V126, P663, DOI 10.1007/BF00351333; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Woodin SA, 2013, ECOL EVOL, V3, P3334, DOI 10.1002/ece3.680; YONGE CM, 1967, PHILOS T ROY SOC B, V252, P49, DOI 10.1098/rstb.1967.0003	52	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199212	10.1371/journal.pone.0199212	http://dx.doi.org/10.1371/journal.pone.0199212			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902260	gold, Green Published			2022-12-26	WOS:000435424900101
J	Solebo, AL; Austin, AM; Theodorou, M; Timms, C; Hancox, J; Adams, GGW				Solebo, Ameenat Lola; Austin, Anne-Marie; Theodorou, Maria; Timms, Chris; Hancox, Joanne; Adams, Gillian G. W.			Botulinum toxin chemodenervation for childhood strabismus in England: National and local patterns of practice	PLOS ONE			English	Article							INFANTILE ESOTROPIA; SURGERY; CHILDREN; REOPERATION; RETREATMENT; INJECTION	Background Botulinum toxin injection chemodenervation is a well-established intervention for adult strabismus, and has also been recognised as an effective alternative to routine incisional surgery for paediatric disease. We aimed to investigate the temporal patterns of practice, indications and outcomes of chemodenervation for paediatric strabismus at national and tertiary centre level. Methods Retrospective study using routinely collected patient data: Hospital Episode Statistics (HES) data were used to identify children undergoing non-incisional strabismus procedures in England from 2007 to 2016. Single-centre retrospective data on children undergoing botulinum toxin injections (Dysport (R) 2.5 units/ 0.1ml) as an isolated intervention (not involving incisional procedures) was undertaken to identify indications and outcomes. Successful outcome was defined as deviation <11 prism dioptres (PD). Results Between 2007 and 2016, there was no increase in the proportion of childhood strabismus involving non-incisional procedures. Amongst 150 children undergoing chemodenervation for strabismus within the tertiary centre, the most common diagnoses were acute onset esotropia (n = 34), infantile esotropia (n = 16) and consecutive exotropia (n = 15). Median age at injection was 8.5 years (range 0.9-15 years), and median follow up 12 months (6 months-11 years). Success rates differed by diagnosis, from 66% (non or partially accommodative esotropia) to 0% (congenital cranial disorders). Adverse events were seen in 62/150, 41%, most commonly transient ptosis (39%, n = 58). Overcorrection was seen in 14/119, 13%. Mild subconjunctival haemorrhage (n = 2) was the only other adverse event. Conclusions Botulinum toxin for childhood strabismus has an acceptable safety profile, and considerable potential therapeutic benefit. However, nationally there has been no increased uptake of chemodenervation non-incisional procedures. Further prospective studies are necessary to understand the predictors of outcome within the separate clinical subgroups, to guide clinical decision making.	[Solebo, Ameenat Lola; Austin, Anne-Marie; Theodorou, Maria; Timms, Chris; Hancox, Joanne; Adams, Gillian G. W.] Moorfields Eye Hosp, Dept Strabismus & Paediat Ophthalmol, London, England; [Solebo, Ameenat Lola; Austin, Anne-Marie; Theodorou, Maria; Timms, Chris; Hancox, Joanne; Adams, Gillian G. W.] UCL, Inst Ophthalmol, Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Solebo, Ameenat Lola] UCL, Great Ormond St Inst Child Hlth, Lifecourse Epidemiol & Biostat Sect, Populat Policy & Practice Programme, London, England; [Solebo, Ameenat Lola] Ulverscroft Vis Res Grp, London, England; [Solebo, Ameenat Lola; Austin, Anne-Marie; Adams, Gillian G. W.] Great Ormond St Hosp Sick Children, Clin & Acad Dept Ophthalmol, London, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Adams, GGW (corresponding author), Moorfields Eye Hosp, Dept Strabismus & Paediat Ophthalmol, London, England.; Adams, GGW (corresponding author), UCL, Inst Ophthalmol, Natl Inst Hlth Res, Biomed Res Ctr, London, England.; Adams, GGW (corresponding author), Great Ormond St Hosp Sick Children, Clin & Acad Dept Ophthalmol, London, England.	a.solebo@ucl.ac.uk		Solebo, Ameenat/0000-0002-8933-5864	Department of Health's National Institute for Health Research (NIHR) BRC funding scheme; Lola Solebo; NIHR BRC based at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology	Department of Health's National Institute for Health Research (NIHR) BRC funding scheme; Lola Solebo; NIHR BRC based at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology	This work was undertaken at Moorfields Eye Hospital Biomedical Research Centre (BRC) which receives a proportion of funding from the Department of Health's National Institute for Health Research (NIHR) BRC funding scheme. Lola Solebo is funded, and Maria Theodorou is supported in part by the NIHR BRC based at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri A, 2017, J CURR OPHTHALMOL, V29, P50, DOI 10.1016/j.joco.2016.09.004; Arora A, 2005, BRIT J OPHTHALMOL, V89, P409, DOI 10.1136/bjo.2004.053678; Campomanes AGD, 2010, J AAPOS, V14, P111, DOI 10.1016/j.jaapos.2009.12.162; Couser NL, 2012, STRABISMUS, V20, P158, DOI 10.3109/09273972.2012.702324; Dawson ELM, 1999, OPHTHALMOLOGY, V106, P1727, DOI 10.1016/S0161-6420(99)90360-3; ELSTON JS, 1985, BRIT J OPHTHALMOL, V69, P718, DOI 10.1136/bjo.69.10.718; Hug D, 2015, CURR OPIN OPHTHALMOL, V26, P371, DOI 10.1097/ICU.0000000000000190; Issaho DC, 2017, INVEST OPHTH VIS SCI, V58, P5468, DOI 10.1167/iovs.17-22576; Mahan M, 2017, CURR OPIN OPHTHALMOL, V28, P460, DOI 10.1097/ICU.0000000000000408; Nabie R, 2017, EYE, V31, P148, DOI 10.1038/eye.2016.226; Nussgens Z, 1997, GRAEF ARCH CLIN EXP, V235, P197; Robaei D, 2006, OPHTHALMOLOGY, V113, P1146, DOI 10.1016/j.ophtha.2006.02.019; Rowe FJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006499.pub4; Rowe FJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006499.pub2; Rystedt A, 2015, CLIN NEUROPHARMACOL, V38, P170, DOI 10.1097/WNF.0000000000000101; SCOTT AB, 1973, INVEST OPHTH VISUAL, V12, P924; Speeg-Schatz C, 2017, EUR J OPHTHALMOL, V27, P285, DOI 10.5301/ejo.5000947; Taylor, PAEDIATRIC OPHTHALMO; Tejedor J, 1998, BRIT J OPHTHALMOL, V82, P110, DOI 10.1136/bjo.82.2.110; Tejedor J, 1999, BRIT J OPHTHALMOL, V83, P783, DOI 10.1136/bjo.83.7.783; Wan MJ, 2017, AM J OPHTHALMOL, V176, P33, DOI 10.1016/j.ajo.2016.12.024; Wen G, 2011, OPHTHALMOLOGY, V118, P574, DOI 10.1016/j.ophtha.2010.06.039	22	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199074	10.1371/journal.pone.0199074	http://dx.doi.org/10.1371/journal.pone.0199074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902283	Green Published, gold, Green Submitted			2022-12-26	WOS:000435424900084
J	Bai, MZ; Yang, LL; Liao, H; Liang, XY; Xie, BY; Xiong, J; Tao, X; Chen, X; Cheng, YL; Chen, XJ; Feng, YJ; Zhang, ZB; Zheng, WX				Bai, Mingzhu; Yang, Linlin; Liao, Hong; Liang, Xiaoyan; Xie, Bingying; Xiong, Ji; Tao, Xiang; Chen, Xiong; Cheng, Yali; Chen, Xiaojun; Feng, Youji; Zhang, Zhenbo; Zheng, Wenxin			Metformin sensitizes endometrial cancer cells to chemotherapy through IDH1-induced Nrf2 expression via an epigenetic mechanism	ONCOGENE			English	Article							PREDICT LONGER SURVIVAL; GLUTAMINE-METABOLISM; PROGESTIN RESISTANCE; OXIDATIVE STRESS; GASTRIC-CANCER; UP-REGULATION; GENE; P53; IDH1; PROMOTES	Chemoresistance is the major obstacle to cure endometrial cancer, whereas metformin has demonstrated sensitization to chemotherapy in endometrial cancer. A novel finding states that isocitrate dehydrogenase 1 (IDH1) involves in cancer chemoresistance. Recent studies have revealed that epigenetic modifications facilitate chemoresistance. However, whether IDH1 play a role in metformin-induced endometrial cancer chemosensitivity through epigenetic modification is incompletely understood. Immunohistochemistry and Elisa assays were used to evaluate the expression pattern of IDH1 in endometrial tissue and serum, respectively. Western blot was performed to determine changes in expression of key molecules in the IDH1-alpha-KG-TET1-Nrf2 signaling pathway after various treatments. Dot blot assays were used to assess global hydroxymethylation levels after metformin administration or plasmid transfection. Antioxidant response element (ARE) activity in the IDH1 promoter region was monitored by luciferase assay. Cancer cell sensitivity to chemotherapy was detected by SRB assay. We found that activation of the IDH1 signaling pathway in endometrial cancer tissue resulting from aberrant expression of IDH1 and its downstream mediators conferred chemoresistance. We found that this effect was abated by metformin treatment. Dot blot and HMeDIP assays revealed that metformin blocked IDH1-alpha-KG-TET1-mediated enhancement of Nrf2 hydroxymethylation levels, eliminating chemoresistance. Moreover, we observed that chemoresistance was enhanced via a regulatory loop in which Nrf2 activated IDH1-alpha-KG-TET1-Nrf2 signaling via binding to the ARE sites in the IDH1 promoter region. Our findings highlight a critical role of IDH1-alpha-KG-TET1-Nrf2 signaling in chemoresistance and suggest that rational combination therapy with metformin and chemotherapeutics has the potential to suppress chemoresistance. These authors contributed equally: Mingzhu Bai, Linlin Yang, Hong Liao.	[Bai, Mingzhu; Yang, Linlin; Xie, Bingying; Feng, Youji; Zhang, Zhenbo] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Obstet & Gynecol, Reprod Med Ctr, Shanghai 200080, Peoples R China; [Yang, Linlin; Liang, Xiaoyan; Chen, Xiong; Zhang, Zhenbo] Shanghai First Peoples Hosp, Baoshan Branch, Dept Obstet & Gynecol, Shanghai 201900, Peoples R China; [Liao, Hong] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Cerv Dis, Shanghai 200040, Peoples R China; [Xiong, Ji] Fudan Univ, Huashan Hosp, Dept Pathol, Shanghai 200040, Peoples R China; [Tao, Xiang] Fudan Univ, Obstet & Gynecol Hosp, Dept Pathol, Shanghai 200011, Peoples R China; [Cheng, Yali; Chen, Xiaojun] Fudan Univ, Obstet & Gynecol Hosp, Dept Gynecol, Shanghai 200011, Peoples R China; [Zheng, Wenxin] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Zheng, Wenxin] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA	Shanghai Jiao Tong University; Tongji University; Fudan University; Fudan University; Fudan University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, ZB (corresponding author), Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Obstet & Gynecol, Reprod Med Ctr, Shanghai 200080, Peoples R China.; Zhang, ZB (corresponding author), Shanghai First Peoples Hosp, Baoshan Branch, Dept Obstet & Gynecol, Shanghai 201900, Peoples R China.; Zheng, WX (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA.; Zheng, WX (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA.	zhangzhenbozzb@aliyun.com; Wenxin.Zheng@UTSouthwestern.edu		, Linlin/0000-0002-4260-1934; Bai, Mingzhu/0000-0001-6210-4890	National Natural Science Foundation of China [81672562, 81370074]; Shanghai Municipal Public Health Bureau [XYQ2013119]; "Chenxing Project" from Shanghai Jiao Tong University; Mark and Jane Gibson distinguished professorship endowment fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Public Health Bureau; "Chenxing Project" from Shanghai Jiao Tong University; Mark and Jane Gibson distinguished professorship endowment fund	We thank Prof. Zhao Shimin (Fudan University, Shanghai, China) for providing the plasmids pcDNA3.0-TET1-flag and pRSF-Duet1-IDH1. We also thank Prof. Shi Yujiang (Harvard University, Cambridge, MA) for providing pPB-TET1 plasmid. This work was supported by grants from the National Natural Science Foundation of China (grant numbers 81672562, 81370074), the Shanghai Municipal Public Health Bureau (grant number XYQ2013119) and the "Chenxing Project" from Shanghai Jiao Tong University to ZZ. The work was also partially supported by the Mark and Jane Gibson distinguished professorship endowment fund to WZ. We thank Dr. Yinhua Yu (The University of Texas, M.D. Anderson Cancer Center) for helpful discussions.	Antony S, 2017, MOL CARCINOGEN, V56, P2643, DOI 10.1002/mc.22708; Bajpai R, 2016, ONCOGENE, V35, P3955, DOI 10.1038/onc.2015.464; Cairncross JG, 2014, J CLIN ONCOL, V32, P783, DOI 10.1200/JCO.2013.49.3726; Calvert AE, 2017, CELL REP, V19, P1858, DOI 10.1016/j.celrep.2017.05.014; Chaudhry P, 2009, ENDOCR-RELAT CANCER, V16, P363, DOI 10.1677/ERC-08-0266; Chen HF, 2016, BIOMEDICINE-TAIWAN, V6, P1, DOI 10.7603/s40681-016-0001-9; Chen J, 2016, ONCOGENE, V35, P2506, DOI 10.1038/onc.2015.316; Chen N, 2011, INT J CLIN EXP PATHO, V4, P85; Chin RM, 2014, NATURE, V510, P397, DOI 10.1038/nature13264; Cho JM, 2008, CANCER LETT, V260, P96, DOI 10.1016/j.canlet.2007.10.022; Cuyas E, 2017, CELL CYCLE, V16, P1022, DOI 10.1080/15384101.2017.1310353; Dong LL, 2012, J OBSTET GYNAECOL RE, V38, P1077, DOI 10.1111/j.1447-0756.2011.01839.x; El-Ashmawy NE, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317692235; Fadare O, 2013, MODERN PATHOL, V26, P1101, DOI 10.1038/modpathol.2013.35; Feinberg AP, 2016, NAT REV GENET, V17, P284, DOI 10.1038/nrg.2016.13; Gasparre G, 2011, CANCER RES, V71, P6220, DOI 10.1158/0008-5472.CAN-11-1042; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3271, DOI 10.1200/JCO.2009.22.1630; Hanna RK, 2012, GYNECOL ONCOL, V125, P458, DOI 10.1016/j.ygyno.2012.01.009; Hernandez AV, 2015, EUR J CANCER, V51, P2747, DOI 10.1016/j.ejca.2015.08.031; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Hu X, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-43; Ikeda H, 2004, BIOCHEM J, V380, P515, DOI 10.1042/BJ20031948; Jia L, 2008, CLIN CANCER RES, V14, P2263, DOI 10.1158/1078-0432.CCR-07-4837; Jiang T, 2010, CANCER RES, V70, P5486, DOI 10.1158/0008-5472.CAN-10-0713; Kang KA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.149; Kastl L, 2010, INT J ONCOL, V36, P1235, DOI 10.3892/ijo_00000607; Keenan MM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005599; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Khor TO, 2008, PLANTA MED, V74, P1540, DOI 10.1055/s-0028-1088303; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Kwon OH, 2013, CANCER SCI, V104, P391, DOI 10.1111/cas.12076; Li B, 2016, ONCOTARGET, V7, P59458, DOI 10.18632/oncotarget.10694; Liu Y, 2017, ONCOTARGET, V8, P75206, DOI 10.18632/oncotarget.20663; Lu YX, 2017, CANCER RES, V77, P1709, DOI 10.1158/0008-5472.CAN-16-2773; Lv QY, 2017, J CANCER, V8, P894, DOI 10.7150/jca.17064; Ma QL, 2015, INT J CANCER, V137, P1058, DOI 10.1002/ijc.29395; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; Matassa DS, 2016, CELL DEATH DIFFER, V23, P1542, DOI 10.1038/cdd.2016.39; Meireles CG, 2017, GYNECOL ONCOL, V147, P167, DOI 10.1016/j.ygyno.2017.07.120; Do MT, 2014, FREE RADICAL BIO MED, V74, P21, DOI [10.1016/j.freeradbiomed2014.06.010, 10.1016/j.freeradbiomed.2014.06.010]; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Molenaar RJ, 2015, CANCER RES, V75, P4790, DOI 10.1158/0008-5472.CAN-14-3603; Montgomery RM, 2015, ARQ NEURO-PSIQUIAT, V73, P561, DOI 10.1590/0004-282X20150059; Nanduri J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119762; Ning CC, 2016, CANCER RES, V76, P1354, DOI 10.1158/0008-5472.CAN-15-1260; Ogura R, 2015, NEUROPATHOLOGY, V35, P324, DOI 10.1111/neup.12196; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Qi ST, 2012, CANCER SCI, V103, P269, DOI 10.1111/j.1349-7006.2011.02134.x; Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Saygin C, 2017, J EXP MED, V214, P2715, DOI 10.1084/jem.20170438; Shim GS, 2009, FREE RADICAL BIO MED, V47, P1619, DOI 10.1016/j.freeradbiomed.2009.09.006; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh A, 2008, CANCER RES, V68, P7975, DOI 10.1158/0008-5472.CAN-08-1401; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Sorosky JI, 2012, OBSTET GYNECOL, V120, P383, DOI 10.1097/AOG.0b013e3182605bf1; Stacy DR, 2006, HEAD NECK-J SCI SPEC, V28, P813, DOI 10.1002/hed.20430; Sun N, 2013, CLIN CANCER RES, V19, P5136, DOI 10.1158/1078-0432.CCR-13-0046; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan BK, 2011, J CLIN ENDOCR METAB, V96, P808, DOI 10.1210/jc.2010-1803; Tanaka K, 2015, J CLIN INVEST, V125, P1591, DOI 10.1172/JCI78239; Tao X, 2013, ENDOCR-RELAT CANCER, V20, P415, DOI 10.1530/ERC-12-0005; Tsai YP, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0513-0; Valtorta S, 2017, ONCOTARGET, V8, P113090, DOI 10.18632/oncotarget.23028; Vatrinet R, 2017, CANCER METAB, V5, DOI 10.1186/s40170-017-0165-0; Wang JB, 2014, ASIAN PAC J CANCER P, V15, P427, DOI 10.7314/APJCP.2014.15.1.427; Wang LW, 2008, WORLD J GASTROENTERO, V14, P7192, DOI 10.3748/wjg.14.7192; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wang YY, 2016, ONCOTARGET, V7, P10363, DOI 10.18632/oncotarget.7004; Wei KR, 2013, CHINA CANC, V22, P605; Wei Kuang-rong, 2012, Zhonghua Fu Chan Ke Za Zhi, V47, P445; Xiang L, 2012, GYNECOL ONCOL, V127, P595, DOI 10.1016/j.ygyno.2012.08.028; Xu T, 2015, DIABETES CARE, V38, P1858, DOI 10.2337/dc15-0658; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yang SH, 2016, ONCOTARGET, V7, P78787, DOI 10.18632/oncotarget.12859; Yates MS, 2007, MOL CANCER THER, V6, P154, DOI 10.1158/1535-7163.MCT-06-0516; Yu GZ, 2015, ONCOTARGET, V6, P12748, DOI 10.18632/oncotarget.3327; Zarei M, 2017, CANCER RES, V77, P4460, DOI 10.1158/0008-5472.CAN-17-0015; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zhang HH, 2016, CANCER CHEMOTH PHARM, V78, P13, DOI 10.1007/s00280-016-3037-3; Zhang P, 2010, MOL CANCER THER, V9, P336, DOI 10.1158/1535-7163.MCT-09-0589; Zhang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081264; Zhang ZB, 2012, CANCER LETT, V319, P89, DOI 10.1016/j.canlet.2011.12.033; Zhang ZB, 2011, INT J GYNECOL CANCER, V21, P213, DOI 10.1097/IGC.0b013e318207dac7; Zhuo ZH, 2016, ARCH GYNECOL OBSTET, V294, P1055, DOI 10.1007/s00404-016-4148-0	85	40	42	3	34	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 18	2018	37	42					5666	5681		10.1038/s41388-018-0360-7	http://dx.doi.org/10.1038/s41388-018-0360-7			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX3JJ	29921847				2022-12-26	WOS:000447619100006
J	Fujita, R; Yoshioka, K; Seko, D; Suematsu, T; Mitsuhashi, S; Senoo, N; Miura, S; Nishino, I; Ono, Y				Fujita, Ryo; Yoshioka, Kiyoshi; Seko, Daiki; Suematsu, Takashi; Mitsuhashi, Satomi; Senoo, Nanami; Miura, Shinji; Nishino, Ichizo; Ono, Yusuke			Zmynd17 controls muscle mitochondrial quality and whole-body metabolism	FASEB JOURNAL			English	Article						skeletal muscle; Mss51; insulin resistance; glucose intolerance; metabolic homeostasis	HUMAN SKELETAL-MUSCLE; INSULIN-RESISTANCE; GENE-EXPRESSION; OXIDATIVE-PHOSPHORYLATION; STEM-CELL; EXERCISE; DYSFUNCTION; HOMEOSTASIS; CHAIN; DEFICIENCY	Muscle mitochondria are crucial for systemic metabolic function, yet their regulation remains unclear. The zinc finger MYND domain-containing protein 17 (Zmynd17) was recently identified as a muscle-specific gene in mammals. Here, we investigated the role of Zmynd17 in mice. We found Zmynd17 predominantly expressed in skeletal muscle, especially in fast glycolytic muscle. Genetic Zmynd17 inactivation led to morphologic and functional abnormalities in muscle mitochondria, resulting in decreased respiratory function. Metabolic stress induced by a high-fat diet upregulated Zmynd17 expression and further exacerbated muscle mitochondrial morphology in Zmynd17-deficient mice. Strikingly, Zmynd17 deficiency significantly aggravated metabolic stress-induced hepatic steatosis, glucose intolerance, and insulin resistance. Furthermore, middle-aged mice lacking Zmynd17 exhibited impaired aerobic exercise performance, glucose intolerance, and insulin resistance. Thus, our results indicate that Zmynd17 is a metabolic stress-inducible factor that maintains muscle mitochondrial integrity, with its deficiency profoundly affecting whole-body glucose metabolism.Fujita, R., Yoshioka, K., Seko, D., Suematsu, T., Mitsuhashi, S., Senoo, N., Miura, S., Nishino, I., Ono, Y. Zmynd17 controls muscle mitochondrial quality and whole-body metabolism.	[Fujita, Ryo; Yoshioka, Kiyoshi; Seko, Daiki; Ono, Yusuke] Nagasaki Univ, Grad Sch Biomed Sci, Basic & Translat Res Ctr Hard Tissue Dis, Musculoskeletal Mol Biol Res Grp, 1-7-1 Sakamoto, Nagasaki 8528588, Japan; [Fujita, Ryo; Yoshioka, Kiyoshi; Seko, Daiki; Ono, Yusuke] Nagasaki Univ, Grad Sch Biomed Sci, Dept Stem Cell Biol, Nagasaki, Japan; [Suematsu, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Cent Electron Microscope Lab, Nagasaki, Japan; [Mitsuhashi, Satomi; Nishino, Ichizo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo, Japan; [Senoo, Nanami; Miura, Shinji] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Nutr Biochem, Shizuoka, Japan; [Ono, Yusuke] Agcy Med Res & Dev, Tokyo, Japan; [Fujita, Ryo] McGill Univ, Montreal, PQ, Canada	Nagasaki University; Nagasaki University; Nagasaki University; National Center for Neurology & Psychiatry - Japan; University of Shizuoka; McGill University	Ono, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Basic & Translat Res Ctr Hard Tissue Dis, Musculoskeletal Mol Biol Res Grp, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	yusuke-ono@nagasaki-u.ac.jp	Miura, Shinji/K-6516-2013; Nishino, Ichizo/G-2676-2010; Fujita, Ryo/GWZ-1472-2022	Miura, Shinji/0000-0001-8806-9763; Nishino, Ichizo/0000-0001-9452-112X; Fujita, Ryo/0000-0002-8392-0122; Yoshioka, Kiyoshi/0000-0001-5472-8142; Ono, Yusuke/0000-0002-4802-7507	Special Coordination Funds for Promoting Science and Technology (Japan Science and Technology Agency); Japan Agency for Medical Research and Development (AMED) [16bm0704010h0001]; Japan Society for the Promotion of Science (JSPS) [16K13046, 15H05368]; Center for Clinical and Translational Research of Kyushu University; Takeda Science Foundation; ONO Medical Research Foundation; Meiji Yasuda Life Foundation of Health and Welfare;  [15J03833]	Special Coordination Funds for Promoting Science and Technology (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center for Clinical and Translational Research of Kyushu University; Takeda Science Foundation(Takeda Science Foundation (TSF)); ONO Medical Research Foundation; Meiji Yasuda Life Foundation of Health and Welfare(Meiji Yasuda Life Foundation of Health and Welfare); 	The authors thank Dr. K. Yamamoto (Nagasaki University School of Medicine, Nagasaki, Japan) and all lab members for technical support. The Zmynd17<SUP>Lacz/+</SUP> ES cells used in this study were obtained from the Knockout Mouse Project (KOMP) Repository (Davis, CA, USA). This work was supported by the Special Coordination Funds for Promoting Science and Technology (Japan Science and Technology Agency), the Japan Agency for Medical Research and Development (AMED; Project 16bm0704010h0001), a Grant-in-Aid for Challenging Exploratory Research (Project 16K13046), a Grant-in-Aid for Young Scientists A (Project 15H05368) from the Japan Society for the Promotion of Science (JSPS), the Center for Clinical and Translational Research of Kyushu University, the Takeda Science Foundation, and the ONO Medical Research Foundation. This work was also supported, in part, by a Grant-in-Aid for JSPS Research Fellows (15J03833) and the Meiji Yasuda Life Foundation of Health and Welfare. The authors declare no conflicts of interest.	Akasaki Y, 2014, AGING CELL, V13, P80, DOI 10.1111/acel.12153; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Buzaglo-Azriel L, 2016, CELL REP, V14, P1602, DOI 10.1016/j.celrep.2016.01.046; Carnio S, 2014, CELL REP, V8, P1509, DOI 10.1016/j.celrep.2014.07.061; Carter HN, 2015, PHYSIOLOGY, V30, P208, DOI 10.1152/physiol.00039.2014; Cortopassi GA, 1999, BBA-BIOENERGETICS, V1410, P183, DOI 10.1016/S0005-2728(98)00166-2; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Fujita R, 2015, STEM CELLS, V33, P962, DOI 10.1002/stem.1900; Fujita R, 2014, BBA-GEN SUBJECTS, V1840, P3170, DOI 10.1016/j.bbagen.2014.01.014; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hesselink MKC, 2016, NAT REV ENDOCRINOL, V12, P633, DOI 10.1038/nrendo.2016.104; Hood DA, 2011, COMPR PHYSIOL, V1, P1119, DOI 10.1002/cphy.c100074; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Lach-Trifilieff E, 2014, MOL CELL BIOL, V34, P606, DOI 10.1128/MCB.01307-13; Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Mansueto G, 2017, CELL METAB, V25, P182, DOI 10.1016/j.cmet.2016.11.003; Masayesva BG, 2006, CANCER EPIDEM BIOMAR, V15, P19, DOI 10.1158/1055-9965.EPI-05-0210; Meng ZX, 2013, NAT MED, V19, P640, DOI 10.1038/nm.3144; Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Moyer Adam L, 2015, J Neuromuscul Dis, V2, P371; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; Ono Y, 2015, CELL REP, V10, P1135, DOI 10.1016/j.celrep.2015.01.045; Ono Y, 2012, J CELL SCI, V125, P1309, DOI 10.1242/jcs.096198; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Picard M, 2012, AM J PHYSIOL-CELL PH, V302, pC629, DOI 10.1152/ajpcell.00368.2011; Quiat D, 2011, P NATL ACAD SCI USA, V108, P10196, DOI 10.1073/pnas.1107413108; Rahimov F, 2011, PHYSIOL GENOMICS, V43, P398, DOI 10.1152/physiolgenomics.00223.2010; Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009; Romanello V, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00422; Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023; Safdar A, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0075-9; Seko D, 2016, FASEB J, V30, P1733, DOI 10.1096/fj.15-280933; Senoo N, 2015, J LIPID RES, V56, P2286, DOI 10.1194/jlr.M060533; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Soto IC, 2012, CELL METAB, V16, P801, DOI 10.1016/j.cmet.2012.10.018; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Szklarczyk R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r12; Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021; Wijngaarden MA, 2013, AM J PHYSIOL-ENDOC M, V304, pE1012, DOI 10.1152/ajpendo.00008.2013; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008	56	10	10	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5012	5025		10.1096/fj.201701264R	http://dx.doi.org/10.1096/fj.201701264R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913553				2022-12-26	WOS:000443817700032
J	Shastrula, PK; Lund, PJ; Garcia, BA; Janicki, SM				Shastrula, Prashanth Krishna; Lund, Peder J.; Garcia, Benjamin A.; Janicki, Susan M.			Rpp29 regulates histone H3.3 chromatin assembly through transcriptional mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin regulation; histone modification; gene regulation; glioblastoma; transcription; epigenetics; antisense RNA; histone H3; 3; RNase P; Rpp29; histone post-translational modifications (PTMs)	EMBRYONIC STEM-CELLS; RNA-POLYMERASE-III; LONG NONCODING RNAS; VARIANT H3.3; PEDIATRIC GLIOBLASTOMA; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; TRANSCRIBED GENES; MASS-SPECTROMETRY; DRIVER MUTATIONS	The histone H3 variant H3.3 is a highly conserved and dynamic regulator of chromatin organization. Therefore, fully elucidating its nucleosome incorporation mechanisms is essential to understanding its functions in epigenetic inheritance. We previously identified the RNase P protein subunit, Rpp29, as a repressor of H3.3 chromatin assembly. Here, we use a biochemical assay to show that Rpp29 interacts with H3.3 through a sequence element in its own N terminus, and we identify a novel interaction with histone H2B at an adjacent site. The fact that archaeal Rpp29 does not include this N-terminal region suggests that it evolved to regulate eukaryote-specific functions. Oncogenic H3.3 mutations alter the H3.3-Rpp29 interaction, which suggests that they could dysregulate Rpp29 function in chromatin assembly. We also used KNS42 cells, an H3.3(G34V) pediatric high-grade glioma cell line, to show that Rpp29 1) represses H3.3 incorporation into transcriptionally active protein-coding, rRNA, and tRNA genes; 2) represses mRNA, protein expression, and antisense RNA; and 3) represses euchromatic post-translational modifications (PTMs) and promotes heterochromatic PTM deposition (i.e. histone H3 Lys-9 trimethylation (H3K9me3) and H3.1/2/3K27me3). Notably, we also found that K27me2 is increased and K36me1 decreased on H3.3(G34V), which suggests that Gly-34 mutations dysregulate Lys-27 and Lys-36 methylation in cis. The fact that Rpp29 represses H3.3 chromatin assembly and sense and antisense RNA and promotes H3K9me3 and H3K27me3 suggests that Rpp29 regulates H3.3-mediated epigenetic mechanisms by processing a transcribed signal that recruits H3.3 to its incorporation sites.	[Shastrula, Prashanth Krishna; Janicki, Susan M.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Shastrula, Prashanth Krishna] Univ Sci Philadelphia, Dept Biol Sci, Philadelphia, PA 19104 USA; [Lund, Peder J.; Garcia, Benjamin A.] Univ Penn, Sch Med, Dept Biochem & Biophys, Epigenet Inst, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania	Janicki, SM (corresponding author), Rowan Univ, Dept Biol Sci, 201 Mullica Hill Rd, Glassboro, NJ 08028 USA.	janicki@rowan.edu	李, 金帝/ABH-1924-2021		Wistar Cancer Center Core Facilities Grant [P30 CA10815]; NATIONAL CANCER INSTITUTE [P30CA010815, T32CA009140, P01CA196539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110174] Funding Source: NIH RePORTER	Wistar Cancer Center Core Facilities Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the Wistar Cancer Center Genomics and Molecular Screening Core Facilities (supported by Wistar Cancer Center Core Facilities Grant P30 CA10815). Wethank Sylvie Shaffer for artistic contributions to the model.	Abu-Zhayia ER, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01185-6; Adam S, 2013, CELL, V155, P94, DOI 10.1016/j.cell.2013.08.029; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Banaszynski LA, 2013, CELL, V155, P107, DOI 10.1016/j.cell.2013.08.061; Barraza-Garcia J, 2017, CLIN GENET, V92, P91, DOI 10.1111/cge.12964; Behjati S, 2013, NAT GENET, V45, P1479, DOI 10.1038/ng.2814; Beltran M, 2016, GENOME RES, V26, P896, DOI 10.1101/gr.197632.115; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Bjerke L, 2013, CANCER DISCOV, V3, P512, DOI 10.1158/2159-8290.CD-12-0426; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Davidovich C, 2015, RNA, V21, P2007, DOI 10.1261/rna.053918.115; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Elalaoui SC, 2016, AM J MED GENET A, V170, P2462, DOI 10.1002/ajmg.a.37839; Elsasser SJ, 2015, NATURE, V522, P240, DOI 10.1038/nature14345; Everett RD, 2008, J VIROL, V82, P2661, DOI 10.1128/JVI.02308-07; Fang D, 2016, SCIENCE, V352, P1344, DOI 10.1126/science.aae0065; Feng WX, 2017, ARCH MED SCI, V13, P1315, DOI 10.5114/aoms.2017.66747; Ferenczy MW, 2011, J VIROL, V85, P4993, DOI 10.1128/JVI.02265-10; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Frey A, 2014, CURR BIOL, V24, P2195, DOI 10.1016/j.cub.2014.07.077; Futamura N, 2016, ONCOL LETT, V11, P2629, DOI 10.3892/ol.2016.4264; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Glazov EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002027; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Gopalan V, 2018, RNA, V24, P1, DOI 10.1261/rna.063107.117; Hennig BP, 2013, TRANSCR-AUSTIN, V4, P97, DOI 10.4161/trns.24884; Huang C, 2014, BIOESSAYS, V36, P579, DOI 10.1002/bies.201400005; Huang C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003558; Huang W, 2015, NATURE, V528, P517, DOI 10.1038/nature16193; Jang CW, 2015, GENE DEV, V29, P1377, DOI 10.1101/gad.264150.115; Jarrous N, 2017, TRENDS GENET, V33, P594, DOI 10.1016/j.tig.2017.06.006; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jones JM, 2011, IMMUNOL LETT, V136, P156, DOI 10.1016/j.imlet.2011.01.005; Jullien J, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-17; Kim JH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16122; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Kraushaar DC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r121; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Li X, 2016, ELIFE, V5, DOI 10.7554/eLife.15129; Lim JM, 2017, SCI REP-UK, V7, DOI 10.1038/srep39669; Lin CJ, 2014, DEV CELL, V30, P268, DOI 10.1016/j.devcel.2014.06.022; Lin S, 2012, METHOD ENZYMOL, V512, P3, DOI 10.1016/B978-0-12-391940-3.00001-9; Lindroth AM, 2013, NAT GENET, V45, P1413, DOI 10.1038/ng.2832; Loppin B, 2005, NATURE, V437, P1386, DOI 10.1038/nature04059; Lu C, 2016, SCIENCE, V352, P844, DOI 10.1126/science.aac7272; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luijsterburg MS, 2016, MOL CELL, V61, P547, DOI 10.1016/j.molcel.2016.01.019; MAIZELS N, 1994, P NATL ACAD SCI USA, V91, P6729, DOI 10.1073/pnas.91.15.6729; Marvin MC, 2011, RNA, V17, P1441, DOI 10.1261/rna.2737511; Meng QJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164845; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Molla-Herman A, 2015, EMBO J, V34, P3009, DOI 10.15252/embj.201591006; Natrajan R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3154; Newhart A, 2016, MOL BIOL CELL, V27, P1154, DOI 10.1091/mbc.E15-02-0099; Newhart A, 2013, J BIOL CHEM, V288, P19882, DOI 10.1074/jbc.M113.473181; Newhart A, 2013, MOL BIOL CELL, V24, P1454, DOI 10.1091/mbc.E12-09-0669; Newhart A, 2012, J CELL SCI, V125, P5489, DOI 10.1242/jcs.110148; Park J, 2015, ONCOTARGET, V6, P34658, DOI 10.18632/oncotarget.5778; Pchelintsev NA, 2013, CELL REP, V3, P1012, DOI 10.1016/j.celrep.2013.03.026; Reiner R, 2006, GENE DEV, V20, P1621, DOI 10.1101/gad.386706; Reiner R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004072; Rheinbay E, 2017, NATURE, V547, P55, DOI 10.1038/nature22992; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Rougemaille M, 2010, ADV EXP MED BIOL, V702, P122, DOI 10.1007/978-1-4419-7841-7_10; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sandman K, 2006, CURR OPIN MICROBIOL, V9, P520, DOI 10.1016/j.mib.2006.08.003; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Serruya R, 2015, NUCLEIC ACIDS RES, V43, P5442, DOI 10.1093/nar/gkv447; Shi LL, 2018, J MOL BIOL, V430, P1562, DOI 10.1016/j.jmb.2018.04.014; Sidoli S, 2017, METHODS MOL BIOL, V1528, P121, DOI 10.1007/978-1-4939-6630-1_8; Silva AC, 2012, J BIOL CHEM, V287, P1709, DOI 10.1074/jbc.M111.316489; Song HJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-225; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Talbert PB, 2017, NAT REV MOL CELL BIO, V18, P115, DOI 10.1038/nrm.2016.148; Tanaka Y, 2010, EMBO J, V29, P1510, DOI 10.1038/emboj.2010.56; Torres-Padilla ME, 2006, INT J DEV BIOL, V50, P455, DOI 10.1387/ijdb.052073mt; van der Heijden GW, 2007, NAT GENET, V39, P251, DOI 10.1038/ng1949; Venkatesh S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-16; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Venneti S, 2013, BRAIN PATHOL, V23, P558, DOI 10.1111/bpa.12042; Voon HPJ, 2016, NUCLEIC ACIDS RES, V44, P1496, DOI 10.1093/nar/gkw012; Wang XY, 2017, NAT STRUCT MOL BIOL, V24, P1028, DOI 10.1038/nsmb.3487; Weinberg DN, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026443; Wirbelauer C, 2005, GENE DEV, V19, P1761, DOI 10.1101/gad.347705; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Wrzeszczynski KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028503; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Yadav RK, 2017, ELIFE, V6, DOI 10.7554/eLife.27406; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027; Yuan ZF, 2015, MOL CELL PROTEOMICS, V14, P1696, DOI 10.1074/mcp.M114.046011	98	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12360	12377		10.1074/jbc.RA118.001845	http://dx.doi.org/10.1074/jbc.RA118.001845			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29921582	Green Published, hybrid			2022-12-26	WOS:000441408500005
J	Tomamichel, MM; Hodgins, NC; Venturelli, PA; Phelps, NBD				Tomamichel, Megan M.; Hodgins, Nathaniel C.; Venturelli, Paul A.; Phelps, Nicholas B. D.			The prevalence and potential fisheries consequences of Heterosporis sutherlandae in a Minnesota lake	PLOS ONE			English	Article							MICROSPORIDIAN PARASITE; YELLOW PERCH; PLEISTOPHORA-MULLERI; FISH MICROSPORIDIA; CHINOOK SALMON; MORTALITY; MICHIGAN; TEMPERATURE; POPULATION; INFECTIONS	Heterosporis sutherlandae is an emerging microsporidian fish parasite in the Great Lakes region. H. sutherlandae forms lesions in the muscle tissue of fishes important to aquaculture and sport fishing. These lesions render the filet inedible and may have fitness consequences. We evaluated the prevalence and severity of H. sutherlandae among yellow perch (Perca flavescens) in a known-positive Minnesota lake, and used an equilibrium yield model to evaluate impacts on harvest. Twenty-eight percent of the 400 yellow perch sampled were infected with H. sutherlandae. Males were 1.5 times more likely to be infected than females and were more severely infected. The presence of the parasite did not vary with relative weight or age, but infection severity was highest among older individuals that were in better condition. These results suggest that males are more susceptible to infection, and that infection is not associated with maturity or a gape-limiting food source. These results also suggest that heterosporosis increases in severity with time or by increased exposure. Our equilibrium yield model found that a 10% increase in mortality due to H. sutherlandae could result in 30% and 10% reductions in yield and mean catch weight, respectively. The results of this study direct future field sampling and laboratory experiments to further understand and predict the impacts of this parasite.	[Tomamichel, Megan M.; Phelps, Nicholas B. D.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Tomamichel, Megan M.; Phelps, Nicholas B. D.] Univ Minnesota, Minnesota Aquat Invas Species Res Ctr, St Paul, MN 55108 USA; [Hodgins, Nathaniel C.] Minnesota Dept Nat Resources, Windom Area Fisheries Off, Windom, MN USA; [Venturelli, Paul A.] Ball State Univ, Dept Biol, Muncie, IN 47306 USA; [Tomamichel, Megan M.] 135 Skok Hall, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Ball State University	Tomamichel, MM (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.; Tomamichel, MM (corresponding author), Univ Minnesota, Minnesota Aquat Invas Species Res Ctr, St Paul, MN 55108 USA.; Tomamichel, MM (corresponding author), 135 Skok Hall, St Paul, MN 55108 USA.	tomam002@umn.edu	Venturelli, Paul A/A-2337-2008	Venturelli, Paul A/0000-0002-7329-7517; Phelps, Nicholas/0000-0003-3116-860X	2013 06a Sub-Project 6: Determining Heterosporosis Threats Grant [M.L. 2013 Chp. 52, Sec. 2 Subd. 06a]	2013 06a Sub-Project 6: Determining Heterosporosis Threats Grant	This work was supported by the 2013 06a Sub-Project 6: Determining Heterosporosis Threats, Grant Number: M.L. 2013, Chp. 52, Sec. 2, Subd. 06a (http://www.legacy.leg.mn/funds/environment-natural-resources-trust-fund). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghaffar F, 2011, PARASITOL RES, V108, P219, DOI 10.1007/s00436-010-2061-1; Al-Quraishy S, 2012, PARASITOLOGY, V139, P454, DOI 10.1017/S0031182011001971; Alaoui HE, 2006, FOLIA PARASIT, V53, P37; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; ANTONIO DB, 1995, DIS AQUAT ORGAN, V22, P233, DOI 10.3354/dao022233; Becker JA, 2005, AQUACULTURE, V250, P533, DOI 10.1016/j.aquaculture.2005.04.004; Becnel JJ, 2000, BIOL CONTROL, V18, P39, DOI 10.1006/bcon.1999.0805; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Bunnell DB, 2006, CAN J FISH AQUAT SCI, V63, P832, DOI 10.1139/f05-271; Diamant A, 2010, DIS AQUAT ORGAN, V91, P137, DOI 10.3354/dao02256; Doublet V, 2015, ENVIRON MICROBIOL, V17, P969, DOI 10.1111/1462-2920.12426; Dykova I., 1995, PHYLUM MICROSPORA FI, P205; Escobar LE, 2018, REV FISH SCI AQUAC, V26, P121, DOI 10.1080/23308249.2017.1363715; Ferguson JA, 2007, DIS AQUAT ORGAN, V76, P205, DOI 10.3354/dao076205; Fielding NJ, 2005, PARASITOLOGY, V131, P331, DOI 10.1017/S0031182005007754; Froese R, 2017, FISHBASE WORLD WIDE; Glover DC, 2008, CAN J FISH AQUAT SCI, V65, P1919, DOI 10.1139/F08-100; Goodwin AE, 2004, FISHERIES, V29, P19, DOI 10.1577/1548-8446(2004)29[19:TOEFV]2.0.CO;2; HAMLEY JM, 1975, J FISH RES BOARD CAN, V32, P1943, DOI 10.1139/f75-233; HAUCK AK, 1984, J FISH DIS, V7, P217, DOI 10.1111/j.1365-2761.1984.tb00926.x; Haukos NA, 1995, LARGE LAKE SAMPLING; Hedrick RP, 1999, J AQUAT ANIM HEALTH, V11, P330, DOI 10.1577/1548-8667(1999)011&lt;0330:SOSIST&gt;2.0.CO;2; Johnson MW, 2001, CAN J ZOOL, V79, P1980, DOI 10.1139/cjz-79-11-1980; Kellner K, 2016, JAGSUI WRAPPER RJAGS, DOI DOI 10.1111/j.1472-4642.2007.00394.x; Kohler SL, 2001, ECOLOGY, V82, P2294, DOI 10.1890/0012-9658(2001)082[2294:PRIAAI]2.0.CO;2; Lom J, 2003, INT J PARASITOL, V33, P107, DOI 10.1016/S0020-7519(02)00252-7; Lom J, 2000, DIS AQUAT ORGAN, V43, P225, DOI 10.3354/dao043225; Marcogliese DJ, 2011, TRENDS PARASITOL, V27, P123, DOI 10.1016/j.pt.2010.11.002; Marsden JE, 2004, N AM J FISH MANAGE, V24, P952, DOI 10.1577/M02-195.1; MAULE AG, 1989, J ENDOCRINOL, V120, P135, DOI 10.1677/joe.0.1200135; Miller P.E., 2009, DIAGNOSIS PREVALENCE; Morales-Nin B., 1992, DETERMINATION GROWTH; Neath A.A., 2006, J DATA SCI, V4, P131, DOI [10.6339/JDS.2006.04(2).266, DOI 10.6339/JDS.2006.04(2).266]; NEPSZY SJ, 1972, J FISH RES BOARD CAN, V29, P1639, DOI 10.1139/f72-254; PAULY D, 1980, J CONSEIL, V39, P175; Paxton CGM, 1999, ECOL FRESHW FISH, V8, P78, DOI 10.1111/j.1600-0633.1999.tb00057.x; Pedersen C, 2017, SUMMER CREEL SURVEY; Phelps NBD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132027; Plummer M., 2016, RJAGS BAYESIAN GRAPH; RICKER W E, 1975, P382; ROBERTSON L, 1987, PROG FISH CULT, V49, P1, DOI 10.1577/1548-8640(1987)49&lt;1:PCASSR&gt;2.0.CO;2; Rodriguez-Tovar LE, 2011, FISH SHELLFISH IMMUN, V30, P999, DOI 10.1016/j.fsi.2011.02.011; Sanders JL, 2012, ILAR J, V53, P106, DOI 10.1093/ilar.53.2.106; SHAW MW, 1993, PLANT PATHOL, V42, P882, DOI 10.1111/j.1365-3059.1993.tb02674.x; Stentiford GD, 2016, TRENDS PARASITOL, V32, P336, DOI 10.1016/j.pt.2015.12.004; Sutherland D, 2000, 62 MIDWEST FISH WILD, P231; Tanner S., 2016, WINTER CREEL SURVEY; Terry RS, 2003, J EUKARYOT MICROBIOL, V50, P266, DOI 10.1111/j.1550-7408.2003.tb00133.x; Tomamichel M., 2018, PREDICTING IMPACTS H; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; Weller TH, 1938, COPEIA, V2, P61; WILLIS D W, 1991, North American Journal of Fisheries Management, V11, P374, DOI 10.1577/1548-8675(1991)011<0374:DAEOAS>2.3.CO;2	53	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199580	10.1371/journal.pone.0199580	http://dx.doi.org/10.1371/journal.pone.0199580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940005	Green Published, gold, Green Submitted			2022-12-26	WOS:000436088700026
J	Buckley, SJ; Timms, P; Davies, MR; McMillan, DJ				Buckley, Sean J.; Timms, Peter; Davies, Mark R.; McMillan, David J.			In silico characterisation of the two-component system regulators of Streptococcus pyogenes	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; ACUTE RHEUMATIC-FEVER; RESPONSE REGULATOR; GENOME SEQUENCE; VIRULENCE; DISEASE; RECOMBINATION; POPULATION; STRESS; GROWTH	Bacteria respond to environmental changes through the co-ordinated regulation of gene expression, often mediated by two-component regulatory systems (TCS). Group A Streptococcus (GAS), a bacterium which infects multiple human body sites and causes multiple diseases, possesses up to 14 TCS. In this study we examined genetic variation in the coding sequences and non-coding DNA upstream of these TCS as a method for evaluating relationships between different GAS emm-types, and potential associations with GAS disease. Twelve of the 14 TCS were present in 90% of the genomes examined. The length of the inter genic regions (IGRs) upstream of TCS coding regions varied from 39 to 345 nucleotides, with an average nucleotide diversity of 0.0064. Overall, IGR allelic variation was generally conserved with an emm-type. Subsequent phylogenetic analysis of concatenated sequences based on all TCS IGR sequences grouped genomes of the same emm-type together. However grouping with emm-pattern and emm-cluster-types was much weaker, suggesting epidemiological and functional properties associated with the latter are not due to evolutionary relatedness of emm-types. All emm5, emm6 and most of the emm18 genomes, all historically considered rheumatogenic emm-types clustered together, suggesting a shared evolutionary history. However emm1, emm3 and several emm18 genomes did not cluster within this group. These latter emm18 isolates were epidemiologically distinct from other emm18 genomes in study, providing evidence for local variation. emm-types associated with invasive disease or nephritogenicity also did not cluster together. Considering the TCS coding sequences (cds), correlation with emm-type was weaker than for the IGRs, and no strong correlation with disease was observed. Deletion of the malate transporter, maeP, was identified that serves as a putative marker for the emm89.0 subtype, which has been implicated in invasive outbreaks. A recombination-related, subclade-forming DNA motif was identified in the putative receiver domain of the Spy1556 response regulator that correlated with throat associated emm-pattern-type A-C strains.	[Buckley, Sean J.; Timms, Peter; McMillan, David J.] Univ Sunshine Coast, Fac Sci, Inflammat & Healing Biomed Res Cluster, Sippy Downs, Qld, Australia; [Buckley, Sean J.; Timms, Peter; McMillan, David J.] Univ Sunshine Coast, Fac Sci, Sch Hlth & Sports Sci, Sippy Downs, Qld, Australia; [Davies, Mark R.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia	University of the Sunshine Coast; University of the Sunshine Coast; University of Melbourne	McMillan, DJ (corresponding author), Univ Sunshine Coast, Fac Sci, Inflammat & Healing Biomed Res Cluster, Sippy Downs, Qld, Australia.; McMillan, DJ (corresponding author), Univ Sunshine Coast, Fac Sci, Sch Hlth & Sports Sci, Sippy Downs, Qld, Australia.	david.mcmillan@usc.edu.au	Davies, Mark R/J-2128-2014; McMillan, David/P-5582-2016	Davies, Mark R/0000-0001-6141-5179; McMillan, David/0000-0002-9339-0639; Timms, Peter/0000-0002-1682-0025	Australian Government	Australian Government(Australian GovernmentCGIAR)	SB was the recipient of an Australian Government post-graduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athey TBT, 2014, J CLIN MICROBIOL, V52, P1871, DOI 10.1128/JCM.00029-14; Baroux N, 2014, CLIN INFECT DIS, V59, pE84, DOI 10.1093/cid/ciu490; Belotserkovsky I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000651; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Beres SB, 2017, J MED MICROBIOL, V66, P1765, DOI 10.1099/jmm.0.000622; Beres SB, 2016, MBIO, V7, DOI 10.1128/mBio.00403-16; Bessen DE, 2000, J INFECT DIS, V182, P1109, DOI 10.1086/315842; Bessen DE., 2016, STREPTOCOCCUS PYOGEN; Bessen DE, 2015, INFECT GENET EVOL, V33, P393, DOI 10.1016/j.meegid.2014.10.011; Bessen DE, 2010, FUTURE MICROBIOL, V5, P623, DOI [10.2217/fmb.10.28, 10.2217/FMB.10.28]; Bessen DE, 2009, INFECT GENET EVOL, V9, P581, DOI 10.1016/j.meegid.2009.03.002; Bessen DE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-59; Bisno A.L., 1980, STREPTOCOCCAL DISEAS, P789; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Chiang-Ni C, 2017, INT J MED MICROBIOL, V307, P329, DOI 10.1016/j.ijmm.2017.06.002; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Cunningham MW, 2008, ADV EXP MED BIOL, V609, P29, DOI 10.1007/978-0-387-73960-1_3; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Davies MR, 2015, NAT GENET, V47, P84, DOI 10.1038/ng.3147; Dmitriev AV, 2006, J BACTERIOL, V188, P7230, DOI 10.1128/JB.00877-06; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Falugi F, 2008, J INFECT DIS, V198, P1834, DOI 10.1086/593176; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Friaes A, 2015, MBIO, V6, DOI 10.1128/mBio.01780-15; Friaes A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12057; Hanage WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/j.jtbi.2005.08.035; Hasegawa T, 2010, APMIS, V118, P167, DOI 10.1111/j.1600-0463.2009.02574.x; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; HOLLINGSHEAD SK, 1993, MOL MICROBIOL, V8, P707, DOI 10.1111/j.1365-2958.1993.tb01614.x; Ichikawa M, 2011, MICROBIOL-SGM, V157, P3187, DOI 10.1099/mic.0.050534-0; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; Kawada-Matsuo M, 2016, APPL ENVIRON MICROB, V82, P5930, DOI 10.1128/AEM.01897-16; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kreikemeyer B, 2001, MOL MICROBIOL, V39, P392, DOI 10.1046/j.1365-2958.2001.02226.x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Leday TV, 2008, INFECT IMMUN, V76, P4659, DOI 10.1128/IAI.00597-08; Lees JA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12797; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu MY, 2006, MICROBIOL-SGM, V152, P967, DOI 10.1099/mic.0.28706-0; Lynskey NN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003842; McDonald MI, 2007, EPIDEMIOL INFECT, V135, P1398, DOI 10.1017/S0950268807008023; McGregor KF, 2004, J BACTERIOL, V186, P4285, DOI 10.1128/JB.186.13.4285-4294.2004; McMillan DJ, 2006, CLIN INFECT DIS, V43, P884, DOI 10.1086/507537; McMillan DJ, 2013, CURR TOP MICROBIOL, V368, P29, DOI 10.1007/82_2012_278; McMillan DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021346; Miguel-Romero L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02900-z; Mostowy R, 2017, MOL BIOL EVOL, V34, P1167, DOI 10.1093/molbev/msx066; Namprachan-Frantz P, 2014, J BACTERIOL, V196, P604, DOI 10.1128/JB.01009-13; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; Okada R, 2014, APMIS, V122, P914, DOI 10.1111/apm.12230; Paluscio E, 2015, INFECT IMMUN, V83, P1162, DOI 10.1128/IAI.02814-14; Pancholi V., 2016, STREPTOCOCCUS PYOGEN; Plainvert C, 2014, J CLIN MICROBIOL; Port GC, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00725-15; Pruksakorn S, 2000, J CLIN MICROBIOL, V38, P1250, DOI 10.1128/JCM.38.3.1250-1254.2000; Remenyi B., 2014, PEDIAT CONGENITAL CA, P2329, DOI [10.1007/978-1-4471-4619-3_5, DOI 10.1007/978-1-4471-4619-3_5]; Riani C, 2007, INT J MED MICROBIOL, V297, P513, DOI 10.1016/j.ijmm.2007.04.005; Rush CM, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00116; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; Seale AC, 2016, EMERG INFECT DIS, V22, P224, DOI 10.3201/eid2202.151358; Severiano A, 2011, J CLIN MICROBIOL, V49, P3997, DOI 10.1128/JCM.00624-11; Sharma A, 2014, VACCINE DEV THERAPY, V4, P39; Shelburne SA, 2005, P NATL ACAD SCI USA, V102, P16037, DOI 10.1073/pnas.0505839102; Sitkiewicz I, 2006, INFECT IMMUN, V74, P1339, DOI 10.1128/IAI.74.2.1339-1351.2006; Sitkiewicz I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009785; Smeesters PR, 2008, VACCINE, V26, P5835, DOI 10.1016/j.vaccine.2008.08.037; Smeesters PR, 2009, EXPERT REV VACCINES, V8, P1705, DOI 10.1586/ERV.09.133; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Steer AC, 2009, MED J AUSTRALIA, V190, P133, DOI 10.5694/j.1326-5377.2009.tb02312.x; Steiner K, 2000, MOL MICROBIOL, V38, P1004, DOI 10.1046/j.1365-2958.2000.02203.x; Stollerman GH, 2001, CLIN INFECT DIS, V33, P806, DOI 10.1086/322665; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Tatsuno Ichiro, 2014, BMC Res Notes, V7, P189, DOI 10.1186/1756-0500-7-189; Teatero S, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx042; Tesorero RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064021; Thorpe HA, 2017, GENETICS, V206, P363, DOI 10.1534/genetics.116.195784; Tokajian Sima, 2014, Genome Announc, V2, DOI 10.1128/genomeA.00358-14; Turner CE, 2015, MBIO, V6; Tyrrell GJ, 2010, CLIN INFECT DIS, V51, P1290, DOI 10.1086/657068; Vega LA, 2016, VIRULENCE RELATED TR; Voyich JM, 2003, P NATL ACAD SCI USA, V100, P1996, DOI 10.1073/pnas.0337370100; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Walker MJ, 2014, CLIN MICROBIOL REV, V27, P264, DOI 10.1128/CMR.00101-13; Wilkening RV, 2017, TRENDS MICROBIOL; Yano H, 2017, GENOME BIOL EVOL, V9, P2403, DOI 10.1093/gbe/evx183; Zakour NLB, 2015, SCI REPORTS, V5; Zhu LC, 2015, MBIO, V6, DOI 10.1128/mBio.01378-15; Zhu LC, 2015, J CLIN INVEST, V125, P3545, DOI 10.1172/JCI82478	93	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199163	10.1371/journal.pone.0199163	http://dx.doi.org/10.1371/journal.pone.0199163			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927994	Green Published, gold			2022-12-26	WOS:000435802500052
J	Tomazi, T; de Souza, AF; Heinemann, MB; dos Santos, MV				Tomazi, Tiago; de Souza Filho, Antonio Francisco; Heinemann, Marcos Bryan; dos Santos, Marcos Veiga			Molecular characterization and antimicrobial susceptibility pattern of Streptococcus agalactiae isolated from clinical mastitis in dairy cattle	PLOS ONE			English	Article							GROUP-B STREPTOCOCCI; BOVINE MASTITIS; MILK SAMPLES; RISK-FACTORS; COW-LEVEL; EPIDEMIOLOGY; HERDS; RESISTANCE; PATHOGENS; DNA	The objectives of this study were to: (a) genotypically characterize Streptococcus agalactiae isolates recovered from clinical mastitis (CM) cases in dairy cows and, (b) determine the association of antimicrobial susceptibility (AMS) and genotypes of Strep. agalactiae clustered according to the genetic similarity. A total of 89 Strep. agalactiae isolates recovered from bovine CM were genotyped using random amplified polymorphic DNA (RAPD) analysis. In addition, the AMS of the isolates was determined using a commercial broth microdilution test composed of 10 antimicrobials (penicillin, ampicillin, oxacillin, cephalothin, ceftiofur, penicillin/novobiocin, erythromycin, pirlimycin, tetracycline, and sulfadimethoxine). Descriptive analysis was used to report the frequency of RAPD-types and genotypic clusters within herd, housing system, season and CM severity scores. The minimal antimicrobial concentrations that inhibited 50% (MIC50) and 90% (MIC90) of the isolates were calculated and survival analysis was completed to verify the differences of AMS among genotypic clusters. Results of RAPD showed a great genotypic diversity of Strep. agalactiae (45 RAPD-types) and three clusters (Ia, Ib and II) were created based on the genetic similarity among genotypes. After clustering, a high genetic similarity was observed within and between herds. Overall, Strep. agalactiae showed high susceptibility to most antimicrobials, except to tetracycline and erythromycin. Differences in the AMS among clusters were observed for ampicillin, ceftiofur, erythromycin, pirlimycin, sulfadimethoxine and tetracycline. In conclusion, Strep. agalactiae is still highly susceptible to most antimicrobials, although differences in susceptibility to certain antimicrobials were observed among genotypic clusters.	[Tomazi, Tiago; dos Santos, Marcos Veiga] Univ Sao Paulo, Dept Anim Prod & Nutr, Milk Qual Res Lab Qualileite, Pirassununga, Brazil; [de Souza Filho, Antonio Francisco; Heinemann, Marcos Bryan] Univ Sao Paulo, Dept Prevent Vet Med & Anim Hlth, Lab Bacterial Zoonosis, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	dos Santos, MV (corresponding author), Univ Sao Paulo, Dept Anim Prod & Nutr, Milk Qual Res Lab Qualileite, Pirassununga, Brazil.	mveiga@usp.br	Tomazi, Tiago/AAA-9895-2020; Heinemann, Marcos B/G-2780-2015; Heinemann, Marcos Bryan/AAI-9390-2020; Santos, Marcos Veiga/AAA-4290-2021; de Souza Filho, Antonio Francisco/G-2382-2015; Tomazi, Tiago/L-3305-2013; Santos, Marcos V/D-6936-2012	Tomazi, Tiago/0000-0001-8978-6254; Heinemann, Marcos B/0000-0001-6444-9788; Heinemann, Marcos Bryan/0000-0001-6444-9788; Santos, Marcos Veiga/0000-0002-4273-3494; de Souza Filho, Antonio Francisco/0000-0003-4728-1228; Tomazi, Tiago/0000-0001-8978-6254; Santos, Marcos V/0000-0002-4273-3494	Sao Paulo Research Foundation [TT 2013/22286-3, MVS 2014/17411-6, MBH 2015/10332-6]; National Council for Scientific and Technological Development [448357/2014-3]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financially supported by the Sao Paulo Research Foundation (grants: TT 2013/22286-3; MVS 2014/17411-6; MBH 2015/10332-6), and by the National Council for Scientific and Technological Development (grant 448357/2014-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 2016, ENVIRON MICROBIOL, V18, P4216, DOI 10.1111/1462-2920.13550; Carvalho-Castro GA, 2017, BRAZ J MICROBIOL, V48, P551, DOI 10.1016/j.bjm.2017.02.004; CLSI, 2013, VET01S2 CLSI; Cortinhas CS, 2013, AM J VET RES, V74, P683, DOI 10.2460/ajvr.74.5.683; Dogan B, 2005, J CLIN MICROBIOL, V43, P5899, DOI 10.1128/JCM.43.12.5899-5906.2005; Duarte RS, 2005, ANTIMICROB AGENTS CH, V49, P97, DOI 10.1128/AAC.49.1.97-103.2005; Duarte RS, 2004, J CLIN MICROBIOL, V42, P4214, DOI 10.1128/JCM.42.9.4214-4222.2004; Gallego FJ, 1997, BIOTECHNIQUES, V23, P663, DOI 10.2144/97234bm27; Guerin-Faublee V, 2002, INT J ANTIMICROB AG, V19, P219, DOI 10.1016/S0924-8579(01)00485-X; Jorgensen HJ, 2016, VET MICROBIOL, V184, P64, DOI 10.1016/j.vetmic.2015.12.014; Kaczorek E, 2017, J DAIRY SCI, V100, P6442, DOI 10.3168/jds.2017-12660; Katholm J, 2012, J DAIRY SCI, V95, P5702, DOI 10.3168/jds.2011-5307; Keefe G, 2012, VET CLIN N AM-FOOD A, V28, P203, DOI 10.1016/j.cvfa.2012.03.010; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lyhs U, 2016, EMERG INFECT DIS, V22, P2097, DOI 10.3201/eid2212.151447; Mahmmod YS, 2015, J DAIRY SCI, V98, P6913, DOI 10.3168/jds.2015-9397; Martinez G, 2000, J CLIN MICROBIOL, V38, P71; McDonald WL, 2005, VET MICROBIOL, V111, P241, DOI 10.1016/j.vetmic.2005.10.012; Mweu MM, 2014, PREV VET MED, V113, P219, DOI 10.1016/j.prevetmed.2013.10.020; National Mastitis Council, 2017, LAB HDB BOV MAST NAT; Oliveira CSF, 2015, PREV VET MED, V121, P297, DOI 10.1016/j.prevetmed.2015.08.001; Oliveira L, 2013, J DAIRY SCI, V96, P7538, DOI 10.3168/jds.2012-6078; Patel J.B., 2015, PERFORMANCE STANDARD; Piepers S, 2007, J DAIRY RES, V74, P478, DOI 10.1017/S0022029907002841; Ramirez NF, 2014, J DAIRY SCI, V97, P4141, DOI 10.3168/jds.2013-6815; Rato MG, 2013, VET MICROBIOL, V161, P286, DOI 10.1016/j.vetmic.2012.07.043; Reyes J, 2017, J DAIRY SCI, V100, P9294, DOI 10.3168/jds.2017-13363; Reyes J, 2015, J DAIRY SCI, V98, P5294, DOI 10.3168/jds.2014-9199; Reyher KK, 2011, J DAIRY SCI, V94, P3387, DOI 10.3168/jds.2010-3907; Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026; SPEER BS, 1992, CLIN MICROBIOL REV, V5, P387, DOI 10.1128/CMR.5.4.387-399.1992; Tomazi T., 2017, THESIS; Uh Y, 2001, EUR J CLIN MICROBIOL, V20, P52, DOI 10.1007/s10096-001-8044-5; Yang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067755; Zadoks RN, 2006, VET CLIN N AM-FOOD A, V22, P229, DOI 10.1016/j.cvfa.2005.11.005; Zadoks RN, 2003, EPIDEMIOL INFECT, V130, P335, DOI 10.1017/S0950268802008221; Zadoks RN, 2011, J MAMMARY GLAND BIOL, V16, P357, DOI 10.1007/s10911-011-9236-y	37	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199561	10.1371/journal.pone.0199561	http://dx.doi.org/10.1371/journal.pone.0199561			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928042	Green Submitted, Green Published, gold			2022-12-26	WOS:000435802500110
J	Bonvallot, N; Canlet, C; Blas-Y-Estrada, F; Gautier, R; Tremblay-Franco, M; Chevolleau, S; Cordier, S; Cravedi, JP				Bonvallot, Nathalie; Canlet, Cecile; Blas-Y-Estrada, Florence; Gautier, Roselyne; Tremblay-Franco, Marie; Chevolleau, Sylvie; Cordier, Sylvaine; Cravedi, Jean-Pierre			Metabolome disruption of pregnant rats and their offspring resulting from repeated exposure to a pesticide mixture representative of environmental contamination in Brittany	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PYRETHROID INSECTICIDE EXPOSURE; LONG-TERM; ORGANOPHOSPHATE PESTICIDES; METABONOMIC TECHNIQUES; SUBCHRONIC EXPOSURE; CHILDREN; URINE; CHLORPYRIFOS; SERUM	The use of pesticides exposes humans to numerous harmful molecules. Exposure in early-life may be responsible for adverse effects in later life. This study aimed to assess the metabolic modifications induced in pregnant rats and their offspring by a pesticide mixture representative of human exposure. Ten pregnant rats were exposed to a mixture of eight pesticides: acetochlor (246 mu g/kg bw/d) + bromoxynil (12 mu g/kg bw/d) + carbofuran (22.5 mu g/kg bw/d) + chlormequat (35 mu g/kg bw/d) + ethephon (22.5 mu g/kg bw/d) + fenpropimorph (15.5 mu g/kg bw/d) + glyphosate (12 mu g/kg bw/d) + imidacloprid (12.5 mu g/kg bw/d) representing the main environmental pesticide exposure in Brittany (France) in 2004. Another group of 10 pregnant rats served as controls. Females were fed ad libitum from early pregnancy, which is from gestational day (GD) 4 to GD 21. Urine samples were collected at GD 15. At the end of the exposure, mothers and pups were euthanized and blood, liver, and brain samples collected. H-1 NMR-based metabolomics and GC-FID analyses were performed and PCA and PLS-DA used to discriminate between control and exposed groups. Metabolites for which the levels were significantly modified were then identified using the Kruskal-Wallis test, and p-values were adjusted for multiple testing correction using the False Discovery Rate. The metabolomics analysis revealed many differences between dams of the two groups, especially in the plasma, liver and brain. The modified metabolites are involved in TCA cycle, energy production and storage, lipid and carbohydrate metabolism, and amino-acid metabolism. These modifications suggest that the pesticide mixture may induce oxidative stress associated with mitochondrial dysfunction and the impairment of glucose and lipid metabolism. These observations may reflect liver dysfunction with increased relative liver weight and total lipid content. Similar findings were observed for glucose and energy metabolism in the liver of the offspring, and oxidative stress was also suggested in the brains of male offspring.	[Bonvallot, Nathalie; Cordier, Sylvaine] Univ Rennes, EHESP, Inserm, Irset,UMR S 1085, Rennes, France; [Bonvallot, Nathalie; Canlet, Cecile; Blas-Y-Estrada, Florence; Gautier, Roselyne; Tremblay-Franco, Marie; Chevolleau, Sylvie; Cravedi, Jean-Pierre] Univ Toulouse, INRA UMR Toxalim 1331, UMR1331, INP,ENVT,EIP,UPS, Toulouse, France	Ecole des Hautes Etudes en Sante Publique (EHESP); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse	Bonvallot, N (corresponding author), Univ Rennes, EHESP, Inserm, Irset,UMR S 1085, Rennes, France.; Bonvallot, N (corresponding author), Univ Toulouse, INRA UMR Toxalim 1331, UMR1331, INP,ENVT,EIP,UPS, Toulouse, France.	nathalia.bonvallot@ehesp.fr	Cordier, Sylvaine/F-7919-2013; Bonvallot, Nathalie/ABF-7860-2020; Cordier, Sylvaine/X-7440-2019	Bonvallot, Nathalie/0000-0002-8070-6008; Cordier, Sylvaine/0000-0002-2349-2277	EHESP-School of Public Health; French Ministry of Environment in the national program Grenelle de l'Environnement Programme [LOLF 189]	EHESP-School of Public Health; French Ministry of Environment in the national program Grenelle de l'Environnement Programme	This work was supported by grants from the EHESP-School of Public Health (Young Researchers) and the French Ministry of Environment in the national program Grenelle de l'Environnement Programme LOLF 189 Funding (EXPi0 mark).	Al-Eryani L, 2015, TOXICOL PATHOL, V43, P482, DOI 10.1177/0192623314549960; Alavanja MCR, 2004, ANNU REV PUBL HEALTH, V25, P155, DOI 10.1146/annurev.publhealth.25.101802.123020; Baltazar MT, 2014, TOXICOL LETT, V230, P85, DOI 10.1016/j.toxlet.2014.01.039; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonvallot N, 2014, J TOXICOL ENV HEAL B, V17, P21, DOI 10.1080/10937404.2013.860318; Bonvallot N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064433; Bradman A, 2011, INT J ENV RES PUB HE, V8, P1061, DOI 10.3390/ijerph8041061; Canlet C, 2013, J TOXICOL-US, V2013, DOI 10.1155/2013/545802; Cao C, 2016, XENOBIOTICA, V46, P805, DOI 10.3109/00498254.2015.1121552; Chevrier C, 2014, ENVIRON INT, V63, P11, DOI 10.1016/j.envint.2013.10.010; Chevrier C, 2011, ENVIRON HEALTH PERSP, V119, P1034, DOI 10.1289/ehp.1002775; Counihan JL, 2017, ACS CHEM BIOL, V12, P635, DOI 10.1021/acschembio.6b01001; Demur C, 2013, TOXICOLOGY, V308, P74, DOI 10.1016/j.tox.2013.03.004; Deng YF, 2016, SCI TOTAL ENVIRON, V544, P507, DOI 10.1016/j.scitotenv.2015.11.162; Du LF, 2013, TOXICOL SCI, V134, P195, DOI 10.1093/toxsci/kft091; Eriksson L., 2006, MULTI MEGAVARIATE 1; Eskenazi B, 2010, ENVIRON HEALTH PERSP, V118, P1775, DOI 10.1289/ehp.1002234; European Chemicals Agency (ECHA) Committee for Risk Assessment RAC, OP PROP HARM CLASS L; Feng ZJ, 2012, CHEM-BIOL INTERACT, V199, P143, DOI 10.1016/j.cbi.2012.07.004; Ford B, 2017, CELL CHEM BIOL, V24, P1, DOI [10.1016/j.chembiol.2017.01.001, DOI 10.1016/J.CHEMBIOL.2017.01.001]; Gunier RB, 2011, ENVIRON HEALTH PERSP, V119, P970, DOI 10.1289/ehp.1002532; Hanke Wojciech, 2004, Int J Occup Med Environ Health, V17, P223; Harley KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023923; Hou YR, 2015, MOL BIOSYST, V11, P506, DOI 10.1039/c4mb00523f; Jamin EL, 2014, ANAL BIOANAL CHEM, V406, P1149, DOI 10.1007/s00216-013-7136-2; Karami-Mohajeri S, 2013, TOXICOL APPL PHARM, V270, P39, DOI 10.1016/j.taap.2013.04.001; Klein J, 2000, J NEURAL TRANSM, V107, P1027, DOI 10.1007/s007020070051; Krahenbuhl L, 1997, HEPATOLOGY, V25, P278, DOI 10.1053/jhep.1997.v25.pm0009021934; Lee JE, 2012, TOXICOL APPL PHARM, V263, P148, DOI 10.1016/j.taap.2012.06.005; Li HY, 2011, TOXICOL IND HEALTH, V27, P579, DOI 10.1177/0748233710393400; Li LX, 2016, PESTIC BIOCHEM PHYS, V128, P82, DOI 10.1016/j.pestbp.2015.09.013; Liang YJ, 2013, CHEM-BIOL INTERACT, V206, P302, DOI 10.1016/j.cbi.2013.10.002; Liang YJ, 2012, BIOANALYSIS, V4, P2897, DOI [10.4155/BIO.12.277, 10.4155/bio.12.277]; Liang YJ, 2012, BIOMARKERS, V17, P566, DOI 10.3109/1354750X.2012.704527; Marks AR, 2010, ENVIRON HEALTH PERSP, V118, P1768, DOI 10.1289/ehp.1002056; Mattix KD, 2007, J PEDIATR SURG, V42, P947, DOI 10.1016/j.jpedsurg.2007.01.027; Merhi M, 2010, TOXICOLOGY, V267, P80, DOI 10.1016/j.tox.2009.10.024; Mesnage R, 2017, SCI REP-UK, V7, DOI 10.1038/srep39328; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Ochoa-Acuna H, 2009, ENVIRON HEALTH PERSP, V117, P1619, DOI 10.1289/ehp.0900784; Ostrea EM, 2012, NEUROTOXICOLOGY, V33, P669, DOI 10.1016/j.neuro.2011.11.006; Park Y, 2013, J AGR FOOD CHEM, V61, P255, DOI 10.1021/jf3039814; Pathak R, 2011, REPROD TOXICOL, V31, P534, DOI 10.1016/j.reprotox.2011.02.007; Petrat F, 2012, BRIT J PHARMACOL, V165, P2059, DOI 10.1111/j.1476-5381.2011.01711.x; PRITCHARD PH, 1981, BIOCHEM J, V196, P261, DOI 10.1042/bj1960261; Quiros-Alcala L, 2014, ENVIRON HEALTH PERSP, V122, P1336, DOI 10.1289/ehp.1308031; Rauh V, 2011, ENVIRON HEALTH PERSP, V119, P1196, DOI 10.1289/ehp.1003160; Rauh VA, 2006, PEDIATRICS, V118, pE1845, DOI 10.1542/peds.2006-0338; Sun QC, 2016, J AGR FOOD CHEM, V64, P9293, DOI 10.1021/acs.jafc.6b04322; Verwaest KA, 2011, BBA-MOL BASIS DIS, V1812, P1371, DOI 10.1016/j.bbadis.2011.08.001; Viel JF, 2017, OCCUP ENVIRON MED, V74, P275, DOI 10.1136/oemed-2016-104035; Viel JF, 2015, ENVIRON INT, V82, P69, DOI 10.1016/j.envint.2015.05.009; Wagner-Schuman M, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0030-y; Waller SA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.023; Wang HP, 2013, CHEM-BIOL INTERACT, V203, P588, DOI 10.1016/j.cbi.2013.03.017; Wang HP, 2011, PESTIC BIOCHEM PHYS, V101, P232, DOI 10.1016/j.pestbp.2011.09.011; Wang HP, 2009, CHEM RES TOXICOL, V22, P1026, DOI 10.1021/tx8004746; Ward MH, 2006, ENVIRON HEALTH PERSP, V114, P893, DOI 10.1289/ehp.8770; Waters NJ, 2002, BIOCHEM PHARMACOL, V64, P67, DOI 10.1016/S0006-2952(02)01016-X; Watkins DJ, 2016, ENVIRON RES, V147, P307, DOI 10.1016/j.envres.2016.02.025; Weselak M, 2008, REPROD TOXICOL, V25, P472, DOI 10.1016/j.reprotox.2008.05.060; Wold S, 1998, CHEMOMETR INTELL LAB, V44, P175, DOI 10.1016/S0169-7439(98)00109-9; Zhang LM, 2011, J PROTEOME RES, V10, P614, DOI 10.1021/pr100792q; Zhao YP, 2016, CHEMOSPHERE, V153, P287, DOI 10.1016/j.chemosphere.2016.03.055	64	28	31	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0198448	10.1371/journal.pone.0198448	http://dx.doi.org/10.1371/journal.pone.0198448			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924815	gold, Green Published, Green Submitted			2022-12-26	WOS:000435655600024
J	Tams, KW; Soe, MJ; Merkyte, I; Seersholm, FV; Henriksen, PS; Klingenberg, S; Willerslev, E; Kjaer, KH; Hansen, AJ; Kapel, CMO				Tams, Katrine Wegener; Soe, Martin Jensen; Merkyte, Inga; Seersholm, Frederik Valeur; Henriksen, Peter Steen; Klingenberg, Susanne; Willerslev, Eske; Kjaer, Kurt H.; Hansen, Anders Johannes; Kapel, Christian Moliin Outzen			Parasitic infections and resource economy of Danish Iron Age settlement through ancient DNA sequencing	PLOS ONE			English	Article							EGGS; ASCARIS; COPROLITES	In this study, we screen archaeological soil samples by microscopy and analyse the samples by next generation sequencing to obtain results with parasites at species level and untargeted findings of plant and animal DNA. Three separate sediment layers of an ancient man-made pond in Hoby, Denmark, ranging from 100 BC to 200 AD, were analysed by microscopy for presence of intestinal worm eggs and DNA analysis were performed to identify intestinal worms and dietary components. Ancient DNA of parasites, domestic animals and edible plants revealed a change in use of the pond over time reflecting the household practice in the adjacent Iron Age settlement. The most abundant parasite found belonged to the Ascaris genus, which was not possible to type at species level. For all sediment layers the presence of eggs of the human whipworm Trichuris trichiura and the beef tapeworm Taenia saginata suggests continuous disposal of human faeces in the pond. Moreover, the continuous findings of T. saginata further imply beef consumption and may suggest that cattle were living in the immediate surrounding of the site throughout the period. Findings of additional host-specific parasites suggest fluctuating presence of other domestic animals over time: Trichuris suis (pig), Parascaris univalens (horse), Taenia hydatigena (dog and sheep). Likewise, alternating occurrence of aDNA of edible plants may suggest changes in agricultural practices. Moreover, the composition of aDNA of parasites, plants and vertebrates suggests a significant change in the use of the ancient pond over a period of three centuries.	[Tams, Katrine Wegener; Soe, Martin Jensen; Kapel, Christian Moliin Outzen] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg C, Denmark; [Tams, Katrine Wegener; Soe, Martin Jensen; Willerslev, Eske; Kjaer, Kurt H.; Hansen, Anders Johannes] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Copenhagen K, Denmark; [Merkyte, Inga] Univ Copenhagen, Saxo Inst, Copenhagen S, Denmark; [Seersholm, Frederik Valeur] Curtin Univ, Trace & Environm DNA TrEnD Lab, Dept Environm & Agr, Perth, WA, Australia; [Henriksen, Peter Steen] Natl Museum Museum Denmark, Environm Archaeol & Mat Sci, Lyngby, Denmark; [Klingenberg, Susanne] Natl Museum Denmark, Ancient Cultures Denmark & Mediterranean, Lyngby, Denmark; [Willerslev, Eske] Univ Cambridge, Dept Zool, Cambridge, England; [Willerslev, Eske] Sanger Inst, Cambridge, England	University of Copenhagen; University of Copenhagen; University of Copenhagen; Curtin University; University of Cambridge; Wellcome Trust Sanger Institute	Tams, KW; Kapel, CMO (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg C, Denmark.; Tams, KW (corresponding author), Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, Copenhagen K, Denmark.	katrine_tams@hotmail.com; chk@plen.ku.dk	Kapel, Christian M. O./G-9168-2014; Søe, Martin J/F-7736-2014; Hansen, Anders Johannes/A-5608-2013; Seersholm, Frederik/AAN-2985-2021; Willerslev, Eske/A-9619-2011; Willerslev, Eske/AAA-5686-2019; Kjaer, Kurt/A-4199-2013	Kapel, Christian M. O./0000-0002-9539-457X; Søe, Martin J/0000-0002-0386-6294; Hansen, Anders Johannes/0000-0002-1890-2702; Willerslev, Eske/0000-0002-7081-6748; Seersholm, Frederik Valeur/0000-0003-2217-3247; Tams, Katrine Wegener/0000-0002-8154-6122; Henriksen, Peter Steen/0000-0003-0728-4029; Kjaer, Kurt/0000-0002-8871-5179	University of Copenhagen [KU2016]	University of Copenhagen	The University of Copenhagen for funding to M.J.S. and all laboratory expenses through the KU2016 initiative, 'The Genomic History of Denmark'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; Betson M, 2014, J INFECT DIS, V210, P932, DOI 10.1093/infdis/jiu193; Bouchet F, 2003, MEM I OSWALDO CRUZ, V98, P95, DOI 10.1590/S0074-02762003000900015; Cote NML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146230; Dold C, 2014, ENCY FOOD SAF, V2, P83, DOI [10.1016/B978-0-12-378612-8.00141-4, DOI 10.1016/B978-0-12-378612-8.00141-4]; FERREIRA LF, 1991, J PARASITOL, V77, P491, DOI 10.2307/3283143; Goncalves MLC, 2003, MEM I OSWALDO CRUZ, V98, P103, DOI 10.1590/S0074-02762003000900016; Helbaek H, 1950, AARBOGER NORDISK OLD, P311; Jahrtausendn Chr, 2017, ARCHAOLOGISCHES MUSE, P41; Jimenez JA, 2010, TROP MED INT HEALTH, V15, P1077, DOI 10.1111/j.1365-3156.2010.02579.x; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Klingenberg S, 2011, IRON AGE ZEAL STAT C, V8, P31; Larsen MN, 1999, PARASITOLOGY, V119, P209, DOI 10.1017/S0031182099004503; Leles D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-42; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Loreille O, 2001, INT J PARASITOL, V31, P1101, DOI 10.1016/S0020-7519(01)00214-4; Mejer H, 2011, P 23 INT C WORLD ASS, P113; Mitchell PD, 2017, PARASITOLOGY, V144, P48, DOI 10.1017/S0031182015001651; Morrow JJ, 2016, INT J PALEOPATHOL, V13, P56, DOI 10.1016/j.ijpp.2016.01.005; Oh CS, 2010, J ARCHAEOL SCI, V37, P1269, DOI 10.1016/j.jas.2009.12.029; Paulo S, 2009, ANIMAL HELMINTHS HUM, V51, P119; Schubert M, 2014, NAT PROTOC, V9, P1056, DOI 10.1038/nprot.2014.063; Seersholm FV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13389; Soe MJ, 2015, J PARASITOL, V101, P57, DOI 10.1645/14-650.1; Soe MJ, PLOSONE UNPUB; van der Plicht J, 2004, J ARCHAEOL SCI, V31, P471, DOI 10.1016/j.jas.2003.09.012; YOSHIKAWA H, 1989, PARASITOL RES, V75, P649, DOI 10.1007/BF00930964	28	1	1	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0197399	10.1371/journal.pone.0197399	http://dx.doi.org/10.1371/journal.pone.0197399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ8QS	29924800	Green Submitted, Green Published, gold			2022-12-26	WOS:000435655600004
J	Groppo, R; DiNapoli, J; Jeong, KI; Kishko, M; Jackson, N; Kleanthous, H; Delagrave, S; Zhang, LN; Parrington, M				Groppo, Rachel; DiNapoli, Joshua; Jeong, Kwang Il; Kishko, Michael; Jackson, Nicholas; Kleanthous, Harold; Delagrave, Simon; Zhang, Linong; Parrington, Mark			Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccine	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; COTTON RATS; MONOCLONAL-ANTIBODY; EPITHELIAL-CELLS; YOUNG-CHILDREN; M2-2 PROTEIN; F PROTEIN; SH GENE; INFECTION; CHIMPANZEES	A safe and effective vaccine against RSV remains an important unmet public health need. Intranasally (IN) delivered live-attenuated vaccines represent the most extensively studied approach for immunization of RSV-naive infants and children, however, achieving an effective balance of attenuation and immunogenicity has proven challenging. Here we report preclinical immunogenicity and efficacy data utilizing a live-attenuated vaccine candidate, RG.M2-2, which was obtained by deleting the M2-2 open reading frame from the genome of the MSA1 clinical isolate. Intramuscular (IM) administration of RG.M2-2 in cotton rats induced immunity and protective efficacy that was comparable to that induced by intranasal (IN) immunization. In contrast, the protective efficacy of RG.M2-2 delivered by the IM route to African green monkeys was substantially reduced as compared to the efficacy following IN administration, despite comparable levels of serum neutralizing antibodies. This result suggests that mucosal immunity may play an important role in RSV protection. The RG.M2-2 vaccine also demonstrated different attenuation profiles when tested in cotton rats, non-human primates, and a human airway epithelial (HAE) cell model. The data suggest RG.M2-2 is less attenuated than a similarly designed vaccine candidate constructed on the A2 genetic background. These findings have important implications with regard to both the design and the preclinical safety testing of live-attenuated vaccines.	[Groppo, Rachel; Jeong, Kwang Il; Kishko, Michael; Jackson, Nicholas; Delagrave, Simon; Zhang, Linong] Sanofi Pasteur, Res & Nonclin Safety, Cambridge, MA 02139 USA; [DiNapoli, Joshua; Kleanthous, Harold] Sanofi Pasteur, FluNeXt, Cambridge, MA USA; [Parrington, Mark] Sanofi Pasteur, External R&D, Cambridge, MA USA; [Jeong, Kwang Il] LG Chem, Vaccine Ctr, Life Sci, Seoul, South Korea	Sanofi-Aventis; Sanofi-Aventis; Sanofi-Aventis; LG Chem	Zhang, LN (corresponding author), Sanofi Pasteur, Res & Nonclin Safety, Cambridge, MA 02139 USA.	Linong.zhang@sanofi.com			LG Chemistry Ltd.; Sanofi Pasteur	LG Chemistry Ltd.; Sanofi Pasteur	The funder, Sanofi Pasteur, provided support in the form of salaries for authors RG, JD, KJ, MK, NJ, HK, SD, LZ, and MP and research materials but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. However, the funder had to approve submission of the manuscript and what data was acceptable for public dissemination. KJ is currently affiliated with LG Chemistry which is providing support in the form of salary. LG Chemistry Ltd. did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELSHE RB, 1982, J INFECT DIS, V145, P311, DOI 10.1093/infdis/145.3.311; Bermingham A, 1999, P NATL ACAD SCI USA, V96, P11259, DOI 10.1073/pnas.96.20.11259; Boukhvalova MS, 2007, J VIROL, V81, P9443, DOI 10.1128/JVI.00102-07; Bukreyev A, 1997, J VIROL, V71, P8973, DOI 10.1128/JVI.71.12.8973-8982.1997; BUYNAK EB, 1979, P SOC EXP BIOL MED, V160, P272, DOI 10.3181/00379727-160-40433; BUYNAK EB, 1978, P SOC EXP BIOL MED, V157, P636; CHANOCK RM, 1988, VACCINE, V6, P129, DOI 10.1016/S0264-410X(88)80014-8; Cheng X, 2001, VIROLOGY, V283, P59, DOI 10.1006/viro.2001.0894; Chirkova T, 2015, J GEN VIROL, V96, P2543, DOI 10.1099/vir.0.000218; Crowe James E Jr, 2003, Paediatr Respir Rev, V4, P112, DOI 10.1016/S1526-0542(03)00033-2; FRIEDEWALD WT, 1968, J AMER MED ASSOC, V204, P690, DOI 10.1001/jama.1968.03140210044011; Habibi MS, 2015, AM J RESP CRIT CARE, V191, P1040, DOI 10.1164/rccm.201412-2256OC; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Jeong KI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130517; Jin H, 2000, VIROLOGY, V273, P210, DOI 10.1006/viro.2000.0393; Johnson SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005318; Karron RA, 1997, J INFECT DIS, V176, P1428, DOI 10.1086/514138; Karron RA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8463; Malley R, 1998, J INFECT DIS, V178, P1555, DOI 10.1086/314523; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Neuzil KM, 2016, CLIN VACCINE IMMUNOL, V23, P186, DOI 10.1128/CVI.00037-16; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Piedra PA, 2003, VACCINE, V21, P3479, DOI 10.1016/S0264-410X(03)00355-4; PRINCE GA, 1979, INFECT IMMUN, V23, P723, DOI 10.1128/IAI.23.3.723-728.1979; Prince GA, 1999, LAB INVEST, V79, P1385; RANDOLPH VB, 1994, VIRUS RES, V33, P241, DOI 10.1016/0168-1702(94)90106-6; Rostad CA, 2016, J VIROL, V90, P7508, DOI 10.1128/JVI.00012-16; Schaap-Nutt A, 2010, VACCINE, V28, P2788, DOI 10.1016/j.vaccine.2010.01.050; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Stobart CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13916; Taylor G, 2017, VACCINE, V35, P469, DOI 10.1016/j.vaccine.2016.11.054; Teng MN, 2000, J VIROL, V74, P9317, DOI 10.1128/JVI.74.19.9317-9321.2000; Vissers M, 2016, CLIN VACCINE IMMUNOL, V23, P243, DOI 10.1128/CVI.00590-15; Whitehead SS, 1999, J VIROL, V73, P3438, DOI 10.1128/JVI.73.4.3438-3442.1999; Wright PF, 2006, J INFECT DIS, V193, P573, DOI 10.1086/499600; Wright PF, 2005, J VIROL, V79, P8651, DOI 10.1128/JVI.79.13.8651-8654.2005; Wright PF, 2000, J INFECT DIS, V182, P1331, DOI 10.1086/315859	37	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199452	10.1371/journal.pone.0199452	http://dx.doi.org/10.1371/journal.pone.0199452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920563	Green Published, Green Submitted, gold			2022-12-26	WOS:000435541300046
J	Soteros, BM; Cong, QF; Palmer, CR; Sia, GM				Soteros, Breeanne M.; Cong, Qifei; Palmer, Christian R.; Sia, Gek-Ming			Sociability and synapse subtype-specific defects in mice lacking SRPX2, a language-associated gene	PLOS ONE			English	Article							VESICULAR GLUTAMATE TRANSPORTERS; AUTISM SPECTRUM DISORDERS; CHINESE HAN POPULATION; ONE-STEP GENERATION; ULTRASONIC VOCALIZATION; SUSCEPTIBILITY GENE; MEF2C HAPLOINSUFFICIENCY; TRANSCRIPTION FACTORS; VOCAL COMMUNICATION; EXCITATORY SYNAPSE	The FoxP2 transcription factor and its target genes have been implicated in developmental brain diseases with a prominent language component, such as developmental verbal dyspraxia and specific language impairment. How FoxP2 affects neural circuitry development remains poorly understood. The sushi domain protein SRPX2 is a target of FoxP2, and mutations in SRPX2 are associated with language defects in humans. We have previously shown that SRPX2 is a synaptogenic protein that increases excitatory synapse density. Here we provide the first characterization of mice lacking the SRPX2 gene, and show that these mice exhibit defects in both neural circuitry and communication and social behaviors. Specifically, we show that mice lacking SRPX2 show a specific reduction in excitatory VGlut2 synapses in the cerebral cortex, while VGlut1 and inhibitory synapses were largely unaffected. SRPX2 KO mice also exhibit an abnormal ultrasonic vocalization ontogenetic profile in neonatal pups, and reduced preference for social novelty. These data demonstrate a functional role for SRPX2 during brain development, and further implicate FoxP2 and its targets in regulating the development of vocalization and social circuits.	[Soteros, Breeanne M.; Cong, Qifei; Sia, Gek-Ming] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Palmer, Christian R.] Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA	University of Texas System; University of Texas Health San Antonio; Vanderbilt University	Sia, GM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA.	siag@uthscsa.edu		Cong, Qifei/0000-0002-4446-7222; Sia, Gek Ming/0000-0001-9333-0065; Soteros, Breeanne/0000-0002-4714-5165	UTHSCSA Department of Pharmacology; Rising STARs from the University of Texas System; NARSAD Young Investigator [25248]; UTHSCSA, NIH-NCI [P30 CA54174]; NIH-NIA [P01AG19316]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019316] Funding Source: NIH RePORTER	UTHSCSA Department of Pharmacology; Rising STARs from the University of Texas System; NARSAD Young Investigator(NARSAD); UTHSCSA, NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by startup funds from UTHSCSA Department of Pharmacology, the Rising STARs award from the University of Texas System, as well as the NARSAD Young Investigator grant number 25248 to GMS. Images were generated in the Core Optical Imaging Facility which is supported by UTHSCSA, NIH-NCI P30 CA54174 (CTRC at UTHSCSA) and NIH-NIA P01AG19316 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Andreae LC, 2014, CURR OPIN NEUROBIOL, V27, P47, DOI 10.1016/j.conb.2014.02.008; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Biermann B, 2010, J NEUROSCI, V30, P1385, DOI 10.1523/JNEUROSCI.3172-09.2010; Bowers JM, 2013, J NEUROSCI, V33, P3276, DOI 10.1523/JNEUROSCI.0425-12.2013; Branchi I, 2001, BEHAV BRAIN RES, V125, P49, DOI 10.1016/S0166-4328(01)00277-7; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Campbell P, 2009, J COMP NEUROL, V512, P84, DOI 10.1002/cne.21881; Chen XS, 2017, SCI REP-UK, V7, DOI 10.1038/srep46105; Chen YC, 2016, NAT NEUROSCI, V19, P1513, DOI 10.1038/nn.4380; Chien YL, 2017, J FORMOS MED ASSOC, V116, P755, DOI 10.1016/j.jfma.2016.11.015; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dong W, 2012, J NEUROSCI, V32, P16872, DOI 10.1523/JNEUROSCI.2372-12.2012; Dudek SM, 2016, NAT REV NEUROSCI, V17, P89, DOI 10.1038/nrn.2015.22; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Fitch WT, 2010, NEURON, V65, P795, DOI 10.1016/j.neuron.2010.03.011; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; French CA, 2007, GENESIS, V45, P440, DOI 10.1002/dvg.20305; Fujita E, 2008, P NATL ACAD SCI USA, V105, P3117, DOI 10.1073/pnas.0712298105; Gaub S, 2010, GENES BRAIN BEHAV, V9, P390, DOI 10.1111/j.1601-183X.2010.00570.x; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Gong XH, 2004, AM J MED GENET B, V127B, P113, DOI 10.1002/ajmg.b.20162; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Havik B, 2011, BIOL PSYCHIAT, V70, P35, DOI 10.1016/j.biopsych.2011.01.030; HENNESSY MB, 1980, DEV PSYCHOBIOL, V13, P573, DOI 10.1002/dev.420130603; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Herzog E, 2006, J NEUROCHEM, V99, P1011, DOI 10.1111/j.1471-4159.2006.04144.x; Hisaoka T, 2010, NEUROSCIENCE, V166, P551, DOI 10.1016/j.neuroscience.2009.12.055; Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; HOSHINO M, 1993, NEURON, V10, P395, DOI 10.1016/0896-6273(93)90329-P; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Jiang JM, 2012, NEURAL REGEN RES, V7, P96, DOI 10.3969/j.issn.1673-5374.2012.02.003; Kaneko T, 2002, J COMP NEUROL, V444, P39, DOI 10.1002/cne.10129; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Kohara K, 2014, NAT NEUROSCI, V17, P269, DOI 10.1038/nn.3614; Konopka G, 2016, CELL, V164, P1269, DOI 10.1016/j.cell.2016.02.039; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Kwon HB, 2012, NAT NEUROSCI, V15, P1667, DOI 10.1038/nn.3256; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Le Meur N, 2010, J MED GENET, V47, P22, DOI 10.1136/jmg.2009.069732; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li T, 2013, WORLD J BIOL PSYCHIA, V14, P146, DOI 10.3109/15622975.2011.615860; Liguz-Lecznar M, 2007, INT J DEV NEUROSCI, V25, P107, DOI 10.1016/j.ijdevneu.2006.12.005; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; Mukamel Z, 2011, J NEUROSCI, V31, P11437, DOI 10.1523/JNEUROSCI.0181-11.2011; Nakamura K, 2005, J COMP NEUROL, V492, P263, DOI 10.1002/cne.20705; Nakayama M, 2014, J NEUROSCI, V34, P13872, DOI 10.1523/JNEUROSCI.1585-14.2014; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Newbury DF, 2002, AM J HUM GENET, V70, P1318, DOI 10.1086/339931; Novara F, 2010, CLIN GENET, V78, P471, DOI 10.1111/j.1399-0004.2010.01413.x; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pinker S, 2010, P NATL ACAD SCI USA, V107, P8993, DOI 10.1073/pnas.0914630107; Roberts TF, 2012, NAT NEUROSCI, V15, P1454, DOI 10.1038/nn.3206; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Roll P, 2010, HUM MOL GENET, V19, P4848, DOI 10.1093/hmg/ddq415; Salmi M, 2013, BRAIN, V136, P2457, DOI 10.1093/brain/awt161; Scearce-Levie K, 2008, GENES BRAIN BEHAV, V7, P344, DOI 10.1111/j.1601-183X.2007.00357.x; Shimizu A, 2003, BIOCHEM BIOPH RES CO, V309, P143, DOI 10.1016/S0006-291X(03)01555-9; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Sia GM, 2013, SCIENCE, V342, P987, DOI 10.1126/science.1245079; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tanaka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027922; Tolosa A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-114; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Tsui D, 2013, J NEUROSCI, V33, P244, DOI 10.1523/JNEUROSCI.1665-12.2013; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wassink TH, 2002, AM J MED GENET, V114, P566, DOI 10.1002/ajmg.10415; White SA, 2006, J NEUROSCI, V26, P10376, DOI 10.1523/JNEUROSCI.3379-06.2006; Whitehouse AJO, 2011, GENES BRAIN BEHAV, V10, P451, DOI 10.1111/j.1601-183X.2011.00684.x; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang M, 2001, CURRENT PROTOCOLS NE, DOI [10.1002/0471142301.ns0826s56/abstract, DOI 10.1002/0471142301.NS0826S56/ABSTRACT]; Yu ZL, 2007, J NEUROSCI RES, V85, P166, DOI 10.1002/jnr.21103; Zander JF, 2010, J NEUROSCI, V30, P7634, DOI 10.1523/JNEUROSCI.0141-10.2010	85	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199399	10.1371/journal.pone.0199399	http://dx.doi.org/10.1371/journal.pone.0199399			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920554	gold, Green Published, Green Submitted			2022-12-26	WOS:000435541300045
J	Gesesew, HA; Ward, P; Woldemichael, K; Mwanri, L				Gesesew, Hailay Abrha; Ward, Paul; Woldemichael, Kifle; Mwanri, Lillian			Early mortality among children and adults in antiretroviral therapy programs in Southwest Ethiopia, 2003-15	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; CARE; AFRICA; PREDICTORS; BURDEN; TRENDS; PREVALENCE; ENGAGEMENT; PREVENTION; FACILITIES	Background Several studies reported that the majority of deaths in HIV-infected people are documented in their early antiretroviral therapy (ART) follow-ups. Early mortality refers to death of people on ART for follow up period of below 24 months due to any cause. The current study assessed predictors of early HIV mortality in Southwest Ethiopia. Methods We have conducted a retrospective analysis of 5299 patient records dating from June 2003-March 2015. To estimate survival time and compare the time to event among the different groups of patients, we used a Kaplan Meir curve and log-rank test. To identify mortality predictors, we used a cox regression analysis. We used SPSS-20 for all analyses. Results A total of 326 patients died in the 12 years follow-up period contributing to 6.2% cumulative incidence and 21.7 deaths per 1000 person-year observations incidence rate. Eighty-nine percent of the total deaths were documented in the first two years follow up-an early-term ART follow up. Early HIV mortality rates among adults were 50% less in separated, divorced or widowed patients compared with never married patients, 1.6 times higher in patients with baseline CD4 count <200 cells/mu L compared to baseline CD4 count >= 200 cells/mu L, 1.5 times higher in patients with baseline WHO clinical stage 3 or 4 compared to baseline WHO clinical stage 1 or 2, 2.1 times higher in patients with immunologic failure compared with no immunologic failure, 60% less in patients with fair or poor compared with good adherence, 2.9 times higher in patients with bedridden functional status compared to working functional status, and 2.7 times higher with patients who had no history of HIV testing before diagnosis compared to those who had history of HIV testing. Most predictors of early mortality remained the same to the predictors of an overall HIV mortality. When discontinuation was assumed as an event, the predictors of an overall HIV mortality included age between 25-50 years, base line CD4 count, developing immunologic failure, bedridden functional status, and no history of HIV testing before diagnosis. Conclusions The great majority of deaths were documented in the first two years of ART, and several predictors of early HIV mortality were also for the overall mortality when discontinuation was assumed as event or censored. Considering the above population, interventions to improve HIV program in the first two years of ART follow up should be improved.	[Gesesew, Hailay Abrha; Ward, Paul; Mwanri, Lillian] Flinders Univ S Australia, Publ Hlth, Adelaide, SA, Australia; [Gesesew, Hailay Abrha; Woldemichael, Kifle] Jimma Univ, Epidemiol, Jimma, Ethiopia	Flinders University South Australia; Jimma University	Gesesew, HA (corresponding author), Flinders Univ S Australia, Publ Hlth, Adelaide, SA, Australia.; Gesesew, HA (corresponding author), Jimma Univ, Epidemiol, Jimma, Ethiopia.	hailushepi@gmail.com	Gesesew, Hailay/AAF-6486-2020; Mwanri, Lillian/AGG-3711-2022	Gesesew, Hailay/0000-0002-3531-4400; Mwanri, Lillian/0000-0002-5792-7785; Ward, Paul/0000-0002-5559-9714	Australian Government Research Training Program Scholarship	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	We acknowledge Jimma University Teaching Hospital for providing access to the data. This study was conducted for the partial fulfilment of a PhD in Public Health at Faculty of Medicine, Nursing and Health Sciences, Flinders University. We acknowledge Australian Government Research Training Program Scholarship for supporting the PhD program. The scholarship provider had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors did not receive any specific grant for this research.	Abaynew Y, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-8; Abebe N, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.88.3262; Adamu B.T., 2013, PUBLIC HLTH RES, V3, P98, DOI DOI 10.5923/J.PHR.20130304.03; Ahmed E, 2013, J AIDS CLIN RES, V4; Alemu AW, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5398; Amberbir A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-265; [Anonymous], 1994, MMWR Recomm Rep, V43, P1; Assefa Y, 2015, JAIDS-J ACQ IMM DEF, V70, P414, DOI 10.1097/QAI.0000000000000753; Assefa Y, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-43; Assen A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3263-y; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Bachani D, 2010, NATL MED J INDIA, V23, P7; Biadgilign S, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-15; Biressaw S, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-132; Campbell C, 2010, AIDS CARE, V22, P1569, DOI 10.1080/09540121.2010.525812; CDC, 2015, HIV AIDS PROGR 2014; *CDC, 1993, JAMA-J AM MED ASSOC, V269, P729; Tran DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073181; Damtew B, 2015, PAN AFR MED J, V22, DOI 10.11604/pamj.2015.22.138.4352; Endrias M, 2008, ETHIOP J HEALTH DEV, V22, P174; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gesesew H, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0202-1; Gesesew H, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0193-y; Gesesew Hailay, 2016, BMC Res Notes, V9, P89, DOI 10.1186/s13104-016-1905-x; Gesesew HA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179533; Gesesew HA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173928; Granich R, 2010, CURR OPIN HIV AIDS, V5, P298, DOI 10.1097/COH.0b013e32833a6c32; Hickey MD, 2016, AIDS CARE, V28, P1386, DOI 10.1080/09540121.2016.1179253; Hull MW, 2012, CURR OPIN HIV AIDS, V7, P579, DOI 10.1097/COH.0b013e3283590617; Kebede Deribe Kassaye, 2006, Ethiopian Journal of Health Development, V20, P127; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Larson E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-173; Mitiku Habtamu, 2013, ISRN AIDS, V2013, P960954, DOI 10.1155/2013/960954; MoH, 2014, NAT GUID COMPR HIV P; Montaner JSG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087872; Morineau G, 2009, AIDS PATIENT CARE ST, V23, P669, DOI 10.1089/apc.2008.0241; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; Mutasa-Apollo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086305; Pillay-van Wyk V, 2016, LANCET GLOB HEALTH, V4, pE642, DOI 10.1016/S2214-109X(16)30113-9; Ravimohan S, 2013, J INFECT DIS, V208, P1784, DOI 10.1093/infdis/jit368; Reniers G, 2017, LANCET HIV, V4, pE113, DOI 10.1016/S2352-3018(16)30225-9; Reniers G, 2009, AIDS, V23, P511, DOI 10.1097/QAD.0b013e32832403d0; Russell Bennett, 2013, HIV CARE CONTINUUM C; Setegn T, 2015, PREDICTORS MORTALITY, V2015, DOI [10.1155/2015/148769, DOI 10.1155/2015/148769]; Tachbele E, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016049; Tadele A, 2014, J AIDS CLIN RES, V5, DOI [10.4172/2155-6113.1000280, DOI 10.4172/2155-6113.1000280]; Tadesse K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087392; Tadios Y, 2006, ETHIOPIAN MED J, V44; UNAIDS, 2014, GAP REP; United Nations & AIDS (UNAIDS), 2012, WORLD AIDS DAY REP; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; WHO, 2010, ANT THER HIV INF AD; WHO, 2015, UPDATE ETHIOPIA HIV; Wubshet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059197; Yang CH, 2008, HIV MED, V9, P535, DOI 10.1111/j.1468-1293.2008.00600.x; Yared Mekonnen, 2010, 1 USAID, P2010	56	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198815	10.1371/journal.pone.0198815	http://dx.doi.org/10.1371/journal.pone.0198815			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912974	gold, Green Submitted, Green Published			2022-12-26	WOS:000435528600052
J	Johnson, SA; Farrington, MJ; Murphy, CR; Caldo, PD; McAllister, LA; Kaur, S; Chun, C; Ortega, MT; Marshall, BL; Hoffmann, F; Ellersieck, MR; Schenk, AK; Rosenfeld, CS				Johnson, Sarah A.; Farrington, Michelle J.; Murphy, Claire R.; Caldo, Paul D.; McAllister, Leif A.; Kaur, Sarabjit; Chun, Catherine; Ortega, Madison T.; Marshall, Brittney L.; Hoffmann, Frauke; Ellersieck, Mark R.; Schenk, A. Katrin; Rosenfeld, Cheryl S.			Multigenerational effects of bisphenol A or ethinyl estradiol exposure on F-2 California mice (Peromyscus californicus) pup vocalizations	PLOS ONE			English	Article							TURTLES CHRYSEMYS-PICTA; ULTRASONIC VOCALIZATIONS; DEVELOPMENTAL EXPOSURE; XENOPUS-LAEVIS; RAT PUPS; ONTOGENIC DEVELOPMENT; MULTIPLE GENERATIONS; ENDOCRINE DISRUPTION; CALLING BEHAVIOR; SEX-DIFFERENCES	Rodent pups use vocalizations to communicate with one or both parents in biparental species, such as California mice (Peromyscus californicus). Previous studies have shown California mice developmentally exposed to endocrine disrupting chemicals, bisphenol A (BPA) or ethinyl estradiol (EE), demonstrate later compromised parental behaviors. Reductions in F-1 parental behaviors might also be due to decreased emissions of F-2 pup vocalizations. Thus, vocalizations of F-2 male and female California mice pups born to F-1 parents developmentally exposed to BPA, EE, or controls were examined. Postnatal days (PND) 2-4 were considered early postnatal period, PND 7 and 14 were defined as mid-postnatal period, and PND 21 and 28 were classified as late postnatal period. EE pups showed increased latency to emit the first syllable compared to controls. BPA female pups had decreased syllable duration compared to control and EE female pups during the early postnatal period but enhanced responses compared to controls at late postnatal period; whereas, male BPA and EE pups showed greater syllable duration compared to controls during early postnatal period. In mid-postnatal period, F-2 BPA and EE pups emitted greater number of phrases than F-2 control pups. Results indicate aspects of vocalizations were disrupted in F-2 pups born to F-1 parents developmentally exposed to BPA or EE, but their responses were not always identical, suggesting BPA might not activate estrogen receptors to the same extent as EE. Changes in vocalization patterns by F-2 pups may be due to multigenerational exposure to BPA or EE and/or reduced parental care received.	[Johnson, Sarah A.; Farrington, Michelle J.; Murphy, Claire R.; Caldo, Paul D.; McAllister, Leif A.; Kaur, Sarabjit; Chun, Catherine; Ortega, Madison T.; Marshall, Brittney L.; Rosenfeld, Cheryl S.] Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Johnson, Sarah A.; Farrington, Michelle J.; Murphy, Claire R.; Caldo, Paul D.; McAllister, Leif A.; Kaur, Sarabjit; Chun, Catherine; Ortega, Madison T.; Marshall, Brittney L.; Rosenfeld, Cheryl S.] Univ Missouri, Dept Biomed Sci, Columbia, MO 65211 USA; [Johnson, Sarah A.] Univ Missouri, Dept Anim Sci, Columbia, MO USA; [Johnson, Sarah A.] Univ Missouri, Sch Med, Dept Gastroenterol, Columbia, MO USA; [Hoffmann, Frauke] German Fed Inst Risk Assessment, Dept Chem & Prod Safety, Berlin, Germany; [Ellersieck, Mark R.] Univ Missouri, Dept Agr Expt Stn Stat, Columbia, MO USA; [Schenk, A. Katrin] Randolph Coll, Dept Phys, Lynchburg, VA USA; [Rosenfeld, Cheryl S.] Univ Missouri, Genet Area Program, Columbia, MO 65211 USA; [Rosenfeld, Cheryl S.] Univ Missouri, Thompson Ctr Autism & Neurobehav Disorders, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Federal Institute for Risk Assessment; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Rosenfeld, CS (corresponding author), Univ Missouri, Bond Life Sci Ctr, Columbia, MO 65211 USA.; Rosenfeld, CS (corresponding author), Univ Missouri, Dept Biomed Sci, Columbia, MO 65211 USA.; Rosenfeld, CS (corresponding author), Univ Missouri, Genet Area Program, Columbia, MO 65211 USA.; Rosenfeld, CS (corresponding author), Univ Missouri, Thompson Ctr Autism & Neurobehav Disorders, Columbia, MO 65211 USA.	rosenfeldc@missouri.edu		Caldo, Paul/0000-0003-1306-0080	NIEHS [5R21ES023150]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056901] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIEHS Grant 5R21ES023150 (to C.S.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger A, 2016, REPROD TOXICOL, V60, P39, DOI 10.1016/j.reprotox.2015.12.004; Bowers JM, 2014, ENDOCRINOLOGY, V155, P4881, DOI 10.1210/en.2014-1486; Bowers JM, 2013, J NEUROSCI, V33, P3276, DOI 10.1523/JNEUROSCI.0425-12.2013; Briggs JR, 2011, ANIM BEHAV, V82, P1263, DOI 10.1016/j.anbehav.2011.09.003; Campbell P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113628; CHANDLER T, 1979, POPULATION BIOL COAS; Chew V, 1977, AGR RES SERVICE, Viv; Cochran W. G., 1992, EXPT DESIGNS; Cox ET, 2012, BEHAV BRAIN RES, V235, P166, DOI 10.1016/j.bbr.2012.07.035; Curry T, 2013, GENES BRAIN BEHAV, V12, P397, DOI 10.1111/gbb.12037; EISENBERG JOHN F., 1963, AMER MIDLAND NAT, V69, P240, DOI 10.2307/2422858; EISENBERG JOHN F., 1962, BEHAVIOUR, V19, P177, DOI 10.1163/156853962X00014; GEYER LA, 1981, AM ZOOL, V21, P117; Grandjean P, 2015, ENDOCRINOLOGY, V156, P3408, DOI 10.1210/EN.2015-1350; GUBERNICK DJ, 1987, J COMP PSYCHOL, V101, P169, DOI 10.1037/0735-7036.101.2.169; Gubernick DJ, 2000, P ROY SOC B-BIOL SCI, V267, P147, DOI 10.1098/rspb.2000.0979; Harris BN, 2013, HORM BEHAV, V64, P799, DOI 10.1016/j.yhbeh.2013.10.007; Harris EP, 2018, HORM BEHAV, V101, P68, DOI 10.1016/j.yhbeh.2017.09.017; Hofer MA, 1999, BEHAV NEUROSCI, V113, P51; Hoffmann F, 2016, PHYSIOL BEHAV, V167, P172, DOI 10.1016/j.physbeh.2016.09.012; Hoffmann F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044715; Hoffmann F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032097; Hoffmann F, 2012, GEN COMP ENDOCR, V176, P385, DOI 10.1016/j.ygcen.2012.02.009; Hoffmann F, 2010, HORM BEHAV, V58, P653, DOI 10.1016/j.yhbeh.2010.06.008; Hoogesteijn AL, 2008, ENVIRON TOXICOL CHEM, V27, P2071, DOI 10.1897/07-484.1; Jang YJ, 2012, TOXICOLOGY, V296, P73, DOI 10.1016/j.tox.2012.03.007; Jasarevic E, 2013, HORM BEHAV, V63, P180, DOI 10.1016/j.yhbeh.2012.09.009; Jasarevic E, 2011, P NATL ACAD SCI USA, V108, P11715, DOI 10.1073/pnas.1107958108; Johnson SA, 2015, J DEV ORIG HLTH DIS, V6, P539, DOI 10.1017/S2040174415001488; Johnson SA, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13133; Johnson SA, 2017, J COMP PSYCHOL, V131, P30, DOI 10.1037/com0000057; Johnson SA, 2016, HORM BEHAV, V80, P139, DOI 10.1016/j.yhbeh.2015.09.005; Johnson SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126284; Kalcounis-Rueppell Matina C, 2006, Front Zool, V3, P3, DOI 10.1186/1742-9994-3-3; Leon-Olea M, 2014, GEN COMP ENDOCR, V203, P158, DOI 10.1016/j.ygcen.2014.02.005; Li GQ, 2014, TOXICOL LETT, V228, P192, DOI 10.1016/j.toxlet.2014.04.012; Liu RC, 2003, J ACOUST SOC AM, V114, P3412, DOI 10.1121/1.1623787; Lombo M, 2015, ENVIRON POLLUT, V206, P667, DOI 10.1016/j.envpol.2015.08.016; Mahalingam S, 2017, REPROD TOXICOL, V74, P150, DOI 10.1016/j.reprotox.2017.09.013; Manshack LK, 2017, PHYSIOL GENOMICS, V49, P201, DOI 10.1152/physiolgenomics.00103.2016; Manshack LK, 2016, HORM BEHAV, V85, P48, DOI 10.1016/j.yhbeh.2016.07.009; Markman S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001674; Mosienko V, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0003-6; Musolf K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134123; Myers MM, 2004, J COMP PSYCHOL, V118, P95, DOI 10.1037/0735-7036.118.1.95; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Pultorak JD, 2015, HORM BEHAV, V70, P47, DOI 10.1016/j.yhbeh.2015.02.003; Rando OJ, 2015, CELL, V161, P93, DOI 10.1016/j.cell.2015.02.021; Reynolds CD, 2016, NEUROREPORT, V27, P1331, DOI 10.1097/WNR.0000000000000701; Robison WT, 2016, DEV PSYCHOBIOL, V58, P687, DOI 10.1002/dev.21408; Rosenfeld CS, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00057; Rosenfeld CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075725; Rosenfeld CS, 2010, BIOL REPROD, V82, P473, DOI 10.1095/biolreprod.109.080952; Rosenfeld CS, 2014, TRANSGENERATIONAL EP, P123; Saal FSV, 2005, BIRTH DEFECTS RES A, V73, P140, DOI 10.1002/bdra.20120; SAVILLE DJ, 1990, AM STAT, V44, P174, DOI 10.2307/2684163; Shair HN, 2003, DEV PSYCHOBIOL, V42, P206, DOI 10.1002/dev.10087; Sieli PT, 2011, ENVIRON HEALTH PERSP, V119, P1260, DOI 10.1289/ehp.1003385; Steel R., 1997, PRINCIPLES PROCEDURE; Steinberg RM, 2007, HORM BEHAV, V51, P364, DOI 10.1016/j.yhbeh.2006.12.004; Susiarjo M, 2015, ENDOCRINOLOGY, V156, P2049, DOI 10.1210/en.2014-2027; Vandenberg LN, 2014, DOSE-RESPONSE, V12, P259, DOI 10.2203/dose-response.13-020.Vandenberg; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Veres M, 2012, THERIOGENOLOGY, V77, P311, DOI 10.1016/j.theriogenology.2011.07.044; Vieira ML, 2003, DEV PSYCHOBIOL, V42, P246, DOI 10.1002/dev.10097; Vieira ML, 2002, BEHAV PROCESS, V59, P147, DOI 10.1016/S0376-6357(02)00089-X; WETZEL DM, 1980, J COMP PHYSIOL PSYCH, V94, P596, DOI 10.1037/h0077699; Williams SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055698; Wohr M, 2013, BEHAV BRAIN RES, V251, P50, DOI 10.1016/j.bbr.2012.07.024; Wolstenholme JT, 2012, ENDOCRINOLOGY, V153, P3828, DOI 10.1210/en.2012-1195; Wright SL, 2004, BEHAV PROCESS, V65, P155, DOI 10.1016/j.beproc.2003.09.004; Yu P, 2011, BEHAV PROCESS, V88, P162, DOI 10.1016/j.beproc.2011.09.001; Ziv-Gal A, 2015, TOXICOL APPL PHARM, V284, P354, DOI 10.1016/j.taap.2015.03.003	74	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199107	10.1371/journal.pone.0199107	http://dx.doi.org/10.1371/journal.pone.0199107			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912934	Green Published, gold, Green Submitted			2022-12-26	WOS:000435528600074
J	Littlejohn, JR; da Silva, RF; Neale, WA; Smallcombe, CC; Clark, HW; Mackay, RMA; Watson, AS; Madsen, J; Hoods, DW; Burns, I; Greenhough, TJ; Shrive, AK				Littlejohn, Jamie R.; da Silva, Ruben F.; Neale, William A.; Smallcombe, Carrie C.; Clark, Howard W.; Mackay, Rose-Marie A.; Watson, Alastair S.; Madsen, Jens; Hoods, Derek W.; Burns, Ian; Greenhough, Trevor J.; Shrive, Annette K.			Structural definition of hSP-D recognition of Salmonella enterica LPS inner core oligosaccharides reveals alternative binding modes for the same LPS	PLOS ONE			English	Article							SURFACTANT PROTEIN-D; DUST-MITE ALLERGENS; INFLUENZA-A VIRUS; LIPOPOLYSACCHARIDE CORE; BACTERIAL LIPOPOLYSACCHARIDES; RECOMBINANT FRAGMENT; ESCHERICHIA-COLI; LIGAND-BINDING; HOST-DEFENSE; MURINE MODEL	The crystal structures of a biologically and therapeutically active recombinant homotrimeric fragment of native human SP-D (hSP-D) complexed with the inner core oligosaccharide of the Salmonella enterica sv Minnesota rough strains R5 and R7 (rough mutant chemotypes Rc and Rd1) have been determined. The structures reveal that hSP-D specifically and preferentially targets the LPS inner core via the innermost conserved Hep-Kdo pair with the flexibility for alternative recognition when this preferred epitope is not available for binding. Hep-Kdo binding is achieved through calcium dependent recognition of the heptose dihydroxyethyl side chain coupled with specific interactions between the Kdo and the binding site flanking residues Arg343 and Asp325 with evidence for an extended binding site for LPS inner cores containing multiple Kdo residues. In one subunit of the R5-bound structure this preferred mode of binding is precluded by the crystal lattice and oligosaccharide is bound through the terminal inner core glucose. The structures presented here thus provide unique multiple insights into the recognition and binding of bacterial LPS by hSP-D. Not only is it demonstrated that hSP-D targets the highly conserved LPS proximal inner core Hep-Kdo motif, but also that hSP-D can recognise either terminal or non-terminal sugars and has the flexibility and versatility to adopt alternative strategies for bacterial recognition, utilising alternative LPS epitopes when the preferred inner core Hep-Kdo disaccharide is not available for binding.	[Littlejohn, Jamie R.; da Silva, Ruben F.; Neale, William A.; Smallcombe, Carrie C.; Burns, Ian; Greenhough, Trevor J.; Shrive, Annette K.] Keele Univ, Sch Life Sci, Keele, Staffs, England; [Clark, Howard W.; Mackay, Rose-Marie A.; Watson, Alastair S.; Madsen, Jens] Univ Southampton, Southampton Gen Hosp, Div Clin & Expt Sci,Dept Child Hlth, Sir Henry Wellcome Labs,Southampton Gen Hosp, Southampton, Hants, England; [Clark, Howard W.; Madsen, Jens] Southampton Gen Hosp, Southampton NIHR Resp Biomed Res Unit, Southampton, Hants, England; [Clark, Howard W.; Madsen, Jens] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Hoods, Derek W.] MRC Harwell Inst, Mammalian Genet Unit, Harwell Sci & Innovat Campus, Didcot, Oxon, England; [Smallcombe, Carrie C.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44106 USA	Keele University; University of Southampton; University of Southampton; University of Southampton; MRC Harwell; Cleveland Clinic Foundation	Shrive, AK (corresponding author), Keele Univ, Sch Life Sci, Keele, Staffs, England.	a.k.shrive@keele.ac.uk		Hood, Derek/0000-0003-4600-5416; Mackay, Rose-Marie/0000-0002-9493-9654; /0000-0002-5992-8239; Watson, Alastair/0000-0002-6735-2567; Clark, Howard/0000-0001-7354-2028	Diamond Light Source [MX8359, MX10369, MX14692]; MRC [MC_UP_1503/1] Funding Source: UKRI	Diamond Light Source; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Diamond Light Source awards MX8359, MX10369, MX14692 (TJG, AKS). Diamond Light Source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUZANNEAU FI, 1991, J CHEM SOC PERK T 1, P509, DOI 10.1039/p19910000509; BORBOLLA L, 1956, Rev Cubana Pediatr, V28, P611; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark H, 2002, IMMUNOBIOLOGY, V205, P619, DOI 10.1078/0171-2985-00159; Clark HW, 2016, INFECT IMMUN, V84, P1585, DOI 10.1128/IAI.01239-15; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Crouch E, 2005, J BIOL CHEM, V280, P17046, DOI 10.1074/jbc.M413932200; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; Crouch E, 2007, BIOCHEMISTRY-US, V46, P5160, DOI 10.1021/bi700037x; Crouch E, 2006, J BIOL CHEM, V281, P18008, DOI 10.1074/jbc.M601749200; Crouch E, 2009, BIOCHEMISTRY-US, V48, P3335, DOI 10.1021/bi8022703; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hickling TP, 1999, EUR J IMMUNOL, V29, P3478, DOI 10.1002/(SICI)1521-4141(199911)29:11<3478::AID-IMMU3478>3.0.CO;2-W; HOLST O, 1991, CARBOHYD RES, V219, P247, DOI 10.1016/0008-6215(91)89058-N; Holst O, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P21, DOI 10.1007/978-3-7091-0733-1_2; JOUSIMIES H, 1974, J BACTERIOL, V119, P753, DOI 10.1128/JB.119.3.753-759.1974; Kishore U, 1996, BIOCHEM J, V318, P505, DOI 10.1042/bj3180505; KUAN SF, 1992, J CLIN INVEST, V90, P97, DOI 10.1172/JCI115861; LESLIE AGW, 1992, JOINT CCP4 ESF EACMB, V26; LeVine AM, 2001, MICROBES INFECT, V3, P161, DOI 10.1016/S1286-4579(00)01363-0; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; LIM BL, 1994, BIOCHEM BIOPH RES CO, V202, P1674, DOI 10.1006/bbrc.1994.2127; Madan T, 2001, INFECT IMMUN, V69, P2728, DOI 10.1128/IAI.69.4.2728-2731.2001; Madan T, 2001, J CLIN INVEST, V107, P467, DOI 10.1172/JCI10124; Mansfield LP, 2001, J MED MICROBIOL, V50, P339, DOI 10.1099/0022-1317-50-4-339; MASOUD H, 1994, BIOCHEMISTRY-US, V33, P10568, DOI 10.1021/bi00201a002; McCRACKEN D A, 1954, J R Sanit Inst, V74, P1091, DOI 10.1177/146642405407401201; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; MUHLRADT PF, 1971, EUR J BIOCHEM, V18, P20, DOI 10.1111/j.1432-1033.1971.tb01209.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olsthoorn MMA, 1999, J MASS SPECTROM, V34, P622, DOI 10.1002/(SICI)1096-9888(199906)34:6<622::AID-JMS814>3.3.CO;2-M; Que NLS, 2000, J BIOL CHEM, V275, P28006; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reid KBM, 1998, BBA-MOL BASIS DIS, V1408, P290, DOI 10.1016/S0925-4439(98)00074-X; Reinhardt A, 2016, J STRUCT BIOL, V195, P387, DOI 10.1016/j.jsb.2016.06.019; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shrive AK, 2009, J MOL BIOL, V394, P776, DOI 10.1016/j.jmb.2009.09.057; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; Singh M, 2003, IMMUNOL LETT, V86, P299, DOI 10.1016/S0165-2478(03)00033-6; Steinebrunner N, 2013, J MED MICROBIOL, V62, P1360, DOI 10.1099/jmm.0.059352-0; Strong P, 2003, CLIN EXP IMMUNOL, V134, P181, DOI 10.1046/j.1365-2249.2003.02281.x; Ujma S, 2017, J INNATE IMMUN, V9, P3, DOI 10.1159/000451026; Wang H, 2008, BIOCHEMISTRY-US, V47, P710, DOI 10.1021/bi7020553; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yethon JA, 2000, J BACTERIOL, V182, P5620, DOI 10.1128/JB.182.19.5620-5623.2000	46	12	12	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199175	10.1371/journal.pone.0199175	http://dx.doi.org/10.1371/journal.pone.0199175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912941	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000435528600083
J	Loutre, R; Heckel, AM; Jeandard, D; Tarassov, I; Entelis, N				Loutre, Romuald; Heckel, Anne-Marie; Jeandard, Damien; Tarassov, Ivan; Entelis, Nina			Anti-replicative recombinant 5S rRNA molecules can modulate the mtDNA heteroplasmy in a glucose-dependent manner	PLOS ONE			English	Article							MITOCHONDRIAL-DNA REPLICATION; SELECTIVE ELIMINATION; IN-VITRO; IMPORT; MUTATION; NUCLEAR; 5S-RIBOSOMAL-RNA; CONSEQUENCES; APTAMERS; GENOMES	Mutations in mitochondrial DNA are an important source of severe and incurable human diseases. The vast majority of these mutations are heteroplasmic, meaning that mutant and wild-type genomes are present simultaneously in the same cell. Only a very high proportion of mutant mitochondrial DNA (heteroplasmy level) leads to pathological consequences. We previously demonstrated that mitochondrial targeting of small RNAs designed to anneal with mutant mtDNA can decrease the heteroplasmy level by specific inhibition of mutant mtDNA replication, thus representing a potential therapy. We have also shown that 5S ribosomal RNA, partially imported into human mitochondria, can be used as a vector to deliver antireplicative oligoribonucleotides into human mitochondria. So far, the efficiency of cellular expression of recombinant 5S rRNA molecules bearing therapeutic insertions remained very low. In the present study, we designed new versions of anti-replicative recombinant 5S rRNA targeting a large deletion in mitochondrial DNA which causes the KSS syndrome, analyzed their specific annealing to KSS mitochondrial DNA and demonstrated their import into mitochondria of cultured human cells. To obtain an increased level of the recombinant 5S rRNA stable expression, we created transmitochondrial cybrid cell line bearing a site for Flp-recombinase and used this system for the recombinase-mediated integration of genes coding for the anti-replicative recombinant 5S rRNAs into nuclear genome. We demonstrated that stable expression of anti-replicative 5S rRNA versions in human transmitochondrial cybrid cells can induce a shift in heteroplasmy level of KSS mutation in mtDNA. This shift was directly dependent on the level of the recombinant 5S rRNA expression and the sequence of the anti-replicative insertion. Quantification of mtDNA copy number in transfected cells revealed the absence of a non-specific effect on wild type mtDNA replication, indicating that the decreased proportion between mutant and wild type mtDNA molecules is not a consequence of a random repopulation of depleted pool of mtDNA genomes. The heteroplasmy change could be also modulated by cell growth conditions, namely increased by cells culturing in a carbohydrate-free medium, thus forcing them to use oxidative phosphorylation and providing a selective advantage for cells with improved respiration capacities. We discuss the advantages and limitations of this approach and propose further development of that no competing interests exist. the anti-replicative strategy based on the RNA import into human mitochondria.	[Loutre, Romuald; Heckel, Anne-Marie; Jeandard, Damien; Tarassov, Ivan; Entelis, Nina] Strasbourg Univ, CNRS, UMR 7156, GMGM, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Entelis, N (corresponding author), Strasbourg Univ, CNRS, UMR 7156, GMGM, Strasbourg, France.	n.entelis@unistra.fr		Tarassov, Ivan/0000-0001-8763-6703; Entelis, Nina/0000-0002-7915-5528	CNRS; University of Strasbourg; LIA (Laboratoire International Associe) ARN-mitocure; LabEx MitoCross (Programme lnvestissement Avenir, PIA)	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg; LIA (Laboratoire International Associe) ARN-mitocure; LabEx MitoCross (Programme lnvestissement Avenir, PIA)	This work was supported by the CNRS, the University of Strasbourg, LIA (Laboratoire International Associe) ARN-mitocure and LabEx MitoCross (Programme lnvestissement Avenir, PIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev MF, 2008, GENE THER, V15, P516, DOI [10.1038/gt.2008.11, 10.1038/sj.gt.2008.11]; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Autour A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02993-8; Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261; Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200; Cannino G, 2012, J BIOL CHEM, V287, P38729, DOI 10.1074/jbc.M112.386060; Chretien D, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003992; Chrzanowska-Lightowlers Z, 2017, RNA BIOL, V14, P1668, DOI 10.1080/15476286.2017.1356551; Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824; Comte C, 2013, NUCLEIC ACIDS RES, V41, P418, DOI 10.1093/nar/gks965; Desquiret-Dumas V, 2012, BBA-MOL BASIS DIS, V1822, P1019, DOI 10.1016/j.bbadis.2012.01.010; Dott W, 2014, REDOX BIOL, V2, P224, DOI 10.1016/j.redox.2013.12.028; Dovydenko I, 2016, BIOMATERIALS, V76, P408, DOI 10.1016/j.biomaterials.2015.10.075; Dovydenko Ilya, 2015, Methods Mol Biol, V1265, P209, DOI 10.1007/978-1-4939-2288-8_16; Elkalaf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070772; Entelis NS, 2001, J BIOL CHEM, V276, P45642, DOI 10.1074/jbc.M103906200; Frey S, 2017, BBA-MOL BASIS DIS, V1863, P284, DOI 10.1016/j.bbadis.2016.10.028; Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001; Gammage PA, 2016, NUCLEIC ACIDS RES, V44, P7804, DOI 10.1093/nar/gkw676; Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672; Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362; Gowher A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066228; Greber BJ, 2016, ANNU REV BIOCHEM, V85, P103, DOI 10.1146/annurev-biochem-060815-014343; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004; Karicheva OZ, 2011, NUCLEIC ACIDS RES, V39, P8173, DOI 10.1093/nar/gkr546; Kim KM, 2017, BMB REP, V50, P164, DOI 10.5483/BMBRep.2017.50.4.013; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267; Kolesnikova O, 2010, RNA, V16, P926, DOI 10.1261/rna.1914110; Magalhaes PJ, 1998, MOL BIOL CELL, V9, P2375, DOI 10.1091/mbc.9.9.2375; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Ozawa M, 1998, J NEUROL SCI, V159, P170, DOI 10.1016/S0022-510X(98)00152-X; Patananan AN, 2016, CELL METAB, V23, P785, DOI 10.1016/j.cmet.2016.04.004; Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014; Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111; Pohjoismaki JLO, 2011, BIOESSAYS, V33, P290, DOI 10.1002/bies.201000137; Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051; Salinas-Giege T, 2015, INT J MOL SCI, V16, P4518, DOI 10.3390/ijms16034518; Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240; Schneider A, 2011, ANNU REV BIOCHEM, V80, P1033, DOI 10.1146/annurev-biochem-060109-092838; Smirnov A, 2008, RNA, V14, P749, DOI 10.1261/rna.952208; Smirnov A, 2011, GENE DEV, V25, P1289, DOI 10.1101/gad.624711; Smirnov A, 2010, J BIOL CHEM, V285, P30792, DOI 10.1074/jbc.M110.151183; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Szymanski M, 2003, BIOCHEM J, V371, P641, DOI 10.1042/BJ20020872; Tarassov I, 2013, TRANSLATION MITOCHON, P85; Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212; Tonin Y, 2014, J BIOL CHEM, V289, P13323, DOI 10.1074/jbc.M113.528968; Towheed A, 2014, NEUROBIOL DIS, V69, P15, DOI 10.1016/j.nbd.2014.04.017; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; YOSHIONARI S, 1994, FEBS LETT, V338, P137, DOI 10.1016/0014-5793(94)80351-X; Zelenka J, 2014, J BIOENERG BIOMEMBR, V46, P147, DOI 10.1007/s10863-014-9543-2	56	8	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199258	10.1371/journal.pone.0199258	http://dx.doi.org/10.1371/journal.pone.0199258			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912984	Green Published, gold, Green Submitted			2022-12-26	WOS:000435528600097
J	Yu, SL; Zhao, H				Yu, Shenglong; Zhao, Hong			Rough sets and Laplacian score based cost-sensitive feature selection	PLOS ONE			English	Article							ATTRIBUTE REDUCTION; CLASSIFICATION; ACQUISITION; KNOWLEDGE; MODEL	Cost-sensitive feature selection learning is an important preprocessing step in machine learning and data mining. Recently, most existing cost-sensitive feature selection algorithms are heuristic algorithms, which evaluate the importance of each feature individually and select features one by one. Obviously, these algorithms do not consider the relationship among features. In this paper, we propose a new algorithm for minimal cost feature selection called the rough sets and Laplacian score based cost-sensitive feature selection. The importance of each feature is evaluated by both rough sets and Laplacian score. Compared with heuristic algorithms, the proposed algorithm takes into consideration the relationship among features with locality preservation of Laplacian score. We select a feature subset with maximal feature importance and minimal cost when cost is undertaken in parallel, where the cost is given by three different distributions to simulate different applications. Different from existing cost-sensitive feature selection algorithms, our algorithm simultaneously selects out a predetermined number of "good" features. Extensive experimental results show that the approach is efficient and able to effectively obtain the minimum cost subset. In addition, the results of our method are more promising than the results of other cost-sensitive feature selection algorithms.	[Yu, Shenglong; Zhao, Hong] Minnan Normal Univ, Fujian Key Lab Granular Comp & Applicat, Zhangzhou, Fujian, Peoples R China; [Yu, Shenglong; Zhao, Hong] Fujian Prov Univ, Key Lab Data Sci & Intelligence Applicat, Zhangzhou, Fujian, Peoples R China	MinNan Normal University; Fuzhou University	Zhao, H (corresponding author), Minnan Normal Univ, Fujian Key Lab Granular Comp & Applicat, Zhangzhou, Fujian, Peoples R China.; Zhao, H (corresponding author), Fujian Prov Univ, Key Lab Data Sci & Intelligence Applicat, Zhangzhou, Fujian, Peoples R China.	hongzhaocn@163.com	Yu, Shenglong/R-4063-2019	Yu, Shenglong/0000-0002-2983-7344	National Natural Science Foundation of China [61703196]; Natural Science Foundation of Fujian Province [2018J01549]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work was supported by the National Natural Science Foundation of China under Grant No.61703196, and the Natural Science Foundation of Fujian Province under Grant No.2018J01549. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China under Grant No.61703196, and the Natural Science Foundation of Fujian Province under Grant No.2018J01549. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhaj TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166017; Bazan J. G., 1994, Methodologies for Intelligent Systems. 8th International Symposium, ISMIS '94 Proceedings, P346; Blake CL, 1998, UCI REPOSITORY MACHI; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dai J, 2017, 2017 IEEE C ENERGY I, P1; Deng DY, 2009, 2009 IEEE INTERNATIONAL CONFERENCE ON GRANULAR COMPUTING ( GRC 2009), P121, DOI 10.1109/GRC.2009.5255146; Deng DY, 2009, INTERNATIONAL JOINT CONFERENCE ON COMPUTATIONAL SCIENCES AND OPTIMIZATION, VOL 2, PROCEEDINGS, P377, DOI 10.1109/CSO.2009.250; Emary E, 2016, NEUROCOMPUTING, V213, P54, DOI 10.1016/j.neucom.2016.03.101; Fumera G, 2002, COST SENSITIVE LEARN; Golberg DE, 1989, GENETIC ALGORITHMS S; Greiner R, 2002, ARTIF INTELL, V139, P137, DOI 10.1016/S0004-3702(02)00209-6; Guiying Pan, 2011, 2011 IEEE International Conference on Granular Computing, P539, DOI 10.1109/GRC.2011.6122654; He H.P., 2011, P 3 INT C MACH LEARN, V1, P432; He HP, 2011, LECT NOTES ARTIF INT, V6743, P244, DOI 10.1007/978-3-642-21881-1_39; He X., 2005, ADV NEURAL INFORM PR, V18; Hu QH, 2008, KNOWL-BASED SYST, V21, P294, DOI 10.1016/j.knosys.2007.07.001; Ji SH, 2007, PATTERN RECOGN, V40, P1474, DOI 10.1016/j.patcog.2006.11.008; Jia XY, 2013, INFORM SCIENCES, V219, P151, DOI 10.1016/j.ins.2012.07.010; Johnson R.A., 2014, APPL MULTIVARIATE ST; Li JH, 2013, INT J APPROX REASON, V54, P149, DOI 10.1016/j.ijar.2012.07.005; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Ling Charles X., 2004, P 21 INT C MACHINE L, P69; Liu H., 2012, FEATURE SELECTION KN, V454; Liu MX, 2016, NEUROCOMPUTING, V215, P100, DOI 10.1016/j.neucom.2015.07.155; Maji P, 2011, INT J APPROX REASON, V52, P408, DOI 10.1016/j.ijar.2010.09.006; Martina F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177475; Min F, 2016, GRANULAR COMPUTING, P1; Min F, 2016, COSER COST SENSTIVE; Min F, 2012, INFORM SCIENCES, V211, P48, DOI 10.1016/j.ins.2012.04.031; Min F, 2011, INFORM SCIENCES, V181, P4928, DOI 10.1016/j.ins.2011.07.010; Min F, 2009, INFORM SCIENCES, V179, P2442, DOI 10.1016/j.ins.2009.03.007; Qian YH, 2010, ARTIF INTELL, V174, P597, DOI 10.1016/j.artint.2010.04.018; Ruckstiess T, 2013, INT J MACH LEARN CYB, V4, P235, DOI 10.1007/s13042-012-0092-x; Spira A, 2007, NAT MED, V13, P361, DOI 10.1038/nm1556; Subrahmanya N, 2013, INT J MACH LEARN CYB, V4, P609, DOI 10.1007/s13042-012-0121-9; Susmaga R., 1999, Foundations of Intelligent Systems. 11th International Symposium, ISMIS'99. Proceedings, P448; TAN M, 1993, MACH LEARN, V13, P7, DOI 10.1007/BF00993101; Turney PD, 1994, J ARTIF INTELL RES, V2, P369, DOI 10.1613/jair.120; Wan JW, 2015, NEUROCOMPUTING, V152, P333, DOI 10.1016/j.neucom.2014.10.059; Wan SX, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201700262; Wang SP, 2015, PATTERN RECOGN, V48, P10, DOI 10.1016/j.patcog.2014.08.004; Weiss Y, 2013, INFORM SCIENCES, V222, P247, DOI 10.1016/j.ins.2011.01.035; Xie ZX, 2014, INT J MACH LEARN CYB, V5, P201, DOI 10.1007/s13042-013-0156-6; Yang XB, 2013, INFORM SCIENCES, V250, P184, DOI 10.1016/j.ins.2013.06.057; Zhang SC, 2010, KNOWL-BASED SYST, V23, P369, DOI 10.1016/j.knosys.2010.01.008; Zhao H., 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1109/EVS.2013.6914957; Zhao Y, 2007, LECT NOTES ARTIF INT, V4481, P101; Zhong N, 2001, J INTELL INF SYST, V16, P199, DOI 10.1023/A:1011219601502; Zhu PF, 2017, IMAGE VISION COMPUT, V60, P22, DOI 10.1016/j.imavis.2016.11.014; Zhu PF, 2017, PATTERN RECOGN, V66, P364, DOI 10.1016/j.patcog.2017.01.016; Zhu W., 2013, J INF COMPUT SCI, V10, P4105, DOI DOI 10.12733/JICS20102163; Zhu W, 2009, INFORM SCIENCES, V179, P210, DOI 10.1016/j.ins.2008.09.015; Zou Q, 2016, NEUROCOMPUTING, V173, P346, DOI 10.1016/j.neucom.2014.12.123	53	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0197564	10.1371/journal.pone.0197564	http://dx.doi.org/10.1371/journal.pone.0197564			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912884	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600010
J	Blikman, T; Rienstra, W; van Raay, JJAM; Dijkstra, B; Bulstra, SK; Stevens, M; van den Akker-Scheek, I				Blikman, Tim; Rienstra, Wietske; van Raay, Jos J. A. M.; Dijkstra, Baukje; Bulstra, Sjoerd K.; Stevens, Martin; van den Akker-Scheek, Inge			Neuropathic-like symptoms and the association with joint-specific function and quality of life in patients with hip and knee osteoarthritis	PLOS ONE			English	Article							RADIOGRAPHIC SEVERITY; PAIN SYMPTOMS; PAINDETECT; QUESTIONNAIRE; DISCORDANCE; DISABILITY; IMPACT	Objective There is an association between osteoarthritis-related pain severity and function, yet clear evidence about the sole influence of neuropathic-like symptoms on joint function and health-related quality of life (HRQoL) is lacking. Previous studies among knee OA patients show an association between neuropathic-like symptoms, lower functional status and lower quality of life, however analyses were unadjusted or had limited adjustment for influential covariates like pain intensity. The aim of this study was therefore to determine the influence of neuropathic-like symptoms-adjusted for multiple influential covariates-on joint-specific function and HRQoL in hip and knee OA patients. Methods In this observational study 255 patients (117 with hip OA and 138 with knee OA) completed the modified painDETECT questionnaire (mPDQ) to identify subjects with neuropathic-like symptoms (mPDQ score>12, possible neuropathic pain [NP] phenotype). The WOMAC and the RAND-36 were used to asses respectively function and HRQoL. Results were adjusted stepwise for age, sex and BMI (Model 1); back disorder, painful body regions, comorbidities and previous surgery (Model 2); and pain intensity and analgesic usage (Model 3). Results A possible NP phenotype was experienced by 37% of hip and 46% of knee OA patients. Final model 3 analysis revealed that hip OA patients with neuropathic-like symptoms scored significantly lower on pain-related aspects of HRQoL (GRAND-36 bodily pain: 6.8 points, p = 0.047) compared to patients with the unlikely NP phenotype. In knee OA patients, a possible NP phenotype was associated with diminished joint function (AWOMAC domains ranging 7.1 to 10.5 points, p<0.05) and more deficits on the physical functional aspect of HRQoL (GRAND-36 physical functioning: 6.8 points, p = 0.016). Conclusion Neuropathic-like symptoms deteriorate the subjective rating of pain-related quality of life in hip OA patients and significantly influence function in knee OA patients.	[Blikman, Tim; Rienstra, Wietske; Bulstra, Sjoerd K.; Stevens, Martin; van den Akker-Scheek, Inge] Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, Groningen, Netherlands; [van Raay, Jos J. A. M.] Martini Hosp Groningen, Dept Orthoped, Groningen, Netherlands; [Dijkstra, Baukje] Med Ctr Leeuwarden, Dept Orthoped, Groningen, Netherlands	University of Groningen; Martini Hospital; Medical Center Leeuwarden	Blikman, T (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, Groningen, Netherlands.	t.blikman@umcg.nl	Stevens, Martin/A-5196-2013	Stevens, Martin/0000-0001-8183-6894; van den Akker-Scheek, Inge/0000-0002-1614-8419; Rienstra, Wietske/0000-0001-6718-3129	Dutch Arthritis Foundation [BP 12-3-401]	Dutch Arthritis Foundation	This work is supported and financed by the Dutch Arthritis Foundation (project number BP 12-3-401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, HIP DISABILITY OSTEO; Arendt-Nielsen L, 2017, CLIN EXP RHEUMATOL, V35, pS68; Askin A, 2017, KAOHSIUNG J MED SCI, V33, P152, DOI 10.1016/j.kjms.2016.12.007; Bedson J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-116; Bruggink JW., 2011, STAT KWARTAALBLAD DE, V59, P43; Creamer P, 2000, RHEUMATOLOGY, V39, P490, DOI 10.1093/rheumatology/39.5.490; Croft P, 2005, ARTHRITIS RHEUM-US, V52, P2350, DOI 10.1002/art.21218; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; de Groot IB, 2007, OSTEOARTHR CARTILAGE, V15, P104, DOI 10.1016/j.joca.2006.06.014; de Groot IB, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-16; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Eitner A, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00349; Erdogan BD, 2016, J RHEUMATOL, V43, P194, DOI 10.3899/jrheum.141150; FERRAZ MB, 1990, J RHEUMATOL, V17, P1022; Finan PH, 2013, ARTHRITIS RHEUM-US, V65, P363, DOI 10.1002/art.34646; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Fu K, 2017, RHEUMATOLOGY; Hochman JR, 2013, OSTEOARTHR CARTILAGE, V21, P1236, DOI 10.1016/j.joca.2013.06.023; Hochman JR, 2011, OSTEOARTHR CARTILAGE, V19, P647, DOI 10.1016/j.joca.2011.03.007; Hochman JR, 2010, ARTHRIT CARE RES, V62, P1019, DOI 10.1002/acr.20142; International Association for the Study of Pain, IASP TAX; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Moss P, 2018, CLIN J PAIN, V34, P15, DOI 10.1097/AJP.0000000000000504; Mulvey MR, 2014, PAIN MANAG, V4, P233, DOI [10.2217/PMT.14.8, 10.2217/pmt.14.8]; Neogi T, 2013, OSTEOARTHR CARTILAGE, V21, P1145, DOI 10.1016/j.joca.2013.03.018; Nilsdotter AK, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-10; Ohtori S, 2012, YONSEI MED J, V53, P801, DOI 10.3349/ymj.2012.53.4.801; Rienstra W, 2019, DISABIL REHABIL, V41, P941, DOI 10.1080/09638288.2017.1413429; Rienstra W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146117; RIVM, 2016, ARTR CIJF CONT HUID; Roorda LD, 2004, ANN RHEUM DIS, V63, P36, DOI 10.1136/ard.2002.001784; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Roubille C, 2014, ARTHRITIS RES THER, V16, P1; Shigemura T, 2011, EUR ORTHOP TRAUMATOL, V2, P73; Thakur M, 2014, NAT REV RHEUMATOL, V10, P374, DOI 10.1038/nrrheum.2014.47; Valdes AM, 2014, SEMIN ARTHRITIS RHEU, V43, P588, DOI 10.1016/j.semarthrit.2013.10.001; Valdes AM, 2012, SEMIN ARTHRITIS RHEU, V41, P568, DOI 10.1016/j.semarthrit.2011.07.002; van der Zee KI, 1996, INT J BEHAV MED, V3, P104, DOI 10.1207/s15327558ijbm0302_2; Wenham CYJ, 2013, AGE AGEING, V42, P272, DOI 10.1093/ageing/aft043; World Health Organization, CHRON RHEUM COND; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	41	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199165	10.1371/journal.pone.0199165	http://dx.doi.org/10.1371/journal.pone.0199165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902245	Green Published, gold, Green Submitted			2022-12-26	WOS:000435424900093
J	Xia, Y; Amna, A; Opiyo, SO				Xia, Ye; Amna, Amna; Opiyo, Stephen Obol			The culturable endophytic fungal communities of switchgrass grown on a coal-mining site and their effects on plant growth	PLOS ONE			English	Article							PANICUM-VIRGATUM; ARBUSCULAR MYCORRHIZAL; ROOT COLONIZATION; SOIL; AVAILABILITY; TRICHODERMA; RHIZOSPHERE; MICROBIOME; PROMOTION; NUTRIENT	Plants have a diverse endophytic microbiome that is functionally important for their growth, development, and health. In this study, the diversity and specificity of culturable endophytic fungal communities were explored in one of the most important biofuel crops, switchgrass plants (Panicum virgatum L.), which have been cultivated on a reclaimed coal-mining site for more than 20 years. The endophytic fungi were isolated from the surface-sterilized shoot (leaf and stem), root, and seed tissues of switchgrass plants and then cultured for identification. A total of 1339 fungal isolates were found and 22 operational taxonomic units (OTUs) were sequence identified by internal transcribed spacer (ITS) primers and grouped into 7 orders and 4 classes. Although a diverse range of endophytic fungi associated with switchgrass were documented, the most abundant class, order, and species were Sordariomycetes, Hypocreales, and Fusarium spp. respectively. About 86% of the isolated endophytic fungi were able to enhance the heights of the shoots; 69% could increase the shoot fresh weights; and 62% could improve the shoot dry weights after being reintroduced back into the switchgrass plants, which illustrated their functional importance. Through the Shannon Diversity Index analysis, we observed a gradation of species diversity, with shoots and roots having the similar values and seeds having a lesser value. It was observed that the switchgrass plants showing better growth performance displayed higher endophytic fungal species diversity and abundance. It was also discovered that the rhizosphere soil organic matter content was positively correlated with the fungal species diversity. All these data demonstrate the functional association of these beneficial endophytic fungi with switchgrass and their great potential in improving the switchgrass growth and biomass to benefit the biofuel industry by reducing chemical inputs and burden to the environment.	[Xia, Ye; Amna, Amna; Opiyo, Stephen Obol] Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA; [Amna, Amna] Quaid i Azam Univ, Dept Plant Sci, Islamabad, Pakistan	University System of Ohio; Ohio State University; Quaid I Azam University	Xia, Y (corresponding author), Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA.	xia.374@osu.edu	Xia, Ye/B-8217-2016		Ohio Agricultural Research and Development Center (OARDC) [USDA-NIFA-OHO01392, OHOA1615]; Ohio State University	Ohio Agricultural Research and Development Center (OARDC); Ohio State University(Ohio State University)	This project is supported by the Hatch Project from USDA-NIFA-OHO01392 and both the Start-Up fund and OHOA1615 from Ohio Agricultural Research and Development Center (OARDC) and Ohio State University to YX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, R LANG ENV STAT COMP; Berg G, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00491; Bitas V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01248; Bonfante P, 2008, TRENDS PLANT SCI, V13, P492, DOI 10.1016/j.tplants.2008.07.001; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Cai F, 2015, PLANT SOIL, V388, P337, DOI 10.1007/s11104-014-2326-z; Debolt S, 2009, GCB BIOENERGY, V1, P308, DOI 10.1111/j.1757-1707.2009.01023.x; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Ghimire SR, 2011, APPL ENVIRON MICROB, V77, P7063, DOI 10.1128/AEM.05225-11; Ghimire SR, 2011, FUNGAL DIVERS, V47, P19, DOI 10.1007/s13225-010-0085-6; Ginting R. C. B., 2013, Hayati Journal of Biosciences, V20, P127, DOI 10.4308/hjb.20.3.127; HUTCHESON K, 1970, J THEOR BIOL, V29, P151, DOI 10.1016/0022-5193(70)90124-4; Islam Shaikhul, 2014, Archives of Phytopathology and Plant Protection, V47, P2319, DOI 10.1080/03235408.2013.876745; J Benton Jones, 2000, SOIL AN HDB REF METH; Kell DB, 2011, ANN BOT-LONDON, V108, P407, DOI 10.1093/aob/mcr175; Ker K, 2014, ARCH AGRON SOIL SCI, V60, P1553, DOI 10.1080/03650340.2014.898840; Kim S, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-37; Kleczewski NM, 2012, FUNGAL ECOL, V5, P521, DOI 10.1016/j.funeco.2011.12.006; Knief C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00216; Lahlali R, 2010, FEMS MICROBIOL LETT, V311, P152, DOI 10.1111/j.1574-6968.2010.02084.x; Lebeis SL, 2015, SCIENCE, V349, P860, DOI 10.1126/science.aaa8764; Lee K, 2009, FEMS MICROBIOL LETT, V299, P31, DOI 10.1111/j.1574-6968.2009.01719.x; Long HH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002702; Lowman S, 2016, PLANT SOIL, V405, P47, DOI 10.1007/s11104-015-2640-0; Lugtenberg BJJ, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw194; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Luo J, 2017, FUNGAL BIOL-UK, V121, P478, DOI 10.1016/j.funbio.2017.01.005; McGuinness M, 2009, INT J ENV RES PUB HE, V6, P2226, DOI 10.3390/ijerph6082226; Naseby DC, 2000, J APPL MICROBIOL, V88, P161, DOI 10.1046/j.1365-2672.2000.00939.x; Oksanen J., 2018, R PACKAGE VERSION, V2, P4; Petrini O, 1991, FUNGAL ENDOPHYTES TR, P179; Postma JWM, 2007, SOIL BIOL BIOCHEM, V39, P400, DOI 10.1016/j.soilbio.2006.08.007; Radhakrishnan R, 2014, J PLANT INTERACT, V9, P754, DOI 10.1080/17429145.2014.930524; Ray P, 2015, BIOENERG RES, V8, P922, DOI 10.1007/s12155-015-9636-8; ROMaSE Heckendorn, 2010, LAB PROCEDURES VIRGI, P452; Sanderson MA, 2008, INT J MOL SCI, V9, P768, DOI 10.3390/ijms9050768; Schardl CL, 2008, SYST BIOL, V57, P483, DOI 10.1080/10635150802172184; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Singh LP, 2011, PLANT SIGNAL BEHAV, V6, P175, DOI 10.4161/psb.6.2.14146; Vogel KP, 2002, SWITCHGRASS BIOMASS; Wagner MR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12151; WL P, 2016, MICROBIAL BIOTECHNOL, V9, P868; Xia Y, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00490; Yamaji K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169089; Ye Xia, 2013, GCB Bioenergy, V5, P674, DOI 10.1111/j.1757-1707.2012.01208.x	45	18	18	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198994	10.1371/journal.pone.0198994	http://dx.doi.org/10.1371/journal.pone.0198994			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902231	gold, Green Published, Green Submitted			2022-12-26	WOS:000435424900071
J	Su, WJ; Hong, LX; Xu, X; Huang, S; Herpai, D; Li, LS; Xu, YX; Truong, L; Hu, WY; Wu, XH; Xiao, CC; Zhang, W; Han, JH; Debinski, W; Xiang, R; Sun, PQ				Su, Weijun; Hong, Lixin; Xu, Xin; Huang, Shan; Herpai, Denise; Li, Lisheng; Xu, Yingxi; Lan Truong; Hu, Wen-Yuan; Wu, Xiaohua; Xiao, Changchun; Zhang, Wei; Han, Jiahuai; Debinski, Waldemar; Xiang, Rong; Sun, Peiqing			miR-30 disrupts senescence and promotes cancer by targeting both p16(INK4A) and DNA damage pathways	ONCOGENE			English	Article							ONCOGENE-INDUCED SENESCENCE; DOUBLE-STRAND BREAK; RAS-INDUCED SENESCENCE; SMALL RNAS; CHROMATIN IMMUNOPRECIPITATION; MESSENGER-RNAS; CHD7; MICRORNAS; REPAIR; TUMORIGENESIS	miR-30 is a microRNA frequently overexpressed in human cancers. However, the biological consequence of miR-30 overexpression in cancer has been unclear. In a genetic screen, miR-30 was found to abrogate oncogenic-induced senescence, a key tumor-suppressing mechanism that involves DNA damage responses, activation of p53 and induction of p16(INK4A). In cells and mouse models, miR-30 disrupts senescence and promotes cancer by suppressing 2 targets, CHD7 and TNRC6A. We show that while CHD7 is a transcriptional coactivator essential for induction of p16(INK4A) in senescent cells, TNRC6A, a miRNA machinery component, is required for expression and functionality of DNA damage response RNAs (DDRNAs) that mediate DNA damage responses and p53 activation by orchestrating histone modifications, chromatin remodeling and recruitment of DNA damage factors at damaged sites. Thus, miR-30 inhibits both p16(INK4A) and p53, 2 key senescence effectors, leading to efficient senescence disruption. These findings have identified novel signaling pathways mediating oncogene-induced senescence and tumor-suppression, and revealed the molecular and cellular mechanisms underlying the oncogenic activity of miR-30. Thus, the miR-30/CHD7/TNRC6A pathway is potentially a novel diagnostic biomarker and therapeutic target for cancer.	[Su, Weijun; Huang, Shan; Herpai, Denise; Zhang, Wei; Debinski, Waldemar; Sun, Peiqing] Wake Forest Sch Med, Wake Forest Comprehens Canc Ctr, Dept Canc Biol, Winston Salem, NC 27101 USA; [Su, Weijun; Xu, Yingxi; Xiang, Rong] Nankai Univ, Sch Med, Tianjin, Peoples R China; [Hong, Lixin; Xu, Yingxi; Lan Truong; Wu, Xiaohua; Sun, Peiqing] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Hong, Lixin; Li, Lisheng; Han, Jiahuai] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Xu, Xin] 2 Peoples Hosp Wuxi City, Wuxi, Peoples R China; [Herpai, Denise; Debinski, Waldemar] Wake Forest Sch Med, Wake Forest Comprehens Canc Ctr, Brain Tumor Ctr Excellence, Winston Salem, NC USA; [Hu, Wen-Yuan] Biosettia Inc, San Diego, CA USA; [Xiao, Changchun] Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Xiao, Changchun] Scripps Res Inst, Dept Microbial Sci, La Jolla, CA 92037 USA; [Zhang, Wei] Wake Forest Sch Med, Wake Forest Comprehens Canc Ctr, Ctr Canc Genom & Precis Oncol, Winston Salem, NC USA	Wake Forest University; Nankai University; Scripps Research Institute; Xiamen University; Wake Forest University; Scripps Research Institute; Scripps Research Institute; Wake Forest University	Sun, PQ (corresponding author), Wake Forest Sch Med, Wake Forest Comprehens Canc Ctr, Dept Canc Biol, Winston Salem, NC 27101 USA.; Sun, PQ (corresponding author), Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA.	psun@wakehealth.edu	Xu, Yingxi/HGA-1792-2022	Li, Lisheng/0000-0002-0793-272X	Overseas Collaboration Fund from National NSF of China [31428013]; NIH/NCI [CA106768, CA131231, CA172115, P30CA012197]; Thomas K. Hearn Brain Tumor Center; International Postdoctoral Exchange Fellowship Program by Office of China Postdoctoral Council [20140027]; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA131231, R01CA106768, R01CA172115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080677] Funding Source: NIH RePORTER	Overseas Collaboration Fund from National NSF of China; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Thomas K. Hearn Brain Tumor Center; International Postdoctoral Exchange Fellowship Program by Office of China Postdoctoral Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Joanna Wysocka for CHD7 cDNA, and Tumor Tissue and Pathology, Biostatistics and Bioinformatics, Cell & Viral Vector Laboratory and Cellular Imaging Shared Resources of WFBCCC. This study was supported by Overseas Collaboration Fund from National NSF of China 31428013 (PS, RX), NIH/NCI grants CA106768, CA131231, CA172115 (PS), P30CA012197, and Thomas K. Hearn Brain Tumor Center. WS is supported by International Postdoctoral Exchange Fellowship Program by Office of China Postdoctoral Council (20140027).	Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Caldwell ME, 2012, ONCOGENE, V31, P1599, DOI 10.1038/onc.2011.350; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; di Fagagna FD, 2014, TRENDS CELL BIOL, V24, P171, DOI 10.1016/j.tcb.2013.09.008; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIGIOVANNI J, 1992, PHARMACOL THERAPEUT, V54, P63, DOI 10.1016/0163-7258(92)90051-Z; DiGiovanni J, 1991, MODIFICATION TUMOR D, V33, P192; Engelen E, 2011, NAT GENET, V43, P607, DOI 10.1038/ng.825; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; Faraonio R, 2012, CELL DEATH DIFFER, V19, P713, DOI 10.1038/cdd.2011.143; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Francia S, 2012, NATURE, V488, P231, DOI 10.1038/nature11179; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hong LX, 2010, CANCER RES, V70, P8547, DOI 10.1158/0008-5472.CAN-10-1938; Hurd EA, 2007, MAMM GENOME, V18, P94, DOI 10.1007/s00335-006-0107-6; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Kim MS, 2010, J PATHOL, V221, P139, DOI 10.1002/path.2683; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Kwong J, 2013, MOL CELL BIOL, V33, P3780, DOI 10.1128/MCB.00784-13; Kwong J, 2009, J BIOL CHEM, V284, P11237, DOI 10.1074/jbc.M808327200; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Mukhopadhyay A, 2008, NAT PROTOC, V3, P698, DOI 10.1038/nprot.2008.38; Narita M, 2005, NAT MED, V11, P920, DOI 10.1038/nm0905-920; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Srikantan S, 2011, CELL CYCLE, V10, P3211, DOI 10.4161/cc.10.19.17050; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; Wang HL, 2012, J BIOL CHEM, V287, P21471, DOI 10.1074/jbc.M112.355354; Wang QH, 2016, CANCER RES, V76, P1904, DOI 10.1158/0008-5472.CAN-15-2334; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xu Y, 2012, MOL CELL, V48, P723, DOI 10.1016/j.molcel.2012.09.026; Yoshizuka N, 2012, MOL CELL BIOL, V32, P606, DOI 10.1128/MCB.06301-11; Zamudio JR, 2014, CELL, V156, P920, DOI 10.1016/j.cell.2014.01.041; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhao T, 2010, AM J PHYSIOL-ENDOC M, V299, pE110, DOI 10.1152/ajpendo.00192.2010	49	27	29	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 18	2018	37	42					5618	5632		10.1038/s41388-018-0358-1	http://dx.doi.org/10.1038/s41388-018-0358-1			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX3JJ	29907771	Green Accepted			2022-12-26	WOS:000447619100003
J	Yang, XY; Chen, C; Tian, HL; Chi, H; Mu, ZY; Zhang, TQ; Yang, KL; Zhao, Q; Liu, XH; Wang, ZF; Ji, XY; Yang, HT				Yang, Xiaoyun; Chen, Cheng; Tian, Hongliang; Chi, Heng; Mu, Zhongyu; Zhang, Tianqing; Yang, Kailin; Zhao, Qi; Liu, Xiaohua; Wang, Zefang; Ji, Xiaoyun; Yang, Haitao			Mechanism of ATP hydrolysis by the Zika virus helicase	FASEB JOURNAL			English	Article						drug design; structure; mutagenesis	NS3 PROTEIN; INSIGHTS; DESIGN; DOMAIN	During its life cycle, Zika virus (ZIKV), an arthropod-borne flavivirus that is associated with Guillain-Barre syndrome and causes microencephaly in fetuses and newborn children, encodes a critical and indispensable helicase domain that has 5-triphosphatase activity and performs ATP hydrolysis to generate energy and thus, sustains unwinding of double-stranded RNA during ZIKV genome replication. Of these processes, ATP hydrolysis represents the most basic event; however, its dynamic mechanisms remain largely unknown, impeding the further understanding of the function of ZIKV helicase and the ongoing anti-ZIKV drug design. In this work, we determined the crystal structure of ZIKV helicase in complex with ADP-AlF3-Mn2+ and ADP-Mn2+ separately. The structural analysis indicates that these structures represent the intermediate state and posthydrolysis state, respectively, of the ATP hydrolysis process of ZIKV helicase. These findings, together with our earlier work, which identified the prehydrolysis state of ZIKV helicase, lead to a proposal of the ATP hydrolysis cycle for ZIKV helicase. On this basis, we used site-directed mutagenesis combined with an enzymatic study to identify successfully residues that are critical for the ATPase activity of ZIKV helicase; this will provide new ideas to understand the function for the key enzyme of ZIKV.Yang, X., Chen, C., Tian, H., Chi, H., Mu, Z., Zhang, T., Yang, K., Zhao, Q., Liu, X., Wang, Z., Ji, X., Yang, H. Mechanism of ATP hydrolysis by the Zika virus helicase.	[Yang, Xiaoyun; Chen, Cheng; Tian, Hongliang; Chi, Heng; Mu, Zhongyu; Zhang, Tianqing; Liu, Xiaohua; Wang, Zefang; Yang, Haitao] Tianjin Univ, 92 Weijin Rd, Tianjin 300072, Peoples R China; [Yang, Xiaoyun; Yang, Haitao] Tianjin Int Joint Acad Biotechnol & Med, Tianjin, Peoples R China; [Yang, Kailin] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Zhao, Qi] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Ji, Xiaoyun] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China	Tianjin University; Tianjin International Joint Academy of Biomedicine; Case Western Reserve University; Cleveland Clinic Foundation; Yale University; Nanjing University	Wang, ZF; Yang, HT (corresponding author), Tianjin Univ, 92 Weijin Rd, Tianjin 300072, Peoples R China.	zefangwang@tju.edu.cn; yanght@tju.edu.cn			National Natural Science Foundation of China [31528006]; National Key Basic Research Program of China (973 Program) [2015CB859800, 2014CB542800]; National Key Research Program of China [2016YFD0500300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Key Research Program of China	The authors thank the staff at Beamline BL18U1 of the Shanghai Synchrotron Radiation Facility (SSRF) for data collection. Atomic coordinates and structure factors have been deposited in the Research Collaboratory for Structural Bioinformatics (RCSB) PDB IDs: 5Y6M and 5Y6N. This work was supported by the National Natural Science Foundation of China (31528006), the National Key Basic Research Program of China (973 Program) (2015CB859800 and 2014CB542800), and the National Key Research Program of China (2016YFD0500300). The authors declare no conflicts of interest.	Abdelhaleem M, 2010, METHODS MOL BIOL, V587, P1, DOI 10.1007/978-1-60327-355-8_1; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034; Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941; Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Isaguliants MG, 2003, IMMUNOL LETT, V88, P1, DOI 10.1016/S0165-2478(03)00051-8; Jankowsky A, 2011, NUCLEIC ACIDS RES, V39, pD338, DOI 10.1093/nar/gkq1002; Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013; Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierson TC., 2013, FIELDS VIROLOGY, V6th ed., P747; Roze B, 2016, EURO SURVEILL, P21; Silveira GF, 2016, CLIN EXP IMMUNOL, V183, P114, DOI 10.1111/cei.12701; Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341; Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2; Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4; Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005	27	15	16	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5250	5257		10.1096/fj.201701140R	http://dx.doi.org/10.1096/fj.201701140R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29913559	Bronze			2022-12-26	WOS:000447972500005
J	Hanna, DA; Hu, R; Kim, H; Martinez-Guzman, O; Torres, MP; Reddi, AR				Hanna, David A.; Hu, Rebecca; Kim, Hyojung; Martinez-Guzman, Osiris; Torres, Matthew P.; Reddi, Amit R.			Heme bioavailability and signaling in response to stress in yeast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme; biosensor; metal homeostasis; metal; heme oxygenase; stress; xenobiotic; yeast; cell stress; heavy metals; heme; heme sensor; lead; Hap1; labile heme pool	LEAD TOXICITY; SACCHAROMYCES-CEREVISIAE; MOLECULAR-MECHANISM; ESCHERICHIA-COLI; OXIDATIVE STRESS; UP-REGULATION; EXPOSURE; OVEREXPRESSION; TRAFFICKING; METABOLISM	Protoheme (hereafter referred to as heme) is an essential cellular cofactor and signaling molecule that is also potentially cytotoxic. To mitigate heme toxicity, heme synthesis and degradation are tightly coupled to heme utilization in order to limit the intracellular concentration of free heme. Such a model, however, would suggest that a readily accessible steady-state, bioavailable labile heme (LH) pool is not required for supporting heme-dependent processes. Using the yeast Saccharomyces cerevisiae as a model and fluorescent heme sensors, site-specific heme chelators, and molecular genetic approaches, we found here that 1) yeast cells preferentially use LH in heme-depleted conditions; 2) sequestration of cytosolic LH suppresses heme signaling; and 3) lead (Pb2+) stress contributes to a decrease in total heme, but an increase in LH, which correlates with increased heme signaling. We also observed that the proteasome is involved in the regulation of the LH pool and that loss of proteasomal activity sensitizes cells to Pb2+ effects on heme homeostasis. Overall, these findings suggest an important role for LH in supporting heme-dependent functions in yeast physiology.	[Hanna, David A.; Hu, Rebecca; Kim, Hyojung; Martinez-Guzman, Osiris; Reddi, Amit R.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Kim, Hyojung; Torres, Matthew P.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Torres, Matthew P.; Reddi, Amit R.] Georgia Inst Technol, Parker Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Reddi, AR (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	amit.reddi@chemistry.gatech.edu		Torres, Matthew/0000-0001-7296-4536; Hanna, David/0000-0003-0726-8707	National Institutes of Health [ES025661, GM118744]; National Science Foundation [MCB-1552791]; Blanchard Professorship; Georgia Institute of Technology; Petit Institute Scholarship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES025661, R33ES025661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118744] Funding Source: NIH RePORTER; Direct For Biological Sciences [1552791] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Blanchard Professorship; Georgia Institute of Technology; Petit Institute Scholarship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Institutes of Health Grants ES025661 (to A. R. R.) and GM118744 (to A. R. R. with a sub-award to M. P. T.), National Science Foundation Grant MCB-1552791 (to A. R. R.), the Blanchard Professorship (to A. R. R.), and start-up funding from the Georgia Institute of Technology (to A. R. R. and M. P. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Petit Institute Scholarship.	Aich A, 2015, BLOOD CELL MOL DIS, V55, P402, DOI 10.1016/j.bcmd.2015.09.003; ALAM J, 1994, J BIOL CHEM, V269, P1001; Lopes ACBA, 2016, REV ENVIRON CONTAM T, V236, P193, DOI 10.1007/978-3-319-20013-2_3; Barker PD, 1996, BIOCHEMISTRY-US, V35, P13618, DOI 10.1021/bi961127x; Baureder M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036725; BONKOVSKY HL, 1991, AM J GASTROENTEROL, V86, P1050; Bussche JV, 2011, APPL MICROBIOL BIOT, V90, P679, DOI 10.1007/s00253-010-3056-7; Chen C, 2007, APPL MICROBIOL BIOT, V74, P683, DOI 10.1007/s00253-006-0678-x; COHEN AR, 1981, PEDIATRICS, V67, P904; Collinson EJ, 2011, J BIOL CHEM, V286, P2205, DOI 10.1074/jbc.M110.187062; Conant JB, 1930, J BIOL CHEM, V86, P0733; Correia MA, 2011, DRUG METAB REV, V43, P1, DOI 10.3109/03602532.2010.515222; DEMATTEIS F, 1980, BIOCHEM J, V189, P645, DOI 10.1042/bj1890645; DEMATTEIS F, 1983, FEBS LETT, V159, P127, DOI 10.1016/0014-5793(83)80430-X; Dongre NN, 2013, INDIAN J CLIN BIOCHE, V28, P65, DOI 10.1007/s12291-012-0241-8; EBERT PS, 1979, BIOCHEM BIOPH RES CO, V88, P1382, DOI 10.1016/0006-291X(79)91133-1; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Ernst WHO, 2008, PLANT CELL ENVIRON, V31, P123, DOI 10.1111/j.1365-3040.2007.01746.x; FENG YQ, 1991, BIOCHEMISTRY-US, V30, P10150, DOI 10.1021/bi00106a011; FENG YQ, 1994, NAT STRUCT BIOL, V1, P30, DOI 10.1038/nsb0194-30; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; Fu X, 2014, EXP BIOL MED, V239, P202, DOI 10.1177/1535370213509213; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Gillis BS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-344; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Gruenberg-Etkovitz N, 2009, J ENVIRON PATHOL TOX, V28, P5, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i1.20; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUO GG, 1994, J BIOL CHEM, V269, P12399; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Hanna DA, 2017, BIOCHEMISTRY-US, V56, P1815, DOI 10.1021/acs.biochem.7b00007; Hanna DA, 2016, P NATL ACAD SCI USA, V113, P7539, DOI 10.1073/pnas.1523802113; ITAGAKI E, 1967, J BIOL CHEM, V242, P2272; Jaishankar Monisha, 2014, Interdiscip Toxicol, V7, P60, DOI 10.2478/intox-2014-0009; Kiktev DA, 2012, MOL CELL BIOL, V32, P4960, DOI 10.1128/MCB.00875-12; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Lanphear BP, 1998, ENVIRON RES, V76, P120, DOI 10.1006/enrs.1997.3801; Lee KH, 2009, KOREAN J PHYSIOL PHA, V13, P431, DOI 10.4196/kjpp.2009.13.6.431; Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014; LIU SC, 1988, BLOOD, V71, P1755; LUBRAN MM, 1980, ANN CLIN LAB SCI, V10, P402; Magyar JS, 2005, J AM CHEM SOC, V127, P9495, DOI 10.1021/ja0424530; Marques M, 2006, MICROBIOL-SGM, V152, P3595, DOI 10.1099/mic.0.29040-0; Mendoza-Cozatl D, 2005, FEMS MICROBIOL REV, V29, P653, DOI 10.1016/j.femsre.2004.09.004; Michener JK, 2012, P NATL ACAD SCI USA, V109, P19504, DOI 10.1073/pnas.1212287109; Ness F, 1998, J BACTERIOL, V180, P1913, DOI 10.1128/JB.180.7.1913-1919.1998; NIKKILA H, 1991, EUR J BIOCHEM, V202, P309, DOI 10.1111/j.1432-1033.1991.tb16377.x; ORTIZDEMONTELLANO PR, 1978, BIOCHEM BIOPH RES CO, V83, P132; Papinski D, 2016, J MOL BIOL, V428, P1725, DOI 10.1016/j.jmb.2016.03.030; Perez RR, 2013, CURR MICROBIOL, V67, P300, DOI 10.1007/s00284-013-0364-z; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; PIOMELLI S, 1982, P NATL ACAD SCI-BIOL, V79, P3335, DOI 10.1073/pnas.79.10.3335; POUNDS JG, 1984, NEUROTOXICOLOGY, V5, P295; Protchenko O, 2003, J BIOL CHEM, V278, P36582, DOI 10.1074/jbc.M306584200; Protchenko O, 2008, EUKARYOT CELL, V7, P859, DOI 10.1128/EC.00414-07; QIAN ZM, 1990, BIOCHEM PHARMACOL, V40, P1049; Quintanar-Escorza MA, 2010, TOXICOL IN VITRO, V24, P1338, DOI 10.1016/j.tiv.2010.05.002; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Reddi AR, 2007, BIOCHEMISTRY-US, V46, P291, DOI 10.1021/bi061607g; Reddi AR, 2016, ACCOUNTS CHEM RES, V49, P1104, DOI 10.1021/acs.accounts.5b00553; Reddi AR, 2013, CELL, V152, P224, DOI 10.1016/j.cell.2012.11.046; Robinson CR, 1997, BIOCHEMISTRY-US, V36, P16141, DOI 10.1021/bi971470h; Sassa S, 2004, ANTIOXID REDOX SIGN, V6, P819, DOI 10.1089/ars.2004.6.819; Sassa S, 1982, Trans Assoc Am Physicians, V95, P42; Schauder A, 2010, J ENVIRON PATHOL TOX, V29, P137, DOI 10.1615/JEnvironPatholToxicolOncol.v29.i2.70; SCHULZE H, 1978, PLANT PHYSIOL, V62, P727, DOI 10.1104/pp.62.5.727; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Sharma B., 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/640754; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smith AG, 2001, TOXICOL APPL PHARM, V173, P89, DOI 10.1006/taap.2001.9167; Song YQ, 2015, ACS CHEM BIOL, V10, P1610, DOI 10.1021/cb5009734; Sousa CA, 2014, APPL MICROBIOL BIOT, V98, P5153, DOI 10.1007/s00253-014-5631-9; Tu BP, 2007, P NATL ACAD SCI USA, V104, P16886, DOI 10.1073/pnas.0708365104; Tu BP, 2009, P NATL ACAD SCI USA, V106, P14293, DOI 10.1073/pnas.0907786106; URQUHART AJ, 1988, BIOCHEM J, V253, P357, DOI 10.1042/bj2530357; Vallelian F, 2015, CELL DEATH DIFFER, V22, P597, DOI 10.1038/cdd.2014.154; Van der Heggen M, 2010, APPL MICROBIOL BIOT, V88, P1355, DOI 10.1007/s00253-010-2799-5; Wani Ab Latif, 2015, Interdiscip Toxicol, V8, P55, DOI 10.1515/intox-2015-0009; Wysocki R, 2010, FEMS MICROBIOL REV, V34, P925, DOI 10.1111/j.1574-6976.2010.00217.x; Yedjou CG, 2010, INT J ENV RES PUB HE, V7, P2008, DOI 10.3390/ijerph7052008; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442; ZHANG L, 1993, P NATL ACAD SCI USA, V90, P2851, DOI 10.1073/pnas.90.7.2851; Zhang L, 1998, MOL CELL BIOL, V18, P3819, DOI 10.1128/MCB.18.7.3819; Zhang TT, 2017, J BIOL CHEM, V292, P16942, DOI 10.1074/jbc.M117.790923; Zheng G, 2014, TOXICOL LETT, V225, P110, DOI 10.1016/j.toxlet.2013.11.034	84	22	22	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12378	12393		10.1074/jbc.RA118.002125	http://dx.doi.org/10.1074/jbc.RA118.002125			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29921585	hybrid, Green Published			2022-12-26	WOS:000441408500006
J	Matsumura, H; Shinoda, K; Shimanjuntak, T; Oktaviana, AA; Noerwidi, S; Sofian, HO; Prastiningtyas, D; Nguyen, LC; Kakuda, T; Kanzawa-Kiriyama, H; Adachi, N; Hung, HC; Fan, XC; Wu, XJ; Willis, A; Oxenham, MF				Matsumura, Hirofumi; Shinoda, Ken-ichi; Shimanjuntak, Truman; Oktaviana, Adhi Agus; Noerwidi, Sofwan; Sofian, Harry Octavianus; Prastiningtyas, Dyah; Lan Cuong Nguyen; Kakuda, Tsuneo; Kanzawa-Kiriyama, Hideaki; Adachi, Noboru; Hung, Hsiao-Chun; Fan, Xuechun; Wu, Xiujie; Willis, Anna; Oxenham, Marc F.			Cranio-morphometric and aDNA corroboration of the Austronesian dispersal model in ancient Island Southeast Asia: Support from Gua Harimau, Indonesia	PLOS ONE			English	Article							MITOCHONDRIAL-DNA ANALYSIS; LENGTH POLYMORPHISM ANALYSIS; PLEISTOCENE HUMAN SKELETON; HANG-CHO CAVE; JOMON SKELETONS; NUCLEAR-DNA; CONTAMINATION; HYPOTHESIS; HOKKAIDO; ORIGINS	The Austronesian language is spread from Madagascar in the west, Island Southeast Asia (ISEA) in the east (e.g. the Philippines and Indonesian archipelagoes) and throughout the Pacific, as far east as Easter Island. While it seems clear that the remote ancestors of Austronesian speakers originated in Southern China, and migrated to Taiwan with the development of rice farming by c. 5500 BP and onto the northern Philippines by c. 4000 BP (the Austronesian Dispersal Hypothesis or ADH), we know very little about the origins and emergence of Austronesian speakers in the Indonesian Archipelago. Using a combination of cranial morphometric and ancient mtDNA analyses on a new dataset from Gua Hairmau, that spans the pre-Neolithic through to Metal Period (5712-5591cal BP to 1864-1719 cal BP), we rigorously test the validity of the ADH in ISEA. A morphometric analysis of 23 adult male crania, using 16 of Martin's standard measurements, was carried out with results compared to an East and Southeast Asian dataset of 30 sample populations spanning the Late Pleistocene through to Metal Period, in addition to 39 modern samples from East and Southeast Asia, near Oceania and Australia. Further, 20 samples were analyzed for ancient mtDNA and assigned to identified haplogroups. We demonstrate that the archaeological human remains from Gua Harimau cave, Sumatra, Indonesia provide clear evidence for at least two (cranio-morphometrically defined) and perhaps even three (in the context of the ancient mtDNA results) distinct populations from two separate time periods. The results of these analyses provide substantive support for the ADH model in explaining the origins and population history of ISEA peoples.	[Matsumura, Hirofumi] Sapporo Med Univ, Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Shinoda, Ken-ichi; Kanzawa-Kiriyama, Hideaki] Natl Museum Nat & Sci, Dept Anthropol, Tokyo, Japan; [Shimanjuntak, Truman; Prastiningtyas, Dyah] Ctr Prehist & Austronesian Studies, Jakarta, Indonesia; [Oktaviana, Adhi Agus; Noerwidi, Sofwan; Sofian, Harry Octavianus] Natl Res Ctr Archaeol, Jakarta, Indonesia; [Lan Cuong Nguyen] Vietnam Acad Social Sci, Inst Archaeol, Hanoi, Vietnam; [Kakuda, Tsuneo; Adachi, Noboru] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Legal Med, Kofu, Yamanashi, Japan; [Hung, Hsiao-Chun] Australian Natl Univ, Dept Archaeol & Nat Hist, Canberra, ACT, Australia; [Fan, Xuechun] Fujian Museum, Fuzhou, Fujian, Peoples R China; [Wu, Xiujie] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China; [Willis, Anna] James Cook Univ, Coll Arts Soc & Educ, Townsville, Qld, Australia; [Oxenham, Marc F.] Australian Natl Univ, Sch Archeol & Anthropol, Canberra, ACT, Australia	Sapporo Medical University; National Museum of Nature and Science; National Research & Development Centre for Archaeology - Indonesia; University of Yamanashi; Australian National University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; James Cook University; Australian National University	Oxenham, MF (corresponding author), Australian Natl Univ, Sch Archeol & Anthropol, Canberra, ACT, Australia.	marc.oxenham@anyu.edu.au	Sofian, Harry Octavianus/X-2323-2018; Noerwidi, Sofwan/ABH-2778-2021; Oktaviana, Adhi Agus/L-5630-2016; Sofian, Harry Octavianus/AAX-5351-2021	Sofian, Harry Octavianus/0000-0002-5427-4803; Noerwidi, Sofwan/0000-0002-2098-8496; Oktaviana, Adhi Agus/0000-0002-9140-497X; Sofian, Harry Octavianus/0000-0002-5427-4803; Willis, Anna/0000-0002-3265-862X	JSPS KAKENHI [23247040, 16H02527]; Australian Research Council [FT 120100299, DP150104458]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Australian Research Council(Australian Research Council)	This study was supported in part by JSPS KAKENHI Grant No. 23247040 and No. 16H02527 to HM and Australian Research Council Grant No. FT 120100299 to MFO and DP150104458 to HCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in part by JSPS KAKENHI Grant No. No. 23247040 and No. 16H02527 and Australian Research Council Grant number: FT 120100299.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Adachi N, 2004, J ARCHAEOL SCI, V31, P1339, DOI 10.1016/j.jas.2004.02.011; Adachi N, 2011, AM J PHYS ANTHROPOL, V146, P346, DOI 10.1002/ajpa.21561; Adachi N, 2009, AM J PHYS ANTHROPOL, V138, P255, DOI 10.1002/ajpa.20923; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], 2011, ASIAN PERSPECT; [Anonymous], 1976, VIETNAMESE STUDIES, V46, P127; [Anonymous], 2007, PREHISTORY INDO MALA, DOI [DOI 10.26530/OAPEN_459472, 10.22459/PIMA.03.2007, DOI 10.22459/PIMA.03.2007]; [Anonymous], 2006, ASIAN PERSPECT, V45, P129; [Anonymous], 2004, SE ASIA PREHISTORY H; Bayard DT, 1972, NON NOK THA 1968 EXC; Beijing Cultural Relic Institute (BCRI), 2007, JUND BUR GROUNDS; Bellwood P., 2005, PEOPLING E ASIA PUTT, P17; Bellwood P., 2013, ENCY GLOBAL HUMAN MI; Bellwood P, 2017, 1 ISLANDERS PREHISTO; Bellwood P., 1992, ASIAN PERSPECT, V31, P161; Bellwood P., 2005, AUSTRONESIAN STUD, V1, P1, DOI [DOI 10.29884/JAS.200506.0001, 10.29884/JAS.200506.0001]; Bellwood P., 2013, 1 MIGRANTS ANCIENT M; Bellwood P, 2013, HEMUDU CULTURE INT F, P160; Bellwood P, 2008, ROUTLEDGE STUD EARLY, V5, P23; Bellwood Peter S, 2005, 1 FARMERS ORIGINS AG; Blust R, 1996, T AM PHILOS SOC, V86, P117, DOI 10.2307/1006623; Blust R, 1996, T AM PHILOS SOC, V86, P28, DOI 10.2307/1006619; BROTHWELL DR, 1960, SARAWAK MUS J, V9, P323; Buckley H., 2016, ROUTLEDGE HDB BIOARC, P9; Bui P. D, 2001, ARCHAEOLOGY LONG PRO; Capelli C, 2001, AM J HUM GENET, V68, P432, DOI 10.1086/318205; Chen Xingcan, 1999, B INDOPACIFIC PREHIS, V18, P81; Chi Z, 2010, ANTIQUITY, V84, P11, DOI 10.1017/S0003598X00099737; Colani M., 1939, B SOC PREHISTORIQUE, V36; Colani M, 1927, ANTHROPOLOGIE, V37, P227; Colani M., 1927, MEMOIRES SERVICE GEO, VXIV; Cox MP, 2010, P ROYAL SOC B; Cox MP., 2013, ENCY GLOBAL HUMAN MI; Crawford GW, 1998, ANTIQUITY, V72, P858, DOI 10.1017/S0003598X00087494; CUONG N L, 1986, Zeitschrift fuer Morphologie und Anthropologie, V77, P11; Cuong N. L., 2003, KHAO CO HOC, V3, P66; Cuong N. L., 2006, KHAO CO HOC, V6, P39; Dang VT, 1997, J SE ASIAN ARCHAEOL, V17, P30; Debets G. F, 1951, T I ETNOGRAFII, V17, P1; Demeter F, 2012, P NATL ACAD SCI USA, V109, P14375, DOI 10.1073/pnas.1208104109; Derenko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032179; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; [方园 Fang Yuan], 2015, [人类学学报, Acta Anthropologica Sinica], V34, P202; Fujian Provincial Museum, EXC REP MINH BAISH X; Fujian Provincial Museum, 2 EXC REP MINH BAISH; Fujian Provincial Museum Tanishishan Site Museum, 2004, FUJIAN WENBO, V1, P1; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Gilbert MTP, 2003, AM J HUM GENET, V72, P32, DOI 10.1086/345378; GLOVER IC, 1996, ORIGINS SPREAD AGR P, P413; Gorman C. F, 1976, EXPEDITION, V18, P14; HABU J., 2004, ANCIENT JOMON JAPAN; Han KX, 1982, CONTRIBUTIONS STUDY, P50; Hanihara T, 2000, AM J PHYS ANTHROPOL, V111, P105, DOI 10.1002/(SICI)1096-8644(200001)111:1<105::AID-AJPA7>3.0.CO;2-O; HANIHARA T, 1993, ANTHROPOL SCI, V101, P25, DOI 10.1537/ase.101.25; HARRISSON B, 1967, Sarawak Museum Journal, V15, P126; HARRISSON T, 1975, ASIAN PERSPECT, V18, P161; Higham C., 2011, ORIGINS CIVILIZATI 2, V4; Higham C. F. W., 2009, ORIGINS CIVILIZATION, V3; Higham C. F. W., 1993, EXCAVATION KHOK PHAN; Higham CFW, 2012, ORIGINS CIVILIZATI 3, VV; Higham CFW., 2013, ENCY GLOBAL HUMAN MI; HIGHAM CFW, 2001, GENETIC LINGUISTIC A, P3, DOI DOI 10.1142/9789812810847_0001; Higham CFW, 1998, ARCHAEOLOGY LANGUAGE, P103; HIGHAM CHARLES, 2012, ORIGINS CIVILIZATI 4, V6; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; HOWELLS WW, 1989, PAP PEABODY MUS, P79; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; IACAS (Institute of Archaeology Chinese Academy of Social Science) ATGZM (Archaeological Team of the Guangxi Zhuang Municipality) ZM (Zengpiyan Museum) and ATGC (Archaeological Team of Guilin City), 2003, ZENGP PREH SIT GUIL; Institute of History and Institute of Archaeology (IHIA) & Chinese Academy of Social Science (CASS), 1982, CONTR STUD HUM SKULL; Ishida H, 1997, HOMO, V48, P106; Ishida H, 1996, ANTHROPOL SCI, V104, P233, DOI 10.1537/ase.104.233; ISHIDA H, 1990, J ANTHROPOL SOC NIP, V98, P137; Jinam TA, 2012, MOL BIOL EVOL, V29, P3513, DOI 10.1093/molbev/mss169; Kanzawa-Kiriyama H, 2017, J HUM GENET, V62, P213, DOI 10.1038/jhg.2016.110; KENNEDY KAR, 1977, ASIAN PERSPECT, V20, P32; Ko AMS, 2014, AM J HUM GENET, V94, P426, DOI 10.1016/j.ajhg.2014.02.003; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MACINTOSH N W G, 1978, Archaeology and Physical Anthropology in Oceania, V13, P143; Mansuy H., 1925, B SERVICE GEOLOGIQUE, V12, P1; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Masanari N., 2002, B INDOPACIFIC PREHIS, V22, P101; Matsumura H, 2005, HOMO, V56, P93, DOI 10.1016/j.jchb.2005.05.004; Matsumura H, 1999, AM J PHYS ANTHROPOL, V109, P327, DOI 10.1002/(SICI)1096-8644(199907)109:3<327::AID-AJPA4>3.0.CO;2-5; Matsumura H., 2015, EMERGENCE DIVERSITY, P117; Matsumura H, 2014, AM J PHYS ANTHROPOL, V155, P45, DOI 10.1002/ajpa.22537; Matsumura H, 2008, ANTHROPOL SCI, V116, P201, DOI 10.1537/ase.070416; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer M, 2016, NATURE, V531, P504, DOI 10.1038/nature17405; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Nakahashi T, 2002, ANCIENT PEOPLE JIANG; Nakahashi T, 1989, RES YAYOI CULTURE, P23; Nguyen L. C, 1996, ANTHR CHARACTERISTIC; Oxenham MF, ANTIQUITY; Oxenham MF, 2011, EXCAVATION NEOLITHIC; Peng MS, 2010, MOL BIOL EVOL, V27, P2417, DOI 10.1093/molbev/msq131; Pietrusewsky M, 2003, ANTHROPOL SCI, V111, P293, DOI 10.1537/ase.111.293; PIETRUSEWSKY M, 1981, HOMO, V32, P1; Pietrusewsky M., 2002, BAN CHIANG PREHISTOR; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Renaud G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0776-0; RENFREW C, 1989, T PHILOL SOC, V87, P103, DOI 10.1111/j.1467-968X.1989.tb00622.x; Renfrew C., 1992, TRANSITION MODERNITY, P11; Renfrew C., 1990, ARCHAEOLOGY LANGUAGE; Renfrew Cohn, 2002, EXAMINING FARMING LA; Ricaut FX, 2006, AM J HUM BIOL, V18, P654, DOI 10.1002/ajhb.20535; Sagart L, 2008, ROUTLEDGE STUD EARLY, V5, P133; Sangvichien S, 1971, THESIS; Schubert Mikkel, 2016, BMC Res Notes, V9, P88, DOI 10.1186/s13104-016-1900-2; Shinoda K, 2006, AM J PHYS ANTHROPOL, V131, P98, DOI 10.1002/ajpa.20408; Shinoda K, 2017, TERRA AUSTRALIS, V45, P51; Sieveking G., 1954, FED MUS J, V1, P75; Simanjuntak HT, 2016, GUA HARIMAU CAVE LON; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; SUZUKI H, 1993, ANTHROPOL SCI, V101, P111, DOI 10.1537/ase.101.111; Tabbada KA, 2010, MOL BIOL EVOL, V27, P21, DOI 10.1093/molbev/msp215; Tayles N., 1999, EXCAVATION KHOK PHAN, V5; Thuy NK, 1990, KHAO CO HOC, V3, P37; Trevor JC, 1962, FEDERATION MUSEUMS J, V7, P6; Umetsu K, 2001, ELECTROPHORESIS, V22, P3533, DOI 10.1002/1522-2683(200109)22:16<3533::AID-ELPS3533>3.0.CO;2-S; Umetsu K, 2005, ELECTROPHORESIS, V26, P91, DOI 10.1002/elps.200406129; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW58, DOI 10.1093/nar/gkw233; White J.C., 2011, DYNAMICS HUMAN DIVER, P9; WOO J. K., 1959, VERTEBR PALASIAT [CHINA], V3, P109; WOODWARD SR, 1994, PCR METH APPL, V3, P244; Wu X, 2015, ACTA ANTHR SIN, V33, P448; Yamagata M, 2012, EXCAVATION HOA DIEM; Yi S, 2008, BULL INDO PAC PRE HI, V28, P73; Zhang C, 2013, ENCY GLOBAL HUMAN MI; Zhejiang Cultural Relics Archaeological Research Institute (ZCARI), 2003, HEM REP EXC NEOL SET	133	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0198689	10.1371/journal.pone.0198689	http://dx.doi.org/10.1371/journal.pone.0198689			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK3VI	29933384	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000436076600013
J	Butorac, L; Hancevic, K; Luksic, K; Skvorc, Z; Leko, M; Maul, E; Zdunic, G				Butorac, Lukrecija; Hancevic, Katarina; Luksic, Katarina; Skvorc, Zeljko; Leko, Mario; Maul, Erika; Zdunic, Goran			Assessment of wild grapevine (Vitis vinifera ssp sylvestris) chlorotypes and accompanying woody species in the Eastern Adriatic region	PLOS ONE			English	Article							GENETIC DIVERSITY; POPULATIONS; CONSERVATION; EVOLUTION; ORIGINS	The Eastern Adriatic region, encompassing Croatia and Bosnia and Herzegovina, is considered an important area of natural populations of wild grapevines (Vitis vinifera ssp. sylvestris). The wild grapevine arises in the Eastern Adriatic region in a contact zone of the EU-Mediterranean and the sub-Mediterranean characterized by typical karst relief. This study focuses on the chloroplast DNA (cpDNA) analysis of wild grapevines and the biodiversity of accompanying woody species to better understand the genetic variation of the sylvestris populations of the Eastern Adriatic region and to investigate how this variation fits within today's wild grapevine distribution in the European continent. The allelic variation at nine cpDNA microsatellite loci of wild individuals was used to characterize haplotype diversity in 53 individuals from four population sites. All individuals were grouped into two chlorotypes: A and D, D being the rare haplotype among wild populations on the European continent. In total, 52 woody plant species were identified. However, the studied vegetation structures have been affected by permanent human pressure on natural resources and the preservation status of the collection sites. Based on our results, we conclude that the investigated areas were probably shelter zones for wild grapevine preservation during the unfavorable glaciation era.	[Butorac, Lukrecija; Hancevic, Katarina; Luksic, Katarina; Zdunic, Goran] Inst Adriat Crops & Karst Reclamat, Split, Croatia; [Skvorc, Zeljko] Univ Zagreb, Fac Forestry, Zagreb, Croatia; [Leko, Mario] Fed Agromediterranean Inst, Mostar, Bosnia & Herceg; [Maul, Erika] JKI, Fed Res Ctr Cultivated Plants, Inst Grapevine Breeding, Siebeldingen, Germany	Institute for Adriatic Crops and Karst Reclamation Split; University of Zagreb	Zdunic, G (corresponding author), Inst Adriat Crops & Karst Reclamat, Split, Croatia.	goran.zdunic@krs.hr	Mucalo, Ana/AAA-7745-2021	Luksic, Katarina/0000-0002-3485-8705	Croatian Science Foundation [UIP-2014-09-9737]	Croatian Science Foundation	This work was funded by the Croatian Science Foundation (URL: http://www.hrzz.hr/default.aspx?id=47) within the project: The wild grapevine Vitis vinifera subsp. sylvestris: a valuable source of genes for grape breeding (Leader. Dr. Goran Zdunic; Grant agreement No UIP-2014-09-9737). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold C, 1998, VITIS, V41, P59; Arnold C., 2002, GEOBOTANICA HELVETIC; Garcia RAA, 2013, MEDITERRANEAN GENETIC CODE - GRAPEVINE AND OLIVE, P51, DOI 10.5772/52933; Arroyo-Garcia R, 2006, MOL ECOL, V15, P3707, DOI 10.1111/j.1365-294X.2006.03049.x; Biscotti N, 2015, INF BOT ITAL, V4, P179; Cambrolle J, 2015, PLANT SOIL, V396, P97, DOI 10.1007/s11104-015-2576-4; Cambrolle J, 2014, ENVIRON EXP BOT, V105, P25, DOI 10.1016/j.envexpbot.2014.04.004; Cantos M, 2017, CR BIOL, V340, P164, DOI 10.1016/j.crvi.2017.01.004; De Andres MT, 2012, MOL ECOL, V21, P800, DOI 10.1111/j.1365-294X.2011.05395.x; De Mattia F, 2008, REND LINCEI-SCI FIS, V19, P223, DOI 10.1007/s12210-008-0016-6; Di Vecchi-Staraz M, 2009, J HERED, V100, P66, DOI 10.1093/jhered/esn084; Ellenberg H., 1992, SCRIPTA GEOBOT, V18, P1, DOI DOI 10.1002/FEDR.19931040323; Euro + Med, 2006, EURO MED PLANTBASE I; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; GAMS I, 1991, QUADERNI DEL DIPARTIMENTO DI GEOGRAFIA, UNIVERSITA DEGLI STUDI DI PADOVA, 13, P1; Gams I., 1999, INT J SPELEOL, V28, P55, DOI DOI 10.5038/1827-806X.28.1.4; Grassi F, 2006, CONSERV GENET, V7, P837, DOI 10.1007/s10592-006-9118-9; Grassi F, 2003, THEOR APPL GENET, V107, P1315, DOI 10.1007/s00122-003-1321-1; Grassi F, 2002, VITIS, V41, P157; Grassi F, 2008, BIOL J LINN SOC, V95, P611, DOI 10.1111/j.1095-8312.2008.01081.x; Guarino R., 2012, Flora Mediterranea, V22, P197, DOI 10.7320/FlMedit22.197; Horvat A., 1957, KRS HRVATSKE DRUS TV, P185; Imazio S, 2006, GENET RESOUR CROP EV, V53, P1003, DOI 10.1007/s10722-004-6896-0; Karatas DD, 2014, HEREDITAS, V151, P73, DOI 10.1111/hrd2.00039; Klepac D., 1998, HRVATSKO SUMARSTVO 1, P9; Lopes MS, 2009, GENOME, V52, P790, DOI [10.1139/g09-048, 10.1139/G09-048]; McGovern PE, 2003, ANCIENT WINE SEARCH; Ocete R, 2015, VITIS, V54, P207; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pignatti S., 2005, BIONDICAZIONE ATTRAV; R Core Team, 2021, R LANGUAGE ENV STAT; Schneider A, 2015, VITIS, V54, P223; Sikora M, 2014, ACTA ADRIAT, V55, P3; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; Trondle D, 2010, AM J BOT, V97, P1168, DOI 10.3732/ajb.0900218; Weising K, 1999, GENOME, V42, P9, DOI 10.1139/gen-42-1-9; WILLIS KJ, 1994, QUATERNARY SCI REV, V13, P769, DOI 10.1016/0277-3791(94)90104-X; Zdunic G, 2017, AM J ENOL VITICULT, V68, P252, DOI 10.5344/ajev.2016.16072; Zecca G, 2012, MOL PHYLOGENET EVOL, V62, P736, DOI 10.1016/j.ympev.2011.11.015; Zoghlami N, 2013, FOREST ECOL MANAG, V310, P896, DOI 10.1016/j.foreco.2013.09.039	41	7	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199495	10.1371/journal.pone.0199495	http://dx.doi.org/10.1371/journal.pone.0199495			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928046	Green Submitted, Green Published, gold			2022-12-26	WOS:000435802500100
J	Wong, CC; Lim, SH; Tan, CT; Lui, SY; Lee, YL; Chan, KP				Wong, Chui Ching; Lim, Siew Hoon; Tan, Chai Teng; Lui, Sook Yin; Lee, Yee Leng; Chan, Kwai Peng			Performance of the HIV Blot 2.2, INNO-LIA HIV I/II Score, and Geenius HIV 1/2 Confirmatory Assay for use in HIV confirmation	PLOS ONE			English	Article							HIV-1/HIV-2 RAPID TEST; WESTERN-BLOT; IMMUNOASSAY; INFECTION; AGREEMENT	In view of recent revised recommendations for human immunodeficiency virus (HIV) confirmatory testing, the performance of 3 HIV confirmatory assays was compared. Using the HIV Blot 2.2 (MP-WB), the INNO-LIA HIV I/II Score (INNO), and the Geenius HIV 1/2 Confirmatory Assay (Geenius), we tested 199 HIV-1 positive, 161 HIV negative, 65 HIV western blot indeterminate, 26 HIV seroconversion, 34 early HIV infection and 4 HIV-2 positive archived specimens. We show that all 3 assays had comparable test sensitivity in the detection of HIV-1 positive cases. However, less non-specific reactivity was observed with the INNO and Geenius assays, where both of them were able to resolve MP-WB indeterminate cases. When early HIV cases were considered, INNO and Geenius were more likely to confirm an early-stage infection as positive. Nevertheless, overall poor sensitivity (25.5% - 44.7%) of these assays for the detection of early cases was observed, likely because these cases had very low or non-detectable levels of HIV antibodies. Hence, further testing by a nucleic acid test or a p24 antigen test of specimens reactive on screening with a fourth generation Ag/Ab assay that are negative on confirmatory testing for HIV-specific antibody, may be useful. In conclusion, INNO and Geenius had comparable test performance, although the ease of use and shorter assay time for Geenius may make it the preferred choice for laboratories. In that regard, of note is our observation of non-specific reactivity of lipaemic specimens to the HIV 2 gp140 band in the Geenius assay, which should prompt caution when interpreting results of such specimens.	[Wong, Chui Ching; Lim, Siew Hoon; Tan, Chai Teng; Lui, Sook Yin; Lee, Yee Leng; Chan, Kwai Peng] Singapore Gen Hosp, Dept Microbiol, Div Pathol, HIV Reference Lab,Virol Lab, Singapore, Singapore; [Chan, Kwai Peng] Duke NUS Med Sch, Singapore, Singapore; [Lui, Sook Yin] Mt Alvernia Hosp, Singapore, Singapore; [Lee, Yee Leng] Minist Hlth, Biosafety Branch, Singapore, Singapore	Singapore General Hospital; National University of Singapore; Ministry of Health-Singapore	Chan, KP (corresponding author), Singapore Gen Hosp, Dept Microbiol, Div Pathol, HIV Reference Lab,Virol Lab, Singapore, Singapore.; Chan, KP (corresponding author), Duke NUS Med Sch, Singapore, Singapore.	chan.kwai.peng@singhealth.com.sg		Wong, Judith Chui Ching/0000-0002-2061-4486				Australasian Society for HIV, 2015, VIR HEP SEX HLTH MED; Camacho RJ, 2012, INTERVIROLOGY, V55, P179, DOI 10.1159/000332025; CDC, 2014, LAB TEST DIAGN HIV I; Centers for Disease Control and Prevention, 2017, SUGG REP LANG HIV LA; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Fleiss JL, 2004, STAT METHODS RATES P, P598, DOI DOI 10.1002/0471445428.CH18; Herssens N, 2014, J VIROL METHODS, V208, P11, DOI 10.1016/j.jviromet.2014.07.025; Kfutwah A, 2013, J CLIN VIROL, V58, pE70, DOI 10.1016/j.jcv.2013.08.015; Manlutac ALM, 2013, J CLIN VIROL, V58, pE44, DOI 10.1016/j.jcv.2013.08.031; Ministry of Health Singapore, 2017, UPD HIV AIDS SIT SIN; Montesinos I, 2014, J CLIN VIROL, V60, P399, DOI 10.1016/j.jcv.2014.04.025; Moon HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139169; Mor O, 2014, J CLIN MICROBIOL, V52, P2677, DOI 10.1128/JCM.01184-14; Nasrullah M, 2011, J CLIN VIROL, V52, pS23, DOI 10.1016/j.jcv.2011.09.020; Public Health England, 2017, UK STAND MICR INV HI; Ramos EM, 2013, J CLIN VIROL, V58, pE104, DOI 10.1016/j.jcv.2013.08.018; The Public Health Laboratory Network, 2016, HIV LAB CAS DEF; Tinguely C, 2014, J VIROL METHODS, V206, P1, DOI 10.1016/j.jviromet.2014.05.010; Torian LV, 2010, CLIN INFECT DIS, V51, P1334, DOI 10.1086/657117; Tuaillon E, 2017, J CLIN VIROL, V95, P47, DOI 10.1016/j.jcv.2017.08.003; Viera AJ, 2005, FAM MED, V37, P360; WHO, 2015, CONSOLIDATED GUIDELI; *WHO, 2007, GUID PROV INT HIV TE	23	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199502	10.1371/journal.pone.0199502	http://dx.doi.org/10.1371/journal.pone.0199502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928045	Green Submitted, gold, Green Published			2022-12-26	WOS:000435802500101
J	Kuo, C; Wu, L; Loza, J; Senif, D; Anderson, SC; Camarillo, DB				Kuo, Calvin; Wu, Lyndia; Loza, Jesus; Senif, Daniel; Anderson, Scott C.; Camarillo, David B.			Comparison of video-based and sensor-based head impact exposure	PLOS ONE			English	Article							SPORT-RELATED CONCUSSION; FOOTBALL PLAYERS; IN-VIVO; MOUTHGUARD; MANAGEMENT; KINEMATICS; DEVICE; SYSTEM	Previous research has sought to quantify head impact exposure using wearable kinematic sensors. However, many sensors suffer from poor accuracy in estimating impact kinematics and count, motivating the need for additional independent impact exposure quantification for comparison. Here, we equipped seven collegiate American football players with instrumented mouthguards, and video recorded practices and games to compare video-based and sensor-based exposure rates and impact location distributions. Over 50 player-hours, we identified 271 helmet contact periods in video, while the instrumented mouthguard sensor recorded 2,032 discrete head impacts. Matching video and mouthguard real-time stamps yielded 193 video-identified helmet contact periods and 217 sensor-recorded impacts. To compare impact locations, we binned matched impacts into frontal, rear, side, oblique, and top locations based on video observations and sensor kinematics. While both video-based and sensor-based methods found similar location distributions, our best method utilizing integrated linear and angular position only correctly predicted 81 of 217 impacts. Finally, based on the activity timeline from video assessment, we also developed a new exposure metric unique to American football quantifying number of cross-verified sensor impacts per player-play. We found significantly higher exposure during games (0.35, 95% CI: 0.29 - 0.42) than practices (0.20, 95% CI: 0.17 - 0.23) (p<0.05). In the traditional impacts per player-hour metric, we observed higher exposure during practices (4.7) than games (3.7) due to increased player activity in practices. Thus, our exposure metric accounts for variability in on-field participation. While both video-based and sensor-based exposure datasets have limitations, they can complement one another to provide more confidence in exposure statistics.	[Kuo, Calvin; Loza, Jesus; Camarillo, David B.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Wu, Lyndia; Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Senif, Daniel; Anderson, Scott C.] Stanford Univ, Stanford Sports Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Kuo, C (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.	calvink@stanford.edu	Wu, Lyndia/AAQ-1106-2020; Kuo, Calvin/AAH-1933-2019	Wu, Lyndia/0000-0002-8236-032X; Kuo, Calvin/0000-0001-8401-9136; Camarillo, David/0000-0003-4965-2977	National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering (NIBIB) [3R21EB01761101S1]; Stanford Child Health Research Institute Transdisciplinary Initiatives Program; Stanford Bio-X Graduate Research Fellowship Program	National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Stanford Child Health Research Institute Transdisciplinary Initiatives Program; Stanford Bio-X Graduate Research Fellowship Program	This study was supported by the National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering (NIBIB) 3R21EB01761101S1, the Stanford Child Health Research Institute Transdisciplinary Initiatives Program, and the Stanford Bio-X Graduate Research Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barris S, 2008, SPORTS MED, V38, P1025, DOI 10.2165/00007256-200838120-00006; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Group BD and TCW, 2018, TRAUM BRAIN INJ COMM; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Higgins M, 2015, CLIN J SPORT MED, V25, P201; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/0363546506293899; Kuo C, 2016, J BIOMECH; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Li BX, 2001, IEEE WORKSHOP ON CONTENT-BASED ACCESS OF IMAGE AND VIDEO LIBRARIES, PROCEEDINGS, P132, DOI 10.1109/IVL.2001.990867; Makdissi M, 2016, J SCI MED SPORT, V19, P958, DOI 10.1016/j.jsams.2016.02.014; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2014, AM SOC TEST MATER, V1552, P41, DOI 10.1520/STP155220120108; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; SAE, 1995, SAE HDB, V384-392; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Wu LC, 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Wu LC, 2014, IEEE T BIO-MED ENG, V61, P2659, DOI 10.1109/TBME.2014.2320153; Xing JL, 2011, IEEE T IMAGE PROCESS, V20, P1652, DOI 10.1109/TIP.2010.2102045	44	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199238	10.1371/journal.pone.0199238	http://dx.doi.org/10.1371/journal.pone.0199238			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920559	Green Published, gold			2022-12-26	WOS:000435541300028
J	Park, M; Hong, SG; Park, H; Lee, BH; Lee, H				Park, Mira; Hong, Soon Gyu; Park, Hyun; Lee, Byeong-ha; Lee, Hyoungseok			Identification of reference genes for RT-qPCR in the Antarctic moss Sanionia uncinata under abiotic stress conditions	PLOS ONE			English	Article							REAL-TIME PCR; CANDIDATE REFERENCE GENES; SUPERIOR REFERENCE GENES; TRANSCRIPT NORMALIZATION; HOUSEKEEPING GENES; EXPRESSION; RESPONSES; PATTERNS; ARABIDOPSIS; VALIDATION	Sanionia uncinata is a dominant moss species in the maritime Antarctic. Due to its high adaptability to harsh environments, this extremophile plant has been considered a good target for studying the molecular adaptation mechanisms of plants to a variety of environmental stresses. Despite the importance of S. uncinata as a representative Antarctic plant species for the identification and characterization of genes associated with abiotic stress tolerance, suitable reference genes, which are critical for RT-qPCR analyses, have not yet been identified. In this report, 11 traditionally used and 6 novel candidate reference genes were selected from transcriptome data of S. uncinata and the expression stability of these genes was evaluated under various abiotic stress conditions using three statistical algorithms; geNorm, NormFinder, and BestKeeper. The stability ranking analysis selected the best reference genes depending on the stress conditions. Among the 17 candidates, the most stable references were POB1 and UFD2 for cold stress, POB1 and AKB for drought treatment, and UFD2 and AKB for the field samples from a different water contents in Antarctica. Overall, novel genes POB1 and AKB were the most reliable references across all samples, irrespective of experimental conditions. In addition, 6 novel candidate genes including AKB, POB1 and UFD2, were more stable than the housekeeping genes traditionally used for internal controls, indicating that transcriptome data can be useful for identifying novel robust normalizers. The reference genes validated in this study will be useful for improving the accuracy of RT-qPCR analysis for gene expression studies of S. uncinata in Antarctica and for further functional genomic analysis of bryophytes.	[Park, Mira; Park, Hyun; Lee, Hyoungseok] Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea; [Park, Mira; Lee, Byeong-ha] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Hong, Soon Gyu] Korea Polar Res Inst, Div Life Sci, Incheon, South Korea; [Hong, Soon Gyu; Park, Hyun; Lee, Hyoungseok] Univ Sci &Technol, Polar Sci, Daejeon, South Korea	Korea Polar Research Institute (KOPRI); Sogang University; Korea Polar Research Institute (KOPRI); University of Science & Technology (UST)	Lee, H (corresponding author), Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea.; Lee, BH (corresponding author), Sogang Univ, Dept Life Sci, Seoul, South Korea.; Lee, H (corresponding author), Univ Sci &Technol, Polar Sci, Daejeon, South Korea.	byeongha@sogang.ac.kr; soulaid@kopri.re.kr	Lee, Byeong-ha/B-8478-2009	Lee, Byeong-ha/0000-0001-7633-3264; Lee, Hyoungseok/0000-0002-5831-6345	'Modeling responses of terrestrial organisms to environmental changes on King George Island' [PE18090]; Korea Polar Research Institute [PE18080]; Rural Development Administration, South Korea [PJ01330101]	'Modeling responses of terrestrial organisms to environmental changes on King George Island'; Korea Polar Research Institute(Korea Polar Research Institute of Marine Research Placement (KOPRI)); Rural Development Administration, South Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by grants 'Modeling responses of terrestrial organisms to environmental changes on King George Island' (PE18090) to SGH, 'The Polar Genomics 101 Project: Genome analysis of polar organisms and establishment of application platform' (PE18080) to HP, funded by the Korea Polar Research Institute, and 'Next-Generation BioGreen21 Program' (PJ01330101) to BhL, funded by the Rural Development Administration, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Boava Leonardo P, 2010, BMC Res Notes, V3, P43, DOI 10.1186/1756-0500-3-43; Borowski JM, 2014, PLANTA, V239, P1187, DOI 10.1007/s00425-014-2041-2; Bramley-Alves J, 2014, ADV PHOTOSYNTH RESP, V37, P309, DOI 10.1007/978-94-007-6988-5_17; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Gonzalez-Aguero M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-878; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Hokkanen PJ, 2006, FOREST ECOL MANAG, V229, P73, DOI 10.1016/j.foreco.2006.03.025; Hong SM, 2010, PLANT CELL PHYSIOL, V51, P1694, DOI 10.1093/pcp/pcq128; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kushnevskaya H, 2007, FOREST ECOL MANAG, V250, P25, DOI 10.1016/j.foreco.2007.03.006; Le Bail A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070998; Lenne T, 2010, PLANT CELL ENVIRON, V33, P1731, DOI 10.1111/j.1365-3040.2010.02178.x; Li WG, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00729; Li XS, 2012, INT J MOL SCI, V13, P6944, DOI 10.3390/ijms13066944; Li XS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00038; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; MELICK DR, 1994, BRYOLOGIST, V97, P13, DOI 10.2307/3243343; Moura Jullyana Cristina Magalhaes Silva, 2012, BMC Res Notes, V5, P634, DOI 10.1186/1756-0500-5-634; Nakatsubo T, 2002, J PLANT RES, V115, P99, DOI 10.1007/s102650200014; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Saint-Marcoux D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118678; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Smith Ronald I. Lewis, 1996, Antarctic Research Series, V70, P15; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ueno T, 2006, J BRYOL, V28, P345, DOI 10.1179/174328206X152270; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Virtanen RJ, 1997, POLAR BIOL, V17, P95, DOI 10.1007/s003000050111; Wang H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171646; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Xiao XL, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00788; Zuniga-Gonzalez P, 2016, BIOL RES, V49, DOI 10.1186/s40659-015-0058-z	39	4	4	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199356	10.1371/journal.pone.0199356	http://dx.doi.org/10.1371/journal.pone.0199356			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920565	gold, Green Submitted, Green Published			2022-12-26	WOS:000435541300038
J	Olejniczak, P; Czarnoleski, M; Delimat, A; Majcher, BM; Szczepka, K				Olejniczak, Pawel; Czarnoleski, Marcin; Delimat, Anna; Majcher, Bartosz Marek; Szczepka, Kamil			Seed size in mountain herbaceous plants changes with elevation in a species-specific manner	PLOS ONE			English	Article							GEOGRAPHIC-VARIATION; MASS; ALTITUDE; GERMINATION; NUMBER; GROWTH; POLYMORPHISM; RECRUITMENT; POPULATIONS; SURVIVAL	Research devoted to investigating the relationship between elevation and seed size in alpine plants gives contradictory results. Some studies document a positive correlation between seed size and elevation, whereas in others a negative correlation is reported. We propose a novel approach to the problem by looking at the whole strategy of seed production, including seed number, and by focusing on a range of environmental variables. In the Tatra Mountains (southern Poland), we selected 73 sites at which seeds of six widely occurring mountain herbaceous species were collected. Each site was characterized by 13 parameters that included climatic and physicochemical soil variables. For each parameter, residuals from a linear regression against elevation were calculated and the residuals were used in a factor analysis. The obtained factors, together with elevation, were used as independent variables in a multiple regression analysis. Elevation affected seed size in four species: in two species the correlation was positive, and in two others it was negative. In three species seed number was related to elevation, and the correlation was negative in all cases. Our results indicate that elevation-dependence of seed production is specific to the species and reflects different resource allocation strategies. Diverse correlations of plant characteristics with elevation may also result from area-specific patterns, because different mountain ranges may exhibit different correlations between elevation and environmental factors. Only by attaining a reproductive allocation perspective and thorough assessment of environmental factors, a full understanding of elevational variation in seed size is possible.	[Olejniczak, Pawel; Delimat, Anna] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland; [Czarnoleski, Marcin; Majcher, Bartosz Marek] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland; [Szczepka, Kamil] Pedag Univ Cracow, Dept Bot, Krakow, Poland	Polish Academy of Sciences; Jagiellonian University; Pedagogical University of Cracow	Olejniczak, P (corresponding author), Polish Acad Sci, Inst Nat Conservat, Krakow, Poland.	olejniczak@iop.krakow.pl	Czarnoleski, Marcin/H-2893-2015; Majcher, Bartosz Marek/ABE-8315-2021	Czarnoleski, Marcin/0000-0003-2645-0360; Olejniczak, Pawel/0000-0002-6269-6811; Majcher, Bartosz/0000-0002-5679-3340	National Science Centre, Poland [N N304 3092 40]	National Science Centre, Poland(National Science Centre, Poland)	The study was supported by the National Science Centre, Poland, grant N N304 3092 40.; This study was supported by the National Science Centre, Poland, grant N N304 3092 40. We would like to express our thanks to Andrzej Antol, Magdalena Gasienica-Staszeczek, Patrycja Gibas, Pawel Dudzik, Filip Kapustka, Dominika Kustosz, Sara and Jan Olejniczak, Ewa Samulak, Mateusz Sobczyk, and to students doing their internship at the Centre for Research and Conservation of Mountain Plants in Zakopane for their assistance in the data collection and analysis. We are also grateful to the anonymous reviewers for helpful comments on the manuscript.	Bing HJ, 2016, J SOIL SEDIMENT, V16, P405, DOI 10.1007/s11368-015-1200-9; Boulli A, 2001, EUPHYTICA, V119, P309, DOI 10.1023/A:1017571904517; Bu HY, 2007, PLANT ECOL, V191, P127, DOI 10.1007/s11258-006-9221-5; Coomes DA, 2003, TRENDS ECOL EVOL, V18, P283, DOI 10.1016/S0169-5347(03)00072-7; Czarnoleski M, 2010, EVOL ECOL RES, V12, P769; Dalling JW, 2002, J ECOL, V90, P557, DOI 10.1046/j.1365-2745.2002.00695.x; Dolezal J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24881; Dori T, 2016, ECOL RES, V31, P417; Eriksson O, 2005, OECOLOGIA, V144, P98, DOI 10.1007/s00442-005-0001-z; GERITZ SAH, 1995, AM NAT, V146, P685, DOI 10.1086/285820; Guo H, 2010, J ECOL, V98, P1232, DOI 10.1111/j.1365-2745.2010.01688.x; He X., 2016, SCI REP, V6, P1, DOI DOI 10.1038/S41598-016-0001-8; Hnilickova H, 2016, PLANT SOIL ENVIRON, V62, P341, DOI 10.17221/116/2016-PSE; Hofmann K, 2016, MICROB ECOL, V72, P704, DOI 10.1007/s00248-016-0803-z; IBM, 2016, IBM SPSS STAT WINDOW; Jakobsson A, 2000, OIKOS, V88, P494, DOI 10.1034/j.1600-0706.2000.880304.x; Kichenin E, 2013, FUNCT ECOL, V27, P1254, DOI 10.1111/1365-2435.12116; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Leishman M. R., 2000, SEEDS ECOLOGY REGENE, P31, DOI [DOI 10.1126/science.1156831, DOI 10.1079/9780851994321.0031]; MAZER SJ, 1990, EVOL ECOL, V4, P326, DOI 10.1007/BF02270931; Moles AT, 2006, OIKOS, V113, P91, DOI 10.1111/j.0030-1299.2006.14194.x; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Norden N, 2009, FUNCT ECOL, V23, P203, DOI 10.1111/j.1365-2435.2008.01477.x; Pluess AR, 2005, OECOLOGIA, V144, P55, DOI 10.1007/s00442-005-0047-y; Qi W, 2015, PLANT ECOL, V216, P283, DOI 10.1007/s11258-014-0435-7; READER RJ, 1993, J ECOL, V81, P169, DOI 10.2307/2261232; Rees M, 1997, OIKOS, V78, P116, DOI 10.2307/3545807; Schramm BW, 2015, BIOTECHNIQUES, V59, P99, DOI 10.2144/000114316; Shaukat SS, 1999, PAK J BOT, V31, P253; SILVERTOWN J, 1989, TRENDS ECOL EVOL, V4, P24, DOI 10.1016/0169-5347(89)90013-X; Simons AM, 2000, AM J BOT, V87, P124, DOI 10.2307/2656690; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stearns S.C., 1992, pi; THOMPSON K, 1987, NEW PHYTOL, V106, P23; Turnbull LA, 2008, ECOLOGY, V89, P1352, DOI 10.1890/07-1531.1; VENABLE DL, 1988, AM NAT, V131, P360, DOI 10.1086/284795; Wang YJ, 2014, ECOL EVOL, V4, P1913, DOI 10.1002/ece3.1067	37	16	17	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199224	10.1371/journal.pone.0199224	http://dx.doi.org/10.1371/journal.pone.0199224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912939	Green Published, gold, Green Submitted			2022-12-26	WOS:000435528600093
J	Adimonye, A; Stankiewicz, E; La-Touche, S; Kudahetti, S; Trevisan, G; Tinwell, B; Corbishley, C; Lu, YJ; Watkin, N; Berney, D				Adimonye, Anthony; Stankiewicz, Elzbieta; La-Touche, Susannah; Kudahetti, Sakunthala; Trevisan, Giorgia; Tinwell, Brendan; Corbishley, Cathy; Lu, Yong-Jie; Watkin, Nick; Berney, Daniel			PIK3CA copy number aberration and activation of the PI3K-AKT-mTOR pathway in varied disease states of penile cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; NUCLEAR/CYTOPLASMIC LOCALIZATION; EXPRESSION; MTOR; THERAPY; GAIN; 3Q	Background Therapeutic targeting of the PI3K-AKT-mTOR pathway may benefit patients with advanced penile squamous cell carcinoma (PSCC). Objectives To determine the prevalence of PIK3CA copy number gain and correlate this with the activity status of PI3K-AKT-mTOR pathway in pre-malignant penile intraepithelial neoplasia (PeIN) and invasive PSCC. Materials and methods Archival tissue blocks were obtained from 58 PeIN and 244 primary PSCC patients treated at St George's Hospital. PIK3CA copy number status (CNS) was assessed by fluorescence in-situ hybridisation. High-risk HPV DNA was detected with INNO-LiPA assay. p16(INK4A), p_ AKT and p-mTOR protein expression were assessed using immunohistochemistry (IHC). Results Increased prevalence of PIK3CA copy number gain was seen in PSCC in comparison to PeIN (84/199 (42%) vs. 10/58 (17%); p = 0.0009). Analysis of the p-AKT and p-mTOR revealed a tendency to a more common expression of cytoplasmic p-AKT (p = 0.1318), nuclear p-AKT (p<0.0001) and cytoplasmic mTOR (p = 0.0006) in PeIN than PSCC. A significant association between p-AKT cytoplasmic immunoexpression and PIK3CA CNS (p = 0.0404) was found in PeIN. Conclusion Overall, PIK3CA copy number gain correlated with activation of the PI3K-AKT-mTOR pathway in PeIN and activation of this pathway is primarily involved in early penile carcinogenesis. Based on these results therapeutic targeting of this pathway in advanced PSCC is unlikely to produce significant clinical benefit. Future studies will need to focus on alternative therapeutic targets.	[Adimonye, Anthony; Stankiewicz, Elzbieta; La-Touche, Susannah; Kudahetti, Sakunthala; Lu, Yong-Jie; Berney, Daniel] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Mol Oncol, Barts Canc Inst, London, England; [Trevisan, Giorgia] Barts Hlth NHS Trust, Royal London Hosp, Dept Histopathol, London, England; [Tinwell, Brendan; Corbishley, Cathy] St George Hosp, Dept Cellular Pathol, London, England; [Watkin, Nick] St George Hosp, Dept Urol, London, England	University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital; St Georges University London; St Georges University London	Adimonye, A (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Mol Oncol, Barts Canc Inst, London, England.	anthony247@doctors.org.uk		Stankiewicz, Elzbieta/0000-0003-0812-4086	Orchid; Barts Charity	Orchid; Barts Charity	This work was supported and funded by Orchid (www.orchid-cancer.org.uk) and Barts Charity to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Orchid (www.orchid-cancer.org.uk) and Barts Charity.	Ali SM, 2016, ONCOLOGIST, V21, P33, DOI 10.1634/theoncologist.2015-0241; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Busso-Lopes AF, 2015, CANCER RES, V8, P149; Chaux A, 2014, HISTOPATHOLOGY, V64, P863, DOI 10.1111/his.12338; Chaux A, 2010, UROLOGY, V76, pS7, DOI 10.1016/j.urology.2010.02.038; Christodoulidou M, 2015, CURR PROB CANCER, V39, P126, DOI 10.1016/j.currproblcancer.2015.03.010; Ferguson LR, 2015, SEMIN CANCER BIOL, V35, pS5, DOI 10.1016/j.semcancer.2015.03.005; Ferrandiz-Pulido C, 2015, GENES CHROMOSOMES CA; Ferrandiz-Pulido C, 2013, J UROLOGY, V190, P2288, DOI 10.1016/j.juro.2013.06.015; Ferrandiz-Pulido C, 2013, J AM ACAD DERMATOL, V68, P73, DOI 10.1016/j.jaad.2012.05.029; Guimaraes GC, 2011, CURR ONCOL REP, V13, P231, DOI 10.1007/s11912-011-0163-2; Hakenberg OW, 2015, EUR UROL, V67, P142, DOI 10.1016/j.eururo.2014.10.017; Heselmeyer K, 1997, GENE CHROMOSOME CANC, V19, P233, DOI 10.1002/(SICI)1098-2264(199708)19:4<233::AID-GCC5>3.0.CO;2-Y; Heselmeyer K, 1996, P NATL ACAD SCI USA, V93, P479, DOI 10.1073/pnas.93.1.479; Kim TJ, 2006, BRIT J CANCER, V94, P1678, DOI 10.1038/sj.bjc.6603180; La-Touche S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146740; Mannweiler S, 2013, J AM ACAD DERMATOL, V69, P73, DOI 10.1016/j.jaad.2012.12.973; McDaniel AS, 2015, CANCER RES, V75, P5219, DOI 10.1158/0008-5472.CAN-15-1004; Murayama T, 2009, BRIT J CANCER, V100, P782, DOI 10.1038/sj.bjc.6604915; Pedrero JMG, 2005, INT J CANCER, V114, P242, DOI 10.1002/ijc.20711; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Rosner M, 2007, AMINO ACIDS, V32, P341, DOI 10.1007/s00726-007-0509-0; Rosner M, 2007, ONCOGENE, V26, P521, DOI 10.1038/sj.onc.1209812; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Sakai N, 2010, DIS ESOPHAGUS, V23, P415, DOI 10.1111/j.1442-2050.2009.01026.x; Sonpavde G, 2013, ANN ONCOL, V24, P1179, DOI 10.1093/annonc/mds635; Stankiewicz E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017517; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860	28	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198905	10.1371/journal.pone.0198905	http://dx.doi.org/10.1371/journal.pone.0198905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902261	gold, Green Published, Green Submitted			2022-12-26	WOS:000435424900056
J	Pletto, D; Capra, S; Finardi, A; Colciaghi, F; Nobili, P; Battaglia, GS; Locatelli, D; Cagnoli, C				Pletto, Daniela; Capra, Silvia; Finardi, Adele; Colciaghi, Francesca; Nobili, Paola; Battaglia, Giorgio Stefano; Locatelli, Denise; Cagnoli, Cinzia			Axon outgrowth and neuronal differentiation defects after a-SMN and FL-SMN silencing in primary hippocampal cultures	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; MOUSE MODEL; INITIAL SEGMENT; MESSENGER-RNA; GENE-PRODUCT; NEURITE OUTGROWTH; PROTEIN INTERACTS; CARDIAC DEFECTS; NERVOUS-SYSTEM; GROWTH CONES	Spinal Muscular Atrophy (SMA) is a severe autosomal recessive disease characterized by selective motor neuron degeneration, caused by disruptions of the Survival of Motor Neuron 1 (Smn 1) gene. The main product of SMN1 is the full-length SMN protein (FL-SMN), that plays an established role in mRNA splicing. FL-SMN is also involved in neurite outgrowth and axonal transport. A shorter SMN isoform, axonal-SMN or a-SMN, displays a more specific axonal localization and has remarkable axonogenic properties in NSC-34. Introduction of known SMA mutations into the a-SMN transcript leads to impairment of axon growth and morphological defects similar to those observed in SMA patients and animal models. Although there is increasing evidence for the relevance of SMN axonal functions in SMA pathogenesis, the specific contributions of FL-SMN and a-SMN are not known yet. This work aimed to analyze the differential roles of FL-SMN and a-SMN in axon outgrowth and in neuronal homeostasis during differentiation of neurons into a mature phenotype. We employed primary cultures of hippocampal neurons as a well-defined model of polarization and differentiation. By analyzing subcellular localization, we showed that a-SMN is preferentially localized in the growing axonal compartment. By specifically silencing FL-SMN or a-SMN proteins, we demonstrated that both proteins play a role in axon growth, as their selective down-regulation reduces axon length without affecting dendritic arborization. a-SMN silencing, and in minor extent FL-SMN silencing, resulted in the growth of multi-neuritic neurons, impaired in the differentiation process of selecting a single axon out of multiple neurites. In these neurons, neurites often display mixed axonal and dendritic markers and abnormal distribution of the axonal initial segment protein Ankirin G, suggesting loss of neuronal polarity. Our results indicate that a-SMN and FL-SMN are needed for neuronal polarization and organization of axonal and dendritic compartments, processes that are fundamental for neuronal function and survival.	[Pletto, Daniela; Capra, Silvia; Finardi, Adele; Colciaghi, Francesca; Nobili, Paola; Battaglia, Giorgio Stefano; Locatelli, Denise; Cagnoli, Cinzia] Fdn IRCCS Neurol Inst C Besta, Mol Neuroanat & Pathogenesis Unit, Neurol Clin & Expt Epileptol Unit 7, Milan, Italy; [Nobili, Paola] Paris Descartes Univ, INSERM, U1128, Neurophysiol & New Microcopies Lab, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Cagnoli, C (corresponding author), Fdn IRCCS Neurol Inst C Besta, Mol Neuroanat & Pathogenesis Unit, Neurol Clin & Expt Epileptol Unit 7, Milan, Italy.	cinzia.cagnoli@istituto-besta.it	Nobili, Paola/Z-2701-2019; Colciaghi, Francesca/J-8772-2016; Cagnoli, Cinzia/AAK-2004-2021	Nobili, Paola/0000-0003-2313-4223; Colciaghi, Francesca/0000-0002-6487-380X; Cagnoli, Cinzia/0000-0001-6863-6687	Telethon-Italy Foundation [GGP13081]; Girotondo ONLUS; Smarathon ONLUS; Italian Ministry of Health	Telethon-Italy Foundation(Fondazione Telethon); Girotondo ONLUS; Smarathon ONLUS; Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by financial supports from Telethon-Italy Foundation (GGP13081) http://www.telethon.it/; Girotondo ONLUS http://www.atrofiaspinale.it/; Smarathon ONLUS http://www.smarathon.eu/; Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript	Akten B, 2011, P NATL ACAD SCI USA, V108, P10337, DOI 10.1073/pnas.1104928108; Araki S, 2003, ACTA NEUROPATHOL, V106, P441, DOI 10.1007/s00401-003-0743-9; Bevan AK, 2010, HUM MOL GENET, V19, P3895, DOI 10.1093/hmg/ddq300; Bowerman M, 2012, ANN NEUROL, V72, P256, DOI 10.1002/ana.23582; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Briese M, 2005, BIOESSAYS, V27, P946, DOI 10.1002/bies.20283; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Buffington SA, 2011, EUR J NEUROSCI, V34, P1609, DOI 10.1111/j.1460-9568.2011.07875.x; Butchbach MER, 2016, EXP NEUROL, V279, P13, DOI 10.1016/j.expneurol.2016.02.009; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chen PC, 2012, ACS CHEM NEUROSCI, V3, P5, DOI 10.1021/cn200085z; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; d'Errico P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082654; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fallini C, 2016, J NEUROSCI, V36, P3811, DOI 10.1523/JNEUROSCI.2396-15.2016; Fallini C, 2012, BRAIN RES, V1462, P81, DOI 10.1016/j.brainres.2012.01.044; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; Fan L, 2002, HUM MOL GENET, V11, P1605, DOI 10.1093/hmg/11.14.1605; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Gartner A, 2014, J CELL SCI, V127, P4409, DOI 10.1242/jcs.149815; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Garcera A, 2011, NEUROBIOL DIS, V42, P415, DOI 10.1016/j.nbd.2011.02.003; Gogliotti RG, 2012, J NEUROSCI, V32, P3818, DOI 10.1523/JNEUROSCI.5775-11.2012; Guo Y, 2017, NEUROSCI BULL, V33, P641, DOI 10.1007/s12264-017-0169-3; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; Hao LT, 2013, HUM MOL GENET, V22, P2612, DOI 10.1093/hmg/ddt110; Hazan J, J NEUROSCI; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Heier CR, 2010, HUM MOL GENET, V19, P3906, DOI 10.1093/hmg/ddq330; Hunter G, 2014, HUM MOL GENET, V23, P2235, DOI 10.1093/hmg/ddt612; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Jablonka S, 2006, HUM MOL GENET, V15, P511, DOI 10.1093/hmg/ddi467; Jablonka S, 2001, HUM MOL GENET, V10, P497, DOI 10.1093/hmg/10.5.497; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jones SL, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6808293; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Le Bras B, 2014, BRAIN STRUCT FUNCT, V219, P1433, DOI 10.1007/s00429-013-0578-7; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Little D, 2015, MOL THER, V23, P270, DOI 10.1038/mt.2014.209; Liu H, 2010, J NEUROSCI RES, V88, P111, DOI 10.1002/jnr.22189; Locatelli D, 2012, J BIOL CHEM, V287, P25782, DOI 10.1074/jbc.M112.362830; Locatelli D, 2012, J NEUROCHEM, V121, P465, DOI 10.1111/j.1471-4159.2012.07689.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; Lyon AN, 2014, HUM MOL GENET, V23, P1990, DOI 10.1093/hmg/ddt595; Makhortova NR, 2011, NAT CHEM BIOL, V7, P544, DOI [10.1038/NCHEMBIO.595, 10.1038/nchembio.595]; McGivern JV, 2013, GLIA, V61, P1418, DOI 10.1002/glia.22522; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Monani UR, 1999, BBA-GENE STRUCT EXPR, V1445, P330, DOI 10.1016/S0167-4781(99)00060-3; Ning K, 2010, HUM MOL GENET, V19, P3159, DOI 10.1093/hmg/ddq226; Nolle A, 2011, HUM MOL GENET, V20, P4865, DOI 10.1093/hmg/ddr425; Pagliardini S, 2000, HUM MOL GENET, V9, P47, DOI 10.1093/hmg/9.1.47; Park GH, 2010, J NEUROSCI, V30, P12005, DOI 10.1523/JNEUROSCI.2208-10.2010; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Prior TW, 2010, AM J MED GENET A, V152A, P1608, DOI 10.1002/ajmg.a.33474; Rathod R, 2012, HISTOCHEM CELL BIOL, V138, P737, DOI 10.1007/s00418-012-0989-1; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Rossoll W, 2009, RESULTS PROBL CELL D, V48, P289, DOI 10.1007/400_2009_4; Rudnik-Schoneborn S, 2009, CLIN GENET, V76, P168, DOI 10.1111/j.1399-0004.2009.01200.x; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sanchez G, 2013, HUM MOL GENET, V22, P668, DOI 10.1093/hmg/dds474; Setola V, 2007, P NATL ACAD SCI USA, V104, P1959, DOI 10.1073/pnas.0610660104; Shababi M, 2010, HUM MOL GENET, V19, P4059, DOI 10.1093/hmg/ddq329; Singh RN, 2017, BBA-GENE REGUL MECH, V1860, P299, DOI 10.1016/j.bbagrm.2016.12.008; Sleigh JN, 2014, HUM MOL GENET, V23, P855, DOI 10.1093/hmg/ddt477; Sohn PD, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0109-0; Soler-Botija C, 2002, BRAIN, V125, P1624, DOI 10.1093/brain/awf155; Somers E, 2012, NEUROMUSCULAR DISORD, V22, P435, DOI 10.1016/j.nmd.2011.10.021; Tadesse H, 2008, HUM MOL GENET, V17, P506, DOI 10.1093/hmg/ddm327; Tizzano EF, 1998, AM J PATHOL, V153, P355, DOI 10.1016/S0002-9440(10)65578-2; Torres-Benito L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026164; Totaro A, 2012, BIOL CELL, V104, P533, DOI 10.1111/boc.201100060; Tuvia S, 1997, P NATL ACAD SCI USA, V94, P12957, DOI 10.1073/pnas.94.24.12957; van Bergeijk J, 2007, FASEB J, V21, P1492, DOI 10.1096/fj.06-7136com; van Beuningen SFB, 2015, NEURON, V88, P1208, DOI 10.1016/j.neuron.2015.11.012; Wang ZB, 2013, CELL RES, V23, P378, DOI 10.1038/cr.2012.166; Wen HL, 2010, HUM MOL GENET, V19, P1766, DOI 10.1093/hmg/ddq058; Winckler B, 1999, NEURON, V23, P637, DOI 10.1016/S0896-6273(01)80021-0; Wirth Brunhilde, 2006, Semin Pediatr Neurol, V13, P121, DOI 10.1016/j.spen.2006.06.008; Wishart TM, 2010, HUM MOL GENET, V19, P4216, DOI 10.1093/hmg/ddq340; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Yau KW, 2014, NEURON, V82, P1058, DOI 10.1016/j.neuron.2014.04.019; Zhang HLL, 2003, J NEUROSCI, V23, P6627; Zhang HL, 2007, J NEUROSCI RES, V85, P2657, DOI 10.1002/jnr.21308; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	99	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199105	10.1371/journal.pone.0199105	http://dx.doi.org/10.1371/journal.pone.0199105			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902268	Green Submitted, gold, Green Published			2022-12-26	WOS:000435424900088
J	Razzak, RA; Alshaiji, AF; Qareeballa, AA; Mohamed, MW; Bagust, J; Docherty, S				Razzak, Rima Abdul; Alshaiji, Abdulla Faisal; Qareeballa, Abdulrahman Ahmed; Mohamed, Mohamed Wael; Bagust, Jeff; Docherty, Sharon			High-normal blood glucose levels may be associated with decreased spatial perception in young healthy adults	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; SLEEP	The negative effects of high normal glucose on cognitive function were previously reported in euglycemic individuals of middle age and the elderly population. This study aimed at examining the effect of baseline blood glucose levels on spatial ability, specifically verticality perception on the computerized rod and frame test (CRFT) in young healthy adults. 63 healthy male medical students (age range from 18-23 years), of whom 30 were non-fasting outside the month of Ramadan and 33 fasting during Ramadan of the year 2016, were recruited in order to create varying degrees of glycemia during which verticality perception was carried out. Baseline blood glucose reading was obtained prior to commencing the CRFT test. Blood glucose levels at the time of testing decreased as the duration between the last meal and testing increased. A blood glucose range of 62-117 mg/dl was achieved among participants for this study. Linear regression analysis showed that blood glucose level at testing correlated positively with all alignment spatial error parameters, indicating a probable reduction of spatial perception ability with higher blood glucose levels. These results are consistent with other cognitive studies in older healthy humans and emphasize the critical impact of early glucose dys-homeostasis on cognitive function. They also indicate that elevated blood glucose may affect cognitive functioning outside of the usual complications of diabetes.	[Razzak, Rima Abdul] Arabian Gulf Univ, Coll Med & Med Sci, Dept Physiol, Manama, Bahrain; [Alshaiji, Abdulla Faisal; Qareeballa, Abdulrahman Ahmed; Mohamed, Mohamed Wael] Arabian Gulf Univ, Coll Med & Med Sci, Manama, Bahrain; [Bagust, Jeff] Bournemouth Univ, Fac Hlth & Social Sci, Poole, Dorset, England; [Docherty, Sharon] Bournemouth Univ, Sch Hlth & Social Care, Poole, Dorset, England	Arabian Gulf University; Arabian Gulf University; Bournemouth University; Bournemouth University	Razzak, RA (corresponding author), Arabian Gulf Univ, Coll Med & Med Sci, Dept Physiol, Manama, Bahrain.	reemala@agu.edu.bh		Docherty, Sharon/0000-0003-3209-1560; Wael, Mohamed/0000-0002-9034-2084; Abdul Razzak, Rima/0000-0002-2994-5150	Arabian Gulf University	Arabian Gulf University	The Arabian Gulf University provided the funding for buying the software and other material require for this study.	Akin Faith W., 2009, Seminars in Hearing, V30, P281, DOI 10.1055/s-0029-1241128; Bagust J, 2005, ARCH PHYS MED REHAB, V86, P1062, DOI 10.1016/j.apmr.2004.05.022; Bagust J., 2005, CLIN CHIROPRACTIC, V8, P134, DOI [10.1016/j.clch.2005.07.001, DOI 10.1016/J.CLCH.2005.07.001]; Bagust J., 2013, PSYCHOL BEHAV SCI, V2, DOI [10.11648/j.pbs.20130202.17, DOI 10.11648/J.PBS.20130202.17]; Bagust J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065321; Bohmer A, 1999, ACTA OTO-LARYNGOL, V119, P126, DOI 10.1080/00016489950181495; Cherbuin N, 2012, NEUROLOGY, V79, P1019, DOI 10.1212/WNL.0b013e31826846de; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI [10.1056/NEJMoa1215740, 10.1056/NEJMc1311765]; Docherty Sharon, 2010, BMC Res Notes, V3, P9, DOI 10.1186/1756-0500-3-9; Donohoe RT, 1999, PSYCHOPHARMACOLOGY, V145, P378, DOI 10.1007/s002130051071; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Fitzgerald S, 2013, NEUROLOGY TODAY, P25; Fitzgerald S, 2013, NEUROLOGY TODAY, P20; Guyton AC, 2016, INSULIN GLUCAGON DIA; Hijazi MMK, 2013, J HUM KINET, V39, P195, DOI 10.2478/hukin-2013-0082; KATO N, 1965, JPN PSYCHOL RES, V7, P61, DOI 10.4992/psycholres1954.7.61; Kemeny A, 2003, TRENDS COGN SCI, V7, P31, DOI 10.1016/S1364-6613(02)00011-6; Kerti L, 2013, NEUROLOGY; Lopez C, 2005, GAIT POSTURE, V21, pS49, DOI [10.1016/S0966-6362(05)80164-X, DOI 10.1016/S0966-6362(05)80164-X]; Mazibrada G, 2008, GAIT POSTURE, V27, P202, DOI 10.1016/j.gaitpost.2007.03.006; McCrimmon RJ, 2012, LANCET, V379, P2291, DOI 10.1016/S0140-6736(12)60360-2; Messier C, 2005, NEUROBIOL AGING, V26, pS26, DOI 10.1016/j.neurobiolaging.2005.09.014; Mortby ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073697; Murray KJ, 2007, PHYS THER, V87, P143, DOI 10.2522/ptj.20060004; Nakashima R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01837; NYBORG H, 1974, SCAND J PSYCHOL, V15, P119, DOI 10.1111/j.1467-9450.1974.tb00563.x; PERLMUTER LC, 1984, AM J MED, V77, P1043, DOI 10.1016/0002-9343(84)90186-4; Razzak RA, 2015, J DIABETES COMPLICAT, V29, P68, DOI 10.1016/j.jdiacomp.2014.09.009; Reilly T, 2007, PHYSIOL BEHAV, V90, P274, DOI 10.1016/j.physbeh.2006.09.017; Reivich M, 1983, POSITRON EMISSION TO, P153; Roky R, 2003, J SLEEP RES, V12, P95, DOI 10.1046/j.1365-2869.2003.00341.x; Roky R, 2012, J SPORT SCI, V30, pS75, DOI 10.1080/02640414.2012.693622; Romeas T., 2015, J VIS, V15, P504; Scholey AB, 2001, PHYSIOL BEHAV, V73; Simmons A., 2003, PHILOS TOPICS, V31, P395, DOI [10.5840/philtopics2003311/22, DOI 10.5840/PHILTOPICS2003311/22]; Sprague Jennifer E, 2011, Pediatr Endocrinol Rev, V9, P463; Vingerhoets RAA, 2009, J NEUROPHYSIOL, V101, P1321, DOI 10.1152/jn.90725.2008; Waterhouse J, 2010, BRIT J SPORT MED, V44, P509, DOI 10.1136/bjsm.2007.071712	39	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199051	10.1371/journal.pone.0199051	http://dx.doi.org/10.1371/journal.pone.0199051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902276	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000435424900082
J	Chiu, HC; Huang, WR; Liao, TL; Chi, PI; Nielsen, BL; Liu, JH; Liu, HJ				Chiu, Hung-Chuan; Huang, Wei-Ru; Liao, Tsai-Ling; Chi, Pei-I; Nielsen, Brent L.; Liu, Jyung-Hurng; Liu, Hung-Jen			Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cell cycle; cyclin; mutagenesis; cyclin-dependent kinase 7 (CDK7); avian reovirus; CDK inhibitor; CDK-cyclin complexes; cyclin-dependent kinase (CDK); p17	DEPENDENT KINASES; NONSTRUCTURAL PROTEIN; ACTIVATION; PHOSPHORYLATION; APOPTOSIS; INHIBITORS; SEQUENCE; P21; WEB; IDENTIFICATION	The avian reovirus p17 protein is a nucleocytoplasmic shuttling protein. Although we have demonstrated that p17 causes cell growth retardation via activation of p53, the precise mechanisms remain unclear. This is the first report that avian reovirus p17 possesses broad inhibitory effects on cell cycle CDKs, cyclins, CDK-cyclin complexes, and CDK-activating kinase activity in various mammalian, avian, and cancer cell lines. Suppression of CDK activity by p17 occurs by direct binding to CDKs, cyclins, and CDK-cyclin complexes; transcriptional down-regulation of CDKs; cytoplasmic retention of CDKs and cyclins; and inhibition of CDK-activating kinase activity by promoting p53-cyclin H interaction. p17 binds to CDK-cyclin except for CDK1-cyclin B1 and CDK7-cyclin H complexes. We have determined that the negatively charged (151)LAVXDVDA(E/D)DGADPN(165) motif in cyclin B1 interacts with a positively charged region of CDK1. p17 mimics the cyclin B1 sequence to compete for CDK1 binding. The PSTAIRE motif is not required for interaction of CDK1-cyclin B1, but it is required for other CDK-cyclin complexes. p17 interacts with cyclins by its cyclin-binding motif, (RXL127)-R-125. Sequence and mutagenic analyses of p17 indicated that a (WXFD143)-W-140 motif and residues Asp-113 and Lys-122 in p17 are critical for CDK2 and CDK6 binding, leading to their sequestration in the cytoplasm. Exogenous expression of p17 significantly enhanced virus replication, whereas p17 mutants with low binding ability to cell cycle CDKs had no effect on virus yield, suggesting that p17 inhibits cell growth and the cell cycle, benefiting virus replication. An in vivo tumorigenesis assay also showed a significant reduction in tumor size.	[Chiu, Hung-Chuan; Huang, Wei-Ru; Liu, Hung-Jen] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan; [Chiu, Hung-Chuan; Liu, Hung-Jen] Natl Chung Hsing Univ, iEGG & Anim Biotechnol Ctr, Taichung 402, Taiwan; [Liao, Tsai-Ling; Liu, Hung-Jen] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 402, Taiwan; [Liu, Jyung-Hurng] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 402, Taiwan; [Liu, Hung-Jen] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan; [Liao, Tsai-Ling] Taichung Vet Gen Hosp, Dept Med Res, Taichung 407, Taiwan; [Nielsen, Brent L.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; Taichung Veterans General Hospital; Brigham Young University	Liu, HJ (corresponding author), Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan.	hjliu5257@nchu.edu.tw	Liu, Jyung-Hurng/C-1340-2010	Liu, Jyung-Hurng/0000-0002-7173-0372; Huang, Wei-Ru/0000-0002-2508-8374; Liu, Hung-Jen/0000-0002-1460-1494	Taichung Veterans General Hospital [TCVGH-NCHU1057603, TCVGH-NCHU1067601]; National Chung Hsing University [TCVGH-NCHU1057603, TCVGH-NCHU1067601]; Ministry of Science and Technology of Taiwan [MOST 106-2313-B-005-054-MY3, 106-2622-B-005-009-CC2]; iEGG and Animal Biotechnology Center from the Feature Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan	Taichung Veterans General Hospital; National Chung Hsing University; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); iEGG and Animal Biotechnology Center from the Feature Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan	This work was supported by Taichung Veterans General Hospital Grants TCVGH-NCHU1057603 and TCVGH-NCHU1067601, National Chung Hsing University Grants TCVGH-NCHU1057603 and TCVGH-NCHU1067601, Ministry of Science and Technology of Taiwan Grants MOST 106-2313-B-005-054-MY3 and 106-2622-B-005-009-CC2, and the iEGG and Animal Biotechnology Center from the Feature Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan. The authors declare that they have no conflicts of interest with the contents of this article.	Boehme KW, 2013, J VIROL, V87, P12967, DOI 10.1128/JVI.02080-13; Brown NR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7769; Brown NR, 1999, J BIOL CHEM, V274, P8746, DOI 10.1074/jbc.274.13.8746; Chang IA, 2012, FASEB J, V26, P2401, DOI 10.1096/fj.11-199018; Chen JJ, 1996, MOL CELL BIOL, V16, P4673; Chi PI, 2013, J BIOL CHEM, V288, P3571, DOI 10.1074/jbc.M112.390245; Chiu HW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153087; Costas C, 2005, J VIROL, V79, P2141, DOI 10.1128/JVI.79.4.2141-2150.2005; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DeLano W. L., 2004, PYMOL MOL GRAPH SYST; GLASS SE, 1973, AVIAN DIS, V17, P415, DOI 10.2307/1589226; Hengst L, 1998, GENE DEV, V12, P3882, DOI 10.1101/gad.12.24.3882; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Hsu HW, 2005, AVIAN DIS, V49, P36, DOI 10.1637/7264-081904R1; Huang WR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05510-x; Huang WR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133699; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Ji WT, 2009, BIOCHEM BIOPH RES CO, V384, P301, DOI 10.1016/j.bbrc.2009.04.116; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Kozak R. A., 2017, VIRUSES, V9, pE90; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavoie JN, 1998, J CELL BIOL, V140, P637, DOI 10.1083/jcb.140.3.637; Li M, 2010, J BIOL CHEM, V285, P21487, DOI 10.1074/jbc.M109.092692; Lin PY, 2009, VIROLOGY, V385, P323, DOI 10.1016/j.virol.2008.12.028; Liu HJ, 2005, BIOCHEM BIOPH RES CO, V336, P709, DOI 10.1016/j.bbrc.2005.08.149; Liu HJ, 2003, VIROLOGY, V314, P336, DOI 10.1016/S0042-6822(03)00415-X; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; MATSUOKA M, 1994, MOL CELL BIOL, V14, P7265, DOI 10.1128/MCB.14.11.7265; McGrath CF, 2005, J BIOMOL STRUCT DYN, V22, P493, DOI 10.1080/07391102.2005.10531227; Morris MC, 2002, J BIOL CHEM, V277, P23847, DOI 10.1074/jbc.M107890200; Murakami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086840; NAKANISHI M, 1995, EMBO J, V14, P555, DOI 10.1002/j.1460-2075.1995.tb07031.x; Noh SJ, 1999, CANCER RES, V59, P558; NUGENT JHA, 1991, J CELL SCI, V99, P669; Petri ET, 2007, CELL CYCLE, V6, P1342, DOI 10.4161/cc.6.11.4297; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; ROSENBERGER JK, 1989, AVIAN DIS, V33, P535, DOI 10.2307/1591118; Roulstone V, 2013, GENE THER, V20, P521, DOI 10.1038/gt.2012.68; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Schneider E, 1998, ONCOGENE, V17, P2733, DOI 10.1038/sj.onc.1202504; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shih WL, 2004, VIROLOGY, V321, P65, DOI 10.1016/j.virol.2003.12.004; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wohlschlegel JA, 2001, MOL CELL BIOL, V21, P4868, DOI 10.1128/MCB.21.15.4868-4874.2001; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024	49	28	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12542	12562		10.1074/jbc.RA118.002341	http://dx.doi.org/10.1074/jbc.RA118.002341			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29907572	Green Published, hybrid			2022-12-26	WOS:000441408500020
J	Vishwakarma, H; Junaid, A; Manjhi, J; Singh, GP; Gaikwad, K; Padaria, JC				Vishwakarma, Harinder; Junaid, Alim; Manjhi, Jayanand; Singh, Gyanendra Pratap; Gaikwad, Kishor; Padaria, Jasdeep Chatrath			Heat stress transcripts, differential expression, and profiling of heat stress tolerant gene TaHsp90 in Indian wheat (Triticum aestivum L.) cv C306	PLOS ONE			English	Article							ESCHERICHIA-COLI; CHAPERONE COMPLEX; ABIOTIC STRESS; SHOCK-PROTEIN; HSP90; METALLOTHIONEIN; RESISTANCE; MECHANISM; SCAVENGER; RECEPTOR	To generate a genetic resource of heat stress responsive genes/ESTs, suppression sub-tractive hybridization (SSH) library was constructed in a heat and drought stress tolerant Indian bread wheat cultivar C306. Ninety three days old plants during grain filling stage were subjected to heat stress at an elevated temperature of 37 degrees C and 42 degrees C for different time intervals (30 min, 1h, 2h, 4h, and 6h). Two subtractiv cDNA libraries were prepared with RNA isolated from leaf samples at 37 degrees C and 42 degrees C heat stress. The ESTs obtained were reconfirmed by reverse northern dot blot hybridization. A total of 175 contigs and 403 singlets were obtained from 1728 ESTs by gene ontology analysis. Differential expression under heat stress was validated for a few selected genes (10) by qRT-PCR. A transcript showing homology to Hsp90 was observed to be upregulated (7.6 fold) under heat stress in cv. C306. CDS of TaHsp90 (Accession no. MF383197) was isolated from cv. C306 and characterized. Heterologous expression of TaHsp90 was validated in E. coli BL21 and confirmed by protein gel blot and MALDI-TOF analysis. Computational based analysis was carried out to understand the molecular functioning of TaHsp90. The heat stress responsive SSH library developed led to identification of a number of heat responsive genes/ESTs, which can be utilized for unravelling the heat tolerance mechanism in wheat. Gene TaHsp90 isolated and characterized in the present study can be utilized for developing heat tolerant transgenic crops.	[Vishwakarma, Harinder; Junaid, Alim; Gaikwad, Kishor; Padaria, Jasdeep Chatrath] Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi, India; [Manjhi, Jayanand] Shobhit Univ, Meerut, Uttar Pradesh, India; [Singh, Gyanendra Pratap] Indian Inst Wheat & Barley Res, Kernel, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Shobhit University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research	Padaria, JC (corresponding author), Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi, India.	jasdeep_kaur64@yahoo.co.in	Padaria, Jasdeep Chatrath/B-4510-2012; , Jayanand/AAV-5367-2021		ICAR (Indian Council of Agricultural Research, New Delhi) - project NICRA (National innovations in Climate Resilient Agriculture)	ICAR (Indian Council of Agricultural Research, New Delhi) - project NICRA (National innovations in Climate Resilient Agriculture)	The Financial support from ICAR (Indian Council of Agricultural Research, New Delhi) funded project NICRA (National innovations in Climate Resilient Agriculture) is duly acknowledged (http://www.nicra-icarin/nicrarevised/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Almeselmani M., 2012, PLANT STRESS, V6, P25; Basharat Z., 2015, J COMP BIOL BIOINFO, V7, P1, DOI DOI 10.5897/JCBBR2013.082; Bita CE, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00273; Chaurasia N, 2008, BIOCHEM BIOPH RES CO, V376, P225, DOI 10.1016/j.bbrc.2008.08.129; Chen H, 2016, PLANT BIOTECHNOL J, V14, P682, DOI 10.1111/pbi.12415; Chen LT, 2010, CELL HOST MICROBE, V7, P185, DOI 10.1016/j.chom.2010.02.008; Chopra RK, 2013, INDIAN J PLANT GENET, V26, P25; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Goswami S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01230; Gray WM, 2003, PLANT CELL, V15, P1310, DOI 10.1105/tpc.010884; Gupta K, 2010, PLANT CELL REP, V29, P1131, DOI 10.1007/s00299-010-0896-7; Gurjar K, 2014, APPL BIOCHEM BIOTECH, V173, P2116, DOI 10.1007/s12010-014-1011-2; Hahn A, 2011, PLANT CELL, V23, P741, DOI 10.1105/tpc.110.076018; Hairat S, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1179416; Haldimann P, 2004, PLANT CELL ENVIRON, V27, P1169, DOI 10.1111/j.1365-3040.2004.01222.x; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Joshi AK, 2007, FIELD CROP RES, V103, P53, DOI 10.1016/j.fcr.2007.04.010; Kadota Y, 2012, BBA-MOL CELL RES, V1823, P689, DOI 10.1016/j.bbamcr.2011.09.016; Kumar R. R., 2012, International Research Journal of Biochemistry and Bioinformatics, V2, P168; Kurek I, 1999, PLANT PHYSIOL, V119, P693, DOI 10.1104/pp.119.2.693; Lean JL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038932; Liu HC, 2013, PLANT PHYSIOL, V163, P276, DOI 10.1104/pp.113.221168; Liu Y, 2005, BIOCHEM BIOPH RES CO, V331, P325, DOI 10.1016/j.bbrc.2005.03.165; Manikandan R, 2014, MOL BIOL, V49, P585; Margaritopoulou T, 2016, PLANT J, V87, P174, DOI 10.1111/tpj.13191; May T, 2000, PLANT CELL, V12, P53, DOI 10.1105/tpc.12.1.53; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Mishra RC, 2016, CRIT REV BIOTECHNOL, V36, P862, DOI 10.3109/07388551.2015.1051942; Mittler R, 2007, TRENDS BIOCHEM SCI, V37, P118; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Ogiso H, 2004, BIOCHEMISTRY-US, V43, P15510, DOI 10.1021/bi048736m; Padaria JC, 2016, INDIAN J BIOTECHNOL, V15, P467; Padaria JC, 2016, MOL BIOL REP, V43, P849, DOI 10.1007/s11033-016-4013-z; Padaria Jasdeep Chatrath, 2014, BMC Res Notes, V7, P713, DOI 10.1186/1756-0500-7-713; Padaria JC, 2013, PLANT OMICS, V6, P150; Pandurangaiah M, 2013, ACTA PHYSIOL PLANT, V35, P139, DOI 10.1007/s11738-012-1056-1; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Reddy PS, 2010, MOL GENET GENOMICS, V283, P243, DOI 10.1007/s00438-010-0518-7; Rubio A, 2008, J BIOL CHEM, V283, P24816, DOI 10.1074/jbc.M804000200; Samakovli D, 2007, J EXP BOT, V58, P3513, DOI 10.1093/jxb/erm191; Sambrook JD, 2001, LAB MANUAL; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Wang GF, 2011, NEW PHYTOL, V191, P418, DOI 10.1111/j.1469-8137.2011.03715.x; Wang XX, 2012, PLANT MOL BIOL REP, V30, P547, DOI 10.1007/s11105-011-0361-y; Wong HL, 2004, PLANT PHYSIOL, V135, P1447, DOI 10.1104/pp.103.036384; Xu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069810, 10.1371/journal.pone.0079289]; Xu Yan, 2011, Int J Proteomics, V2011, P529648, DOI 10.1155/2011/529648; Xue TT, 2009, J EXP BOT, V60, P339, DOI 10.1093/jxb/ern291; Zhang XN, 2009, PLANT PHYSIOL, V150, P1450, DOI 10.1104/pp.109.138180; Zhu JH, 2010, PLANT PHYSIOL BIOCH, V48, P710, DOI 10.1016/j.plaphy.2010.04.004	56	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0198293	10.1371/journal.pone.0198293	http://dx.doi.org/10.1371/journal.pone.0198293			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29939987	gold, Green Submitted, Green Published			2022-12-26	WOS:000436088700003
J	Zhu, N; Yu, N; Zhu, Y; Wei, YL; Zhang, HP; Sun, AD				Zhu, Ning; Yu, Ning; Zhu, Yue; Wei, Yulong; Zhang, Haiping; Sun, Ai-Dong			Inactivation of Pichia rhodanensis in relation to membrane and intracellular compounds due to microchip pulsed electric field (MPEF) treatment	PLOS ONE			English	Article							HIGH HYDROSTATIC-PRESSURE; FLOW-CYTOMETRIC ANALYSIS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; INDUCED DAMAGE; LISTERIA-MONOCYTOGENES; SALMONELLA-TYPHIMURIUM; STAPHYLOCOCCUS-AUREUS; CIRCULAR-DICHROISM; SUBLETHAL INJURY	The effect of microchip pulsed electric field (MPEF) treatment on lethal and sublethal injury of Pichia rhodanensis (P. rhodanensis) were employed under 100-500 V for 20-100 pulses and the underlying mechanism of MPEF treatment was investigated as well. A 6.48 log(10) reduction of P. rhodanensis was achieved at 500V for 80 pulse. The fluorescent staining with Propidium Iodide (PI) verified that the rate of sublethal injury cells maximum up to 27.2% under 200 V. MPEF can cause the damage of cell morphology and ultrastructure, meanwhile causing a decrease in cellular enzymes, antioxidant enzyme activity and cell membrane fluidity. The leakage of intracellular compounds (protein, nucleic acid, K+, Mg2+) and Ca2+-ATPase gradually increased as the growth of voltage, especially the proportion of protein in the supernatants increased from 2.0% to 26.4%. Flow cytometry analysis showed that MPEF has significant effect on membrane potential, but no obvious influence on nonspecific esterase. MPEF can cause the changing of the secondary structure of protein, at the same time, double helix structure of DNA became loose and unwinding. These results provide a theoretical guidance for the widespread using of MPEF technology in the application of a non-thermal processing technique for food.	[Zhu, Ning; Yu, Ning; Zhu, Yue; Wei, Yulong; Zhang, Haiping; Sun, Ai-Dong] Beijing Forestry Univ, Coll Biol Sci & Technol, Dept Food Sci & Engn, Beijing, Peoples R China	Beijing Forestry University	Sun, AD (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Dept Food Sci & Engn, Beijing, Peoples R China.	adsun@bjfu.edu.cn			National Natural Science Foundation [31471593]; Special Commonweal of Forestry Industry [201504606]; National Key R D Program [2016YFD04003024]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Special Commonweal of Forestry Industry; National Key R D Program	Ning Zhu thanks the support from National Natural Science Foundation (No. 31471593), Special Commonweal of Forestry Industry (201504606), and National Key R & D Program (2016YFD04003024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadil RM, 2015, INT J FOOD SCI TECH, V50, P2290, DOI 10.1111/ijfs.12891; Ananta E, 2004, FOOD MICROBIOL, V21, P567, DOI 10.1016/j.fm.2003.11.008; Ananta E, 2009, FOOD MICROBIOL, V26, P542, DOI 10.1016/j.fm.2009.01.008; Anvarian AHP, 2016, INT J FOOD MICROBIOL, V219, P38, DOI 10.1016/j.ijfoodmicro.2015.11.016; Aronsson K, 2005, INT J FOOD MICROBIOL, V99, P19, DOI 10.1016/j.ijfoodmicro.2004.07.012; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Corona JC, 2014, NEUROMETHODS, V90, P161, DOI 10.1007/978-1-4939-1059-5_7; Cebrian G, 2015, INNOV FOOD SCI EMERG, V32, P91, DOI 10.1016/j.ifset.2015.09.017; Chueca B, 2015, INNOV FOOD SCI EMERG, V29, P78, DOI 10.1016/j.ifset.2014.09.003; Coustets M, 2015, BIOELECTROCHEMISTRY, V103, P74, DOI 10.1016/j.bioelechem.2014.08.022; Craiu A, 2005, BLOOD, V105, P2235, DOI 10.1182/blood-2003-12-4399; Diaz M, 2010, BIOCHEM ENG J, V48, P385, DOI 10.1016/j.bej.2009.07.013; Evrendilek GA, 2005, J FOOD ENG, V68, P271, DOI 10.1016/j.jfoodeng.2004.06.001; Ferrario M, 2014, FOOD BIOPROCESS TECH, V7, P1001, DOI 10.1007/s11947-013-1121-9; Flisar K, 2014, BIOELECTROCHEMISTRY, V100, P44, DOI 10.1016/j.bioelechem.2014.03.008; Garcia-Gonzalo D., 2016, HDB ELECTROPORATION, P1, DOI [10.1007/978-3-319-26779-1_137-1, DOI 10.1007/978-3-319-26779-1_137-1.]; Heldal M, 2012, ISME J, V6, P524, DOI 10.1038/ismej.2011.130; Holmstrup M, 2014, ENVIRON SCI TECHNOL, V48, P9797, DOI 10.1021/es502221g; Huang K, 2014, FOOD BIOPROCESS TECH, V7, P1981, DOI 10.1007/s11947-014-1272-3; Ivorra A, 2010, SER BIOMED ENG, P23, DOI 10.1007/978-3-642-05420-4_2; Kethireddy V, 2016, INT J FOOD MICROBIOL, V233, P73, DOI 10.1016/j.ijfoodmicro.2016.06.008; Gelaw TK, 2014, FOOD BIOPROCESS TECH, V7, P2084, DOI 10.1007/s11947-013-1195-4; Krasteva M, 2007, BBA-BIOENERGETICS, V1767, P114, DOI 10.1016/j.bbabio.2006.11.003; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Li H, 2012, INNOV FOOD SCI EMERG, V14, P99, DOI 10.1016/j.ifset.2011.11.009; Li J, 2016, APPL ENVIRON MICROB, V82, P1828, DOI 10.1128/AEM.03080-15; Li Jing, 2011, Transactions of the Chinese Society of Agricultural Engineering, V27, P355; Liu ZW, 2017, LWT-FOOD SCI TECHNOL, V76, P18, DOI 10.1016/j.lwt.2016.10.019; Lotfi R, 2015, CROP J, V3, P434, DOI 10.1016/j.cj.2015.05.006; Luengo E, 2014, J MEMBRANE BIOL, V247, P1269, DOI 10.1007/s00232-014-9688-2; Machado LF, 2010, J FOOD ENG, V96, P520, DOI 10.1016/j.jfoodeng.2009.08.035; Marx G, 2011, INT J FOOD MICROBIOL, V151, P327, DOI 10.1016/j.ijfoodmicro.2011.09.027; Mattar JR, 2014, FOOD BIOPROCESS TECH, V7, P3328, DOI 10.1007/s11947-014-1336-4; Mayle A, 2013, CYTOM PART A, V83A, P27, DOI 10.1002/cyto.a.22093; McAuley CM, 2016, INNOV FOOD SCI EMERG, V38, P365, DOI 10.1016/j.ifset.2016.09.030; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Moody A, 2014, FOOD CONTROL, V37, P305, DOI 10.1016/j.foodcont.2013.09.052; Perni S, 2007, INT J FOOD MICROBIOL, V120, P311, DOI 10.1016/j.ijfoodmicro.2007.10.002; Raithatha SA, 2009, J MICROBIOL METH, V78, P357, DOI 10.1016/j.mimet.2009.06.015; Saldana G, 2012, FOOD RES INT, V45, P1080, DOI 10.1016/j.foodres.2011.03.059; Sanchez-Moreno C, 2009, CRIT REV FOOD SCI, V49, P552, DOI 10.1080/10408390802145526; Schreiber R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3948; Somolinos M, 2010, INT J FOOD MICROBIOL, V141, P32, DOI 10.1016/j.ijfoodmicro.2010.04.023; Spilimbergo S, 2010, PROCESS BIOCHEM, V45, P647, DOI 10.1016/j.procbio.2009.12.013; Tao XY, 2015, INT J FOOD PROP, V18, P1416, DOI 10.1080/10942912.2014.917098; Velly H, 2015, APPL MICROBIOL BIOT, V99, P907, DOI 10.1007/s00253-014-6152-2; Vijayabhaskar K., 2016, WORLD J PHARM PHARM, V5, P1337; Waite-Cusic JG, 2011, J FOOD PROTECT, V74, P1655, DOI 10.4315/0362-028X.JFP-11-099; Wang MS, 2015, LWT-FOOD SCI TECHNOL, V60, P672, DOI 10.1016/j.lwt.2014.09.028; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Ying N. J., 2014, BIOTECHNOLOGY INDIAN, V10; Yun O, 2016, INNOV FOOD SCI EMERG, V36, P252, DOI 10.1016/j.ifset.2016.06.013; Zhao W, 2014, FOOD CONTROL, V39, P204, DOI 10.1016/j.foodcont.2013.11.015; Zhao W, 2013, FOOD CONTROL, V32, P6, DOI 10.1016/j.foodcont.2012.11.029; Zhao W, 2011, FOOD CONTROL, V22, P566, DOI 10.1016/j.foodcont.2010.10.006; Zhu N, 2017, INNOV FOOD SCI EMERG, V42, P180, DOI 10.1016/j.ifset.2017.07.016; Zulueta A, 2013, FOOD BIOPROCESS TECH, V6, P2018, DOI 10.1007/s11947-012-0858-x	57	4	5	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0198467	10.1371/journal.pone.0198467	http://dx.doi.org/10.1371/journal.pone.0198467			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29939985	Green Published, gold, Green Submitted			2022-12-26	WOS:000436088700004
J	Gianino, MM; Lenzi, J; Bonaudo, M; Fantini, MP; Ricciardi, W; Damiani, G				Gianino, Maria Michela; Lenzi, Jacopo; Bonaudo, Marco; Fantini, Maria Pia; Ricciardi, Walter; Damiani, Gianfranco			Predictors and trajectories of antibiotic consumption in 22 EU countries: Findings from a time series analysis (2000-2014)	PLOS ONE			English	Article							GENERAL-PRACTITIONERS; CARE; PERCEPTIONS; BEHAVIOR; ACCESS; INCOME	Background This study analyzes the trajectories of antibiotic consumption using different indicators of patients' socioeconomic status, category and age-group of physicians. Methods This study uses a pooled, cross-sectional, time series analysis. The data focus on 22 European countries from 2000 to 2014 and were obtained from the European Center for Disease and Control, Organization for Economic Co-operation and Development, Eurostat and Global Economic Monitor. Results There are large variations in community and hospital use of antibiotics in European countries, and the consumption of antibiotics has remained stable over the years. This applies to the community (b = 0.07, p = 0.267, 95% -0.06, 0.19, b-squared < 0.01, p = 0.813, 95% = -0.01, 0.02) as well as the hospital sector (b = -0.02; p = 0.450; CI 95% = -0.06, 0.03; b-squared < 0.01; p = 0.396; CI95% = > -0.01, < 0.01). Some socioeconomic variables, such as level of education, income, Gini index and unemployment, are not related to the rate of antibiotic use. The age-group of physicians and general practitioners is associated with the use of antibiotics in the hospital. An increase in the proportion of young doctors (< 45 years old) leads to a significant increase in antibiotics consumption, and as the percentage of generalist practitioners increases, there use of antibiotics in hospitals decreases by 0.04 DDD/1000 inhabitants. Conclusions Understanding that age-groups and categories (general/specialist practitioners) of physicians may predict antibiotic consumption is potentially useful in defining more effectivehealth care policies to reduce the inappropriate antibiotic use while promoting rational use.	[Gianino, Maria Michela; Bonaudo, Marco] Univ Torino, Dept Publ Hlth Sci & Pediat, Turin, Italy; [Lenzi, Jacopo; Fantini, Maria Pia] Alma Mater Studiorum Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Ricciardi, Walter; Damiani, Gianfranco] Univ Cattolica Sacro Cuore, Dept Publ Hlth, Fdn Policlin Agostino Gemelli IRCCS, Rome, Italy	University of Turin; University of Bologna; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Bonaudo, M (corresponding author), Univ Torino, Dept Publ Hlth Sci & Pediat, Turin, Italy.	marco.bonaudo@unito.it	Ricciardi, Walter/AAB-2056-2019; Damiani, Gianfranco/K-2782-2016; Lenzi, Jacopo/W-4835-2017	Ricciardi, Walter/0000-0002-5655-688X; Damiani, Gianfranco/0000-0003-3028-6188; Lenzi, Jacopo/0000-0003-2882-4223; Bonaudo, Marco/0000-0001-9278-8998				Allerberger F, 2009, EXPERT REV ANTI-INFE, V7, P1175, DOI [10.1586/eri.09.96, 10.1586/ERI.09.96]; BRADLEY CP, 1992, BRIT J GEN PRACT, V42, P454; Bruyndonckx R, 2014, J ANTIMICROB CHEMOTH, V69, P1981, DOI 10.1093/jac/dku063; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Cadieux G, 2007, CAN MED ASSOC J, V177, P877, DOI 10.1503/cmaj.070151; Cockburn J, 1997, BRIT MED J, V315, P520, DOI 10.1136/bmj.315.7107.520; CSDH, 2008, CLOS GAP GEN HLTH EQ; Dyar OJ, 2017, CLIN MICROBIOL INFEC, V23, P441, DOI 10.1016/j.cmi.2017.04.016; European Commission, 2017C21201 EUR COMM; Filippini M, 2006, HEALTH POLICY, V78, P77, DOI 10.1016/j.healthpol.2005.09.009; French GL, 2005, ADV DRUG DELIVER REV, V57, P1514, DOI 10.1016/j.addr.2005.04.005; GALOBARDES B., 2004, J EPIDEMIOLOGY COMMU, V60, P7, DOI DOI 10.1136/J; Goossens H, 2008, EURO SURVEILL B EUR, V13; Greene W.H., 2007, ECONOMETRIC ANAL; Howard P, 2017, J ANTIMICROB CHEMOTH, V72, P2910, DOI 10.1093/jac/dkx243; Hsiao C., 2003, ANAL PANEL DATA, Vsecond; Kirby A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073115; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Little P, 1997, BRIT MED J, V315, P350; Macinko J, 2003, HEALTH SERV RES, V38, P831, DOI 10.1111/1475-6773.00149; Masiero G, 2010, INT J PUBLIC HEALTH, V55, P469, DOI 10.1007/s00038-010-0167-y; Matuz M, 2006, BRIT J CLIN PHARMACO, V61, P96, DOI 10.1111/j.1365-2125.2005.02525.x; Ministry of Health, 2017, PNCAR NATL ACTION PL; Rezal RSM, 2015, EXPERT REV ANTI-INFE, V13, P665, DOI 10.1586/14787210.2015.1025057; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; SAYRS L., 1989, POOLED TIME SERIES A; Steffensen FH, 1997, SCAND J INFECT DIS, V29, P409, DOI 10.3109/00365549709011839; Stone S, 2000, ANN EMERG MED, V36, P320, DOI 10.1067/mem.2000.109341; van Doorslaer E, 2006, CAN MED ASSOC J, V174, P177, DOI 10.1503/cmaj.050584; Verbrugh Henri A., 1998, Clin Microbiol Infect, V4, P58, DOI 10.1111/j.1469-0691.1998.tb00339.x; World Health Organization, 2006, US IND MEAS COUNTR P; Zhao ZW, 2006, POPUL DEV REV, V32, P461, DOI 10.1111/j.1728-4457.2006.00133.x	32	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199436	10.1371/journal.pone.0199436	http://dx.doi.org/10.1371/journal.pone.0199436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933377	Green Published, gold, Green Submitted			2022-12-26	WOS:000436076600024
J	El Seifi, OS; Mortada, EM; Abdo, NM				El Seifi, Omnia S.; Mortada, Eman M.; Abdo, Naglaa M.			Effect of community-based intervention on knowledge, attitude, and self-efficacy toward home injuries among Egyptian rural mothers having preschool children	PLOS ONE			English	Article								Background Parent's level of knowledge, state of their attitude, and their self-efficacy are the most incriminated reasons for the faulty application of the first aid measures, particularly in children's home injuries. Objectives To assess the effect of a health education intervention on improving knowledge, attitude and self-efficacy of mothers having preschool children about home injuries and the basic first aid measures. Methods A pre-posttest evaluation of the effect of a health education intervention on changing knowledge, attitude, and self-efficacy about home injuries and the basic first aid measures of 244 rural Egyptian mothers having preschool children. Results About 35% of the male children had home injuries 8 weeks earlier to the study. Mean score of total knowledge increased from 10.21 +/- 3.1 in pretest to 18.90 +/- 2.6 in posttest, total attitude from 6.19 +/- 1.8 to 10.26 +/- 2.3 and self-efficacy from 20.75 +/- 6.1 to 34.43 +/- 10.1 with (p < 0.001) for all changes. Age, education level and previous home injuries were the significant predicting factors for total knowledge, attitude and self-efficacy of the mothers. Conclusion Health education improves knowledge, attitude, and self-efficacy of the mothers which were obvious regarding home injuries than first aid measures. There is a need for including knowledge about home injuries in the educational curriculum of high schools and universities and to perform training courses to mothers about first aid measures.	[El Seifi, Omnia S.; Mortada, Eman M.; Abdo, Naglaa M.] Zagazig Univ, Fac Med, Dept Community Environm & Occupat Med, Zagazig, Egypt; [Mortada, Eman M.] Princess Nourah Bint Abdulrahman Univ, Hlth & Rehabil Sci Coll, Hlth Sci Dept, Riyadh, Saudi Arabia	Egyptian Knowledge Bank (EKB); Zagazig University; Princess Nourah bint Abdulrahman University	El Seifi, OS (corresponding author), Zagazig Univ, Fac Med, Dept Community Environm & Occupat Med, Zagazig, Egypt.	omnia2200@yahoo.com	Mortada, Eman/AAP-4354-2020; Elseifi, Omnia Samir/A-9264-2018	Mortada, Eman/0000-0002-8660-4299; Elseifi, Omnia Samir/0000-0002-0510-7128				Abd El-Aty NS, 2005, AUBER J, V8, P11; Abd El-Wahed MA, 2000, ALEXANDRIA J PEDIAT, V14, P65; Aggarwal R, 2010, INTERNET J HEAL, V11, DOI [10.5580/1d1f, DOI 10.5580/1D1F]; Amin M, 1998, EGYPTIAN J COMMUNITY, V16, P31; [Anonymous], 2010, PROTECT ONES YOU LOV; [Anonymous], 2010, IBM SPSS STAT 19 COR; Bayomi SS, 2013, J AM SCI, V9, P203; CAPMAS. Central Agency for Public Mobilization And Statistics, 2016, NAT ANN REP 2016; Chatsantiprapa K, 2001, SAFETY PROMOTION INJ, V7, P214; Eldosoky RSH, 2010, E MEDITERR HEALTH J, V18, P1021; Fardazar FE, 2016, INT J PEDIATR-MASSHA, V4, P2051; Fathi Shekhi M, 2015, J SAF PROM INJ PREV, V3, P199; Golshiri P., 2011, IRAN J MED ED, V10, P927; Grossman D., 2000, PEDIATR CLIN N AM, V39, P471; Kamal NN, 2013, J COMMUN HEALTH, V38, P873, DOI 10.1007/s10900-013-9692-y; Kamel EG, 2014, SCI J PUBLIC HEAL, V2, P653, DOI [10.11648/j.sjph.20140206.35, DOI 10.11648/J.SJPH.20140206.35]; Kendrick D., 2007, COCHRANE DB SYST REV, V24; Kendrick Denise, 2013, Evid Based Child Health, V8, P761, DOI 10.1002/ebch.1911; Kluwer W., 2010, COMMUNITY HLTH NURSI, P577; Mack KA, 2010, AM J LIFESTYLE MED, V4, P75, DOI 10.1177/1559827609348476; Mahalakshmy T, 2011, INDIAN J PEDIATR, V78, P821, DOI 10.1007/s12098-010-0343-3; Mason M, 2007, ARCH PEDIAT ADOL MED, V161, P759, DOI 10.1001/archpedi.161.8.759; Mohammed Ahmed WA, 2014, PRIM HLTH CARE, V4, P156, DOI DOI 10.4172/2167-1079.1000156; Morrongiello BA, 2009, SOC SCI MED, V68, P1030, DOI 10.1016/j.socscimed.2008.12.019; Nansel TR, 2002, PATIENT EDUC COUNS, V46, P175, DOI 10.1016/S0738-3991(01)00211-7; Nits AM, 2007, COMMUNITY PUBLIC HLT, P267; Ozturk C, 2010, ANATOL J CLIN INVEST, V4, P15; Rafiefar SH, 2005, SYSTEMATIC EMPOWERME; Royal Society for the Prevention of Accidents home, DEL ACC PREV LOC LEV; SHERER M, 1982, PSYCHOL REP, V51, P663, DOI 10.2466/pr0.1982.51.2.663; Suguna TC, 2015, INT J DEV RES, V5, P3729; Tomrulk O, 2007, ADV THER, V24, P691, DOI 10.1007/BF02849962; Vahdaninya Z, 2015, MOD CARE J, V12, P119; WHO, 2008, 10 FACTS INJ VIOL	34	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198964	10.1371/journal.pone.0198964	http://dx.doi.org/10.1371/journal.pone.0198964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK0LV	29927950	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500039
J	Panga, V; Raghunathan, S				Panga, Venugopal; Raghunathan, Srivatsan			A cytokine protein-protein interaction network for identifying key molecules in rheumatoid arthritis	PLOS ONE			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; SYNOVIAL FIBROBLASTS; CHEMOKINE PRODUCTION; TNF-ALPHA; PROINFLAMMATORY CYTOKINES; INFLAMMATORY CYTOKINES; INCREASED EXPRESSION; UP-REGULATION	Rheumatoid arthritis (RA) is a chronic inflammatory disease of the synovial joints. Though the current RA therapeutics such as disease-modifying antirheumatic drugs (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs) and biologics can halt the progression of the disease, none of these would either dramatically reduce or cure RA. So, the identification of potential therapeutic targets and new therapies for RA are active areas of research. Several studies have discovered the involvement of cytokines in the pathogenesis of this disease. These cytokines induce signal transduction pathways in RA synovial fibroblasts (RASF). These pathways share many signal transducers and their interacting proteins, resulting in the formation of a signaling network. In order to understand the involvement of this network in RA pathogenesis, it is essential to identify the key transducers and their interacting proteins that are part of this network. In this study, based on a detailed literature survey, we have identified a list of 12 cytokines that induce signal transduction pathways in RASF. For these cytokines, we have built a signaling network using the protein-protein interaction (PPI) data that was obtained from public repositories such as HPRD, BioGRID, MINT, IntAct and STRING. By combining the network centrality measures with the gene expression data from the RA related microarrays that are available in the open source Gene Expression Omnibus (GEO) database, we have identified 24 key proteins of this signaling network. Two of these 24 are already drug targets for RA, and of the remaining, 12 have direct PPI links to some of the current drug targets of RA. Therefore, these key proteins seem to be crucial in the pathogenesis of RA and hence might be treated as potential drug targets.	[Panga, Venugopal; Raghunathan, Srivatsan] Inst Bioinformat & Appl Biotechnol, Biotech Pk,Elect City Phase 1, Bengaluru, Karnataka, India; [Panga, Venugopal] Manipal Acad Higher Educ, Manipal, Karnataka, India	Manipal Academy of Higher Education (MAHE)	Raghunathan, S (corresponding author), Inst Bioinformat & Appl Biotechnol, Biotech Pk,Elect City Phase 1, Bengaluru, Karnataka, India.	srivatsan@ibab.ac.in		panga, venugopal/0000-0002-9262-3277	Council of Scientific and Industrial Research (CSIR), Government of India [09/1086(0001)/2012-EMR-1]; Department of Biotechnology, Government of India [BTPR12422/MED/31/287/2014]	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Mr. Venugopal Panga has received his fellowship from the Council of Scientific and Industrial Research (CSIR), Government of India, Grant No. 09/1086(0001)/2012-EMR-1, URL: http://www.csirhrdg.res.in/. This project was partially supported by a grant from the Department of Biotechnology, Government of India (BTPR12422/MED/31/287/2014, valid November 2014 to 2017), URL: http://www.dbtindia.nic.in/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2006, ARTHRITIS RHEUM-US, V54, P2393, DOI 10.1002/art.22023; Ahn JK, 2012, INFLAMMATION, V35, P474, DOI 10.1007/s10753-011-9336-2; Aikawa Y, 2008, NAT BIOTECHNOL, V26, P817, DOI 10.1038/nbt1412; Akhtar N, 2016, J IMMUNOL, V197, P2219, DOI 10.4049/jimmunol.1600360; Angiolilli C, 2017, ANN RHEUM DIS, V76, P277, DOI 10.1136/annrheumdis-2015-209064; Angiolilli C, 2016, ANN RHEUM DIS, V75, P430, DOI 10.1136/annrheumdis-2014-205635; [Anonymous], [No title captured]; Araki Y, 2016, ARTHRITIS RHEUMATOL, V68, P1111, DOI 10.1002/art.39563; Bang JS, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2662; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bhattacharjee M, 2016, CLIN PROTEOM, V13, DOI 10.1186/s12014-016-9113-1; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Browne F, 2018, INT J MACH LEARN CYB, V9, P455, DOI 10.1007/s13042-016-0503-5; Chang X, 2014, CLIN EXP IMMUNOL, V176, P222, DOI 10.1111/cei.12268; Charbonneau M, 2016, J IMMUNOL, V196, P3264, DOI 10.4049/jimmunol.1500502; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Cheon H, 2002, CLIN EXP IMMUNOL, V127, P547, DOI 10.1046/j.1365-2249.2002.01785.x; Chung BKS, 2013, J ANTIMICROB CHEMOTH, V68, P2701, DOI 10.1093/jac/dkt273; Craig J, 2008, NAT ED, V1, P184; Dey P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161306; Filer A, 2009, ARTHRITIS RHEUM, V60, P1604, DOI 10.1002/art.24574; Fleishaker DL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3685; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Fujikado N, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1985; Gautam R, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1069-1; Gerlag DM, 2010, ARTHRITIS RHEUM-US, V62, P3154, DOI 10.1002/art.27652; Granet C, 2004, ARTHRITIS RES THER, V6, pR190, DOI 10.1186/ar1159; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; Hammaker DR, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2215; Han CW, 2001, RHEUMATOLOGY, V40, P267, DOI 10.1093/rheumatology/40.3.267; Hashiramoto A, 1999, ARTHRITIS RHEUM, V42, P954, DOI 10.1002/1529-0131(199905)42:5<954::AID-ANR14>3.0.CO;2-J; Hwang D, 2017, NAT REV RHEUMATOL, V13, P5, DOI 10.1038/nrrheum.2016.194; Hwang SY, 2004, ARTHRITIS RES THER, V6, pR120, DOI 10.1186/ar1038; Igarashi H, 2012, IMMUNOL LETT, V141, P246, DOI 10.1016/j.imlet.2011.10.011; Ishida S, 2008, J RHEUMATOL, V35, P960; Jailkhani N, 2011, GENOME RES, V21, P2067, DOI 10.1101/gr.116145.110; Ji JD, 2001, J AUTOIMMUN, V17, P215, DOI 10.1006/jaut.2001.0542; Kang YM, 2007, ARTHRITIS RHEUM, V56, P1106, DOI 10.1002/art.22493; Kasperkovitz PV, 2004, ANN RHEUM DIS, V63, P233, DOI 10.1136/ard.2003.013276; Killock David, 2012, Nat Rev Rheumatol, V8, P247, DOI 10.1038/nrrheum.2012.45; Kim HR, 2007, RHEUMATOLOGY, V46, P57, DOI 10.1093/rheumatology/kel159; Kim KJ, 2015, KOREAN J INTERN MED, V30, P148, DOI 10.3904/kjim.2015.30.2.148; Kim KW, 2007, ARTHRITIS RHEUM-US, V56, P1076, DOI 10.1002/art.22439; Kitahara K, 2012, INFLAMM RES, V61, P1385, DOI 10.1007/s00011-012-0541-8; Kong QZ, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/3906108; Kontny E, 2000, ARTHRITIS RHEUM, V43, P2169, DOI 10.1002/1529-0131(200010)43:10<2169::AID-ANR4>3.0.CO;2-#; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lazzerini PE, 2007, CLIN EXP RHEUMATOL, V25, P696; Lee A, 2013, ARTHRITIS RHEUM-US, V65, P928, DOI 10.1002/art.37853; Lee EJ, 2016, CYTOKINE, V77, P35, DOI 10.1016/j.cyto.2015.10.005; Lee HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136122; Lee SY, 2014, IMMUNOLOGY, V141, P353, DOI 10.1111/imm.12196; Lee SY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4179; Lee Y, 2011, J DERMATOL, V38, P1072, DOI 10.1111/j.1346-8138.2011.01260.x; Liu FL, 2007, RHEUMATOLOGY, V46, P1266, DOI 10.1093/rheumatology/kem055; Matthys P, 2001, J IMMUNOL, V167, P4686, DOI 10.4049/jimmunol.167.8.4686; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Miossec P, 2003, ARTHRITIS RHEUM-US, V48, P594, DOI 10.1002/art.10816; Moelants EAV, 2013, IMMUNOL CELL BIOL, V91, P393, DOI 10.1038/icb.2013.15; Morel JCM, 2001, LAB INVEST, V81, P1371, DOI 10.1038/labinvest.3780351; Muller-Ladner U, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2337; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okamoto H, 2010, ARTHRITIS RHEUM-US, V62, P82, DOI 10.1002/art.25063; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Pap T, 2004, ARTHRITIS RHEUM-US, V50, P2794, DOI 10.1002/art.20461; Perdigones N, 2010, ARTHRITIS RHEUM-US, V62, P705, DOI 10.1002/art.27292; Plant D, 2012, ARTHRITIS RHEUM-US, V64, P665, DOI 10.1002/art.33381; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Sakuma M, 2007, INT IMMUNOL, V19, P117, DOI 10.1093/intimm/dxl128; Schmutz C, 2005, ARTHRITIS RES THER, V7, pR217, DOI 10.1186/ar1475; Shibata Y, 2009, J PHOTOCH PHOTOBIO B, V94, P164, DOI 10.1016/j.jphotobiol.2008.11.012; Sohn C, 2015, ARTHRITIS RHEUMATOL, V67, P86, DOI 10.1002/art.38871; Sotoudehmanesh R, 2010, Middle East J Dig Dis, V2, P104; Sprenger J, 2008, NUCLEIC ACIDS RES, V36, pD230, DOI 10.1093/nar/gkm950; Swanson CD, 2012, J IMMUNOL, V188, P3513, DOI 10.4049/jimmunol.1102693; Swanson CD, 2009, NAT REV RHEUMATOL, V5, P317, DOI 10.1038/nrrheum.2009.82; Sweeney SE, 2010, J IMMUNOL, V184, P7162, DOI 10.4049/jimmunol.0903944; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tamamura H, 2004, FEBS LETT, V569, P99, DOI 10.1016/j.febslet.2004.05.056; Tieri P, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00059; Trenkmann M, 2013, ARTHRITIS RHEUM-US, V65, P916, DOI 10.1002/art.37834; Tsuchiya A, 2010, J PHARMACOL EXP THER, V333, P236, DOI 10.1124/jpet.109.158899; Warstat K, 2010, ANN RHEUM DIS, V69, P270, DOI 10.1136/ard.2008.091116; Watanabe K, 2010, ARTHRITIS RHEUM-US, V62, P3211, DOI 10.1002/art.27650; Wong CK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3067; Xing R, 2016, CLIN EXP IMMUNOL, V184, P147, DOI 10.1111/cei.12751; Xing R, 2016, SCAND J IMMUNOL, V83, P64, DOI 10.1111/sji.12396; Xu H, 2007, RHEUMATOLOGY, V46, P920, DOI 10.1093/rheumatology/kem014; Xu J, 2011, BIOL PHARM BULL, V34, P1724; Yang CM, 2010, J CELL PHYSIOL, V224, P516, DOI 10.1002/jcp.22153; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zhang Lin, 2011, Laser Therapy, V20, P53; Zhang QY, 2009, ARTHRITIS RHEUM-US, V60, P3602, DOI 10.1002/art.24999; Zhou R, 2006, ARTIF INTELL, V170, P385, DOI 10.1016/j.artint.2005.12.002; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	101	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199530	10.1371/journal.pone.0199530	http://dx.doi.org/10.1371/journal.pone.0199530			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928007	Green Published, Green Submitted, gold			2022-12-26	WOS:000435802500106
J	Thakar, M; Hu, Y; Morreale, M; Lerner, L; Lin, WY; Sen, R; Cai, Y; Karunasena, E; Thakar, M; Saggi, S; Keer, H; Ahuja, N				Thakar, Manjusha; Hu, Yue; Morreale, Michael; Lerner, Lane; Lin, Wan Ying; Sen, Rupashree; Cai, Yi; Karunasena, Enusha; Thakar, Maya; Saggi, Soren; Keer, Harold; Ahuja, Nita			A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent	PLOS ONE			English	Article							DNA METHYLTRANSFERASE INHIBITORS; OVARIAN-CANCER; CYCLE ARREST; METHYLATION; EXPRESSION; ADENOCARCINOMA; DECITABINE; MUTATIONS; THERAPY; PATHWAY	Pancreatic ductal adenocarcinoma (PDAC) is expected to be the second leading cause of cancer mortality by 2030. PDAC remains resistant to the majority of systemic chemotherapies. In this paper, we explore if epigenetic sensitization can improve chemotherapy response in PDAC. Multiple PDAC cell lines were tested with serial concentrations of the epigenetic modulators 5-azacitidine (Aza) and guadecitabine (SGI-110). Guadecitabine was effective at inhibiting the expression of DNA Methyltransferase 1 (DNMT1) and in decreasing cell viability at nanomolar concentrations. We also report that guadecitabine has increased efficacy following a delay period or as we reference, a 'rest period'. Sensitization with guadecitabine improved response to the chemotherapeutic agent-Irinotecan-as measured by decreased cell viability and accompanied by an increase in caspase activity. Additional studies are needed to understand the mechanism of action.	[Thakar, Manjusha; Hu, Yue; Morreale, Michael; Lerner, Lane; Lin, Wan Ying; Thakar, Maya; Saggi, Soren; Ahuja, Nita] Johns Hopkins Univ, Dept Surg Oncol, Baltimore, MD 21218 USA; [Sen, Rupashree; Cai, Yi; Karunasena, Enusha; Ahuja, Nita] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA; [Keer, Harold] Astex Pharmaceut Inc, Pleasanton, CA USA; [Ahuja, Nita] Johns Hopkins Univ, Dept Urol, Baltimore, MD 21218 USA; [Hu, Yue] Hosp Zhejiang Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Ahuja, Nita] Yale Univ, Dept Surg, New Haven, CT 06520 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Zhejiang University; Yale University	Thakar, M; Ahuja, N (corresponding author), Johns Hopkins Univ, Dept Surg Oncol, Baltimore, MD 21218 USA.; Ahuja, N (corresponding author), Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA.; Ahuja, N (corresponding author), Johns Hopkins Univ, Dept Urol, Baltimore, MD 21218 USA.; Ahuja, N (corresponding author), Yale Univ, Dept Surg, New Haven, CT 06520 USA.	mthakar3@jhmi.edu; nita.ahuja@yale.edu	Sen, Rupashree/AAM-9430-2020	KARUNASENA, ENUSHA/0000-0002-9069-9681; Sen, Rupashree/0000-0003-2121-6161; Morreale, Michael/0000-0003-3610-9641	National Cancer Institute [R01CA185357]; Astex Pharmaceuticals; NATIONAL CANCER INSTITUTE [R01CA185357] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Astex Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute under award number R01CA185357 as well as by Astex Pharmaceuticals (N.A.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder provided support in the form of salary for author (H. K.), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.	Ahuja N, 2016, ANNU REV MED, V67, P73, DOI 10.1146/annurev-med-111314-035900; Alexander VM, 2010, INT J CLIN EXP MED, V3, P95; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Cai Y, 2017, GENOME RES, V27, P533, DOI 10.1101/gr.208108.116; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; CHABNER BA, 1973, BIOCHEM PHARMACOL, V22, P2763, DOI 10.1016/0006-2952(73)90137-8; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; Clozel T, 2013, CANCER DISCOV, V3, P1002, DOI 10.1158/2159-8290.CD-13-0117; Cohen AL, 2017, ONCOTARGET, V8, P52413, DOI 10.18632/oncotarget.14183; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Coral S, 2013, CANCER IMMUNOL IMMUN, V62, P605, DOI 10.1007/s00262-012-1365-7; De Carvalho Fischer Cynthia, 2018, Oncotarget, V9, P19379, DOI 10.18632/oncotarget.25056; Easwaran H, 2012, GENOME RES, V22, P837, DOI 10.1101/gr.131169.111; Fang F, 2014, CLIN CANCER RES, V20, P6504, DOI 10.1158/1078-0432.CCR-14-1553; Fu SQ, 2011, CANCER-AM CANCER SOC, V117, P1661, DOI 10.1002/cncr.25701; Gao J, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-86; Gayet O, 2015, ONCOTARGET, V6, P746, DOI 10.18632/oncotarget.2685; Gore SD, 2006, CANCER RES, V66, P6361, DOI 10.1158/0008-5472.CAN-06-0080; Iacobuzio-Donahue CA, 2004, CLIN CANCER RES, V10, P1597, DOI 10.1158/1078-0432.CCR-1121-3; Issa JPJ, 2004, BLOOD, V103, P1635, DOI 10.1182/blood-2003-03-0687; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kantarjian HM, 2017, LANCET ONCOL, V18, P1317, DOI 10.1016/S1470-2045(17)30576-4; Lee V WJ, 2016, AACR 107 ANN M; Li A, 2010, CANCER BIOL THER, V9, P321, DOI 10.4161/cbt.9.4.10750; Ma JA, 2010, CARCINOGENESIS, V31, P1552, DOI 10.1093/carcin/bgq140; Matei D, 2012, CANCER RES, V72, P2197, DOI 10.1158/0008-5472.CAN-11-3909; Matei DE, 2010, GYNECOL ONCOL, V116, P195, DOI 10.1016/j.ygyno.2009.09.043; Missiaglia E, 2005, ONCOGENE, V24, P199, DOI 10.1038/sj.onc.1208018; Mostovich LA, 2011, CELL ADHES MIGR, V5, P395, DOI 10.4161/cam.5.5.17949; Oronsky B, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00134; Pan FP, 2016, ONCOL REP, V35, P1941, DOI 10.3892/or.2016.4554; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; REDSTON MS, 1994, CANCER RES, V54, P3025; Rosty C, 2003, AM J SURG PATHOL, V27, P1495, DOI 10.1097/00000478-200312000-00001; SCARPA A, 1993, AM J PATHOL, V142, P1534; Schutte M, 1997, CANCER RES, V57, P3126; Sen R, 2007, J MED MICROBIOL, V56, P1213, DOI 10.1099/jmm.0.47364-0; Shakya R, 2013, CANCER RES, V73, P885, DOI 10.1158/0008-5472.CAN-12-1880; Sharma A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176139; Silverman LR, 2004, BEST PRACT RES CL HA, V17, P585, DOI 10.1016/j.beha.2004.08.010; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Subramaniam D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00080; Tan AC, 2009, MOL ONCOL, V3, P425, DOI 10.1016/j.molonc.2009.03.004; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; VANGROENINGEN CJ, 1986, CANCER RES, V46, P4831; Wang X, 2013, GENET MOL RES, V12, P5560, DOI 10.4238/2013.November.18.6; Wrangle J, 2014, CLIN CANCER RES, V20, P1856, DOI 10.1158/1078-0432.CCR-13-2109; Yi JM, 2008, CANCER RES, V68, P8094, DOI 10.1158/0008-5472.CAN-07-6208; Yi JM, 2013, CLIN CANCER RES, V19, P6544, DOI 10.1158/1078-0432.CCR-12-3224	50	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199130	10.1371/journal.pone.0199130	http://dx.doi.org/10.1371/journal.pone.0199130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927979	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500046
J	Weber, S; Dienemann, T; Jacobi, J; Eckardt, KU; Weidemann, A				Weber, Susanne; Dienemann, Thomas; Jacobi, Johannes; Eckardt, Kai-Uwe; Weidemann, Alexander			Delayed graft function is associated with an increased rate of renal allograft rejection: A retrospective single center analysis	PLOS ONE			English	Article							PROPORTIONAL HAZARDS MODELS; KIDNEY-TRANSPLANTATION; RISK-FACTORS; LOGISTIC-REGRESSION; REPERFUSION INJURY; PROTOCOL BIOPSIES; PATIENT SURVIVAL; CLINICAL-TRIALS; IMPACT; PERSPECTIVE	Introduction The association of delayed graft function (DGF) and biopsy proven acute rejection (BPAR) of renal allografts is controversial. Borderline rejections comprise a major portion of biopsy results but the significance of such histologic changes is debated. The present study explores the impact of DGF on BPAR with a special emphasis on discriminating the effects of borderline rejection. Methods Single center analysis of 417 deceased donor kidney recipients (age>18; transplantation date 1/2008-2/2015). Patients with primary non-function were excluded. DGF was defined as the need for dialysis within the first week after transplantation. Acute rejection was defined according to Banff criteria. Cox proportional hazards models were used to examine the relationship of DGF with BPAR within the first year. Results No graft loss was observed during the first year after transplantation. DGF significantly associated with BPAR in the first year, irrespective of whether borderline rejections were included (HR 1.71, 95%Cl 1.16,2.53) or excluded (HR 1.79, 95%Cl 1.13,2.84). Conclusion DGF is significantly associated-with rejection with or without borderline changes-within the first year.	[Weber, Susanne; Dienemann, Thomas; Jacobi, Johannes; Weidemann, Alexander] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Nephrol & Hypertensiol, Med Klin 4, Erlangen, Germany; [Eckardt, Kai-Uwe] Charite, Nephrol & Internist Intens Med, Med Klin, Berlin, Germany; [Weidemann, Alexander] Klinikum Univ Witten Herdecke, Krankenhaus Koln Merheim, Transplantat & Internist Intens Med, Nephrol,Med Klin 1, Cologne, Germany	University of Erlangen Nuremberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Dienemann, T (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Nephrol & Hypertensiol, Med Klin 4, Erlangen, Germany.	thomas.dienemann@uk-erlangen.de		Dienemann, Thomas/0000-0001-8846-3445				ABBOTT RD, 1985, AM J EPIDEMIOL, V121, P465, DOI 10.1093/oxfordjournals.aje.a114019; Akkina SK, 2009, AM J TRANSPLANT, V9, P1460, DOI 10.1111/j.1600-6143.2009.02651.x; ANNESI I, 1989, STAT MED, V8, P1515, DOI 10.1002/sim.4780081211; Bouamar R, 2013, AM J TRANSPLANT, V13, P1253, DOI 10.1111/ajt.12191; Brennan DC, 2006, NEW ENGL J MED, V355, P1967, DOI 10.1056/NEJMoa060068; Chaumont M, 2015, J TRANSPLANT, V2015, DOI 10.1155/2015/163757; de Freitas DG, 2012, AM J TRANSPLANT, V12, P191, DOI 10.1111/j.1600-6143.2011.03784.x; Doshi MD, 2011, TRANSPLANTATION, V91, P666, DOI 10.1097/TP.0b013e318209f22b; Dunn TB, 2011, AM J TRANSPLANT, V11, P2132, DOI 10.1111/j.1600-6143.2011.03640.x; Fonseca I, 2015, TRANSPL INT, V28, P738, DOI 10.1111/tri.12543; Gill J, 2016, KIDNEY INT, V89, P1331, DOI 10.1016/j.kint.2016.01.028; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hellemans R, 2017, AM J TRANSPLANT, V17, P22, DOI 10.1111/ajt.13884; Hruba P, 2015, KIDNEY INT, V88, P785, DOI 10.1038/ki.2015.211; Irish WD, 2010, AM J TRANSPLANT, V10, P2279, DOI 10.1111/j.1600-6143.2010.03179.x; Kayler LK, 2011, AM J TRANSPLANT, V11, P2657, DOI 10.1111/j.1600-6143.2011.03817.x; Klein R, 2013, TRANSPLANTATION, V95, P611, DOI 10.1097/TP.0b013e318279153c; Land WG, 2005, TRANSPLANTATION, V79, P505, DOI 10.1097/01.TP.0000153160.82975.86; Lebranchu Y, 2005, TRANSPLANT P, V37, P345, DOI 10.1016/j.transproceed.2004.12.297; LEVEY AS, 1993, J AM SOC NEPHROL, V4, P1159; Maggiore U, 2015, NEPHROL DIAL TRANSPL, V30, P217, DOI 10.1093/ndt/gfu212; McLaren AJ, 1999, CLIN TRANSPLANT, V13, P266, DOI 10.1034/j.1399-0012.1999.130308.x; Meehan SM, 1999, J AM SOC NEPHROL, V10, P1806; Mengel M, 2011, AM J TRANSPLANT, V11, P708, DOI 10.1111/j.1600-6143.2010.03339.x; Mikhalski D, 2008, TRANSPLANTATION, V85, pS3, DOI 10.1097/TP.0b013e318169c29e; Nicholson ML, 1996, TRANSPL INT, V9, P415, DOI 10.1111/j.1432-2277.1996.tb00901.x; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; Oppenheimer F, 2004, NEPHROL DIAL TRANSPL, V19, P11, DOI 10.1093/ndt/gfh1008; Perasaari JP, 2016, NEPHROL DIAL TRANSPL, V31, P672, DOI 10.1093/ndt/gfv391; Ponticelli C, 2014, NEPHROL DIAL TRANSPL, V29, P1134, DOI 10.1093/ndt/gft488; Pratschke J, 2016, TRANSPLANT REV-ORLAN, V30, P77, DOI 10.1016/j.trre.2016.02.002; Qureshi F, 2002, TRANSPLANTATION, V74, P1400, DOI 10.1097/00007890-200211270-00010; Rodrigo E, 2005, TRANSPL P, V37, P1431, DOI 10.1016/j.transproceed.2005.02.052; Rodrigo E, 2016, TRANSPLANTATION, V100, P2479, DOI 10.1097/TP.0000000000001040; Seron D, 2007, KIDNEY INT, V72, P690, DOI 10.1038/sj.ki.5002396; Sharif A, 2013, AM J KIDNEY DIS, V62, P150, DOI 10.1053/j.ajkd.2012.11.050; Siedlecki A, 2011, AM J TRANSPLANT, V11, P2279, DOI 10.1111/j.1600-6143.2011.03754.x; Tennankore KK, 2016, KIDNEY INT, V89, P648, DOI 10.1016/j.kint.2015.09.002; Troppmann C, 1996, TRANSPLANTATION, V61, P1331, DOI 10.1097/00007890-199605150-00008; van der Net JB, 2008, EUR J HUM GENET, V16, P1111, DOI 10.1038/ejhg.2008.59; Wu WK, 2015, KIDNEY INT, V88, P851, DOI 10.1038/ki.2015.190; Yarlagadda G, 2008, NEPHROL DIAL TRANSPL, V23, P2995, DOI 10.1093/ndt/gfn158; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667	43	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199445	10.1371/journal.pone.0199445	http://dx.doi.org/10.1371/journal.pone.0199445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928026	gold, Green Published, Green Submitted			2022-12-26	WOS:000435802500093
J	Helber, SB; Hoeijmakers, DJJ; Muhando, CA; Rohde, S; Schupp, PJ				Helber, Stephanie B.; Hoeijmakers, Dieuwke J. J.; Muhando, Christopher A.; Rohde, Sven; Schupp, Peter J.			Sponge chemical defenses are a possible mechanism for increasing sponge abundance on reefs in Zanzibar	PLOS ONE			English	Article							WESTERN INDIAN-OCEAN; BIOLOGICALLY-ACTIVE SUBSTANCES; CORAL POCILLOPORA-DAMICORNIS; CRAMBE CRAMBE DEMOSPONGIAE; HALICLONA RENIERA SP; MARINE SPONGE; ANTIMICROBIAL ACTIVITY; SECONDARY METABOLITES; VIBRIO-ALGINOLYTICUS; CARIBBEAN SPONGES	Coral reefs are experiencing increasing anthropogenic impacts that result in substantial declines of reef-building corals and a change of community structure towards other benthic invertebrates or macroalgae. Reefs around Zanzibar are exposed to untreated sewage and runoff from the main city Stonetown. At many of these sites, sponge cover has increased over the last years. Sponges are one of the top spatial competitors on reefs worldwide. Their success is, in part, dependent on their strong chemical defenses against predators, microbial attacks and other sessile benthic competitors. This is the first study that investigates the bioactive properties of sponge species in the Western Indian Ocean region. Crude extracts of the ten most dominant sponge species were assessed for their chemical defenses against 35 bacterial strains (nine known as marine pathogens) using disc diffusion assays and general cytotoxic activities were assessed with brine shrimp lethality assays. The three chemically most active sponge species were additionally tested for their allelopathic properties against the scleractinian coral competitor Porites sp.. The antimicrobial assays revealed that all tested sponge extracts had strong antimicrobial properties and that the majority (80%) of the tested sponges were equally defended against pathogenic and environmental bacterial strains. Additionally, seven out of ten sponge species exhibited cytotoxic activities in the brine shrimp assay. Moreover, we could also show that the three most bioactive sponge species were able to decrease the photosynthetic performance of the coral symbionts and thus were likely to impair the coral physiology.	[Helber, Stephanie B.; Hoeijmakers, Dieuwke J. J.] Leibniz Ctr Trop Marine Res ZMT, Bremen, Germany; [Helber, Stephanie B.; Rohde, Sven; Schupp, Peter J.] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Wilhelmshaven, Germany; [Muhando, Christopher A.] Univ Dar es Salaam, IMS, Stonetown, Zanzibar, Tanzania; [Schupp, Peter J.] Carl von Ossietzky Univ Oldenburg, Helmholtz Inst Funct Marine Biodivers, Oldenburg, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Carl von Ossietzky Universitat Oldenburg; University of Dar es Salaam; Carl von Ossietzky Universitat Oldenburg	Helber, SB (corresponding author), Leibniz Ctr Trop Marine Res ZMT, Bremen, Germany.; Helber, SB; Schupp, PJ (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Wilhelmshaven, Germany.; Schupp, PJ (corresponding author), Carl von Ossietzky Univ Oldenburg, Helmholtz Inst Funct Marine Biodivers, Oldenburg, Germany.	stephanie.helber@leibniz.zmt.de; peter.schupp@uni-oldenburg.de	Schupp, Peter j/D-3296-2015; FENG, SHUXIAN/W-4643-2018	Helber, Stephanie/0000-0001-6579-7928; Schupp, Peter Josef/0000-0003-4831-2751	German Leibniz Association (WGL) [SAW-2013-ZMT-4]; internal funds of the Institute for Chemistry and Biology of the Marine Environment (ICBM); SUTAS project [SAW-2013-ZMT-4]; German Leibniz Association (WGL); ICBM, University of Oldenburg	German Leibniz Association (WGL); internal funds of the Institute for Chemistry and Biology of the Marine Environment (ICBM); SUTAS project; German Leibniz Association (WGL); ICBM, University of Oldenburg	The study was funded by the German Leibniz Association (WGL) and had the Grant number SAW-2013-ZMT-4 to Peter Schupp. Additional funding was provided by internal funds of the Institute for Chemistry and Biology of the Marine Environment (ICBM) to Peter Schupp, University of Oldenburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank staff and students at the IMS in Zanzibar, the ZMT and the members of the environmental biochemistry group at the ICBM in Wilhelmshaven (especially M Moller, S Nietzer and G Steinert), University of Oldenburg. We greatly appreciate the field and diving assistance of NS Jiddawi, MS Shalli, FE Belshe, S Brohl and U Pint. We would like to thank JG Plass-Johnson and FE Belshe for insightful comments on the manuscript. Stephanie B Helber acknowledges funding of the SUTAS project (SAW-2013-ZMT-4) by the German Leibniz Association (WGL) and PJ Schupp internal funding by the ICBM, University of Oldenburg.	Aerts LAM, 1997, MAR ECOL PROG SER, V148, P125, DOI 10.3354/meps148125; Aerts LAM, 1999, SPONGE CORAL INTERAC, DOI [10.1159/000144207, DOI 10.1159/000144207]; AMADE P, 1987, MAR BIOL, V94, P271, DOI 10.1007/BF00392940; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andras TD, 2012, J CHEM ECOL, V38, P1203, DOI 10.1007/s10886-012-0204-9; Angermeier H, 2011, FEMS MICROBIOL ECOL, V75, P218, DOI 10.1111/j.1574-6941.2010.01001.x; Anguiano-Beltran C, 1998, DIS AQUAT ORGAN, V33, P119, DOI 10.3354/dao033119; Angulo-Preckler C, 2015, POLAR BIOL, V38, P1941, DOI 10.1007/s00300-015-1754-4; Ankisetty S, 2004, J NAT PROD, V67, P1295, DOI 10.1021/np049965c; Aoki S, 2003, BIOORGAN MED CHEM, V11, P1969, DOI 10.1016/S0968-0896(03)00086-5; Austin B., 2012, BACTERIAL FISH PATHO, DOI [10. 1007/978-94-007-4884-2, DOI 10.1007/978-94-007-4884-2]; Baker BJ, 1988, AM CHEM SOC, V110, p966 ; Baker DM, 2010, LIMNOL OCEANOGR, V55, P2139, DOI 10.4319/lo.2010.55.5.2139; Barnes DKA, 2002, AFR J ECOL, V40, P350, DOI 10.1046/j.1365-2028.2002.00388.x; Becerro MA, 1998, MAR ECOL PROG SER, V168, P187, DOI 10.3354/meps168187; BECERRO MA, 1994, J EXP MAR BIOL ECOL, V179, P195, DOI 10.1016/0022-0981(94)90114-7; Beer S, 1998, MAR BIOL, V131, P607, DOI 10.1007/s002270050352; Bell JJ, 2013, GLOBAL CHANGE BIOL, V19, P2613, DOI 10.1111/gcb.12212; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Ben-Haim Y, 1999, ENVIRON MICROBIOL, V1, P223, DOI 10.1046/j.1462-2920.1999.00027.x; Bergman KC, 2001, P 20 ANN C ADV MAR S, P263; BERGQUIST PR, 1978, MAR BIOL, V46, P215, DOI 10.1007/BF00390683; Betti F, 2012, MAR ECOL-EVOL PERSP, V33, P49, DOI [10.1111/j.1439-0485.2012.00525.x, 10.1111/j.1439-0485.2011.00456.x]; Bhatnagar I, 2010, MAR DRUGS, V8, P2673, DOI 10.3390/md8102673; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Blunt JW, 2015, NAT PROD REP, V32, P116, DOI 10.1039/c4np00144c; Bonaldo RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085786; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Buchanan MS, 2008, J NAT PROD, V71, P1066, DOI 10.1021/np0706623; Burns E, 2003, MAR ECOL PROG SER, V252, P105, DOI 10.3354/meps252105; Carballo JL, 2002, BMC BIOTECHNOL, V2, P1; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; Cervino JM, 2006, MAR ECOL PROG SER, V324, P139, DOI 10.3354/meps324139; Chadwick NE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P347, DOI 10.1007/978-94-007-0114-4_20; Chaves-Fonnegra A, 2015, MOL ECOL, V24, P1447, DOI 10.1111/mec.13134; Clark RJ, 2001, J NAT PROD, V64, P1568, DOI 10.1021/np010246x; Crews P, 2000, TETRAHEDRON, V56, P9039, DOI 10.1016/S0040-4020(00)00758-4; CRONIN G, 1995, MAR ECOL PROG SER, V119, P265, DOI 10.3354/meps119265; DAVIES PS, 1984, CORAL REEFS, V2, P181; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; De Voogd N. J., 2005, INDONESIAN SPONGES B; De Voogd NJ, 2004, B MUS I BIOL U GEN, V68, P253; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; Diaz MC, 2001, B MAR SCI, V69, P535; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; Dobretsov S, 2005, AQUAT MICROB ECOL, V38, P191, DOI 10.3354/ame038191; Edrada RA, 2000, Z NATURFORSCH C, V55, P218; Ely R, 2004, J EXP MAR BIOL ECOL, V309, P121, DOI 10.1016/j.jembe.2004.03.010; Engel S, 2000, MAR ECOL PROG SER, V207, P273, DOI 10.3354/meps207273; Epifanio RD, 2005, J BRAZIL CHEM SOC, V16, P1367, DOI 10.1590/S0103-50532005000800010; Erickson AA, 2006, J CHEM ECOL, V32, P1883, DOI 10.1007/s10886-006-9116-x; FAULKNER DJ, 1984, NAT PROD REP, V1, P551, DOI 10.1039/np9840100551; Folmer F., 2009, GASTROENT HEPAT-BARC, V2, P34; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Freeman CJ, 2010, MAR BIOL, V157, P1083, DOI 10.1007/s00227-010-1389-5; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Fu WT, 2013, CHINESE SCI BULL, V58, P766, DOI 10.1007/s11434-012-5400-z; Fukami A, 1997, TETRAHEDRON LETT, V38, P1201, DOI 10.1016/S0040-4039(97)00016-6; Fusetani N, 2008, NAT PROD REP, V2, P1, DOI [10.1002/9780470048672.wecb371, DOI 10.1002/9780470048672.WECB371]; Futch JC, 2011, MAR POLLUT BULL, V62, P2308, DOI 10.1016/j.marpolbul.2011.08.046; Garderes J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097662; Garderes J, 2012, MAR BIOL, V159, P1685, DOI 10.1007/s00227-012-1956-z; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; Gochfeld DJ, 2008, MAR ECOL PROG SER, V362, P119, DOI 10.3354/meps07418; Goosen NK, 1997, DEEP-SEA RES PT II, V44, P1235, DOI 10.1016/S0967-0645(97)00016-7; Govinden-Soulange J, 2014, TROP J PHARM RES, V13, P249, DOI 10.4314/tjpr.v13i2.13; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Haugland G, 2017, J FISH DIS; HAY ME, 1994, ECOLOGY, V75, P1714, DOI 10.2307/1939631; Heikoop JM, 2000, CORAL REEFS, V19, P189, DOI 10.1007/s003380000092; Helber SB, 2017, HYDROBIOLOGIA, V790, P247, DOI 10.1007/s10750-016-3036-8; Hernandez-Delgado EA, 2008, P 11 INT COR REEF S, p7 ; HIGGS MD, 1978, J ORG CHEM, V43, P3454, DOI 10.1021/jo00412a006; Hughes TP, 2017, NATURE, V546, P82, DOI 10.1038/nature22901; HUGHES TP, 1987, J EXP MAR BIOL ECOL, V113, P39, DOI 10.1016/0022-0981(87)90081-5; Idjadi JA, 2007, ECOLOGY, V88, P2449, DOI 10.1890/06-2031.1; JACKSON JBC, 1975, P NATL ACAD SCI USA, V72, P5160, DOI 10.1073/pnas.72.12.5160; Jormalainen V, 2001, MAR ECOL PROG SER, V220, P219, DOI 10.3354/meps220219; Kelly SR, 2005, AQUAT MICROB ECOL, V40, P191, DOI 10.3354/ame040191; Kelly SR, 2003, AQUAT MICROB ECOL, V31, P175, DOI 10.3354/ame031175; Kim TK, 2005, ENVIRON MICROBIOL, V7, P509, DOI 10.1111/j.1462-2920.2005.00716.x; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; KOBAYASHI M, 1995, TETRAHEDRON, V51, P3727, DOI 10.1016/0040-4020(95)95723-9; Krug PJ, 2006, MAR MOL BIOTECHNOL, V42, P1; Kubanek J, 2002, OECOLOGIA, V131, P125, DOI 10.1007/s00442-001-0853-9; Kubota T, 2013, BIOORG MED CHEM LETT, V23, P244, DOI 10.1016/j.bmcl.2012.10.109; Kuguru BL, 2004, MAR BIOL, V145, P875, DOI 10.1007/s00227-004-1376-9; KUSHLAN DM, 1991, J NAT PROD, V54, P1451, DOI 10.1021/np50077a043; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Larcher R, 2005, J ANTIMICROB CHEMOTH, V56, P893, DOI [10.1093/jac/, DOI 10.1093/JAC/]; Lebouvier N, 2009, MAR DRUGS, V7, P640, DOI 10.3390/md7040640; LEE KK, 1995, MICROB PATHOGENESIS, V19, P39, DOI 10.1016/S0882-4010(85)90000-2; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; LEWIS GE, 1995, S AFR J SCI, V91, P382; Li J, 2017, APPL MICROBIOL BIOT, V101, P6459, DOI 10.1007/s00253-017-8392-4; Limbu SM, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1439-z; Lin YC, 2015, FISH SHELLFISH IMMUN, V45, P104, DOI 10.1016/j.fsi.2015.02.012; Lippert H, 2003, POLAR BIOL, V26, P591, DOI 10.1007/s00300-003-0525-9; Lira NS, 2011, MAR DRUGS, V9, P2316, DOI 10.3390/md9112316; Littler MM, 1995, SCIENCE, P267; Liu PC, 2004, J BASIC MICROB, V44, P23, DOI 10.1002/jobm.200310316; Loh TL, 2015, PEERJ, V3, DOI 10.7717/peerj.901; Loh TL, 2009, J EXP MAR BIOL ECOL, V374, P45, DOI 10.1016/j.jembe.2009.04.007; Lokrantz J, 2009, ENVIRON CONSERV, V36, P327, DOI 10.1017/S0376892910000147; Lopez S, 2005, J ORG CHEM, V70, P6346, DOI 10.1021/jo050807f; Lopez-Victoria M, 2006, MAR ECOL PROG SER, V312, P113, DOI 10.3354/meps312113; Luter HM, 2010, MAR FRESHWATER RES, V61, P484, DOI 10.1071/MF09200; Madduppa H, 2017, MAR BIODIVERS, V47, P149, DOI 10.1007/s12526-015-0426-5; Maliao RJ, 2008, MAR BIOL, V154, P841, DOI 10.1007/s00227-008-0977-0; Mansoor TA, 2007, J NAT PROD, V70, P1481, DOI 10.1021/np070078u; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2014, CURR OPIN ENV SUST, V7, P59, DOI 10.1016/j.cosust.2013.11.028; Mohammed R, 2010, AUST J CHEM, V63, P877, DOI 10.1071/CH09665; Moynihan MA, 2012, MAR POLLUT BULL, V64, P1348, DOI 10.1016/j.marpolbul.2012.05.001; Muhando C.A., 2008, 11 INT COR REEF S FT, P1127; Muhando CA, 2002, AMBIO, V31, P558, DOI 10.1639/0044-7447(2002)031[0558:EEOTDO]2.0.CO;2; Muhando Christopher A., 2002, Western Indian Ocean Journal of Marine Science, V1, P43; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Muthiga N, 1998, STATUS CORAL REEFS W, p91 ; Newbold RW, 1999, AQUAT MICROB ECOL, V19, P279, DOI 10.3354/ame019279; Noble RT, 2003, WATER RES, V37, P1637, DOI 10.1016/S0043-1354(02)00496-7; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Obura DO, 2005, ESTUAR COAST SHELF S, V63, P353, DOI 10.1016/j.ecss.2004.11.010; Park T, 2009, CHEM PHARM BULL, V57, P106, DOI 10.1248/cpb.57.106; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Pawlik JR, 2007, LIMNOL OCEANOGR, V52, P907, DOI 10.4319/lo.2007.52.2.0907; Pawlik JR, 2016, BIOSCIENCE, V66, P470, DOI 10.1093/biosci/biw047; Pawlik JR, 2015, MAR ECOL PROG SER, V519, P265, DOI 10.3354/meps11093; Pawlik JR, 2011, BIOSCIENCE, V61, P888, DOI 10.1525/bio.2011.61.11.8; PAWLIK JR, 1995, MAR ECOL PROG SER, V127, P183, DOI 10.3354/meps127183; Pelka M, 2000, J DENT, V28, P341, DOI 10.1016/S0300-5712(00)00007-5; Perovic-Ottstadt S, 2004, EUR J BIOCHEM, V271, P1924, DOI 10.1111/j.1432-1033.2004.04102.x; Piskorska M, 2007, AFRICAN J ENV SCI TE, V1, P93; PORTER JW, 1988, BIOL BULL, V175, P230, DOI 10.2307/1541563; Ralph PJ, 2002, MAR BIOL, V141, P639, DOI 10.1007/s00227-002-0866-x; Rasher DB, 2011, P NATL ACAD SCI USA, V108, P17726, DOI 10.1073/pnas.1108628108; Redding JE, 2013, MAR POLLUT BULL, V73, P57, DOI 10.1016/j.marpolbul.2013.06.002; Richelle-Maurer E, 2002, B MUS I BIOL U GEN, V66-67, P165; Rifai S, 2005, J MYCOL MED, V15, P33, DOI 10.1016/j.mycmed.2004.11.001; Risk M, 2009, MAR POLLUT BULL, V58, P787, DOI 10.1016/j.marpolbul.2009.03.021; Rohde S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132236; Rohde S, 2012, J CHEM ECOL, V38, P463, DOI 10.1007/s10886-012-0124-8; Rohde S, 2011, J EXP MAR BIOL ECOL, V399, P76, DOI 10.1016/j.jembe.2011.01.012; ROMANO SL, 1990, J EXP MAR BIOL ECOL, V140, P135, DOI 10.1016/0022-0981(90)90087-S; Ross SA, 2000, J NAT PROD, V63, P501, DOI 10.1021/np980414u; Ruetzler Klaus, 2004, Bollettino dei Musei e degli Istituti Biologici dell'Universita di Genova, V68, P85; SAKAI R, 1986, J AM CHEM SOC, V108, P6404, DOI 10.1021/ja00280a055; Salim AA, 2012, TETRAHEDRON, V68, P9802, DOI 10.1016/j.tet.2012.09.008; Sanzchez-Fortun S, 1996, ENV CONTAM TOXICOL, V31, P391; Sapar A, 2014, KUROSHIO SCI, V8, p25 ; Sata N, 2005, J NAT PROD, V68, P1400, DOI 10.1021/np0500528; Schupp P, 1999, MAR BIOL, V135, P573, DOI 10.1007/s002270050658; Shaala LA, 2015, MAR DRUGS, V13, P1621, DOI 10.3390/md13041621; Siegl A, 2011, ISME J, V5, P61, DOI 10.1038/ismej.2010.95; Singh A, 2016, CHEM-BIOL INTERACT, V243, P135, DOI 10.1016/j.cbi.2015.09.009; Sinko J, 2012, VET MED-CZECH, V57, P177, DOI 10.17221/5914-VETMED; Slattery M, 2014, J PHYCOL, V50, P493, DOI 10.1111/jpy.12160; Soapi K., 2013, The South Pacific Journal of Natural and Applied Sciences, V31, P89; Sorek H, 2006, TETRAHEDRON, V62, P8838, DOI 10.1016/j.tet.2006.06.063; SOROKIN YI, 1985, MAR ECOL PROG SER, V24, P27, DOI 10.3354/meps024027; Sotka EE, 2009, INTEGR COMP BIOL, V49, P291, DOI 10.1093/icb/icp049; Stabili L, 2012, MICROB ECOL, V64, P802, DOI 10.1007/s00248-012-0068-0; Steinert G, 2014, MAR BIOTECHNOL, V16, P594, DOI 10.1007/s10126-014-9575-y; Su JH, 2013, MAR DRUGS, V11, P3168, DOI 10.3390/md11093168; Sweet M, 2015, CORAL REEFS, V34, P871, DOI 10.1007/s00338-015-1284-0; Takada N, 2001, TETRAHEDRON LETT, V42, P5265, DOI 10.1016/S0040-4039(01)00993-5; Tanner JE, 1997, J EXP MAR BIOL ECOL, V214, P19, DOI 10.1016/S0022-0981(97)00024-5; TANNER JE, 1995, J EXP MAR BIOL ECOL, V190, P151, DOI 10.1016/0022-0981(95)00027-O; Teruya T, 2006, J NAT PROD, V69, P135, DOI 10.1021/np050308+; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; THOMPSON JE, 1985, MAR BIOL, V88, P11, DOI 10.1007/BF00393038; Thoms C, 2006, J CHEM ECOL, V32, P97, DOI 10.1007/s10886-006-9355-x; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Tsukamoto S, 1996, TETRAHEDRON, V52, P8181, DOI 10.1016/0040-4020(96)00387-0; Turon X, 1996, OECOLOGIA, V108, P351, DOI 10.1007/BF00334661; Turon X, 2009, SCI MAR, V73, P387, DOI 10.3989/scimar.2009.73n2387; URIZ MJ, 1992, MAR BIOL, V113, P287; URIZ MJ, 1995, MAR ECOL PROG SER, V124, P159, DOI 10.3354/meps124159; Uriz MJ, 1996, MAR BIOL, V124, P583, DOI 10.1007/BF00351039; Ushijima B, 2014, APPL ENVIRON MICROB, V80, P2102, DOI 10.1128/AEM.03463-13; Ushijima B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046717; VanVeghel MLJ, 1996, B MAR SCI, V58, P792; Voss JD, 2006, CORAL REEFS, V25, P569, DOI 10.1007/s00338-006-0131-8; WAHL M, 1989, MAR ECOL PROG SER, V58, P175, DOI 10.3354/meps058175; WAHL M, 1994, MAR ECOL PROG SER, V110, P45, DOI 10.3354/meps110045; Ward-Paige CA, 2005, MAR POLLUT BULL, V51, P570, DOI 10.1016/j.marpolbul.2005.04.006; Wiebinga CJ, 1997, DEEP-SEA RES PT I, V44, P451, DOI 10.1016/S0967-0637(96)00115-X; Wiens M, 2007, MOL BIOL EVOL, V24, P792, DOI 10.1093/molbev/msl208; Xie ZY, 2005, LETT APPL MICROBIOL, V41, P202, DOI 10.1111/j.1472-765X.2005.01688.x; Yamada A, 1997, B CHEM SOC JPN, V70, P3061, DOI 10.1246/bcsj.70.3061; Youssef DTA, 2015, PHYTOCHEM LETT, V12, P296, DOI 10.1016/j.phytol.2015.04.024; ZENG CM, 1993, J NAT PROD, V56, P2016, DOI 10.1021/np50101a027; Ziegler M, 2016, MAR POLLUT BULL, V105, P629, DOI 10.1016/j.marpolbul.2015.12.045	200	22	23	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e097617	10.1371/journal.pone.0197617	http://dx.doi.org/10.1371/journal.pone.0197617			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924803	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000435655600006
J	Lath, DL; Buckle, CH; Evans, HR; Fisher, M; Down, JM; Lawson, MA; Chantry, AD				Lath, Darren L.; Buckle, Clive H.; Evans, Holly R.; Fisher, Matthew; Down, Jenny M.; Lawson, Michelle A.; Chantry, Andrew D.			ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; MULTIPLE-MYELOMA; ARQ 197; ENDOTHELIAL-CELLS; TYROSINE KINASES; GENE-EXPRESSION; CANCER-THERAPY; DEXAMETHASONE; LENALIDOMIDE; COMBINATION	The receptor tyrosine kinase c-Met, its ligand HGF, and components of the downstream signalling pathway, have all been implicated in the pathogenesis of myeloma, both as modulators of plasma cell proliferation and as agents driving osteoclast differentiation and osteoblast inhibition thus, all these contribute substantially to the bone destruction typically caused by myeloma. Patients with elevated levels of HGF have a poor prognosis, therefore, targeting these entities in such patients may be of substantial benefit. We hypothesized that ARQ-197 (Tivantinib), a small molecule c-Met inhibitor, would reduce myeloma cell growth and prevent myeloma-associated bone disease in a murine model. In vitro we assessed the effects of ARQ-197 on myeloma cell proliferation, cytotoxicity and c-Met protein expression in human myeloma cell lines. In vivo we injected NOD/SCID-gamma mice with PBS (non-tumour bearing) or JJN3 cells and treated them with either ARQ-197 or vehicle. In vitro exposure of JJN3, U266 or NCI-H929 cells to ARQ-197 resulted in a significant inhibition of cell proliferation and an induction of cell death by necrosis, probably caused by significantly reduced levels of phosphorylated c-Met. In vivo ARQ-197 treatment of JJN3 tumour-bearing mice resulted in a significant reduction in tumour burden, tumour cell proliferation, bone lesion number, trabecular bone loss and prevented significant decreases in the bone formation rate on the cortico-endosteal bone surface compared to the vehicle group. However, no significant differences on bone parameters were observed in non-tumour mice treated with ARQ-197 compared to vehicle, implying that in tumour-bearing mice the effects of ARQ-197 on bone cells was indirect. In summary, these res ults suggest that ARQ-197 could be a promising therapeutic in myeloma patients, leading to both a reduction in tumour burden and an inhibition of myeloma-induced bone disease.	[Lath, Darren L.; Buckle, Clive H.; Evans, Holly R.; Fisher, Matthew; Down, Jenny M.; Lawson, Michelle A.; Chantry, Andrew D.] Univ Sheffield, Med Sch, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Lath, Darren L.; Buckle, Clive H.; Evans, Holly R.; Down, Jenny M.; Lawson, Michelle A.; Chantry, Andrew D.] Univ Sheffield, Med Sch, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England; [Chantry, Andrew D.] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Dept Haematol, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Lath, DL (corresponding author), Univ Sheffield, Med Sch, Dept Oncol & Metab, Sheffield, S Yorkshire, England.; Lath, DL (corresponding author), Univ Sheffield, Med Sch, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England.	d.lath@shef.ac.uk	Lawson, Michelle/M-6095-2019	Lawson, Michelle/0000-0002-5446-923X; Chantry, Andrew/0000-0002-2797-7626	Bloodwise [12053]	Bloodwise	This work was supported by a Bloodwise (https://bloodwise.org.uk/) Specialist Programme Grant (no. 12053) awarded to Dr A.D Chantry. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abildgaard N, 2000, EUR J HAEMATOL, V64, P121, DOI 10.1034/j.1600-0609.2000.90074.x; Adjei AA, 2011, ONCOLOGIST, V16, P788, DOI 10.1634/theoncologist.2010-0380; Agrawal A, METHODS MOL BIOL MET, V806; An G, 2016, BLOOD, V128, P1590, DOI 10.1182/blood-2016-03-707547; Borset M, 1996, J BIOL CHEM, V271, P24655, DOI 10.1074/jbc.271.40.24655; Borset M, 1996, BLOOD, V88, P3998, DOI 10.1182/blood.V88.10.3998.bloodjournal88103998; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Dimopoulos MA, 2016, NEW ENGL J MED, V375, P1319, DOI 10.1056/NEJMoa1607751; Dimopoulos MA, 2001, ANN ONCOL, V12, P991, DOI 10.1023/A:1011132808904; Dimopoulos MA, 2016, LANCET ONCOL, V17, P27, DOI 10.1016/S1470-2045(15)00464-7; Dimopoulos MA, 2009, J CLIN ONCOL, V27, P6086, DOI 10.1200/JCO.2009.22.2232; Eathiraj S, 2011, J BIOL CHEM, V286, P20666, DOI 10.1074/jbc.M110.213801; Evans HR, 2016, BONE, V83, P9, DOI 10.1016/j.bone.2015.10.004; Ferrucci A, 2014, CLIN CANCER RES, V20, P5796, DOI 10.1158/1078-0432.CCR-14-0847; Grano M, 1996, P NATL ACAD SCI USA, V93, P7644, DOI 10.1073/pnas.93.15.7644; Hamid R, 2004, TOXICOL IN VITRO, V18, P703, DOI 10.1016/j.tiv.2004.03.012; Hov H, 2004, CLIN CANCER RES, V10, P6686, DOI 10.1158/1078-0432.CCR-04-0874; Jagannath S, 2006, HAEMATOL-HEMATOL J, V91, P929; Jiang WG, 2005, CRIT REV ONCOL HEMAT, V53, P35, DOI 10.1016/j.critrevonc.2004.09.004; Kassen D, 2016, BRIT J HAEMATOL, V172, P64, DOI 10.1111/bjh.13790; Katayama R, 2013, CANCER RES, V73, P3087, DOI 10.1158/0008-5472.CAN-12-3256; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Lacy MQ, 2010, LEUKEMIA, V24, P1934, DOI 10.1038/leu.2010.190; Lawson MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119546; Lee JW, 2004, BLOOD, V103, P2308, DOI 10.1182/blood-2003-06-1992; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonial S, 2015, NEW ENGL J MED, V373, P621, DOI 10.1056/NEJMoa1505654; Ludek P, 2010, EUR J HAEMATOL, V84, P332, DOI 10.1111/j.1600-0609.2009.01396.x; Mahmood T, 2012, N AM J MED SCI, V4, P429, DOI 10.4103/1947-2714.100998; Mahtouk K, 2010, BBA-REV CANCER, V1806, P208, DOI 10.1016/j.bbcan.2010.07.006; Moreau P, 2015, BLOOD, V125, P3076, DOI 10.1182/blood-2014-09-568915; Moschetta M, 2013, CLIN CANCER RES, V19, P4371, DOI 10.1158/1078-0432.CCR-13-0039; Munshi N, 2010, MOL CANCER THER, V9, P1544, DOI 10.1158/1535-7163.MCT-09-1173; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Orlowski RZ, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.1953.1953; Palumbo A, 2001, HAEMATOLOGICA, V86, P399; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Phillip CJ, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0335-5; Podar K, 2004, BLOOD, V103, P3474, DOI 10.1182/blood-2003-10-3527; Podar K, 2006, P NATL ACAD SCI USA, V103, P19478, DOI 10.1073/pnas.0609329103; Puzanov I, 2015, INVEST NEW DRUG, V33, P159, DOI 10.1007/s10637-014-0167-5; Richardson PG, 2006, BLOOD, V108, P3458, DOI 10.1182/blood-2006-04-015909; Seidel C, 1998, BLOOD, V91, P806, DOI 10.1182/blood.V91.3.806.806_806_812; Seidel C, 2002, BRIT J HAEMATOL, V119, P672, DOI 10.1046/j.1365-2141.2002.03898.x; Stadtmauer EA, 2009, EUR J HAEMATOL, V82, P426, DOI 10.1111/j.1600-0609.2009.01257.x; Standal T, 2007, BLOOD, V109, P3024, DOI 10.1182/blood-2006-07-034884; Stewart AK, 2015, NEW ENGL J MED, V372, P142, DOI 10.1056/NEJMoa1411321; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Traxler P, 2003, EXPERT OPIN THER TAR, V7, P215, DOI 10.1517/14728222.7.2.215; Underiner TL, 2010, ANTI-CANCER AGENT ME, V10, P7, DOI 10.2174/1871520611009010007; Wader KF, 2012, HISTOPATHOLOGY, V60, P443, DOI 10.1111/j.1365-2559.2011.04112.x; Zaman S, 2015, NEOPLASIA, V17, P289, DOI 10.1016/j.neo.2015.01.006	53	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199517	10.1371/journal.pone.0199517	http://dx.doi.org/10.1371/journal.pone.0199517			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924867	Green Published, gold, Green Accepted			2022-12-26	WOS:000435655600073
J	Li, A; Chen, DY; Wu, ZQ; Sun, GL; Lin, KZ				Li, Ao; Chen, Deyun; Wu, Zhiqiang; Sun, Guanglu; Lin, Kezheng			Self-supervised sparse coding scheme for image classification based on low rank representation	PLOS ONE			English	Article							DICTIONARY; GRAPH	Recently, sparse representation, which relies on the underlying assumption that samples can be sparsely represented by their labeled neighbors, has been applied with great success to image classification problems. Through sparse representation-based classification (SRC), the label can be assigned with minimum residual between the sample and its synthetic version with class-specific coding, which means that the coding scheme is the most significant factor for classification accuracy. However, conventional SRC-based coding schemes ignore dependency among the samples, which leads to an undesired result that similar samples may be coded into different categories due to quantization sensitivity. To address this problem, in this paper, a novel approach based on self-supervised sparse representation is proposed for image classification. In the proposed approach, the manifold structure of samples is firstly exploited with low rank representation. Next, the low-rank representation matrix is used to characterize the similarity of samples in order to establish a self-supervised sparse coding model, which aims to preserve the local structure of codings for similar samples. Finally, a numerical algorithm utilizing the alternating direction method of multipliers (ADMM) is developed to obtain the approximate solution. Experiments on several publicly available datasets validate the effectiveness and efficiency of our proposed approach compared with existing state-of-the-art methods.	[Li, Ao; Chen, Deyun; Sun, Guanglu; Lin, Kezheng] Harbin Univ Sci & Technol, Sch Comp Sci & Technol, Postdoctoral Stn, Harbin, Heilongjiang, Peoples R China; [Li, Ao; Wu, Zhiqiang] Wright State Univ, Dept Elect Engn, Dayton, OH 45435 USA; [Wu, Zhiqiang] Univ Tibet, Dept Elect & Informat Engn, Lhasa, Peoples R China	Harbin University of Science & Technology; University System of Ohio; Wright State University Dayton; Tibet University	Li, A (corresponding author), Harbin Univ Sci & Technol, Sch Comp Sci & Technol, Postdoctoral Stn, Harbin, Heilongjiang, Peoples R China.; Li, A (corresponding author), Wright State Univ, Dept Elect Engn, Dayton, OH 45435 USA.	dargonboy@126.com	Li, Ao/GRR-5311-2022; Li, aoyu/GXV-4925-2022	Wu, Zhiqiang/0000-0001-9055-5680	National Natural Science Foundation of China [61501147]; China Postdoctoral Science Foundation [2016M601438]; Natural Science Foundation of Heilongjiang Province [F2015040]; Postdoctoral Foundation of Heilongjiang Province [LBH-Z15099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Postdoctoral Foundation of Heilongjiang Province	The paper was supported in part by National Natural Science Foundation of China (Grant 61501147), China Postdoctoral Science Foundation (Grant 2016M601438), Natural Science Foundation of Heilongjiang Province (Grant F2015040) and Postdoctoral Foundation of Heilongjiang Province (Grant LBH-Z15099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAI SJ, 2016, PROC CVPR IEEE, P2950, DOI DOI 10.1109/CVPR.2016.322; Candes EJ, 2011, J ACM, V58, DOI 10.1145/1970392.1970395; Chen CF, 2012, PROC CVPR IEEE, P2618, DOI 10.1109/CVPR.2012.6247981; Dong W, 2015, INT J COMPUT VISION, V114, P2; Fang XZ, 2015, IEEE T IMAGE PROCESS, V24, P2760, DOI 10.1109/TIP.2015.2425545; Gu QQ, 2016, JMLR WORKSH CONF PRO, V51, P600; He Z, 2016, PATTERN RECOGN, V60, P1041, DOI 10.1016/j.patcog.2016.04.009; Jia X, 2016, IEEE T IMAGE PROCESS, V25, P4555, DOI 10.1109/TIP.2016.2592701; Jiang ZL, 2013, IEEE T PATTERN ANAL, V35, P2651, DOI 10.1109/TPAMI.2013.88; Lin ZC, 2011, PROG MOL BIOL TRANSL, V98, P1, DOI 10.1016/B978-0-12-385506-0.00001-6; Liu G., 2010, P INT C MACH LEARN, P663, DOI DOI 10.1109/ICDMW.2010.64; Liu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125001; Liu GC, 2013, IEEE T PATTERN ANAL, V35, P171, DOI 10.1109/TPAMI.2012.88; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Turk M., 2013, IEEE C COMP VIS PATT, P586; Wang HR, 2012, PATTERN RECOGN, V45, P3902, DOI 10.1016/j.patcog.2012.04.024; Wang JJ, 2010, PROC CVPR IEEE, P3360, DOI 10.1109/CVPR.2010.5540018; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Yang M, 2014, INT J COMPUT VISION, V109, P209, DOI 10.1007/s11263-014-0722-8; Zhang CJ, 2011, PROC CVPR IEEE, P1673, DOI 10.1109/CVPR.2011.5995484; Zhang J, 2013, IEEE DATA COMPR CONF, P331, DOI 10.1109/DCC.2013.41; Zhang L, 2011, IEEE I CONF COMP VIS, P471, DOI 10.1109/ICCV.2011.6126277; Zhang YMZ, 2013, PROC CVPR IEEE, P676, DOI 10.1109/CVPR.2013.93; Zhuang LS, 2015, IEEE T IMAGE PROCESS, V24, P3717, DOI 10.1109/TIP.2015.2441632	24	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199141	10.1371/journal.pone.0199141	http://dx.doi.org/10.1371/journal.pone.0199141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924830	Green Submitted, Green Published, gold			2022-12-26	WOS:000435655600050
J	Mishra, SK; Jernigan, RL				Mishra, Sambit Kumar; Jernigan, Robert L.			Protein dynamic communities from elastic network models align closely to the communities defined by molecular dynamics	PLOS ONE			English	Article							SINGLE-PARAMETER; ENZYME-ACTIVITY; SIMULATIONS; CENTRALITY; CATALYSIS; DATABASE; MOTIONS; DECOMPOSITION; MECHANISMS; STABILITY	Dynamic communities in proteins comprise the cohesive structural units that individually exhibit rigid body motions. These can correspond to structural domains, but are usually smaller parts that move with respect to one another in a protein's internal motions, key to its functional dynamics. Previous studies emphasized their importance to understand the nature of ligand-induced allosteric regulation. These studies reported that mutations to key community residues can hinder transmission of allosteric signals among the communities. Usually molecular dynamic (MD) simulations (similar to 100 ns or longer) have been used to identify the communities-a demanding task for larger proteins. In the present study, we propose that dynamic communities obtained from MD simulations can also be obtained alternatively with simpler models - the elastic network models (ENMs). To verify this premise, we compare the specific communities obtained from MD and ENMs for 44 proteins. We evaluate the correspondence in communities from the two methods and compute the extent of agreement in the dynamic cross-correlation data used for community detection. Our study reveals a strong correspondence between the communities from MD and ENM and also good agreement for the residue cross-correlations. Importantly, we observe that the dynamic communities from MD can be closely reproduced with ENMs. With ENMs, we also compare the community structures of stable and unstable mutant forms of T4 Lysozyme with its wildtype. We find that communities for unstable mutants show substantially poorer agreement with the wild-type communities than do stable mutants, suggesting such ENM-based community structures can serve as a means to rapidly identify deleterious mutants.	[Mishra, Sambit Kumar; Jernigan, Robert L.] Iowa State Univ, Bioinformat & Computat Biol Program, Ames, IA 50011 USA; [Mishra, Sambit Kumar; Jernigan, Robert L.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University; Iowa State University	Jernigan, RL (corresponding author), Iowa State Univ, Bioinformat & Computat Biol Program, Ames, IA 50011 USA.; Jernigan, RL (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	jernigan@istate.edu	Mishra, Sambit/ABB-3784-2020; Jernigan, Robert L/A-5421-2012	Mishra, Sambit/0000-0001-8319-0599; Jernigan, Robert L/0000-0003-0996-8360	NIH [R01-GM72014]; NSF [DBI-1661391]; Carver Trust awarded	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Carver Trust awarded	This research was supported by NIH grant R01-GM72014 and NSF grant DBI-1661391, as well as funds from the Carver Trust awarded to the Roy J. Carver Department of Biochemistry, Biophysics and Molecular Biology.	Alberts B, 2002, MOL BIOL CELL, DOI [10.1091/MBC.E14-10-1437, DOI 10.1091/MBC.E14-10-1437]; Amadei A, 1999, PROTEINS, V36, P419, DOI 10.1002/(SICI)1097-0134(19990901)36:4<419::AID-PROT5>3.3.CO;2-L; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e; BAVELAS A, 1950, J ACOUST SOC AM, V22, P723; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Brignole EJ, 2009, NAT STRUCT MOL BIOL, V16, P190, DOI 10.1038/nsmb.1532; Calligari P, 2017, J CHEM THEORY COMPUT, V13, P309, DOI 10.1021/acs.jctc.6b00702; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Chopra N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004826; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445; Doruker P, 2006, J BIOMOL STRUCT DYN, V24, P1; Doshi U, 2016, P NATL ACAD SCI USA, V113, P4735, DOI 10.1073/pnas.1523573113; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Greives N, 2014, P NATL ACAD SCI USA, V111, P10197, DOI 10.1073/pnas.1407545111; Gromiha MM, 2002, NUCLEIC ACIDS RES, V30, P301, DOI 10.1093/nar/30.1.301; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Gur M, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4936133; Haliloglu T, 2015, CURR OPIN STRUC BIOL, V35, P17, DOI 10.1016/j.sbi.2015.07.007; Hinsen K, 1999, PROTEINS, V34, P369, DOI 10.1002/(SICI)1097-0134(19990215)34:3<369::AID-PROT9>3.0.CO;2-F; Kasahara K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112419; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kundu S, 2004, PROTEINS, V57, P725, DOI 10.1002/prot.20268; Kundu S, 2002, BIOPHYS J, V83, P723, DOI 10.1016/S0006-3495(02)75203-X; Leioatts N, 2012, J CHEM THEORY COMPUT, V8, P2424, DOI 10.1021/ct3000316; Li HC, 2016, NUCLEIC ACIDS RES, V44, pD415, DOI 10.1093/nar/gkv1236; Li HC, 2014, J CHEM INF MODEL, V54, P2275, DOI 10.1021/ci500261z; MCCAMMON JA, 1984, REP PROG PHYS, V47, P1, DOI 10.1088/0034-4885/47/1/001; McClendon CL, 2014, P NATL ACAD SCI USA, V111, pE4623, DOI 10.1073/pnas.1418402111; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Meyer T, 2010, STRUCTURE, V18, P1399, DOI 10.1016/j.str.2010.07.013; Mooers BHM, 2009, PROTEIN SCI, V18, P871, DOI 10.1002/pro.94; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nussinov R, 2016, CHEM REV, V116, P6263, DOI 10.1021/acs.chemrev.6b00283; O'Rourke KF, 2016, COMPUT STRUCT BIOTEC, V14, P245, DOI 10.1016/j.csbj.2016.06.002; Potestio R, 2009, BIOPHYS J, V96, P4993, DOI 10.1016/j.bpj.2009.03.051; Rader A. J., 2006, P41; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Romo TD, 2011, PROTEINS, V79, P23, DOI 10.1002/prot.22855; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Shudler M, 2009, J PHYS CHEM A, V113, P7528, DOI 10.1021/jp900885w; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Song G, 2007, J MOL BIOL, V369, P880, DOI 10.1016/j.jmb.2007.03.059; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Yang L, 2008, STRUCTURE, V16, P321, DOI 10.1016/j.str.2007.12.011; Yao XQ, 2016, J BIOL CHEM, V291, P4742, DOI 10.1074/jbc.M115.702605; Yesylevskyy SO, 2006, BIOPHYS CHEM, V119, P84, DOI 10.1016/j.bpc.2005.07.004; Yon JM, 1998, BIOCHIMIE, V80, P33, DOI 10.1016/S0300-9084(98)80054-0	52	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199225	10.1371/journal.pone.0199225	http://dx.doi.org/10.1371/journal.pone.0199225			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ8QS	29924847	Green Published, gold, Green Submitted			2022-12-26	WOS:000435655600056
J	Qi, K; Li, XD; Geng, YJ; Cui, HH; Jin, C; Wang, PH; Li, Y; Yang, YJ				Qi, Kang; Li, Xiangdong; Geng, Yongjian; Cui, Hehe; Jin, Chen; Wang, Peihe; Li, Yue; Yang, Yuejin			Tongxinluo attenuates reperfusion injury in diabetic hearts by angiopoietin-like 4-mediated protection of endothelial barrier integrity via PPAR-alpha pathway	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ISCHEMIA/REPERFUSION INJURY; NO-REFLOW; SIGNALING PATHWAY; TOTAL GLUCOSIDES; ISCHAEMIA/REPERFUSION INJURY; INFLAMMATORY CYTOKINES; INSULIN-TREATMENT; OXIDATIVE STRESS; SWINE HEARTS	Objective Endothelial barrier function in the onset and Tongxinluo (TXL) protection of myocardial ischemia/reperfusion (I/R) injury, and TXL can induce the secretion of Angiopoietin-like 4 (Angptl4) in human cardiac microvascular endothelial cells during hypoxia/reoxygenation. We intend to demonstrate whether TXL can attenuate myocardial I/R injury in diabetes, characterized with microvascular endothelial barrier disruption, by induction of Angptl4-mediated protection of endothelial barrier integrity. Methods and results I/R injury was created by coronary ligation in ZDF diabetic and non-diabetic control rats. The animals were anesthetized and randomized to sham operation or I/R injury with or without the exposure to insulin, rhAngptl4, TXL, Angptl4 siRNA, and the PPAR-alpha inhibitor MK886. Tongxinluo, insulin and rhAngptl4 have the similar protective effect on diabetic hearts against I/R injury. In I/R-injured diabetic hearts, TXL treatment remarkably reduced the infarct size, and protected endothelial barrier integrity demonstrated by decreased endothelial cells apoptosis, microvascular permeability, and myocardial hemorrhage, fortified tight junction, and upregulated expression of JAM-A, integrin-alpha 5, and VE-cadherin, and these effects of TXL were as effective as insulin and rhAngptl4. However, Angptl4 knock-down with siRNA interference and inhibition of PPAR-alpha with MK886 partially diminished these beneficial effects of TXL and rhAngptl4. TXL induced the expression of Angptl4 in I/R-injured diabetic hearts, and was canceled by Angptl4 siRNA and MK886. TXL treatment increased myocardial PPAR-a activity, and was abolished by MK886 but not by Angptl4 siRNA. Conclusions TXL protects diabetic hearts against I/R injury by activating Angptl4-mediated restoration of endothelial barrier integrity via the PPAR-alpha pathway.	[Qi, Kang; Li, Xiangdong; Cui, Hehe; Jin, Chen; Yang, Yuejin] Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Qi, Kang; Li, Xiangdong; Cui, Hehe; Jin, Chen; Wang, Peihe; Li, Yue; Yang, Yuejin] Peking Union Med Coll, Beijing, Peoples R China; [Geng, Yongjian] Univ Texas Hlth Sci Ctr Houston, Div Cardiovasc Med, Houston, TX 77030 USA; [Wang, Peihe; Li, Yue] Chinese Acad Med Sci, Peking Key Lab Preclin Evaluat Cardiovasc Implant, State Key Lab Cardiovasc Dis, Natl Ctr Cardiovasc Dis,Anim Expt Ctr,Fuwai Hosp, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Texas System; University of Texas Health Science Center Houston; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Yang, YJ (corresponding author), Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China.; Yang, YJ (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	yangyjfw@126.com			National Basic Research Program (973 Program) in China [2012CB518602]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-009]; National Science Foundation of China [81370223, 81573957]; Postgraduates Innovative Foundation of PUMC, China [2013-1002-39]	National Basic Research Program (973 Program) in China(National Basic Research Program of China); CAMS Innovation Fund for Medical Sciences (CIFMS); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postgraduates Innovative Foundation of PUMC, China	This study was supported by National Basic Research Program (973 Program) in China (No. 2012CB518602), CAMS Innovation Fund for Medical Sciences (CIFMS) (No. 2016-I2M-1-009), the National Science Foundation of China (No. 81370223 and 81573957) and Postgraduates Innovative Foundation of PUMC, China (2013-1002-39).	Barrabes JA, 1998, AM J PHYSIOL-HEART C, V274, pH1767, DOI 10.1152/ajpheart.1998.274.5.H1767; Baumuller S, 2015, PEDIATR DEVEL PATHOL, V18, P17, DOI 10.2350/13-11-1400-OA.1; Beker MC, 2015, ONCOTARGET, V6, P30604, DOI 10.18632/oncotarget.5773; Bouleti C, 2015, INT J CARDIOL, V187, P511, DOI 10.1016/j.ijcard.2015.03.263; Canfield SG, 2016, ANESTH ANALG, V122, P1269, DOI 10.1213/ANE.0000000000001254; Chen YN, 2016, CELL PHYSIOL BIOCHEM, V40, P1094, DOI 10.1159/000453164; Cheng YT, 2009, CHINESE MED J-PEKING, V122, P1529, DOI 10.3760/cma.j.issn.0366-6999.2009.13.011; Cui HH, 2016, AM J TRANSL RES, V8, P4370; Cui HH, 2014, J CARDIOVASC PHARM, V64, P180, DOI 10.1097/FJC.0000000000000104; de Resende MM, 2006, PHYSIOL GENOMICS, V25, P325, DOI 10.1152/physiolgenomics.00253.2005; Eldor R, 2013, DIABETES CARE, V36, pS162, DOI 10.2337/dcS13-2003; Galaup A, 2012, CIRCULATION, V125, P140, DOI 10.1161/CIRCULATIONAHA.111.049072; Gunduz D, 2010, ARTERIOSCL THROM VAS, V30, P1237, DOI 10.1161/ATVBAHA.110.203901; Hafstad AD, 2006, AM J PHYSIOL-HEART C, V290, pH1763, DOI 10.1152/ajpheart.01063.2005; Hillis LD, 2006, NEW ENGL J MED, V355, P2475, DOI 10.1056/NEJMe068251; Hu CF, 2017, CHIN J INTEGR MED, V23, P438, DOI 10.1007/s11655-016-2617-8; Huang RL, 2011, BLOOD, V118, P3990, DOI 10.1182/blood-2011-01-328716; Oidor-Chan VH, 2016, PPAR RES, V2016, DOI 10.1155/2016/8237264; Javanmard Shaghayegh Haghjooy, 2016, Adv Biomed Res, V5, P174, DOI 10.4103/2277-9175.194801; Jiao SJ, 2016, BIOMED PHARMACOTHER, V84, P1533, DOI 10.1016/j.biopha.2016.11.028; Karalliedde LD, 2009, AM J PHYSIOL-HEART C, V297, pH1967, DOI 10.1152/ajpheart.00944.2009; Larter CZ, 2012, J GASTROEN HEPATOL, V27, P341, DOI 10.1111/j.1440-1746.2011.06939.x; Lee TI, 2013, DIABETES RES CLIN PR, V100, P330, DOI 10.1016/j.diabres.2013.01.008; Lejay A, 2016, J MOL CELL CARDIOL, V91, P11, DOI 10.1016/j.yjmcc.2015.12.020; Li XD, 2013, INT J CARDIOL, V167, P2657, DOI 10.1016/j.ijcard.2012.06.121; Li XD, 2013, CHINESE MED J-PEKING, V126, P1469, DOI 10.3760/cma.j.issn.0366-6999.20130224; Li XD, 2010, AM J PHYSIOL-HEART C, V299, pH1255, DOI 10.1152/ajpheart.00459.2010; Liu BS, 2017, ONCOTARGET, V8, P19413, DOI 10.18632/oncotarget.14297; Mangialardi G, 2013, ARTERIOSCL THROM VAS, V33, P555, DOI 10.1161/ATVBAHA.112.300424; Mather KJ, 2013, J CLIN INVEST, V123, P1003, DOI 10.1172/JCI67166; Pei HF, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0322-0; Prasad A, 2005, J AM COLL CARDIOL, V45, P508, DOI 10.1016/j.jacc.2004.10.054; Qi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119846; Rangasamy S, 2011, INVEST OPHTH VIS SCI, V52, P3784, DOI 10.1167/iovs.10-6386; Rausch WD, 2006, ACTA NEUROBIOL EXP, V66, P369; Rui T, 2012, CARDIOVASC RES, V94, P370, DOI 10.1093/cvr/cvs015; Slettom G, 2017, J CARDIOVASC PHARM T, V22, P179, DOI 10.1177/1074248416657611; Su H, 2013, J CELL MOL MED, V17, P181, DOI 10.1111/j.1582-4934.2012.01661.x; Su J, 2010, PHYTOMEDICINE, V17, P254, DOI 10.1016/j.phymed.2009.07.005; Tan DX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122124; Wang C, 2015, INT IMMUNOPHARMACOL, V24, P325, DOI 10.1016/j.intimp.2014.12.026; Wang HQ, 2012, CHINESE MED J-PEKING, V125, P3675, DOI 10.3760/cma.j.issn.0366-6999.2012.20.014; Wang JY, 2013, ADV EDUC RES, V10, P528; Wang YN, 2016, INT IMMUNOPHARMACOL, V36, P67, DOI 10.1016/j.intimp.2016.04.010; Xie R, 2017, FOOD FUNCT, V8, P299, DOI 10.1039/c6fo01601d; Yin T, 2010, J MOL CELL CARDIOL, V49, P354, DOI 10.1016/j.yjmcc.2010.05.002; Zeng XC, 2002, TOXICON, V40, P1719, DOI 10.1016/S0041-0101(02)00134-4; Zhang HT, 2010, CHINESE MED J-PEKING, V123, P2858, DOI 10.3760/cma.j.issn.0366-6999.2010.20.021; Zhang L, 2009, AM J PHYSIOL-HEART C, V297, pH2004, DOI 10.1152/ajpheart.00208.2009; Zhang Y, 2014, AM J PHYSIOL-GASTR L, V306, pG289, DOI 10.1152/ajpgi.00168.2013	50	13	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198403	10.1371/journal.pone.0198403	http://dx.doi.org/10.1371/journal.pone.0198403			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912977	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600027
J	McDonnell, SL; Baggerly, CA; French, CB; Baggerly, LL; Garland, CF; Gorham, ED; Hollis, BW; Trump, DL; Lappe, JM				McDonnell, Sharon L.; Baggerly, Carole A.; French, Christine B.; Baggerly, Leo L.; Garland, Cedric F.; Gorham, Edward D.; Hollis, Bruce W.; Trump, Donald L.; Lappe, Joan M.			Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations >= 60 vs < 20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort	PLOS ONE			English	Article							VITAMIN-D; CALCIUM SUPPLEMENTATION; UNITED-STATES; PREVENTION; HEALTH; WOMEN; ASSOCIATION; NUTRITION; MORTALITY; PROSTATE	Background While numerous epidemiologic studies have found an association between higher serum 25-hydroxyvitamin D [25(OH)D] concentrations and lower breast cancer risk, few have assessed this association for concentrations >40 ng/ml. Objective To investigate the relationship between 25(OH)D concentration and breast cancer risk across a broad range of 25(OH)D concentrations among women aged 55 years and older. Methods Analyses used pooled data from two randomized clinical trials (N = 1129, N = 2196) and a prospective cohort (N = 1713) to examine a broad range of 25(OH)D concentrations. The outcome was diagnosis of breast cancer during the observation periods (median: 4.0 years). Three analyses were conducted: 1) Incidence rates were compared according to 25(OH)D concentration from <20 to >= 60 ng/ml (<50 to >= 150 nmol/L), 2) Kaplan-Meier plots were developed and 3) multivariate Cox regression was used to examine the association between 25(OH)D and breast cancer risk using multiple 25(OH)D measurements. Results Within the pooled cohort (N = 5038), 77 women were diagnosed with breast cancer (ageadjusted incidence: 512 cases per 100,000 person-years). Results were similar for the three analyses. First, comparing incidence rates, there was an 82% lower incidence rate of breast cancer for women with 25(OH)D concentrations >= 60 vs <20 ng/ml (Rate Ratio = 0.18, P= 0.006). Second, Kaplan-Meier curves for concentrations of <20, 20-39, 40-59 and >= 60 ng/ml were significantly different (P= 0.02), with the highest proportion breast cancer-free in the >= 60 ng/ml group (99.3%) and the lowest proportion breast cancer-free in the <20 ng/ml group (96.8%). The proportion with breast cancer was 78% lower for >= 60 vs <20 ng/ml (P= 0.02). Third, multivariate Cox regression revealed that women with 25(OH)D concentrations >= 60 ng/ml had an 80% lower risk of breast cancer than women with concentrations <20 ng/ml (HR = 0.20, P= 0.03), adjusting for age, BMI, smoking status, calcium supplement intake, and study of origin. Conclusions Higher 25(OH)D concentrations were associated with a dose-response decrease in breast cancer risk with concentrations >= 60 ng/ml being most protective.	[McDonnell, Sharon L.; Baggerly, Carole A.; French, Christine B.; Baggerly, Leo L.] GrassrootsHealth, Encinitas, CA 92024 USA; [Garland, Cedric F.; Gorham, Edward D.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Hollis, Bruce W.] Med Univ South Carolina, Charleston, SC 29425 USA; [Trump, Donald L.] Inova Schar Canc Inst, Falls Church, VA USA; [Lappe, Joan M.] Creighton Univ, Dept Med, Omaha, NE 68178 USA	University of California System; University of California San Diego; Medical University of South Carolina; Creighton University	McDonnell, SL (corresponding author), GrassrootsHealth, Encinitas, CA 92024 USA.	sharon@grassrootshealth.org			National Institute of Aging; National Cancer Institute; Creighton University; Bio-Tech Pharmacal; Pure North S'Energy Foundation; Vitamin D Society	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Creighton University; Bio-Tech Pharmacal; Pure North S'Energy Foundation; Vitamin D Society	The 2007 Lappe RCT was funded by the National Institute of Aging. The 2017 Lappe RCT was funded by the National Cancer Institute and Creighton University internal funding. GrassrootsHealth is a nonprofit entity; this project was funded by self-sponsorship by the participants and donations from Bio-Tech Pharmacal, Pure North S'Energy Foundation, and the Vitamin D Society. These funds provided the resources for the study design and data collection for the GRH study and the analysis and interpretations of this pooled analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, INT J CANCER, V124, P250, DOI 10.1002/ijc.23904; Abbas S, 2008, CARCINOGENESIS, V29, P93, DOI 10.1093/carcin/bgm240; Bilinski K, 2013, BREAST CANCER RES TR, V137, P599, DOI 10.1007/s10549-012-2381-1; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Bolland MJ, 2011, AM J CLIN NUTR, V94, P1144, DOI 10.3945/ajcn.111.015032; Brestoff JR, 2013, EPIDEMIOLOGY PRINCIP, P455; Cannell J, 2008, EXPERT OPIN PHARMACO, V9, P107, DOI 10.1517/14656566.9.1.107; Crew KD, 2009, CANCER PREV RES, V2, P598, DOI 10.1158/1940-6207.CAPR-08-0138; Eyles D, 2009, CLIN CHIM ACTA, V403, P145, DOI 10.1016/j.cca.2009.02.005; Freedman DM, 2008, CANCER EPIDEM BIOMAR, V17, P889, DOI 10.1158/1055-9965.EPI-07-2594; Garland CF, 2007, J STEROID BIOCHEM, V103, P708, DOI 10.1016/j.jsbmb.2006.12.007; Garland CF, 2011, ANTICANCER RES, V31, P607; Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021; GARLAND FC, 1990, PREV MED, V19, P614, DOI 10.1016/0091-7435(90)90058-R; GORHAM ED, 1989, CAN J PUBLIC HEALTH, V80, P96; GORHAM ED, 1990, INT J EPIDEMIOL, V19, P820, DOI 10.1093/ije/19.4.820; Grant WB, 2015, ANTICANCER RES, V35, P1154; Hardiman G, 2016, PHARMACOGENOMICS, V17, P1129, DOI 10.2217/pgs-2016-0025; Holick MF, 2013, ANTI-CANCER AGENT ME, V13, P70; Kuhn T, 2013, INT J CANCER, V133, P1689, DOI 10.1002/ijc.28172; Lappe J, 2017, JAMA-J AM MED ASSOC, V317, P1234, DOI 10.1001/jama.2017.2115; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lappe JM, 2006, J AM COLL NUTR, V25, P395, DOI 10.1080/07315724.2006.10719551; Lowe LC, 2005, EUR J CANCER, V41, P1164, DOI 10.1016/j.ejca.2005.01.017; Luxwolda MF, 2012, BRIT J NUTR, V108, P1557, DOI 10.1017/S0007114511007161; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Marshall DT, 2012, J CLIN ENDOCR METAB, V97, P2315, DOI 10.1210/jc.2012-1451; McCullough ML, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2356; McDonnell SL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152441; Naing N N, 2000, Malays J Med Sci, V7, P10; Narvaez CJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00213; National Academy of Sciences-Institute of Medicine-Food and Nutrition Board, 2010, DIETARY REFERENCE IN; National Cancer Institute (NCI), CANC STAT BREAST FEM; National Center for Health Statistics, 2018, NAT HLTH NUTR EX SUR; Neuhouser ML, 2012, AM J EPIDEMIOL, V175, P673, DOI 10.1093/aje/kwr350; O'Brien KM, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP943; Park S, 2015, BREAST CANCER RES TR, V152, P147, DOI 10.1007/s10549-015-3433-0; Peppone LJ, 2012, ANN SURG ONCOL, V19, P2590, DOI 10.1245/s10434-012-2297-3; Rejnmark L, 2009, CANCER EPIDEM BIOMAR, V18, P2655, DOI 10.1158/1055-9965.EPI-09-0531; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P321; Selvin S, 2011, STAT TOOLS EPIDEMIOL, P258; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Souberbielle JC, 2010, AUTOIMMUN REV, V9, P709, DOI 10.1016/j.autrev.2010.06.009; Wu YY, 2017, CANCERS, V9, DOI 10.3390/cancers9100144; Yao S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017251	48	70	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2018	13	6							e0199265	10.1371/journal.pone.0199265	http://dx.doi.org/10.1371/journal.pone.0199265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5RI	29906273	Green Published, gold, Green Submitted			2022-12-26	WOS:000435439400016
J	Peng, MG; Wang, JJ; Zhang, DY; Jin, HL; Li, JX; Wu, XR; Huang, CS				Peng, Minggang; Wang, Jingjing; Zhang, Dongyun; Jin, Honglei; Li, Jingxia; Wu, Xue-Ru; Huang, Chuanshu			PHLPP2 stabilization by p27 mediates its inhibition of bladder cancer invasion by promoting autophagic degradation of MMP2 protein	ONCOGENE			English	Article							DOWN-REGULATION CONTRIBUTES; MATRIX METALLOPROTEINASES; PROGNOSTIC-SIGNIFICANCE; UP-REGULATION; IN-VITRO; CELL; EXPRESSION; P27(KIP1); AKT; ISORHAPONTIGENIN	Pleckstrin homology domain leucine-rich repeat protein phosphatase 2 (PHLPP2) is a tumor suppressor that catalyzes the dephosphorylation of the AGC kinases, while p27 acts as a tumor suppressor that regulates cell cycle, apoptosis, and cell motility. Our previous studies have identified that PHLPP2 participates in inhibition of transformation of human bronchial epithelial cells following lung carcinogen B[a] P/B[a] PDE exposure. However, nothing was known about the association of p27 with regulation of PHLPP2 expression and the role of PHLPP2 in bladder cancer (BC) invasion. In our current studies, we demonstrated that PHLPP2 inhibited BC invasion through promoting MMP2 degradation via p62-mediated autophagy; and p27 expression was able to stabilize PHLPP2 protein by inhibiting protein degradation of Hsp90, which could directly bind to PHLPP2 and protect it from degradation. More in-depth studies discovered that stabilization of Hsp90 by p27 was mediated by calpain1 proteolysis system, whereas p27 inhibited calpain1 gene transcription by attenuating Jak1/Stat1 cascade in human invasive BC cells. Collectively, we for the first time revealed PHLPP2 downregulation in BCs and its participating in promotion of BC invasion, as well as novel role of p27 and mechanisms underlying its regulation of PHLPP2 protein degradation through Hsp90-dependent manner. Our findings improve our understanding of p27 and PHLPP2 roles and their crosstalk in regulation of BC invasion, which further contributes to improve the current strategy for invasive bladder cancer therapy.	[Peng, Minggang; Wang, Jingjing; Zhang, Dongyun; Li, Jingxia; Huang, Chuanshu] NYU, Nelson Inst Environm Med, Sch Med, Tuxedo Pk, NY 10987 USA; [Peng, Minggang] Huazhong Univ Sci & Technol, Union Hosp, Dept Obstet & Gynecol, Tongji Med Coll, 1277 JieFang Ave, Wuhan 430022, Hubei, Peoples R China; [Jin, Honglei] Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou 325035, Zhejiang, Peoples R China; [Wu, Xue-Ru] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; Huazhong University of Science & Technology; Wenzhou Medical University; New York University; New York University	Huang, CS (corresponding author), NYU, Nelson Inst Environm Med, Sch Med, Tuxedo Pk, NY 10987 USA.	Chuanshu.huang@nyumc.org		Huang, Chuanshu/0000-0003-4133-5096; Wu, Xue-Ru/0000-0001-6058-6291	NIH/NCI [CA165980, CA177665, CA217923]; NIH/NIEHS [ES000260]; Natural Science Foundation of China [NSFC91773391]; Scientific Research Training Program for Young Talents (Union Hospital, Wuhan, China); NATIONAL CANCER INSTITUTE [P01CA165980, R01CA177665, R01CA217923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Training Program for Young Talents (Union Hospital, Wuhan, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partially supported by the grants of NIH/NCI CA165980, CA177665, and CA217923, and NIH/NIEHS ES000260, and by grants of the Natural Science Foundation of China NSFC91773391 and the Scientific Research Training Program for Young Talents (Union Hospital, Wuhan, China).	Au-Yeung Nancy, 2013, JAKSTAT, V2, pe23931, DOI 10.4161/jkst.23931; Averna M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116738; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Catzavelos C, 1997, NAT MED, V3, P227, DOI 10.1038/nm0297-227; Chou R, 2016, CANCER-AM CANCER SOC, V122, P842, DOI 10.1002/cncr.29843; Dikic I, 2010, CANCER RES, V70, P3431, DOI 10.1158/0008-5472.CAN-09-4027; Dong GJ, 2015, EUR J IMMUNOL, V45, P2377, DOI 10.1002/eji.201445349; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Esposito V, 1997, CANCER RES, V57, P3381; Fang Y, 2013, MOL CANCER THER, V12, P1492, DOI 10.1158/1535-7163.MCT-12-0922; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Huang HS, 2016, AUTOPHAGY, V12, P1687, DOI 10.1080/15548627.2016.1196313; Huang HS, 2015, CLIN CANCER RES, V21, P3783, DOI 10.1158/1078-0432.CCR-14-2829; Huang HS, 2014, ONCOTARGET, V5, P493, DOI 10.18632/oncotarget.1643; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jiang GS, 2016, CANCER PREV RES, V9, P567, DOI 10.1158/1940-6207.CAPR-15-0338; Jin HL, 2015, ONCOTARGET, V6, P522, DOI 10.18632/oncotarget.2680; Kamai T, 2000, BJU INT, V86, P14, DOI 10.1046/j.1464-410x.2000.00726.x; Kamai T, 2001, BRIT J CANCER, V84, P1242, DOI 10.1054/bjoc.2000.1736; Knowles MA, 2015, NAT REV CANCER, V15, P25, DOI 10.1038/nrc3817; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kumar B, 2010, CANCER RES, V70, P832, DOI 10.1158/0008-5472.CAN-09-2918; LEVI F, 1993, INT J CANCER, V55, P419, DOI 10.1002/ijc.2910550316; Lippai M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/832704; Liu JY, 2011, MOL CELL BIOL, V31, P4917, DOI 10.1128/MCB.05799-11; Liu JY, 2010, J BIOL CHEM, V285, P26058, DOI 10.1074/jbc.M110.100271; Liu T, 2015, GENET TEST MOL BIOMA, V19, P548, DOI 10.1089/gtmb.2015.0123; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; Lovaas JD, 2013, PROSTATE, V73, P522, DOI 10.1002/pros.22592; Masciullo V, 1999, CANCER RES, V59, P3790; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Park SL, 2015, ONCOL REP, V34, P1605, DOI 10.3892/or.2015.4119; Piechaczyk M, 2008, BIOCHEM SOC T, V36, P864, DOI 10.1042/BST0360864; Primdahl H, 2002, J CANCER RES CLIN, V128, P295, DOI 10.1007/s00432-002-0344-3; Puzio-Kuter AM, 2009, GENE DEV, V23, P675, DOI 10.1101/gad.1772909; Rabbani F, 2007, BJU INT, V100, P259, DOI 10.1111/j.1464-410X.2007.06927.x; Ren F, 2014, MOL CELL BIOCHEM, V385, P95, DOI 10.1007/s11010-013-1818-0; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sossey-Alaoui K, 2005, EXP CELL RES, V308, P135, DOI 10.1016/j.yexcr.2005.04.011; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Steeg PS, 1997, NAT MED, V3, P152, DOI 10.1038/nm0297-152; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050; VANDERBURG MEL, 1988, GYNECOL ONCOL, V30, P307, DOI 10.1016/0090-8258(88)90244-2; von Reyn CR, 2012, J NEUROCHEM, V121, P793, DOI 10.1111/j.1471-4159.2012.07735.x; Wang Y, 2016, ONCOGENE, V35, P4080, DOI 10.1038/onc.2015.470; Wang Y, 2014, CELL REP, V6, P278, DOI 10.1016/j.celrep.2013.12.031; Xu JW, 2016, ONCOTARGET, V7, P34112, DOI 10.18632/oncotarget.8746; Yuen EY, 2007, J PHYSIOL-LONDON, V580, P241, DOI 10.1113/jphysiol.2006.122754; Zhang D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.496; Zhang DY, 2014, J CELL SCI, V127, P2920, DOI 10.1242/jcs.148130; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448; Zhou L, 2013, ACTA PHARMACOL SIN, V34, P651, DOI 10.1038/aps.2013.12	57	26	28	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 25	2018	37	43					5735	5748		10.1038/s41388-018-0374-1	http://dx.doi.org/10.1038/s41388-018-0374-1			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GY1KL	29930380	Green Published, hybrid			2022-12-26	WOS:000448288200003
J	Theurl, M; Lener, D; Albrecht-Schgoer, K; Beer, A; Schgoer, W; Liu, Y; Stanzl, U; Fischer-Colbrie, R; Kirchmair, R				Theurl, Markus; Lener, Daniela; Albrecht-Schgoer, Karin; Beer, Arno; Schgoer, Wilfried; Liu, Yu; Stanzl, Ursula; Fischer-Colbrie, Reiner; Kirchmair, Rudolf			Gene therapy with the angiogenic neuropeptide secretoneurin ameliorates experimental diabetic neuropathy	FASEB JOURNAL			English	Article						signaling; Schwann cell; nerve conduction velocity	ACUTE MYOCARDIAL-INFARCTION; REPAIR-AMI TRIAL; PERIPHERAL NEUROPATHY; BLOOD-FLOW; SECRETOGRANIN-II; PROGENITOR CELLS; VASA NERVORUM; BASIC FGF; IN-VITRO; ISCHEMIA	The pathogenesis of diabetic neuropathy remains enigmatic. Damage to the vasa nervorum may be responsible for this disorder. Recently, we showed that secretoneurin (SN) induces angiogenesis in hindlimb and myocardial ischemia. Moreover, beneficial effects were observed in wound healing. We therefore hypothesized that SN therapy may ameliorate diabetic neuropathy. We used db/db mice as animal model for neuropathy. Gene therapy was accomplished by intramuscular injection of SN plasmid along the sciatic nerve. Sciatic nerve motor and sensory conduction velocities were then measured for 9 wk. Nerve conduction velocities showed normal values in heterozygous mice for the observational period, but were severely reduced in homozygous mice in which velocities were significantly improved by SN, but not by control plasmid gene therapy. The reaction time in the tail-flick test improved significantly in SN-treated animals. The induction of growth of vasa nervorum seems to be part of the underlying mechanism. In addition, SN positively affected Schwann cell function in vitro and induced activation of important signaling pathways. Our observations suggest that SN exerts beneficial effects on nerve function in vivo and on Schwann cells in vitro. It therefore may be a promising treatment option for diabetic neuropathy.Theurl, M., Lener, D., Albrecht-Schgoer, K., Beer, A., Schgoer, W., Liu, Y., Stanzl, U., Fischer-Colbrie, R., Kirchmair, R. Gene therapy with the angiogenic neuropeptide secretoneurin ameliorates experimental diabetic neuropathy.	[Theurl, Markus; Lener, Daniela; Albrecht-Schgoer, Karin; Beer, Arno; Schgoer, Wilfried; Stanzl, Ursula; Kirchmair, Rudolf] Med Univ Innsbruck, Univ Hosp Internal Med 3, Dept Cardiol & Angiol, Innsbruck, Austria; [Albrecht-Schgoer, Karin] Med Univ Innsbruck, Div Translat Cell Genet, Innsbruck, Austria; [Fischer-Colbrie, Reiner] Med Univ Innsbruck, Inst Pharmacol, Innsbruck, Austria; [Liu, Yu] Capital Med Univ, Sch Basic Med Sci, Dept Pathol, Beijing, Peoples R China	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Capital Medical University	Theurl, M; Kirchmair, R (corresponding author), Med Univ Innsbruck, Univ Hosp Internal Med Cardiol & Angiol, Anichstr 35, A-6020 Innsbruck, Austria.	markus.theurl@i-med.ac.at; rudolf.kirchmair@i-med.ac.at	Albrecht-Schgoer, Karin/AAG-4463-2020	Albrecht-Schgoer, Karin/0000-0001-8551-4067; Theurl, Markus/0000-0002-3609-9730	Austrian Diabetes Association (oDG); Ernst-Mach fellowship awarded by the Eurasia-Pacific-Uninet; Austrian Science Fund (FWF) [L500-B05]	Austrian Diabetes Association (oDG); Ernst-Mach fellowship awarded by the Eurasia-Pacific-Uninet; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors thank Sylvia Berger (Department of Infectious Diseases, Immunology, Rheumatology, Pneumology, University Hospital of Internal Medicine II, Medical University Innsbruck) for excellent technical assistance. The current study was supported by a grant of the Austrian Science Fund (FWF; translational research grant L500-B05) and a 2007 research grant of the Austrian Diabetes Association (oDG) (to R.K.). Y.L. is the recipient of an Ernst-Mach fellowship awarded by the Eurasia-Pacific-Uninet. The authors declare no conflicts of interest.	Albrecht-Schgoer K, 2014, ANGIOGENESIS, V17, P27, DOI 10.1007/s10456-013-9375-4; Albrecht-Schgoer K, 2012, CIRCULATION, V126, P2491, DOI 10.1161/CIRCULATIONAHA.111.076950; APFEL SC, 1994, BRAIN RES, V634, P7, DOI 10.1016/0006-8993(94)90252-6; Belch J, 2011, LANCET, V377, P1929, DOI 10.1016/S0140-6736(11)60394-2; CAMERON NE, 1991, AM J PHYSIOL, V261, pE1, DOI 10.1152/ajpendo.1991.261.1.E1; CAMERON NE, 1994, DIABETES METAB REV, V10, P189, DOI 10.1002/dmr.5610100302; Cho YR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083204; Cohen JA, 1998, MUSCLE NERVE, V21, P72, DOI 10.1002/(SICI)1097-4598(199801)21:1<72::AID-MUS10>3.0.CO;2-2; CULLUM NA, 1991, DIABETOLOGIA, V34, P387, DOI 10.1007/BF00403175; DYCK PJ, 1989, NEUROLOGY, V39, P111, DOI 10.1212/WNL.39.1.111; Egger M, 2007, FASEB J, V21, P2906, DOI 10.1096/fj.06-7440com; GREENE DA, 1987, NEW ENGL J MED, V316, P599; He B, 2011, EUR J PHARMACOL, V667, P195, DOI 10.1016/j.ejphar.2011.06.001; Jeong JO, 2009, CIRCULATION, V119, P699, DOI 10.1161/CIRCULATIONAHA.108.789297; Kirchmair R, 2004, CIRCULATION, V109, P777, DOI 10.1161/01.CIR.0000112574.07422.C1; KIRCHMAIR R, 1993, NEUROSCIENCE, V53, P359, DOI 10.1016/0306-4522(93)90200-Y; Kirchmair R, 2007, MOL THER, V15, P69, DOI 10.1038/sj.mt.6300019; Kusano KF, 2004, ARTERIOSCL THROM VAS, V24, P2102, DOI 10.1161/01.ATV.0000144813.44650.75; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Norrmen C, 2013, BIOCHEM SOC T, V41, P944, DOI 10.1042/BST20130046; Pang ZD, 2017, FASEB J, V31, P4053, DOI 10.1096/fj.201700110R; PARKHOUSE N, 1988, NEW ENGL J MED, V318, P1306, DOI 10.1056/NEJM198805193182005; Pittenger Gary, 2003, Exp Diabesity Res, V4, P271, DOI 10.1155/EDR.2003.271; Posod A, 2017, NEUROSCIENCE, V352, P88, DOI 10.1016/j.neuroscience.2017.03.055; Ropper AH, 2009, ANN NEUROL, V65, P386, DOI 10.1002/ana.21675; Rosjo H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037401; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Schachinger V, 2009, EUR J HEART FAIL, V11, P973, DOI 10.1093/eurjhf/hfp113; Schgoer W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074029; Schgoer W, 2009, CIRC RES, V105, P994, DOI 10.1161/CIRCRESAHA.109.199513; SCHMID KW, 1995, HISTOCHEM J, V27, P473; Schratzberger P, 2001, J CLIN INVEST, V107, P1083, DOI 10.1172/JCI12188; Schratzberger P, 2000, NAT MED, V6, P405, DOI 10.1038/74664; Stavniichuk Roman, 2013, J Diabetes Mellitus, V3, DOI 10.4236/jdm.2013.33015; STEVENS EJ, 1994, DIABETOLOGIA, V37, P43, DOI 10.1007/BF00428776; Suenaga T, 2010, P NATL ACAD SCI USA, V107, P866, DOI 10.1073/pnas.0913351107; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; TESFAYE S, 1993, DIABETOLOGIA, V36, P1266, DOI 10.1007/BF00400804; Theurl M, 2015, CARDIOVASC RES, V105, P96, DOI 10.1093/cvr/cvu237; TUCK RR, 1984, BRAIN, V107, P935, DOI 10.1093/brain/107.3.935; Veves A, 1998, DIABETES, V47, P457, DOI 10.2337/diabetes.47.3.457; Walter DH, 2011, CIRC-CARDIOVASC INTE, V4, P26, DOI 10.1161/CIRCINTERVENTIONS.110.958348	42	4	4	3	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					4815	4823		10.1096/fj.201701391R	http://dx.doi.org/10.1096/fj.201701391R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913555				2022-12-26	WOS:000443817700017
J	Jahan, F; Madhavan, S; Rolova, T; Viazmina, L; Gronholm, M; Gahmberg, CG				Jahan, Farhana; Madhavan, Sudarrshan; Rolova, Taisia; Viazmina, Larisa; Gronholm, Mikaela; Gahmberg, Carl G.			Phosphorylation of the alpha-chain in the integrin LFA-1 enables beta 2-chain phosphorylation and alpha-actinin binding required for cell adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						integrin; phosphorylation; leukocyte; adhesion; talin; 14-3-3 protein; filamin; alpha-actinin	FUNCTION-ASSOCIATED ANTIGEN-1; INSIDE-OUT ACTIVATION; CYTOPLASMIC DOMAIN; LEUKOCYTE ADHESION; LIGAND-BINDING; THREONINE PHOSPHORYLATION; T-LYMPHOCYTES; BETA-SUBUNIT; CD18; AFFINITY	The integrin leukocyte function-associated antigen-1 (LFA-1) plays a pivotal role in leukocyte adhesion and migration, but the mechanism(s) by which this integrin is regulated has remained incompletely understood. LFA-1 integrin activity requires phosphorylation of its 2-chain and interactions of its cytoplasmic tail with various cellular proteins. The -chain is constitutively phosphorylated and necessary for cellular adhesion, but how the -chain regulates adhesion has remained enigmatic. We now show that substitution of the -chain phosphorylation site (S1140A) in T cells inhibits the phosphorylation of the functionally important Thr-758 in the 2-chain, binding of -actinin and 14-3-3 protein, and expression of an integrin-activating epitope after treatment with the stromal cell-derived factor-1. The presence of this substitution resulted in a loss of cell adhesion and directional cell migration. Moreover, LFA-1 activation through the T-cell receptor in cells expressing the S1140A LFA-1 variant resulted in less Thr-758 phosphorylation, -actinin and talin binding, and cell adhesion. The finding that the LFA-1 -chain regulates adhesion through the -chain via specific phosphorylation at Ser-1140 in the -chain has not been previously reported and emphasizes that both chains are involved in the regulation of LFA-1 integrin activity.	[Jahan, Farhana; Madhavan, Sudarrshan; Rolova, Taisia; Viazmina, Larisa; Gronholm, Mikaela; Gahmberg, Carl G.] Univ Helsinki, Fac Biol & Environm Sci, Mol & Integrat Biosci Res Program, FIN-00014 Helsinki, UH, Finland	University of Helsinki	Gronholm, M; Gahmberg, CG (corresponding author), Univ Helsinki, Fac Biol & Environm Sci, Mol & Integrat Biosci Res Program, FIN-00014 Helsinki, UH, Finland.	mikaela.gronholm@helsinki.fi; carl.gahmberg@helsinki.fi	Gahmberg, Carl/AAE-1876-2019	Gahmberg, Carl/0000-0001-9892-9296; Chernyaeva, Larisa/0000-0002-4979-381X; Jahan, Farhana/0000-0003-3607-5736; Gronholm, Mikaela/0000-0002-2378-8924; Rolova, Taisia/0000-0002-8869-593X	Academy of Finland; Sigrid Juselius Foundation; Medicinska Understodsforeningen Liv och Halsa; Finska Lakaresallskapet; Wilhelm and Else Stockmann Foundation; Ruth och Nils-Erik Stenback Foundation; Magnus Ehrnrooth Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medicinska Understodsforeningen Liv och Halsa; Finska Lakaresallskapet; Wilhelm and Else Stockmann Foundation; Ruth och Nils-Erik Stenback Foundation; Magnus Ehrnrooth Foundation	This work was supported by the Academy of Finland, the Sigrid Juselius Foundation, the Medicinska Understodsforeningen Liv och Halsa, the Finska Lakaresallskapet, the Wilhelm and Else Stockmann Foundation, the Ruth och Nils-Erik Stenback Foundation, and the Magnus Ehrnrooth Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Abair TD, 2008, BLOOD, V112, P3242, DOI 10.1182/blood-2007-12-126433; Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Bhunia A, 2009, J BIOL CHEM, V284, P3873, DOI 10.1074/jbc.M807236200; Bouvard D, 2013, NAT REV MOL CELL BIO, V14, P430, DOI 10.1038/nrm3599; CHATILA TA, 1989, J CELL BIOL, V109, P3435, DOI 10.1083/jcb.109.6.3435; Fagerholm S, 2002, J BIOL CHEM, V277, P1728, DOI 10.1074/jbc.M106856200; Fagerholm S, 2002, EUR J IMMUNOL, V32, P1670, DOI 10.1002/1521-4141(200206)32:6<1670::AID-IMMU1670>3.0.CO;2-M; Fagerholm SC, 2005, J CELL BIOL, V171, P705, DOI 10.1083/jcb.200504016; Fagerholm SC, 2006, BLOOD, V108, P3379, DOI 10.1182/blood-2006-03-013557; FILARDO EJ, 1994, J BIOL CHEM, V269, P4641; Gahmberg CG, 2014, ADV EXP MED BIOL, V819, P85, DOI 10.1007/978-94-017-9153-3_6; Gahmberg CG, 2009, BBA-GEN SUBJECTS, V1790, P431, DOI 10.1016/j.bbagen.2009.03.007; Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x; Gronholm M, 2016, BLOOD, V128, P1270, DOI 10.1182/blood-2016-03-705160; Gronholm M, 2011, J IMMUNOL, V187, P3613, DOI 10.4049/jimmunol.1100704; HIBBS ML, 1991, J EXP MED, V174, P1227, DOI 10.1084/jem.174.5.1227; Hilden TJ, 2003, J IMMUNOL, V170, P4170, DOI 10.4049/jimmunol.170.8.4170; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jones Matthew C, 2015, Curr Protoc Cell Biol, V66, DOI 10.1002/0471143030.cb0908s66; KASSNER PD, 1995, MOL BIOL CELL, V6, P661, DOI 10.1091/mbc.6.6.661; KASSNER PD, 1993, J EXP MED, V178, P649, DOI 10.1084/jem.178.2.649; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; LARSON RS, 1990, CELL REGUL, V1, P359, DOI 10.1091/mbc.1.4.359; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Li YF, 2007, J BIOL CHEM, V282, P24310, DOI 10.1074/jbc.M701860200; Liu JF, 2015, J CELL SCI, V128, P1718, DOI 10.1242/jcs.160663; Lu CF, 1997, J IMMUNOL, V159, P268; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Morse EM, 2014, BIOCHEMISTRY-US, V53, P810, DOI 10.1021/bi401596q; NORTAMO P, 1988, SCAND J IMMUNOL, V28, P537, DOI 10.1111/j.1365-3083.1988.tb01485.x; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; PARDI R, 1995, J IMMUNOL, V155, P1252; PAVALKO FM, 1993, J IMMUNOL, V151, P3795; Pouwels J, 2012, J CELL SCI, V125, P3271, DOI 10.1242/jcs.093641; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; SHAW LM, 1993, J CELL BIOL, V123, P1017, DOI 10.1083/jcb.123.4.1017; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101; Uotila LM, 2014, J BIOL CHEM, V289, P32230, DOI 10.1074/jbc.M114.588111; Uotila LM, 2013, J BIOL CHEM, V288, P33494, DOI 10.1074/jbc.C113.497446; Valmu L, 1999, BIOCHEM J, V339, P119, DOI 10.1042/0264-6021:3390119; VALMU L, 1995, J IMMUNOL, V155, P1175; VANKOOYK Y, 1991, J CELL BIOL, V112, P345, DOI 10.1083/jcb.112.2.345; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Weber KSC, 1997, J IMMUNOL, V158, P273; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Yauch RL, 1997, J EXP MED, V186, P1347, DOI 10.1084/jem.186.8.1347; YLANNE J, 1995, J BIOL CHEM, V270, P9550	56	8	8	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12318	12330		10.1074/jbc.RA118.004318	http://dx.doi.org/10.1074/jbc.RA118.004318			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29903913	Green Published, hybrid			2022-12-26	WOS:000441408500002
J	Azrag, AGA; Pirk, CWW; Yusuf, AA; Pinard, F; Niassy, S; Mosomtai, G; Babin, R				Azrag, Abdelmutalab G. A.; Pirk, Christian W. W.; Yusuf, Abdullahi A.; Pinard, Fabrice; Niassy, Saliou; Mosomtai, Gladys; Babin, Regis			Prediction of insect pest distribution as influenced by elevation: Combining field observations and temperature-dependent development models for the coffee stink bug, Antestiopsis thunbergii (Gmelin)	PLOS ONE			English	Article							CLIMATE-CHANGE; SPECIES DISTRIBUTIONS; ARABICA; PENTATOMIDAE; KILIMANJARO; ABUNDANCE; IMPACT	The antestia bug, Antestiopsis thunbergii (Gmelin 1790) is a major pest of Arabica coffee in Africa. The bug prefers coffee at the highest elevations, contrary to other major pests. The objectives of this study were to describe the relationship between A. thunbergii populations and elevation, to elucidate this relationship using our knowledge of the pest thermal biology and to predict the pest distribution under climate warming. Antestiopsis thunbergii population density was assessed in 24 coffee farms located along a transect delimited across an elevation gradient in the range 1000 +/- 1700 m asl, on Mt. Kilimanjaro, Tanzania. Density was assessed for three different climatic seasons, the cool dry season in June 2014 and 2015, the short rainy season in October 2014 and the warm dry season in January 2015. The pest distribution was predicted over the same transect using three risk indices: the establishment risk index (ERI), the generation index (GI) and the activity index (AI). These indices were computed using simulated life table parameters obtained from temperature-dependent development models and temperature data from 1) field records using data loggers deployed over the transect and 2) predictions for year 2055 extracted from AFRICLIM database. The observed population density was the highest during the cool dry season and increased significantly with increasing elevation. For current temperature, the ERI increased with an increase in elevation and was therefore distributed similarly to observed populations, contrary to the other indices. This result suggests that immature stage susceptibility to extreme temperatures was a key factor of population distribution as impacted by elevation. In the future, distribution of the risk indices globally indicated a decrease of the risk at low elevation and an increase of the risk at the highest elevations. Based on these results, we concluded with recommendations to mitigate the risk of A. thunbergii infestation.	[Azrag, Abdelmutalab G. A.; Niassy, Saliou; Mosomtai, Gladys; Babin, Regis] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Azrag, Abdelmutalab G. A.; Pirk, Christian W. W.; Yusuf, Abdullahi A.] Univ Pretoria, Dept Zool & Entomol, Pretoria, South Africa; [Azrag, Abdelmutalab G. A.] Univ Gezira, Fac Agr Sci, Dept Crop Protect, Wad Madani, Sudan; [Pinard, Fabrice; Babin, Regis] Ctr Cooperat Int Rech Agron Dev, UPR Bioagresseurs, Nairobi, Kenya; [Pinard, Fabrice; Babin, Regis] Univ Montpellier, Ctr Cooperat Int Rech Agron Dev, Bioagresseurs, Montpellier, France	International Centre of Insect Physiology & Ecology (ICIPE); University of Pretoria; CIRAD; CIRAD; Universite de Montpellier	Azrag, AGA (corresponding author), Int Ctr Insect Physiol & Ecol, Nairobi, Kenya.; Azrag, AGA (corresponding author), Univ Pretoria, Dept Zool & Entomol, Pretoria, South Africa.; Azrag, AGA (corresponding author), Univ Gezira, Fac Agr Sci, Dept Crop Protect, Wad Madani, Sudan.	agesmalla@icipe.org	Azrag, Abdelmutalab G. A./V-2040-2019; Babin, Régis/N-3682-2019; mosomtai, gladys/AAG-8677-2019; Babin, Régis/D-5322-2014; Yusuf, Abdullahi Ahmed/E-4701-2011; Pirk, Christian/E-4180-2010	Azrag, Abdelmutalab G. A./0000-0002-2192-3803; mosomtai, gladys/0000-0001-9010-1996; Babin, Régis/0000-0002-3753-1193; Yusuf, Abdullahi Ahmed/0000-0002-8625-6490; Pirk, Christian/0000-0001-6821-7044	Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD), Montpellier, France; CHIESA project (Climate Change Impacts on Ecosystem Services and Food Security in Eastern Africa) - Ministry of Foreign Affairs of Finland; German Academic Exchange Service (DAAD) In-Region Postgraduate Scholarship; UK's Department for International Development (DFID); Swedish International Development Cooperation Agency; Swiss Agency for Development and Cooperation (SDC); Kenyan Government; Regional Administrative Secretary Kilimanjaro [FA/191/228/01/61]	Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD), Montpellier, France; CHIESA project (Climate Change Impacts on Ecosystem Services and Food Security in Eastern Africa) - Ministry of Foreign Affairs of Finland; German Academic Exchange Service (DAAD) In-Region Postgraduate Scholarship; UK's Department for International Development (DFID); Swedish International Development Cooperation Agency; Swiss Agency for Development and Cooperation (SDC); Kenyan Government; Regional Administrative Secretary Kilimanjaro	Financial support for this research was received from the following organisations, projects and agencies: 1) The Centre de Cooperation Internationale en Recherche Agronomique pour le Developpement (CIRAD), Montpellier, France, https://www.cirad.fr/, in support of PhD student stipend (AGAA); 2) CHIESA project (Climate Change Impacts on Ecosystem Services and Food Security in Eastern Africa) funded by the Ministry of Foreign Affairs of Finland, http://chiesa.icipe.org/, in support of laboratory and field experimentation; 3) The German Academic Exchange Service (DAAD) In-Region Postgraduate Scholarship, in support of student stipends and school fees. International Centre of Insect Physiology and Ecology is core-funded by UK's Department for International Development (DFID), Swedish International Development Cooperation Agency, the Swiss Agency for Development and Cooperation (SDC) and the Kenyan Government.; We thank Dr. James Odanga for providing the current climatic data and all the coffee pest staff at International Centre of Insect Physiology and Ecology, especially Ephantus Guandaru and Dickson Mwenda for technical support in the laboratory. Also, we are grateful to the coffee farmers of the study area for allowing us to access their farm for surveys. Permission to carry research (surveys and insect field collections) by the "Climate Change Impacts of Ecosystem Services and Food Security in Eastern Africa" (CHIESA) project was granted by the Regional Administrative Secretary Kilimanjaro under reference FA/191/228/01/61.	ABEBE M, 1987, INSECT SCI APPL, V8, P977, DOI 10.1017/S1742758400023274; Ahmed AG, 2016, INT J TROP INSECT SC, V36, P119, DOI 10.1017/S1742758416000072; Azrag AGA, 2017, J THERM BIOL, V70, P27, DOI 10.1016/j.jtherbio.2017.10.009; Babin R, 2018, INVASIVE STINK BUGS, P466; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Bigirimana J., 2012, African Journal of Agricultural Research, V7, P3847; Booth TH, 2014, DIVERS DISTRIB, V20, P1, DOI 10.1111/ddi.12144; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Cilas C, 1998, J APPL ENTOMOL, V122, P601, DOI 10.1111/j.1439-0418.1998.tb01552.x; Cilas C, 2016, CLIMATE CHANGE AGR W, P73, DOI DOI 10.1007/978-94-017-7462-8_6; Craparo ACW, 2015, AGR FOREST METEOROL, V207, P1, DOI 10.1016/j.agrformet.2015.03.005; Davis AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047149, 10.1371/journal.pone.0047981]; Estay SA, 2009, J APPL ENTOMOL, V133, P491, DOI 10.1111/j.1439-0418.2008.01380.x; Fand BB, 2014, ECOL MODEL, V288, P62, DOI 10.1016/j.ecolmodel.2014.05.018; Foucart G, 1959, CONTRIBUTION ETUDE P, P327; Gichuhi JM, 2017, J ECON ENTOMOL, V110, P1120, DOI 10.1093/jee/tow283; GREATHEAD DJ, 1966, B ENTOMOL RES, V56, P515, DOI 10.1017/S000748530005656X; Gueule D, 2015, INT J SYST EVOL MICR, V65, P23, DOI 10.1099/ijs.0.063545-0; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hemp A, 2006, BIODIVERS CONSERV, V15, P1193, DOI 10.1007/s10531-004-8230-8; Hijmans RJ, PREPRINT; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Kirkpatrick T. W., 1937, Transactions of the Royal Entomological Society of London, V86, P247; Kroschel J, 2013, AGR FOREST METEOROL, V170, P228, DOI 10.1016/j.agrformet.2012.06.017; Matsuura Y, 2014, APPL ENVIRON MICROB, V80, P3769, DOI 10.1128/AEM.00554-14; MCNUTT DN, 1979, PANS, V25, P5, DOI 10.1080/09670877909411653; Mugo HM., 2013, INT J SCI NATURE, V4, P324; Mwalusepo S, 2016, DATA BRIEF, V8, P1115, DOI 10.1016/j.dib.2016.07.041; Mwalusepo S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130427; Ovalle-Rivera O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124155; Phillips S.J., 2005, ATT RES, V190, P231; Platts PJ, 2015, AFR J ECOL, V53, P103, DOI 10.1111/aje.12180; RCore Team, 2020, R LANG ENV STAT COMP; Ribeyre F, 2012, SPECIALTY COFFEE MAN, P151; Scrucca L, PREPRINT; Sutherst R W, 2007, CLIMEX VERSION 3 USE; Tanga CM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189138; Thomson AM, 2011, CLIMATIC CHANGE, V109, P77, DOI 10.1007/s10584-011-0151-4; Tonnang E.Z.H., 2013, ILCYM INSECT LIFE CY; van der Meulen H.J., 1990, Phytophylactica, V22, P423; Zehnder CB, 2009, ENVIRON ENTOMOL, V38, P1161, DOI 10.1603/022.038.0424	42	31	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199569	10.1371/journal.pone.0199569	http://dx.doi.org/10.1371/journal.pone.0199569			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933391	Green Published, gold, Green Submitted			2022-12-26	WOS:000436076600034
J	Mollner, C; Hammerschmidt, D; Albrecht, H				Moellner, Clemens; Hammerschmidt, David; Albrecht, Henning			Slow motion in films and video clips: Music influences perceived duration and emotion, autonomic physiological activation and pupillary responses	PLOS ONE			English	Article							AROUSAL; TEMPO; TIME; EYE; EXPERIENCE; PERCEPTION; VALENCE; CHILLS; IMPACT; HAPPY	Slow motion scenes are ubiquitous in screen-based audiovisual media and are typically accompanied by emotional music. The strong effects of slow motion on observers are hypothetically related to heightened emotional states in which time seems to pass more slowly. These states are simulated in films and video clips, and seem to resemble such experiences in daily life. The current study investigated time perception and emotional response to media clips containing decelerated human motion, with or without music using psychometric and psychophysiological testing methods. Participants were presented with slow-motion scenes taken from commercial films, ballet and sports footage, as well as the same scenes converted to real-time. Results reveal that slow-motion scenes, compared to adapted real-time scenes, led to systematic underestimations of duration, lower perceived arousal but higher valence, lower respiration rates and smaller pupillary diameters. The presence of music compared to visual-only presentations strongly affected results in terms of higher accuracy in duration estimates, higher perceived arousal and valence, higher physiological activation and larger pupillary diameters, indicating higher arousal. Video genre affected responses in addition. These findings suggest that perceiving slow motion is not related to states of high arousal, but rather affects cognitive dimensions of perceived time and valence. Music influences these experiences profoundly, thus strengthening the impact of stretched time in audiovisual media.	[Moellner, Clemens; Hammerschmidt, David; Albrecht, Henning] Univ Hamburg, Hamburg, Germany	University of Hamburg	Mollner, C (corresponding author), Univ Hamburg, Hamburg, Germany.	clemens.woellner@uni-hamburg.de	Wöllner, Clemens/AAF-7756-2020	Wöllner, Clemens/0000-0002-8508-3508; Hammerschmidt, David/0000-0002-5786-4040	European Research Council; five-years project "Slow motion: Transformations of musical time in perception and performance" (SloMo) [725319]	European Research Council(European Research Council (ERC)European Commission); five-years project "Slow motion: Transformations of musical time in perception and performance" (SloMo)	This research was supported by a Consolidator Grant from the European Research Council to the first author. The research is part of the five-years project "Slow motion: Transformations of musical time in perception and performance" (SloMo; Grant no. 725319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arstila V, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00196; Bailey N, 2006, J RETAILING, V82, P189, DOI 10.1016/j.jretai.2006.05.003; Baumgartner T, 2006, INT J PSYCHOPHYSIOL, V60, P34, DOI 10.1016/j.ijpsycho.2005.04.007; Baumgartner T, 2006, BRAIN RES, V1075, P151, DOI 10.1016/j.brainres.2005.12.065; Becker A., 2012, ERZAHLEN ANDEREN DIM; Berenstein Robin, 2000, J DRAMATIC THEORY CR, V14, P121; Block RA, 2010, ACTA PSYCHOL, V134, P330, DOI 10.1016/j.actpsy.2010.03.006; BLUMENTHAL TD, 1991, PSYCHOPHYSIOLOGY, V28, P296, DOI 10.1111/j.1469-8986.1991.tb02198.x; Boltz MG, 2004, MEM COGNITION, V32, P1194, DOI 10.3758/BF03196892; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Brockmann T., 2014, ANATOMIE FILMISCHEN; Cameron MA, 2003, J BUS RES, V56, P421, DOI 10.1016/S0148-2963(01)00244-2; Capestany J., 2014, R FEDERER SLOW MOTIO; Cohen AJ, 2010, HDB MUSIC EMOTION TH, P879; Collins R., 2013, KARIS SCARLETTE SLOW; Coutrot A, 2012, J EYE MOVEMENT RES, V5; Dobrich I., 2014, TABLE TENNIS SLOW MO; Droit-Volet S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00417; Ellis RJ., 2005, PSYCHOMUSICOLOGY J R, V19, P15, DOI DOI 10.1037/H0094042; Epstein D., 1995, SHAPING TIME MUSIC B; Filmmusik Pauli H., 1976, MUSIK MASSENMEDIEN R, P91; Ford BQ, 2010, PSYCHOL SCI, V21, P1098, DOI 10.1177/0956797610375450; Fraisse P., 1967, PSYCHOL DU TEMPS; Gil S, 2012, COGNITION EMOTION, V26, P847, DOI 10.1080/02699931.2011.625401; Gingras B, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00619; Grewe O, 2011, PSYCHOL MUSIC, V39, P220, DOI 10.1177/0305735610362950; Hammerschmidt D, 2018, J EYE MOVEMENT RES, V11, DOI 10.16910/jemr.11.2.10; Hirsch H, 2012, SILENT YOUTH; Hodges D.A., 2010, HDB MUSIC EMOTION TH, P279; Husserl E., 1928, LECT PHENOMENOLOGY I; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Jefferies LN, 2008, PSYCHOL SCI, V19, P290, DOI 10.1111/j.1467-9280.2008.02082.x; Joy J., 2014, BADMINTON SMASH TECH; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Khalfa S, 2008, INT J PSYCHOPHYSIOL, V68, P17, DOI 10.1016/j.ijpsycho.2007.12.001; Kubrick S, 2010, A CLOCKWORK ORANGE; Laeng B, 2016, CONSCIOUS COGN, V44, P161, DOI 10.1016/j.concog.2016.07.009; LERDAHL F, 1983, MUSIC PERCEPT, V1, P229; London J., 2012, HEARING TIME; Lundqvist LO, 2009, PSYCHOL MUSIC, V37, P61, DOI 10.1177/0305735607086048; Mera M., 2014, MUSIC MOVING IMAGE, V7, P3, DOI [10.5406/musimoviimag.7.3.0003, DOI 10.5406/MUSIMOVIIMAG.7.3.0003]; NOYES R, 1976, PSYCHIATRY, V39, P19, DOI 10.1080/00332747.1976.11023873; Oakes S, 2003, PSYCHOL MARKET, V20, P685, DOI 10.1002/mar.10092; Poppel E, 1997, TRENDS COGN SCI, V1, P56, DOI 10.1016/S1364-6613(97)01008-5; Rogers S., 2013, PSYCHOCINEMATICS EXP, P146; Roy M, 2009, INT J PSYCHOPHYSIOL, V71, P37, DOI 10.1016/j.ijpsycho.2008.07.010; Sacks O., 2004, NEW YORKER, V80, P60; Schafer T, 2015, ATTEN PERCEPT PSYCHO, V77, P551, DOI 10.3758/s13414-014-0777-1; Terrone E., 2017, ROUTLEDGE HDB PHILOS, P326; Thayer J., 1983, PSYCHOMUSICOLOGY, V3, P44, DOI DOI 10.1037/H0094256; Tisch S, 1994, FORREST GUMP; van Dyck E, 2017, MUSIC SCI, V21, P390, DOI 10.1177/1029864917700706; Vicario CM, 2017, PSYCHOL RES-PSYCH FO, V81, P1201, DOI 10.1007/s00426-016-0804-z; White EL, 2016, MUSIC SCI, V20, P11, DOI 10.1177/1029864915608911	54	10	10	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199161	10.1371/journal.pone.0199161	http://dx.doi.org/10.1371/journal.pone.0199161			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK3VI	29933380	gold, Green Published, Green Submitted			2022-12-26	WOS:000436076600015
J	Mirkuzie, AH				Mirkuzie, Alemnesh H.			Implementation and outcomes of guideline revisions for the prevention of mother-to-child HIV transmission in Mother Support Programme, Addis Ababa, Ethiopia	PLOS ONE			English	Article							NORTHERN ETHIOPIA; EXPOSED INFANTS; INFECTION; PMTCT; PREDICTORS; ADHERENCE; COHORT	About 40% of the new HIV infections in Ethiopia are among children < 15 years of age. The great majority of these infections occur through Mother-to-child HIV transmission (MTCT). For prevention of MTCT, the national guidelines has been revised to incorporate scientific advances in HIV prevention, treatment and care. Since 2005, the country has been implementing a peer mentor programme called Mother Support Group (MSG), which provides psychosocial and adherence support for HIV positive mothers. This study examined implementation of PMTCT guidelines revisions and outcomes of HIV exposed babies in the MSG in Addis Ababa. Retrospective routine data were collected between 2005 and August 2013 from seven randomly selected primary health facilities. Odds ratios and 95% confidence intervals were calculated using logistic regression models. Several guidelines revisions were made between 2001 and 2013 in HIV testing approaches, prophylactic antiretroviral options, infant feeding recommendations and infant HIV testing algorithms. Revisions on the CD4 thresholds were associated with a significant increase in the proportion of women initiating antiretroviral treatment from 0 in 2005 to 62% in 2013. Revisions in infant feeding recommendations led to a 92.3% reported practice of exclusive breastfeeding in 2013 compared to 60.9% in 2005. Two and four percent of the HIV exposed babies were HIV positive by six and 18 months respectively. Not receiving prophylactic ART and receiving mixed feeding were independent predictors for babies having an HIV positive antibody test at 18 months. The rate of HIV status disclosure increased significantly year by year. Over the years, the PMTCT recommendations have moved from having a solo focus on PMTCT to holistic and inclusive approaches emphasizing survival beyond HIV prevention. The data reflect favourable outcomes of HIV exposed babies in terms of averted MTCT though serious gaps in data quality remain. For successful implementation of Option-B plus, the identified gaps in the MSG need to be addressed.	[Mirkuzie, Alemnesh H.] Ethiopian Publ Hlth Inst, Natl Data Management Ctr, Addis Ababa, Ethiopia		Mirkuzie, AH (corresponding author), Ethiopian Publ Hlth Inst, Natl Data Management Ctr, Addis Ababa, Ethiopia.	alemmirkuzie@yahoo.com			university of Bergen in Norway; University of Bergen, Norway	university of Bergen in Norway; University of Bergen, Norway	The university of Bergen in Norway has funded the project.; The study was financially supported by the University of Bergen, Norway. I acknowledge Yaw Davis, Alemayehu Gebremariam and Lorena Ruano for language editing and reviewing the manuscript.	Ahoua L, 2010, J TROP PEDIATRICS, V56, P43, DOI 10.1093/tropej/fmp054; Asfaw E, 2014, HEALTH POLICY PLANN, V29, P50, DOI 10.1093/heapol/czu072; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Derebe Gebremedhin, 2014, BMC Res Notes, V7, P309, DOI 10.1186/1756-0500-7-309; Ebuy H, 2015, INT J INFECT DIS, V33, P123, DOI 10.1016/j.ijid.2014.12.026; Federal HIV/AIDS Preventi on and Control Office Federal Ministry of Health, 2001, GUID PREV MOTH TO CH; Federal HIV/AIDS Preventi on and Control Office Federal Ministry of Health, 2011, GUID PREV MOTH TO CH; Federal Ministry of Health, 2013, OPT BTHORN TRAIN CUR; Haile F, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-65; HAPCO (Federal HIV/AIDS Prevention and Control Office), 2007, HIVAIDS COUSELING TE; Hope R, 2009, ETHIOPIA EVALUATION; Horvath T, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006734.pub2; Hyun K., 2013, KOREAN J ANESTHESIOL, V64, P402, DOI [10.4097/kjae.2013.64.5.402, DOI 10.4097/KJAE.2013.64.5.402]; Koye DN, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-398; Kredo T, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007331.pub3; Ministry of Finance and Economic Development Federal Democratic Republic of Ethiopia UN, 2012, ASS PROGR MILL DEV G; Mirkuzie AH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1113; Mirkuzie AH, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-50; Mirkuzie AH, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-267; Schlomer GL, 2010, J COUNS PSYCHOL, V57, P1, DOI 10.1037/a0018082; Siegfried N, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub3; UNAIDS, 2014, THE GAP; UNAIDS, 2011, COUNTD ZER GLOB PLAN; Viadro C, 2008, MOTH SUPP GROUPS ETH; Westreich D, 2012, EPIDEMIOLOGY, V23, P159, DOI 10.1097/EDE.0b013e31823b6296; WHO, 2022, ANT DRUGS TREAT PREG; World Health Organization, 2021, ANT DRUGS TREAT PREG	27	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198438	10.1371/journal.pone.0198438	http://dx.doi.org/10.1371/journal.pone.0198438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927946	gold, Green Published, Green Submitted			2022-12-26	WOS:000435802500021
J	Hardison, DR; Holland, WC; Darius, HT; Chinain, M; Tester, PA; Shea, D; Bogdanoff, AK; Morris, JA; Quintana, HAF; Loeffler, CR; Buddo, D; Litaker, RW				Hardison, D. Ransom; Holland, William C.; Darius, H. Taiana; Chinain, Mireille; Tester, Patricia A.; Shea, Damian; Bogdanoff, Alex K.; Morris, James A., Jr.; Quintana, Harold A. Flores; Loeffler, Christopher R.; Buddo, Dayne; Litaker, R. Wayne			Investigation of ciguatoxins in invasive lionfish from the greater caribbean region: Implications for fishery development	PLOS ONE			English	Article							INDO-PACIFIC LIONFISH; BINDING ASSAY; CIGUATERA; GAMBIERDISCUS; PERSPECTIVES; BARRACUDA; ABUNDANCE; TOXICITY; COMPLEX; TOXINS	Lionfish, native to reef ecosystems of the tropical and sub-tropical Indo-Pacific, were introduced to Florida waters in the 1980s, and have spread rapidly throughout the northwestern Atlantic, Caribbean Sea and the Gulf of Mexico. These invasive, carnivorous fish significantly reduce other fish and benthic invertebrate biomass, fish recruitment, and species richness in reef ecosystems. Fisheries resource managers have proposed the establishment of a commercial fishery to reduce lionfish populations and mitigate adverse effects on reef communities. The potential for a commercial fishery for lionfish is the primary reason to identify locations where lionfish accumulate sufficient amounts of ciguatoxin (CTX) to cause ciguatera fish poisoning (CFP), the leading cause of non-bacterial seafood poisoning associated with fish consumption. To address this issue, an initial geographic assessment of CTX toxicity in lionfish from the Caribbean and Gulf of Mexico was conducted. Lionfish samples (n = 293) were collected by spearfishing from 13 locations (74 sampling sites) around the Caribbean and Gulf of Mexico between 2012 and 2015. The highest frequencies of lionfish containing measurable CTX occurred in areas known to be high-risk regions for CFP in the central to eastern Caribbean (e.g., 53% British Virgin Islands and 5% Florida Keys). Though measurable CTX was found in some locations, the majority of the samples (99.3%) contained CTX concentrations below the United States Food and Drug Administration guidance level of 0.1 ppb Caribbean ciguatoxin-1 (C-CTX-1) equivalents (eq.). Only 0.7% of lionfish tested contained more than 0.1 ppb C-CTX-1 eq. As of 2018, there has been one suspected case of CFP from eating lionfish. Given this finding, current risk reduction techniques used to manage CTX accumulating fish are discussed.	[Hardison, D. Ransom; Holland, William C.; Bogdanoff, Alex K.; Morris, James A., Jr.; Litaker, R. Wayne] NOAA, Ctr Coastal Fisheries & Habitat Res, Beaufort, NC 28516 USA; [Darius, H. Taiana; Chinain, Mireille] ILM, Lab Tox Microalgae, EIO, UMR 241, Tahiti, French Polynesi, France; [Tester, Patricia A.] Ocean Tester LLC, Beaufort, NC USA; [Shea, Damian] North Carolina State Univ, Environm Chem & Toxicol Lab, Raleigh, NC 27695 USA; [Quintana, Harold A. Flores; Loeffler, Christopher R.] US FDA, Div Seafood Sci & Technol, Gulf Coast Seafood Lab, Dauphin Isl, AL USA; [Buddo, Dayne] Univ West Indies, Discovery Bay Marine Lab, Discovery Bay, St Ann, Jamaica; [Buddo, Dayne] Field Stn, Discovery Bay, St Ann, Jamaica	National Oceanic Atmospheric Admin (NOAA) - USA; Ifremer; University of North Carolina; North Carolina State University; US Food & Drug Administration (FDA); University West Indies Mona Jamaica	Hardison, DR (corresponding author), NOAA, Ctr Coastal Fisheries & Habitat Res, Beaufort, NC 28516 USA.	rance.hardison@noaa.gov	DARIUS, Hélène Taiana/J-6163-2015; Loeffler, Christopher/AAD-6894-2020; Litaker, Richard Wayne/AAH-2036-2021; CHINAIN, Mireille/G-7055-2017; Shea, Damian/K-1360-2014	DARIUS, Hélène Taiana/0000-0002-1184-7034; Loeffler, Christopher/0000-0002-5744-5743; Litaker, Richard Wayne/0000-0001-6293-8000; CHINAIN, Mireille/0000-0001-6560-1278; Shea, Damian/0000-0003-1348-6639; Buddo, Dayne/0000-0002-1595-9500	NOAA Ecology and Oceanography of Harmful Algal Blooms Program, ECOHAB [EC0926]; NOM, National Ocean Service, National Centers for Coastal Ocean Science	NOAA Ecology and Oceanography of Harmful Algal Blooms Program, ECOHAB; NOM, National Ocean Service, National Centers for Coastal Ocean Science	This work was supported by the NOAA Ecology and Oceanography of Harmful Algal Blooms Program, ECOHAB contribution no. EC0926 and by program funds provided by NOM, National Ocean Service, National Centers for Coastal Ocean Science. Ocean Tester did not contribute funding for this project.	Akins JL, 2014, ECOL EVOL, V4, P3768, DOI 10.1002/ece3.1171; Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Albins MA, 2015, MAR ECOL PROG SER, V522, P231, DOI 10.3354/meps11159; ANDERSON DM, 1987, BIOL BULL, V172, P89, DOI 10.2307/1541609; [Anonymous], 2011, FISH FISH PROD HAZ C; Barbour AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019666; Botana L.M., 2014, SEAFOOD FRESHWATER T; Caillaud A, 2012, FOOD ADDIT CONTAM A, V29, P1000, DOI 10.1080/19440049.2012.660707; Caillaud A, 2010, MAR DRUGS, V8, P1838, DOI 10.3390/md8061838; Cerino D, 2013, T AM FISH SOC, V142, P1522, DOI 10.1080/00028487.2013.811098; Chan TYK, 2016, AM J TROP MED HYG, V94, P704, DOI 10.4269/ajtmh.15-0686; Chinain M, 1999, MAR BIOL, V135, P259, DOI 10.1007/s002270050623; Chinain M, 2010, TOXICON, V56, P674, DOI 10.1016/j.toxicon.2009.05.032; Cote IM, 2010, MAR ECOL PROG SER, V404, P219, DOI 10.3354/meps08458; Darius HT, 2007, TOXICON, V50, P612, DOI 10.1016/j.toxicon.2007.05.007; Darius HT, 2013, FOOD ADDIT CONTAM A, V30, P550, DOI 10.1080/19440049.2012.752581; Dechraoui MYB, 2005, TOXICON, V46, P261, DOI 10.1016/j.toxicon.2005.04.006; Dickey Robert W., 2008, P479; Dickey RW, 2010, TOXICON, V56, P123, DOI 10.1016/j.toxicon.2009.09.008; FDA. Guidance for Industry, 2013, GUID IND PURCH REEF; Fishelson L, 1997, ENVIRON BIOL FISH, V50, P391, DOI 10.1023/A:1007331304122; Friedman MA, 2017, MAR DRUGS, V15, DOI 10.3390/md15030072; Green SJ, 2011, MAR ECOL PROG SER, V433, P159, DOI 10.3354/meps09208; Green SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032596; GRZEBYK D, 1994, J EXP MAR BIOL ECOL, V178, P51, DOI 10.1016/0022-0981(94)90224-0; Hardison DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153348; Kibler SR, 2012, HARMFUL ALGAE, V19, P1, DOI 10.1016/j.hal.2012.04.007; Layman CA, 2014, MAR BIOL, V161, P2179, DOI 10.1007/s00227-014-2491-x; Lehane L, 2000, INT J FOOD MICROBIOL, V61, P91, DOI 10.1016/S0168-1605(00)00382-2; LEWIS ND, 1986, SOC SCI MED, V23, P983, DOI 10.1016/0277-9536(86)90255-8; Lewis RJ, 2006, TOXICON, V48, P799, DOI 10.1016/j.toxicon.2006.07.019; Lewis RJ, 2001, TOXICON, V39, P97, DOI 10.1016/S0041-0101(00)00161-6; Litaker RW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185776; Litaker RW, 2010, TOXICON, V56, P711, DOI 10.1016/j.toxicon.2010.05.017; Manger RL, 1995, P INT S CIG MAR NAT; McCall JR, 2014, J AOAC INT, V97, P307, DOI 10.5740/jaoacint.SGEMcCall; McCall JR, 2012, HARMFUL ALGAE, V19, P85, DOI 10.1016/j.hal.2012.06.003; Morris J. A. Jr., 2011, AACL Bioflux, V4, P21; Morris JA, 2012, INVASIVE LIONFISH GU; Morris JA, 2011, BIOL INVASIONS, V13, P7, DOI 10.1007/s10530-010-9786-8; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A, DOI [DOI 10.17226/12910, 10.17226/12910]; NMFS, 2016, ANN COMM LAND STAT 2; NOAA/NCCOS, 2016, LIONF 2016 FEBR; OLSEN DA, 1984, MAR FISH REV, V46, P13; Pottier I, 2003, TOXICON, V42, P663, DOI 10.1016/j.toxicon.2003.09.004; Pottier I, 2002, FOOD ADDIT CONTAM, V19, P1034, DOI 10.1080/02652030210155378; Rains LK, 2015, HARMFUL ALGAE, V49, P29, DOI 10.1016/j.hal.2015.08.005; Robertson A, 2014, MAR DRUGS, V12, P88, DOI 10.3390/md12010088; Solino L, 2015, TOXICON, V102, P62, DOI 10.1016/j.toxicon.2015.05.015; Villareal TA, 2007, HARMFUL ALGAE, V6, P253, DOI 10.1016/j.hal.2006.08.008; Whitfield PE, 2007, BIOL INVASIONS, V9, P53, DOI 10.1007/s10530-006-9005-9; Wilcox CL, 2015, ENVIRON BIOL FISH, V98, P961, DOI 10.1007/s10641-014-0313-0	53	18	18	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							0198358	10.1371/journal.pone.0198358	http://dx.doi.org/10.1371/journal.pone.0198358			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924826	gold, Green Published			2022-12-26	WOS:000435655600019
J	Kendall, CE; Shoemaker, ES; Boucher, L; Rolfe, DE; Crowe, L; Becker, M; Asghari, S; Rourke, SB; Rosenes, R; Bibeau, C; Lundrigan, P; Liddy, C				Kendall, Claire E.; Shoemaker, Esther Susanna; Boucher, Lisa; Rolfe, Danielle E.; Crowe, Lois; Becker, Marissa; Asghari, Shabnam; Rourke, Sean B.; Rosenes, Ron; Bibeau, Christine; Lundrigan, Philip; Liddy, Clare			The organizational attributes of HIV care delivery models in Canada: A cross-sectional study	PLOS ONE			English	Article							QUALITY-OF-CARE; PEOPLE; ASSOCIATION; HIV/AIDS; OUTCOMES	HIV treatment in Canada has rapidly progressed with the advent of new drug therapies and approaches to care. With this evolution, there is increasing interest in Canada in understanding the current delivery of HIV care, specifically where care is delivered, how, and by whom, to inform the design of care models required to meet the evolving needs of the population. We conducted a cross-sectional survey of Canadian care settings identified as delivering HIV care between June 2015 and January 2016. Given known potential differences in delivery approaches, we stratified settings as primary care or specialist settings, and described their structure, geographic location, populations served, health human resources, technological resources, and available clinical services. We received responses from 22 of 43 contacted care settings located in seven Canadian provinces (51.2% response rate). The total number of patients and HIV patients served by the participating settings was 38,060 and 17,678, respectively (mean number of HIV patients in primary care settings = 1,005, mean number of HIV patients in specialist care settings = 562). Settings were urban for 20 of the 22 (90.9%) clinics and 14 (63.6%) were entirely HIV focused. Primary care settings were more likely to offer preventative services (e.g., cervical smear, needle exchange, IUD insertion, chronic disease self-management program) than specialist settings. The study illustrates diversity in Canadian HIV care settings. All settings were team based, but primary care settings offered a broader range of preventative services and comprehensive access to mental health services, including addictions and peer support.	[Kendall, Claire E.; Shoemaker, Esther Susanna; Boucher, Lisa; Crowe, Lois; Rosenes, Ron; Bibeau, Christine; Lundrigan, Philip; Liddy, Clare] Bruyere Res Inst, CT Lamont Primary Hlth Care Res Ctr, Ottawa, ON, Canada; [Kendall, Claire E.; Shoemaker, Esther Susanna; Boucher, Lisa; Rolfe, Danielle E.; Liddy, Clare] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Kendall, Claire E.; Shoemaker, Esther Susanna] Inst Clin & Evaluat Sci, Toronto, ON, Canada; [Kendall, Claire E.; Rourke, Sean B.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Kendall, Claire E.; Shoemaker, Esther Susanna] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Becker, Marissa] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Becker, Marissa] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Becker, Marissa] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Asghari, Shabnam] Mem Univ Newfoundland, Ctr Rural Hlth Studies, Dept Family Med, St John, NF, Canada; [Rourke, Sean B.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	University of Ottawa; University of Ottawa; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Manitoba; University of Manitoba; University of Manitoba; Memorial University Newfoundland; University of Toronto	Kendall, CE (corresponding author), Bruyere Res Inst, CT Lamont Primary Hlth Care Res Ctr, Ottawa, ON, Canada.; Kendall, CE (corresponding author), Univ Ottawa, Fac Med, Ottawa, ON, Canada.; Kendall, CE (corresponding author), Inst Clin & Evaluat Sci, Toronto, ON, Canada.; Kendall, CE (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.; Kendall, CE (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.	ckendall@uottawa.ca	Boucher, Lisa/GYV-4476-2022; Shoemaker, Esther/AAC-6216-2019	Shoemaker, Esther/0000-0003-4552-4978; Boucher, Lisa/0000-0002-1543-0965; Kendall, Claire/0000-0003-2686-1135; Liddy, Clare/0000-0003-0699-5494; Crowe, Lois/0000-0002-6487-5821	Canadian Institutes of Health Research (CIHR) [FRN TT5-128270]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding for this project was provided through the Canadian Institutes of Health Research (CIHR) FRN TT5-128270 to CEK. The authors affirm their independence from these funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canadian Institute for Health Information, 2013, MEAS ORG ATTR PRIM H; Carmichael D, 2009, AVERTING CRISIS HIV; Centers for Disease Control and Prevention, CDC FACT SHEET HIV U; Chandrasekar PH, 2015, CLIN INFECT DIS, V60, P1438, DOI 10.1093/cid/civ037; Cheng QJ, 2014, J AIDS CLIN RES, P5; Choi SKY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156652; Chu C, 2011, J URBAN HEALTH, V88, P556, DOI 10.1007/s11524-011-9552-y; College of Family Physicians of Canada, 2011, VIS CAN FAM PRACT PA; Ding L, 2008, AIDS CARE, V20, P35, DOI 10.1080/09540120701439295; Drummond KL, 2017, AIDS CARE, V29, P290, DOI 10.1080/09540121.2016.1255704; Fix GM, 2014, J GEN INTERN MED, V29, P695, DOI 10.1007/s11606-013-2677-9; Glazier RH., 2012, COMP PRIMARY CARE MO; Granich R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002253; Guenter D, 2004, CAN FAM PHYSICIAN, V50, P1011; Haldane V, 2018, AIDS CARE, V30, P103, DOI 10.1080/09540121.2017.1344350; Handford CD, 2012, AIDS CARE, V24, P267, DOI 10.1080/09540121.2011.608419; Hogg W, 2008, INT J QUAL HEALTH C, V20, P308, DOI 10.1093/intqhc/mzm054; Johnston Steve, 2015, 2015 IEEE 42nd Photovoltaic Specialist Conference (PVSC). Proceedings, P1, DOI 10.1109/PVSC.2015.7356423; Justice AC, 2007, TOP HIV MED, V14, P159; Justice Amy C, 2010, Curr HIV/AIDS Rep, V7, P69, DOI 10.1007/s11904-010-0041-9; Kang R, 2017, N AM PRIM CAR RES GR; Kaposy C, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-017-0171-3; Kendall CE, 2015, ANN FAM MED, V13, P436, DOI 10.1370/afm.1822; Kendall CE, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007428; Kendall CE, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0723-5; Kendall CE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-161; Kimmel AD, 2016, AIDS CARE, V28, P1215, DOI 10.1080/09540121.2016.1178702; Lakshmi S, 2018, AIDS CARE, V30, P569, DOI 10.1080/09540121.2017.1385720; Landovitz RJ, 2016, AIDS PATIENT CARE ST, V30, P395, DOI 10.1089/apc.2016.0170; Lemon SM, 2006, ENS INF DIS WORKF ED; Mahy M, 2014, AIDS, V28, pS453, DOI 10.1097/QAD.0000000000000479; Mapp F, 2015, INT J STD AIDS, V26, P991, DOI 10.1177/0956462415577496; Mizuno Y, 2015, AIDS BEHAV, V19, P684, DOI 10.1007/s10461-014-0890-0; Molloy A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2708-y; Pasricha A, 2013, J GEN INTERN MED, V28, P127, DOI 10.1007/s11606-012-2145-y; Public Health Agency of Canada, 2015, SUMM EST HIV INC PRE; Public Health England, 2014, NATL DIET NUTR SURVE; Rachlis B, 2017, AIDS CARE, V29, P828, DOI 10.1080/09540121.2016.1271389; Rank C, 2009, CAN ASS HIV RES 18 A; Raphael D., 2009, SOCIAL DETERMINANTS, V2nd ed; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Sheth AN, 2006, AIDS PATIENT CARE ST, V20, P318, DOI 10.1089/apc.2006.20.318; Stange KC, 2010, J GEN INTERN MED, V25, P601, DOI 10.1007/s11606-010-1291-3; Stange KC, 2009, ANN FAM MED, V7, P293, DOI 10.1370/afm.1023; Veinot T, 2010, IMPROVING ACCESS HIV; Wong C, 2017, CLIN INFECT DIS	46	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199395	10.1371/journal.pone.0199395	http://dx.doi.org/10.1371/journal.pone.0199395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ8QS	29924865	Green Submitted, gold, Green Published			2022-12-26	WOS:000435655600067
J	de Boer, RA; Eens, M; Muller, W				de Boer, Raissa A.; Eens, Marcel; Mueller, Wendt			An experimental study: Does inbreeding increase the motivation to mate?	PLOS ONE			English	Article							SEXUALLY SELECTED TRAITS; REPRODUCTIVE SUCCESS; OUTBRED MALES; HOUSE MICE; DEPRESSION; BEHAVIOR; HETEROZYGOSITY; SELECTION; COMPETITION; EXTINCTION	Inbreeding is a central topic in evolutionary biology and ecology and is of major concern for the conservation of endangered species. Yet, it remains challenging to comprehend the fitness consequences of inbreeding, because studies typically focus only on short-term effects on inbreeding in the offspring (e.g. survival until independence). However, there is no a priori reason to assume that inbreeding has no more effects in adulthood. Specifically, inbred males should have lower reproductive success than outbred males among other things because of inbreeding depression in attractiveness to females and a reduced lifespan. Such differences in future reproductive value should affect male mating behaviour, such that an inbred male of a given age should be more motivated to seize a current mating opportunity than an outbred male of the same age. We used an inventive experimental set-up that enabled us to assess male behaviour in relation to an apparent mating opportunity while excluding potential confounding effects of female preference. Age-, weight-, and size- matched inbred and outbred male canaries (Serinus canaria) were presented with a female that only one male at a time could access visually via a 'peephole' and thus when both males were equally interested in seizing the apparent mating opportunity this would result in contest. We find that inbred males spent more than twice as much time 'peeping' at the female than outbred males, suggesting that inbreeding indeed causes different behavioural responses to an apparent mating opportunity. Our study is among the first to highlight that inbreeding affects male mating behaviour, and therewith potentially male-male competition, which should be taken into account in order to understand the full range of inbreeding effects on fitness.	[de Boer, Raissa A.; Eens, Marcel; Mueller, Wendt] Univ Antwerp, Behav Ecol & Ecophysiol Grp, Univ Pl 1, Antwerp, Belgium	University of Antwerp	de Boer, RA (corresponding author), Univ Antwerp, Behav Ecol & Ecophysiol Grp, Univ Pl 1, Antwerp, Belgium.	deboer.raissa@gmail.com	Eens, Marcel/AAC-8466-2020	Muller, Wendt/0000-0001-7273-4095; de Boer, Raissa/0000-0002-6064-6562	Research Foundation Flanders (FWO) [1105914N, G.0102.12N]	Research Foundation Flanders (FWO)(FWO)	The Research Foundation Flanders (FWO: htttp://www.fwo.be/) has funded this research (grant number 1105914N and G.0102.12N). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1990, AM NAT, V135, P464, DOI 10.1086/285056; Aspi J, 2000, HEREDITY, V84, P273, DOI 10.1046/j.1365-2540.2000.00655.x; Ball GF, 2010, ILAR J, V51, P310, DOI 10.1093/ilar.51.4.310; Balthazart J, 2004, PHYSIOL BEHAV, V83, P247, DOI 10.1016/j.physbeh.2004.08.025; BALTHAZART J, 1995, BEHAV NEUROSCI, V109, P485, DOI 10.1037/0735-7044.109.3.485; Bebbington K, 2016, MOL ECOL, V25, P2949, DOI 10.1111/mec.13670; Bedford T, 2017, ANIM BEHAV, V128, P51, DOI 10.1016/j.anbehav.2017.03.026; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; de Boer RA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1142; de Boer RA, 2015, EVOLUTION, V69, P1063, DOI 10.1111/evo.12625; Drayton JM, 2007, J EVOLUTION BIOL, V20, P1138, DOI 10.1111/j.1420-9101.2006.01286.x; Eklund A, 1996, BEHAVIOUR, V133, P883, DOI 10.1163/156853996X00297; Fitzpatrick JL, 2009, BIOL LETTERS, V5, P320, DOI 10.1098/rsbl.2008.0734; GARNETT MC, 1981, IBIS, V123, P31, DOI 10.1111/j.1474-919X.1981.tb00170.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; HAUSER MD, 1991, TRENDS ECOL EVOL, V6, P186, DOI 10.1016/0169-5347(91)90211-F; Hoffman JI, 2004, EVOLUTION, V58, P2087; Hoglund J, 2002, P ROY SOC B-BIOL SCI, V269, P711, DOI 10.1098/rspb.2001.1937; Huisman J, 2016, P NATL ACAD SCI USA, V113, P3585, DOI 10.1073/pnas.1518046113; Ilmonen P, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-104; Janicke T, 2013, EVOLUTION, V67, P2861, DOI 10.1111/evo.12167; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Liao W, 2009, ANIM CONSERV, V12, P54, DOI 10.1111/j.1469-1795.2008.00220.x; Lucia-Simmons KE, 2015, BEHAV ECOL, V26, P1060, DOI 10.1093/beheco/arv053; Margulis SW, 1998, ANIM BEHAV, V55, P427, DOI 10.1006/anbe.1997.0618; Mariette M, 2006, ETHOLOGY, V112, P807, DOI 10.1111/j.1439-0310.2006.01236.x; Mattey SN, 2015, AM NAT, V185, P1, DOI 10.1086/679067; Meagher S, 2000, P NATL ACAD SCI USA, V97, P3324, DOI 10.1073/pnas.060284797; Okada K, 2011, J EVOLUTION BIOL, V24, P363, DOI 10.1111/j.1420-9101.2010.02170.x; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; POTTS WK, 1994, PHILOS T R SOC B, V346, P369, DOI 10.1098/rstb.1994.0154; R Core Development Team, 2017, R LANG ENV STAT COMP; Reed DH, 2002, CONSERV GENET, V3, P301, DOI 10.1023/A:1019948130263; Richardson J, 2017, AM NAT, V189, P539, DOI 10.1086/691328; Seddon N, 2004, P ROY SOC B-BIOL SCI, V271, P1823, DOI 10.1098/rspb.2004.2805; Spencer KA, 2007, HORM BEHAV, V51, P273, DOI 10.1016/j.yhbeh.2006.11.001; Szulkin M, 2013, TRENDS ECOL EVOL, V28, P205, DOI 10.1016/j.tree.2012.10.016; THESSING A, 1994, J EVOLUTION BIOL, V7, P713, DOI 10.1046/j.1420-9101.1994.7060713.x; Valimaki K, 2007, BEHAV ECOL SOCIOBIOL, V61, P997, DOI 10.1007/s00265-006-0332-8; van Oosterhout C, 2003, J EVOLUTION BIOL, V16, P273, DOI 10.1046/j.1420-9101.2003.00511.x; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Zajitschek SRK, 2009, J EVOLUTION BIOL, V22, P1338, DOI 10.1111/j.1420-9101.2009.01738.x; Zajitschek SRK, 2010, BEHAV ECOL, V21, P884, DOI 10.1093/beheco/arq077; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	44	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199182	10.1371/journal.pone.0199182	http://dx.doi.org/10.1371/journal.pone.0199182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912975	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600085
J	Hainsworth, SW; Dietze, PM; Wilson, DP; Sutton, B; Hellard, ME; Scott, N				Hainsworth, Samuel W.; Dietze, Paul M.; Wilson, David P.; Sutton, Brett; Hellard, Margaret E.; Scott, Nick			Hepatitis C virus notification rates in Australia are highest in socioeconomically disadvantaged areas	PLOS ONE			English	Article							SERVICES	Background Poor access to health services is a significant barrier to achieving the World Health Organization's hepatitis C virus (HCV) elimination targets. We demonstrate how geospatial analysis can be performed with commonly available data to identify areas with the greatest unmet demand for HCV services. Methods We performed an Australia-wide cross-sectional analysis of 2015 HCV notification rates using local government areas (LGAs) as our unit of analysis. A zero-inflated negative binomial regression was used to determine associations between notification rates and socioeconomic/demographic factors, health service and geographic remoteness area (RA) classification variables. Additionally, component scores were extracted from a principal component analysis (PCA) of the healthcare service variables to provide rankings of relative service coverage and unmet demand across Australia. Results Among LGAs with non-zero notifications, higher rates were associated with areas that had increased socioeconomic disadvantage, more needle and syringe services (incidence rate ratio [IRR] 1.022; 95%CI 1.001, 1.044) and more alcohol and other drug services (IRR 1.019; 1.005, 1.034). The distribution of PCA component scores indicated that per-capita healthcare service coverage was lower in areas outside of major Australian cities. Areas outside of major cities also contained 94% of LGAs in the lowest two socioeconomic quintiles, as well as 35% of HCV notifications despite only representing 29% of the population. Conclusions As countries aim for HCV elimination, routinely collected data can be used to identify geographical areas for priority service delivery. In Australia, the unmet demand for HCV treatment services is greatest in socioeconomically disadvantaged and non-metropolitan areas.	[Hainsworth, Samuel W.; Wilson, David P.; Hellard, Margaret E.; Scott, Nick] Burnet Inst, Dis Eliminat Program, Melbourne, Vic, Australia; [Dietze, Paul M.] Burnet Inst, Behav & Hlth Risks, Melbourne, Vic, Australia; [Dietze, Paul M.; Hellard, Margaret E.; Scott, Nick] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic, Australia; [Sutton, Brett] Victorian Dept Hlth & Human Serv, Melbourne, Vic, Australia; [Hellard, Margaret E.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Hellard, Margaret E.] Monash Univ, Melbourne, Vic, Australia	Burnet Institute; Burnet Institute; Monash University; Florey Institute of Neuroscience & Mental Health; Monash University	Hainsworth, SW (corresponding author), Burnet Inst, Dis Eliminat Program, Melbourne, Vic, Australia.	sam.hainsworth@burnet.edu.au		Hainsworth, Samuel/0000-0002-7940-7051; Dietze, Paul/0000-0001-7871-6234	Ian Potter Foundation [01]	Ian Potter Foundation	This work was funded by Ian Potter Foundation Grant 01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2011, SOC EC IND AR; Australian Bureau of Statistics, 2016, 1270055005 AUSTR STA; Australian Bureau of Statistics, 2011, REM STRUCT; Australian Bureau of Statistics, 2015, REG POP GROWTH; Australian Bureau of Statistics, 2013, EST AB TORR STRAIT I; Australian Government, 2016, PSMA ADM BOUND SHAP; Australian Institute of Health and Welfare, 2008, RUR REG REM HLTH IND; Australian Pharmaceutical Benefits Scheme, 2016, GEN STAT DRUGS TREAT; Australian Urban Research Infrastructure Network, 2015, NAT HLTH SERV DIR NH; Brener L, 2010, DRUG ALCOHOL REV, V29, P491, DOI 10.1111/j.1465-3362.2010.00173.x; Butler T, 2015, NATL PRISON ENTRANTS; Choosing Wisely Australia, 2016, REC; Department of Health and Human Services, 2010, HEP C VIR NOT DAT; Dietze PM, 2000, EVAL PROGRAM PLANN, V23, P429, DOI 10.1016/S0149-7189(00)00033-1; Gibney KB, 2017, LANCET INFECT DIS, V17, P86, DOI 10.1016/S1473-3099(16)30309-7; Government of South Australia, 2016, CLEAN NEEDL PROGR; Government of South Australia, 2010, S AUSTR PRIS; Government of Western Australia, 2015, FIND NEEDL SYR PROGR; Graham S, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.38640; Hay M, 2017, ADV HEALTH SCI EDUC, V22, P533, DOI 10.1007/s10459-016-9727-0; McGrail MR, 2015, GEOSPATIAL HEALTH, V10, P138, DOI 10.4081/gh.2015.358; Neale J, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-31; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; New South Wales Government, 2015, NSW NEEDL SYR PROGR; Northern Terrirtory Aids and Hepatitis Council, 2016, HARM RED NEEDL SYR P; Northern Territory Government, 2016, PRIS PROB; Queensland Government, 2016, QUEENSL NEEDL SYR PR; Queensland Government, 2015, PRIS DET CTR; Scott N, 2017, INT J DRUG POLICY, V47, P107, DOI 10.1016/j.drugpo.2017.07.006; Scott N, 2017, GUT, V66, P1507, DOI 10.1136/gutjnl-2016-311504; State Government of Victoria, 2016, CORR PRIS PAR; Tasmanian Government, 2016, VIS PRIS; Tasmanian Government, 2015, NEEDL SYR PROGR; Temple-Smith Meredith, 2004, Aust Health Rev, V27, P46; The Kirby Institute, 2016, MAIN FIND BLOODB VIR; Thompson AJV, 2016, MED J AUSTRALIA, V204, P1, DOI 10.5694/mja16.00106; Urbis, 2008, REV EN BARR IND DRUG; Victoria State Government, 2015, NEEDL SYR PROGR; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wakerman J, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-276; WHO, DRAFT GLOB HLTH SECT	41	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198336	10.1371/journal.pone.0198336	http://dx.doi.org/10.1371/journal.pone.0198336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912897	Green Submitted, Green Published, gold			2022-12-26	WOS:000435528600025
J	Hung, SH; Su, CH; Lin, HC; Huang, CC; Kao, S				Hung, Shih-Han; Su, Chin-Hui; Lin, Herng-Ching; Huang, Chung-Chien; Kao, Senyeong			A sialoadenectomy is associated with an increased risk of coronary heart disease: A three-year follow-up study	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; SUBMANDIBULAR-GLAND EXCISION; BLOOD-FLOW; NITRITE; NITRATE; SALIVA; COMPLICATIONS; MICE	Little is known regarding the long-term adverse effects of a sialoadenectomy. The purpose of this study was to estimate the risk of coronary heart disease (CHD) among patients receiving a sialoadenectomy procedure by utilizing a cohort study based on a population-based database in Taiwan. This study retrieved data of the study sample from the Longitudinal Health Insurance Database 2005. This retrospective cohort study included 608 patients who underwent a sialoadenectomy and 1824 propensity score-matched comparison patients. We individually tracked each sampled patient for a 3-year period from their index date to discriminate those who subsequently received a diagnosis of CHD during the followup period. We found that respective incidence rates of CHD during the 3-year follow-up period were 3.87 (95% confidence interval (CI): 3.01-4.91) and 1.79 (95% CI: 1.45-2.18) per 100 person-years for patients who did and those who did not undergo a sialoadenectomy. The stratified Cox proportional analysis revealed that the hazard ratio of CHD during the 3-year follow-up period was 2.43 (95% CI: 1.77-3.33) than comparison patients. This study demonstrates an association between sialoadenectomy and CHD.	[Hung, Shih-Han] Taipei Med Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Hung, Shih-Han] Taipei Med Univ, Sch Med, Dept Otolaryngol, Coll Med, Taipei, Taiwan; [Su, Chin-Hui] Mackay Mem Hosp, Dept Otorhinolaryngol, Taipei, Taiwan; [Lin, Herng-Ching; Huang, Chung-Chien] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Kao, Senyeong] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Mackay Memorial Hospital; Taipei Medical University; National Defense Medical Center	Kao, S (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.	kao@ndmctsgh.edu.tw	Huang, CC/AAX-5872-2021	Huang, CC/0000-0003-0818-7175; Hung, Shih-Han/0000-0001-9591-5489; Kao, Senyeong/0000-0002-0209-240X				Affoo RH, 2015, J AM GERIATR SOC, V63, P2142, DOI 10.1111/jgs.13652; Azuma Naoto, 2016, Nihon Rinsho Meneki Gakkai Kaishi, V39, P42, DOI 10.2177/jsci.39.42; Bjorne H, 2004, J CLIN INVEST, V113, P106, DOI [10.1172/JCI200419019, 10.1172/JCI19019]; EISENBRAND G, 1980, ONCOLOGY-BASEL, V37, P227, DOI 10.1159/000225441; Ge N, INT J ORAL MAXILLOF, V45, P750, DOI [10.1016/Mom.2015.12.013, DOI 10.1016/MOM.2015.1]; Grosse Y, 2006, LANCET ONCOL, V7, P628, DOI 10.1016/S1470-2045(06)70789-6; HALD J, 1994, ORL J OTO-RHINO-LARY, V56, P87, DOI 10.1159/000276616; Hernando M, 2012, ACTA OTORRINOLAR ESP, V63, P42, DOI 10.1016/j.otorri.2011.08.001; Hord NG, 2011, CURR ATHEROSCLER REP, V13, P484, DOI 10.1007/s11883-011-0209-9; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Ishirnoto SI, 2008, AURIS NASUS LARYNX, V35, P89, DOI 10.1016/j.anl.2007.05.002; JORGE AOC, 1993, J ORAL PATHOL MED, V22, P138, DOI 10.1111/j.1600-0714.1993.tb01045.x; KENNEDY PJ, 1989, AUST NZ J SURG, V59, P411; KONTUREK PK, 1990, GASTROENTEROLOGY, V99, P1607, DOI 10.1016/0016-5085(90)90464-C; Koskenpato K, 2016, SCAND J RHEUMATOL, V45, P118, DOI 10.3109/03009742.2015.1072243; Lundberg JO, 2012, P NATL ACAD SCI USA, V109, P13144, DOI 10.1073/pnas.1210412109; MILTON CM, 1986, ANN ROY COLL SURG, V68, P148; Moosavijazi Mahvash, 2014, J Dent (Tehran), V11, P516; Myers E. N., 2007, SALIVARY GLAND DISOR; NAVA-RIVERA ARMANDO, 1964, BOL INST ESTUD MED BIOL, V22, P331; NOGUCHI S, 1991, AM J PHYSIOL, V260, pE620, DOI 10.1152/ajpendo.1991.260.4.E620; OKAMOTO S, 1984, P NATL ACAD SCI-BIOL, V81, P6059, DOI 10.1073/pnas.81.19.6059; Oxford GE, 2000, J DIABETES COMPLICAT, V14, P140, DOI 10.1016/S1056-8727(00)00073-8; RUSSELL LD, 1990, TISSUE CELL, V22, P263, DOI 10.1016/0040-8166(90)90001-P; SODERLING E, 1993, SCAND J DENT RES, V101, P98; Speight PM, 2002, ORAL DIS, V8, P229, DOI 10.1034/j.1601-0825.2002.02870.x; Su CH, 2016, B-ENT, V12, P199; TANNENBAUM SR, 1974, JNCI-J NATL CANCER I, V53, P79; TENOVUO J, 1986, J ORAL PATHOL MED, V15, P303, DOI 10.1111/j.1600-0714.1986.tb00630.x; TRIPP MA, 1995, BRIT J PHARMACOL, V115, P344, DOI 10.1111/j.1476-5381.1995.tb15883.x; TSUTSUMI O, 1986, SCIENCE, V233, P975, DOI 10.1126/science.3090686; WASE AW, 1956, NATURE, V177, P624, DOI 10.1038/177624a0; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; Wilson KF, 2014, AM FAMILY PHYS, V89	34	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199135	10.1371/journal.pone.0199135	http://dx.doi.org/10.1371/journal.pone.0199135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912946	Green Published, gold, Green Submitted			2022-12-26	WOS:000435528600078
J	Silva, CP; Horton, WJ; Caruso, MJ; Sebastian, A; Klein, LC; Alberta, I; Kamens, HM				Silva, Constanza P.; Horton, William J.; Caruso, Michael J.; Sebastian, Aswathy; Klein, Laura C.; Alberta, Istvan; Kamens, Helen M.			The influence of adolescent nicotine exposure on ethanol intake and brain gene expression	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; MESSENGER-RNA EXPRESSION; PITUITARY-ADRENAL AXIS; SHORT-SLEEP MICE; ACETYLCHOLINE-RECEPTOR; ALCOHOL-CONSUMPTION; C57BL/6J MICE; PARAVENTRICULAR NUCLEUS; ARGININE-VASOPRESSIN; GENDER-DIFFERENCES	Nicotine and alcohol are often co-abused. Adolescence is a vulnerable period for the initiation of both nicotine and alcohol use, which can lead to subsequent neurodevelopmental and behavioral alterations. It is possible that during this vulnerable period, use of one drug leads to neurobiological alterations that affect subsequent consumption of the other drug. The aim of the present study was to determine the effect of nicotine exposure during adolescence on ethanol intake, and the effect of these substances on brain gene expression. Forty-three adolescent female C57BL/6J mice were assigned to four groups. In the first phase of the experiment, adolescent mice (PND 36-41 days) were exposed to three bottles filled with water or nicotine (200 mu g/ml) for 22 h a day and a single bottle of water 2 h a day for six days. In the second phase (PND 42-45 days), the 4-day Drinking-in-the-Dark paradigm consisting of access to 20% v/v ethanol or water for 2h or 4h (the last day) was overlaid during the time when the mice did not have nicotine available. Ethanol consumption (g/kg) and blood ethanol concentrations (BEC, mg %) were measured on the final day and whole brains including the cerebellum, were dissected for RNA sequencing. Differentially expressed genes (DEG) were detected with CuffDiff and gene networks were built using WGCNA. Prior nicotine exposure increased ethanol consumption and resulting BEC. Significant DEG and biological pathways found in the group exposed to both nicotine and ethanol included genes important in stress-related neuropeptide signaling, hypothalamic-pituitary-adrenal (HPA) axis activity, glutamate release, GABA signaling, and dopamine release. These results replicate our earlier findings that nicotine exposure during adolescence increases ethanol consumption and extends this work by examining gene expression differences which could mediate these behavioral effects.	[Silva, Constanza P.; Caruso, Michael J.; Klein, Laura C.; Kamens, Helen M.] Penn State Univ, Biobehav Hlth Dept, University Pk, PA 16802 USA; [Horton, William J.] Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA; [Sebastian, Aswathy; Alberta, Istvan] Penn State Univ, Biochem & Mol Biol, University Pk, PA 16802 USA; [Caruso, Michael J.] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Pennsylvania; Pennsylvania Medicine	Kamens, HM (corresponding author), Penn State Univ, Biobehav Hlth Dept, University Pk, PA 16802 USA.	hmk123@psu.edu	Caruso, Michael/P-1612-2019; Silva Gallardo, Constanza Paulina Paulina Silva/AAW-9375-2021; Albert, Istvan/J-3734-2015	Silva Gallardo, Constanza Paulina Paulina Silva/0000-0001-8385-7613; Kamens, Helen/0000-0001-5085-8847; Albert, Istvan/0000-0001-8366-984X; Horton, William/0000-0001-9717-0169	National Institutes of Health [M019447, P50 DA039838]; Pennsylvania State University Huck Institutes of the Life Sciences; Broadhurst Career Development Professorship for the Study of Health Promotion and Disease Prevention; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT)/BECAS CHILE fellowship program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA019447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA039838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania State University Huck Institutes of the Life Sciences; Broadhurst Career Development Professorship for the Study of Health Promotion and Disease Prevention; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT)/BECAS CHILE fellowship program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health grants M019447 (National Institute on Alcohol Abuse and Alcoholism grant to HMK) and P50 DA039838 (National Institute on Drug Abuse grant to Linda Collins; Dr. Helen Kamens is a co-investigator). Additional support came from The Pennsylvania State University Huck Institutes of the Life Sciences, the Broadhurst Career Development Professorship for the Study of Health Promotion and Disease Prevention, and the Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT)/BECAS CHILE fellowship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding institutions as mentioned above.	Abreu-Villaca Y, 2008, NEUROPSYCHOPHARMACOL, V33, P599, DOI 10.1038/sj.npp.1301429; Albrecht C, 2000, J BIOL CHEM, V275, P28929, DOI 10.1074/jbc.M003053200; ANTHONY JC, 1995, DRUG ALCOHOL DEPEN, V40, P9, DOI 10.1016/0376-8716(95)01194-3; Aramburo C, 2014, GEN COMP ENDOCR, V203, P35, DOI 10.1016/j.ygcen.2014.04.035; Baker JA, 2017, ALCOHOL, V58, P139, DOI 10.1016/j.alcohol.2016.08.008; Barrett SP, 2006, DRUG ALCOHOL DEPEN, V81, P197, DOI 10.1016/j.drugalcdep.2005.06.009; Barron Susan, 2005, Alcohol Clin Exp Res, V29, P1720, DOI 10.1097/01.alc.0000179220.79356.e5; Benjamin E., 2013, ALCOHOL CLIN EXPT RE, V37, pE364, DOI DOI 10.1111/J.1530-0277.2012.01911.X; Biondolillo KD, 2007, NEUROPSYCHOBIOLOGY, V55, P73, DOI 10.1159/000103905; Blomqvist O, 1996, EUR J PHARMACOL, V314, P257, DOI 10.1016/S0014-2999(96)00583-3; Blood-Siegfried J, 2010, J MIDWIFERY WOM HEAL, V55, P143, DOI 10.1016/j.jmwh.2009.05.006; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Brolese G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127845; Brunzell DH, 2009, NEUROPSYCHOPHARMACOL, V34, P1993, DOI 10.1038/npp.2009.11; Buu A, 2014, J STUD ALCOHOL DRUGS, V75, P850, DOI 10.15288/jsad.2014.75.850; Chandrasekar R, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00014; Clark A, 2001, NEUROPHARMACOLOGY, V41, P108, DOI 10.1016/S0028-3908(01)00037-5; Conti F, 2004, BRAIN RES REV, V45, P196, DOI 10.1016/j.brainresrev.2004.03.003; Costin BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072979; Counotte DS, 2011, DEV COGN NEUROS-NETH, V1, P430, DOI 10.1016/j.dcn.2011.05.010; Cui WY, 2012, HUM GENET, V131, P843, DOI 10.1007/s00439-011-1108-4; Darlington TM, 2016, GENES BRAIN BEHAV, V15, P474, DOI 10.1111/gbb.12294; Darlington TM, 2013, GENES BRAIN BEHAV, V12, P263, DOI 10.1111/gbb.12018; De Pauli RF, 2014, PHARMACOL BIOCHEM BE, V117, P70, DOI 10.1016/j.pbb.2013.12.007; Devesa P, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-100; DIFRANZA JR, 1990, J STUD ALCOHOL, V51, P130, DOI 10.15288/jsa.1990.51.130; Ding WQ, 1998, ALCOHOL CLIN EXP RES, V22, P225, DOI 10.1111/j.1530-0277.1998.tb03642.x; Doyon WM, 2013, BIOCHEM PHARMACOL, V86, P1181, DOI 10.1016/j.bcp.2013.07.007; Doyon WM, 2013, NEURON, V79, P530, DOI 10.1016/j.neuron.2013.06.006; Ducci F, 2011, BIOL PSYCHIAT, V69, P650, DOI 10.1016/j.biopsych.2010.09.055; Dwyer JB, 2009, PHARMACOL THERAPEUT, V122, P125, DOI 10.1016/j.pharmthera.2009.02.003; Edwards S, 2012, ADDICT BIOL, V17, P76, DOI 10.1111/j.1369-1600.2010.00291.x; Ehringer MA, 2009, ALCOHOL, V43, P443, DOI 10.1016/j.alcohol.2009.06.003; Enoch MA, 2014, GENES BRAIN BEHAV, V13, P758, DOI 10.1111/gbb.12179; Floyd DW, 2003, J PHARMACOL EXP THER, V307, P1020, DOI 10.1124/jpet.103.057505; Follesa P, 1996, J NEUROSCI, V16, P2172; Gilman SE, 2009, PEDIATRICS, V123, pE274, DOI 10.1542/peds.2008-2251; Grant BF, 1998, J SUBST ABUSE, V10, P59, DOI 10.1016/S0899-3289(99)80141-2; Griffin KW, 2000, J STUD ALCOHOL, V61, P603, DOI 10.15288/jsa.2000.61.603; Gudehithlu KP, 2012, NEUROPEPTIDES, V46, P125, DOI 10.1016/j.npep.2012.03.001; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Halder S, 2013, AM J DRUG ALCOHOL AB, V39, P161, DOI 10.3109/00952990.2013.776065; Halff AW, 2014, J NEUROSCI, V34, P2051, DOI 10.1523/JNEUROSCI.2795-13.2014; Henniger MSH, 2003, EUR J PHARMACOL, V470, P33, DOI 10.1016/S0014-2999(03)01787-4; Hoffman JH, 2001, ADDICT BEHAV, V26, P63, DOI 10.1016/S0306-4603(00)00089-7; Huang LZ, 2007, DEV NEUROBIOL, V67, P363, DOI 10.1002/dneu.20348; Husky MM, 2007, J ADDICT MED, V1, P161, DOI 10.1097/ADM.0b013e318142d06c; illumina&REG, 2013, TRUSEQ STRAND MRNA S; Isiegas C, 2009, NICOTINE TOB RES, V11, P851, DOI 10.1093/ntr/ntp076; Jensen MK, 2003, ADDICTION, V98, P355, DOI 10.1046/j.1360-0443.2003.00304.x; Jung Y, 2016, NAT NEUROSCI, V19, P905, DOI 10.1038/nn.4315; Kalluri H, 1998, UP REGULATION NMDA R; Kamens HM, 2012, ALCOHOL, V46, P463, DOI 10.1016/j.alcohol.2012.03.001; Kaur S, 2012, ALCOHOL CLIN EXP RES, V36, P369, DOI 10.1111/j.1530-0277.2011.01610.x; Kawashima T, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00037; Kenny PJ, 2000, MOL BRAIN RES, V85, P234, DOI 10.1016/S0169-328X(00)00246-1; Kitanaka N, 2008, SYNAPSE, V62, P689, DOI 10.1002/syn.20543; Klee EW, 2012, HUM GENET, V131, P977, DOI 10.1007/s00439-011-1128-0; Klein LC, 2004, PHARMACOL BIOCHEM BE, V78, P13, DOI 10.1016/j.pbb.2004.01.005; Koob G, 2007, AM J PSYCHIAT, V164, P1149, DOI 10.1176/appi.ajp.2007.05030503; Kota D, 2007, J PHARMACOL EXP THER, V322, P399, DOI 10.1124/jpet.107.121616; Kota D, 2009, BIOCHEM PHARMACOL, V78, P873, DOI 10.1016/j.bcp.2009.06.099; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kramer PR, 2007, REGUL PEPTIDES, V138, P66, DOI 10.1016/j.regpep.2006.08.002; Kurschner C, 1999, J NEUROSCI, V19, P7770; L Shen, 2013, BIOCONDUCTOR; Lallemand F, 2007, ALCOHOL ALCOHOLISM, V42, P207, DOI 10.1093/alcalc/agm023; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Larraga A, 2017, FRONT BEHAV NEUROSCI, V11, P1, DOI 10.3389/fnbeh.2017.00025; Larsson A, 2004, NEUROSCI BIOBEHAV R, V27, P713, DOI 10.1016/j.neubiorev.2003.11.010; Le AD, 2003, PSYCHOPHARMACOLOGY, V168, P216, DOI 10.1007/s00213-002-1330-9; Lee S, 2004, ENDOCRINOLOGY, V145, P4470, DOI 10.1210/en.2004-0110; Lenz B, 2010, INT J NEUROPSYCHOPH, V13, P207, DOI 10.1017/S1461145709991052; Li J, 2010, ALCOHOL CLIN EXP RES, V34, P1742, DOI 10.1111/j.1530-0277.2010.01261.x; Locker AR, 2016, BRAIN RES BULL, V123, P13, DOI 10.1016/j.brainresbull.2015.09.009; Lopez MF, 2003, ADDICT BIOL, V8, P419, DOI 10.1080/13556210310001648176; Luscher C, 2016, ANNU REV NEUROSCI, V39, P257, DOI 10.1146/annurev-neuro-070815-013920; Lutfy K, 2012, J NEUROCHEM, V120, P1108, DOI 10.1111/j.1471-4159.2011.07633.x; Malki K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1431-6; Mandal C, 2015, ACTA BIOCH BIOPH SIN, V47, P581, DOI 10.1093/abbs/gmv050; Marballi K, 2016, GENES BRAIN BEHAV, V15, P318, DOI 10.1111/gbb.12266; Martinez D, 2005, BIOL PSYCHIAT, V58, P779, DOI 10.1016/j.biopsych.2005.04.044; Mendel JR, 2012, AM J HEALTH BEHAV, V36, P542, DOI 10.5993/AJHB.36.4.11; Middaugh LD, 1999, ALCOHOL, V17, P175, DOI 10.1016/S0741-8329(98)00055-X; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Morud J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181084; Muhammad A, 2012, SYNAPSE, V66, P950, DOI 10.1002/syn.21589; Mulligan MK, 2011, ALCOHOL CLIN EXP RES, V35, P659, DOI 10.1111/j.1530-0277.2010.01384.x; Nagy J, 2004, NEUROCHEM INT, V44, P17, DOI 10.1016/S0197-0186(03)00100-1; Nagy J, 2008, CURR NEUROPHARMACOL, V6, P39, DOI 10.2174/157015908783769662; Nesill T, 2011, NEUROPHARMACOLOGY, V61, P189, DOI 10.1016/j.neuropharm.2011.03.027; Nestler EJ, 2001, J NEUROSCI, V21, P8324, DOI 10.1523/JNEUROSCI.21-21-08324.2001; Nunez YO, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-725; Osterndorff-Kahanek E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059870; Osterndorff-Kahanek EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121522; Ostroumov A, 2018, ANNU REV PHARMACOL, V58, P547, DOI 10.1146/annurev-pharmtox-010617-052735; Padilla SL, 2012, ENDOCRINOLOGY, V153, P1219, DOI 10.1210/en.2011-1665; Pan Y, 2013, J PSYCHIATR RES, V47, P1717, DOI 10.1016/j.jpsychires.2013.07.013; Penland S, 2001, ALCOHOL, V24, P45, DOI 10.1016/S0741-8329(01)00142-2; Perkins K A, 1999, Nicotine Tob Res, V1, P301, DOI 10.1080/14622299050011431; Perrotti LI, 2008, SYNAPSE, V62, P358, DOI 10.1002/syn.20500; Petit G, 2013, SOCIOAFFECTIVE NEURO, V3, DOI 10.3402/snp.v3i0.21890; Procopio DO, 2013, ALCOHOL CLIN EXP RES, V37, P896, DOI 10.1111/acer.12060; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Revitsky AR, 2014, NEUROBIOLGICAL UNDER; Rhodes JS, 2007, GENES BRAIN BEHAV, V6, P1, DOI 10.1111/j.1601-183X.2006.00210.x; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; Rhodes ME, 2001, BRAIN RES BULL, V54, P681, DOI 10.1016/S0361-9230(01)00488-9; Ridge JP, 2008, ANN NY ACAD SCI, V1139, P10, DOI 10.1196/annals.1432.053; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Romberger DJ, 2004, BIOMED PHARMACOTHER, V58, P77, DOI 10.1016/j.biopha.2003.12.002; Romeo RD, 2013, CURR DIR PSYCHOL SCI, V22, P140, DOI 10.1177/0963721413475445; Schmitt HF, 2008, NEUROSCIENCE, V157, P349, DOI 10.1016/j.neuroscience.2008.09.018; Schochet TL, 2005, NEUROSCIENCE, V135, P285, DOI 10.1016/j.neuroscience.2005.05.057; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shah SN, 2006, ALCOHOL CLIN EXP RES, V30, p118A; Sikela JM, 2006, ALCOHOL CLIN EXP RES, V30, P700, DOI 10.1111/j.1530-0277.2006.00081.x; Silva JP, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0348-2; Silva SM, 2002, BRAIN RES, V925, P76, DOI 10.1016/S0006-8993(01)03261-9; Simons-Morton B, 1999, PREV MED, V28, P138, DOI 10.1006/pmed.1998.0404; Smith AM, 2002, ALCOHOL CLIN EXP RES, V26, P976, DOI 10.1097/01.ALC.0000021176.13538.55; Smith BR, 1999, PSYCHOPHARMACOLOGY, V142, P408, DOI 10.1007/s002130050906; SMOLEN A, 1986, ALCOHOL CLIN EXP RES, V10, P198; Sparrow AM, 2012, NEUROPSYCHOPHARMACOL, V37, P1409, DOI 10.1038/npp.2011.327; Strong MN, 2010, HORM BEHAV, V58, P82, DOI 10.1016/j.yhbeh.2009.10.008; Tang B, 2015, SCI REP-UK, V5, DOI 10.1038/srep14099; Tapinc DE, 2017, NEUROSCI LETT, V637, P75, DOI 10.1016/j.neulet.2016.11.049; Thiele TE, 2014, ALCOHOL, V48, P235, DOI 10.1016/j.alcohol.2013.08.005; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Truitt WA, 2015, PSYCHOPHARMACOLOGY, V232, P639, DOI 10.1007/s00213-014-3702-3; Tweed JO, 2012, TRENDS ENDOCRIN MET, V23, P334, DOI 10.1016/j.tem.2012.03.006; Velazquez FN, 2015, AGING-US, V7, P1028, DOI 10.18632/aging.100862; Weitzman ER, 2005, DRUG ALCOHOL DEPEN, V80, P377, DOI 10.1016/j.drugalcdep.2005.05.008; Xiang YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134907; YAMAGUCHI K, 1984, AM J PUBLIC HEALTH, V74, P668, DOI 10.2105/AJPH.74.7.668; Yu GL, 2008, J NEUROSCI, V28, P2773, DOI 10.1523/JNEUROSCI.3837-07.2008; Yu GL, 2010, J NEUROCHEM, V113, P919, DOI 10.1111/j.1471-4159.2010.06654.x; Zhou Y, 2011, ALCOHOL CLIN EXP RES, V35, P1876, DOI 10.1111/j.1530-0277.2011.01532.x	139	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198935	10.1371/journal.pone.0198935	http://dx.doi.org/10.1371/journal.pone.0198935			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912970	Green Published, gold, Green Submitted			2022-12-26	WOS:000435528600063
J	Wall, L; Mohr, A; Ripoli, FL; Schulze, N; Penter, CD; Hungerbuehler, S; Bach, JP; Lucas, K; Nolte, I				Wall, Leona; Mohr, Annika; Ripoli, Florenza Lueder; Schulze, Nayeli; Penter, Camila Duarte; Hungerbuehler, Stephanoscar; Bach, Jan-Peter; Lucas, Karin; Nolte, Ingo			Clinical use of submaximal treadmill exercise testing and assessments of cardiac biomarkers NT-proBNP and cTnl in dogs with presymptomatic mitral regurgitation	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; CONGESTIVE-HEART-FAILURE; TROPONIN-I; VALVE DISEASE; SERUM CONCENTRATIONS; DOBERMAN-PINSCHERS; PIMOBENDAN; CATS; AGE; PREVENTION	Exercise intolerance is the first symptom of heart disease. Yet an objective and standardised method in canine cardiology to assess exercise capacity in a clinical setting is lacking. In contrast, exercise testing is a powerful diagnostic tool in humans, providing valuable information on prognosis and impact of therapeutic intervention. To investigate whether an exercise test reveals differences between dogs with early stage mitral regurgitation (MR) and dogs without cardiac disease, 12 healthy beagles (healthy group, HG) and 12 dogs with presymptomatic MR (CHIEF B1 / B2, patient group, PG) underwent a six-stage submaximal exercise test (ET) on a motorised treadmill. They trotted in their individual comfort speed for three minutes per stage, first without incline, afterwards increasing it by 4% for every subsequent stage. Blood samples were taken at rest and during two 3-minute breaks in the course of the test. Further samples were taken after the completion of the exercise test and again after a 3-hour recovery period. Measured parameters included heart rate, lactate and the cardiac biomarkers N-terminal pro-B-Type natriuretic peptide and cardiac Troponin I. The test was performed again under the same conditions in the same dogs three weeks after the first trial to evaluate individual repeatability. Cardiac biomarkers increased significantly in both HG and PG in the course of the test. The increase was more pronounced in CHIEF B1 / B2 dogs than in the HG. N-terminal pro-B-Type natriuretic peptide increased from 435 +/- 195 to 523 +/- 239 pmol/L (HG) and from 690 to 815 pmol/L (PG). cTnl increased from 0.020 to 0.024 ng/mL (HG) and from 0.06 to 0.08 ng/ml (PG). The present study provides a method to assess exercise-induced changes in cardiac biomarkers under clinical conditions. The increase of NT-proBNP and cTnl is more pronounced in dogs with early-stage MR than in healthy dogs. Results indicate that measuring the parameters before and after exercise is adequate and taking blood samples between the different stages of the ET does not provide additional information. Also, stress echocardiography was inconclusive. It can be concluded that exercise testing, especially in combination with measuring cardiac biomarkers, could be a helpful diagnostic tool in canine cardiology.	[Wall, Leona; Mohr, Annika; Ripoli, Florenza Lueder; Schulze, Nayeli; Penter, Camila Duarte; Hungerbuehler, Stephanoscar; Bach, Jan-Peter; Lucas, Karin; Nolte, Ingo] Univ Vet Med Hannover, Small Anim Clin, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Nolte, I (corresponding author), Univ Vet Med Hannover, Small Anim Clin, Hannover, Germany.	ingo.nolte@tiho-honnover.de	Bach, Jan-Peter/AAM-7963-2020	Inglis, Camila/0000-0001-7687-399X	Studienstiftung des deutschen Volkes (German academic scholarship foundation); Gesellschaft zur Forderung Kynologischer Forschung e.V.	Studienstiftung des deutschen Volkes (German academic scholarship foundation); Gesellschaft zur Forderung Kynologischer Forschung e.V.	Funding: LW was the recipient of a scholarship from the "Studienstiftung des deutschen Volkes (German academic scholarship foundation)" https/www.studienstiftung.de/. The study was financially supported by the "Gesellschaft zur Forderung Kynologischer Forschung e.V." https://www.gkf-bonn.de/index.php/startseite.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano K, 1999, J VET MED SCI, V61, P523, DOI 10.1292/jvms.61.523; Atkins C, 2009, J VET INTERN MED, V23, P1142, DOI 10.1111/j.1939-1676.2009.0392.x; Atkins CE, 2007, JAVMA-J AM VET MED A, V231, P1061, DOI 10.2460/javma.231.7.1061; Bergler-Klein J, 2014, CAN J CARDIOL, V30, P1027, DOI 10.1016/j.cjca.2014.07.014; Boswood A, 2016, J VET INTERN MED, V30, P1765, DOI 10.1111/jvim.14586; Burgener IA, 2006, J VET INTERN MED, V20, P277; Cartee G D, 1994, Exerc Sport Sci Rev, V22, P91; Cianciolo RE, 2016, VET PATHOL, V53, P299, DOI 10.1177/0300985815612153; Consitt LA, 2016, AM J PHYSIOL-ENDOC M, V311, pE145, DOI 10.1152/ajpendo.00452.2015; de Lima GV, 2017, VET WORLD, V10, P1072, DOI 10.14202/vetworld.2017.1072-1082; Ferasin L, 2007, VET RES COMMUN, V31, P725, DOI 10.1007/s11259-007-3566-7; Ferasin L, 2009, J COMP PHYSIOL B, V179, P839, DOI 10.1007/s00360-009-0367-z; Fonfara S, 2010, VET J, V184, P334, DOI 10.1016/j.tvjl.2009.04.004; Goutal CM, 2010, J VET EMERG CRIT CAR, V20, P330, DOI 10.1111/j.1476-4431.2010.00524.x; Haggstrom J, 2013, J VET INTERN MED, V27, P1441, DOI 10.1111/jvim.12181; HAIDET GC, 1989, AM J PHYSIOL, V257, pH1428, DOI 10.1152/ajpheart.1989.257.5.H1428; Henri C, 2014, CAN J CARDIOL, V30, P1012, DOI 10.1016/j.cjca.2014.03.013; Herichova I, 2014, PHYSIOL RES, V63, pS573, DOI 10.33549/physiolres.932937; Kittleson MD, 1996, J VET INTERN MED, V10, P21, DOI 10.1111/j.1939-1676.1996.tb02019.x; Kosic LS, 2012, RES VET SCI, V93, P1446, DOI 10.1016/j.rvsc.2012.04.002; Krupicka J, 2010, PHYSIOL RES, V59, P625, DOI 10.33549/physiolres.931773; Kvart C, 2002, J VET INTERN MED, V16, P80, DOI 10.1892/0891-6640(2002)016&lt;0080:EOEFPO&gt;2.3.CO;2; Lebrun F, 2001, J AM COLL CARDIOL, V38, P1685, DOI 10.1016/S0735-1097(01)01605-9; Lucia P, 2001, INT J CARDIOL, V77, P215, DOI 10.1016/S0167-5273(00)00429-0; Magne J, 2012, EUR J HEART FAIL, V14, P1293, DOI 10.1093/eurjhf/hfs114; Marcondes-Santos M, 2015, BRAZ J MED BIOL RES, V48, P886, DOI 10.1590/1414-431X20154568; Marinus SM, 2017, J VET INTERN MED, V31, P661, DOI 10.1111/jvim.14667; McEntee K, 1998, AM J VET RES, V59, P1160; McKenzie EC, 2007, JAVMA-J AM VET MED A, V230, P1486, DOI 10.2460/javma.230.10.1486; Miller TD, 2014, CARDIOL CLIN, V32, P387, DOI 10.1016/j.ccl.2014.04.008; MUSCH TI, 1986, J APPL PHYSIOL, V61, P1914, DOI 10.1152/jappl.1986.61.5.1914; Nie JL, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13083; Niemela M, 2016, SCAND J CLIN LAB INV, V76, P575, DOI 10.1080/00365513.2016.1225122; ORDWAY GA, 1984, J APPL PHYSIOL, V57, P601, DOI 10.1152/jappl.1984.57.2.601; Oyama MA, 2004, J VET INTERN MED, V18, P831, DOI 10.1892/0891-6640(2004)18&lt;831:CTCIDW&gt;2.0.CO;2; Oyama MA, 2008, JAVMA-J AM VET MED A, V232, P1496, DOI 10.2460/javma.232.10.1496; Oyama MA, 2013, VET CLIN N AM-SMALL, V43, P1261, DOI 10.1016/j.cvsm.2013.07.010; Picano E, 2009, J AM COLL CARDIOL, V54, P2251, DOI 10.1016/j.jacc.2009.07.046; Porciello F, 2008, AUST VET J, V86, P390, DOI 10.1111/j.1751-0813.2008.00345.x; RIMOLDI O, 1990, J AUTONOM NERV SYST, V30, pS129, DOI 10.1016/0165-1838(90)90116-Z; Schulz O, 2002, AM HEART J, V144, P351, DOI 10.1067/mhj.2002.123313; Serra M, 2010, VET J, V185, P50, DOI 10.1016/j.tvjl.2010.04.013; Shave R, 2010, J AM COLL CARDIOL, V56, P169, DOI 10.1016/j.jacc.2010.03.037; Sinha Santosh Kumar, 2016, J Clin Med Res, V8, P797; Sjostrand K, 2014, J VET INTERN MED, V28, P451, DOI 10.1111/jvim.12310; Stepien, 2009, J VET CARDIOL, V11, P93; Summerfield NJ, 2012, J VET INTERN MED, V26, P1337, DOI 10.1111/j.1939-1676.2012.01026.x; Suni JH, 1996, ARCH PHYS MED REHAB, V77, P399, DOI 10.1016/S0003-9993(96)90092-1; Tanaka H, 2008, J PHYSIOL-LONDON, V586, P55, DOI 10.1113/jphysiol.2007.141879; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Tharwat M, 2013, VET J, V197, P900, DOI 10.1016/j.tvjl.2013.01.023; TIPTON CM, 1974, J APPL PHYSIOL, V37, P271, DOI 10.1152/jappl.1974.37.2.271; Triposkiadis F, 2009, J AM COLL CARDIOL, V54, P1747, DOI 10.1016/j.jacc.2009.05.015; Valandro MA, 2017, ARQ BRAS MED VET ZOO, V69, P325, DOI 10.1590/1678-4162-9230; VATNER SF, 1976, PROG CARDIOVASC DIS, V19, P91, DOI 10.1016/0033-0620(76)90018-9; Wakshlag JJ, 2010, J VET INTERN MED, V24, P1388, DOI 10.1111/j.1939-1676.2010.0594.x; Wess G, 2010, J VET INTERN MED, V24, P1069, DOI 10.1111/j.1939-1676.2010.0575.x; Wolf J, 2013, VET CLIN PATH, V42, P196, DOI 10.1111/vcp.12044	58	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199023	10.1371/journal.pone.0199023	http://dx.doi.org/10.1371/journal.pone.0199023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902265	Green Published, gold, Green Submitted			2022-12-26	WOS:000435424900077
J	Goetzl, EJ; Nogueras-Ortiz, C; Mustapic, M; Mullins, RJ; Abner, EL; Schwartz, JB; Kapogiannis, D				Goetzl, Edward J.; Nogueras-Ortiz, Carlos; Mustapic, Maja; Mullins, Roger J.; Abner, Erin L.; Schwartz, Janice B.; Kapogiannis, Dimitrios			Deficient neurotrophic factors of CSPG4-type neural cell exosomes in Alzheimer disease	FASEB JOURNAL			English	Article						neurodegeneration; dementia; growth factors	HEPATOCYTE GROWTH-FACTOR; NEURONAL DIFFERENTIATION; CEREBROSPINAL-FLUID; SYNAPTIC PROTEINS; STEM-CELLS; FGF; PROLIFERATION; SURVIVAL; INSULIN; ROLES	Exosomes derived from chondroitin sulfate proteoglycan (CSPG) 4 type neural precursor cells (CSPG4Es) were purified from human plasma by sequential immunoabsorption with anti-CSPG4 and anti-platelet growth factor receptor mAb to characterize the potential in vivo roles of CSPG4 cells in neuronal repair. Hepatocyte growth factor, fibroblast growth factors (FGFs)-2 and -13, and type 1 insulin-like growth factor (IGF-1), which enhance neuronal survival and functions, were quantified in CSPG4E extracts. For CSPG4Es of 24 healthy control subjects, mean levels of hepatocyte growth factor, FGF-13, and IGF-1, but not FGF-2, were significantly higher by up to 7-fold than in their neuronal-derived exosomes, and mean levels of all 4 growth factors were significantly higher by up to 8-fold than in their astrocyte-derived exosomes. Mean CSPG4E levels of all growth factors were significantly lower in patients with mild Alzheimer disease (AD) (n = 24) than in age- and sex-matched cognitively normal control subjects (n = 24). Mean CSPG4E levels of all growth factors were also significantly lower in 15 patients at the stage of moderate dementia from AD (AD(2)) and at their preclinical stage 3 to 8 yr earlier (AD(1)), with no differences between values at stages AD(1) and AD(2). Current findings suggest that CSPG4 cells export in exosomes higher levels of neurotrophic factors than neurons or astrocytes and that CSPG4E neurotrophic factors are diminished early in AD, with no significant progression of decreases later in the course.Goetzl, E. J., Nogueras-Ortiz, C., Mustapic, M., Mullins, R. J., Abner, E. L., Schwartz, J. B., Kapogiannis, D. Deficient neurotrophic factors of CSPG4-type neural cell exosomes in Alzheimer disease.	[Goetzl, Edward J.; Schwartz, Janice B.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Schwartz, Janice B.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Goetzl, Edward J.; Schwartz, Janice B.] Jewish Home San Francisco, San Francisco, CA USA; [Nogueras-Ortiz, Carlos; Mustapic, Maja; Mullins, Roger J.; Kapogiannis, Dimitrios] NIA, Lab Neurosci, Baltimore, MD 21224 USA; [Abner, Erin L.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Kentucky	Goetzl, EJ (corresponding author), Univ Calif San Francisco, Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Schwartz, Janice/K-6354-2019; Kapogiannis, Dimitrios/AAW-4934-2020; Mustapic, Maja/AAV-3212-2020	Kapogiannis, Dimitrios/0000-0003-2181-3118; Mullins, Roger/0000-0002-0561-4402; Mustapic, Maja/0000-0003-0511-2047	Intramural Research Program of the U.S. National Institutes of Health/National Institute on Aging; NIA [P30 AG028383]; NATIONAL INSTITUTE ON AGING [ZIAAG000966, P30AG028383, ZIAAG000975] Funding Source: NIH RePORTER	Intramural Research Program of the U.S. National Institutes of Health/National Institute on Aging; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank J. H. Goetzl (Jewish Home of San Francisco) for expert preparation of the illustrations. D.K., C.N.-O., and M.M. were supported by the Intramural Research Program of the U.S. National Institutes of Health/National Institute on Aging. E.L.A. was supported by NIA Grant P30 AG028383. E.J.G. has filed an application with the U.S. Patent Office for the platform and methodologies described in this report. All other authors declare no conflicts of interest.	Aron L, 2016, NATURE, V540, P207, DOI 10.1038/540207a; Bianchi VE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112441; Cano SJ, 2010, J NEUROL NEUROSUR PS, V81, P1363, DOI 10.1136/jnnp.2009.204008; Carro E, 2004, EUR J PHARMACOL, V490, P127, DOI 10.1016/j.ejphar.2004.02.050; del Corral RD, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00058; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Eugenin-von Bernhardi J, 2016, ADV EXP MED BIOL, V949, P27, DOI 10.1007/978-3-319-40764-7_2; Fenton H, 1998, BRAIN RES, V779, P262, DOI 10.1016/S0006-8993(97)00958-X; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Goetzl EJ, 2018, FASEB J, V32, P888, DOI 10.1096/fj.201700731R; Goetzl EJ, 2017, FASEB J, V31, P1792, DOI 10.1096/fj.201601221R; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Goetzl EJ, 2016, FASEB J, V30, P3853, DOI 10.1096/fj.201600756R; Guan J, 1996, ENDOCRINOLOGY, V137, P893, DOI 10.1210/en.137.3.893; Kelly CM, 2003, CELL TRANSPLANT, V12, P215, DOI 10.3727/000000003108746777; Kokuzawa J, 2003, MOL CELL NEUROSCI, V24, P190, DOI 10.1016/S1044-7431(03)00160-X; Lim CS, 2008, CELL SIGNAL, V20, P825, DOI 10.1016/j.cellsig.2007.12.013; Maina F, 1998, NEURON, V20, P835, DOI 10.1016/S0896-6273(00)80466-3; Mashayekhi F, 2010, J CLIN NEUROSCI, V17, P357, DOI 10.1016/j.jocn.2009.05.037; Matsumoto K, 2014, BIOMEDICINES, V2, P275, DOI 10.3390/biomedicines2040275; Mattson MP, 2004, AGEING RES REV, V3, P445, DOI 10.1016/j.arr.2004.08.001; NAKANO M, 2017, SCI REP UK, V7; Nieto-Estevez V, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00052; Nishiyama A, 2001, Hum Cell, V14, P77; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pitt J, 2017, MOL BIOL CELL, V28, P2623, DOI 10.1091/mbc.E17-06-0416; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; STEMPLE DL, 1988, NEURON, V1, P517, DOI 10.1016/0896-6273(88)90182-1; STOPA EG, 1990, BIOCHEM BIOPH RES CO, V171, P690, DOI 10.1016/0006-291X(90)91201-3; Sun WJ, 2016, ELIFE, V5, DOI 10.7554/eLife.16262; Thorns V, 2001, NEUROPATHOLOGY, V21, P203, DOI 10.1046/j.1440-1789.2001.00399.x; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; UNSICKER K, 1987, P NATL ACAD SCI USA, V84, P5459, DOI 10.1073/pnas.84.15.5459; Vinters HV, 2015, ANNU REV PATHOL-MECH, V10, P291, DOI 10.1146/annurev-pathol-020712-163927; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; Wu QF, 2012, CELL, V149, P1549, DOI 10.1016/j.cell.2012.04.046; Zhang X, 2012, SCI CHINA LIFE SCI, V55, P1038, DOI 10.1007/s11427-012-4412-x	41	29	28	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					231	238		10.1096/fj.201801001	http://dx.doi.org/10.1096/fj.201801001			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29924942	Green Published			2022-12-26	WOS:000457401500019
J	Morris, JS; Groves, RA; Hagel, JM; Facchini, PJ				Morris, Jeremy S.; Groves, Ryan A.; Hagel, Jillian M.; Facchini, Peter J.			An N-methyltransferase from Ephedra sinica catalyzing the formation of ephedrine and pseudoephedrine enables microbial phenylalkylamine production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plant biochemistry; plant molecular biology; secondary metabolism; genomics; synthetic biology; biochemical genomics; Ephedra sinica; N-methyltransferase; substituted phenylalkylamine; synthetic biology; natural product; secondary metabolite	CAFFEINE SYNTHASE GENE; ADENOSYL-L-METHIONINE; ESCHERICHIA-COLI; OPIUM POPPY; S-ADENOSYLMETHIONINE; MOLECULAR-CLONING; COPTIS-JAPONICA; CULTURED-CELLS; ENZYME; PLANTS	Phenylalkylamines, such as the plant compounds ephedrine and pseudoephedrine and the animal neurotransmitters dopamine and adrenaline, compose a large class of natural and synthetic molecules with important physiological functions and pharmaceutically valuable bioactivities. The final steps of ephedrine and pseudoephedrine biosynthesis in members of the plant genus Ephedra involve N-methylation of norephedrine and norpseudoephedrine, respectively. Here, using a plant transcriptome screen, we report the isolation and characterization of an N-methyltransferase (NMT) from Ephedra sinica able to catalyze the formation of (pseudo)ephedrine and other naturally occurring phenylalkylamines, including N-methylcathinone and N-methyl(pseudo)ephedrine. Phenylalkylamine N-methyltransferase (PaNMT) shares substantial amino acid sequence identity with enzymes of the NMT family involved in benzylisoquinoline alkaloid (BIA) metabolism in members of the higher plant order Ranunculales, which includes opium poppy (Papaver somniferum). PaNMT accepted a broad range of substrates with phenylalkylamine, tryptamine, -carboline, tetrahydroisoquinoline, and BIA structural scaffolds, which is in contrast to the specificity for BIA substrates of NMT enzymes within the Ranunculales. PaNMT transcript levels were highest in young shoots of E. sinica, which corresponded to the location of NMT activity yielding (pseudo)ephedrine, N-methylcathinone, and N-methyl(pseudo)ephedrine, and with in planta accumulation of phenylalkylamines. Co-expression of recombinant genes encoding PaNMT and an -transaminase (PP2799) from Pseudomonas putida in Escherichia coli enabled the conversion of exogenous (R)-phenylacetylcarbinol (PAC) and (S)-PAC to ephedrine and pseudoephedrine, respectively. Our work further demonstrates the utility of plant biochemical genomics for the isolation of key enzymes that facilitate microbial engineering for the production of medicinally important metabolites.	[Morris, Jeremy S.; Groves, Ryan A.; Hagel, Jillian M.; Facchini, Peter J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Facchini, PJ (corresponding author), Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada.	pfacchin@ucalgary.ca						Abourashed EA, 2003, PHYTOTHER RES, V17, P703, DOI 10.1002/ptr.1337; AXELROD J, 1962, J PHARMACOL EXP THER, V138, P28; Bartlem D, 2000, PLANT PHYSIOL, V123, P101, DOI 10.1104/pp.123.1.101; Beng G. T., 2011, MALAYSIAN J ANAL SCI, V15, P54; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Brobst A., 2009, AM J UNDERGRAD RES, V8, P1; Chen YW, 2017, RSC ADV, V7, P22409, DOI 10.1039/c7ra02538f; Choi KB, 2002, J BIOL CHEM, V277, P830, DOI 10.1074/jbc.M106405200; Choi KB, 2001, PHYTOCHEMISTRY, V56, P649, DOI 10.1016/S0031-9422(00)00481-7; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; DIXON SL, 1993, J COMPUT CHEM, V14, P1460, DOI 10.1002/jcc.540141208; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Faraone SV, 2018, NEUROSCI BIOBEHAV R, V87, P255, DOI 10.1016/j.neubiorev.2018.02.001; Finberg JPM, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00340; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Garcia-Moreno Bertrand, 2009, Journal of Biology (London), V8, P98, DOI 10.1186/jbiol199; Groves RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119701; GRUESORENSEN G, 1994, J AM CHEM SOC, V116, P6195, DOI 10.1021/ja00093a019; GRUNEWALD GL, 1988, J MED CHEM, V31, P1984, DOI 10.1021/jm00118a021; Hagel JM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0596-0; Hagel JM, 2012, TRENDS PLANT SCI, V17, P404, DOI 10.1016/j.tplants.2012.03.004; Hagel JM, 2012, IN VITRO CELL DEV-PL, V48, P233, DOI 10.1007/s11627-012-9426-3; HOLM S, 1979, SCAND J STAT, V6, P65; Hu Xiaoqing, 2012, Subcell Biochem, V64, P327, DOI 10.1007/978-94-007-5055-5_16; Huang RQ, 2016, P NATL ACAD SCI USA, V113, P10613, DOI 10.1073/pnas.1602575113; IMASEKI I, 1956, Pharm Bull, V4, P277; Kato M, 2000, NATURE, V406, P956, DOI 10.1038/35023072; Korte SM, 2015, EUR J PHARMACOL, V753, P88, DOI 10.1016/j.ejphar.2014.11.045; Krizevski R, 2012, PHYTOCHEMISTRY, V81, P71, DOI 10.1016/j.phytochem.2012.05.018; Krizevski R, 2010, PHYTOCHEMISTRY, V71, P895, DOI 10.1016/j.phytochem.2010.03.019; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kunjapur AM, 2014, J AM CHEM SOC, V136, P11644, DOI 10.1021/ja506664a; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Liscombe DK, 2009, PLANT J, V60, P729, DOI 10.1111/j.1365-313X.2009.03980.x; Meisel L, 2005, BIOL RES, V38, P83, DOI 10.4067/S0716-97602005000100010; Meyer D, 2011, J AM CHEM SOC, V133, P3609, DOI 10.1021/ja110236w; Mizuno K, 2003, FEBS LETT, V534, P75, DOI 10.1016/S0014-5793(02)03781-X; Morris JS, 2016, J BIOL CHEM, V291, P23416, DOI 10.1074/jbc.M116.750893; Ng J, 2015, NAT REV NEUROL, V11, P567, DOI 10.1038/nrneurol.2015.172; O'Dowd N. A., 1998, BIOTECHNOLOGY AGR FO, V41, P154; Okada T, 2008, BIOL PHARM BULL, V31, P2194, DOI 10.1248/bpb.31.2194; OKEEFE BR, 1994, PLANT PHYSIOL, V105, P395, DOI 10.1104/pp.105.1.395; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ravanel S, 2004, J BIOL CHEM, V279, P22548, DOI 10.1074/jbc.M313250200; RETI L, 1953, ALKALOIDS-CHEM BIOL, V3, P339; RUEFFER M, 1990, PHYTOCHEMISTRY, V29, P3727, DOI 10.1016/0031-9422(90)85321-6; Satpute K., 2015, INT P CHEM BIOL ENV, V88, P65; Sehl T, 2014, GREEN CHEM, V16, P3341, DOI 10.1039/c4gc00100a; Sehl T, 2013, ANGEW CHEM INT EDIT, V52, P6772, DOI 10.1002/anie.201300718; Sehl T, 2012, J BIOTECHNOL, V159, P188, DOI 10.1016/j.jbiotec.2011.12.023; Shen JB, 2013, MOL PLANT, V6, P1419, DOI 10.1093/mp/sst079; Thompson MA, 1998, J BIOL CHEM, V273, P34502, DOI 10.1074/jbc.273.51.34502; Torres MA, 2016, J BIOL CHEM, V291, P23403, DOI 10.1074/jbc.M116.747261; WELSH LH, 1949, J AM CHEM SOC, V71, P3500, DOI 10.1021/ja01178a071; Wu XR, 2014, APPL MICROBIOL BIOT, V98, P7399, DOI 10.1007/s00253-014-5797-1; Zhao XQ, 2010, ARCH MICROBIOL, V192, P289, DOI 10.1007/s00203-010-0548-x; ZHINGEL KY, 1991, J FORENSIC SCI, V36, P915	59	10	10	6	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13364	13376		10.1074/jbc.RA118.004067	http://dx.doi.org/10.1074/jbc.RA118.004067			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29929980	Green Published, hybrid			2022-12-26	WOS:000443375500002
J	Valegard, K; Andralojc, PJ; Haslam, RP; Pearce, FG; Eriksen, GK; Madgwickn, PJ; Kristoffersen, AK; van Lun, M; Klein, U; Eilertsen, HC; Parry, MAJ; Andersson, I				Valegard, Karin; Andralojc, P. John; Haslam, Richard P.; Pearce, F. Grant; Eriksen, Gunilla K.; Madgwickn, Pippa J.; Kristoffersen, Anne K.; van Lun, Michiel; Klein, Uwe; Eilertsen, Hans C.; Parry, Martin A. J.; Andersson, Inger			Structural and functional analyses of Rubisco from arctic diatom species reveal unusual posttranslational modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; CO2 CONCENTRATING MECHANISMS; CRYSTAL-STRUCTURE; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE; RIBULOSEBISPHOSPHATE CARBOXYLASE; SPECIFICITY FACTOR; LARGE SUBUNIT; CELL-WALL; OXYGENASE; PROTEIN	The catalytic performance of the major CO2-assimilating enzyme, ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco), restricts photosynthetic productivity. Natural diversity in the catalytic properties of Rubisco indicates possibilities for improvement. Oceanic phytoplankton contain some of the most efficient Rubisco enzymes, and diatoms in particular are responsible for a significant proportion of total marine primary production as well as being a major source of CO2 sequestration in polar cold waters. Until now, the biochemical properties and three-dimensional structures of Rubisco from diatoms were unknown. Here, diatoms from arctic waters were collected, cultivated, and analyzed for their CO2-fixing capability. We characterized the kinetic properties of five and determined the crystal structures of four Rubiscos selected for their high CO2-fixing efficiency. The DNA sequences of the rbcL, and rbcS genes of the selected diatoms were similar, reflecting their close phylogenetic relationship. The V-max and K-m for the oxygenase and carboxylase activities at 25 degrees C and the specificity factors (S-c/o) at 15, 25, and 35 degrees C were determined. The S-c/o values were high, approaching those of mono- and dicot plants, thus exhibiting good selectivity for CO(2 )relative to O-2. Structurally, diatom Rubiscos belong to form I C/D, containing small subunits characterized by a short beta A-beta B loop and a C-terminal extension that forms a beta-hairpin structure (beta E-beta F loop). Of note, the diatom Rubiscos featured a number of posttranslational modifications of the large subunit, including 4-hydroxyproline, beta-hydroxyleucine, hydroxylated and nitrosylated cysteine, mono- and dihydroxylated lysine, and trimethylated lysine. Our studies suggest adaptation toward achieving efficient CO2 fixation in arctic diatom Rubiscos.	[Valegard, Karin; Pearce, F. Grant; van Lun, Michiel; Andersson, Inger] Uppsala Univ, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden; [Andralojc, P. John; Haslam, Richard P.; Madgwickn, Pippa J.; Parry, Martin A. J.] Rothamsted Res, Dept Plant Sci, Harpenden AL5 2JQ, Herts, England; [Eriksen, Gunilla K.; Eilertsen, Hans C.] Arctic Univ Norway, Norwegian Coll Fisheries Sci, N-9037 Tromso, Norway; [Kristoffersen, Anne K.; Klein, Uwe] Univ Oslo, Dept Biosci, POB 1066, N-0316 Oslo, Norway; [Pearce, F. Grant] Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 8140, New Zealand; [Kristoffersen, Anne K.] Univ Oslo, Fac Dent, Dept Oral Biol, POB 1052, N-0316 Oslo, Norway; [Parry, Martin A. J.] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England	Uppsala University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UiT The Arctic University of Tromso; University of Oslo; University of Canterbury; University of Oslo; Lancaster University	Andersson, I (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden.	inger.andersson@icm.uu.se		Parry, Martin/0000-0002-4477-672X; Haslam, Richard/0000-0001-6226-5643	MAX-lab (Lund, Sweden); European Union [QLK3-CT-2002-01945]; Swedish Research Council for Environment, Agricultural Sciences; Spatial Planning (FORMAS); Biotechnology and Biological Sciences Research Council, UK, through the 20:20 Wheat(R) Institute Strategic Program (BBSRC) [BB/J/00426X/1]; BBSRC [BBS/E/C/00005202] Funding Source: UKRI	MAX-lab (Lund, Sweden); European Union(European Commission); Swedish Research Council for Environment, Agricultural Sciences(Swedish Research Council Formas); Spatial Planning (FORMAS)(Swedish Research Council Formas); Biotechnology and Biological Sciences Research Council, UK, through the 20:20 Wheat(R) Institute Strategic Program (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the European Union (QLK3-CT-2002-01945) the Swedish Research Council for Environment, Agricultural Sciences, and Spatial Planning (FORMAS). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Biotechnology and Biological Sciences Research Council, UK, through the 20:20 Wheat (R) Institute Strategic Program (BBSRC Grant BB/J/00426X/1).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Carmo-Silva AE, 2010, J EXP BOT, V61, P2355, DOI 10.1093/jxb/erq071; Carmo-Silva E, 2015, PLANT CELL ENVIRON, V38, P1817, DOI 10.1111/pce.12425; Cassab GI, 1998, ANNU REV PLANT PHYS, V49, P281, DOI 10.1146/annurev.arplant.49.1.281; CHEN Z, 1988, P NATL ACAD SCI USA, V85, P4696, DOI 10.1073/pnas.85.13.4696; Chung CC, 2008, APPL ENVIRON MICROB, V74, P6521, DOI 10.1128/AEM.01481-08; Degerlund M, 2010, ESTUAR COAST, V33, P242, DOI 10.1007/s12237-009-9167-7; Delwiche CF, 1996, MOL BIOL EVOL, V13, P873, DOI 10.1093/oxfordjournals.molbev.a025647; Eilertsen HC, 2010, J PLANKTON RES, V32, P899, DOI 10.1093/plankt/fbq017; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Falkowski P, 2012, NATURE, V483, pS17, DOI 10.1038/483S17a; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Galmes J, 2005, PLANT CELL ENVIRON, V28, P571, DOI 10.1111/j.1365-3040.2005.01300.x; Galmes J, 2014, PLANT CELL ENVIRON, V37, P1989, DOI 10.1111/pce.12335; Ghiron JHL, 2008, PROTIST, V159, P91, DOI 10.1016/j.protis.2007.06.002; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Hansen S, 1999, J MOL BIOL, V288, P609, DOI 10.1006/jmbi.1999.2701; Haslam RP, 2005, PLANT RESPONSES TO AIR POLLUTION AND GLOBAL CHANGE, P157, DOI 10.1007/4-431-31014-2_18; Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5; Heinhorst S, 2002, CURR MICROBIOL, V45, P115, DOI 10.1007/s00284-001-0094-5; HOBSON LA, 1985, PLANT PHYSIOL, V79, P833, DOI 10.1104/pp.79.3.833; HOLM-HANSEN OSMUND, 1965, J CONS CONS PERMS INTE EXPLOR MER, V30, P3; Hopkinson BM, 2016, CURR OPIN PLANT BIOL, V31, P51, DOI 10.1016/j.pbi.2016.03.013; Houtz RL, 2003, ARCH BIOCHEM BIOPHYS, V414, P150, DOI 10.1016/S0003-9861(03)00122-X; HOUTZ RL, 1992, PLANT PHYSIOL, V98, P1170, DOI 10.1104/pp.98.3.1170; HOUTZ RL, 1991, PLANT PHYSIOL, V96, P335, DOI 10.1104/pp.96.1.335; Houtz RL, 2008, J EXP BOT, V59, P1635, DOI 10.1093/jxb/erm360; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORDAN DB, 1981, NATURE, V291, P513, DOI 10.1038/291513a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karkehabadi S, 2005, BIOCHEMISTRY-US, V44, P113, DOI 10.1021/bi047928e; Kroger N, 2001, J BIOL CHEM, V276, P26066, DOI 10.1074/jbc.M102093200; LAING WA, 1974, PLANT PHYSIOL, V54, P678, DOI 10.1104/pp.54.5.678; LAMPORT DTA, 1960, NATURE, V188, P665, DOI 10.1038/188665b0; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; LORIMER GH, 1976, BIOCHEMISTRY-US, V15, P529, DOI 10.1021/bi00648a012; LORIMER GH, 1980, BIOCHEMISTRY-US, V19, P5321, DOI 10.1021/bi00564a027; Losh JL, 2013, NEW PHYTOL, V198, P52, DOI 10.1111/nph.12143; Moreno J, 2008, J EXP BOT, V59, P1605, DOI 10.1093/jxb/erm310; Morin B, 1998, CHEM RES TOXICOL, V11, P1265, DOI 10.1021/tx980118h; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; PARRY MAJ, 1993, PLANT PHYSIOL BIOCH, V31, P113; Parry MAJ, 2003, J EXP BOT, V54, P1321, DOI 10.1093/jxb/erg141; PARRY MAJ, 1989, J EXP BOT, V40, P317, DOI 10.1093/jxb/40.3.317; Quillfeldt CH, 2001, BOT MAR, V44, P375; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; SARGENT JR, 1985, MAR BIOL, V85, P109, DOI 10.1007/BF00397428; Savir Y, 2010, P NATL ACAD SCI USA, V107, P3475, DOI 10.1073/pnas.0911663107; SMAYDA THEODORE J., 1958, OIKOS, V9, P158, DOI 10.2307/3564763; SMITH WG, 1965, J BACTERIOL, V89, P136, DOI 10.1128/JB.89.1.136-140.1965; Spreitzer RJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P141, DOI 10.1016/S0003-9861(03)00171-1; Stec B, 2012, P NATL ACAD SCI USA, V109, P18785, DOI 10.1073/pnas.1210754109; Sugawara H, 1999, J BIOL CHEM, V274, P15655, DOI 10.1074/jbc.274.22.15655; Syvertsen E, 1977, NOVA HEDWIGIA S, V54, P99; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; Taylor TC, 2001, J BIOL CHEM, V276, P48159, DOI 10.1074/jbc.M107765200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Lun M, 2011, J MOL BIOL, V411, P1083, DOI 10.1016/j.jmb.2011.06.052; Watson GMF, 1997, FEMS MICROBIOL LETT, V146, P13, DOI 10.1016/S0378-1097(96)00417-X; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YOKOTA A, 1985, PLANT PHYSIOL, V77, P735, DOI 10.1104/pp.77.3.735; Young JN, 2016, J EXP BOT, V67, P3445, DOI 10.1093/jxb/erw163	67	13	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13033	13043		10.1074/jbc.RA118.003518	http://dx.doi.org/10.1074/jbc.RA118.003518			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29925588	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-26	WOS:000442730200006
J	Grajevskaja, V; Camerota, D; Bellipanni, G; Balciuniene, J; Balciunas, D				Grajevskaja, Viktorija; Camerota, Diana; Bellipanni, Gianfranco; Balciuniene, Jorune; Balciunas, Darius			Analysis of a conditional gene trap reveals that tbx5a is required for heart regeneration in zebrafish	PLOS ONE			English	Article							HOLT-ORAM-SYNDROME; CARDIAC TRANSCRIPTION FACTORS; SITE-SPECIFIC RECOMBINATION; VERTEBRATE PROTEOME; EFFICIENT; EXPRESSION; TRANSPOSON; MUTATIONS; SYSTEM; GENOME	The ability to conditionally inactivate genes is instrumental for fine genetic analysis of all biological processes, but is especially important for studies of biological events, such as regeneration, which occur late in ontogenesis or in adult life. We have constructed and tested a fully conditional gene trap vector, and used it to inactivate tbx5a in the cardiomyocytes of larval and adult zebrafish. We observe that loss of tbx5a function significantly impairs the ability of zebrafish hearts to regenerate after ventricular resection, indicating that Tbx5a plays an essential role in the transcriptional program of heart regeneration.	[Grajevskaja, Viktorija; Camerota, Diana; Bellipanni, Gianfranco; Balciuniene, Jorune; Balciunas, Darius] Temple Univ, Coll Sci & Technol, Dept Biol, Philadelphia, PA 19122 USA; [Grajevskaja, Viktorija] Vilnius Univ, Fac Nat Sci, Dept Zool, Vilnius, Lithuania	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Vilnius University	Balciunas, D (corresponding author), Temple Univ, Coll Sci & Technol, Dept Biol, Philadelphia, PA 19122 USA.	darius@temple.edu	Balciunas, Darius/AAD-1420-2019	Balciunas, Darius/0000-0003-1938-3243	Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD061749]; Temple University College of Science and Technology; Temple University Creative Arts, Research and Scholarship (CARAS) Program; NIH [HD061749]	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Temple University College of Science and Technology; Temple University Creative Arts, Research and Scholarship (CARAS) Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Our research was funded by Eunice Kennedy Shriver National Institute of Child Health and Human Development grant HD061749 to DB, and by funds from Temple University College of Science and Technology, and Temple University Creative Arts, Research and Scholarship (CARAS) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Leonard Zon, Christian Mosimann, Pierre Chambon and Philippe Soriano for sharing fish strains and recombinase-encoding plasmids. We thank Dr. Didier Stainier for critical reading of the manuscript. The research has been supported by NIH R01 grant HD061749 to DB, funds from Temple University College of Science and Technology, and Temple University Creative Arts, Research and Scholarship (CARAS) Program.	Ahn DG, 2002, NATURE, V417, P754, DOI 10.1038/nature00814; Anderson JL, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007105; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Auer TO, 2016, METHODS MOL BIOL, P31, DOI 10.1007/978-1-4939-3771-4_3; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Balciunas D, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007197; Balciuniene J, 2013, JOVE-J VIS EXP, DOI 10.3791/50113; Balciuniene J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-619; Barrionuevo FJ, 2016, ELIFE, V5, DOI 10.7554/eLife.15635; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bello EP, 2016, MOL PSYCHIAT; Boniface EJ, 2009, GENESIS, V47, P484, DOI 10.1002/dvg.20526; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Clark KJ, 2011, NAT METHODS, V8, P506, DOI [10.1038/NMETH.1606, 10.1038/nmeth.1606]; Craig MP, 2015, ARTERIOSCL THROM VAS, V35, P865, DOI 10.1161/ATVBAHA.114.304768; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; FU JD, 2013, CIRCULATION S, V128; Garrity DM, 2002, DEVELOPMENT, V129, P4635; Gemberling M, 2013, TRENDS GENET; Hans S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004640; Hermanson S, 2004, METHOD CELL BIOL, V77, P349; Hoshijima K, 2016, DEV CELL, V36, P654, DOI 10.1016/j.devcel.2016.02.015; Hyatt TM, 1999, METHOD CELL BIOL, V59, P117; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li J, 2015, CELL RES, V25, P634, DOI 10.1038/cr.2015.43; Li QY, 1997, NAT GENET, V15, P21; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Gonzalez-Rosa JM, 2011, DEVELOPMENT, V138, P1663, DOI 10.1242/dev.060897; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Nam YJ, 2014, DEVELOPMENT, V141, P4267, DOI 10.1242/dev.114025; Ni TT, 2012, P NATL ACAD SCI USA, V109, P15389, DOI 10.1073/pnas.1206131109; Petzold AM, 2009, P NATL ACAD SCI USA, V106, P18662, DOI 10.1073/pnas.0908247106; Porrello ER, 2014, STEM CELL RES, V13, P556, DOI 10.1016/j.scr.2014.06.003; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Pradhan L, 2016, BIOCHEMISTRY-US, V55, P1702, DOI 10.1021/acs.biochem.6b00171; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Rossant J, 1999, GENE DEV, V13, P142, DOI 10.1101/gad.13.2.142; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Seifert AW, 2014, INT REV CEL MOL BIO, V310, P129, DOI 10.1016/B978-0-12-800180-6.00004-9; Seiler C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131908; Shen T, 2011, J CLIN INVEST, V121, P4640, DOI 10.1172/JCI59472; Shin J, 2014, DEVELOPMENT, V141, P3807, DOI 10.1242/dev.108019; Sivasubbu S, 2006, MECH DEVELOP, V123, P513, DOI 10.1016/j.mod.2006.06.002; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Sleep E, 2010, J CARDIOVASC MED, V11, P369, DOI 10.2459/JCM.0b013e3283375900; SMITH AT, 1979, J PEDIATR-US, V95, P538, DOI 10.1016/S0022-3476(79)80758-1; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Sugimoto K, 2017, ELIFE, V6, DOI 10.7554/eLife.24635; Trinh LA, 2013, DEV GROWTH DIFFER, V55, P434, DOI 10.1111/dgd.12055; Trinh LA, 2011, GENE DEV, V25, P2306, DOI 10.1101/gad.174037.111; Zhang RL, 2013, NATURE, V498, P497, DOI 10.1038/nature12322	60	13	13	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0197293	10.1371/journal.pone.0197293	http://dx.doi.org/10.1371/journal.pone.0197293			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933372	Green Published, Green Submitted, gold			2022-12-26	WOS:000436076600003
J	Hozumi, H; Oyama, Y; Yasui, H; Suzuki, Y; Kono, M; Karayama, M; Furuhashi, K; Enomoto, N; Fujisawa, T; Inui, N; Nakamura, Y; Suda, T				Hozumi, Hironao; Oyama, Yoshiyuki; Yasui, Hideki; Suzuki, Yuzo; Kono, Masato; Karayama, Masato; Furuhashi, Kazuki; Enomoto, Noriyuki; Fujisawa, Tomoyuki; Inui, Naoki; Nakamura, Yutaro; Suda, Takafumi			Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias	PLOS ONE			English	Article							PULMONARY-FIBROSIS; MICROSCOPIC POLYANGIITIS; CONSENSUS CONFERENCE; FEATURES; VASCULITIDES; NOMENCLATURE; PREVALENCE	Objective Although a possible association among myeloperoxidase-anti-neutrophil cytoplasmic antibody (MPO-ANCA), microscopic polyangiitis (MPA), and idiopathic pulmonary fibrosis (IPF) has been suggested, the clinical significance of MPO-ANCA in idiopathic interstitial pneumonias (IIPs), including IPF and non-IPF, remains unclear. We aimed to investigate the frequency of MPO-ANCA positivity, as well as MPA incidence and risk factors for development in patients initially diagnosed with IIP. Methods We retrospectively analysed 305 consecutive patients who were initially diagnosed as IIP and had MPO-ANCA results available. Results Of the 305 patients, 26 (8.5%) were MPO-ANCA-positive. Baseline characteristics were similar between the MPO-ANCA-positive and-negative patients. The cumulative 5-year MPA incidence was 24.3% in the MPO-ANCA-positive patients and 0% in the-negative patients (P < 0.0001). MPO-ANCA was positive in 15 of 133 (11.3%) patients initially diagnosed with IPF and in 11 of 172 (6.3%) patients initially diagnosed with non-IPF (P = 0.56), with cumulative 5-year MPA incidence of 6.2% and 1.0%, respectively (P = 0.10). Multivariate analysis revealed that UIP pattern on HRCT (HR = 3.20, P < 0.01) and no treatment for IIP (HR = 3.52, P < 0.01) were independently associated with MPA development in MPO-ANCA-positive patients. Conclusion MPO-ANCA positivity was uncommon, but was associated with subsequent MPA development in patients initially diagnosed with IIP, including both IPF and non-IPF cases. The study suggested that attention should be paid to MPA development in MPO-ANCA-positive IIP patients with UIP pattern on HRCT and those without treatment for IIP.	[Hozumi, Hironao; Oyama, Yoshiyuki; Yasui, Hideki; Suzuki, Yuzo; Kono, Masato; Karayama, Masato; Furuhashi, Kazuki; Enomoto, Noriyuki; Fujisawa, Tomoyuki; Inui, Naoki; Nakamura, Yutaro; Suda, Takafumi] Hamamatsu Univ, Sch Med, Div 2, Dept Internal Med, Hamamatsu, Shizuoka, Japan; [Inui, Naoki] Hamamatsu Univ, Sch Med, Dept Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Hozumi, H (corresponding author), Hamamatsu Univ, Sch Med, Div 2, Dept Internal Med, Hamamatsu, Shizuoka, Japan.	hozumi@hama-med.ac.jp	Karayama, Masato/AAR-8423-2020; Karayama, Masato/AAD-7029-2022; Enomoto, Noriyuki/GLS-0691-2022; Suzuki, Yuzo/AAE-6747-2020	Karayama, Masato/0000-0003-0455-4070; Enomoto, Noriyuki/0000-0003-3187-4264; Suzuki, Yuzo/0000-0001-6154-9791; Hozumi, Hironao/0000-0001-5439-1543				Ando M, 2013, RESP MED, V107, P608, DOI 10.1016/j.rmed.2013.01.006; Arulkumaran N, 2011, RHEUMATOLOGY, V50, P2035, DOI 10.1093/rheumatology/ker236; Fischer A, 2015, EUR RESPIR J, V46, P976, DOI 10.1183/13993003.00150-2015; Foulon G, 2008, RESP MED, V102, P1392, DOI 10.1016/j.rmed.2008.04.023; Hervier B, 2009, ANN RHEUM DIS, V68, P404, DOI 10.1136/ard.2008.096131; Hoffman GS, 1998, ARTHRITIS RHEUM-US, V41, P1521, DOI 10.1002/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A; Homma S, 2004, RESPIROLOGY, V9, P190, DOI 10.1111/j.1440-1843.2004.00581.x; Hosoda C, 2016, RESPIROLOGY, V21, P920, DOI 10.1111/resp.12763; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Kagiyama N, 2015, BMJ OPEN RESPIR RES, V2, DOI 10.1136/bmjresp-2014-000058; Kono M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094775; Nozu T, 2009, RESPIRATION, V77, P407, DOI 10.1159/000183754; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Tanaka T, 2012, RESP MED, V106, P1765, DOI 10.1016/j.rmed.2012.08.024; Travis W.D., 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Tzelepis GE, 2010, EUR RESPIR J, V36, P116, DOI 10.1183/09031936.00110109; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; Yamagata M, 2016, ARTHRITIS RHEUMATOL, V68, P713, DOI 10.1002/art.39475	20	38	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199659	10.1371/journal.pone.0199659	http://dx.doi.org/10.1371/journal.pone.0199659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928060	Green Submitted, gold, Green Published			2022-12-26	WOS:000435802500120
J	Huhn, S; da Silva, MI; Sanmuganantham, T; Pichulik, T; Catalano, C; Pardini, B; Naccarati, A; Polakova-Vymetalkova, V; Jiraskova, K; Vodickova, L; Vodicka, P; Loffler, MW; Courth, L; Wehkamp, J; Din, FVN; Timofeeva, M; Farrington, SM; Jansen, L; Hemminki, K; Chang-Claude, J; Brenner, H; Hoffmeister, M; Dunlop, MG; Weber, ANR; Forsti, A				Huhn, Stefanie; da Silva Filho, Miguel, I; Sanmuganantham, Tharmila; Pichulik, Tica; Catalano, Calogerina; Pardini, Barbara; Naccarati, Alessio; Polakova-Vymetalkova, Veronika; Jiraskova, Katerina; Vodickova, Ludmila; Vodicka, Pavel; Loeffler, Markus W.; Courth, Lioba; Wehkamp, Jan; Din, Farhat V. N.; Timofeeva, Maria; Farrington, Susan M.; Jansen, Lina; Hemminki, Kari; Chang-Claude, Jenny; Brenner, Hermann; Hoffmeister, Michael; Dunlop, Malcolm G.; Weber, Alexander N. R.; Foersti, Asta			Coding variants in NOD-like receptors: An association study on risk and survival of colorectal cancer	PLOS ONE			English	Article							GENES; SUSCEPTIBILITY; RECOGNITION; SEQUENCE; MEMBERS	Nod-like receptors (NLRs) are important innate pattern recognition receptors and regulators of inflammation or play a role during development. We systematically analysed 41 non-synonymous single nucleotide polymorphisms (SNPs) in 21 NLR genes in a Czech discovery cohort of sporadic colorectal cancer (CRC) (1237 cases, 787 controls) for their association with CRC risk and survival. Five SNPs were found to be associated with CRC risk and eight with survival at 5% significance level. In a replication analysis using data of two large genome-wide association studies (GWASs) from Germany (DACHS: 1798 cases and 1810 controls) and Scotland (2210 cases and 9350 controls) the associations found in the Czech discovery set were not confirmed. However, expression analysis in human gut-related tissues and immune cells revealed that the NLRs associated with CRC risk or survival in the discovery set were expressed in primary human colon or rectum cells, CRC tissue and/or cell lines, providing preliminary evidence for a potential involvement of NLRs in general in CRC development and/or progression. Most interesting was the finding that the enigmatic development-related NLRP5 (also known as MATER) was not expressed in normal colon tissue but in colon cancer tissue and cell lines. Future studies may show whether regulatory variants instead of coding variants might affect the expression of NLRs and contribute to CRC risk and survival.	[Huhn, Stefanie; da Silva Filho, Miguel, I; Catalano, Calogerina; Hemminki, Kari; Foersti, Asta] German Canc Res Ctr, Dept Mol Genet Epidemiol, Heidelberg, Germany; [Huhn, Stefanie] Heidelberg Univ Hosp, Dept Multiple Myeloma Internal Med Hematol Oncol, Heidelberg, Germany; [Sanmuganantham, Tharmila; Pichulik, Tica; Loeffler, Markus W.; Weber, Alexander N. R.] Univ Tubingen, Interfac Inst Cell Biol, Dept Immunol, Tubingen, Germany; [Pardini, Barbara; Naccarati, Alessio] IIGM, Turin, Italy; [Pardini, Barbara; Naccarati, Alessio; Polakova-Vymetalkova, Veronika; Jiraskova, Katerina; Vodickova, Ludmila; Vodicka, Pavel] Acad Sci Czech Republ, Inst Expt Med, Prague, Czech Republic; [Polakova-Vymetalkova, Veronika; Jiraskova, Katerina; Vodickova, Ludmila; Vodicka, Pavel] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic; [Vodickova, Ludmila; Vodicka, Pavel] Charles Univ Prague, Fac Med Pilsen, Biomed Ctr, Plzen, Czech Republic; [Loeffler, Markus W.] Univ Hosp Tubingen, Dept Gen Visceral & Transplant Surg, Tubingen, Germany; [Courth, Lioba; Wehkamp, Jan] Univ Hosp Tubingen, Dept Internal Med 1, Tubingen, Germany; [Din, Farhat V. N.; Timofeeva, Maria; Farrington, Susan M.; Dunlop, Malcolm G.] Univ Edinburgh, Western Gen Hosp, MRC Human Genet Unit, Colon Canc Genet Grp, Edinburgh, Midlothian, Scotland; [Jansen, Lina; Brenner, Hermann; Hoffmeister, Michael] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Hemminki, Kari; Foersti, Asta] Lund Univ, Ctr Primary Hlth Care Res, Clin Res Ctr, Malmo, Sweden; [Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, Div Prevent Oncol, Neuenheimer Feld 460, Heidelberg, Germany; [Brenner, Hermann] Natl Ctr Tumor Dis NCT, Neuenheimer Feld 460, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Italian Institute for Genomic Medicine (IIGM); Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; Charles University Prague; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Edinburgh; Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Huhn, S (corresponding author), German Canc Res Ctr, Dept Mol Genet Epidemiol, Heidelberg, Germany.; Huhn, S (corresponding author), Heidelberg Univ Hosp, Dept Multiple Myeloma Internal Med Hematol Oncol, Heidelberg, Germany.; Weber, ANR (corresponding author), Univ Tubingen, Interfac Inst Cell Biol, Dept Immunol, Tubingen, Germany.	Stefanie.Huhn@med.uni-heidelberg.de; alexander.weber@uni.tuebingen.de	Löffler, Markus/K-2239-2014; Pardini, Barbara/ABI-2295-2020; Hoffmeister, Michael/T-7187-2019; Brenner, Hermann/ABE-6383-2020; Farrington, Susan M/C-7319-2013; Farrington, Susan M/Q-2710-2019; Brenner, Hermann/B-4627-2017; Hoffmeister, Michael/AAB-2321-2022; Jiraskova, Katerina/C-8232-2017; Dunlop, Malcolm/F-1973-2011	Löffler, Markus/0000-0003-2513-1317; Pardini, Barbara/0000-0001-9571-4257; Hoffmeister, Michael/0000-0002-8307-3197; Brenner, Hermann/0000-0002-6129-1572; Farrington, Susan M/0000-0001-5955-7389; Brenner, Hermann/0000-0002-6129-1572; Hoffmeister, Michael/0000-0002-8307-3197; Jiraskova, Katerina/0000-0001-8462-6358; Timofeeva, Maria/0000-0002-2503-4253; Naccarati, Alessio/0000-0001-5774-0905; Vodicka, Pavel/0000-0003-2376-1243; Dunlop, Malcolm/0000-0002-3033-5851	COST Action [BM1206, COST-CZ: LD14050, AZV 15-26535A, 15-27580A, Q28/LF1]; DFG collaborative research center [SFB685]; University of Tubingen; Federal State Baden-Wurttemberg Junior Professor-Program; German Cancer Consortium (DKTK); Henriette-and-Ottmar-Eier Stiftung; German Research Council [BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1]; German Federal Ministry of Education and Research [01KH0404, 01ER0814, 01ER0815, 01ER1505A, 01ER1505B]; National Institutes of Health (USA) [U01 CM 37088]; Cancer Research UK [C348/A18927]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F019394/1, 15/SAG09977]; Royal Society; Chief Scientist Office of the Scottish Government; Age UK-The Disconnected Mind project; Centre for Cognitive Ageing and Cognitive Epidemiology - BBSRC [G0700704/84698, MR/K026992/1]; Centre for Cognitive Ageing and Cognitive Epidemiology - Medical Research Council [G0700704/84698, MR/K026992/1]; Chief Scientist Office of the Scottish Government Health Directorate [CZD/16/6]; Scottish Funding Council [HR03006]; Medical Research Council UK [104036/Z/14/Z]; Wellcome Trust [104036/Z/14/Z]; Cancer Research UK [18927, 12076] Funding Source: researchfish; Medical Research Council [MC_UU_00007/1, G0600237, MC_PC_U127527198, MC_U127527198, G0600329] Funding Source: researchfish; Worldwide Cancer Research [12-1087] Funding Source: researchfish; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G0600329, MC_PC_U127527198, G0700704, MC_UU_00007/1, MC_U127527198, G0600237, MR/K018647/1] Funding Source: UKRI	COST Action(European Cooperation in Science and Technology (COST)); DFG collaborative research center(German Research Foundation (DFG)); University of Tubingen; Federal State Baden-Wurttemberg Junior Professor-Program; German Cancer Consortium (DKTK); Henriette-and-Ottmar-Eier Stiftung; German Research Council(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Chief Scientist Office of the Scottish Government; Age UK-The Disconnected Mind project; Centre for Cognitive Ageing and Cognitive Epidemiology - BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Centre for Cognitive Ageing and Cognitive Epidemiology - Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of the Scottish Government Health Directorate; Scottish Funding Council; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the COST Action BM1206 to AF, COST-CZ: LD14050, AZV 15-26535A, 15-27580A and Progres Q28/LF1 to PV. TS, TP, MWL and ANRW were supported by the DFG collaborative research center SFB685 "Immunotherapy", the University of Tubingen, the Federal State Baden-Wurttemberg Junior Professor-Program, the German Cancer Consortium (DKTK) and/or the Henriette-and-Ottmar-Eier Stiftung. DACHS: This work was further supported by the German Research Council (BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1) to HB, the German Federal Ministry of Education and Research (01KH0404, 01ER0814, 01ER0815, 01ER1505A and 01ER1505B) to HB, and from the National Institutes of Health (USA) (U01 CM 37088) to HB. In Scotland, the work was supported by Programme Grant funding from Cancer Research UK [C348/A18927] to MGD which funded genotyping, phenotyping and follow up of cases and matched population controls. Additional genotyping and phenotyping of Scottish population control subjects received grant support as follows: Lothian Birth Cohorts (Ian J Deary and Sarah E Harris) - Biotechnology and Biological Sciences Research Council (BBSRC; BB/F019394/1, 15/SAG09977) to MGD, The Royal Society, The Chief Scientist Office of the Scottish Government, Age UK-The Disconnected Mind project, and the Centre for Cognitive Ageing and Cognitive Epidemiology (co-funded by BBSRC and Medical Research Council G0700704/84698 and MR/K026992/1) to MGD. Generation Scotland received core funding from the Chief Scientist Office of the Scottish Government Health Directorate CZD/16/6 and the Scottish Funding Council HR03006 to MGD. Genotyping of the GS:SFHS samples was carried out by the Genetics Core Laboratory at the Edinburgh Clinical Research Facility, University of Edinburgh, Scotland and was funded by the Medical Research Council UK and the Wellcome Trust (Wellcome Trust Strategic Award "STratifying Resilience and Depression Longitudinally" (STRADL) Reference 104036/Z/14/Z) to MGD.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Barrett JH, 2003, CARCINOGENESIS, V24, P275, DOI 10.1093/carcin/24.2.275; Brenner H, 2014, GASTROENTEROLOGY, V146, P709, DOI 10.1053/j.gastro.2013.09.001; Carvalho FA, 2012, ANNU REV PHYSIOL, V74, P177, DOI 10.1146/annurev-physiol-020911-153330; Castro FA, 2011, EUR J CANCER, V47, P1203, DOI 10.1016/j.ejca.2010.12.011; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Deary IJ, 2012, INT J EPIDEMIOL, V41, P1576, DOI 10.1093/ije/dyr197; Fernandes R, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093583; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoffmeister M, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv045; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Klimosch SN, 2013, CANCER RES, V73, P7232, DOI 10.1158/0008-5472.CAN-13-1746; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lukens JR, 2015, IMMUNITY, V42, P654, DOI 10.1016/j.immuni.2015.03.006; Lupfer C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00285; Naccarati A, 2012, CARCINOGENESIS, V33, P1346, DOI 10.1093/carcin/bgs172; Neerincx A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00397; Ogino S, 2018, GUT, V67, P1168, DOI 10.1136/gutjnl-2017-315537; Oviedo-Boyso J, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/432785; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rudolph A, 2012, INT J CANCER, V131, pE841, DOI 10.1002/ijc.27428; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith BH, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-74; Smith BH, 2013, INT J EPIDEMIOL, V42, P689, DOI 10.1093/ije/dys084; Theodoratou E, 2008, INT J CANCER, V123, P2170, DOI 10.1002/ijc.23769; Timofeeva MN, 2015, SCI REP-UK, V5, DOI 10.1038/srep16286; Ungerback J, 2012, CARCINOGENESIS, V33, P2126, DOI 10.1093/carcin/bgs256; Wang H, 2014, J BIOL CHEM, V289, P23123, DOI 10.1074/jbc.M113.492934; Watson NFS, 2006, INT J CANCER, V118, P6, DOI 10.1002/ijc.21303; Weber ANR, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27763; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wilmanski JM, 2008, J LEUKOCYTE BIOL, V83, P13, DOI 10.1189/jlb.0607402	35	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199350	10.1371/journal.pone.0199350	http://dx.doi.org/10.1371/journal.pone.0199350			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928061	Green Published, gold			2022-12-26	WOS:000435802500076
J	Szternel, L; Krintus, M; Bergmann, K; Derezinski, T; Sypniewska, G				Szternel, Lukasz; Krintus, Magdalena; Bergmann, Katarzyna; Derezinski, Tadeusz; Sypniewska, Grazyna			Non-fasting lipid profile determination in presumably healthy children: Impact on the assessment of lipid abnormalities	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; GENERAL-POPULATION; REMNANT CHOLESTEROL; LDL CHOLESTEROL; RISK-FACTOR; TRIGLYCERIDES; GUIDELINES; APOLIPOPROTEINS; LIPOPROTEINS	Objective Despite the common use of non-fasting measurements for lipid profile in children it remains unclear as to the extent non-fasting conditions have on laboratory results of lipids measurements. We aimed to assess the impact of non-fasting lipid profile on the occurrence of dyslipidemia in children. Materials and methods Basic lipid profile including: total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG), as well as small, dense-LDL-C (sd-LDL-C), apolipoprotein Al (ApoAl), apolipoprotein B (ApoB) and lipoprotein(a) [Lp(a)], were measured in 289 presumably healthy children aged 9-11 in both fasting and non-fasting condition. The clinical impact of non-fasting lipid profile was evaluated individually for each child with estimation of false positive (FP) and false negative (FN) results. Results The highest percentage of FP results in non-fasting condition was observed for TG (42.3%) being significantly higher when compared to FN results (p = 0.003). In contrast, the highest percentage of FN results in a non-fasting state were shown for LDL-C (14.3%), but the difference was statistically insignificant when compared to FP results. When comparing fasting and non-fasting lipid profile a number of significant differences was shown for: TG (p<0.001), HDL-C (p = 0.002) LDL-C (p<0.001) and ApoAl (p<0.001), respectively. The occurrence of dyslipidemia, recognized on the basis of non-fasting lipids was significantly higher (p = 0.010) when compared to fasting lipid profile. Conclusions A higher occurrence of dyslipidemia, based on the measurement of non-fasting lipids in children, is suggestive of possible disorders in lipid metabolism. However, accurate identification of dyslipidemia by assessment of non-fasting lipids requires the establishment of appropriate cut-off values for children.	[Szternel, Lukasz; Krintus, Magdalena; Bergmann, Katarzyna; Sypniewska, Grazyna] Nicolaus Copernicus Univ, Dept Lab Med, Coll Med Bydgoszcz, Torun, Poland; [Derezinski, Tadeusz] Outpatient Clin Esculap Gniewkowo, Gniewkowo, Poland	Nicolaus Copernicus University	Krintus, M (corresponding author), Nicolaus Copernicus Univ, Dept Lab Med, Coll Med Bydgoszcz, Torun, Poland.	krintus@wp.pl	Krintus, Magdalena/H-9419-2014; Dereziński, Tadeusz/GQP-7792-2022	Krintus, Magdalena/0000-0003-2627-7473; Dereziński, Tadeusz/0000-0001-9627-9787; Grazyna, Sypniewska/0000-0003-1350-7073; Szternel, Lukasz/0000-0003-1499-3675				[Anonymous], 2012, J LAWS REPUBLIC POLA; [Anonymous], 2011, PEDIATRICS, V128, pS213, DOI 10.1542/peds.2009-2107C; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Burns SF, 2012, J PEDIATR-US, V161, P991, DOI 10.1016/j.jpeds.2012.06.013; Central Statistical Office Statistical Office in Cracow, 2011, HLTH CHILDR YOUTH PO; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; Freiberg JJ, 2008, JAMA-J AM MED ASSOC, V300, P2142, DOI 10.1001/jama.2008.621; Instytut Pomnik, CENTR ZDROW DZIECK; Kulaga Z., 2010, STAND MED, V7, P690; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Langsted A, 2011, CLIN CHEM, V57, P482, DOI 10.1373/clinchem.2010.157164; Moriyama K, 2016, J ATHEROSCLER THROMB, V23, P1126, DOI 10.5551/jat.33985; Mysliwiec M, 2013, KARDIOL POL, V1099, P1105; National Institute for Health and Care Excellence, 2014, PSYCH SCHIZ AD PREV; Newman TB, 2012, PEDIATRICS, V130, P349, DOI 10.1542/peds.2012-0481; Nishikura T, 2014, J ATHEROSCLER THROMB, V21, P755, DOI 10.5551/jat.23465; Nordestgaard BG, 2016, CLIN CHEM, V930, P946; Peterson Amy L, 2012, WMJ, V111, P274; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Sidhu D, 2012, ARCH INTERN MED, V172, P1707, DOI 10.1001/archinternmed.2012.3708; Steiner MJ, 2011, PEDIATRICS, V128, P463, DOI 10.1542/peds.2011-0844; Third report of the National Cholesterol Education Program (NCEP), 2002, CIRCULATION, V3143, P3421; Thomsen M, 2014, CLIN CHEM, V60, P737, DOI 10.1373/clinchem.2013.219881; Varbo A, 2015, CLIN CHEM, V61, P533, DOI 10.1373/clinchem.2014.234146; Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026; Walldius G, 2006, J INTERN MED, V259, P493, DOI 10.1111/j.1365-2796.2006.01643.x; White KT, 2015, CLIN CHEM, V61, P1156, DOI 10.1373/clinchem.2015.241752; Yoo DY, 2017, ANN PEDIATR ENDOCRIN, V22, P158, DOI 10.6065/apem.2017.22.3.158	28	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198433	10.1371/journal.pone.0198433	http://dx.doi.org/10.1371/journal.pone.0198433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927973	Green Published, Green Submitted, gold			2022-12-26	WOS:000435802500019
J	McManamay, RA; Troia, MJ; DeRolph, CR; Sheldon, AO; Barnett, AR; Kao, SC; Anderson, MG				McManamay, Ryan A.; Troia, Matthew J.; DeRolph, Christopher R.; Sheldon, Arlene Olivero; Barnett, Analie R.; Kao, Shih-Chieh; Anderson, Mark G.			A stream classification system to explore the physical habitat diversity and anthropogenic impacts in riverscapes of the eastern United States	PLOS ONE			English	Article							HYDROLOGIC CLASSIFICATION; GEOMORPHIC DIVERSITY; LANDSCAPE ECOLOGY; RIVER FLOODPLAIN; SPECIES TRAITS; FISH COMMUNITY; ROANOKE RIVER; WALKER BRANCH; FLOW REGIMES; CONSERVATION	Describing the physical habitat diversity of stream types is important for understanding stream ecosystem complexity, but also prioritizing management of stream ecosystems, especially those that are rare. We developed a stream classification system of six physical habitat layers (size, gradient, hydrology, temperature, valley confinement, and substrate) for approximately 1 million stream reaches within the Eastern United States in order to conduct an inventory of different types of streams and examine stream diversity. Additionally, we compare stream diversity to patterns of anthropogenic disturbances to evaluate associations between stream types and human disturbances, but also to prioritize rare stream types that may lack natural representation in the landscape. Based on combinations of different layers, we estimate there are anywhere from 1,521 to 5,577 different physical types of stream reaches within the Eastern US. By accounting for uncertainty in class membership, these estimates could range from 1,434 to 6,856 stream types. However, 95% of total stream distance is represented by only 30% of the total stream habitat types, which suggests that most stream types are rare. Unfortunately, as much as one third of stream physical diversity within the region has been compromised by anthropogenic disturbances. To provide an example of the stream classification's utility in management of these ecosystems, we isolated 5% of stream length in the entire region that represented 87% of the total physical diversity of streams to prioritize streams for conservation protection, restoration, and biological monitoring. We suggest that our stream classification framework could be important for exploring the diversity of stream ecosystems and is flexible in that it can be combined with other stream classification frameworks developed at higher resolutions (meso-and micro-habitat scales). Additionally, the exploration of physical diversity helps to estimate the rarity and patchiness of riverscapes over large region and assist in conservation and management.	[McManamay, Ryan A.; Troia, Matthew J.; DeRolph, Christopher R.; Kao, Shih-Chieh] Oak Ridge Natl Lab, Environm Sci Div, POB 2008, Oak Ridge, TN 37831 USA; [Sheldon, Arlene Olivero; Barnett, Analie R.; Anderson, Mark G.] Eastern Reg Off, Eastern Conservat Sci, Nat Conservancy, Boston, MA USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; Nature Conservancy	McManamay, RA (corresponding author), Oak Ridge Natl Lab, Environm Sci Div, POB 2008, Oak Ridge, TN 37831 USA.	mcmanamayra@ornl.gov	KAO, SHIH-CHIEH/B-9428-2012	KAO, SHIH-CHIEH/0000-0002-3207-5328	U.S. Department of Energy, Water Power Technologies Office within the Office of Energy Efficiency and Renewable Energy [DE-AC05-000R22725]	U.S. Department of Energy, Water Power Technologies Office within the Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE))	This work was supported by the U.S. Department of Energy, Water Power Technologies Office within the Office of Energy Efficiency and Renewable Energy under contract DE-AC05-000R22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JD., 2021, STREAM ECOLOGY STRUC, DOI [DOI 10.1007/978-3-030-61286-3, 10.1007/978-3-030-61286-3]; Allen T. F. H., 1982, HIERARCHY PERSPECTIV; Arthington AH, 2006, ECOL APPL, V16, P1311, DOI 10.1890/1051-0761(2006)016[1311:TCOPEF]2.0.CO;2; BAILEY RG, 1983, ENVIRON MANAGE, V7, P365, DOI 10.1007/BF01866919; BALON EK, 1975, J FISH RES BOARD CAN, V32, P821, DOI 10.1139/f75-110; Barnett A., 2015, STREAM CLASSIFICATIO; Bartley R, 2005, RIVER RES APPL, V21, P39, DOI 10.1002/rra.813; Bendix J, 2000, HYDROL PROCESS, V14, P2977, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;2977::AID-HYP130&gt;3.0.CO;2-4; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Bisson Peter A., 2007, P23, DOI 10.1016/B978-012332908-0.50004-8; Brenden TO, 2008, T AM FISH SOC, V137, P1621, DOI 10.1577/T07-166.1; Brooks TM, 2004, BIOSCIENCE, V54, P1081, DOI 10.1641/0006-3568(2004)054[1081:CPBTGP]2.0.CO;2; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Cote D, 2009, LANDSCAPE ECOL, V24, P101, DOI 10.1007/s10980-008-9283-y; Davies SP, 2006, ECOL APPL, V16, P1251, DOI 10.1890/1051-0761(2006)016[1251:TBCGAD]2.0.CO;2; DeWeber JT, 2014, J HYDROL, V517, P187, DOI 10.1016/j.jhydrol.2014.05.035; Deweber JT, 2014, FISHERIES, V39, P155, DOI 10.1080/03632415.2014.891503; Esselman Peter C., 2011, Ecological Restoration, V29, P133, DOI 10.3368/er.29.1-2.133; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; Frimpong EA, 2010, T AM FISH SOC, V139, P1872, DOI 10.1577/T09-142.1; FRISSELL CA, 1986, ENVIRON MANAGE, V10, P199, DOI 10.1007/BF01867358; Goldstein RM, 2004, T AM FISH SOC, V133, P971, DOI 10.1577/T03-080.1; Gordon ND, 2004, STREAM HYDROLOGY INT; Griffiths NA, 2014, ECOSYSTEMS, V17, P1169, DOI 10.1007/s10021-014-9785-1; Hall JE, 2007, J AM WATER RESOUR AS, V43, P786, DOI 10.1111/j.1752-1688.2007.00063.x; Harman W., 2012, 843K12006 EPA OFF WE; Heavens N.G., 2013, NAT ED KNOWL, V4, P4; Heiner M, 2011, FRESHWATER BIOL, V56, P89, DOI 10.1111/j.1365-2427.2010.02466.x; Hill RA, 2013, FRESHW SCI, V32, P39, DOI 10.1899/12-009.1; Hitt NP, 2011, J N AM BENTHOL SOC, V30, P296, DOI 10.1899/09-155.1; Horizon Systems Corporation, 2017, NAT HYDR DAT PLUS NH; Hortal J, 2005, BIODIVERS CONSERV, V14, P2913, DOI 10.1007/s10531-004-0224-z; HORTON RE, 1945, GEOL SOC AM BULL, V56, P275, DOI 10.1130/0016-7606(1945)56[275:edosat]2.0.co;2; HUPP CR, 1985, ECOLOGY, V66, P670, DOI 10.2307/1940528; Hynes H., 1975, INT VER THEOR ANGEW, V19, P1, DOI DOI 10.1080/03680770.1974.11896033; Ignatius AR, 2014, ISPRS INT GEO-INF, V3, P460, DOI 10.3390/ijgi3020460; Juracek KE, 2003, J AM WATER RESOUR AS, V39, P659, DOI 10.1111/j.1752-1688.2003.tb03683.x; Kidova A, 2016, GEOMORPHOLOGY, V272, P137, DOI 10.1016/j.geomorph.2016.01.002; Kiffney PM, 2006, CAN J FISH AQUAT SCI, V63, P2518, DOI 10.1139/F06-138; Lave R, 2009, J AM WATER RESOUR AS, V45, P1519, DOI 10.1111/j.1752-1688.2009.00385.x; Leasure DR, 2016, RIVER RES APPL, V32, P18, DOI 10.1002/rra.2838; Leathwick JR, 2011, FRESHWATER BIOL, V56, P21, DOI 10.1111/j.1365-2427.2010.02414.x; Legleiter CJ, 2014, GEOMORPHOLOGY, V205, P65, DOI 10.1016/j.geomorph.2012.01.016; Lehner B, 2011, FRONT ECOL ENVIRON, V9, P494, DOI 10.1890/100125; LEOPOLD LB, 1962, AM SCI, V50, P511; Liermann CAR, 2012, RIVER RES APPL, V28, P1340, DOI 10.1002/rra.1541; Lutz BD, 2012, ECOL MONOGR, V82, P367, DOI 10.1890/11-1129.1; Maheu A, 2016, RIVER RES APPL, V32, P896, DOI 10.1002/rra.2906; McManamay RA, 2012, RIVER RES APPL, V28, P1325, DOI 10.1002/rra.1535; Mcmanamay RA, 2015, ECOL APPL, V25, P243, DOI 10.1890/14-0247.1; McManamay RA, 2014, J HYDROL, V519, P1278, DOI 10.1016/j.jhydrol.2014.08.053; McManamay RA, 2014, ECOHYDROLOGY, V7, P903, DOI 10.1002/eco.1410; Melles SJ, 2012, FRESHWATER BIOL, V57, P415, DOI 10.1111/j.1365-2427.2011.02716.x; Merritt R.W., 1996, INTRO AQUATIC INSECT; Mitch ME, 1990, EPA600890055 ENV RES; Montgomery DR, 1999, J AM WATER RESOUR AS, V35, P397, DOI 10.1111/j.1752-1688.1999.tb03598.x; Mulholland PJ, 2004, BIOGEOCHEMISTRY, V70, P403, DOI 10.1007/s10533-004-0364-y; Mulholland PJ, 1997, J N AM BENTHOL SOC, V16, P61, DOI 10.2307/1468235; Nagel D.E., 2014, LANDSCAPE SCALE VALL; National Fish Habitat Partnership, 2016, FISHS EYE STAT FISH; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Olden JD, 2012, ECOHYDROLOGY, V5, P503, DOI 10.1002/eco.251; Olivero A. P., 2008, NE AQUATIC HABITAT C; Olivero Sheldon A, 2013, 07011101 SE AQ RES P; Olson JR, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011088; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; OSTROFF A, 2013, 2012 NATL ANTHROPOGE; Pearsall SH, 2005, ENVIRON MANAGE, V35, P353, DOI 10.1007/s00267-003-0255-3; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Poff NL, 1996, FRESHWATER BIOL, V36, P71, DOI 10.1046/j.1365-2427.1996.00073.x; POFF NL, 1990, ENVIRON MANAGE, V14, P629, DOI 10.1007/BF02394714; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; Poole GC, 2002, FRESHWATER BIOL, V47, P641, DOI 10.1046/j.1365-2427.2002.00922.x; Quinn J, 2000, RIPARIAN ECOLOGY MAN, P451; R Core Team, 2020, R LANG ENV STAT COMP; Rasmussen JJ, 2011, AQUAT ECOL, V45, P231, DOI 10.1007/s10452-010-9349-1; Rayburg SC, 2008, RIVER RES APPL, V24, P1343, DOI 10.1002/rra.1096; Ready J, 2010, ECOL MODEL, V221, P467, DOI 10.1016/j.ecolmodel.2009.10.025; Richter BD, 1996, CONSERV BIOL, V10, P1163, DOI 10.1046/j.1523-1739.1996.10041163.x; Roberts BJ, 2007, ECOSYSTEMS, V10, P588, DOI 10.1007/s10021-007-9059-2; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; ROSGEN DL, 1994, CATENA, V22, P169, DOI 10.1016/0341-8162(94)90001-9; Seelbach PW, 2006, AM FISH S S, V48, P25; SMITH K, 1975, OIKOS, V26, P228, DOI 10.2307/3543713; Snelder TH, 2002, J AM WATER RESOUR AS, V38, P1225, DOI 10.1111/j.1752-1688.2002.tb04344.x; Snelder TH, 2007, CONSERV BIOL, V21, P365, DOI 10.1111/j.1523-1739.2006.00632.x; SOKAL RR, 1974, SCIENCE, V185, P1115, DOI 10.1126/science.185.4157.1115; Sowa SP, 2007, ECOL MONOGR, V77, P301, DOI 10.1890/06-1253.1; STEINMAN AD, 1990, ENVIRON MANAGE, V14, P589, DOI 10.1007/BF02394711; Strahler A.N., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI [DOI 10.1029/TR038I006P00913, 10.1029/TR038i006p00913]; Sudduth EB, 2007, RESTOR ECOL, V15, P573, DOI 10.1111/j.1526-100X.2007.00252.x; The World Conservation Union, 1993, PARKS LIF 4 WORLD C; Thorp JH, 2006, RIVER RES APPL, V22, P123, DOI 10.1002/rra.901; Townsend PA, 2001, PLANT ECOL, V156, P43, DOI 10.1023/A:1011996822576; Troia MJ, 2016, ECOL EVOL; Trush WJ, 2000, P NATL ACAD SCI USA, V97, P11858, DOI 10.1073/pnas.97.22.11858; U.S. Environmental Protection Agency, 2016, NAT STREATM SURV DAT; U.S. Environmental Protection Agency, 2016, EPA841R16007 OFF WAT; US Geological Survey, 2016, HYDR UN MAP BAS DAT; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Vorosmarty CJ, 2000, J HYDROL, V237, P17, DOI 10.1016/S0022-1694(00)00282-1; Walter RC, 2008, SCIENCE, V319, P299, DOI 10.1126/science.1151716; Wehrly KE, 2003, T AM FISH SOC, V132, P18, DOI 10.1577/1548-8659(2003)132<0018:CRVITR>2.0.CO;2; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Wiens JA, 2002, FRESHWATER BIOL, V47, P501, DOI 10.1046/j.1365-2427.2002.00887.x; Wohl E, 2016, PROG PHYS GEOG, V40, P598, DOI 10.1177/0309133316658615; Wolock DM, 2004, ENVIRON MANAGE, V34, pS71, DOI 10.1007/s00267-003-5077-9; Xenopoulos MA, 2006, ECOLOGY, V87, P1907, DOI 10.1890/0012-9658(2006)87[1907:GWTFUS]2.0.CO;2	109	13	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0198439	10.1371/journal.pone.0198439	http://dx.doi.org/10.1371/journal.pone.0198439			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924829	Green Published, gold, Green Submitted			2022-12-26	WOS:000435655600022
J	Nygren, A; Parapar, J; Pons, J; Meissner, K; Bakken, T; Kongsrud, JA; Oug, E; Gaeva, D; Sikorski, A; Johansen, RA; Hutchings, PA; Lavesque, N; Capa, M				Nygren, Arne; Parapar, Julio; Pons, Joan; Meissner, Karin; Bakken, Torkild; Kongsrud, Jon Anders; Oug, Eivind; Gaeva, Daria; Sikorski, Andrey; Johansen, Robert Andre; Hutchings, Pat Ann; Lavesque, Nicolas; Capa, Maria			A mega-cryptic species complex hidden among one of the most common annelids in the North East Atlantic	PLOS ONE			English	Article							TEREBELLIDES POLYCHAETA; TRICHOBRANCHIDAE; MITOCHONDRIAL; PHYLOGENY; DIVERSITY; TAXONOMY; WATERS	We investigate mitochondrial (COI, 16S rDNA) and nuclear (ITS2, 28S rDNA) genetic structure of North East Atlantic lineages of Terebellides, a genus of sedentary annelids mainly inhabiting continental shelf and slope sediments. We demonstrate the presence of more than 25 species of which only seven are formally described. Species boundaries are determined with molecular data using a broad range of analytical methods. Many of the new species are common and wide spread, and the majority of the species are found in sympatry with several other species in the complex. Being one of the most regularly encountered annelid taxa in the North East Atlantic, it is more likely to find an undescribed species of Terebellides than a described one.	[Nygren, Arne] Sjofartmuseet Akvariet, Gothenburg, Sweden; [Nygren, Arne] Gothenburg Univ, Inst Marina Vetenskaper, Gothenburg, Sweden; [Parapar, Julio] Univ A Coruna, Fac Ciencias, Dept Biol, La Coruna, Spain; [Pons, Joan] IMEDEA, Mediterranean Inst Adv Studies, Dept Biodivers & Conservat, Balearic Isl, Spain; [Meissner, Karin] German Ctr Marine Biodivers Res, Senckenberg Forsch Inst, Hamburg, Germany; [Meissner, Karin] German Ctr Marine Biodivers Res, Nat Museun, Hamburg, Germany; [Bakken, Torkild; Capa, Maria] Norwegian Univ Sci & Technol, NTNU Univ Museum, Trondheim, Norway; [Kongsrud, Jon Anders] Univ Museum Bergen, Dept Nat Hist, Bergen, Norway; [Oug, Eivind] Norwegian Inst Water Res, Grimstad, Region South, Norway; [Gaeva, Daria] Russian Acad Sci, Shirshov Inst Oceanol, Moscow, Russia; [Sikorski, Andrey] Akvaplan Niva AS, Fram Ctr, Tromso, Norway; [Johansen, Robert Andre] Inst Marine Res, Tromso, Norway; [Hutchings, Pat Ann] Australian Museum, Res Inst, Sydney, NSW, Australia; [Lavesque, Nicolas] CNRS, Arcachon, France; [Lavesque, Nicolas] Univ Bordeaux, Environm & Paleoenvironm Ocean & Continentaux, Stn Marine Arcachon, Arcachon, France; [Capa, Maria] Univ Balearic Isl, Dept Biol, Ctra Valldemossa, Balearic Island, Spain	University of Gothenburg; Universidade da Coruna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Senckenberg Gesellschaft fur Naturforschung (SGN); Norwegian University of Science & Technology (NTNU); University of Bergen; Russian Academy of Sciences; Shirshov Institute of Oceanology; Akvaplan-niva; Institute of Marine Research - Norway; Australian Museum; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Universitat de les Illes Balears	Nygren, A (corresponding author), Sjofartmuseet Akvariet, Gothenburg, Sweden.; Nygren, A (corresponding author), Gothenburg Univ, Inst Marina Vetenskaper, Gothenburg, Sweden.; Capa, M (corresponding author), Norwegian Univ Sci & Technol, NTNU Univ Museum, Trondheim, Norway.; Capa, M (corresponding author), Univ Balearic Isl, Dept Biol, Ctra Valldemossa, Balearic Island, Spain.	maskmedmera@gmail.com; maria.capa@ntnu.co	Pons, Joan/A-5124-2008; Bakken, Torkild/E-5883-2011; Lavesque, Nicolas/AAB-1623-2021; Balears, Universitat de les Illes/K-5821-2015	Pons, Joan/0000-0002-4683-8840; Bakken, Torkild/0000-0002-5188-7305; Balears, Universitat de les Illes/0000-0002-5063-7961; Nygren, Arne/0000-0001-5761-8803	Norwegian Taxonomy Initiative; Swedish Taxonomy Initiative; Kungliga Fysiografiska sallskapet Nilsson-Ehle donationerna; ForBio Research School - Research Council of Norway [248799]; Norwegian Taxonomy Initiative [70184215]; Ramon y Cajal program - Spanish Ministerio de Economia, Industria y Competitividad, Agencia Estatal de Investigacion, Comunidad Autonoma de las Islas Baleares [RYC-2016-20799]; European Social Fund; Akvaplan Niva; NTNU's	Norwegian Taxonomy Initiative; Swedish Taxonomy Initiative; Kungliga Fysiografiska sallskapet Nilsson-Ehle donationerna; ForBio Research School - Research Council of Norway; Norwegian Taxonomy Initiative; Ramon y Cajal program - Spanish Ministerio de Economia, Industria y Competitividad, Agencia Estatal de Investigacion, Comunidad Autonoma de las Islas Baleares; European Social Fund(European Social Fund (ESF)); Akvaplan Niva(Akvaplan-niva); NTNU's	Financial support was provided by the Norwegian Taxonomy Initiative [http://www.biodiversity.no/Pages/135523] to AN (Cryptic polychaete species in Norwegian waters, knr 49-13, pnr 70184228), to EO, TB and JAK (Polychaetes in Skagerrak, knr 53-09, pnr 70184216), to TB, EO and JAK (Polychaetes in the Norwegian Sea, knr 55-12, pnr 70184227); and by the Swedish Taxonomy Initiative [https://www.artdatabanken.se/en/the-swedish-taxonomy-initiative/] (Polychaete species complexes in Swedish waters, dnr 140/07 1.4 and 166/08 1.4), and Kungliga Fysiografiska sallskapet Nilsson-Ehle donationerna [https://www.fysiografen.se/sv/] to AN; and by the ForBio Research School funded by the Research Council of Norway [https://www.forskningsradet.no/en/Home_page/1177315753906] (project no. 248799) and the Norwegian Taxonomy Initiative (pnr 70184215) and the Ramon y Cajal program (RYC-2016-20799) funded by Spanish Ministerio de Economia, Industria y Competitividad, Agencia Estatal de Investigacion, Comunidad Autonoma de las Islas Baleares and the European Social Fund to MC; and by Akvaplan Niva [http://www.akvaplan.niva.no/en/] to AS and JP. Publication fees were covered by NTNU's [https://www.ntnu.no/] Publishing Fund to MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen BG, 1997, ICE AGE WORLD INTRO; [Anonymous], 2006, 2 MINUTE GRIDDED GLO; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bely AE, 2004, MOL PHYLOGENET EVOL, V30, P50, DOI 10.1016/S1055-7903(03)00180-5; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blindheim J., 2004, NORWEGIAN SEA ECOSYS, P65; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Brasier MJ, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160432; Bremec CS, 1999, OPHELIA, V51, P177, DOI 10.1080/00785326.1999.10409407; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CURTIS M A, 1977, Ophelia, V16, P9; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; DUCHENE JC, 1977, CR ACAD SCI D NAT, V284, P2543; Ezard T, 2009, PACKAGE SPLITS SPECI; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Grassle J., 1980, Aquatic Oligochaete Biology, V1, P25; GRASSLE JP, 1976, SCIENCE, V192, P567, DOI 10.1126/science.1257794; Holthe T., 1986, MARINE INVERTEBRATES, V7, P1, DOI [10.1017/s0025315400026783, DOI 10.1017/S0025315400026783]; Hutchings P, 2000, INVERTEBR TAXON, V14, P225, DOI 10.1071/IT98005; Hutchings PA, 2017, HDB ZOOLOGY ONLINE; Hutchings PA, 2017, INVERT SYST; Imajima M., 1985, Bulletin of the National Science Museum Series A (Zoology), V11, P7; Ingvaldsen R, 2009, PHYS OCEANOGRAPHY EC; Jirkov I.A., 2013, Zoologiya Bespozvonochnykh, V10, P217; Jones G, 2017, J MATH BIOL, V74, P447, DOI 10.1007/s00285-016-1034-0; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; LECOINTRE G, 1993, MOL PHYLOGENET EVOL, V2, P205, DOI 10.1006/mpev.1993.1021; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Maddison WP, 2008, MESQUITE MODULAR SYS, DOI [10.1080/10635150600852011, DOI 10.1080/10635150600852011]; Meissner K, 2014, ZOOTAXA, V3786, P201, DOI 10.11646/zootaxa.3786.3.1; Nygren A, 2014, ZOOL SCR, V43, P172, DOI 10.1111/zsc.12044; Nygren A, 2011, MOL PHYLOGENET EVOL, V58, P132, DOI 10.1016/j.ympev.2010.10.010; Nygren A, 2009, MAR BIOL RES, V5, P315, DOI 10.1080/17451000802441301; OSPAR, 2010, QUAL STAT REP 2010; Oug Eivind, 2014, Memoirs of Museum Victoria, V71, P217; Palumbi Stephen R., 1996, P205; Parapar J, 2016, MAR BIODIVERS, V46, P211, DOI 10.1007/s12526-015-0353-5; Parapar J, 2015, J MAR BIOL ASSOC UK, V95, P323, DOI 10.1017/S0025315414000903; Parapar J, 2016, PEERJ, V4, DOI 10.7717/peerj.2313; Parapar J, 2011, ZOOTAXA, P1; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; ROUSE G.W., 2001, POLYCHAETES; Schuller M, 2012, ZOOTAXA, P1; Schuller M, 2013, ZOOTAXA, V3619, P1, DOI 10.11646/zootaxa.3619.1.1; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Sjolin E, 2005, MOL PHYLOGENET EVOL, V35, P431, DOI 10.1016/j.ympev.2004.12.018; SOLISWEISS V, 1991, P BIOL SOC WASH, V104, P147; Stocsits RR, 2009, NUCLEIC ACIDS RES, V37, P6184, DOI 10.1093/nar/gkp600; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Willemoes-Suhm R., 1871, Z WISSENSCHAFTLICHE, V21, P380; Williams S.J., 1984, P118; Yashayaev I, 2015, PROG OCEANOGR, V132, P1, DOI 10.1016/j.pocean.2014.12.012	60	51	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							0198356	10.1371/journal.pone.0198356	http://dx.doi.org/10.1371/journal.pone.0198356			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924805	gold, Green Published, Green Submitted			2022-12-26	WOS:000435655600018
J	Pane, M; Coratti, G; Brogna, C; Mazzone, ES; Mayhew, A; Fanelli, L; Messina, S; D'Amico, A; Catteruccia, M; Scutifero, M; Frosini, S; Lanzillotta, V; Colia, G; Cavallaro, F; Rolle, E; De Sanctis, R; Forcina, N; Petillo, R; Barp, A; Gardani, A; Pini, A; Monaco, G; D'Angelo, MG; Zanin, R; Vita, GL; Bruno, C; Mongini, T; Ricci, F; Pegoraro, E; Bello, L; Berardinelli, A; Battini, R; Sansone, V; Albamonte, E; Baranello, G; Bertini, E; Politano, L; Sormani, MP; Mercuri, E				Pane, Marika; Coratti, Giorgia; Brogna, Claudia; Mazzone, Elena Stacy; Mayhew, Anna; Fanelli, Lavinia; Messina, Sonia; D'Amico, Adele; Catteruccia, Michela; Scutifero, Marianna; Frosini, Silvia; Lanzillotta, Valentina; Colia, Giulia; Cavallaro, Filippo; Rolle, Enrica; De Sanctis, Roberto; Forcina, Nicola; Petillo, Roberta; Barp, Andrea; Gardani, Alice; Pini, Antonella; Monaco, Giulia; D'Angelo, Maria Grazia; Zanin, Riccardo; Vita, Gian Luca; Bruno, Claudio; Mongini, Tiziana; Ricci, Federica; Pegoraro, Elena; Bello, Luca; Berardinelli, Angela; Battini, Roberta; Sansone, Valeria; Albamonte, Emilio; Baranello, Giovanni; Bertini, Enrico; Politano, Luisa; Sormani, Maria Pia; Mercuri, Eugenio			Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data	PLOS ONE			English	Article							PERFORMANCE	The aim of the study was to establish 24 month changes in upper limb function using a revised version of the performance of upper limb test (PUL 2.0) in a large cohort of ambulant and non-ambulant boys with Duchenne muscular dystrophy and to identify possible trajectories of progression. Of the 187 patients studied, 87 were ambulant (age range: 7-15.8 years), and 90 non-ambulant (age range: 9.08-24.78). The total scores changed significantly over time (p<0.001). Non-ambulant patients had lower total scores at baseline (mean 19.7) when compared to the ambulant ones (mean 38.4). They also had also a bigger decrease in total scores over 24 months compared to the ambulant boys (4.36 vs 2.07 points). Multivariate model analysis showed that the Performance of Upper Limb changes reflected the entry level and ambulation status, that were independently associated to the slope of Performance of Upper Limb changes. This information will be of help both in clinical practice and at the time of designing clinical trials.	[Pane, Marika; Coratti, Giorgia; Brogna, Claudia; Mazzone, Elena Stacy; Fanelli, Lavinia; De Sanctis, Roberto; Forcina, Nicola; Mercuri, Eugenio] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Pediat Neurol & Nemo Clin Ctr, Rome, Italy; [Mayhew, Anna] Int Ctr Life, Inst Genet Med, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Messina, Sonia; Cavallaro, Filippo; Vita, Gian Luca] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Messina, Sonia; Cavallaro, Filippo; Vita, Gian Luca] Univ Messina, Nemo Sud Clin Ctr, Messina, Italy; [D'Amico, Adele; Catteruccia, Michela; Colia, Giulia; Bertini, Enrico] Bambino Gesu Pediat Hosp, Dept Neurosci, Unit Neuromuscular & Neurodegenerat Disorders, Rome, Italy; [Scutifero, Marianna; Petillo, Roberta; Politano, Luisa] Univ Naples 2, Dept Expt Med, Cardiomiol & Med Genet, Naples, Italy; [Frosini, Silvia; Battini, Roberta] IRCCS Stella Maris, Dept Dev Neurosci, Pisa, Italy; [Lanzillotta, Valentina; Bruno, Claudio] Ist Giannina Gaslini, Ctr Myol & Neurodegenerat Disorders, Genoa, Italy; [Lanzillotta, Valentina; Bruno, Claudio] Ist Giannina Gaslini, Phys & Rehabil Med Unit, Genoa, Italy; [Rolle, Enrica; Mongini, Tiziana; Ricci, Federica] Univ Turin, AOU Citta Salute & Sci, Neuromuscular Ctr, Turin, Italy; [Barp, Andrea; Pegoraro, Elena; Bello, Luca] Univ Padua, Dept Neurosci, Padua, Italy; [Gardani, Alice; Berardinelli, Angela] IRCCS, Natl Neurol Inst Casimiro Mondino Fdn, Child & Adolescence Neurol Unit, Pavia, Italy; [Pini, Antonella; Monaco, Giulia] Bellaria Hosp, IRCCS, Inst Neurol Sci, Child Neurol & Psychiat Unit, Bologna, Italy; [D'Angelo, Maria Grazia] IRCCS Eugenio Medea, NeuroMuscular Unit, Bosisio Parini, Italy; [Zanin, Riccardo; Baranello, Giovanni] Neurol Inst Carlo Besta, Dev Neurol, Milan, Italy; [Sansone, Valeria; Albamonte, Emilio] Ctr Clin Nemo, Milan, Italy; [Sormani, Maria Pia] Univ Genoa, Dept Hlth Sci, Biostat Unit, Genoa, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Messina; University of Messina; IRCCS Bambino Gesu; Universita della Campania Vanvitelli; IRCCS Fondazione Stella Maris; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; University of Padua; University of Pavia; AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); IRCCS Eugenio Medea; IRCCS Istituto Neurologico Besta; University of Genoa	Mercuri, E (corresponding author), Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Pediat Neurol & Nemo Clin Ctr, Rome, Italy.	eugeniomaria.mercuri@unicatt.it	Coratti, Giorgia/AAV-3224-2021; Bruno, Claudio/A-3148-2015; Sormani, Maria Pia/ABH-8756-2020; Mazzone, Elena/AAF-4444-2020; pini, antonella/AAB-9171-2020; Berardinelli, angela/AAA-9496-2019; Bertini, Enrico/ABG-1278-2020; battini, roberta/P-9095-2017; Catteruccia, Michela/AAB-5714-2020; POLITANO, LUISA/AAK-6885-2020; Ricci, Federica/AAY-9172-2021; Zanin, Riccardo/AAM-6341-2021; Vita, Gianluca/AAR-4587-2020; Coratti, Giorgia/Y-6292-2019; Mercuri, Eugenio/G-1351-2015; D'Angelo, Maria Grazia/K-4685-2016; BROGNA, Claudia/K-9759-2016; Bertini, Enrico/A-2284-2014	Coratti, Giorgia/0000-0001-6666-5628; Bruno, Claudio/0000-0002-3426-2901; pini, antonella/0000-0003-3603-5478; battini, roberta/0000-0002-7889-1355; Zanin, Riccardo/0000-0002-6200-3632; Vita, Gianluca/0000-0003-4190-8042; Coratti, Giorgia/0000-0001-6666-5628; Mercuri, Eugenio/0000-0002-9851-5365; berardinelli, angela/0000-0002-4645-8055; SORMANI, MARIA PIA/0000-0001-6892-104X; D'Angelo, Maria Grazia/0000-0003-1241-4350; Frosini, Silvia/0000-0001-6169-4382; Bello, Luca/0000-0002-3075-6525; Pane, Marika/0000-0002-4851-6124; BROGNA, Claudia/0000-0002-9526-6367; Ricci, Federica/0000-0003-2019-612X; ALBAMONTE, EMILIO/0000-0002-8465-4460; COLIA, GIULIA/0000-0002-4261-5877; Bertini, Enrico/0000-0001-9276-4590	Telethon grant [GUP 1002]	Telethon grant(Fondazione Telethon)	The study was supported by a Telethon grant (GUP 1002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mayhew A, 2013, DEV MED CHILD NEUROL, V55, P1038, DOI 10.1111/dmcn.12213; Mazzone ES, 2012, DEV MED CHILD NEUROL, V54, P879, DOI 10.1111/j.1469-8749.2012.04345.x; Mercuri E, 2012, INT WORKSH ASS UPP L; Pane Marika, 2014, PLoS Curr, V6, DOI 10.1371/currents.md.a93d9904d57dcb08936f2ea89bca6fe6; Pane M, 2015, NEUROMUSCULAR DISORD, V25, P749, DOI 10.1016/j.nmd.2015.07.009; Pane M, 2014, NEUROMUSCULAR DISORD, V24, P201, DOI 10.1016/j.nmd.2013.11.014	6	30	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199223	10.1371/journal.pone.0199223	http://dx.doi.org/10.1371/journal.pone.0199223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924848	Green Published, gold, Green Submitted			2022-12-26	WOS:000435655600055
J	Zeng, J; He, YJ; Jie, T; Zhang, RY; Su, TC; Sun, JL; Gao, HY; Li, GL; Cao, M; Song, MD				Zeng, Jie; He, Yajie; Jie, Tian; Zhang, Ruiyao; Su, Tongchao; Sun, Junliang; Gao, Haiyan; Li, Guanglei; Cao, Meng; Song, Mengdi			Chemoenzymatic synthesis of sialylated lactuloses and their inhibitory effects on Staphylococcus aureus	PLOS ONE			English	Article							MILK OLIGOSACCHARIDES INHIBIT; MULTIENZYME OPME SYNTHESIS; ESCHERICHIA-COLI; ENZYMATIC PRODUCTION; SIALIC-ACID; BINDING; CELLS; SIALOSIDES; RESISTANCE; SUBSTRATE	Background Sialylated glycoconjugates play important roles in physiological and pathological processes. However, available sialylated oligosaccharides source is limited which is a barrier to study their biological roles. This work reports an efficient approach to produce sialic acid-modified lactuloses and investigates their inhibitory effects on Staphylococcus aureus (S. aureus). Methods A one-pot two-enzyme (OPTE) sialylation system was used to efficiently synthesize sialylated lactuloses. Silica gel flash chromatography column was employed to purify the sialylated products. The purity and identity of the product structures were confirmed with mass spectrometry (MS) and nuclear magnetic resonance (NMR). The inhibitory effect of sialylated lactuloses against S. aureus was evaluated by using microplate assay, fluorescence microscopy, DAPI (4', 6-diamidino-2-phenylindole) fluorescence staining and protein leakage quantification. Results Neu5Ac-containing sialylated lactuloses with either alpha 2,3-or alpha 2,6-linkages were efficiently synthesized via an efficient OPTE sialylation system using alpha-2,3-sialyltransferase or alpha-2,6sialyltransferase, respectively. Neu5Ac-alpha 2,3-lactulose and Neu5Ac-alpha 2,6-lactulose significantly inhibited the growth of S. aureus. Fluorescence microscopy and DAPI fluorescence staining indicated that the sialylated lactuloses might disrupt nucleic acid synthesis of S. aureus. Conclusions Neu5Ac-containing sialylated lactuloses had higher antibacterial activity against S. aureus than non-sialylated lactulose. The inhibitory effect of Neu5Ac-alpha 2,3-lactulose was superior to that of Neu5Ac-alpha 2,6-lactulose. The sialylated lactuloses might inhibit S. aureus by causing cell membrane leakage and disrupting nucleic acid synthesis.	[Zeng, Jie; He, Yajie; Jie, Tian; Zhang, Ruiyao; Su, Tongchao; Sun, Junliang; Gao, Haiyan; Li, Guanglei; Cao, Meng; Song, Mengdi] Henan Inst Sci & Technol, Sch Food Sci, Xinxiang, Peoples R China	Henan Institute of Science & Technology	Zeng, J (corresponding author), Henan Inst Sci & Technol, Sch Food Sci, Xinxiang, Peoples R China.	zengjie623@163.com			Program for Innovative Research Talents (in Science and Technology) of University of Henan Province [16HASTIT015]; Excellent Youth Foundation of He'nan Scientific Committee [2017JQ0003]; Science and Technology Projects in Henan Province [162102210105, 162102110065]; Program for Innovative Research Team (in Science and Technology) of University of Henan Province [161RTSTHN007]	Program for Innovative Research Talents (in Science and Technology) of University of Henan Province; Excellent Youth Foundation of He'nan Scientific Committee; Science and Technology Projects in Henan Province; Program for Innovative Research Team (in Science and Technology) of University of Henan Province	This work is financially supported by Program for Innovative Research Talents (in Science and Technology) of University of Henan Province (16HASTIT015), Excellent Youth Foundation of He'nan Scientific Committee (2017JQ0003), Science and Technology Projects in Henan Province (162102210105 and 162102110065) and Program for Innovative Research Team (in Science and Technology) of University of Henan Province (161RTSTHN007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Boehm G, 2007, J NUTR, V137, p847S, DOI 10.1093/jn/137.3.847S; Chen CC, 2015, CHEM COMMUN, V51, P7689, DOI 10.1039/c5cc01330e; Coppa GV, 2006, PEDIATR RES, V59, P377, DOI 10.1203/01.pdr.0000200805.45593.17; CRANE JK, 1994, J NUTR, V124, P2358, DOI 10.1093/jn/124.12.2358; Gardete S, 2014, J CLIN INVEST, V124, P2836, DOI 10.1172/JCI68834; Gopal Pramod K., 2000, British Journal of Nutrition, V84, pS69; Hakkarainen J, 2005, J NUTR, V135, P2445, DOI 10.1093/jn/135.10.2445; He YP, 2016, J NANOBIOTECHNOL, V14, DOI 10.1186/s12951-016-0202-0; Kim YS, 2012, BIORESOURCE TECHNOL, V104, P668, DOI 10.1016/j.biortech.2011.11.016; Lee YJ, 2004, APPL MICROBIOL BIOT, V64, P787, DOI 10.1007/s00253-003-1506-1; Martin MJ, 2002, GLYCOCONJUGATE J, V19, P5, DOI 10.1023/A:1022572628891; Mayer J, 2004, J AGR FOOD CHEM, V52, P6983, DOI 10.1021/jf048912y; Morrow AL, 2004, J PEDIATR-US, V145, P297, DOI 10.1016/j.jpeds.2004.04.054; Olano A, 2009, J SCI FOOD AGR, V89, P1987, DOI 10.1002/jsfa.3694; Plata K, 2009, ACTA BIOCHIM POL, V56, P597; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Saei H. D., 2012, Comparative Clinical Pathology, V21, P301, DOI 10.1007/s00580-010-1096-0; Saito T, 2002, J GASTROENTEROL, V37, P68, DOI 10.1007/s535-002-8136-7; Sasidharan S., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P130, DOI 10.1016/S2221-1691(11)60010-5; Simon PM, 1997, INFECT IMMUN, V65, P750, DOI 10.1128/IAI.65.2.750-757.1997; Tang L, 2011, J IND MICROBIOL BIOT, V38, P471, DOI 10.1007/s10295-010-0897-0; Wang H, 2013, APPL MICROBIOL BIOT, V97, P6167, DOI 10.1007/s00253-013-4998-3; Yu H, 2006, ANGEW CHEM INT EDIT, V45, P3938, DOI 10.1002/anie.200600572; Yu H, 2016, ORG BIOMOL CHEM, V14, P8586, DOI 10.1039/c6ob01706a; Zeng J, 2017, TROP J PHARM RES, V16, P1655, DOI 10.4314/tjpr.v16i7.26	26	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199334	10.1371/journal.pone.0199334	http://dx.doi.org/10.1371/journal.pone.0199334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924858	gold, Green Submitted, Green Published			2022-12-26	WOS:000435655600064
J	Shibuya, K; Onodera, S; Hori, M				Shibuya, Kazuki; Onodera, Shun; Hori, Masatoshi			Toxic wavelength of blue light changes as insects grow	PLOS ONE			English	Article							IRRADIATION; ULTRAVIOLET; RESPONSES; AGE	Short-wavelength visible light (blue light: 400-500 nm) has lethal effects on various insects, such as fruit flies, mosquitoes, and flour beetles. However, the most toxic wavelengths of blue light might differ across developmental stages. Here, we investigate how the toxicity of blue light changes with the developmental stages of an insect by irradiating Drosophila melanogaster with different wavelengths of blue light. Specifically, the lethal effect on eggs increased at shorter light wavelengths (i.e.,toward 405 nm). In contrast, wavelengths from 405 to 466 nm had similar lethal effects on larvae. A wavelength of 466 nm had the strongest lethal effect on pupae; however, mortality declined as pupae grew. A wavelength of 417 nm was the most harmful to adults at low photon flux density, while 466 nm was the most harmful to adults at high photon flux density. These findings suggest that, as the morphology of D. melanogaster changes with growth, the most harmful wavelength also changes. In addition, our results indicated that reactive oxygen species influence the lethal effect of blue light. Our findings show that blue light irradiation could be used as an effective pest control method by adjusting the wavelength to target specific developmental stages.	[Shibuya, Kazuki; Onodera, Shun; Hori, Masatoshi] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi, Japan; [Shibuya, Kazuki] Natl Agr & Food Res Org, Cent Reg Agr Res Ctr, Joetsu, Niigata, Japan	Tohoku University; National Agriculture & Food Research Organization - Japan	Hori, M (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi, Japan.	hori@tohoku.ac.jp	Hori, Masatoshi/T-2688-2019	Hori, Masatoshi/0000-0002-4813-1443	Cabinet Office, Government of Japan; Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO); JSPS KAKENHI [25660261]; Japan Society for the Promotion of Science (JSPS) through the JSPS Core-to-Core Program (Advanced Research Networks), titled "Establishment of international agricultural immunology research-core fora quantum improvement in food safety"	Cabinet Office, Government of Japan; Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science (JSPS) through the JSPS Core-to-Core Program (Advanced Research Networks), titled "Establishment of international agricultural immunology research-core fora quantum improvement in food safety"	This work was supported by Cabinet Office, Government of Japan, Cross-ministerial Strategic Innovation Promotion Program (SIP), "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO) to Masatoshi Hori, a JSPS KAKENHI Grant Number 25660261 to Masatoshi Hori, and the Japan Society for the Promotion of Science (JSPS) through the JSPS Core-to-Core Program (Advanced Research Networks), titled "Establishment of international agricultural immunology research-core fora quantum improvement in food safety". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBOGAST RT, 1973, J STORED PROD RES, V9, P31, DOI 10.1016/0022-474X(73)90036-2; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Bickford ED, 1964, IES NAT TECH C, P2; COHEN SH, 1973, J ECON ENTOMOL, V66, P859, DOI 10.1093/jee/66.4.859; Cowan T, 2009, ENTOMOL EXP APPL, V131, P148, DOI 10.1111/j.1570-7458.2009.00838.x; Ghanem I, 2007, J STORED PROD RES, V43, P362, DOI 10.1016/j.jspr.2006.09.002; GINGRICH JB, 1975, CAN J ZOOL, V53, P154, DOI 10.1139/z75-018; GOODMAN LJ, 1965, J EXP BIOL, V42, P385; HARADA T, 1991, J INSECT PHYSIOL, V37, P27, DOI 10.1016/0022-1910(91)90015-R; Hori M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03017-z; Hori M, 2014, SCI REP-UK, V4, DOI 10.1038/srep07383; Kuse Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05223; LUBART R, 1992, J PHOTOCH PHOTOBIO B, V12, P305, DOI 10.1016/1011-1344(92)85032-P; Matsumura Massaya, 2001, Journal of Asia-Pacific Entomology, V4, P195, DOI 10.1016/S1226-8615(08)60123-5; MEYERROC.VB, 1974, J INSECT PHYSIOL, V20, P573, DOI 10.1016/0022-1910(74)90164-4; Mishiro Koji, 2009, Bulletin of the National Institute of Fruit Tree Science, V9, P23; NOMURA K, 1965, Japanese Journal of Applied Entomology and Zoology, V9, P179, DOI 10.1303/jjaez.9.179; NOMURA K., 1966, Technical Bulletin. Faculty of Horticulture, Chiba University, P27; Okamoto K., 1989, Japanese Journal of Sanitary Zoology, V40, P259; Okamoto Kiku, 1992, Japanese Journal of Sanitary Zoology, V43, P235; Shimoda M, 2013, APPL ENTOMOL ZOOL, V48, P413, DOI 10.1007/s13355-013-0219-x; Simmons AM, 2010, CROP PROT, V29, P898, DOI 10.1016/j.cropro.2010.04.003; Sprecher SG, 2008, NATURE, V454, P533, DOI 10.1038/nature07062; Suzuki M, 2012, J CELL SCI, V125, P2407, DOI 10.1242/jcs.097683; Suzuki T, 2014, J INSECT PHYSIOL, V62, P1, DOI 10.1016/j.jinsphys.2014.01.005; Tariq K, 2017, B ENTOMOL RES, P1; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Yang EC, 2003, PHYSIOL ENTOMOL, V28, P362, DOI 10.1111/j.1365-3032.2003.00351.x	28	19	21	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199266	10.1371/journal.pone.0199266	http://dx.doi.org/10.1371/journal.pone.0199266			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920536	Green Published, gold, Green Submitted			2022-12-26	WOS:000435541300031
J	Banfi, C; Kemeny, F; Gang, M; Schulte-Korne, G; Mo, K; Landerl, K				Banfi, Chiara; Kemeny, Ferenc; Gang, Melanie; Schulte-Koerne, Gerd; Mo, Kristina; Landerl, Karin			Visual attention span performance in German-speaking children with differential reading and spelling profiles: No evidence of group differences	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; EUROPEAN ORTHOGRAPHIES; SPATIAL ATTENTION; DEFICITS; SYMBOLS; IDENTIFICATION; RECOGNITION; PERCEPTION; DIGITS; RAN	An impairment in the visual attention span (VAS) has been suggested to hamper reading performance of individuals with dyslexia. It is not clear, however, if the very nature of the deficit is visual or verbal and, importantly, if it affects spelling skills as well. The current study investigated VAS by means of forced choice tasks with letters and symbols in a sample of third and fourth graders with age-adequate reading and spelling skills (n = 43), a typical dyslexia profile with combined reading and spelling deficits (n = 26) and isolated spelling deficits (n = 32). The task was devised to contain low phonological short-term memory load and to overcome the limitations of oral reports. Notably, eye-movements were monitored to control that children fixated the center of the display when stimuli were presented. Results yielded no main effect of group as well as no group-related interactions, thus showing that children with dyslexia and isolated spelling deficits did not manifest a VAS deficit for letters or symbols once certain methodological aspects were controlled for. The present results could not replicate previous evidence for the involvement of VAS in reading and dyslexia.	[Banfi, Chiara; Kemeny, Ferenc; Gang, Melanie; Landerl, Karin] Karl Franzens Univ Graz, Inst Psychol, Graz, Austria; [Schulte-Koerne, Gerd; Mo, Kristina] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany; [Landerl, Karin] BioTechMed Graz, Graz, Austria	University of Graz; University of Munich	Banfi, C (corresponding author), Karl Franzens Univ Graz, Inst Psychol, Graz, Austria.	chiara.banfi@uni-graz.at	Schulte-Körne, Gerd/AAI-4828-2021; Kemény, Ferenc/L-8685-2015	Schulte-Körne, Gerd/0000-0002-9960-1572; Kemény, Ferenc/0000-0003-2961-3014; Landerl, Karin/0000-0003-4074-0233	German Research Foundation (DFG) [MO 2569/2-1]; Austrian Science Fund (FWF) [I 1658-G22]; Austrian Science Fund; German Research Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund(Austrian Science Fund (FWF)); German Research Foundation(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation (DFG, grant no. MO 2569/2-1) and the Austrian Science Fund (FWF, grant no. I 1658-G22). CB, MG, KL were funded by the Austrian Science Fund, KM and GS were funded by the German Research Foundation.	Ans B, 1998, PSYCHOL REV, V105, P678, DOI 10.1037/0033-295X.105.4.678-723; Aschenbrenner AJ, 2017, J EXP PSYCHOL HUMAN, V43, P700, DOI 10.1037/xhp0000342; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; Bosse ML, 2009, J RES READ, V32, P230, DOI 10.1111/j.1467-9817.2008.01387.x; Collis NL, 2013, Q J EXP PSYCHOL, V66, P245, DOI 10.1080/17470218.2012.705305; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Doepfner M., 2008, DIAGNOSTIK SYSTEM PS; Dubois M, 2010, CORTEX, V46, P717, DOI 10.1016/j.cortex.2009.11.002; Galuschka K, 2016, DTSCH ARZTEBL INT, V113, P279, DOI 10.3238/arztebl.2016.0279; Grainger J, 2010, J EXP PSYCHOL HUMAN, V36, P673, DOI 10.1037/a0016888; Grund M., 2004, DRT 4 DIAGNOSTISCHER; Hawelka S, 2008, VISION RES, V48, P850, DOI 10.1016/j.visres.2007.11.003; Jones MW, 2008, DYSLEXIA, V14, P95, DOI 10.1002/dys.345; Landerl K, 2013, J CHILD PSYCHOL PSYC, V54, P686, DOI 10.1111/jcpp.12029; Lobier M, 2012, CORTEX, V48, P768, DOI 10.1016/j.cortex.2011.09.003; Macmillan N. A., 2002, STEVENS HDB EXPT PSY, V4, P43, DOI DOI 10.1002/0471214426.PAS0402; Majerus S, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01522; Martelli M, 2009, J VISION, V9, DOI 10.1167/9.4.14; Mayringer, 2014, SALZBURGER LESE SCRE; Moll K., 2010, SLRT 2 LESE RECHTSCH; Moll K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103537; Moll K, 2014, LEARN INSTR, V29, P65, DOI 10.1016/j.learninstruc.2013.09.003; Moll K, 2009, SCI STUD READ, V13, P359, DOI 10.1080/10888430903162878; Moll K, 2009, SCI STUD READ, V13, P1, DOI 10.1080/10888430802631684; Muller R., 2004, DRT 3 DIAGNOSTISCHER; Pammer K, 2004, BRAIN LANG, V89, P601, DOI 10.1016/j.bandl.2004.01.009; Petermann FP., 2011, MANUAL 1 GRUNDLAGEN, VFourth; Scaltritti M, 2013, ACTA PSYCHOL, V144, P397, DOI 10.1016/j.actpsy.2013.07.018; Schubert T, 2017, J EXP CHILD PSYCHOL, V162, P163, DOI 10.1016/j.jecp.2017.05.008; SHARE DL, 1995, COGNITION, V55, P151, DOI 10.1016/0010-0277(94)00645-2; Shovman MM, 2006, VISION RES, V46, P3514, DOI 10.1016/j.visres.2006.05.011; Spinelli D, 2002, CORTEX, V38, P179, DOI 10.1016/S0010-9452(08)70649-X; Tydgat I, 2009, J EXP PSYCHOL HUMAN, V35, P480, DOI 10.1037/a0013027; Valdois S, 2004, DYSLEXIA, V10, P339, DOI 10.1002/dys.284; van den Boer M, 2013, SCI STUD READ, V17, P243, DOI 10.1080/10888438.2012.683222; Van den bos K.P., 2002, SCI STUD READ, V6, P25, DOI [10.1207/S1532799XSSR0601_02, DOI 10.1207/S1532799XSSR0601_02]; Wei&beta; R.H., 2006, CFT 20 R GRUNDINTELL; Whitney D, 2011, TRENDS COGN SCI, V15, P160, DOI 10.1016/j.tics.2011.02.005; Wimmer H, 2002, J EDUC PSYCHOL, V94, P272, DOI 10.1037//0022-0663.94.2.272; Yeari M, 2017, ANN DYSLEXIA, V67, P128, DOI 10.1007/s11881-016-0132-4; Ziegler JC, 2010, DEVELOPMENTAL SCI, V13, pF8, DOI 10.1111/j.1467-7687.2010.00983.x; Zorzi M, 2012, P NATL ACAD SCI USA, V109, P11455, DOI 10.1073/pnas.1205566109; Zoubrinetzky R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099337	44	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198903	10.1371/journal.pone.0198903	http://dx.doi.org/10.1371/journal.pone.0198903			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ6XV	29912915	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600060
J	Dompe, N; Klijn, C; Watson, SA; Leng, K; Port, J; Cuellar, T; Watanabe, C; Haley, B; Neve, R; Evangelista, M; Stokoe, D				Dompe, Nicholas; Klijn, Christiaan; Watson, Sara A.; Leng, Katherine; Port, Jenna; Cuellar, Trinna; Watanabe, Colin; Haley, Benjamin; Neve, Richard; Evangelista, Marie; Stokoe, David			A CRISPR screen identifies MAPK7 as a target for combination with MEK inhibition in KRAS mutant NSCLC	PLOS ONE			English	Article							CELL LUNG-CANCER; TRAMETINIB GSK1120212; IN-VIVO; ERK5; PATHWAY; PROLIFERATION; RESISTANCE; RAF; RNA; TUMORS	Mutant KRAS represents one of the most frequently observed oncogenes in NSCLC, yet no therapies are approved for tumors that express activated KRAS variants. While there is strong rationale for the use of MEK inhibitors to treat tumors with activated RAS/MAPK signaling, these have proven ineffective clinically. We therefore implemented a CRISPR screening approach to identify novel agents to sensitize KRAS mutant NSCLC cells to MEK inhibitor treatment. This approach identified multiple components of the canonical RAS/MAPK pathway consistent with previous studies. In addition, we identified MAPK7 as a novel, strong hit and validated this finding using multiple orthogonal approaches including knockdown and pharmacological inhibition. We show that MAPK7 inhibition attenuates the re-activation of MAPK signaling occurring following long-term MEK inhibition, thereby illustrating that MAPK7 mediates pathway reactivation in the face of MEK inhibition. Finally, genetic knockdown of MAPK7 combined with the MEK inhibitor cobimetinib in a mutant KRAS NSCLC xenograft model to mediate improved tumor growth inhibition. These data highlight that MAPK7 represents a promising target for combination treatment with MEK inhibition in KRAS mutant NSCLC.	[Dompe, Nicholas; Watson, Sara A.; Leng, Katherine; Port, Jenna; Neve, Richard; Evangelista, Marie; Stokoe, David] Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA; [Klijn, Christiaan; Watanabe, Colin] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Cuellar, Trinna; Haley, Benjamin] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Leng, Katherine] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Port, Jenna] Brown Univ, Providence, RI 02912 USA; [Cuellar, Trinna] Gotham Therapeut, New York, NY USA; [Neve, Richard] Gilead Sci, Foster City, CA USA; [Stokoe, David] Calico, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of Michigan System; University of Michigan; Brown University; Gilead Sciences	Stokoe, D (corresponding author), Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA.; Stokoe, D (corresponding author), Calico, San Francisco, CA 94080 USA.	dstokoe@pacbell.net		, Jenna/0000-0003-2729-5446; Watson, Sara/0000-0002-3730-9357	Genentech	Genentech(Roche HoldingGenentech)	Genentech provided financial support for salaries as described above and materials, but did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atefi M, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0293-5; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bedard PL, 2015, CLIN CANCER RES, V21, P730, DOI 10.1158/1078-0432.CCR-14-1814; Blake JF, 2016, J MED CHEM, V59, P5650, DOI 10.1021/acs.jmedchem.6b00389; Blumenschein GR, 2015, ANN ONCOL, V26, P894, DOI 10.1093/annonc/mdv072; Carter CA, 2016, ANN ONCOL, V27, P693, DOI 10.1093/annonc/mdw008; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; de Jong PR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11551; Deng XM, 2013, EUR J MED CHEM, V70, P758, DOI 10.1016/j.ejmech.2013.10.052; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Engelman JA, 2008, NAT MED, DOI DOI 10.1038/NRE.1890; Janne PA, 2017, JAMA-J AM MED ASSOC, V317, P1844, DOI 10.1001/jama.2017.3438; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lamba S, 2014, CELL REP, V8, P1475, DOI 10.1016/j.celrep.2014.07.033; Lin ECK, 2016, P NATL ACAD SCI USA, V113, P11865, DOI 10.1073/pnas.1609019113; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Lochhead PA, 2016, CELL CYCLE, V15, P506, DOI 10.1080/15384101.2015.1120915; Loriot Y, 2009, NAT REV CLIN ONCOL, V6, P528, DOI 10.1038/nrclinonc.2009.106; Manchado E, 2016, NATURE, V534, P647, DOI 10.1038/nature18600; McArthur GA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00161; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Merchant M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185862; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Morimoto H, 2007, J BIOL CHEM, V282, P35449, DOI 10.1074/jbc.M704079200; Ndubaku CO, 2015, ACS MED CHEM LETT, V6, P1241, DOI 10.1021/acsmedchemlett.5b00398; Tan N, 2013, MOL CANCER THER, V12, P853, DOI 10.1158/1535-7163.MCT-12-0949; Nithianandarajah-Jones GN, 2012, CELL SIGNAL, V24, P2187, DOI 10.1016/j.cellsig.2012.07.007; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Rice KD, 2012, ACS MED CHEM LETT, V3, P416, DOI 10.1021/ml300049d; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Shrestha G, 2016, SEMIN CELL DEV BIOL, V58, P108, DOI 10.1016/j.semcdb.2016.06.012; Simoes AES, 2016, DRUG DISCOV TODAY, V21, P1654, DOI 10.1016/j.drudis.2016.06.010; Squires MS, 2002, BIOCHEM J, V366, P673, DOI 10.1042/BJ20020372; Whittaker SR, 2015, MOL CANCER THER, DOI [10.1158/1535-7183.MCT-15-013641, DOI 10.1158/1535-7183.SICT-15-013641]; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	42	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199264	10.1371/journal.pone.0199264	http://dx.doi.org/10.1371/journal.pone.0199264			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912950	Green Submitted, Green Published, gold			2022-12-26	WOS:000435528600099
J	Singh, AK; Das, S; Singh, S; Gajamer, VR; Pradhan, N; Lepcha, YD; Tiwari, HK				Singh, Ashish Kumar; Das, Saurav; Singh, Samer; Gajamer, Varsha Rani; Pradhan, Nilu; Lepcha, Yangchen Doma; Tiwari, Hare Krishna			Prevalence of antibiotic resistance in commensal Escherichia coli among the children in rural hill communities of Northeast India	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; HEALTHY-CHILDREN; SELF-MEDICATION; BOLIVIA; SURVEILLANCE; BACTERIA; PERU	Commensal bacteria are the representative of the reservoir of antibiotic resistance genes present in a community. The usage of antibiotics along with the demographic factors is generally associated with an increase in antibiotics resistance in pathogens. Northeast (NE) India is untapped with regard to antibiotic resistance prevalence and spread. In the current study, the prevalence of antibiotic-resistant commensal Escherichia coli in pre-school and school-going children (n = 550, 1-14 years old) from the rural areas of the state of Sikkim- an NE Indian state, with respect to associated demographic factors was investigated. A total of 550 fecal E. coli isolates were collected during July 2015 to June 2017. A structured questionnaire was used to collect data to ascertain the potential factors associated with the carriage of antibiotic resistance E. coli among the children. Statistical analysis along with a logistic regression identified potential external factors affecting the observed antibiotic resistance pattern. The data indicated a high prevalence of resistance to common antibiotics like ampicillin (92%), ceftazidime (90%), cefoxitin (88%), streptomycin (40%) and tetracycline (36%), but no resistance to chloramphenicol. The resistance to the combination of penicillin and quinolone group of antibiotics was observed in fifty-two percent of the isolates. A positive correlation between the harboring of antibiotics resistant E. co/iwith different demographic factors was observed such as, with children living in nuclear family (vs joint family 63.15%, OR 0.18, 95% CI:0.11-0.28, p < 0.01), below higher secondary maternal education (vs college graduates 59.27% OR 0.75, 95% CI:0.55-1.02, p < 0.02). A close association between different demographic factors and the high prevalence of antibiotic-resistant commensal E. coli in the current study suggests a concern over rising misuse of antibiotics that warrants a future threat of emergence of multidrug-resistant pathogen isolates.	[Singh, Ashish Kumar; Das, Saurav; Gajamer, Varsha Rani; Pradhan, Nilu; Tiwari, Hare Krishna] Sikkim Univ, Sch Life Sci, Dept Microbiol, Gangtok, Sikkim, India; [Singh, Samer] Panjab Univ, Dept Microbial Biotechnol, Chandigarh, India; [Lepcha, Yangchen Doma] Govt Sikkim, State Inst Rural Dev, Gangtok, Sikkim, India	Sikkim University; Panjab University	Tiwari, HK (corresponding author), Sikkim Univ, Sch Life Sci, Dept Microbiol, Gangtok, Sikkim, India.	hktiwari@cus.ac.in	Das, Saurav/J-9114-2019; Singh, Samer/H-8468-2013; Singh, Dr Ashish Kumar/C-8623-2017	Singh, Samer/0000-0002-0921-1686; Das, Saurav/0000-0002-1239-6271; Singh, Ashish Kumar/0000-0003-3103-4871; Singh, Dr Ashish Kumar/0000-0003-0652-5425				Allin S, 2012, HEALTH ECON POLICY L, V7, P227, DOI 10.1017/S174413311100034X; [Anonymous], 2011, SOURCE CENSUS INDIA; Bartoloni A, 1998, TROP MED INT HEALTH, V3, P116, DOI 10.1046/j.1365-3156.1998.00201.x; Bartoloni A, 2006, EMERG INFECT DIS, V12, P907, DOI 10.3201/eid1206.051258; Bi P, 2000, SOC SCI MED, V50, P1445, DOI 10.1016/S0277-9536(99)00304-4; Bok E, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040617; Calva JJ, 1996, ANTIMICROB AGENTS CH, V40, P1699, DOI 10.1128/AAC.40.7.1699; Census of India. Sikkim, 2011, DISTR CENS HDB N W S, P1; Clinical and Laboratory Standards Institute, 2009, PERF STAND ANT DISK; Gajamer V.R., 2015, INT J PURE APP BIOSC, V3, P522; Gajamer VR, 2018, MICROB DRUG RESIST, V24, P1284, DOI 10.1089/mdr.2017.0159; Gajamer VR, 2018, RES REV, V7, P32; Infante B, 2005, INT J ANTIMICROB AG, V25, P308, DOI 10.1016/j.ijantimicag.2004.12.004; Laxminarayan R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001974; Lestari ES, 2008, EUR J CLIN MICROBIOL, V27, P45, DOI 10.1007/s10096-007-0396-z; Mathai E, 2008, TROP MED INT HEALTH, V13, P41, DOI 10.1111/j.1365-3156.2007.01969.x; OECD WHO, 2003, J APPL MICROBIOL, V85, P291, DOI [10.1016/S0048-9697(04)00275-X, DOI 10.1016/S0048-9697(04)00275-X]; Okumura J, 2002, SOC SCI MED, V54, P1875, DOI 10.1016/S0277-9536(01)00155-1; Oluyege AO, 2015, INT J CURR MICROBIOL, V4, P1096; Purohit MR, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040386; Sabde YD, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-351; Sahoo KC, 2012, INT J ENV RES PUB HE, V9, P746, DOI 10.3390/ijerph9030746; Sahoo KC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-629; Samore MH, 2011, ANTIMICROB AGENTS CH, V55, P1135, DOI 10.1128/AAC.01708-09; Seidman JC, 2009, EPIDEMIOL INFECT, V137, P879, DOI 10.1017/S0950268808001519; Shakya P, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-477; Silva N, 2012, ANN MICROBIOL, V62, P449, DOI 10.1007/s13213-011-0308-4; Sullivan KM, 2009, PUBLIC HEALTH REP, V124, P471, DOI 10.1177/003335490912400320; Takahashi K, 2010, BIOSCI BIOTECH BIOCH, V74, P691, DOI 10.1271/bbb.90962; Tambe S, 2012, RURAL WATER SECURITY; Togoobaatar G, 2010, B WORLD HEALTH ORGAN, V88, P930, DOI 10.2471/BLT.10.079004; Tule A., 2017, INT J CURR MICROBIOL, V6, P1623; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Vatopoulos A. C., 1998, Clin Microbiol Infect, V4, P563, DOI 10.1111/j.1469-0691.1998.tb00038.x; World Health Organization Ministry of Health & Family Welfare G of I., 2017, NAT ACT PALN ANT CRO; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614	36	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199179	10.1371/journal.pone.0199179	http://dx.doi.org/10.1371/journal.pone.0199179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912980	Green Submitted, Green Published, gold			2022-12-26	WOS:000435528600084
J	Yi, DG; Hong, S; Huh, WK				Yi, Dae-Gwan; Hong, Sujin; Huh, Won-Ki			Mitochondrial dysfunction reduces yeast replicative lifespan by elevating RAS-dependent ROS production by the ER-localized NADPH oxidase Yno1	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; DAMAGED PROTEINS; OXIDATIVE STRESS; PATHWAY; LONGEVITY; APOPTOSIS; EXPRESSION; RDNA; SIR2	Mitochondrial dysfunction leads to the accumulation of reactive oxygen species (ROS) which is associated with cellular dysfunction, disease etiology, and senescence. Here, we used the eukaryotic model Saccharomyces cerevisiae, commonly studied for cellular aging, to demonstrate how defective mitochondrial function affects yeast replicative lifespan (RLS). We show that RLS of respiratory-deficient cells decreases significantly, indicating that the maintenance of RLS requires active respiration. The shortening of RLS due to mitochondrial dysfunction was not related to the accumulation of extrachromosomal ribosomal DNA circles, a well-known cause of aging in yeast. Instead, intracellular ROS and oxidatively damaged proteins increased in respiratory-deficient mutants. We show that, while the protein kinase A activity is not elevated, ROS generation in respiratory-deficient cells depends on RAS signaling pathway. The ER-localized NADPH oxidase Yno1 also played a role in producing ROS. Our data suggest that a severe defect in mitochondrial respiration accelerates cellular aging by disturbing protein homeostasis in yeast.	[Yi, Dae-Gwan; Hong, Sujin; Huh, Won-Ki] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Huh, Won-Ki] Seoul Natl Univ, Inst Microbiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Huh, WK (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea.; Huh, WK (corresponding author), Seoul Natl Univ, Inst Microbiol, Seoul, South Korea.	wkh@snu.ac.kr	Huh, Won-Ki/AAQ-6767-2021	Huh, Won-Ki/0000-0002-9091-6594	National Research Foundation of Korea - Ministry of Education, Science and Technology, Republic of Korea [2015R1A2A1A01007871]	National Research Foundation of Korea - Ministry of Education, Science and Technology, Republic of Korea	This work was supported by the National Research Foundation of Korea grant (2015R1A2A1A01007871) funded by the Ministry of Education, Science and Technology, Republic of Korea (www.nrf.re.kr) to Won-Ki Huh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts AM, 2009, FEBS LETT, V583, P113, DOI 10.1016/j.febslet.2008.11.028; Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Aguilaniu H, 2001, J BIOL CHEM, V276, P35396, DOI 10.1074/jbc.M101796200; Bonawitz ND, 2006, MOL CELL BIOL, V26, P4818, DOI 10.1128/MCB.02360-05; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Budovskaya YV, 2004, J BIOL CHEM, V279, P20663, DOI 10.1074/jbc.M400272200; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Cassarino DS, 1999, BRAIN RES REV, V29, P1, DOI 10.1016/S0165-0173(98)00046-0; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Dirick L, 2014, G3-GENES GENOM GENET, V4, P411, DOI 10.1534/g3.113.010108; Erjavec N, 2008, P NATL ACAD SCI USA, V105, P18764, DOI 10.1073/pnas.0804550105; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001; Golla U, 2016, SCI REP-UK, V6, DOI 10.1038/srep35322; Gourlay CW, 2006, MOL CELL BIOL, V26, P6487, DOI 10.1128/MCB.00117-06; Gourlay CW, 2005, J CELL SCI, V118, P2119, DOI 10.1242/jcs.02337; Graef M, 2011, EMBO J, V30, P2101, DOI 10.1038/emboj.2011.104; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; Ha CW, 2011, NUCLEIC ACIDS RES, V39, P1336, DOI 10.1093/nar/gkq895; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hayes P, 2013, ANTIOXID REDOX SIGN, V18, P1937, DOI 10.1089/ars.2012.4895; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hlavata L, 2008, AGING CELL, V7, P148, DOI 10.1111/j.1474-9726.2007.00361.x; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; Jakubowski W, 2000, CELL BIOL INT, V24, P757, DOI 10.1006/cbir.2000.0556; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Kirchman PA, 1999, GENETICS, V152, P179; Leadsham JE, 2013, CELL METAB, V18, P279, DOI 10.1016/j.cmet.2013.07.005; Leadsham JE, 2009, J CELL SCI, V122, P706, DOI 10.1242/jcs.042424; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Maris AF, 2001, CURR GENET, V39, P137, DOI 10.1007/s002940100194; Miceli Michael V., 2012, Frontiers in Genetics, V2, P102, DOI 10.3389/fgene.2011.00102; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Ocampo A, 2012, CELL METAB, V16, P55, DOI 10.1016/j.cmet.2012.05.013; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Park PU, 2002, METHOD ENZYMOL, V351, P468; Ray A, 2003, NAT GENET, V33, P522, DOI 10.1038/ng1132; Rinnerthaler M, 2012, P NATL ACAD SCI USA, V109, P8658, DOI 10.1073/pnas.1201629109; Rubio-Texeira M, 2010, FEMS YEAST RES, V10, P134, DOI 10.1111/j.1567-1364.2009.00587.x; Sesti F, 2010, TRENDS CELL BIOL, V20, P45, DOI 10.1016/j.tcb.2009.09.008; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smets B, 2010, CURR GENET, V56, P1, DOI 10.1007/s00294-009-0287-1; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; Umebayashi K, 2001, J BIOL CHEM, V276, P41444, DOI 10.1074/jbc.M105829200; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Wallace Douglas C, 2002, Methods Mol Biol, V197, P3, DOI 10.1385/1-59259-284-8:003; Woo DK, 2009, EXP GERONTOL, V44, P390, DOI 10.1016/j.exger.2009.03.001; Wullschleger S, 2006, CELL, V127, P5, DOI 10.1016/j.cell.2006.01.016; Yi DG, 2016, FREE RADICAL BIO MED, V101, P424, DOI 10.1016/j.freeradbiomed.2016.11.005; Yi DG, 2015, FEBS LETT, V589, P2409, DOI 10.1016/j.febslet.2015.07.015	66	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198619	10.1371/journal.pone.0198619	http://dx.doi.org/10.1371/journal.pone.0198619			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912878	gold, Green Submitted, Green Published			2022-12-26	WOS:000435528600038
J	Kim, JM; Shin, Y; Lee, S; Kim, MY; Punj, V; Shin, HI; Kim, K; Koh, JM; Jeong, D; An, W				Kim, Jin-Man; Shin, Yonghwan; Lee, Sunyoung; Kim, Mi Yeong; Punj, Vasu; Shin, Hong-In; Kim, Kyunghwan; Koh, Jung-Min; Jeong, Daewon; An, Woojin			MacroH2A1.2 inhibits prostate cancer-induced osteoclastogenesis through cooperation with HP1 alpha and H1.2	ONCOGENE			English	Article							NF-KAPPA-B; LYMPHOTOXIN-ALPHA; HISTONE VARIANTS; EXPRESSION; METASTASIS; CELLS; TUMOR; PHOSPHORYLATION; DIFFERENTIATION; TRANSCRIPTION	Osteoclasts are multinuclear bone-resorbing cells that differentiate from hematopoietic precursor cells. Prostate cancer cells frequently spread to bone and secrete soluble signaling factors to accelerate osteoclast differentiation and bone resorption. However, processes and mechanisms that govern the expression of osteoclastogenic soluble factors secreted by prostate cancer cells are largely unknown. MacroH2A (mH2A) is a histone variant that replaces canonical H2A at designated genomic loci and establishes functionally distinct chromatin regions. Here, we report that mH2A1.2, one of the mH2A isoforms, attenuates prostate cancer-induced osteoclastogenesis by maintaining the inactive state of genes encoding soluble factors in prostate cancer cells. Our functional analyses of soluble factors identify lymphotoxin beta (LT beta) as a major stimulator of osteoclastogenesis and an essential mH2A1.2 target for its anti-osteoclastogenic activity. Mechanistically, mH2A1.2 directly interacts with HP1 alpha and H1.2 and requires them to inactivate LT beta gene in prostate cancer cells. Consistently, HP1 alpha and H1.2 have an intrinsic ability to inhibit osteoclast differentiation in a mH2A1.2-dependent manner. Together, our data uncover a new and specific role for mH2A1.2 in modulating osteoclastogenic potential of prostate cancer cells and demonstrate how this signaling pathway can be exploited to treat osteolytic bone metastases at the molecular level.	[Kim, Jin-Man; Shin, Yonghwan; Lee, Sunyoung; Kim, Kyunghwan; An, Woojin] Univ Southern Calif, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Kim, Mi Yeong; Jeong, Daewon] Yeungnam Univ, Dept Microbiol, Coll Med, Daegu 705717, South Korea; [Punj, Vasu] Univ Southern Calif, Dept Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Shin, Hong-In] Kyungpook Natl Univ, Sch Dent, Dept Oral Pathol, Daegu 700412, South Korea; [Kim, Kyunghwan] Chungbuk Natl Univ, Dept Biol, Coll Nat Sci, Cheongju 361763, Chungbuk, South Korea; [Koh, Jung-Min] Univ Ulsan, Div Endocrinol & Metab, Asan Med Ctr, Coll Med, Seoul 138736, South Korea	University of Southern California; Yeungnam University; University of Southern California; Kyungpook National University; Chungbuk National University; University of Ulsan; Asan Medical Center	An, W (corresponding author), Univ Southern Calif, Dept Biochem & Mol Biol, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	woojinan@usc.edu			NIH [CA201561]; Keck School of Medicine of USC; NATIONAL CANCER INSTITUTE [R01CA201561] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck School of Medicine of USC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH Grant CA201561 awarded to W.A. The study was also funded in part by pilot project grants from Keck School of Medicine of USC.	Armstrong AP, 2008, PROSTATE, V68, P92, DOI 10.1002/pros.20678; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; ASH P, 1980, NATURE, V283, P669, DOI 10.1038/283669a0; Baron R, 2004, NAT MED, V10, P458, DOI 10.1038/nm0504-458; Boyce BF, 2010, ANN NY ACAD SCI, V1192, P367, DOI 10.1111/j.1749-6632.2009.05315.x; Chen HS, 2014, NAT STRUCT MOL BIOL, V21, P981, DOI 10.1038/nsmb.2903; Dell'Orso S, 2016, CELL REP, V14, P1156, DOI 10.1016/j.celrep.2015.12.103; Edwards Claire M, 2008, Int J Med Sci, V5, P263; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Hideshima T, 2001, CANCER RES, V61, P3071; Jimi E, 2005, IMMUNOL REV, V208, P80, DOI 10.1111/j.0105-2896.2005.00329.x; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Kim JM, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.40; Kim JM, 2015, NUCLEIC ACIDS RES, V43, P8868, DOI 10.1093/nar/gkv874; Kim K, 2016, GENE DEV, V30, P208, DOI 10.1101/gad.268714.115; Kim K, 2013, CELL REP, V5, P1690, DOI 10.1016/j.celrep.2013.11.038; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; Liepinsh DJ, 2006, MOL CELL BIOL, V26, P4214, DOI 10.1128/MCB.01751-05; Madge LA, 2008, J IMMUNOL, V180, P3467, DOI 10.4049/jimmunol.180.5.3467; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Maze I, 2014, NAT REV GENET, V15, P259, DOI 10.1038/nrg3673; Melters DP, 2015, GENES-BASEL, V6, P751, DOI 10.3390/genes6030751; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mori K, 2007, BONE, V40, P981, DOI 10.1016/j.bone.2006.11.006; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; PEHRSON JR, 1992, SCIENCE, V257, P1398; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Punj V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037498; Rasmussen TP, 1999, NUCLEIC ACIDS RES, V27, P3685, DOI 10.1093/nar/27.18.3685; Richart AN, 2012, J BIOL CHEM, V287, P18730, DOI 10.1074/jbc.M111.337204; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yin JJ, 2005, CELL RES, V15, P57, DOI 10.1038/sj.cr.7290266; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zelzer E, 2003, NATURE, V423, P343, DOI 10.1038/nature01659; Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685	46	16	16	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 25	2018	37	43					5749	5765		10.1038/s41388-018-0356-3	http://dx.doi.org/10.1038/s41388-018-0356-3			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GY1KL	29925860	Green Accepted			2022-12-26	WOS:000448288200004
J	Roh, E; Lee, MH; Zykova, TA; Zhu, F; Nadas, J; Kim, HG; Bae, KB; Li, Y; Cho, YY; Curiel-Lewandrowski, C; Einspahr, J; Dickinson, SE; Bode, AM; Dong, ZG				Roh, Eunmiri; Lee, Mee-Hyun; Zykova, Tatyana A.; Zhu, Feng; Nadas, Janos; Kim, Hong-Gyum; Bae, Ki Beom; Li, Yan; Cho, Yong Yeon; Curiel-Lewandrowski, Clara; Einspahr, Janine; Dickinson, Sally E.; Bode, Ann M.; Dong, Zigang			Targeting PRPK and TOPK for skin cancer prevention and therapy	ONCOGENE			English	Article							SQUAMOUS-CELL CARCINOMA; CYCLIN D1 EXPRESSION; BETAMETHASONE VALERATE; GROWTH-FACTOR; RISK-FACTORS; PROTEIN; KINASE; CARCINOGENESIS; METASTASIS; PHOSPHORYLATION	Solar ultraviolet (sUV) irradiation is a major environmental carcinogen that can cause inflammation and skin cancer. The costs and morbidity associated with skin cancer are increasing, and therefore identifying molecules that can help prevent skin carcinogenesis is important. In this study, we identified the p53-related protein kinase (PRPK) as a novel oncogenic protein that is phosphorylated by the T-LAK cell-originated protein kinase (TOPK). Knockdown of TOPK inhibited PRPK phosphorylation and conferred resistance to solar-simulated light (SSL)-induced skin carcinogenesis in mouse models. In the clinic, acute SSL irradiation significantly increased epidermal thickness as well as total protein and phosphorylation levels of TOPK and PRPK in human skin tissues. We identified two PRPK inhibitors, FDA-approved rocuronium bromide (Zemuron (R)) or betamethasone 17-valerate (Betaderm (R)) that could attenuate TOPK-dependent PRPK signaling. Importantly, topical application of either rocuronium bromide or betamethasone decreased SSL-induced epidermal hyperplasia, neovascularization, and cutaneous squamous cell carcinoma (cSCC) development in SKH1 (Crl: SKH1-Hr(hr)) hairless mice by inhibiting PRPK activation, and also reduced expression of the proliferation and oncogenesis markers, COX-2, cyclin D1, and MMP-9. This study is the first to demonstrate that targeting PRPK could be useful against sUV-induced cSCC development.	[Roh, Eunmiri; Lee, Mee-Hyun; Zykova, Tatyana A.; Zhu, Feng; Nadas, Janos; Kim, Hong-Gyum; Bae, Ki Beom; Li, Yan; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Lee, Mee-Hyun] China US Hormel Canc Inst, Zhengzhou 45008, Henan, Peoples R China; [Zhu, Feng] Huazhong Univ Sci & Technol, Sch Basic Med, Wuhan 430030, Hubei, Peoples R China; [Cho, Yong Yeon] Catholic Univ Korea, Coll Pharm, Bucheon 420743, South Korea; [Curiel-Lewandrowski, Clara; Einspahr, Janine; Dickinson, Sally E.] Univ Arizona, Ctr Canc, Tucson, AZ USA	University of Minnesota System; Huazhong University of Science & Technology; Catholic University of Korea; University of Arizona	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	ZHU, Feng/C-1303-2010; Cho, Yong-Yeon/AAD-4263-2020	Cho, Yong-Yeon/0000-0003-1107-2651; Zhu, Feng/0000-0003-1172-0102	Hormel Foundation; National of Institutes of Health [CA027502, CA166011, CA187027, CA196639]; NATIONAL CANCER INSTITUTE [P01CA027502, R01CA166011, P30CA023074, R01CA196639, R01CA187027] Funding Source: NIH RePORTER	Hormel Foundation; National of Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The Hormel Foundation and National of Institutes of Health grants CA027502, CA166011, CA187027, and CA196639 (ZD). We thank Dr. Lorenzo A. Pinna (Universita di Padova, Italy) for the pQE-81L-PRPK plasmid, Alyssa Langfald for confocal microscopy analysis, and Dr. Tia Rai and Nicki Brickman for assistance with manuscript submission.	Abe Y, 2006, BIOCHEM BIOPH RES CO, V344, P377, DOI 10.1016/j.bbrc.2006.03.071; Abe Y, 2001, J BIOL CHEM, V276, P44003, DOI 10.1074/jbc.M105669200; Allanson M, 2007, CANCER IMMUNOL IMMUN, V56, P1807, DOI 10.1007/s00262-007-0324-1; Atzmony L, 2016, AM J CLIN DERMATOL, V17, P11, DOI 10.1007/s40257-015-0160-6; Bode AM, 2006, MOL CARCINOGEN, V45, P422, DOI 10.1002/mc.20222; BOYLE JO, 1993, CANCER RES, V53, P4477; Brantsch KD, 2008, LANCET ONCOL, V9, P713, DOI 10.1016/S1470-2045(08)70178-5; Burton KA, 2016, AM J CLIN DERMATOL, V17, P491, DOI 10.1007/s40257-016-0207-3; Chang CF, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071007; Cherpelis BS, 2002, DERMATOL SURG, V28, P268, DOI 10.1046/j.1524-4725.2002.01169.x; Dobrev H, 2001, PHOTODERMATOL PHOTO, V17, P184, DOI 10.1034/j.1600-0781.2001.170408.x; Edlund K, 2012, P NATL ACAD SCI USA, V109, P9551, DOI 10.1073/pnas.1200019109; Facchin S, 2007, CELL MOL LIFE SCI, V64, P2680, DOI 10.1007/s00018-007-7179-7; Fan XM, 2016, ONCOTARGET, V7, P24633, DOI 10.18632/oncotarget.8260; Farasat S, 2011, J AM ACAD DERMATOL, V64, P1051, DOI 10.1016/j.jaad.2010.08.033; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gao G, 2017, MOL CANCER THER, V16, P1843, DOI 10.1158/1535-7163.MCT-17-0212; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Guy GP, 2014, AM J PUBLIC HEALTH, V104, pE69, DOI [10.2105/AJPH.2013.301850, 10.1016/j.amepre.2014.08.036]; Hensler S, 2013, CANCER J, V19, P517, DOI 10.1097/PPO.0000000000000010; Huang K, 2012, CLIN EXP DERMATOL, V37, P411, DOI 10.1111/j.1365-2230.2011.04275.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jensen JM, 2012, ALLERGY, V67, P413, DOI 10.1111/j.1398-9995.2011.02747.x; Joel M, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0398-x; Katiyar SK, 2007, TOXICOL APPL PHARM, V224, P220, DOI 10.1016/j.taap.2006.11.017; Katiyar SK, 2015, PHOTOCHEM PHOTOBIOL, V91, P156, DOI 10.1111/php.12330; Kim JE, 2016, ONCOGENE, V35, P4091, DOI 10.1038/onc.2015.471; Kim JE, 2016, ONCOTARGET, V7, P14616, DOI 10.18632/oncotarget.7524; Kwon JY, 2009, CARCINOGENESIS, V30, P1932, DOI 10.1093/carcin/bgp216; Li Y, 2016, ONCOTARGET, V7, P6748, DOI 10.18632/oncotarget.6826; Lohmann CM, 2001, ADV ANAT PATHOL, V8, P27, DOI 10.1097/00125480-200101000-00005; Loyo M, 2013, HEAD NECK-J SCI SPEC, V35, P454, DOI 10.1002/hed.23100; Marcil I, 2000, ARCH DERMATOL, V136, P1524, DOI 10.1001/archderm.136.12.1524; Matsuo Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010277; Missero C, 2014, EXP DERMATOL, V23, P143, DOI 10.1111/exd.12320; Muller-Decker K, 2011, CANCER METAST REV, V30, P343, DOI 10.1007/s10555-011-9306-z; Nakagawa K, 1999, MOL CELL BIOL, V19, P2828; Oh SM, 2007, CANCER RES, V67, P5186, DOI 10.1158/0008-5472.CAN-06-4506; Panelos J, 2008, MODERN PATHOL, V21, P316, DOI 10.1038/modpathol.3801007; Park JH, 2014, CELL SIGNAL, V26, P849, DOI 10.1016/j.cellsig.2014.01.004; Peterson D, 2010, CANCER RES, V70, P6325, DOI 10.1158/0008-5472.CAN-10-0015; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; Ridley AJ, 2009, INT J RADIAT BIOL, V85, P177, DOI 10.1080/09553000902740150; Rogers HW, 2015, JAMA DERMATOL, V151, P1081, DOI 10.1001/jamadermatol.2015.1187; Runger TM, 2007, J INVEST DERMATOL, V127, P2103, DOI 10.1038/sj.jid.5700988; Saraceno R, 2010, J DERMATOL TREAT, V21, P363, DOI 10.3109/09546630903386606; Schwarz A, 2005, J EXP MED, V201, P173, DOI 10.1084/jem.20041212; Shen YY, 2014, MOL CLIN ONCOL, V2, P545, DOI 10.3892/mco.2014.273; Shih MC, 2012, ONCOGENE, V31, P2389, DOI 10.1038/onc.2011.419; Thompson AK, 2016, JAMA DERMATOL, V152, P419, DOI 10.1001/jamadermatol.2015.4994; Trifan OC, 2003, J CELL MOL MED, V7, P207, DOI 10.1111/j.1582-4934.2003.tb00222.x; Yano K, 2004, J INVEST DERMATOL, V122, P201, DOI 10.1046/j.0022-202X.2003.22101.x; Yokogawa M, 2013, MOL CARCINOGEN, V52, P760, DOI 10.1002/mc.21901; Zhu F, 2007, GASTROENTEROLOGY, V133, P219, DOI 10.1053/j.gastro.2007.04.048	54	21	22	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 18	2018	37	42					5633	5647		10.1038/s41388-018-0350-9	http://dx.doi.org/10.1038/s41388-018-0350-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX3JJ	29904102	Green Accepted			2022-12-26	WOS:000447619100004
J	Nho, B; Lee, J; Lee, J; Ko, KR; Lee, SJ; Kim, S				Nho, Boram; Lee, Junghun; Lee, Junsub; Ko, Kyeong Ryang; Lee, Sung Joong; Kim, Sunyoung			Effective control of neuropathic pain by transient expression of hepatocyte growth factor in a mouse chronic constriction injury model	FASEB JOURNAL			English	Article						VM202; plasmid DNA; gene therapy; DRG; microglia	CRITICAL LIMB ISCHEMIA; FACTOR SCATTER FACTOR; DIABETIC PERIPHERAL NEUROPATHY; SCIATIC-NERVE INJURY; FACTOR GENE-THERAPY; 2 ISOFORMS; NAKED DNA; INTRAMYOCARDIAL TRANSFER; PLASMID DNA; PHASE-I	Hepatocyte growth factor (HGF) is a multifunctional protein that contains angiogenic and neurotrophic properties. In the current study, we investigated the analgesic effects of HGF by using a plasmid DNA that was designed to express 2 isoforms of human HGFpCK-HGF-X7 (or VM202)in a chronic constriction injury (CCI) -induced mouse neuropathic pain model. Intramuscular injection of pCK-HGF-X7 into proximal thigh muscle induced the expression of HGF in the muscle, sciatic nerve, and dorsal root ganglia (DRG). This gene transfer procedure significantly attenuated mechanical allodynia and thermal hyperalgesia after CCI. Injury-induced expression of activating transcription factor 3, calcium channel subunit 21, and CSF1 in the ipsilateral DRG neurons was markedly down-regulated in the pCK-HGF-X7-treated group, which suggested that HGF might exert its analgesic effects by inhibiting pain-mediating genes in the sensory neurons. In addition, suppressed CSF1 expression in DRG neurons by pCK-HGF-X7 treatment was accompanied by a noticeable suppression of the nerve injury-induced glial cell activation in the spinal cord dorsal horn. Taken together, our data show that pCK-HGF-X7 attenuates nerve injury-induced neuropathic pain by inhibiting pain-related factors in DRG neurons and subsequent spinal cord glial activation, which suggests its therapeutic efficacy in the treatment of neuropathic pain.Nho, B., Lee, J., Lee, J., Ko, K. R., Lee, S. J., Kim, S. Effective control of neuropathic pain by transient expression of hepatocyte growth factor in a mouse chronic constriction injury model.	[Nho, Boram; Lee, Junghun; Lee, Junsub; Ko, Kyeong Ryang; Kim, Sunyoung] Seoul Natl Univ, Sch Biol Sci, Bldg 504,1 Gwanak Ro,Gwanak Gu 151-742, Seoul 08826, South Korea; [Lee, Sung Joong] Seoul Natl Univ, Dept Neurosci & Physiol, Seoul, South Korea; [Lee, Junghun; Ko, Kyeong Ryang; Kim, Sunyoung] ViroMed, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, S (corresponding author), Seoul Natl Univ, Sch Biol Sci, Bldg 504,1 Gwanak Ro,Gwanak Gu 151-742, Seoul 08826, South Korea.	sunyoung@snu.ac.kr		Lee, Junghun/0000-0003-4524-0625	ViroMed	ViroMed	The authors thank Subin Kim (ViroMed) for providing the pCK-HGF-X7 plasmid and Hyoungsub Lim (School of Dentistry, Seoul National University) for technical support. This work was supported by grants from ViroMed. B.N. and S.J.L. declare no conflicts of interest.	Ajroud-Driss S, 2013, MOL THER, V21, P1279, DOI 10.1038/mt.2013.69; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Bell A, 1999, ONCOGENE, V18, P887, DOI 10.1038/sj.onc.1202379; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Boroujerdi A, 2011, PAIN, V152, P649, DOI 10.1016/j.pain.2010.12.014; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; Carlsson M, 2008, AM J PHYSIOL-HEART C, V295, pH522, DOI 10.1152/ajpheart.00280.2008; Cho KR, 2008, EUR J CARDIO-THORAC, V34, P857, DOI 10.1016/j.ejcts.2008.05.045; Colburn RW, 1999, EXP NEUROL, V157, P289, DOI 10.1006/exnr.1999.7065; Colloca L, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.2; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Gascon E, 2010, J NEUROSCI, V30, P12414, DOI 10.1523/JNEUROSCI.3135-10.2010; Gille J, 1998, J INVEST DERMATOL, V111, P1160, DOI 10.1046/j.1523-1747.1998.00418.x; Gore M, 2005, J PAIN SYMPTOM MANAG, V30, P374, DOI 10.1016/j.jpainsymman.2005.04.009; Gu YQ, 2011, J GENE MED, V13, P602, DOI 10.1002/jgm.1614; Guan ZH, 2016, NAT NEUROSCI, V19, P94, DOI 10.1038/nn.4189; Hahn W, 2011, J GENE MED, V13, P549, DOI 10.1002/jgm.1603; Hashimoto N, 2001, NEUROREPORT, V12, P1403, DOI 10.1097/00001756-200105250-00022; Henry TD, 2011, GENE THER, V18, P788, DOI 10.1038/gt.2011.21; Hunt D, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00007; Ji RR, 2006, NEURON GLIA BIOL, V2, P259, DOI 10.1017/S1740925X07000403; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Jiang W, 1999, CRIT REV ONCOL HEMAT, V29, P209, DOI 10.1016/S1040-8428(98)00019-5; Kagawa T, 2006, NEPHRON PHYSIOL, V102, P92, DOI 10.1159/000090071; Kessler JA, 2015, ANN CLIN TRANSL NEUR, V2, P465, DOI 10.1002/acn3.186; Kibbe MR, 2016, GENE THER, V23, P306, DOI 10.1038/gt.2015.110; Kim DS, 2009, PAIN, V143, P114, DOI 10.1016/j.pain.2009.02.006; Kim JS, 2013, GENE THER, V20, P717, DOI 10.1038/gt.2012.87; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; Lee Y, 2000, BIOCHEM BIOPH RES CO, V272, P230, DOI 10.1006/bbrc.2000.2758; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Lutz BM, 2014, ANESTHESIOLOGY, V121, P409, DOI 10.1097/ALN.0000000000000265; Macauley SL, 2014, J NEUROSCI, V34, P13077, DOI 10.1523/JNEUROSCI.2518-14.2014; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; Maina F, 1998, NEURON, V20, P835, DOI 10.1016/S0896-6273(00)80466-3; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; McMahon SB, 2009, NEURON, V64, P46, DOI 10.1016/j.neuron.2009.09.033; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; MIZUNO K, 1994, J BIOL CHEM, V269, P1131; Morishita R, 2002, ENDOCR J, V49, P273, DOI 10.1507/endocrj.49.273; Nakagami H, 2005, EXPERT REV CARDIOVAS, V3, P513, DOI 10.1586/14779072.3.3.513; Newton RA, 2001, MOL BRAIN RES, V95, P1, DOI 10.1016/S0169-328X(01)00188-7; Okubo M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153375; Old EA, 2015, HANDB EXP PHARMACOL, V227, P145, DOI 10.1007/978-3-662-46450-2_8; Pyun WB, 2010, GENE THER, V17, P1442, DOI 10.1038/gt.2010.101; Romero-Sandoval A, 2008, BRAIN RES, V1219, P116, DOI 10.1016/j.brainres.2008.05.004; Saeed M, 2008, RADIOLOGY, V249, P107, DOI 10.1148/radiol.2483071579; Saeed M, 2011, CARDIOVASC REVASCULA, V12, P111, DOI 10.1016/j.carrev.2010.05.003; SEKI T, 1991, GENE, V102, P213; Sorkin A, 2010, CURR PROTOC CELL BIO, DOI [10. 1002/0471143030. cb1514s46, DOI 10.1002/0471143030.CB1514S46]; Sufit RL, 2017, AMYOTROPH LAT SCL FR, V18, P269, DOI 10.1080/21678421.2016.1259334; Tanga FY, 2004, NEUROCHEM INT, V45, P397, DOI 10.1016/j.neuint.2003.06.002; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Tsuchihara T, 2009, MOL THER, V17, P42, DOI 10.1038/mt.2008.214; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Yang JW, 2002, J AM SOC NEPHROL, V13, P2464, DOI 10.1097/01.ASN.0000031827.16102.C1; Yang XM, 1998, J NEUROSCI, V18, P8369; Zhou HJ, 1998, STRUCTURE, V6, P109, DOI 10.1016/S0969-2126(98)00012-4	61	19	21	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5119	5131		10.1096/fj.201800476R	http://dx.doi.org/10.1096/fj.201800476R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913557	Green Published, hybrid			2022-12-26	WOS:000443817700040
J	Colineau, L; Lambertz, U; Fornes, O; Wasserman, WW; Reiner, NE				Colineau, Lucie; Lambertz, Ulrike; Fornes, Oriol; Wasserman, Wyeth W.; Reiner, Neil E.			c-Myc is a novel Leishmania virulence factor by proxy that targets the host miRNA system and is essential for survival in human macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); microRNA biogenesis; Leishmania; protozoan; infection; macrophage; Myc (c-Myc); transcription regulation; virulence factor	VIRUS-INFECTION; EXPRESSION; CANCER; GENE; TRANSCRIPTION; REPRESSION; BIOGENESIS; METABOLISM; ACTIVATION; INHIBITOR	Leishmania species are intracellular protozoan pathogens that have evolved to successfully infect and deactivate host macrophages. How this deactivation is brought about is not completely understood. Recently, microRNAs (miRNAs) have emerged as ubiquitous regulators of macrophage gene expression that contribute to shaping the immune responses to intracellular pathogens. Conversely, several pathogens have evolved the ability to exploit host miRNA expression to manipulate host-cell phenotype. However, very little is known about the mechanisms used by intracellular pathogens to drive changes in host-cell miRNA abundance. Using miRNA expression profiling of Leishmania donovani-infected human macrophages, we show here that Leishmania infection induced a genome-wide down-regulation of host miRNAs. This repression occurred at the level of miRNA gene transcription, because the synthesis rates of primary miRNAs were significantly decreased in infected cells. miRNA repression depended on the host macrophage transcription factor c-Myc. Indeed, the expression of host c-Myc was markedly up-regulated by Leishmania infection, and c-Myc silencing reversed the miRNA suppression. Furthermore, c-Myc silencing significantly reduced intracellular survival of Leishmania, demonstrating that c-Myc is essential for Leishmania pathogenesis. Taken together, these findings identify c-Myc not only as being responsible for miRNA repression in Leishmania-infected macrophages but also as a novel and essential virulence factor by proxy that promotes Leishmania survival.	[Colineau, Lucie; Lambertz, Ulrike; Reiner, Neil E.] Vancouver Coastal Hlth Res Inst, Dept Med, Div Infect Dis, Vancouver, BC V5Z 1M9, Canada; [Fornes, Oriol; Wasserman, Wyeth W.] Univ British Columbia, British Columbia Childrens Hosp, Res Inst, Ctr Mol Med & Therapeut,Dept Med Genet, Vancouver, BC V5Z 3J5, Canada	Vancouver Coastal Health Research Institute; BC Childrens Hospital; University of British Columbia	Reiner, NE (corresponding author), Univ British Columbia, Dept Med, D452-2733 Heather St, Vancouver, BC V5Z 3J5, Canada.	nreiner@mail.ubc.ca	Fornés, Oriol/L-2645-2014	Fornés, Oriol/0000-0002-5969-3054; Wasserman, Wyeth/0000-0001-6098-6412; Colineau, Lucie/0000-0001-6221-0765	Canadian Institutes for Health Research [MOP-125879]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by Grant MOP-125879 from the Canadian Institutes for Health Research. The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Amatori S., 2017, J CANC METASTASIS TR, V3, P90, DOI [10.20517/2394-4722.2017.22, DOI 10.20517/2394-4722.2017.22]; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cheneby J, 2018, NUCLEIC ACIDS RES, V46, pD267, DOI 10.1093/nar/gkx1092; Colineau L, 2017, MED MICROBIOL IMMUN, V206, P235, DOI 10.1007/s00430-017-0500-7; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Frank B, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0974-3; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guo X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125429; Huang MJ, 2006, EXP HEMATOL, V34, P1480, DOI 10.1016/j.exphem.2006.06.019; Huang Q, 2016, MED SCI MONITOR, V22, P1837, DOI 10.12659/MSM.895642; Iraci N, 2011, CANCER RES, V71, P404, DOI 10.1158/0008-5472.CAN-10-2627; Izumi H, 2001, J CELL SCI, V114, P1533; Jackstadt R, 2015, BBA-GENE REGUL MECH, V1849, P544, DOI 10.1016/j.bbagrm.2014.04.003; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kulakovskiy IV, 2018, NUCLEIC ACIDS RES, V46, pD252, DOI 10.1093/nar/gkx1106; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lee S, 2013, CELL HOST MICROBE, V13, P678, DOI 10.1016/j.chom.2013.05.007; Lemaire J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002478; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00083; Liu LL, 2016, P NATL ACAD SCI USA, V113, P1564, DOI 10.1073/pnas.1518000113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marr AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004419; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Muralidhar B, 2007, J PATHOL, V212, P368, DOI 10.1002/path.2179; Muxel SM, 2017, SCI REP-UK, V7, DOI 10.1038/srep44141; Nothelfer K, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9076823; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Psathas JN, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014175; Qi YT, 2007, J CELL PHYSIOL, V210, P63, DOI 10.1002/jcp.20816; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; ROY AL, 1993, NATURE, V365, P359, DOI 10.1038/365359a0; Rupaimoole R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6202; Rzymski T, 2008, ONCOGENE, V27, P4532, DOI 10.1038/onc.2008.100; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; SHRIVASTAVA A, 1993, SCIENCE, V262, P1889, DOI 10.1126/science.8266081; Singh AK, 2016, AUTOPHAGY, V12, P1817, DOI 10.1080/15548627.2016.1203500; Sun HL, 2016, CANCER CELL, V30, P723, DOI 10.1016/j.ccell.2016.10.001; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tao JC, 2014, CELL CYCLE, V13, P191, DOI 10.4161/cc.27646; Tiwari N, 2017, FRONT MICROBIOL, V8, DOI [10.3389/fmicb.2017.00314, 10.3389/fmicb.2017.01190]; von Brandenstein M, 2012, AM J PATHOL, V180, P1787, DOI 10.1016/j.ajpath.2012.01.014; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wang XW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01942; Weber B, 2007, CELL CYCLE, V6, P1001, DOI 10.4161/cc.6.9.4209; Whitfield JR, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00010; Wisskirchen C, 2011, J VIROL, V85, P8646, DOI 10.1128/JVI.02559-10; Wu D, 2013, RNA, V19, P876, DOI 10.1261/rna.035055.112; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Xu YM, 2015, INT J CLIN EXP MED, V8, P2024; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Yim HCH, 2011, P NATL ACAD SCI USA, V108, P17749, DOI 10.1073/pnas.1104892108; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110973; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681; Zhu BB, 2016, SCI REP-UK, V6, DOI 10.1038/srep22581	67	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12805	12819		10.1074/jbc.RA118.002462	http://dx.doi.org/10.1074/jbc.RA118.002462			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29934305	hybrid, Green Published			2022-12-26	WOS:000442203500014
J	Tognon, CE; Rafn, B; Cetinbas, NM; Kamura, T; Trigo, G; Rotblat, B; Okumura, F; Matsumoto, M; Chow, C; Davare, M; Pollak, M; Mayor, T; Sorensen, PH				Tognon, Cristina E.; Rafn, Bo; Cetinbas, Naniye Malli; Kamura, Takumi; Trigo, Genny; Rotblat, Barak; Okumura, Fumihiko; Matsumoto, Masaki; Chow, Christine; Davare, Monika; Pollak, Michael; Mayor, Thibault; Sorensen, Poul H.			Insulin-like growth factor 1 receptor stabilizes the ETV6-NTRK3 chimeric oncoprotein by blocking its KPC1/Rnf123-mediated proteasomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Non-receptor tyrosine kinase (nRTK); insulin-like growth factor (IGF); fusion protein; ubiquitylation (ubiquitination); oncogene	FACTOR-I RECEPTOR; ACUTE PROMYELOCYTIC LEUKEMIA; SMALL-MOLECULE INHIBITOR; PROTEIN-TYROSINE KINASE; GENE FUSION; CONGENITAL FIBROSARCOMA; CYCLOLIGNAN PPP; TEL ETV6; TRANSFORMATION; CELLS	Many oncogenes, including chimeric oncoproteins, require insulin-like growth factor 1 receptor (IGF1R) for promoting cell transformation. The ETS variant 6 (ETV6)-neurotrophic receptor tyrosine kinase 3 (NTRK3) (EN) chimeric tyrosine kinase is expressed in mesenchymal, epithelial, and hematopoietic cancers and requires the IGF1R axis for transformation. However, current models of IGF1R-mediated EN activation are lacking mechanistic detail. We demonstrate here that IGF-mediated IGF1R stimulation enhances EN tyrosine phosphorylation and that blocking IGF1R activity or decreasing protein levels of the adaptor protein insulin receptor substrate 1/2 (IRS1/2) results in rapid EN degradation. This was observed both in vitro and in vivo in fibroblast and breast epithelial cell line models and in MO91, an EN-expressing human leukemia cell line. Stable isotope labeling with amino acids in cell culture (SILAC)-based MS analysis identified the E3 ligase RING-finger protein 123 (Rnf123, more commonly known as KPC1) as an EN interactor upon IGF1R/insulin receptor (INSR) inhibitor treatment. KPC1/Rnf123 ubiquitylated EN in vitro, and its overexpression decreased EN protein levels. In contrast, KPC1/Rnf123 knockdown rendered EN resistant to IGF1R inhibitor-mediated degradation. These results support a critical function for IGF1R in protecting EN from KPC1/Rnf123-mediated proteasomal degradation. Attempts to therapeutically target oncogenic chimeric tyrosine kinases have traditionally focused on blocking kinase activity to restrict downstream activation of essential signaling pathways. In this study, we demonstrate that IGF1R inhibition results in rapid ubiquitylation and degradation of the EN oncoprotein through a proteasome-dependent mechanism that is reversible, highlighting a potential strategy for targeting chimeric tyrosine kinases in cancer.	[Tognon, Cristina E.; Rafn, Bo; Cetinbas, Naniye Malli; Trigo, Genny; Rotblat, Barak; Chow, Christine; Sorensen, Poul H.] British Columbia Canc Res Ctr, Dept Mol Oncol, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada; [Mayor, Thibault] Univ British Columbia, Michael Smith Labs, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada; [Kamura, Takumi; Okumura, Fumihiko; Matsumoto, Masaki] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan; [Davare, Monika] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97239 USA; [Pollak, Michael] Jewish Gen Hosp, Lady Davis Inst Med Res SMBD, Montreal, PQ H3T 1E2, Canada	British Columbia Cancer Agency; University of British Columbia; Kyushu University; Oregon Health & Science University; Lady Davis Institute; McGill University	Sorensen, PH (corresponding author), British Columbia Canc Res Ctr, Dept Mol Oncol, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	psor@mail.ubc.ca	Rotblat, Barak/H-5970-2019	Rotblat, Barak/0000-0003-2985-7115; Davare, Monika/0000-0003-1802-7597; Pollak, Michael/0000-0003-3047-0604	Canadian Institutes of Health Research [49520]; ReThink Breast Cancer for a Career Development Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); ReThink Breast Cancer for a Career Development Award	This work was supported in part by Canadian Institutes of Health Research Grant 49520 (to P.H.S.) and a ReThink Breast Cancer for a Career Development Award (to C.E.T.). The authors declare that they have no conflicts of interest with the contents of this article.	Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Cetinbas N, 2013, J BIOL CHEM, V288, P27940, DOI 10.1074/jbc.M113.475301; Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070; De Braekeleer E, 2014, EXPERT REV HEMATOL, V7, P347, DOI 10.1586/17474086.2014.903794; Drilon A, 2018, NEW ENGL J MED, V378, P731, DOI 10.1056/NEJMoa1714448; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Frantsve J, 2001, MOL CELL BIOL, V21, P3547, DOI 10.1128/MCB.21.10.3547-3557.2001; Gu TL, 2007, LEUKEMIA, V21, P563, DOI 10.1038/sj.leu.2404555; Hailey J, 2002, MOL CANCER THER, V1, P1349; Hara T, 2005, MOL CELL BIOL, V25, P9292, DOI 10.1128/MCB.25.21.9292-9303.2005; Hechtman JF, 2016, MOL CANCER RES, V14, P296, DOI 10.1158/1541-7786.MCR-15-0392-T; Chi HT, 2012, BIOCHEM BIOPH RES CO, V429, P87, DOI 10.1016/j.bbrc.2012.10.087; Hu J, 2009, P NATL ACAD SCI USA, V106, P3342, DOI 10.1073/pnas.0813280106; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Knezevich SR, 1998, CANCER RES, V58, P5046; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lannon CL, 2004, J BIOL CHEM, V279, P6225, DOI 10.1074/jbc.M307388200; Leeman-Neill RJ, 2014, CANCER-AM CANCER SOC, V120, P799, DOI 10.1002/cncr.28484; Li Z, 2007, CANCER CELL, V12, P542, DOI 10.1016/j.ccr.2007.11.012; Martin MJ, 2006, MOL CELL BIOL, V26, P1754, DOI 10.1128/MCB.26.5.1754-1769.2006; Menu E, 2006, BLOOD, V107, P655, DOI 10.1182/blood-2005-01-0293; Monni R, 2001, ONCOGENE, V20, P849, DOI 10.1038/sj.onc.1204201; Morrison KB, 2002, ONCOGENE, V21, P5684, DOI 10.1038/sj.onc.1205669; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Roberts KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMoa1403088; Roukens MG, 2008, MOL CELL BIOL, V28, P4394, DOI 10.1128/MCB.01914-07; Roukens MG, 2008, MOL CELL BIOL, V28, P2342, DOI 10.1128/MCB.01159-07; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Skalova A, 2010, AM J SURG PATHOL, V34, P599, DOI 10.1097/PAS.0b013e3181d9efcc; Sun HS, 2011, BLOOD, V117, P3151, DOI 10.1182/blood-2010-03-276477; Taipale M, 2013, NAT BIOTECHNOL, V31, P630, DOI 10.1038/nbt.2620; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tognon C, 2001, CANCER RES, V61, P8909; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Tognon CE, 2012, ONCOGENE, V31, P1334, DOI 10.1038/onc.2011.323; Tognon CE, 2004, MOL CELL BIOL, V24, P4636, DOI 10.1128/MCB.24.11.4636-4650.2004; Tognon CE, 2011, CANCER RES, V71, P1060, DOI 10.1158/0008-5472.CAN-10-3096; Toretsky JA, 1997, J BIOL CHEM, V272, P30822, DOI 10.1074/jbc.272.49.30822; Vasilcanu D, 2004, ONCOGENE, V23, P7854, DOI 10.1038/sj.onc.1208065; Wai DH, 2000, ONCOGENE, V19, P906, DOI 10.1038/sj.onc.1203396; Wang S, 2014, P NATL ACAD SCI USA, V111, P4251, DOI 10.1073/pnas.1322198111; Wang W, 1998, CANCER RES, V58, P4426; Wilde IB, 2011, J PROTEOME RES, V10, P1062, DOI 10.1021/pr1008543; Wittman M, 2005, J MED CHEM, V48, P5639, DOI 10.1021/jm050392q; Wittman MD, 2009, J MED CHEM, V52, P7360, DOI 10.1021/jm900786r; Wu G, 2014, NAT GENET, V46, P444, DOI 10.1038/ng.2938; Yamamoto H, 2016, HISTOPATHOLOGY, V69, P72, DOI 10.1111/his.12910	49	9	10	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12502	12515		10.1074/jbc.RA117.000321	http://dx.doi.org/10.1074/jbc.RA117.000321			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29903916	hybrid, Green Published			2022-12-26	WOS:000441408500016
J	Chen, LY; Lotz, M; Terkeltaub, R; Liu-Bryan, R				Chen, Liang-Yu; Lotz, Martin; Terkeltaub, Robert; Liu-Bryan, Ru			Modulation of matrix metabolism by ATP-citrate lyase in articular chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); acetylation; AMP-activated kinase (AMPK); epigenetics; chondrocyte; ATP-citrate lyase; hydroxycitric acid; nucleocytosolic acetyl-CoA	ACETYL-COENZYME; OSTEOARTHRITIS; AUTOPHAGY; CHONDROPROTECTION; PATHOGENESIS; CARTILAGE; TARGET; GROWTH; BONE	Certain dysregulated chondrocyte metabolic adaptive responses such as decreased activity of the master regulator of energy metabolism AMP-activated protein kinase (AMPK) promote osteoarthritis (OA). Metabolism intersects with epigenetic and transcriptional responses. Hence, we studied chondrocyte ATP-citrate lyase (ACLY), which generates acetyl-CoA from mitochondrial-derived citrate, and modulates acetylation of histones and transcription factors. We assessed ACLY in normal and OA human knee chondrocytes and cartilages by Western blotting and immunohistochemistry, and quantified acetyl-CoA fluorometrically. We examined histone and transcription factor lysine acetylation by Western blotting, and assessed histone H3K9 and H3K27 occupancy of iNOS, MMP3, and MMP13 promoters by chromatin immunoprecipitation (ChIP) and quantitative PCR (qPCR). We analyzed iNOS, MMP3, MMP13, aggrecan (ACAN), and Col2a1 gene expression by RT-qPCR. Glucose availability regulated ACLY expression and function, nucleocytosolic acetyl-CoA, and histone acetylation. Human knee OA chondrocytes exhibited increased ACLY activation (assessed by Ser-455 phosphorylation), associated with increased H3K9 and H3K27 acetylation. Inhibition of ACLY attenuated IL-1-induced transcription of iNOS, MMP3, and MMP13 by suppressing acetylation of p65 NF-B, H3K9, and H3K27, blunted release of NO, MMP3, and MMP13, and also reduced SOX9 acetylation that promoted SOX9 nuclear translocation, leading to increased aggrecan and Col2a1 mRNA expression. ACLY is a novel player involved in regulation of cartilage matrix metabolism. Increased ACLY activity in OA chondrocytes increased nucleocytosolic acetyl-CoA, leading to increased matrix catabolism via dysregulated histone and transcription factor acetylation. Pharmacologic ACLY inhibition in OA chondrocytes globally reverses these changes and stimulates matrix gene expression and AMPK activation, supporting translational investigation in OA.	[Chen, Liang-Yu; Terkeltaub, Robert; Liu-Bryan, Ru] Vet Affairs San Diego Healthcare Syst, 111K,3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Lotz, Martin] Scripps Res Inst, La Jolla, CA 92037 USA; [Terkeltaub, Robert; Liu-Bryan, Ru] Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Scripps Research Institute; University of California System; University of California San Diego	Liu-Bryan, R (corresponding author), Vet Affairs San Diego Healthcare Syst, 111K,3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ruliu@ucsd.edu		Liu-Bryan, Ru/0000-0002-9611-8163	Department of Veterans Affairs [1I01BX002234, I01BX001660]; National Institutes of Health [AG007996]; NATIONAL INSTITUTE ON AGING [P01AG007996] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002234, I01BX001660] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Department of Veterans Affairs Grants 1I01BX002234 and I01BX001660 and National Institutes of Health Grant AG007996. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bar Oz M, 2016, AGING CELL, V15, P499, DOI 10.1111/acel.12456; Beigneux AP, 2004, J BIOL CHEM, V279, P9557, DOI 10.1074/jbc.M310512200; Berenbaum F, 2017, ARTHRITIS RHEUMATOL, V69, P9, DOI 10.1002/art.39842; Bohensky J, 2010, PEDIATR NEPHROL, V25, P633, DOI 10.1007/s00467-009-1310-y; Burke AC, 2017, CURR OPIN LIPIDOL, V28, P193, DOI 10.1097/MOL.0000000000000390; Carames B, 2012, ARTHRITIS RHEUM-US, V64, P1182, DOI 10.1002/art.33444; Carames B, 2010, ARTHRITIS RHEUM-US, V62, P791, DOI 10.1002/art.27305; Carling D, 2017, CURR OPIN CELL BIOL, V45, P31, DOI 10.1016/j.ceb.2017.01.005; Cecil DL, 2008, J IMMUNOL, V180, P8378, DOI 10.4049/jimmunol.180.12.8378; Chang XT, 2011, INT J RHEUM DIS, V14, P217, DOI 10.1111/j.1756-185X.2011.01598.x; Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144; Courties A, 2017, CURR OPIN RHEUMATOL, V29, P214, DOI 10.1097/BOR.0000000000000373; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Das S, 2015, CELL METAB, V21, P868, DOI 10.1016/j.cmet.2015.05.006; Eisenberg T, 2014, CELL METAB, V19, P431, DOI 10.1016/j.cmet.2014.02.010; Hardie David Grahame, 2017, F1000Res, V6, P1724, DOI 10.12688/f1000research.11960.1; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Infantino V, 2013, BIOCHEM BIOPH RES CO, V440, P105, DOI 10.1016/j.bbrc.2013.09.037; Keating ST, 2015, CIRC RES, V116, P715, DOI 10.1161/CIRCRESAHA.116.303936; Khwairakpam AD, 2015, CURR DRUG TARGETS, V16, P156, DOI 10.2174/1389450115666141224125117; Kim H, 2015, MOL CELLS, V38, P677, DOI 10.14348/molcells.2015.0200; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Madeo F, 2014, NAT REV DRUG DISCOV, V13, P727, DOI 10.1038/nrd4391; Marino G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016; Martel-Pelletier J, 1998, INFLAMM RES, V47, P90, DOI 10.1007/s000110050288; Mobasheri A, 2017, NAT REV RHEUMATOL, V13, P302, DOI 10.1038/nrrheum.2017.50; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Phillips T, 2005, VET J, V169, P216, DOI 10.1016/j.tvjl.2004.01.026; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Rosa SC, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2713; Schroeder S, 2014, AUTOPHAGY, V10, P1335, DOI 10.4161/auto.28919; Shi L, 2015, CURR OPIN CELL BIOL, V33, P125, DOI 10.1016/j.ceb.2015.02.003; Shikhman AR, 2009, OSTEOARTHR CARTILAGE, V17, P1022, DOI 10.1016/j.joca.2009.03.004; Terkeltaub R, 2011, ARTHRITIS RHEUM-US, V63, P1928, DOI 10.1002/art.30333; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yamada K, 2002, OSTEOARTHR CARTILAGE, V10, P360, DOI 10.1053/joca.2002.0525; Zhao XL, 2014, ARTHRITIS RHEUMATOL, V66, P3073, DOI 10.1002/art.38791; Zhou S, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43245	39	13	14	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12259	12270		10.1074/jbc.RA118.002261	http://dx.doi.org/10.1074/jbc.RA118.002261			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29929979	hybrid, Green Published			2022-12-26	WOS:000440803200023
J	de Albuquerque, CP; Suhandynata, RT; Carlson, CR; Yuan, WT; Zhou, HL				de Albuquerque, Claudio Ponte; Suhandynata, Raymond T.; Carlson, Christopher R.; Yuan, Wei-Tsung; Zhou, Huilin			Binding to small ubiquitin-like modifier and the nucleolar protein Csm1 regulates substrate specificity of the Ulp2 protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						SUMO-interacting motif (SIM); sumoylation; post-translational modification (PTM); protease; substrate specificity; isothermal titration calorimetry (ITC); Cdc14; Net1; Tof2; Ulp1; Ulp2	SACCHAROMYCES-CEREVISIAE; SUMO ISOPEPTIDASE; SUMOYLATED PROTEINS; MONOPOLIN COMPLEX; NUCLEAR-PORE; YEAST; PATHWAY; LIGASE; LOCALIZATION; RECOGNITION	Ulp1 and Ulp2, in the yeast Saccharomyces cerevisiae, are the founding members of deSUMOylating enzymes. These enzymes remove small ubiquitin-like modifier (SUMO) from proteins and are conserved in all eukaryotes. Previous studies have shown that Ulp1 deSUMOylates the bulk of intracellular SUMOylated proteins, whereas Ulp2 is a highly specific enzyme. However, the mechanism for Ulp2's substrate specificity has been insufficiently understood. Here we show that the C-terminal regulatory domain of Ulp2 contains three distinct, yet conserved, motifs that control its in vivo substrate specificity and cell growth. Among them, a SUMO-interacting motif (SIM) was found to coordinate with the domain of Ulp2 that binds to the nucleolar protein Csm1 to ensure maximal deSUMOylation of Ulp2's nucleolar substrates. We found that whereas the Csm1-binding domain of Ulp2 recruits this enzyme to the nucleolus, Ulp2's C-terminal SIM promotes its SUMO protease activity and plays a key role in mediating the in vivo specificity of Ulp2. Thus, the substrate specificity of Ulp2 is controlled by both its subcellular localization and the SUMOylation status of its substrates. These findings illustrate the highly coordinated and dynamic nature of the SUMO pathways in maintaining homeostasis of intracellular SUMOylation.	[de Albuquerque, Claudio Ponte; Suhandynata, Raymond T.; Carlson, Christopher R.; Yuan, Wei-Tsung; Zhou, Huilin] Univ Calif San Diego, San Diego Branch, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Yuan, Wei-Tsung] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhou, HL (corresponding author), Univ Calif San Diego, Cellular & Mol Med, 9500 Gilman Dr,CMM East 2055, La Jolla, CA 92093 USA.	huzhou@ucsd.edu		Zhou, Huilin/0000-0002-1350-4430	National Institutes of Health NIGMS [R01 GM116897]; Ludwig Institute for Cancer Research; National Institutes of Health NCI [NCI T32 CA009523]; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116897] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023498] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ludwig Institute for Cancer Research; National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health NIGMS Grant R01 GM116897 and the Ludwig Institute for Cancer Research (to H. Z.) and National Institutes of Health NCI Grant NCI T32 CA009523 (to R. T. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albuquerque CP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143810; Albuquerque CP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003670; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Corbett KD, 2012, CELL REPORTS, V1, P583, DOI 10.1016/j.celrep.2012.05.012; Corbett KD, 2010, CELL, V142, P556, DOI 10.1016/j.cell.2010.07.017; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; de Albuquerque CP, 2016, J BIOL CHEM, V291, P8825, DOI 10.1074/jbc.M116.716399; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Eckhoff J, 2015, J BIOL CHEM, V290, P12268, DOI 10.1074/jbc.M114.622217; Elmore ZC, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-74; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gillies J, 2016, GENETICS, V202, P1377, DOI 10.1534/genetics.116.187252; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kroetz MB, 2009, MOL BIOL CELL, V20, P2196, DOI 10.1091/mbc.E08-10-1090; Lee MT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001355; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Liang J, 2017, GENE DEV, V31, P802, DOI 10.1101/gad.296145.117; Lima CD, 2008, J BIOL CHEM, V283, P32045, DOI 10.1074/jbc.M805655200; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Namanja AT, 2012, J BIOL CHEM, V287, P3231, DOI 10.1074/jbc.M111.293118; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Panse VG, 2003, NAT CELL BIOL, V5, P21, DOI 10.1038/ncb893; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Rosonina E, 2010, GENE DEV, V24, P1242, DOI 10.1101/gad.1917910; Ryu HY, 2016, GENE DEV, V30, P1881, DOI 10.1101/gad.282194.116; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Srikumar T, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.23; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhao XL, 2004, J CELL BIOL, V167, P605, DOI 10.1083/jcb.200405168; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	45	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12105	12119		10.1074/jbc.RA118.003022	http://dx.doi.org/10.1074/jbc.RA118.003022			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29903909	Green Published, hybrid			2022-12-26	WOS:000440803200011
J	Xin, D; Gu, HY; Liu, EP; Sun, QM				Xin, Di; Gu, Haiyan; Liu, Enping; Sun, Qinmiao			Parkin negatively regulates the antiviral signaling pathway by targeting TRAF3 for degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; cell signaling; Parkin; interferon; ubiquitylation (ubiquitination); TRAF3	VIRAL-INFECTION; INNATE IMMUNITY; MITOFUSIN 1; DISEASE; LIGASE; UBIQUITINATION; INFLAMMATION; RECOGNITION; MITOPHAGY; PROMOTES	Chronic neuroinflammation is a characteristic of Parkinson's disease (PD). Previous investigations have shown that Parkin gene mutations are related to the early-onset recessive form of PD and isolated juvenile-onset PD. Further, Parkin plays important roles in mitochondrial quality control and cytokine-induced cell death. However, whether Parkin regulates other cellular events is still largely unknown. In this study, we performed overexpression and knockout experiments and found that Parkin negatively regulates antiviral immune responses against RNA and DNA viruses. Mechanistically, we show that Parkin interacts with tumor necrosis factor receptor-associated factor 3 (TRAF3) to regulate stability of TRAF3 protein by promoting Lys(48)-linked ubiquitination. Our findings suggest that Parkin plays a novel role in innate immune signaling by targeting TRAF3 for degradation and maintaining the balance of innate antiviral immunity.	[Xin, Di; Gu, Haiyan; Liu, Enping; Sun, Qinmiao] Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, 1 Beichen West Rd, Beijing 100101, Peoples R China; [Xin, Di; Gu, Haiyan; Liu, Enping; Sun, Qinmiao] Univ Chinese Acad Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, QM (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, 1 Beichen West Rd, Beijing 100101, Peoples R China.	qinmiaosun@ioz.ac.cn			Strategic Priority Research Program of Chinese Academy of Sciences [XDB13000000]; National Natural Science Foundation of China [31570916, 31370882, 31371450]	Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Strategic Priority Research Program of Chinese Academy of Sciences Grant XDB13000000 and National Natural Science Foundation of China Grants 31570916, 31370882, and 31371450. The authors declare that they have no conflicts of interest with the contents of this article.	Abdullah Z, 2014, EMBO J, V33, P2283, DOI 10.15252/embj.201489055; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Baum A, 2010, AMINO ACIDS, V38, P1283, DOI 10.1007/s00726-009-0374-0; Birsa N, 2014, J BIOL CHEM, V289, P14569, DOI 10.1074/jbc.M114.563031; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Chen HL, 2003, ARCH NEUROL-CHICAGO, V60, P1059, DOI 10.1001/archneur.60.8.1059; Chen H, 2008, AM J EPIDEMIOL, V167, P90, DOI 10.1093/aje/kwm260; Chung JY, 2013, LAB INVEST, V93, P663, DOI 10.1038/labinvest.2013.60; Cottier F, 2012, IMMUNOL RES, V53, P127, DOI 10.1007/s12026-012-8265-y; Dzamko N, 2015, NEUROSCIENCE, V302, P89, DOI 10.1016/j.neuroscience.2014.10.028; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Hu HB, 2013, NATURE, V494, P371, DOI 10.1038/nature11831; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Kannarkat GT, 2013, J PARKINSON DIS, V3, P493, DOI 10.3233/JPD-130250; Kazlauskaite A, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130213; Khan M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005693; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Kumagai Y, 2010, J ALLERGY CLIN IMMUN, V125, P985, DOI 10.1016/j.jaci.2010.01.058; Lee JK, 2009, J NEUROIMMUNE PHARM, V4, P419, DOI 10.1007/s11481-009-9176-0; Li ZX, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004783; Lin DD, 2015, P NATL ACAD SCI USA, V112, P11324, DOI 10.1073/pnas.1509968112; Lin W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11848; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; McGeer EG, 2005, NEUROBIOL AGING, V26, pS94, DOI 10.1016/j.neurobiolaging.2005.08.008; Muller-Rischart AK, 2013, MOL CELL, V49, P908, DOI 10.1016/j.molcel.2013.01.036; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Paz S, 2011, CELL RES, V21, P895, DOI 10.1038/cr.2011.2; Sai Y, 2012, NEUROSCI BIOBEHAV R, V36, P2034, DOI 10.1016/j.neubiorev.2012.06.007; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sun LJ, 2010, CELL, V140, P436, DOI 10.1016/j.cell.2010.01.041; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zhao YY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003086	44	13	13	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					11996	12010		10.1074/jbc.RA117.001201	http://dx.doi.org/10.1074/jbc.RA117.001201			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29903906	Green Published, hybrid			2022-12-26	WOS:000440803200003
J	Breitwieser, M; Dubillot, E; Barbarin, M; Churlaud, C; Huet, V; Muttin, F; Thomas, H				Breitwieser, Marine; Dubillot, Emmanuel; Barbarin, Marine; Churlaud, Carine; Huet, Valerie; Muttin, Frederic; Thomas, Helene			Assessment of the biological quality of port areas: A case study on the three harbours of La Rochelle: The marina, the fishing harbour and the seaport	PLOS ONE			English	Article							SCALLOP CHLAMYS-VARIA; OXIDATIVE STRESS; CONTAMINATION; PECTINIDAE; RESPONSES; EXPOSURE; METALS; CD; ACCUMULATION; BIOMARKERS	This work was designed to investigate biological impacts at 3 dates (day 0, day 7 and day 21) on black scallops (Mimachlamys varia) in the three ports areas of La Rochelle town in winter 2017. In order to assess the biological effects on the wild population of black scallops, bivalves were place in four different locations: in the three ports (semi-closed areas), and in a marshland uncontaminated site (closed area). Biomarkers of effects (heavy metals) and exposure (oxidative stress and immunological effects) were assessed in the digestive glands of specimens in order to compare two techniques of sampling: "pool" technique and "inter-subject" technique. Our findings reported in the both techniques show significant modulation of GST (detoxification), SOD (antioxidant response) and MDA (lipid peroxidation) in bivalves exposed to a specific contamination in each port. Laccase-type enzyme also highlighted an important aspect in terms of biomarker response of the immune function at the 7th day of exposition. Overall, our study demonstrated that the "pool" technique using the same quality indicator M. varia could be used to obtain reliable results at lower costs. In contrast, in fundamental context, the "inter-subject" technique could bring more precise results to light. However, it requires burdensome and costly handling.	[Breitwieser, Marine; Dubillot, Emmanuel; Barbarin, Marine; Churlaud, Carine; Huet, Valerie; Thomas, Helene] Univ La Rochelle, CNRS, UMR 7266, Littoral Environm Soc LIENSs, La Rochelle, France; [Muttin, Frederic] EIGSI, La Rochelle, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite	Breitwieser, M (corresponding author), Univ La Rochelle, CNRS, UMR 7266, Littoral Environm Soc LIENSs, La Rochelle, France.	marine.breitwieser@univ-lr.fr	Muttin, Frederic/AAH-5906-2020	Muttin, Frederic/0000-0002-0217-7841; Barbarin, Marine/0000-0001-6281-6249				Akcha F, 2000, AQUAT TOXICOL, V49, P269, DOI 10.1016/S0166-445X(99)00082-X; Ansaldo M, 2007, COMP BIOCHEM PHYS C, V146, P118, DOI 10.1016/j.cbpc.2006.11.004; Breitwieser M, 2018, ECOTOX ENVIRON SAFE, V153, P168, DOI 10.1016/j.ecoenv.2018.01.033; Breitwieser M, 2017, COMP BIOCHEM PHYS C, V199, P28, DOI 10.1016/j.cbpc.2017.02.006; Breitwieser M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150184; Bustamante P, 2005, ENVIRON POLLUT, V138, P109, DOI 10.1016/j.envpol.2005.02.014; Bustamante P, 2004, CHEMOSPHERE, V57, P1355, DOI 10.1016/j.chemosphere.2004.08.077; Cheung CCC, 2004, ENVIRON POLLUT, V128, P393, DOI 10.1016/j.envpol.2003.09.010; Hawkins CA, 2017, AQUAT TOXICOL, V192, P251, DOI 10.1016/j.aquatox.2017.09.028; Jupp BP, 2017, MAR POLLUT BULL, V121, P260, DOI 10.1016/j.marpolbul.2017.05.015; Liu N, 2012, MAR ENVIRON RES, V80, P38, DOI 10.1016/j.marenvres.2012.06.008; Ludeking A, 2002, MAR ECOL PROG SER, V238, P115, DOI 10.3354/meps238115; Luna-Acosta A, 2017, MAR POLLUT BULL, V122, P5, DOI 10.1016/j.marpolbul.2017.06.031; Luna-Acosta A, 2015, SCI TOTAL ENVIRON, V514, P511, DOI 10.1016/j.scitotenv.2014.10.050; Luna-Acosta A, 2011, FISH SHELLFISH IMMUN, V31, P795, DOI 10.1016/j.fsi.2011.07.016; Luna-Acosta A, 2010, FISH SHELLFISH IMMUN, V28, P719, DOI 10.1016/j.fsi.2010.01.008; MAURI M, 1990, MAR ECOL PROG SER, V67, P27, DOI 10.3354/meps067027; Metian M, 2008, ENVIRON POLLUT, V152, P543, DOI 10.1016/j.envpol.2007.07.009; Metian M, 2007, J EXP MAR BIOL ECOL, V353, P58, DOI 10.1016/j.jembe.2007.09.001; Metian M, 2009, SCI TOTAL ENVIRON, V407, P3503, DOI 10.1016/j.scitotenv.2009.02.010; Meybeck M., 1998, RIVERS LAKES ENERGY, P1; Milinkovitch T, 2015, AQUAT TOXICOL, V161, P170, DOI 10.1016/j.aquatox.2015.02.003; Pan LQ, 2005, COMP BIOCHEM PHYS C, V141, P248, DOI 10.1016/j.cca.2005.07.005; PAOLETTI F, 1986, ANAL BIOCHEM, V154, P536, DOI 10.1016/0003-2697(86)90026-6; R Core Team, 2021, R LANGUAGE ENV STAT; Regoli F, 2003, ENVIRON TOXICOL CHEM, V22, P2120, DOI 10.1897/02-378; Regoli F, 2002, SCI TOTAL ENVIRON, V289, P205, DOI 10.1016/S0048-9697(01)01047-6; Rocher B, 2006, AQUAT TOXICOL, V79, P65, DOI 10.1016/j.aquatox.2006.05.005; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tsai PS, 2006, GEN COMP ENDOCR, V148, P48, DOI 10.1016/j.ygcen.2005.09.016; Venables W. N., 2013, MODERN APPL STAT S P; Viarengo A, 1999, AM J PHYSIOL-REG I, V277, pR1612, DOI 10.1152/ajpregu.1999.277.6.R1612; WINSTON GW, 1991, AQUAT TOXICOL, V19, P137, DOI 10.1016/0166-445X(91)90033-6	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0198255	10.1371/journal.pone.0198255	http://dx.doi.org/10.1371/journal.pone.0198255			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940009	Green Submitted, Green Published, gold			2022-12-26	WOS:000436088700002
J	Ma, C; Hao, W; Pan, F; Xiang, W				Ma, Changxi; Hao, Wei; Pan, Fuquan; Xiang, Wang			Road screening and distribution route multi objective robust optimization for hazardous materials based on neural network and genetic algorithm	PLOS ONE			English	Article							MATERIALS TRANSPORTATION	Route optimization of hazardous materials transportation is one of the basic steps in ensuring the safety of hazardous materials transportation. The optimization scheme may be a security risk if road screening is not completed before the distribution route is optimized. For road screening issues of hazardous materials transportation, a road screening algorithm of hazardous materials transportation is built based on genetic algorithm and Levenberg Marquardt neural network (GA-LM-NN) by analyzing 15 attributes data of each road network section. A multi-objective robust optimization model with adjustable robustness is constructed for the hazardous materials transportation problem of single distribution center to minimize transportation risk and time. A multi-objective genetic algorithm is designed to solve the problem according to the characteristics of the model. The algorithm uses an improved strategy to complete the selection operation, applies partial matching cross shift and single ortho swap methods to complete the crossover and mutation operation, and employs an exclusive method to construct Pareto optimal solutions. Studies show that the sets of hazardous materials transportation road can be found quickly through the proposed road screening algorithm based on GA-LM-NN, whereas the distribution route Pareto solutions with different levels of robustness can be found rapidly through the proposed multi objective robust optimization model and algorithm.	[Ma, Changxi] Lanzhou Jiaotong Univ, Sch Traff & Transportat, Lanzhou, Gansu, Peoples R China; [Hao, Wei; Xiang, Wang] Changsha Univ Sci & Technol, Hunan Key Lab Smart Roadway & Cooperat Vehicle In, Changsha, Hunan, Peoples R China; [Hao, Wei] Changsha Univ Sci & Technol, Key Lab Safety Design & Reliabil Technol Engn Veh, Changsha, Hunan, Peoples R China; [Hao, Wei] Changsha Univ Sci & Technol, Hunan Prov Key Lab Intelligent Proc Big Data Tran, Changsha, Hunan, Peoples R China; [Pan, Fuquan] Qingdao Univ Technol, Sch Automobile & Transportat, Qingdao, Shandong, Peoples R China	Lanzhou Jiaotong University; Changsha University of Science & Technology; Changsha University of Science & Technology; Changsha University of Science & Technology; Qingdao University of Technology	Hao, W; Xiang, W (corresponding author), Changsha Univ Sci & Technol, Hunan Key Lab Smart Roadway & Cooperat Vehicle In, Changsha, Hunan, Peoples R China.; Hao, W (corresponding author), Changsha Univ Sci & Technol, Key Lab Safety Design & Reliabil Technol Engn Veh, Changsha, Hunan, Peoples R China.; Hao, W (corresponding author), Changsha Univ Sci & Technol, Hunan Prov Key Lab Intelligent Proc Big Data Tran, Changsha, Hunan, Peoples R China.	haowei@csust.edu.cn; 158995646@qq.com	Xiang, Wang/K-4832-2019	Xiang, Wang/0000-0002-4619-5849				Akgun V, 2000, EUR J OPER RES, V121, P232, DOI 10.1016/S0377-2217(99)00214-3; Akgun V, 2007, COMPUT OPER RES, V34, P1351, DOI 10.1016/j.cor.2005.06.005; Amir AS, 2005, WORLD ACAD SCI ENG T, p45 ; Ben-Tal A, 1998, MATH OPER RES, V23, P769, DOI 10.1287/moor.23.4.769; Bertsimas D, 2004, OPER RES, V52, P35, DOI 10.1287/opre.1030.0065; Clark RM, 2009, RISK ANAL, V29, P344, DOI 10.1111/j.1539-6924.2008.01163.x; Dadkar Y, 2008, TRANSPORT RES E-LOG, V44, P333, DOI 10.1016/j.tre.2006.10.010; Das A, 2012, J HAZARD MATER, V227, P341, DOI 10.1016/j.jhazmat.2012.05.068; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Erkut E, 2008, COMPUT OPER RES, V35, P2234, DOI 10.1016/j.cor.2006.10.022; Erkut E, 2007, TRANSPORT SCI, V41, P107, DOI 10.1287/trsc.1060.0176; He ZB, 2017, COMPUT-AIDED CIV INF, V32, P252, DOI 10.1111/mice.12251; He ZB, 2013, TRANSPORT RES C-EMER, V32, P89, DOI 10.1016/j.trc.2013.04.005; Horn J., 1994, Proceedings of the First IEEE Conference on Evolutionary Computation. IEEE World Congress on Computational Intelligence (Cat. No.94TH0650-2), P82, DOI 10.1109/ICEC.1994.350037; Jassbi J, 2010, APPL MATH SCI, V4, P3121; Kara BY, 2004, TRANSPORT SCI, V38, P188, DOI 10.1287/trsc.1030.0065; KARKAZIS J, 1995, EUR J OPER RES, V86, P201, DOI 10.1016/0377-2217(94)00099-X; [刘浩学 Liu Haoxue], 2006, [交通运输工程学报, Journal of triffic and transportation engineering], V6, P80; Ma C., 2015, THESIS; Ma CX, 2013, INT J BIO-INSPIR COM, V5, P252, DOI 10.1504/IJBIC.2013.055473; Ma CX, 2013, THESIS; Ma XL, 2015, TRANSPORT RES C-EMER, V54, P187, DOI 10.1016/j.trc.2015.03.014; Mary EH, 1997, TRANSPORT SCI, V31, P216; Meng Q, 2005, J TRANSP ENG, V131, P699, DOI 10.1061/(ASCE)0733-947X(2005)131:9(699); Pradhananga R, 2014, SOCIO-ECON PLAN SCI, V48, P135, DOI 10.1016/j.seps.2014.02.003; Shen X., 2009, THESIS; Vasiliki K, 2011, J LOSS PREVENT PROC, V24, p767 ; Verma M, 2009, TRANSPORT RES D-TR E, V14, P300, DOI 10.1016/j.trd.2009.03.002; Xie C, 2012, COMPUT-AIDED CIV INF, V27, P77, DOI 10.1111/j.1467-8667.2011.00720.x; Zitzler E, 2001, EVOLUTIONARY METHODS; Zografos KG, 2004, EUR J OPER RES, V152, P507, DOI 10.1016/S0377-2217(03)00041-9; ZOGRAFOS KG, 1989, J TRANSP ENG-ASCE, V115, P661, DOI 10.1061/(ASCE)0733-947X(1989)115:6(661)	33	80	80	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198931	10.1371/journal.pone.0198931	http://dx.doi.org/10.1371/journal.pone.0198931			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK0LV	29927981	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500035
J	Uhde, K; van Tol, HTA; Stout, TAE; Roelen, BAJ				Uhde, Karen; van Tol, Helena T. A.; Stout, Tom A. E.; Roelen, Bernard A. J.			Exposure to elevated glucose concentrations alters the metabolomic profile of bovine blastocysts	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; ENCLOSED MOUSE OOCYTES; IN-VITRO MATURATION; MEIOTIC MATURATION; DIABETES-MELLITUS; PREIMPLANTATION EMBRYOS; PROTEIN-SYNTHESIS; OXIDATIVE STRESS; IVM/IVF EMBRYOS; CUMULUS CELLS	Chronically high blood glucose concentrations are a characteristic of diabetes mellitus. Maternal diabetes affects the metabolism of early embryos and can cause a delay in development. To mimic maternal diabetes, bovine in vitro fertilization and embryo culture were performed in fertilization medium and culture medium containing 0.5, 2, 3, and 5 mM, glucose whereas under control conditions, the medium was glucose free (0 mM). Compared to control conditions (0 mM, 31%), blastocyst development was decreased to 23% with 0.5 and 2 mM glucose. Presence of 3 or 5 mM glucose in the medium resulted in decreased blastocyst rates (20% and 10% respectively). The metabolomic profile of resulting day 8 blastocysts was analysed by UPLC-MS/MS, and compared to that of blastocysts cultured in control conditions. Elevated glucose concentrations stimulated an increase in glycolysis and activity of the hexosamine pathway, which is involved in protein glycosylation. However, components of the tricarboxylic acid cycle, such as citrate and alpha-ketoglutarate, were reduced in glucose stimulated blastocysts, suggesting that energy production from pyruvate was inefficient. On the other hand, activity of the polyol pathway, an alternative route to energy generation, was increased. In short, cattle embryos exposed to elevated glucose concentrations during early development showed changes in their metabolomic profile consistent with the expectations of exposure to diabetic conditions.	[Uhde, Karen; van Tol, Helena T. A.; Stout, Tom A. E.; Roelen, Bernard A. J.] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Stout, Tom A. E.; Roelen, Bernard A. J.] Univ Utrecht, Fac Vet Med, Dept Equine Sci, Utrecht, Netherlands	Utrecht University; Utrecht University	Roelen, BAJ (corresponding author), Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands.; Roelen, BAJ (corresponding author), Univ Utrecht, Fac Vet Med, Dept Equine Sci, Utrecht, Netherlands.	b.a.j.roelen@uu.nl			EU FP7 EpiHealthNet [PITN-GA-2012-317146]	EU FP7 EpiHealthNet	This work was supported by EU FP7 EpiHealthNet, PITN-GA-2012-317146.	Akude E, 2011, DIABETES, V60, P288, DOI 10.2337/db10-0818; Baerwald AR, 2012, HUM REPROD UPDATE, V18, P73, DOI 10.1093/humupd/dmr039; Bermejo-Alvarez P, 2012, MOL REPROD DEV, V79, P329, DOI 10.1002/mrd.22028; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cagnone GLM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094391; CARLSON D, 1970, J REPROD FERTIL, V22, P549, DOI 10.1530/jrf.0.0220549; Cetica PD, 1999, THERIOGENOLOGY, V51, P541, DOI 10.1016/S0093-691X(99)00008-4; Cha KY, 1998, HUM REPROD UPDATE, V4, P103, DOI 10.1093/humupd/4.2.103; Chang AS, 2005, ENDOCRINOLOGY, V146, P2445, DOI 10.1210/en.2004-1472; Colton SA, 2002, BIOL REPROD, V67, P220, DOI 10.1095/biolreprod67.1.220; COUSTAN DR, 1980, AM J MED, V68, P845, DOI 10.1016/0002-9343(80)90204-1; Dobbs KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066230; DOWNS SM, 1994, DEV BIOL, V162, P154, DOI 10.1006/dbio.1994.1075; Downs SM, 1998, BIOL REPROD, V58, P1084, DOI 10.1095/biolreprod58.4.1084; Downs SM, 1996, MOL REPROD DEV, V44, P121, DOI 10.1002/(SICI)1098-2795(199605)44:1&lt;121::AID-MRD14&gt;3.0.CO;2-7; Driancourt MA, 2001, THERIOGENOLOGY, V55, P1211, DOI 10.1016/S0093-691X(01)00479-4; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; GARDNER DK, 1990, J REPROD FERTIL, V88, P361, DOI 10.1530/jrf.0.0880361; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; Green MP, 2016, MOL REPROD DEV, V83, P50, DOI 10.1002/mrd.22590; Greene MF, 1999, SEMIN REPROD ENDOCR, V17, P127, DOI 10.1055/s-2007-1016220; Gutierrez-Adan A, 2001, REPROD FERT DEVELOP, V13, P361, DOI 10.1071/RD00039; HARDY K, 1989, HUM REPROD, V4, P188, DOI 10.1093/oxfordjournals.humrep.a136869; Hashimoto S, 2000, MOL REPROD DEV, V56, P520, DOI 10.1002/1098-2795(200008)56:4&lt;520::AID-MRD10&gt;3.0.CO;2-0; Hinder LM, 2013, J ENDOCRINOL, V216, P1, DOI 10.1530/JOE-12-0356; HORNNES PJ, 1986, ACTA ENDOCRINOL-COP, V112, P24; Hugentobler SA, 2008, MOL REPROD DEV, V75, P496, DOI 10.1002/mrd.20760; HUNTER AG, 1987, J DAIRY SCI, V70, P1646, DOI 10.3168/jds.S0022-0302(87)80192-3; International Diabetes Federation, 2020, IDF DIABETES ATLAS; Iwata H, 1998, THERIOGENOLOGY, V50, P365, DOI 10.1016/S0093-691X(98)00146-0; Jungheim ES, 2008, SEMIN REPROD MED, V26, P186, DOI 10.1055/s-2008-1042957; Khurana NK, 2000, THERIOGENOLOGY, V54, P741, DOI 10.1016/S0093-691X(00)00387-3; Kolm-Litty V, 1998, J CLIN INVEST, V101, P160, DOI 10.1172/JCI119875; Kuijk EW, 2012, DEVELOPMENT, V139, P871, DOI 10.1242/dev.071688; LEESE HJ, 1984, J REPROD FERTIL, V72, P9, DOI 10.1530/jrf.0.0720009; Memisogullari R, 2003, CELL BIOCHEM FUNCT, V21, P291, DOI 10.1002/cbf.1025; Moley KH, 1998, NAT MED, V4, P1421, DOI 10.1038/4013; MOLEY KH, 1991, J REPROD FERTIL, V93, P325; OFALLON JV, 1986, BIOL REPROD, V34, P58, DOI 10.1095/biolreprod34.1.58; Pantaleon M, 2010, BIOL REPROD, V82, P751, DOI 10.1095/biolreprod.109.076661; PARRISH JJ, 1989, BIOL REPROD, V41, P683, DOI 10.1095/biolreprod41.4.683; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; Ramin N, 2010, ENDOCRINOLOGY, V151, P4158, DOI 10.1210/en.2010-0187; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; RIEGER D, 1992, REPROD FERT DEVELOP, V4, P547, DOI 10.1071/RD9920547; RIEGER D, 1994, J REPROD FERTIL, V100, P257; SCHULTZ RM, 1977, J CELL SCI, V24, P167; Sekhar RV, 2011, DIABETES CARE, V34, P162, DOI 10.2337/dc10-1006; Sutton ML, 2003, REPRODUCTION, V126, P27, DOI 10.1530/rep.0.1260027; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; van Tol HTA, 2008, MOL REPROD DEV, V75, P578, DOI 10.1002/mrd.20801; VERCHEVAL M, 1990, DIABETOLOGIA, V33, P187, DOI 10.1007/BF00404794; WALES RG, 1993, REPROD FERT DEVELOP, V5, P329, DOI 10.1071/RD9930329; Zheng J, 2014, BRIT J NUTR, V112, P1850, DOI 10.1017/S0007114514002827	55	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199310	10.1371/journal.pone.0199310	http://dx.doi.org/10.1371/journal.pone.0199310			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924852	Green Published, Green Submitted, gold			2022-12-26	WOS:000435655600058
J	Shih, HN; Tsai, WH; Chang, SH; Lin, CY; Hong, RB; Hwang, YS				Shih, Hui-Ning; Tsai, Wen-Hui; Chang, Shao-Hsia; Lin, Chung-Ying; Hong, Rong-Bin; Hwang, Yea-Shwu			Chinese handwriting performance in preterm children in grade 2	PLOS ONE			English	Article							MOVEMENT ASSESSMENT BATTERY; LOW-BIRTH-WEIGHT; DEVELOPMENTAL COORDINATION DISORDER; GESTATIONAL-AGE; BORN CHILDREN; SCHOOL; ABILITIES; GENDER; SCHOOLCHILDREN; DIFFICULTIES	Background First graders born prematurely perform poorly on handwriting speed and legibility. However, whether there are specific legibility factors in which preterm children demonstrate difficulty remains unknown. In addition, handwriting performance beyond the first grade and the influence of sex on handwriting performance in preterm children are still unclear. We aimed to investigate the influence of prematurity and sex on multiple dimensions of handwriting in grade two and to identify the contributors to performance. Methods Sixty-three preterm (34 boys and 29 girls) and 67 full-term (27 boys and 40 girls) peers in grade two were included. Class teachers were asked to complete the Chinese Handwriting Evaluation Form. A subgroup of 39 preterm children received assessments on intelligence, visual perception, tactile and kinesthetic sensation, and fine motor skills. Their inattention behavior was rated using a maternal self-report with a behavioral scale. Results Boys born prematurely exhibited poorer performance in the speed dimension than full-term boys (p = 0.008), whereas there was comparable performance in the two groups of girls (p = 0.221). In the dimensions related to legibility, preterm boys (32.4%) had a higher percentage of children with difficulty in the construction dimension than the other groups (preterm girls: 6.9%, full-term boys: 7.4%, full-term girls: 5.0%). However, no group difference was found in the dimensions of accuracy and directionality. Of the sensory-perceptual-motor factors, attention was the most significant predictor of accuracy in performance (p = 0.046) and speed dimensions (p = 0.001) in preterm children. Conclusions Boys appear to be vulnerable to the adverse impacts of preterm birth in terms of performance in the dimensions of speed and construction in grade two. Based on the significant contribution of attention to handwriting performance in preterm children, assessment and intervention in the area of attention is strongly suggested for preterm children with handwriting problems.	[Shih, Hui-Ning; Hwang, Yea-Shwu] Natl Cheng Kung Univ, Dept Occupat Therapy, Coll Med, Tainan, Taiwan; [Tsai, Wen-Hui] Chi Mei Med Ctr, Dept Pediat, Tainan, Taiwan; [Tsai, Wen-Hui] Chang Jung Christian Univ, Grad Inst Med Sci, Coll Hlth Sci, Tainan, Taiwan; [Chang, Shao-Hsia] I Shou Univ, Dept Occupat Therapy, Kaohsiung, Taiwan; [Lin, Chung-Ying] Hong Kong Polytech Univ, Fac Hlth & Social Sci, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; [Hong, Rong-Bin] Chi Mei Med Ctr, Dept Phys Med & Rehabil, Tainan, Taiwan; [Hwang, Yea-Shwu] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Phys Med & Rehabil, Coll Med, Tainan, Taiwan	National Cheng Kung University; Chi Mei Hospital; Chang Jung Christian University; I Shou University; Hong Kong Polytechnic University; Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Hwang, YS (corresponding author), Natl Cheng Kung Univ, Dept Occupat Therapy, Coll Med, Tainan, Taiwan.; Hwang, YS (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Phys Med & Rehabil, Coll Med, Tainan, Taiwan.	yshwang@mail.ncku.edu.tw	Lin, Chung-Ying/I-5434-2016	Lin, Chung-Ying/0000-0002-2129-4242; Chang, Shao-Hsia/0000-0002-6228-4729	Ministry of Science and Technology, Taiwan [MOST 104-2410-H-006-068]; Chi Mei Medical Center [CMFHR 10604]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chi Mei Medical Center	This study was supported by the Ministry of Science and Technology, Taiwan (grant number: MOST 104-2410-H-006-068) and Chi Mei Medical Center (grant number: CMFHR 10604).	Ahlsson F, 2015, EPIDEMIOLOGY, V26, P106, DOI 10.1097/EDE.0000000000000171; Amundson S.J., 1995, EVALUATION TOOL CHIL; [Anonymous], 1977, Acta Obstet Gynecol Scand, V56, P247; [Anonymous], 2010, MOVEMENT ASSESSMENT; [Anonymous], 1993, J OCCUP THER ASS REP, DOI DOI 10.6594/JTOTA; Ayres A.J., 1989, SENSORY INTEGRATION; Breeman LD, 2016, J CHILD PSYCHOL PSYC, V57, P132, DOI 10.1111/jcpp.12456; Brown L., 1997, TEST NONVERBAL INTEL; Caravale B, 2012, EARLY HUM DEV, V88, P363, DOI 10.1016/j.earlhumdev.2011.09.011; Chang S. H., 2012, CHINESE HANDWRITING; Chang SH, 2005, PERCEPT MOTOR SKILL, V101, P631, DOI 10.2466/PMS.101.6.631-647; Chang SH, 2013, RES DEV DISABIL, V34, P2433, DOI 10.1016/j.ridd.2013.02.028; Fan RG, 2013, CLINICS, V68, P915, DOI 10.6061/clinics/2013(07)05; Feder KP, 2007, DEV MED CHILD NEUROL, V49, P312, DOI 10.1111/j.1469-8749.2007.00312.x; Feder KP, 2005, DEV MED CHILD NEUROL, V47, P163, DOI 10.1017/S0012162205000307; Gardner Martin, 2006, TEST VISUAL PERCEPTU; Hintz SR, 2006, ACTA PAEDIATR, V95, P1239, DOI 10.1080/08035250600599727; Hornman J, 2017, J PEDIATR-US, V187, P73, DOI 10.1016/j.jpeds.2017.05.022; Hu Wu, 2006, TEST NONVERBAL INTEL; Karlsdottir R, 2002, PERCEPT MOTOR SKILL, V94, P623, DOI 10.2466/PMS.94.2.623-662; Kita Y, 2016, BRAIN DEV-JPN, V38, P706, DOI 10.1016/j.braindev.2016.02.012; Kovachy VN, 2015, DEV MED CHILD NEUROL, V57, P410, DOI 10.1111/dmcn.12652; Lee TI, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.016865; Lin SC, 2002, ED SOCIOLOGY; Lindstrom K, 2011, PEDIATRICS, V127, P858, DOI 10.1542/peds.2010-1279; Liu YC., 2006, TAIWAN J PSYCHIAT, V20, P290, DOI [DOI 10.29478/TJP.200612.0006, 10.1002/mpr.237, DOI 10.1002/MPR.237]; Maitra K, 2014, AM J OCCUP THER, V68, P140, DOI 10.5014/ajot.2014.009985; Mansson J, 2015, ACTA PAEDIATR, V104, P514, DOI 10.1111/apa.12937; Overvelde A, 2011, RES DEV DISABIL, V32, P540, DOI 10.1016/j.ridd.2010.12.027; Petkovic M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01104; Pritchard VE, 2009, EARLY HUM DEV, V85, P215, DOI 10.1016/j.earlhumdev.2008.10.004; Prunty M, 2016, HUM MOVEMENT SCI, V49, P54, DOI 10.1016/j.humov.2016.06.003; Putnick DL, 2017, J PEDIATR-US, V181, P74, DOI 10.1016/j.jpeds.2016.09.006; Reiss AL, 2004, J PEDIATR-US, V145, P242, DOI 10.1016/j.jpeds.2004.04.031; Research Academy for Educational Research, 2014, MOD K 12 CURR MIN ED; Romeo DM, 2016, EUR J PAEDIATR NEURO, V20, P518, DOI 10.1016/j.ejpn.2016.04.011; Shen IH, 2012, RES DEV DISABIL, V33, P1301, DOI 10.1016/j.ridd.2012.02.010; Swanson JM., 1995, SNAP 4 SCALE; The Ministry of Education in Taiwan, 1996, MAN ORD STROK COMM C; Tseng M. H., 1997, OCCUPATIONAL THERAPY, V4, P294, DOI DOI 10.1002/0TI.61; TSENG MH, 1994, OCCUP THER J RES, V14, P19, DOI 10.1177/153944929401400102; TSENG MH, 1993, AM J OCCUP THER, V47, P919, DOI 10.5014/ajot.47.10.919; Urben S, 2017, CHILD NEUROPSYCHOL, V23, P188, DOI 10.1080/09297049.2015.1099619; Valentini NC, 2014, RES DEV DISABIL, V35, P733, DOI 10.1016/j.ridd.2013.10.028; Volman MJM, 2006, AM J OCCUP THER, V60, P451, DOI 10.5014/ajot.60.4.451; Wuang YP, 2012, DEV MED CHILD NEUROL, V54, P160, DOI 10.1111/j.1469-8749.2011.04177.x; ZIVIANI J, 1984, EDUC REV, V36, P249, DOI 10.1080/0013191840360304	47	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199355	10.1371/journal.pone.0199355	http://dx.doi.org/10.1371/journal.pone.0199355			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ7CA	29920537	Green Submitted, Green Published, gold			2022-12-26	WOS:000435541300037
J	Arenas-Castro, S; Goncalves, J; Alves, P; Alcaraz-Segura, D; Honrado, JP				Arenas-Castro, Salvador; Goncalves, Joao; Alves, Paulo; Alcaraz-Segura, Domingo; Honrado, Joao P.			Assessing the multi-scale predictive ability of ecosystem functional attributes for species distribution modelling	PLOS ONE			English	Article							REMOTE-SENSING DATA; LAND-COVER DATA; HIERARCHICAL FRAMEWORK; HABITAT SUITABILITY; CLIMATE-CHANGE; SPATIAL DATA; SAMPLE-SIZE; FINE-SCALE; IMPROVE; BIODIVERSITY	Global environmental changes are rapidly affecting species' distributions and habitat suitability worldwide, requiring a continuous update of biodiversity status to support effective decisions on conservation policy and management. In this regard, satellite-derived Ecosystem Functional Attributes (EFAs) offer a more integrative and quicker evaluation of ecosystem responses to environmental drivers and changes than climate and structural or compositional landscape attributes. Thus, EFAs may hold advantages as predictors in Species Distribution Models (SDMs) and for implementing multi-scale species monitoring programs. Here we describe a modelling framework to assess the predictive ability of EFAs as Essential Biodiversity Variables (EBVs) against traditional datasets (climate, land-cover) at several scales. We test the framework with a multi-scale assessment of habitat suitability for two plant species of conservation concern, both protected under the EU Habitats Directive, differing in terms of life history, range and distribution pattern (Iris boissieri and Taxus baccata). We fitted four sets of SDMs for the two test species, calibrated with: interpolated climate variables; landscape variables; EFAs; and a combination of climate and landscape variables. EFA-based models performed very well at the several scales (AUC(median) from 0.881 +/- 0.072 to 0.983 +/- 0.125), and similarly to traditional climate-based models, individually or in combination with land-cover predictors (AUC(median) from 0.882 +/- 0.059 to 0.995 +/- 0.083). Moreover, EFA-based models identified additional suitable areas and provided valuable information on functional features of habitat suitability for both test species (narrowly vs. widely distributed), for both coarse and fine scales. Our results suggest a relatively small scale-dependence of the predictive ability of satellite-derived EFAs, supporting their use as meaningful EBVs in SDMs from regional and broader scales to more local and finer scales. Since the evaluation of species' conservation status and habitat quality should as far as possible be performed based on scalable indicators linking to meaningful processes, our framework may guide conservation managers in decision-making related to biodiversity monitoring and reporting schemes.	[Arenas-Castro, Salvador; Goncalves, Joao; Alves, Paulo; Honrado, Joao P.] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet InBIO, Vairao, Portugal; [Alcaraz-Segura, Domingo] Univ Granada, Fac Ciencias, Dept Botan, Granada, Spain; [Alcaraz-Segura, Domingo] Univ Almeria, Andalusian Ctr Assessment & Monitoring Global Cha, Almeria, Spain; [Alcaraz-Segura, Domingo] Univ Granada, Iecolab, Interuniversitary Inst Earth Syst Res IISTA, Granada, Spain; [Honrado, Joao P.] Univ Porto, Fac Ciencias, Porto, Portugal	Universidade do Porto; University of Granada; Universidad de Almeria; University of Granada; Universidade do Porto	Arenas-Castro, S (corresponding author), Univ Porto, Ctr Invest Biodiversidade & Recursos Genet InBIO, Vairao, Portugal.	sarenascastro78@gmail.com	Alcaraz-Segura, Domingo/B-8063-2008; Danielisova, Alzbeta/H-1869-2014; Arenas-Castro, Salvador/I-4024-2013; Alves, Paulo/AAH-9085-2021; Alves, Paulo J. M./J-1153-2014; Honrado, Joao/L-8365-2013; Goncalves, Joao/L-9383-2013	Alcaraz-Segura, Domingo/0000-0001-8988-4540; Arenas-Castro, Salvador/0000-0001-8671-4968; Alves, Paulo/0000-0002-4931-0582; Alves, Paulo J. M./0000-0002-4931-0582; Honrado, Joao/0000-0001-8443-4276; Goncalves, Joao/0000-0002-6615-0218	European Union [641762]; ECOPOTENTIAL project; FCT (Portuguese Science Foundation) [SFRH/BD/90112/2012]; Ministerio de Educacion, Cultura y Deporte [JC2015-00316]; Ministerio de Ciencia e Innovacion [CGL2014-61610-EXP]	European Union(European Commission); ECOPOTENTIAL project; FCT (Portuguese Science Foundation)(Portuguese Foundation for Science and Technology); Ministerio de Educacion, Cultura y Deporte(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This research was developed as part of the ECOPOTENTIAL project financed by European Unions Horizon 2020 research and innovation program under grant agreement No. 641762. SAC, DAS and JPH received funding from the ECOPOTENTIAL project. JG was supported by FCT (Portuguese Science Foundation) through PhD grant SFRH/BD/90112/2012. DAS received funding from Ministerio de Educacion, Cultura y Deporte, JC2015-00316 grant, and Ministerio de Ciencia e Innovacion, CGL2014-61610-EXP project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A Pulgar SanudoI, 2004, IRIS BOISSIERI HENRI, V1, P326; Alcaraz-Segura D, 2006, GLOBAL ECOL BIOGEOGR, V15, P200, DOI 10.1111/j.1466-822x.2006.00215.x; Alcaraz-Segura D., 2013, EARTH OBSERVATION EC; Alcaraz-Segura D, 2017, INT J APPL EARTH OBS, V57, P86, DOI 10.1016/j.jag.2016.12.009; Alcaraz-Segura D, 2009, PLANT ECOL, V202, P13, DOI 10.1007/s11258-008-9555-2; [Anonymous], [No title captured], DOI [10.1080/10106040208542232, DOI 10.1080/10106040208542232]; [Anonymous], 2014, R LANG ENV STAT COMP; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Baasch DM, 2010, ECOL MODEL, V221, P565, DOI 10.1016/j.ecolmodel.2009.10.033; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Benayas JMR, 2002, J VEG SCI, V13, P245, DOI 10.1658/1100-9233(2002)013[0245:PDBAEI]2.0.CO;2; Bradley BA, 2008, J BIOGEOGR, V35, P1158, DOI 10.1111/j.1365-2699.2008.01928.x; Buermann W, 2008, J BIOGEOGR, V35, P1160, DOI 10.1111/j.1365-2699.2007.01858.x; Butchart SHM, 2005, PHILOS T R SOC B, V360, P255, DOI 10.1098/rstb.2004.1583; Cabello J, 2012, BIODIVERS CONSERV, V21, P3287, DOI 10.1007/s10531-012-0370-7; Castro M, 2005, PRESENT SCENARIOS 21, P1; Coops NC, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8010065; Cord A, 2011, ECOL APPL, V21, P3285, DOI 10.1890/11-0114.1; Cord AF, 2013, J BIOGEOGR, V40, P2226, DOI 10.1111/jbi.12199; Cord AF, 2014, J BIOGEOGR, V41, P736, DOI 10.1111/jbi.12225; Cord AF, 2014, ECOL MODEL, V272, P129, DOI 10.1016/j.ecolmodel.2013.09.011; Dahlin KM, 2017, ECOGRAPHY, V40, P314, DOI 10.1111/ecog.02443; Deblauwe V, 2016, GLOBAL ECOL BIOGEOGR, V25, P443, DOI 10.1111/geb.12426; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Drake JM, 2006, J APPL ECOL, V43, P424, DOI 10.1111/j.1365-2664.2006.01141.x; Ehrlen J, 2015, ECOL LETT, V18, P303, DOI 10.1111/ele.12410; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engler R, 2013, FOREST ECOL MANAG, V310, P64, DOI 10.1016/j.foreco.2013.07.059; ESRI, 2014, ARCGIS DESKT VERS 10; ETC/BD, 2011, EXPL NOT GUID PER 20; Farris E, 2012, PHYTOCOENOLOGIA, V41, P231, DOI 10.1127/0340-269X/2011/0041-0501; Fernandes RF, 2014, BIOL INVASIONS, V16, P2577, DOI 10.1007/s10530-014-0688-z; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fox Jr J., 2015, APPL REGRESSION ANAL; Franklin J, 2016, P NATL ACAD SCI USA, V113, P3725, DOI 10.1073/pnas.1519911113; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; FT Maestre Gil, 2008, INTRODUCCION ANALISI, P661; Gao Q, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17091966; Garcia D, 2000, BIOL CONSERV, V95, P31, DOI 10.1016/S0006-3207(00)00016-1; Gogol-Prokurat M, 2011, ECOL APPL, V21, P33, DOI 10.1890/09-1190.1; Goncalves J, 2016, BIODIVERS CONSERV, V25, P2867, DOI 10.1007/s10531-016-1206-7; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Hagen-Zanker A, 2009, INT J GEOGR INF SCI, V23, P61, DOI 10.1080/13658810802570317; Hardiman BS, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9020182; He KS, 2015, REMOTE SENS ECOL CON, V1, P4, DOI 10.1002/rse2.7; Henle K., 2014, ADV BOOKS, V1, pe1169, DOI [10.3897/ab.e1169, DOI 10.3897/AB.E1169]; Holmes KR, 2015, APPL GEOGR, V56, P135, DOI 10.1016/j.apgeog.2014.11.020; Honrado JP, 2016, J APPL ECOL, V53, P1299, DOI 10.1111/1365-2664.12777; Hoskins AJ, 2016, ECOL EVOL, V6, P3040, DOI 10.1002/ece3.2104; Huete AR, 1997, REMOTE SENS ENVIRON, V59, P440, DOI 10.1016/S0034-4257(96)00112-5; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Ivits E, 2013, REMOTE SENS-BASEL, V5, P3305, DOI 10.3390/rs5073305; J Honrado, 1999, THESIS; Jax K., 2010, ECOSYSTEM FUNCTIONIN; JE Loidi, 2017, VEGETATION IBERIAN P, P676; Jetz W, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.24, 10.1038/nplants.2016.24]; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kissling W.D., 2012, Journal of Biogeography, V39, P2163; Kissling WD, 2018, BIOL REV, V93, P600, DOI 10.1111/brv.12359; Kosicki JZ, 2015, ECOL RES, V30, P625, DOI 10.1007/s11284-015-1263-5; Lassueur T, 2006, ECOL MODEL, V198, P139, DOI 10.1016/j.ecolmodel.2006.04.004; Lausch A, 2013, ENVIRON MONIT ASSESS, V185, P1215, DOI 10.1007/s10661-012-2627-8; Lawson CR, 2014, METHODS ECOL EVOL, V5, P54, DOI 10.1111/2041-210X.12123; Lengyel S, 2008, BIODIVERS CONSERV, V17, P3341, DOI 10.1007/s10531-008-9359-7; Lipsey MK, 2017, DIVERS DISTRIB, V23, P783, DOI 10.1111/ddi.12567; Lomba A, 2010, BIOL CONSERV, V143, P2647, DOI 10.1016/j.biocon.2010.07.007; Louette G, 2011, J NAT CONSERV, V19, P224, DOI 10.1016/j.jnc.2011.02.001; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Martin Y, 2013, GLOBAL ECOL BIOGEOGR, V22, P1204, DOI 10.1111/geb.12087; Martins IS, 2014, ACTA OECOL, V61, P41, DOI 10.1016/j.actao.2014.10.005; McGarigal K., 2012, SPATIAL PATTERN ANAL; McPherson JM, 2006, ECOL MODEL, V192, P499, DOI 10.1016/j.ecolmodel.2005.08.007; Mertes K, 2018, ECOGRAPHY, V41, P1604, DOI 10.1111/ecog.02871; Milbau A, 2009, BIOL INVASIONS, V11, P941, DOI 10.1007/s10530-008-9306-2; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Muller OV, 2014, J CLIMATE, V27, P6754, DOI 10.1175/JCLI-D-13-00463.1; Nagendra H, 2013, ECOL INDIC, V33, P45, DOI 10.1016/j.ecolind.2012.09.014; Ortiz O, 2011, IUCN RED LIST THREAT; Paruelo JM, 2001, ECOSYSTEMS, V4, P683, DOI 10.1007/s10021-001-0037-9; Parviainen M, 2013, BIODIVERS CONSERV, V22, P1731, DOI 10.1007/s10531-013-0509-1; Pasetto D, 2018, METHODS ECOL EVOL, V9, P1810, DOI 10.1111/2041-210X.13018; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2018, REMOTE SENS ECOL CON, V4, P71, DOI 10.1002/rse2.59; Pettorelli N, 2016, REMOTE SENS ECOL CON, V2, P122, DOI 10.1002/rse2.15; Plummer SE, 2000, ECOL MODEL, V129, P169, DOI 10.1016/S0304-3800(00)00233-7; Pocas I, 2014, INT J GEOGR INF SCI, V28, P2356, DOI 10.1080/13658816.2014.924627; Potter Christopher, 2007, Carbon Balance Manag, V2, P9, DOI 10.1186/1750-0680-2-9; Quantum GIS Development Team, 2017, QUANT GIS GEOGR INF; Requena-Mullor JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172107; Scholes RJ, 2012, CURR OPIN ENV SUST, V4, P139, DOI 10.1016/j.cosust.2011.12.005; Shabani F, 2016, ECOL EVOL, V6, P5973, DOI 10.1002/ece3.2332; Sirami C, 2017, GLOBAL ECOL BIOGEOGR, V26, P385, DOI 10.1111/geb.12555; Sousa-Silva R, 2014, GLOB ECOL CONSERV, V2, P226, DOI 10.1016/j.gecco.2014.09.011; Stanton JC, 2012, METHODS ECOL EVOL, V3, P349, DOI 10.1111/j.2041-210X.2011.00157.x; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Thomas PA, 2016, J ECOL, V104, P1158, DOI 10.1111/1365-2745.12566; Thomas PA, 2015, FOREST SYST, V24, DOI 10.5424/fs/2015243-07465; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; Tuanmu MN, 2014, GLOBAL ECOL BIOGEOGR, V23, P1031, DOI 10.1111/geb.12182; Underwood EC, 2009, DIVERS DISTRIB, V15, P188, DOI 10.1111/j.1472-4642.2008.00518.x; van Proosdij ASJ, 2016, ECOGRAPHY, V39, P542, DOI 10.1111/ecog.01509; Vicente J, 2011, BIOL INVASIONS, V13, P1209, DOI 10.1007/s10530-011-9952-7; Vicente JR, 2014, ECOL COMPLEX, V20, P151, DOI 10.1016/j.ecocom.2014.10.005; Visser H, 2006, ENVIRON MODELL SOFTW, V21, P346, DOI 10.1016/j.envsoft.2004.11.013; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wisz Mary S., 2009, BMC Ecology, V9, P8, DOI 10.1186/1472-6785-9-8; Zimmermann NE, 2010, ECOGRAPHY, V33, P985, DOI 10.1111/j.1600-0587.2010.06953.x	121	28	28	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199292	10.1371/journal.pone.0199292	http://dx.doi.org/10.1371/journal.pone.0199292			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912933	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600102
J	Park, S; Majd, S				Park, SooHyun; Majd, Sheereen			Reconstitution and functional studies of hamster P-glycoprotein in giant liposomes	PLOS ONE			English	Article							MULTIDRUG EFFLUX PUMP; BLOOD-BRAIN-BARRIER; DRUG-BINDING SITE; UNILAMELLAR VESICLES; MEMBRANE-PROTEINS; ATP HYDROLYSIS; TRANSPORTERS; RESISTANCE; BILAYER; CHOLESTEROL	This paper describes the preparation of giant unilamellar vesicles with reconstituted hamster P-glycoprotein (Pgp, ABCB1) for studying the transport activity of this efflux pump in individual liposomes using optical microscopy. Pgp, a member of ABC (ATP-binding cassette) transporter family, is known to contribute to the cellular multidrug resistance (MDR) against variety of drugs. The efficacy of many therapeutics is, thus, hampered by this efflux pump, leading to a high demand for simple and effective strategies to monitor the interactions of candidate drugs with this protein. Here, we applied small Pgp proteoliposomes to prepare giant Pgp-bearing liposomes via modified electroformation techniques. The presence of Pgp in the membrane of giant proteoliposomes was confirmed using immunohistochemistry. Assessment of Pgp ATPase activity suggested that this transporter retained its activity upon reconstitution into giant liposomes, with an ATPase specific activity of 439 +/- 103 nmol/mg protein/min. For further confirmation, we assessed the transport activity of Pgp in these proteoliposomes by monitoring the translocation of rhodamine 123 (Rho123) across the membrane using confocal microscopy at various ATP concentrations (0-2 mM) and in the presence of Pgp inhibitors. Rate of change in Rho123 concentration inside the liposomal lumen was used to estimate the Rho123 transport rates (1/s) for various ATP concentrations, which were then applied to retrieve the Michaelis-Menten constant (K-m) of ATP in Rho123 transport (0.42 +/- 0.75 mM). Similarly, inhibitory effects of verapamil, colchicine, and cyclosporin A on Pgp were studied in this system and the IC50 values for these Pgp inhibitors were found 26.6 +/- 6.1 mu M, 94.6 +/- 47.6 mu M, and 0.21 +/- 0.07 mu M, respectively. We further analyzed the transport data using a kinetic model that enabled dissecting the passive diffusion of Rho123 from its Pgp-mediated transport across the membrane. Based on this model, the permeability coefficient of Rho123 across the liposomal membrane was approximately 1.25x10(-7) cm/s. Comparing the membrane permeability in liposomes with and without Pgp revealed that the presence of this protein did not have a significant impact on membrane integrity and permeability. Furthermore, we used this model to obtain transport rate constants for the Pgp-mediated transport of Rho123 (m(3)/mol/s) at various ATP and inhibitor concentrations, which were then applied to estimate values of 0.53 +/- 0.66 mM for K-m of ATP and 25.2 +/- 5.0 mu M for verapamil IC50 , 61.8 +/- 34.8 mu M for colchicine IC50, and 0.23 +/- 0.09 mu M for cyclosporin A IC50. The kinetic parameters obtained from the two analyses were comparable, suggesting a minimal contribution from the passive Rho123 diffusion across the membrane. This approach may, therefore, be applied for screening the transport activity of Pgp against potential drug candidates.	[Park, SooHyun] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Park, SooHyun] Univ Texas Hlth Sci Ctr Houston, Texas Therapeut Inst, Houston, TX 77030 USA; [Majd, Sheereen] Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston	Majd, S (corresponding author), Univ Houston, Dept Biomed Engn, Houston, TX 77004 USA.	smajd9@uh.edu		park, soohyun/0000-0001-9847-9985; Majd, Sheereen/0000-0002-3131-9845	Charles Kaufman Young Investigator Research Grant by the Pittsburg Foundation [UN2013-66933]; University of Houston	Charles Kaufman Young Investigator Research Grant by the Pittsburg Foundation; University of Houston	This work was funded by a Charles Kaufman Young Investigator Research Grant by the Pittsburg Foundation (SM)(http://kaufman.pittsburghfoundation.org/) grant no. UN2013-66933 and Start-up Funds at University of Houston (SM). There was no additional external funding received for this study.	Aimon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025529; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; AMBUDKAR SV, 1995, J BIOENERG BIOMEMBR, V27, P23, DOI 10.1007/BF02110327; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; Biner O, 2016, FEBS LETT, V590, P2051, DOI 10.1002/1873-3468.12233; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; BROWN MF, 1994, CHEM PHYS LIPIDS, V73, P159, DOI 10.1016/0009-3084(94)90180-5; Chan LMS, 2004, EUR J PHARM SCI, V21, P25, DOI 10.1016/j.ejps.2003.07.003; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Deeken JF, 2007, CLIN CANCER RES, V13, P1663, DOI 10.1158/1078-0432.CCR-06-2854; Doeven MK, 2005, BIOPHYS J, V88, P1134, DOI 10.1529/biophysj.104.053413; Eckford PDW, 2008, BIOCHEMISTRY-US, V47, P13686, DOI 10.1021/bi801409r; GenoMembrane Co. L, 2016, DAT SHEET MOUS MDR1A; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Girard P, 2004, BIOPHYS J, V87, P419, DOI 10.1529/biophysj.104.040360; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gutierrez MG, 2016, BIOPHYS J, V110, P2486, DOI 10.1016/j.bpj.2016.04.042; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Horger KS, 2015, BBA-BIOMEMBRANES, V1848, P643, DOI 10.1016/j.bbamem.2014.10.023; Huang J, 2011, J AM CHEM SOC, V133, P15818, DOI 10.1021/ja2046342; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kang YJ, 2013, ADV MATER, V25, P6834, DOI 10.1002/adma.201303290; Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200; Lein M, 2015, BBA-BIOMEMBRANES, V1848, P2980, DOI 10.1016/j.bbamem.2015.09.004; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Li S, 2010, ANAL CHEM, V82, P7766, DOI 10.1021/ac1016826; Loscher W, 2005, PROG NEUROBIOL, V76, P22, DOI 10.1016/j.pneurobio.2005.04.006; Lu PH, 2001, EUR J BIOCHEM, V268, P1687, DOI 10.1046/j.1432-1033.2001.02041.x; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P643, DOI 10.1021/bi0485326; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P14020, DOI 10.1021/bi0511179; Majd S, 2010, CURR OPIN BIOTECH, V21, P439, DOI 10.1016/j.copbio.2010.05.002; Majd S, 2009, J AM CHEM SOC, V131, P16119, DOI 10.1021/ja904072s; Melchior DL, 2012, J PHARMACOL TOX MET, V65, P64, DOI 10.1016/j.vascn.2012.02.002; Modok S, 2004, J LIPID RES, V45, P1910, DOI 10.1194/jlr.M400220-JLR200; Oppedisano F, 2010, BIOCHEM PHARMACOL, V80, P1266, DOI 10.1016/j.bcp.2010.06.032; Palmeira A, 2012, CURR MED CHEM, V19, P1946, DOI 10.2174/092986712800167392; Palmeira A, 2012, CURR PHARM DESIGN, V18, P4197, DOI 10.2174/138161212802430530; PAPAHADJOPOULOS D, 1972, BIOCHIM BIOPHYS ACTA, V266, P561, DOI 10.1016/0005-2736(72)90354-9; Perez-Tomas R, 2006, CURR MED CHEM, V13, P1859, DOI 10.2174/092986706777585077; Pott T, 2008, CHEM PHYS LIPIDS, V154, P115, DOI 10.1016/j.chemphyslip.2008.03.008; Qu Q, 2002, BIOCHEMISTRY-US, V41, P4744, DOI 10.1021/bi0120897; Romsicki Y, 1997, BIOCHEMISTRY-US, V36, P9807, DOI 10.1021/bi963120l; Romsicki Y, 1999, BIOCHEMISTRY-US, V38, P6887, DOI 10.1021/bi990064q; Romsicki Y, 2001, BIOCHEMISTRY-US, V40, P6937, DOI 10.1021/bi0024456; Sardan M, 2013, FARADAY DISCUSS, V166, P269, DOI 10.1039/c3fd00058c; Sasaki H, 2012, LAB CHIP, V12, P702, DOI 10.1039/c2lc21058d; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Sharom FJ, 2010, METHODS MOL BIOL, V637, P133, DOI 10.1007/978-1-60761-700-6_7; Sharom FJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00041; Shen YX, 2015, P NATL ACAD SCI USA, V112, P9810, DOI 10.1073/pnas.1508575112; Siarheyeva A, 2006, BIOCHEMISTRY-US, V45, P6203, DOI 10.1021/bi0524870; Szewczyk P, 2015, ACTA CRYSTALLOGR D, V71, P732, DOI 10.1107/S1399004715000978; Tan B, 2000, CURR OPIN ONCOL, V12, P450, DOI 10.1097/00001622-200009000-00011; Williams TL, 2009, FABRICATION APPL SUR, P251; Wong K, 2014, TRENDS BIOCHEM SCI, V39, P8, DOI 10.1016/j.tibs.2013.11.002	57	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199279	10.1371/journal.pone.0199279	http://dx.doi.org/10.1371/journal.pone.0199279			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912971	Green Submitted, gold, Green Published			2022-12-26	WOS:000435528600100
J	Heidrich, ES; Bruser, T				Heidrich, Eyleen Sabine; Brueser, Thomas			Evidence for a second regulatory binding site on PspF that is occupied by the C-terminal domain of PspA	PLOS ONE			English	Article							SHOCK-PROTEIN RESPONSE; ESCHERICHIA-COLI; YERSINIA-ENTEROCOLITICA; TRANSCRIPTIONAL ACTIVATOR; STRESS-RESPONSE; MEMBRANE STRESS; A PSPA; EXPRESSION; SEQUENCES; PARTNERS	PspA is a key component of the bacterial Psp membrane-stress response system. The biochemical and functional characterization of PspA is impeded by its oligomerization and aggregation properties. It was recently possible to solve the coiled coil structure of a completely soluble PspA fragment, PspA(1-144), that associates with the e enhancer binding protein PspF at its W56-loop and thereby down-regulates the Psp response. We now found that the C-terminal part of PspA, PspA(145-222), also interacts with PspF and inhibits its activity in the absence of full-length PspA. Surprisingly, PspA(145-222) effects changed completely in the presence of full-length PspA, as promoter activity was triggered instead of being inhibited under this condition. PspA(145-222) thus interfered with the inhibitory effect of full-length PspA on PspF, most likely by interacting with full-length PspA that remained bound to PspF. In support of this view, a comprehensive bacterial-2-hybrid screen as well as co-purification analyses indicated a self-interaction of PspA(145-222) and an interaction with full-length PspA. This is the first direct demonstration of PspA/PspA and PspA/PspF interactions in vivo that are mediated by the C-terminus of PspA. The data indicate that regulatory binding sites on PspF do not only exist for the N-terminal coiled coil domain but also for the C-terminal domain of PspA. The inhibition of PspF by PspA-(145222) was reduced upon membrane stress, whereas the inhibition of PspF by PspA(1-144) did not respond to membrane stress. We therefore propose that the C-terminal domain of PspA is crucial for the regulation of PspF in response to Psp system stimuli.	[Heidrich, Eyleen Sabine; Brueser, Thomas] Leibniz Univ Hannover, Inst Microbiol, Hannover, Germany	Leibniz University Hannover	Bruser, T (corresponding author), Leibniz Univ Hannover, Inst Microbiol, Hannover, Germany.	brueser@ifmb.uni-hannover.de		Bruser, Thomas/0000-0002-5889-8306	Deutsche Forschungsgemeinschaft [BR2285/4-2]; Open Access fund of Leibniz Universitat Hannover	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access fund of Leibniz Universitat Hannover	This study was funded by the Deutsche Forschungsgemeinschaft (www..dfg.de) by grant BR2285/4-2 of TB. The publication of this article was funded by the Open Access fund of Leibniz Universitat Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BERGLER H, 1994, MICROBIOL-SGM, V140, P1937, DOI 10.1099/13500872-140-8-1937; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dworkin J, 1997, J MOL BIOL, V273, P377, DOI 10.1006/jmbi.1997.1317; Dworkin J, 2000, J BACTERIOL, V182, P311, DOI 10.1128/JB.182.2.311-319.2000; Elderkin S, 2005, J BACTERIOL, V187, P3238, DOI 10.1128/JB.187.9.3238-3248.2005; Flores-Kim J, 2016, ANNU REV MICROBIOL, V70, P83, DOI 10.1146/annurev-micro-102215-095359; Flores-Kim J, 2015, J BIOL CHEM, V290, P11417, DOI 10.1074/jbc.M114.614107; Flores-Kim J, 2012, J BACTERIOL, V194, P6548, DOI 10.1128/JB.01250-12; Horstman NK, 2012, MOL MICROBIOL, V85, P445, DOI 10.1111/j.1365-2958.2012.08120.x; Hou B, 2018, J BIOL CHEM, V293, P7592, DOI 10.1074/jbc.RA118.002205; Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x; Joly N, 2009, J MOL BIOL, V394, P764, DOI 10.1016/j.jmb.2009.09.055; Jovanovic G, 1996, J BACTERIOL, V178, P1936, DOI 10.1128/jb.178.7.1936-1945.1996; Jovanovic G, 2014, J MOL BIOL, V426, P1498, DOI 10.1016/j.jmb.2013.12.016; Kleerebezem M, 1996, EMBO J, V15, P162, DOI 10.1002/j.1460-2075.1996.tb00344.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maxson ME, 2006, MOL MICROBIOL, V59, P1610, DOI 10.1111/j.1365-2958.2006.05047.x; McDonald C, 2017, BBA-BIOMEMBRANES, V1859, P28, DOI 10.1016/j.bbamem.2016.10.018; McDonald C, 2015, MBIO, V6, DOI 10.1128/mBio.01188-15; Mehner D, 2012, J BIOL CHEM, V287, P27834, DOI 10.1074/jbc.M112.374983; Mehta P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2997; Osadnik H, 2015, MOL MICROBIOL, V98, P743, DOI 10.1111/mmi.13154; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Wilms B, 2001, BIOTECHNOL BIOENG, V73, P95, DOI 10.1002/bit.1041; Yamaguchi S, 2013, MOL MICROBIOL, V87, P656, DOI 10.1111/mmi.12122; Yamaguchi S, 2010, MOL MICROBIOL, V78, P429, DOI 10.1111/j.1365-2958.2010.07344.x	28	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2018	13	6							e0198564	10.1371/journal.pone.0198564	http://dx.doi.org/10.1371/journal.pone.0198564			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5RI	29906279	gold, Green Published, Green Submitted			2022-12-26	WOS:000435439400006
J	Jun, K; Kim, D				Jun, Kyungtaek; Kim, Dongwook			Alignment theory of parallel-beam computed tomography image reconstruction for elastic-type objects using virtual focusing method	PLOS ONE			English	Article							ROTATION; CT; VISUALIZATION	X-ray computed tomography has been studied in various fields. Considerable effort has been focused on reconstructing the projection image set from a rigid-type specimen. However, reconstruction of images projected from an object showing elastic motion has received minimal attention. In this paper, a mathematical solution to reconstructing the projection image set obtained from an object with specific elastic motions-periodically, regularly, and elliptically expanded or contracted specimens-is proposed. To reconstruct the projection image set from expanded or contracted specimens, methods are presented for detection of the sample's motion modes, mathematical rescaling of pixel values, and conversion of the projection angle for a common layer.	[Jun, Kyungtaek] IM Technol Res Ctr, Seoul, South Korea; [Kim, Dongwook] Atlanta Metropolitan State Coll, Dept Math, Atlanta, GA USA		Jun, K (corresponding author), IM Technol Res Ctr, Seoul, South Korea.	ktfriends@gmail.com	jun, kyungtaek/O-3380-2018	jun, kyungtaek/0000-0003-4620-4220				Amat F, 2008, J STRUCT BIOL, V161, P260, DOI 10.1016/j.jsb.2007.07.007; Chen H, 1996, J STRUCT BIOL, V116, P56, DOI 10.1006/jsbi.1996.0010; Chen Y, 2018, IEEE T CIRC SYST VID, V28, P414, DOI 10.1109/TCSVT.2016.2615444; Chen Y, 2014, IEEE T MED IMAGING, V33, P2271, DOI 10.1109/TMI.2014.2336860; Donath T, 2006, J OPT SOC AM A, V23, P1048, DOI 10.1364/JOSAA.23.001048; Gao ZF, 2017, MED IMAGE ANAL, V37, P1, DOI 10.1016/j.media.2017.01.004; Gursoy D, 2014, J SYNCHROTRON RADIAT, V21, P1188, DOI 10.1107/S1600577514013939; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Larabell CA, 2010, CURR OPIN STRUC BIOL, V20, P623, DOI 10.1016/j.sbi.2010.08.008; Liu J., 2016, SOFT COMPUT, V1, P1, DOI DOI 10.1007/S00500-016-2161-7; Liu J, 2017, IEEE T MED IMAGING, V36, P2499, DOI 10.1109/TMI.2017.2739841; LIU Y, 1995, ULTRAMICROSCOPY, V58, P393, DOI 10.1016/0304-3991(95)00006-M; Lu MH, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-15; Pan YS, 2012, PROC SPIE, V8313, DOI 10.1117/12.911561; Parkinson DY, 2012, J STRUCT BIOL, V177, P259, DOI 10.1016/j.jsb.2011.11.027; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Vo NT, 2014, OPT EXPRESS, V22, P19078, DOI 10.1364/OE.22.019078; Yang YM, 2015, J SYNCHROTRON RADIAT, V22, P452, DOI 10.1107/S160057751402726X; Zheng SQ, 2007, J STRUCT BIOL, V157, P138, DOI 10.1016/j.jsb.2006.06.005; Zhu WL, 2011, SCIENCE, V332, P88, DOI 10.1126/science.1202221	24	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2018	13	6							e0198259	10.1371/journal.pone.0198259	http://dx.doi.org/10.1371/journal.pone.0198259			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5RI	29906792	gold, Green Published, Green Submitted			2022-12-26	WOS:000435439400004
J	Benedeti, PD; Silva, BD; Pacheco, MVC; Serao, NVL; Carvalho, I; Lopes, MM; Marcondes, MI; Mantovani, HC; Valadares, SD; Detmann, E; Duarte, MD				Benedeti, Pedro Del Bianco; Silva, Breno de Castro; Carneiro Pacheco, Marcos Vinicius; Lopes Serao, Nicola Vergara; Carvalho Filho, Ivan; Lopes, Mariana Mescouto; Marcondes, Marcos Inacio; Mantovani, Hilario Cuquetto; Valadares Filho, Sebastiao de Campos; Detmann, Edenio; Duarte, Marcio de Souza			Effects of grain processing methods on the expression of genes involved in volatile fatty acid transport and pH regulation, and keratinization in rumen epithelium of beef cattle	PLOS ONE			English	Article							RUMINAL EPITHELIUM; GASTROINTESTINAL-TRACT; MESSENGER-RNA; BLOOD-FLOW; DAIRY-COWS; ABSORPTION; STARCH; CELLS; FEEDS; CONSERVATION	Two experiments were carried out to evaluate the effects of corn and sorghum with different processing methods on the expression of genes involved in volatile fatty acids transport and pH regulation, and ruminal keratinization in rumen epithelium of finishing bulls. For Exp. 1, five rumen cannulated Nellore bulls were used in a 5x5 Latin square arrangement, with 14 d for adaptation and 9 d for sample collection. Treatments were: dry ground corn, dry ground sorghum, reconstituted corn, reconstituted sorghum, and control (forage-based diet). Samples of rumen epithelium from ventral sac were excised, rinsed, snap-frozen and stored at -80 degrees C until total RNA isolation and quantitative real-time PCR analysis. In the Exp. 2, 24 Nellore bulls were assigned to a completely randomized design lasting 168 d. Experimental treatments were similar to those at Exp. 1, but without the control treatment. After the experimental period, bulls were slaughtered and rumen epithelium samples were rapidly excised for further histological analysis. Rumen epithelial tissue from animals fed reconstituted corn had lower expression of downregulated-in-adenoma (P= 0.03) and Na+/H+ exchanger 2 (trend; P= 0.09). The expression of Na+/H+ exchanger 1 (P= 0.10) and putative anion transporter (P = 0.06) tended to be lower in rumen epithelium of bulls fed reconstituted grains. Ruminal concentration of valerate was greater for animals fed reconstituted grain (P= 0.01). Likewise, animals fed reconstituted corn tended to have greater butyrate ruminal concentration (P = 0.08). Keratinized layer thickness did not differ among treatments (P> 0.10). Therefore, reconstituted grains (especially corn) decrease the mRNA expression of genes involved in volatile fatty acids transport and pH control in the rumen epithelium.	[Benedeti, Pedro Del Bianco; Silva, Breno de Castro; Carneiro Pacheco, Marcos Vinicius; Carvalho Filho, Ivan; Lopes, Mariana Mescouto; Marcondes, Marcos Inacio; Valadares Filho, Sebastiao de Campos; Detmann, Edenio; Duarte, Marcio de Souza] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Benedeti, Pedro Del Bianco] Univ Estado Santa Catarina, Dept Anim Sci, Chapeco, SC, Brazil; [Lopes Serao, Nicola Vergara] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Mantovani, Hilario Cuquetto] Univ Fed Vicosa, Dept Microbiol, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade do Estado de Santa Catarina; Iowa State University; Universidade Federal de Vicosa	Benedeti, PD; Duarte, MD (corresponding author), Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil.; Benedeti, PD (corresponding author), Univ Estado Santa Catarina, Dept Anim Sci, Chapeco, SC, Brazil.	pedro.benedeti@ufv.br; marcio.duarte@ufv.br	Detmann, Edenio/O-9048-2019; Duarte, Marcio/G-3815-2015; Del Bianco Benedeti, Pedro/C-3120-2016; Serão, Nick/AAE-5868-2019; Mantovani, Hilario C/J-5287-2012; Lopes, Mariana/ABG-3540-2020; Marcondes, Marcos/AAH-7553-2020	Duarte, Marcio/0000-0002-5795-6420; Del Bianco Benedeti, Pedro/0000-0003-2515-8974; Serão, Nick/0000-0002-6758-208X; Mantovani, Hilario C/0000-0002-3481-5318; Marcondes, Marcos/0000-0003-4843-2809; de Castro Silva, Breno/0000-0002-6855-5550; Carvalho Filho, Ivan/0000-0001-9675-8999	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [PPM-00366-15]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Institute Nacional de Ciencia e Tecnologia - Ciencia Animal (INCT-CA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [172728031]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Institute Nacional de Ciencia e Tecnologia - Ciencia Animal (INCT-CA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - http://www.fapernig.br (FAPEMIG; Project number: PPM-00366-15), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - http://cnpq.br (CNPq), the Institute Nacional de Ciencia e Tecnologia - Ciencia Animal (INCT-CA) - http://inct.cnpq.br/web/inct-ca, and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - http://www.capes.gov.br (CAPES; Project number: 172728031). The funding agencies had no role in the study design, data collection, and analyses, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, REG INSP IND SAN PRO; AOAC, 2007, OFFICIAL METHODS ANA, V18th; Bilk S, 2005, J COMP PHYSIOL B, V175, P365, DOI 10.1007/s00360-005-0493-1; Connor EE, 2010, ANIMAL, V4, P993, DOI 10.1017/S1751731109991285; DeCastro M, 2005, MOL BRAIN RES, V142, P28, DOI 10.1016/j.molbrainres.2005.09.002; Defoor PJ, OKL CATTL GRAIN PROC; Detmann E, 2010, ARQ BRAS MED VET ZOO, V62, P980, DOI 10.1590/S0102-09352010000400030; DOBSON A, 1971, AM J PHYSIOL, V220, P1337, DOI 10.1152/ajplegacy.1971.220.5.1337; Firkins JL, 2001, J ANIM SCI, V79, P218, DOI DOI 10.2527/JAS2001.79E-SUPPLE218X; GABEL G, 1991, J VET MED A, V38, P523, DOI 10.1111/j.1439-0442.1991.tb01043.x; Graham C, 2007, AM J PHYSIOL-REG I, V292, pR997, DOI 10.1152/ajpregu.00343.2006; Huntington G B, 2006, J Anim Sci, V84 Suppl, pE14; Huntington GB, 1997, J ANIM SCI, V75, P852; Kristensen N. B., 2006, P249; Laarman AH, 2012, J DAIRY SCI, V95, P2585, DOI 10.3168/jds.2011-4788; Licitra G, 1996, ANIM FEED SCI TECH, V57, P347, DOI 10.1016/0377-8401(95)00837-3; Liu T, 2016, ANIM FEED SCI TECH, V217, P27, DOI 10.1016/j.anifeedsci.2016.04.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machado MG, 2016, ANIM FEED SCI TECH, V222, P132, DOI 10.1016/j.anifeedsci.2016.10.009; Melo LQ, 2013, J ANIM SCI, V91, P1775, DOI 10.2527/jas.2011-4999; Mertens DR, 2002, J AOAC INT, V85, P1217; Muller F, 2000, J COMP PHYSIOL B, V170, P337, DOI 10.1007/s003600000107; NOCEK JE, 1991, J DAIRY SCI, V74, P3598, DOI 10.3168/jds.S0022-0302(91)78552-4; Oba M, 2003, J DAIRY SCI, V86, P174, DOI 10.3168/jds.S0022-0302(03)73598-X; Oliveira CA, 2014, ANIM FEED SCI TECH, V197, P64, DOI 10.1016/j.anifeedsci.2014.08.010; Owens F, 2005, MANAGING MARKETING Q, P121; Rotta PP, 2014, J ANIM SCI, V92, P2996, DOI 10.2527/jas.2013-7364; SAKATA T, 1978, J DAIRY SCI, V61, P1109, DOI 10.3168/jds.S0022-0302(78)83694-7; Schlau N, 2012, J DAIRY SCI, V95, P5866, DOI 10.3168/jds.2011-5167; Sehested J, 1999, COMP BIOCHEM PHYS A, V123, P359, DOI 10.1016/S1095-6433(99)00074-4; SIEGFRIED R, 1984, LANDWIRT FORSCH, V37, P298; Silva LFC, 2016, BR CORTE NUTR REQUIR; Steele MA, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-39; Stevens CE, 1998, PHYSIOL REV, V78, P393, DOI 10.1152/physrev.1998.78.2.393; Storm AC, 2012, J DAIRY SCI, V95, P2919, DOI 10.3168/jds.2011-4239; Voge JL, 2004, DOMEST ANIM ENDOCRIN, V26, P241, DOI 10.1016/j.domaniend.2003.11.002; Yan L, 2014, J DAIRY SCI, V97, P5668, DOI 10.3168/jds.2013-7807; Yang W, 2012, J ANIM SCI, V90, P307, DOI 10.2527/jas.2011-3854	38	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198963	10.1371/journal.pone.0198963	http://dx.doi.org/10.1371/journal.pone.0198963			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902237	gold, Green Published, Green Submitted			2022-12-26	WOS:000435424900069
J	Jenkins, GJ; Hakim, CH; Yang, NN; Yao, G; Duan, DS				Jenkins, Gregory J.; Hakim, Chady H.; Yang, N. Nora; Yao, Gang; Duan, Dongsheng			Automatic characterization of stride parameters in canines with a single wearable inertial sensor	PLOS ONE			English	Article							TROTTING DOGS; GAIT ANALYSIS; KINEMATICS; ANIMALS	Background and objective Gait analysis is valuable for studying neuromuscular and skeletal diseases. Wearable motion sensors or inertial measurement units (IMUs) have become common for human gait analysis. Canines are important large animal models for translational research of human diseases. Our objective is to develop a method for accurate and reliable determination of the timing of each stride in dogs using a wearable IMU. Methods We built a wireless IMU sensor using off-the-shelf components. We also developed a MATLAB algorithm for data acquisition and stride timing determination. Stride parameters from 1,259 steps of three adult mixed breed dogs were determined across a range of six height-normalized speeds using the IMU system. The IMU results were validated by frameby-frame manual counting of high-speed video recordings. Results Comparing IMU derived results with video revealed that the mean error +/- standard deviation for stride, stance, and swing duration was 0.001 +/- 0.025, -0.001 +/- 0.030, and 0.001 +/- 0.019 s respectively. A mean error +/- standard deviation of 0.000 +/- 0.020 and -0.008 +/- 0.027 s was obtained for determining toe-off and toe-touch events respectively. Only one step was missed by the algorithm in the video dataset of 1,259 steps. Conclusion We have developed and validated an IMU method for automatic canine gait analysis. Our method can be used for studying neuromuscular diseases in veterinary clinics and in translational research.	[Jenkins, Gregory J.; Hakim, Chady H.; Duan, Dongsheng] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA; [Yao, Gang; Duan, Dongsheng] Univ Missouri, Dept Bioengn, Columbia, MO 65212 USA; [Hakim, Chady H.; Yang, N. Nora] Natl Ctr Advancing Translat Sci, Bethesda, MD USA; [Duan, Dongsheng] Univ Missouri, Coll Vet Med, Dept Vet Biomed Sci, Columbia, MO 65211 USA; [Duan, Dongsheng] Univ Missouri, Sch Med, Dept Neurol, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Duan, DS (corresponding author), Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA.; Yao, G; Duan, DS (corresponding author), Univ Missouri, Dept Bioengn, Columbia, MO 65212 USA.; Duan, DS (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Biomed Sci, Columbia, MO 65211 USA.; Duan, DS (corresponding author), Univ Missouri, Sch Med, Dept Neurol, Columbia, MO 65211 USA.	yaog@missouri.edu; duand@missouri.edu	Yao, Gang/E-8025-2015	Yao, Gang/0000-0002-2763-8667; Jenkins, Gregory/0000-0002-5440-6570	National Institutes of Health [NS-90634, AR-71517]; Department of Defense [MD130014]; Jesse's Journey-The Foundation for Gene and Cell Therapy; Jackson Freel DMD Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR070517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS090634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Jesse's Journey-The Foundation for Gene and Cell Therapy; Jackson Freel DMD Research Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health (www.nih.gov) (NS-90634 and AR-71517 to DD), Department of Defense (www.defense.gov) (MD130014 to DD), Jesse's Journey-The Foundation for Gene and Cell Therapy (www. jessesjourney.com) (to DD) and Jackson Freel DMD Research Fund (to DD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1984, INT J ROBOT RES, V3, P49, DOI 10.1177/027836498400300205; Barthelemy I, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-75; Biknevicius AR, 2006, J EXP ZOOL PART A, V305A, P923, DOI 10.1002/jez.a.332; Chen SS, 2016, IEEE J BIOMED HEALTH, V20, P1521, DOI 10.1109/JBHI.2016.2608720; Clark K, 2014, CAN J VET RES, V78, P226; Dewhirst OP, 2017, J EXP BIOL, V220, P341, DOI 10.1242/jeb.146035; Duan DS, 2015, HUM GENE THER CL DEV, V26, P57, DOI 10.1089/humc.2015.006; Duerr FM, 2016, VET COMP ORTHOPAED, V29, P475, DOI 10.3415/VCOT-16-01-0012; Gillette RL, 2008, VET J, V178, P165, DOI 10.1016/j.tvjl.2008.01.009; Gorton GE, 2009, GAIT POSTURE, V29, P398, DOI 10.1016/j.gaitpost.2008.10.060; Gustas P, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0265-9; HILDEBRAND M, 1989, BIOSCIENCE, V39, P766, DOI 10.2307/1311182; Kano WT, 2016, BMC VET RES, V12, DOI 10.1186/s12917-015-0631-2; Ladha C, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17020309; Lizama LEC, 2016, MULT SCLER J, V22, P1768, DOI 10.1177/1352458516658137; Maes LD, 2008, J EXP BIOL, V211, P138, DOI 10.1242/jeb.008243; Marsh AP, 2010, NEUROMUSCULAR DISORD, V20, P16, DOI 10.1016/j.nmd.2009.10.007; Picerno P, 2017, GAIT POSTURE, V51, P239, DOI 10.1016/j.gaitpost.2016.11.008; Pillard P, 2012, Comput Methods Biomech Biomed Engin, V15 Suppl 1, P129; Rathinam C, 2014, GAIT POSTURE, V40, P279, DOI 10.1016/j.gaitpost.2014.04.187; Rhodin M, 2017, VET J, V222, P54, DOI 10.1016/j.tvjl.2017.02.004; Shin JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059875; Simmons AD, 1997, AM J PHYSIOL-REG I, V273, pR1352, DOI 10.1152/ajpregu.1997.273.4.R1352; Thewlis D, 2013, J APPL BIOMECH, V29, P112, DOI 10.1123/jab.29.1.112; Wilshin S, 2017, J EXP BIOL, V220, P1864, DOI 10.1242/jeb.149112	25	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198893	10.1371/journal.pone.0198893	http://dx.doi.org/10.1371/journal.pone.0198893			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902280	gold, Green Published, Green Submitted			2022-12-26	WOS:000435424900054
J	Liu, AD; Dong, W; Peng, J; Dirsch, O; Dahmen, U; Fang, HS; Zhang, CT; Sun, J				Liu, Anding; Dong, Wei; Peng, Jing; Dirsch, Olaf; Dahmen, Uta; Fang, Haoshu; Zhang, Cuntai; Sun, Jian			Growth differentiation factor 11 worsens hepatocellular injury and liver regeneration after liver ischemia reperfusion injury	FASEB JOURNAL			English	Article						aging; hepatocyte; cell cycle	CELL-CYCLE CONTROL; ISCHEMIA/REPERFUSION INJURY; PARTIAL-HEPATECTOMY; PROLIFERATIVE RESPONSE; SKELETAL-MUSCLE; GDF11; AGE; DISEASE; RATS; NEUROGENESIS	Growth differentiation factor 11 (GDF11) has been implicated in a variety of aging conditions and the regulation of organ regeneration after injury; however, the role of GDF11 in liver ischemia reperfusion injury (IRI) is unknown. The aim of the current study was to investigate the possible role of GDF11 in liver IRI. We investigated the effects of GDF11 in liver IRI in both young (3 mo) and old (22 mo) mice in vivo, and in primary young and old mouse hepatocytes in vitro. Both serum and hepatic GDF11 protein expression levels increased with age and after IRI. Treatment with recombinant GDF11 significantly increased IRI-induced elevations of serum aminotransferase levels, worsened the histologic status of livers, and impaired liver regeneration. In contrast, inhibition of GDF11 activity with neutralizing Abs significantly decreased liver injury and improved liver regeneration after IRI. In vitro, treatment with recombinant GDF11 significantly delayed cell proliferation in cultured hepatocytes that were subjected to hypoxia/reoxygenation insult. Moreover, suppression of cell-cycle progression may be a key mechanism by which GDF11 inhibited hepatocyte regeneration. Collectively, rather than acting as a rejuvenating agent, GDF11 worsens hepatocellular injury and impairs liver regeneration after IRI.Liu, A., Dong, W., Peng, J., Dirsch, O., Dahmen, U., Fang, H., Zhang, C., Sun, J. Growth differentiation factor 11 worsens hepatocellular injury and liver regeneration after liver ischemia reperfusion injury.	[Liu, Anding] Huazhong Univ Sci & Technol, Ctr Med Expt, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Dong, Wei] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, Wuhan, Hubei, Peoples R China; [Peng, Jing] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Clin Lab, Wuhan, Hubei, Peoples R China; [Zhang, Cuntai] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr, Wuhan, Hubei, Peoples R China; [Dirsch, Olaf] Klinikum Chemnitz, Inst Pathol, Chemnitz, Germany; [Dahmen, Uta] Friedrich Schiller Univ Jena, Dept Gen Visceral & Vasc Surg, Expt Transplantat Surg, Jena, Germany; [Fang, Haoshu] Anhui Med Univ, Dept Pathophysiol, Hefei, Anhui, Peoples R China; [Sun, Jian] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Biliopancreat Surg, 107 Yanjiang, Guangzhou, Guangdong, Peoples R China; [Sun, Jian] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chemnitz Clinic; Friedrich Schiller University of Jena; Anhui Medical University; Sun Yat Sen University; Sun Yat Sen University	Sun, J (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Biliopancreat Surg, 107 Yanjiang, Guangzhou, Guangdong, Peoples R China.	sjmed02@outlook.com	Liu, Anding/AAU-2477-2020		National Natural Science Fund of China [81300343, 81770680]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Fund of China Grants 81300343 and 81770680. The authors declare no conflicts of interest.	Andersson O, 2006, EMBO REP, V7, P831, DOI 10.1038/sj.embor.7400752; Brun CE, 2015, CELL METAB, V22, P54, DOI 10.1016/j.cmet.2015.05.009; Chen L, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-18; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Deneme MA, 2006, J SURG RES, V136, P280, DOI 10.1016/j.jss.2006.08.020; Do N, 2012, AM J PHYSIOL-GASTR L, V303, pG1220, DOI 10.1152/ajpgi.00105.2012; Du GQ, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-016-0593-y; Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010; Elliott BT, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13343; Glass DJ, 2016, CELL METAB, V24, P7, DOI 10.1016/j.cmet.2016.06.017; Golias CH, 2004, INT J CLIN PRACT, V58, P1134, DOI 10.1111/j.1742-1241.2004.00284.x; Hammers DW, 2017, EMBO MOL MED, V9, P531, DOI 10.15252/emmm.201607231; Harmon EB, 2004, DEVELOPMENT, V131, P6163, DOI 10.1242/dev.01535; Harper SC, 2016, CIRC RES, V118, P1143, DOI 10.1161/CIRCRESAHA.116.306206; Hinken AC, 2016, AGING CELL, V15, P582, DOI 10.1111/acel.12475; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Karkampouna S, 2016, ARCH TOXICOL, V90, P347, DOI 10.1007/s00204-014-1436-y; Karkampouna S, 2012, CURR PHARM DESIGN, V18, P4103, DOI 10.2174/138161212802430521; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; Liu AD, 2018, AGING CELL, V17, DOI 10.1111/acel.12708; Liu AD, 2016, ONCOTARGET, V7, P78372, DOI 10.18632/oncotarget.13281; Liu AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep25042; Liu AD, 2015, INT IMMUNOPHARMACOL, V24, P72, DOI 10.1016/j.intimp.2014.11.014; Liu AD, 2014, CRIT CARE MED, V42, pE762, DOI 10.1097/CCM.0000000000000659; Liu WQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12794; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; Nakamura T, 2004, J HEPATOL, V41, P974, DOI 10.1016/j.jhep.2004.08.015; Oh SP, 2002, GENE DEV, V16, P2749, DOI 10.1101/gad.1021802; Olson KA, 2015, EUR HEART J, V36, P3426, DOI 10.1093/eurheartj/ehv385; Onodera K, 2017, THORAX, V72, P893, DOI 10.1136/thoraxjnl-2016-209352; Rebo J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13363; Rodgers BD, 2015, ENDOCRINOLOGY, V156, P3885, DOI 10.1210/en.2015-1628; Romero-Gallo J, 2005, ONCOGENE, V24, P3028, DOI 10.1038/sj.onc.1208475; RUSSELL WE, 1988, P NATL ACAD SCI USA, V85, P5126, DOI 10.1073/pnas.85.14.5126; Schafer MJ, 2016, CELL METAB, V23, P1207, DOI 10.1016/j.cmet.2016.05.023; Selzner N, 2003, GASTROENTEROLOGY, V125, P917, DOI 10.1016/S0016-5085(03)01048-5; Shi YT, 2011, J NEUROSCI, V31, P883, DOI 10.1523/JNEUROSCI.2394-10.2011; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Smith SC, 2015, CIRC RES, V117, P926, DOI 10.1161/CIRCRESAHA.115.307527; Stein GS, 2006, J CELL PHYSIOL, V209, P706, DOI 10.1002/jcp.20843; Sun J, 2017, LIVER TRANSPLANT, V23, P510, DOI 10.1002/lt.24733; Walker RG, 2016, CIRC RES, V118, P1125, DOI 10.1161/CIRCRESAHA.116.308391; Williams G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078478; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; Zhang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep34624; Zimmers TA, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0639-9	48	14	14	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5186	5198		10.1096/fj.201800195R	http://dx.doi.org/10.1096/fj.201800195R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29913561	Bronze			2022-12-26	WOS:000443817700045
J	Hsieh, LY; Chou, FJ; Guo, SE				Hsieh, Ling-Yu; Chou, Fang-Ju; Guo, Su-Er			Information needs of patients with lung cancer from diagnosis until first treatment follow-up	PLOS ONE			English	Article							SUPPORTIVE CARE NEEDS; BREAST-CANCER; RADIOTHERAPY	The aim of this study was to analyze the information needs of lung cancer patients from diagnosis until first treatment follow-up. Sixty-nine participants with lung cancer were recruited from Ditmanson Medical Foundation Chia-Yi Christian Hospital in Midwest Taiwan. The Modified Toronto Informational Needs Questionnaire (TINQ) was used to assess information needs during visits to the outpatient oncology department. Generalized estimating equations were applied to compare changes in information needs over time and to examine correlates of information needs of lung cancer patients. The greatest concern of lung cancer patients was the cancer itself and access to recovery information. The need for information regarding food selection and social welfare resources was also high. However, the means of information needs for each domain significantly decreased over time. Demographic information (age, gender, disease stage, current treatment, education, work status, and having children) was significantly associated with information needs over time. The need for "disease-related information" remained high regardless of disease stage. Oncology nurses can use the results of this study to better address the information needs of patients in an effort to fill knowledge gaps between patients and healthcare providers. Further studies are needed to explore the use of an appropriate instrument, like that used in this study, to identify newly diagnosed lung cancer patients' difficulties, concerns, and target interventions to improve their quality of life.	[Hsieh, Ling-Yu] Ditmanson Med Fdn, Dept Nursing, Chia Yi Christian Hosp, Chiayi, Taiwan; [Chou, Fang-Ju] Ditmanson Med Fdn, Canc Ctr, Chia Yi Christian Hosp, Chiayi, Taiwan; [Guo, Su-Er] Chang Gung Univ Sci & Technol, Coll Nursing, Grad Inst Nursing & Chron Dis, Puzi, Chiayi, Taiwan; [Guo, Su-Er] Chang Gung Univ Sci & Technol, Coll Nursing, Hlth Promot Res Ctr, Puzi, Chiayi, Taiwan; [Guo, Su-Er] Chang Gung Med Fdn, Chiayi Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Puzi, Chiayi, Taiwan; [Guo, Su-Er] Ming Chi Univ Technol, Dept Safety Hlth & Environm Engn, New Taipei, Taiwan	Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Ming Chi University of Technology	Guo, SE (corresponding author), Chang Gung Univ Sci & Technol, Coll Nursing, Grad Inst Nursing & Chron Dis, Puzi, Chiayi, Taiwan.; Guo, SE (corresponding author), Chang Gung Univ Sci & Technol, Coll Nursing, Hlth Promot Res Ctr, Puzi, Chiayi, Taiwan.; Guo, SE (corresponding author), Chang Gung Med Fdn, Chiayi Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Puzi, Chiayi, Taiwan.; Guo, SE (corresponding author), Ming Chi Univ Technol, Dept Safety Hlth & Environm Engn, New Taipei, Taiwan.	sxg90huang@gmail.com		Guo, Su-Er/0000-0001-8521-5331				Ancel G, 2012, J CANCER EDUC, V27, P631, DOI 10.1007/s13187-012-0416-2; Beesley VL, 2013, PSYCHO-ONCOLOGY, V22, P1565, DOI 10.1002/pon.3169; Boyes AW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-150; Douma KFL, 2012, SUPPORT CARE CANCER, V20, P2167, DOI 10.1007/s00520-011-1328-0; Galloway S, 1997, J ADV NURS, V25, P1175, DOI 10.1046/j.1365-2648.1997.19970251175.x; Giuliani ME, 2016, CURR ONCOL, V23, P258, DOI 10.3747/co.23.3012; Guleser GN, 2012, J CANCER EDUC, V27, P46, DOI 10.1007/s13187-011-0254-7; Guo SE, 2001, CHUNG GUNG NURSING, V12, P112; Halkett GKB, 2010, EUR J CANCER CARE, V19, P538, DOI 10.1111/j.1365-2354.2009.01090.x; Krishnasamy M, 2001, PALLIATIVE MED, V15, P213, DOI 10.1191/026921601678576202; Lai GM, 2005, SURVEY NUTR KNOWLEDG; Lee Yik Mun, 2004, Eur J Oncol Nurs, V8, P224; Lei CP, 2011, ASIAN PAC J CANCER P, V12, P797; Liao YC, 2011, SUPPORT CARE CANCER, V19, P1743, DOI 10.1007/s00520-010-1014-7; Luo YY, 2010, LEADERSHIP NURSING, V11, P16; Maguire R, 2013, EUR J ONCOL NURS, V17, P449, DOI 10.1016/j.ejon.2012.10.013; Matsuyama RK, 2013, PATIENT EDUC COUNS, V90, P96, DOI 10.1016/j.pec.2012.09.009; Mistry A, 2010, JRSM Short Rep, V1, P30, DOI 10.1258/shorts.2010.010032; Mraz L., 2003, RES CONNECTION, V1, P2; O'Connor G, 2010, EUR J ONCOL NURS, V14, P271, DOI 10.1016/j.ejon.2010.01.024; Papadakos J, 2015, HEALTH EXPECT, V18, P3088, DOI 10.1111/hex.12296; Papadakos J, 2012, GYNECOL ONCOL, V124, P452, DOI 10.1016/j.ygyno.2011.10.030; Rutten LJF, 2005, PATIENT EDUC COUNS, V57, P250, DOI 10.1016/j.pec.2004.06.006; Taiwanese Ministry of Health and Welfare, 2013, CANC REG ANN REP 201; Tishelman C, 2010, J CLIN ONCOL, V28, P1942, DOI 10.1200/JCO.2009.23.3403; Turner NJ, 2007, PSYCHO-ONCOL, V16, P707, DOI 10.1002/pon.1109; Ugalde A, 2012, SUPPORT CARE CANCER, V20, P419, DOI 10.1007/s00520-011-1296-4; Zeguers M, 2012, INT J RADIAT ONCOL, V82, P418, DOI 10.1016/j.ijrobp.2010.09.032	28	6	7	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199515	10.1371/journal.pone.0199515	http://dx.doi.org/10.1371/journal.pone.0199515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK0LV	29928027	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500104
J	Lee, B; Kim, SJ; Park, JD; Park, J; Jung, AH; Jung, SH; Choi, YH; Kang, HG; Ha, IS; Cheong, HI				Lee, Bongjin; Kim, Soo Jung; Park, June Dong; Park, Jiun; Jung, Ae Hee; Jung, Sun Hoi; Choi, Yu Hyeon; Kang, Hee Gyung; Ha, Il Soo; Cheong, Hae Il			Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration	PLOS ONE			English	Article							RENAL REPLACEMENT THERAPY; STAPHYLOCOCCUS-AUREUS INFECTIONS; ULTRAFILTRATION FLOW-RATES; REGULATOR AGR GROUP; PRACTICE GUIDELINES; SOLUTE CLEARANCES; CLINICAL-PRACTICE; DISEASES SOCIETY; SEPTIC SHOCK; HEMOFILTRATION	Vancomycin is known to be unintentionally eliminated by continuous renal replacement therapy, and the protein bound fraction of vancomycin is also known to be different in adults and children. However, there are only a few studies investigating the relationship between the dose of continuous venovenous hemodiafiltration (CVVHDF) parameters and serum concentration of vancomycin in pediatric patients. The aim of this study was to determine clinical and demographic parameters that significantly affect serum vancomycin concentrations. This retrospective cohort study was conducted at a pediatric intensive care unit in a tertiary university children's hospital. Data from oliguric patients who underwent CVVHDF and vancomycin therapeutic drug monitoring were collected. The correlation between factors affecting serum concentration of vancomycin was analyzed using mixed effect model. A total of 177 serum samples undergoing vancomycin therapeutic drug monitoring were analyzed. The median age of study participants was 2.23 (interquartile range, 0.3-11.84) years, and 126 (71.19%) were male patients. Serum concentration of vancomycin decreased significantly as the effluent flow rate (EFR; P < 0.001), dialysate flow rate (DFR; P = 0.009), replacement fluid flow rate (RFFR; P = 0.008), the proportion of RFFR in the sum of DFR and RFFR (P = 0.025), and residual urine output increased. The adjusted R-2 of the multivariate regression model was 0.874 (P < 0.001) and the equation was as follows: Vancomycin trough level (mg/L) = (0.283 x daily dose of vancomycin [mg/kg/d]) + (365.139 / EFR [mL/h/kg])-(15.842 x residual urine output [mL/h/kg]). This study demonstrated that the serum concentration of vancomycin was associated with EFR, DFR, RFFR, the proportion of RFFR, and residual urine output in oliguric pediatric patients receiving CVVHDF.	[Lee, Bongjin; Park, June Dong; Choi, Yu Hyeon; Kang, Hee Gyung; Ha, Il Soo; Cheong, Hae Il] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Lee, Bongjin] Chungnam Natl Univ Hosp, Dept Pediat, Daejeon, South Korea; [Kim, Soo Jung; Park, Jiun; Jung, Ae Hee; Jung, Sun Hoi] Seoul Natl Univ Hosp, Dept Pharm, Seoul, South Korea	Seoul National University (SNU); Chungnam National University; Chungnam National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Park, JD (corresponding author), Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea.	jdparkmd@snu.ac.kr		Lee, Bongjin/0000-0001-7878-9644; Park, June Dong/0000-0001-8113-1384				Bhargava D, 2013, J MAXILLOFAC ORAL SU, V12, P354, DOI 10.1007/s12663-012-0374-6; Boereboom FTJ, 1999, INTENS CARE MED, V25, P1100, DOI 10.1007/s001340051018; Bouman CSC, 2006, INTENS CARE MED, V32, P2013, DOI 10.1007/s00134-006-0397-x; Brunet S, 1999, AM J KIDNEY DIS, V34, P486, DOI 10.1016/S0272-6386(99)70076-4; Bugge JF, 2001, ACTA ANAESTH SCAND, V45, P929, DOI 10.1034/j.1399-6576.2001.450802.x; Choi G, 2010, BLOOD PURIFICAT, V30, P195, DOI 10.1159/000321488; COLLINS DM, 1993, J AM SOC NEPHROL, V4, P148; De Cock PAJG, 2017, J ANTIMICROB CHEMOTH, V72, P801, DOI 10.1093/jac/dkw495; DEBOCK V, 1989, NEPHROL DIAL TRANSPL, V4, P635; Eiland LS, 2011, ANN PHARMACOTHER, V45, P582, DOI 10.1345/aph.1P588; Frazee EN, 2012, ANTIMICROB AGENTS CH, V56, P6181, DOI 10.1128/AAC.00459-12; Heintz BH, 2009, PHARMACOTHERAPY, V29, P562, DOI 10.1592/phco.29.5.562; Jamal JA, 2014, CRIT CARE MED, V42, P1640, DOI 10.1097/CCM.0000000000000317; JEFFREY RF, 1994, ARTIF ORGANS, V18, P425, DOI 10.1111/j.1525-1594.1994.tb02228.x; Joy MS, 1998, AM J KIDNEY DIS, V31, P1019, DOI 10.1053/ajkd.1998.v31.pm9631848; Kliegman R. M., 2015, NELSON TXB PEDIAT; Kubin C, 2005, J PHARM PRACT, V18, P109, DOI 10.1177/0897190004273596; 박인휘, 2010, Kidney Research and Clinical Practice, V29, P585; Lewis SJ, 2014, SEMIN DIALYSIS, V27, P441, DOI 10.1111/sdi.12203; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; Matsumoto K, 2013, J INFECT CHEMOTHER, V19, P365, DOI 10.1007/s10156-013-0599-4; Omrani AS, 2015, SAUDI PHARM J, V23, P327, DOI 10.1016/j.jsps.2014.08.005; Oyaert M, 2015, ANTIMICROB AGENTS CH, V59, P7073, DOI 10.1128/AAC.01185-15; Paciullo CA, 2013, ANN PHARMACOTHER, V47, pE14, DOI 10.1345/aph.1Q488; Petejova N, 2014, BIOMED PAP, V158, P65, DOI 10.5507/bp.2012.092; Roberts DM, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0818-8; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; Sakoulas G, 2003, J INFECT DIS, V187, P929, DOI 10.1086/368128; Thomas M, 2011, CONTRIB NEPHROL, V173, P119, DOI 10.1159/000328961; Trotman RL, 2005, CLIN INFECT DIS, V41, P1159, DOI 10.1086/444500; Troyanov S, 2003, NEPHROL DIAL TRANSPL, V18, P961, DOI 10.1093/ndt/gfg055; Tsuji BT, 2007, ANTIMICROB AGENTS CH, V51, P1089, DOI 10.1128/AAC.00671-06; Udy AA, 2013, INT J ANTIMICROB AG, V41, P564, DOI 10.1016/j.ijantimicag.2013.01.018; Ulldemolins M, 2015, ANTIMICROB AGENTS CH, V59, P5520, DOI 10.1128/AAC.00712-15; Ulldemolins M, 2014, CRIT CARE, V18, DOI 10.1186/cc13938; Wilson FP, 2012, CLIN NEPHROL, V77, P329, DOI 10.5414/CN106993	36	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199158	10.1371/journal.pone.0199158	http://dx.doi.org/10.1371/journal.pone.0199158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927988	Green Submitted, Green Published, gold			2022-12-26	WOS:000435802500050
J	Preston, C; Ehrsson, HH				Preston, Catherine; Ehrsson, H. Henrik			Implicit and explicit changes in body satisfaction evoked by body size illusions: Implications for eating disorder vulnerability in women	PLOS ONE			English	Article							RUBBER-HAND ILLUSION; QUESTIONNAIRE EDE-Q; ANOREXIA-NERVOSA; MULTISENSORY ILLUSIONS; IMAGE DISTURBANCE; ADOLESCENT GIRLS; PRIMARY-CARE; Q NORMS; DISSATISFACTION; MEDIA	Dissatisfaction with one's body is a widespread issue in modern society and has been linked to vulnerability for developing eating disorders. Recent studies have demonstrated a direct relationship between body perception and body satisfaction by manipulating perceived body size using multisensory body illusions. However, how these body size illusions influence implicit affective experience has not previously been examined. The current experiment used an established full-body ownership illusion paradigm to induce feelings of illusory obesity in male and female participants. The effects of illusory obesity on explicit and implicit body satisfaction were measured in naive participants across two separate experiments. In terms of explicit measures, owning an obese body decreased body satisfaction, and owning a slimmer body increased body satisfaction in females but not in males. However, implicit feelings regarding the body were only influenced by the synchrony of the touch and not the size of the body in the illusion. These results suggest that implicit and explicit affective experiences of the body may be mediated by different factors. In addition, these findings may have clinical implications because both implicit and explicit changes in affective experience of the body were related to behaviours and thoughts associated with disordered eating in a non-clinical sample.	[Preston, Catherine] Univ York, Psychol Dept, York, N Yorkshire, England; [Preston, Catherine; Ehrsson, H. Henrik] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	University of York - UK; Karolinska Institutet	Preston, C (corresponding author), Univ York, Psychol Dept, York, N Yorkshire, England.; Preston, C (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	catherine.preston@york.ac.uk			James S. McDonnell Foundation; Torsten Soderbergs Stiftelse; Vetenskapsradet; Hjarnfonden; The Wenner-Gren Foundations; Marie Curie Actions	James S. McDonnell Foundation; Torsten Soderbergs Stiftelse; Vetenskapsradet(Swedish Research Council); Hjarnfonden; The Wenner-Gren Foundations; Marie Curie Actions(European Commission)	This work was supported by the James S. McDonnell Foundation (HE), Torsten Soderbergs Stiftelse (HE), Vetenskapsradet (HE), Hjarnfonden (HE & CP), The Wenner-Gren Foundations (CP) and FP7 People: Marie Curie Actions (CP).	Algars M, 2009, J AGING HEALTH, V21, P1112, DOI 10.1177/0898264309348023; Austin SB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-313; Bluemke M, 2006, J EXP SOC PSYCHOL, V42, P163, DOI 10.1016/j.jesp.2005.03.004; Boehm I, 2016, EUR CHILD ADOLES PSY, V25, P1319, DOI 10.1007/s00787-016-0854-1; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Cash Thomas F, 2002, Eat Disord, V10, P103, DOI 10.1080/10640260290081678; Cazzato V, 2016, EXP BRAIN RES, V234, P695, DOI 10.1007/s00221-015-4498-z; Cazzato V, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00235; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Crucianelli L, CORTEX; Crucianelli Laura, 2013, Front Psychol, V4, P703, DOI 10.3389/fpsyg.2013.00703; Cunningham WA, 2004, J COGNITIVE NEUROSCI, V16, P1717, DOI 10.1162/0898929042947919; Darby A, 2009, INT J EAT DISORDER, V42, P104, DOI 10.1002/eat.20601; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Docteur A, 2010, OBESITY, V18, P1464, DOI 10.1038/oby.2009.418; Ehrsson H.H., 2012, NEW HDB MULTISENSORY, P775, DOI DOI 10.1126/SCIENCE.1097011; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Eshkevari E, 2012, PSYCHOL MED, V42, P819, DOI 10.1017/S0033291711002091; Espeset EMS, 2012, CLIN PSYCHOL PSYCHOT, V19, P518, DOI 10.1002/cpp.760; Fairburn CG, 2000, ARCH GEN PSYCHIAT, V57, P659, DOI 10.1001/archpsyc.57.7.659; Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1; Fonseca H, 2009, ACTA PAEDIATR, V98, P847, DOI 10.1111/j.1651-2227.2009.01244.x; Friederich HC, 2007, NEUROIMAGE, V37, P674, DOI 10.1016/j.neuroimage.2007.05.039; Galioto R, 2013, BODY IMAGE, V10, P566, DOI 10.1016/j.bodyim.2013.07.009; Garfinkel SN, 2013, SOC COGN AFFECT NEUR, V8, P231, DOI 10.1093/scan/nss140; Grabe S, 2008, PSYCHOL BULL, V134, P460, DOI 10.1037/0033-2909.134.3.460; Green SP, 2003, SOC BEHAV PERSONAL, V31, P215, DOI 10.2224/sbp.2003.31.3.215; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Guardia D, 2010, NEUROPSYCHOLOGIA, V48, P3961, DOI 10.1016/j.neuropsychologia.2010.09.004; Gumble A, 2012, BODY IMAGE, V9, P101, DOI 10.1016/j.bodyim.2011.07.005; Hilbert A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029125; Hoek HW, 2006, CURR OPIN PSYCHIATR, V19, P389, DOI 10.1097/01.yco.0000228759.95237.78; Holmstrom AJ, 2004, J BROADCAST ELECTRON, V48, P196, DOI 10.1207/s15506878jobem4802_3; Jenkinson PM, 2015, CONSCIOUS COGN, V33, P432, DOI 10.1016/j.concog.2015.02.020; Jennings KM, 2017, ARCH PSYCHIAT NURS, V31, P73, DOI 10.1016/j.apnu.2016.08.004; Kalckert A, 2014, CONSCIOUS COGN, V26, P117, DOI 10.1016/j.concog.2014.02.003; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Keizer A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163921; Keizer A, 2014, NEUROPSYCHOLOGIA, V62, P26, DOI 10.1016/j.neuropsychologia.2014.07.003; Keizer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064602; Keizer A, 2011, PSYCHIAT RES, V190, P115, DOI 10.1016/j.psychres.2011.04.031; Kilteni K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00141; Kilteni K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040867; Knauss C, 2007, BODY IMAGE, V4, P353, DOI 10.1016/j.bodyim.2007.06.007; Krones PG, 2005, INT J EAT DISORDER, V38, P134, DOI 10.1002/eat.20171; Lane K. A., 2007, IMPLICIT MEASURES AT, P59, DOI DOI 10.1016/J.BRAT.2008.02.003; Lavender JM, 2010, EAT BEHAV, V11, P119, DOI 10.1016/j.eatbeh.2009.09.005; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Leit RA, 2001, INT J EAT DISORDER, V29, P90, DOI 10.1002/1098-108X(200101)29:1<90::AID-EAT15>3.0.CO;2-F; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Mascolo M, 2012, INT J EAT DISORDER, V45, P977, DOI 10.1002/eat.22035; Mele S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081378; Mitchison D, 2012, PLOS ONE, V7, DOI [10.1002/eat.20316, DOI 10.1002/EAT.20316]; Mond J, 2014, INT J EAT DISORDER, V47, P335, DOI 10.1002/eat.22237; Mond JM, 2008, BEHAV RES THER, V46, P612, DOI 10.1016/j.brat.2008.02.003; Morrison I, 2011, J NEUROSCI, V31, P9554, DOI 10.1523/JNEUROSCI.0397-11.2011; Mosley PE, 2009, EUR EAT DISORD REV, V17, P191, DOI 10.1002/erv.897; Mussap AJ, 2006, J HEALTH PSYCHOL, V11, P627, DOI 10.1177/1359105306065022; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Normand JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016128; O'Brien KS, 2013, BODY IMAGE, V10, P619, DOI 10.1016/j.bodyim.2013.07.012; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Pallant J., 2005, SPSS SURVIVAL MANUAL, V2; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; Penelo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083245; Peterson CB, 2007, INT J EAT DISORDER, V40, P386, DOI 10.1002/eat.20373; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Pingitore R, 1997, OBES RES, V5, P402, DOI 10.1002/j.1550-8528.1997.tb00662.x; Piryankova IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103428; Preston C, 2016, CEREB CORTEX, V26, P4450, DOI 10.1093/cercor/bhw313; Preston C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085773; Preston C, 2013, ACTA PSYCHOL, V142, P177, DOI 10.1016/j.actpsy.2012.12.005; Preston C, 2012, PERCEPTION, V41, P247, DOI 10.1068/p7103; Preston C, 2011, COGN NEUROSCI-UK, V2, P163, DOI 10.1080/17588928.2011.582944; Preston C, 2011, RHEUMATOLOGY, V50, P2314, DOI 10.1093/rheumatology/ker104; Quick VM, 2013, EAT WEIGHT DISORD-ST, V18, P29, DOI 10.1007/s40519-013-0015-1; Reas DL, 2012, EAT DISORD, V20, P437, DOI 10.1080/10640266.2012.715523; RINTALA M, 1992, BRIT MED J, V305, P1575, DOI 10.1136/bmj.305.6868.1575; Robinson A, 2015, EAT BEHAV, V18, P186, DOI 10.1016/j.eatbeh.2015.05.011; Robinson E, 2017, J EAT DISORD, V5, DOI 10.1186/s40337-017-0142-6; Rodgers RF, 2015, DEV PSYCHOL, V51, P706, DOI 10.1037/dev0000013; Rose JS, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-42; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Samad M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117178; Samoilov A, 2000, CLIN PSYCHOL-SCI PR, V7, P373, DOI 10.1093/clipsy/7.4.373; Scarpina F, 2014, PSYCHIAT RES, V220, P960, DOI 10.1016/j.psychres.2014.08.020; Serino S, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00837; SLADE PD, 1973, PSYCHOL MED, V3, P188, DOI 10.1017/S0033291700048510; Smeets MAM, 1999, J PSYCHOSOM RES, V46, P465, DOI 10.1016/S0022-3999(99)00005-7; Smink FRE, 2012, CURR PSYCHIAT REP, V14, P406, DOI 10.1007/s11920-012-0282-y; Smith KE, 2017, INT J EAT DISORDER, V50, P769, DOI 10.1002/eat.22716; Stefanucci JK, 2009, PERCEPTION, V38, P1782, DOI 10.1068/p6437; Stice E, 1998, BEHAV THER, V29, P257, DOI 10.1016/S0005-7894(98)80006-3; Stice E, 2002, J PSYCHOSOM RES, V53, P985, DOI 10.1016/S0022-3999(02)00488-9; Stokes R, 2003, J WOMEN AGING, V15, P17, DOI 10.1300/J074v15n01_03; Sugovic M, 2016, ACTA PSYCHOL, V165, P1, DOI 10.1016/j.actpsy.2016.01.012; Sweeting H, 2015, INT J MENS HLTH, V4, P86; Terasawa Y, 2013, SOC COGN AFFECT NEUR, V8, P259, DOI 10.1093/scan/nss108; Thompson JK, 2001, CURR DIR PSYCHOL SCI, V10, P181, DOI 10.1111/1467-8721.00144; Tsakiris M, 2010, EXP BRAIN RES, V204, P343, DOI 10.1007/s00221-009-2039-3; van Den Berg P, 2007, BODY IMAGE, V4, P257, DOI 10.1016/j.bodyim.2007.04.003; van der Hoort B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020195; van Son GE, 2006, INT J EAT DISORDER, V39, P565, DOI 10.1002/eat.20316; Wagner A, 2006, INT J EAT DISORDER, V39, P276, DOI 10.1002/eat.20251; White HJ, 2014, INT J EAT DISORDER, V47, P99, DOI 10.1002/eat.22199	108	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199426	10.1371/journal.pone.0199426	http://dx.doi.org/10.1371/journal.pone.0199426			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK0LV	29928005	gold, Green Published, Green Accepted			2022-12-26	WOS:000435802500087
J	Brogna, C; Cristiano, L; Tartaglione, T; Verdolotti, T; Fanelli, L; Ficociello, L; Tasca, G; Battini, R; Coratti, G; Forcina, N; De Santis, R; Norcia, G; Carnicella, S; Colosimo, C; Carlier, P; Pane, M; Mercuri, E				Brogna, Claudia; Cristiano, Lara; Tartaglione, Tommaso; Verdolotti, Tommaso; Fanelli, Lavinia; Ficociello, Luana; Tasca, Giorgio; Battini, Roberta; Coratti, Giorgia; Forcina, Nicola; De Santis, Roberto; Norcia, Giulia; Carnicella, Sara; Colosimo, Cesare; Carlier, Pierre; Pane, Marika; Mercuri, Eugenio			Functional levels and MRI patterns of muscle involvement in upper limbs in Duchenne muscular dystrophy	PLOS ONE			English	Article							NEUROMUSCULAR DISORDERS; RELIABILITY; PERFORMANCE; BOYS/MEN	The aim of the study was to evaluate the spectrum of upper limb functional activities and imaging finding in a cohort of patients affected by Duchenne muscular dystrophy. Thirty-one patients of age between 5 and 29 years were included in the study (17 ambulant and 14 non-ambulant). They were all assessed using the Performance of Upper Limb (PUL) test and muscle MRI of shoulder, arm and forearm in order to establish if the functional scores obtained at shoulder, mid and distal level related to specific patterns of involvement in each upper limb segment on muscle MRI. At shoulder level, latissimus dorsi, serratus anterior, infraspinatus and subscapularis were always involved, even in patients with full functional scores at shoulder level. Diffuse and severe involvement of all muscles was found in the patients with a PUL shoulder functional score of <= 5. At arm level biceps brachii, brachialis and triceps were generally concordantly involved or spared. Some degree of involvement could already be detected in patients with reduced scores on the PUL mid domain. They were generally severely involved in patients with functional scores less than 6 at mid-level. At distal level supinator and pronator muscles were often involved, followed by brachioradialis and, less frequently, by the muscles of the flexor compartment. The extensor muscles were generally completely spared. A diffuse and severe involvement was found only in patients who had very low scores (8 or below) on the PUL distal domain. The integrated use of functional scales and imaging allowed to establish patterns of involvement at each level, and the functional scores that were more frequently associated with diffuse and severe involvement.	[Brogna, Claudia; Cristiano, Lara; Fanelli, Lavinia; Battini, Roberta; Coratti, Giorgia; Forcina, Nicola; De Santis, Roberto; Norcia, Giulia; Carnicella, Sara; Pane, Marika; Mercuri, Eugenio] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCSS, Pediat Neurol & Nemo Clin Ctr, Rome, Italy; [Tartaglione, Tommaso; Verdolotti, Tommaso; Ficociello, Luana; Colosimo, Cesare] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCSS, Dept Radiol, Rome, Italy; [Tasca, Giorgio] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCSS, Inst Neurol, Rome, Italy; [Battini, Roberta] IRCSS Stella Maris, Pisa, Italy; [Carlier, Pierre] AIM, Paris, France; [Carlier, Pierre] Inst Myol, CEA NMR Lab, Paris, France	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Fondazione Stella Maris; UDICE-French Research Universities; Sorbonne Universite	Mercuri, E (corresponding author), Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCSS, Pediat Neurol & Nemo Clin Ctr, Rome, Italy.	eugeniomaria.mercuri@unicatt.it	Coratti, Giorgia/AAV-3224-2021; Tasca, Giorgio/J-5153-2018; Verdolotti, Tommaso/K-7221-2018; battini, roberta/P-9095-2017; Coratti, Giorgia/Y-6292-2019	Coratti, Giorgia/0000-0001-6666-5628; Tasca, Giorgio/0000-0003-0849-9144; Verdolotti, Tommaso/0000-0001-8094-2847; battini, roberta/0000-0002-7889-1355; Coratti, Giorgia/0000-0001-6666-5628; Pane, Marika/0000-0002-4851-6124	Bioimage Neuromuscular disorders (Eu Grant FP7) [602485]; Italian Telethon to Eugenio Mercuri [BM1304]	Bioimage Neuromuscular disorders (Eu Grant FP7); Italian Telethon to Eugenio Mercuri(Fondazione Telethon)	This work was supported by Bioimage Neuromuscular disorders (Eu Grant FP7) 602485 to Eugenio Mercuri, Italian Telethon to Eugenio Mercuri, and Cost, BM1304, Prof Eugenio Mercuri.	Bartels B, 2011, J REHABIL MED, V43, P770, DOI 10.2340/16501977-0841; Connolly AM, 2015, MUSCLE NERVE, V51, P522, DOI 10.1002/mus.24346; HILLER LB, 1992, ARCH PHYS MED REHAB, V73, P527; Hogrel JY, 2016, NEUROLOGY, V86, P1022, DOI 10.1212/WNL.0000000000002464; Jannssen MHP H J, 2017, J NEUROENGINEERING R, V14; Klingels K, 2017, DEV MED CHILD NEUROL, V59, P224, DOI 10.1111/dmcn.13277; Mayhew A, 2013, DEV MED CHILD NEUROL, V55, P1038, DOI 10.1111/dmcn.12213; Mazzone E, 2011, NEUROMUSCULAR DISORD, V21, P406, DOI 10.1016/j.nmd.2011.02.014; Mazzone ES, 2012, DEV MED CHILD NEUROL, V54, P879, DOI 10.1111/j.1469-8749.2012.04345.x; Mercuri E, 2003, NEUROMUSCULAR DISORD, V13, P554, DOI 10.1016/S0960-8966(03)00091-9; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; Mercuri Eugenio, 2002, Eur J Paediatr Neurol, V6, P305; Pane M, 2015, NEUROMUSCULAR DISORD, V25, P749, DOI 10.1016/j.nmd.2015.07.009; Pane M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108205; Pane M, 2014, NEUROMUSCULAR DISORD, V24, P201, DOI 10.1016/j.nmd.2013.11.014; Ricotti V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162542; Servais L, 2010, NEUROMUSCULAR DISORD, V20, P669, DOI 10.1016/j.nmd.2010.07.232; Tartaglione T, 2017, NEUROMUSCUL DISORD; Tasca G, 2016, ANN NEUROL; Tasca G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100292; van der Velde G, 2009, ARTHRIT RHEUM-ARTHR, V61, P544, DOI 10.1002/art.24399; Wary C, 2015, NMR BIOMED, V28, P1150, DOI 10.1002/nbm.3352; Willcocks RJ, 2017, J NEUROL, V264, P64, DOI 10.1007/s00415-016-8311-0	23	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199222	10.1371/journal.pone.0199222	http://dx.doi.org/10.1371/journal.pone.0199222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924868	gold, Green Published, Green Submitted			2022-12-26	WOS:000435655600054
J	Bertolini, F; Casarotti, G; Righi, L; Bollito, E; Albera, C; Racca, SA; Colangelo, D; Mognetti, B				Bertolini, Francesca; Casarotti, Giulia; Righi, Luisella; Bollito, Enrico; Albera, Carlo; Racca, Silvia Anna; Colangelo, Donato; Mognetti, Barbara			Human renal angiomyolipoma cells of male and female origin can migrate and are influenced by microenvironmental factors	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; EPIDERMAL-GROWTH-FACTOR; BREAST-CANCER CELLS; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; EPITHELIOID ANGIOMYOLIPOMA; MATRIX METALLOPROTEINASES; FACTOR RECEPTOR; ESTROGEN; METASTASIS; PATHOGENESIS	Background Improving the knowledge of angiomyolipoma physiopathology might help in refining its pharmacological treatment. We investigated if angiomyolipoma cells have migratory properties, how their growth and motility can be influenced by the hormonal milieu, and if this can be related to a specific gender. Methods Primary cells were isolated from angiomyolipomas surgically resected for therapeutical reasons in a female and in a male patient. The genetic control demonstrated no TSC2 deletion. Bi-(wound healing) and three-dimensional (transwell assay) migration were analyzed in vitro in basal conditions and under the influence of 17-beta-estradiol and SDF-1 alpha. Results Treatment up to 72 hours with 17-beta-estradiol (0.1 +/- 100 nM), tamoxifen (0.2 +/- 20 mu M) or with both, does not modify angiomyolipoma cells proliferation. On the other hand, SDF-1 alpha and 17-beta-estradiol treatment induce a significant motility increase (both bi-and three-dimensional) which becomes evident already after 2 hours of incubation. Angiomyolipoma cells express mRNA coding for SDF-1 alpha and 17-beta-estradiol receptors and secrete both the metalloproteases principally involved in malignant phenotype acquisition, i.e. MMP-2 and MMP-9. Conclusion Angiomyolipoma cells behave similarly, despite their different source. Primary angiomyolipoma cells migrate in response to hormonal milieu and soluble factors, and produce active metalloproteases, both aspects being consistent with the theory claiming they can migrate to the lungs (and/or other organs) and colonizing them. No main feature, among the aspects we analyzed, seems to be referable to the gender of origin.	[Bertolini, Francesca; Albera, Carlo; Racca, Silvia Anna; Mognetti, Barbara] Univ Turin, Dept Clin & Biol Sci, Orbassano, Italy; [Casarotti, Giulia; Colangelo, Donato] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Righi, Luisella] Univ Turin, Dept Oncol, Pathol Unit, Orbassano, Italy; [Bollito, Enrico] San Luigi Gonzaga Hosp, Pathol Unit, Turin, Italy	University of Turin; University of Eastern Piedmont Amedeo Avogadro; University of Turin; Azienda Ospedaliero-Universitaria San Luigi Gonzaga	Mognetti, B (corresponding author), Univ Turin, Dept Clin & Biol Sci, Orbassano, Italy.	barbara.mognetti@unito.it	Mognetti, Barbara/AAZ-2933-2020; Colangelo, Donato/ABB-2772-2020; Bertolini, Francesca/AAC-7740-2022; bertolini, francesca/AAX-3836-2021; Righi, Luisella/K-4583-2018	Mognetti, Barbara/0000-0003-2888-8999; Colangelo, Donato/0000-0003-2277-3226; Bertolini, Francesca/0000-0003-4390-0394; BOLLITO, ENRICO/0000-0002-8483-893X; Righi, Luisella/0000-0002-8927-204X	Universita degli Studi di Torino; Universita degli Studi del Piemonte Orientale; Compagnia di San Paolo	Universita degli Studi di Torino; Universita degli Studi del Piemonte Orientale; Compagnia di San Paolo(Compagnia di San Paolo)	Funding for this study was provided by Universita degli Studi di Torino to Prof Carlo Albera and Dr Barbara Mognetti, Universita degli Studi del Piemonte Orientale and Compagnia di San Paolo to Dr Donato Colangelo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi BG, 2011, CLINICS, V66, P1301, DOI 10.1590/S1807-59322011000700031; Bissler JJ, 2004, KIDNEY INT, V66, P924, DOI 10.1111/j.1523-1755.2004.00838.x; Boorjian SA, 2007, UROLOGY, V70, P1064, DOI 10.1016/j.urology.2007.07.045; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Cui L, 2011, CLIN IMAG, V35, P320, DOI 10.1016/j.clinimag.2010.08.017; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Flavin RJ, 2011, AM J CLIN PATHOL, V135, P776, DOI 10.1309/AJCPPC9EX1ZHMRMA; Flum AS, 2016, J UROLOGY, V195, P834, DOI 10.1016/j.juro.2015.07.126; Gambarotta G, 2004, J BIOL CHEM, V279, P48808, DOI 10.1074/jbc.M408374200; Gaston CLL, 2010, PATHOLOGY, V42, P591, DOI 10.3109/00313025.2010.508781; Hayashi T, 1997, HUM PATHOL, V28, P1071, DOI 10.1016/S0046-8177(97)90061-7; Henske EP, 2003, GENE CHROMOSOME CANC, V38, P376, DOI 10.1002/gcc.10252; HOON V, 1994, ARCH PATHOL LAB MED, V118, P732; Johnson SR, 1999, AM J RESP CRIT CARE, V160, P628, DOI 10.1164/ajrccm.160.2.9901027; Karbowniczek M, 2003, AM J PATHOL, V162, P491, DOI 10.1016/S0002-9440(10)63843-6; Kucia M, 2004, J MOL HISTOL, V35, P233; Lam ET, 2011, ONCOLOGY-NY, V25, P832; Lesma E, 2005, AM J PATHOL, V167, P1093, DOI 10.1016/S0002-9440(10)61198-4; Lesma E, 2009, AM J PATHOL, V174, P2150, DOI 10.2353/ajpath.2009.080799; Logginidou H, 2000, CHEST, V117, P25, DOI 10.1378/chest.117.1.25; Martignoni G, 2008, VIRCHOWS ARCH, V452, P119, DOI 10.1007/s00428-007-0509-1; Matsui K, 2000, ARCH PATHOL LAB MED, V124, P267; Mognetti B, 2014, INT J MED BIOL, V1, P1; Mognetti B, 2013, J CELL MOL MED, V17, P287, DOI 10.1111/jcmm.12010; Mognetti B, 2010, J NANOSCI NANOTECHNO, V10, P7971, DOI 10.1166/jnn.2010.3049; Muratori L, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/860546; Niida Y, 2001, AM J HUM GENET, V69, P493, DOI 10.1086/321972; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Song RXD, 2007, ENDOCRINOLOGY, V148, P4091, DOI 10.1210/en.2007-0240; Stone CH, 2001, ARCH PATHOL LAB MED, V125, P751; Vonesh E., 1996, LINEAR NONLINEAR MOD; Yates DR, 2011, EUR UROL, V60, P45, DOI 10.1016/j.eururo.2011.04.002; Yu J, 2004, AM J PHYSIOL-LUNG C, V286, pL694, DOI 10.1152/ajplung.00204.2003; Yu J, 2001, AM J RESP CRIT CARE, V164, P1537, DOI 10.1164/ajrccm.164.8.2104095; Yu JJ, 2009, P NATL ACAD SCI USA, V106, P2635, DOI 10.1073/pnas.0810790106; Yu TH, 2014, J STEROID BIOCHEM, V143, P392, DOI 10.1016/j.jsbmb.2014.05.003; Zaitseva L, 2014, ONCOTARGET, V5, P9930, DOI 10.18632/oncotarget.2479	37	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199371	10.1371/journal.pone.0199371	http://dx.doi.org/10.1371/journal.pone.0199371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920561	Green Published, gold, Green Submitted			2022-12-26	WOS:000435541300041
J	Seo, Y; Kim, JS; Park, ES; Ryu, E				Seo, Yeji; Kim, Ji-Su; Park, Eun-shim; Ryu, Eunjung			Assessment of the awareness and knowledge of cancer survivors regarding the components of metabolic syndrome	PLOS ONE			English	Article							PUBLIC AWARENESS; HEART-DISEASE; BREAST; RISK; CARE; SATISFACTION; INFORMATION; PREVALENCE; BEHAVIORS; PROSTATE	This study aimed to assess the prevalence of metabolic syndrome and the level of knowledge and awareness of its related conditions in a sample of cancer survivor patients. In this cross-sectional survey, a self-reported questionnaire was administered to outpatients aged >20 years with a diagnosis of cancer. This self-reported questionnaire on patient demographic characteristics, disease characteristics, and knowledge and awareness of metabolic syndrome was used as an instrument to assess patient's knowledge of metabolic syndrome. A total of 88 participants were included; of these 34.1% had metabolic syndrome, although only 6.8% of participants were diagnosed with metabolic syndrome. Over half of the participants had heard about metabolic syndrome; however, 70% of the participants did not know about the blood tests for the diagnosis of metabolic syndrome although they were aware of the physical measurements, such as weight, blood pressure, and waist circumference. The highest proportion of correct answers for questions about metabolic syndrome was related to stroke, while the lowest was about cholesterol levels. The proportions of correct answers for selected parameters were as follows: diabetes, 39.1%; adiposity, 47.2%; hypertension, 46.8%; cholesterol levels, 36.7%; arteriosclerosis, 45.5%; myocardial infarction, 37.8%; and stroke, 62.8%. The results suggest that the level of knowledge of metabolic syndrome among the cancer survivors in our sample was poor, although more than one-third of them had metabolic syndrome. Thus, it is essential to educate cancer survivors about metabolic syndrome and its related conditions to improve their overall health and quality of life.	[Seo, Yeji] Chung Ang Univ, Grad Sch, Seoul, South Korea; [Kim, Ji-Su; Ryu, Eunjung] Chung Ang Univ, Fac Coll Nursing, Seoul, South Korea; [Park, Eun-shim] Seoul Med Ctr, Cardiovasc Ctr, Seoul, South Korea	Chung Ang University; Chung Ang University; Seoul Medical Center	Kim, JS (corresponding author), Chung Ang Univ, Fac Coll Nursing, Seoul, South Korea.	jisu80@cau.ac.kr	Ryu, Eunjung/AAH-8482-2019	Ryu, Eunjung/0000-0002-2232-6082	National Research Foundation of Korea [NRF-2015R1C1A1A02036408]	National Research Foundation of Korea(National Research Foundation of Korea)	The authors wish to acknowledge funding from the National Research Foundation of Korea (NRF-2015R1C1A1A02036408) Fund to Ji-Su Kim.	Becker Bettina-Maria, 2008, Psychol Health Med, V13, P367, DOI 10.1080/13548500701405525; Bering T, 2015, NUTR HOSP, V31, P751, DOI 10.3305/nh.2015.31.2.8056; de Haas EC, 2010, LANCET ONCOL, V11, P193, DOI 10.1016/S1470-2045(09)70287-6; Gillespie C., 2011, Morbidity and Mortality Weekly Report, V60, P103; Green T, 2016, HEALTH EXPECT, V19, P377, DOI 10.1111/hex.12362; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hewitt M, 2006, CANC PATIENT CANC SU, DOI DOI 10.17226/11613; Jiang Y, 2011, EUR J EPIDEMIOL, V26, P863, DOI 10.1007/s10654-011-9617-y; Jung HS, 2012, DIABETES RES CLIN PR, V95, P275, DOI 10.1016/j.diabres.2011.08.029; Kazanjian A, 2012, EUR J ONCOL NURS, V16, P399, DOI 10.1016/j.ejon.2011.09.002; Mallinger JB, 2005, PATIENT EDUC COUNS, V57, P342, DOI 10.1016/j.pec.2004.09.009; Mayer DK, 2007, PATIENT EDUC COUNS, V65, P342, DOI 10.1016/j.pec.2006.08.015; Mayer DK, 2017, LANCET ONCOL, V18, pE11, DOI 10.1016/S1470-2045(16)30573-3; Nadas J, 2007, DIABETES RES CLIN PR, V76, P155, DOI 10.1016/j.diabres.2006.07.017; National Cancer Institution, 2005, CANC SURV RES; Nuver J, 2002, CANCER TREAT REV, V28, P195, DOI 10.1016/S0305-7372(02)00038-5; Oh Eui-Geum, 2007, Taehan Kanho Hakhoe Chi, V37, P790; Patnaik JL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2901; Phelan S, 2007, INT J OBESITY, V31, P1442, DOI 10.1038/sj.ijo.0803606; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Rosato V, 2011, METABOLISM, V60, P1372, DOI 10.1016/j.metabol.2011.03.005; Russo A, 2008, EUR J CANCER, V44, P293, DOI 10.1016/j.ejca.2007.11.005; Sepucha KR, 2002, J CLIN ONCOL, V20, P2695, DOI 10.1200/JCO.2002.10.068; Sierpina V, 2015, SEMIN ONCOL NURS, V31, P42, DOI 10.1016/j.soncn.2014.11.005; Smith SC, 2012, EUR HEART J, V33, P2910, DOI 10.1093/eurheartj/ehs313; Templeton H, 2003, PATIENT EDUC COUNS, V49, P243, DOI 10.1016/S0738-3991(02)00181-7; Wang YY, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003320; Weaver KE, 2013, J CANCER SURVIV, V7, P253, DOI 10.1007/s11764-013-0267-9; Willemse PM, 2013, BRIT J CANCER, V109, P60, DOI 10.1038/bjc.2013.226; World Health Organization, 2000, AS PAC PERSP RED OB, P15; Wu YT, 2018, J CANCER, V9, P548, DOI 10.7150/jca.22968; Yahia N, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-111; Yang Y, 2013, CANCER-AM CANCER SOC, V119, P1512, DOI 10.1002/cncr.27923; Yi M, 2013, EUR J ONCOL NURS, V17, P138, DOI 10.1016/j.ejon.2012.05.001	34	4	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199142	10.1371/journal.pone.0199142	http://dx.doi.org/10.1371/journal.pone.0199142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920529	Green Submitted, Green Published, gold			2022-12-26	WOS:000435541300019
J	Heng, K; Chevalier, M; Lek, S; Laffaille, P				Heng, Kong; Chevalier, Mathieu; Lek, Sovan; Laffaille, Pascal			Seasonal variations in diet composition, diet breadth and dietary overlap between three commercially important fish species within a flood-pulse system: The Tonle Sap Lake (Cambodia)	PLOS ONE			English	Article							TROPHIC RELATIONSHIPS; AMAZONIAN FLOODPLAIN; COMMUNITY STRUCTURE; RIVER FLOODPLAIN; CONNECTIVITY; STREAM; BIODIVERSITY; ASSEMBLAGES; POPULATIONS; COMPETITION	Tropical lakes and their associated floodplain habitats are dynamic habitat mosaics strongly influenced by seasonal variations in hydrologic conditions. In flood-pulse systems, water level oscillations directly influence the connectivity to floodplain habitats for fish. Here, we aimed to investigate whether seasonal changes in the water level of a flood-pulse system (the Tonle Sap Lake, Cambodia) differentially affect diet breadth and dietary overlap of three common and commercially important fish species (Anabas testudineus, Boesemania microplepis and Notopterus notopterus) presenting important differences in their life-cycle (e.g. seasonal migration). For this purpose, the three fish species were sampled at four locations spread over the lake and their stomach contents extracted for analyses. Dietary differences were investigated across seasons regarding the diet composition and diet breadth of each species as well as the amount of dietary overlap between species. We found that the proportion of empty stomachs changed similarly across seasons for the three species, thus suggesting that ecological differences between species are not sufficient to outweigh the effect of seasonal variations in resource abundance. In contrast, changes in diet composition were species-specific and can be explained by ecological and behavioral differences between species. Diet breadth differed between species in all seasons, except during the wet season, and tended to be higher during the dry season when dietary overlap was the lowest. These variations likely result from changes in the diversity and amount of resources and may lead to habitat use shifts with potential implications for competitive interactions. In particular, increasing connectivity to floodplain habitats may reduce the competitive pressure during the wet season, while resource scarcity during the dry season may constrain individuals to diversify their diet to avoid competition. Overall, our results suggest a considerable plasticity in the feeding behavior of the three species as demonstrated by seasonal variation in both diet breadth and dietary overlap. Such variations can be explained by a number of factors and processes, including changes in resource availability or competitive interactions between individuals for resources, whose relative influence might vary depending on the magnitude and the timing of the flood-pulse driving the connectivity to floodplain habitats. Gaining knowledge on the seasonal evolution of fish's diet is relevant for fisheries management and conservation and our result could be used to guide aquaculture development in Cambodia.	[Heng, Kong; Chevalier, Mathieu; Lek, Sovan] Univ Toulouse, CNRS, EDB, ENFA,UPS, Toulouse, France; [Heng, Kong; Laffaille, Pascal] Univ Toulouse, CNRS, EcoLab, INPT,UPS, Toulouse, France; [Chevalier, Mathieu] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Swedish University of Agricultural Sciences	Chevalier, M (corresponding author), Univ Toulouse, CNRS, EDB, ENFA,UPS, Toulouse, France.; Chevalier, M (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	Mathieu.chevalier38@gmail.com	Chevalier, Mathieu/AAU-6540-2020	Chevalier, Mathieu/0000-0002-1170-5343	'Investissement d'Avenir' grants (CEBA) [ANR-10-LABX-0025, ANR-10-LABX-41]	'Investissement d'Avenir' grants (CEBA)	We are grateful to the Belmont Forum (TLSCC project) and Erasmus Mundus TECHNO II Program for providing financial support for our studies. EDB lab was supported by 'Investissement d'Avenir' grants (CEBA, ref. ANR-10-LABX-0025; TULIP, ref. ANR-10-LABX-41).	Abdel AN, 2007, EGYPT J AQUAT RES, V33, P202; Adetuyi O. O., 2014, Journal of Fisheries and Aquatic Science, V9, P372, DOI 10.3923/jfas.2014.372.376; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; [Anonymous], 2014, R LANG ENV STAT COMP; Arias ME, 2014, ENVIRON CONSERV, V41, P165, DOI 10.1017/S0376892913000283; Arrington DA, 2002, ECOLOGY, V83, P2145, DOI 10.1890/0012-9658(2002)083[2145:HODFRO]2.0.CO;2; Baird Ian G., 2001, Natural History Bulletin of the Siam Society, V49, P161; Blessing JJ, 2010, J FISH BIOL, V76, P2571, DOI 10.1111/j.1095-8649.2010.02633.x; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Burgess OT, 2013, RIVER RES APPL, V29, P718, DOI 10.1002/rra.2567; Castello L, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150299; Chea R, 2016, ECOL FRESHW FISH, P1, DOI DOI 10.1111/EFF.12301; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Correa SB, 2014, ECOLOGY, V95, P210, DOI 10.1890/13-0393.1; Courant J, 2017, PEERJ, V5, DOI 10.7717/peerj.3250; da Silva JC, 2012, NEOTROP ICHTHYOL, V10, P389, DOI 10.1590/S1679-62252012005000008; Davis AM, 2012, FRESHWATER BIOL, V57, P2156, DOI 10.1111/j.1365-2427.2012.02858.x; Mérona Bernard de, 2004, Neotrop. ichthyol., V2, P75, DOI 10.1590/S1679-62252004000200004; Dudgeon D, 2000, BIOSCIENCE, V50, P793, DOI 10.1641/0006-3568(2000)050[0793:LSHCIT]2.0.CO;2; Dudgeon D., 1999, TROPICAL ASIAN STREA; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Froese R, 2002, WORLD WIDE WEB ELECT; Gillespie JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053041; Goulding M., 1980, FISHES FOREST EXPLOR; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Hahn NS, 2004, BIO INL WAT, P247; HAMILTON SK, 1987, LIMNOL OCEANOGR, V32, P1277, DOI 10.4319/lo.1987.32.6.1277; Hinojosa-Garro D, 2013, NEOTROP ICHTHYOL, V11, P881, DOI 10.1590/S1679-62252013000400016; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Junk WJ, 2006, AQUAT SCI, V68, P400, DOI 10.1007/s00027-006-0856-z; Kong H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174582; Kummu M, 2008, AMBIO, V37, P185, DOI 10.1579/0044-7447(2008)37[185:IOTMRF]2.0.CO;2; Lasne E, 2007, BIOL CONSERV, V139, P258, DOI 10.1016/j.biocon.2007.07.002; Linhoss AC, 2012, ECOL MODEL, V228, P27, DOI 10.1016/j.ecolmodel.2011.12.022; Lowe McConnell R. H., 1964, Journal of the Linnean Society London, V45, P103; Luz-Agostinho KDG, 2008, HYDROBIOLOGIA, V607, P187, DOI 10.1007/s10750-008-9390-4; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Morse J.C., 1994, AQUATIC INSECTS CHIN; Murchie KJ, 2008, RIVER RES APPL, V24, P197, DOI 10.1002/rra.1058; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Perga ME, 2005, ISOT ENVIRON HEALT S, V41, P109, DOI 10.1080/10256010500131734; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Polito MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026642; Pouilly M, 2003, J FISH BIOL, V62, P1137, DOI 10.1046/j.1095-8649.2003.00108.x; PREJS A, 1987, OECOLOGIA, V71, P397, DOI 10.1007/BF00378713; Pusey B. J., 1996, Ecology of Freshwater Fish, V5, P183, DOI 10.1111/j.1600-0633.1996.tb00132.x; Rainboth W J, 1996, FAO SPECIES IDENTIFI, P265; Seegert SEZ, 2014, T AM FISH SOC, V143, P1072, DOI 10.1080/00028487.2014.901250; Sithirith, 2015, J ENVIRON SCI ENG, V4, P331, DOI [10.17265/2162-5263/2015.06.004, DOI 10.17265/2162-5263/2015.06.004]; Sousa RGC, 2008, NEOTROP ICHTHYOL, V6, P249, DOI 10.1590/S1679-62252008000200013; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Taki Y, 1978, ANAL STUDY FISH FAUN, P77; Taylor CM, 1997, OECOLOGIA, V110, P560, DOI 10.1007/s004420050196; Tejerina-Garro FL, 1998, ENVIRON BIOL FISH, V51, P399, DOI 10.1023/A:1007401714671; WARD JV, 1995, REGUL RIVER, V11, P105, DOI 10.1002/rrr.3450110109; Welcomme R., 2001, BLACKWELL ECOLOGY MA, DOI [10.1002/9780470995693, DOI 10.1002/9780470995693]; WINEMILLER KO, 1990, ECOL MONOGR, V60, P331, DOI 10.2307/1943061; WINEMILLER KO, 1995, ENVIRON BIOL FISH, V44, P235, DOI 10.1007/BF00005919; Zampacavallo G, 2015, J FOOD SCI TECH MYS, V52, P2585, DOI 10.1007/s13197-014-1324-8; ZARET TM, 1971, ECOLOGY, V52, P336, DOI 10.2307/1934593	63	10	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198848	10.1371/journal.pone.0198848	http://dx.doi.org/10.1371/journal.pone.0198848			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912953	Green Submitted, gold, Green Published			2022-12-26	WOS:000435528600054
J	Perez-Carro, R; Blanco-Kelly, F; Galbis-Martinez, L; Garcia-Garcia, G; Aller, E; Garcia-Sandoval, B; Minguez, P; Corton, M; Mahillo-Fernandez, I; Martin-Merida, I; Avila-Fernandez, A; Millan, JM; Ayuso, C				Perez-Carro, Raquel; Blanco-Kelly, Fiona; Galbis-Martinez, Lilian; Garcia-Garcia, Gema; Aller, Elena; Garcia-Sandoval, Blanca; Minguez, Pablo; Corton, Marta; Mahillo-Fernandez, Ignacio; Martin-Merida, Inmaculada; Avila-Fernandez, Almudena; Millan, Jose M.; Ayuso, Carmen			Unravelling the pathogenic role and genotype-phenotype correlation of the USH2A p.(Cys759Phe) variant among Spanish families	PLOS ONE			English	Article							SYNDROME TYPE-II; RECESSIVE RETINITIS-PIGMENTOSA; USHER-SYNDROME; MOLECULAR DIAGNOSIS; MUTATION SPECTRUM; VISUAL-ACUITY; GENE; IDENTIFICATION; REVEALS; PROTEIN	Introduction Mutations in USH2A cause both isolated Retinitis Pigmentosa (RP) and Usher syndrome (that implies RP and hearing impairment). One of the most frequent variants identified in this gene and among these patients is the p.(Cys759Phe) change. However, the pathogenic role of this allele has been questioned since it was found in homozygosity in two healthy siblings of a Spanish family. To assess the causative role of USH2A p.(Cys759Phe) in autosomal recessive RP (ARRP) and Usher syndrome type II (USH2) and to establish possible genotype-phenotype correlations associated with p.(Cys759Phe), we performed a comprehensive genetic and clinical study in patients suffering from any of the two above-mentioned diseases and carrying at least one p.(Cys759Phe) allele. Materials and methods Diagnosis was set according to previously reported protocols. Genetic analyses were performed by using classical molecular and Next-Generation Sequencing approaches. Probands of 57 unrelated families were molecularly studied and 63 patients belonging to these families were phenotypically evaluated. Results Molecular analysis characterized 100% of the cases, identifying: 11 homozygous patients for USH2A p.(Cys759Phe), 42 compound heterozygous patients (12 of them with another missense USH2A pathogenic variant and 30 with a truncating USH2A variant), and 4 patients carrying the p.(Cys759Phe) allele and a pathogenic variant in another RP gene (PROM1, CNGB1 or RP1). No additional causative variants were identified in symptomatic homozygous patients. Statistical analysis of clinical differences between zygosity states yielded differences (p <= 0.05) in age at diagnosis of RP and hypoacusis, and progression of visual field loss. Homozygosity of p.(Cys759Phe) and compound heterozygosity with another USH2A missense variant is associated with ARRP or ARRP plus late onset hypoacusis (OR = 20.62, CI = 95%, p = 0.041). Conclusions The present study supports the role of USH2A p.(Cys759Phe) in ARRP and USH2 pathogenesis, and demonstrates the clinical differences between different zygosity states. Phenotype-genotype correlations may guide the genetic characterization based upon specific clinical signs and may advise on the clinical management and prognosis based upon a specific genotype.	[Perez-Carro, Raquel; Blanco-Kelly, Fiona; Galbis-Martinez, Lilian; Minguez, Pablo; Corton, Marta; Martin-Merida, Inmaculada; Avila-Fernandez, Almudena; Ayuso, Carmen] UAM, Univ Hosp, Dept Genet, IIS,FJD, Madrid, Spain; [Blanco-Kelly, Fiona; Garcia-Garcia, Gema; Aller, Elena; Garcia-Sandoval, Blanca; Corton, Marta; Martin-Merida, Inmaculada; Avila-Fernandez, Almudena; Millan, Jose M.; Ayuso, Carmen] ISCIII, Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain; [Garcia-Garcia, Gema; Aller, Elena; Millan, Jose M.] Hlth Res Inst La Fe IIS La Fe, Res Grp Mol Cellular & Genom Biomed, Valencia, Spain; [Garcia-Sandoval, Blanca] UAM, Dept Ophthalmol, Univ Hosp, IIS,FJD, Madrid, Spain; [Mahillo-Fernandez, Ignacio] UAM, Dept Epidemiol & Biostat, FJD, IIS, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Hospital Universitari i Politecnic La Fe; Instituto de Investigacion Sanitaria La Fe (IIS La Fe); Autonomous University of Madrid; Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz	Ayuso, C (corresponding author), UAM, Univ Hosp, Dept Genet, IIS,FJD, Madrid, Spain.; Ayuso, C (corresponding author), ISCIII, Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain.	cayuso@fjd.es	Garcia, Gema/AEN-8767-2022; Miguez, Pablo/D-4822-2013; Ayuso, Carmen/A-4843-2019; García-García, Gema/J-9387-2015; Aller, Elena/A-4803-2010; Mahillo-Fernandez, Ignacio/T-2042-2018	Miguez, Pablo/0000-0003-4099-9421; García-García, Gema/0000-0002-2113-0600; Aller, Elena/0000-0001-7973-5250; Corton, Marta/0000-0003-0087-1626; Mahillo-Fernandez, Ignacio/0000-0003-0558-6541; Blanco-Kelly, Fiona/0000-0003-0052-5651	Center for Biomedical Network Research on Rare Diseases (CIBERER), FIS from Institute of Health Carlos III (ISCIII, Spanish Ministry of the Economy, Industry and Competitiveness) [PI16/00425, PI16/00539]; European Regional Development Fund (ERDF); Ramon Areces Foundation; IIS-Fundacion Jimenez Diaz-UAM Genome Medicine Chair; Spanish National Organization of the Blind (ONCE); Spanish Fighting Blindness Foundation (FUNDALUCE); Conchita Rabago Foundation; Rio Hortega Programs from ISCIII [CM16/00126, CM14/00079]	Center for Biomedical Network Research on Rare Diseases (CIBERER), FIS from Institute of Health Carlos III (ISCIII, Spanish Ministry of the Economy, Industry and Competitiveness); European Regional Development Fund (ERDF)(European Commission); Ramon Areces Foundation; IIS-Fundacion Jimenez Diaz-UAM Genome Medicine Chair; Spanish National Organization of the Blind (ONCE); Spanish Fighting Blindness Foundation (FUNDALUCE); Conchita Rabago Foundation; Rio Hortega Programs from ISCIII	This project was financially supported by the Center for Biomedical Network Research on Rare Diseases (CIBERER), FIS (PI16/00425 and PI16/00539) from Institute of Health Carlos III (ISCIII, Spanish Ministry of the Economy, Industry and Competitiveness), the European Regional Development Fund (ERDF), the Ramon Areces Foundation, the IIS-Fundacion Jimenez Diaz-UAM Genome Medicine Chair, the Spanish National Organization of the Blind (ONCE) and the Spanish Fighting Blindness Foundation (FUNDALUCE). RP-C were sponsored by the Conchita Rabago Foundation, and LG-M and IM-M by the Rio Hortega Programs (CM16/00126 and CM14/00079, respectively) from ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Aller E, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041764; Aller E, 2004, EUR J HUM GENET, V12, P407, DOI 10.1038/sj.ejhg.5201138; Auffarth GU, 1997, OPHTHALMOLOGE, V94, P791, DOI 10.1007/s003470050205; Avila-Fernandez A, 2012, OPHTHALMOLOGY, V119, P2616, DOI 10.1016/j.ophtha.2012.06.033; Avila-Fernandez A, 2010, MOL VIS, V16, P2550; Ayuso C, 2010, GENOME MED, V2, DOI 10.1186/gm155; Bernal S, 2005, CLIN GENET, V68, P204, DOI 10.1111/j.1399-0004.2005.00481.x; Bernal S, 2003, J Med Genet, V40, pe8, DOI 10.1136/jmg.40.1.e8; Bernardis I, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6341870; Besnard T, 2014, MOL GENET GENOM MED, V2, P30, DOI 10.1002/mgg3.25; Bhattacharya G, 2004, J CELL SCI, V117, P233, DOI 10.1242/jcs.00850; Blanco-Kelly F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149473; Blanco-Kelly F, 2015, JAMA OPHTHALMOL, V133, P157, DOI 10.1001/jamaophthalmol.2014.4498; Bonnet C, 2016, EUR J HUM GENET, V24, P1730, DOI 10.1038/ejhg.2016.99; Bravo-Gil N, 2016, SCI REP-UK, V6, DOI 10.1038/srep23910; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Corton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065574; Cosgrove D, 2014, INT J BIOCHEM CELL B, V46, P80, DOI 10.1016/j.biocel.2013.11.001; David Baux, 2007, HUM MUTAT, V28, P781, DOI [10.1002/humu.20513, DOI 10.1002/HUMU.20513]; den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258; Dopazo J, 2016, MOL BIOL EVOL, V33, P1205, DOI 10.1093/molbev/msw005; Dreyer B, 2000, EUR J HUM GENET, V8, P500, DOI 10.1038/sj.ejhg.5200491; Dreyer B, 2008, HUM MUTAT, V29, P451, DOI 10.1002/humu.9524; Eandi CM, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Edwards A, 1998, ARCH OPHTHALMOL-CHIC, V116, P165; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; FISHMAN GA, 1995, ARCH OPHTHALMOL-CHIC, V113, P770, DOI 10.1001/archopht.1995.01100060096040; Fuster-Garcia C, 2017, MOL THER-NUCL ACIDS, V8, P529, DOI 10.1016/j.omtn.2017.08.003; Garcia-Garcia G, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-65; Glockle N, 2014, EUR J HUM GENET, V22, P99, DOI 10.1038/ejhg.2013.72; Gonzalez-del Pozo M, 2015, AM J MED GENET A, V167, P1597, DOI 10.1002/ajmg.a.37003; Huang XF, 2015, GENET MED, V17, P271, DOI 10.1038/gim.2014.138; KUMAR A, 1984, ANN OTO RHINOL LARYN, V93, P600, DOI 10.1177/000348948409300613; Lenassi E, 2015, EUR J HUM GENET, V23, P1318, DOI 10.1038/ejhg.2014.283; Liu XQ, 2007, P NATL ACAD SCI USA, V104, P4413, DOI 10.1073/pnas.0610950104; Ma Sandberg, 2009, GENE, V49, P5532, DOI [10.1167/iovs.08-2009, DOI 10.1167/I3VS.08-2009.DISEASE]; Magliulo G, 2017, OTOLARYNG HEAD NECK, V157, P853, DOI 10.1177/0194599817715235; Mayer AK, 2017, HUM MUTAT, V38, P1579, DOI 10.1002/humu.23311; Minguez P, 2015, NUCLEIC ACIDS RES, V43, pD494, DOI 10.1093/nar/gku1081; MOLLER CG, 1989, LARYNGOSCOPE, V99, P73; Najera Carmen, 2002, Hum Mutat, V20, P76, DOI 10.1002/humu.9042; Pennings RJE, 2004, ACTA OPHTHALMOL SCAN, V82, P131, DOI 10.1111/j.1600-0420.2004.00234.x; Perez-Carro R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19531; PIAZZA L, 1986, ARCH OPHTHALMOL-CHIC, V104, P1336; Posey JE, 2017, NEW ENGL J MED, V376, P21, DOI 10.1056/NEJMoa1516767; Pras E, 2009, MOL VIS, V15, P1709; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; Rivolta C, 2002, ARCH OPHTHALMOL-CHIC, V120, P1566, DOI 10.1001/archopht.120.11.1566; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Schwartz SB, 2005, INVEST OPHTH VIS SCI, V46, P734, DOI 10.1167/iovs.04-1136; Seeliger M, 1999, GRAEF ARCH CLIN EXP, V237, P301, DOI 10.1007/s004170050237; Sengillo JD, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Seyedahmadia BJ, 2004, EXP EYE RES, V79, P167, DOI 10.1016/j.exer.2004.03.005; Sheskin D.J, 2004, TECHNOMETRICS, V46, P1193, DOI DOI 10.1198/TECH.2004.S209; Simpson DA, 2011, J MED GENET, V48, P145, DOI 10.1136/jmg.2010.083568; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Testa F, 2017, RETINA-J RET VIT DIS, V37, P1581, DOI 10.1097/IAE.0000000000001389; Vache C, 2012, HUM MUTAT, V33, P104, DOI 10.1002/humu.21634; van Wijk E, 2004, AM J HUM GENET, V74, P738, DOI 10.1086/383096; Wang J, 2014, INVEST OPHTH VIS SCI, V55, P6213, DOI 10.1167/iovs.14-14936; Weston MD, 2000, AM J HUM GENET, V66, P1199, DOI 10.1086/302855; Zhao L, 2015, HUM GENET, V134, P217, DOI 10.1007/s00439-014-1512-7; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031	66	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199048	10.1371/journal.pone.0199048	http://dx.doi.org/10.1371/journal.pone.0199048			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912909	Green Published, gold, Green Submitted			2022-12-26	WOS:000435528600070
J	Campagna, L; Rodriguez, P; Mazzulla, JC				Campagna, Leonardo; Rodriguez, Pablo; Carlos Mazzulla, Jose			Transgressive phenotypes and evidence of weak postzygotic isolation in F1 hybrids between closely related capuchino seedeaters	PLOS ONE			English	Article							AVIAN RADIATION; SPOROPHILA; EVOLUTION; PASSERIFORMES; SYSTEMATICS; DOMINANCE; PATTERNS; BIRDS; MORPH; AVES	Postzygotic reproductive isolation may become strong only once the process of speciation is in its advanced stages. For taxa in the early stages of speciation, prezygotic reproductive isolation barriers may play a predominant role in maintaining species boundaries. Here, we study the recent capuchino seedeater biological radiation, a group of highly sympatric species from the genus Sporophila that have diversified during the Pleistocene in Neotropical grasslands. Capuchinos can be diagnosed by adult male coloration patterns and song, two sets of characters known to contribute to pre-mating reproductive isolation. However, it remains unknown whether potzygotic incompatibilities contribute to maintaining species limits in this group. Here we use existing breeding records from captive individuals to test for patterns consistent with Fl inviability. We compare hatching success, fledging success, and the sex ratio at adulthood between conspecific and hybrid capuchino pairs. We observed a trend towards lower numbers of the heterogametic sex among adult hybrids, consistent Haldane's rule, but this was supported by only one of our statistical tests. Our study is the first to document hybrid male capuchino phenotypes based on known crosses. We observed phenotypes that were similar or intermediate to those of the parental species, as well as novel plumage patterns that have not been described in the wild. One cross produced a plumage pattern that has been observed at low frequencies in natural populations. We discuss the implications of our results for understanding the relative importance of the mechanisms of reproductive isolation in capuchino seedeaters.	[Campagna, Leonardo] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA; [Campagna, Leonardo] Cornell Univ, Cornell Lab Ornithol, Fuller Evolutionary Biol Program, Ithaca, NY 14850 USA; [Rodriguez, Pablo] Federac Ornitol Argentina, Buenos Aires, DF, Argentina; [Carlos Mazzulla, Jose] Asociac Canaricultores Roller Uruguay, Montevideo, Uruguay	Cornell University; Cornell University	Campagna, L (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA.; Campagna, L (corresponding author), Cornell Univ, Cornell Lab Ornithol, Fuller Evolutionary Biol Program, Ithaca, NY 14850 USA.	lc736@cornell.edu						Areta JI, 2008, J FIELD ORNITHOL, V79, P352, DOI 10.1111/j.1557-9263.2008.00186.x; Arrieta RS, 2013, BIOL J LINN SOC, V110, P528, DOI 10.1111/bij.12153; Baldassarre DT, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2175; Benites P, 2015, J AVIAN BIOL, V46, P55, DOI 10.1111/jav.00447; Benites P, 2010, J AVIAN BIOL, V41, P597, DOI 10.1111/j.1600-048X.2010.05205.x; Campagna L, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602404; Campagna L, 2015, MOL ECOL, V24, P4238, DOI 10.1111/mec.13314; Campagna L, 2013, AUK, V130, P645, DOI 10.1525/auk.2013.13064; Campagna L, 2012, P ROY SOC B-BIOL SCI, V279, P1847, DOI 10.1098/rspb.2011.2170; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Greig EI, 2013, BEHAV ECOL, V24, P1004, DOI 10.1093/beheco/art005; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Areta JI, 2012, WILSON J ORNITHOL, V124, P688, DOI 10.1676/1559-4491-124.4.688; Areta JI, 2011, CONDOR, V113, P678, DOI 10.1525/cond.2011.100059; Ignacio Areta Juan, 2011, BULLETIN OF THE BRITISH ORNITHOLOGISTS CLUB, V131, P4; Irwin DE, 2018, MOL ECOLOGY; Kim KW, 2017, NAT ECOL EVOL, V1, P1168, DOI 10.1038/s41559-017-0235-2; Kopuchian, 2016, NUESTRAS AVES, V61, P3; Lijtmaer DA, 2004, MOL PHYLOGENET EVOL, V33, P562, DOI 10.1016/j.ympev.2004.07.011; Lijtmaer DA, 2003, EVOLUTION, V57, P1411, DOI 10.1111/j.0014-3820.2003.tb00348.x; Mazzulla JC., 2011, CAPUCHINO PECHO BLAN; Mazzulla JC., 2010, REPRODUCCION CAPUCHI; Medolago CAB, 2016, WILSON J ORNITHOL, V128, P638, DOI 10.1676/1559-4491-128.3.638; Poelstra JW, 2014, SCIENCE, V344, P1410, DOI 10.1126/science.1253226; Price T, 2008, SPECIATION BIRDS; Price TD, 2002, EVOLUTION, V56, P2083; Repenning M, 2010, IHERINGIA SER ZOOL, V100, P369, DOI 10.1590/S0073-47212010000400012; RIDGELY RS, 1989, BIRDS S AM; Spottiswoode C, 2004, P ROY SOC B-BIOL SCI, V271, P267, DOI 10.1098/rspb.2003.2605; Stryjewski KF, 2017, NAT ECOL EVOL, V1, P1912, DOI 10.1038/s41559-017-0364-7; Toews DPL, 2016, CURR BIOL, V26, P2313, DOI 10.1016/j.cub.2016.06.034; Turelli M, 2000, GENETICS, V154, P1663; TURELLI M, 1995, GENETICS, V140, P389; Vizentin-Bugoni J, 2013, BIRD CONSERV INT, V23, P147, DOI 10.1017/S0959270913000221	34	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199113	10.1371/journal.pone.0199113	http://dx.doi.org/10.1371/journal.pone.0199113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902247	Green Published, gold, Green Submitted			2022-12-26	WOS:000435424900091
J	Yoshino, H; Yamaji, F; Ohsawa, TA				Yoshino, Hiroki; Yamaji, Futa; Ohsawa, Takeshi A.			Genetic structure and dispersal patterns in Limnoria nagatai (Limnoriidae, Isopoda) dwelling in non-buoyant kelps, Eisenia bicyclis and E. arborea, in Japan	PLOS ONE			English	Article							CRUSTACEA; SEA; PHAEOPHYCEAE; MIGRATION; SOFTWARE; UTILITY; MTDNA; RATES	The marine isopod genus Limnoria contains algae-eating species. Previous phylogeo-graphic studies have suggested that Limnoria species feeding on buoyant kelp underwent low genetic differentiation on a large spatial scale because rafting on floating host kelps promotes high levels of gene flow. In this paper, we survey the genetic structure of Limnoria nagatai, which bores into the non-buoyant kelps Eisenia bicyclis and E. arborea. We analyze the mitochondrial DNA (cytochrome oxidase subunit I [CO/]gene) and morphological traits of L. nagatai, and the host kelps E. bicyclis and E. arborea from 14 populations along the Japanese archipelago of the Pacific Ocean and the Sea of Japan. Four major lineages are recognized within L. nagatai: three lineages in the Pacific Ocean, and one lineage in the Sea of Japan which might be a cryptic species. For L. nagatai, we show high genetic differentiation between geographically separated habitats in the Pacific Ocean, while low differentiation is found among continuous host kelps habitats in the Pacific Ocean as well as the Sea of Japan. L. nagatai in E. bicyclis in the Pacific Ocean has experienced large population expansion after the Last Glacial Maximum (LGM), whereas the lineage in E. bicyclis in the Sea of Japan has not. We suggest that Limnoria feeding on non-buoyant kelps, may attain low genetic differentiation because they might be able to disperse long distance if the habitat of host kelps is continuous. The historical events affecting Limnoria after the LGM may differ between the coasts of the Pacific Ocean and the Sea of Japan.	[Yoshino, Hiroki] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Yamaji, Futa; Ohsawa, Takeshi A.] Chiba Univ, Grad Sch Sci, Dept Biol, Chiba, Japan	University of Tokyo; Chiba University	Yoshino, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.	yosino@fr.a.u-tokyo.ac.jp		Yoshino, Hiroki/0000-0003-1850-1033				Achiha H, 2014, B AICHI FISH RES I, V19, P38; Biodiversity Center of Japan, 2017, INV SEAGR ALG BED EC; Biodiversity Center of Japan, 2008, INV SHALL SEA EC; Borges LMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109593; Brearley A, 2008, MAR BIOL, V156, P65, DOI 10.1007/s00227-008-1065-1; Bruce Niel L., 2004, Species Diversity, V9, P47; Child CA., 1998, MARINE FAUNA NZ PYCN; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COOKSON L J, 1991, Memoirs of the Museum of Victoria, V52, P137; Cumming RA, 2014, J BIOGEOGR, V41, P2357, DOI 10.1111/jbi.12376; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Doi W, 2011, INVAD NAT SPRING SER, V6, P419, DOI 10.1007/978-94-007-0591-3_15; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dugan KA, 2002, J FORENSIC SCI, V47, P811; ELTRINGHAM SK, 1961, LIMNOL OCEANOGR, V6, P467, DOI 10.4319/lo.1961.6.4.0467; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feldberg MJ, 2002, MAR MICROPALEONTOL, V44, P1, DOI 10.1016/S0377-8398(01)00035-4; Fraser CI, 2009, P NATL ACAD SCI USA, V106, P3249, DOI 10.1073/pnas.0810635106; Fu YX, 1997, GENETICS, V147, P915; Hay Mark E., 1992, P371; Haye PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088613; Haye PA, 2012, MAR ECOL PROG SER, V455, P111, DOI 10.3354/meps09673; Hirata Tetsu, 2001, Phycological Research, V49, P215, DOI 10.1111/j.1440-1835.2001.tb00252.x; Holsinger KE., 2006, LECT NOTES POPULATIO; Ketmaier V, 2003, MOL ECOL, V12, P547, DOI 10.1046/j.1365-294X.2003.01734.x; Kim S.Y., 2012, ISRN NTOMOL, V2013, P1, DOI [10.1155/2013/286182, DOI 10.1155/2013/286182]; Kussakin O. G., 1963, Crustaceana, V5, P281, DOI 10.1163/156854063X00237; Kussakin O.G., 1979, MORSKYE SOLONOVATOVO; Kyle CJ, 2000, MAR BIOL, V137, P835, DOI 10.1007/s002270000412; Lane CE, 2007, MOL PHYLOGENET EVOL, V44, P634, DOI 10.1016/j.ympev.2007.03.016; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maegawa Miyuki, 1996, Japanese Journal of Phycology, V44, P95; MANTEL N, 1967, CANCER RES, V27, P209; McDevit DC, 2009, PHYCOL RES, V57, P131, DOI 10.1111/j.1440-1835.2009.00530.x; MENZIES ROBERT JAMES, 1957, BULL MARINE SCI GULF AND CARIBBEAN, V7, P101; Mori Y., 2007, TEMPERATURE CHARACTE; Nei M., 1987, MOL EVOLUTIONARY GEN; Nichols J., 2001, DISPERSAL; Nikula R, 2010, MAR ECOL PROG SER, V405, P221, DOI 10.3354/meps08523; Nikula R, 2011, ECOL EVOL, V1, P169, DOI 10.1002/ece3.16; Nimura K., 2007, AQUACULTURE SCI, V55, P541; Nunomura N, 2015, KUROSHIO BIOSPHERE, V11, P1; Nunomura N., 2012, CONTRIBUTIONS TOYAMA, V35, P77; Oba T, 1991, PALEOCEANOGRAPHY, V6, P499, DOI 10.1029/91PA00560; OMORI M, 1967, DEEP-SEA RES, V14, P525, DOI 10.1016/0011-7471(67)90062-9; Ortiz M., 1988, Revista de Investigaciones Marinas, V9, P37; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pillai N. K., 1957, Bulletin res Inst Univ Kerala, V5C, P149; Quayle D.B., 1992, CAN SPEC PUBL FISH A, V115, P1; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; SETOGUCHI H, 1995, J PLANT RES, V108, P87, DOI 10.1007/BF02344310; Shiino SM, 1951, WASMANN J BIOL, V8, P333; Shimaya M, 2007, P CIVIL ENG OCEAN, V23, P405; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teske PR, 2007, MAR BIOL, V152, P697, DOI 10.1007/s00227-007-0724-y; Thiel M, 2003, REV CHIL HIST NAT, V76, P205; Thiel M, 2003, J NAT HIST, V37, P1713, DOI 10.1080/00222930210125416; Thiel M, 2006, OCEANOGR MAR BIOL, V44, P323, DOI 10.1201/9781420006391.ch7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Volf M, 2015, J ANIM ECOL, V84, P1123, DOI 10.1111/1365-2656.12349; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Wetzer R, 2001, CONTRIB ZOOL, V70, P23, DOI 10.1163/18759866-07001002; Winston JE, 2012, INTEGR COMP BIOL, V52, P447, DOI 10.1093/icb/ics040; Yoshino H, 2017, ZOOTAXA, V4232, P251, DOI 10.11646/zootaxa.4232.2.8; Yoshizaki M, 1996, B BIOL SOC CHIBA, V45, P447, DOI [10.1093/icb/ics040, DOI 10.1093/ICB/ICS040]	70	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198451	10.1371/journal.pone.0198451	http://dx.doi.org/10.1371/journal.pone.0198451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902241	Green Published, Green Submitted, gold			2022-12-26	WOS:000435424900024
J	Hu, GF; Liu, YM; Duo, TQ; Zhao, BY; Cui, GW; Ji, J; Kuang, X; Ervin, EH; Zhang, XZ				Hu, Guofu; Liu, Yiming; Duo, Tianqi; Zhao, Bingyu; Cui, Guowen; Ji, Jing; Kuang, Xiao; Ervin, Erik H.; Zhang, Xunzhong			Antioxidant metabolism variation associated with alkali-salt tolerance in thirty switchgrass (Panicum virgatum) lines	PLOS ONE			English	Article							WATER-STRESS; SALINITY; PROLINE; ACCUMULATION; GENOTYPES; BIOMASS; GROWTH; GERMINATION; COLLECTION; CULTIVARS	Soil salinization is a major factor limiting crop growth and development in many areas. Switchgrass (Panicum virgatum L.) is an important warm-season grass species used for biofuel production. The objective of this study was to investigate antioxidant metabolism, proline, and protein variation associated with alkali-salt tolerance among 30 switchgrass lines and identify metabolic markers for evaluating alkali-salt tolerance of switchgrass lines. The grass lines were transplanted into plastic pots containing fine sand. When the plants reached E5 developmental stage, they were subjected to either alkali-salt stress treatment (150 mM Na+ and pH of 9.5) or control (no alkali-salt stress) for 20 d. The 30 switchgrass lines differed in alkali-salt tolerance as determined by the level of leaf malondialdehyde (MDA), antioxidant enzyme activity [(superoxide dismutase (SOD), catalase (CAT), ascorbate peroxidase (APX)], proline and protein. Alkali-salt stress increased MDA, proline, SOD, reduced CAT activity, but its effect on protein and APX varied depending on lines. Wide variations in the five parameters existed among the 30 lines. In general, the lines with higher CAT activity and lower proline content under alkali-salt stress had less MDA, exhibiting better alkali-salt tolerance. Among the five parameters, CAT can be considered as valuable metabolic markers for assessment of switchgrass tolerance to alkali-salt stress.	[Hu, Guofu; Duo, Tianqi; Cui, Guowen; Ji, Jing; Kuang, Xiao] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Hu, Guofu; Liu, Yiming; Zhang, Xunzhong] Virginia Tech, Dept Crop & Soil Environm Sci, Blacksburg, VA 24061 USA; [Liu, Yiming] CATAS, Trop Crops Genet Resources Inst, Key Lab Crop Gene Resources & Germplasm Enhanceme, Minist Agr, Danzhou, Hainan, Peoples R China; [Zhao, Bingyu] Virginia Tech, Dept Hort, Blacksburg, VA 24061 USA; [Ervin, Erik H.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA	Northeast Agricultural University - China; Virginia Polytechnic Institute & State University; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Virginia Polytechnic Institute & State University; University of Delaware	Zhang, XZ (corresponding author), Virginia Tech, Dept Crop & Soil Environm Sci, Blacksburg, VA 24061 USA.; Zhao, BY (corresponding author), Virginia Tech, Dept Hort, Blacksburg, VA 24061 USA.	bzhao07@vt.edu; xuzhang@vt.edu			Natural Science Fund of Heilongjiang Province [LC2016009]; U.S. Department of Energy; U.S. Department of Agriculture's Plant Feedstocks Genomics for Bioenergy Program [DE-SC0008338]; Virginia Tech's Virginia Agricultural Experiment Station [VA135872]	Natural Science Fund of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Agriculture's Plant Feedstocks Genomics for Bioenergy Program; Virginia Tech's Virginia Agricultural Experiment Station	This research was funded by The Natural Science Fund of Heilongjiang Province (LC2016009) (GH) and U.S. Department of Energy and U.S. Department of Agriculture's Plant Feedstocks Genomics for Bioenergy Program (DE-SC0008338 to XZ and BZ). The study was also partially supported by Virginia Tech's Virginia Agricultural Experiment Station (VA135872 to BZ).	Abogadallah GM, 2011, PLANT SCI, V180, P540, DOI 10.1016/j.plantsci.2010.12.004; Alexopoulou E, 2008, BIOMASS BIOENERG, V32, P926, DOI 10.1016/j.biombioe.2008.01.015; Arnon, 1950, WATER CULTURE METHOD, V347, DOI DOI 10.1073/PNAS.1211132109; Barney JN, 2010, BIOMASS BIOENERG, V34, P124, DOI 10.1016/j.biombioe.2009.10.009; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Ben Amor N, 2007, J INTEGR PLANT BIOL, V49, P982, DOI 10.1111/j.1672-9072.2007.00491.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Chen P, 2012, PLOS ONE, V8; COMIS D, 2006, AGR RES, V54, P19; de Lacerda CF, 2003, ENVIRON EXP BOT, V49, P107, DOI 10.1016/S0098-8472(02)00064-3; [范希峰 FAN Xi-feng], 2010, [草业科学, Pratacultural Science], V27, P97; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Ghoulam C, 2002, ENVIRON EXP BOT, V47, P39, DOI 10.1016/S0098-8472(01)00109-5; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P309, DOI 10.1104/pp.59.2.309; Guo R, 2011, CAN J PLANT SCI, V91, P1077, DOI [10.4141/CJPS10167, 10.4141/cjps10167]; Hardin CF, 2013, BIOENERG RES, V6, P755, DOI 10.1007/s12155-012-9292-1; Hellmann H, 2000, PLANT PHYSIOL, V123, P779, DOI 10.1104/pp.123.2.779; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hu GW, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt546; Huang BR, 2014, CRIT REV PLANT SCI, V33, P141, DOI 10.1080/07352689.2014.870411; Huh GH, 2002, PLANT J, V29, P649, DOI 10.1046/j.0960-7412.2001.01247.x; Keshwani DR, 2009, BIORESOURCE TECHNOL, V100, P1515, DOI 10.1016/j.biortech.2008.09.035; Kim J, 2016, PLANT PHYSIOL BIOCH, V105, P203, DOI 10.1016/j.plaphy.2016.04.020; Kim S, 2012, BIOENERG RES, V5, P225, DOI 10.1007/s12155-011-9145-3; LYND LR, 1991, SCIENCE, V251, P1318, DOI 10.1126/science.251.4999.1318; McLaughlin SB, 1998, BIOMASS BIOENERG, V14, P317, DOI 10.1016/S0961-9534(97)10066-6; Mclaughlin SB, PROC; Mokhamed AM, 2006, RUSS J PLANT PHYSL+, V53, P649, DOI 10.1134/S1021443706050086; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Peng YL, 2008, J INTEGR PLANT BIOL, V50, P29, DOI 10.1111/j.1744-7909.2007.00607.x; RENGASAMY P, 1998, SODIC SOILS DISTRIBU; Shahzad A, 2012, GENET MOL RES, V11, P679, DOI 10.4238/2012.March.19.2; Shi DC, 2005, PLANT SOIL, V271, P15, DOI 10.1007/s11104-004-1307-z; Srivastava AC, 2010, BIOENERG RES, V3, P278, DOI 10.1007/s12155-010-9080-8; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Tarchoune I, 2010, PLANT PHYSIOL BIOCH, V48, P772, DOI 10.1016/j.plaphy.2010.05.006; Tavakkoli E, 2012, J EXP BOT, V63, P3853, DOI 10.1093/jxb/ers085; Thomson JA, 2002, BOT J LINN SOC, V140, P237, DOI 10.1046/j.1095-8339.2002.00089.x; Trovato M, 2008, REND LINCEI-SCI FIS, V19, P325, DOI 10.1007/s12210-008-0022-8; Vranova E, 2002, J EXP BOT, V53, P1227, DOI 10.1093/jexbot/53.372.1227; Wang QZ, 2012, PLANT PHYSIOL BIOCH, V58, P288, DOI 10.1016/j.plaphy.2012.06.021; Yildiztugay E, 2011, PLANT PHYSIOL BIOCH, V49, P816, DOI 10.1016/j.plaphy.2011.01.021; Zhang XZ, 2005, J AM SOC HORTIC SCI, V130, P836, DOI 10.21273/JASHS.130.6.836	44	9	12	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199681	10.1371/journal.pone.0199681	http://dx.doi.org/10.1371/journal.pone.0199681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940015	Green Published, gold, Green Submitted			2022-12-26	WOS:000436088700035
J	da Costa, WLO; Araujo, CLD; Dias, LM; Pereira, LCD; Alves, JTC; Araujo, FA; Folador, EL; Henriques, I; Silva, A; Folador, ARC				Oliveira da Costa, Wana Lailan; de Aragao Araujo, Carlos Leonardo; Dias, Larissa Maranhao; de Sousa Pereira, Lino Cesar; Castro Alves, Jorianne Thyeska; Araujo, Fabricio Almeida; Folador, Edson Luiz; Henriques, Isabel; Silva, Artur; Carneiro Folador, Adriana Ribeiro			Functional annotation of hypothetical proteins from the Exiguobacterium antarcticum strain B7 reveals proteins involved in adaptation to extreme environments, including high arsenic resistance	PLOS ONE			English	Article							PHENOLIC-ACID DECARBOXYLASE; BIOFILM FORMATION; TRANSCRIPTIONAL REPRESSOR; COMPUTATIONAL PREDICTION; CAROTENOID BIOSYNTHESIS; INTERACTION NETWORKS; GENE-EXPRESSION; HOMOLOGY; IDENTIFICATION; VISUALIZATION	Exiguobacterium antarcticum strain B7 is a psychrophilic Gram-positive bacterium that possesses enzymes that can be used for several biotechnological applications. However, many proteins from its genome are considered hypothetical proteins (HPs). These functionally unknown proteins may indicate important functions regarding the biological role of this bacterium, and the use of bioinformatics tools can assist in the biological understanding of this organism through functional annotation analysis. Thus, our study aimed to assign functions to proteins previously described as HPs, present in the genome of E. antarcticum B7. We used an extensive in silico workflow combining several bioinformatics tools for function annotation, sub-cellular localization and physicochemical characterization, three-dimensional structure determination, and protein-protein interactions. This genome contains 2772 genes, of which 765 CDS were annotated as HPs. The amino acid sequences of all HPs were submitted to our workflow and we successfully attributed function to 132 HPs. We identified 11 proteins that play important roles in the mechanisms of adaptation to adverse environments, such as flagellar biosynthesis, biofilm formation, carotenoids biosynthesis, and others. In addition, three predicted HPs are possibly related to arsenic tolerance. Through an in vitro assay, we verified that E. antarcticum B7 can grow at high concentrations of this metal. The approach used was important to precisely assign function to proteins from diverse classes and to infer relationships with proteins with functions already described in the literature. This approach aims to produce a better understanding of the mechanism by which this bacterium adapts to extreme environments and to the finding of targets with biotechnological interest.	[Oliveira da Costa, Wana Lailan; de Aragao Araujo, Carlos Leonardo; Dias, Larissa Maranhao; de Sousa Pereira, Lino Cesar; Castro Alves, Jorianne Thyeska; Araujo, Fabricio Almeida; Silva, Artur; Carneiro Folador, Adriana Ribeiro] Fed Univ Para, Ctr Genom & Syst Biol, Inst Biol Sci, Lab Genom & Bioinformat, Belem, Para, Brazil; [Folador, Edson Luiz] Univ Fed Paraiba, Biotechnol Ctr, Joao Pessoa, Paraiba, Brazil; [Henriques, Isabel] Univ Aveiro, Biol Dept, Aveiro, Portugal; [Henriques, Isabel] Univ Aveiro, CESAM, Aveiro, Portugal	Universidade Federal do Para; Universidade Federal da Paraiba; Universidade de Aveiro; Universidade de Aveiro	Folador, ARC (corresponding author), Fed Univ Para, Ctr Genom & Syst Biol, Inst Biol Sci, Lab Genom & Bioinformat, Belem, Para, Brazil.	adrianarc@ufpa.br	Folador, Adriana Ribeiro Carneiro/R-2658-2019; Luiz Silva, Artur da Costa da/AAI-3516-2021; Henriques, Isabel/B-1667-2008; Araujo, Fabricio A/B-9294-2018; Folador, Adriana R.C./H-6410-2016	Luiz Silva, Artur da Costa da/0000-0002-4082-1132; Henriques, Isabel/0000-0001-7717-4939; Araujo, Fabricio A/0000-0001-8134-5964; Folador, Adriana R.C./0000-0003-1522-9871; de Aragao Araujo, Carlos Leonardo/0000-0002-5243-7891	Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior CAPES [88881.068052/2014-01]; PROPESP/UFPA; FCT (Fundagao para a Glenda e Tecnologia, Portugal) [UID/AMB/50017/2013 - POCI-01-0145-FEDER-007638]; Isabel Henriques (FCT Investigator Programme) [IF/00492/2013]	Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior CAPES; PROPESP/UFPA; FCT (Fundagao para a Glenda e Tecnologia, Portugal); Isabel Henriques (FCT Investigator Programme)	Authors thank the Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior CAPES (88881.068052/2014-01) and PROPESP/UFPA for the financial support on this study. We also acknowledge FCT (Fundagao para a Glenda e Tecnologia, Portugal) financing to CESAM (UID/AMB/50017/2013 - POCI-01-0145-FEDER-007638) and Isabel Henriques (FCT Investigator Programme IF/00492/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agustiandari H, 2008, J BACTERIOL, V190, P759, DOI 10.1128/JB.01151-07; Andrade MA, 1998, J MOL BIOL, V276, P517, DOI 10.1006/jmbi.1997.1498; Andreani J, 2014, ARCH BIOCHEM BIOPHYS, V554, P65, DOI 10.1016/j.abb.2014.05.010; Araujo FA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20211-9; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Banco MT, 2018, ANAL CHEM, V90, P1740, DOI 10.1021/acs.analchem.7b03556; Barauna RA, 2017, PROTEOMES, V5, DOI 10.3390/proteomes5010009; Barauna Rafael A, 2016, BMC Res Notes, V9, P447, DOI 10.1186/s13104-016-2250-9; Barthelmebs L, 2000, J BACTERIOL, V182, P6724, DOI 10.1128/JB.182.23.6724-6731.2000; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Belfiore C, 2013, EXTREMOPHILES, V17, P421, DOI 10.1007/s00792-013-0523-y; Biedendieck R, 2010, MICROB BIOTECHNOL, V3, P24, DOI 10.1111/j.1751-7915.2009.00125.x; Bloom MS, 2014, INT J HYG ENVIR HEAL, V217, P709, DOI 10.1016/j.ijheh.2014.03.004; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carabetta VJ, 2013, MOL MICROBIOL, V88, P283, DOI 10.1111/mmi.12186; Carneiro AR, 2012, J BACTERIOL, V194, P6689, DOI 10.1128/JB.01791-12; Castro-Severyn J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00456; Chen CM, 2017, METHODS MOL BIOL, V1558, P3, DOI 10.1007/978-1-4939-6783-4_1; Ciprandi A, 2012, J INTEGR OMICS, V2, P69, DOI DOI 10.5584/JIORNICS.V2I1.84; Dall'Agnol HPMB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-986; Dastager SG, 2015, INT J SYST EVOL MICR, V65, P1611, DOI 10.1099/ijs.0.000149; Denef VJ, 2010, P NATL ACAD SCI USA, V107, P2383, DOI 10.1073/pnas.0907041107; Doerks T, 2004, NUCLEIC ACIDS RES, V32, P6321, DOI 10.1093/nar/gkh973; Enany S, 2014, J INFECT PUBLIC HEAL, V7, P296, DOI 10.1016/j.jiph.2014.02.002; Eng J., 2014, ROC ANAL WEB BASED C; Eswar N, 2006, CURRENT PROTOCOLS BI, DOI [10.1002/0471250953.b10506s15, DOI 10.1002/0471250953.B10506S15]; Fang H, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0631-y; Feng GP, 2015, NPJ BIOFILMS MICROBI, V1, DOI 10.1038/npjbiofilms.2015.22; Ferrer A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00748; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Folador EL, 2014, INTEGR BIOL-UK, V6, P1080, DOI 10.1039/c4ib00136b; Folador EL, 2016, BMC SYST BIOL BMC SY, P1; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Frias A, 2010, MICROB ECOL, V59, P476, DOI 10.1007/s00248-009-9622-9; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Grabowska M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14833; Gury J, 2004, APPL ENVIRON MICROB, V70, P2146, DOI 10.1128/AEM.70.4.2146-2153.2004; Hauser R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002815; Hakansson K, 2002, EUR J BIOCHEM, V269, P443, DOI 10.1046/j.0014-2956.2001.02665.x; Hara I, 2007, BIOCHEMISTRY-US, V46, P11, DOI 10.1021/bi061519w; Harada J, 2012, BIOSCI BIOTECH BIOCH, V76, P986, DOI 10.1271/bbb.110997; Hawkins Troy, 2007, J Bioinform Comput Biol, V5, P1, DOI 10.1142/S0219720007002503; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Hwang BY, 2005, BIOTECHNOL BIOPROC E, V10, P367, DOI 10.1007/BF02931857; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Islam Md. Saiful, 2015, Genomics & Informatics, V13, P53, DOI 10.5808/GI.2015.13.2.53; JAGANNADHAM MV, 1991, J BACTERIOL, V173, P7911, DOI 10.1128/jb.173.24.7911-7917.1991; Jagannadham MV, 2000, ARCH MICROBIOL, V173, P418, DOI 10.1007/s002030000163; Jeong H, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1215-2; Jez JM, 2017, J INVERTEBR PATHOL, V142, P11, DOI 10.1016/j.jip.2016.07.013; Jiang M, 2007, J BACTERIOL, V189, P3434, DOI 10.1128/JB.00090-07; Jiro H, 2001, PLANT CELL PHYSIOL, V42, P1112, DOI 10.1093/pcp/pce140; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kasana RC, 2007, CURR MICROBIOL, V54, P224, DOI 10.1007/s00284-006-0402-1; Kaval KG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00772; Kawasaki R, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7863706; Kirti K., 2014, ADV BIOL, V2014, DOI [10.1155/2014/837891.611, DOI 10.1155/2014/837891.611, DOI 10.1155/2014/837891, 10.1155/2014/837891]; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE BY, 1992, INFECT IMMUN, V60, P2066, DOI 10.1128/IAI.60.5.2066-2074.1992; Lee CW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169540; Lei FF, 2014, APPL BIOCHEM BIOTECH, V174, P1260, DOI 10.1007/s12010-014-1088-7; Lei Y, 2013, J BACTERIOL, V195, P1697, DOI 10.1128/JB.02201-12; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li XJ, 2015, STRUCTURE, V23, P1858, DOI 10.1016/j.str.2015.07.014; Limoli DH, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0011-2014; Liu L, 2016, FRONT MICROBIOL, V7, P1; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; Malhotra H, 2016, IMP J INTERDISCIP RE, V2, P1601; Ortiz-Guerrero JM, 2011, P NATL ACAD SCI USA, V108, P7565, DOI 10.1073/pnas.1018972108; Martens JH, 2002, APPL MICROBIOL BIOT, V58, P275, DOI 10.1007/s00253-001-0902-7; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Moreno-Paz M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-404; Mosca R, 2013, CURR OPIN STRUC BIOL, V23, P929, DOI 10.1016/j.sbi.2013.07.005; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Naqvi Ahmad Abu Turab, 2016, Genomics & Informatics, V14, P125, DOI 10.5808/GI.2016.14.3.125; Naqvi AAT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124177; Nimrod G, 2008, STRUCTURE, V16, P1755, DOI 10.1016/j.str.2008.10.017; de Azevedo JSN, 2008, CAN J MICROBIOL, V54, P137, DOI [10.1139/W07-123, 10.1139/w07-123]; Nourani E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00094; Ohtsuka J, 2009, PROTEINS, V75, P774, DOI 10.1002/prot.22365; Ordonez OF, 2015, FRONT ENV SCI, V3, P1, DOI [10.3389/ferws.2015.00050, DOI 10.3389/FERWS.2015.00050]; Paez-Espino D, 2009, BIOMETALS, V22, P117, DOI 10.1007/s10534-008-9195-y; Peabody MA, 2016, NUCLEIC ACIDS RES, V44, pD663, DOI 10.1093/nar/gkv1271; Peschel BA, 2001, STAPHYLOCOCCUS AUREU, V193, P1067, DOI [10.1084/jem.193.9.1067, DOI 10.1084/JEM.193.9.1067]; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pradhan S. K., 2016, Critical Reviews in Environmental Science and Technology, V46, P1659; Puzon GJ, 2002, BIOCHEM BIOPH RES CO, V294, P76, DOI 10.1016/S0006-291X(02)00438-2; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rao V Srinivasa, 2014, Int J Proteomics, V2014, P147648, DOI 10.1155/2014/147648; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sarkar A, 2013, ECOTOXICOLOGY, V22, P363, DOI 10.1007/s10646-012-1031-z; School K, 2016, BIOINFORMATION, V12, P209, DOI 10.6026/97320630012209; Schumann P, 2002, INT J SYST EVOL MICR, P1171, DOI [10.1099/00207713-52-4-1171, DOI 10.1099/00207713-52-4-1171]; Shahbaaz M, 2013, FUNCTIONAL ANNOTATIO, V20, P8; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Shen ZQ, 2014, ANTIMICROB AGENTS CH, V58, P2021, DOI 10.1128/AAC.02137-13; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Sillitoe I, 2015, NUCLEIC ACIDS RES, V43, pD376, DOI 10.1093/nar/gku947; Singh A., 2015, BIO, V3, P57, DOI [10.11648/J.BIO.20150305.16., DOI 10.11648/J.BIO.20150305.16, 10.11648/j.bio.20150305.16]; Snider J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156351; SUBCZYNSKI WK, 1993, BIOCHIM BIOPHYS ACTA, V1150, P173, DOI 10.1016/0005-2736(93)90087-G; Suga S, 2000, ARCH MICROBIOL, V173, P200, DOI 10.1007/s002039900129; Suvorova IA, 2015, GNTR FAMILY BACTERIA, P1, DOI [10.1371/journal.pone.0132618, DOI 10.1371/JOURNAL.PONE.0132618]; Swets JA, 2000, SCI AM, V283, P82, DOI 10.1038/scientificamerican1000-82; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tawfik DS, 2011, BIOCHEMISTRY-US, V50, P1128, DOI 10.1021/bi200002a; Tian B, 2010, TRENDS MICROBIOL, V18, P512, DOI 10.1016/j.tim.2010.07.007; Tran NP, 2008, J BACTERIOL, V190, P3213, DOI 10.1128/JB.01936-07; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Usuda Y, 1998, BBA-GENE STRUCT EXPR, V1442, P373, DOI 10.1016/S0167-4781(98)00166-3; Varma PBS, 2015, J INFECT PUBLIC HEAL, V8, P526, DOI 10.1016/j.jiph.2015.03.007; Vishnivetskaya TA, 2009, EXTREMOPHILES, V13, P541, DOI 10.1007/s00792-009-0243-5; Wada M, 2004, BIOSCI BIOTECH BIOCH, V68, P1481, DOI 10.1271/bbb.68.1481; Walian PJ, 2012, J PROTEOME RES, V11, P5720, DOI 10.1021/pr300548d; Welsch R, 2000, PLANTA, V211, P846, DOI 10.1007/s004250000352; Wetie AGN, 2014, CELL MOL LIFE SCI, V71, P205, DOI 10.1007/s00018-013-1333-1; Yang YR, 2015, PEERJ, V3, DOI 10.7717/peerj.943; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zahiri J, 2013, CURR GENOMICS, V14, P397, DOI 10.2174/1389202911314060004; Zanphorlin LM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23776; Zheng M, 2009, RES PAPERS STRUCTURE, P356; Zhu YG, 2014, ANNU REV EARTH PL SC, V42, P443, DOI 10.1146/annurev-earth-060313-054942	135	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0198965	10.1371/journal.pone.0198965	http://dx.doi.org/10.1371/journal.pone.0198965			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940001	Green Published, gold, Green Submitted			2022-12-26	WOS:000436088700007
J	Vychodilova, L; Necesankova, M; Albrechtova, K; Hlavac, J; Modry, D; Janova, E; Vyskocil, M; Mihalca, AD; Kennedy, LJ; Horin, P				Vychodilova, Leona; Necesankova, Michaela; Albrechtova, Katerina; Hlavac, Jan; Modry, David; Janova, Eva; Vyskocil, Mirko; Mihalca, Andrei D.; Kennedy, Lorna J.; Horin, Petr			Genetic diversity and population structure of African village dogs based on microsatellite and immunity-related molecular markers	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; CANINE DLA DIVERSITY; CHROMOSOMAL EVOLUTION; BALANCING SELECTION; DOMESTIC DOG; ALLELES; MHC; HAPLOTYPES; BREED; LOCI	The village and street dogs represent a unique model of canine populations. In the absence of selective breeding and veterinary care, they are subject mostly to natural selection. Their analyses contribute to understanding general mechanisms governing the genetic diversity, evolution and adaptation. In this study, we analyzed the genetic diversity and population structure of African village dogs living in villages in three different geographical areas in Northern Kenya. Data obtained for neutral microsatellite molecular markers were compared with those computed for potentially non-neutral markers of candidate immunity-related genes. The neutral genetic diversity was similar to other comparable village dog populations studied so far. The overall genetic diversity in microsatellites was higher than the diversity of European pure breeds, but it was similar to the range of diversity observed in a group composed of many European breeds, indicating that the African population has maintained a large proportion of the genetic diversity of the canine species as a whole. Microsatellite marker diversity indicated that the entire population is subdivided into three genetically distinct, although closely related subpopulations. This genetical partitioning corresponded to their geographical separation and the observed gene flow well correlated with the communication patterns among the three localities. In contrast to neutral microsatellites, the genetic diversity in immunity-related candidate SNP markers was similar across all three subpopulations and to the European group. It seems that the genetic structure of this particular population of Kenyan village dogs is mostly determined by geographical and anthropogenic factors influencing the gene flow between various subpopulations rather than by biological factors, such as genetic contribution of original migrating populations and/or the pathogenmediated selection. On the other hand, the study of oldest surviving dogs suggested a biological mechanism, i.e. a possible advantage of the overal heterozygosity marked by the the microsatellite loci analyzed.	[Vychodilova, Leona; Necesankova, Michaela; Janova, Eva; Vyskocil, Mirko; Horin, Petr] Univ Vet & Pharmaceut Sci, Dept Anim Genet, Brno, Czech Republic; [Albrechtova, Katerina; Hlavac, Jan; Modry, David] Univ Vet & Pharmaceut Sci, Dept Pathol & Parasitol, Brno, Czech Republic; [Modry, David; Janova, Eva; Horin, Petr] Univ Vet & Pharmaceut Sci, Ceitec VFU, Brno, Czech Republic; [Modry, David] Veterinaires Sans Frontieres Czech Republ, Brno, Czech Republic; [Modry, David] Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic; [Mihalca, Andrei D.] Univ Agr Sci & Vet Med Cluj Napoca, Fac Vet Med, Dept Parasitol & Parasit Dis, Cluj Napoca, Romania; [Kennedy, Lorna J.] Univ Manchester, Ctr Integrated Genom Med Res, Manchester, Lancs, England	University of Veterinary Sciences Brno; University of Veterinary Sciences Brno; University of Veterinary Sciences Brno; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; University of Manchester	Horin, P (corresponding author), Univ Vet & Pharmaceut Sci, Dept Anim Genet, Brno, Czech Republic.; Horin, P (corresponding author), Univ Vet & Pharmaceut Sci, Ceitec VFU, Brno, Czech Republic.	horin@dior.ics.muni.cz	Kennedy, Lorna/AAK-8767-2020; Mihalca, Andrei Daniel/A-1561-2008; Modry, David/G-7815-2014	Kennedy, Lorna/0000-0002-3087-4548; Mihalca, Andrei Daniel/0000-0001-6076-7914; Modry, David/0000-0001-9649-6255; Vychodilova, Leona/0000-0002-9839-4073	Central European Institute of Technology (CEITEC) [CZ.1.05/1.1.00/02.0068]	Central European Institute of Technology (CEITEC)	The work was supported by the Central European Institute of Technology (CEITEC) CZ.1.05/1.1.00/02.0068.	Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101; Angles JM, 2005, TISSUE ANTIGENS, V66, P173, DOI 10.1111/j.1399-0039.2005.00461.x; [Anonymous], 2012, STATISTICA, V12; Bairagya BB, 2008, INFECT GENET EVOL, V8, P360, DOI 10.1016/j.meegid.2008.02.009; Bigi D, 2015, ANIMAL, V9, P1921, DOI 10.1017/S1751731115001561; Bomcke E, 2001, J ANIM SCI, V4, P972; Borghans JAM, 2004, IMMUNOGENETICS, V55, P732, DOI 10.1007/s00251-003-0630-5; Botigue LR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16082; Boyko AR, 2009, P NATL ACAD SCI USA, V106, P13903, DOI 10.1073/pnas.0902129106; Brouillette JA, 2002, ANIM GENET, V33, P464, DOI 10.1046/j.1365-2052.2002.00918.x; Brown SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028496; Coppinger R, 2016, NAUTILUS, V16, P80; D'Amico G, 2013, GEOSPATIAL HEALTH, V7, P409, DOI 10.4081/gh.2013.98; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Foulley JL, 2006, LIVEST SCI, V113, P296; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Galibert F, 2011, CR BIOL, V334, P190, DOI 10.1016/j.crvi.2010.12.011; Grasso AN, 2014, GENET MOL BIOL, V37, P389, DOI 10.1590/S1415-47572014000300011; Gray MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-16; Greyling LM, 2004, ACTA THERIOL, V49, P369, DOI 10.1007/BF03192535; Hayward JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10460; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Hyeroba D, 2017, PREV VET MED, V137, P24, DOI 10.1016/j.prevetmed.2016.12.009; Irion DN, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-6; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jones P, 2008, GENETICS, V179, P1033, DOI 10.1534/genetics.108.087866; Kennedy LJ, 2007, TISSUE ANTIGENS, V69, P292, DOI 10.1111/j.1399-0039.2006.00781.x; Kennedy LJ, 2007, TISSUE ANTIGENS, V69, P272, DOI 10.1111/j.1399-0039.2006.00779.x; Kennedy LJ, 1999, VET IMMUNOL IMMUNOP, V69, P101, DOI 10.1016/S0165-2427(99)00046-X; Kennedy LJ, 2002, TISSUE ANTIGENS, V59, P194, DOI 10.1034/j.1399-0039.2002.590303.x; Kennedy LJ, 2007, J HERED, V98, P491, DOI 10.1093/jhered/esm051; Kim KS, 2001, J HERED, V92, P398, DOI 10.1093/jhered/92.5.398; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; LAMPHEAR J, 1988, J AFR HIST, V29, P27, DOI 10.1017/S0021853700035970; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; Lazarus R, 2003, GENOMICS, V81, P85, DOI 10.1016/S0888-7543(02)00022-8; Leroy G, 2009, ANIM GENET, V40, P333, DOI 10.1111/j.1365-2052.2008.01843.x; Li Y, 2013, MOL BIOL EVOL, V30, P1867, DOI 10.1093/molbev/mst088; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Mastrangelo Salvatore, 2018, BMC Research Notes, V11, P13, DOI 10.1186/s13104-017-3112-9; Morris KM, 2015, MOL ECOLOGY RESOURCE, V11, P123; Necesankova M, 2016, MOL BIOL REP, V43, P1451, DOI 10.1007/s11033-016-4078-8; Niskanen AK, 2014, MOL ECOL, V23, P875, DOI 10.1111/mec.12647; Oliver MK, 2009, MOL ECOL, V18, P80, DOI 10.1111/j.1365-294X.2008.04015.x; Ollier WER, 2001, IMMUNOGENETICS, V53, P669, DOI 10.1007/s002510100372; Ortutay C, 2012, HUM MUTAT, V33, P1456, DOI 10.1002/humu.22125; Ostrander EA, 2005, GENOME RES, V15, P1706, DOI 10.1101/gr.3736605; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pedersen N, 2013, J ANIM BREED GENET, V130, P236, DOI 10.1111/jbg.12017; Porras-Hurtado Liliana, 2013, Frontiers in Genetics, V4, P98, DOI 10.3389/fgene.2013.00098; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Puja IK, 2005, J HERED, V96, P854, DOI 10.1093/jhered/esi067; Quignon P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001324; Quinnell RJ, 2003, IMMUNOGENETICS, V55, P23, DOI 10.1007/s00251-003-0545-1; Radko A, 2018, J APPL ANIM RES, V46, P254, DOI 10.1080/09712119.2017.1292912; Ramirez O, 2014, BMC GENOMICS, V15, P1, DOI [10.1186/1471-2164-15-1, DOI 10.1186/1471-2164-15-1]; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Runstadler JA, 2006, TISSUE ANTIGENS, V68, P418, DOI 10.1111/j.1399-0039.2006.00696.x; Sacks BN, 2013, MOL BIOL EVOL, V30, P1103, DOI 10.1093/molbev/mst027; Schierup MH, 2000, GENET RES, V76, P51, DOI 10.1017/S0016672300004535; Schoenebeck JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002849; Shannon LM, 2015, P NATL ACAD SCI USA, V112, P13639, DOI 10.1073/pnas.1516215112; Shiel RE, 2014, TISSUE ANTIGENS, V84, P271, DOI 10.1111/tan.12365; Siddle KJ, 2014, CURR OPIN GENET DEV, V29, P31, DOI 10.1016/j.gde.2014.07.004; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Soutter F, 2015, VET J, V203, P345, DOI 10.1016/j.tvjl.2014.12.032; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Waller R., 1985, AFR AFFAIRS, V336, P347; Wan QH, 2004, ELECTROPHORESIS, V25, P2165, DOI 10.1002/elps.200305922; Wang GD, 2016, CELL RES, V26, P21, DOI 10.1038/cr.2015.147; WATSONJONES DL, 1988, ANN TROP MED PARASIT, V82, P343, DOI 10.1080/00034983.1988.11812256; WAYNE RK, 1987, CYTOGENET CELL GENET, V44, P134, DOI 10.1159/000132357; WAYNE RK, 1987, CYTOGENET CELL GENET, V44, P123, DOI 10.1159/000132356; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zajc I, 1997, MAMM GENOME, V8, P182, DOI 10.1007/s003359900386	81	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199506	10.1371/journal.pone.0199506	http://dx.doi.org/10.1371/journal.pone.0199506			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940023	Green Published, Green Submitted, gold			2022-12-26	WOS:000436088700022
J	Chen, SH; Lue, JH; Hsiao, YJ; Lai, SM; Wang, HY; Lin, CT; Chen, YC; Tsai, YJ				Chen, Seu-Hwa; Lue, June-Horng; Hsiao, Yung-Jung; Lai, Shu-Mei; Wang, Hsin-Ying; Lin, Chi-Te; Chen, Ya-Chin; Tsai, Yi-Ju			Elevated galanin receptor type 2 primarily contributes to mechanical hypersensitivity after median nerve injury	PLOS ONE			English	Article							PRIMARY SENSORY NEURONS; RAT CUNEATE NUCLEUS; DORSAL-ROOT GANGLION; NITRIC-OXIDE SYNTHASE; C-FOS EXPRESSION; CUNEOTHALAMIC RELAY NEURONS; SPINAL-CORD NEURONS; NEUROPEPTIDE-Y; SCIATIC-NERVE; PERIPHERAL GALANIN	In this study, we investigated temporal changes in galanin receptor type 2 (GaIR2) expression in NF200-, galanin-, neuropeptide Y (NPY)-, and neuronal nitric oxide synthase (nNOS)-like immunoreactive (LI) dorsal root ganglion (DRG) neurons after median nerve chronic constriction injury (CCI), and the effects of GaIR2 on c-Fos expression in the cuneate nucleus (CN). Double immunofluorescence labeling methods were used to appraise changes in GaIR2 expression in NF200-LI, galanin-LI, NPY-LI, and nNOS-LI DRG neurons after CCI. The von Frey assay was used to assess the efficiency of intraplantar administration of saline, M871 (a GaIR2 antagonist), or AR-M1896 (a GaIR2 agonist) on neuropathic signs of rats with CCI. The effects of alterations in c-Fos expression were assessed in all treatments. The percentage of GaIR2-LI neurons in lesioned DRGs increased and peaked at 1 week after CCI. We further detected that percentages of GaIR2-LI neurons labeled for NF200, galanin, NPY, and nNOS significantly increased following CCI. Furthermore, M871 remarkably attenuated tactile allodynia, but the sensation was slightly aggravated by AR-M1896 after CCI. Consequentially, after electrical stimulation of the CCI-treated median nerve, the number of c-Fos-LI neurons in the cuneate nucleus (CN) was significantly reduced in the M871 group, whereas it increased in the AR-M1896 group. These results suggest that activation of GaIR2, probably through NPY or nitric oxide, induces c-Fos expression in the CN and transmits mechanical allodynia sensations to the thalamus.	[Chen, Seu-Hwa] Taipei Med Univ, Coll Med, Sch Med, Dept Anat & Cell Biol, Taipei, Taiwan; [Lue, June-Horng; Hsiao, Yung-Jung; Lai, Shu-Mei; Wang, Hsin-Ying; Chen, Ya-Chin] Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei, Taiwan; [Lin, Chi-Te] Cent Taiwan Univ Sci & Technol, Dept Nursing, Taichung, Taiwan; [Tsai, Yi-Ju] Fu Jen Catholic Univ, Coll Med, Grad Inst Biomed & Pharmaceut Sci, New Taipei, Taiwan	Taipei Medical University; National Taiwan University; Central Taiwan University Science & Technology; Fu Jen Catholic University	Tsai, YJ (corresponding author), Fu Jen Catholic Univ, Coll Med, Grad Inst Biomed & Pharmaceut Sci, New Taipei, Taiwan.	065735@mail.fju.edu.tw		LUE, JUNE-HORNG/0000-0002-1087-1382	National Science Council [NSC101-2320-6002-006, NSC102-2320-6002-004-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by NSC101-2320-6002-006 and NSC102-2320-6002-004-MY3, National Science Council (https://www.most.gov.tw/), JHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN P, 1964, J NEUROPHYSIOL, V27, P1080, DOI 10.1152/jn.1964.27.6.1080; BERKLEY KJ, 1986, BRAIN RES REV, V11, P199, DOI 10.1016/0165-0173(86)90012-3; Boateng EK, 2015, EUR J PAIN, V19, P236, DOI 10.1002/ejp.541; Brumovsky P, 2006, J CHEM NEUROANAT, V31, P243, DOI 10.1016/j.jchemneu.2006.02.001; Burazin TCD, 1998, J NEUROCHEM, V71, P879; Cizkova D, 2002, BRAIN RES BULL, V58, P161, DOI 10.1016/S0361-9230(02)00761-X; Coronel MF, 2008, J CHEM NEUROANAT, V35, P94, DOI 10.1016/j.jchemneu.2007.07.001; Day AS, 2001, BRAIN RES, V895, P194, DOI 10.1016/S0006-8993(01)02095-9; Flatters SJL, 2003, NEUROSCIENCE, V116, P1005, DOI 10.1016/S0306-4522(02)00947-8; Funck VR, 2018, BRAIN RES, V1687, P74, DOI 10.1016/j.brainres.2018.02.036; Gonzalez-Hernandez T, 1999, J COMP NEUROL, V404, P64; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; He B, 2017, J NEUROSCI RES, V95, P1036, DOI 10.1002/jnr.23869; Hobson SA, 2008, CELL MOL LIFE SCI, V65, P1806, DOI 10.1007/s00018-008-8154-7; HOEFLINGER BF, 1993, J COMP NEUROL, V332, P378, DOI 10.1002/cne.903320309; HOKFELT T, 1987, NEUROSCI LETT, V83, P217, DOI 10.1016/0304-3940(87)90088-7; HOKFELT T, 1994, TRENDS NEUROSCI, V17, P22, DOI 10.1016/0166-2236(94)90031-0; Huang CT, 2016, ANESTHESIOLOGY, V125, P1202, DOI 10.1097/ALN.0000000000001360; Hulse RP, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/545386; Hulse RP, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-26; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Jimenez-Andrade JM, 2005, BRAIN RES, V1056, P113, DOI 10.1016/j.brainres.2005.07.007; Jimenez-Andrade JM, 2004, PAIN, V110, P10, DOI 10.1016/j.pain.2004.02.032; Jimenez-Andrade JM, 2006, PHARMACOL BIOCHEM BE, V85, P273, DOI 10.1016/j.pbb.2006.08.008; Kim DH, 2001, J NEUROSURG, V95, P584, DOI 10.3171/jns.2001.95.4.0584; Lin CT, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/921405; Liu HX, 2001, P NATL ACAD SCI USA, V98, P9960, DOI 10.1073/pnas.161293598; Liu Z, 2008, IN VITRO CELL DEV-AN, V44, P379, DOI 10.1007/s11626-008-9118-9; Lue JH, 1996, NEUROSCI RES, V24, P363, DOI 10.1016/0168-0102(95)01014-9; Lue JH, 2002, J NEUROTRAUM, V19, P897, DOI 10.1089/08977150260190483; LUE JH, 1994, EXP BRAIN RES, V98, P13; Ma W, 1997, NEUROSCIENCE, V79, P1183, DOI 10.1016/S0306-4522(97)00088-2; MASLANY S, 1991, BRAIN RES, V564, P56, DOI 10.1016/0006-8993(91)91351-Z; MELLER ST, 1992, NEUROSCIENCE, V50, P7, DOI 10.1016/0306-4522(92)90377-E; MOLANDER C, 1994, BRAIN RES, V644, P74, DOI 10.1016/0006-8993(94)90349-2; MOLANDER C, 1992, NEUROSCIENCE, V50, P223, DOI 10.1016/0306-4522(92)90394-H; OMER GE, 1982, CLIN ORTHOP RELAT R, P15; Pirondi S, 2005, J NEUROCHEM, V95, P821, DOI 10.1111/j.1471-4159.2005.03437.x; Ramer LM, 2004, J NEUROSCI, V24, P10796, DOI 10.1523/JNEUROSCI.3337-04.2004; Ramer MS, 2001, J NEUROCHEM, V77, P864, DOI 10.1046/j.1471-4159.2001.00288.x; Scholz T, 2009, J RECONSTR MICROSURG, V25, P339, DOI 10.1055/s-0029-1215529; Shi TJS, 1997, NEUROSCI LETT, V237, P57, DOI 10.1016/S0304-3940(97)00805-7; Sollenberg UE, 2006, INT J PEPT RES THER, V12, P115, DOI 10.1007/s10989-005-9008-x; TAL M, 1994, PAIN, V57, P375, DOI 10.1016/0304-3959(94)90013-2; Tsai YJ, 2007, J NEUROTRAUM, V24, P1878, DOI 10.1089/neu.2007.3488; Tsai YJ, 2009, J NEUROTRAUM, V26, P1609, DOI 10.1089/neu.2008.0642; Tsai YJ, 2004, NEUROSCI RES, V48, P369, DOI 10.1016/j.neures.2003.12.003; VILLAR MJ, 1989, NEUROSCIENCE, V33, P587, DOI 10.1016/0306-4522(89)90411-9; Wang HY, 2013, PHARMACOL BIOCHEM BE, V106, P47, DOI 10.1016/j.pbb.2013.03.002; Wang HY, 2012, NEUROCHEM RES, V37, P84, DOI 10.1007/s11064-011-0585-0; Xu XF, 2016, NEURAL REGEN RES, V11, P1517, DOI 10.4103/1673-5374.191228; Xu ZQ, 1996, NEUROREPORT, V8, P237, DOI 10.1097/00001756-199612200-00048; Yeh JH, 2008, J CHEM NEUROANAT, V36, P27, DOI 10.1016/j.jchemneu.2008.05.006; Zhang X, 1998, ANN NY ACAD SCI, V863, P402, DOI 10.1111/j.1749-6632.1998.tb10710.x; ZHANG X, 1993, EUR J NEUROSCI, V5, P1510, DOI 10.1111/j.1460-9568.1993.tb00219.x; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	56	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199512	10.1371/journal.pone.0199512	http://dx.doi.org/10.1371/journal.pone.0199512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928003	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500103
J	Shah, AK; Kreibich, CD; Amdam, GV; Munch, D				Shah, Ashish K.; Kreibich, Claus D.; Amdam, Gro, V; Munch, Daniel			Metabolic enzymes in glial cells of the honeybee brain and their associations with aging, starvation and food response	PLOS ONE			English	Article							DIVISION-OF-LABOR; GLUTAMINE-SYNTHETASE; POSTEMBRYONIC DEVELOPMENT; CARBOHYDRATE-METABOLISM; GENE-EXPRESSION; SOCIAL-ROLE; BEE BRAIN; LOCALIZATION; SUCROSE; NEURONS	The honey bee has been extensively studied as a model for neuronal circuit and memory function and more recently has emerged as an unconventional model in biogerontology. Yet, the detailed knowledge of neuronal processing in the honey bee brain contrasts with the very sparse information available on glial cells. In other systems glial cells are involved in nutritional homeostasis, detoxification, and aging. These glial functions have been linked to metabolic enzymes, such as glutamine synthetase and glycogen phosphorylase. As a step in identifying functional roles and potential differences among honey bee glial types, we examined the spatial distribution of these enzymes and asked if enzyme abundance is associated with aging and other processes essential for survival. Using immunohistochemistry and confocal laser microscopy we demonstrate that glutamine synthetase and glycogen phosphorylase are abundant in glia but appear to co-localize with different glial sub-types. The overall spatial distribution of both enzymes was not homogenous and differed markedly between different neuropiles and also within each neuropil. Using semi-quantitative Western blotting we found that rapid aging, typically observed in shortest-lived worker bees (foragers), was associated with declining enzyme levels. Further, we found enzyme abundance changes after severe starvation stress, and that glutamine synthetase is associated with food response. Together, our data indicate that aging and nutritional physiology in bees are linked to glial specific metabolic enzymes. Enzyme specific localization patterns suggest a functional differentiation among identified glial types.	[Shah, Ashish K.] Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, As, Norway; [Kreibich, Claus D.; Amdam, Gro, V; Munch, Daniel] Norwegian Univ Life Sci, Fac Ecol & Nat Resource Management, As, Norway; [Amdam, Gro, V] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Norwegian University of Life Sciences; Norwegian University of Life Sciences; Arizona State University; Arizona State University-Tempe	Munch, D (corresponding author), Norwegian Univ Life Sci, Fac Ecol & Nat Resource Management, As, Norway.	daniel.munch@nmbu.no			Marie Curie ITN/FP7 [238665]; Research Council of Norway [213976, 191699]	Marie Curie ITN/FP7; Research Council of Norway(Research Council of Norway)	This work was supported by Marie Curie ITN/FP7 (ec.europa.eu/research/mariecurieactions/), project ID 238665 to GVA and AS; and the Research Council of Norway (www.nfr.no), project IDs 213976 and 191699 to GVA and DM.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Amdam GV, 2011, AGING CELL, V10, P18, DOI 10.1111/j.1474-9726.2010.00647.x; Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; Aurori CM, 2014, J GERONTOL A-BIOL, V69, P633, DOI 10.1093/gerona/glt134; Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Behrends A, 2007, EXP GERONTOL, V42, P1146, DOI 10.1016/j.exger.2007.09.003; Ben-Shahar Y, 2001, J COMP PHYSIOL A, V187, P891, DOI 10.1007/s00359-001-0260-z; BENJAMIN AM, 1975, J NEUROCHEM, V25, P197, DOI 10.1111/j.1471-4159.1975.tb06953.x; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; BICKER G, 1988, J NEUROSCI, V8, P2108; Boyan G, 2011, DEV GENES EVOL, V221, P141, DOI 10.1007/s00427-011-0366-4; Boyan GS, 2012, DEV GENES EVOL, V222, P125, DOI 10.1007/s00427-012-0394-8; CAGGESE C, 1994, GENETICA, V94, P275, DOI 10.1007/BF01443441; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; Doherty J, 2009, J NEUROSCI, V29, P4768, DOI 10.1523/JNEUROSCI.5951-08.2009; Dukas R, 2008, INSECT SOC, V55, P252, DOI 10.1007/s00040-008-0995-4; Edwards TN, 2010, PROG NEUROBIOL, V90, P471, DOI 10.1016/j.pneurobio.2010.01.001; Eid T, 2013, NEUROCHEM INT, V63, P670, DOI 10.1016/j.neuint.2013.06.008; French AS, 2014, J INSECT PHYSIOL, V61, P8, DOI 10.1016/j.jinsphys.2013.12.005; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Gocht D, 2009, MICROSC RES TECHNIQ, V72, P385, DOI 10.1002/jemt.20683; Haussinger D, 2008, GUT, V57, P1156, DOI 10.1136/gut.2007.122176; Hahnlein I, 1996, J COMP NEUROL, V376, P175, DOI 10.1002/(SICI)1096-9861(19961209)376:2&lt;175::AID-CNE1&gt;3.0.CO;2-0; Hahnlein I, 1997, DEV GENES EVOL, V207, P29, DOI 10.1007/s004270050089; Hahnlein I, 1996, J COMP NEUROL, V367, P235, DOI 10.1002/(SICI)1096-9861(19960401)367:2&lt;235::AID-CNE6&gt;3.0.CO;2-6; HALTER DA, 1995, DEVELOPMENT, V121, P317; Havukainen H, 2013, J BIOL CHEM, V288, P28369, DOI 10.1074/jbc.M113.465021; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Hilgetag CC, 2009, BRAIN STRUCT FUNCT, V213, P365, DOI 10.1007/s00429-009-0202-z; Hsieh YS, 2011, EXP GERONTOL, V46, P233, DOI 10.1016/j.exger.2010.10.007; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; Kucharski R, 2000, GENE, V242, P399, DOI 10.1016/S0378-1119(99)00503-X; Labow BI, 2001, J NUTR, V131, p2467S, DOI 10.1093/jn/131.9.2467S; Leboulle G., 2013, HDB BEHAV NEUROSCIEN, P171, DOI [10.1016/j.neulet.2006.01.007, DOI 10.1016/J.NEULET.2006.01.007]; Liu WW, 2013, P NATL ACAD SCI USA, V110, P10294, DOI 10.1073/pnas.1220560110; Margotta Joseph W., 2013, Insects, V4, P9, DOI 10.3390/insects4010009; Menzel R, 2001, LEARN MEMORY, V8, P198, DOI 10.1101/lm.40001; Menzel R, 2013, HDB BEHAV NEUROSCIEN; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mortera P, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00045; Munch D, 2013, JOVE-J VIS EXP, DOI 10.3791/50550; Munch D, 2013, HBK BEHAV NEUROSCI, V22, P487, DOI 10.1016/B978-0-12-415823-8.00037-X; Munch D, 2013, J EXP BIOL, V216, P1638, DOI 10.1242/jeb.078915; Munch D, 2015, EXP GERONTOL, V71, P103, DOI 10.1016/j.exger.2015.08.001; Munch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013504; Munch D, 2010, FEBS LETT, V584, P2496, DOI 10.1016/j.febslet.2010.04.007; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Obel Linea F, 2012, Front Neuroenergetics, V4, P3, DOI 10.3389/fnene.2012.00003; Olabarria M, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-55; Oland LA, 1999, CELL TISSUE RES, V297, P527, DOI 10.1007/s004410051379; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; Pankiw T, 2000, BEHAV ECOL SOCIOBIOL, V47, P265, DOI 10.1007/s002650050664; Pankiw T, 2003, J COMP PHYSIOL A, V189, P675, DOI 10.1007/s00359-003-0442-y; Parker JD, 2010, MYRMECOL NEWS, V13, P103; Parker RJ, 2006, SEMIN CELL DEV BIOL, V17, P66, DOI 10.1016/j.semcdb.2005.11.012; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; Remolina SC, 2007, J INSECT PHYSIOL, V53, P1027, DOI 10.1016/j.jinsphys.2007.05.015; Richter K, 1996, GLIA, V17, P263, DOI 10.1002/(SICI)1098-1136(199608)17:4<263::AID-GLIA1>3.0.CO;2-0; Saez I, 2014, J CEREBR BLOOD F MET, V34, P945, DOI 10.1038/jcbfm.2014.33; Satake S, 2000, ARCH INSECT BIOCHEM, V44, P90, DOI 10.1002/1520-6327(200006)44:2&lt;90::AID-ARCH4&gt;3.0.CO;2-0; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Scheiner R, 2010, APIDOLOGIE, V41, P29, DOI 10.1051/apido/2009040; Scheiner R, 2009, J EXP BIOL, V212, P994, DOI 10.1242/jeb.021188; Seeley TD, 1994, WISDOM HIVE; SIEGERT KJ, 1987, ARCH INSECT BIOCHEM, V4, P151, DOI 10.1002/arch.940040208; Sinakevitch I, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-10; Smedal B, 2009, J EXP BIOL, V212, P3795, DOI 10.1242/jeb.035063; SOHAL RS, 1972, Z ZELLFORSCH MIK ANA, V135, P449, DOI 10.1007/BF00583429; Speth MT, 2015, EXP GERONTOL, V65, P46, DOI 10.1016/j.exger.2015.03.006; Stork Tobias, 2012, Cold Spring Harb Protoc, V2012, P1, DOI 10.1101/pdb.top067587; Suarez I, 2002, NEUROCHEM INT, V41, P123, DOI 10.1016/S0197-0186(02)00033-5; Suh SW, 2017, J PHARMACOL EXP THER, V321, p45 ; Thamm M, 2014, J COMP NEUROL, V522, P1786, DOI 10.1002/cne.23500; Tolfsen CC, 2011, J EXP BIOL, V214, P1322, DOI 10.1242/jeb.049155; TSACOPOULOS M, 1994, J NEUROSCI, V14, P1339, DOI 10.1523/JNEUROSCI.14-03-01339.1994; Vance JT, 2009, J EXP BIOL, V212, P2604, DOI 10.1242/jeb.028100; Wang Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002779; Wolschin F, 2009, J EXP BIOL, V212, P4027, DOI 10.1242/jeb.033845; Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411; Zannat MT, 2006, NEUROSCI LETT, V398, P274, DOI 10.1016/j.neulet.2006.01.007; Zimmerman JE, 2004, J NEUROCHEM, V88, P32, DOI 10.1046/j.1471-4159.2003.02126.x	86	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198322	10.1371/journal.pone.0198322	http://dx.doi.org/10.1371/journal.pone.0198322			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927967	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500015
J	Slunge, D; Boman, A				Slunge, Daniel; Boman, Anders			Learning to live with ticks? The role of exposure and risk perceptions in protective behaviour against tick-borne diseases	PLOS ONE			English	Article							IXODES-RICINUS TICKS; WILLINGNESS-TO-PAY; LYME-DISEASE; GEOGRAPHICAL-DISTRIBUTION; PREVENTIVE BEHAVIORS; ENCEPHALITIS; VACCINATION; COMMUNICATION; PREVALENCE; KNOWLEDGE	The purpose of this study is to analyse the role of risk perceptions and exposure for protective behaviour against tick bites and the related diseases Lyme borreliosis (LB) and tickborne encephalitis (TBE), both of which are growing health concerns. We use data from a national survey in Sweden with respondents in geographical areas with substantial differences in both abundance of ticks and incidence of LB and TBE. We find that the share of respondents who frequently use protective clothing (64%), perform tick checks (63%) or avoid tall grass while in areas with ticks (48%) is relatively high. However, the use of protective measures is uneven and a considerably lower share tuck their trousers into their socks (18%), use repellent against ticks (16%) or use a combination of protective measures. Thirty-one per cent of the respondents report one or more tick bites in the last year and 68% report one or more lifetime tick bites, indicating that it is difficult to protect oneself from tick bites. There is a strong positive association between exposure and checking the skin for ticks, but exposure is only weakly associated with other protective measures. Tick bites are perceived as a serious health risk by as many as 43% of the respondents. The perception that a single tick bite is serious is negatively associated with actual exposure to ticks, while the opposite is true for the perception that tick bites constitute a serious lifetime health risk. This indicates a learning effect in relation to risk perceptions and the performance of tick checks, but not in relation to other protective measures. Recommendations include informing people of the risks associated with tick bites, the efficacy of various protective measures and the importance of combining multiple types of protection. Given the high exposure to tick bites, the growing incidence of TBE and LB, and the difficulties in preventing tick bites, other preventive measures should be further discussed, including vaccination programmes.	[Slunge, Daniel; Boman, Anders] Univ Gothenburg, Dept Econ, Gothenburg, Sweden; [Slunge, Daniel] Univ Gothenburg, Gothenburg Ctr Sustainable Dev, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Slunge, D (corresponding author), Univ Gothenburg, Dept Econ, Gothenburg, Sweden.; Slunge, D (corresponding author), Univ Gothenburg, Gothenburg Ctr Sustainable Dev, Gothenburg, Sweden.	daniel.slunge@gu.se		Slunge, Daniel/0000-0002-6219-3376	Gothenburg Centre for Sustainable Development; Region Vastra Gotaland [RUN 612-0973-14]	Gothenburg Centre for Sustainable Development; Region Vastra Gotaland	Support was provided by the Gothenburg Centre for Sustainable Development (http://gmv. gu.se/english) and Region Vastra Gotaland (http:// www.vgregion.se/en) RUN 612-0973-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLA CW, 1990, WATER RESOUR BULL, V26, P451; Aenishaenslin C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1539-2; Aenishaenslin C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1298; Askling HH, 2015, VACCINE, V33, P4962, DOI 10.1016/j.vaccine.2015.07.030; Beaujean D, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2760; Beaujean DJMA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-225; Bresnahan BW, 1997, LAND ECON, V73, P340, DOI 10.2307/3147172; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Conner M, 2005, PREDICTING HLTH BEHA; des Vignes F, 2001, J INFECT DIS, V183, P773, DOI 10.1086/318818; Dickie M, 1996, REV ECON STAT, V78, P451, DOI 10.2307/2109792; FISCHHOFF B, 1995, RISK ANAL, V15, P137, DOI 10.1111/j.1539-6924.1995.tb00308.x; Fredman P., 2008, 1 FORSKN PROGR FRIL; Gerking S, 2017, J RISK UNCERTAINTY, V55, P177, DOI 10.1007/s11166-017-9267-x; Gould LH, 2008, VECTOR-BORNE ZOONOT, V8, P769, DOI 10.1089/vbz.2007.0221; Gutierrez RL, 2012, DM-DIS MON, V58, P377, DOI 10.1016/j.disamonth.2012.03.009; Haglund M, 2003, VACCINE, V21, pS11, DOI 10.1016/S0264-410X(02)00811-3; HARRINGTON W, 1989, J URBAN ECON, V25, P116, DOI 10.1016/0094-1190(89)90048-X; Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024; Heinz FX, 2013, EMERG INFECT DIS, V19, P69, DOI 10.3201/eid1901.120458; Herrington JE, 2004, AM J PREV MED, V26, P135, DOI 10.1016/j.amepre.2003.10.010; JAENSON TGT, 1994, J MED ENTOMOL, V31, P240, DOI 10.1093/jmedent/31.2.240; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-184; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-8; Johansson-Stenman O, 2008, J HEALTH ECON, V27, P234, DOI 10.1016/j.jhealeco.2007.04.004; Jones TF, 2002, AM J PREV MED, V23, P47, DOI 10.1016/S0749-3797(02)00440-3; Jore S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-11; Kaaijk P, 2016, HUM VACC IMMUNOTHER, V12, P757, DOI 10.1080/21645515.2015.1087628; Kunz C, 2003, VACCINE, V21, pS50, DOI 10.1016/S0264-410X(02)00813-7; Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4; Lindsay L R, 2015, Can Commun Dis Rep, V41, P146; Lloyd-Smith P, 2018, ENVIRON RESOUR ECON, V69, P217, DOI 10.1007/s10640-016-0075-6; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Mowbray F, 2014, TICKS TICK-BORNE DIS, V5, P392, DOI 10.1016/j.ttbdis.2014.01.006; Mowbray F, 2012, VECTOR-BORNE ZOONOT, V12, P817, DOI 10.1089/vbz.2011.0774; Pettersson JHO, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-102; Piesman J, 2008, ANNU REV ENTOMOL, V53, P323, DOI 10.1146/annurev.ento.53.103106.093429; Piesman J, 2012, J ENVIRON HEALTH, V74, P30; Quine CP, 2011, PHILOS T R SOC B, V366, P2010, DOI 10.1098/rstb.2010.0397; Rauter C, 2005, APPL ENVIRON MICROB, V71, P7203, DOI 10.1128/AEM.71.11.7203-7216.2005; Shadick NA, 1997, AM J PREV MED, V13, P265, DOI 10.1016/S0749-3797(18)30173-9; Sjoberg L, 2000, RISK ANAL, V20, P1, DOI 10.1111/0272-4332.00001; Sjoberg L, 2006, J RISK RES, V9, P683, DOI 10.1080/13669870600799952; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Smit R, 2012, VACCINE, V30, P6301, DOI 10.1016/j.vaccine.2012.07.083; Sood SK, 1997, J INFECT DIS, V175, P996, DOI 10.1086/514009; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Stjernberg L, 2005, SCAND J PUBLIC HEALT, V33, P432, DOI 10.1080/14034940510005932; Swedish Public Health Agency, 2014, VACC MOT TBE UND REG; Tonks A, 2007, BMJ-BRIT MED J, V335, P910, DOI 10.1136/bmj.39363.530961.AD; Trafikanalys, 2014, ROAD TRAFF INJ 2013; Valente SL, 2015, J PUBLIC HEALTH MAN, V21, pE16, DOI 10.1097/PHH.0000000000000098; Vazquez M, 2008, EMERG INFECT DIS, V14, P210, DOI 10.3201/eid1402.070725; Wilhelmsson P, 2016, TICKS TICK-BORNE DIS, V7, P71, DOI 10.1016/j.ttbdis.2015.08.009; Wilhelmsson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081433	56	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							0198286	10.1371/journal.pone.0198286	http://dx.doi.org/10.1371/journal.pone.0198286			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ8QS	29924806	Green Published, gold, Green Submitted			2022-12-26	WOS:000435655600016
J	Yu, HW; Shen, N; Yu, SQ; Yu, D; Liu, CH				Yu, Hongwei; Shen, Nan; Yu, Siqi; Yu, Dan; Liu, Chunhua			Responses of the native species Sparganium angustifolium and the invasive species Egeria densa to warming and interspecific competition	PLOS ONE			English	Article							AQUATIC PLANTS; MYRIOPHYLLUM-SPICATUM; BIOMASS ALLOCATION; CLIMATE-CHANGE; TEMPERATURE; GROWTH; MACROPHYTES; HYDROCHARITACEAE; COMMUNITIES; PERFORMANCE	Climate change, especially warming temperatures, may increase invasion and modify the ecological impacts of invasive species by enhancing their ability to compete. To test the effects of warming on invasive plants, a mesocosm experiment was conducted to study competition between the invasive plant Egeria densa and the native hygrophyte Sparganium angustifolium under simulated warming conditions in a greenhouse. These two species were grown in monoculture (no competitor control) or mixed culture (competitor control) for two months under different temperature conditions (warming treatment or no-warming treatment). In S. angustifolium, the higher temperatures led to a shorter root length and significantly increased the aboveground traits of ramets, the total biomass, and the RGR (relative growth rate) but had no effect on the aboveground traits of genets. Growth in mixed culture significantly decreased the S. angustifolium ramet height under warmer conditions and significantly reduced the ramet root length, ramet number, genet biomass, root-to-shoot ratio and RGR of S. angustifolium under natural temperature conditions. All the morphological, biomass and growth traits of E. densa except for the root-to-shoot ratio were significantly increased by the warmer temperatures and decreased by growth in mixed culture. The RCI and RII of E. densa in both the no-warming and warmer environments were two and three times greater than those of S. angustifolium, whereas the ACI values for the two species were similar. Thus, S. angustifolium was a better competitor than E. densa under both temperature conditions. These results suggest that although the superior competitive ability of native species can inhibit E. densa growth, the performance of this species will be enhanced under future climate warming in cold regions.	[Yu, Hongwei; Shen, Nan; Yu, Siqi; Yu, Dan; Liu, Chunhua] Wuhan Univ, Coll Life Sci, Dept Ecol, Natl Field Stn Freshwater Ecosyst Liangzi Lake, Wuhan, Hubei, Peoples R China	Wuhan University	Liu, CH (corresponding author), Wuhan Univ, Coll Life Sci, Dept Ecol, Natl Field Stn Freshwater Ecosyst Liangzi Lake, Wuhan, Hubei, Peoples R China.	liuchh@163.com		Yu, Hongwei/0000-0002-1802-1323; liu, chunhua/0000-0002-3932-477X	Special Foundation of National Science and Technology Basic Research [2013FY112300]; Major Science and Technology Program for Water Pollution Control and Treatment [2015ZX07503-005]	Special Foundation of National Science and Technology Basic Research; Major Science and Technology Program for Water Pollution Control and Treatment	The authors gratefully acknowledge funding support from the Special Foundation of National Science and Technology Basic Research (2013FY112300) and Major Science and Technology Program for Water Pollution Control and Treatment (2015ZX07503-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; BARKO JW, 1981, ECOL MONOGR, V51, P219, DOI 10.2307/2937264; Biondini M, 2001, ECOL MODEL, V142, P189, DOI 10.1016/S0304-3800(01)00285-X; Blumenthal DM, 2007, ECOLOGY, V88, P2758, DOI 10.1890/06-2115.1; Bornette G, 2011, AQUAT SCI, V73, P1, DOI 10.1007/s00027-010-0162-7; Broadbent A, 2018, OECOLOGIA, V186, P577, DOI 10.1007/s00442-017-4039-5; Chen BM, 2017, AOB PLANTS, V9, DOI 10.1093/aobpla/plx028; COOK CDK, 1984, AQUAT BOT, V19, P73, DOI 10.1016/0304-3770(84)90009-3; Day KJ, 2003, FUNCT ECOL, V17, P454, DOI 10.1046/j.1365-2435.2003.00758.x; Drenovsky RE, 2012, ANN BOT-LONDON, V110, P141, DOI 10.1093/aob/mcs100; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dukes JS, 2011, ECOL APPL, V21, P1887, DOI 10.1890/11-0111.1; Fleming JP, 2015, HYDROBIOLOGIA, V746, P23, DOI 10.1007/s10750-014-2026-y; Funk JL, 2016, ECOLOGY, V97, P75, DOI 10.1890/15-0974.1; Gibson DJ, 1999, J ECOL, V87, P1, DOI 10.1046/j.1365-2745.1999.00321.x; GOLDBERG DE, 1991, J ECOL, V79, P1013, DOI 10.2307/2261095; GUREVITCH J, 1990, J ECOL, V78, P727, DOI 10.2307/2260895; Hagiwara Y, 2010, ANN BOT-LONDON, V106, P173, DOI 10.1093/aob/mcq096; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Huang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024733; Huang W, 2012, OECOLOGIA, V170, P373, DOI 10.1007/s00442-012-2328-6; Hussner A, 2005, LIMNOLOGICA, V35, P18, DOI 10.1016/j.limno.2005.01.001; IPCC, 2013, INT PAN CLIM CHANG; Lacoul P, 2006, ENVIRON REV, V14, P89, DOI 10.1139/a06-001; Leger EA, 2003, ECOL LETT, V6, P257, DOI 10.1046/j.1461-0248.2003.00423.x; Li B, 1999, ECOL RES, V14, P255, DOI 10.1046/j.1440-1703.1999.143298.x; Lucassen ECHET, 2009, FRESHWATER BIOL, V54, P2300, DOI 10.1111/j.1365-2427.2009.02264.x; MADSEN JD, 1991, FRESHWATER BIOL, V26, P233, DOI 10.1111/j.1365-2427.1991.tb01732.x; Madsen TV, 1997, OECOLOGIA, V110, P320, DOI 10.1007/s004420050165; Mony C, 2007, AQUAT BOT, V86, P236, DOI 10.1016/j.aquabot.2006.11.007; NICHOLS SA, 1986, HYDROBIOLOGIA, V131, P3, DOI 10.1007/BF00008319; Niu SL, 2008, J PLANT ECOL-UK, V1, P103, DOI 10.1093/jpe/rtn003; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Santos MJ, 2011, BIOL INVASIONS, V13, P443, DOI 10.1007/s10530-010-9840-6; Savicka M., 2010, EKOLOGIJA, V56, P26, DOI [10.2478/v10055-010-0004-x, DOI 10.2478/V10055-010-0004-X]; Spencer DF, 2000, AQUAT BOT, V67, P237, DOI 10.1016/S0304-3770(00)00091-7; Stiers I, 2011, BIOL INVASIONS, V13, P2715, DOI 10.1007/s10530-011-9942-9; Teller BJ, 2016, DIVERS DISTRIB, V22, P708, DOI 10.1111/ddi.12436; Thiebaut G, 2016, AQUAT ECOL, V50, P175, DOI 10.1007/s10452-016-9566-3; Thiebaut G, 2007, BIOL INVASIONS, V9, P1, DOI 10.1007/s10530-006-9000-1; Totland O, 1999, OECOLOGIA, V120, P242, DOI 10.1007/s004420050854; Verlinden M, 2014, WEED RES, V54, P234, DOI 10.1111/wre.12076; Verlinden M, 2013, PLANT ECOL, V214, P243, DOI 10.1007/s11258-012-0163-9; Warren RJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182502; Weigelt A, 2003, J ECOL, V91, P707, DOI 10.1046/j.1365-2745.2003.00805.x; WOODWARD FI, 1987, VEGETATIO, V69, P189, DOI 10.1007/BF00038700; Wu H, 2017, SCI TOTAL ENVIRON, V575, P1415, DOI 10.1016/j.scitotenv.2016.09.226; Xu BC, 2011, PLANT SCI, V181, P644, DOI 10.1016/j.plantsci.2011.03.005; Yarrow M, 2009, REV CHIL HIST NAT, V82, P299, DOI 10.4067/S0716-078X2009000200010	51	12	12	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199478	10.1371/journal.pone.0199478	http://dx.doi.org/10.1371/journal.pone.0199478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924874	Green Published, Green Submitted, gold			2022-12-26	WOS:000435655600071
J	Morrison, M; Parton, K; Hine, DW				Morrison, Mark; Parton, Kevin; Hine, Donald W.			Increasing belief but issue fatigue: Changes in Australian Household Climate Change Segments between 2011 and 2016	PLOS ONE			English	Article							CHANGE COMMUNICATION	Using national Australian samples collected in 2011 (n = 1927) and 2016 (n = 2503), we identified six Australian household segments which we labelled Alarmed, Concerned, Cautious, Disengaged, Doubtful and Dismissive. Between the two periods, we found the proportion of households in the Alarmed and Concerned segments was stable; however there was a decrease (28% to 20%) in the proportion of households in the Doubtful and Dismissive segments and an increase (27% to 33%) in the Cautious and Disengaged segments. We found that a greater proportion of households have personally experienced climate change, and were more likely to believe in human causation and believe that there is a scientific consensus about the issue. However, there was evidence of issue fatigue. Households were less likely to report that they had thought about climate change or talked about it with their friends in 2016 relative to 2011. They were also less likely to pursue certain climate friendly behaviours or reward or punish companies for their climate behaviours. These findings suggest a need to motivate households to maintain efforts to mitigate climate change, particularly the Cautious and Disengaged households that are more amenable to changing their views about this issue.	[Morrison, Mark; Parton, Kevin] Charles Stun Univ, Fac Business Justice & Behav Sci, Bathurst, NSW, Australia; [Hine, Donald W.] Univ New England, Sch Behav Cognit & Social Sci, Armidale, NSW, Australia	Charles Sturt University; University of New England	Morrison, M (corresponding author), Charles Stun Univ, Fac Business Justice & Behav Sci, Bathurst, NSW, Australia.	mmorrison@csu.edu.au	Parton, Kevin/Q-7695-2019	Parton, Kevin/0000-0003-3378-799X; Morrison, Mark/0000-0002-8761-0682	Faculty of Business, Charles Sturt University	Faculty of Business, Charles Sturt University	This work was supported by the Faculty of Business, Charles Sturt University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian PV Institute, 2017, AUSTR PV MARK APR 20; Bain PG, 2012, NAT CLIM CHANGE, V2, P600, DOI 10.1038/NCLIMATE1532; Barr S, 2011, APPL GEOGR, V31, P712, DOI 10.1016/j.apgeog.2010.12.003; Deng G., 2016, ASSESSING IMPACT SOL; Flora JA, 2014, CLIMATIC CHANGE, V127, P419, DOI 10.1007/s10584-014-1274-1; Hine DW, 2016, GLOBAL ENVIRON CHANG, V36, P1, DOI 10.1016/j.gloenvcha.2015.11.002; Hine DW, 2014, WIRES CLIM CHANGE, V5, P441, DOI 10.1002/wcc.279; Hine DW, 2013, J ENVIRON PSYCHOL, V36, P229, DOI 10.1016/j.jenvp.2013.08.006; HINE DW, 2017, OXFORD ENCY CLIMATE; Horton K, 2011, CLIMATE CHANGE SUSTA; Kahan DM, 2017, NAT CLIM CHANGE, V7, P309, DOI 10.1038/nclimate3283; Krosnick Jon A., 2000, PUBLIC UNDERST SCI, V9, P239, DOI DOI 10.1088/0963-6625/9/3/303; Leiserowitz A., 2009, GLOBAL WARMINGS 6 AM; Leiserowitz A., 2013, GLOBAL WARMINGS 6 IN; Leiserowitz A., 2011, GLOBAL WARMINGS 6 AM; Leiserowitz A., 2013, CLIMATE CHANGE AM MI; Leiserowitz A., 2015, CLIMATE CHANGE AM CH; Leiserowitz A, 2012, GLOBAL WARMINGS 6 AM; Leiserowitz A, 2014, CLIMATE CHANGE AM MI; Leiserowitz A., 2013, GLOBAL WARMINGS 6 AM; Leiserowitz A., 2010, GLOBAL WARMINGS 6 AM; Levine AS, 2017, CLIMATIC CHANGE, V142, P301, DOI 10.1007/s10584-017-1952-x; Leviston Z., 2011, BASELINE SURVEY AUST; Leviston Z., 2015, AUSTRALIANS ATTITUDE, DOI [10.4225/08/584AF21158FE9., DOI 10.4225/08/584AF21158FE9, 10.4225/08/584af21158fe9]; Maibach EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017571; Malka A, 2009, RISK ANAL, V29, P633, DOI 10.1111/j.1539-6924.2009.01220.x; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; Metag J, 2017, PUBLIC UNDERST SCI, V26, P434, DOI 10.1177/0963662515592558; Morrison M, 2013, AUSTRALAS J ENV MAN, V20, P87, DOI 10.1080/14486563.2012.762946; Morrison M, 2017, AUSTRALAS J ENV MAN, V24, P133, DOI 10.1080/14486563.2017.1300953; Morrison M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134868; Roser-Renouf C, 2014, ENGAGING DIVERSE AUD; Roser-Renouf C., 2014, GLOBAL WARMINGS 6 AM; Roser-Renouf C., 2016, GLOBAL WARMINGS 6 AM; Sherley C, 2014, J NONPROFIT PUBLIC S, V26, P258, DOI 10.1080/10495142.2014.918792; van der Linden S, 2017, GLOB CHALL, V1, DOI 10.1002/gch2.201600008; Vermunt J.K., 2005, LATENT GOLD 40 USERS	37	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0197988	10.1371/journal.pone.0197988	http://dx.doi.org/10.1371/journal.pone.0197988			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ6XV	29912888	Green Published, gold			2022-12-26	WOS:000435528600015
J	Okuhara, Y; Asakura, M; Azuma, K; Orihara, Y; Nishimura, K; Ando, T; Kondo, H; Naito, Y; Kashiwase, K; Hirotani, S; Ishihara, M; Masuyama, T				Okuhara, Yoshitaka; Asakura, Masanori; Azuma, Kohei; Orihara, Yoshiyuki; Nishimura, Koichi; Ando, Tomotaka; Kondo, Hideyuki; Naito, Yoshiro; Kashiwase, Kazunori; Hirotani, Shinichi; Ishihara, Masaharu; Masuyama, Tohru			Effects of early diuretic response to carperitide in acute decompensated heart failure treatment: A single-center retrospective study	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; PREDICTORS; CONGESTION; NESIRITIDE; INFUSION	Background Diuretic response is a strong predictor of outcome for admitted patients of acute decompensated heart failure (ADHF). However, little is known about the effects of early diuretic response to carperitide. Methods We retrospectively analyzed records of 85 patients hospitalized for ADHF who received carperitide as initial treatment and <40 mg furosemide during the early period. The eligible patients were divided into good diuretic responder (GR) group and poor diuretic responder (PR) group on the basis of median urinary volume. Results The PR group demonstrated older age, lower body mass index (BMI), lower estimated glomerular filtration rate, and higher blood urea nitrogen (BUN) level, left ventricular ejection fraction, and 6-blockers prescribed at baseline than the GR group. The incidence of worsening renal function (WRF) was significantly higher in the PR group than in the GR group. There was no correlation between early intravenous furosemide dose and urinary volume (Spearman correlation, rho = 0.111, p = 0.312). Multivariate analysis showed that the statistically significant independent factors associated with poor diuretic response to carperitide were BMI (Odds ratio (OR) = 0.82, 95% confidence interval (CI) 0.68-0.94, p = 0.004) and BUN (OR = 1.07, 95%CI 1.01-1.15, p = 0.018). Kaplan-Meier analysis indicated a lower event-free rate in the PR group than in the GR group (log-rank, p = 0.007). Conclusions BMI and BUN levels on admission were significant determinants of early poor diuretic response to carperitide. Early poor diuretic response to carperitide was associated with future poor outcomes.	[Okuhara, Yoshitaka; Asakura, Masanori; Azuma, Kohei; Orihara, Yoshiyuki; Nishimura, Koichi; Ando, Tomotaka; Kondo, Hideyuki; Naito, Yoshiro; Kashiwase, Kazunori; Hirotani, Shinichi; Ishihara, Masaharu; Masuyama, Tohru] Hyogo Coll Med, Cardiovasc Div, Dept Internal Med, Nishinomiya, Hyogo, Japan	Hyogo College of Medicine	Okuhara, Y (corresponding author), Hyogo Coll Med, Cardiovasc Div, Dept Internal Med, Nishinomiya, Hyogo, Japan.	okuhara@hyo-med.ac.jp		Kondo, Hideyuki/0000-0003-2307-7177				Aronson D, 2013, EUR J HEART FAIL, V15, P637, DOI 10.1093/eurjhf/hft036; Gottlieb SS, 2013, J AM COLL CARDIOL, V62, P1177, DOI 10.1016/j.jacc.2013.04.073; Hanberg JS, 2017, INT J CARDIOL, V241, P277, DOI 10.1016/j.ijcard.2017.03.114; Hata N, 2008, CIRC J, V72, P1787, DOI 10.1253/circj.CJ-08-0130; Ishikawa C, 2005, J CARDIOVASC PHARM, V46, P513, DOI 10.1097/01.fjc.0000177980.83810.2e; Izumi T, 2013, CIRC J, V77, P2157, DOI 10.1253/circj.CJ-66-0068; Kitashiro S, 1999, J CARDIOVASC PHARM, V33, P948, DOI 10.1097/00005344-199906000-00016; Lazaros G, 2012, INT J CARDIOL, V155, P97, DOI 10.1016/j.ijcard.2010.10.024; Matsue Y, 2015, J CARD FAIL, V21, P859, DOI 10.1016/j.cardfail.2015.05.007; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mizuno A, 2017, INT J CARDIOL, V241, P243, DOI 10.1016/j.ijcard.2017.04.078; Nakano Y, 2018, INT HEART J, V59, P105, DOI 10.1536/ihj.16-625; O'Connor CM, 2011, NEW ENGL J MED, V365, P32, DOI 10.1056/NEJMoa1100171; Ogiso M, 2017, HEART VESSELS, V32, P916, DOI 10.1007/s00380-017-0952-0; Okuhara Y, 2017, HEART VESSELS, V32, P419, DOI 10.1007/s00380-016-0883-1; Palazzuoli A, 2016, INT J CARDIOL, V224, P213, DOI 10.1016/j.ijcard.2016.09.005; Rubio-Gracia J, 2018, INT J CARDIOL, V258, P185, DOI 10.1016/j.ijcard.2018.01.067; Sato N, 2010, AM HEART J, V159, P949, DOI 10.1016/j.ahj.2010.03.019; Schmieder RE, 2015, CLIN RES CARDIOL, V104, P621, DOI 10.1007/s00392-015-0839-y; Schreiner GF, 2002, CURR OPIN PHARMACOL, V2, P142, DOI 10.1016/S1471-4892(02)00142-X; ter Maaten JM, 2016, CLIN RES CARDIOL, V105, P145, DOI 10.1007/s00392-015-0896-2; ter Maaten JM, 2015, AM HEART J, V170, P313, DOI 10.1016/j.ahj.2015.05.003; ter Maaten JM, 2015, NAT REV CARDIOL, V12, P184, DOI 10.1038/nrcardio.2014.215; Testani JM, 2014, CIRC-HEART FAIL, V7, P261, DOI 10.1161/CIRCHEARTFAILURE.113.000895; Wang GG, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002947	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199263	10.1371/journal.pone.0199263	http://dx.doi.org/10.1371/journal.pone.0199263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912952	Green Submitted, Green Published, gold			2022-12-26	WOS:000435528600098
J	Paes, W; Dowle, A; Coldwell, J; Leech, A; Ganderton, T; Brzozowski, A				Paes, Wayne; Dowle, Adam; Coldwell, Jamie; Leech, Andrew; Ganderton, Tim; Brzozowski, Andrzej			The Chlamydia trachomatis PmpD adhesin forms higher order structures through disulphide-mediated covalent interactions	PLOS ONE			English	Article							POLYMORPHIC-MEMBRANE-PROTEIN; LIFE-CYCLE; AUTOTRANSPORTER; INFECTION; FAMILY; EXPRESSION; VIRULENCE; ISOMERASE; STRAINS; VACCINE	Chlamydia trachomatis (Ct) is the most common sexually transmitted bacterial pathogen, and the leading cause of infectious blindness worldwide. We have recently shown that immunization with the highly conserved antigenic passenger domain of recombinant Ct polymorphic membrane protein D (rPmpD) is protective in the mouse model of Ct genital tract infection, and previously, that ocular anti-rPmpD antibodies are elicited following vaccination. However, the mechanisms governing the assembly and structure-function relationship of PmpD are unknown. Here, we provide a biophysical analysis of this immunogenic 65 kDa passenger domain fragment of PmpD. Using differential cysteine labeling coupled with LC-MS/MS analysis, we show that widespread intra- and intermolecular disulphide interactions play important roles in the preservation of native monomeric secondary structure and the formation of higher-order oligomers. While it has been proposed that FxxN and GGA(I, L,V) repeat motifs in the Pmp21 ortholog in Chlamydia pneumoniae mediate self-interaction, no such role has previously been identified for cysteine residues in chlamydial Pmps. Further characterisation reveals that oligomeric proteoforms and rPmpD monomers adopt 13 sheet folds, consistent with previously described Gram-negative bacterial type V secretion systems (T5SSs). We also highlight adhesin-like properties of rPmpD, showing that both soluble rPmpD and anti-rPmpD serum from immunized mice abrogate binding of rPmpD-coated beads to mammalian cells in a dose-dependent fashion. Hence, our study provides further evidence that chlamydial Pmps may function as adhesins, while elucidating yet another important mechanism of self-association of bacterial T5SS virulence factors that may be unique to the Chlamydiaceae.	[Paes, Wayne; Coldwell, Jamie; Ganderton, Tim; Brzozowski, Andrzej] Univ York, York Struct Biol Lab, York, N Yorkshire, England; [Paes, Wayne] Univ York, Ctr Immunol & Infect, York, N Yorkshire, England; [Dowle, Adam; Leech, Andrew] Univ York, Technol Facil, York, N Yorkshire, England	University of York - UK; University of York - UK; University of York - UK	Paes, W (corresponding author), Univ York, York Struct Biol Lab, York, N Yorkshire, England.; Paes, W (corresponding author), Univ York, Ctr Immunol & Infect, York, N Yorkshire, England.	wayne.paes@ndm.ox.ac.uk	Dowle, Adam/AAW-6410-2021	Dowle, Adam/0000-0002-6501-5444; Ganderton, Timothy Richard/0000-0002-3949-4795; Paes, Wayne/0000-0002-0529-2765	Wellcome Trust [097325/Z/11/Z]; Yorkshire Forward; Northern Way Initiative; EPSRC [EP/K039660/1, EP/M028127/1]	Wellcome Trust(Wellcome TrustEuropean Commission); Yorkshire Forward; Northern Way Initiative; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was supported by a Wellcome Trust (https://wellcome.ac.uk) PhD studentship to WP (Grant 097325/Z/11/Z). The York Centre of Excellence in Mass Spectrometry was created thanks to a major capital investment through Science City York, supported by Yorkshire Forward with funds from the Northern Way Initiative, and subsequent support from EPSRC (https://www.epsrc.ac.uk) Grants EP/K039660/1 and EP/M028127/1.	Badamchi-Zadeh A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141209; Becker E, 2014, MICROBIOLOGYOPEN, V3, P544, DOI 10.1002/mbo3.186; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; Cherry JD, 1998, VACCINE, V16, P1901, DOI 10.1016/S0264-410X(98)00226-6; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; Davis CH, 2002, INFECT IMMUN, V70, P3413, DOI 10.1128/IAI.70.7.3413-3418.2002; Fan EG, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0009-2015; Grimwood J, 1999, Microb Comp Genomics, V4, P187, DOI 10.1089/omi.1.1999.4.187; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; HATCH TP, 1984, J BACTERIOL, V157, P13, DOI 10.1128/JB.157.1.13-20.1984; Jain S, 2007, J VIROL, V81, P2328, DOI 10.1128/JVI.01940-06; Kari L, 2014, INFECT IMMUN, V82, P2756, DOI 10.1128/IAI.01686-14; Kiselev AO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005191; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Luczak SET, 2016, J BIOL CHEM, V291, P22806, DOI 10.1074/jbc.M116.728915; Molleken K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003325; Molleken K, 2010, MOL MICROBIOL, V78, P1004, DOI 10.1111/j.1365-2958.2010.07386.x; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Nishimura K, 2010, J MOL MED, V88, P451, DOI 10.1007/s00109-010-0600-y; Nunes A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000878; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; Paes W, 2016, VACCINE, V34, P4123, DOI 10.1016/j.vaccine.2016.06.081; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; RYSER HJP, 1991, J BIOL CHEM, V266, P18439; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Sun G, 2007, J BACTERIOL, V189, P6222, DOI 10.1128/JB.00552-07; Swanson KA, 2009, INFECT IMMUN, V77, P508, DOI 10.1128/IAI.01173-08; Tan C, 2009, INFECT IMMUN, V77, P3218, DOI 10.1128/IAI.01566-08; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; Wells TJ, 2007, FEMS MICROBIOL LETT, V274, P163, DOI 10.1111/j.1574-6968.2007.00833.x; Wheelhouse NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049190; Yu H, 2014, VACCINE, V32, P4672, DOI 10.1016/j.vaccine.2014.06.002	35	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198662	10.1371/journal.pone.0198662	http://dx.doi.org/10.1371/journal.pone.0198662			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912892	Green Published, gold			2022-12-26	WOS:000435528600039
J	Mizobuchi, H; Fujii, W; Isokawa, S; Ishizuka, K; Wang, YH; Watanabe, S; Sanjoba, C; Matsumoto, Y; Goto, Y				Mizobuchi, Haruka; Fujii, Wataru; Isokawa, Shoko; Ishizuka, Kanna; Wang, Yihan; Watanabe, Sayoko; Sanjoba, Chizu; Matsumoto, Yoshitsugu; Goto, Yasuyuki			Exacerbation of hepatic injury during rodent malaria by myeloid-related protein 14	PLOS ONE			English	Article							PLASMODIUM-BERGHEI INFECTION; TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE; NEUTROPHIL RECRUITMENT; GAMMA-INTERFERON; DISEASE-ACTIVITY; LIVER-INJURY; IN-VIVO; S100A9; MRP14	Hepatic dysfunction is one of the clinical features in severe malaria. However, the mechanism of hepatic injury during malaria is still unknown. Myeloid-related protein (MRP) 14 is abundantly expressed by myeloid cells and involved in various inflammatory diseases. We previously reported that serum MRP14 is elevated in mice infected with Plasmodium berghei ANKA. In order to verify whether extracellular MRP14 is involved in the pathology of hepatic injury during rodent malaria, we intravenously administrated recombinant MRP14 (rMRP14) to mice infected with P. berghei ANKA. The administration of rMRP14 did not affect parasite number or hematocrit. On the other hand, the hepatic injury was exacerbated in rMRP14-treated mice, and their serum concentration of hepatic enzymes increased significantly more than PBS-treated controls. Immunohistochemical analysis of the liver showed that more MRP14(+) macrophages accumulated in rMRP14-treated mice than PBStreated controls after infection. The administration of rMRP14 also promotes the up-regulation of pro-inflammatory molecules in the liver, such as iNOS, IL-1 beta, IL-12, and TNF-alpha. Even in the absence of Plasmodium infection, administration of rMRP14 could induce the accumulation of MRP14(+) macrophages and up-regulation of the pro-inflammatory molecules in the liver of naive mice. The results indicate that MRP14 promotes the accumulation of MRP14(+) cells and the up-regulation of pro-inflammatory molecules and NO, which amplify inflammatory cascade leading to hepatic injury. In conclusion, MRP14 is a one of key molecules for liver inflammation during rodent malaria.	[Mizobuchi, Haruka; Isokawa, Shoko; Ishizuka, Kanna; Wang, Yihan; Watanabe, Sayoko; Sanjoba, Chizu; Matsumoto, Yoshitsugu; Goto, Yasuyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Mol Immunol, Bunkyo Ku, Tokyo, Japan; [Fujii, Wataru] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Appl Genet, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo	Goto, Y (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Mol Immunol, Bunkyo Ku, Tokyo, Japan.	aygoto@mail.u-tokyo.ac.jp	Goto, Yasuyuki/E-9028-2011	Goto, Yasuyuki/0000-0002-8654-7888; Fujii, Wataru/0000-0002-6438-7350; Mizobuchi, Haruka/0000-0002-6667-4820	KAKENHI from the Japan Society for the Promotion of Science [15J08617, 26660247, 16K15051, 26712025]	KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI Grant (grant No. 15J08617 to HM, No. 26660247 and No. 16K15051 to YG, No. 26712025 to WF) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/index.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2001, J IMMUNOL, V167, P5928, DOI 10.4049/jimmunol.167.10.5928; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Altwegg LA, 2007, EUR HEART J, V28, P941, DOI 10.1093/eurheartj/ehm078; ANAND A C, 1992, National Medical Journal of India, V5, P59; Anand AC, 2005, J GASTROEN HEPATOL, V20, P1322, DOI 10.1111/j.1440-1746.2005.03884.x; Anavi S, 2015, LAB INVEST, V95, P914, DOI 10.1038/labinvest.2015.67; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Basir R, 2012, IRAN J PARASITOL, V7, P62; Benoit S, 2006, BRIT J DERMATOL, V155, P62, DOI 10.1111/j.1365-2133.2006.07198.x; Bordmann G, 1997, CLIN DIAGN LAB IMMUN, V4, P435, DOI 10.1128/CDLI.4.4.435-439.1997; Chen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115828; CLARK IA, 1987, J IMMUNOL, V139, P3493; CLARK IA, 1991, PARASITOL TODAY, V7, P205, DOI 10.1016/0169-4758(91)90142-B; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Das S N, 2007, J Indian Med Assoc, V105, P247; De Jong HK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003663; De Nardo D, 2009, J IMMUNOL, V183, P8110, DOI 10.4049/jimmunol.0901031; De Ponti A, 2015, INT J CANCER, V136, P2458, DOI 10.1002/ijc.29282; Drummond GR, 2014, TRENDS ENDOCRIN MET, V25, P452, DOI 10.1016/j.tem.2014.06.012; EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; FINLEY RW, 1982, J IMMUNOL, V129, P2213; Frosch M, 2000, ARTHRITIS RHEUM-US, V43, P628, DOI 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X; Frosch M, 2003, ARTHRITIS RHEUM, V48, P2622, DOI 10.1002/art.11177; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; GOEBELER M, 1993, J LEUKOCYTE BIOL, V53, P11, DOI 10.1002/jlb.53.1.11; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Haque A, 2011, INFECT IMMUN, V79, P1882, DOI 10.1128/IAI.01210-10; Hon WM, 2002, ANN NY ACAD SCI, V962, P275, DOI 10.1111/j.1749-6632.2002.tb04074.x; Hunter MJ, 1998, J BIOL CHEM, V273, P12427, DOI 10.1074/jbc.273.20.12427; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kochar D K, 2003, J Assoc Physicians India, V51, P1069; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Laouedj M, 2017, BLOOD, V129, P1980, DOI 10.1182/blood-2016-09-738005; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; MACKEY LJ, 1980, CLIN EXP IMMUNOL, V42, P412; Malaria S, 2014, TROP MED INT HEALTH, V19, P7, DOI [10.1111/tmi.12313, 10.1111/tmi.12313_2]; MEDING SJ, 1990, INFECT IMMUN, V58, P3671, DOI 10.1128/IAI.58.11.3671-3678.1990; Mizobuchi H, 2018, IMMUNOL LETT, V194, P13, DOI 10.1016/j.imlet.2017.12.003; Mizobuchi H, 2014, EXP PARASITOL, V138, P1, DOI 10.1016/j.exppara.2014.01.003; Moles A, 2014, J HEPATOL, V60, P782, DOI 10.1016/j.jhep.2013.12.005; Mossanen JC, 2016, HEPATOLOGY, V64, P1667, DOI 10.1002/hep.28682; Prommano Oranan, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1359; Rammes A, 1997, J BIOL CHEM, V272, P9496; Raquil MA, 2008, J IMMUNOL, V180, P3366, DOI 10.4049/jimmunol.180.5.3366; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; ROCKETT KA, 1994, PARASITE IMMUNOL, V16, P243, DOI 10.1111/j.1365-3024.1994.tb00346.x; ROCKETT KA, 1992, INFECT IMMUN, V60, P3725, DOI 10.1128/IAI.60.9.3725-3730.1992; Rupani AB, 2009, ANN TROP MED PARASIT, V103, P119, DOI 10.1179/136485909X385054; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Ryckman C, 2003, ARTHRITIS RHEUM-US, V48, P2310, DOI 10.1002/art.11079; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Schnekenburger J, 2008, J CELL PHYSIOL, V216, P558, DOI 10.1002/jcp.21433; STEVENSON MM, 1990, INFECT IMMUN, V58, P3225, DOI 10.1128/IAI.58.10.3225-3232.1990; van Lent PLEM, 2008, ANN RHEUM DIS, V67, P1750, DOI 10.1136/ard.2007.077800; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Venkatraman A, 2004, HEPATOLOGY, V40, P565, DOI 10.1002/hep.20326; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Vogl T, 2012, INT J MOL SCI, V13, P2893, DOI 10.3390/ijms13032893; WAKI S, 1992, IMMUNOLOGY, V75, P646; Yoshimoto T, 1998, J IMMUNOL, V160, P5500	65	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199111	10.1371/journal.pone.0199111	http://dx.doi.org/10.1371/journal.pone.0199111			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902248	Green Published, gold, Green Submitted			2022-12-26	WOS:000435424900090
J	Tang, P; Wu, J; Liu, H; Liu, YC; Zhou, XD				Tang, Peng; Wu, Jie; Liu, Hou; Liu, Youcai; Zhou, Xingding			Assimilable organic carbon (AOC) determination using GFP-tagged Pseudomonas fluorescens P-17 in water by flow cytometry	PLOS ONE			English	Article							BIOLOGICAL STABILITY; DISTRIBUTION-SYSTEMS; BACTERIAL-GROWTH; RECLAIMED WATER; DERIVATIVES	One of the newly developed methods for Assimilable organic carbon (AOC) determination is leveraged on the cell enumeration by flow cytometry (FC) which could provide a rapid and automated solution for AOC measurement. However, cell samples staining with fluorescence dye is indispensable to reduce background and machine noise. This step would bring additional cost and time consuming for this method. In this study, a green fluorescence protein (GFP) tagged strain derived of AOC testing strain Pseudomonas fluorescens P-17 (GFP-P17) was generated using Tn5 transposon mutagenesis. Continuous culture of this mutant GFP-P17 showed stable expression of eGFP signal detected by flow cytometry without staining step. In addition, this GFP-P17 strain displayed faster growth rate and had a wider range of carbon substrate utilization patterns as compared with P17 wild-type. With this strain, the capability of a new FC method with no dye staining was explored in standard acetate solution, which suggests linear correlation of counts with acetate carbon concentration. Furthermore, this FC method with GFP-P17 strain is applicable in monitoring GAC/BAC efficiency and condition as similar trends of AOC level in water treatment process were measured by both FC method and conventional spread plating count method. Therefore, this fast and easily applicable GFP-P17 based FC method could serve as a tool for routine microbiological drinking water monitoring.	[Tang, Peng; Zhou, Xingding] Ngee Ann Polytech, Sch Life Sci & Chem Technol, Singapore 599489, Singapore; [Wu, Jie; Liu, Hou; Liu, Youcai] Cent South Univ, Coll Chem & Chem Engn, Changsha 410083, Hunan, Peoples R China	Central South University	Zhou, XD (corresponding author), Ngee Ann Polytech, Sch Life Sci & Chem Technol, Singapore 599489, Singapore.	ZHOU_Xingding@np.edu.sg		Zhou, Xingding/0000-0002-0062-8207	R&D grant from Public Utilities Board, Singapore;  [RND-WAQU-1509-0006]	R&D grant from Public Utilities Board, Singapore; 	This work was supported by R&D grant from Public Utilities Board, Singapore. The project reference no. is RND-WAQU-1509-0006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by R&D grant from Public Utilities Board, Singapore. The project reference no. is RND-WAQU-1509-0006.	Aggarwal S, 2015, BIODEGRADATION, V26, P387, DOI 10.1007/s10532-015-9741-6; BOCHNER BR, 1989, NATURE, V339, P157, DOI 10.1038/339157a0; Chen M, 2015, SCI REP-UK, V5, DOI [10.1038/srep15043, 10.1038/srep10701]; Chen M, 2015, BIOTECHNOL ADV, V33, P745, DOI 10.1016/j.biotechadv.2015.05.003; Chen Z, 2018, BIORESOURCE TECHNOL, V254, P290, DOI 10.1016/j.biortech.2018.01.111; Cheng L, 2014, BIOTECHNOL BIOENG, V111, P2412, DOI 10.1002/bit.25315; Chien CC, 2009, ENVIRON MONIT ASSESS, V153, P127, DOI 10.1007/s10661-008-0343-1; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Elhadidy AM, 2016, J MICROBIOL METH, V130, P154, DOI 10.1016/j.mimet.2016.09.009; Escobar IC, 2001, ENVIRON SCI TECHNOL, V35, P3442, DOI 10.1021/es0106669; Escobar IC, 2001, WATER RES, V35, P4444, DOI 10.1016/S0043-1354(01)00173-7; Haddix PL, 2004, APPL ENVIRON MICROB, V70, P850, DOI 10.1128/AEM.70.2.850-854.2004; Hammes FA, 2005, ENVIRON SCI TECHNOL, V39, P3289, DOI 10.1021/es048277c; Hem LJ, 2001, WATER RES, V35, P1106, DOI 10.1016/S0043-1354(00)00354-7; Jeong S, 2013, DESALINATION, V317, P160, DOI 10.1016/j.desal.2013.03.005; KAPLAN LA, 1993, APPL ENVIRON MICROB, V59, P1532, DOI 10.1128/AEM.59.5.1532-1539.1993; LECHEVALLIER MW, 1993, APPL ENVIRON MICROB, V59, P1526, DOI 10.1128/AEM.59.5.1526-1531.1993; Li GQ, 2017, WATER RES, V123, P345, DOI 10.1016/j.watres.2017.06.082; Liu XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128825; Ma JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028519; Rice EW, 2012, STANDARD METHODS EXA; Ross PS, 2013, WATER SCI TECH-W SUP, V13, P1024, DOI 10.2166/ws.2013.079; Thayanukul P, 2013, WATER RES, V47, P225, DOI 10.1016/j.watres.2012.09.051; Van der Kooij D., 2002, ENCY ENV MICROBIOLOG, P312; Van Nevel S, 2017, WATER RES, V113, P191, DOI 10.1016/j.watres.2017.01.065; Van Nevel S, 2017, WATER RES, V111, P66, DOI 10.1016/j.watres.2016.12.040; VANDERKOOIJ D, 1982, J AM WATER WORKS ASS, V74, P540; Wang QH, 2014, DESALIN WATER TREAT, V52, P2734, DOI 10.1080/19443994.2013.830683; Weinrich L, 2016, WATER RES, V101, P203, DOI 10.1016/j.watres.2016.05.075; Weinrich LA, 2011, APPL ENVIRON MICROB, V77, P1148, DOI 10.1128/AEM.01829-10; Weinrich LA, 2009, APPL ENVIRON MICROB, V75, P7385, DOI 10.1128/AEM.01728-09	31	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199193	10.1371/journal.pone.0199193	http://dx.doi.org/10.1371/journal.pone.0199193			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902279	Green Published, Green Submitted, gold			2022-12-26	WOS:000435424900097
J	Phoomak, C; Silsirivanit, A; Park, D; Sawanyawisuth, K; Vaeteewoottacharn, K; Wongkham, C; Lam, EWF; Pairojkul, C; Lebrilla, CB; Wongkham, S				Phoomak, Chatchai; Silsirivanit, Atit; Park, Dayoung; Sawanyawisuth, Kanlayanee; Vaeteewoottacharn, Kulthida; Wongkham, Chaisiri; Lam, Eric W. -F.; Pairojkul, Chawalit; Lebrilla, Carlito B.; Wongkham, Sopit			O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1	ONCOGENE			English	Article							ABERRANT GLYCOSYLATION; N-ACETYLGLUCOSAMINE; CANCER; CELLS; TRANSCRIPTION; EXPRESSION; OLIGOSACCHARIDES; AGGRESSIVENESS; RELEVANCE; INVASION	The leading cause of death in cancer patients is metastasis, for which an effective treatment is still necessary. During metastasis, cancer cells aberrantly express several glycans that are correlated with poor patient outcome. This study was aimed toward exploring the effects of O-GlcNAcylation on membranous N-glycans that are associated with the progression of cholangiocarcinoma (CCA). Global O-GlcNAcylation in CCA cells was depleted using specific siRNA against O-GlcNAc transferase (OGT), which transfers GlcNAc to the acceptor proteins. Using an HPLC-Chip/Time-of-Flight (Chip/ TOF) MS system, the N-glycans associated with O-GlcNAcylation were identified by comparing the membranous N-glycans of siOGT-treated cells with those of scramble siRNA-treated cells. In parallel, the membranous N-glycans of the parental cells (KKU-213 and KKU-214) were compared with those of the highly metastatic cells (KKU-213L5 and KKU-214L5). Together, these data revealed that high mannose (Hex(9)HexNAc(2)) and biantennary complex (Hex(5)HexNAc(4)Fuc(1)NeuAc(1)) N-linked glycans correlated positively with metastasis. We subsequently demonstrate that suppression of O-GlcNAcylation decreased the expression of these two N-glycans, suggesting that O-GlcNAcylation mediates their levels in CCA. In addition, the ability of highly metastatic cells to migrate and invade was reduced by the presence of Pisum Sativum Agglutinin (PSA), a mannose-specific lectin, further indicating the association of high mannose type N-glycans with CCA metastasis. The molecular mechanism of O-GlcNAc-mediated progression of CCA was shown to proceed via a series of signaling events, involving the activation of Akt/Erk (i), an increase in FOXO3 phosphorylation (ii), which results in the reduction of MAN1A1 expression (iii) and thus the accumulation of Hex(9)HexNAc(2) N-glycans (iv). This study demonstrates for the first time the association between O-GlcNAcylation, high mannose type N-glycans, and the progression of CCA metastasis, suggesting a novel therapeutic target for treatment of metastatic CCA.	[Phoomak, Chatchai; Silsirivanit, Atit; Sawanyawisuth, Kanlayanee; Vaeteewoottacharn, Kulthida; Wongkham, Chaisiri; Wongkham, Sopit] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen 40002, Thailand; [Phoomak, Chatchai; Silsirivanit, Atit; Sawanyawisuth, Kanlayanee; Vaeteewoottacharn, Kulthida; Wongkham, Chaisiri; Pairojkul, Chawalit; Wongkham, Sopit] Khon Kaen Univ, Cholangiocarcinoma Res Inst, Khon Kaen 40002, Thailand; [Park, Dayoung; Lebrilla, Carlito B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Park, Dayoung] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02115 USA; [Lam, Eric W. -F.] Imperial Coll London, Imperial Ctr Translat & Expt Med, Dept Surg & Canc, London W12 0NN, England; [Pairojkul, Chawalit] Khon Kaen Univ, Fac Med, Dept Pathol, Khon Kaen 40002, Thailand	Khon Kaen University; Khon Kaen University; University of California System; University of California Davis; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Imperial College London; Khon Kaen University	Wongkham, S (corresponding author), Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen 40002, Thailand.; Wongkham, S (corresponding author), Khon Kaen Univ, Cholangiocarcinoma Res Inst, Khon Kaen 40002, Thailand.; Lebrilla, CB (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	cblebrilla@ucdavis.edu; sopit@kku.ac.th	Park, Diane Dayoung/N-5390-2019; Sawanyawisuth, Kanlayanee/AAU-8424-2020; Silsirivanit, Atit/AAN-1728-2020; Park, Dayoung/V-7537-2017; Lebrilla, Carlito Bangeles/ABE-6369-2020; Vaeteewoottacharn, Kulthida/GSE-1017-2022; Wongkham, Sopit/ABB-6966-2021; Lam, Eric W-F/AAW-8566-2020	Park, Diane Dayoung/0000-0003-4983-4340; Sawanyawisuth, Kanlayanee/0000-0003-2260-6372; Park, Dayoung/0000-0003-4983-4340; Vaeteewoottacharn, Kulthida/0000-0001-6557-9680; Lam, Eric W-F/0000-0003-1274-3576; Lebrilla, Carlito/0000-0001-7190-5323; Silsirivanit, Atit/0000-0002-5777-3843; Phoomak, Chatchai/0000-0002-3808-8816	Thailand Research Fund; Medical Research Council-UK [DBG5980004]; National Research University; Khon Kaen University [NRU592010]; Research Affairs and Graduate School, Khon Kaen University, Thailand [59151]; National Institutes of Health (USA) [R01GM049077]; MRC [MR/N012097/1]; CRUK [A12011]; Breast Cancer Now [2012MayPR070, 2012NovPhD016]; Cancer Research UK Imperial Centre; Imperial ECMC; NIHR Imperial BRC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049077] Funding Source: NIH RePORTER	Thailand Research Fund(Thailand Research Fund (TRF)); Medical Research Council-UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research University; Khon Kaen University; Research Affairs and Graduate School, Khon Kaen University, Thailand; National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); Breast Cancer Now; Cancer Research UK Imperial Centre; Imperial ECMC; NIHR Imperial BRC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was co-supported by the Thailand Research Fund and Medical Research Council-UK (Newton Fund) project no. DBG5980004, and National Research University grant, Khon Kaen University (NRU592010), a scholarship under the Post-Doctoral Training Program from Research Affairs and Graduate School, Khon Kaen University, Thailand (59151) and National Institutes of Health (USA) R01GM049077. EW-FL work is supported by MRC (MR/N012097/1), CRUK (A12011), Breast Cancer Now (2012MayPR070; 2012NovPhD016), the Cancer Research UK Imperial Centre, Imperial ECMC and NIHR Imperial BRC.	Anderson CD, 2004, ONCOLOGIST, V9, P43, DOI 10.1634/theoncologist.9-1-43; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Chen S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.380; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; de Brachene AC, 2016, CELL MOL LIFE SCI, V73, P1159, DOI 10.1007/s00018-015-2112-y; de Leoz MLA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002717; de Queirozl RM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00132; Ghazarian H, 2011, ACTA HISTOCHEM, V113, P236, DOI 10.1016/j.acthis.2010.02.004; Handerson T, 2005, CLIN CANCER RES, V11, P2969, DOI 10.1158/1078-0432.CCR-04-2211; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Heath JM, 2014, CIRC RES, V114, P1094, DOI 10.1161/CIRCRESAHA.114.302968; Higashi M, 1999, HEPATOLOGY, V30, P1347, DOI 10.1002/hep.510300609; Indramanee S, 2012, ASIAN PAC J CANCER P, V13, P119, DOI 10.7314/APJCP.2012.13.KKSuppl.119; KAKU H, 1991, CARBOHYD RES, V213, P109, DOI 10.1016/S0008-6215(00)90602-5; Kannagi R, 2008, BBA-GEN SUBJECTS, V1780, P525, DOI 10.1016/j.bbagen.2007.10.007; Kronewitter SR, 2009, PROTEOMICS, V9, P2986, DOI 10.1002/pmic.200800760; Li X, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00033; Lin CY, 2011, CLIN CANCER RES, V17, P3089, DOI 10.1158/1078-0432.CCR-10-3068; Litynska A, 2006, BIOCHIMIE, V88, P527, DOI 10.1016/j.biochi.2005.10.012; Liu TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107941; Liu YB, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0522-0; Lucena MC, 2016, J BIOL CHEM, V291, P12917, DOI 10.1074/jbc.M116.729236; Matsuda A, 2015, ANAL CHEM, V87, P7274, DOI 10.1021/acs.analchem.5b01329; Milde-Langosch K, 2014, BREAST CANCER RES TR, V145, P295, DOI 10.1007/s10549-014-2949-z; Morishima S, 2003, J ENDOCRINOL, V176, P285, DOI 10.1677/joe.0.1760285; Park D, 2016, MOL CELL PROTEOMICS, V15, P3653, DOI 10.1074/mcp.M116.063206; Park HM, 2015, CARBOHYD RES, V413, P5, DOI 10.1016/j.carres.2015.04.019; Patel T, 2006, NAT CLIN PRACT GASTR, V3, P33, DOI 10.1038/ncpgasthep0389; Phoomak C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43842; Phoomak C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27853; Phoomak C, 2012, ASIAN PAC J CANCER P, V13, P101, DOI 10.7314/APJCP.2012.13.KKSuppl.101; Pilobello KT, 2007, P NATL ACAD SCI USA, V104, P11534, DOI 10.1073/pnas.0704954104; Powers TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106255; Saentaweesuk W, 2018, ONCOL RES, V26, P605, DOI 10.3727/096504017X15009778205068; Silsirivanit A, 2011, CANCER-AM CANCER SOC, V117, P3393, DOI 10.1002/cncr.25912; Sripa B, 2008, CURR OPIN GASTROEN, V24, P349, DOI 10.1097/MOG.0b013e3282fbf9b3; Stanley P., 2009, ESSENTIALS GLYCOBIOL; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; Takahashi M, 2009, CARBOHYD RES, V344, P1387, DOI 10.1016/j.carres.2009.04.031; Tao SC, 2008, GLYCOBIOLOGY, V18, P761, DOI 10.1093/glycob/cwn063; Tolek A, 2012, EXP BIOL MED, V237, P1142, DOI 10.1258/ebm.2012.012215; Uthaisar K, 2016, ONCOL REP, V36, P1435, DOI 10.3892/or.2016.4974; Uttaravichien T, 1999, J Hepatobiliary Pancreat Surg, V6, P128, DOI 10.1007/s005340050095; Varki A, 2009, ESSENTIALS GLYCOBIOL, P617; Varki A., 2009, ESSENTIALS GLYCOBIOL, P601; Vojta A, 2016, BBA-GEN SUBJECTS, V1860, P1776, DOI 10.1016/j.bbagen.2016.01.002; Yan FX, 2016, BIOMED PHARMACOTHER, V84, P1538, DOI 10.1016/j.biopha.2016.11.027; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zhang P, 2015, ONCOTARGETS THER, V8, P3305, DOI 10.2147/OTT.S82845; Zhang XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087978; Zhao YX, 2007, INDIAN J BIOCHEM BIO, V44, P145; Zhu QQ, 2012, MED ONCOL, V29, P985, DOI 10.1007/s12032-011-9912-1	54	19	19	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 18	2018	37	42					5648	5665		10.1038/s41388-018-0366-1	http://dx.doi.org/10.1038/s41388-018-0366-1			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX3JJ	29915392	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000447619100005
J	Santin, O; Moncalian, G				Santin, Omar; Moncalian, Gabriel			Loading of malonyl-CoA onto tandem acyl carrier protein domains of polyunsaturated fatty acid synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid synthase (FAS); polyketide; polyunsaturated fatty acid (PUFA); acyl carrier protein (ACP); acyltransferase	MODULAR POLYKETIDE SYNTHASES; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; SELF-ACYLATION; BIOSYNTHESIS; PREDICTION; ORGANIZATION; INTERPRO; REVEALS; ENZYMES	Omega-3 polyunsaturated fatty acids (PUFA) are produced in some unicellular organisms, such as marine gammaproteobacteria, myxobacteria, and thraustochytrids, by large enzyme complexes called PUFA synthases. These enzymatic complexes resemble bacterial antibiotic-producing proteins known as polyketide synthases (PKS). One of the PUFA synthase subunits is a conserved large protein (PfaA in marine proteobacteria) that contains three to nine tandem acyl carrier protein (ACP) domains as well as condensation and modification domains. In this work, a study of the PfaA architecture and its ability to initiate the synthesis by selecting malonyl units has been carried out. As a result, we have observed a self-acylation ability in tandem ACPs whose biochemical mechanism differ from the previously described for type II PKS. The acyltransferase domain of PfaA showed a high selectivity for malonyl-CoA that efficiently loads onto the ACPs domains. These results, together with the structural organization predicted for PfaA, suggest that this protein plays a key role at early stages of the anaerobic pathway of PUFA synthesis.	Univ Cantabria, Dept Biol Mol, Santander 39011, Spain; Univ Cantabria, Inst Biomed & Biotecnol Cantabria IBBTEC, CSIC, Santander 39011, Spain	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Moncalian, G (corresponding author), Univ Cantabria, Inst Biomed & Biotecnol Cantabria, CSIC, Santander 39011, Spain.	gabriel.moncalian@unican.es	Moncalian, Gabriel/AAI-9723-2021	Moncalian, Gabriel/0000-0002-3007-6490	Spanish Ministry of Economy and Competitiveness [BFU2014-55534-C2-2-P]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by Grant BFU2014-55534-C2-2-P from the Spanish Ministry of Economy and Competitiveness (to G.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Arthur CJ, 2006, CHEM BIOL, V13, P587, DOI 10.1016/j.chembiol.2006.03.010; Arthur CJ, 2005, BIOCHEMISTRY-US, V44, P15414, DOI 10.1021/bi051499i; Beld J, 2015, MOL BIOSYST, V11, P38, DOI 10.1039/c4mb00443d; Bumpus SB, 2008, J AM CHEM SOC, V130, P11614, DOI 10.1021/ja8040042; Chan YA, 2009, NAT PROD REP, V26, P90, DOI 10.1039/b801658p; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dillon SC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-109; Dunn BJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0297; Gemperlein K, 2014, CHEM SCI, V5, P1733, DOI 10.1039/c3sc53163e; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hayashi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep35441; Hitchman TS, 1998, CHEM BIOL, V5, P35, DOI 10.1016/S1074-5521(98)90085-0; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Jiang H, 2008, J AM CHEM SOC, V130, P6336, DOI 10.1021/ja801911t; Jiang H, 2009, METHOD ENZYMOL, V459, P79, DOI 10.1016/S0076-6879(09)04604-7; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kaulmann U, 2002, ANGEW CHEM INT EDIT, V41, P1866, DOI 10.1002/1521-3773(20020603)41:11<1866::AID-ANIE1866>3.0.CO;2-3; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lee JM, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010023; Li ZX, 2007, J MOL BIOL, V371, P1075, DOI 10.1016/j.jmb.2007.06.004; Liew CW, 2012, J BIOL CHEM, V287, P23203, DOI 10.1074/jbc.M112.362210; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Matharu AL, 1998, CHEM BIOL, V5, P699, DOI 10.1016/S1074-5521(98)90663-9; Misra A, 2007, CHEM BIOL, V14, P775, DOI 10.1016/j.chembiol.2007.05.013; Misra A, 2009, MOL BIOSYST, V5, P651, DOI 10.1039/b820420a; Mulder Nicola, 2007, V396, P59; Nanson JD, 2015, SCI REP-UK, V5, DOI 10.1038/srep14797; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Okuyama H, 2007, APPL ENVIRON MICROB, V73, P665, DOI 10.1128/AEM.02270-06; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Orikasa Y, 2006, FEBS LETT, V580, P4423, DOI 10.1016/j.febslet.2006.07.008; Orikasa Y, 2006, BIOTECHNOL LETT, V28, P1841, DOI 10.1007/s10529-006-9168-6; Orikasa Y, 2009, FEMS MICROBIOL LETT, V295, P170, DOI 10.1111/j.1574-6968.2009.01582.x; Poust S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109421; Ray L, 2016, NAT PROD REP, V33, P150, DOI 10.1039/c5np00112a; Shulse CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020146; Szu PH, 2011, CHEM BIOL, V18, P1021, DOI 10.1016/j.chembiol.2011.07.015; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P215, DOI 10.1016/S0753-3322(02)00193-2; Trujillo U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057859; Tufar P, 2014, CHEM BIOL, V21, P552, DOI 10.1016/j.chembiol.2014.02.014; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8; Yoshida K, 2016, MAR DRUGS, V14, DOI 10.3390/md14050094; Zheng JT, 2011, J MOL BIOL, V410, P105, DOI 10.1016/j.jmb.2011.04.065	51	18	18	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12491	12501		10.1074/jbc.RA118.002443	http://dx.doi.org/10.1074/jbc.RA118.002443			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29921583	Green Published, hybrid			2022-12-26	WOS:000441408500015
J	Ni, RX; Ma, YB				Ni, Runxiang; Ma, Yibing			Current inventory and changes of the input/output balance of trace elements in farmland across China	PLOS ONE			English	Article							HEAVY-METALS; AGRICULTURAL SOILS; PARTICULATE MATTER; MERCURY EMISSION; SEWAGE-SLUDGE; INPUT FLUXES; DEPOSITION; REMOVAL; NICKEL	The inventory and input/output balance of trace elements in farmland play an important role in risk assessment and soil management, but there is little information about nationwide changes of the input/output balance of trace elements in farmland in China. In the present study, the inventory of trace element inputs to farmland was updated based on the dataset from the literature published during 2006-2015, and changes of the input/output balance were investigated. Compared with 1999-2006, net inputs of Cr, Ni, and Zn increased by 52.9%, 59.7%, and 20.6%, respectively. The increases in fossil fuel derived energy consumption, industrial manufacture, municipal solid waste incineration, and transportation were the predominant contributors to these increases. Net inputs of Cd, Cu, and Hg decreased dramatically by 46.7%, 25.2%, and 50.4%, respectively. The decreases are due to the strict management of feed additives, fertilizers, and emissions of atmospheric pollutants. Net inputs of As and Pb still remained relatively stable. These results demonstrated that better achievements have been gained by administration of air, water and soil in China. Regulation of atmospheric emission for Cr, Ni, and Zn was recommended as atmospheric deposition was the predominant source for increases of Cr, Ni, and Zn inputs to farmland across China.	[Ni, Runxiang; Ma, Yibing] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS	Ma, YB (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing, Peoples R China.	mayibing@caas.cn		Ma, Yibing/0000-0002-9340-8181	Research on Migration/Transformation and Safety Threshold of Heavy Metals in Farmland Systems grant [2016YFD0800406]	Research on Migration/Transformation and Safety Threshold of Heavy Metals in Farmland Systems grant	This work was financially supported by the Research on Migration/Transformation and Safety Threshold of Heavy Metals in Farmland Systems (grant No. 2016YFD0800406) (YM).	Alvarenga P, 2015, WASTE MANAGE, V40, P44, DOI 10.1016/j.wasman.2015.01.027; [Anonymous], 2009, 233492009 GBT STAND; Belon E, 2012, SCI TOTAL ENVIRON, V439, P87, DOI 10.1016/j.scitotenv.2012.09.011; Chang J., 2012, CHINA PETROLEUM CHEM, P41; [陈敏敏 Chen Minmin], 2016, [环境污染与防治, Environmental Pollution & Control], V38, P106; [陈同斌 Chen Tongbin], 2003, [环境科学学报, Acta Scientiae Circumstantiae], V23, P561; Cheng HG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087753; Cheng K., 2015, RES ENV SCI, V28, P1369; GB, 2011, EM STAND AIR POLL TH; Guo LC, 2014, ATMOS ENVIRON, V83, P136, DOI 10.1016/j.atmosenv.2013.11.012; He B., 2015, AGR EC LOSS WATER PO; Hou DY, 2017, ENVIRON POLLUT, V231, P1188, DOI 10.1016/j.envpol.2017.07.021; Hou DY, 2017, LAND DEGRAD DEV, V28, P2315, DOI 10.1002/ldr.2741; Hou QY, 2014, J GEOCHEM EXPLOR, V139, P68, DOI 10.1016/j.gexplo.2013.08.007; Jiang W, 2014, ENVIRON SCI POLLUT R, V21, P7876, DOI 10.1007/s11356-014-2679-0; Liu JK, 2016, ATMOS ENVIRON, V125, P178, DOI 10.1016/j.atmosenv.2015.11.023; Luo L, 2009, J ENVIRON MANAGE, V90, P2524, DOI 10.1016/j.jenvman.2009.01.011; Ministry of Agriculture of the People's Republic of China, 2000, REG FERT REG MAN; Ministry of Agriculture of the People's Republic of China, 2016, CHIN AGR STAT YB 201; Ministry of Agriculture of the People's Republic of China, 2005, ANN MIN AGR NO 560; Ministry of Agriculture of the People's Republic of China, 2009, SAF SPEC FEED ADD 20; Ministry of Agriculture of the People's Republic of China, 2017, SAF MON RES FEED CHI; Ministry of Agriculture of the People's Republic of China National Development and Reform Commission, 2016, INSTR COMP IMPL PLAN; Ministry of Environmental Protection of the People's Republic of China, 2016, CHIN ENV YB 2016; Ministry of Water Resources of the People's Republic of China, 2015, CHIN WAT RES B 2015; Mo CeHui, 2001, Chinese Journal of Applied and Environmental Biology, V7, P511; Moolenaar S. W., 1998, J IND ECOL, V2, P45, DOI [10.1162/jiec.1998.2.4.45, DOI 10.1162/JIEC.1998.2.4.45]; National Bureau of Statistics of China, 2016, CHIN STAT YB 2016; National Bureau of Statistics of the People's Republic of China Ministry of Environmental Protection of the People's Republic of China, 2016, CHIN STAT YB ENV 201; National Development and Reform Commission, 2016, 13 5 YEAR CONSTR PLA; Nicholson FA, 2003, SCI TOTAL ENVIRON, V311, P205, DOI 10.1016/S0048-9697(03)00139-6; Prajapati RP, 2010, ORIENT J CHEM, V26, P721; Su F., 2016, PESTIC SCI ADM, V37, P1; The Central People's Government of the People's Republic of China, 2013, REC WORK SOIL ENV PR; Tian HZ, 2015, ATMOS CHEM PHYS, V15, P10127, DOI 10.5194/acp-15-10127-2015; Tian HZ, 2012, SCI TOTAL ENVIRON, V417, P148, DOI 10.1016/j.scitotenv.2011.11.069; Wang FangHao, 2006, China Environmental Science, V26, P614; Wang H, 2014, TOXICOL ENVIRON CHEM, V96, P1346, DOI 10.1080/02772248.2015.1023305; Wang SXA, 2010, J AIR WASTE MANAGE, V60, P722, DOI 10.3155/1047-3289.60.6.722; Xia XQ, 2014, J GEOCHEM EXPLOR, V139, P85, DOI 10.1016/j.gexplo.2013.06.008; Xu Q, 2015, FEED RES, P69; Zhang L, 2012, ENVIRON POLLUT, V171, P109, DOI 10.1016/j.envpol.2012.07.036; Zhang LiLi, 2013, Research of Environmental Sciences, V26, P313; [张团慧 Zhang Tuanhui], 2015, [材料导报, Materials Review], V29, P113; Zhang XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135182; Zhao SL, 2017, FUEL, V199, P653, DOI 10.1016/j.fuel.2017.03.038	46	19	30	7	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199460	10.1371/journal.pone.0199460	http://dx.doi.org/10.1371/journal.pone.0199460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940011	Green Published, gold, Green Submitted			2022-12-26	WOS:000436088700019
J	Isani, M; Bell, BA; Delaplain, PT; Bowling, JD; Golden, JM; Elizee, M; Illingworth, L; Wang, J; Gayer, CP; Grishin, AV; Ford, HR				Isani, Mubina; Bell, Brandon A.; Delaplain, Patrick T.; Bowling, Jordan D.; Golden, Jamie M.; Elizee, Melissa; Illingworth, Laura; Wang, Jin; Gayer, Christopher P.; Grishin, Anatoly, V; Ford, Henri R.			Lactobacillus murinus HF12 colonizes neonatal gut and protects rats from necrotizing enterocolitis	PLOS ONE			English	Article							EPITHELIAL-CELL INJURY; PRETERM-INFANT; NITRIC-OXIDE; PROBIOTICS; MICROBIOTA; MOUSE; METAANALYSIS; MANAGEMENT; IMPACT; TRACT	The use of lactobacilli in prevention of necrotizing enterocolitis (NEC) is hampered by insufficient knowledge about optimal species/strains and effects on intestinal bacterial populations. We therefore sought to identify lactobacilli naturally occurring in postnatal rats and examine their ability to colonize the neonatal intestine and protect from NEC. L. murinus, L. acidophilus, and L. johnsonii were found in 42, 20, and 1 out of 51 4-day old rats, respectively. Higher proportion of L. murinus in microbiota correlated with lower NEC scores. Inoculation with each of the three species during first feeding significantly augmented intestinal populations of lactobacilli four days later, indicating successful colonization. L. murinus, but not L. acidophilus or L. johnsonii, significantly protected against NEC. Thus, lactobacilli protect rats from NEC in a species- or strain-specific manner. Our results may help rationalizing probiotic therapy in NEC.	[Isani, Mubina; Bell, Brandon A.; Delaplain, Patrick T.; Bowling, Jordan D.; Golden, Jamie M.; Elizee, Melissa; Illingworth, Laura; Wang, Jin; Gayer, Christopher P.; Grishin, Anatoly, V; Ford, Henri R.] Childrens Hosp Los Angeles, Div Pediat Surg, Los Angeles, CA 90027 USA; [Isani, Mubina; Delaplain, Patrick T.; Bowling, Jordan D.; Golden, Jamie M.; Elizee, Melissa; Gayer, Christopher P.; Grishin, Anatoly, V; Ford, Henri R.] Univ Southern Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90007 USA	Children's Hospital Los Angeles; University of Southern California	Grishin, AV (corresponding author), Childrens Hosp Los Angeles, Div Pediat Surg, Los Angeles, CA 90027 USA.; Grishin, AV (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90007 USA.	agrishin@chla.usc.edu			National Institute of Allergy and Infectious Diseases	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases. The grantor (NIAID) did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlFaleh K, 2011, COCHRANE DB SYST REV, DOI [10.1097/AOG.0b013e3181726f2f, 10.1002/14651858.CD005496.pub3]; Almiron M, 2013, CURR MICROBIOL, V67, P395, DOI 10.1007/s00284-013-0367-9; Bron PA, 2017, BRIT J NUTR, V117, P93, DOI 10.1017/S0007114516004037; Chang HY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171579; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; Deshpande G, 2015, AUST NZ J OBSTET GYN, V55, P210, DOI 10.1111/ajo.12328; Frost BL, 2017, JAMA PEDIATR, V171, P83, DOI 10.1001/jamapediatrics.2016.2708; Grishin A, 2016, J PEDIATR SURG, V51, P13, DOI 10.1016/j.jpedsurg.2015.10.006; Gupta A, 2016, EARLY HUM DEV, V97, P17, DOI 10.1016/j.earlhumdev.2016.03.008; HEMME D, 1980, ANN INST PASTEUR MIC, VA131, P297; Hull MA, 2014, J AM COLL SURGEONS, V218, P1148, DOI 10.1016/j.jamcollsurg.2013.11.015; Hunter CJ, 2008, J INFECT DIS, V198, P586, DOI 10.1086/590186; Hunter CJ, 2009, INFECT IMMUN, V77, P1031, DOI 10.1128/IAI.01192-08; Lagkouvardos I, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.131, 10.1038/nmicrobiol.2016.131]; Lau CSM, 2015, J PEDIATR SURG, V50, P1405, DOI 10.1016/j.jpedsurg.2015.05.008; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; Molinaro Manuela, 2016, Recenti Progressi in Medicina, V107, P485, DOI 10.1701/2354.25230; Nadler EP, 2000, J SURG RES, V92, P71, DOI 10.1006/jsre.2000.5877; Neu J, 2017, SEMIN PERINATOL, V41, P29, DOI 10.1053/j.semperi.2016.09.015; Papillon Stephanie, 2013, Adv Pediatr, V60, P263, DOI 10.1016/j.yapd.2013.04.011; Sawh SC, 2016, PEERJ, V4, DOI 10.7717/peerj.2429; Siggers RH, 2011, J NUTR BIOCHEM, V22, P511, DOI 10.1016/j.jnutbio.2010.08.002; Thomas DM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188211; Underwood MA, 2017, CLIN PERINATOL, V44, P407, DOI 10.1016/j.clp.2017.01.005; Underwood MA, 2017, SEMIN PERINATOL, V41, P41, DOI 10.1053/j.semperi.2016.09.017; Walker AW, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0087-4	26	15	15	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0196710	10.1371/journal.pone.0196710	http://dx.doi.org/10.1371/journal.pone.0196710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933378	Green Published, gold, Green Submitted			2022-12-26	WOS:000436076600001
J	Kohno, K; Koya-Miyata, S; Harashima, A; Ariyasu, T; Ushio, S				Kohno, Keizo; Koya-Miyata, Satomi; Harashima, Akira; Ariyasu, Toshio; Ushio, Shimpei			NK-4 exerts selective regulatory effects on the activation and function of allergy-related Th2 cells	PLOS ONE			English	Article							PROTOONCOGENE C-MAF; TRANSCRIPTION FACTOR; SUPLATAST TOSILATE; INTERFERON-GAMMA; GENE-EXPRESSION; T-BET; TNF-ALPHA; IL-4; CHEMOKINE; EOTAXIN	NK-4 is the main component of the antiallergic drug Lumin, which has been in popular usage since the early 1950s. In this study, we examined whether NK-4 exerts a regulatory effect on the activation and effector function of Th2 cells. NK-4 inhibited IL-4 production by anti-CD3e mAb-stimulated BALB/c mouse spleen cells, whereas NK-4 had little effect on IFN-. production. IL-4 and IL-5 secretion by anti-CD3e mAb-or antigen-stimulated Th2 cells (D10. G4.1) was abrogated by NK-4 without affecting cell numbers, whereas IFN-. secretion by activated Th1 cells was unchanged. Mechanistic analysis revealed that NK-4 inhibited mRNA expression of the Th2-associated transcription factors GATA-3 and NFATc1 in antiCD3e mAb-stimulated D10. G4.1 cells. Regarding the regulation of Th2 cell effector functions, NK-4 inhibited the secretion of eotaxin and thymus and activation-regulated chemokine (TARC) by normal human dermal fibroblasts in response to IL-4 and/or TNF-alpha. NK-4 achieved TARC attenuation comparable to what is observed with suplatast tosilate, an antiallergic drug that selectively inhibits Th2 cytokine production, at 14-fold lower concentrations of suplatast tosilate. Dexamethasone increased TARC production by 2.2-to 2.6-fold of control cultures. NK-4 successfully inhibited the STAT6 signaling pathway, suggesting a potential mechanism for down-regulating chemokines expression. In addition, NK-4 abrogated IL4- driven modulation of cytokine production profile in human monocytic THP-1 cells from proinflammatory to anti-inflammatory response, as seen in the inverted ratio of TNF-alpha to IL10 produced in response to LPS. These results suggest that NK-4 could prevent IL-4-driven polarization to alternatively activated macrophages, which are proposed to have pathogenic roles in allergic asthma. The importance of Th2 cytokines and chemokines in the development and progression of type 2 inflammatory disorders has been highlighted by recent advance in our understanding the immunological mechanism underlying allergic disease. Our results support the use of NK-4 as a reasonable therapeutic option to alleviate Th2mediated allergic inflammation.	[Kohno, Keizo; Koya-Miyata, Satomi; Harashima, Akira; Ariyasu, Toshio; Ushio, Shimpei] Hayashibara Co Ltd, R&D Div, Okayama, Japan		Kohno, K (corresponding author), Hayashibara Co Ltd, R&D Div, Okayama, Japan.	keizo.kono@hb.nagase.co.jp			Hayashibara Co. Ltd.	Hayashibara Co. Ltd.	The funder [Hayashibara Co. Ltd.] provided support in the form of salaries for authors [KK, S K-M, AH, TA, SU], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Bae SJ, 2010, IMMUNOL INVEST, V39, P93, DOI 10.3109/08820130903496769; Baldo A, 2009, CLIN COSMET INV DERM, V2, P1; Cao SJ, 2005, J IMMUNOL, V174, P3484, DOI 10.4049/jimmunol.174.6.3484; Caza T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/521957; Conroy DM, 2001, RESP RES, V2, P150, DOI 10.1186/rr52; Fukuda K, 2003, J ALLERGY CLIN IMMUN, V111, P520, DOI 10.1067/mai.2003.59; Furukido K, 2002, AM J RHINOL, V16, P329, DOI 10.1177/194589240201600609; Genin M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1546-9; Glimcher LH, 2000, GENE DEV, V14, P1693; Grela F, 2011, J IMMUNOL, V186, P284, DOI 10.4049/jimmunol.1001348; Gurish MF, 2004, J IMMUNOL, V172, P1139, DOI 10.4049/jimmunol.172.2.1139; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hoeck J, 2001, J IMMUNOL, V166, P4507, DOI 10.4049/jimmunol.166.7.4507; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Ismail N, 2002, FEMS MICROBIOL LETT, V207, P111, DOI 10.1111/j.1574-6968.2002.tb11038.x; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Kabata H, 2015, ALLERGOL INT, V64, P227, DOI 10.1016/j.alit.2015.03.004; Kataoka Y, 2014, J DERMATOL, V41, P221, DOI 10.1111/1346-8138.12440; Kohno K, 1997, J IMMUNOL, V158, P1541; Krug N, 2015, NEW ENGL J MED, V372, P1987, DOI 10.1056/NEJMoa1411776; Kunikata T, 2002, BIOL PHARM BULL, V25, P1018, DOI 10.1248/bpb.25.1018; Kunikata T, 2011, YAKUGAKU ZASSHI, V131, P1667, DOI 10.1248/yakushi.131.1667; Levings MK, 1999, J IMMUNOL, V162, P5224; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Matsue H, 2002, J IMMUNOL, V169, P3555, DOI 10.4049/jimmunol.169.7.3555; Melgert BN, 2011, J ALLERGY CLIN IMMUN, V127, P831, DOI 10.1016/j.jaci.2010.10.045; Mimura T, 2005, J PHARMACOL EXP THER, V314, P293, DOI 10.1124/jpet.104.080846; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mochizuki M, 1998, J IMMUNOL, V160, P60; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Oda N, 2002, CLIN EXP ALLERGY, V32, P1782, DOI 10.1046/j.1365-2222.2002.01547.x; Oh YJ, 2015, IMMUNE NETW, V15, P199, DOI 10.4110/in.2015.15.4.199; Possa SS, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00046; SASAKI Y, 1987, FOLIA PHARMACOL JPN, V89, P1, DOI 10.1254/fpj.89.1; Shichijo M, 1999, JPN J PHARMACOL, V79, P501, DOI 10.1254/jjp.79.501; Shoda T, 2014, J DERMATOL SCI, V76, P90, DOI 10.1016/j.jdermsci.2014.08.009; Simon D, 2004, ALLERGY, V59, P561, DOI 10.1111/j.1398-9995.2004.00476.x; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Staples KJ, 2012, J ALLERGY CLIN IMMUN, V130, P1404, DOI 10.1016/j.jaci.2012.07.023; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Teixeira LK, 2005, MEM I OSWALDO CRUZ, V100, P137, DOI 10.1590/S0074-02762005000900024; Tohda Y, 2001, INT IMMUNOPHARMACOL, V1, P1183, DOI 10.1016/S1567-5769(01)00053-4; VANLIER RAW, 1989, IMMUNOLOGY, V68, P45; Wang ZY, 2006, J IMMUNOL, V176, P880, DOI 10.4049/jimmunol.176.2.880; Yagi R, 2002, INT IMMUNOL, V14, P1, DOI 10.1093/intimm/14.1.1; Yamashita M, 2004, J BIOL CHEM, V279, P26983, DOI 10.1074/jbc.M403688200; Yawalkar N, 1999, J INVEST DERMATOL, V113, P43, DOI 10.1046/j.1523-1747.1999.00619.x; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	53	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199666	10.1371/journal.pone.0199666	http://dx.doi.org/10.1371/journal.pone.0199666			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933387	Green Published, Green Submitted, gold			2022-12-26	WOS:000436076600040
J	AlRuthia, Y; Balkhi, B; Alrasheed, M; Altuwaijri, A; Alarifi, M; Alzahrani, H; Mansy, W				AlRuthia, Yazed; Balkhi, Bander; Alrasheed, Marwan; Altuwaijri, Ahmed; Alarifi, Mohammad; Alzahrani, Huda; Mansy, Wael			Use of dietary and performance-enhancing supplements among male fitness center members in Riyadh: A cross-sectional study	PLOS ONE			English	Article								This study aimed to explore the health beliefs and patterns of dietary supplement usage among fitness center members. This cross-sectional study was conducted in four large indoor fitness centers in Riyadh, Saudi Arabia. This study involved male fitness center members aged >= 18 years with no speech or hearing disabilities. In-person interviews were conducted with fitness center members who agreed to participate using a newly developed questionnaire. Information on participants' sociodemographics (e.g., age and education), smoking status, health status, exercise frequency, average time spent exercising, different supplements used, used supplements sources, and health beliefs regarding dietary supplements were obtained. A total of 445 fitness center members agreed to participate, and 198 of them reported taking dietary supplements. Most participants were between the age of 18 and 25 years (66%), had a college degree (74%), non-smokers (77%), healthy (84%), and perform exercise at least thrice weekly (52%) for at least 1 hour (63%). The percentage of participants who had favorable health views on dietary supplements was significantly higher among the supplement users than among the non-users (P<0.0001). Proteins, multivitamins, amino acids, and omega 3 fatty acids were the most commonly reported supplements used. Almost 30% of the supplement users reported buying them overseas, 28% online, 25% from a pharmacy or supplement store, 19% from a medical clinic, and 17% from peddlers. Public health campaigns are needed to educate the public on the potential harmful effects of supplements if purchased from an unofficial seller or taken without seeking medical advice before using them.	[AlRuthia, Yazed; Balkhi, Bander; Alrasheed, Marwan; Alarifi, Mohammad; Mansy, Wael] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia; [AlRuthia, Yazed; Balkhi, Bander] King Saud Univ, Coll Pharm, Pharmacoecon Res Unit, Riyadh, Saudi Arabia; [Altuwaijri, Ahmed] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia; [Alzahrani, Huda] King Khalid Univ Hosp, Dept Pharm, Riyadh, Saudi Arabia	King Saud University; King Saud University; King Saud University; King Saud University; King Khalid University Hospital	AlRuthia, Y (corresponding author), King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia.; AlRuthia, Y (corresponding author), King Saud Univ, Coll Pharm, Pharmacoecon Res Unit, Riyadh, Saudi Arabia.	yazed@ksu.edu.sa	Mansy, Wael/AAY-3782-2020	Mansy, Wael/0000-0002-7988-2717; AlRuthia, Yazed/0000-0002-0029-5924	College of Pharmacy Research Center; Deanship of Scientific Research, King Saud University (Riyadh, Saudi Arabia)	College of Pharmacy Research Center; Deanship of Scientific Research, King Saud University (Riyadh, Saudi Arabia)	The authors acknowledge financial support from the College of Pharmacy Research Center and the Deanship of Scientific Research, King Saud University (Riyadh, Saudi Arabia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhomoud FK, 2016, J CLIN DIAGN RES, V10, pJC5, DOI 10.7860/JCDR/2016/19300.8439; Aljaloud SO, 2016, INT J FOOD SCI NUTR, V5, P287; Aljaloud SO, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/245349; [Anonymous], 2014, SAUD FOOD DRUG AUTH, P9; Archer JRH, 2015, DRUG TEST ANAL, V7, P433, DOI 10.1002/dta.1764; Bailey RL, 2013, JAMA INTERN MED, V173, P355, DOI 10.1001/jamainternmed.2013.2299; Carvajal R, 2010, NEW ENGL J MED, V362, P274, DOI 10.1056/NEJMc0911467; Cohen PA, 2014, JAMA-J AM MED ASSOC, V312, P1691, DOI 10.1001/jama.2014.10308; Cohen PA, 2013, JAMA INTERN MED, V173, P1169, DOI 10.1001/jamainternmed.2013.854; Cohen PA, 2013, JAMA INTERN MED, V173, P595, DOI 10.1001/jamainternmed.2013.3776; Deldicque L, 2016, CURR OPIN CLIN NUTR, V19, P439, DOI 10.1097/MCO.0000000000000321; Eliason B C, 1997, J Am Board Fam Pract, V10, P265; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Karnatovskaia LV, 2015, CLIN J SPORT MED, V25, pE23, DOI 10.1097/JSM.0000000000000103; Lindstrom A., 2014, HERBALGRAM, V103, P52; Marcus DM, 2016, DRUG TEST ANAL, V8, P410, DOI 10.1002/dta.1855; Morrison LJ, 2004, INT J SPORT NUTR EXE, V14, P481, DOI 10.1123/ijsnem.14.4.481; Owens DJ, 2017, MED SCI SPORT EXER, V49, P349, DOI 10.1249/MSS.0000000000001105; Pawar RS, 2017, DRUG TEST ANAL, V9, P500, DOI 10.1002/dta.1980; Pawar RS, 2013, ANAL BIOANAL CHEM, V405, P4373, DOI 10.1007/s00216-012-6691-2; Tawfik S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161252; Waly Mostafa I, 2013, Oman Med J, V28, P360, DOI 10.5001/omj.2013.103; Zoller H, 2004, NUTRITION, V20, P615, DOI 10.1016/j.nut.2004.04.006	23	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199289	10.1371/journal.pone.0199289	http://dx.doi.org/10.1371/journal.pone.0199289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928034	Green Submitted, Green Published, gold			2022-12-26	WOS:000435802500067
J	Fuentes, A; Braswell, WE; Ruiz-Arce, R; Racelis, A				Fuentes, A.; Braswell, W. E.; Ruiz-Arce, R.; Racelis, A.			Genetic variation and population structure of Diaphorina citri using cytochrome oxidase I sequencing	PLOS ONE			English	Article							TAMARIXIA-RADIATA HYMENOPTERA; HEMIPTERA PSYLLIDAE; WOLBACHIA; EULOPHIDAE; HOMOPTERA; IMPACT; FRUIT	Citrus greening disease, or huanglongbing (HLB), is currently one of the most devastating diseases of citrus. The bacteria thought to be responsible for the disease, Candidatus Liberi-bacter asiaticus impact the majority of commercial citrus species worldwide. These bacteria are transmitted by the Asian citrus psyllid (ACP), Diaphorina citri Kuwayama, which is now found in most citrus growing regions. With no known cure, ACP-vectored HLB is responsible for significant economic losses to the global citrus industry. A better understanding of the global genetic diversity of D. citri would improve current and future pest management and mitigation programs. To assess the genetic diversity of D. citri in worldwide collections, a total of 1,108 sequences belonging to ACP gathered from 27 countries in the Americas, the Caribbean, Southeast and Southwest Asia were examined for the study. 883 D. citri came from 98 locations in 18 different countries, and were sequenced using a 678bp fragment of the mitochondrial cytochrome oxidase I (COI) gene. Additionally, 225 previously-reported D. citri COI sequences, were also included in our analysis. Analyses revealed 28 haplotypes and a low genetic diversity. This is in accordance with previous reports on the little diversity of D. citri in worldwide populations. Our analyses reveal population structure with 21 haplotypes showing geographic association, increasing the resolution for the source estimation of ACP. This study reveals the distribution of haplotypes observed in different geographic regions and likely geographic sources for D. citri introductions.	[Fuentes, A.; Racelis, A.] Univ Texas Rio Grande Valley, Dept Biol, Edinburg, TX 78539 USA; [Fuentes, A.; Braswell, W. E.; Ruiz-Arce, R.] USDA APHIS CPHST Mission Lab, Edinburg, TX 78451 USA	University of Texas System; University of Texas Rio Grande Valley	Fuentes, A (corresponding author), Univ Texas Rio Grande Valley, Dept Biol, Edinburg, TX 78539 USA.; Fuentes, A (corresponding author), USDA APHIS CPHST Mission Lab, Edinburg, TX 78451 USA.	Alejandra.Fuentes@aphis.usda.gov		Godoy, Alejandra/0000-0003-0958-9432	United States Department of Agriculture Animal Plant Health Inspection Service - Science and Technology (USDA APHIS ST) [12-8130-0162]; University of Texas - Rio Grande Valley [12-8130-0162]	United States Department of Agriculture Animal Plant Health Inspection Service - Science and Technology (USDA APHIS ST); University of Texas - Rio Grande Valley	This research was supported by a cooperative agreement, 12-8130-0162, between the United States Department of Agriculture Animal Plant Health Inspection Service - Science and Technology (USDA APHIS S&T) and the University of Texas - Rio Grande Valley. Mention of trade names or commercial products in this publication is solely for the purpose of providing scientific information and does not imply recommendation or endorsement by the USDA; USDA is an equal opportunity provider and employer.; This research was supported by a cooperative agreement, 12-8130-0162, between the United States Department of Agriculture-Animal Plant Health Inspection Service-Science and Technology (USDA APHIS S&T) and the University of Texas-Rio Grande Valley. Mention of trade names or commercial products in this publication is solely for the purpose of providing scientific information and does not imply recommendation or endorsement by the USDA; USDA is an equal opportunity provider and employer. The authors would like to thank David Hall (USDA-ARS), Robert Shatters (USDA-ARS), Jesse De Leon (USDA-ARS), Matthew Purcell (USDA-ARS), Jeffry Makinson (CSIRO), Craig A. Webb (USDA-APHIS), Mark Schmaedick (American Samoa Community College), Emilio Arevalo Penaranda (Instituto Colombiano Agropecuario), Florinda Garcia Perez (Colegio de Posgraduados en Ciencias Agricolas, Texcoco), Isabel Lopez-Arroyo (Instituto Nacional de Investigaciones Forestales, Agricolas y Pecuarias-INIFAP), Manjunath Keremane (USDA-ARS), Aixa Ramirez (Universidad de Puerto Rico at Rio Piedras), Edda Martinez (Department of Agriculture of Puerto Rico), Siripor Donnua (Kasetsart University), Chandebham Shripat, Mamoudu Setamou (Texas A&M Kingsville-Citrus Center) and Marjorie Bestwick (USDA-APHIS), for assistance on D. citri collections.	ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Ayres AJ, 2005, P 2 INT CITR CANK HU, pH4; Barr NB, 2009, J ECON ENTOMOL, V102, P2325, DOI 10.1603/029.102.0639; Beattie G. A. C., 2009, P INT RES C HUANGL D, P23; Bove JM, 2006, J PLANT PATHOL, V88, P7; Boykin LM, 2012, B ENTOMOL RES, V102, P573, DOI 10.1017/S0007485312000181; Chaitanya BN, 2016, ECOSYSTEMS, V22, P51; Chien ChingChin, 1996, Biological pest control in systems of integrated pest management. Proceedings of the International Symposium on "The use of Biological Control Agents under Integrated Pest Management".., P93; Chu C, INSECT SCI; Chu CC, 2016, MICROB ECOL, V71, P999, DOI 10.1007/s00248-016-0733-9; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Costa Lima AM, 1942, ESCOLA NACL AGRONOMI, V3, P141; Da Graca J, 2004, DIS FRUITS VEGETABLE, VI, P229, DOI DOI 10.1007/1-4020-2606-4_4; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Leon JH, 2011, ANN ENTOMOL SOC AM, V104, P1392, DOI 10.1603/AN11086; de Leon JH, 2010, ANN ENTOMOL SOC AM, V103, P100, DOI 10.1603/008.103.0113; ETIENNE J, 1980, P 8 C INT ORG CITR V, P118; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; French J. V., 2001, Subtropical Plant Science, V53, P14; FU YX, 1993, GENETICS, V133, P693; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Guidolin AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115749; Guillemaud T, 2011, CR BIOL, V334, P237, DOI 10.1016/j.crvi.2010.12.008; Guindon S, 2010, SYST BIOL, P20, DOI [10.1111/j.1574-6968.2008.01110.x, DOI 10.1111/J.1574-6968.2008.01110.X]; Halbert SE, 2004, FLA ENTOMOL, V87, P401, DOI 10.1653/0015-4040(2004)087[0401:DOTACP]2.0.CO;2; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hall DG, 2011, FLA ENTOMOL, V94, P1094, DOI 10.1653/024.094.0459; Hall DG, 2008, P TALL INT HUANGL PS, P11; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hodges AW, 2012, EC IMPACTS CITRUS GR, P5; HOLLIS D, 1987, SYST ENTOMOL, V12, P47, DOI 10.1111/j.1365-3113.1987.tb00547.x; Hoy MA, 2001, CITRUS IND, P81; Johnson EG, 2014, PLANT PATHOL, V63, P290, DOI 10.1111/ppa.12109; Lashkari M, 2014, PEST MANAG SCI, V70, P1033, DOI 10.1002/ps.3643; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Lopez-Collado J, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.11401; McCLEAN A. P. D., 1970, Phytophylactica, V2, P177; Mead F., 1977, ASIATIC CITRUS PSYLL; Michaud JP, 2004, BIOL CONTROL, V29, P260, DOI 10.1016/S1049-9644(03)00161-0; Miller M.A., 2010, P GAT COMP ENV WORKS; Pluke RWH, 2008, FLA ENTOMOL, V91, P36, DOI 10.1653/0015-4040(2008)091[0036:CFPDCH]2.0.CO;2; Qureshi JA, 2009, J ECON ENTOMOL, V102, P247, DOI 10.1603/029.102.0134; Riegler M, 2002, MOL ECOL, V11, P2425, DOI 10.1046/j.1365-294X.2002.01614.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saha S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050067; Spreen TH, 2014, HORTSCIENCE, V49, P1052, DOI 10.21273/HORTSCI.49.8.1052; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai JH, 2000, J ECON ENTOMOL, V93, P1721, DOI 10.1603/0022-0493-93.6.1721; Wang N, 2017, ANNU REV PHYTOPATHOL, V55, P451, DOI 10.1146/annurev-phyto-080516-035513	55	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198399	10.1371/journal.pone.0198399	http://dx.doi.org/10.1371/journal.pone.0198399			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927954	gold, Green Published, Green Submitted			2022-12-26	WOS:000435802500017
J	Wang, X; Bourne, A; Liu, PL; Sun, JL; Cai, T; Mburu, G; Cassolato, M; Wang, BY; Zhou, W				Wang, Xia; Bourne, Adam; Liu, Pulin; Sun, Jiangli; Cai, Thomas; Mburu, Gitau; Cassolato, Matteo; Wang, Bangyuan; Zhou, Wang			Understanding willingness to use oral pre-exposure prophylaxis for HIV prevention among men who have sex with men in China	PLOS ONE			English	Article							UNPROTECTED ANAL INTERCOURSE; ANTIRETROVIRAL PROPHYLAXIS; PREVALENCE; INFECTION; RISK; ACCEPTABILITY; METAANALYSIS; ADHERENCE; GUANGZHOU; THAILAND	Background Oral pre-exposure prophylaxis (PrEP) is recommended as an additional prevention choice for men who have sex with men (MSM) at substantial risk of HIV. The aim of this study was to evaluate the extent, and reasons, for MSM's willingness to use oral PrEP in Wuhan and Shanghai, China. Methods Between May and December 2015, a cross-sectional survey was conducted among 487 MSM recruited through snowball sampling in physical locations frequented by MSM and through social media applications. Exploratory factor analysis was used to group reasons for being willing or not willing to use PrEP. Chi-square tests were used to explore bivariate associations between groupings of reasons for being willing or unwilling to use PrEP, and key sociodemographic and sexual-behavioral characteristics of MSM. Results Overall, 71.3% of respondents were willing to use PrEP. The most commonly reported reasons for being willing to use PrEP were preventing HIV infection (91.6%), taking responsibility for own sexual health (72.6%) and protecting family members from harm (59.4%). The main reasons for being unwilling to use PrEP were being worried about side effects (72.9%), the necessity of taking PrEP for long periods of time (54.3%) and cost (40.4%). Individual characteristics that influenced the type of reasons given for being willing or unwilling to use PrEP included being married to a woman, having a regular sex partner, rates of condom use with regular and casual sex partners, and the number of casual sex partners. Conclusion The introduction of PrEP in China could benefit from promotion campaigns that emphasize its role in preventing HIV infection, in taking responsibility for own sexual health, and in protecting family members from potential harm. To reduce uptake barriers, it will be essential to provide accurate information to potential PrEP users about the mild and short-term nature of side effects, and the possibility of taking PrEP only during particular periods of life when the risk of HIV exposure might be highest.	[Wang, Xia; Liu, Pulin; Zhou, Wang] Wuhan Ctr Dis Prevent & Control, Wuhan, Hubei, Peoples R China; [Bourne, Adam] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia; [Bourne, Adam] London Sch Hyg & Trop Med, Sigma Res, London, England; [Sun, Jiangli] AIDS Care China, Kunming, Yunnan, Peoples R China; [Cai, Thomas] AIDS Care China, Nanning, Guangxi, Peoples R China; [Mburu, Gitau; Cassolato, Matteo; Wang, Bangyuan] Int HIV AIDS Alliance, Brighton, E Sussex, England; [Mburu, Gitau] Univ Lancaster, Div Hlth Res, Bailrigg, Lancs, England	La Trobe University; University of London; London School of Hygiene & Tropical Medicine; Lancaster University	Zhou, W (corresponding author), Wuhan Ctr Dis Prevent & Control, Wuhan, Hubei, Peoples R China.	rising-up@hotmail.com		Mburu, Gitau/0000-0002-5812-0529	International HIV/AIDS Alliance [INN/AIDS/ACC/2015/01]	International HIV/AIDS Alliance	This work was supported by the International HIV/AIDS Alliance, Grant NO.: INN/AIDS/ACC/2015/01 to AB (http://www.aidsalliance.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico KR, 2014, CLIN INFECT DIS, V59, pS55, DOI 10.1093/cid/ciu266; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Beyrer C, 2016, LANCET, V388, P198, DOI 10.1016/S0140-6736(16)30781-4; Bourne A, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21899; Chakrapani V, 2015, AIDS PATIENT CARE ST, V29, P569, DOI 10.1089/apc.2015.0143; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Ding YY, 2016, BIOSCI TRENDS, V10, P113, DOI 10.5582/bst.2016.01035; Draper BL, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21885; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Haire BG, 2015, HIV AIDS-RES PALLIAT, V7, P241, DOI 10.2147/HIV.S72419; Holt M, 2012, SEX TRANSM INFECT, V88, P258, DOI 10.1136/sextrans-2011-050312; Hoots BE, 2016, CLIN INFECT DIS, V63, P672, DOI 10.1093/cid/ciw367; Huang X, 2016, CHIN J AIDS STD, V22, P525; Jackson T, 2012, AIDS BEHAV, V16, P1853, DOI 10.1007/s10461-012-0188-z; Karuga RN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151716; Kim J, 1978, FACTOR ANAL STAT MET; Ko NY, 2016, AIDS EDUC PREV, V28, P128, DOI 10.1521/aeap.2016.28.2.128; Le Vu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039872; Lewnard JA, 2014, SEX TRANSM INFECT, V90, P290, DOI 10.1136/sextrans-2013-051332; Li YZ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-531; Liu PL, 2010, CHINESE J DIS CONTRO, V14, P917; Liu Y, 2016, AIDS BEHAV, V20, P2222, DOI 10.1007/s10461-016-1371-4; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; NCAIDS and China CDC, 2012, CHINESE J AIDS STD, V18, P64; NCAIDS NCSTD and China CDC, 2016, CHIN J AIDS STD, V22; Song DD, 2013, AIDS BEHAV, V17, P2395, DOI 10.1007/s10461-012-0334-7; Tang WM, 2013, AIDS BEHAV, V17, P1415, DOI 10.1007/s10461-013-0413-4; UNAIDS, 2015, GAP REP PEOPL WHO IN; van Griensven F, 2013, AIDS, V27, P825, DOI 10.1097/QAD.0b013e32835c546e; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; Wang QQ, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18849; Wang Y, 2013, PRACTICAL PREVENTIVE, V20, P260; Wei Suo-su, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P786; Wheelock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054288; Wong FY, 2009, AIDS EDUC PREV, V21, P430, DOI 10.1521/aeap.2009.21.5.430; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2017, WHO IMPL TOOL PRE EX; Xue Hui, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P973; Yi S, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21580; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7; Zhang Y, 2013, AIDS PATIENT CARE ST, V27, P137, DOI 10.1089/apc.2012.0412; Zheng J, 2017, J SHANGDONG U HLTH, V55, P11; Zhou F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032329	43	16	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199525	10.1371/journal.pone.0199525	http://dx.doi.org/10.1371/journal.pone.0199525			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK0LV	29928008	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000435802500105
J	Zhang, CH; Ma, RJ; Xu, JL; Yan, J; Guo, L; Song, J; Feng, RC; Yu, ML				Zhang, Chunhua; Ma, Ruijuan; Xu, Jianlan; Yan, Juan; Guo, Lei; Song, Juan; Feng, Ruchao; Yu, Mingliang			Genome-wide identification and classification of MYB superfamily genes in peach	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SUPERFAMILY; ANTHOCYANIN BIOSYNTHESIS; EXPRESSION; FAMILY; ARABIDOPSIS; EVOLUTION; COLOR	The MYB transcription factor superfamily is one of the largest superfamilies modulating various biological processes in plants. Over the past few decades, many MYB superfamily genes have been identified and characterized in some plant species. However, genes belonging to the MYB superfamily in peach (Prunus persica) have not been comprehensively identified and characterized although the genome sequences of peach were released several years ago. In total, this study yielded a set of 256 MYB superfamily genes that was divided into five subfamilies: the R2R3-MYB (2R-MYB), R1R2R3-MYB (3R-MYB), MYBrelated (1R-MYB), 4R-MYB, and Atypical-MYB subfamilies. These subfamilies contained 128, 4, 109, 1, and 14 members, respectively. The 128 R2R3-MYB subfamily genes in peach were further clustered into 35 groups, and the 109 MYB-related subfamily genes were further clustered into 6 groups: the CCA1-like, CPC-like, TBP-like, I-box-binding-like,R-R-type, and Peach-specific groups. The motif compositions and exon/intron structures within each group within the R2R3-MYB or MYB-related subfamily in peach were highly conserved. The logo sequences of the R2 and R3 repeats of R2R3-MYB subfamily members were highly conserved with those in these repeats of several other plant species. Except for 48 novel peach-specific MYB genes, the remaining 208 out of 256 MYB genes in peach were conserved with the corresponding 198 MYB genes in A. thaliana. Additionally, the 256 MYB genes unevenly distributed on chromosomes 1 to 8 of the peach genome. Eighty-one orthologous pairs of peach/A. thaliana MYB genes were identified among 256 MYB genes in peach and 198 MYB genes in A. thaliana in this study. In addition, 146 pairs of paralogous MYB genes were identified on the eight chromosomes of peach. The expression levels of some of the 51 MYB genes selected for qRT-PCR analysis decreased or increased with red-fleshed fruit development, while the expression patterns of some genes followed no clear rules over the five developmental stages of fruits. This study laid the foundation for further functional analysis of MYB superfamily genes in peach and enriched the knowledge of MYB superfamily genes in plant species.	[Zhang, Chunhua; Ma, Ruijuan; Xu, Jianlan; Yan, Juan; Guo, Lei; Song, Juan; Feng, Ruchao; Yu, Mingliang] Jiangsu Acad Agr Sci, Inst Pomol, Jiangsu Key Lab Hort Crop Genet Improvement, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences	Yu, ML (corresponding author), Jiangsu Acad Agr Sci, Inst Pomol, Jiangsu Key Lab Hort Crop Genet Improvement, Nanjing, Jiangsu, Peoples R China.	mly1008@aliyun.com			National Natural Science Foundation of China [31471848]; China Agriculture Research System [CARS-30]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	This work was supported by the National Natural Science Foundation of China, No. 31471848 to MY (http://www.nsfc.gov.cn/) and the China Agriculture Research System, No. CARS-30 to MY (http://123.127.160.231/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Cao YP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00577; Cao ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069955; Chen SK, 2017, PLANT CELL PHYSIOL, V58, P1777, DOI 10.1093/pcp/pcx115; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chen YS, 2017, PLANT MOL BIOL, V93, P299, DOI 10.1007/s11103-016-0562-8; Du H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-106; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Grotewold E, 1998, PLANT CELL, V10, P721, DOI 10.1105/tpc.10.5.721; Guilfoyle T. J., 1997, Genetic engineering: principles and methods. Volume 19., P15; Hajiebrahimi A, 2017, GENOME, V60, P797, DOI 10.1139/gen-2017-0059; Hou XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112375; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lai B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086293; Li CL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-277; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li WB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16905-1; Li XL, 2016, PLANT CELL PHYSIOL, V57, P824, DOI 10.1093/pcp/pcw029; Li YY, 2012, PLANT PHYSIOL, V160, P1011, DOI 10.1104/pp.112.199703; Li ZJ, 2016, PLANT CELL PHYSIOL, V57, P1657, DOI 10.1093/pcp/pcw091; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Liu LS, 1999, EUR J BIOCHEM, V262, P247, DOI 10.1046/j.1432-1327.1999.00349.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Martin C, 1997, TRENDS GENET, V13, P67, DOI 10.1016/S0168-9525(96)10049-4; McCarthy RL, 2010, PLANT CELL PHYSIOL, V51, P1084, DOI 10.1093/pcp/pcq064; Medina-Puche L, 2014, J EXP BOT, V65, P401, DOI 10.1093/jxb/ert377; Mmadi MA, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120362; Muthamilarasan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109920; Niu SS, 2010, PLANTA, V231, P887, DOI 10.1007/s00425-009-1095-z; Tuan PA, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0664-5; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Riechmann JL, 2000, CURR OPIN PLANT BIOL, V3, P423, DOI 10.1016/S1369-5266(00)00107-2; Stegmeir T, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0337-y; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Trainotti L, 2006, PLANT SCI, V170, P606, DOI 10.1016/j.plantsci.2005.10.015; Vendramin E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090574; Verde I, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3606-9; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Wei X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9609; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Zhao PP, 2014, MOL GENET GENOMICS, V289, P1183, DOI 10.1007/s00438-014-0879-4; Zhao Y, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01552; Zhou H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01557; Zhou H, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00908; Zhou Y, 2013, TREE GENET GENOMES, V9, P265, DOI 10.1007/s11295-012-0552-1; Zhu H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-149	54	35	38	22	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199192	10.1371/journal.pone.0199192	http://dx.doi.org/10.1371/journal.pone.0199192			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927971	gold, Green Submitted, Green Published			2022-12-26	WOS:000435802500053
J	Curran, B; Higham, K; Ortiz, E; Filho, DV				Curran, Ben; Higham, Kyle; Ortiz, Elisenda; Filho, Demival Vasques			Look who's talking: Two-mode networks as representations of a topic model of New Zealand parliamentary speeches	PLOS ONE			English	Article							POSITIONS; GRAPHS	Quantitative methods to describe the participation to debate of Members of Parliament and the parties they belong to are lacking. Here we propose a new approach that combines topic modeling with complex networks techniques, and use it to characterize the political discourse at the New Zealand Parliament. We implement a Latent Dirichlet Allocation model to discover the thematic structure of the government's digital database of parliamentary speeches, and construct from it two-mode networks linking Members of the Parliament to the topics they discuss. Our results show how topic popularity changes over time and allow us to relate the trends followed by political parties in their discourses with specific social, economic and legislative events. Moreover, the community analysis of the two-mode network projections reveals which parties dominate the political debate as well as how much they tend to specialize in a small or large number of topics. Our work demonstrates the benefits of performing quantitative analysis in a domain normally reserved for qualitative approaches, providing an efficient way to measure political activity.	[Curran, Ben; Filho, Demival Vasques] Univ Auckland, Te Punaha Matatini, Auckland, New Zealand; [Higham, Kyle] Victoria Univ Wellington, Sch Chem & Phys Sci, Te Punaha Matatini, Wellington, New Zealand; [Ortiz, Elisenda] Victoria Univ Wellington, Sch Engn & Comp Sci, Te Punaha Matatini, Wellington, New Zealand; [Filho, Demival Vasques] Univ Auckland, Dept Phys, Auckland, New Zealand; [Ortiz, Elisenda] Univ Barcelona, Dept Fis Mat Condensada, Barcelona, Spain	University of Auckland; Victoria University Wellington; Victoria University Wellington; University of Auckland; University of Barcelona	Filho, DV (corresponding author), Univ Auckland, Te Punaha Matatini, Auckland, New Zealand.; Filho, DV (corresponding author), Univ Auckland, Dept Phys, Auckland, New Zealand.	d.vasques@auckland.ac.nz	Filho, Demival Vasques/Q-4760-2019; Higham, Kyle/AAN-2114-2020	Filho, Demival Vasques/0000-0002-4552-0427; Higham, Kyle/0000-0002-8287-4101	Te Punaha Matatini	Te Punaha Matatini	Te Punaha Matatini provided funding for this work.	[Anonymous], 2002, NZ PARLIAMENTARY DEB; BENDER EA, 1978, J COMB THEORY A, V24, P296, DOI 10.1016/0097-3165(78)90059-6; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bollobas B., 1980, EUROPEAN J COMBIN, V1, P311, DOI [10.1016/S0195-6698(80)80030-8, DOI 10.1016/S0195-6698(80)80030-8]; BREIGER RL, 1974, SOC FORCES, V53, P181, DOI 10.2307/2576011; Camps J, 2014, ADV EXP MED BIOL, V824, P1, DOI 10.1007/978-3-319-07320-0_1; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Griffiths T., GIBBS SAMPLING GENER; Guillaume JL, 2006, PHYSICA A, V371, P795, DOI 10.1016/j.physa.2006.04.047; Holzhacker R., 2002, EUR UNION POLIT, V3, P459, DOI DOI 10.1177/1465116502003004004; Koskinen J, 2012, SOC NETWORKS, V34, P309, DOI 10.1016/j.socnet.2010.03.001; Laver M, 2003, AM POLIT SCI REV, V97, P311; Laver M, 2000, AM J POLIT SCI, V44, P619, DOI 10.2307/2669268; McCallum A. K., MALLET MACHINE LEARN; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ramage D., 2010, ICWSM, V10, P1; Slapin JB, 2008, AM J POLIT SCI, V52, P705, DOI 10.1111/j.1540-5907.2008.00338.x; Titov I., 2008, P 17 INT C WORLD WID, P111, DOI DOI 10.1145/1367497.1367513; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Zhao WNX, 2011, LECT NOTES COMPUT SC, V6611, P338, DOI 10.1007/978-3-642-20161-5_34; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115	26	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199072	10.1371/journal.pone.0199072	http://dx.doi.org/10.1371/journal.pone.0199072			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ8QS	29924820	Green Submitted, Green Published, gold			2022-12-26	WOS:000435655600043
J	Ortega-Beltran, A; Moral, J; Puckett, RD; Morgan, DP; Cotty, PJ; Michailides, TJ				Ortega-Beltran, Alejandro; Moral, Juan; Puckett, Ryan D.; Morgan, David P.; Cotty, Peter J.; Michailides, Themis J.			Fungal communities associated with almond throughout crop development: Implications for aflatoxin biocontrol management in California	PLOS ONE			English	Article							ASPERGILLUS-FLAVUS; BIOLOGICAL-CONTROL; CONTAMINATION; CLIMATE; IDENTIFICATION; PATHOGENICITY; COTTONSEED; PISTACHIO; STRAIN	Interactions between pathogenic and nonpathogenic fungal species in the tree canopy are complex and can determine if disease will manifest in the plant and in other organisms such as honey bees. Seasonal dynamics of fungi were studied in an almond orchard in California where experimental release of the atoxigenic biopesticide Aspergillus flavus AF36 to displace toxigenic Aspergillus strains has been conducted for five years. The presence of the vegetative compatibility group (VCG) YV36, to which AF36 belongs, in the blossoms, and the honey bees that attend these blossoms, was assessed. In blossoms, A. flavus frequencies ranged from 0 to 4.5%, depending on the year of study. Frequencies of honey bees carrying A. flavus ranged from 6.5 to 10%. Only one A. flavus isolate recovered from a blossom in 2016 belonged to YV36, while members of the VCG were not detected contaminating honey bees. Exposure of pollinator honey bees to AF36 was detected to be very low. The density of several Aspergillus species was found to increase during almond hull split and throughout the final stages of maturation; this also occurred in pistachio orchards during the maturation period. Additionally, we found that AF36 effectively limited almond aflatoxin contamination in laboratory assays. This study provides knowledge and understanding of the seasonal dynamics of Aspergillus fungi and will help design aflatoxin management strategies for almond. The evidence of the low levels of VCG YV36 encountered on almond blossoms and bees during pollination and AF36's effectiveness in limiting aflatoxin contamination in almond provided additional support for the registration of AF36 with USEPA to use in almond in California.	[Ortega-Beltran, Alejandro; Moral, Juan; Puckett, Ryan D.; Morgan, David P.; Michailides, Themis J.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Ortega-Beltran, Alejandro; Moral, Juan; Puckett, Ryan D.; Morgan, David P.; Michailides, Themis J.] Kearney Agr Res & Extens Ctr, Parlier, CA 93648 USA; [Cotty, Peter J.] Univ Arizona, USDA ARS, Sch Plant Sci, Tucson, AZ USA; [Ortega-Beltran, Alejandro] Int Inst Trop Agr, Ibadan, Nigeria; [Moral, Juan] Univ Cordoba, Dept Agron, Cordoba, Spain	University of California System; University of California Davis; United States Department of Agriculture (USDA); University of Arizona; CGIAR; International Institute of Tropical Agriculture (IITA); Universidad de Cordoba	Ortega-Beltran, A; Michailides, TJ (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.; Ortega-Beltran, A; Michailides, TJ (corresponding author), Kearney Agr Res & Extens Ctr, Parlier, CA 93648 USA.; Ortega-Beltran, A (corresponding author), Int Inst Trop Agr, Ibadan, Nigeria.	a.beltran@cgiar.org; tjmichailides@ucanr.edu	Michailides, Themis/AAI-6592-2020	Ortega-Beltran, Alejandro/0000-0003-3747-8094; Cotty, Peter/0000-0003-3887-833X	Almond Board of California; Consejo Nacional de Ciencia y Tecnologia - Mexico, Estancia postdoctoral en el extranjero [237422]; European Union's H2020, Marie Skfodowska Curie fellowship [658579]	Almond Board of California; Consejo Nacional de Ciencia y Tecnologia - Mexico, Estancia postdoctoral en el extranjero; European Union's H2020, Marie Skfodowska Curie fellowship	This work was supported by the Almond Board of California (15-AFLA1-Michailides and 16-AFLA1-Michailides (TJM); Consejo Nacional de Ciencia y Tecnologia - Mexico, Estancia postdoctoral en el extranjero, contract number 237422 (AOB); and European Union's H2020, Marie Skfodowska Curie fellowship, contract number 658579 (JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, none of the authors are employed, have relationship as consultants, or are working in patents, product development nor marketing of products for the Almond Board of California.	Amaike S, 2011, ANNU REV PHYTOPATHOL, V49, P107, DOI 10.1146/annurev-phyto-072910-095221; [Anonymous], 2003, BIOPESTICIDE REGISTR; [Anonymous], 2015, 1 CAL ALM ACR REP; [Anonymous], 2012, AMMENDMENT ADD PISTA; Arechavaleta-Velasco ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047269; Bandyopadhyay R, 2016, WORLD MYCOTOXIN J, V9, P771, DOI 10.3920/WMJ2016.2130; Barnett H.L., 1998, ILLUSTRATED GENERA I; Begon M., 1996, ECOLOGY; Campbell BC, 2003, J TOXICOL-TOXIN REV, V22, P225, DOI 10.1081/TXR-120024093; Cavigli I, 2016, APIDOLOGIE, V47, P251, DOI 10.1007/s13592-015-0395-5; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cotty PJ, 2006, MYCOTOXIN FACTBOOK: FOOD & FEED TOPICS, P179; Cotty PJ, 2007, INT J FOOD MICROBIOL, V119, P109, DOI 10.1016/j.ijfoodmicro.2007.07.060; Cotty PJ, 2007, BIOLOGICAL CONTROL: A GLOBAL PERSPECTIVE, P241, DOI 10.1079/9781845932657.0241; COTTY PJ, 1994, PHYTOPATHOLOGY, V84, P1270, DOI 10.1094/Phyto-84-1270; COTTY PJ, 1994, MYCOPATHOLOGIA, V125, P157, DOI 10.1007/BF01146521; COTTY PJ, 1989, PHYTOPATHOLOGY, V79, P808, DOI 10.1094/Phyto-79-808; COTTY PJ, 1994, FEMS SYMP, P1; Council for Agricultural Science and Technology (CAST), 2003, MYCOTOXINS RISKS PLA, P139; Cundiff P., 1995, OFFICIAL METHODS ANA; Diella G, 2015, ANN IG MED PREV COMU, V27, P533, DOI 10.7416/ai.2015.2044; Donner M, 2015, PLANT DIS, V99, P1161, DOI 10.1094/PDIS-05-14-0450-RE; Dorner J W, 2006, Mycotoxin Res, V22, P33, DOI 10.1007/BF02954555; Dorner JW, 2004, J TOXICOL-TOXIN REV, V23, P425, DOI 10.1081/TXR-200027877; Doster M, 2009, BIOCONTROL AFLATOXIN; Doster M, 2007, 2007 ANN MULT AFL FU; Doster MA, 2014, PLANT DIS, V98, P948, DOI 10.1094/PDIS-10-13-1053-RE; Ehrlich KC, 2004, APPL MICROBIOL BIOT, V65, P473, DOI 10.1007/s00253-004-1670-y; Eiri DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126330; Foley K, 2014, VET MICROBIOL, V169, P203, DOI 10.1016/j.vetmic.2013.11.029; Glenny William, 2017, PLoS One, V12, pe0182814, DOI 10.1371/journal.pone.0182814; Jaime-Garcia R, 2003, PHYTOPATHOLOGY, V93, P1190, DOI 10.1094/PHYTO.2003.93.9.1190; Magan N, 2011, PLANT PATHOL, V60, P150, DOI 10.1111/j.1365-3059.2010.02412.x; MICHAILIDES TJ, 1991, PHYTOPATHOLOGY, V81, P566, DOI 10.1094/Phyto-81-566; NEWBERNE PM, 1969, CANCER RES, V29, P236; Palumbo JD, 2014, PLANT DIS, V98, P1194, DOI 10.1094/PDIS-09-13-1015-RE; Paterson RRM, 2010, FOOD RES INT, V43, P1902, DOI 10.1016/j.foodres.2009.07.010; Picot A, 2017, EUR J PLANT PATHOL, V148, P521, DOI 10.1007/s10658-016-1108-2; Probst C, 2011, PLANT DIS, V95, P212, DOI 10.1094/PDIS-06-10-0438; Schafer MO, 2014, VET MICROBIOL, V170, P291, DOI 10.1016/j.vetmic.2014.02.006; Stott PA, 2014, B AM METEOROL SOC, V95, pS1; Sumner D.A., 2014, EC IMPACTS CALIFORNI; Swain DL, 2014, B AM METEOROL SOC, V95, pS3; Teviotdale B. L., 2002, COMPENDIUM NUT CROP; USEPA, 2017, ASP FLAV AF36 AM EX; VanEngelsdorp D, 2015, FRONTIERS GENETICS, V6; von Arx JA, 1981, GENERA FUNGI SPORULA; Whitaker T, 2010, WORLD MYCOTOXIN J, V3, P157, DOI 10.3920/WMJ2010.1209; Williams JH, 2004, AM J CLIN NUTR, V80, P1106, DOI 10.1093/ajcn/80.5.1106; Wu F, 2015, WORLD MYCOTOXIN J, V8, P137, DOI 10.3920/WMJ2014.1737; Xu XM, 2011, PHYTOPATHOLOGY, V101, P1024, DOI 10.1094/PHYTO-08-10-0216; Zar JH, 1999, BIOSTATISTICAL ANAL	52	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199127	10.1371/journal.pone.0199127	http://dx.doi.org/10.1371/journal.pone.0199127			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924839	Green Published, Green Submitted, gold			2022-12-26	WOS:000435655600047
J	Shiono, A; Kogo, J; Sasaki, H; Yomoda, R; Jujo, T; Tokuda, N; Kitaoka, Y; Takagi, H				Shiono, Akira; Kogo, Jiro; Sasaki, Hiroki; Yomoda, Ryo; Jujo, Tatsuya; Tokuda, Naoto; Kitaoka, Yasushi; Takagi, Hitoshi			Optical coherence tomography findings as a predictor of clinical course in patients with branch retinal vein occlusion treated with ranibizumab	PLOS ONE			English	Article							EPIRETINAL MEMBRANE SURGERY; MACULAR HOLE SURGERY; INTRAVITREAL BEVACIZUMAB THERAPY; 3 MONTHLY INJECTIONS; CAPILLARY NONPERFUSION; FOVEAL MICROSTRUCTURE; DIABETIC-RETINOPATHY; PROGNOSTIC-FACTOR; VISUAL-ACUITY; AUTOMATED QUANTIFICATION	Purpose To examine the relationship between optical coherence tomography (OCT) images and clinical course in eyes with branch retinal vein occlusion (BRVO) treated with intravitreal ranibizumab injection (IVR). Design Prospective cohort study. Participants Thirty eyes of 30 patients with BRVO treated with IVR. Methods All patients received 1 initial IVR followed by repeated injections in the pro re nata (PRN) regimen. Correlations between logarithm of minimum angle of resolution best-corrected visual acuity (logMAR BCVA) or number of IVRs after 12 months and OCT parameters including the external limiting membrane (ELM), ellipsoid zone (EZ), interdigitation zone (IZ), and photoreceptor outer segment (PROS) length at first resolution of macular edema (ME) were assessed. Resolution of ME was defined as central foveal thickness <300 mu m and the absence of subretinal fluid. OCT parameters influencing BCVA and number of IVRs were evaluated using multivariate analysis. Correlations between nonperfusion areas (NPAs) and thinning areas and changes in retinal thickness of BRVO-affected areas were assessed. Results Of the 30 patients, 27 completed this study and were included in the statistical analyses. The mean logMAR BCVA at 3, 6, and 12 months was 0.16 +/- 0.19, 0.09 +/- 0.20, and 0.07 +/- 0.20, respectively, which improved significantly from baseline at each visit (p < 0.0001, respectively), while the mean number of IVRs at 12 months was 3.9 +/- 2.2. The mean number of IVRs for the first resolution of ME was 1.6 +/- 0.8. Eyes with ELM and EZ defects at the points of first resolution of ME were correlated with a significantly lower BCVA at 12 months compared with eyes with preserved ELMs and EZs (p = 0.035, p = 0.002, respectively). However, eyes with IZ defects at the points of first resolution of ME were not correlated with a significantly lower BCVA at 12 months compared with eyes with preserved IZs (p = 0.160). Defects in the EZ at the points of first resolution of ME significantly affected the number of IVRs at 12 months (p = 0.042), although the ELM and IZ did not. PROS length at the points of first resolution of ME was significantly correlated with BCVA and number of IVRs at 12 months (p = 0.006, p = 0.0008, respectively). In multivariate analysis, PROS length at the points of first resolution of ME had the most significant effect on BCVA and number of IVRs (p = 0.013, p = 0.012, respectively). NPA size on fluorescein angiography and thinning area on OCT within the macular area showed a significant correlation (p = 0.003, r = 0.971). The retinal thickness of ischemic BRVO-affected areas was significantly less than that of control areas at 10, 11, and 12 months (p = 0.001, p = 0.005, p = 0.003, respectively). Conclusion We showed that the 1+PRN regimen may be a useful therapy for ME due to BRVO. In addition, PROS length at points of first resolution of ME appears to be a good indicator of BCVA and number of IVRs in BRVO patients.	[Shiono, Akira; Kogo, Jiro; Sasaki, Hiroki; Yomoda, Ryo; Jujo, Tatsuya; Tokuda, Naoto; Kitaoka, Yasushi; Takagi, Hitoshi] St Marianna Univ, Sch Med, Dept Ophthalmol, Kawasaki, Kanagawa, Japan	Saint Marianna University	Kogo, J (corresponding author), St Marianna Univ, Sch Med, Dept Ophthalmol, Kawasaki, Kanagawa, Japan.	kogo@marianna-u.ac.jp		Kogo, Jiro/0000-0003-1259-1509	Novartis Pharma K.K.	Novartis Pharma K.K.(Novartis)	This work received research funding support from Novartis Pharma K.K. The providers of that funding had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkabes M, 2013, GRAEF ARCH CLIN EXP, V251, P2521, DOI 10.1007/s00417-013-2347-y; [Anonymous], 1984, AM J OPHTHALMOL, V98, P271; Ashraf M, 2016, BRIT J OPHTHALMOL, V100, P1596, DOI 10.1136/bjophthalmol-2016-308388; Brown DM, 2011, OPHTHALMOLOGY, V118, P1594, DOI 10.1016/j.ophtha.2011.02.022; Campochiaro PA, 2015, OPHTHALMOLOGY, V122, P538, DOI 10.1016/j.ophtha.2014.08.031; Campochiaro PA, 2014, OPHTHALMOLOGY, V121, P209, DOI 10.1016/j.ophtha.2013.08.038; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P1102, DOI 10.1016/j.ophtha.2010.02.021; Chang YC, 2015, AM J OPHTHALMOL, V160, P100, DOI 10.1016/j.ajo.2015.03.019; Chen SN, 2011, RETINA-J RET VIT DIS, V31, P730, DOI 10.1097/IAE.0b013e3181f2a15c; Cheng D, 2016, INVEST OPHTH VIS SCI, V57, P5470, DOI 10.1167/iovs.16-19568; Chung EJ, 2008, GRAEF ARCH CLIN EXP, V246, P1241, DOI 10.1007/s00417-008-0866-8; Ebneter A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119046; Hasegawa T, 2015, GRAEF ARCH CLIN EXP, V253, P343, DOI 10.1007/s00417-014-2695-2; Hasegawa T, 2014, AM J OPHTHALMOL, V157, P390, DOI 10.1016/j.ajo.2013.10.007; Heier JS, 2012, OPHTHALMOLOGY, V119, P802, DOI 10.1016/j.ophtha.2011.12.005; Hwang TS, 2016, JAMA OPHTHALMOL, V134, P367, DOI 10.1001/jamaophthalmol.2015.5658; Imai A, 2015, EUR J OPHTHALMOL, V25, P153, DOI 10.5301/ejo.5000514; Ito Y, 2015, CLIN OPHTHALMOL, V9, P175, DOI 10.2147/OPTH.S76261; Jaissle GB, 2011, GRAEF ARCH CLIN EXP, V249, P183, DOI 10.1007/s00417-010-1470-2; Kang HM, 2013, GRAEF ARCH CLIN EXP, V251, P501, DOI 10.1007/s00417-012-2067-8; Kim M, 2017, GRAEF ARCH CLIN EXP, V255, P691, DOI 10.1007/s00417-016-3535-3; Kimura M, 2016, CLIN OPHTHALMOL, V10, P1291, DOI 10.2147/OPTH.S108630; Kogo J, 2017, ADV THER, V34, P2139, DOI 10.1007/s12325-017-0598-4; Lim HB, 2015, INVEST OPHTH VIS SCI, V56, P6622, DOI 10.1167/iovs.15-17678; Miwa Y, 2017, RETINA-J RET VIT DIS, V37, P702, DOI 10.1097/IAE.0000000000001224; Narayanan R, 2015, BRIT J OPHTHALMOL, V99, P954, DOI 10.1136/bjophthalmol-2014-306543; Okamoto F, 2015, RETINA-J RET VIT DIS, V35, P2107, DOI 10.1097/IAE.0000000000000602; Ooka E, 2011, AM J OPHTHALMOL, V152, P283, DOI 10.1016/j.ajo.2011.02.001; Pichi F, 2019, INT OPHTHALMOL, V39, P145, DOI 10.1007/s10792-017-0798-6; PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217; Sakimoto S, 2015, INVEST OPHTH VIS SCI, V56, P640, DOI 10.1167/iovs.14-15673; Scott IU, 2009, ARCH OPHTHALMOL-CHIC, V127, P1115, DOI 10.1001/archophthalmol.2009.233; Shimozono M, 2012, AM J OPHTHALMOL, V153, P698, DOI 10.1016/j.ajo.2011.09.011; Shiono A, 2013, OPHTHALMOLOGY, V120, P788, DOI 10.1016/j.ophtha.2012.09.044; Simader C, 2014, OPHTHALMOLOGY, V121, P1237, DOI 10.1016/j.ophtha.2013.12.029; Thach AB, 2014, OPHTHALMOLOGY, V121, P1059, DOI 10.1016/j.ophtha.2013.11.022; Unoki N, 2007, AM J OPHTHALMOL, V144, P755, DOI 10.1016/j.ajo.2007.07.011; Wakabayashi T, 2010, OPHTHALMOLOGY, V117, P1815, DOI 10.1016/j.ophtha.2010.01.017; Zhang M, 2016, INVEST OPHTH VIS SCI, V57, P5101, DOI 10.1167/iovs.16-19776	39	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199552	10.1371/journal.pone.0199552	http://dx.doi.org/10.1371/journal.pone.0199552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924853	Green Published, gold, Green Submitted			2022-12-26	WOS:000435655600074
J	Kabir, A; Miah, S; Islam, A				Kabir, Ashraful; Miah, Shahgahan; Islam, Asraful			Factors influencing eating behavior and dietary intake among resident students in a public university in Bangladesh: A qualitative study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; YOUNG-ADULTS; FOOD CHOICE; HABITS; DETERMINANTS; PATTERN; STRESS	Background Over the past decades, Bangladesh has made substantial progress in improving higher education, and in part, this was achieved by promoting residence based higher education in public universities. University residency is considered a crucial period for students to develop healthy eating habits and adopt nutritious intake, which comprise a strong foundation for good health throughout life. Although, there is extensive literature on eating behaviors and dietary intake internationally, there appears to be relatively scarce research and analysis concerning Bangladesh. This study aims to address this, by investigating the factors that influence eating behavior and dietary intake. Methods Adopting a qualitative approach, we conducted 25 in-depth interviews and 13 focus group discussions with students of various disciplines and semesters. We used thematic analysis to analyze the textual data, and methodological triangulation to validate the information provided. Results Student eating behavior and dietary intake are influenced by a variety of factors. Individual factors (cooking skills, food taste, food taboos, and knowledge and perceptions), societal factors (influence of peers and social norms), factors related to university (campus culture and frequency of examination), and environmental factors (availability of cooking resources and facilities and food prices) emerged as the key aspects that determine students' eating behavior and dietary intake. Conclusion This is the first study that explored factors influencing nutritional behavior and dietary intake among resident graduates in a Bangladeshi university. The results suggest that resident students have a poor dietary intake that might have a harmful impact on their health, wellbeing, and academic performance. Therefore, multilevel nutritional interventions may be beneficial to promote healthy eating behavior and dietary intake among university students.	[Kabir, Ashraful] Dushtha Shasthya Kendra, Dhaka, Bangladesh; [Miah, Shahgahan; Islam, Asraful] Shahjalal Univ Sci & Technol, Dept Anthropol, Sylhet, Bangladesh	Shahjalal University of Science & Technology (SUST)	Kabir, A (corresponding author), Dushtha Shasthya Kendra, Dhaka, Bangladesh.	ashraful262@yahoo.com	Miah, Md./AGH-4618-2022	Miah, Md./0000-0001-9604-8823				Albert Bandura, 1986, SOCIAL FDN THOUGHT A; ALSUDAIRY A, 1992, J ROY SOC HEALTH, V112, P217, DOI 10.1177/146642409211200503; Alves Hayda Josiane, 2007, Rev. Saúde Pública, V41, P197, DOI 10.1590/S0034-89102007000200005; Bagordo F, 2013, J FOOD NUTR RES, V52; Banna JC, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2724-7; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Contento IR, 2006, J ADOLESCENT HEALTH, V38, P575, DOI 10.1016/j.jadohealth.2005.05.025; Cooper R G, 2011, West Afr J Med, V30, P42; Davis J., 2013, CROSSING CUSTOMS INT; Deliens T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-53; Downes L, 2015, JNP-J NURSE PRACT, V11, P192, DOI 10.1016/j.nurpra.2014.11.015; DREWNOWSKI A, 1995, AM J CLIN NUTR, V62, P1081, DOI 10.1093/ajcn/62.5.1081S; Drewnowski A, 1997, ANNU REV NUTR, V17, P237, DOI 10.1146/annurev.nutr.17.1.237; Duarte-Cuervo Clara Y, 2015, Rev. salud pública, V17, P925, DOI 10.15446/rsap.v17n6.38368; Dyson R, 2006, J CLIN PSYCHOL, V62, P1231, DOI 10.1002/jclp.20295; El Ansari W, 2015, CENT EUR J PUBL HEAL, V23, P306, DOI 10.21101/cejph.a4195; Fismen AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148541; Florence MD, 2008, J SCHOOL HEALTH, V78, P209, DOI 10.1111/j.1746-1561.2008.00288.x; Gan W Y, 2011, Malays J Nutr, V17, P213; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hernandez J, 2016, EATING BEHAV U STUDE; Hilger J, 2017, APPETITE, V109, P100, DOI 10.1016/j.appet.2016.11.016; Hu P, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070696; Kabir A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172119; Kretchmer Norman, 1996, American Journal of Clinical Nutrition, V63, p997S; Krueger Richard A, 2000, FOCUS GROUPS PRACTIC, V3rd; LaCaille LJ, 2011, J AM COLL HEALTH, V59, P531, DOI 10.1080/07448481.2010.523855; Larson NI, 2006, J AM DIET ASSOC, V106, P2001, DOI 10.1016/j.jada.2006.09.008; Li KK, 2012, J NUTR EDUC BEHAV, V44, P246, DOI 10.1016/j.jneb.2010.10.002; Neslisah R, 2011, NUTR RES PRACT, V5, P117, DOI 10.4162/nrp.2011.5.2.117; NNANYELUGO DO, 1987, J AM COLL NUTR, V6, P369, DOI 10.1080/07315724.1987.10720201; Otemuyiwa Israel O., 2012, Nutrition and Health (Bicester), V21, P233, DOI 10.1177/0260106013510994; Papadaki A, 2007, APPETITE, V49, P169, DOI 10.1016/j.appet.2007.01.008; Papier K, 2015, NUTRITION, V31, P324, DOI 10.1016/j.nut.2014.08.004; Pei-Lin Hsieh, 2004, J Nurs Res, V12, P83; Peltzer Karl, 2014, Int J Adolesc Med Health, V26, P531, DOI 10.1515/ijamh-2013-0331; Schnettler B, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00165615, 10.1590/0102-311x00165615]; Soriano JM, 2000, NUTR RES, V20, P1249, DOI 10.1016/S0271-5317(00)00217-7; Stock Christiane, 2008, Ugeskr Laeger, V170, P334; Story M, 2002, J AM DIET ASSOC, V102, pS40, DOI 10.1016/S0002-8223(02)90421-9; Thorpe MG, 2014, PUBLIC HEALTH NUTR, V17, P1767, DOI 10.1017/S1368980013001924; UGC, 2014, U GRANTS COMM BANGL; Wyka Joanna, 2006, Rocz Panstw Zakl Hig, V57, P381	43	49	51	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0198801	10.1371/journal.pone.0198801	http://dx.doi.org/10.1371/journal.pone.0198801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ7CA	29920535	Green Published, Green Submitted, gold			2022-12-26	WOS:000435541300010
J	Blay, C; Planes, S; Ky, CL				Blay, Carole; Planes, Serge; Ky, Chin-Long			Optimal age of the donor graft tissue in relation to cultured pearl phenotypes in the mollusc, Pinctada margaritifera	PLOS ONE			English	Article							OYSTER; GROWTH; EXPRESSION; QUALITY; COLOR; DEPENDENCE; SEASON; GRADE; MODEL; SKILL	Ageing is defined as the progressive decline in tissue and organ functions over time. This study aims to evaluate the ageing effect on cultured pearl quality phenotypes (including size and quality traits) in the graft-recipient animal model: Pinctada margaritifera. For this, eight uniform grafting experiments were designed using two hatchery-produced pearl oyster families as donors, which were followed through time, between 7 and 30 months in age. For each age category, 20 donors were studied for each culture site giving a total of 2400 grafted oysters. Several phenotypic measurements were made: 1) donor family growth performance from shell size records, 2) pearl size and corresponding quality traits, and 3) expression of some genes related to biomineralization processes on both the mantle graft and on pearl sac tissues. Results showed that: 1) donor age has an impact on pearl size, with grafts coming from the youngest donors yielding the biggest pearls; and 2) grafts from donors between 12 and 18 months in age produced pearls of the highest quality (grade and surface quality), a result supported by an analysis where the level of expression for a panel of genes associated with biomineralization was greatest in donors within the 12 to 18 months age group. These results indicate that donors aged between 12 and 18 months have high potential for biomineralisation and nacre deposition, and likely produce larger and higher quality cultured pearls than older donors.	[Blay, Carole; Ky, Chin-Long] IFREMER, UMR 241, Ctr Pacifique, EIO,Labex Corail, Tahiti, French Polynesi, France; [Blay, Carole; Planes, Serge] PSL Res Univ, USR 3278, Univ Perpignan, EPHE,UPVD,CNRS,CRIOBE,Labex Corail, Perpignan, France	Ifremer; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Perpignan Via Domitia	Ky, CL (corresponding author), IFREMER, UMR 241, Ctr Pacifique, EIO,Labex Corail, Tahiti, French Polynesi, France.	chinky@ifremer.fr	PLANES, Serge/ABF-1360-2021		"Direction des ressources marines et Minieres", through the TripaGEN project [9532/MEI/DRMM]; SCA Regahiga Pearls (Mangareva island, Gambier archipelago, French Polynesia); Gauguin's pearl farm (Rangiroa atoll, Tuamotu archipelago, French Polynesia)	"Direction des ressources marines et Minieres", through the TripaGEN project; SCA Regahiga Pearls (Mangareva island, Gambier archipelago, French Polynesia); Gauguin's pearl farm (Rangiroa atoll, Tuamotu archipelago, French Polynesia)	This study was supported by grants from the "Direction des ressources marines et Minieres", through the TripaGEN project (2015-2017)-#9532/MEI/DRMM to Chin-Long Ky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors especially would like to thank the host sites, SCA Regahiga Pearls (Mangareva island, Gambier archipelago, French Polynesia) and Gauguin's pearl farm (Rangiroa atoll, Tuamotu archipelago, French Polynesia) for their generous support. The authors are indebted to S. Parrad, S. Escaich, S. Nakasai, C. Lo, P. Cabral and D. Devaux for their helpful assistance.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Blay C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02457-x; Blay C, 2016, ESTUAR COAST SHELF S, V182, P254, DOI 10.1016/j.ecss.2016.05.020; Bronikowski A. M., 2010, NATURE ED KNOWLEDGE, V1, P3; Comas LH, 2010, AUST J GRAPE WINE R, V16, P131, DOI 10.1111/j.1755-0238.2009.00078.x; Fabian D., 2011, NAT EDU KNOW, V2, P9; Flatt Thomas, 2012, Frontiers in Genetics, V3, P148, DOI 10.3389/fgene.2012.00148; Gervis M.H., 1992, ICLARM STUD REV, V21, P49; Jerry DR, 2012, AQUACULTURE, V338, P66, DOI 10.1016/j.aquaculture.2012.02.001; Joubert C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103944; Kubota T, 2018, ANN SURG, V267, P1126, DOI 10.1097/SLA.0000000000002194; Ky C.-L., 2017, J AQUAC RES DEV, V8, P1, DOI [10.4172/2155-9546.1000480., DOI 10.4172/2155-9546.1000480]; Ky CL, 2017, AQUAC RES, V48, P955, DOI 10.1111/are.12938; Ky CL, 2017, AQUAC RES, V48, P270, DOI 10.1111/are.12880; Ky CL, 2015, J SHELLFISH RES, V34, P811, DOI 10.2983/035.034.0310; Ky CL, 2015, AQUACULTURE, V435, P361, DOI 10.1016/j.aquaculture.2014.10.014; Ky CL, 2014, AQUACULT INT, V22, P1689, DOI 10.1007/s10499-014-9774-6; Ky CL, 2013, AQUAT LIVING RESOUR, V26, P133, DOI 10.1051/alr/2013055; Ky CL, 2017, AQUACULTURE RES; Le Pabic L, 2016, ESTUAR COAST SHELF S, V182, P294, DOI 10.1016/j.ecss.2016.03.009; Lemer S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1776-x; McGinty EL, 2010, AQUACULTURE, V302, P175, DOI 10.1016/j.aquaculture.2010.02.023; Medawar PB, 1955, CIBA FDN COLLOQUIA A, V1; Mencuccini M, 2005, ECOL LETT, V8, P1183, DOI 10.1111/j.1461-0248.2005.00819.x; Mencuccini M, 2007, TREE PHYSIOL, V27, P463, DOI 10.1093/treephys/27.3.463; Mudge K., 2009, Horticultural Reviews, V35, P437; Muller A., 2013, SEAWATER CULTURED PE; Partridge L, 1996, P ROY SOC B-BIOL SCI, V263, P1365, DOI 10.1098/rspb.1996.0200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pouvreau S, 2000, AQUACULTURE, V184, P133, DOI 10.1016/S0044-8486(99)00319-1; Pouvreau S, 2001, AQUAT LIVING RESOUR, V14, P155, DOI 10.1016/S0990-7440(01)01120-2; Promislow Daniel E.L., 2006, P464; R Core Team, 2016, R FDN STAT COMP; Rose M.R., 1991, EVOLUTIONARY BIOL AG; Selzner M, 2009, LIVER TRANSPLANT, V15, P1288, DOI 10.1002/lt.21828; Southgate P, 2008, PEARL OYSTER, pVII; Tatar Marc, 2001, P128; Tayale A, 2012, AQUAT LIVING RESOUR, V25, P269, DOI 10.1051/alr/2012034; Taylor J. D., 1969, Bulletin of the British Museum (Natural History) Zoology, P1; Serrano MT, 2010, CLIN TRANSPLANT, V24, P543, DOI 10.1111/j.1399-0012.2009.01135.x; Valadao RM, 2009, LIVER TRANSPLANT, V15, P677, DOI 10.1002/lt.21801; Wang K, 2015, HEPATOB PANCREAT DIS, V14, P50, DOI 10.1016/S1499-3872(15)60334-4; Watson JM, 2011, GERONTOLOGY, V57, P129, DOI 10.1159/000310174; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	44	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198505	10.1371/journal.pone.0198505	http://dx.doi.org/10.1371/journal.pone.0198505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912963	gold, Green Submitted, Green Published			2022-12-26	WOS:000435528600031
J	Zuckerman, A; Douglas, A; Nwosu, S; Choi, L; Chastain, C				Zuckerman, Autumn; Douglas, Andrew; Nwosu, Sam; Choi, Leena; Chastain, Cody			Increasing success and evolving barriers in the hepatitis C cascade of care during the direct acting antiviral era	PLOS ONE			English	Article							VIRUS-INFECTION; UNITED-STATES; ACCESS; FACILITATORS; COMPLETION; ADHERENCE; THERAPY; RISK	Barriers remain in the hepatitis C virus (HCV) cascade of care (CoC), limiting the overall impact of direct acting antivirals. This study examines movement between the stages of the HCV CoC and identifies reasons why patients and specific patient populations fail to advance through care in a real world population. We performed a single-center, ambispective cohort study of patients receiving care in an outpatient infectious diseases clinic between October 2015 and September 2016. Patients were followed from treatment referral through sustained virologic response. Univariate and multivariate analyses were performed to identify factors related to completion of each step of the CoC. Of 187 patients meeting inclusion criteria, 120 (64%) completed an evaluation for HCV treatment, 119 (64%) were prescribed treatment, 114 (61%) were approved for treatment, 113 (60%) initiated treatment, 107 (57%) completed treatment, and 100 (53%) achieved a sustained virologic response. In univariate and multivariate analyses, patients with Medicaid insurance were less likely to complete an evaluation and were less likely to be approved for treatment. Treatment completion and SVR rates are much improved from historical CoC reports. However, linkage to care following referral continues to be a formidable challenge for the HCV CoC in the DAA era. Ongoing efforts should focus on linkage to care to capitalize on DAA treatment advances and improving access for patients with Medicaid insurance.	[Zuckerman, Autumn] Vanderbilt Univ, Med Ctr, Vanderbilt Specialty Pharm Serv, Nashville, TN 37235 USA; [Douglas, Andrew] Belmont Univ, Coll Pharm, Nashville, TN USA; [Nwosu, Sam; Choi, Leena] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Chastain, Cody] Vanderbilt Univ, Med Ctr, Div Infect Dis, Dept Med, Nashville, TN USA	Vanderbilt University; Belmont University; Vanderbilt University; Vanderbilt University	Zuckerman, A (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Specialty Pharm Serv, Nashville, TN 37235 USA.	Autumn.Zuckerman@vanderbilt.edu						AASLD-IDSA, 2017, WHOM IN HCV THER REC; Bagwell AC, 2016, HEPATITIS C TREATMEN, DOI [10.1007/s40506-016-0097-1, DOI 10.1007/S40506-016-0097-1]; Barua S, 2015, ANN INTERN MED, V163, P215, DOI 10.7326/M15-0406; Belperio PS, 2017, ANN INTERN MED, V167, P499, DOI 10.7326/M17-1073; Bourgi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161241; Cachay ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102883; Canary LA, 2015, ANN INTERN MED, V163, P226, DOI 10.7326/M15-0320; Clough B, 2017, TRIO HLTH REAL WORLD; Committee on a National Strategy for the Elimination of Hepatitis B and C Board on Population Health and Public Health Practice Health and Medicine Division National Academies of Sciences E and Medi-cine Eliminating the Public Health Problem of Hepatitis B and C in the United States, 2016, COMM NAT STRAT EL HE; Dever JB, 2017, DIGEST DIS SCI, V62, P1472, DOI 10.1007/s10620-017-4548-4; Dimova RB, 2013, CLIN INFECT DIS, V56, P806, DOI 10.1093/cid/cis1007; Do A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135645; Jonas MC, 2016, CLIN INFECT DIS, V62, P1290, DOI 10.1093/cid/ciw086; Kim AY, 2017, CLIN INFECT DIS, V65, P709, DOI 10.1093/cid/cix501; Koneru A, 2016, MMWR-MORBID MORTAL W, V65, P705, DOI 10.15585/mmwr.mm6528a2; Lo Re V, 2016, CLIN GASTROENTEROL H, V14, P1035, DOI 10.1016/j.cgh.2016.03.040; Loy V, 2016, ANTIVIR THER, V21, P731, DOI 10.3851/IMP3068; Machado SM, 2017, REV SAUDE PUBL, V51, DOI [10.1590/s1518-8787.2017051006468, 10.1590/S1518-8787.2017051006468]; Millman Alexander J, 2017, Top Antivir Med, V25, P110; Rogal SS, 2017, DIGEST DIS SCI, V62, P1933, DOI 10.1007/s10620-017-4608-9; Souliotis K, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0601-3; Sublette VA, 2017, J HEALTH PSYCHOL, V22, P1300, DOI 10.1177/1359105315626786; Wade AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142770; WHOGhssovh, 2016, 2016 2021 WHOGHSSOVH; Yehia BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101554; Younossi Z, 2017, LIV M WASH DC; Younossi ZM, 2016, J VIRAL HEPATITIS, V23, P447, DOI 10.1111/jvh.12506; Zhou K, 2016, LANCET INFECT DIS, V16, P1409, DOI 10.1016/S1473-3099(16)30208-0	28	58	58	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0199174	10.1371/journal.pone.0199174	http://dx.doi.org/10.1371/journal.pone.0199174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912944	Green Published, gold, Green Submitted			2022-12-26	WOS:000435528600082
J	Pereira, SLS; Martins, CPS; Sousa, AO; Camillo, LR; Araujo, CP; Alcantara, GM; Camargo, DS; Cidade, LC; de Almeida, AAF; Costa, MGC				Pereira, Suzam L. S.; Martins, Cristina P. S.; Sousa, Aurizangela O.; Camillo, Luciana R.; Araujo, Caroline P.; Alcantara, Grazielle M.; Camargo, Danielle S.; Cidade, Luciana C.; de Almeida, Alex-Alan F.; Costa, Marcio G. C.			Genome-wide characterization and expression analysis of citrus NUCLEAR FACTOR-Y (NF-Y) transcription factors identified a novel NF-YA gene involved in drought-stress response and tolerance	PLOS ONE			English	Article							CCAAT-BINDING-FACTOR; LEAFY COTYLEDON1; COMPLEX; OVEREXPRESSION; CONSTANS; FAMILIES; PHOTOSYNTHESIS; EMBRYOGENESIS; REGULATOR; PROMOTER	Nuclear factor Y (NF-Y) is a ubiquitous transcription factor found in eukaryotes. It is composed of three distinct subunits called NF-YA, NF-YB and NF-YC. NF-Ys have been identified as key regulators of multiple pathways in the control of development and tolerance to biotic and abiotic factors. The present study aimed to identify and characterize the complete repertoire of genes coding for NF-Y in citrus, as well as to perform the functional characterization of one of its members, namely CsNFYA5, in transgenic tobacco plants. A total of 22 genes coding for NF-Y were identified in the genomes of sweet orange (Citrus sinensis) and Clementine mandarin (C. clementina), including six CsNF-YAs, 11 CsNF-YBs and five CsNF-YCs. Phylogenetic analyses showed that there is a NF-Y orthologous in the Clementine genome for each sweet orange NF-Y gene; this was not observed when compared to Arabidopsis thaliana. CsNF-Y proteins shared the same conserved domains with their orthologous proteins in other organisms, including mouse. Analysis of gene expression by RNA-seq and EST data demonstrated that CsNF-Ys have a tissue-specific and stress inducible expression profile. qRT-PCR analysis revealed that CsNF-YA5 exhibits differential expression in response to water deficit in leaves and roots of citrus plants. Overexpression of CsNF-YA5 in transgenic tobacco plants contributed to the reduction of H2O2 production under dehydration conditions and increased plant growth and photosynthetic rate under normal conditions and drought stress. These biochemical and physiological responses to drought stress promoted by CsNF-YA5 may confer a productivity advantage in environments with frequent short-term soil water deficit.	[Pereira, Suzam L. S.; Martins, Cristina P. S.; Sousa, Aurizangela O.; Camillo, Luciana R.; Araujo, Caroline P.; Alcantara, Grazielle M.; Camargo, Danielle S.; Cidade, Luciana C.; de Almeida, Alex-Alan F.; Costa, Marcio G. C.] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ctr Biotecnol & Genet, Ilheus, BA, Brazil	Universidade Estadual de Santa Cruz	Costa, MGC (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Ctr Biotecnol & Genet, Ilheus, BA, Brazil.	marciogc.costa@gmail.com	Costa, Marcio/AAG-3285-2020	Costa, Marcio/0000-0002-4358-5489	CNPq [478733/2013-5]; Instituto Nacional de Ciencia e Tecnologia (INCT) de Genomica para Melhoramento de Citros (CNPq) [465440/2014-2]; Instituto Nacional de Ciencia e Tecnologia (INCT) de Genomica para Melhoramento de Citros (FAPESP) [2008/2014/50880-0]; Embrapa (Macroprograma 2); CAPES Foundation Masters Degree scholarship; CAPES/PNPD postdoctoral fellowship	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia (INCT) de Genomica para Melhoramento de Citros (CNPq); Instituto Nacional de Ciencia e Tecnologia (INCT) de Genomica para Melhoramento de Citros (FAPESP); Embrapa (Macroprograma 2)(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); CAPES Foundation Masters Degree scholarship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES/PNPD postdoctoral fellowship	This work was supported by research grants from CNPq (Process # 478733/2013-5), Instituto Nacional de Ciencia e Tecnologia (INCT) de Genomica para Melhoramento de Citros (CNPq Process # 465440/2014-2 and FAPESP Process # 2008/2014/50880-0) and Embrapa (Macroprograma 2). S.L.S. Pereira was supported by a CAPES Foundation Masters Degree scholarship. D.S. Camargo and L.R. Camillo were supported by a CAPES/PNPD postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2015, PLANT BIOTECHNOL J, V13, P85, DOI 10.1111/pbi.12239; Ballif J, 2011, PLANT PHYSIOL BIOCH, V49, P579, DOI 10.1016/j.plaphy.2011.01.013; Battaglia M, 2014, PLANT PHYSIOL, V164, P1430, DOI 10.1104/pp.113.230896; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Cao S, 2014, PLANT CELL, V26, P1009, DOI 10.1105/tpc.113.120352; Cao SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021805; Chen M, 2014, PLANT BIOTECHNOL J, V12, P447, DOI [10.1111/pbi.12151, 10.1111/pbi.12270]; Combier JP, 2008, GENE DEV, V22, P1549, DOI 10.1101/gad.461808; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Erismann ND, 2008, PHOTOSYNTH RES, V96, P163, DOI 10.1007/s11120-008-9297-y; Feng ZJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01142; Fornari M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082043; Gnesutta N, 2017, PLANT CELL, V29, P1516, DOI 10.1105/tpc.16.00864; Goncalves LP, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2198-3; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Han X, 2013, J EXP BOT, V64, P4589, DOI 10.1093/jxb/ert262; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; Huang MK, 2015, PLANT CELL, V27, P3099, DOI 10.1105/tpc.15.00750; Jefferson R A, 1987, EMBO J, V6, P3901; Kumimoto RW, 2008, PLANTA, V228, P709, DOI 10.1007/s00425-008-0773-6; Kusnetsov V, 1999, J BIOL CHEM, V274, P36009, DOI 10.1074/jbc.274.50.36009; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Laloum T, 2014, PLANT J, V79, P757, DOI 10.1111/tpj.12587; Laloum T, 2013, TRENDS PLANT SCI, V18, P157, DOI 10.1016/j.tplants.2012.07.004; Laporte P, 2014, J EXP BOT, V65, P481, DOI 10.1093/jxb/ert392; Levesque-Lemay M, 2003, PLANT CELL REP, V21, P804, DOI 10.1007/s00299-003-0588-7; Li S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2334-2; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liang MX, 2014, PLANTA, V239, P107, DOI 10.1007/s00425-013-1964-3; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Martins CPS, 2017, PLANTA, V245, P951, DOI 10.1007/s00425-017-2653-4; Miyoshi K, 2003, PLANT J, V36, P532, DOI 10.1046/j.1365-313X.2003.01897.x; Mu JY, 2013, MOL PLANT, V6, P188, DOI 10.1093/mp/sss061; Myers ZA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006333; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Ni ZY, 2013, PLANT MOL BIOL, V82, P113, DOI 10.1007/s11103-013-0040-5; Parcy F, 1997, PLANT CELL, V9, P1265, DOI 10.1105/tpc.9.8.1265; Pedroso FKJV, 2014, ENVIRON EXP BOT, V101, P26, DOI 10.1016/j.envexpbot.2013.12.024; Petroni K, 2012, PLANT CELL, V24, P4777, DOI 10.1105/tpc.112.105734; Quach T, 2015, MOL GENET GENOMICS, V290, P1095, DOI 10.1007/s00438-014-0978-2; Ripodas C, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00761; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Martins CDS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138786; Siriwardana CL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006496; Sorin C, 2014, NEW PHYTOL, V202, P1197, DOI 10.1111/nph.12735; Soyano T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003352; Steidl S, 2004, J MOL BIOL, V342, P515, DOI 10.1016/j.jmb.2004.07.011; Stephenson TJ, 2011, FUNCT INTEGR GENOMIC, V11, P327, DOI 10.1007/s10142-011-0212-9; Stephenson TJ, 2010, FUNCT INTEGR GENOMIC, V10, P265, DOI 10.1007/s10142-010-0158-3; Sun XC, 2014, GENE, V551, P214, DOI 10.1016/j.gene.2014.08.059; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang Y, 2017, MOL PLANT, V10, P260, DOI 10.1016/j.molp.2016.11.007; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087723; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; WEST MAL, 1994, PLANT CELL, V6, P1731, DOI 10.1105/tpc.6.12.1731; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Zhang T, 2015, PLANT PHYSIOL BIOCH, V94, P153, DOI 10.1016/j.plaphy.2015.05.001; Zhao M, 2011, NEW PHYTOL, V190, P906, DOI 10.1111/j.1469-8137.2011.03647.x	64	18	22	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2018	13	6							e0199187	10.1371/journal.pone.0199187	http://dx.doi.org/10.1371/journal.pone.0199187			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5RI	29906271	gold, Green Submitted, Green Published			2022-12-26	WOS:000435439400014
J	Di Modugno, F; Spada, S; Palermo, B; Visca, P; Iapicca, P; Di Carlo, A; Antoniani, B; Sperduti, I; Di Benedetto, A; Terrenato, I; Mottolese, M; Gandolfi, F; Facciolo, F; Chen, EI; Schwartz, MA; Santoni, A; Bissell, MJ; Nistico, P				Di Modugno, Francesca; Spada, Sheila; Palermo, Belinda; Visca, Paolo; Iapicca, Pierluigi; Di Carlo, Anna; Antoniani, Barbara; Sperduti, Isabella; Di Benedetto, Anna; Terrenato, Irene; Mottolese, Marcella; Gandolfi, Francesco; Facciolo, Francesco; Chen, Emily I.; Schwartz, Martin A.; Santoni, Angela; Bissell, Mina J.; Nistico, Paola			hMENA isoforms impact NSCLC patient outcome through fibronectin/beta 1 integrin axis	ONCOGENE			English	Article							BREAST-CANCER CELLS; EXTRACELLULAR-MATRIX; BETA(1) INTEGRIN; LUNG-CANCER; ACTIN DYNAMICS; BARBED END; TRANSENDOTHELIAL MIGRATION; 3-DIMENSIONAL CULTURE; ENA/VASP PROTEINS; SRF ACTIVITY	We demonstrated previously that the splicing of the actin regulator, hMENA, generates two alternatively expressed isoforms, hMENA(11a) and hMENA Delta v6, which have opposite functions in cell invasiveness. Their mechanisms of action have remained unclear. Here we report two major findings: (i) hMENA regulates beta 1 integrin expression. This was shown by depleting total hMENA, which led to loss of nuclear expression of serum response factor (SRF)-coactivator myocardin-related transcription factor 1 (MRTF-A), leading to an increase in the G-actin/F-actin ratio crucial for MRTF-A localization. This in turn inhibited SRF activity and the expression of its target gene beta 1 integrin. (ii) hMENA(11a) reduces and hMENA Delta v6 increases beta 1 integrin activation and signaling. Moreover, exogenous expression of hMENA(11a) in hMENA Delta v6-positive cancer cells dramatically reduces secretion of extracellular matrix (ECM) components, including beta 1 integrin ligands and metalloproteinases. On the other hand, overexpression of the pro-invasive hMENA.v6 increases fibronectin production. In primary tumors high hMENA(11a) correlates with low stromal fibronectin and a favorable clinical outcome of early node-negative non-small-cell lung cancer patients. These data provide new insights into the roles of hMENA(11a) and hMENA Delta v6 in the druggable beta 1 integrin-ECM signaling axis and allow stratification of patient risk, guiding their clinical management.	[Di Modugno, Francesca; Spada, Sheila; Palermo, Belinda; Iapicca, Pierluigi; Di Carlo, Anna; Nistico, Paola] IRCCS Regina Elena Natl Canc Inst, Tumor Immunol & Immunotherapy Unit, Rome, Italy; [Spada, Sheila; Santoni, Angela] Univ Sapienza, Dept Mol Med, Rome, Italy; [Visca, Paolo; Antoniani, Barbara; Di Benedetto, Anna; Mottolese, Marcella] IRCCS Regina Elena Natl Canc Inst, Pathol Lab, Rome, Italy; [Sperduti, Isabella; Terrenato, Irene] IRCCS Regina Elena Natl Canc Inst, Biostat Sci Direct, Rome, Italy; [Gandolfi, Francesco] Univ Sapienza, Dept Phys, Rome, Italy; [Facciolo, Francesco] IRCCS Regina Elena Natl Canc Inst, Thorac Surg Unit, Rome, Italy; [Chen, Emily I.] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Pharmacol, New York, NY USA; [Schwartz, Martin A.] Yale Sch Med, Yale Cardiovasc Res Ctr, Dept Internal Med, New Haven, CT 06511 USA; [Schwartz, Martin A.] Yale Sch Med, Yale Cardiovasc Res Ctr, Dept Cell Biol, New Haven, CT 06511 USA; [Schwartz, Martin A.] Yale Sch Med, Yale Cardiovasc Res Ctr, Dept Biomed Engn, New Haven, CT 06511 USA; [Bissell, Mina J.] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	Sapienza University Rome; Sapienza University Rome; Columbia University; Yale University; Yale University; Yale University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Nistico, P (corresponding author), IRCCS Regina Elena Natl Canc Inst, Tumor Immunol & Immunotherapy Unit, Rome, Italy.	paola.nistico@ifo.gov.it	Di Carlo, Anna/AAY-4368-2021; Terrenato, Irene/B-1308-2017; Sperduti, Isabella/K-8902-2016; Spada, Sheila/AAN-1520-2020; Di Modugno, Francesca/ABH-9406-2020; Nistico, Paola/B-2862-2018	Di Carlo, Anna/0000-0002-6037-6160; Terrenato, Irene/0000-0002-0187-9323; Sperduti, Isabella/0000-0001-5115-3099; Di Modugno, Francesca/0000-0003-1427-1883; Facciolo, Francesco/0000-0002-7137-8946; iapicca, pierluigi/0000-0002-7995-2391; Di Benedetto, Anna/0000-0002-9853-8671; Palermo, Belinda/0000-0001-6293-0113; Nistico, Paola/0000-0003-4409-2261	Italian Association for Cancer Research AIRC: 5x1000 [12182, IG 15224]; NCI [R37CA064786, U54CA143836]; Department of Defense Breast Cancer Research Program [W81XWH0810736]; Breast Cancer Research Foundation; NIH [RO1 GM47214]; NATIONAL CANCER INSTITUTE [R37CA064786, R01CA064786, U54CA143836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047214] Funding Source: NIH RePORTER	Italian Association for Cancer Research AIRC: 5x1000(Fondazione AIRC per la ricerca sul cancro); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Breast Cancer Research Program(United States Department of Defense); Breast Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	PN is supported by the Italian Association for Cancer Research AIRC: 5x1000, 12182, and IG 15224. M.J.B. is supported by the NCI (awards R37CA064786 and U54CA143836-Bay Area Physical Sciences Oncology Center), the Department of Defense Breast Cancer Research Program (award W81XWH0810736), and by a grant from the Breast Cancer Research Foundation. MAS is supported by NIH, RO1 GM47214.	AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290; Bae YK, 2013, HUM PATHOL, V44, P2028, DOI 10.1016/j.humpath.2013.03.006; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Beaty BT, 2013, MOL BIOL CELL, V24, P1661, DOI 10.1091/mbc.E12-12-0908; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; BOUDREAU N, 1995, TRENDS CELL BIOL, V5, P1, DOI 10.1016/S0962-8924(00)88924-2; Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; Bria E, 2014, ONCOTARGET, V5, P11054, DOI 10.18632/oncotarget.2609; Caccavari F, 2010, CELL ADHES MIGR, V4, P124, DOI 10.4161/cam.4.1.10976; Di Modugno F, 2006, CLIN CANCER RES, V12, P1470, DOI 10.1158/1078-0432.CCR-05-2027; Di Modugno F, 2004, INT J CANCER, V109, P909, DOI 10.1002/ijc.20094; Di Modugno F, 2007, CANCER RES, V67, P2657, DOI 10.1158/0008-5472.CAN-06-1997; Modugno F, 2018, P NATL ACAD SCI USA, V115, P3132, DOI 10.1073/pnas.1715998115; Di Modugno F, 2012, P NATL ACAD SCI USA, V109, P19280, DOI 10.1073/pnas.1214394109; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gertler F, 2011, TRENDS CELL BIOL, V21, P81, DOI 10.1016/j.tcb.2010.10.001; Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287; Han JY, 2003, LUNG CANCER-J IASLC, V41, P65, DOI 10.1016/S0169-5002(03)00146-6; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; HOWLETT AR, 1995, J CELL SCI, V108, P1945; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Jin JK, 2015, ONCOGENE, V34, P1811, DOI 10.1038/onc.2014.116; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kuhnel K, 2004, P NATL ACAD SCI USA, V101, P17027, DOI 10.1073/pnas.0403069101; Li J, 2017, P NATL ACAD SCI USA, V114, P4685, DOI 10.1073/pnas.1704171114; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Melchionna R, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1221556; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morello V, 2011, ONCOGENE, V30, P4087, DOI 10.1038/onc.2011.107; Nam JM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3454; Nam JM, 2010, CANCER RES, V70, P5238, DOI 10.1158/0008-5472.CAN-09-2319; Nistico P, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0459-x; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Oudin MJ, 2016, CANCER DISCOV, V6, P516, DOI 10.1158/2159-8290.CD-15-1183; Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Reymond N, 2012, J CELL BIOL, V199, P653, DOI 10.1083/jcb.201205169; Rotty JD, 2015, DEV CELL, V32, P54, DOI 10.1016/j.devcel.2014.10.026; Roussos ET, 2011, J CELL SCI, V124, P2120, DOI 10.1242/jcs.086231; Schratt G, 2002, J CELL BIOL, V156, P737, DOI 10.1083/jcb.200106008; Shibue T, 2013, CANCER CELL, V24, P481, DOI 10.1016/j.ccr.2013.08.012; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Su Y, 2016, P NATL ACAD SCI USA, V113, pE3872, DOI 10.1073/pnas.1605074113; Trono P, 2016, ONCOGENE, V35, P887, DOI 10.1038/onc.2015.143; Vidaki M, 2017, NEURON, V95, P608, DOI 10.1016/j.neuron.2017.06.048; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Worth DC, 2010, J CELL BIOL, V189, P369, DOI 10.1083/jcb.200912014; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0	56	13	13	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 18	2018	37	42					5605	5617		10.1038/s41388-018-0364-3	http://dx.doi.org/10.1038/s41388-018-0364-3			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX3JJ	29907768	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000447619100002
J	Neill, T; Andreuzzi, E; Wang, ZX; Peiper, SC; Mongiat, M; Iozzo, RV				Neill, Thomas; Andreuzzi, Eva; Wang, Zi-Xuan; Peiper, Stephen C.; Mongiat, Maurizo; Iozzo, Renato, V			Endorepellin remodels the endothelial transcriptome toward a pro-autophagic and pro-mitophagic gene signature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						parkin; mitochondria; mitochondrial membrane potential; vascular endothelial growth factor (VEGF); basement membrane; mitochondrial depolarization; mitofusin 2; mitostatin; Parkin; VEGFR2	UBIQUITIN-PROTEASOME SYSTEM; GROWTH-FACTOR PROGRANULIN; BECLIN 1 PHOSPHORYLATION; BREAST-CANCER; BASEMENT-MEMBRANE; HEPARAN-SULFATE; RECEPTOR 2; ALPHA-2-BETA-1 INTEGRIN; ANGIOGENESIS INHIBITOR; EXTRACELLULAR-MATRIX	Regulation of autophagy by proteolytically cleaved fragments of heparan sulfate proteoglycans is a novel and current research focus in tumor biology. Endorepellin is the C-terminal angiostatic fragment of the heparan sulfate proteoglycan perlecan and induces autophagy in endothelial cells. To further investigate this property, we used NanoString, a digital PCR platform for measuring pre-defined transcripts in biological samples to analyze a custom subset of 95 autophagy-related genes in human umbilical vein endothelial cells treated with ultrapure human recombinant endorepellin. We discovered an endorepellin-evoked pro-autophagic and pro-mitophagic gene expression signatures, which included two coordinately up-regulated mitochondrial-associated genes encoding the E3 ubiquitin protein ligase Parkin and the tumor suppressor mitostatin. Induction of both proteins required the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2). Furthermore, we discovered that endorepellin evoked mitochondrial depolarization in endothelial cells via a specific interaction between its two proximal LG1/2 domains and VEGFR2. We also found that following loss of membrane potential, mitostatin and parkin interact and that mitostatin associates with the established Parkin receptor mitofusin-2. In conclusion, we have identified a critical role for endorepellin in remodeling the autophagic transcriptome and influencing mitochondrial homeostasis.	[Neill, Thomas; Wang, Zi-Xuan; Peiper, Stephen C.; Iozzo, Renato, V] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Neill, Thomas; Wang, Zi-Xuan; Peiper, Stephen C.; Iozzo, Renato, V] Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Andreuzzi, Eva; Mongiat, Maurizo] Natl Canc Inst, CRO Aviano IRCCS, Expt Oncol Div 2, Dept Translat Res, I-33081 Aviano, Italy	Jefferson University; Jefferson University; IRCCS Aviano (CRO)	Iozzo, RV (corresponding author), Thomas Jefferson Univ, 1020 Locust St,Suite 336,Jefferson Alumni Hall, Philadelphia, PA 19107 USA.	renato.iozzo@jefferson.edu	Iozzo, Renato/AAS-1980-2020; Andreuzzi, Eva/AAX-5692-2020; Mongiat, Maurizio/H-8297-2018	Andreuzzi, Eva/0000-0002-5925-5230; Mongiat, Maurizio/0000-0001-6509-0068	National Institutes of Health [RO1 CA39481, RO1 CA47282]; NATIONAL CANCER INSTITUTE [R01CA047282, R01CA039481, P30CA056036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grants RO1 CA39481 and RO1 CA47282 (to R. V. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreuzzi E, 2017, MATRIX BIOL, V64, P40, DOI 10.1016/j.matbio.2017.04.002; Apte SS, 2015, MATRIX BIOL, V44-46, P1, DOI 10.1016/j.matbio.2015.04.005; Arpino V, 2015, MATRIX BIOL, V44-46, P247, DOI 10.1016/j.matbio.2015.03.005; Aspinall-O'Dea M, 2007, PROTEOM CLIN APPL, V1, P1066, DOI 10.1002/prca.200700144; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Cerqua C, 2010, EMBO REP, V11, P854, DOI 10.1038/embor.2010.151; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chang JW, 2008, PROTEOM CLIN APPL, V2, P23, DOI 10.1002/prca.200780049; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; COHEN IR, 1994, CANCER RES, V54, P5771; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Deryugina EI, 2015, MATRIX BIOL, V44-46, P94, DOI 10.1016/j.matbio.2015.04.004; Douglass S, 2015, CONNECT TISSUE RES, V56, P381, DOI 10.3109/03008207.2015.1045297; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Farach-Carson MC, 2014, MATRIX BIOL, V34, P64, DOI 10.1016/j.matbio.2013.08.004; Fassan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019771; Fong TAT, 1999, CANCER RES, V59, P99; Foster MH, 2017, MATRIX BIOL, V57-58, P149, DOI 10.1016/j.matbio.2016.07.008; Fuki IV, 2000, J BIOL CHEM, V275, P25742, DOI 10.1074/jbc.M909173199; Fullgrabe J, 2014, NAT REV MOL CELL BIO, V15, P65, DOI 10.1038/nrm3716; Fullgrabe J, 2013, NATURE, V500, P468, DOI 10.1038/nature12313; Gabel HW, 2015, NATURE, V522, P89, DOI 10.1038/nature14319; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Ghadiali RS, 2017, MATRIX BIOL, V59, P54, DOI 10.1016/j.matbio.2016.07.007; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Goyal A, 2016, J BIOL CHEM, V291, P19245, DOI 10.1074/jbc.M116.740266; Goyal A, 2012, J BIOL CHEM, V287, P43543, DOI 10.1074/jbc.M112.401786; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Gubbiotti MA, 2017, MATRIX BIOL, V57-58, P285, DOI 10.1016/j.matbio.2016.09.003; Gubbiotti MA, 2015, MATRIX BIOL, V48, P6, DOI 10.1016/j.matbio.2015.10.002; He CC, 2013, CELL, V154, P1085, DOI 10.1016/j.cell.2013.07.035; Hong M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7588; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; IOZZO RV, 1993, EXPERIENTIA, V49, P447, DOI 10.1007/BF01923588; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; Jung M, 2013, J BIOL CHEM, V288, P3289, DOI 10.1074/jbc.M112.387811; Le BV, 2011, J MOL BIOL, V414, P231, DOI 10.1016/j.jmb.2011.09.048; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lord MS, 2014, MATRIX BIOL, V35, P112, DOI 10.1016/j.matbio.2014.01.016; Majek P, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-64; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mauri P, 2005, FASEB J, V19, P1125, DOI 10.1096/fj.04-3000fje; Mendel DB, 2000, CLIN CANCER RES, V6, P4848; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Naba A, 2016, MATRIX BIOL, V49, P10, DOI 10.1016/j.matbio.2015.06.003; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Narendra D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011338; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Neill T, 2016, J CELL BIOL, V215, P687, DOI 10.1083/jcb.201603079; Neill T, 2015, BIOCHEMISTRY-US, V54, P4583, DOI 10.1021/acs.biochem.5b00653; Neill T, 2014, AM J PATHOL, V184, P2146, DOI 10.1016/j.ajpath.2014.05.010; Neill T, 2014, J BIOL CHEM, V289, P4952, DOI 10.1074/jbc.M113.512566; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Nguyen TMB, 2009, J CELL MOL MED, V13, P3687, DOI 10.1111/j.1582-4934.2009.00722.x; Nussenzweig SC, 2015, CIRC RES, V116, P480, DOI 10.1161/CIRCRESAHA.116.303805; Nystrom A, 2017, MATRIX BIOL, V57-58, P124, DOI 10.1016/j.matbio.2016.07.012; Nystrom A, 2009, BLOOD, V114, P4897, DOI 10.1182/blood-2009-02-207134; O'Riordan E, 2008, PROTEOM CLIN APPL, V2, P1025, DOI 10.1002/prca.200780137; Oda O, 1996, CLIN CHIM ACTA, V255, P119, DOI 10.1016/0009-8981(96)06395-4; Pallanck L, 2013, CURR BIOL, V23, pR570, DOI 10.1016/j.cub.2013.05.032; Parker TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033714; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Peysselon F, 2014, MATRIX BIOL, V35, P73, DOI 10.1016/j.matbio.2013.11.001; Poluzzi C, 2016, ADV DRUG DELIVER REV, V97, P156, DOI 10.1016/j.addr.2015.10.012; Poluzzi C, 2014, J BIOL CHEM, V289, P16114, DOI 10.1074/jbc.M114.556530; Pozzi A, 2017, MATRIX BIOL, V57-58, P1, DOI 10.1016/j.matbio.2016.12.009; Randles MJ, 2017, MATRIX BIOL, V57-58, P12, DOI 10.1016/j.matbio.2016.08.006; Rohani MG, 2015, MATRIX BIOL, V44-46, P113, DOI 10.1016/j.matbio.2015.03.002; RUDNICKA L, 1994, J CLIN INVEST, V93, P1709, DOI 10.1172/JCI117154; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; Schaefer L, 2017, FEBS J, V284, P10, DOI 10.1111/febs.13963; Seok S, 2014, NATURE, V516, P108, DOI 10.1038/nature13949; Simons M, 2016, NAT REV MOL CELL BIO, V17, P611, DOI 10.1038/nrm.2016.87; Song WH, 2016, P NATL ACAD SCI USA, V113, pE5261, DOI 10.1073/pnas.1605844113; Sun Y, 2012, J BIOL CHEM, V287, P40652, DOI 10.1074/jbc.M112.419721; Surin B, 2013, PROTEOMICS, V13, P142, DOI 10.1002/pmic.201200267; Tanimoto R, 2017, MATRIX BIOL, V64, P27, DOI 10.1016/j.matbio.2017.04.001; Thadikkaran L, 2005, CLIN CHIM ACTA, V360, P27, DOI 10.1016/j.cccn.2005.04.018; Tsangaris GT, 2006, PROTEOMICS, V6, P4410, DOI 10.1002/pmic.200600085; Vadon-Le Goff S, 2015, MATRIX BIOL, V44-46, P14, DOI 10.1016/j.matbio.2015.02.006; Vecchione A, 2009, ONCOGENE, V28, P257, DOI 10.1038/onc.2008.381; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Vuadens F, 2003, PROTEOMICS, V3, P1521, DOI 10.1002/pmic.200300455; Wang H, 2015, CANCER CELL, V27, P193, DOI 10.1016/j.ccell.2014.11.017; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; Wells JM, 2015, MATRIX BIOL, V44-46, P122, DOI 10.1016/j.matbio.2015.01.016; Wijeratne SS, 2016, MATRIX BIOL, V50, P27, DOI 10.1016/j.matbio.2015.11.001; Willis CD, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P171; Willis CD, 2013, FEBS J, V280, P2271, DOI 10.1111/febs.12164; Wilson SE, 2017, MATRIX BIOL, V64, P17, DOI 10.1016/j.matbio.2017.06.003; Wolf SG, 2017, ELIFE, V6, DOI 10.7554/eLife.29929; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yang YF, 2015, HUM GENE THER, V26, P813, DOI 10.1089/hum.2015.098; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	101	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 3	2018	293	31					12137	12148		10.1074/jbc.RA118.002934	http://dx.doi.org/10.1074/jbc.RA118.002934			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GP4BZ	29921586	hybrid, Green Published			2022-12-26	WOS:000440803200013
J	Leuthardt, EC; Guzman, G; Bandt, SK; Hacker, C; Vellimana, AK; Limbrick, D; Milchenko, M; Lamontagne, P; Speidel, B; Roland, J; Miller-Thomas, M; Snyder, AZ; Marcus, D; Shimony, J; Benzinger, TLS				Leuthardt, Eric C.; Guzman, Gloria; Bandt, S. Kathleen; Hacker, Carl; Vellimana, Ananth K.; Limbrick, David; Milchenko, Mikhail; Lamontagne, Pamela; Speidel, Benjamin; Roland, Jarod; Miller-Thomas, Michelle; Snyder, Abraham Z.; Marcus, Daniel; Shimony, Joshua; Benzinger, Tammie L. S.			Integration of resting state functional MRI into clinical practice - A large single institution experience	PLOS ONE			English	Article							DEFAULT MODE; GLIOBLASTOMA-MULTIFORME; MOTION ARTIFACT; BRAIN; CONNECTIVITY; NETWORKS; CORTEX; RESECTION; MOTOR; ORGANIZATION	Functional magnetic resonance imaging (fMRI) is an important tool for pre-surgical evaluation of eloquent cortex. Classic task-based paradigms require patient participation and individual imaging sequence acquisitions for each functional domain that is being assessed. Resting state fMRI (rs-fMRI), however, enables functional localization without patient participation and can evaluate numerous functional domains with a single imaging session. To date, post-processing of this resting state data has been resource intensive, which limits its widespread application for routine clinical use. Through a novel automated algorithm and advanced imaging IT structure, we report the clinical application and the large-scale integration of rs-fMRI into routine neurosurgical practice. One hundred and ninety one consecutive patients underwent a 3T rs-fMRI, 83 of whom also underwent both motor and language task-based fMRI. Data were processed using a novel, automated, multi-layer perceptron algorithm and integrated into stereotactic navigation using a streamlined IT imaging pipeline. One hundred eighty-five studies were performed for intracranial neoplasm, 14 for refractory epilepsy and 33 for vascular malformations or other neurological disorders. Failure rate of rs-fMRI of 13% was significantly better than that for task-based fMRI (38.5%,) (p<0.001). In conclusion, at Washington University in St. Louis, rs-fMRI has become an integral part of standard imaging for neurosurgical planning. Resting state fMRI can be used in all patients, and due to its lower failure rate than task-based fMRI, it is useful for patients who are unable to cooperate with task-based studies.	[Leuthardt, Eric C.; Bandt, S. Kathleen; Hacker, Carl; Vellimana, Ananth K.; Limbrick, David; Roland, Jarod; Benzinger, Tammie L. S.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63130 USA; [Leuthardt, Eric C.] Washington Univ, Sch Med, Ctr Innovat Neurosci & Technol, St Louis, MO 63130 USA; [Leuthardt, Eric C.] Washington Univ, Sch Med, Brain Laser Ctr, St Louis, MO 63130 USA; [Leuthardt, Eric C.; Hacker, Carl] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; [Leuthardt, Eric C.] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA; [Guzman, Gloria; Milchenko, Mikhail; Lamontagne, Pamela; Speidel, Benjamin; Miller-Thomas, Michelle; Snyder, Abraham Z.; Marcus, Daniel; Shimony, Joshua; Benzinger, Tammie L. S.] Washington Univ, Mallinckrodt Inst Radiol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Leuthardt, EC (corresponding author), Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63130 USA.; Leuthardt, EC (corresponding author), Washington Univ, Sch Med, Ctr Innovat Neurosci & Technol, St Louis, MO 63130 USA.; Leuthardt, EC (corresponding author), Washington Univ, Sch Med, Brain Laser Ctr, St Louis, MO 63130 USA.; Leuthardt, EC (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.; Leuthardt, EC (corresponding author), Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO 63130 USA.	leuthardte@wudosis.wustl.edu	Roland, Jarod L/J-1433-2019; Benzinger, Tammie/L-6104-2013	Roland, Jarod L/0000-0002-1312-8826; Benzinger, Tammie/0000-0002-8114-0552; Guzman Perez-Carrillo, Gloria/0000-0002-8217-8376; speidel, benjamin/0000-0001-7343-8191	National Institute of Health [R21CA159470, R01 CA203861, R21CM 59470, P30NS04805, R01 EB009352, NIA/NIH AG003991, 2UF1AG032438, NS098577-01]; Christopher Davidson Brain Tumor Research Fund; Benzinger: Barnes-Jewish Hospital Foundation [800-88]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087011] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA159470, R01CA203861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS090978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG026276, P01AG003991] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Christopher Davidson Brain Tumor Research Fund; Benzinger: Barnes-Jewish Hospital Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by: Leuthardt: National Institute of Health R21CA159470, National Institute of Health R01 CA203861, Christopher Davidson Brain Tumor Research Fund, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Shimony: National Institute of Health R21CM 59470, National Institute of Health R01 CA203861, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Marcus: National Institute of Health P30NS04805, National Institute of Health R01 EB009352, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Benzinger: Barnes-Jewish Hospital Foundation (800-88), National Institute of Health NIA/NIH AG003991, National Institute of Health 2UF1AG032438; Snyder: National Institute of Health NS098577-01, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M. G., 2015, PRESURGICAL RESTING, P143; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Breshears JD, 2012, NEUROSURGERY, V71, P305, DOI 10.1227/NEU.0b013e318258e5d1; Breshears JD, 2010, P NATL ACAD SCI USA, V107, P21170, DOI 10.1073/pnas.1011949107; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Ciric R, 2017, NEUROIMAGE, V154, P174, DOI 10.1016/j.neuroimage.2017.03.020; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gulati S, 2011, WORLD NEUROSURG, V76, P572, DOI 10.1016/j.wneu.2011.06.014; Hacker C. D., 2013, NEUROIMAGE, DOI [10.1038/NATURE05758, DOI 10.1038/NATURE05758]; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Marcus DS, 2007, NEUROINFORMATICS, V5, P11, DOI 10.1385/NI:5:1:11; McGirt MJ, 2009, NEUROSURGERY, V65, P463, DOI 10.1227/01.NEU.0000349763.42238.E9; Mitchell TJ, 2013, NEUROSURGERY, V73, P969, DOI 10.1227/NEU.0000000000000141; Ojemann G A, 1993, Adv Neurol, V63, P155; Petrella JR, 2006, RADIOLOGY, V240, P793, DOI 10.1148/radiol.2403051153; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Tie Y., 2013, HUM BRAIN MAPP, DOI [10.1016/J.NEUROIMAGE.2010.04.246, DOI 10.1016/J.NEUROIMAGE.2010.04.246]; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhang DY, 2009, NEUROSURGERY, V65, P226, DOI 10.1227/01.NEU.0000350868.95634.CA	33	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0198349	10.1371/journal.pone.0198349	http://dx.doi.org/10.1371/journal.pone.0198349			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933375	gold, Green Submitted, Green Published			2022-12-26	WOS:000436076600008
J	Grover, G; Sharma, A; Gill, HS; Srivastava, P; Bains, NS				Grover, Gomti; Sharma, Achla; Gill, Harsimar S.; Srivastava, Puja; Bains, N. S.			Rht8 gene as an alternate dwarfing gene in elite Indian spring wheat cultivars	PLOS ONE			English	Article							REDUCED HEIGHT GENES; PLANT HEIGHT; BREAD WHEAT; GRAIN-YIELD; RHT-D1B; RHT-B1B; COLEOPTILE; MARKERS; TRAITS; LENGTH	Optimizing wheat height to maximize yield has been an important aspect which is evident from a successful example of green revolution. Dwarfing genes (Rht) are known for yield gains due to lodging resistance and partitioning of assimilates into ear. The available and commercially exploited sources of dwarfism in Indian spring wheat are Rhtl and Rht2 genes inspite of availability of over 20 dwarfing genes. Rht8 a Gibberellic acid sensitive dwarfing gene is another reduced height gene commercially exploited in some Mediterranean countries. Two F-2 populations segregating for Rhtl and Rht8 genes with each comprising 398 and 379 plants were developed by crossing European winter wheat cultivars Beauchamp and Capitole with Indian spring wheat cultivar PBW 621. Different genotypic combinations for Rhtl and Rht8 genes were selected from these populations through linked molecular markers and selected F-3:4 lines were evaluated for various agronomic traits in a replicated trial. Reduction in plant height with Rht8 and Rhtl averaged 2.86% and 13.3% respectively as compared to the group of lines lacking dwarfing gene. Reduction was spread along all the internodes of wheat culm and reduction was lower as progress towards the lower inter node. Grain number per spike and highest yield was observed in lines carrying only Rhtl gene. Reduction in plant biomass was observed with either of the dwarfing gene. Longest coleoptile length and seedling shoot length averaged 4.4 +/- 0.09 cm and 19.5 +/- 0.48, respectively was observed in lines lacking any of the dwarfing gene. Negligible reduction of 6.75% and 2.84% in coleoptile length and seedling shoot length, respectively was observed in lines carrying only Rht8 gene whereas F-3:4 lines with Rhtl gene showed 21.64% and 23.35% reduction in coleoptile length and seedling shoot length, respectively. Additive effect of genes was observed as double dwarfs showed 43.31% and 43.34% reduction in coleoptile length and seedling shoot length.	[Grover, Gomti; Sharma, Achla; Gill, Harsimar S.; Srivastava, Puja; Bains, N. S.] Punjab Agr Univ, Dept Plant Breeding & Genet, Ludhiana, Punjab, India	Punjab Agricultural University	Sharma, A (corresponding author), Punjab Agr Univ, Dept Plant Breeding & Genet, Ludhiana, Punjab, India.	achla@pau.edu	Sharma, Achla/AAB-1132-2021	Gill, Harsimardeep/0000-0002-3067-6912; Sharma, Achla/0000-0002-7932-3499				Bonnett D.G., 2001, P 10 AUSTR WHEAT BRE, P154; Borojevic K, 2005, J HERED, V96, P455, DOI 10.1093/jhered/esi060; Chapman SC, 2007, EUPHYTICA, V157, P391, DOI 10.1007/s10681-006-9304-3; Ellis MH, 2005, THEOR APPL GENET, V111, P423, DOI 10.1007/s00122-005-2008-6; Ellis MH, 2004, FUNCT PLANT BIOL, V31, P583, DOI 10.1071/FP03207; Ellis MH, 2002, THEOR APPL GENET, V105, P1038, DOI 10.1007/s00122-002-1048-4; Evans LT, 1997, NEW PHYTOL, V38, p567 , DOI [10.2135/cropsci1998.0011183X003800010048x, DOI 10.2135/CROPSCI1998.0011183X003800010048X]; Flintham JE, 1997, J AGR SCI-CAMBRIDGE, V128, P11, DOI 10.1017/S0021859696003942; He XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162499; Korzun V, 1998, THEOR APPL GENET, V96, P1104, DOI 10.1007/s001220050845; LAW CN, 1978, HEREDITY, V40, P133, DOI 10.1038/hdy.1978.13; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Rasheed A, 2016, THEOR APPL GENET, V129, P1843, DOI 10.1007/s00122-016-2743-x; Rebetzke GJ, 2012, FIELD CROP RES, V127, P17, DOI 10.1016/j.fcr.2011.11.003; Rebetzke GJ, 2011, FIELD CROP RES, V124, P323, DOI 10.1016/j.fcr.2011.06.022; Rebetzke GJ, 1999, EUPHYTICA, V106, P159, DOI 10.1023/A:1003518920119; Rebetzke GJ, 2000, AUST J AGR RES, V51, P235, DOI 10.1071/AR99043; Robbins AM, 2009, DWARFING GENES SPRIN, p1 ; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sheoran S, 2013, INDIAN J AGR SCI, V83, P820; Tang N, 2009, AGR SCI CHINA, V8, P1028, DOI 10.1016/S1671-2927(08)60310-7; Wang YS, 2015, FIELD CROP RES, V179, P35, DOI 10.1016/j.fcr.2015.04.010; Worland AJ, 1998, THEOR APPL GENET, V96, P1110, DOI 10.1007/s001220050846; Worland AJ, 2001, EUPHYTICA, V119, P155, DOI 10.1023/A:1017582122775; Worland AJ, 1995, PLANT BREEDING, V114, P397, DOI 10.1111/j.1439-0523.1995.tb00819.x; Xu XB, 2001, NEUC AGRONOMY J, V15, p188 	26	19	19	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199330	10.1371/journal.pone.0199330	http://dx.doi.org/10.1371/journal.pone.0199330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927977	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500074
J	Liu, LP; Huang, JL; Wang, Y; Li, YM				Liu, Liping; Huang, Jianling; Wang, Ying; Li, Yumei			Risk factors of striae gravidarum in Chinese primiparous women	PLOS ONE			English	Article								Background Striae gravidarum is a common skin problem of considerable cosmetic concern for many pregnant women. Various risk factors associated with the development of striae have been reported, with conflicting results. Objectives To analyze the risk factors of striae gravidarum in Chinese primiparous women and to provide evidence relevant to the prevention of this condition. Methods Singleton primiparous pregnant women who were hospitalized for delivery were included, and relevant data were collected. Independent risk factors associated with striae gravidarum in women with and those without striae gravidarum were identified using logistic regression. Results Among 213 singleton primiparous pregnant women, 125 had striae gravidarum, yielding a prevalence of up to 58.9%. There was a significant variation (P < 0.05, odds ratio >1) between the striae gravidarum and non-striae gravidarum groups in terms of several factors, including younger maternal age, weight gain during pregnancy, body mass index gain, uterine height, abdominal girth, and positive family history. Factors such as maternal height, birth weight, systemic disease, skin type, and neonatal gender did not significantly differ between the 2 groups. Conclusion This study showed that the independent risk factors for striae gravidarum in primiparous women were younger maternal age, weight gain during pregnancy, body mass index gain, uterine height, abdominal girth, and a positive family history. The severity of striae	[Liu, Liping; Huang, Jianling; Wang, Ying; Li, Yumei] Jiangsu Univ, Dept Dermatol, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China; [Liu, Liping; Huang, Jianling; Wang, Ying; Li, Yumei] Jiangsu Univ, Regenerat Med Res Ctr, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China; [Huang, Jianling] Cent Hosp Xiaogan, Xiaogan, Hubei, Peoples R China	Jiangsu University; Jiangsu University	Li, YM (corresponding author), Jiangsu Univ, Dept Dermatol, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China.; Li, YM (corresponding author), Jiangsu Univ, Regenerat Med Res Ctr, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China.	l.yumei@aliyun.com	liu, li/HGC-0900-2022		national natural science foundation of China [81573053]; "333" funded projects of Jiangsu province [BRA2015196]; Science and technology plan projects of Zhenjiang city [SS2015024]; Statistics Department of Jiangsu University	national natural science foundation of China(National Natural Science Foundation of China (NSFC)); "333" funded projects of Jiangsu province; Science and technology plan projects of Zhenjiang city; Statistics Department of Jiangsu University	This work was supported by The national natural science foundation of China, Grant numbers: 81573053, Funders website: http://www.nsfc.gov.cn, Funding recipient: Yumei Li; "333" funded projects of Jiangsu province, Grant numbers: BRA2015196, Funders website: http://www.jsrcgz.gov.cn/, Funding recipient: Yumei Li; Science and technology plan projects of Zhenjiang city, Grant numbers: SS2015024 Funders website: http://kjj.zhenjiang.gov.cn/, Funding recipient: Yumei Li.; We thank all participating women and the Department of Obstetrics in Affiliated Hospital of Jiangsu University, Zhenjiang, China. We also thank the Statistics Department of Jiangsu University for their help and support.	Atwal GSS, 2006, BRIT J DERMATOL, V155, P965, DOI 10.1111/j.1365-2133.2006.07427.x; Chang ALS, 2004, J AM ACAD DERMATOL, V51, P881, DOI 10.1016/j.jaad.2004.05.030; DAVEY CMH, 1972, J OBSTET GYN BR COMM, V79, P1113; Di Lernia V, 2001, PEDIATR DERMATOL, V18, P261, DOI 10.1046/j.1525-1470.2001.018003261.x; Ersoy E, 2016, J CHIN MED ASSOC, V79, P272, DOI 10.1016/j.jcma.2015.12.007; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Ghasemi A, 2007, J EUR ACAD DERMATOL, V21, P743, DOI 10.1111/j.1468-3083.2007.02149.x; J-Orh Ratree, 2008, Journal of the Medical Association of Thailand, V91, P445; Kasielska-Trojan A, 2015, INT J COSMETIC SCI, V37, P236, DOI 10.1111/ics.12188; Korgavkar K, 2015, BRIT J DERMATOL, V172, P606, DOI 10.1111/bjd.13426; Kurt S, 2014, EUR J OBSTET GYN R B, V180, P116, DOI 10.1016/j.ejogrb.2014.07.003; LEE KS, 1994, CLIN EXP DERMATOL, V19, P285, DOI 10.1111/j.1365-2230.1994.tb01196.x; Levin W M, 1995, Arch Fam Med, V4, P98, DOI 10.1001/archfami.4.2.98; Li N, 2018, J COSMET LASER THER, V16, P1; LIU DTY, 1974, LANCET, V1, P624; Liu W, 2006, PHOTODERMATOL PHOTO, V22, P184, DOI 10.1111/j.1600-0781.2006.00225.x; Madlon-Kay D J, 1993, Arch Fam Med, V2, P507, DOI 10.1001/archfami.2.5.507; Narin R, 2015, J OBSTET GYNAECOL RE, V41, P1377, DOI 10.1111/jog.12741; Osman H, 2007, AM J OBSTET GYNECOL, V196, P62, DOI 10.1016/j.ajog.2006.08.044; Picard D, 2015, J AM ACAD DERMATOL, V73, P699, DOI 10.1016/j.jaad.2015.06.037; POIDEVIN LOS, 1959, LANCET, V2, P436; Salter SA, 2006, CLIN DERMATOL, V24, P97, DOI 10.1016/j.clindermatol.2005.10.008; Thomas R G R, 2004, J Obstet Gynaecol, V24, P270, DOI 10.1080/014436104101001660779; Wang F, 2015, BRIT J DERMATOL, V173, P1420, DOI 10.1111/bjd.14027; Watson REB, 1998, BRIT J DERMATOL, V138, P931; Yan SX, 2015, INT J ENV RES PUB HE, V12, P3232, DOI 10.3390/ijerph120303232; Yang J, 2017, PHOTODERMATOL PHOTO, V33, P267, DOI 10.1111/phpp.12317; Yue BS, 2016, LASER MED SCI, V31, P1657, DOI 10.1007/s10103-016-2034-4	29	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198720	10.1371/journal.pone.0198720	http://dx.doi.org/10.1371/journal.pone.0198720			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927959	Green Published, Green Submitted, gold			2022-12-26	WOS:000435802500029
J	Lu, DF; Li, ZR; Li, LL; Yang, LP; Chen, GJ; Yang, DY; Zhang, Y; Singh, V; Smith, S; Xiao, Y; Wang, EL; Ye, YS; Zhang, W; Zhou, L; Rong, YK; Zhou, JM				Lu, Danfeng; Li, Zhuoran; Li, Lingling; Yang, Liping; Chen, Guijun; Yang, Deying; Zhang, Yue; Singh, Vikrant; Smith, Sheryl; Xiao, Yu; Wang, Erlin; Ye, Yunshuang; Zhang, Wei; Zhou, Lei; Rong, Yikang; Zhou, Jumin			The Ubx Polycomb response element bypasses an unpaired Fab-8 insulator via cis transvection in Drosophila	PLOS ONE			English	Article							ENHANCER-PROMOTER INTERACTIONS; CHROMATIN DOMAIN BOUNDARY; BITHORAX-COMPLEX; ABDOMINAL-B; GENE; CTCF; PRE; MELANOGASTER; RECRUITMENT; PROTEINS	Chromatin insulators or boundary elements protect genes from regulatory activities from neighboring genes or chromatin domains. In the Drosophila Abdominal-B (Abd-B) locus, the deletion of such elements, such as Frontabdominal-7 (Fab-7) or Fab-8 led to dominant gain of function phenotypes, presumably due to the loss of chromatin barriers. Homologous chromosomes are paired in Drosophila, creating a number of pairing dependent phenomena including transvection, and whether transvection may affect the function of Polycomb response elements (PREs) and thus contribute to the phenotypes are not known. Here, we studied the chromatin barrier activity of Fab-8 and how it is affected by the zygosity of the transgene, and found that Fab-8 is able to block the silencing effect of the Ubx PRE on the DsRed reporter gene in a CTCF binding sites dependent manner. However, the blocking also depends on the zygosity of the transgene in that the barrier activity is present when the transgene is homozygous, but absent when the transgene is heterozygous. To analyze this effect, we performed chromatin immunoprecipitation and quantitative PCR (ChIP-qPCR) experiments on homozygous transgenic embryos, and found that H3K27me3 and H3K9me3 marks are restricted by Fab-8, but they spread beyond Fab-8 into the DsRed gene when the two CTCF binding sites within Fab-8 were mutated. Consistent with this, the mutation reduced H3K4me3 and RNA PoI II binding to the DsRed gene, and consequently, DsRed expression. Importantly, in heterozygous embryos, Fab-8 is unable to prevent the spread of H3K27me3 and H3K9me3 marks from crossing Fab-8 into DsRed, suggesting an insulator bypass. These results suggest that in the Abd-B locus, deletion of the insulator in one copy of the chromosome could lead to the loss of insulator activity on the homologous chromosome, and in other loci where chromosomal deletion created hemizygous regions of the genome, the chromatin barrier could be compromised. This study highlights a role of homologous chromosome pairing in the regulation of gene expression in the Drosophila genome.	[Lu, Danfeng; Li, Zhuoran; Yang, Liping; Chen, Guijun; Yang, Deying; Zhang, Yue; Xiao, Yu; Wang, Erlin; Ye, Yunshuang; Zhang, Wei; Zhou, Jumin] Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Bioact Peptides Yunnan Prov,Key Lab Anim, Kunming, Yunnan, Peoples R China; [Lu, Danfeng; Wang, Erlin; Ye, Yunshuang; Zhang, Wei] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Lu, Danfeng] Univ Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Li, Lingling; Rong, Yikang] Sun Yat Sen Univ, Sch Life Sci, Inst Entomol, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [Singh, Vikrant; Smith, Sheryl] Wistar Inst Anat & Biol, Gene Express & Regulat Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Zhou, Lei] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sun Yat Sen University; The Wistar Institute; State University System of Florida; University of Florida	Zhou, JM (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Chinese Acad Sci & Yunnan Prov, Key Lab Bioact Peptides Yunnan Prov,Key Lab Anim, Kunming, Yunnan, Peoples R China.	zhoujm@mail.kiz.ac.cn	Wang, Erlin/AAL-8613-2021; Li, Zhuoran/AAL-4124-2020		Chinese Academy of Sciences [KSCXZ-EW-BR-6, KSZD-EW-Z-009]; Kunming Institute of Zoology, Chinese Academy of Sciences [Y102421081]; Ministry of Science and Technology of the People's Republic of China [2016YFA0100900]; National Science Foundation of China [NSFC81471966, NSFC81672040, NSFC31601157, U1602226, 2016YFC1200404]; Yunnan Provincial Government [2016E13039, 2013FA051, 2011HA005, 2016E6179]	Chinese Academy of Sciences(Chinese Academy of Sciences); Kunming Institute of Zoology, Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Government	This work was supported by the grants from Chinese Academy of Sciences (KSCXZ-EW-BR-6; KSZD-EW-Z-009) and a startup fund from Kunming Institute of Zoology, Chinese Academy of Sciences (Y102421081), by the Ministry of Science and Technology of the People's Republic of China (2016YFA0100900), by National Science Foundation of China (NSFC81471966; NSFC81672040; NSFC31601157; U1602226; 2016YFC1200404) and by grants from Yunnan Provincial Government (2016E13039; 2013FA051; 2011HA005) to Jumin Zhou and by a grant from Yunnan Provincial Government (2016E6179) to Yu Xiao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barges S, 2000, DEVELOPMENT, V127, P779; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Cai HN, 2001, SCIENCE, V291, P493, DOI 10.1126/science.291.5503.493; Chen Q, 2005, DEV BIOL, V286, P629, DOI 10.1016/j.ydbio.2005.08.025; Chetverina D, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600233; Chetverina D, 2014, BIOESSAYS, V36, P163, DOI 10.1002/bies.201300125; Comet I, 2006, DEV CELL, V11, P117, DOI 10.1016/j.devcel.2006.05.009; Erokhin M, 2010, CHROMOSOMA, V119, P243, DOI 10.1007/s00412-009-0253-1; Fujioka M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005889; Fujioka M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003883; Fukaya T, 2017, CURR BIOL, V27, pR1047, DOI 10.1016/j.cub.2017.08.001; Fung JC, 1998, J CELL BIOL, V141, P5, DOI 10.1083/jcb.141.1.5; GALLONI M, 1993, EMBO J, V12, P1087, DOI 10.1002/j.1460-2075.1993.tb05750.x; Gemkow MJ, 1998, DEVELOPMENT, V125, P4541; GYURKOVICS H, 1990, EMBO J, V9, P2579, DOI 10.1002/j.1460-2075.1990.tb07439.x; Hagstrom K, 1996, GENE DEV, V10, P3202, DOI 10.1101/gad.10.24.3202; Kahn TG, 2016, NUCLEIC ACIDS RES, V44, P10132, DOI 10.1093/nar/gkw701; Kyrchanova O, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006188; Kyrchanova O, 2015, MECH DEVELOP, V138, P122, DOI 10.1016/j.mod.2015.07.002; Kyrchanova O, 2014, FEBS LETT, V588, P8, DOI 10.1016/j.febslet.2013.10.039; Lang Feng-Chao, 2015, Zoological Research, V36, P142; Lang FC, 2017, P NATL ACAD SCI USA, V114, P10912, DOI 10.1073/pnas.1704076114; Lang FC, 2017, SCI REP-UK, V7, DOI 10.1038/srep39861; Lim B, 2018, MOL CELL, V70, P1, DOI [10.1016/j.molcel.2018.03.022, DOI 10.1016/J.MOLCEL.2018.03.022]; Lin NW, 2011, MOL CELL BIOL, V31, P2729, DOI 10.1128/MCB.05165-11; Lin Q, 2010, DEV BIOL, V339, P329, DOI 10.1016/j.ydbio.2009.12.029; Maksimenko O, 2014, EPIGENET, V9, P170, DOI [10.1038/sj.embor.7400334, DOI 10.1038/SJ.EMBOR.7400334]; Mihaly J, 1997, DEVELOPMENT, V124, P1809; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Morris JR, 1998, P NATL ACAD SCI USA, V95, P10740, DOI 10.1073/pnas.95.18.10740; Muravyova E, 2001, SCIENCE, V291, P495, DOI 10.1126/science.291.5503.495; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Schuettengruber B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056531; Schwartz YB, 2017, GENETICS, V205, P5, DOI 10.1534/genetics.115.185132; Sigrist CJA, 1997, GENETICS, V147, P209; SIMON J, 1995, CURR OPIN CELL BIOL, V7, P376, DOI 10.1016/0955-0674(95)80093-X; Smith ST, 2009, DEV BIOL, V328, P518, DOI 10.1016/j.ydbio.2008.12.039; Van Bortle K, 2012, GENOME RES, V22, P2176, DOI 10.1101/gr.136788.111; Zhou JM, 2004, MOL CELL, V16, P500, DOI 10.1016/S1097-2765(04)00680-X; Zhou JM, 1996, GENE DEV, V10, P3195, DOI 10.1101/gad.10.24.3195; Zhou JM, 1999, DEVELOPMENT, V126, P3057; Zhou JM, 1999, CELL, V99, P567, DOI 10.1016/S0092-8674(00)81546-9	44	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199353	10.1371/journal.pone.0199353	http://dx.doi.org/10.1371/journal.pone.0199353			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928011	Green Submitted, Green Published, gold			2022-12-26	WOS:000435802500078
J	Matveeva, OV; Ogurtsov, AY; Nazipova, NN; Shabalina, SA				Matveeva, Olga, V; Ogurtsov, Aleksey Y.; Nazipova, Nafisa N.; Shabalina, Svetlana A.			Sequence characteristics define trade-offs between on-target and genome-wide off-target hybridization of oligoprobes	PLOS ONE			English	Article							DENSITY OLIGONUCLEOTIDE MICROARRAYS; DNA MICROARRAYS; CROSS-HYBRIDIZATION; AFFYMETRIX MICROARRAYS; GENECHIP-MICROARRAYS; SECONDARY STRUCTURE; INTERGENIC REGIONS; DESIGN; MODEL; BINDING	Off-target oligoprobe's interaction with partially complementary nucleotide sequences represents a problem for many bio-techniques. The goal of the study was to identify oligoprobe sequence characteristics that control the ratio between on-target and off-target hybridization. To understand the complex interplay between specific and genome-wide off-target (cross-hybridization) signals, we analyzed a database derived from genomic comparison hybridization experiments performed with an Affymetrix tiling array. The database included two types of probes with signals derived from (i) a combination of specific signal and cross hybridization and (ii) genomic cross-hybridization only. All probes from the database were grouped into bins according to their sequence characteristics, where both hybridization signals were averaged separately. For selection of specific probes, we analyzed the following sequence characteristics: vulnerability to self-folding, nucleotide composition bias, numbers of G nucleotides and GGG-blocks, and occurrence of probe's k-mers in the human genome. Increases in bin ranges for these characteristics are simultaneously accompanied by a decrease in hybridization specificity the ratio between specific and cross-hybridization signals. However, both averaged hybridization signals exhibit growing trends along with an increase of probes' binding energy, where the hybridization specific signal increases significantly faster in comparison to the cross-hybridization. The same trend is evident for the S function, which serves as a combined evaluation of probe binding energy and occurrence of probe's k-mers in the genome. Application of S allows extracting a larger number of specific probes, as compared to using only binding energy. Thus, we showed that high values of specific and cross-hybridization signals are not mutually exclusive for probes with high values of binding energy and S. In this study, the application of a new set of sequence characteristics allows detection of probes that are highly specific to their targets for array design and other bio-techniques that require selection of specific probes.	[Matveeva, Olga, V] Biopolymer Design LLC, Acton, MA 01721 USA; [Ogurtsov, Aleksey Y.; Shabalina, Svetlana A.] NLM, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Nazipova, Nafisa N.] RAS, Inst Math Problems Biol, Branch Keldysh, Inst Appl Math, Pushchino, Moscow Region, Russia	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences	Matveeva, OV (corresponding author), Biopolymer Design LLC, Acton, MA 01721 USA.; Shabalina, SA (corresponding author), NLM, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.	olga.matveeva@gmail.com; shabalin@ncbi.nlm.nih.gov	Nazipova, Nafisa N./AAC-9129-2022; Назипова, Нафиса/AAC-9117-2022; Nazipova, Nafisa N/N-4270-2013	Nazipova, Nafisa N./0000-0003-0162-7967; Nazipova, Nafisa N/0000-0003-0162-7967; Matveeva, Olga/0000-0001-8555-9847	Department of Health and Human Services (National Institutes of Health, National Library of Medicine); Biopolymer Design LLC	Department of Health and Human Services (National Institutes of Health, National Library of Medicine)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Biopolymer Design LLC	The research was supported by the Department of Health and Human Services (National Institutes of Health, National Library of Medicine) intramural funds to SAS and AYO. The funder Biopolymer Design LLC provided support in the form of salary for author OVM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahn JW, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-9; Aston E, 2008, J MED GENET, V45, P268, DOI 10.1136/jmg.2007.055319; Becker J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3669-7; Binder H, 2006, J PHYS-CONDENS MAT, V18, pS537, DOI 10.1088/0953-8984/18/18/S04; Binder H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007862; Binder H, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-12; Carlon E, 2006, PHYSICA A, V362, P433, DOI 10.1016/j.physa.2005.09.067; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Cho Hyejin, 2016, BMC Res Notes, V9, P305, DOI 10.1186/s13104-016-2113-4; Du Y, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-323; Duan FH, 2010, BIODATA MIN, V3, DOI 10.1186/1756-0381-3-2; Fasold Mario, 2014, Microarrays (Basel), V3, P322, DOI 10.3390/microarrays3040322; Fasold M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-207; Furusawa C, 2009, BIOINFORMATICS, V25, P36, DOI 10.1093/bioinformatics/btn570; Garhyan Jaishree, 2013, BMC Res Notes, V6, P72, DOI 10.1186/1756-0500-6-72; Gharaibeh RZ, 2007, COMPUT BIOL CHEM, V31, P92, DOI 10.1016/j.compbiolchem.2007.02.008; Graf S, 2007, BIOINFORMATICS, V23, pI195, DOI 10.1093/bioinformatics/btm200; Gresham D, 2010, P NATL ACAD SCI USA, V107, P1482, DOI 10.1073/pnas.0913883107; Hadiwikarta WW, 2015, BIOSENS BIOELECTRON, V64, P411, DOI 10.1016/j.bios.2014.09.043; Hooyberghs J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp109; Horak CE, 2002, METHOD ENZYMOL, V350, P469, DOI 10.1016/S0076-6879(02)50979-4; Hurd Paul J., 2009, Briefings in Functional Genomics & Proteomics, V8, P174, DOI 10.1093/bfgp/elp013; Jaksik R, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0077-2; Jakubek YA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-737; Kapur K, 2008, BIOINFORMATICS, V24, P2887, DOI 10.1093/bioinformatics/btn571; Kondrashov AS, 2002, HUM MOL GENET, V11, P669, DOI 10.1093/hmg/11.6.669; Langdon WB, 2009, BRIEF BIOINFORM, V10, P259, DOI 10.1093/bib/bbp018; Matveeva OV, 2016, BIOINFORMATICS, V32, P552, DOI 10.1093/bioinformatics/btw451; Matveeva Olga V., 2012, Frontiers in Genetics, V3, P163, DOI 10.3389/fgene.2012.00163; Matveeva OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010180; Matveeva OV, 2003, NUCLEIC ACIDS RES, V31, P4989, DOI 10.1093/nar/gkg710; Matveeva OV, 2003, NUCLEIC ACIDS RES, V31, P4211, DOI 10.1093/nar/gkg476; Matveeva OV, 2000, NUCLEIC ACIDS RES, V28, P2862, DOI 10.1093/nar/28.15.2862; Memon FN, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/489736; Ogurtsov AY, 2006, BIOINFORMATICS, V22, P1317, DOI 10.1093/bioinformatics/btl083; Ogurtsov AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003599; Pozhitkov AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091295; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Upton Graham J. G., 2009, Briefings in Functional Genomics & Proteomics, V8, P199, DOI 10.1093/bfgp/elp027; Upton GJG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-613; Webb CT, 2002, NUCLEIC ACIDS RES, V30, P1233, DOI 10.1093/nar/30.5.1233; Weckx S, 2007, J PHYS CHEM B, V111, P13583, DOI 10.1021/jp075197x; Wu CL, 2007, BIOINFORMATICS, V23, P2566, DOI 10.1093/bioinformatics/btm271; Wu CL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni082; Xia XQ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq039; Zhang L, 2003, NAT BIOTECHNOL, V21, P818, DOI 10.1038/nbt836	46	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199162	10.1371/journal.pone.0199162	http://dx.doi.org/10.1371/journal.pone.0199162			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928000	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500051
J	Osugui, L; de Roo, JJ; de Oliveira, VC; Sodre, ACP; Staal, FJT; Popi, AF				Osugui, Lika; de Roo, Jolanda J.; de Oliveira, Vivian Cristina; Pires Sodre, Ana Clara; Staal, Frank J. T.; Popi, Ana Flavia			B-1 cells and B-1 cell precursors prompt different responses to Wnt signaling	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; BETA-CATENIN; STEM-CELLS; IN-VITRO; PROLIFERATION; HEMATOPOIESIS; PROGENITORS; ADULT	Recently several studies demonstrated a role for the Wnt pathway in lymphocyte development and self-renewal of hematopoietic stem cells (HSCs). B-1 cells constitute a separate lineage of B lymphocytes, originating during fetal hematopoiesis, expressing lymphoid and myeloid markers and possessing self-renewal ability, similar to early hematopoietic progenitors and HSCs. A plethora of studies have shown an important role for the evolutionary conserved Wnt pathway in the biology of HSCs and T lymphocyte development. Our previous data demonstrated abundant expression of Wnt pathway components by B-1 cells, including Wnt ligands and receptors. Here we report that the canonical Wnt pathway is activated in B-1 cell precursors, but not in mature B-1 cells. However, both B-1 precursors and B-1 cells are able to respond to Wnt ligands in vitro. Canonical Wnt activity promotes proliferation of B-1 cells, while non-canonical Wnt signals induce the expansion of B-1 precursors. Interestingly, using a co-culture system with OP9 cells, Wnt3a stimulus supported the generation of B-1 a cells. Taking together, these results indicate that B-1 cells and their progenitors are differentially responsive to Wnt ligands, and that the balance of activation of canonical and non-canonical Wnt signaling may regulate the maintenance and differentiation of different B-1 cell subsets.	[Osugui, Lika; de Oliveira, Vivian Cristina; Pires Sodre, Ana Clara; Popi, Ana Flavia] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil; [de Roo, Jolanda J.; Staal, Frank J. T.] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands	Universidade Federal de Sao Paulo (UNIFESP); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Popi, AF (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil.	afpoppi@unifesp.br	Osugui, Lika/AFV-5288-2022; Popi, Ana Flavia/V-4437-2019	Osugui, Lika/0000-0002-2755-3487; Popi, Ana Flavia/0000-0001-9814-4181; de Roo, Jolanda/0000-0002-1106-4742	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/001986-2, 2008/55526-9, 2011/23464-7]; Comissao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES) [BEX 10809/14-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Comissao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) - 2015/001986-2; 2008/55526-9 (AFP); 2011/23464-7 (LO). (www.fapesp.br) and the Comissao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES) - BEX 10809/14-7 (www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida SR, 2001, INT IMMUNOL, V13, P1193, DOI 10.1093/intimm/13.9.1193; Baba Y, 2005, IMMUNITY, V23, P599, DOI 10.1016/j.immuni.2005.10.009; Dorshkind K, 2007, NAT REV IMMUNOL, V7, P213, DOI 10.1038/nri2019; Famili F, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.326; FIERING SN, 1991, CYTOMETRY, V12, P291, DOI 10.1002/cyto.990120402; Ghosn EEB, 2016, STEM CELL REP, V6, P137, DOI 10.1016/j.stemcr.2015.11.011; Ghosn EEB, 2011, P NATL ACAD SCI USA, V108, P2879, DOI 10.1073/pnas.1019764108; Ichii M, 2012, BLOOD, V119, P1683, DOI 10.1182/blood-2011-07-369199; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Luis TC, 2012, LEUKEMIA, V26, P414, DOI 10.1038/leu.2011.387; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Malhotra S, 2008, J IMMUNOL, V181, P3955, DOI 10.4049/jimmunol.181.6.3955; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Montecino-Rodriguez E, 2012, IMMUNITY, V36, P13, DOI 10.1016/j.immuni.2011.11.017; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Popi AF, 2009, IMMUNOLOGY, V126, P114, DOI 10.1111/j.1365-2567.2008.02883.x; Popi AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034570; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Reya T, 1999, COLD SPRING HARB SYM, V64, P133, DOI 10.1101/sqb.1999.64.133; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Novo MCT, 2015, IMMUNOBIOLOGY, V220, P60, DOI 10.1016/j.imbio.2014.09.001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yoshimoto M, 2011, P NATL ACAD SCI USA, V108, P1468, DOI 10.1073/pnas.1015841108; Yu Q, 2008, J IMMUNOL, V181, P3777, DOI 10.4049/jimmunol.181.6.3777	31	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199332	10.1371/journal.pone.0199332	http://dx.doi.org/10.1371/journal.pone.0199332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928002	gold, Green Published			2022-12-26	WOS:000435802500075
J	Wagner, AL; Xia, L; Ghosh, A; Datta, S; Pandey, P; Santra, S; Chattopadhyay, S; Nandi, U; Mazumder, T; Joshi, S; Pal, J; Mukherjee, B				Wagner, Abram L.; Xia, Lu; Ghosh, Aparna; Datta, Sandip; Pandey, Priyamvada; Santra, Sujay; Chattopadhyay, Sharmila; Nandi, Uddip; Mazumder, Tanusree; Joshi, Sucheta; Pal, Joyojeet; Mukherjee, Bhramar			Using community health workers to refer pregnant women and young children to health care facilities in rural West Bengal, India: A prospective cohort study	PLOS ONE			English	Article							INCOME COUNTRIES; MIDDLE; COMPLICATIONS	Background Community health workers (CHWs) have been placed in many rural areas in India to increase villagers' connections to basic preventive health care. In this study, we describe how pregnant women and mothers of young children react when CHWs inform them that they, or their child, are at high risk of pregnancy-related complications or early childhood developmental delays, and further screening and health care from a physician is recommended. Methods In this longitudinal study in rural villages in West Bengal, India, pregnant mothers, as well as mothers of children aged 12-24 months, were screened for high risk complications. They were re-contacted and asked questions regarding how and to what extent did visits by the CHWs improve their household's overall health behavior, along with details about what additional care, if any, they sought. These responses are presented by different demographic and medical characteristics. Results Of the 231 pregnant women, all said they had sought additional care in response to the CHW visit, and all stated that feedback from the CHW resulted in improvement to their health behaviors. Most (90%) pregnant women gave birth at an institution. Among the 213 mothers of young children who were followed up, all sought additional care in response to the CHW's visit. Most (67%) mentioned that they had a significant improvement in their health behaviors following feedback from the CHW, and the rest stated that they had some improvement. Conclusions With the proper training, CHWs can be partners in health care to improve the health of vulnerable populations, not only in rural areas of India, but also in other developing countries. CHWs can promote positive health outcomes in their villages of residence.	[Wagner, Abram L.; Ghosh, Aparna; Mukherjee, Bhramar] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Xia, Lu; Mukherjee, Bhramar] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Datta, Sandip; Santra, Sujay; Nandi, Uddip; Mazumder, Tanusree] iKure Techsoft, Kolkata, W Bengal, India; [Pandey, Priyamvada; Chattopadhyay, Sharmila] Univ Nebraska, Med Ctr, Coll Publ Hlth, Ctr Global Hlth & Dev, Omaha, NE USA; [Joshi, Sucheta] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Pediat Neurol, Ann Arbor, MI USA; [Pal, Joyojeet] Univ Michigan, Sch Informat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wagner, AL (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	awag@umich.edu	Wagner, Abram/X-6379-2019	Wagner, Abram/0000-0003-4691-7802; Chatterjee, Sharmila/0000-0001-5905-1089; Chatterjee, Sharmila/0000-0002-3890-8386	Trehan Foundation through the University of Michigan MCubed Diamond program; company iKure Techsoft	Trehan Foundation through the University of Michigan MCubed Diamond program; company iKure Techsoft	This study is funded by the Trehan Foundation through the University of Michigan MCubed Diamond program. The company iKure Techsoft provided support in the form of salaries for several authors [SD, SS, UN, and TM] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alcoba N., 2009, CAN MED ASSOC J, V180, P10, DOI [10.1503/ernaj.090439, DOI 10.1503/ERNAJ.090439]; Balcazar H, 2011, AM J PUBLIC HEALTH, V101, P2199, DOI 10.2105/AJPH.2011.300386; Centers for Disease Control and Prevention, 2015, KEY FIND TRENDS PREV; Chawani MS, 2011, HEALTHINF 2011: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON HEALTH INFORMATICS, P260; Directorate of Census Operations, 2011, DISTR CENS HDB PASCH; Fraser A, 2012, CIRCULATION, V125, P1367, DOI 10.1161/CIRCULATIONAHA.111.044784; Gilmore B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-847; Gogoi M, 2014, J PUBLIC HEALTH-HEID, V22, P351, DOI 10.1007/s10389-014-0614-y; Hartung C., 2010, OPEN DATA KIT TOOLS; Juneja M, 2012, INDIAN PEDIATR, V49, P457, DOI 10.1007/s13312-012-0074-9; Kallander K, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2130; Kapoor S, 2014, INDIAN PEDIATR, V51, P959, DOI 10.1007/s13312-014-0540-7; Labrique AB, 2013, GLOB HEALTH-SCI PRAC, V1, P160, DOI 10.9745/GHSP-D-13-00031; Maulik PK, 2007, PEDIATRICS, V120, pS1, DOI 10.1542/peds.2007-0043B; Ministry of Health and Family Welfare, 2015, DISTR FACT SHEET PAS; Ministry of Panchayati Raj, 2009, NOT BACKW REG GRANT; Nair-Purohit S., 2015, RURAL MARKETING J; National Institute of Medical Statistics Indian Council of Medical Research UNICEF, 2012, INF CHILD MORT IND L; Pal J., 2017, P INT C INF COMM TEC, DOI [10.1145/3136560.3136582, DOI 10.1145/3136560.3136582]; Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354; Rydz D, 2005, J CHILD NEUROL, V20, P4, DOI 10.1177/08830738050200010201; Wagner AL, 2018, MATERN CHILD HLTH J, V22, P1286, DOI 10.1007/s10995-018-2509-y; WHO, 2013, INN CAT; WHO UNICEF, 2015, UNFPA WORLD BANK UN; World Health Organization, 2016, CHILD GROWTH STAND; World Health Organization, 2002, WHO PROGR MAP BEST R	26	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199607	10.1371/journal.pone.0199607	http://dx.doi.org/10.1371/journal.pone.0199607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GK0LV	29928057	gold, Green Submitted, Green Published			2022-12-26	WOS:000435802500117
J	Aghaizu, A; Tosswill, J; De Angelis, D; Ward, H; Hughes, G; Murphy, G; Delpech, V				Aghaizu, Adamma; Tosswill, Jennifer; De Angelis, Daniela; Ward, Helen; Hughes, Gwenda; Murphy, Gary; Delpech, Valerie			HIV incidence among sexual health clinic attendees in England: First estimates for black African heterosexuals using a biomarker, 2009-2013	PLOS ONE			English	Article							TESTING ALGORITHM; MEN; INFECTIONS; ACCURACY; ASSAYS	Introduction The HIV epidemic in England is largely concentrated among heterosexuals who are predominately black African and men who have sex with men (MSM). We present for the first time trends in annual HIV incidence for adults attending sexual health clinics, where 80% of all HIV diagnoses are made. Methods We identified newly diagnosed incident HIV using a recent infection testing algorithm (RITA) consisting of a biomarker (AxSYM assay, modified to determine antibody avidity), epidemiological and clinical information. We estimated HIV incidence using the WHO RITA formula for cross-sectional studies, with HIV testing data from sexual health clinics as the denominator. Results From 2009 to 2013, each year, between 9,700 and 26,000 black African heterosexuals (of between 161,000 and 231,000 heterosexuals overall) were included in analyses. For the same period, annually between 19,000 and 55,000 MSM were included. Estimates of HIV incidence among black Africans increased slightly (although non-significantly) from 0.15% (95% C.I. 0.05%-0.26%) in 2009 to 0.19% (95% C.I. 0.04%-0.34%) in 2013 and was 4-5-fold higher than among all heterosexuals among which it remained stable between 0.03% (95% C.I. 0.02%-0.05%) and 0.05% (95% C.I. 0.03%-0.07%) over the period. Among MSM incidence was highest and increased (non-significantly) from 1.24% (95% C.I 0.96 +/- 1.52%) to 1.46% (95% C.I 1.23%-1.70%) after a peak of 1.52% (95% C.I 1.30%-1.75%) in 2012. Conclusion These are the first nationwide estimates for trends in HIV incidence among black African and heterosexual populations in England which show black Africans, alongside MSM, remain disproportionately at risk of infection. Although people attending sexual health clinics may not be representative of the general population, nearly half of black Africans and MSM had attended in the previous 5 years. Timely and accurate incidence estimates will be critical in monitoring the impact of the reconfiguration of sexual health services in England, and any prevention programmes such as pre- exposure prophylaxis.	[Aghaizu, Adamma; Tosswill, Jennifer; De Angelis, Daniela; Hughes, Gwenda; Murphy, Gary; Delpech, Valerie] Publ Hlth England, Natl Infect Serv, Colindale Ave, London, England; [Aghaizu, Adamma; Ward, Helen] Imperial Coll London, Dept Infect Dis Epidemiol, Sch Publ Hlth, Norfolk Pl, London, England; [De Angelis, Daniela] Inst Publ Hlth, RC Biostat Unit, Forvie Site, Cambridge, England	Public Health England; Imperial College London; University of Cambridge	Aghaizu, A (corresponding author), Publ Hlth England, Natl Infect Serv, Colindale Ave, London, England.; Aghaizu, A (corresponding author), Imperial Coll London, Dept Infect Dis Epidemiol, Sch Publ Hlth, Norfolk Pl, London, England.	adamma.aghaizu@phe.gov.uk	Ward, Helen/A-1836-2009	Ward, Helen/0000-0001-8238-5036; Hughes, Gwenda/0000-0003-2090-7702; De Angelis, Daniela/0000-0001-6619-6112; delpech, valerie/0000-0002-9952-8109	Public Health England; MRC [MC_UU_00002/11] Funding Source: UKRI	Public Health England; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by Public Health England. The research is secondary analysis of surveillance data collected by Public Health England.	AGHAIZU A, 2011, EUROSURVEILLANCE, V19, P20673; [Anonymous], 2014, CEPHIA CONSORTIUM EV; Birrell PJ, 2013, LANCET INFECT DIS, V13, P313, DOI 10.1016/S1473-3099(12)70341-9; CEPHIA, 2015, INC INF US BIOM REC; Dunn D, 2014, AIDS, V28, P773, DOI 10.1097/QAD.0000000000000119; England NHS, 2016, CLIN COMM POL PROP P; Fenton KA, 2001, AIDS, V15, P1442, DOI 10.1097/00002030-200107270-00017; Fisher M, 2007, AIDS, V21, P2309, DOI 10.1097/QAD.0b013e3282ef9fed; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hallet TB, 2014, PLOS ONE, V4, pe5720; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Kirwan PDC, 2016, HIV UK 2016 REPORT; Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5; Mammone A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-65; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Medical Research Council, 2007, REV RES BLACK AFR CO; Mortimer J Y, 1995, Commun Dis Rep CDR Rev, V5, pR183; Murphy G, 2008, Euro Surveill, V13; Murphy G, 2004, AIDS, V18, P265, DOI 10.1097/00002030-200401230-00016; National AIDS Trust, 2014, HIV BLACK AFR COMM U; Office for National Statistics, 2017, CENS COUNTR BIRTH ET; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Presanis AM, 2011, BIOSTATISTICS, V12, P666, DOI 10.1093/biostatistics/kxr006; Public Health England, 2015, SEX TRANSM INF STIS; Remis RS, 2009, AIDS, V23, P493, DOI 10.1097/QAD.0b013e328323ad5f; Rice BD, 2012, AIDS, V26, P1961, DOI 10.1097/QAD.0b013e3283578b80; Romero A, 2014, EUR J PUBLIC HEALTH, V6, P808; Savage EJ, 2014, EUROSURVEILLANCE, V19, P23, DOI 10.2807/1560-7917.ES2014.19.48.20981; Sonnenberg P, 2013, LANCET, V382; Suligoi B, 2002, J CLIN MICROBIOL, V40, P4015, DOI 10.1128/JCM.40.11.4015-4020.2002; UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2011, US ASS REC INF EST H	34	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0197939	10.1371/journal.pone.0197939	http://dx.doi.org/10.1371/journal.pone.0197939			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924799	Green Published, gold, Green Accepted			2022-12-26	WOS:000435655600008
J	Keeley, T; Lin, SC; Lester, DK; Lau, EK; Yang, SY				Keeley, Tyler; Lin, Shengchen; Lester, Daniel K.; Lau, Eric K.; Yang, Shengyu			The fucose salvage pathway inhibits invadopodia formation and extracellular matrix degradation in melanoma cells	PLOS ONE			English	Article							MALIGNANT-MELANOMA; CANCER; METASTASIS; EXPRESSION; INVASION; PROTEIN; ACTIN; FUCOSYLATION; PROGRESSION; PODOSOMES	The fucose salvage pathway is a two-step process in which mammalian cells transform L-fucose into GDP-L-fucose, a universal fucose donor used by fucosyltransferases to modify glycans. Emerging evidence indicates the fucose salvage pathway and the fucosylation of proteins are altered during melanoma progression and metastasis. However the underlying mechanisms are not completely understood. Here, we report that the fucose salvage pathway inhibits invadopodia formation and extracellular matrix degradation by promoting alpha-1,2 fucosylation. Chemically or genetically increasing the fucose salvage pathway decreases invadopodium numbers and inhibits the proteolytic activity of invadopodia in WM793 melanoma cells. Inhibiting fucosylation by depleting fucokinase abrogates L-fucose-mediated inhibition of invadopodia, suggesting dependence on the fucose salvage pathway. The inhibition of invadopodium formation by L-fucose or ectopically expressed FUK could be rescued by treatment with alpha-1,2, but not alpha-1,3/alpha-1,4 fucosidase, implicating an alpha-1,2 fucose linkage-dependent anti-metastatic effect. The expression of FUT1, an alpha-1,2 fucosyltransferase, is remarkably down-regulated during melanoma progression, and the ectopic expression of FUT1 is sufficient to inhibit invadopodium formation and ECM degradation. Our findings indicate that the fucose salvage pathway can inhibit invadopodium formation, and consequently, invasiveness in melanoma via alpha-1,2 fucosylation. Re-activation of this pathway in melanoma could be useful for preventing melanoma invasion and metastasis.	[Keeley, Tyler; Lin, Shengchen; Yang, Shengyu] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Keeley, Tyler; Lester, Daniel K.] Univ S Florida, Canc Biol Grad Program, Tampa, FL USA; [Lester, Daniel K.; Lau, Eric K.] H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Comprehens Melanoma Res Ctr, Tampa, FL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute	Yang, SY (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.	sxy99@psu.edu	Lin, Shengchen/T-3529-2018	Lin, Shengchen/0000-0003-1488-8680	National Cancer Institute [R01 CA175741]; NATIONAL CANCER INSTITUTE [R01CA175741, R00CA172705] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by a grant from the National Cancer Institute (R01 CA175741) (SY). There was no additional external funding received for this study.	Adamczyk B, 2012, BBA-GEN SUBJECTS, V1820, P1347, DOI 10.1016/j.bbagen.2011.12.001; Agrawal P, 2017, CANCER CELL, V31, P804, DOI 10.1016/j.ccell.2017.05.007; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Christiansen MN, 2014, PROTEOMICS, V14, P525, DOI 10.1002/pmic.201300387; Ciolczyk-Wierzbicka D, 2007, MED CHEM, V3, P418, DOI 10.2174/157340607781745401; CLARK WH, 1991, CANCER METAST REV, V10, P83, DOI 10.1007/BF00049406; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Gorelik E, 1997, CANCER RES, V57, P332; Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770; Lau E, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac6479; Lin SC, 2016, J BIOL CHEM, V291, P27323, DOI 10.1074/jbc.M116.767640; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Mandal S, 2008, EXP CELL RES, V314, P3478, DOI 10.1016/j.yexcr.2008.09.013; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Raskin L, 2013, J INVEST DERMATOL, V133, P2585, DOI 10.1038/jid.2013.197; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Sawanobori A, 2016, PROTEOMICS, V16, P3073, DOI 10.1002/pmic.201500472; Smith PL, 2002, J CELL BIOL, V158, P801, DOI 10.1083/jcb.200203125; Sun JW, 2014, J CELL BIOL, V207, P535, DOI 10.1083/jcb.201407082; Sun JW, 2013, J BIOL CHEM, V288, P36971, DOI 10.1074/jbc.M113.506535; Sun JW, 2011, J BIOL CHEM, V286, P38865, DOI 10.1074/jbc.M111.270413; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yamaguchi H, 2011, J CELL BIOL, V193, P1275, DOI 10.1083/jcb.201009126; Yang Shengyu, 2012, Methods Mol Biol, V928, P221, DOI 10.1007/978-1-62703-008-3_17	28	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199128	10.1371/journal.pone.0199128	http://dx.doi.org/10.1371/journal.pone.0199128			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924834	Green Published, Green Submitted, gold			2022-12-26	WOS:000435655600048
J	Valino-Rivas, L; Cuarental, L; Grana, O; Bucala, R; Leng, L; Sanz, A; Gomez, G; Ortiz, A; Sanchez-Nino, MD				Valino-Rivas, Lara; Cuarental, Leticia; Grana, Osvaldo; Bucala, Richard; Leng, Lin; Sanz, Ana; Gomez, Gonzalo; Ortiz, Alberto; Dolores Sanchez-Nino, Maria			TWEAK increases CD74 expression and sensitizes to DDT proinflammatory actions in tubular cells	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; D-DOPACHROME TAUTOMERASE; ANTI-CD74 MONOCLONAL-ANTIBODY; ACUTE KIDNEY INJURY; NF-KAPPA-B; FACTOR MIF; PODOCYTE INJURY; INVARIANT CHAIN; DISEASE; CYTOKINE	CD74 is a multifunctional protein and a receptor for Macrophage Migration Inhibitory Factor (MIF) and MIF-2/D-dopachrome tautomerase (DDT) cytokines, upregulated in diabetic kidney disease. However, the drivers of CD74 expression and DDT function in kidney cells are poorly characterized. TWEAK is a proinflammatory cytokine that promotes kidney injury. We have now identified CD74 gene expression as upregulated in the kidneys in response to systemic TWEAK administration in mice, and have characterized the in vivo CD74 expression and the functional consequences in cultured cells. TWEAK administration to mice resulted in a progressive time-dependent (up to 24h) upregulation of kidney CD74 mRNA (RT-PCR) and protein (Western blot). Furthermore, the CD74 ligands MIF and DDT were also upregulated at the protein level 24h after TWEAK administration. Immunohistochemistry localized the increased CD74, MIF and DDT expression to tubular cells. In cultured tubular cells, TWEAK increased CD74 mRNA and protein expression dose-dependently, with a temporal pattern similar to in vivo. TWEAK-induced CD74 localized to the cell membrane, where it can function as a cytokine receptor. For the first time, we explored the actions of DDT in tubular cells and found that DDT amplified the increase in MCP-1 and RANTES expression in response to TWEAK. By contrast, DDT did not significantly modify TWEAK-induced Klotho downregulation. In conclusion, TWEAK upregulates CD74 and its ligands MIF and DDT in renal tubular cells. This may have functional consequences for kidney injury since DDT amplified the inflammatory response to TWEAK.	[Valino-Rivas, Lara; Cuarental, Leticia; Sanz, Ana; Ortiz, Alberto; Dolores Sanchez-Nino, Maria] IIS Fdn Jimenez Diaz, Madrid, Spain; [Grana, Osvaldo; Gomez, Gonzalo] Spanish Natl Canc Res Ctr, Struct Biol & Biocomp Programme, Bioinformat Unit, Madrid, Spain; [Bucala, Richard; Leng, Lin] Yale Univ, Dept Med, New Haven, CT 06520 USA	Fundacion Jimenez Diaz; Centro Nacional de Investigaciones Oncologicas (CNIO); Yale University	Sanchez-Nino, MD (corresponding author), IIS Fdn Jimenez Diaz, Madrid, Spain.	mdsanchez@fjd.es	Gomez-Lopez, Gonzalo/D-9123-2016; Sanz, Ana Belen/C-9489-2013; Valiño, Lara/ABH-2425-2020; Sanchez-Niño, Maria Dolores/B-7350-2019; ortiz, alberto/Y-7582-2018	Gomez-Lopez, Gonzalo/0000-0002-4146-0551; Sanz, Ana Belen/0000-0002-0255-5689; Valiño, Lara/0000-0003-3340-0716; Sanchez-Niño, Maria Dolores/0000-0001-7110-6409; ortiz, alberto/0000-0002-9805-9523; Grana-Castro, Osvaldo/0000-0003-1615-4242; Leng, Lin/0000-0002-0605-358X	FIS [PI15/00298, CP14/00133, PI16/02057, PI16/01900, FI14/00398]; ISCIII-RETIC REDinREN Fondos FEDER [RD016/0009]; Sociedad Espanola de Nefrologia and Programas de actividades de I + D entre grupos de investigacion de la Comunidad de Madrid en Biomedicina [B2017/BMD-3686 CIFRA2-CM]; FIS Miguel Servet [MS14/00133]; US NIH	FIS(Instituto de Salud Carlos III); ISCIII-RETIC REDinREN Fondos FEDER; Sociedad Espanola de Nefrologia and Programas de actividades de I + D entre grupos de investigacion de la Comunidad de Madrid en Biomedicina; FIS Miguel Servet; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by FIS PI15/00298, CP14/00133, PI16/02057, PI16/01900, ISCIII-RETIC REDinREN RD016/0009 Fondos FEDER, Sociedad Espanola de Nefrologia and Programas de actividades de I + D entre grupos de investigacion de la Comunidad de Madrid en Biomedicina B2017/BMD-3686 CIFRA2-CM. Salary support: FIS Miguel Servet MS14/00133 to MDSN and to ABS, and FIS FI14/00398 to LVR. RB and LL are supported by the US NIH.	Sanz AB, 2011, KIDNEY INT, V80, P708, DOI 10.1038/ki.2011.180; Borghese F, 2011, EXPERT OPIN THER TAR, V15, P237, DOI 10.1517/14728222.2011.550879; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chen L, 2015, J CLIN INVEST, V125, P2399, DOI 10.1172/JCI80467; Djudjaj S, 2016, J AM SOC NEPHROL, V27, P1650, DOI 10.1681/ASN.2015020149; Sanchez-Nino MD, 2013, BBA-MOL BASIS DIS, V1832, P2232, DOI 10.1016/j.bbadis.2013.08.010; Sanchez-Nino MD, 2009, J AM SOC NEPHROL, V20, P353, DOI 10.1681/ASN.2008020194; Esumi N, 1998, MAMM GENOME, V9, P753, DOI 10.1007/s003359900858; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; Heinrichs D, 2014, FASEB J, V28, P5136, DOI 10.1096/fj.14-256776; Heinrichs D, 2011, P NATL ACAD SCI USA, V108, P17444, DOI 10.1073/pnas.1107023108; Hotta K, 2011, KIDNEY INT, V79, P179, DOI 10.1038/ki.2010.379; Kaufman JL, 2013, BRIT J HAEMATOL, V163, P478, DOI 10.1111/bjh.12565; Kiyota T, 2015, MOL THER, V23, P1712, DOI 10.1038/mt.2015.142; Lan HY, 1996, AM J PATHOL, V149, P1119; Leng L, 2006, CELL RES, V16, P162, DOI 10.1038/sj.cr.7310022; Martin P, 2015, LEUKEMIA LYMPHOMA, V56, P3065, DOI 10.3109/10428194.2015.1028052; Matsuda S, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-41; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; MOMBURG F, 1986, J IMMUNOL, V136, P940; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Munoz-Garcia B, 2009, ARTERIOSCL THROM VAS, V29, P2061, DOI 10.1161/ATVBAHA.109.194852; Ochi A, 2017, AM J PHYSIOL-RENAL, V313, pF767, DOI 10.1152/ajprenal.00683.2016; ODH G, 1993, BIOCHEM BIOPH RES CO, V197, P619, DOI 10.1006/bbrc.1993.2524; Ortiz A, 2017, J AM SOC NEPHROL, V28, P823, DOI 10.1681/ASN.2015080898; Pagni F, 2012, AM J NEPHROL, V36, P537, DOI 10.1159/000345465; Rayego-Mateos S, 2013, J PATHOL, V231, P480, DOI 10.1002/path.4250; Rice EK, 2003, KIDNEY INT, V63, P1265, DOI 10.1046/j.1523-1755.2003.00875.x; Roger T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00026; Ruiz-Andres O, 2016, KIDNEY INT, V89, P399, DOI 10.1038/ki.2015.332; Saleem M, 1997, TRANSPLANTATION, V63, P1134, DOI 10.1097/00007890-199704270-00013; Sanchez-Nino MD, 2013, CYTOKINE GROWTH F R, V24, P23, DOI 10.1016/j.cytogfr.2012.08.001; Sanchez-Nino MD, 2011, NEPHROL DIAL TRANSPL, V26, P1797, DOI 10.1093/ndt/gfq306; Sanz AB, 2016, SEMIN NEPHROL, V36, P189, DOI 10.1016/j.semnephrol.2016.03.006; Sanz AB, 2014, NEPHROL DIAL TRANSPL, V29, pI54, DOI 10.1093/ndt/gft342; Sanz AB, 2009, J CELL MOL MED, V13, P3329, DOI 10.1111/j.1582-4934.2009.00766.x; Sanz AB, 2008, J AM SOC NEPHROL, V19, P695, DOI 10.1681/ASN.2007050577; Sasaki S, 2004, KIDNEY INT, V65, P469, DOI 10.1111/j.1523-1755.2004.00394.x; Stein R, 2004, BLOOD, V104, P3705, DOI 10.1182/blood-2004-03-0890; Su HT, 2017, INFLAMM RES, V66, P209, DOI 10.1007/s00011-016-0995-1; Sugimoto H, 1999, BIOCHEMISTRY-US, V38, P3268, DOI 10.1021/bi982184o; Ucero AC, 2013, BBA-MOL BASIS DIS, V1832, P1744, DOI 10.1016/j.bbadis.2013.05.032; Ucero AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051992; Valino-Rivas L, 2016, SCI REP-UK, V6, DOI 10.1038/srep28857; Valino-Rivas L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00483; Xia YM, 2015, J AM SOC NEPHROL, V26, P1053, DOI 10.1681/ASN.2014030233; Xin D, 2010, MOL CANCER RES, V8, P1601, DOI 10.1158/1541-7786.MCR-10-0101; Young AN, 2001, AM J PATHOL, V158, P1639, DOI 10.1016/S0002-9440(10)64120-X	50	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199391	10.1371/journal.pone.0199391	http://dx.doi.org/10.1371/journal.pone.0199391			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924850	Green Published, gold, Green Submitted			2022-12-26	WOS:000435655600066
J	Zeng, FF; Xu, PX; Tan, KM; Zarbin, PHG; Leal, WS				Zeng, Fangfang; Xu, Pingxi; Tan, Kaiming; Zarbin, Paulo H. G.; Leal, Walter S.			Methyl dihydrojasmonate and lilial are the constituents with an "off-label" insect repellence in perfumes	PLOS ONE			English	Article							JASMONATE	Insect repellents are widely used to fend off nuisance mosquitoes and, more importantly, to reduce or eliminate mosquito bites in areas where viruses and other vector-borne diseases are circulating. Synthesized more than six decades ago, DEET is the most widely used insect repellent. Plant-derived compounds are used in a plethora of commercial formulations and natural recipes to repel mosquitoes. They are also used as fragrances. We analysed Bombshell (R) to identify the constituent(s) eliciting a previously reported "off-label" repellence activity. The two major fragrance ingredients in Bombshell, i.e., methyl dihydrojasmonate and lilial, demonstrated strong repellence against the southern house mosquito, Culex quinquefasciatus, in laboratory assays. Both compounds activated a previously identified DEET-sensitive odorant receptor, CquiOR136. These compounds were also major constituents of Ivanka Trump eau de parfum. The methyl dihydrojasmonate content was higher in the Ivanka Trump perfume than in Bombshell, the reverse being true for lilial. Both Bombshell and Ivanka Trump eaux de parfums retained activity for as long as 6 hours in laboratory assays. Although wearing these perfumes may repel nuisance mosquitoes, their use as "off-label" repellents against infected mosquitoes is not recommended.	[Zeng, Fangfang; Xu, Pingxi; Tan, Kaiming; Leal, Walter S.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Zarbin, Paulo H. G.] Univ Fed Parana, Lab Ecol Quim & Sintese Organ, Dept Quim, Curitiba, Parana, Brazil	University of California System; University of California Davis; Universidade Federal do Parana	Leal, WS (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021; Zarbin, Paulo H G/C-1383-2013	Leal Filho, Walter/0000-0002-1241-5225	China Scholarship Council (CSC); Huazhong Agricultural University	China Scholarship Council (CSC)(China Scholarship Council); Huazhong Agricultural University	The authors received no specific funding for this work. However, F.Z. was supported by a student fellowship from the China Scholarship Council (CSC) and Huazhong Agricultural University. CSC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapuis C, 2012, HELV CHIM ACTA, V95, P1479, DOI 10.1002/hlca.201200070; EPA, DEET 2016; Gross AD, 2015, INSECT REPELLENTS HANDBOOK, 2ND EDITION, P75; Gu X, 2005, BRIT J DERMATOL, V152, P1263, DOI 10.1111/j.1365-2133.2005.06691.x; Leal WS, 2017, SCI REP-UK, V7, DOI 10.1038/srep42826; Linstrom P., 1997, NIST STANDARD REFERE, V69; Moore SJ, 2015, INSECT REPELLENTS HANDBOOK, 2ND EDITION, P179; Norris EJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020124; Patel RV, 2016, PHARMACOTHERAPY, V36, P1272, DOI 10.1002/phar.1854; Rodriguez SD, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev125; Sell CS, 2014, CHEMISTRY AND THE SENSE OF SMELL, P1; Strickman D, 2015, INSECT REPELLENTS HANDBOOK, 2ND EDITION, P231; Who, 2009, GUID EFF TEST MOSQ R, P1; Xu PX, 2014, P NATL ACAD SCI USA, V111, P16592, DOI 10.1073/pnas.1417244111	14	10	11	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2018	13	6							e0199386	10.1371/journal.pone.0199386	http://dx.doi.org/10.1371/journal.pone.0199386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ7CA	29920544	Green Published, gold, Green Submitted			2022-12-26	WOS:000435541300042
J	Bhakti, T; Goulart, F; de Azevedo, CS; Antonini, Y				Bhakti, Tulaci; Goulart, Fernando; de Azevedo, Cristiano Schetini; Antonini, Yasmine			Does scale matter? The influence of three- level spatial scales on forest bird occurrence in a tropical landscape	PLOS ONE			English	Article							ATLANTIC FOREST; RELATIVE IMPORTANCE; FUNCTIONAL CONNECTIVITY; INSECTIVOROUS BIRDS; SPECIES RICHNESS; FRAGMENTATION; UNDERSTORY; PATTERNS; AREA; AVAILABILITY	Consequences of habitat fragmentation for species occurrence are amongst the most important issues in landscape and conservation ecology. Empirical and theoretical studies have demonstrated that the total amount of habitat, patch size and connectivity have nonlinear effects on species survival on multiple spatial and temporal scales. Therefore, population models need to incorporate multiple scales, which can be extremely valuable to prioritizing conservation efforts in these changing landscapes. We tested how the amount and configuration of habitat affect understory bird species occurrence using fine to broadscale habitat features. We used playback to sample birds in 13 Atlantic Forest fragments in Southeast Brazil. Microhabitat, local and regional landscape variables were tested against bird occurrence. Our results demonstrate that different bird species respond to different habitat scales. Sclerurus scansor, Xiphorhynchus fuscus, Automolus leucophthalmus, Drymophila ochropyga, Mackenziaena leachii, and Chiroxiphia caudata were most influenced by tree height and diameter (microhabitat characteristics), S. scansor, F. serrana and Pyriglena leucoptera were most influenced by forest cover and red-edge reflectance(local-scale metrics) and S. scansor, X. fuscus, D. ochropyga, P. leucoptera, F. serrana and M. leachii had area, core area and functional connectivity index (landscape features) as stronger predictors of species occurrence. Small forest fragments acted as corridors and increased overall connectivity of the entire community. The most effective means of maintaining long-term population connectivity of understory birds involves retaining both large and small areas, including forests with different micro-habitat characteristics. No management approach based on a single-scale would benefit all species. Implementing multiscale conservation strategies are necessary for maintaining long-term viability of forest birds on tropical landscapes.	[Bhakti, Tulaci; Antonini, Yasmine] Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, Dept Biodiversidade Evolucao & Meio Ambiente, Lab Biodiversidade, Ouro Preto, MG, Brazil; [Goulart, Fernando] Univ Fed Minas Gerais, Inst Ciencias Geol, Dept Cartog, Programa Posgrad Anal & Modelagem Sistemas Ambien, Belo Horizonte, MG, Brazil; [de Azevedo, Cristiano Schetini] Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, Dept Biodiversidade Evolucao & Meio Ambiente, Lab Zool Vertebrados, Ouro Preto, MG, Brazil	Universidade Federal de Ouro Preto; Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto	Antonini, Y (corresponding author), Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, Dept Biodiversidade Evolucao & Meio Ambiente, Lab Biodiversidade, Ouro Preto, MG, Brazil.	antonini.y@gmail.com	Azevedo, Cristiano S/D-4473-2013; Bhakti, Tulaci/W-9452-2019; Goulart, Fernando/N-5602-2018	Bhakti, Tulaci/0000-0002-2191-1829; Goulart, Fernando/0000-0002-6327-5285; Azevedo, Cristiano/0000-0003-0256-9017; Antonini, Yasmine/0000-0002-5582-8193				Auguie B, 2017, GRIDEXTRA MISCELLANE; Awade M, 2008, AUSTRAL ECOL, V33, P863, DOI 10.1111/j.1442-9993.2008.01857.x; Awade M, 2012, LANDSCAPE ECOL, V27, P185, DOI 10.1007/s10980-011-9667-2; Banks-Leite C, 2013, ECOL INDIC, V31, P82, DOI 10.1016/j.ecolind.2012.04.015; Banks-Leite C, 2010, OIKOS, V119, P918, DOI 10.1111/j.1600-0706.2009.18061.x; Barbosa KVD, 2017, PERSPECT ECOL CONSER, V15, P42, DOI 10.1016/j.pecon.2016.11.001; Berkes F, 2007, P NATL ACAD SCI USA, V104, P15188, DOI 10.1073/pnas.0702098104; Bibby C., 2000, EXPEDITION FIELD TEC; Bino G, 2008, INT J REMOTE SENS, V29, P3675, DOI 10.1080/01431160701772534; Boscolo D, 2006, AN ACAD BRAS CIENC, V78, P629, DOI 10.1590/S0001-37652006000400003; Boscolo D, 2009, LANDSCAPE ECOL, V24, P907, DOI 10.1007/s10980-009-9370-8; Brooks T, 1999, ANIM CONSERV, V2, P211, DOI 10.1111/j.1469-1795.1999.tb00067.x; Burnham K. P., 2002, ECOLOGICAL MODELLING, V172, DOI [10.1016/j.ecolmodel.2003.11.004, DOI 10.1016/J.ECOLMODEL.2003.11.004]; Casas G, 2016, TROP CONSERV SCI, V9, P503, DOI 10.1177/194008291600900126; Corry RC, 2005, LANDSCAPE ECOL, V20, P591, DOI 10.1007/s10980-004-5036-8; Cushman SA, 2016, LANDSCAPE ECOL, V31, P1337, DOI 10.1007/s10980-015-0292-3; DeMars CA, 2010, BIOL CONSERV, V143, P1485, DOI 10.1016/j.biocon.2010.03.029; Denoel M, 2006, BIOL CONSERV, V130, P495, DOI 10.1016/j.biocon.2006.01.009; dos Anjos L, 2015, BIOL CONSERV, V188, P32, DOI 10.1016/j.biocon.2015.01.016; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Ferreira RP, 2013, NEOTROP ENTOMOL, V42, P466, DOI 10.1007/s13744-013-0145-1; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gitelson AA, 1996, J PLANT PHYSIOL, V148, P501, DOI 10.1016/S0176-1617(96)80285-9; Goulart FF, 2015, NAT CONSERVACAO, V13, P47, DOI 10.1016/j.ncon.2015.03.003; Hansbauer MM, 2008, J TROP ECOL, V24, P291, DOI 10.1017/S0266467408005002; Hansbauer MM, 2010, LANDSCAPE ECOL, V25, P407, DOI 10.1007/s10980-009-9418-9; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; Holland GJ, 2009, BIODIVERS CONSERV, V18, P2997, DOI 10.1007/s10531-009-9621-7; Imani M, 2015, ISPRS J PHOTOGRAMM, V102, P1, DOI 10.1016/j.isprsjprs.2014.12.024; Keinath DA, 2017, GLOBAL ECOL BIOGEOGR, V26, P115, DOI 10.1111/geb.12509; Kennedy CM, 2011, ECOL APPL, V21, P1837, DOI 10.1890/10-1044.1; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Lees AC, 2008, ANIM CONSERV, V11, P128, DOI 10.1111/j.1469-1795.2008.00162.x; Leme Andrea, 2001, Ararajuba, V9, P7; Lima CA, 2010, ORNITOL NEOTROP, V21, P425; Lindenmayer David, 2016, Proceedings of the Royal Society of Victoria, V128, P64, DOI 10.1071/RS16006; Marantz C.A., 2018, HDB BIRDS WORLD ALIV; Marini MA, 2010, STUD NEOTROP FAUNA E, V45, P1, DOI 10.1080/01650521003656606; Martensen AC, 2012, CONSERV BIOL, V26, P1100, DOI 10.1111/j.1523-1739.2012.01940.x; Mateo-Sanchez MC, 2016, LANDSCAPE ECOL, V31, P1261, DOI 10.1007/s10980-015-0324-z; Mathias LB, 2016, WILSON J ORNITHOL, V128, P752; McGarigal K., 2012, TECH REP; Melles S, 2003, CONSERV ECOL, V7; Mendes P, 2017, LANDSCAPE ECOL, V32, P745, DOI 10.1007/s10980-016-0483-6; Mesquita RCG, 1999, BIOL CONSERV, V91, P129, DOI 10.1016/S0006-3207(99)00086-5; MMA, 2016, CAT IM SAT RAP MIN M; Moore RP, 2008, ECOL LETT, V11, P960, DOI 10.1111/j.1461-0248.2008.01196.x; Moreira-Lima L., 2014, AVES MATA ATLANTICA; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Neel MC, 2004, LANDSCAPE ECOL, V19, P435, DOI 10.1023/B:LAND.0000030521.19856.cb; Newbold T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2131; North MP, 2017, ELSEVIER, V405, P166, DOI [10.1016/j.foreco.2017.09.019, DOI 10.1016/J.FORECO.2017.09.019]; Parker TA III, 1996, NEOTROPICAL BIRDS EC; Pascual-Hortal L, 2008, EUR J FOREST RES, V127, P23, DOI 10.1007/s10342-006-0165-z; Peter F, 2015, BIOTROPICA, V47, P626, DOI 10.1111/btp.12239; Piratelli A, 2008, BRAZ J BIOL, V68, P259, DOI 10.1590/S1519-69842008000200006; Piratelli A., 2012, ORNITOL NEOTROP, V23, P139; Pollock HS, 2015, BIOL CONSERV, V188, P116, DOI 10.1016/j.biocon.2014.11.013; Powell LL, 2015, BIOL CONSERV, V188, P1, DOI 10.1016/j.biocon.2015.03.025; Tubelis DP, 2007, LANDSCAPE ECOL, V22, P1045, DOI 10.1007/s10980-007-9090-x; Rempel R. S., 2012, PATCH ANAL PATCH GRI; Remsen Jr JV, 2018, HDB BIRDS WORLD ALIV; Ribon R, 2006, PLANO MANEJO PARQUE; Ribon R, 2016, REV BRAS ORNITOL, V24, P303; Richmond S, 2012, CAN J ZOOL, V90, P815, DOI [10.1139/z2012-051, 10.1139/Z2012-051]; Sahana M, 2015, MODEL EARTH SYST ENV, V1, DOI 10.1007/s40808-015-0043-0; Saura S, 2012, CONEFOR USER MANUAL, P19; Sekercioglu CH, 2002, P NATL ACAD SCI USA, V99, P263, DOI 10.1073/pnas.012616199; Sick H, 2001, ORNITOLOGIA BRASILEI; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Smith AC, 2011, ECOGRAPHY, V34, P103, DOI 10.1111/j.1600-0587.2010.06201.x; STOUFFER PC, 1995, CONSERV BIOL, V9, P1085, DOI 10.1046/j.1523-1739.1995.9051072.x-i1; Stratford JA, 2005, FRONT ECOL ENVIRON, V3, P91, DOI 10.2307/3868515; Stratford JA, 2015, BIOL CONSERV, V188, P109, DOI 10.1016/j.biocon.2015.01.017; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Thompson FR, 2002, STUD AVIAN BIOL-SER, P8; Torres A, 2016, LANDSCAPE ECOL, V31, P2291, DOI 10.1007/s10980-016-0400-z; Tozer DC, 2010, WETL ECOL MANAG, V18, P679, DOI 10.1007/s11273-010-9187-x; Uezu A, 2005, BIOL CONSERV, V123, P507, DOI 10.1016/j.biocon.2005.01.001; Uezu A, 2011, BIODIVERS CONSERV, V20, P3627, DOI 10.1007/s10531-011-0154-5; Visco DM, 2015, BIOL CONSERV, V191, P117, DOI 10.1016/j.biocon.2015.05.018; Walz U, 2011, LIVING REV LANDSC RE, V5, P1, DOI [10.12942/lrlr-2011-3, DOI 10.12942/LRLR-2011-3]; Wikelski M, 2000, ECOLOGY, V81, P2458, DOI 10.1890/0012-9658(2000)081[2458:SORIAN]2.0.CO;2; Wood Jesse M., 2016, Journal of Urban Ecology, V2, pjuw003; Yong DL, 2011, J TROP ECOL, V27, P1, DOI 10.1017/S0266467410000520; Zanette L, 2000, ECOLOGY, V81, P1654, DOI 10.1890/0012-9658(2000)081[1654:FSISFE]2.0.CO;2; Zimmer K, 2018, HDB BIRDS WORLD ALIV; Zuria I, 2013, AGROFOREST SYST, V87, P377, DOI 10.1007/s10457-012-9558-9	90	14	14	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198732	10.1371/journal.pone.0198732	http://dx.doi.org/10.1371/journal.pone.0198732			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912911	gold, Green Published, Green Submitted			2022-12-26	WOS:000435528600044
J	Lewis, G; Ioannidis, K; van Harmelen, AL; Neufeld, S; Stochl, J; Lewis, G; Jones, PB; Goodyer, I				Lewis, Gemma; Ioannidis, Konstantinos; van Harmelen, Anne-Laura; Neufeld, Sharon; Stochl, Jan; Lewis, Glyn; Jones, Peter B.; Goodyer, Ian			The association between pubertal status and depressive symptoms and diagnoses in adolescent females: A population-based cohort study	PLOS ONE			English	Article							GENDER-DIFFERENCES; HEALTH OUTCOMES; AGE; HORMONES; BRAIN; GIRLS; VICTIMIZATION; PROGESTERONE; TRANSITION; ESTRADIOL	Background There is an association between puberty and depression, but many things remain poorly understood. When assessing puberty in females, most studies combine indicators of breast and pubic hair development which are controlled by different hormonal pathways. The contributions of pubertal timing (age at onset) and pubertal status (stage of development, irrespective of timing) are also poorly understood. We tested the hypothesis that stage of breast development in female adolescents, controlled largely by increased estradiol, would be more strongly associated with depression than pubic hair development which occurs in both males and females, and is controlled by adrenal androgens. We investigated whether this association was independent of pubertal timing. Methods ROOTS is an ongoing cohort of 1,238 adolescents (54% female) recruited in Cambridgeshire (UK) at age 14.5, and followed-up at ages 16 and 17.5. Depression was assessed using the Mood and Feelings Questionnaire (MFQ) and clinical interview. Breast and pubic hair development were assessed at 14.5, using Tanner rating scales. Results For each increase in Tanner breast stage at 14.5, depressive symptoms increased by 1.4 MFQ points (95% CI 0.6 to 2.3), irrespective of age at onset. Pubic hair status was only associated with depressive symptoms before adjustment for breast status, and was not associated with depression in males. The same pattern was observed longitudinally, and for depression diagnoses. Limitations We did not directly measure hormone levels, our findings are observational, and the study had a relatively low response rate. Conclusions Females at more advanced stages of breast development are at increased risk of depression, even if their age at pubertal onset is not early. Alongside social and psychological factors, hormones controlling breast but not pubic hair development may contribute to increased incidence of female depression during puberty.	[Lewis, Gemma; Lewis, Glyn] UCL, Div Psychiat, London, England; [Ioannidis, Konstantinos; van Harmelen, Anne-Laura; Neufeld, Sharon; Stochl, Jan; Jones, Peter B.; Goodyer, Ian] Univ Cambridge, Dept Psychiat, Cambridge, England	University of London; University College London; University of Cambridge	Lewis, G (corresponding author), UCL, Div Psychiat, London, England.	gemma.lewis@ucl.ac.uk	Ioannidis, Konstantinos/AAZ-3147-2021; Lewis, Glyn/E-9944-2012; Stochl, Jan/AAF-1379-2020; Stochl, Jan/D-2284-2018	Lewis, Glyn/0000-0001-5205-8245; Stochl, Jan/0000-0002-9693-9930; Stochl, Jan/0000-0002-9693-9930; Neufeld, Sharon/0000-0001-5470-3770; van Harmelen, Anne-Laura/0000-0003-1108-2921	Wellcome Trust [074296]; NIHR Collaboration for Leadership in Applied Research & Care East of England (CLARHRC-EoE); NIHR Cambridge Biomedical Research Centre; Friends of Peterhouse College, Research Associate post	Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Collaboration for Leadership in Applied Research & Care East of England (CLARHRC-EoE); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Friends of Peterhouse College, Research Associate post	The ROOTS study was supported by a programme grant awarded to Ian Goodyer and Peter Jones by the Wellcome Trust (grant number 074296), the NIHR Collaboration for Leadership in Applied Research & Care East of England (CLARHRC-EoE), and the NIHR Cambridge Biomedical Research Centre. Gemma Lewis was funded by a Friends of Peterhouse College, Research Associate post.	ANGOLD A, 1993, J AFFECT DISORDERS, V29, P145, DOI 10.1016/0165-0327(93)90029-J; Angold A, 1995, INT J METHOD PSYCH, V5, P237; Angold A, 1999, PSYCHOL MED, V29, P1043, DOI 10.1017/S0033291799008946; ANGOLD A, 1992, DEV PSYCHOPATHOL, V4, P5, DOI 10.1017/S0954579400005538; Angold A, 1998, PSYCHOL MED, V28, P51, DOI 10.1017/S003329179700593X; Balzer BWR, 2015, EUR J PEDIATR, V174, P289, DOI 10.1007/s00431-014-2475-3; Bebbington PE, 1998, PSYCHOL MED, V28, P9, DOI 10.1017/S0033291797006077; Biro FM, 2013, PEDIATRICS, V132, P1019, DOI 10.1542/peds.2012-3773; Boivin JR, 2017, PSYCHONEUROENDOCRINO, V85, P78, DOI 10.1016/j.psyneuen.2017.08.009; Catanzaro MF, 2011, PASTOR CARE EDUC, V29, P83, DOI 10.1080/02643944.2011.573495; Christensen KY, 2010, J ADOLESCENT HEALTH, V47, P282, DOI 10.1016/j.jadohealth.2010.02.005; Copeland W, 2010, AM J PSYCHIAT, V167, P1218, DOI 10.1176/appi.ajp.2010.09081190; Day FR, 2015, SCI REP-UK, V5, DOI 10.1038/srep11208; DORN LD, 1990, DEV PSYCHOL, V26, P322, DOI 10.1037/0012-1649.26.2.322; Dunn VJ, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-109; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Freeman EW, 2004, ARCH GEN PSYCHIAT, V61, P62, DOI 10.1001/archpsyc.61.1.62; Galvao TF, 2014, J AFFECT DISORDERS, V155, P13, DOI 10.1016/j.jad.2013.10.034; Ge XJ, 2001, DEV PSYCHOL, V37, P404, DOI 10.1037//0012-1649.37.3.404; Gleason CE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001833; Goddings AL, 2014, NEUROIMAGE, V88, P242, DOI 10.1016/j.neuroimage.2013.09.073; Goddings AL, 2012, DEVELOPMENTAL SCI, V15, P801, DOI 10.1111/j.1467-7687.2012.01174.x; Gordon JL, 2018, JAMA PSYCHIAT, V75, P149, DOI 10.1001/jamapsychiatry.2017.3998; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; Joinson C, 2012, PSYCHOL MED, V42, P2579, DOI 10.1017/S003329171200061X; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Lee KJ, 2016, INT J SOC RES METHOD, V19, P575, DOI 10.1080/13645579.2015.1126486; Lewis G, 2016, SOC PSYCH PSYCH EPID, V51, P161, DOI 10.1007/s00127-015-1150-y; Li L, 2014, INT J EPIDEMIOL, V43, P1163, DOI 10.1093/ije/dyu071; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; McEwen BS, 2012, BEHAV NEUROSCI, V126, P4, DOI 10.1037/a0026708; O'Connor RC, 2009, BRIT J PSYCHIAT, V194, P68, DOI 10.1192/bjp.bp.107.047704; Patton GC, 2008, J AM ACAD CHILD PSY, V47, P1424, DOI 10.1097/CHI.0b013e3181886ebe; Piekarski DJ, 2017, CURR BIOL, V27, P1735, DOI 10.1016/j.cub.2017.05.027; Sequeira M- E, 2016, BR J PSYCHIAT; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Skovlund CW, 2016, JAMA PSYCHIAT, P1, DOI [10.1001/jamapsychistry.2016.2387, DOI 10.1001/JAMAPSYCHISTRY.2016.2387]; St Clair MC, 2015, DEV PSYCHOPATHOL, V27, P885, DOI 10.1017/S0954579414000625; Steiner M, 2003, J AFFECT DISORDERS, V74, P67, DOI 10.1016/S0165-0327(02)00432-9; Takizawa R, 2014, AM J PSYCHIAT, V171, P777, DOI 10.1176/appi.ajp.2014.13101401; Toffoletto S, 2014, PSYCHONEUROENDOCRINO, V50, P28, DOI 10.1016/j.psyneuen.2014.07.025; Wang H, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3231; Whincup PH, 2001, BMJ, V322; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yeung SLA, 2018, PSYCHIAT RES, V259, P32, DOI 10.1016/j.psychres.2017.09.040	45	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198804	10.1371/journal.pone.0198804	http://dx.doi.org/10.1371/journal.pone.0198804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ6XV	29912985	Green Published, gold, Green Submitted			2022-12-26	WOS:000435528600048
J	Takada, H; Kurosaki, M; Nakanishi, H; Takahashi, Y; Itakura, J; Tsuchiya, K; Yasui, Y; Tamaki, N; Takaura, K; Komiyama, Y; Higuchi, M; Kubota, Y; Wang, W; Okada, M; Enomoto, N; Izumi, N				Takada, Hitomi; Kurosaki, Masayuki; Nakanishi, Hiroyuki; Takahashi, Yuka; Itakura, Jun; Tsuchiya, Kaoru; Yasui, Yutaka; Tamaki, Nobuharu; Takaura, Kenta; Komiyama, Yasuyuki; Higuchi, Mayu; Kubota, Youhei; Wang, Wann; Okada, Mao; Enomoto, Nobuyuki; Izumi, Namiki			Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma	PLOS ONE			English	Article							SKELETAL-MUSCLE DEPLETION; RENAL-CELL CARCINOMA; POSTOPERATIVE COMPLICATIONS; LIVER-TRANSPLANTATION; CRITERIA; OUTCOMES; PROGNOSIS; CIRRHOSIS; PREVALENCE; RESECTION	Background The present study aimed to investigate the impact of pre-sarcopenia on the prognosis of patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib. Methods We enrolled 214 patients (71 +/- 10 years old; 166 men and 48 women; 90% Child-Pugh grade A and 10% Child-Pugh grade B) treated with sorafenib in our hospital from July 2009 to August 2016. The muscle volume was measured from CT images just before sorafenib administration using software (SliceOmatic). Skeletal muscle mass index was calculated, and the presence of pre-sarcopenia was judged according to the standard (42 cm(2)/m(2) for men and 38 cm(2)/m(2) for women) proposed by the Japan Society of Hepatology. Results Pre-sarcopenia was found in 123 patients (57%). The overall survival (OS) in patients with pre-sarcopenia tended to be worse than in patients without pre-sarcopenia (median 252 vs. 284 days, respectively; p= 0.16). Multivariate Cox hazard analysis revealed a baseline serum albumin level of <= 3.5 g/dl [hazard ratio (HR) 1.9; p= 0.0006], a baseline alpha-fetoprotein(AFP) level of >= 100 ng/ml (HR 2.1; p= 0.002), presence of lesions in bilateral hepatic lobes (HR 1.7; p= 0.03), and presence of major portal vein invasion (HR 1.8; p= 0.01) to be independent prognostic factors. In the 68 patients who had three or more negative prognostic factors, the presence of pre-sarcopenia did not correlate with prognosis. Of the 146 patients who had two or less prognostic factors, OS was significantly worse in 84 patients (58%) with pre-sarcopenia than in 62 patients without pre-sarcopenia (median 417 vs. 562 days, respectively; p= 0.047), and Cox hazard analysis revealed pre-sarcopenia to be an important prognostic factor (HR 1.6; p= 0.047). Conclusion In sorafenib treatment for advanced HCC, pre-sarcopenia is a significant prognostic factor in patients with two or less negative prognostic factors, and could be the target of intervention to improve prognosis.	[Takada, Hitomi; Kurosaki, Masayuki; Nakanishi, Hiroyuki; Takahashi, Yuka; Itakura, Jun; Tsuchiya, Kaoru; Yasui, Yutaka; Tamaki, Nobuharu; Takaura, Kenta; Komiyama, Yasuyuki; Higuchi, Mayu; Kubota, Youhei; Wang, Wann; Okada, Mao; Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Takada, Hitomi; Komiyama, Yasuyuki; Enomoto, Nobuyuki] Univ Yamanashi, Dept Internal Med 1, Fac Med, Yamanashi, Japan	University of Yamanashi	Izumi, N (corresponding author), Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan.	izumi012@musashino.jrc.or.jp	Nakanishi, Hiroyuki/AAD-9324-2020	Nakanishi, Hiroyuki/0000-0003-3982-3314; Tamaki, Nobuharu/0000-0003-4634-6616; Yasui, Yutaka/0000-0002-6117-4990				Antoun S, 2010, ANN ONCOL, V21, P1594, DOI 10.1093/annonc/mdp605; Antoun S, 2013, CANCER-AM CANCER SOC, V119, P3377, DOI 10.1002/cncr.28218; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115; Dodson RM, 2013, J GASTROINTEST SURG, V17, P2123, DOI 10.1007/s11605-013-2348-5; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fujiwara N, 2015, J HEPATOL, V63, P131, DOI 10.1016/j.jhep.2015.02.031; Hamaguchi Y, 2016, WORLD J SURG, V40, P1959, DOI 10.1007/s00268-016-3504-3; Hara N, 2016, INTERNAL MED, V55, P863, DOI 10.2169/internalmedicine.55.5676; Harimoto N, 2016, HEPATOL RES, V46, P1247, DOI 10.1111/hepr.12674; Hayashi F, 2013, HEPATOL RES, V43, P1264, DOI 10.1111/hepr.12085; Hiraoka A, 2017, HEPATOL RES, V47, P558, DOI 10.1111/hepr.12780; Hiraoka A, 2015, J GASTROENTEROL, V50, P1206, DOI 10.1007/s00535-015-1068-x; Imai K, 2015, INT J MOL SCI, V16, P9612, DOI 10.3390/ijms16059612; Iritani S, 2015, J GASTROENTEROL, V50, P323, DOI 10.1007/s00535-014-0964-9; Itoh S, 2014, ANN SURG ONCOL, V21, P3063, DOI 10.1245/s10434-014-3686-6; Kaido T, 2017, NUTRITION, V33, P195, DOI 10.1016/j.nut.2016.07.002; Kaido T, 2016, LIVER CANCER, V5, P121, DOI 10.1159/000367749; Kalafateli M, 2015, WORLD J GASTROENTERO, V21, P7357, DOI 10.3748/wjg.v21.i24.7357; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kappus Matthew R, 2016, Curr Gastroenterol Rep, V18, P43, DOI 10.1007/s11894-016-0516-y; Kim JE, 2012, ONCOLOGY-BASEL, V82, P119, DOI 10.1159/000336082; Kobayashi A, 2016, J HEPATO-BIL-PAN SCI, V23, P57, DOI 10.1002/jhbp.302; Kumada T, 2011, J GASTROENTEROL, V46, P536, DOI 10.1007/s00535-010-0349-7; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mir O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037563; Montano-Loza AJ, 2016, J CACHEXIA SARCOPENI, V7, P126, DOI 10.1002/jcsm.12039; Montano-Loza AJ, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2015.31; Montano-Loza AJ, 2014, WORLD J GASTROENTERO, V20, P8061, DOI 10.3748/wjg.v20.i25.8061; Morimoto M, 2011, HEPATOL RES, V41, P296, DOI 10.1111/j.1872-034X.2011.00778.x; Nishikawa H, 2016, HEPATOL RES, V46, P951, DOI 10.1111/hepr.12774; Nishikawa H, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/872152; Nishikawa H, 2014, INT J ONCOL, V45, P2295, DOI 10.3892/ijo.2014.2654; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Prado Carla M M, 2009, Curr Opin Support Palliat Care, V3, P269, DOI 10.1097/SPC.0b013e328331124a; Roman E, 2014, DIGEST DIS SCI, V59, P1966, DOI 10.1007/s10620-014-3086-6; SATO Y, 1993, NEW ENGL J MED, V328, P1802, DOI 10.1056/NEJM199306243282502; Tandon P, 2012, LIVER TRANSPLANT, V18, P1209, DOI 10.1002/lt.23495; Thandassery Ragesh B, 2016, Curr Treat Options Gastroenterol, V14, P257, DOI 10.1007/s11938-016-0093-z; Valero V, 2015, J GASTROINTEST SURG, V19, P272, DOI 10.1007/s11605-014-2680-4	42	32	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198812	10.1371/journal.pone.0198812	http://dx.doi.org/10.1371/journal.pone.0198812			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912922	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600050
J	Emerman, AB; Blower, MD				Emerman, Amy B.; Blower, Michael D.			The RNA-binding complex ESCRT-II in Xenopus laevis eggs recognizes purine-rich sequences through its subunit, Vps25	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA-binding protein; RNA-protein interaction; RNA; endocytosis; RNA metabolism; RNA localization; ESCRT-II; polypurine motif; endosome maturation; GA-rich sequence; membrane trafficking	MESSENGER-RNA; GLOBAL ANALYSIS; UBIQUITIN RECOGNITION; FUNCTIONAL-ANALYSIS; STRUCTURAL BASIS; GENE-EXPRESSION; LOCALIZATION; PROTEINS; MECHANISM; REVEALS	RNA-binding proteins (RBP) are critical regulators of gene expression. Recent studies have uncovered hundreds of mRNA-binding proteins that do not contain annotated RNA-binding domains and have well-established roles in other cellular processes. Investigation of these nonconventional RBPs is critical for revealing novel RNA-binding domains and may disclose connections between RNA regulation and other aspects of cell biology. The endosomal sorting complex required for transport II (ESCRT-II) is a nonconventional RNA-binding complex that has a canonical role in multivesicular body formation. ESCRT-II was identified previously as an RNA-binding complex in Drosophila oocytes, but whether its RNA-binding properties extend beyond Drosophila is unknown. In this study, we found that the RNA-binding properties of ESCRT-II are conserved in Xenopus eggs, where ESCRT-II interacted with hundreds of mRNAs. Using a UV cross-linking approach, we demonstrated that ESCRT-II binds directly to RNA through its subunit, Vps25. UV cross-linking and immunoprecipitation (CLIP)-Seq revealed that Vps25 specifically recognizes a polypurine (i.e. GA-rich) motif in RNA. Using purified components, we could reconstitute the selective Vps25-mediated binding of the polypurine motif in vitro. Our results provide insight into the mechanism by which ESCRT-II selectively binds to mRNA and also suggest an unexpected link between endosome biology and RNA regulation.	[Blower, Michael D.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Med Sch, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Blower, MD (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	blower@molbio.mgh.harvard.edu		Blower, Michael/0000-0002-5037-1972	NIGMS, National Institutes of Health [RO1 GM086434]; National Science Foundation Graduate Research Fellowships Program (GRFP); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086434] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation Graduate Research Fellowships Program (GRFP); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant RO1 GM086434 (to M. D. B.) and a grant from the National Science Foundation Graduate Research Fellowships Program (GRFP) (to A. B. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alam SL, 2006, NAT STRUCT MOL BIOL, V13, P1029, DOI 10.1038/nsmb1160; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Beckmann BM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10127; Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163; Buxbaum AR, 2015, NAT REV MOL CELL BIO, V16, P95, DOI 10.1038/nrm3918; Castello A, 2016, MOL CELL, V63, P696, DOI 10.1016/j.molcel.2016.06.029; Castello A, 2015, TRENDS ENDOCRIN MET, V26, P746, DOI 10.1016/j.tem.2015.09.012; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Harami GM, 2013, TRENDS BIOCHEM SCI, V38, P364, DOI 10.1016/j.tibs.2013.04.006; He CS, 2016, MOL CELL, V64, P416, DOI 10.1016/j.molcel.2016.09.034; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P1031, DOI 10.1038/nsmb1163; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Im YJ, 2008, DEV CELL, V14, P902, DOI 10.1016/j.devcel.2008.04.004; Im YJ, 2009, DEV CELL, V17, P234, DOI 10.1016/j.devcel.2009.07.008; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Irion U, 2007, NATURE, V445, P554, DOI 10.1038/nature05503; James-Zorn C, 2015, GENESIS, V53, P486, DOI 10.1002/dvg.22873; Konig J., 2011, J VIS EXP, V30; Konopacki FA, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150218; Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mardakheh FK, 2015, DEV CELL, V35, P344, DOI 10.1016/j.devcel.2015.10.005; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Medioni C, 2012, DEVELOPMENT, V139, P3263, DOI 10.1242/dev.078626; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schwarz DS, 2014, J CELL BIOL, V207, P41, DOI 10.1083/jcb.201406037; Schweidenback CTH, 2015, RNA, V21, P279, DOI 10.1261/rna.047787.114; Sharp JA, 2011, MOL BIOL CELL, V22, P4312, DOI 10.1091/mbc.E11-07-0629; Slagsvold T, 2005, J BIOL CHEM, V280, P19600, DOI 10.1074/jbc.M501510200; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Teo H, 2004, J BIOL CHEM, V279, P28689, DOI 10.1074/jbc.M400023200; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849	53	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12593	12605		10.1074/jbc.RA118.003718	http://dx.doi.org/10.1074/jbc.RA118.003718			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29903915	hybrid, Green Published			2022-12-26	WOS:000441408500023
J	Gattinger, P; Lupinek, C; Kalogiros, L; Silar, M; Zidarn, M; Korosec, P; Koessler, C; Novak, N; Valenta, R; Mittermann, I				Gattinger, Pia; Lupinek, Christian; Kalogiros, Lampros; Silar, Mira; Zidarn, Mihaela; Korosec, Peter; Koessler, Christine; Novak, Natalija; Valenta, Rudolf; Mittermann, Irene			The culprit insect but not severity of allergic reactions to bee and wasp venom can be determined by molecular diagnosis	PLOS ONE			English	Article							DOUBLE POSITIVITY; MAJOR ALLERGENS; IGE ANTIBODIES; VESPULA VENOM; SKIN-TESTS; HONEY-BEE; HYMENOPTERA; ANAPHYLAXIS; HYPERSENSITIVITY; ALLERGOLOGY	Background Allergy to bee and wasp venom can lead to life-threatening systemic reactions. The identification of the culprit species is important for allergen-specific immunotherapy. Objectives To determine a panel of recombinant bee and wasp allergens which is suitable for the identification of bee or wasp as culprit allergen sources and to search for molecular surrogates of clinical severity of sting reactions. Methods Sera from eighty-seven patients with a detailed documentation of their severity of sting reaction (Mueller grade) and who had been subjected to titrated skin testing with bee and wasp venom were analyzed for bee and wasp-specific IgE levels by ImmunoCAP (TM). IgE-reactivity testing was performed using a comprehensive panel of recombinant bee and wasp venom allergens (rApi m 1, 2, 3, 4, 5 and 10; rVes v 1 and 5) by ISAC chip technology, ImmunoCAP and ELISA. IgG(4) antibodies to rApi m 1 and rVes v 5 were determined by ELISA and IgE/IgG(4) ratios were calculated. Results from skin testing, IgE serology and IgE/IgG(4) ratios were compared with severity of sting reactions. Results The panel of rApi m 1, rApi m 10, rVes v 1 and rVes v 5 allowed identification of the culprit venom in all but two of the 87 patients with good agreement to skin testing. Severities of sting reactions were not associated with results obtained by skin testing, venom-specific IgE levels or molecular diagnosis. Severe sting reactions were observed in patients showing < 1 ISU and < 2kU(A)/L of IgE to Api m 1 and/or Ves v 5. Conclusion We identified a minimal panel of recombinant bee and wasp allergens for molecular diagnosis which may permit identification of bee and/or wasp as culprit insect in venom-sensitized subjects. The severity of sting reactions was not associated with parameters obtained by molecular diagnosis.	[Gattinger, Pia; Lupinek, Christian; Valenta, Rudolf; Mittermann, Irene] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Div Immunopathol, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Kalogiros, Lampros] 401 Gen Mil Hosp, Dept Allergol & Clin Immunol, Athens, Greece; [Silar, Mira; Zidarn, Mihaela; Korosec, Peter] Univ Clin Resp & Allerg Dis, Golnik, Slovenia; [Koessler, Christine; Novak, Natalija] Univ Bonn, Dept Dermatol & Allergy, Bonn, Germany	Medical University of Vienna; University of Bonn	Mittermann, I (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Div Immunopathol, Dept Pathophysiol & Allergy Res, Vienna, Austria.	irene.mittermann@meduniwien.ac.at	Lupinek, Christian/I-3311-2019	Lupinek, Christian/0000-0002-8612-8245; Zidarn, Mihaela/0000-0003-0515-5207; Gattinger, Pia/0000-0001-6724-8543; Mittermann, Irene/0000-0002-6240-6730; Valenta, Rudolf/0000-0001-5944-3365	Austrian Science Fund [P26728-B20, F4605, DK W1248]	Austrian Science Fund(Austrian Science Fund (FWF))	This study was supported by grants from the Austrian Science Fund P26728-B20 (IM), F4605 and DK W1248 (RV).	[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Arzt L, 2017, ALLERGY; Blank S, 2010, J IMMUNOL, V184, P5403, DOI 10.4049/jimmunol.0803709; Bokanovic D, 2011, ALLERGY, V66, P1395, DOI 10.1111/j.1398-9995.2011.02659.x; Campana R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10278-1; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; Frick M, 2015, ALLERGY, V70, P1665, DOI 10.1111/all.12725; GEORGITIS JW, 1985, J ALLERGY CLIN IMMUN, V76, P803, DOI 10.1016/0091-6749(85)90752-3; Golden DBK, 2015, IMMUNOL ALLERGY CLIN, V35, P287, DOI 10.1016/j.iac.2015.01.007; Golden DBK, 2014, CURR OPIN ALLERGY CL, V14, P334, DOI 10.1097/ACI.0000000000000072; Golden DBK, 2011, J ALLERGY CLIN IMMUN, V127, P852, DOI 10.1016/j.jaci.2011.01.025; Grabenhenrich LB, 2016, J ALLERGY CLIN IMMUN, V137, P1128, DOI 10.1016/j.jaci.2015.11.015; Heinzerling Lucie, 2013, Clin Transl Allergy, V3, P3, DOI 10.1186/2045-7022-3-3; Hemmer W, 2001, J ALLERGY CLIN IMMUN, V108, P1045, DOI 10.1067/mai.2001.120013; Jakob T, 2017, ALLERGO J, V26, P93, DOI 10.1007/s40629-017-0014-2; Kohler J, 2014, J ALLERGY CLIN IMMUN, V133, P1383, DOI 10.1016/j.jaci.2013.10.060; Korosec P, 2012, J ALLERGY CLIN IMMUN, V129, P1406, DOI 10.1016/j.jaci.2011.12.975; Krishna MT, 2011, CLIN EXP ALLERGY, V41, P1201, DOI 10.1111/j.1365-2222.2011.03788.x; Lupinek Christian, 2016, Curr Treat Options Allergy, V3, P189; Lupinek C, 2014, METHODS, V66, P106, DOI 10.1016/j.ymeth.2013.10.008; Matricardi PM, 2016, PEDIAT ALLERG IMM-UK, V27, P1, DOI 10.1111/pai.12563; Mittermann I, 2010, J ALLERGY CLIN IMMUN, V125, P1300, DOI 10.1016/j.jaci.2010.03.017; Mobs C, 2015, ALLERGY, V70, P715, DOI 10.1111/all.12606; Muller UR, 2009, ALLERGY, V64, P543, DOI 10.1111/j.1398-9995.2008.01794.x; Mueller Ulrich R., 2011, Inflammation & Allergy Drug Targets, V10, P420; Pahr S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111483; Resch Y, 2011, CLIN EXP ALLERGY, V41, P1468, DOI 10.1111/j.1365-2222.2011.03798.x; Rueff F, 2011, Pneumologie, V65, P484, DOI 10.1055/s-0030-1256476; Selb J, 2016, CLIN EXP ALLERGY, V46, P621, DOI 10.1111/cea.12639; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Sturm GJ, 2018, ALLERGY, V73, P744, DOI 10.1111/all.13262; TURKELTAUB PC, 1982, J ALLERGY CLIN IMMUN, V70, P343, DOI 10.1016/0091-6749(82)90023-9; Valenta R, 2015, GASTROENTEROLOGY, V148, P1120, DOI 10.1053/j.gastro.2015.02.006; van Hage M, 2017, J ALLERGY CLIN IMMUN, V140, P974, DOI 10.1016/j.jaci.2017.05.008; VANDERLINDEN PWG, 1994, J ALLERGY CLIN IMMUN, V94, P151, DOI 10.1053/ai.1994.v94.a54889; Warrington Rj, 2006, Allergy Asthma Clin Immunol, V2, P62, DOI 10.1186/1710-1492-2-2-62; WEBER A, 1987, ALLERGY, V42, P464, DOI 10.1111/j.1398-9995.1987.tb00364.x; Worm M, 2014, DTSCH ARZTEBL INT, V111, P367, DOI 10.3238/arztebl.2014.0367	38	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2018	13	6							e0199250	10.1371/journal.pone.0199250	http://dx.doi.org/10.1371/journal.pone.0199250			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3YY	29940036	Green Published, Green Submitted, gold			2022-12-26	WOS:000436088700011
J	Mioduchowska, M; Czyz, MJ; Goldyn, B; Kur, J; Sell, J				Mioduchowska, Monika; Czyz, Michel Jan; Goldyn, Bartlomiej; Kur, Jaroslaw; Sell, Jerzy			Instances of erroneous DNA barcoding of metazoan invertebrates: Are universal cox1 gene primers too "universal" ?	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; OXIDASE SUBUNIT-I; SP NOV.; MITOCHONDRIAL PSEUDOGENES; AMPLIFICATION; AEROMONAS; EVOLUTION; GASTROTRICHA; PATELLOGASTROPODA; IDENTIFICATION	The cytochrome c oxidase subunit I (cox1) gene is the main mitochondrial molecular marker playing a pivotal role in phylogenetic research and is a crucial barcode sequence. Folmer's universal? primers designed to amplify this gene in metazoan invertebrates allowed quick and easy barcode and phylogenetic analysis. On the other hand, the increase in the number of studies on barcoding leads to more frequent publishing of incorrect sequences, due to amplification of non-target taxa, and insufficient analysis of the obtained sequences. Consequently, some sequences deposited in genetic databases are incorrectly described as obtained from invertebrates, while being in fact bacterial sequences. In our study, in which we used Folmer's primers to amplify COI sequences of the crustacean fairy shrimp Branchipus schaefferi (Fischer 1834), we also obtained COI sequences of microbial contaminants from Aeromonas sp. However, when we searched the GenBank database for sequences closely matching these contaminations we found entries described as representatives of Gastrotricha and Mollusca. When these entries were compared with other sequences bearing the same names in the database, the genetic distance between the incorrect and correct sequences amplified from the same species was c. a. 65%. Although the responsibility for the correct molecular identification of species rests on researchers, the errors found in already published sequences data have not been re-evaluated so far. On the basis of the standard sampling technique we have estimated with 95% probability that the chances of finding incorrectly described metazoan sequences in the GenBank depend on the systematic group, and variety from less than 1% (Mollusca and Arthropoda) up to 6.9% (Gastrotricha). Consequently, the increasing popularity of DNA barcoding and metabarcoding analysis may lead to overestimation of species diversity. Finally, the study also discusses the sources of the problems with amplification of non-target sequences.	[Mioduchowska, Monika; Sell, Jerzy] Univ Gdansk, Fac Biol, Dept Genet & Biosystemat, Gdansk, Poland; [Czyz, Michel Jan] Natl Res Inst, Inst Plant Protect, Res Ctr Quarantine Invas & Genetically Modified O, Poznan, Poland; [Goldyn, Bartlomiej] Adam Mickiewicz Univ, Fac Biol, Inst Environm Biol, Dept Gen Zool, Poznan, Poland; [Kur, Jaroslaw] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland	Fahrenheit Universities; University of Gdansk; Adam Mickiewicz University; Polish Academy of Sciences	Mioduchowska, M (corresponding author), Univ Gdansk, Fac Biol, Dept Genet & Biosystemat, Gdansk, Poland.	monika.mioduchowska@biol.ug.edu.pl	Gołdyn, Bartłomiej/A-6166-2011	Gołdyn, Bartłomiej/0000-0002-5470-6709; Mioduchowska, Monika/0000-0003-1707-5028	Polish National Science Center [NCN DEC-2011/01/N/NZ8/03649]; University of Gdahsk [538-L260-B518-17-1M]	Polish National Science Center; University of Gdahsk	The research was supported by the Polish National Science Center grant no. NCN DEC-2011/01/N/NZ8/03649 to MJC (https://www.ncn.gov.pl/finansowanie-nauki/konkursy) and grant from the University of Gdahsk no. 538-L260-B518-17-1M to MM (https://ug.edu.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bekkouche N, 2016, ZOOL LETT, V2, DOI 10.1186/s40851-016-0054-3; Boehme P, 2012, PARASITOL RES, V110, P2325, DOI 10.1007/s00436-011-2767-8; Bruder K, 2007, NOVA HEDWIGIA, V85, P331, DOI 10.1127/0029-5035/2007/0085-0331; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Chai BZ, 2012, J BACTERIOL, V194, P6693, DOI 10.1128/JB.01807-12; Couillault C, 2002, INFECT IMMUN, V70, P4705, DOI 10.1128/IAI.70.8.4705-4707.2002; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Czyz Michal Jan, 2016, Biological Letters, V53, P79, DOI 10.1515/biolet-2017-0006; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Derycke S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013716; DeWaard Jeremy R., 2008, V410, P275; Ding JY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00251; Dorai-Raj S, 2014, BINOM BINOMIAL CONDE; Elbrecht V, 2016, PEERJ PREPRINTS; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frati F, 1997, J MOL EVOL, V44, P145, DOI 10.1007/PL00006131; Gardes A, 2010, STAND GENOMIC SCI, V3, P97, DOI 10.4056/sigs.922139; Gao X, 2013, APPL MICROBIOL BIOT, V97, P9099, DOI 10.1007/s00253-013-5189-y; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Gibson JF, 2011, ANN ENTOMOL SOC AM, V104, P976, DOI 10.1603/AN10153; Graf J, 2000, ASM NEWS, V66, P147; Gudmundsdottir B. K., 1998, ICELAND AGR SCI, V12, P61; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0333; Hebert PDN, 2002, EVOLUTION, V56, P909; Hoareau TB, 2010, MOL ECOL RESOUR, V10, P960, DOI 10.1111/j.1755-0998.2010.02848.x; Hyun DW, 2014, INT J SYST EVOL MICR, V64, P2312, DOI 10.1099/ijs.0.060780-0; IPPC, 2008, 31 IPPC ISPM; Jahn R, 2007, P 1 CENTR EUR DIAT M, P113, DOI [10.3372/cediatom.113, DOI 10.3372/CEDIATOM.113]; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jeong H, 2005, NUCLEIC ACIDS RES, V33, P7066, DOI 10.1093/nar/gki1016; Kanneby T, 2014, ZOOSYSTEMA, V36, P723, DOI 10.5252/z2014n4a2; Kanneby T, 2013, ZOOL SCR, V42, P88, DOI 10.1111/j.1463-6409.2012.00558.x; Kanneby T, 2012, HYDROBIOLOGIA, V683, P185, DOI 10.1007/s10750-011-0956-1; Kieneke A, 2012, MOL ECOL, V21, P1239, DOI 10.1111/j.1365-294X.2011.05421.x; Kisielewska G, 2015, EUR J PROTISTOL, V51, P138, DOI 10.1016/j.ejop.2014.12.003; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kur J, 2016, WORLD SCI NEWS, V57, P664; Kurahashi M, 2007, SYST APPL MICROBIOL, V30, P202, DOI 10.1016/j.syapm.2006.07.003; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Lin JP, 2016, MITOCHONDRIAL DNA A, V27, P2310, DOI 10.3109/19401736.2015.1022758; Liu LH, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01567-15; Lobo J, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-34; Lohman DJ, 2009, MOL ECOL RESOUR, V9, P37, DOI 10.1111/j.1755-0998.2008.02221.x; Manylov Oleg G., 1999, Protistology, V1, P17; Meyer A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-70; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; Michalczyk L, 2013, J LIMNOL, V72, P175, DOI 10.4081/jlimnol.2013.s1.e22; Mioduchowska M, 2018, NORTH-WEST J ZOOL, V14, P127; Mioduchowska M, 2016, J EXP ZOOL PART A, V325, P610, DOI 10.1002/jez.2055; Morohoshi T, 2014, GENOME ANNOUNC, V2; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Nakano T, 2005, J MOLLUS STUD, V71, P357, DOI 10.1093/mollus/eyi039; Nakano T, 2007, J MOLLUS STUD, V73, P79, DOI 10.1093/mollus/eym001; Nei M., 2000, MOL EVOLUTION PHYLOG; Nishijima M, 2013, INT J SYST EVOL MICR, V63, P709, DOI 10.1099/ijs.0.042077-0; Nolan M, 2010, STAND GENOMIC SCI, V3, P174, DOI 10.4056/sigs.1161239; Pinceel T, 2013, HYDROBIOLOGIA, V700, P313, DOI 10.1007/s10750-012-1240-8; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; R Core Team, 2021, R LANGUAGE ENV STAT; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schubart Christoph D., 2009, Crustacean Issues, V18, P47; Sharma P, 2014, J APPL GENET, V55, P485, DOI 10.1007/s13353-014-0218-9; Siddall ME, 2009, SYST BIOL, V58, P445, DOI 10.1093/sysbio/syp033; Simison WB, 2000, EVOLUTION PHYLOGEOGR; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Staats M, 2016, ANAL BIOANAL CHEM, V408, P4615, DOI 10.1007/s00216-016-9595-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tasiemski A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17498; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Todaro MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017892; Weekers PHH, 2002, MOL PHYLOGENET EVOL, V25, P535, DOI 10.1016/S1055-7903(02)00289-0; Williams ST, 2001, MOL BIOL EVOL, V18, P1484, DOI 10.1093/oxfordjournals.molbev.a003934; Yang CS, 2010, INT J SYST EVOL MICR, V60, P1158, DOI 10.1099/ijs.0.014357-0; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x	79	26	29	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2018	13	6							e0199609	10.1371/journal.pone.0199609	http://dx.doi.org/10.1371/journal.pone.0199609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK3VI	29933389	Green Published, Green Submitted, gold			2022-12-26	WOS:000436076600036
J	Benedeti, PD; Fonseca, MA; Shenkoru, T; Marcondes, MI; de Paula, EM; da Silva, LG; Faciola, AP				Benedeti, Pedro Del Bianco; Fonseca, Mozart Alves; Shenkoru, Teshome; Marcondes, Marcos Inacio; de Paula, Eduardo Marostegan; da Silva, Lorrayny Galoro; Faciola, Antonio Pinheiro			Does partial replacement of corn with glycerin in beef cattle diets affect in vitro ruminal fermentation, gas production kinetic, and enteric greenhouse gas emissions?	PLOS ONE			English	Article							METHANE PRODUCTION; NUTRIENT DIGESTIBILITY; RUMEN FERMENTATION; INCREASING CONCENTRATIONS; CELLULOLYTIC ACTIVITY; CONTINUOUS-CULTURE; CRUDE GLYCERIN; STEERS; FEEDS; SUPPLEMENT	Five in vitro experiments were conducted with the following objectives: 1) To evaluate the ruminal fermentation of three different single ingredients: corn, glycerin, and starch (Exp. 1 and 2); 2) To assess effects of partially replacing corn with glycerin in beef cattle diets on ruminal fermentation pattern (Exp. 3 and 4); and 3) To evaluate the effects of glycerin inclusion on the extension of ruminal DM digestibility of feeds with high (orchard hay) and low (corn) fiber content (Exp. 5). For Exp. 1 and 2, two in vitro systems (24-bottle Ankom(RF) and 20-serum bottles) were used in four consecutive fermentation batches to evaluate gas production (GP), fermentation profiles, enteric methane (CH4), and carbon dioxide (CO2) of corn, glycerin, and starch. The 24 h total GP, acetate concentration, and acetate: propionate ratio decreased only when glycerin was added to the diet (P < 0.01). The 48-h total GP and metabolizable energy were greatest for corn (P < 0.01), and similar between glycerin and starch. The starch treatment had the lowest total volatile fatty acids concentration (P = 0.01). Glycerin had greatest CH4 production, lag time, and maximum gas volume of the first pool (P < 0.05). However, the maximum gas volume of the second pool was greatest for corn (P < 0.05), and similar between glycerin and starch. The starch treatment had the greatest specific rates of digestion for first and second pools (P < 0.05). Production of CO2 (m/Lg) was greater for corn (P < 0.01), but similar for glycerin and starch. For Exp. 3 and 4, the same systems were used to evaluate four different levels of glycerin [0, 100, 200, and 300 g/kg of dry matter (DM)] replacing corn in beef cattle finishing diets. Glycerin levels did not affect 24 and 48 h total GP, CH4, and CO2 (P > 0.05). The inclusion of glycerin linearly decreased acetate concentration (P = 0.03) and acetate: propionate ratio (P = 0.04). For Exp. 5, two Daisy" incubators were used to evaluate the in vitro dry matter digestibility (IVDMD) of the following treatments: orchard hay; corn; orchard hay + glycerin; and corn + glycerin. Glycerin inclusion decreased orchard hay IVDMD (P < 0.01) but did not affect corn IVDMD (P > 0.05). We concluded that, under these experimental conditions, glycerin has similar energy efficiency when used in replacement of corn and included at up to 300 g/kg in beef cattle diets.	[Benedeti, Pedro Del Bianco; Marcondes, Marcos Inacio] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Benedeti, Pedro Del Bianco; Fonseca, Mozart Alves; Shenkoru, Teshome; de Paula, Eduardo Marostegan] Univ Nevada, Dept Agr Nutr & Vet Sci, Reno, NV 89557 USA; [Benedeti, Pedro Del Bianco; da Silva, Lorrayny Galoro] Univ Estado Santa Catarina, Dept Anim Sci, Chapeco, SC, Brazil; [Faciola, Antonio Pinheiro] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA	Universidade Federal de Vicosa; Nevada System of Higher Education (NSHE); University of Nevada Reno; Universidade do Estado de Santa Catarina; State University System of Florida; University of Florida	Faciola, AP (corresponding author), Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA.	afaciola@ufl.edu	Faciola, Antonio/U-4800-2018; Del Bianco Benedeti, Pedro/C-3120-2016; Faciola, Antonio/AAF-3865-2019; da Silva, Lorrayny Galoro/H-2312-2019; Marcondes, Marcos/AAH-7553-2020; de Paula, Eduardo Marostegan/S-8509-2019	Faciola, Antonio/0000-0003-0935-6233; Del Bianco Benedeti, Pedro/0000-0003-2515-8974; Faciola, Antonio/0000-0003-0935-6233; da Silva, Lorrayny Galoro/0000-0002-7843-1623; Marcondes, Marcos/0000-0003-4843-2809; de Paula, Eduardo Marostegan/0000-0002-1891-6303	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) provided a scholarship to P. Del Bianco Benedeti.	AOAC, 2006, OFFICIAL METHODS ANA; Avila JS, 2011, ANIM FEED SCI TECH, V166-67, P265, DOI 10.1016/j.anifeedsci.2011.04.016; Avila-Stagno J, 2013, J ANIM SCI, V91, P829, DOI 10.2527/jas.2012-5215; Avila-Stagno J, 2014, BRIT J NUTR, V111, P829, DOI 10.1017/S0007114513003206; BALDWIN RL, 1968, J DAIRY SCI, V51, P104, DOI 10.3168/jds.S0022-0302(68)86928-0; Benedeti PD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148224; Benedeti PD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143201; BERGNER H, 1995, ARCH ANIM NUTR, V48, P245, DOI 10.1080/17450399509381845; Blummel M, 1997, J ANIM PHYSIOL AN N, V77, P24, DOI 10.1111/j.1439-0396.1997.tb00734.x; Boadi D, 2004, CAN J ANIM SCI, V84, P319, DOI 10.4141/A03-109; van Cleef EHCB, 2014, REV BRAS ZOOTECN, V43, P86, DOI 10.1590/S1516-35982014000200006; CHANEY AL, 1962, CLIN CHEM, V8, P130; DAVIS CS, 1989, APPL STAT-J ROY ST C, V38, P535, DOI 10.2307/2347751; El-Nor SA, 2010, ANIM FEED SCI TECH, V162, P99, DOI 10.1016/j.anifeedsci.2010.09.012; Ferraro SM, 2009, ANIM FEED SCI TECH, V154, P112, DOI 10.1016/j.anifeedsci.2009.07.009; Gemeda BS, 2014, J ANIM PLANT SCI, V24, P1293; Grings EE, 2005, ANIM FEED SCI TECH, V123, P527, DOI 10.1016/j.anifeedsci.2005.04.041; Hales KE, 2013, J ANIM SCI, V91, P4277, DOI 10.2527/jas.2013-6341; Holden LA, 1999, J DAIRY SCI, V82, P1791, DOI 10.3168/jds.S0022-0302(99)75409-3; Lee SY, 2011, ANIM FEED SCI TECH, V166-67, P269, DOI 10.1016/j.anifeedsci.2011.04.070; Mach N, 2009, J ANIM SCI, V87, P632, DOI 10.2527/jas.2008-0987; Menke K.H, 1988, ANIM RES DEV, V28, P7, DOI DOI 10.1016/S0301-6226(01)00298-6.PALMQUIST; Monnerat J. P. I. S., 2013, ENERGY PROTEIN METAB, V134, P97, DOI [10.3920/978-90-8686-781-3, DOI 10.3920/978-90-8686-781-3]; Moss AR, 2000, ANN ZOOTECH, V49, P231, DOI 10.1051/animres:2000119; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Nelson D.L., 2009, PRINCIPLES BIOCH; ORSKOV ER, 1986, J ANIM SCI, V63, P1624, DOI 10.2527/jas1986.6351624x; Paggi RA, 2004, J AGR SCI-CAMBRIDGE, V142, P89, DOI 10.1017/S0021859604003958; REMOND B, 1993, ANIM FEED SCI TECH, V41, P121, DOI 10.1016/0377-8401(93)90118-4; Rico DE, 2012, J DAIRY SCI, V95, P3310, DOI 10.3168/jds.2011-5059; ROGER V, 1992, CURR MICROBIOL, V25, P197, DOI 10.1007/BF01570719; San Vito E, 2016, LIVEST SCI, V192, P17, DOI 10.1016/j.livsci.2016.08.011; SCHEIFINGER CC, 1975, APPL MICROBIOL, V29, P480, DOI 10.1128/AEM.29.4.480-483.1975; SCHOFIELD P, 1994, J ANIM SCI, V72, P2980, DOI 10.2527/1994.72112980x; Silva LG, 2016, J ANIM SCI, V94, P1600, DOI 10.2527/jas.2015-9750; Stewart CS., 1997, RUMEN MICROBIAL ECOS, P10, DOI [10.1007/978-94-009-1453-7_2, DOI 10.1007/978-94-009-1453-7_2]; Tagliapietra F, 2013, ANIM FEED SCI TECH, V183, P210, DOI 10.1016/j.anifeedsci.2013.05.010; Tagliapietra F, 2011, ANIM FEED SCI TECH, V170, P182, DOI 10.1016/j.anifeedsci.2011.09.008; van Cleef EHCB, 2015, LIVEST SCI, V178, P158, DOI 10.1016/j.livsci.2015.06.016; Van Cleef EHCB, 2013, PRIOR ADAPTATION IMP, P1083; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wang C, 2009, LIVEST SCI, V121, P15, DOI 10.1016/j.livsci.2008.05.010; Zhang A, 2009, PROCESS BIOCHEM, V44, P1346, DOI 10.1016/j.procbio.2009.07.013	43	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199577	10.1371/journal.pone.0199577	http://dx.doi.org/10.1371/journal.pone.0199577			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928065	Green Submitted, Green Published, gold			2022-12-26	WOS:000435802500111
J	Joanisse, GD; Bradley, RL; Preston, CM				Joanisse, Gilles D.; Bradley, Robert L.; Preston, Caroline M.			The spread of Kalmia angustifolia on black spruce forest cutovers contributes to the spatial heterogeneity of soil resources	PLOS ONE			English	Article							CARBON-NUTRIENT BALANCE; HOME-FIELD ADVANTAGE; LITTER DECOMPOSITION; COMPETITIVE ABILITY; MICROBIAL BIOMASS; PLANT-COMMUNITIES; NITROGEN; HUMUS; QUALITY; SEEDLINGS	Kalmia angustifolia is a boreal ericaceous shrub that can rapidly spread on black spruce forest cutovers in eastern Canada, where CPRS (i.e. Cutting with Protection of Regeneration and Soils") is practiced. The proliferation of Kalmia often coincides with a reduction in the growth rate of regenerating black spruce seedlings. We report on a study where we compared the local effects of Kalmia and black spruce seedling patches (i.e. two types of "Vegetation") on chemical and biochemical soil properties in CPRS cutovers within mesic spruce moss and xeric spruce-lichen ecosystems, as well as in four mature spruce-moss forests (i.e. three "Site Types"). Results from C-13-CPMAS-NMR revealed lower O-alkyl C (i.e. carbohydrates), higher aromatic C (i.e. lignin and other phenolics) and higher carbonyl-C (i.e. amide-C and carboxyl groups) in spruce-moss than in spruce-lichen forest floors (F-horizon). In spite of these distinctions, we observed only a small number of Site Type x Vegetation interactions controlling soil properties. Vegetation had a significant effect on ten forest floor properties. Most notably, Kalmia patches had higher concentrations of condensed tannins and lower mineral N cycling. On the other hand, Site Type had a relatively greater effect on the deeper podzolic-B horizons, where mineral N and microbial activity were higher in mature spruce-moss forests than in the cutovers. Green and senescent Kalmia leaves collected at these sites had higher N, tannin and phenolic concentrations than green and senescent spruce needles. A 25 month litter bag study found lower decomposition of Kalmia leaf litter in spruce patches on spruce-lichen cutovers compared to spruce patches on spruce-moss cutovers, or to Kalmia patches on spruce-lichen cutovers. Given that black spruce seedlings obtain most of their nutrients from the forest floor, our results suggest that CPRS may have long-term negative effects on black spruce forest productivity if the spread of Kalmia is left unchecked.	[Joanisse, Gilles D.] St Foy Inc, CERFO, Ctr Enseignement Rech Foresterie, Quebec City, PQ, Canada; [Joanisse, Gilles D.; Bradley, Robert L.] Univ Sherbrooke, Dept Biol, Blvd Univ, Sherbrooke, PQ, Canada; [Preston, Caroline M.] Pacific Forestry Ctr, Canadian Forest Serv, Victoria, BC, Canada	University of Sherbrooke; Natural Resources Canada; Canadian Forest Service	Bradley, RL (corresponding author), Univ Sherbrooke, Dept Biol, Blvd Univ, Sherbrooke, PQ, Canada.	Robert.Bradley@USherbrooke.ca		Bradley, Robert/0000-0003-2276-3028	Natural Sciences and Engineering Research Council (NSERC) of Canada; NSERC Strategic Research Grant; NSERC research grants	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Strategic Research Grant; NSERC research grants(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support was provided by a graduate student scholarship awarded to G. Joanisse by the Natural Sciences and Engineering Research Council (NSERC) of Canada, as well as by an NSERC Strategic Research Grant awarded to R.L. Bradley.; We thank W.F.J. Parsons for technical assistance. Financial support was provided by a graduate student scholarship awarded to G. Joanisse by the Natural Sciences and Engineering Research Council (NSERC) of Canada, as well as by NSERC research grants awarded to R.L. Bradley.	Almendros G, 2000, SOIL BIOL BIOCHEM, V32, P793, DOI 10.1016/S0038-0717(99)00202-3; ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2005, PERMANOVA FORTRAN CO; Ayres E, 2009, SOIL BIOL BIOCHEM, V41, P606, DOI 10.1016/j.soilbio.2008.12.022; Bernier PY, 2011, AGR FOREST METEOROL, V151, P521, DOI 10.1016/j.agrformet.2010.12.013; Bradley R. L., 1997, Recent Research Developments in Soil Biology & Biochemistry, V1, P63; Bradley RL, 2000, PLANT SOIL, V223, P197, DOI 10.1023/A:1004896116130; Bradley RL, 1997, SOIL BIOL BIOCHEM, V29, P1275, DOI 10.1016/S0038-0717(97)00018-7; Bradley RL, 2000, SOIL BIOL BIOCHEM, V32, P1227, DOI 10.1016/S0038-0717(00)00039-0; Bradley RL, 1997, PLANT SOIL, V195, P209, DOI 10.1023/A:1004263716346; BRADLEY RL, 1995, SOIL BIOL BIOCHEM, V27, P167, DOI 10.1016/0038-0717(94)00160-3; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; Canadian Agricultural Services Coordinating Committee, 1998, CAN SYST SOIL CLASS; Cline LC, 2015, ECOLOGY, V96, P3374, DOI 10.1890/15-0184.1; Czimczik CI, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001956; DAMMAN AWH, 1971, ECOL MONOGR, V41, P253, DOI 10.2307/1942368; Environment Canada, 2015, WEATH CLIM HIST DAT; FAO, 2014, WORLD SOIL RESOURCES; FERIC, 2006, OPT RES CPRS; Gauthier MM, 2015, FORESTS, V6, P510, DOI 10.3390/f6020510; Hagemann U, 2015, SOIL BIOL BIOCHEM, V87, P10, DOI 10.1016/j.soilbio.2015.04.002; HESTER AJ, 1991, J ECOL, V79, P303, DOI 10.2307/2260714; Houle D, 2014, ECOLOGY, V95, P1127, DOI 10.1890/14-0191.1; HUFFMAN DW, 1994, CAN J BOT, V72, P39, DOI 10.1139/b94-006; IASON GR, 1993, J ECOL, V81, P75, DOI 10.2307/2261225; Inderjit, 2002, FOREST ECOL MANAG, V160, P75, DOI 10.1016/S0378-1127(01)00463-7; Joanisse GD, 2007, NEW PHYTOL, V175, P535, DOI 10.1111/j.1469-8137.2007.02113.x; Joanisse GD, 2009, NEW PHYTOL, V181, P187, DOI 10.1111/j.1469-8137.2008.02622.x; Joanisse GD, 2008, BIOL FERT SOILS, V44, P903, DOI 10.1007/s00374-008-0297-z; Kogel-Knabner I, 2002, SOIL BIOL BIOCHEM, V34, P139, DOI 10.1016/S0038-0717(01)00158-4; Lagomarsino A, 2006, SCI TOTAL ENVIRON, V372, P256, DOI 10.1016/j.scitotenv.2006.08.031; Lebel P, 2008, FOREST ECOL MANAG, V256, P1780, DOI 10.1016/j.foreco.2008.02.050; Liu P, 2006, APPL SOIL ECOL, V34, P266, DOI 10.1016/j.apsoil.2005.12.009; Lorente M, 2012, FOREST ECOL MANAG, V269, P168, DOI 10.1016/j.foreco.2011.12.029; Lorenz K, 2000, SOIL BIOL BIOCHEM, V32, P779, DOI 10.1016/S0038-0717(99)00201-1; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MRNFPQ, 2003, MAN AM FOR; Niemi RM, 2014, NAT CONSERV-BULGARIA, P1, DOI 10.3897/natureconservation.8.6369; NORTHUP RR, 1995, NATURE, V377, P227, DOI 10.1038/377227a0; Perez G, 2013, SOIL BIOL BIOCHEM, V67, P245, DOI 10.1016/j.soilbio.2013.09.004; Pietikainen J, 1999, CAN J FOREST RES, V29, P1197, DOI 10.1139/cjfr-29-8-1197; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Preston CM, 2006, CLIMATIC CHANGE, V74, P223, DOI 10.1007/s10584-006-0466-8; Preston CM, 2000, CAN J BOT, V78, P1269, DOI 10.1139/cjb-78-10-1269; Preston CM, 1997, CAN J BOT, V75, P1601, DOI 10.1139/b97-872; Preston CM, 2001, CAN J SOIL SCI, V81, P255, DOI 10.4141/S00-074; Preston CM, 2000, BASIC LIFE SCI, V66, P825; R Development Core Team, 2005, R LANG ENV STAT COMP; Rousk K, 2017, NEW PHYTOL, V214, P97, DOI 10.1111/nph.14331; Saucier J.P., 1998, R GIONS COLOGIQUES Q, P1; Sedia EG, 2003, OIKOS, V100, P447, DOI 10.1034/j.1600-0706.2003.12058.x; STANFORD G, 1974, SOIL SCI SOC AM J, V38, P99, DOI 10.2136/sssaj1974.03615995003800010031x; Thiffault N, 2004, CAN J FOREST RES, V34, P1657, DOI [10.1139/x04-046, 10.1139/X04-046]; Thiffault N, 2015, ECOL EVOL, V5, P1837, DOI 10.1002/ece3.1476; Thiffault N, 2013, FORESTS, V4, P613, DOI 10.3390/f4030613; Waterman PG, 1994, BLACKWELL SCI PUBLIC, V38, P1064, DOI DOI 10.1007/BF03028669	59	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0198860	10.1371/journal.pone.0198860	http://dx.doi.org/10.1371/journal.pone.0198860			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927964	gold, Green Published, Green Submitted			2022-12-26	WOS:000435802500032
J	Koblish, H; Li, YL; Shin, N; Hall, L; Wang, Q; Wang, K; Covington, M; Marando, C; Bowman, K; Boer, J; Burke, K; Wynn, R; Margulis, A; Reuther, GW; Lambert, QT; Roman, VD; Zhang, K; Feng, H; Xue, CB; Diamond, S; Hollis, G; Yeleswaram, S; Yao, WQ; Huber, R; Vaddi, K; Scherle, P				Koblish, Holly; Li, Yun-Long; Shin, Niu; Hall, Leslie; Wang, Qian; Wang, Kathy; Covington, Maryanne; Marando, Cindy; Bowman, Kevin; Boer, Jason; Burke, Krista; Wynn, Richard; Margulis, Alex; Reuther, Gary W.; Lambert, Que T.; Roman, Valerie Dostalik; Zhang, Ke; Feng, Hao; Xue, Chu-Biao; Diamond, Sharon; Hollis, Greg; Yeleswaram, Swamy; Yao, Wenqing; Huber, Reid; Vaddi, Kris; Scherle, Peggy			Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; SIGNAL-TRANSDUCTION; TYROSINE KINASES; DRUG-RESISTANCE; PROSTATE-CANCER; CD25 EXPRESSION; MICE DEFICIENT; ONCOGENIC PIM; CELL LYMPHOMA; AML CELLS	The Proviral Integration site of Moloney murine leukemia virus (PIM) serine/threonine protein kinases are overexpressed in many hematologic and solid tumor malignancies and play central roles in intracellular signaling networks important in tumorigenesis, including the Janus kinase signal transducer and activator of transcription (JAK/STAT) and phosphatidylinositol 3-kinase (PI3K)/AKT pathways. The three PIM kinase isozymes (PIM1, PIM2, and PIM3) share similar downstream substrates with other key oncogenic kinases and have differing but mutually compensatory functions across tumors. This supports the therapeutic potential of pan-PIM kinase inhibitors, especially in combination with other anticancer agents chosen based on their role in overlapping signaling networks. Reported here is a pre clinical characterization of INCB053914, a novel, potent, and selective adenosine triphosphate-competitive pan-PIM kinase inhibitor. In vitro, INCB053914 inhibited proliferation and the phosphorylation of downstream substrates in cell lines from multiple hematologic malignancies. Effects were confirmed in primary bone marrow blasts from patients with acute myeloid leukemia treated ex vivo and in blood samples from patients receiving INCB053914 in an ongoing phase 1 dose-escalation study. In vivo, single-agent INCB053914 inhibited Bcl-2-associated death promoter protein phosphorylation and dose-dependently inhibited tumor growth in acute myeloid leukemia and multiple myeloma xenografts. Additive or synergistic inhibition of tumor growth was observed when INCB053914 was combined with selective PI3K delta inhibition, selective JAK1 or JAK1/2 inhibition, or cytarabine. Based on these data, pan-PIM kinase inhibitors, including INCB053914, may have therapeutic utility in hematologic malignancies when combined with other inhibitors of oncogenic kinases or standard chemotherapeutics.	[Koblish, Holly; Li, Yun-Long; Shin, Niu; Hall, Leslie; Wang, Qian; Wang, Kathy; Covington, Maryanne; Marando, Cindy; Bowman, Kevin; Boer, Jason; Burke, Krista; Wynn, Richard; Margulis, Alex; Roman, Valerie Dostalik; Zhang, Ke; Feng, Hao; Xue, Chu-Biao; Diamond, Sharon; Hollis, Greg; Yeleswaram, Swamy; Yao, Wenqing; Huber, Reid; Vaddi, Kris; Scherle, Peggy] Incyte Corp, Wilmington, DE 19803 USA; [Reuther, Gary W.; Lambert, Que T.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL USA; [Vaddi, Kris; Scherle, Peggy] Prelude Therapeut Inc, Wilmington, DE USA	Incyte; H Lee Moffitt Cancer Center & Research Institute	Koblish, H (corresponding author), Incyte Corp, Wilmington, DE 19803 USA.	hkoblish@incyte.com	Reuther, Gary/AFR-2892-2022		Incyte Corporation (Wilmington, DE); Incyte Corporation	Incyte Corporation (Wilmington, DE); Incyte Corporation	The study was funded, sponsored and designed by Incyte Corporation (Wilmington, DE). The data were analyzed and interpreted by the sponsors in collaboration with all the authors. Medical writing assistance was provided by Simon J. Slater, PhD, and was funded by Incyte Corporation. The lead author (Holly Koblish, PhD) made the final decision to submit the manuscript for publication. G.W. Reuther receives research funding from Incyte Corporation.	Akagi K, 2014, GENOME RES, V24, P185, DOI 10.1101/gr.164806.113; Arunesh GM, 2014, EXPERT OPIN THER PAT, V24, P5, DOI 10.1517/13543776.2014.848196; Blanco-Aparicio C, 2011, CANCER LETT, V300, P145, DOI 10.1016/j.canlet.2010.09.016; Brady A, 2012, EUR J HAEMATOL, V89, P288, DOI 10.1111/j.1600-0609.2012.01825.x; Bullock AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007112; Cen B, 2013, CANCER RES, V73, P3402, DOI 10.1158/0008-5472.CAN-12-4619; Cerny J, 2013, BRIT J HAEMATOL, V160, P262, DOI 10.1111/bjh.12109; Cervantes-Gomez F, 2016, LEUKEMIA LYMPHOMA, V57, P436, DOI 10.3109/10428194.2015.1063141; Chatterjee A, 2014, CELL REP, V9, P1333, DOI 10.1016/j.celrep.2014.10.039; Chen K, 2016, ONCOTARGET, V7, P10073, DOI 10.18632/oncotarget.7164; Chen LS, 2016, LEUKEMIA LYMPHOMA, V57, P2863, DOI 10.3109/10428194.2016.1166489; Chen LS, 2009, BLOOD, V114, P4150, DOI 10.1182/blood-2009-03-212852; Cohen AM, 2004, LEUKEMIA LYMPHOMA, V45, P951, DOI 10.1080/10428190310001641251; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; Foucquier J, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.149; Fujiwara S, 2017, HEMATOLOGY, V22, P347, DOI 10.1080/10245332.2016.1276240; Garcia PD, 2014, CLIN CANCER RES, V20, P1834, DOI 10.1158/1078-0432.CCR-13-2062; Gonen M, 2012, BLOOD, V120, P2297, DOI 10.1182/blood-2012-02-414425; Gomez-Abad C, 2011, BLOOD, V118, P5517, DOI 10.1182/blood-2011-03-344374; Gozgit JM, 2008, J BIOL CHEM, V283, P32334, DOI 10.1074/jbc.M803813200; Guo ZY, 2014, BLOOD, V124, P1777, DOI 10.1182/blood-2014-01-551234; Harada M, 2015, ONCOTARGET, V6, P37930, DOI 10.18632/oncotarget.6122; Horiuchi D, 2016, NAT MED, V22, P1321, DOI 10.1038/nm.4213; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Hsi ED, 2008, LEUKEMIA LYMPHOMA, V49, P2081, DOI 10.1080/10428190802419640; Huang SMA, 2014, ONCOTARGET, V5, P3362, DOI 10.18632/oncotarget.1951; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Isaac M, 2011, DRUG RESIST UPDATE, V14, P203, DOI 10.1016/j.drup.2011.04.002; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kawashima T, 2001, J IMMUNOL, V167, P3652, DOI 10.4049/jimmunol.167.7.3652; Keane NA, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.46; Keeton EK, 2014, BLOOD, V123, P905, DOI 10.1182/blood-2013-04-495366; Kelly KR, 2012, BRIT J HAEMATOL, V156, P129, DOI 10.1111/j.1365-2141.2011.08792.x; Koblish H, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-5416; Le XN, 2016, CANCER DISCOV, V6, P1134, DOI 10.1158/2159-8290.CD-16-0305; Li GQ, 2010, BLOOD, V115, P1416, DOI 10.1182/blood-2009-07-234963; [李国强 Li Guoqiang], 2007, [振动与冲击, Journal of Vibration and Shock], V26, P8; Li J, 2010, NEOPLASIA, V12, P28, DOI 10.1593/neo.91192; Liu H., 2010, CONCRETE, V8, P6, DOI DOI 10.1016/J.EJRAD.2010.06.008; Lu J, 2013, BLOOD, V122, P1610, DOI 10.1182/blood-2013-01-481457; Mazzacurati L, 2015, ONCOTARGET, V6, P40141, DOI 10.18632/oncotarget.5653; MEEKER TC, 1987, J CELL BIOCHEM, V35, P105, DOI 10.1002/jcb.240350204; Meja K, 2014, BRIT J HAEMATOL, V167, P69, DOI 10.1111/bjh.13013; Merkel Anna Lena, 2012, Expert Opin Investig Drugs, V21, P425, DOI 10.1517/13543784.2012.668527; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Mondello P, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0095-z; Moriggl R, 1996, MOL CELL BIOL, V16, P5691; Musiani D, 2014, J PROTEOME RES, V13, P4970, DOI 10.1021/pr500651n; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; Paino T, 2017, CLIN CANCER RES, V23, P225, DOI 10.1158/1078-0432.CCR-16-0230; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Paukku K, 2004, CYTOKINE GROWTH F R, V15, P435, DOI 10.1016/j.cytogfr.2004.09.001; Peltola K, 2009, NEOPLASIA, V11, P629, DOI 10.1593/neo.81038; Peltola KJ, 2004, BLOOD, V103, P3744, DOI 10.1182/blood-2003-09-3126; Peng YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076693; Petraitis V, 2009, ANTIMICROB AGENTS CH, V53, P2382, DOI 10.1128/AAC.00329-09; Pircher TJ, 1999, MOL ENDOCRINOL, V13, P555, DOI 10.1210/mend.13.4.0263; Qu YC, 2016, MED SCI MONITOR, V22, P4254, DOI 10.12659/MSM.898223; Rzymski T, 2017, ONCOTARGET, V8, P33779, DOI 10.18632/oncotarget.16810; Schatz JH, 2011, J EXP MED, V208, P1799, DOI 10.1084/jem.20110846; Shah N, 2008, EUR J CANCER, V44, P2144, DOI 10.1016/j.ejca.2008.06.044; Shin N, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-2671; Silvennoinen O, 1997, APMIS, V105, P497, DOI 10.1111/j.1699-0463.1997.tb05047.x; Tamburini J, 2009, BLOOD, V114, P1618, DOI 10.1182/blood-2008-10-184515; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Terwijn M, 2009, EUR J CANCER, V45, P1692, DOI 10.1016/j.ejca.2009.02.021; Vainchenker W, 2013, ONCOGENE, V32, P2601, DOI 10.1038/onc.2012.347; VANDERLUGT NMT, 1995, EMBO J, V14, P2536, DOI 10.1002/j.1460-2075.1995.tb07251.x; Vechorkin O, United States patent US, Patent No. [9,540,347 B2, 9540347B2]; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; Warnecke-Eberz U, 2009, ANTICANCER RES, V29, P4451; Xu JW, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0406-z; Yang JF, 2010, IMMUNOLOGY, V131, P174, DOI 10.1111/j.1365-2567.2010.03286.x; Zhang P, 2009, J CELL PHYSIOL, V220, P82, DOI 10.1002/jcp.21733; Zhou ZG, 2016, TUMOR BIOL, V37, P9151, DOI 10.1007/s13277-016-4806-7	75	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199108	10.1371/journal.pone.0199108	http://dx.doi.org/10.1371/journal.pone.0199108			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29927999	Green Published, gold, Green Submitted			2022-12-26	WOS:000435802500045
J	Navas, T; Pfister, TD; Colantonio, S; Aziz, A; Dieckman, L; Saul, RG; Kaczmarczyk, J; Borgel, S; Alcoser, SY; Hollingshead, MG; Lee, YH; Bottaro, DP; Hiltke, T; Whiteley, G; Takebe, N; Kinders, RJ; Parchment, RE; Tomaszewski, JE; Doroshow, JH				Navas, Tony; Pfister, Thomas D.; Colantonio, Simona; Aziz, Amina; Dieckman, Lynda; Saul, Richard G.; Kaczmarczyk, Jan; Borgel, Suzanne; Alcoser, Sergio Y.; Hollingshead, Melinda G.; Lee, Young H.; Bottaro, Donald P.; Hiltke, Tara; Whiteley, Gordon; Takebe, Naoko; Kinders, Robert J.; Parchment, Ralph E.; Tomaszewski, Joseph E.; Doroshow, James H.			Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells	PLOS ONE			English	Article							BREAST-CANCER; PANCREATIC-CANCER; GENE CLONING; LUNG-CANCER; CLAUDIN-LOW; METASTASIS; EXPRESSION; EMT; PLASTICITY; CD133	The presence of cancer stem cells (CSCs) and the induction of epithelial-to-mesenchymal transition (EMT) in tumors are associated with tumor aggressiveness, metastasis, drug resistance, and poor prognosis, necessitating the development of reagents for unambiguous detection of CSC- and EMT-associated proteins in tumor specimens. To this end, we generated novel antibodies to EMT- and CSC-associated proteins, including Goosecoid, Sox9, Slug, Snail, and CD133. Importantly, unlike several widely used antibodies to CD133, the anti-CD133 antibodies we generated recognize epitopes distal to known glycosylation sites, enabling analyses that are not confounded by differences in CD133 glycosylation. For all target proteins, we selected antibodies that yielded the expected target protein molecular weights by Western analysis and the correct subcellular localization patterns by immunofluorescence microscopy assay (IFA); binding selectivity was verified by immunoprecipitation-mass spectrometry and by immunohistochemistry and IFA peptide blocking experiments. Finally, we applied these reagents to assess modulation of the respective markers of EMT and CSCs in xenograft tumor models by IFA. We observed that the constitutive presence of human hepatocyte growth factor (hHGF) in the tumor microenvironment of H596 non-small cell lung cancer tumors implanted in homozygous hHGF knock-in transgenic mice induced a more mesenchymal-like tumor state (relative to the epithelial-like state when implanted in control SCID mice), as evidenced by the elevated expression of EMT-associated transcription factors detected by our novel antibodies. Similarly, our new anti-CD133 antibody enabled detection and quantitation of drug-induced reductions in CD133-positive tumor cells following treatment of SUM149PT triple-negative breast cancer xenograft models with the CSC/focal adhesion kinase (FAK) inhibitor VS-6063. Thus, our novel antibodies to CSC- and EMT-associated factors exhibit sufficient sensitivity and selectivity for immunofluorescence microscopy studies of these processes in preclinical xenograft tumor specimens and the potential for application with clinical samples.	[Navas, Tony; Pfister, Thomas D.; Kinders, Robert J.; Parchment, Ralph E.] NCI, Clin Pharmacodynam Biomarker Program, Appl Dev Res Directorate, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA; [Colantonio, Simona; Saul, Richard G.; Kaczmarczyk, Jan; Whiteley, Gordon] NCI, Antibody Characterizat Lab, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA; [Aziz, Amina; Dieckman, Lynda] Argonne Natl Lab, Biosci Div, 9700 S Cass Ave, Argonne, IL 60439 USA; [Borgel, Suzanne; Alcoser, Sergio Y.; Hollingshead, Melinda G.] NCI, Biol Testing Branch, Dev Therapeut Program, Frederick, MD 21701 USA; [Lee, Young H.; Bottaro, Donald P.] NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Hiltke, Tara] NCI, Off Canc Clin Prote Res, Ctr Strateg Sci Initiat, Bethesda, MD 20892 USA; [Takebe, Naoko; Tomaszewski, Joseph E.; Doroshow, James H.] NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA; [Doroshow, James H.] NCI, Ctr Canc Res, Bethesda, MD 20892 USA; [Pfister, Thomas D.] Princess Margaret Canc Ctr, Tumour Immunotherapy Program, Toronto, ON, Canada	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Energy (DOE); Argonne National Laboratory; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Doroshow, JH (corresponding author), NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA.; Doroshow, JH (corresponding author), NCI, Ctr Canc Res, Bethesda, MD 20892 USA.	doroshoj@mail.nih.gov	Alcoser, Sergio Y/G-9074-2012; Bottaro, Donald P/AAF-3853-2020; Bottaro, Donald P/F-8550-2010	Alcoser, Sergio Y/0000-0002-6896-2551; Bottaro, Donald P/0000-0002-5057-5334; Bottaro, Donald P/0000-0002-5057-5334	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; American Recovery and Reinvestment Act funds; Frederick National Laboratory for Cancer Research; Leidos Biomedical Research, Inc.; NATIONAL CANCER INSTITUTE [ZIABC011124] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Recovery and Reinvestment Act funds; Frederick National Laboratory for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leidos Biomedical Research, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported [in part] by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. This research was supported [in part] by American Recovery and Reinvestment Act funds. The Frederick National Laboratory for Cancer Research, which is funded by the federal government and operated by Leidos Biomedical Research, Inc., provided support in the form of salaries for authors T.N., T.D.P, S.C., R.G.S., J.K., G.W., A.A., L.D., R.J. K., and R.E.P. Leidos Biomedical Research, Inc. is prime contractor for the operation of Frederick National Laboratory and is therefore precluded from conducting any business that represents a conflict of interest with this contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afify A, 2009, EXP MOL PATHOL, V86, P95, DOI 10.1016/j.yexmp.2008.12.003; Aiello NM, 2017, NATURE, V547, pE7, DOI 10.1038/nature22963; Athauda G, 2006, CLIN CANCER RES, V12, P4154, DOI 10.1158/1078-0432.CCR-06-0250; Bhatia S, 2017, BIOCHEM J, V474, P3269, DOI 10.1042/BCJ20160782; Brabletz S, 2017, CELL CYCLE, V16, P1729, DOI 10.1080/15384101.2017.1360648; Brady SW, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01174-3; Canadas I, 2014, CLIN CANCER RES, V20, P938, DOI 10.1158/1078-0432.CCR-13-1330; Dieckman L, 2002, PROTEIN EXPRES PURIF, V25, P1, DOI 10.1006/prep.2001.1602; Feng HL, 2010, CANCER BIOL THER, V9, P215; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hemavathy K, 2000, MOL CELL BIOL, V20, P5087, DOI 10.1128/MCB.20.14.5087-5095.2000; Hermansen SK, 2011, J HISTOCHEM CYTOCHEM, V59, P391, DOI 10.1369/0022155411400867; Ivell R, 2014, ENDOCRINOLOGY, V155, P676, DOI 10.1210/en.2013-1971; Jeon HM, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.12.67; Jethwa P, 2008, WORLD J GASTROENTERO, V14, P1044, DOI 10.3748/wjg.14.1044; KASID A, 1985, SCIENCE, V228, P725, DOI 10.1126/science.4039465; KAUFMANN M, 1995, LANCET, V345, P615, DOI 10.1016/S0140-6736(95)90521-9; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Kim JY, 2012, FEBS J, V279, P2929, DOI 10.1111/j.1742-4658.2012.08674.x; Koefinger P, 2011, PIGM CELL MELANOMA R, V24, P382, DOI 10.1111/j.1755-148X.2010.00807.x; Kolev VN, 2017, ONCOTARGET, V8, P51733, DOI 10.18632/oncotarget.18517; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Krebs AM, 2017, NAT CELL BIOL, V19, P518, DOI 10.1038/ncb3513; Liao TT, 2017, MOL ONCOL, V11, P792, DOI 10.1002/1878-0261.12096; Millard CS, 2003, PROTEIN EXPRES PURIF, V29, P311, DOI 10.1016/S1046-5928(03)00063-9; Natarajan TG, 2011, CANCER BIOMARK, V9, P65, DOI 10.3233/CBM-2011-0173; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Sgambato A, 2010, J CELL PHYSIOL, V224, P234, DOI 10.1002/jcp.22124; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Srivastava AK, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.12.78; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Toiyama Y, 2013, CARCINOGENESIS, V34, P2548, DOI 10.1093/carcin/bgt282; Wahl GM, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0012-z; Wu XJ, 2015, J INT MED RES, V43, P173, DOI 10.1177/0300060514559793; Ye X, 2017, NATURE, V547, pE1, DOI 10.1038/nature22816; Yoon JR, 2002, BIOTECHNIQUES, V33, P1328, DOI 10.2144/02336bc03; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	43	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2018	13	6							e0199361	10.1371/journal.pone.0199361	http://dx.doi.org/10.1371/journal.pone.0199361			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GK0LV	29928062	Green Submitted, gold, Green Published			2022-12-26	WOS:000435802500079
J	Li, ZH; Zhou, ZH; Clarke, JA				Li, Zhiheng; Zhou, Zhonghe; Clarke, Julia A.			Convergent evolution of a mobile bony tongue in flighted dinosaurs and pterosaurs	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY DICECT; ALLIGATOR-MISSISSIPPIENSIS; FUNCTIONAL-MORPHOLOGY; HYOLINGUAL APPARATUS; AVIAN TONGUE; F-DOMESTICA; ANATOMY; MUSCULATURE; ARCHOSAURS; INSIGHTS	The tongue, with fleshy, muscular, and bony components, is an innovation of the earliest land-dwelling vertebrates with key functions in both feeding and respiration. Here, we bring together evidence from preserved hyoid elements from dinosaurs and outgroup archosaurs, including pterosaurs, with enhanced contrast x-ray computed tomography data from extant taxa. Midline ossification is a key component of the origin of an avian hyoid. The elaboration of the avian tongue includes the evolution of multiple novel midline hyoid bones and a larynx suspended caudal to these midline elements. While variable in dentition and skull shape, most bird-line archosaurs show a simple hyoid structure. Bony, or well-mineralized, hyoid structures in dinosaurs show limited modification in response to dietary shifts and across significant changes in body-size. In Dinosauria, at least one such narrow, midline element is variably mineralized in some basal paravian theropods. Only in derived ornithischians, pterosaurs and birds is further significant hyoid elaboration recorded. Furthermore, only in the latter two taxa does the bony tongue structure include elongation of paired hyobranchial elements that have been associated in functional studies with hyolingual mobility. Ptero-saurs and enantiornithine birds achieve similar elongation and inferred mobility via elongation of ceratobranchial elements while within ornithurine birds, including living Aves, ossified and separate paired epibranchial elements (caudal to the ceratobranchials) confer an increase in hyobranchial length. The mobile tongues seen in living birds may be present in other flighted archosaurs showing a similar elongation. Shifts from hypercarnivory to more diverse feeding ecologies and diets, with the evolution of novel locomotor strategies like flight, may explain the evolution of more complex tongue function.	[Li, Zhiheng; Zhou, Zhonghe] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Li, Zhiheng; Zhou, Zhonghe] CAS Ctr Excellence Life & Paleoenvironm, Beijing, Peoples R China; [Li, Zhiheng; Clarke, Julia A.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Texas System; University of Texas Austin	Clarke, JA (corresponding author), Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA.	Julia_Clarke@jsg.utexas.edu		Li, Zhiheng/0000-0002-6968-6982	Strategic Priority Research Program of Chinese Academy of Sciences [XDB26000000]; Chinese Academy of Sciences [KC 217113]; Craton destruction and terrestrial life evolution CNSF [41688103]; University of Texas at Austin; Smithsonian Institution; Gordon and Betty Moore Foundation [4498]	Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Craton destruction and terrestrial life evolution CNSF; University of Texas at Austin; Smithsonian Institution(Smithsonian Institution); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	The work was supported by the Strategic Priority Research Program of Chinese Academy of Sciences (Grant No. XDB26000000) and the Hundred Talents Program (KC 217113) from Chinese Academy of Sciences (ZL). This work was also supported by Craton destruction and terrestrial life evolution CNSF 41688103 (ZZ), the University of Texas at Austin (ZL and JAC), a Predoctoral Fellowship (ZL) from the Smithsonian Institution, and the Gordon and Betty Moore Foundation Grant No. 4498 (JAC).	BAUM DA, 1991, SYST ZOOL, V40, P1, DOI 10.2307/2992218; Bellairs A, 1970, LIFE REPTILES, V1; Bhullar BAS, 2012, NATURE, V487, P223, DOI 10.1038/nature11146; Bona P, 2011, J MORPHOL, V272, P780, DOI 10.1002/jmor.10894; Bonaparte J.F., 1990, CARNOTAURUS SASTREI; Bonga Tomlinson Carole A., 2000, P359, DOI 10.1016/B978-012632590-4/50012-5; Burton PJK, 1974, B BR MUS NAT HIST, P719; BUSBEY AB, 1989, J MORPHOL, V202, P99, DOI 10.1002/jmor.1052020108; Chiappe LM, 2014, PEERJ, V2, DOI 10.7717/peerj.234; Clarke JA, 2016, NATURE, V538, P502, DOI 10.1038/nature19852; CLEUREN J, 1992, J MORPHOL, V212, P141, DOI 10.1002/jmor.1052120205; Cong L., 1998, GROSS ANATOMY ALLIGA; Diogo R, 2008, J ANAT, V213, P391, DOI 10.1111/j.1469-7580.2008.00953.x; Diogo R, 2000, MUSCLES VERTEBRATES; Edgeworth FH, 1935, CRANIAL MUSCLES VERT; Erdogan S, 2014, ANN ANAT, V196, P75, DOI 10.1016/j.aanat.2013.09.005; Gignac PM, 2016, J ANAT, V228, P889, DOI 10.1111/joa.12449; Hill RV, 2015, ZOOL J LINN SOC-LOND, V175, P892, DOI 10.1111/zoj.12293; Holliday CM, 2009, ANAT REC, V292, P1246, DOI 10.1002/ar.20982; Homberger D. G., 1999, P 22 INT ORN C DURB, P94; HOMBERGER DG, 1989, AM J ANAT, V186, P217, DOI 10.1002/aja.1001860302; Huang RJ, 1999, ANAT EMBRYOL, V200, P137, DOI 10.1007/s004290050268; Jackowiak H, 2011, ANAT REC, V294, P1574, DOI 10.1002/ar.21447; Jackowiak H, 2010, ZOOL SCI, V27, P589, DOI 10.2108/zsj.27.589; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Li ZH, 2016, J EXP ZOOL PART B, V326, P352, DOI 10.1002/jez.b.22692; Li ZH, 2016, EVOL BIOL, V43, P12, DOI 10.1007/s11692-015-9345-4; Li Zhiheng, 2015, BMC Physiology, V15, P5, DOI 10.1186/s12899-015-0019-3; Li ZH, 2015, J ANAT, V227, P45, DOI 10.1111/joa.12320; Lu Jun-chang, 2015, Acta Geoscientica Sinica, V36, P362; Maddison P, 1992, EVOLUTION; Maryaska T., 1977, PALAEONTOLOGIA POLON, V37, P85; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Owerkowicz T, 1999, SCIENCE, V284, P1661, DOI 10.1126/science.284.5420.1661; PATON DC, 1989, AUST J ECOL, V14, P473, DOI 10.1111/j.1442-9993.1989.tb01457.x; Rico-Guevara A, 2011, P NATL ACAD SCI USA, V108, P9356, DOI 10.1073/pnas.1016944108; Riede T, 2006, P NATL ACAD SCI USA, V103, P5543, DOI 10.1073/pnas.0601262103; Riede T, 2015, J EXP BIOL, V218, P991, DOI 10.1242/jeb.117101; RIEPPEL O, 1978, ANAT ANZEIGER, V144, P429; Rubega Margaret, 2000, P395, DOI 10.1016/B978-012632590-4/50013-7; Schumacher G. H., 1973, P101; SCHWENK K, 1986, J MORPHOL, V188, P129, DOI 10.1002/jmor.1051880202; Schwenk K, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P1; Schwenk Kurt, 2000, P3, DOI 10.1016/B978-012632590-4/50002-2; Skieresz-Szewczyk K, 2014, MICRON, V67, P117, DOI 10.1016/j.micron.2014.07.004; SUZUKI M, 1975, JPN J VET SCI, V37, P289; Wang X-L, 2011, CHINESE SCI BULL, V46, P1669; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Xu X, 2014, SCIENCE, V346, P1341, DOI 10.1126/science.1253293; Zhou ZH, 2005, P NATL ACAD SCI USA, V102, P18998, DOI 10.1073/pnas.0507106102; ZWEERS G A, 1974, Netherlands Journal of Zoology, V24, P323	52	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							0198078	10.1371/journal.pone.0198078	http://dx.doi.org/10.1371/journal.pone.0198078			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924798	gold, Green Submitted, Green Published			2022-12-26	WOS:000435655600011
J	Mekonen, A; Ayele, Y; Berhan, Y; Woldeyohannes, D; Erku, W; Sisay, S				Mekonen, Ayehu; Ayele, Yeshi; Berhan, Yifru; Woldeyohannes, Desalegn; Erku, Woldaregay; Sisay, Solomon			Factors which contributed for low quality sputum smears for the detection of acid fast bacilli (AFB) at selected health centers in Ethiopia: A quality control perspective	PLOS ONE			English	Article							MICROSCOPY; ASSURANCE; IMPACT	Objectives Quality of tuberculosis (TB) microscopy diagnosis is not a guarantee despite implementation of External Quality Assurance (EQA) service in all laboratories of health facilities. Hence, we aimed at evaluating the technical quality and the findings of sputum smear microscopy for acid fast bacilli (AFB) at health centers in Hararge Zone, Oromia Region, Ethiopia. Methods A cross-sectional study was carried out between July 8, 2014 and July 7, 2015. A pre-tested structured questionnaire was used to collect data. Lot Quality Assurance Sampling (LQAS) method was put into practice for collecting all necessary sample slides. Data were analyzed by using SPSS (Statistical Package for Social Sciences) version 20 software. P-value < 0.05 was considered as statistically significant. Results Of the total55 health center laboratories which had been assessed during the study period, 20 (36.4%) had major technical errors; 13 (23.6%) had 15 false negative results and 17 (30.9%) had 22 false positive results. Moreover, poor specimen quality, smear size, smear thickness, staining and evenness were indicated in 40 (72.7%), 39 (70.9%), 37 (67.3%), 27 (49.1%) and 37 (67.3%) of the collected samples, respectively. False negative AFB findings were significantly associated with lack of Internal Quality Control (IQC) measures (AOR (Adjusted Odds Ratio): 2.90 (95% CI (Confidence Interval): 1.25,6.75) and poor staining procedures (AOR: 2.16(95% CI: 1.01, 5.11). Conclusions The qualities of AFB smear microscopy reading and smearing were low in most of the laboratories of the health centers. Therefore, it is essential to strength EQA program through building the capacity of laboratory professionals.	[Mekonen, Ayehu] Management Sci Hlth, Addis Ababa, Ethiopia; [Ayele, Yeshi] West HarargheZonal Hlth Dept, TB & HIV Case Team, Chiro, Ethiopia; [Berhan, Yifru] Addis Ababa Univ, Coll Hlth Sci, Addis Ababa, Ethiopia; [Woldeyohannes, Desalegn] Addis Ababa Univ, Coll Hlth Sci, Aklilu Lemma Inst Pathobiol, Dept Anim Hlth & Zoonoses, Addis Ababa, Ethiopia; [Erku, Woldaregay] Addis Ababa Univ, Coll Hlth Sci, Dept Med Microbiol Parasitol & Immunol, Addis Ababa, Ethiopia; [Sisay, Solomon] Fed Minist Hlth, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University; Addis Ababa University; Federal Ministry of Health - Ethiopia (FMOH)	Sisay, S (corresponding author), Fed Minist Hlth, Addis Ababa, Ethiopia.	solomon.sisay@gmail.com		Sisay, Solomon/0000-0003-1965-2837				Ayana Desalegn Admassu, 2015, BMC Res Notes, V8, P537, DOI 10.1186/s13104-015-1478-0; Basra D, 2006, East Afr Med J, V83, P306; Central Statistical Agency, 2008, 2007 POP HOUS CENS E; Ethiopian Health and Nutrition Research Institute Federal Ministry of Health, 2009, GUID QUAL ASS SMEAR; Ethiopian Health and Nutrition ResearchInstitute, 2009, AFB SMEARS MICR MAN; Federal Ministry of Health, 2016, GUID CLIN PROGR MAN; Jha K, 2011, SAARC J TUBER LUNG D, V8, P20; Melese M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151366; Oromia Regional Health Bureau, 2013, TUB ANN REP; Oromia Regional Health Bureau, 2014, TUB ANN REP W HAR ZO; Ozkutuk A, 2009, MIKROBIYOL BUL, V43, P699; Peter TF, 2010, AM J CLIN PATHOL, V134, P550, DOI 10.1309/AJCPH1SKQ1HNWGHF; Selvakumar N, 2005, J CLIN MICROBIOL, V43, P913, DOI 10.1128/JCM.43.2.913-915.2005; Shiferaw MB, 2015, PLOS ONE, V10; Simsek H, 2011, MYCOBACT DIS, V1, P1, DOI [10.4172/2161-1068.1000101, DOI 10.4172/2161-1068.1000101]; Van Rie A, 2008, J CLIN MICROBIOL, V46, P897, DOI 10.1128/JCM.01553-07; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, GUID TREATM TUB; WHO, 2017, GLOB TUB REP; Wu MH, 2009, INT J TUBERC LUNG D, V13, P606	20	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0198947	10.1371/journal.pone.0198947	http://dx.doi.org/10.1371/journal.pone.0198947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ8QS	29924828	Green Published, Green Submitted, gold			2022-12-26	WOS:000435655600038
J	Cheung, T; Lau, JTF; Wang, JZ; Mo, PKH; Ho, YS				Cheung, Teris; Lau, Joseph T. F.; Wang, Johnson Z.; Mo, P. K. H.; Ho, Y. S.			Acceptability of HPV vaccines and associations with perceptions related to HPV and HPV vaccines among male baccalaureate students in Hong Kong	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; HEALTH BELIEF MODEL; ADVISORY-COMMITTEE; GENITAL WARTS; RISK-FACTORS; INFECTION; KNOWLEDGE; MEN; RECOMMENDATIONS; EPIDEMIOLOGY	Objectives The highly infectious human papillomavirus (HPV) causes both genital warts and cervical cancer in women. In 2009, the prevalence of genital warts in Hong Kong was 203.7 per 100,000 person-years. Cervical cancer, more seriously, was the eight most common cancer among women and girls in Hong Kong, accounting for 2.3% of all new cancer cases in females in 2014. Cervical cancer is a significant global public health problem and HPV is a major risk factor leading to the development of cervical cancer. HPV is also the most common sexually transmitted disease among university students. This is the first study to examine the acceptability of HPV vaccines and associations with perceptions related to HPV and HPV vaccines among the male baccalaureate student population locally. Methods A self-administrative cross-sectional survey was used to assess whether male baccalaureate students from eight local Hong Kong universities intended to be immunized for HPV. The study also asked questions concerning how its subjects perceived HPV and HPV vaccines using the Health Belief Model. Data collection spanned from June to September 2015. A multiple stepwise regression model was used to examine associations between cognitive factors and subjects' intention to take up the HPV vaccine. Results A total of 1,004 (83.7%) students aged 18 and 26 participated in this study. 23.3% found vaccinating for HPV acceptable, a level correlating with a number of indicators. Subjects were more likely to find vaccinating acceptable if 1) they knew something about HPV vaccines; 2) they understood that men were susceptible to infection by HPV; 3) they realised they could benefit by HPV vaccination, and 4) they were aware of the arguments for and against HPV vaccination, as disseminated by either the media or peers. Conclusions HPV remains a significant public health concern in Hong Kong and China more broadly. This study's findings show a disconnect between the perceived and actual risk of being infected with the HPV vaccine among male baccalaureate students. This disconnect may be bridged by informing young men of the benefits of their being vaccinated against HPV, by removing the psychological and financial barriers that prevent them from taking up the vaccine and by improving how primary healthcare providers motivate them to get immunized.	[Cheung, Teris; Ho, Y. S.] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Lau, Joseph T. F.; Wang, Johnson Z.; Mo, P. K. H.] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Lau, Joseph T. F.] Zhejiang Univ, Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China; [Lau, Joseph T. F.; Wang, Johnson Z.; Mo, P. K. H.] Chinese Univ Hong Kong, Ctr Hlth Behav Res, Jockey Club Sch Publ & Primary Care, Fac Med, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Chinese University of Hong Kong; Zhejiang University; Chinese University of Hong Kong	Ho, YS (corresponding author), Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China.	janice.ys.ho@polyu.edu.hk	Mo, Phoenix K.H./K-2853-2013; cheung, teris/G-3179-2017	Mo, Phoenix K.H./0000-0001-9822-5424; HO, Yuen-Shan/0000-0002-2557-6554; cheung, teris/0000-0002-5878-9193				Bloem P, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002325; Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013; Bushley AW, 2005, PREV MED, V41, P98, DOI 10.1016/j.ypmed.2004.10.019; Center for Connected Health Policy, 2013, STAT TEL LAWS REIMB, P1; Chiang VCL, 2016, INT J ENV RES PUBLIC, V13; Chor JSY, 2011, VACCINE, V29, P7364, DOI 10.1016/j.vaccine.2011.07.079; Crosby RA, 2012, J AM COLL HEALTH, V60, P8, DOI 10.1080/07448481.2011.552538; Dietz CA, 2011, J AM OSTEOPATH ASSOC, V111, pS19; Ferris DG, 2009, J AM BOARD FAM MED, V22, P34, DOI 10.3122/jabfm.2009.01.080008; Fontenot HB, 2014, J AM COLL HEALTH, V62, P186, DOI 10.1080/07448481.2013.872649; Ford CA, 2004, PERSPECT SEX REPRO H, V36, P258, DOI 10.1363/3625804; Gerend MA, 2009, SEX TRANSM DIS, V36, P58, DOI 10.1097/OLQ.0b013e31818606fc; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Hershey JH, 2009, J PUBLIC HEALTH MAN, V15, P384, DOI 10.1097/PHH.0b013e3181a23de6; Insinga RP, 2003, CLIN INFECT DIS, V36, P1397, DOI 10.1086/375074; Khumsaen N, 2009, J ASSOC NURSE AIDS C, V20, P218, DOI 10.1016/j.jana.2008.12.006; Krawczyk A, 2013, AM J HEALTH EDUC, V44, P26, DOI 10.1080/19325037.2012.749714; Lau JTF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057204; Liddon N, 2010, J ADOLESCENT HEALTH, V46, P113, DOI 10.1016/j.jadohealth.2009.11.199; Lin CQ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-272; MacPhail C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-493; Makwe CC, 2012, J EPIDEMIOL GLOB HEA, V2, P199, DOI 10.1016/j.jegh.2012.11.001; Markowitz LE, 2014, MMWR RECOMM REP, V63, P1; Mays R M, 2000, Health Care Women Int, V21, P361; Mazul AL, 2017, CANCER-AM CANCER SOC, V123, P71, DOI 10.1002/cncr.30312; Mehta P, 2014, INT Q COMMUNITY HEAL, V34, P101, DOI 10.2190/IQ.34.1.h; Minichiello V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-790; Moscicki AB, 2011, J LOW GENIT TRACT DI, V15, P231, DOI 10.1097/LGT.0b013e318203ae61; Nordin JD, 2010, ANN FAM MED, V8, P511, DOI 10.1370/afm.1188; Nyitray A, 2008, J INFECT DIS, V197, P1676, DOI 10.1086/588145; Patel DA, 2013, J AM COLL HEALTH, V61, P336, DOI 10.1080/07448481.2013.811244; Patel H, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-39; Petrosky E, 2015, MMWR-MORBID MORTAL W, V64, P300; Petrovic K, 2011, J HEALTH PSYCHOL, V16, P1198, DOI 10.1177/1359105311402861; Rahman M, 2013, VACCINE, V31, P5495, DOI 10.1016/j.vaccine.2013.09.022; Samkange-Zeeb FN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-727; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Simwale O, 2011, J EPIDEMIOL COMMUN H, V65, pA101, DOI 10.1136/jech.2011.142976d.17; Sundstrom B, 2015, SOC MARK Q, V21, P173, DOI 10.1177/1524500415598984; Verhoeven V, 2010, PATIENT EDUC COUNS, V81, P101, DOI 10.1016/j.pec.2009.12.006; Westra WH, 2009, HEAD NECK PATHOL, V3, P78, DOI 10.1007/s12105-009-0100-y	42	22	23	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198615	10.1371/journal.pone.0198615	http://dx.doi.org/10.1371/journal.pone.0198615			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ6XV	29912883	Green Published, Green Submitted, gold			2022-12-26	WOS:000435528600037
J	Lat, PK; Sen, D				Lat, Prince Kumar; Sen, Dipankar			(C(2)G(4))(n) repeat expansion sequences from the C9orf72 gene form an unusual DNA higher-order structure in the pH range of 5-6	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; HEXANUCLEOTIDE REPEAT; G-QUADRUPLEX; RNA FOCI; INTRAMOLECULAR TRIPLEX; ANTISENSE TRANSCRIPTS; CIRCULAR-DICHROISM; BRAID-LIKE; ALS; PROTEINS	Massive expansion of a DNA hexanucleotide sequence repeat (C(2)G(4)) within the human C9orf72 gene has been linked to a number of neurodegenerative diseases. In sodium or potassium salt solutions, single-stranded d(C(2)G(4))(n) DNAs fold to form G-quadruplexes. We have found that in magnesium or lithium salt solutions, especially under slightly acidic conditions, d(C(2)G(4))(n) oligonucleotides fold to form a distinctive higher order structure whose most striking feature is an "inverted" circular dichroism spectrum, which is distinguishable from the spectrum of the left handed DNA double-helix, Z-DNA. On the basis of CD spectroscopy, gel mobility as well as chemical protection analysis, we propose that this structure, which we call "iCD-DNA", may be a left-handed Hoogsteen base-paired duplex, an unorthodox G-quadruplex/i-motif composite, or a non-canonical, "braided" DNA triplex. Given that iCD-DNA forms under slightly acidic solution conditions, we do not know at this point in time whether or not it forms within living cells.	[Lat, Prince Kumar; Sen, Dipankar] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC, Canada; [Sen, Dipankar] Simon Fraser Univ, Dept Chem, Burnaby, BC, Canada	Simon Fraser University; Simon Fraser University	Sen, D (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC, Canada.; Sen, D (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC, Canada.	sen@sfu.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC).	Asensio JL, 1999, STRUCT FOLD DES, V7, P1, DOI 10.1016/S0969-2126(99)80004-5; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Beck J, 2013, AM J HUM GENET, V92, P345, DOI 10.1016/j.ajhg.2013.01.011; Benabou S, 2014, RSC ADV, V4, P26956, DOI 10.1039/c4ra02129k; Bolli M, 1996, CHEM BIOL, V3, P197, DOI 10.1016/S1074-5521(96)90263-X; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; CHEN FM, 1991, BIOCHEMISTRY-US, V30, P4472, DOI 10.1021/bi00232a014; Chung WJ, 2015, P NATL ACAD SCI USA, V112, P2729, DOI 10.1073/pnas.1418718112; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Devi G, 2015, WIRES RNA, V6, P111, DOI 10.1002/wrna.1261; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Fong JC, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt130; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; Gendron TF, 2014, ACTA NEUROPATHOL, V127, P359, DOI 10.1007/s00401-013-1237-z; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Gitler AD, 2016, BRAIN RES, V1647, P19, DOI 10.1016/j.brainres.2016.04.004; Gomez-Tortosa E, 2013, NEUROLOGY, V80, P366, DOI 10.1212/WNL.0b013e31827f08ea; Gondeau C, 1998, NUCLEIC ACIDS RES, V26, P4996, DOI 10.1093/nar/26.21.4996; Gondeau C, 1998, J BIOMOL STRUCT DYN, V15, P1133, DOI 10.1080/07391102.1998.10509007; Grigg JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106449; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Jain A, 2017, NATURE, V546, P243, DOI 10.1038/nature22386; Jang YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09943; KALKHOFF RK, 1987, ENDOCRINOLOGY, V121, P429, DOI 10.1210/endo-121-1-429; Kendrick S, 2010, PURE APPL CHEM, V82, P1609, DOI 10.1351/PAC-CON-09-09-29; Kettani A, 1998, J MOL BIOL, V282, P619, DOI 10.1006/jmbi.1998.2030; Khomyakova EB, 2000, NUCLEIC ACIDS RES, V28, P3511, DOI 10.1093/nar/28.18.3511; Kovanda A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17944; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Liu CQ, 1995, J THEOR BIOL, V177, P411, DOI 10.1006/jtbi.1995.0257; LYAMICHEV VI, 1988, NUCLEIC ACIDS RES, V16, P2165, DOI 10.1093/nar/16.5.2165; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; Mizielinska S, 2013, ACTA NEUROPATHOL, V126, P845, DOI 10.1007/s00401-013-1200-z; Mori K, 2013, ACTA NEUROPATHOL, V126, P881, DOI 10.1007/s00401-013-1189-3; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Nikolova EN, 2013, J AM CHEM SOC, V135, P6766, DOI 10.1021/ja400994e; PILCH DS, 1991, BIOCHEMISTRY-US, V30, P6083, DOI 10.1021/bi00239a001; PLUM GE, 1990, P NATL ACAD SCI USA, V87, P9436, DOI 10.1073/pnas.87.23.9436; Qin Y, 2008, BIOCHIMIE, V90, P1149, DOI 10.1016/j.biochi.2008.02.020; Reddy K, 2013, J BIOL CHEM, V288, P9860, DOI 10.1074/jbc.C113.452532; Reijenga J, 2013, ANAL CHEM INSIGHTS, V8, P53, DOI 10.4137/ACI.S12304; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Sket P, 2015, NEUROBIOL AGING, V36, P1091, DOI 10.1016/j.neurobiolaging.2014.09.012; STERNS RH, 1981, MEDICINE, V60, P339, DOI 10.1097/00005792-198109000-00002; van Blitterswijk M, 2013, LANCET NEUROL, V12, P978, DOI 10.1016/S1474-4422(13)70210-2; Yang LJ, 1999, J MOL STRUCT, V477, P7, DOI 10.1016/S0022-2860(98)00510-9; Zamiri B, 2015, NUCLEIC ACIDS RES, V43, P10055, DOI 10.1093/nar/gkv1008; Zhou B, 2015, SCI REP-UK, V5, DOI 10.1038/srep16673; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	54	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2018	13	6							e0198418	10.1371/journal.pone.0198418	http://dx.doi.org/10.1371/journal.pone.0198418			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ6XV	29912891	Green Submitted, gold, Green Published			2022-12-26	WOS:000435528600028
J	Chan, TS; Cassim, S; Raymond, VA; Gottschalk, S; Merlen, G; Zwingmann, C; Lapierre, P; Darby, P; Mazer, CD; Bilodeau, M				Chan, Tom S.; Cassim, Shamir; Raymond, Valerie-Ann; Gottschalk, Sven; Merlen, Gregory; Zwingmann, Claudia; Lapierre, Pascal; Darby, Peter; Mazer, Cyril David; Bilodeau, Marc			Upregulation of Krebs cycle and anaerobic glycolysis activity early after onset of liver ischemia	PLOS ONE			English	Article							LEFT PORTAL-VEIN; GLUCOSE-METABOLISM; ENERGY-METABOLISM; ISCHEMIA/REPERFUSION INJURY; MITOCHONDRIAL; HOMEOSTASIS; SUBSTRATE; HYPOXIA; HEPATOCYTES; REPERFUSION	The liver is a highly vascularized organ receiving a dual input of oxygenated blood from the hepatic artery and portal vein. The impact of decreased blood flow on glucose metabolism and how hepatocytes could adapt to this restrictive environment are still unclear. Using the left portal vein ligation (LPVL) rat model, we found that cellular injury was delayed after the onset of liver ischemia. We hypothesized that a metabolic adaptation by hepatocytes to maintain energy homeostasis could account for this lag phase. Liver glucose metabolism was characterized by C-13- and H-1-NMR spectroscopy and analysis of high-energy metabolites. ALT levels and caspase 3 activity in LPVL animals remained normal during the first 12 h following surgery (P<0.05). lschemia rapidly led to decreased intrahepatic tissue oxygen tension and blood flow (P<0.05) and increased expression of Hypoxia-inducible factor 1-alpha. Intrahepatic glucose uptake, ATP/ADP ratio and energy charge level remained stable for up to 12 h after ligation. Entry of glucose in the Krebs cycle was impaired with lowered incorporation of C-13 from [U-13C]glucose into glutamate and succinate from 0.25 to 12 h after LPVL. However, total hepatic succinate and glutamate increased 6 and 12 h after ischemia (P<0.05). Glycolysis was initially reduced (P<0.05) but reached maximum C-13-lactate (P<0.001) and C-13-alanine (P<0.01) enrichments 12 h after LPVL. In conclusion, early liver homeostasis stems from an inherent ability of ischemic hepatocytes to metabolically adapt through increased Krebs cycle and glycolysis activity to preserve bioenergetics and cell viability. This metabolic plasticity of hepatocytes could be harnessed to develop novel metabolic strategies to prevent ischemic liver damage.	[Chan, Tom S.; Cassim, Shamir; Raymond, Valerie-Ann; Gottschalk, Sven; Merlen, Gregory; Lapierre, Pascal; Bilodeau, Marc] Ctr Hosp Univ Montreal, Ctr Rech, Lab Hepatol Cellulaire, Montreal, PQ, Canada; [Zwingmann, Claudia] Univ Montreal, Hop St Luc, Neurosci Res Unit, Montreal, PQ, Canada; [Lapierre, Pascal; Bilodeau, Marc] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Darby, Peter; Mazer, Cyril David] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Dept Anesthesia,Keenan Res Ctr, Toronto, ON, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Bilodeau, M (corresponding author), Ctr Hosp Univ Montreal, Ctr Rech, Lab Hepatol Cellulaire, Montreal, PQ, Canada.; Bilodeau, M (corresponding author), Univ Montreal, Dept Med, Montreal, PQ, Canada.	marc.bilodeau@umontreal.ca	Lapierre, Pascal/ABD-2247-2021; MERLEN, Grégory M/Q-4448-2018; MERLEN, Grégory/ABE-7951-2020	Lapierre, Pascal/0000-0002-2753-3566; MERLEN, Grégory M/0000-0003-1230-5971; MERLEN, Grégory/0000-0003-1230-5971; Cassim, Shamir/0000-0003-1072-5868; Chan, Tom/0000-0001-9691-4349; Mazer, Cyril David/0000-0003-2566-4308				Abt P, 2003, TRANSPLANTATION, V75, P1659, DOI 10.1097/01.TP.0000062574.18648.7C; Alberti K G, 1981, Acta Med Port, P35; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Beyoglu D, 2013, HEPATOLOGY, V58, P229, DOI 10.1002/hep.26350; BIHARI D, 1985, J HEPATOL, V1, P405, DOI 10.1016/S0168-8278(85)80778-9; Bilodeau M, 1999, J HEPATOL, V30, P29, DOI 10.1016/S0168-8278(99)80005-1; Bulkley G B, 1987, Br J Cancer Suppl, V8, P66; Cassim S, 2018, CELL CYCLE, V17, P903, DOI 10.1080/15384101.2018.1460023; Cassim S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190366; Cave AC, 2000, CIRCULATION, V101, P2090, DOI 10.1161/01.CIR.101.17.2090; DILISA F, 1989, MOL CELL BIOCHEM, V88, P169; EBERLI FR, 1991, CIRC RES, V68, P466, DOI 10.1161/01.RES.68.2.466; Ethier C, 2003, AM J PHYSIOL-GASTR L, V285, pG298, DOI 10.1152/ajpgi.00040.2003; FERRARI R, 1993, BASIC RES CARDIOL, V88, P495, DOI 10.1007/BF00795415; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Gautier-Benoit C, 1973, Med Chir Dig, V2, P157; Gomez-Lechon MJ, 2003, CURR DRUG METAB, V4, P292, DOI 10.2174/1389200033489424; Gottschalk S, 2012, APOPTOSIS, V17, P143, DOI 10.1007/s10495-011-0669-y; GRONOW GHJ, 1984, AM J PHYSIOL, V247, pF618, DOI 10.1152/ajprenal.1984.247.4.F618; HARDY L, 1991, BIOCHEM J, V274, P133, DOI 10.1042/bj2740133; HARVEY PRC, 1988, TRANSPLANTATION, V45, P1016, DOI 10.1097/00007890-198806000-00004; Jaeschke H, 2003, GASTROENTEROLOGY, V125, P1246, DOI 10.1016/S0016-5085(03)01209-5; Jassem W, 2002, TRANSPLANTATION, V73, P493, DOI 10.1097/00007890-200202270-00001; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; KAMIYAMA Y, 1977, SURG GYNECOL OBSTET, V145, P33; Krebs H A, 1972, Essays Biochem, V8, P1; LAUTT WW, 1990, GASTROENTEROLOGY, V98, P1024, DOI 10.1016/0016-5085(90)90029-Z; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; NICHOLS JC, 1994, GASTROENTEROLOGY, V106, P168, DOI 10.1016/S0016-5085(94)95147-0; Nowak G, 2002, LIVER TRANSPLANT, V8, P424, DOI 10.1053/jlts.2002.32943; Nozue M, 1997, J SURG ONCOL, V66, P30, DOI 10.1002/(SICI)1096-9098(199709)66:1<30::AID-JSO7>3.0.CO;2-O; Rocheleau B, 1999, AM J PHYSIOL-GASTR L, V277, pG1000, DOI 10.1152/ajpgi.1999.277.5.G1000; ROUSLIN W, 1983, J BIOL CHEM, V258, P9657; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; SANO W, 1995, GASTROENTEROLOGY, V108, P1785, DOI 10.1016/0016-5085(95)90141-8; SCHUMER W, 1979, JAMA-J AM MED ASSOC, V242, P1906; Seifalian AM, 2001, FASEB J, V15, P2642, DOI 10.1096/fj.01-0308com; Selzner M, 2007, LIVER TRANSPLANT, V13, P382, DOI 10.1002/lt.21100; Soucek T, 2003, NEURON, V39, P43, DOI 10.1016/S0896-6273(03)00367-2; Spiegel HU, 2006, J INVEST SURG, V19, P113, DOI 10.1080/08941930600569704; Tanaka M, 1998, HEPATOLOGY, V27, P488, DOI 10.1002/hep.510270224; Theodoraki K, 2006, LIVER TRANSPLANT, V12, P1825, DOI 10.1002/lt.20911; VANDENBERGHE G, 1991, J INHERIT METAB DIS, V14, P407, DOI 10.1007/BF01797914; Vogt AM, 2002, BBA-MOL BASIS DIS, V1586, P219, DOI 10.1016/S0925-4439(01)00100-4; WANLESS IR, 1995, HEPATOLOGY, V21, P1238, DOI 10.1002/hep.1840210505; WATANABE F, 1983, J BIOCHEM-TOKYO, V94, P493, DOI 10.1093/oxfordjournals.jbchem.a134380; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025; Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225	49	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0199177	10.1371/journal.pone.0199177	http://dx.doi.org/10.1371/journal.pone.0199177			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902244	gold, Green Submitted, Green Published			2022-12-26	WOS:000435424900094
J	Koosakulnirand, S; Phokrai, P; Jenjaroen, K; Roberts, RA; Utaisincharoen, P; Dunachie, SJ; Brett, PJ; Burtnick, MN; Chantratita, N				Koosakulnirand, Sirikamon; Phokrai, Phornpun; Jenjaroen, Kemajittra; Roberts, Rosemary A.; Utaisincharoen, Pongsak; Dunachie, Susanna J.; Brett, Paul J.; Burtnick, Mary N.; Chantratita, Narisara			Immune response to recombinant Burkholderia pseudomallei FIiC	PLOS ONE			English	Article							GRAM-NEGATIVE FLAGELLIN; TOLL-LIKE RECEPTORS; T-CELL; BACTERIAL FLAGELLIN; TLR5; MELIOIDOSIS; IMMUNOGENICITY; ACTIVATION; INFECTION; DEFENSE	Burkholderia pseudomallei is a flagellated Gram-negative bacterium which is the causative agent of melioidosis. The disease poses a major public health problem in tropical regions and diabetes is a major risk factor. The high mortality rate of melioidosis is associated with severe sepsis which involves the overwhelming production of pro-inflammatory cytokines. Bacterial flagellar protein (flagellin) activates Toll-like receptor 5 (TLR5)-mediated innate immune signaling pathways and induces adaptive immune response. However, previous studies of TLR5 signaling in melioidosis have been performed using recombinant flagellin from Salmonella Typhimurium instead of B. pseudomallei. This study aimed to investigate human innate immune response and antibody response against a recombinant B. pseudomallei flagellin (rFliC). We prepared B. pseudomallei rFliC and used it to stimulate HEKBlue (TM)-hTLR5 and THP1-Dual (TM) cells to assess TLR5 activation. Subsequently, whole blood stimulation assays with rFliC were performed ex vivo. TLR5-flagellin interactions trigger activation of transcription factor NF-kappa B in HEK-Blue (TM)-hTLR5 cells. Pro-inflammatory cytokine (IL-beta, IL-6, and TNF-alpha) productions from whole blood in response to rFliC differed between fourteen healthy individuals. The levels of these cytokines changed in a dose and time-dependent manner. ELISA was used to determine rFliC-specific antibodies in serum samples from different groups of melioidosis patients and healthy subjects. IgG antibody to rFliC in melioidosis patients with diabetes were higher compared with non-diabetic patients. Our results show that B. pseudomallei flagellin is a potent immune stimulator and that the immune responses to rFliC are different among individuals. This may provide valuable insights toward the potential use of rFliC in vaccine development.	[Koosakulnirand, Sirikamon; Utaisincharoen, Pongsak] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand; [Koosakulnirand, Sirikamon; Phokrai, Phornpun; Chantratita, Narisara] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Jenjaroen, Kemajittra; Dunachie, Susanna J.; Chantratita, Narisara] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Roberts, Rosemary A.; Brett, Paul J.; Burtnick, Mary N.] Univ S Alabama, Dept Microbiol & Immunol, Mobile, AL USA; [Dunachie, Susanna J.] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Brett, Paul J.; Burtnick, Mary N.] Univ Nevada, Reno Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA	Mahidol University; Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of South Alabama; University of Oxford; Nevada System of Higher Education (NSHE); University of Nevada Reno	Chantratita, N (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.; Chantratita, N (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.	narisara@tropmedres.ac	Chantratita, Narisara/P-2169-2019; Phokrai, Phornpun/GQG-9042-2022	Dunachie, Susanna/0000-0001-5665-6293; Chantratita, Narisara/0000-0003-3906-7379	Development and Promotion of Science and Technology Talents Project (DPST), The Royal Thai Government Scholarship, Thailand; National Institute of Allergy and Infectious Diseases/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [U01AI115520]; ICTM grant of the Faculty of Tropical Medicine, Mahidol University; Wellcome Trust [WT1001741Z/12/Z]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI115520] Funding Source: NIH RePORTER	Development and Promotion of Science and Technology Talents Project (DPST), The Royal Thai Government Scholarship, Thailand; National Institute of Allergy and Infectious Diseases/National Institute of Allergy and Infectious Diseases (NIH/NIAID); ICTM grant of the Faculty of Tropical Medicine, Mahidol University; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Development and Promotion of Science and Technology Talents Project (DPST), The Royal Thai Government Scholarship, Thailand to SK. NC was supported by National Institute of Allergy and Infectious Diseases/National Institute of Allergy and Infectious Diseases (NIH/NIAID) (U01AI115520) (https://www.nih.gov) and the ICTM grant of the Faculty of Tropical Medicine, Mahidol University (www.tm.mahidol.ac.th). SJD is grateful for the support of the Wellcome Trust (WT1001741Z/12/Z) (http://www.wellcome.ac.uk). The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aachoui Y, 2015, CELL HOST MICROBE, V18, P320, DOI 10.1016/j.chom.2015.07.016; Brett PJ, 1996, INFECT IMMUN, V64, P2824, DOI 10.1128/IAI.64.7.2824-2828.1996; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; Chaichana P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005587; Chantratita N, 2014, GENES IMMUN, V15, P63, DOI 10.1038/gene.2013.60; Chantratita N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081617; Chen YL, 2007, MICROBIOL IMMUNOL, V51, P81, DOI 10.1111/j.1348-0421.2007.tb03893.x; Chen YS, 2006, INFECT IMMUN, V74, P1699, DOI 10.1128/IAI.74.3.1699-1705.2006; Chen YS, 2006, VACCINE, V24, P750, DOI 10.1016/j.vaccine.2005.08.069; Cookson BT, 1997, J IMMUNOL, V158, P4310; Currie BJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000900; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Figueroa-Santiago O, 2017, ANN CLIN PATHOL, V5; Forstneric V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158894; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Jenjaroen K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004152; Koh GCKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054961; Lankelma JM, 2017, VIRULENCE, V8, P1683, DOI 10.1080/21505594.2017.1307485; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; McSorley SJ, 2000, J IMMUNOL, V164, P986, DOI 10.4049/jimmunol.164.2.986; Mizel SB, 2002, J BIOL CHEM, V277, P22414, DOI 10.1074/jbc.M201762200; Nithichanon A, 2017, IMMUNOLOGY, V151, P98, DOI 10.1111/imm.12709; Nithichanon A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003917; Paksanont S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27356-7; Plumley BA, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00780-16; Pumpuang A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005499; Roux D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189810; Suttisunhakul V, 2016, J CLIN MICROBIOL, V54, P1259, DOI 10.1128/JCM.02856-15; Suwannasaen D, 2011, J INFECT DIS, V203, P1002, DOI 10.1093/infdis/jiq142; Tallant T, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-33; West TE, 2012, GENES IMMUN, V13, P38, DOI 10.1038/gene.2011.49; West TE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003178; West TE, 2013, J IMMUNOL, V190, P3373, DOI 10.4049/jimmunol.1202974; West TE, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-46; Wiersinga WJ, 2007, PLOS MED, V4, P1268, DOI 10.1371/journal.pmed.0040248; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	39	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2018	13	6							e0198906	10.1371/journal.pone.0198906	http://dx.doi.org/10.1371/journal.pone.0198906			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ5MF	29902230	Green Submitted, Green Published, gold			2022-12-26	WOS:000435424900057
